{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Pulling NERs from LLM (openai)\n",
    "\n",
    "##### Date: 11-13-2023\n",
    "##### Author: Tanmayi Balla (tballa@iu.edu)\n",
    "\n",
    "###### Naming Convention for the output files:\n",
    "###### task_names: Abbreviations: ABBR, Named Entities: NER, KeyPhrases: KP\n",
    "###### LLM Responses: \"Management_<model_name>_<task_name>_response.json\"\n",
    "###### Extracted Results: \"Management_<model_name>_<task_name>_results.json\"\n",
    "###### Cleaned Results: \"Management_<model_name>_<task_name>_results_cleaned.json\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "import re\n",
    "import openai\n",
    "import time\n",
    "import json\n",
    "#import datetime\n",
    "import timeout_decorator\n",
    "from langchain.text_splitter import RecursiveCharacterTextSplitter\n",
    "import secret\n",
    "import datetime"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Store all keys in your private `secret.py` file. This file is not synced with GitHub as specified in `.gitignore`."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [],
   "source": [
    "openai.api_key = secret.openai_api_key # \"<Your API-KEY>\"\n",
    "model = \"gpt-4\" # \"gpt-3.5-turbo\"\n",
    "#model = \"gpt-3.5-turbo\"\n",
    "#model = \"gpt-4-1106-preview\"\n",
    "task = 'NER'\n",
    "\n",
    "chunk_ = 1\n",
    "if model in [\"gpt-4-1106-preview\" ]: # , ): #'gpt-4'):\n",
    "    chunk_ = 0"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [],
   "source": [
    "INSTRUCTION = \"\"\" \n",
    "    ## Instructions ##\n",
    "\n",
    "    You are an NLP Expert. \n",
    "\n",
    "    Extract all the Named Entities from the input that belongs to one of the following categories:\n",
    "\n",
    "    {\n",
    "        \"CARDINAL\": \"Cardinal_Number\",\n",
    "        \"DATE\": \"Date\",\n",
    "        \"EVENT\": \"Event\",\n",
    "        \"FAC\": \"Facilities\",\n",
    "        \"GPE\": \"Geopolitical_Entity\",\n",
    "        \"LANGUAGE\": \"Language\",\n",
    "        \"LAW\": \"Law_Document\",\n",
    "        \"LOC\": \"Location\",\n",
    "        \"MONEY\": \"Money\",\n",
    "        \"NORP\": \"Nationalities or religious or political groups\",\n",
    "        \"ORDINAL\": \"Ordinal\",\n",
    "        \"ORG\": \"Organisation\",\n",
    "        \"PERCENT\": \"Percent\",\n",
    "        \"PERSON\": \"Person\",\n",
    "        \"PRODUCT\": \"Product\",\n",
    "        \"QUANTITY\": \"Quantity\",\n",
    "        \"TIME\": \"Time\",\n",
    "        \"WORK_OF_ART\": \"Work_Of_Art\"\n",
    "    }\n",
    "\n",
    "    Display the output only in the form: \n",
    "\n",
    "    DATE:entity1#entity2#.. <new-line> \n",
    "    EVENT:entity1#entity2#...<new-line>.\n",
    "    .\n",
    "    .\n",
    "    .\n",
    "\n",
    "    CARDINAL:entity1#entity2#...<new-line>\n",
    "    If no entities are present for a particular category - that's fine. Do not display that category in the output. Do not extract the entities that doesn’t belong to the category list provided.\n",
    "\n",
    "    Do not make up or guess ANY extra information. Only extract what exactly is in the text.\n",
    "\n",
    "    ### Examples ###\n",
    "    Sample Input: Mary works at Apple and has received $1.5 million for a product launch on Dec 23, 2022, at Cupertino, California, United States. This event took place around 5PM. After the event, Mary reached home by 7PM and she first started reading Hamlet by Shakespeare. Later, she had 2 eggs for dinner and started booking 3 tickets for Paris, to visit the Eiffel Tower, along with Peter and Lisa. She has chosen the Hilton Hotel for her stay. The tickets have reduced her bank balance to 15%.\n",
    "\n",
    "    Expected Results:\n",
    "\n",
    "    {CARDINAL#3#2 \\n\n",
    "    DATE#Dec 23, 2022\\n\n",
    "    EVENT#product launch\\n\n",
    "    FAC#Eiffel Tower#Hilton Hotel\\n\n",
    "    GPE#Paris#United States\\n\n",
    "    LOC#Cupertino#California\\n\n",
    "    MONEY#$1.5 million\\n\n",
    "    ORDINAL#first\\n\n",
    "\n",
    "    ORG#Apple\\n\n",
    "    PERCENT#15%\\n\n",
    "    PERSON#Mary#Shakespeare#Peter#Lisa\\n\n",
    "    QUANTITY#2\\n\n",
    "    TIME#5PM#7PM\\n\n",
    "    WORK_OF_ART#Hamlet\\n}\n",
    "\n",
    "    Note that since there are no entities in the following categories: LANGUAGE, LAW, NORP, and QUANTITY, these categories are not mentioned in the final output.\n",
    "\n",
    "    Do Not forget to enclose all the entities in a single curly braces {}.\n",
    "\n",
    "    ## Input ##\n",
    "\n",
    "\"\"\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [],
   "source": [
    "@timeout_decorator.timeout(200,timeout_exception=StopIteration)\n",
    "def llm_pipeline(x):\n",
    "\n",
    "    prompt = INSTRUCTION + '\\n' + x\n",
    "    response = openai.ChatCompletion.create(\n",
    "        #model = \"gpt-4\",  \n",
    "        model=model,\n",
    "        messages=[\n",
    "            {\"role\": \"user\", \"content\": prompt}\n",
    "        ]\n",
    "    )\n",
    "    print(response)\n",
    "    try:\n",
    "        res = response.choices[0].message.content\n",
    "        return res\n",
    "    except openai.error.RateLimitError:\n",
    "        print(\"RateLimitError\")\n",
    "        return -1\n",
    "    except:\n",
    "        return None"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [],
   "source": [
    "def to_json_ner(x):\n",
    "  categories = [\"DATE\",\"EVENT\",\"FAC\",\"GPE\",\"LANGUAGE\",\"LAW\",\"LOC\",\"MONEY\",\"NORP\",\"ORG\",\"PERCENT\",\"PERSON\",\"PRODUCT\",\"QUANTITY\",\"TIME\",\"WORK_OF_ART\",\"ORDINAL\",\"CARDINAL\"]\n",
    "  x = x.lstrip()\n",
    "  x = x.rstrip()\n",
    "  #lines = x.split('\\n')\n",
    "  entities = []\n",
    "  char_rem = \"{}''\"\"[]#():\"\n",
    "  pattern = \"[\" + re.escape(char_rem) + \"]\"\n",
    "\n",
    "  for category in categories:\n",
    "    while x.find(category) != -1:\n",
    "      x = x.lstrip()\n",
    "      x = x.rstrip()\n",
    "      req_x = x[x.find(category):]\n",
    "      del_x = req_x\n",
    "      if(req_x.find('\\n')!=-1):\n",
    "        del_x = req_x[req_x.find(category):req_x.find('\\n')]\n",
    "        req_x = req_x[req_x.find(category)+len(category)+1:req_x.find('\\n')]\n",
    "      else:\n",
    "        del_x = req_x[req_x.find(category):]\n",
    "        req_x = req_x[req_x.find(category)+len(category)+1:]\n",
    "      x = x.replace(del_x,\"\")\n",
    "      req_x = req_x.lstrip()\n",
    "      req_x = req_x.rstrip()\n",
    "      if(len(req_x) == 0):\n",
    "        continue\n",
    "      items = req_x\n",
    "      if(req_x.find('#')!=-1):\n",
    "        items = req_x.split('#')\n",
    "      else:\n",
    "        items = req_x.split(',')\n",
    "      for itm in items:\n",
    "        if itm.lower() == 'non' or itm.lower() == 'none' or len(itm)==0 or itm == '' or itm == None:\n",
    "          continue\n",
    "        itm = re.sub(pattern, \"\", itm)\n",
    "        itm = itm.lstrip()\n",
    "        itm = itm.rstrip()\n",
    "        tmp_dictionary = {\n",
    "          \"entity\": itm,\"category\":category\n",
    "          }\n",
    "        entities.append(tmp_dictionary)\n",
    "  print(entities)\n",
    "  return entities"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [],
   "source": [
    "def invoke_LLM(input_, chunk_):\n",
    "    docs_rec = []\n",
    "    if(not chunk_):\n",
    "       docs_rec.append(input_)\n",
    "    else:\n",
    "        ## Chunk the input into different segments:\n",
    "        text_splitter_rec = RecursiveCharacterTextSplitter(\n",
    "            chunk_size = 8000,\n",
    "            chunk_overlap  = 20\n",
    "        )\n",
    "        docs_split = text_splitter_rec.create_documents([input_])\n",
    "\n",
    "        for doc in docs_split:\n",
    "            docs_rec.append(doc.page_content)\n",
    "\n",
    "    entities_dictionary = []\n",
    "    responses = []\n",
    "    ## For each document, call the LLM pipeline:\n",
    "    for i in range(0, len(docs_rec)):\n",
    "        print(\"Length of chunks: \", len(docs_rec))\n",
    "        split_input = docs_rec[i]\n",
    "        split_input = split_input.lstrip()\n",
    "        split_input = split_input.rstrip()\n",
    "        response = None\n",
    "        try:\n",
    "            response = llm_pipeline(split_input)\n",
    "        except StopIteration as err:\n",
    "            print(\"Timeout Error, trying again...\")\n",
    "            for i in range(3):\n",
    "                try:\n",
    "                    time.sleep(20)\n",
    "                    response = llm_pipeline(split_input)\n",
    "                except Exception as e:\n",
    "                     print(e, \"Trying again in 20sec...\")\n",
    "            if response == None:\n",
    "                print(\"Tried to call the API 3 times but facing Timeout... Moving on to the next chunk.\")\n",
    "                continue\n",
    "            if response == -1:\n",
    "                return -1,-1\n",
    "        except Exception as e:\n",
    "            print(e, \"Trying again in 20sec...\")\n",
    "            for i in range(3):\n",
    "                try:\n",
    "                    time.sleep(20)\n",
    "                    response = llm_pipeline(split_input)\n",
    "                except Exception as e:\n",
    "                     print(e, \"Trying again in 20sec...\")\n",
    "            if response == None:\n",
    "                print(\"Couldn't process the Task. Moving to next chunk....\")\n",
    "                continue\n",
    "            if response == -1:\n",
    "                return -1,-1\n",
    "        responses.append(response)\n",
    "        entities_dictionary.extend(to_json_ner(response))\n",
    "        time.sleep(25)\n",
    "    return responses,entities_dictionary"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{\n",
      "  \"id\": \"chatcmpl-8RV3CMlEgWlt5U8DyH2nj9MmvuE1Y\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701564906,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#3 \\n\\nDATE#2014#2013 \\n\\nEVENT#diabetes business divestiture \\n\\nFAC#Devens\\n\\nGPE#U.S.#Japan#EU#Ireland#Massachusetts \\n\\nMONEY#$628 million#$348 million#$256 million#$3.5 billion \\n\\nNORP#Japanese \\n\\nORG#Bristol-Myers Squibb Company#Bristol-Myers Squibb#BMS#Opdivo#Eliquis#Hepatitis C Franchise#Daklinza#Sunvepra#Yervoy#Orencia#Sprycel#Abilify#Baraclude \\n\\nPERCENT#3%#36% \\n\\nPERSON#Hodgkin Lymphoma \\n\\nPRODUCT#diabetes \\n\\nWORK_OF_ART#Abilify*}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 1217,\n",
      "    \"completion_tokens\": 169,\n",
      "    \"total_tokens\": 1386\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n"
     ]
    }
   ],
   "source": [
    "## Test sample to invoke LLM:\n",
    "res_N = None\n",
    "try:\n",
    "    res_N = llm_pipeline(\"\"\"Bristol-Myers Squibb Company (which may be referred to as Bristol-Myers Squibb, BMS, the Company, we, our or us) is a global specialty biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.\n",
    "\n",
    "    We continue to evolve our business to a leading diversified specialty biopharma company. The evolution was accelerated as a result of the diabetes business divestiture and continued focus on certain therapeutic areas, including immuno-oncology. The following provides a brief summary of certain key events in 2014 ,as discussed in more detail throughout this report.\n",
    "\n",
    "    Opdivo was approved in the U.S. and Japan for unresectable or metastatic melanoma, and we announced positive results from certain other studies in melanoma, lung, Hodgkin Lymphoma and renal cell carcinoma. Several clinical collaborations were also entered into by us to seek opportunities to strategically combine Opdivo with other targeted agents in more than a dozen tumor types. Eliquis obtained an important label extension in 2014. We received regulatory approvals for our Hepatitis C Franchise, including Daklinza in the EU and our dual regimen of Daklinza and Sunvepra in Japan. Several business development transactions were completed in 2014, to advance our pipeline in other therapeutic areas, including fibrosis and genetically defined diseases. We are also expanding our biologics manufacturing capacity at Devens, Massachusetts and announced plans to build a new facility in Ireland.\n",
    "\n",
    "    Our revenues decreased by 3% in 2014 as a result of the diabetes business divestiture, exclusivity losses and expiration of rights partially offset by higher sales of key products, including recently launched products in certain markets. Our focus to optimize global brands and key markets accelerated growth of several key products. Eliquis sales increased in 2014 by $628 million following its global launch in 2013. Yervoy sales increased by 36%, or $348 million, from continued penetration in the U.S. community-based setting and first line indication and improved access internationally. Hepatitis C Franchise sales were $256 million following launches in Japan and certain EU countries. We expect these products will continue to grow in 2015 along with Orencia, Sprycel and recently launched Opdivo which will partially offset revenue reductions resulting from the expiration of certain rights pertaining to Abilify* in the U.S., royalty and alliance agreements, exclusivity losses for Baraclude in the U.S. and changes in foreign currency rates.\n",
    "\n",
    "    Higher pension and research and development related charges contributed to the reduction of GAAP EPS from $1.54 in 2013 to $1.20 in 2014. Non-GAAP EPS increased from $1.82 to $1.85. Proceeds from the diabetes divestiture increased cash and marketable securities by $3.5 billion.\n",
    "\n",
    "    \"\"\")\n",
    "except StopIteration as err:\n",
    "    print(err) "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{DATE#2014#2013#2015\n",
      "\n",
      "EVENT#diabetes business divestiture\n",
      "\n",
      "GPE#U.S.#Japan#EU#Ireland#Massachusetts\n",
      "\n",
      "MONEY#$628 million#$348 million#$256 million#$3.5 billion#1.54#1.20#1.82#1.85\n",
      "\n",
      "ORG#Bristol-Myers Squibb Company#Bristol-Myers Squibb#BMS#Opdivo#Eliquis#Hepatitis C Franchise#Daklinza#Sunvepra#Yervoy#Orencia#Sprycel#Abilify*#Baraclude\n",
      "\n",
      "PERCENT#3%#36%\n",
      "\n",
      "PRODUCT#Opdivo#Eliquis#Daklinza#Sunvepra#Yervoy#Orencia#Sprycel#Hepatitis C Franchise\n",
      "\n",
      "}\n"
     ]
    }
   ],
   "source": [
    "print(res_N)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{CARDINAL#3%#36%#2013#2014#2015 \n",
      "\n",
      "DATE#2014#2013\n",
      "\n",
      "EVENT#diabetes business divestiture\n",
      "\n",
      "GPE#U.S.#Japan#EU#Devens#Massachusetts#Ireland\n",
      "\n",
      "MONEY#$628 million#$348 million#$256 million#$3.5 billion#1.54#$1.20#$1.82#$1.85\n",
      "\n",
      "ORG#Bristol-Myers Squibb Company#Bristol-Myers Squibb#BMS#Opdivo#Eliquis#Daklinza#Sunvepra#Hepatitis C Franchise#Yervoy#Orencia#Sprycel#Abilify*#Baraclude\n",
      "\n",
      "PERCENT#3%\n",
      "\n",
      "PRODUCT#Eliquis#Yervoy#Hepatitis C Franchise#Opdivo#Orencia#Sprycel#Abilify#Baraclude\n",
      "\n",
      "}\n"
     ]
    }
   ],
   "source": [
    "print(res_N)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[{'entity': '2014', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': 'diabetes business divestiture', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'EU', 'category': 'GPE'}, {'entity': 'Ireland', 'category': 'GPE'}, {'entity': 'Massachusetts', 'category': 'GPE'}, {'entity': '$628 million', 'category': 'MONEY'}, {'entity': '$348 million', 'category': 'MONEY'}, {'entity': '$256 million', 'category': 'MONEY'}, {'entity': '$3.5 billion', 'category': 'MONEY'}, {'entity': '1.54', 'category': 'MONEY'}, {'entity': '1.20', 'category': 'MONEY'}, {'entity': '1.82', 'category': 'MONEY'}, {'entity': '1.85', 'category': 'MONEY'}, {'entity': 'Bristol-Myers Squibb Company', 'category': 'ORG'}, {'entity': 'Bristol-Myers Squibb', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'Hepatitis C Franchise', 'category': 'ORG'}, {'entity': 'Daklinza', 'category': 'ORG'}, {'entity': 'Sunvepra', 'category': 'ORG'}, {'entity': 'Yervoy', 'category': 'ORG'}, {'entity': 'Orencia', 'category': 'ORG'}, {'entity': 'Sprycel', 'category': 'ORG'}, {'entity': 'Abilify*', 'category': 'ORG'}, {'entity': 'Baraclude', 'category': 'ORG'}, {'entity': '3%', 'category': 'PERCENT'}, {'entity': '36%', 'category': 'PERCENT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Eliquis', 'category': 'PRODUCT'}, {'entity': 'Daklinza', 'category': 'PRODUCT'}, {'entity': 'Sunvepra', 'category': 'PRODUCT'}, {'entity': 'Yervoy', 'category': 'PRODUCT'}, {'entity': 'Orencia', 'category': 'PRODUCT'}, {'entity': 'Sprycel', 'category': 'PRODUCT'}, {'entity': 'Hepatitis C Franchise', 'category': 'PRODUCT'}]\n",
      "[{'entity': '2014', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': 'diabetes business divestiture', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'EU', 'category': 'GPE'}, {'entity': 'Ireland', 'category': 'GPE'}, {'entity': 'Massachusetts', 'category': 'GPE'}, {'entity': '$628 million', 'category': 'MONEY'}, {'entity': '$348 million', 'category': 'MONEY'}, {'entity': '$256 million', 'category': 'MONEY'}, {'entity': '$3.5 billion', 'category': 'MONEY'}, {'entity': '1.54', 'category': 'MONEY'}, {'entity': '1.20', 'category': 'MONEY'}, {'entity': '1.82', 'category': 'MONEY'}, {'entity': '1.85', 'category': 'MONEY'}, {'entity': 'Bristol-Myers Squibb Company', 'category': 'ORG'}, {'entity': 'Bristol-Myers Squibb', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'Hepatitis C Franchise', 'category': 'ORG'}, {'entity': 'Daklinza', 'category': 'ORG'}, {'entity': 'Sunvepra', 'category': 'ORG'}, {'entity': 'Yervoy', 'category': 'ORG'}, {'entity': 'Orencia', 'category': 'ORG'}, {'entity': 'Sprycel', 'category': 'ORG'}, {'entity': 'Abilify*', 'category': 'ORG'}, {'entity': 'Baraclude', 'category': 'ORG'}, {'entity': '3%', 'category': 'PERCENT'}, {'entity': '36%', 'category': 'PERCENT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Eliquis', 'category': 'PRODUCT'}, {'entity': 'Daklinza', 'category': 'PRODUCT'}, {'entity': 'Sunvepra', 'category': 'PRODUCT'}, {'entity': 'Yervoy', 'category': 'PRODUCT'}, {'entity': 'Orencia', 'category': 'PRODUCT'}, {'entity': 'Sprycel', 'category': 'PRODUCT'}, {'entity': 'Hepatitis C Franchise', 'category': 'PRODUCT'}]\n"
     ]
    }
   ],
   "source": [
    "print(to_json_ner(res_N))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Extracting the NERs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "/home/damir/Dropbox/Documents/Teaching/2023/L715/l715_23/data/10-Ks/Rocket_Lab_USA_Inc/2022/Management.txt\n",
      "Length of chunks:  8\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RV6Dexpcu0YMzOyd2rEbElLHS1ne\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701565093,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#7#10#109#20#2021#8,000#2029\\n\\nDATE#December 31, 2021#March 2021#August 25, 2021#May 7, 2021#June 25, 2021\\n\\nEVENT#Business Combination#First Merger\\n\\nFAC#International Space Station\\n\\nGPE#United States#Cayman Islands#State of Delaware\\n\\nLAW#Merger Agreement\\n\\nORG#Rocket Lab#Electron#U.S. government#Neutron#Photon#Sinclair Interplanetary#Planetary Systems Corporation#SolAero Holdings#ASI Aerospace LLC#Vector Acquisition Corporation#Vector#Legacy Rocket Lab#Nasdaq\\n\\nPERSON#Management\\n\\nPRODUCT#3D printed electric turbo-pump rocket engines#fully carbon composite first stage fuel tanks#a private orbital launch complex#a rocket stage#Merger Sub#Merger Agreement#Vector Delaware\\n\\nWORK_OF_ART#Annual Report on Form 10-K#\\u201cRisk Factors\\u201d#\\u201cCautionary Note Regarding Forward-Looking Statements}\\n\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2036,\n",
      "    \"completion_tokens\": 223,\n",
      "    \"total_tokens\": 2259\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': 'March 2021', 'category': 'DATE'}, {'entity': 'August 25, 2021', 'category': 'DATE'}, {'entity': 'May 7, 2021', 'category': 'DATE'}, {'entity': 'June 25, 2021', 'category': 'DATE'}, {'entity': 'Business Combination', 'category': 'EVENT'}, {'entity': 'First Merger', 'category': 'EVENT'}, {'entity': 'International Space Station', 'category': 'FAC'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'Cayman Islands', 'category': 'GPE'}, {'entity': 'State of Delaware', 'category': 'GPE'}, {'entity': 'Merger Agreement', 'category': 'LAW'}, {'entity': 'Rocket Lab', 'category': 'ORG'}, {'entity': 'Electron', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'Neutron', 'category': 'ORG'}, {'entity': 'Photon', 'category': 'ORG'}, {'entity': 'Sinclair Interplanetary', 'category': 'ORG'}, {'entity': 'Planetary Systems Corporation', 'category': 'ORG'}, {'entity': 'SolAero Holdings', 'category': 'ORG'}, {'entity': 'ASI Aerospace LLC', 'category': 'ORG'}, {'entity': 'Vector Acquisition Corporation', 'category': 'ORG'}, {'entity': 'Vector', 'category': 'ORG'}, {'entity': 'Legacy Rocket Lab', 'category': 'ORG'}, {'entity': 'Nasdaq', 'category': 'ORG'}, {'entity': 'Management', 'category': 'PERSON'}, {'entity': '3D printed electric turbo-pump rocket engines', 'category': 'PRODUCT'}, {'entity': 'fully carbon composite first stage fuel tanks', 'category': 'PRODUCT'}, {'entity': 'a private orbital launch complex', 'category': 'PRODUCT'}, {'entity': 'a rocket stage', 'category': 'PRODUCT'}, {'entity': 'Merger Sub', 'category': 'PRODUCT'}, {'entity': 'Merger Agreement', 'category': 'PRODUCT'}, {'entity': 'Vector Delaware', 'category': 'PRODUCT'}, {'entity': 'Annual Report on Form 10-K', 'category': 'WORK_OF_ART'}, {'entity': '“Risk Factors”', 'category': 'WORK_OF_ART'}, {'entity': '“Cautionary Note Regarding Forward-Looking Statements', 'category': 'WORK_OF_ART'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '109', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '2021', 'category': 'CARDINAL'}, {'entity': '8,000', 'category': 'CARDINAL'}, {'entity': '2029', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  8\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RV6klxg7QJwyaNciMWDjtHREAdFv\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701565126,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#100\\n\\nDATE#October 12, 2021#December 31, 2021#October 12, 2021#November 15, 2021#November 30, 2021#December 10, 2021#January 18, 2022#December 2019#January 30, 2020#March 11, 2020#December 2, 2021 \\n\\nEVENT#First Merger#Second Merger#Business Combination#the Domestication#COVID-19 \\n\\nFAC#Rocket Lab USA, Inc.\\n\\nGPE#Vector Delaware#USA#Wuhan#China#United States#New Zealand#Auckland \\n\\nLAW#ASI Purchase Agreement#PSC Merger Agreement#SolAero Merger Agreement \\n\\nMONEY#$40 million#$5.5 million#approximately $42 million#$80 million#$3.6 million\\n\\nNORP#American \\n\\nORG#Legacy Rocket Lab#Vector#ASI Aerospace LLC#Willis Vern Holdings, Inc.#Vector Acquisition Corporation#Rocket Lab USA, Inc.#Post Combination Company#Platinum Merger Sub, Inc.#Planetary Systems Corporation#Supernova Acquisition Corp.#SolAero Holdings, Inc.#Fortis Advisors LLC#World Health Organization\\n\\nPERSON#John A. Cuseo#Michael Whalen \\n\\nPRODUCT#ASI#PSC Acquisition#SolAero Acquisition \\n\\nWORK_OF_ART#COVID-19 }\\n\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2200,\n",
      "    \"completion_tokens\": 297,\n",
      "    \"total_tokens\": 2497\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'October 12, 2021', 'category': 'DATE'}, {'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': 'October 12, 2021', 'category': 'DATE'}, {'entity': 'November 15, 2021', 'category': 'DATE'}, {'entity': 'November 30, 2021', 'category': 'DATE'}, {'entity': 'December 10, 2021', 'category': 'DATE'}, {'entity': 'January 18, 2022', 'category': 'DATE'}, {'entity': 'December 2019', 'category': 'DATE'}, {'entity': 'January 30, 2020', 'category': 'DATE'}, {'entity': 'March 11, 2020', 'category': 'DATE'}, {'entity': 'December 2, 2021', 'category': 'DATE'}, {'entity': 'First Merger', 'category': 'EVENT'}, {'entity': 'Second Merger', 'category': 'EVENT'}, {'entity': 'Business Combination', 'category': 'EVENT'}, {'entity': 'the Domestication', 'category': 'EVENT'}, {'entity': 'COVID-19', 'category': 'EVENT'}, {'entity': 'Rocket Lab USA', 'category': 'FAC'}, {'entity': 'Inc.', 'category': 'FAC'}, {'entity': 'Vector Delaware', 'category': 'GPE'}, {'entity': 'USA', 'category': 'GPE'}, {'entity': 'Wuhan', 'category': 'GPE'}, {'entity': 'China', 'category': 'GPE'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'New Zealand', 'category': 'GPE'}, {'entity': 'Auckland', 'category': 'GPE'}, {'entity': 'ASI Purchase Agreement', 'category': 'LAW'}, {'entity': 'PSC Merger Agreement', 'category': 'LAW'}, {'entity': 'SolAero Merger Agreement', 'category': 'LAW'}, {'entity': '$40 million', 'category': 'MONEY'}, {'entity': '$5.5 million', 'category': 'MONEY'}, {'entity': 'approximately $42 million', 'category': 'MONEY'}, {'entity': '$80 million', 'category': 'MONEY'}, {'entity': '$3.6 million', 'category': 'MONEY'}, {'entity': 'American', 'category': 'NORP'}, {'entity': 'Legacy Rocket Lab', 'category': 'ORG'}, {'entity': 'Vector', 'category': 'ORG'}, {'entity': 'ASI Aerospace LLC', 'category': 'ORG'}, {'entity': 'Willis Vern Holdings, Inc.', 'category': 'ORG'}, {'entity': 'Vector Acquisition Corporation', 'category': 'ORG'}, {'entity': 'Rocket Lab USA, Inc.', 'category': 'ORG'}, {'entity': 'Post Combination Company', 'category': 'ORG'}, {'entity': 'Platinum Merger Sub, Inc.', 'category': 'ORG'}, {'entity': 'Planetary Systems Corporation', 'category': 'ORG'}, {'entity': 'Supernova Acquisition Corp.', 'category': 'ORG'}, {'entity': 'SolAero Holdings, Inc.', 'category': 'ORG'}, {'entity': 'Fortis Advisors LLC', 'category': 'ORG'}, {'entity': 'World Health Organization', 'category': 'ORG'}, {'entity': 'John A. Cuseo', 'category': 'PERSON'}, {'entity': 'Michael Whalen', 'category': 'PERSON'}, {'entity': 'ASI', 'category': 'PRODUCT'}, {'entity': 'PSC Acquisition', 'category': 'PRODUCT'}, {'entity': 'SolAero Acquisition', 'category': 'PRODUCT'}, {'entity': 'COVID-19', 'category': 'WORK_OF_ART'}, {'entity': '100', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  8\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RV7JvKbIEzEVsVTq9fpfPxoiFUUu\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701565161,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#20#109#100#8#2020#8#2021#seven#2020#six#2021#62.2#35.2#77#$8.1#5.5#9.2#6.5#$241.5#60#12\\n\\nDATE#December 31, 2021#2020#2021#December 31, 2021#2020#December 31, 2021#2020#December 31, 2021\\n\\nEVENT#COVID-19 shutdowns#COVID-19 restrictions#COVID-19 Considerations#COVID-19 shutdowns#COVID-19 restrictions#COVID-19 Considerations#COVID-19 impacts\\n\\nFAC#Moon#Mars#Venus\\n\\nGPE#\\n\\nLANGUAGE#\\n\\nLAW#\\n\\nLOC#\\n\\nMONEY#\\n\\nNORP#\\n\\nORDINAL#\\n\\nORG#Electron#Photon#Neutron\\n\\nPERCENT#\\n\\nPERSON#Business Combination\\n\\nPRODUCT#launch services#space systems services#spacecraft components#launch vehicle#launch vehicles#launch services#spacecraft constellation missions#spacecraft components#products#products#services#launch vehicles#launch vehicles#launch vehicles#launch vehicles#products#services#launch service#Revenue\\n\\nQUANTITY#\\n\\nTIME#\\n\\nWORK_OF_ART#}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2038,\n",
      "    \"completion_tokens\": 268,\n",
      "    \"total_tokens\": 2306\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': 'COVID-19 shutdowns', 'category': 'EVENT'}, {'entity': 'COVID-19 restrictions', 'category': 'EVENT'}, {'entity': 'COVID-19 Considerations', 'category': 'EVENT'}, {'entity': 'COVID-19 shutdowns', 'category': 'EVENT'}, {'entity': 'COVID-19 restrictions', 'category': 'EVENT'}, {'entity': 'COVID-19 Considerations', 'category': 'EVENT'}, {'entity': 'COVID-19 impacts', 'category': 'EVENT'}, {'entity': 'Moon', 'category': 'FAC'}, {'entity': 'Mars', 'category': 'FAC'}, {'entity': 'Venus', 'category': 'FAC'}, {'entity': 'Electron', 'category': 'ORG'}, {'entity': 'Photon', 'category': 'ORG'}, {'entity': 'Neutron', 'category': 'ORG'}, {'entity': 'Business Combination', 'category': 'PERSON'}, {'entity': 'launch services', 'category': 'PRODUCT'}, {'entity': 'space systems services', 'category': 'PRODUCT'}, {'entity': 'spacecraft components', 'category': 'PRODUCT'}, {'entity': 'launch vehicle', 'category': 'PRODUCT'}, {'entity': 'launch vehicles', 'category': 'PRODUCT'}, {'entity': 'launch services', 'category': 'PRODUCT'}, {'entity': 'spacecraft constellation missions', 'category': 'PRODUCT'}, {'entity': 'spacecraft components', 'category': 'PRODUCT'}, {'entity': 'products', 'category': 'PRODUCT'}, {'entity': 'products', 'category': 'PRODUCT'}, {'entity': 'services', 'category': 'PRODUCT'}, {'entity': 'launch vehicles', 'category': 'PRODUCT'}, {'entity': 'launch vehicles', 'category': 'PRODUCT'}, {'entity': 'launch vehicles', 'category': 'PRODUCT'}, {'entity': 'launch vehicles', 'category': 'PRODUCT'}, {'entity': 'products', 'category': 'PRODUCT'}, {'entity': 'services', 'category': 'PRODUCT'}, {'entity': 'launch service', 'category': 'PRODUCT'}, {'entity': 'Revenue', 'category': 'PRODUCT'}, {'entity': '', 'category': 'WORK_OF_ART'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '109', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': '2020', 'category': 'CARDINAL'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': '2021', 'category': 'CARDINAL'}, {'entity': 'seven', 'category': 'CARDINAL'}, {'entity': '2020', 'category': 'CARDINAL'}, {'entity': 'six', 'category': 'CARDINAL'}, {'entity': '2021', 'category': 'CARDINAL'}, {'entity': '62.2', 'category': 'CARDINAL'}, {'entity': '35.2', 'category': 'CARDINAL'}, {'entity': '77', 'category': 'CARDINAL'}, {'entity': '$8.1', 'category': 'CARDINAL'}, {'entity': '5.5', 'category': 'CARDINAL'}, {'entity': '9.2', 'category': 'CARDINAL'}, {'entity': '6.5', 'category': 'CARDINAL'}, {'entity': '$241.5', 'category': 'CARDINAL'}, {'entity': '60', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  8\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RV7rgTqVCCvfO6BcYryAMk2y18D4\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701565195,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#60#1,021#118#103#134\\n\\nDATE#Years Ended December 31,20212020#Years Ended December 31, 2021#the year ended December 31, 2021#the year ended December 31, 2020#the year ended December 31, 2021#the year ended December 31, 2020#the year ended December 31, 2021#the year ended December 31, 2020#the year ended December 31, 2021#the year ended December 31, 2020#the year ended December 31, 2021#the year ended December 31, 2020\\n\\nMONEY#$ 62,237100.0 %$ 35,160100.0 %#$64,130103.0 %46,977133.6 %#$1,893(3.0)%(11,817)(33.6)%#$41,76567.1 %19,14254.4 %#$58,39593.8 %23,99368.2 %#$100,160160.9 %43,135122.6 %#$(102,053)(163.9)%(54,952)(156.2)%#$(6,128)(9.8)%2240.6%#$(567)(0.9)%2,4206.9 %#$(15,294)(24.6)%(2,417)(6.9)%#$(798)(1.3)%1870.5 %#$(22,787)(36.6)%4141.1 %#$(124,840)(200.5)%(54,538)(155.1)%#$7,52012.1 %(467)(1.3)%#$(117,320)(188.4)%$(55,005)(156.4)%#$62,237$ 35,160$ 27,077\\t77 %#$ 39.0 million#$5.9 million#18%#$23.3 million#$21.2 million#1,021%#$ 64,130$ 46,977$ 17,15337 %#9.6 million\\n\\nORG#Business Combination#Neutron#Research and Development\\n\\nPERCENT#100.0 #%103.0 %#133.6 %#(3.0)%#(33.6)%#67.1 %54.4 %#93.8 %68.2 %#160.9 %122.6 %#(163.9)%#(9.8)%0.6%#(0.9)%6.9 %#(24.6)%#(1.3)%0.5 %#(36.6)%1.1 %#(200.5)%#12.1 %#(188.4)%#(156.4)%#77 %#18%#1,021%#37 %\\n\\nPERSON#COVID-19#COVID-19}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2342,\n",
      "    \"completion_tokens\": 624,\n",
      "    \"total_tokens\": 2966\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'Years Ended December 31,20212020', 'category': 'DATE'}, {'entity': 'Years Ended December 31, 2021', 'category': 'DATE'}, {'entity': 'the year ended December 31, 2021', 'category': 'DATE'}, {'entity': 'the year ended December 31, 2020', 'category': 'DATE'}, {'entity': 'the year ended December 31, 2021', 'category': 'DATE'}, {'entity': 'the year ended December 31, 2020', 'category': 'DATE'}, {'entity': 'the year ended December 31, 2021', 'category': 'DATE'}, {'entity': 'the year ended December 31, 2020', 'category': 'DATE'}, {'entity': 'the year ended December 31, 2021', 'category': 'DATE'}, {'entity': 'the year ended December 31, 2020', 'category': 'DATE'}, {'entity': 'the year ended December 31, 2021', 'category': 'DATE'}, {'entity': 'the year ended December 31, 2020', 'category': 'DATE'}, {'entity': '$ 62,237100.0 %$ 35,160100.0 %', 'category': 'MONEY'}, {'entity': '$64,130103.0 %46,977133.6 %', 'category': 'MONEY'}, {'entity': '$1,8933.0%11,81733.6%', 'category': 'MONEY'}, {'entity': '$41,76567.1 %19,14254.4 %', 'category': 'MONEY'}, {'entity': '$58,39593.8 %23,99368.2 %', 'category': 'MONEY'}, {'entity': '$100,160160.9 %43,135122.6 %', 'category': 'MONEY'}, {'entity': '$102,053163.9%54,952156.2%', 'category': 'MONEY'}, {'entity': '$6,1289.8%2240.6%', 'category': 'MONEY'}, {'entity': '$5670.9%2,4206.9 %', 'category': 'MONEY'}, {'entity': '$15,29424.6%2,4176.9%', 'category': 'MONEY'}, {'entity': '$7981.3%1870.5 %', 'category': 'MONEY'}, {'entity': '$22,78736.6%4141.1 %', 'category': 'MONEY'}, {'entity': '$124,840200.5%54,538155.1%', 'category': 'MONEY'}, {'entity': '$7,52012.1 %4671.3%', 'category': 'MONEY'}, {'entity': '$117,320188.4%$55,005156.4%', 'category': 'MONEY'}, {'entity': '$62,237$ 35,160$ 27,077\\t77 %', 'category': 'MONEY'}, {'entity': '$ 39.0 million', 'category': 'MONEY'}, {'entity': '$5.9 million', 'category': 'MONEY'}, {'entity': '18%', 'category': 'MONEY'}, {'entity': '$23.3 million', 'category': 'MONEY'}, {'entity': '$21.2 million', 'category': 'MONEY'}, {'entity': '1,021%', 'category': 'MONEY'}, {'entity': '$ 64,130$ 46,977$ 17,15337 %', 'category': 'MONEY'}, {'entity': '9.6 million', 'category': 'MONEY'}, {'entity': 'Business Combination', 'category': 'ORG'}, {'entity': 'Neutron', 'category': 'ORG'}, {'entity': 'Research and Development', 'category': 'ORG'}, {'entity': '100.0', 'category': 'PERCENT'}, {'entity': '%103.0 %', 'category': 'PERCENT'}, {'entity': '133.6 %', 'category': 'PERCENT'}, {'entity': '3.0%', 'category': 'PERCENT'}, {'entity': '33.6%', 'category': 'PERCENT'}, {'entity': '67.1 %54.4 %', 'category': 'PERCENT'}, {'entity': '93.8 %68.2 %', 'category': 'PERCENT'}, {'entity': '160.9 %122.6 %', 'category': 'PERCENT'}, {'entity': '163.9%', 'category': 'PERCENT'}, {'entity': '9.8%0.6%', 'category': 'PERCENT'}, {'entity': '0.9%6.9 %', 'category': 'PERCENT'}, {'entity': '24.6%', 'category': 'PERCENT'}, {'entity': '1.3%0.5 %', 'category': 'PERCENT'}, {'entity': '36.6%1.1 %', 'category': 'PERCENT'}, {'entity': '200.5%', 'category': 'PERCENT'}, {'entity': '12.1 %', 'category': 'PERCENT'}, {'entity': '188.4%', 'category': 'PERCENT'}, {'entity': '156.4%', 'category': 'PERCENT'}, {'entity': '77 %', 'category': 'PERCENT'}, {'entity': '18%', 'category': 'PERCENT'}, {'entity': '1,021%', 'category': 'PERCENT'}, {'entity': '37 %', 'category': 'PERCENT'}, {'entity': 'COVID-19', 'category': 'PERSON'}, {'entity': 'COVID-19', 'category': 'PERSON'}, {'entity': '60', 'category': 'CARDINAL'}, {'entity': '1,021', 'category': 'CARDINAL'}, {'entity': '118', 'category': 'CARDINAL'}, {'entity': '103', 'category': 'CARDINAL'}, {'entity': '134', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  8\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RV8h1TvLJPjB8GsP0tvtEChAKOqZ\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701565247,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#58395#23993#34402143#344#196#6.4#2836#567#24202987#123#3.0#15294#241712877#533#12.9#798#187985#527#1.0500#7.5#0.5#6.0#0.9#691.0#100.1#2.8#100#15#121689#1.28#35 \\n\\nDATE#December 31, 2021#December 31, 2020#December 31, 2020#December 31, 2020#Years Ended December 31#December 31, 2020#Years Ended December 31#December 31, 2020#December 31, 2021, 2022#December 31, 2021#December 31, 2022#since inception#December 31, 2021#the next twelve months#June 10, 2021#June 1, 2024#December 31, 2021#December 31, 2021#December 31, 2021#December 23, 2020#May 13, 2021 \\n\\n\\nEVENT#Product launch \\n\\nMONEY#34.4 million#19.6 million#6.4 million#3.0 million#12.9 million#7.5 million#691.0 million#100 million#100.1 million#2.8 million \\n\\n\\nORG#Business Combination#Net Years Ended#U.S.#Business Combination#change in fair value of liability classified warrants#Hercules#SVB#Hercules Capital, Inc.#the Hercules Capital Secured Term Loan#assets of the Company#Company#Loan and Security Agreement#Silicon Valley Bank#common stock#Revolving Line and Term Loan Line  \\n\\nPERCENT#143%#2,836%#123%#533%#527%#1,710%#6.0%\\n\\nPERSON#Hercules \\n\\nPRODUCT#Our primary requirements \\n\\nTIME#monthly in arrears \\n\\nWORK_OF_ART#our capital stock }\\n\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2330,\n",
      "    \"completion_tokens\": 453,\n",
      "    \"total_tokens\": 2783\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'Years Ended December 31', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'Years Ended December 31', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'December 31, 2021, 2022', 'category': 'DATE'}, {'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': 'December 31, 2022', 'category': 'DATE'}, {'entity': 'since inception', 'category': 'DATE'}, {'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': 'the next twelve months', 'category': 'DATE'}, {'entity': 'June 10, 2021', 'category': 'DATE'}, {'entity': 'June 1, 2024', 'category': 'DATE'}, {'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': 'December 23, 2020', 'category': 'DATE'}, {'entity': 'May 13, 2021', 'category': 'DATE'}, {'entity': 'Product launch', 'category': 'EVENT'}, {'entity': '34.4 million', 'category': 'MONEY'}, {'entity': '19.6 million', 'category': 'MONEY'}, {'entity': '6.4 million', 'category': 'MONEY'}, {'entity': '3.0 million', 'category': 'MONEY'}, {'entity': '12.9 million', 'category': 'MONEY'}, {'entity': '7.5 million', 'category': 'MONEY'}, {'entity': '691.0 million', 'category': 'MONEY'}, {'entity': '100 million', 'category': 'MONEY'}, {'entity': '100.1 million', 'category': 'MONEY'}, {'entity': '2.8 million', 'category': 'MONEY'}, {'entity': 'Business Combination', 'category': 'ORG'}, {'entity': 'Net Years Ended', 'category': 'ORG'}, {'entity': 'U.S.', 'category': 'ORG'}, {'entity': 'Business Combination', 'category': 'ORG'}, {'entity': 'change in fair value of liability classified warrants', 'category': 'ORG'}, {'entity': 'Hercules', 'category': 'ORG'}, {'entity': 'SVB', 'category': 'ORG'}, {'entity': 'Hercules Capital, Inc.', 'category': 'ORG'}, {'entity': 'the Hercules Capital Secured Term Loan', 'category': 'ORG'}, {'entity': 'assets of the Company', 'category': 'ORG'}, {'entity': 'Company', 'category': 'ORG'}, {'entity': 'Loan and Security Agreement', 'category': 'ORG'}, {'entity': 'Silicon Valley Bank', 'category': 'ORG'}, {'entity': 'common stock', 'category': 'ORG'}, {'entity': 'Revolving Line and Term Loan Line', 'category': 'ORG'}, {'entity': '143%', 'category': 'PERCENT'}, {'entity': '2,836%', 'category': 'PERCENT'}, {'entity': '123%', 'category': 'PERCENT'}, {'entity': '533%', 'category': 'PERCENT'}, {'entity': '527%', 'category': 'PERCENT'}, {'entity': '1,710%', 'category': 'PERCENT'}, {'entity': '6.0%', 'category': 'PERCENT'}, {'entity': 'Hercules', 'category': 'PERSON'}, {'entity': 'Our primary requirements', 'category': 'PRODUCT'}, {'entity': 'monthly in arrears', 'category': 'TIME'}, {'entity': 'our capital stock', 'category': 'WORK_OF_ART'}, {'entity': '58395', 'category': 'CARDINAL'}, {'entity': '23993', 'category': 'CARDINAL'}, {'entity': '34402143', 'category': 'CARDINAL'}, {'entity': '344', 'category': 'CARDINAL'}, {'entity': '196', 'category': 'CARDINAL'}, {'entity': '6.4', 'category': 'CARDINAL'}, {'entity': '2836', 'category': 'CARDINAL'}, {'entity': '567', 'category': 'CARDINAL'}, {'entity': '24202987', 'category': 'CARDINAL'}, {'entity': '123', 'category': 'CARDINAL'}, {'entity': '3.0', 'category': 'CARDINAL'}, {'entity': '15294', 'category': 'CARDINAL'}, {'entity': '241712877', 'category': 'CARDINAL'}, {'entity': '533', 'category': 'CARDINAL'}, {'entity': '12.9', 'category': 'CARDINAL'}, {'entity': '798', 'category': 'CARDINAL'}, {'entity': '187985', 'category': 'CARDINAL'}, {'entity': '527', 'category': 'CARDINAL'}, {'entity': '1.0500', 'category': 'CARDINAL'}, {'entity': '7.5', 'category': 'CARDINAL'}, {'entity': '0.5', 'category': 'CARDINAL'}, {'entity': '6.0', 'category': 'CARDINAL'}, {'entity': '0.9', 'category': 'CARDINAL'}, {'entity': '691.0', 'category': 'CARDINAL'}, {'entity': '100.1', 'category': 'CARDINAL'}, {'entity': '2.8', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '15', 'category': 'CARDINAL'}, {'entity': '121689', 'category': 'CARDINAL'}, {'entity': '1.28', 'category': 'CARDINAL'}, {'entity': '35', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  8\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RV9POsFuLqTj764RCzZVirMjlNES\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701565291,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#$15 million#$15 million#117.3 million#$53.5 million#$8.0 million#$32.6 million#$15.3 million#$10.9 million#$12.7 million#$10.5 million#$7.8 million#$28.1 million#$66.4 million#$25.7 million#$799.9 million#$728.3 million#$98.9 million#$3.1 million#$30.4 million \\n\\nDATE#2021#June 10, 2021#Years Ended December 31,2021#2020#the year ended December 31, 2021#the year ended December 31, 2021#the year ended December 31, 2021\\n\\nEVENT#Business Combination\\n\\nFAC#Launch Complex 1\\n\\nGPE#Long Beach#California#Mahia#New Zealand#Auckland#New Zealand\\n\\nLAW#Loan and Security Agreement#Loan and Security Agreement\\n\\nMONEY#$15 million#$15 million#$71,791#$27,757#$92,134#$37,329#$799,939#$21,478#2,128#$153#$638,142#$43,761#$71.8 million#$117.3 million#$53.5 million#$8.0 million#$32.6 million#$15.3 million#$10.9 million#$12.7 million#$10.5 million#$7.8 million#$28.1 million#$92.1 million#$66.4 million#$25.7 million#$799.9 million#$728.3 million#$98.9 million#$3.1 million#$30.4 million\\n\\nORG#Hercules Capital#ASI#PSC#Vector\\n\\nPERSON#Curie\\n\\nPRODUCT#PIPE\\n\\nQUANTITY#second\\n\\nWORK_OF_ART#Annual Report on Form 10-K}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2076,\n",
      "    \"completion_tokens\": 381,\n",
      "    \"total_tokens\": 2457\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': '2021', 'category': 'DATE'}, {'entity': 'June 10, 2021', 'category': 'DATE'}, {'entity': 'Years Ended December 31,2021', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': 'the year ended December 31, 2021', 'category': 'DATE'}, {'entity': 'the year ended December 31, 2021', 'category': 'DATE'}, {'entity': 'the year ended December 31, 2021', 'category': 'DATE'}, {'entity': 'Business Combination', 'category': 'EVENT'}, {'entity': 'Launch Complex 1', 'category': 'FAC'}, {'entity': 'Long Beach', 'category': 'GPE'}, {'entity': 'California', 'category': 'GPE'}, {'entity': 'Mahia', 'category': 'GPE'}, {'entity': 'New Zealand', 'category': 'GPE'}, {'entity': 'Auckland', 'category': 'GPE'}, {'entity': 'New Zealand', 'category': 'GPE'}, {'entity': 'Loan and Security Agreement', 'category': 'LAW'}, {'entity': 'Loan and Security Agreement', 'category': 'LAW'}, {'entity': '$15 million', 'category': 'MONEY'}, {'entity': '$15 million', 'category': 'MONEY'}, {'entity': '$71,791', 'category': 'MONEY'}, {'entity': '$27,757', 'category': 'MONEY'}, {'entity': '$92,134', 'category': 'MONEY'}, {'entity': '$37,329', 'category': 'MONEY'}, {'entity': '$799,939', 'category': 'MONEY'}, {'entity': '$21,478', 'category': 'MONEY'}, {'entity': '2,128', 'category': 'MONEY'}, {'entity': '$153', 'category': 'MONEY'}, {'entity': '$638,142', 'category': 'MONEY'}, {'entity': '$43,761', 'category': 'MONEY'}, {'entity': '$71.8 million', 'category': 'MONEY'}, {'entity': '$117.3 million', 'category': 'MONEY'}, {'entity': '$53.5 million', 'category': 'MONEY'}, {'entity': '$8.0 million', 'category': 'MONEY'}, {'entity': '$32.6 million', 'category': 'MONEY'}, {'entity': '$15.3 million', 'category': 'MONEY'}, {'entity': '$10.9 million', 'category': 'MONEY'}, {'entity': '$12.7 million', 'category': 'MONEY'}, {'entity': '$10.5 million', 'category': 'MONEY'}, {'entity': '$7.8 million', 'category': 'MONEY'}, {'entity': '$28.1 million', 'category': 'MONEY'}, {'entity': '$92.1 million', 'category': 'MONEY'}, {'entity': '$66.4 million', 'category': 'MONEY'}, {'entity': '$25.7 million', 'category': 'MONEY'}, {'entity': '$799.9 million', 'category': 'MONEY'}, {'entity': '$728.3 million', 'category': 'MONEY'}, {'entity': '$98.9 million', 'category': 'MONEY'}, {'entity': '$3.1 million', 'category': 'MONEY'}, {'entity': '$30.4 million', 'category': 'MONEY'}, {'entity': 'Hercules Capital', 'category': 'ORG'}, {'entity': 'ASI', 'category': 'ORG'}, {'entity': 'PSC', 'category': 'ORG'}, {'entity': 'Vector', 'category': 'ORG'}, {'entity': 'Curie', 'category': 'PERSON'}, {'entity': 'PIPE', 'category': 'PRODUCT'}, {'entity': 'second', 'category': 'QUANTITY'}, {'entity': 'Annual Report on Form 10-K', 'category': 'WORK_OF_ART'}, {'entity': '$15 million', 'category': 'CARDINAL'}, {'entity': '$15 million', 'category': 'CARDINAL'}, {'entity': '117.3 million', 'category': 'CARDINAL'}, {'entity': '$53.5 million', 'category': 'CARDINAL'}, {'entity': '$8.0 million', 'category': 'CARDINAL'}, {'entity': '$32.6 million', 'category': 'CARDINAL'}, {'entity': '$15.3 million', 'category': 'CARDINAL'}, {'entity': '$10.9 million', 'category': 'CARDINAL'}, {'entity': '$12.7 million', 'category': 'CARDINAL'}, {'entity': '$10.5 million', 'category': 'CARDINAL'}, {'entity': '$7.8 million', 'category': 'CARDINAL'}, {'entity': '$28.1 million', 'category': 'CARDINAL'}, {'entity': '$66.4 million', 'category': 'CARDINAL'}, {'entity': '$25.7 million', 'category': 'CARDINAL'}, {'entity': '$799.9 million', 'category': 'CARDINAL'}, {'entity': '$728.3 million', 'category': 'CARDINAL'}, {'entity': '$98.9 million', 'category': 'CARDINAL'}, {'entity': '$3.1 million', 'category': 'CARDINAL'}, {'entity': '$30.4 million', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  8\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVA39gCYIpqHwfAqjNnG8FqMyi9r\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701565331,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#12-month#one-year#90-days#ten years\\n\\nDATE#August 2021\\n\\nEVENT#Business Combination\\n\\nGPE#U.S.\\n\\nLAW#stock compensation plan#employee equity incentive plan\\n\\nMONEY#zero\\n\\nORG#Stock-based Compensation ExpenseOur#Business Combination#employee equity incentive plans\\n\\nPERSON#Black-Scholes\\n\\nPRODUCT#spacecraft#space software\\n\\nTIME#succeeding 12-month period\\n\\nWORK_OF_ART#Business Combination}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 1990,\n",
      "    \"completion_tokens\": 99,\n",
      "    \"total_tokens\": 2089\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'August 2021', 'category': 'DATE'}, {'entity': 'Business Combination', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'stock compensation plan', 'category': 'LAW'}, {'entity': 'employee equity incentive plan', 'category': 'LAW'}, {'entity': 'zero', 'category': 'MONEY'}, {'entity': 'Stock-based Compensation ExpenseOur', 'category': 'ORG'}, {'entity': 'Business Combination', 'category': 'ORG'}, {'entity': 'employee equity incentive plans', 'category': 'ORG'}, {'entity': 'Black-Scholes', 'category': 'PERSON'}, {'entity': 'spacecraft', 'category': 'PRODUCT'}, {'entity': 'space software', 'category': 'PRODUCT'}, {'entity': 'succeeding 12-month period', 'category': 'TIME'}, {'entity': 'Business Combination', 'category': 'WORK_OF_ART'}, {'entity': '12-month', 'category': 'CARDINAL'}, {'entity': 'one-year', 'category': 'CARDINAL'}, {'entity': '90-days', 'category': 'CARDINAL'}, {'entity': 'ten years', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  8\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVAWCKoUcQsTVtPSnpplM6UJ4WqW\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701565360,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{LAW#ASC 815-40, Derivatives and Hedging\\n\\nORG#Consolidated Statements of Operations and Comprehensive Loss}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 715,\n",
      "    \"completion_tokens\": 29,\n",
      "    \"total_tokens\": 744\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'ASC 815-40', 'category': 'LAW'}, {'entity': 'Derivatives and Hedging', 'category': 'LAW'}, {'entity': 'Consolidated Statements of Operations and Comprehensive Loss', 'category': 'ORG'}]\n",
      "/home/damir/Dropbox/Documents/Teaching/2023/L715/l715_23/data/10-Ks/Aerojet_Rocketdyne_Holdings_Inc./2016/Management.txt\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVAxmuBUJ21AiJd9eeBroxyzpwqP\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701565387,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#7#10#2#8#1#1A#1#6#8#2#8#1#0.5#3.1#7.8#1.3#2.9#1.2#1.5#0.3#0.3#3.0#5.0#1#2#11,500#2015#1,708.3#1,602.2#16.2#0.27#50.0#0.86#217.9#12.8#181.5#11.3#200.1#152.8#65.1#150.6#28.3#107.2#2.4#2.2#4.1#3.1#440.9#516.3#30 \\n\\nDATE#first nine months of fiscal 2015#Fiscal 2014#Fiscal 2013#fiscal 2015#fiscal 2014#November 30, 2015#November 30, 2014#fiscal 2013#first quarter of fiscal 2013#first quarter of fiscal 2015#2013 calendar#First nine months of fiscal 2015#Fiscal 2014#Fiscal 2013 \\n\\nEVENT#Restatement#financial highlights\\n\\nFAC#U.S. Highway 50 \\n\\nGPE#United States of America#Rancho Cordova#Folsom#California#Sacramento \\n\\nLAW#Form 10-K\\n\\nMONEY#$1,708.3 million#$1,602.2 million#$16.2 million#$50.0 million#$217.9 million#$181.5 million#$200.1 million#$152.8 million#$65.1 million#$150.6 million#$28.3 million#$107.2 million#$2.4 billion#$2.2 billion#$4.1 billion#$3.1 billion#$440.9 million#$516.3 million\\n\\nORG#Aerojet Rocketdyne Holdings, Inc.#GAAP#Aerojet Rocketdyne#DoD#NASA#Easton#Non-GAAP\\n\\nPERCENT#15%\\n\\nPERSON#\\n\\nPRODUCT# \\n\\nQUANTITY#\\n\\nTIME#14 weeks#13 weeks\\n\\nWORK_OF_ART#Management\\u2019s Discussion and Analysis of Financial Condition and Results of Operations}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2391,\n",
      "    \"completion_tokens\": 494,\n",
      "    \"total_tokens\": 2885\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'first nine months of fiscal 2015', 'category': 'DATE'}, {'entity': 'Fiscal 2014', 'category': 'DATE'}, {'entity': 'Fiscal 2013', 'category': 'DATE'}, {'entity': 'fiscal 2015', 'category': 'DATE'}, {'entity': 'fiscal 2014', 'category': 'DATE'}, {'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'fiscal 2013', 'category': 'DATE'}, {'entity': 'first quarter of fiscal 2013', 'category': 'DATE'}, {'entity': 'first quarter of fiscal 2015', 'category': 'DATE'}, {'entity': '2013 calendar', 'category': 'DATE'}, {'entity': 'First nine months of fiscal 2015', 'category': 'DATE'}, {'entity': 'Fiscal 2014', 'category': 'DATE'}, {'entity': 'Fiscal 2013', 'category': 'DATE'}, {'entity': 'Restatement', 'category': 'EVENT'}, {'entity': 'financial highlights', 'category': 'EVENT'}, {'entity': 'U.S. Highway 50', 'category': 'FAC'}, {'entity': 'United States of America', 'category': 'GPE'}, {'entity': 'Rancho Cordova', 'category': 'GPE'}, {'entity': 'Folsom', 'category': 'GPE'}, {'entity': 'California', 'category': 'GPE'}, {'entity': 'Sacramento', 'category': 'GPE'}, {'entity': 'Form 10-K', 'category': 'LAW'}, {'entity': '$1,708.3 million', 'category': 'MONEY'}, {'entity': '$1,602.2 million', 'category': 'MONEY'}, {'entity': '$16.2 million', 'category': 'MONEY'}, {'entity': '$50.0 million', 'category': 'MONEY'}, {'entity': '$217.9 million', 'category': 'MONEY'}, {'entity': '$181.5 million', 'category': 'MONEY'}, {'entity': '$200.1 million', 'category': 'MONEY'}, {'entity': '$152.8 million', 'category': 'MONEY'}, {'entity': '$65.1 million', 'category': 'MONEY'}, {'entity': '$150.6 million', 'category': 'MONEY'}, {'entity': '$28.3 million', 'category': 'MONEY'}, {'entity': '$107.2 million', 'category': 'MONEY'}, {'entity': '$2.4 billion', 'category': 'MONEY'}, {'entity': '$2.2 billion', 'category': 'MONEY'}, {'entity': '$4.1 billion', 'category': 'MONEY'}, {'entity': '$3.1 billion', 'category': 'MONEY'}, {'entity': '$440.9 million', 'category': 'MONEY'}, {'entity': '$516.3 million', 'category': 'MONEY'}, {'entity': 'Aerojet Rocketdyne Holdings, Inc.', 'category': 'ORG'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': 'DoD', 'category': 'ORG'}, {'entity': 'NASA', 'category': 'ORG'}, {'entity': 'Easton', 'category': 'ORG'}, {'entity': 'Non-GAAP', 'category': 'ORG'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': '14 weeks', 'category': 'TIME'}, {'entity': '13 weeks', 'category': 'TIME'}, {'entity': 'Management’s Discussion and Analysis of Financial Condition and Results of Operations', 'category': 'WORK_OF_ART'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1A', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '0.5', 'category': 'CARDINAL'}, {'entity': '3.1', 'category': 'CARDINAL'}, {'entity': '7.8', 'category': 'CARDINAL'}, {'entity': '1.3', 'category': 'CARDINAL'}, {'entity': '2.9', 'category': 'CARDINAL'}, {'entity': '1.2', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '0.3', 'category': 'CARDINAL'}, {'entity': '0.3', 'category': 'CARDINAL'}, {'entity': '3.0', 'category': 'CARDINAL'}, {'entity': '5.0', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '11,500', 'category': 'CARDINAL'}, {'entity': '2015', 'category': 'CARDINAL'}, {'entity': '1,708.3', 'category': 'CARDINAL'}, {'entity': '1,602.2', 'category': 'CARDINAL'}, {'entity': '16.2', 'category': 'CARDINAL'}, {'entity': '0.27', 'category': 'CARDINAL'}, {'entity': '50.0', 'category': 'CARDINAL'}, {'entity': '0.86', 'category': 'CARDINAL'}, {'entity': '217.9', 'category': 'CARDINAL'}, {'entity': '12.8', 'category': 'CARDINAL'}, {'entity': '181.5', 'category': 'CARDINAL'}, {'entity': '11.3', 'category': 'CARDINAL'}, {'entity': '200.1', 'category': 'CARDINAL'}, {'entity': '152.8', 'category': 'CARDINAL'}, {'entity': '65.1', 'category': 'CARDINAL'}, {'entity': '150.6', 'category': 'CARDINAL'}, {'entity': '28.3', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '2.4', 'category': 'CARDINAL'}, {'entity': '2.2', 'category': 'CARDINAL'}, {'entity': '4.1', 'category': 'CARDINAL'}, {'entity': '3.1', 'category': 'CARDINAL'}, {'entity': '440.9', 'category': 'CARDINAL'}, {'entity': '516.3', 'category': 'CARDINAL'}, {'entity': '30', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVBf3NJUHQX2eEyYszz38mzDyUCs\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701565431,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#27.8#550#411#550#55#50#14#2015#28#23#20#17#33#19#25#18#11#11#10#90#92#95#14#12#22#13#12#3 \\n\\nDATE#first quarter of fiscal 2013#January 20, 2016#July 2012#June 12, 2013#June 14, 2013#June 14, 2015#fiscal 2013#Year Ended 2013#Year Ended 2015#Year Ended 2014#fiscal 2015#fiscal 2014#fiscal 2013#Budget Control Act of 2011#Bipartisan Budget Act of 2013#GFY 2014#GFY 2015#November 2015#Bipartisan Budget Act of 2015#GFY 2016#GFY 2017 \\n\\nEVENT#RDA Acquisition#Acquisition#Standard Missile program#THAAD program \\n\\nFAC#\\n\\nGPE#U.S.#Russia \\n\\nLOC#\\n\\nMONEY#$27.8 million#$550 million#$411 million#$55 million#$1,378.1#$1,757.7#$162.9#$25.7#$2.68#$0.42#$2.05#$0.41#$1,529.2#$1,478.6#$1,305.9#$1.1 trillion#$514.1 billion \\n\\nNORP#Russian \\n\\nORDINAL#first \\n\\nORG#UTC#Rocketdyne Business#RD Amross#NPO Energomash of Khimki#NASA#Missile Defense Agency#Lockheed Martin#Raytheon#ULA#DoD \\n\\nPERCENT#50%#29%#28%#23%#20%#17%#33%#19%#25%#18%#11%#10%#90%#92%#95%#14%#12%#22%#13% \\n\\nPERSON#\\n\\nPRODUCT#\\n\\nQUANTITY#\\n\\nTIME#\\n\\nWORK_OF_ART#Budget Control Act}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2369,\n",
      "    \"completion_tokens\": 451,\n",
      "    \"total_tokens\": 2820\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'first quarter of fiscal 2013', 'category': 'DATE'}, {'entity': 'January 20, 2016', 'category': 'DATE'}, {'entity': 'July 2012', 'category': 'DATE'}, {'entity': 'June 12, 2013', 'category': 'DATE'}, {'entity': 'June 14, 2013', 'category': 'DATE'}, {'entity': 'June 14, 2015', 'category': 'DATE'}, {'entity': 'fiscal 2013', 'category': 'DATE'}, {'entity': 'Year Ended 2013', 'category': 'DATE'}, {'entity': 'Year Ended 2015', 'category': 'DATE'}, {'entity': 'Year Ended 2014', 'category': 'DATE'}, {'entity': 'fiscal 2015', 'category': 'DATE'}, {'entity': 'fiscal 2014', 'category': 'DATE'}, {'entity': 'fiscal 2013', 'category': 'DATE'}, {'entity': 'Budget Control Act of 2011', 'category': 'DATE'}, {'entity': 'Bipartisan Budget Act of 2013', 'category': 'DATE'}, {'entity': 'GFY 2014', 'category': 'DATE'}, {'entity': 'GFY 2015', 'category': 'DATE'}, {'entity': 'November 2015', 'category': 'DATE'}, {'entity': 'Bipartisan Budget Act of 2015', 'category': 'DATE'}, {'entity': 'GFY 2016', 'category': 'DATE'}, {'entity': 'GFY 2017', 'category': 'DATE'}, {'entity': 'RDA Acquisition', 'category': 'EVENT'}, {'entity': 'Acquisition', 'category': 'EVENT'}, {'entity': 'Standard Missile program', 'category': 'EVENT'}, {'entity': 'THAAD program', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Russia', 'category': 'GPE'}, {'entity': '$27.8 million', 'category': 'MONEY'}, {'entity': '$550 million', 'category': 'MONEY'}, {'entity': '$411 million', 'category': 'MONEY'}, {'entity': '$55 million', 'category': 'MONEY'}, {'entity': '$1,378.1', 'category': 'MONEY'}, {'entity': '$1,757.7', 'category': 'MONEY'}, {'entity': '$162.9', 'category': 'MONEY'}, {'entity': '$25.7', 'category': 'MONEY'}, {'entity': '$2.68', 'category': 'MONEY'}, {'entity': '$0.42', 'category': 'MONEY'}, {'entity': '$2.05', 'category': 'MONEY'}, {'entity': '$0.41', 'category': 'MONEY'}, {'entity': '$1,529.2', 'category': 'MONEY'}, {'entity': '$1,478.6', 'category': 'MONEY'}, {'entity': '$1,305.9', 'category': 'MONEY'}, {'entity': '$1.1 trillion', 'category': 'MONEY'}, {'entity': '$514.1 billion', 'category': 'MONEY'}, {'entity': 'Russian', 'category': 'NORP'}, {'entity': 'UTC', 'category': 'ORG'}, {'entity': 'Rocketdyne Business', 'category': 'ORG'}, {'entity': 'RD Amross', 'category': 'ORG'}, {'entity': 'NPO Energomash of Khimki', 'category': 'ORG'}, {'entity': 'NASA', 'category': 'ORG'}, {'entity': 'Missile Defense Agency', 'category': 'ORG'}, {'entity': 'Lockheed Martin', 'category': 'ORG'}, {'entity': 'Raytheon', 'category': 'ORG'}, {'entity': 'ULA', 'category': 'ORG'}, {'entity': 'DoD', 'category': 'ORG'}, {'entity': '50%', 'category': 'PERCENT'}, {'entity': '29%', 'category': 'PERCENT'}, {'entity': '28%', 'category': 'PERCENT'}, {'entity': '23%', 'category': 'PERCENT'}, {'entity': '20%', 'category': 'PERCENT'}, {'entity': '17%', 'category': 'PERCENT'}, {'entity': '33%', 'category': 'PERCENT'}, {'entity': '19%', 'category': 'PERCENT'}, {'entity': '25%', 'category': 'PERCENT'}, {'entity': '18%', 'category': 'PERCENT'}, {'entity': '11%', 'category': 'PERCENT'}, {'entity': '10%', 'category': 'PERCENT'}, {'entity': '90%', 'category': 'PERCENT'}, {'entity': '92%', 'category': 'PERCENT'}, {'entity': '95%', 'category': 'PERCENT'}, {'entity': '14%', 'category': 'PERCENT'}, {'entity': '12%', 'category': 'PERCENT'}, {'entity': '22%', 'category': 'PERCENT'}, {'entity': '13%', 'category': 'PERCENT'}, {'entity': 'Budget Control Act', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '27.8', 'category': 'CARDINAL'}, {'entity': '550', 'category': 'CARDINAL'}, {'entity': '411', 'category': 'CARDINAL'}, {'entity': '550', 'category': 'CARDINAL'}, {'entity': '55', 'category': 'CARDINAL'}, {'entity': '50', 'category': 'CARDINAL'}, {'entity': '14', 'category': 'CARDINAL'}, {'entity': '2015', 'category': 'CARDINAL'}, {'entity': '28', 'category': 'CARDINAL'}, {'entity': '23', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '17', 'category': 'CARDINAL'}, {'entity': '33', 'category': 'CARDINAL'}, {'entity': '19', 'category': 'CARDINAL'}, {'entity': '25', 'category': 'CARDINAL'}, {'entity': '18', 'category': 'CARDINAL'}, {'entity': '11', 'category': 'CARDINAL'}, {'entity': '11', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '90', 'category': 'CARDINAL'}, {'entity': '92', 'category': 'CARDINAL'}, {'entity': '95', 'category': 'CARDINAL'}, {'entity': '14', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '22', 'category': 'CARDINAL'}, {'entity': '13', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVCK4DLeMiTKefzGluvGHx5B1dbA\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701565472,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#58.6#12.8#7.7#19.3#1.3#2016#2012#2014#500#110#145#2019#43#27#40#0.8#2.6 \\n\\nDATE#January 2012#fiscal 2019#July 2015\\n\\nEVENT#CIP#CST-100 Starliner\\n\\nFAC#Aerojet Rocketdyne - Sacramento#Aerojet Rocketdyne - BPOU\\n\\nGPE#U.S.#Russian\\n\\nLAW#NASA Authorization Act\\n\\nMONEY#$19.3 billion#$1.3 billion#$110 million#$145 million#$43 million#$27 million#$40 million#$0.8 million#$2.6 million\\n\\nNORP#Russian\\n\\nORG#DoD#NASA#NASA GFY 2016#Congress#U.S. space program#SLS#Aerojet Rocketdyne#Boeing#ISS#SpaceX#Blue Origin\\n\\nPERSON#Missile Defense#Space#Nuclear Deterrence\\n\\nPRODUCT#Aerojet Rocketdyne propulsion#SLS vehicle#space taxi\\n\\nQUANTITY#four years\\n\\nTIME#\\n\\nWORK_OF_ART#Competitive Improvement Program}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2262,\n",
      "    \"completion_tokens\": 259,\n",
      "    \"total_tokens\": 2521\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'January 2012', 'category': 'DATE'}, {'entity': 'fiscal 2019', 'category': 'DATE'}, {'entity': 'July 2015', 'category': 'DATE'}, {'entity': 'CIP', 'category': 'EVENT'}, {'entity': 'CST-100 Starliner', 'category': 'EVENT'}, {'entity': 'Aerojet Rocketdyne - Sacramento', 'category': 'FAC'}, {'entity': 'Aerojet Rocketdyne - BPOU', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Russian', 'category': 'GPE'}, {'entity': 'NASA Authorization Act', 'category': 'LAW'}, {'entity': '$19.3 billion', 'category': 'MONEY'}, {'entity': '$1.3 billion', 'category': 'MONEY'}, {'entity': '$110 million', 'category': 'MONEY'}, {'entity': '$145 million', 'category': 'MONEY'}, {'entity': '$43 million', 'category': 'MONEY'}, {'entity': '$27 million', 'category': 'MONEY'}, {'entity': '$40 million', 'category': 'MONEY'}, {'entity': '$0.8 million', 'category': 'MONEY'}, {'entity': '$2.6 million', 'category': 'MONEY'}, {'entity': 'Russian', 'category': 'NORP'}, {'entity': 'DoD', 'category': 'ORG'}, {'entity': 'NASA', 'category': 'ORG'}, {'entity': 'NASA GFY 2016', 'category': 'ORG'}, {'entity': 'Congress', 'category': 'ORG'}, {'entity': 'U.S. space program', 'category': 'ORG'}, {'entity': 'SLS', 'category': 'ORG'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': 'Boeing', 'category': 'ORG'}, {'entity': 'ISS', 'category': 'ORG'}, {'entity': 'SpaceX', 'category': 'ORG'}, {'entity': 'Blue Origin', 'category': 'ORG'}, {'entity': 'Missile Defense', 'category': 'PERSON'}, {'entity': 'Space', 'category': 'PERSON'}, {'entity': 'Nuclear Deterrence', 'category': 'PERSON'}, {'entity': 'Aerojet Rocketdyne propulsion', 'category': 'PRODUCT'}, {'entity': 'SLS vehicle', 'category': 'PRODUCT'}, {'entity': 'space taxi', 'category': 'PRODUCT'}, {'entity': 'four years', 'category': 'QUANTITY'}, {'entity': 'Competitive Improvement Program', 'category': 'WORK_OF_ART'}, {'entity': '58.6', 'category': 'CARDINAL'}, {'entity': '12.8', 'category': 'CARDINAL'}, {'entity': '7.7', 'category': 'CARDINAL'}, {'entity': '19.3', 'category': 'CARDINAL'}, {'entity': '1.3', 'category': 'CARDINAL'}, {'entity': '2016', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '500', 'category': 'CARDINAL'}, {'entity': '110', 'category': 'CARDINAL'}, {'entity': '145', 'category': 'CARDINAL'}, {'entity': '2019', 'category': 'CARDINAL'}, {'entity': '43', 'category': 'CARDINAL'}, {'entity': '27', 'category': 'CARDINAL'}, {'entity': '40', 'category': 'CARDINAL'}, {'entity': '0.8', 'category': 'CARDINAL'}, {'entity': '2.6', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVCtfOpXRT71AgeEffg86LUbxYGv\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701565507,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#68.7#652.0#751.5#23#83#1#9#2015#1,708.3#1,602.2#1,378.1#1,459.5#1,406.2#1,234.3#32.1#49.0#65.1#1.9#50.0#17.4#1,675.0#33.3#19.6#12.8#50.1#52.6#48.5#16.8#33.0#35.7#0.3#16.3#17.1#49.3#162.7#0.9#0.7#0.2#16.2#50.0#162.9#1,708.3#1,602.2#106.1#1,602.2#1,378.1#224.1#84.3#80.3#42.0#109.7#681.9#311.8#71.9#27.8#1,459.5#1,406.2#53.3#1,406.2#1,234.3#171.9#85.4#87.8#82.5#86.0#1,409.0#1,377.8#31.2#1,377.8#1,187.9#189.9#0.3#3.2#2.9#3.2#2.2#1.0#50.2#25.2#25.0#25.2#44.2#19.0#1,459.5#1,406.2#53.3#1,406.2#1,234.3#171.9#550#30.6#1.8\\n\\nDATE#November 30, 2015#November 30, 2015#fiscal 2016#November 30, 2015#Year Ended 2015#2014#2013#Year Ended 2014#2013#Year Ended 2015#2014#Year Ended 2014#2013\\n\\nEVENT#RS-25 program#Orion program#J-2X program#THAAD and Standard Missile programs#The Rocketdyne Business#Antares AJ-26 program#Standard Missile-3 Block IB contract#the TDACS#Standard Missile-3 Block IIA contract#Standard Missile-1 Regrain contract#T3 IIA and IIB contracts#the Antares program#retirement benefit assets#PPA#Aerojet Rocketdyne#Orbital Sciences Corporation\\n\\nGPE#U.S.#U.S.#U.S.#U.S.#U.S.#Sacramento\\n\\nMONEY#$23 million#approximately $30.6 million\\n\\nORG#Northrop#the U.S. government#Northrop#our U.S.#Note 9(c)#d#our U.S. government contracts#Aerojet Rocketdyne#the SLS development program#Orion program#the Standard Missile#AJ60#THAAD#Orion#the IRS#PPA#the \\u201cAgreement\\u201d\\n\\nPERCENT#83%\\n\\nPERSON#Sacramento Land#Antares AJ-26\\n\\nPRODUCT#RS-25#J-2X#AJ-26\\n\\nTIME#first quarter \\n\\nWORK_OF_ART#The Rocketdyne Business}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2785,\n",
      "    \"completion_tokens\": 733,\n",
      "    \"total_tokens\": 3518\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': 'fiscal 2016', 'category': 'DATE'}, {'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': 'Year Ended 2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': 'Year Ended 2014', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': 'Year Ended 2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': 'Year Ended 2014', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': 'RS-25 program', 'category': 'EVENT'}, {'entity': 'Orion program', 'category': 'EVENT'}, {'entity': 'J-2X program', 'category': 'EVENT'}, {'entity': 'THAAD and Standard Missile programs', 'category': 'EVENT'}, {'entity': 'The Rocketdyne Business', 'category': 'EVENT'}, {'entity': 'Antares AJ-26 program', 'category': 'EVENT'}, {'entity': 'Standard Missile-3 Block IB contract', 'category': 'EVENT'}, {'entity': 'the TDACS', 'category': 'EVENT'}, {'entity': 'Standard Missile-3 Block IIA contract', 'category': 'EVENT'}, {'entity': 'Standard Missile-1 Regrain contract', 'category': 'EVENT'}, {'entity': 'T3 IIA and IIB contracts', 'category': 'EVENT'}, {'entity': 'the Antares program', 'category': 'EVENT'}, {'entity': 'retirement benefit assets', 'category': 'EVENT'}, {'entity': 'PPA', 'category': 'EVENT'}, {'entity': 'Aerojet Rocketdyne', 'category': 'EVENT'}, {'entity': 'Orbital Sciences Corporation', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Sacramento', 'category': 'GPE'}, {'entity': '$23 million', 'category': 'MONEY'}, {'entity': 'approximately $30.6 million', 'category': 'MONEY'}, {'entity': 'Northrop', 'category': 'ORG'}, {'entity': 'the U.S. government', 'category': 'ORG'}, {'entity': 'Northrop', 'category': 'ORG'}, {'entity': 'our U.S.', 'category': 'ORG'}, {'entity': 'Note 9c', 'category': 'ORG'}, {'entity': 'd', 'category': 'ORG'}, {'entity': 'our U.S. government contracts', 'category': 'ORG'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': 'the SLS development program', 'category': 'ORG'}, {'entity': 'Orion program', 'category': 'ORG'}, {'entity': 'the Standard Missile', 'category': 'ORG'}, {'entity': 'AJ60', 'category': 'ORG'}, {'entity': 'THAAD', 'category': 'ORG'}, {'entity': 'Orion', 'category': 'ORG'}, {'entity': 'the IRS', 'category': 'ORG'}, {'entity': 'PPA', 'category': 'ORG'}, {'entity': 'the “Agreement”', 'category': 'ORG'}, {'entity': '83%', 'category': 'PERCENT'}, {'entity': 'Sacramento Land', 'category': 'PERSON'}, {'entity': 'Antares AJ-26', 'category': 'PERSON'}, {'entity': 'RS-25', 'category': 'PRODUCT'}, {'entity': 'J-2X', 'category': 'PRODUCT'}, {'entity': 'AJ-26', 'category': 'PRODUCT'}, {'entity': 'first quarter', 'category': 'TIME'}, {'entity': 'The Rocketdyne Business', 'category': 'WORK_OF_ART'}, {'entity': '68.7', 'category': 'CARDINAL'}, {'entity': '652.0', 'category': 'CARDINAL'}, {'entity': '751.5', 'category': 'CARDINAL'}, {'entity': '23', 'category': 'CARDINAL'}, {'entity': '83', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '9', 'category': 'CARDINAL'}, {'entity': '2015', 'category': 'CARDINAL'}, {'entity': '1,708.3', 'category': 'CARDINAL'}, {'entity': '1,602.2', 'category': 'CARDINAL'}, {'entity': '1,378.1', 'category': 'CARDINAL'}, {'entity': '1,459.5', 'category': 'CARDINAL'}, {'entity': '1,406.2', 'category': 'CARDINAL'}, {'entity': '1,234.3', 'category': 'CARDINAL'}, {'entity': '32.1', 'category': 'CARDINAL'}, {'entity': '49.0', 'category': 'CARDINAL'}, {'entity': '65.1', 'category': 'CARDINAL'}, {'entity': '1.9', 'category': 'CARDINAL'}, {'entity': '50.0', 'category': 'CARDINAL'}, {'entity': '17.4', 'category': 'CARDINAL'}, {'entity': '1,675.0', 'category': 'CARDINAL'}, {'entity': '33.3', 'category': 'CARDINAL'}, {'entity': '19.6', 'category': 'CARDINAL'}, {'entity': '12.8', 'category': 'CARDINAL'}, {'entity': '50.1', 'category': 'CARDINAL'}, {'entity': '52.6', 'category': 'CARDINAL'}, {'entity': '48.5', 'category': 'CARDINAL'}, {'entity': '16.8', 'category': 'CARDINAL'}, {'entity': '33.0', 'category': 'CARDINAL'}, {'entity': '35.7', 'category': 'CARDINAL'}, {'entity': '0.3', 'category': 'CARDINAL'}, {'entity': '16.3', 'category': 'CARDINAL'}, {'entity': '17.1', 'category': 'CARDINAL'}, {'entity': '49.3', 'category': 'CARDINAL'}, {'entity': '162.7', 'category': 'CARDINAL'}, {'entity': '0.9', 'category': 'CARDINAL'}, {'entity': '0.7', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '16.2', 'category': 'CARDINAL'}, {'entity': '50.0', 'category': 'CARDINAL'}, {'entity': '162.9', 'category': 'CARDINAL'}, {'entity': '1,708.3', 'category': 'CARDINAL'}, {'entity': '1,602.2', 'category': 'CARDINAL'}, {'entity': '106.1', 'category': 'CARDINAL'}, {'entity': '1,602.2', 'category': 'CARDINAL'}, {'entity': '1,378.1', 'category': 'CARDINAL'}, {'entity': '224.1', 'category': 'CARDINAL'}, {'entity': '84.3', 'category': 'CARDINAL'}, {'entity': '80.3', 'category': 'CARDINAL'}, {'entity': '42.0', 'category': 'CARDINAL'}, {'entity': '109.7', 'category': 'CARDINAL'}, {'entity': '681.9', 'category': 'CARDINAL'}, {'entity': '311.8', 'category': 'CARDINAL'}, {'entity': '71.9', 'category': 'CARDINAL'}, {'entity': '27.8', 'category': 'CARDINAL'}, {'entity': '1,459.5', 'category': 'CARDINAL'}, {'entity': '1,406.2', 'category': 'CARDINAL'}, {'entity': '53.3', 'category': 'CARDINAL'}, {'entity': '1,406.2', 'category': 'CARDINAL'}, {'entity': '1,234.3', 'category': 'CARDINAL'}, {'entity': '171.9', 'category': 'CARDINAL'}, {'entity': '85.4', 'category': 'CARDINAL'}, {'entity': '87.8', 'category': 'CARDINAL'}, {'entity': '82.5', 'category': 'CARDINAL'}, {'entity': '86.0', 'category': 'CARDINAL'}, {'entity': '1,409.0', 'category': 'CARDINAL'}, {'entity': '1,377.8', 'category': 'CARDINAL'}, {'entity': '31.2', 'category': 'CARDINAL'}, {'entity': '1,377.8', 'category': 'CARDINAL'}, {'entity': '1,187.9', 'category': 'CARDINAL'}, {'entity': '189.9', 'category': 'CARDINAL'}, {'entity': '0.3', 'category': 'CARDINAL'}, {'entity': '3.2', 'category': 'CARDINAL'}, {'entity': '2.9', 'category': 'CARDINAL'}, {'entity': '3.2', 'category': 'CARDINAL'}, {'entity': '2.2', 'category': 'CARDINAL'}, {'entity': '1.0', 'category': 'CARDINAL'}, {'entity': '50.2', 'category': 'CARDINAL'}, {'entity': '25.2', 'category': 'CARDINAL'}, {'entity': '25.0', 'category': 'CARDINAL'}, {'entity': '25.2', 'category': 'CARDINAL'}, {'entity': '44.2', 'category': 'CARDINAL'}, {'entity': '19.0', 'category': 'CARDINAL'}, {'entity': '1,459.5', 'category': 'CARDINAL'}, {'entity': '1,406.2', 'category': 'CARDINAL'}, {'entity': '53.3', 'category': 'CARDINAL'}, {'entity': '1,406.2', 'category': 'CARDINAL'}, {'entity': '1,234.3', 'category': 'CARDINAL'}, {'entity': '171.9', 'category': 'CARDINAL'}, {'entity': '550', 'category': 'CARDINAL'}, {'entity': '30.6', 'category': 'CARDINAL'}, {'entity': '1.8', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVDoTAmCkLmaQG3DNfahBbgntZ0F\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701565564,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#20#26#50.0#2015#2014#2.2#7.9#10.1#10.3#40.2#50.5#8.1#32.3#40.4#0.5#2.0#23.6#2014#32.1#1.9#49.0#38.2#10.8#38.2#53.6#15.4#2.9#2.4#2.4#3.9#1.3#1.3#1.3#1.4#23.0#21.2#1.8#21.2#18.7#2.5#8.6#5.7#2.9#5.7#14.1#8.4#17.4#11.3#6.1#11.3#20.8#9.5#49.0#38.2#10.8#38.2#53.6#15.4#65.1#63.7#1.4#63.7#43.5#20.2#49.8#48.5#1.3#48.5#35.5#13.0#13.4#13.5#0.1#13.5#6.5#7.0#1.9#1.7#0.2#1.7#1.5#0.2#65.1#63.7#1.4#63.7#43.5#20.2#0.8#2015#69.3#74.5#5.2#74.5#33.9#40.6#9.8#6.5#37.2#2.8#2.4#50.0#0.9#1.0#2.6#50.0#0.9#1.6#1.9#60.6#5.0#0.5#1.9#60.8#22.9#51.9#61.7#24.5#50.0#76.0#1.9#59.6#119.9#0.3#60.6#0.2#0.9 \\n\\nDATE#October 28, 2014#Year Ended#Year Ended#Year Ended#Year Ended#Year Ended#Year Ended#Year Ended#Year Ended#Year Ended#Year Ended#Year Ended#Year Ended#2013#2013#2015#2014#2014#2014#2013#2014 \\n\\nEVENT#launch failure#Antares AJ-26 program#AR1 Research and Development\\n\\nFAC#BPOU site\\n\\nGPE#U.S.#U.S.\\n\\nMONEY#$50.0 million\\n\\nORG#Orbital#Aerojet Rocketdyne#Antares#Cygnus ORB-3#Rocketdyne Business\\n\\nPERSON#CIP#ERP#Advance Agreement\\n\\nPRODUCT#AR1#ERP system\\n\\nTIME#third quarter of fiscal 2015#fourth quarter of fiscal 2015}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2944,\n",
      "    \"completion_tokens\": 683,\n",
      "    \"total_tokens\": 3627\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'October 28, 2014', 'category': 'DATE'}, {'entity': 'Year Ended', 'category': 'DATE'}, {'entity': 'Year Ended', 'category': 'DATE'}, {'entity': 'Year Ended', 'category': 'DATE'}, {'entity': 'Year Ended', 'category': 'DATE'}, {'entity': 'Year Ended', 'category': 'DATE'}, {'entity': 'Year Ended', 'category': 'DATE'}, {'entity': 'Year Ended', 'category': 'DATE'}, {'entity': 'Year Ended', 'category': 'DATE'}, {'entity': 'Year Ended', 'category': 'DATE'}, {'entity': 'Year Ended', 'category': 'DATE'}, {'entity': 'Year Ended', 'category': 'DATE'}, {'entity': 'Year Ended', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': 'launch failure', 'category': 'EVENT'}, {'entity': 'Antares AJ-26 program', 'category': 'EVENT'}, {'entity': 'AR1 Research and Development', 'category': 'EVENT'}, {'entity': 'BPOU site', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '$50.0 million', 'category': 'MONEY'}, {'entity': 'Orbital', 'category': 'ORG'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': 'Antares', 'category': 'ORG'}, {'entity': 'Cygnus ORB-3', 'category': 'ORG'}, {'entity': 'Rocketdyne Business', 'category': 'ORG'}, {'entity': 'CIP', 'category': 'PERSON'}, {'entity': 'ERP', 'category': 'PERSON'}, {'entity': 'Advance Agreement', 'category': 'PERSON'}, {'entity': 'AR1', 'category': 'PRODUCT'}, {'entity': 'ERP system', 'category': 'PRODUCT'}, {'entity': 'third quarter of fiscal 2015', 'category': 'TIME'}, {'entity': 'fourth quarter of fiscal 2015', 'category': 'TIME'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '26', 'category': 'CARDINAL'}, {'entity': '50.0', 'category': 'CARDINAL'}, {'entity': '2015', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2.2', 'category': 'CARDINAL'}, {'entity': '7.9', 'category': 'CARDINAL'}, {'entity': '10.1', 'category': 'CARDINAL'}, {'entity': '10.3', 'category': 'CARDINAL'}, {'entity': '40.2', 'category': 'CARDINAL'}, {'entity': '50.5', 'category': 'CARDINAL'}, {'entity': '8.1', 'category': 'CARDINAL'}, {'entity': '32.3', 'category': 'CARDINAL'}, {'entity': '40.4', 'category': 'CARDINAL'}, {'entity': '0.5', 'category': 'CARDINAL'}, {'entity': '2.0', 'category': 'CARDINAL'}, {'entity': '23.6', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '32.1', 'category': 'CARDINAL'}, {'entity': '1.9', 'category': 'CARDINAL'}, {'entity': '49.0', 'category': 'CARDINAL'}, {'entity': '38.2', 'category': 'CARDINAL'}, {'entity': '10.8', 'category': 'CARDINAL'}, {'entity': '38.2', 'category': 'CARDINAL'}, {'entity': '53.6', 'category': 'CARDINAL'}, {'entity': '15.4', 'category': 'CARDINAL'}, {'entity': '2.9', 'category': 'CARDINAL'}, {'entity': '2.4', 'category': 'CARDINAL'}, {'entity': '2.4', 'category': 'CARDINAL'}, {'entity': '3.9', 'category': 'CARDINAL'}, {'entity': '1.3', 'category': 'CARDINAL'}, {'entity': '1.3', 'category': 'CARDINAL'}, {'entity': '1.3', 'category': 'CARDINAL'}, {'entity': '1.4', 'category': 'CARDINAL'}, {'entity': '23.0', 'category': 'CARDINAL'}, {'entity': '21.2', 'category': 'CARDINAL'}, {'entity': '1.8', 'category': 'CARDINAL'}, {'entity': '21.2', 'category': 'CARDINAL'}, {'entity': '18.7', 'category': 'CARDINAL'}, {'entity': '2.5', 'category': 'CARDINAL'}, {'entity': '8.6', 'category': 'CARDINAL'}, {'entity': '5.7', 'category': 'CARDINAL'}, {'entity': '2.9', 'category': 'CARDINAL'}, {'entity': '5.7', 'category': 'CARDINAL'}, {'entity': '14.1', 'category': 'CARDINAL'}, {'entity': '8.4', 'category': 'CARDINAL'}, {'entity': '17.4', 'category': 'CARDINAL'}, {'entity': '11.3', 'category': 'CARDINAL'}, {'entity': '6.1', 'category': 'CARDINAL'}, {'entity': '11.3', 'category': 'CARDINAL'}, {'entity': '20.8', 'category': 'CARDINAL'}, {'entity': '9.5', 'category': 'CARDINAL'}, {'entity': '49.0', 'category': 'CARDINAL'}, {'entity': '38.2', 'category': 'CARDINAL'}, {'entity': '10.8', 'category': 'CARDINAL'}, {'entity': '38.2', 'category': 'CARDINAL'}, {'entity': '53.6', 'category': 'CARDINAL'}, {'entity': '15.4', 'category': 'CARDINAL'}, {'entity': '65.1', 'category': 'CARDINAL'}, {'entity': '63.7', 'category': 'CARDINAL'}, {'entity': '1.4', 'category': 'CARDINAL'}, {'entity': '63.7', 'category': 'CARDINAL'}, {'entity': '43.5', 'category': 'CARDINAL'}, {'entity': '20.2', 'category': 'CARDINAL'}, {'entity': '49.8', 'category': 'CARDINAL'}, {'entity': '48.5', 'category': 'CARDINAL'}, {'entity': '1.3', 'category': 'CARDINAL'}, {'entity': '48.5', 'category': 'CARDINAL'}, {'entity': '35.5', 'category': 'CARDINAL'}, {'entity': '13.0', 'category': 'CARDINAL'}, {'entity': '13.4', 'category': 'CARDINAL'}, {'entity': '13.5', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '13.5', 'category': 'CARDINAL'}, {'entity': '6.5', 'category': 'CARDINAL'}, {'entity': '7.0', 'category': 'CARDINAL'}, {'entity': '1.9', 'category': 'CARDINAL'}, {'entity': '1.7', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '1.7', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '65.1', 'category': 'CARDINAL'}, {'entity': '63.7', 'category': 'CARDINAL'}, {'entity': '1.4', 'category': 'CARDINAL'}, {'entity': '63.7', 'category': 'CARDINAL'}, {'entity': '43.5', 'category': 'CARDINAL'}, {'entity': '20.2', 'category': 'CARDINAL'}, {'entity': '0.8', 'category': 'CARDINAL'}, {'entity': '2015', 'category': 'CARDINAL'}, {'entity': '69.3', 'category': 'CARDINAL'}, {'entity': '74.5', 'category': 'CARDINAL'}, {'entity': '5.2', 'category': 'CARDINAL'}, {'entity': '74.5', 'category': 'CARDINAL'}, {'entity': '33.9', 'category': 'CARDINAL'}, {'entity': '40.6', 'category': 'CARDINAL'}, {'entity': '9.8', 'category': 'CARDINAL'}, {'entity': '6.5', 'category': 'CARDINAL'}, {'entity': '37.2', 'category': 'CARDINAL'}, {'entity': '2.8', 'category': 'CARDINAL'}, {'entity': '2.4', 'category': 'CARDINAL'}, {'entity': '50.0', 'category': 'CARDINAL'}, {'entity': '0.9', 'category': 'CARDINAL'}, {'entity': '1.0', 'category': 'CARDINAL'}, {'entity': '2.6', 'category': 'CARDINAL'}, {'entity': '50.0', 'category': 'CARDINAL'}, {'entity': '0.9', 'category': 'CARDINAL'}, {'entity': '1.6', 'category': 'CARDINAL'}, {'entity': '1.9', 'category': 'CARDINAL'}, {'entity': '60.6', 'category': 'CARDINAL'}, {'entity': '5.0', 'category': 'CARDINAL'}, {'entity': '0.5', 'category': 'CARDINAL'}, {'entity': '1.9', 'category': 'CARDINAL'}, {'entity': '60.8', 'category': 'CARDINAL'}, {'entity': '22.9', 'category': 'CARDINAL'}, {'entity': '51.9', 'category': 'CARDINAL'}, {'entity': '61.7', 'category': 'CARDINAL'}, {'entity': '24.5', 'category': 'CARDINAL'}, {'entity': '50.0', 'category': 'CARDINAL'}, {'entity': '76.0', 'category': 'CARDINAL'}, {'entity': '1.9', 'category': 'CARDINAL'}, {'entity': '59.6', 'category': 'CARDINAL'}, {'entity': '119.9', 'category': 'CARDINAL'}, {'entity': '0.3', 'category': 'CARDINAL'}, {'entity': '60.6', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '0.9', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVEgKerAKxFFw3z2qHBCRySPeifV\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701565618,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#2013#0.5#1.0#20.0#1.4#5.2#10.1#0.1#5.0#2015#2014#0.3#0.1#0.2#52.7#52.7#48.7#50.4#52.7#2.3#49.0#5.5#47.7#49.1#1.4#2.7#3.6#48.7#4.0#4.0#4.9#0.9#4.5#0.9#89.0#4#1/16#33.0#35.0#35.7#102.6#473.6#409.9#178.7#1.1#3#2014 \\n\\nDATE#Fiscal 2013#fiscal 2013#fiscal 2014#fiscal 2014#fiscal 2014#fiscal 2014#fiscal 2013#the beginning of the year#as of November 30, 2015#beginning in fiscal 2015#as of November 30, 2015#2014#November 30, 2015 \\n\\nEVENT#the Rocketdyne Business acquisition#the 4 1/16% Debentures repurchased \\n\\nFAC#SEC \\n\\nGPE#U.S.#U.S. \\n\\nLAW#401(k)#7 1/8% Notes#subordinated delayed draw term loan facility \\n\\nMONEY#$0.5 million#$1.0 million#$20.0 million#$1.4 million#$5.2#$10.1#$0.1#$5.0#$0.3#$0.1#$0.2#$50.4#$52.7#$2.3#$49.0 million#$47.7#$49.1#$1.4#$2.7#$3.6#$50.4#$52.7#$2.3#$52.7#$48.7#$4.0#$4.9#$0.9#$4.5#$0.9#$89.0 million#$0.3#$16.3#$198.4#5.9#11.5#12.5#2.7#3.2#0.2#7.7#0.4#0.3#1.5#178.4#0.4#1.4#2.3#2.8#21.1#1.7#1.2#1.4#1.0#1.4#0.3#0.6#0.4#0.3#0.8#0.5#0.3#$16.3#$198.4#$16.8 million#$33.0 million#$35.7 million#$282.4 million#$178.7 million#$1.1 million#$102.6 million#$473.6 million#$409.9 million \\n\\nNORP#U.S. federal \\n\\nORDINAL#First \\n\\nORG#SEC#Rocketdyne Business#our U.S. government contracts \\n\\nPERCENT#4.0 \\n\\nPERSON#the ISSUANCE of \\n\\nPRODUCT#common stock \\n\\nQUANTITY#5.5 million shares \\n\\nTIME#fiscal 2015#fiscal 2015#fiscal 2014#fiscal 2014#fiscal 2014#fiscal 2014#fiscal 2013 \\n\\nWORK_OF_ART#the 4 1/16% Debentures#the $49.0 million of 4 1/16% Debentures#the 4 1/16% Debentures}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2657,\n",
      "    \"completion_tokens\": 792,\n",
      "    \"total_tokens\": 3449\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'Fiscal 2013', 'category': 'DATE'}, {'entity': 'fiscal 2013', 'category': 'DATE'}, {'entity': 'fiscal 2014', 'category': 'DATE'}, {'entity': 'fiscal 2014', 'category': 'DATE'}, {'entity': 'fiscal 2014', 'category': 'DATE'}, {'entity': 'fiscal 2014', 'category': 'DATE'}, {'entity': 'fiscal 2013', 'category': 'DATE'}, {'entity': 'the beginning of the year', 'category': 'DATE'}, {'entity': 'as of November 30, 2015', 'category': 'DATE'}, {'entity': 'beginning in fiscal 2015', 'category': 'DATE'}, {'entity': 'as of November 30, 2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': 'the Rocketdyne Business acquisition', 'category': 'EVENT'}, {'entity': 'the 4 1/16% Debentures repurchased', 'category': 'EVENT'}, {'entity': 'SEC', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '401k', 'category': 'LAW'}, {'entity': '7 1/8% Notes', 'category': 'LAW'}, {'entity': 'subordinated delayed draw term loan facility', 'category': 'LAW'}, {'entity': '$0.5 million', 'category': 'MONEY'}, {'entity': '$1.0 million', 'category': 'MONEY'}, {'entity': '$20.0 million', 'category': 'MONEY'}, {'entity': '$1.4 million', 'category': 'MONEY'}, {'entity': '$5.2', 'category': 'MONEY'}, {'entity': '$10.1', 'category': 'MONEY'}, {'entity': '$0.1', 'category': 'MONEY'}, {'entity': '$5.0', 'category': 'MONEY'}, {'entity': '$0.3', 'category': 'MONEY'}, {'entity': '$0.1', 'category': 'MONEY'}, {'entity': '$0.2', 'category': 'MONEY'}, {'entity': '$50.4', 'category': 'MONEY'}, {'entity': '$52.7', 'category': 'MONEY'}, {'entity': '$2.3', 'category': 'MONEY'}, {'entity': '$49.0 million', 'category': 'MONEY'}, {'entity': '$47.7', 'category': 'MONEY'}, {'entity': '$49.1', 'category': 'MONEY'}, {'entity': '$1.4', 'category': 'MONEY'}, {'entity': '$2.7', 'category': 'MONEY'}, {'entity': '$3.6', 'category': 'MONEY'}, {'entity': '$50.4', 'category': 'MONEY'}, {'entity': '$52.7', 'category': 'MONEY'}, {'entity': '$2.3', 'category': 'MONEY'}, {'entity': '$52.7', 'category': 'MONEY'}, {'entity': '$48.7', 'category': 'MONEY'}, {'entity': '$4.0', 'category': 'MONEY'}, {'entity': '$4.9', 'category': 'MONEY'}, {'entity': '$0.9', 'category': 'MONEY'}, {'entity': '$4.5', 'category': 'MONEY'}, {'entity': '$0.9', 'category': 'MONEY'}, {'entity': '$89.0 million', 'category': 'MONEY'}, {'entity': '$0.3', 'category': 'MONEY'}, {'entity': '$16.3', 'category': 'MONEY'}, {'entity': '$198.4', 'category': 'MONEY'}, {'entity': '5.9', 'category': 'MONEY'}, {'entity': '11.5', 'category': 'MONEY'}, {'entity': '12.5', 'category': 'MONEY'}, {'entity': '2.7', 'category': 'MONEY'}, {'entity': '3.2', 'category': 'MONEY'}, {'entity': '0.2', 'category': 'MONEY'}, {'entity': '7.7', 'category': 'MONEY'}, {'entity': '0.4', 'category': 'MONEY'}, {'entity': '0.3', 'category': 'MONEY'}, {'entity': '1.5', 'category': 'MONEY'}, {'entity': '178.4', 'category': 'MONEY'}, {'entity': '0.4', 'category': 'MONEY'}, {'entity': '1.4', 'category': 'MONEY'}, {'entity': '2.3', 'category': 'MONEY'}, {'entity': '2.8', 'category': 'MONEY'}, {'entity': '21.1', 'category': 'MONEY'}, {'entity': '1.7', 'category': 'MONEY'}, {'entity': '1.2', 'category': 'MONEY'}, {'entity': '1.4', 'category': 'MONEY'}, {'entity': '1.0', 'category': 'MONEY'}, {'entity': '1.4', 'category': 'MONEY'}, {'entity': '0.3', 'category': 'MONEY'}, {'entity': '0.6', 'category': 'MONEY'}, {'entity': '0.4', 'category': 'MONEY'}, {'entity': '0.3', 'category': 'MONEY'}, {'entity': '0.8', 'category': 'MONEY'}, {'entity': '0.5', 'category': 'MONEY'}, {'entity': '0.3', 'category': 'MONEY'}, {'entity': '$16.3', 'category': 'MONEY'}, {'entity': '$198.4', 'category': 'MONEY'}, {'entity': '$16.8 million', 'category': 'MONEY'}, {'entity': '$33.0 million', 'category': 'MONEY'}, {'entity': '$35.7 million', 'category': 'MONEY'}, {'entity': '$282.4 million', 'category': 'MONEY'}, {'entity': '$178.7 million', 'category': 'MONEY'}, {'entity': '$1.1 million', 'category': 'MONEY'}, {'entity': '$102.6 million', 'category': 'MONEY'}, {'entity': '$473.6 million', 'category': 'MONEY'}, {'entity': '$409.9 million', 'category': 'MONEY'}, {'entity': 'U.S. federal', 'category': 'NORP'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'Rocketdyne Business', 'category': 'ORG'}, {'entity': 'our U.S. government contracts', 'category': 'ORG'}, {'entity': '4.0', 'category': 'PERCENT'}, {'entity': 'the ISSUANCE of', 'category': 'PERSON'}, {'entity': 'common stock', 'category': 'PRODUCT'}, {'entity': '5.5 million shares', 'category': 'QUANTITY'}, {'entity': 'fiscal 2015', 'category': 'TIME'}, {'entity': 'fiscal 2015', 'category': 'TIME'}, {'entity': 'fiscal 2014', 'category': 'TIME'}, {'entity': 'fiscal 2014', 'category': 'TIME'}, {'entity': 'fiscal 2014', 'category': 'TIME'}, {'entity': 'fiscal 2014', 'category': 'TIME'}, {'entity': 'fiscal 2013', 'category': 'TIME'}, {'entity': 'the 4 1/16% Debentures', 'category': 'WORK_OF_ART'}, {'entity': 'the $49.0 million of 4 1/16% Debentures', 'category': 'WORK_OF_ART'}, {'entity': 'the 4 1/16% Debentures', 'category': 'WORK_OF_ART'}, {'entity': 'First', 'category': 'ORDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '0.5', 'category': 'CARDINAL'}, {'entity': '1.0', 'category': 'CARDINAL'}, {'entity': '20.0', 'category': 'CARDINAL'}, {'entity': '1.4', 'category': 'CARDINAL'}, {'entity': '5.2', 'category': 'CARDINAL'}, {'entity': '10.1', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '5.0', 'category': 'CARDINAL'}, {'entity': '2015', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '0.3', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '52.7', 'category': 'CARDINAL'}, {'entity': '52.7', 'category': 'CARDINAL'}, {'entity': '48.7', 'category': 'CARDINAL'}, {'entity': '50.4', 'category': 'CARDINAL'}, {'entity': '52.7', 'category': 'CARDINAL'}, {'entity': '2.3', 'category': 'CARDINAL'}, {'entity': '49.0', 'category': 'CARDINAL'}, {'entity': '5.5', 'category': 'CARDINAL'}, {'entity': '47.7', 'category': 'CARDINAL'}, {'entity': '49.1', 'category': 'CARDINAL'}, {'entity': '1.4', 'category': 'CARDINAL'}, {'entity': '2.7', 'category': 'CARDINAL'}, {'entity': '3.6', 'category': 'CARDINAL'}, {'entity': '48.7', 'category': 'CARDINAL'}, {'entity': '4.0', 'category': 'CARDINAL'}, {'entity': '4.0', 'category': 'CARDINAL'}, {'entity': '4.9', 'category': 'CARDINAL'}, {'entity': '0.9', 'category': 'CARDINAL'}, {'entity': '4.5', 'category': 'CARDINAL'}, {'entity': '0.9', 'category': 'CARDINAL'}, {'entity': '89.0', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '1/16', 'category': 'CARDINAL'}, {'entity': '33.0', 'category': 'CARDINAL'}, {'entity': '35.0', 'category': 'CARDINAL'}, {'entity': '35.7', 'category': 'CARDINAL'}, {'entity': '102.6', 'category': 'CARDINAL'}, {'entity': '473.6', 'category': 'CARDINAL'}, {'entity': '409.9', 'category': 'CARDINAL'}, {'entity': '178.7', 'category': 'CARDINAL'}, {'entity': '1.1', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVFZdsDgPTn8mENLSeZmL1O9nwpl\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701565673,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#2.7#3#67#24.9#24.4#14.7#1,660.0#1,596.0#64.0#1,372.4#223.6#189.2#177.3#11.9#155.6#21.7#50.0#0.9#50.0#12.0#12.0#11.2#13.5#0.3#3.2#48.9#113.7#84.3#80.3#109.7\\n\\nDATE#three-year#fiscal 2013#fiscal 2016#the first quarter of fiscal 2016#November 30, 2014#November 30, 2013#fiscal 2016#fiscal 2015#fiscal 2014#fiscal 2013#the third quarter of fiscal 2015\\n\\nEVENT#the acquisition of the Rocketdyne Business\\n\\nGPE#U.S.\\n\\nLAW#The Protecting Americans from Tax Hikes Act of 2015\\n\\nMONEY#$2.7 million#$3 million\\n\\nORG#Rocketdyne Business#Aerospace and Defense Segment#SLS development program#Orion program#J-2X program#THAAD and Standard Missile programs#RL10 and RS-68 programs#Antares AJ-26 program#AR1 program\\n\\nPERCENT#3.96%#4.54%\\n\\nPRODUCT#RS-25\\n\\nTIME#three years}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2648,\n",
      "    \"completion_tokens\": 324,\n",
      "    \"total_tokens\": 2972\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'three-year', 'category': 'DATE'}, {'entity': 'fiscal 2013', 'category': 'DATE'}, {'entity': 'fiscal 2016', 'category': 'DATE'}, {'entity': 'the first quarter of fiscal 2016', 'category': 'DATE'}, {'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'November 30, 2013', 'category': 'DATE'}, {'entity': 'fiscal 2016', 'category': 'DATE'}, {'entity': 'fiscal 2015', 'category': 'DATE'}, {'entity': 'fiscal 2014', 'category': 'DATE'}, {'entity': 'fiscal 2013', 'category': 'DATE'}, {'entity': 'the third quarter of fiscal 2015', 'category': 'DATE'}, {'entity': 'the acquisition of the Rocketdyne Business', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'The Protecting Americans from Tax Hikes Act of 2015', 'category': 'LAW'}, {'entity': '$2.7 million', 'category': 'MONEY'}, {'entity': '$3 million', 'category': 'MONEY'}, {'entity': 'Rocketdyne Business', 'category': 'ORG'}, {'entity': 'Aerospace and Defense Segment', 'category': 'ORG'}, {'entity': 'SLS development program', 'category': 'ORG'}, {'entity': 'Orion program', 'category': 'ORG'}, {'entity': 'J-2X program', 'category': 'ORG'}, {'entity': 'THAAD and Standard Missile programs', 'category': 'ORG'}, {'entity': 'RL10 and RS-68 programs', 'category': 'ORG'}, {'entity': 'Antares AJ-26 program', 'category': 'ORG'}, {'entity': 'AR1 program', 'category': 'ORG'}, {'entity': '3.96%', 'category': 'PERCENT'}, {'entity': '4.54%', 'category': 'PERCENT'}, {'entity': 'RS-25', 'category': 'PRODUCT'}, {'entity': 'three years', 'category': 'TIME'}, {'entity': '2.7', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '67', 'category': 'CARDINAL'}, {'entity': '24.9', 'category': 'CARDINAL'}, {'entity': '24.4', 'category': 'CARDINAL'}, {'entity': '14.7', 'category': 'CARDINAL'}, {'entity': '1,660.0', 'category': 'CARDINAL'}, {'entity': '1,596.0', 'category': 'CARDINAL'}, {'entity': '64.0', 'category': 'CARDINAL'}, {'entity': '1,372.4', 'category': 'CARDINAL'}, {'entity': '223.6', 'category': 'CARDINAL'}, {'entity': '189.2', 'category': 'CARDINAL'}, {'entity': '177.3', 'category': 'CARDINAL'}, {'entity': '11.9', 'category': 'CARDINAL'}, {'entity': '155.6', 'category': 'CARDINAL'}, {'entity': '21.7', 'category': 'CARDINAL'}, {'entity': '50.0', 'category': 'CARDINAL'}, {'entity': '0.9', 'category': 'CARDINAL'}, {'entity': '50.0', 'category': 'CARDINAL'}, {'entity': '12.0', 'category': 'CARDINAL'}, {'entity': '12.0', 'category': 'CARDINAL'}, {'entity': '11.2', 'category': 'CARDINAL'}, {'entity': '13.5', 'category': 'CARDINAL'}, {'entity': '0.3', 'category': 'CARDINAL'}, {'entity': '3.2', 'category': 'CARDINAL'}, {'entity': '48.9', 'category': 'CARDINAL'}, {'entity': '113.7', 'category': 'CARDINAL'}, {'entity': '84.3', 'category': 'CARDINAL'}, {'entity': '80.3', 'category': 'CARDINAL'}, {'entity': '109.7', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVG9cdtGsaaFaCfaydSiS7ZOz4BY\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701565709,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#1#32.1#8.1#213.2#3.6#$50.0#311.8#681.9#12#51/2#71.9#27.8#23.6#1.5#$2.4#$2.2#1.7#$4.1#39%#$1.6#333.0#110.9#2018#48.3#6.2#42.1#34.4#4.2#30.2#57.0#46.7#10.3#700#550#40.0#9.0#30.6#3.0#7#1.0#6.0#7#1.3#150#50#6.7 \\n\\nDATE#November 30, 2015#November 30, 2014#Year Ended#2015#2014#2014#2013#End of 2018#Second quarter of fiscal 2015#Second quarter of fiscal 2015#7 years after close of escrow#7 years after close of escrow.\\n\\nEVENT#Antares AJ-26 program\\n\\nGPE#U.S.\\n\\nLAW#Note 1#Note 9(b)\\n\\nMONEY#$189.2 #$177.3 #$11.9 #50.0 million#$681.9 million #$311.8 million #$23.6 million, #$2.4 billion #$2.2 billion #$1.7 billion #$4.1 billion #$1.6 billion #$333.0 million #$110.9 million #$57.0 million #$46.7 million #$10.3 million #$40.0 million #$3.0 million #$1.0 million #$6.0 million #$1.3 million #$6.7 million\\n\\nORG#the AR1#Rocketdyne#a $50.0 million\\n\\nPRODUCT#Antares AJ-26\\n\\nQUANTITY#7%#7%\\n\\nWORK_OF_ART#Liquid booster engine}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2558,\n",
      "    \"completion_tokens\": 423,\n",
      "    \"total_tokens\": 2981\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'Year Ended', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': 'End of 2018', 'category': 'DATE'}, {'entity': 'Second quarter of fiscal 2015', 'category': 'DATE'}, {'entity': 'Second quarter of fiscal 2015', 'category': 'DATE'}, {'entity': '7 years after close of escrow', 'category': 'DATE'}, {'entity': '7 years after close of escrow.', 'category': 'DATE'}, {'entity': 'Antares AJ-26 program', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Note 1', 'category': 'LAW'}, {'entity': 'Note 9b', 'category': 'LAW'}, {'entity': '$189.2', 'category': 'MONEY'}, {'entity': '$177.3', 'category': 'MONEY'}, {'entity': '$11.9', 'category': 'MONEY'}, {'entity': '50.0 million', 'category': 'MONEY'}, {'entity': '$681.9 million', 'category': 'MONEY'}, {'entity': '$311.8 million', 'category': 'MONEY'}, {'entity': '$23.6 million,', 'category': 'MONEY'}, {'entity': '$2.4 billion', 'category': 'MONEY'}, {'entity': '$2.2 billion', 'category': 'MONEY'}, {'entity': '$1.7 billion', 'category': 'MONEY'}, {'entity': '$4.1 billion', 'category': 'MONEY'}, {'entity': '$1.6 billion', 'category': 'MONEY'}, {'entity': '$333.0 million', 'category': 'MONEY'}, {'entity': '$110.9 million', 'category': 'MONEY'}, {'entity': '$57.0 million', 'category': 'MONEY'}, {'entity': '$46.7 million', 'category': 'MONEY'}, {'entity': '$10.3 million', 'category': 'MONEY'}, {'entity': '$40.0 million', 'category': 'MONEY'}, {'entity': '$3.0 million', 'category': 'MONEY'}, {'entity': '$1.0 million', 'category': 'MONEY'}, {'entity': '$6.0 million', 'category': 'MONEY'}, {'entity': '$1.3 million', 'category': 'MONEY'}, {'entity': '$6.7 million', 'category': 'MONEY'}, {'entity': 'the AR1', 'category': 'ORG'}, {'entity': 'Rocketdyne', 'category': 'ORG'}, {'entity': 'a $50.0 million', 'category': 'ORG'}, {'entity': 'Antares AJ-26', 'category': 'PRODUCT'}, {'entity': '7%', 'category': 'QUANTITY'}, {'entity': '7%', 'category': 'QUANTITY'}, {'entity': 'Liquid booster engine', 'category': 'WORK_OF_ART'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '32.1', 'category': 'CARDINAL'}, {'entity': '8.1', 'category': 'CARDINAL'}, {'entity': '213.2', 'category': 'CARDINAL'}, {'entity': '3.6', 'category': 'CARDINAL'}, {'entity': '$50.0', 'category': 'CARDINAL'}, {'entity': '311.8', 'category': 'CARDINAL'}, {'entity': '681.9', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '51/2', 'category': 'CARDINAL'}, {'entity': '71.9', 'category': 'CARDINAL'}, {'entity': '27.8', 'category': 'CARDINAL'}, {'entity': '23.6', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '$2.4', 'category': 'CARDINAL'}, {'entity': '$2.2', 'category': 'CARDINAL'}, {'entity': '1.7', 'category': 'CARDINAL'}, {'entity': '$4.1', 'category': 'CARDINAL'}, {'entity': '39%', 'category': 'CARDINAL'}, {'entity': '$1.6', 'category': 'CARDINAL'}, {'entity': '333.0', 'category': 'CARDINAL'}, {'entity': '110.9', 'category': 'CARDINAL'}, {'entity': '2018', 'category': 'CARDINAL'}, {'entity': '48.3', 'category': 'CARDINAL'}, {'entity': '6.2', 'category': 'CARDINAL'}, {'entity': '42.1', 'category': 'CARDINAL'}, {'entity': '34.4', 'category': 'CARDINAL'}, {'entity': '4.2', 'category': 'CARDINAL'}, {'entity': '30.2', 'category': 'CARDINAL'}, {'entity': '57.0', 'category': 'CARDINAL'}, {'entity': '46.7', 'category': 'CARDINAL'}, {'entity': '10.3', 'category': 'CARDINAL'}, {'entity': '700', 'category': 'CARDINAL'}, {'entity': '550', 'category': 'CARDINAL'}, {'entity': '40.0', 'category': 'CARDINAL'}, {'entity': '9.0', 'category': 'CARDINAL'}, {'entity': '30.6', 'category': 'CARDINAL'}, {'entity': '3.0', 'category': 'CARDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '1.0', 'category': 'CARDINAL'}, {'entity': '6.0', 'category': 'CARDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '1.3', 'category': 'CARDINAL'}, {'entity': '150', 'category': 'CARDINAL'}, {'entity': '50', 'category': 'CARDINAL'}, {'entity': '6.7', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVGoafcAOohYrQ4Mz0MAuFPir9Tu\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701565750,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#118.0#153.0#108.1#140.1#7.6#7.8#0.7#5.2#234.4#306.1#65.1#150.6#77.4#36.8#43.4#63.2#28.3#107.2#14.2#440.9#516.3#5.5#7.1#4.9#140.5#31.2#10.8#182.5#7.0#189.5#9.8#5.1#0.1#15.0#3.8#18.8#22.3#9.4#2.7#34.4#2.6#37.0#128.0#26.9#8.2#163.1#8.2#171.3#24.0#4.5#3.3#31.8#1.9#33.7#21.6#9.7#3.4#34.7#4.3#39.0#130.4#21.7#8.1#160.2#5.8#166.0#44.3#129.7#2.0#176.0#0.6#176.6#21.7#11.3#2.3#35.3#1.2#36.5#44.3#129.7#2.0#176.0#0.6#176.6#153.0#140.1#7.8#300.9#5.2#306.1#176.6#126.3#13.8#13.5#5.2#17.8#33.7#8.1#5.8#4.0#3.0#1.5#11.3#18.8\\n\\nDATE#2015#2014#2013#November 30, 2015#November 30, 2014#November 30, 2012#November 30, 2013#November 30, 2014#November 30, 2015\\n\\nMONEY#$68.7 million\\n\\nORG#GAAP#Non-GAAP#Aerojet Rocketdyne#Northrop#AerojetRocketdyne-Sacramento#AerojetRocketdyne-BPOU#OtherAerojetRocketdyneSites#TotalAerojetRocketdyne#Other#TotalEnvironmentalReserve\\n\\nPERSON#Sacramento#BPOU}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2634,\n",
      "    \"completion_tokens\": 559,\n",
      "    \"total_tokens\": 3193\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'November 30, 2012', 'category': 'DATE'}, {'entity': 'November 30, 2013', 'category': 'DATE'}, {'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': '$68.7 million', 'category': 'MONEY'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': 'Non-GAAP', 'category': 'ORG'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': 'Northrop', 'category': 'ORG'}, {'entity': 'AerojetRocketdyne-Sacramento', 'category': 'ORG'}, {'entity': 'AerojetRocketdyne-BPOU', 'category': 'ORG'}, {'entity': 'OtherAerojetRocketdyneSites', 'category': 'ORG'}, {'entity': 'TotalAerojetRocketdyne', 'category': 'ORG'}, {'entity': 'Other', 'category': 'ORG'}, {'entity': 'TotalEnvironmentalReserve', 'category': 'ORG'}, {'entity': 'Sacramento', 'category': 'PERSON'}, {'entity': 'BPOU', 'category': 'PERSON'}, {'entity': '118.0', 'category': 'CARDINAL'}, {'entity': '153.0', 'category': 'CARDINAL'}, {'entity': '108.1', 'category': 'CARDINAL'}, {'entity': '140.1', 'category': 'CARDINAL'}, {'entity': '7.6', 'category': 'CARDINAL'}, {'entity': '7.8', 'category': 'CARDINAL'}, {'entity': '0.7', 'category': 'CARDINAL'}, {'entity': '5.2', 'category': 'CARDINAL'}, {'entity': '234.4', 'category': 'CARDINAL'}, {'entity': '306.1', 'category': 'CARDINAL'}, {'entity': '65.1', 'category': 'CARDINAL'}, {'entity': '150.6', 'category': 'CARDINAL'}, {'entity': '77.4', 'category': 'CARDINAL'}, {'entity': '36.8', 'category': 'CARDINAL'}, {'entity': '43.4', 'category': 'CARDINAL'}, {'entity': '63.2', 'category': 'CARDINAL'}, {'entity': '28.3', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '14.2', 'category': 'CARDINAL'}, {'entity': '440.9', 'category': 'CARDINAL'}, {'entity': '516.3', 'category': 'CARDINAL'}, {'entity': '5.5', 'category': 'CARDINAL'}, {'entity': '7.1', 'category': 'CARDINAL'}, {'entity': '4.9', 'category': 'CARDINAL'}, {'entity': '140.5', 'category': 'CARDINAL'}, {'entity': '31.2', 'category': 'CARDINAL'}, {'entity': '10.8', 'category': 'CARDINAL'}, {'entity': '182.5', 'category': 'CARDINAL'}, {'entity': '7.0', 'category': 'CARDINAL'}, {'entity': '189.5', 'category': 'CARDINAL'}, {'entity': '9.8', 'category': 'CARDINAL'}, {'entity': '5.1', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '15.0', 'category': 'CARDINAL'}, {'entity': '3.8', 'category': 'CARDINAL'}, {'entity': '18.8', 'category': 'CARDINAL'}, {'entity': '22.3', 'category': 'CARDINAL'}, {'entity': '9.4', 'category': 'CARDINAL'}, {'entity': '2.7', 'category': 'CARDINAL'}, {'entity': '34.4', 'category': 'CARDINAL'}, {'entity': '2.6', 'category': 'CARDINAL'}, {'entity': '37.0', 'category': 'CARDINAL'}, {'entity': '128.0', 'category': 'CARDINAL'}, {'entity': '26.9', 'category': 'CARDINAL'}, {'entity': '8.2', 'category': 'CARDINAL'}, {'entity': '163.1', 'category': 'CARDINAL'}, {'entity': '8.2', 'category': 'CARDINAL'}, {'entity': '171.3', 'category': 'CARDINAL'}, {'entity': '24.0', 'category': 'CARDINAL'}, {'entity': '4.5', 'category': 'CARDINAL'}, {'entity': '3.3', 'category': 'CARDINAL'}, {'entity': '31.8', 'category': 'CARDINAL'}, {'entity': '1.9', 'category': 'CARDINAL'}, {'entity': '33.7', 'category': 'CARDINAL'}, {'entity': '21.6', 'category': 'CARDINAL'}, {'entity': '9.7', 'category': 'CARDINAL'}, {'entity': '3.4', 'category': 'CARDINAL'}, {'entity': '34.7', 'category': 'CARDINAL'}, {'entity': '4.3', 'category': 'CARDINAL'}, {'entity': '39.0', 'category': 'CARDINAL'}, {'entity': '130.4', 'category': 'CARDINAL'}, {'entity': '21.7', 'category': 'CARDINAL'}, {'entity': '8.1', 'category': 'CARDINAL'}, {'entity': '160.2', 'category': 'CARDINAL'}, {'entity': '5.8', 'category': 'CARDINAL'}, {'entity': '166.0', 'category': 'CARDINAL'}, {'entity': '44.3', 'category': 'CARDINAL'}, {'entity': '129.7', 'category': 'CARDINAL'}, {'entity': '2.0', 'category': 'CARDINAL'}, {'entity': '176.0', 'category': 'CARDINAL'}, {'entity': '0.6', 'category': 'CARDINAL'}, {'entity': '176.6', 'category': 'CARDINAL'}, {'entity': '21.7', 'category': 'CARDINAL'}, {'entity': '11.3', 'category': 'CARDINAL'}, {'entity': '2.3', 'category': 'CARDINAL'}, {'entity': '35.3', 'category': 'CARDINAL'}, {'entity': '1.2', 'category': 'CARDINAL'}, {'entity': '36.5', 'category': 'CARDINAL'}, {'entity': '44.3', 'category': 'CARDINAL'}, {'entity': '129.7', 'category': 'CARDINAL'}, {'entity': '2.0', 'category': 'CARDINAL'}, {'entity': '176.0', 'category': 'CARDINAL'}, {'entity': '0.6', 'category': 'CARDINAL'}, {'entity': '176.6', 'category': 'CARDINAL'}, {'entity': '153.0', 'category': 'CARDINAL'}, {'entity': '140.1', 'category': 'CARDINAL'}, {'entity': '7.8', 'category': 'CARDINAL'}, {'entity': '300.9', 'category': 'CARDINAL'}, {'entity': '5.2', 'category': 'CARDINAL'}, {'entity': '306.1', 'category': 'CARDINAL'}, {'entity': '176.6', 'category': 'CARDINAL'}, {'entity': '126.3', 'category': 'CARDINAL'}, {'entity': '13.8', 'category': 'CARDINAL'}, {'entity': '13.5', 'category': 'CARDINAL'}, {'entity': '5.2', 'category': 'CARDINAL'}, {'entity': '17.8', 'category': 'CARDINAL'}, {'entity': '33.7', 'category': 'CARDINAL'}, {'entity': '8.1', 'category': 'CARDINAL'}, {'entity': '5.8', 'category': 'CARDINAL'}, {'entity': '4.0', 'category': 'CARDINAL'}, {'entity': '3.0', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '11.3', 'category': 'CARDINAL'}, {'entity': '18.8', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVHZI3h6o76rPfUZ8CV3KfynPfN7\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701565797,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#6.6#4.4#2.3#1.5#4.0#20.0#18.5#1.5#24#189.7#113.2#76.5#68.7#7.8#205.5#8.7#22.6#1.6#2.7#87.9#21.4#23.2#1.7#3.2#82.3#133.6#27.2#21.1#6.1#76.5#303.1#133.6#95.6#10.5#10.2#3.9#13.4#31.2#13.8#6.8#3.4#2.8#1.1#3.3#25.4#24#21.4#5.1#3.7#2.5#1.9#1.5#6.7 \\n\\nDATE#November 30, 2015#January 12, 1999#December 1, 1998#November 30, 2012#November 30, 2013#November 30, 2014#November 30, 2015#Fiscal 2015#Fiscal 2014\\n\\nGPE#Toledo, Ohio#Sacramento#Azusa#Northrop\\n\\nLOC#BPOU\\n\\nMONEY#$6.6 million#$4.4 million#$2.3 million#$1.5 million#$4.0 million#$20.0 million#$189.7 million#$76.5 million#$68.7 million#$7.8 million#$205.5 million#$8.7 million#$22.6 million#$111.5 million#$94.0 million#$99.2 million#$87.9 million#$21.4 million#$23.2 million#$99.1 million#$82.3 million#$133.6 million#$27.2 million#$21.1 million#$76.5 million#$303.1 million#$133.6 million#$95.6 million#$10.5 million#$10.2 million#$3.9 million#$13.4 million#$31.2 million#$13.8 million#$6.8 million#$3.4 million#$2.8 million#$1.1 million#$3.3 million#$25.4 million#$24 million#$21.4 million#$5.1 million#$3.7 million#$2.5 million#$1.9 million#$1.5 million#$6.7 million\\n\\nORG#Atlantic Research Corporation#Aerojet Rocketdyne#ARC#U.S. government#Aerospace and Defense#Company\\n\\nPERCENT#24%#24%}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2484,\n",
      "    \"completion_tokens\": 583,\n",
      "    \"total_tokens\": 3067\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': 'January 12, 1999', 'category': 'DATE'}, {'entity': 'December 1, 1998', 'category': 'DATE'}, {'entity': 'November 30, 2012', 'category': 'DATE'}, {'entity': 'November 30, 2013', 'category': 'DATE'}, {'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': 'Fiscal 2015', 'category': 'DATE'}, {'entity': 'Fiscal 2014', 'category': 'DATE'}, {'entity': 'Toledo, Ohio', 'category': 'GPE'}, {'entity': 'Sacramento', 'category': 'GPE'}, {'entity': 'Azusa', 'category': 'GPE'}, {'entity': 'Northrop', 'category': 'GPE'}, {'entity': 'BPOU', 'category': 'LOC'}, {'entity': '$6.6 million', 'category': 'MONEY'}, {'entity': '$4.4 million', 'category': 'MONEY'}, {'entity': '$2.3 million', 'category': 'MONEY'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': '$4.0 million', 'category': 'MONEY'}, {'entity': '$20.0 million', 'category': 'MONEY'}, {'entity': '$189.7 million', 'category': 'MONEY'}, {'entity': '$76.5 million', 'category': 'MONEY'}, {'entity': '$68.7 million', 'category': 'MONEY'}, {'entity': '$7.8 million', 'category': 'MONEY'}, {'entity': '$205.5 million', 'category': 'MONEY'}, {'entity': '$8.7 million', 'category': 'MONEY'}, {'entity': '$22.6 million', 'category': 'MONEY'}, {'entity': '$111.5 million', 'category': 'MONEY'}, {'entity': '$94.0 million', 'category': 'MONEY'}, {'entity': '$99.2 million', 'category': 'MONEY'}, {'entity': '$87.9 million', 'category': 'MONEY'}, {'entity': '$21.4 million', 'category': 'MONEY'}, {'entity': '$23.2 million', 'category': 'MONEY'}, {'entity': '$99.1 million', 'category': 'MONEY'}, {'entity': '$82.3 million', 'category': 'MONEY'}, {'entity': '$133.6 million', 'category': 'MONEY'}, {'entity': '$27.2 million', 'category': 'MONEY'}, {'entity': '$21.1 million', 'category': 'MONEY'}, {'entity': '$76.5 million', 'category': 'MONEY'}, {'entity': '$303.1 million', 'category': 'MONEY'}, {'entity': '$133.6 million', 'category': 'MONEY'}, {'entity': '$95.6 million', 'category': 'MONEY'}, {'entity': '$10.5 million', 'category': 'MONEY'}, {'entity': '$10.2 million', 'category': 'MONEY'}, {'entity': '$3.9 million', 'category': 'MONEY'}, {'entity': '$13.4 million', 'category': 'MONEY'}, {'entity': '$31.2 million', 'category': 'MONEY'}, {'entity': '$13.8 million', 'category': 'MONEY'}, {'entity': '$6.8 million', 'category': 'MONEY'}, {'entity': '$3.4 million', 'category': 'MONEY'}, {'entity': '$2.8 million', 'category': 'MONEY'}, {'entity': '$1.1 million', 'category': 'MONEY'}, {'entity': '$3.3 million', 'category': 'MONEY'}, {'entity': '$25.4 million', 'category': 'MONEY'}, {'entity': '$24 million', 'category': 'MONEY'}, {'entity': '$21.4 million', 'category': 'MONEY'}, {'entity': '$5.1 million', 'category': 'MONEY'}, {'entity': '$3.7 million', 'category': 'MONEY'}, {'entity': '$2.5 million', 'category': 'MONEY'}, {'entity': '$1.9 million', 'category': 'MONEY'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': '$6.7 million', 'category': 'MONEY'}, {'entity': 'Atlantic Research Corporation', 'category': 'ORG'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': 'ARC', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'Aerospace and Defense', 'category': 'ORG'}, {'entity': 'Company', 'category': 'ORG'}, {'entity': '24%', 'category': 'PERCENT'}, {'entity': '24%', 'category': 'PERCENT'}, {'entity': '6.6', 'category': 'CARDINAL'}, {'entity': '4.4', 'category': 'CARDINAL'}, {'entity': '2.3', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '4.0', 'category': 'CARDINAL'}, {'entity': '20.0', 'category': 'CARDINAL'}, {'entity': '18.5', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '24', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '113.2', 'category': 'CARDINAL'}, {'entity': '76.5', 'category': 'CARDINAL'}, {'entity': '68.7', 'category': 'CARDINAL'}, {'entity': '7.8', 'category': 'CARDINAL'}, {'entity': '205.5', 'category': 'CARDINAL'}, {'entity': '8.7', 'category': 'CARDINAL'}, {'entity': '22.6', 'category': 'CARDINAL'}, {'entity': '1.6', 'category': 'CARDINAL'}, {'entity': '2.7', 'category': 'CARDINAL'}, {'entity': '87.9', 'category': 'CARDINAL'}, {'entity': '21.4', 'category': 'CARDINAL'}, {'entity': '23.2', 'category': 'CARDINAL'}, {'entity': '1.7', 'category': 'CARDINAL'}, {'entity': '3.2', 'category': 'CARDINAL'}, {'entity': '82.3', 'category': 'CARDINAL'}, {'entity': '133.6', 'category': 'CARDINAL'}, {'entity': '27.2', 'category': 'CARDINAL'}, {'entity': '21.1', 'category': 'CARDINAL'}, {'entity': '6.1', 'category': 'CARDINAL'}, {'entity': '76.5', 'category': 'CARDINAL'}, {'entity': '303.1', 'category': 'CARDINAL'}, {'entity': '133.6', 'category': 'CARDINAL'}, {'entity': '95.6', 'category': 'CARDINAL'}, {'entity': '10.5', 'category': 'CARDINAL'}, {'entity': '10.2', 'category': 'CARDINAL'}, {'entity': '3.9', 'category': 'CARDINAL'}, {'entity': '13.4', 'category': 'CARDINAL'}, {'entity': '31.2', 'category': 'CARDINAL'}, {'entity': '13.8', 'category': 'CARDINAL'}, {'entity': '6.8', 'category': 'CARDINAL'}, {'entity': '3.4', 'category': 'CARDINAL'}, {'entity': '2.8', 'category': 'CARDINAL'}, {'entity': '1.1', 'category': 'CARDINAL'}, {'entity': '3.3', 'category': 'CARDINAL'}, {'entity': '25.4', 'category': 'CARDINAL'}, {'entity': '24', 'category': 'CARDINAL'}, {'entity': '21.4', 'category': 'CARDINAL'}, {'entity': '5.1', 'category': 'CARDINAL'}, {'entity': '3.7', 'category': 'CARDINAL'}, {'entity': '2.5', 'category': 'CARDINAL'}, {'entity': '1.9', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '6.7', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVIHz6c9C0z3m2tn1jBPhAKriv29\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701565841,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#31.0#12.6#8.1#2.7#1.7#1.3#4.6#8.7#3.9#2.6#0.9#1.3#30.5#11.5#9.3#2.1#1.6#6.0#159.3#22.9#10.4#17.3#10.8#8.4#176.6#33.7#18.8#65.1#150.6#77.4#125.4#17.8#19.5#7.8#132.7#69.6#96.9#4.9#96.0#36.8#43.4#63.2#11.3#25.4#16.4#0.2#7.5#411.2#81.2#3.5#64.5#189.0#166.3#4.2#460.0#12.8#14.9#98.8#5.0#93.8#460.0#133.6#49.0#84.6#0.2#89.0#76.0#13.0#0.6#0.2#0.4#782.2#81.2#49.0#652.0#150.0#4.50#1.00#4.25#4.00\\n\\nDATE#Fiscal 2014#Fiscal 2013#Fiscal 2015#Year Ended 2015#2014#2013#November 30, 2014#November 30, 2015#November 30, 2017\\n\\nGPE#U.S.#Camden, Arkansas\\n\\nMONEY#$31.0 million#$12.6 million#$8.1 million#$2.7 million#$1.7 million#$1.3 million#$4.6 million#$8.7 million#$3.9 million#$2.6 million#$0.9 million#$1.3 million#$30.5 million#$11.5 million#$9.3 million#$2.1 million#$1.6 million#$6.0 million#$159.3#$22.9#$10.4#17.3#10.8#8.4#$176.6#$33.7#$18.8#$65.1 million#$150.6 million#$77.4 million#$125.4 million#$17.8 million#$19.5 million#$7.8 million#$132.7 million#$69.6 million#$96.9 million#$4.9 million#$96.0 million#$36.8 million#$43.4 million#$63.2 million#$11.3 million#$25.4 million#$16.4 million#$0.2 million#$7.5 million#$411.2 million#$81.2 million#$64.5 million#$189.0 million#$166.3 million#$4.2 million#$460.0 million#$12.8 million#$14.9 million#$98.8#$5.0#$93.8#$460.0#$133.6#$49.0#$84.6#0.2#89.0#$76.0#$13.0#$0.6#$0.2#$0.4#$782.2#$81.2#$49.0#$652.0#$150.0 million\\n\\nORG#Business integration activities#Transition Service Agreements#Standard Missile#Rocketdyne Business#Northrop#ERP#Senior Credit Facility\\n\\nPERCENT#4.50 to 1.00#4.25 to 1.00#4.00 to 1.00\\n\\nWORK_OF_ART#Note 1#Note 5\\n\\nPERSON#Rocketdyne}\\n\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2573,\n",
      "    \"completion_tokens\": 818,\n",
      "    \"total_tokens\": 3391\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'Fiscal 2014', 'category': 'DATE'}, {'entity': 'Fiscal 2013', 'category': 'DATE'}, {'entity': 'Fiscal 2015', 'category': 'DATE'}, {'entity': 'Year Ended 2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': 'November 30, 2017', 'category': 'DATE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Camden, Arkansas', 'category': 'GPE'}, {'entity': '$31.0 million', 'category': 'MONEY'}, {'entity': '$12.6 million', 'category': 'MONEY'}, {'entity': '$8.1 million', 'category': 'MONEY'}, {'entity': '$2.7 million', 'category': 'MONEY'}, {'entity': '$1.7 million', 'category': 'MONEY'}, {'entity': '$1.3 million', 'category': 'MONEY'}, {'entity': '$4.6 million', 'category': 'MONEY'}, {'entity': '$8.7 million', 'category': 'MONEY'}, {'entity': '$3.9 million', 'category': 'MONEY'}, {'entity': '$2.6 million', 'category': 'MONEY'}, {'entity': '$0.9 million', 'category': 'MONEY'}, {'entity': '$1.3 million', 'category': 'MONEY'}, {'entity': '$30.5 million', 'category': 'MONEY'}, {'entity': '$11.5 million', 'category': 'MONEY'}, {'entity': '$9.3 million', 'category': 'MONEY'}, {'entity': '$2.1 million', 'category': 'MONEY'}, {'entity': '$1.6 million', 'category': 'MONEY'}, {'entity': '$6.0 million', 'category': 'MONEY'}, {'entity': '$159.3', 'category': 'MONEY'}, {'entity': '$22.9', 'category': 'MONEY'}, {'entity': '$10.4', 'category': 'MONEY'}, {'entity': '17.3', 'category': 'MONEY'}, {'entity': '10.8', 'category': 'MONEY'}, {'entity': '8.4', 'category': 'MONEY'}, {'entity': '$176.6', 'category': 'MONEY'}, {'entity': '$33.7', 'category': 'MONEY'}, {'entity': '$18.8', 'category': 'MONEY'}, {'entity': '$65.1 million', 'category': 'MONEY'}, {'entity': '$150.6 million', 'category': 'MONEY'}, {'entity': '$77.4 million', 'category': 'MONEY'}, {'entity': '$125.4 million', 'category': 'MONEY'}, {'entity': '$17.8 million', 'category': 'MONEY'}, {'entity': '$19.5 million', 'category': 'MONEY'}, {'entity': '$7.8 million', 'category': 'MONEY'}, {'entity': '$132.7 million', 'category': 'MONEY'}, {'entity': '$69.6 million', 'category': 'MONEY'}, {'entity': '$96.9 million', 'category': 'MONEY'}, {'entity': '$4.9 million', 'category': 'MONEY'}, {'entity': '$96.0 million', 'category': 'MONEY'}, {'entity': '$36.8 million', 'category': 'MONEY'}, {'entity': '$43.4 million', 'category': 'MONEY'}, {'entity': '$63.2 million', 'category': 'MONEY'}, {'entity': '$11.3 million', 'category': 'MONEY'}, {'entity': '$25.4 million', 'category': 'MONEY'}, {'entity': '$16.4 million', 'category': 'MONEY'}, {'entity': '$0.2 million', 'category': 'MONEY'}, {'entity': '$7.5 million', 'category': 'MONEY'}, {'entity': '$411.2 million', 'category': 'MONEY'}, {'entity': '$81.2 million', 'category': 'MONEY'}, {'entity': '$64.5 million', 'category': 'MONEY'}, {'entity': '$189.0 million', 'category': 'MONEY'}, {'entity': '$166.3 million', 'category': 'MONEY'}, {'entity': '$4.2 million', 'category': 'MONEY'}, {'entity': '$460.0 million', 'category': 'MONEY'}, {'entity': '$12.8 million', 'category': 'MONEY'}, {'entity': '$14.9 million', 'category': 'MONEY'}, {'entity': '$98.8', 'category': 'MONEY'}, {'entity': '$5.0', 'category': 'MONEY'}, {'entity': '$93.8', 'category': 'MONEY'}, {'entity': '$460.0', 'category': 'MONEY'}, {'entity': '$133.6', 'category': 'MONEY'}, {'entity': '$49.0', 'category': 'MONEY'}, {'entity': '$84.6', 'category': 'MONEY'}, {'entity': '0.2', 'category': 'MONEY'}, {'entity': '89.0', 'category': 'MONEY'}, {'entity': '$76.0', 'category': 'MONEY'}, {'entity': '$13.0', 'category': 'MONEY'}, {'entity': '$0.6', 'category': 'MONEY'}, {'entity': '$0.2', 'category': 'MONEY'}, {'entity': '$0.4', 'category': 'MONEY'}, {'entity': '$782.2', 'category': 'MONEY'}, {'entity': '$81.2', 'category': 'MONEY'}, {'entity': '$49.0', 'category': 'MONEY'}, {'entity': '$652.0', 'category': 'MONEY'}, {'entity': '$150.0 million', 'category': 'MONEY'}, {'entity': 'Business integration activities', 'category': 'ORG'}, {'entity': 'Transition Service Agreements', 'category': 'ORG'}, {'entity': 'Standard Missile', 'category': 'ORG'}, {'entity': 'Rocketdyne Business', 'category': 'ORG'}, {'entity': 'Northrop', 'category': 'ORG'}, {'entity': 'ERP', 'category': 'ORG'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': '4.50 to 1.00', 'category': 'PERCENT'}, {'entity': '4.25 to 1.00', 'category': 'PERCENT'}, {'entity': '4.00 to 1.00', 'category': 'PERCENT'}, {'entity': 'Rocketdyne', 'category': 'PERSON'}, {'entity': 'Note 1', 'category': 'WORK_OF_ART'}, {'entity': 'Note 5', 'category': 'WORK_OF_ART'}, {'entity': '31.0', 'category': 'CARDINAL'}, {'entity': '12.6', 'category': 'CARDINAL'}, {'entity': '8.1', 'category': 'CARDINAL'}, {'entity': '2.7', 'category': 'CARDINAL'}, {'entity': '1.7', 'category': 'CARDINAL'}, {'entity': '1.3', 'category': 'CARDINAL'}, {'entity': '4.6', 'category': 'CARDINAL'}, {'entity': '8.7', 'category': 'CARDINAL'}, {'entity': '3.9', 'category': 'CARDINAL'}, {'entity': '2.6', 'category': 'CARDINAL'}, {'entity': '0.9', 'category': 'CARDINAL'}, {'entity': '1.3', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '11.5', 'category': 'CARDINAL'}, {'entity': '9.3', 'category': 'CARDINAL'}, {'entity': '2.1', 'category': 'CARDINAL'}, {'entity': '1.6', 'category': 'CARDINAL'}, {'entity': '6.0', 'category': 'CARDINAL'}, {'entity': '159.3', 'category': 'CARDINAL'}, {'entity': '22.9', 'category': 'CARDINAL'}, {'entity': '10.4', 'category': 'CARDINAL'}, {'entity': '17.3', 'category': 'CARDINAL'}, {'entity': '10.8', 'category': 'CARDINAL'}, {'entity': '8.4', 'category': 'CARDINAL'}, {'entity': '176.6', 'category': 'CARDINAL'}, {'entity': '33.7', 'category': 'CARDINAL'}, {'entity': '18.8', 'category': 'CARDINAL'}, {'entity': '65.1', 'category': 'CARDINAL'}, {'entity': '150.6', 'category': 'CARDINAL'}, {'entity': '77.4', 'category': 'CARDINAL'}, {'entity': '125.4', 'category': 'CARDINAL'}, {'entity': '17.8', 'category': 'CARDINAL'}, {'entity': '19.5', 'category': 'CARDINAL'}, {'entity': '7.8', 'category': 'CARDINAL'}, {'entity': '132.7', 'category': 'CARDINAL'}, {'entity': '69.6', 'category': 'CARDINAL'}, {'entity': '96.9', 'category': 'CARDINAL'}, {'entity': '4.9', 'category': 'CARDINAL'}, {'entity': '96.0', 'category': 'CARDINAL'}, {'entity': '36.8', 'category': 'CARDINAL'}, {'entity': '43.4', 'category': 'CARDINAL'}, {'entity': '63.2', 'category': 'CARDINAL'}, {'entity': '11.3', 'category': 'CARDINAL'}, {'entity': '25.4', 'category': 'CARDINAL'}, {'entity': '16.4', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '7.5', 'category': 'CARDINAL'}, {'entity': '411.2', 'category': 'CARDINAL'}, {'entity': '81.2', 'category': 'CARDINAL'}, {'entity': '3.5', 'category': 'CARDINAL'}, {'entity': '64.5', 'category': 'CARDINAL'}, {'entity': '189.0', 'category': 'CARDINAL'}, {'entity': '166.3', 'category': 'CARDINAL'}, {'entity': '4.2', 'category': 'CARDINAL'}, {'entity': '460.0', 'category': 'CARDINAL'}, {'entity': '12.8', 'category': 'CARDINAL'}, {'entity': '14.9', 'category': 'CARDINAL'}, {'entity': '98.8', 'category': 'CARDINAL'}, {'entity': '5.0', 'category': 'CARDINAL'}, {'entity': '93.8', 'category': 'CARDINAL'}, {'entity': '460.0', 'category': 'CARDINAL'}, {'entity': '133.6', 'category': 'CARDINAL'}, {'entity': '49.0', 'category': 'CARDINAL'}, {'entity': '84.6', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '89.0', 'category': 'CARDINAL'}, {'entity': '76.0', 'category': 'CARDINAL'}, {'entity': '13.0', 'category': 'CARDINAL'}, {'entity': '0.6', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '0.4', 'category': 'CARDINAL'}, {'entity': '782.2', 'category': 'CARDINAL'}, {'entity': '81.2', 'category': 'CARDINAL'}, {'entity': '49.0', 'category': 'CARDINAL'}, {'entity': '652.0', 'category': 'CARDINAL'}, {'entity': '150.0', 'category': 'CARDINAL'}, {'entity': '4.50', 'category': 'CARDINAL'}, {'entity': '1.00', 'category': 'CARDINAL'}, {'entity': '4.25', 'category': 'CARDINAL'}, {'entity': '4.00', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVJA7O2z5KJZt45S0ianF6rg7uMN\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701565896,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#2.40#1.00#4.77#2.21#4.50#2#7#4#1/8#4#1/16#23#44.1 \\n\\nDATE#November 30, 2015#fiscal 2016#the next twelve months#the next 10 years\\n\\nMONEY#$155.9 million#$23 million\\n\\nORDINAL#first\\n\\nORG#Senior Credit Facility#Subordinated Credit Facility#7 1/8% Notes#4 1/16% Debentures#Senior debt#Senior secured notes#Convertible subordinated notes\\n\\nPERSON#Medicare\\n\\nTIME#November 30, 2015\\n\\nWORK_OF_ART#Part I, Item 1A. Risk Factors}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2339,\n",
      "    \"completion_tokens\": 160,\n",
      "    \"total_tokens\": 2499\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': 'fiscal 2016', 'category': 'DATE'}, {'entity': 'the next twelve months', 'category': 'DATE'}, {'entity': 'the next 10 years', 'category': 'DATE'}, {'entity': '$155.9 million', 'category': 'MONEY'}, {'entity': '$23 million', 'category': 'MONEY'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': 'Subordinated Credit Facility', 'category': 'ORG'}, {'entity': '7 1/8% Notes', 'category': 'ORG'}, {'entity': '4 1/16% Debentures', 'category': 'ORG'}, {'entity': 'Senior debt', 'category': 'ORG'}, {'entity': 'Senior secured notes', 'category': 'ORG'}, {'entity': 'Convertible subordinated notes', 'category': 'ORG'}, {'entity': 'Medicare', 'category': 'PERSON'}, {'entity': 'November 30', 'category': 'TIME'}, {'entity': '2015', 'category': 'TIME'}, {'entity': 'Part I', 'category': 'WORK_OF_ART'}, {'entity': 'Item 1A. Risk Factors', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '2.40', 'category': 'CARDINAL'}, {'entity': '1.00', 'category': 'CARDINAL'}, {'entity': '4.77', 'category': 'CARDINAL'}, {'entity': '2.21', 'category': 'CARDINAL'}, {'entity': '4.50', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '1/8', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '1/16', 'category': 'CARDINAL'}, {'entity': '23', 'category': 'CARDINAL'}, {'entity': '44.1', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVJeiKPjhjxN54kftaFmhKTVOzQD\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701565926,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#45.5#120.0#7 1/8#83#2015#2014#2013#41.2#9.2#23.2#24.7#5.5#13.6\\n\\nDATE#April 2016\\n\\nGPE#U.S.\\n\\nMONEY#$45.5 million#$120.0 million\\n\\nORG#Aerojet Rocketdyne#Senior Credit Facility#Aerospace and Defense segment#GAAP#SEC\\n\\nPERSON#Antares AJ-26\\n\\nPRODUCT#Environmental remediation activities#J-2X program\\n\\nQUANTITY#One-year\\n\\nTIME#the last three fiscal years\\n\\nWORK_OF_ART#Note 1 of the consolidated financial statements}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2050,\n",
      "    \"completion_tokens\": 152,\n",
      "    \"total_tokens\": 2202\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'April 2016', 'category': 'DATE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '$45.5 million', 'category': 'MONEY'}, {'entity': '$120.0 million', 'category': 'MONEY'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': 'Aerospace and Defense segment', 'category': 'ORG'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'Antares AJ-26', 'category': 'PERSON'}, {'entity': 'Environmental remediation activities', 'category': 'PRODUCT'}, {'entity': 'J-2X program', 'category': 'PRODUCT'}, {'entity': 'One-year', 'category': 'QUANTITY'}, {'entity': 'the last three fiscal years', 'category': 'TIME'}, {'entity': 'Note 1 of the consolidated financial statements', 'category': 'WORK_OF_ART'}, {'entity': '45.5', 'category': 'CARDINAL'}, {'entity': '120.0', 'category': 'CARDINAL'}, {'entity': '7 1/8', 'category': 'CARDINAL'}, {'entity': '83', 'category': 'CARDINAL'}, {'entity': '2015', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '41.2', 'category': 'CARDINAL'}, {'entity': '9.2', 'category': 'CARDINAL'}, {'entity': '23.2', 'category': 'CARDINAL'}, {'entity': '24.7', 'category': 'CARDINAL'}, {'entity': '5.5', 'category': 'CARDINAL'}, {'entity': '13.6', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVK8jPSCQdoF4pYStJUPpzq484zQ\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701565956,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#50\\n\\nDATE#September 1, 2015#September 1, 2014\\n\\nORG#Aerospace and Defense#U.S. government#DCAA\\n\\nPERSON#Step Zero#Step One\\n\\nPRODUCT#real estate asset\\n\\nLAW#FAR#Cost Accounting Standards#PPA#CAS\\n\\nMONEY#more than 50%\\n\\nWORK_OF_ART#Step Zero analysis#Step One analysis\\n\\nTIME#five-year\\n\\nGPE#U.S.}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2029,\n",
      "    \"completion_tokens\": 102,\n",
      "    \"total_tokens\": 2131\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'September 1, 2015', 'category': 'DATE'}, {'entity': 'September 1, 2014', 'category': 'DATE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'FAR', 'category': 'LAW'}, {'entity': 'Cost Accounting Standards', 'category': 'LAW'}, {'entity': 'PPA', 'category': 'LAW'}, {'entity': 'CAS', 'category': 'LAW'}, {'entity': 'more than 50%', 'category': 'MONEY'}, {'entity': 'Aerospace and Defense', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'DCAA', 'category': 'ORG'}, {'entity': 'Step Zero', 'category': 'PERSON'}, {'entity': 'Step One', 'category': 'PERSON'}, {'entity': 'real estate asset', 'category': 'PRODUCT'}, {'entity': 'five-year', 'category': 'TIME'}, {'entity': 'Step Zero analysis', 'category': 'WORK_OF_ART'}, {'entity': 'Step One analysis', 'category': 'WORK_OF_ART'}, {'entity': '50', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVKbx61gDlDZ6ogHDE8Es0g6Zcke\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701565985,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#2009#401(k)\\n\\nDATE#fiscal 2015#November 30, 2015#December 1, 2015#fiscal 2015\\n\\nEVENT#Retirement Benefit Plans\\n\\nLAW#GAAP\\n\\nMONEY#$26.5#166.1#11.1#22.5#139.6#11.1\\n\\nORG#U.S. Government\\n\\nPERCENT#4.26\\t%#3.96\\t%#3.87\\t%#3.54\\t%#3.96\\t%#4.54\\t%#3.68\\t%#3.54\\t%#3.98\\t%#3.24\\t%#8.00\\t%#8.00\\t%#8.00\\t%\\n\\nPERSON#\\n\\nPRODUCT#\\n\\nQUANTITY#\\n\\nTIME#three years\\n\\nWORK_OF_ART#Notes 9(b)#Notes 9(c)#Notes 9(c)#Notes 9(d)}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2208,\n",
      "    \"completion_tokens\": 203,\n",
      "    \"total_tokens\": 2411\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'fiscal 2015', 'category': 'DATE'}, {'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': 'December 1, 2015', 'category': 'DATE'}, {'entity': 'fiscal 2015', 'category': 'DATE'}, {'entity': 'Retirement Benefit Plans', 'category': 'EVENT'}, {'entity': 'GAAP', 'category': 'LAW'}, {'entity': '$26.5', 'category': 'MONEY'}, {'entity': '166.1', 'category': 'MONEY'}, {'entity': '11.1', 'category': 'MONEY'}, {'entity': '22.5', 'category': 'MONEY'}, {'entity': '139.6', 'category': 'MONEY'}, {'entity': '11.1', 'category': 'MONEY'}, {'entity': 'U.S. Government', 'category': 'ORG'}, {'entity': '4.26\\t%', 'category': 'PERCENT'}, {'entity': '3.96\\t%', 'category': 'PERCENT'}, {'entity': '3.87\\t%', 'category': 'PERCENT'}, {'entity': '3.54\\t%', 'category': 'PERCENT'}, {'entity': '3.96\\t%', 'category': 'PERCENT'}, {'entity': '4.54\\t%', 'category': 'PERCENT'}, {'entity': '3.68\\t%', 'category': 'PERCENT'}, {'entity': '3.54\\t%', 'category': 'PERCENT'}, {'entity': '3.98\\t%', 'category': 'PERCENT'}, {'entity': '3.24\\t%', 'category': 'PERCENT'}, {'entity': '8.00\\t%', 'category': 'PERCENT'}, {'entity': '8.00\\t%', 'category': 'PERCENT'}, {'entity': '8.00\\t%', 'category': 'PERCENT'}, {'entity': 'three years', 'category': 'TIME'}, {'entity': 'Notes 9b', 'category': 'WORK_OF_ART'}, {'entity': 'Notes 9c', 'category': 'WORK_OF_ART'}, {'entity': 'Notes 9c', 'category': 'WORK_OF_ART'}, {'entity': 'Notes 9d', 'category': 'WORK_OF_ART'}, {'entity': '2009', 'category': 'CARDINAL'}, {'entity': '401k', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVL84SKvq4RapEO0kXVfWPIfY7vm\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701566018,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#100\\n\\nDATE#November 30, 2015#November 30, 2014\\n\\nGPE#U.S.\\n\\nMONEY#$652.0 million#13.0#0.6\\n\\nORG#Senior Credit Facility#Subordinated Credit Facility#Company\\n\\nPERCENT#84%#16%#6.65%#3.20%\\n\\nPERSON#Item 7A\\n\\nPRODUCT#7 1/8% Notes#4 1/16% Debentures#term loans#other debt\\n\\nQUANTITY#three fiscal years\\n\\nWORK_OF_ART#Global Settlement Agreement#Northrop Agreement}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 1859,\n",
      "    \"completion_tokens\": 129,\n",
      "    \"total_tokens\": 1988\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '$652.0 million', 'category': 'MONEY'}, {'entity': '13.0', 'category': 'MONEY'}, {'entity': '0.6', 'category': 'MONEY'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': 'Subordinated Credit Facility', 'category': 'ORG'}, {'entity': 'Company', 'category': 'ORG'}, {'entity': '84%', 'category': 'PERCENT'}, {'entity': '16%', 'category': 'PERCENT'}, {'entity': '6.65%', 'category': 'PERCENT'}, {'entity': '3.20%', 'category': 'PERCENT'}, {'entity': 'Item 7A', 'category': 'PERSON'}, {'entity': '7 1/8% Notes', 'category': 'PRODUCT'}, {'entity': '4 1/16% Debentures', 'category': 'PRODUCT'}, {'entity': 'term loans', 'category': 'PRODUCT'}, {'entity': 'other debt', 'category': 'PRODUCT'}, {'entity': 'three fiscal years', 'category': 'QUANTITY'}, {'entity': 'Global Settlement Agreement', 'category': 'WORK_OF_ART'}, {'entity': 'Northrop Agreement', 'category': 'WORK_OF_ART'}, {'entity': '100', 'category': 'CARDINAL'}]\n",
      "/home/damir/Dropbox/Documents/Teaching/2023/L715/l715_23/data/10-Ks/Aerojet_Rocketdyne_Holdings_Inc./2021/Management.txt\n",
      "Length of chunks:  9\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVLbXzZbGyIVvHBVch1RlrR76gDS\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701566047,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#7#8#1#1#1#20#56.00#5.00#2\\u00bc#56.00#51.00#19#10#24#31#2021#1976#31#2020#2019#2,072.7#1,981.5#137.7#141.0#6.6#7.1#138.4#130.1#6.7#6.6#1.66#1.69#1.67#1.56#270.2#271.7#13.0#13.7#363.8#261.2#309.2#218.3#96#2020#96 \\n\\nDATE#December 31, 2019#February 19, 2020#December 31, 2018#December 20, 2020#December 19, 2020#March 24, 2021#March 10, 2021#second half of 2021#December 31, 2020#Year Ended December 31, 2020#2019\\n\\nEVENT#Management's Discussion and Analysis of Financial Condition and Results of Operations#Merger#Pre-Closing Dividend#Merger#COVID-19 pandemic\\n\\nGPE#U.S.\\n\\nLAW#Hart-Scott-Rodino Antitrust Improvements Act of 1976\\n\\nMONEY#$56.00#$5.00#$56.00#$51.00\\n\\nNORP#U.S.\\n\\nORG#Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations#Form 10-K#SEC#Company#Merger Agreement#Lockheed Martin#Merger Sub#Board of Directors#2\\u00bc% Notes#Management\\u2019s Discussion and Analysis#COVID-19#NASA#MDA\\n\\nORDINAL#one-time#second\\n\\nPERCENT#6.6 #%7.1 #%6.7 #%6.6 #%13.0 #%13.7 #%96 #%96 \\n\\nPERSON#Net Income\\n\\nPRODUCT#common stock#Non-GAAP#GAAP#EPS\\n\\nQUANTITY#In millions\\n\\nTIME#the close of business on March 10, 2021\\n\\nWORK_OF_ART#Use of Non-GAAP Financial Measures}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2301,\n",
      "    \"completion_tokens\": 481,\n",
      "    \"total_tokens\": 2782\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2019', 'category': 'DATE'}, {'entity': 'February 19, 2020', 'category': 'DATE'}, {'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': 'December 20, 2020', 'category': 'DATE'}, {'entity': 'December 19, 2020', 'category': 'DATE'}, {'entity': 'March 24, 2021', 'category': 'DATE'}, {'entity': 'March 10, 2021', 'category': 'DATE'}, {'entity': 'second half of 2021', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2020', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': 'Managements Discussion and Analysis of Financial Condition and Results of Operations', 'category': 'EVENT'}, {'entity': 'Merger', 'category': 'EVENT'}, {'entity': 'Pre-Closing Dividend', 'category': 'EVENT'}, {'entity': 'Merger', 'category': 'EVENT'}, {'entity': 'COVID-19 pandemic', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Hart-Scott-Rodino Antitrust Improvements Act of 1976', 'category': 'LAW'}, {'entity': '$56.00', 'category': 'MONEY'}, {'entity': '$5.00', 'category': 'MONEY'}, {'entity': '$56.00', 'category': 'MONEY'}, {'entity': '$51.00', 'category': 'MONEY'}, {'entity': 'U.S.', 'category': 'NORP'}, {'entity': 'Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations', 'category': 'ORG'}, {'entity': 'Form 10-K', 'category': 'ORG'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'Company', 'category': 'ORG'}, {'entity': 'Merger Agreement', 'category': 'ORG'}, {'entity': 'Lockheed Martin', 'category': 'ORG'}, {'entity': 'Merger Sub', 'category': 'ORG'}, {'entity': 'Board of Directors', 'category': 'ORG'}, {'entity': '2¼% Notes', 'category': 'ORG'}, {'entity': 'Management’s Discussion and Analysis', 'category': 'ORG'}, {'entity': 'COVID-19', 'category': 'ORG'}, {'entity': 'NASA', 'category': 'ORG'}, {'entity': 'MDA', 'category': 'ORG'}, {'entity': '6.6', 'category': 'PERCENT'}, {'entity': '%7.1', 'category': 'PERCENT'}, {'entity': '%6.7', 'category': 'PERCENT'}, {'entity': '%6.6', 'category': 'PERCENT'}, {'entity': '%13.0', 'category': 'PERCENT'}, {'entity': '%13.7', 'category': 'PERCENT'}, {'entity': '%96', 'category': 'PERCENT'}, {'entity': '%96', 'category': 'PERCENT'}, {'entity': 'Net Income', 'category': 'PERSON'}, {'entity': 'common stock', 'category': 'PRODUCT'}, {'entity': 'Non-GAAP', 'category': 'PRODUCT'}, {'entity': 'GAAP', 'category': 'PRODUCT'}, {'entity': 'EPS', 'category': 'PRODUCT'}, {'entity': 'In millions', 'category': 'QUANTITY'}, {'entity': 'the close of business on March 10', 'category': 'TIME'}, {'entity': '2021', 'category': 'TIME'}, {'entity': 'Use of Non-GAAP Financial Measures', 'category': 'WORK_OF_ART'}, {'entity': 'one-time', 'category': 'ORDINAL'}, {'entity': 'second', 'category': 'ORDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '56.00', 'category': 'CARDINAL'}, {'entity': '5.00', 'category': 'CARDINAL'}, {'entity': '2¼', 'category': 'CARDINAL'}, {'entity': '56.00', 'category': 'CARDINAL'}, {'entity': '51.00', 'category': 'CARDINAL'}, {'entity': '19', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '24', 'category': 'CARDINAL'}, {'entity': '31', 'category': 'CARDINAL'}, {'entity': '2021', 'category': 'CARDINAL'}, {'entity': '1976', 'category': 'CARDINAL'}, {'entity': '31', 'category': 'CARDINAL'}, {'entity': '2020', 'category': 'CARDINAL'}, {'entity': '2019', 'category': 'CARDINAL'}, {'entity': '2,072.7', 'category': 'CARDINAL'}, {'entity': '1,981.5', 'category': 'CARDINAL'}, {'entity': '137.7', 'category': 'CARDINAL'}, {'entity': '141.0', 'category': 'CARDINAL'}, {'entity': '6.6', 'category': 'CARDINAL'}, {'entity': '7.1', 'category': 'CARDINAL'}, {'entity': '138.4', 'category': 'CARDINAL'}, {'entity': '130.1', 'category': 'CARDINAL'}, {'entity': '6.7', 'category': 'CARDINAL'}, {'entity': '6.6', 'category': 'CARDINAL'}, {'entity': '1.66', 'category': 'CARDINAL'}, {'entity': '1.69', 'category': 'CARDINAL'}, {'entity': '1.67', 'category': 'CARDINAL'}, {'entity': '1.56', 'category': 'CARDINAL'}, {'entity': '270.2', 'category': 'CARDINAL'}, {'entity': '271.7', 'category': 'CARDINAL'}, {'entity': '13.0', 'category': 'CARDINAL'}, {'entity': '13.7', 'category': 'CARDINAL'}, {'entity': '363.8', 'category': 'CARDINAL'}, {'entity': '261.2', 'category': 'CARDINAL'}, {'entity': '309.2', 'category': 'CARDINAL'}, {'entity': '218.3', 'category': 'CARDINAL'}, {'entity': '96', 'category': 'CARDINAL'}, {'entity': '2020', 'category': 'CARDINAL'}, {'entity': '96', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  9\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVMHAxOC87LKuH6nE0dmTT0gy787\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701566089,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#25#23#19#12#10#7#96#4#100#18#17#13#11#10#34#33#21#21#17#10#82#94#43#65\\n\\nDATE#2020#Year Ended December 31, \\t2020#Year Ended December 31, \\t2020#December 31, 2020#December 31, 2020#December 31, 2020#Year Ended December 31, 2020\\n\\nEVENT#COVID-19 pandemic#cyber threats\\n\\nFAC#enterprise resource planning system\\n\\nGPE#U.S.\\n\\nLAW#Part I, Item 1#Item 8#Internal Revenue Service regulations\\n\\nLOC#U.S.\\n\\nMONEY#$624.3 million#approximately $94 million#approximately $43 million#$957.0 million#$1,381.5 million#$424.5 million#$624.3 million#approximately $94 million#approximately $43 million\\n\\nORG#NASA#MDA#U.S. Army#U.S. Air Force#U.S. Navy#U.S. government#Lockheed Martin#NASA#Raytheon #ULA#Aerojet Rocketdyne\\n\\nPERCENT#25 %#23 %#19 %#12 %#10 %#7 %#96 %#4 %#100 %#18 %#17 %#13 % #11 % #10 %#34 % #33 % #21 % #21 % #10 %#82%\\n\\nPERSON#RS-25 program#Standard Missile program#THAAD program#PAC-3 program#Lockheed Martin\\n\\nPRODUCT#RS-25#MRBM#GMLRS#AJ-60 solid rocket motor\\n\\nQUANTITY#\\n\\nWORK_OF_ART#Business under the caption \\\"Industry Overview\\\"#Environmental Matters\\\" below for summary of our environmental reserve activity#our tax-qualified defined benefit pension plan#the performance of our plan assets#Exoatmospheric Kill Vehicle (\\\"RKV\\\") program}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2454,\n",
      "    \"completion_tokens\": 409,\n",
      "    \"total_tokens\": 2863\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': '2020', 'category': 'DATE'}, {'entity': 'Year Ended December 31, \\t2020', 'category': 'DATE'}, {'entity': 'Year Ended December 31, \\t2020', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2020', 'category': 'DATE'}, {'entity': 'COVID-19 pandemic', 'category': 'EVENT'}, {'entity': 'cyber threats', 'category': 'EVENT'}, {'entity': 'enterprise resource planning system', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Part I, Item 1', 'category': 'LAW'}, {'entity': 'Item 8', 'category': 'LAW'}, {'entity': 'Internal Revenue Service regulations', 'category': 'LAW'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': '$624.3 million', 'category': 'MONEY'}, {'entity': 'approximately $94 million', 'category': 'MONEY'}, {'entity': 'approximately $43 million', 'category': 'MONEY'}, {'entity': '$957.0 million', 'category': 'MONEY'}, {'entity': '$1,381.5 million', 'category': 'MONEY'}, {'entity': '$424.5 million', 'category': 'MONEY'}, {'entity': '$624.3 million', 'category': 'MONEY'}, {'entity': 'approximately $94 million', 'category': 'MONEY'}, {'entity': 'approximately $43 million', 'category': 'MONEY'}, {'entity': 'NASA', 'category': 'ORG'}, {'entity': 'MDA', 'category': 'ORG'}, {'entity': 'U.S. Army', 'category': 'ORG'}, {'entity': 'U.S. Air Force', 'category': 'ORG'}, {'entity': 'U.S. Navy', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'Lockheed Martin', 'category': 'ORG'}, {'entity': 'NASA', 'category': 'ORG'}, {'entity': 'Raytheon', 'category': 'ORG'}, {'entity': 'ULA', 'category': 'ORG'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': '25 %', 'category': 'PERCENT'}, {'entity': '23 %', 'category': 'PERCENT'}, {'entity': '19 %', 'category': 'PERCENT'}, {'entity': '12 %', 'category': 'PERCENT'}, {'entity': '10 %', 'category': 'PERCENT'}, {'entity': '7 %', 'category': 'PERCENT'}, {'entity': '96 %', 'category': 'PERCENT'}, {'entity': '4 %', 'category': 'PERCENT'}, {'entity': '100 %', 'category': 'PERCENT'}, {'entity': '18 %', 'category': 'PERCENT'}, {'entity': '17 %', 'category': 'PERCENT'}, {'entity': '13 %', 'category': 'PERCENT'}, {'entity': '11 %', 'category': 'PERCENT'}, {'entity': '10 %', 'category': 'PERCENT'}, {'entity': '34 %', 'category': 'PERCENT'}, {'entity': '33 %', 'category': 'PERCENT'}, {'entity': '21 %', 'category': 'PERCENT'}, {'entity': '21 %', 'category': 'PERCENT'}, {'entity': '10 %', 'category': 'PERCENT'}, {'entity': '82%', 'category': 'PERCENT'}, {'entity': 'RS-25 program', 'category': 'PERSON'}, {'entity': 'Standard Missile program', 'category': 'PERSON'}, {'entity': 'THAAD program', 'category': 'PERSON'}, {'entity': 'PAC-3 program', 'category': 'PERSON'}, {'entity': 'Lockheed Martin', 'category': 'PERSON'}, {'entity': 'RS-25', 'category': 'PRODUCT'}, {'entity': 'MRBM', 'category': 'PRODUCT'}, {'entity': 'GMLRS', 'category': 'PRODUCT'}, {'entity': 'AJ-60 solid rocket motor', 'category': 'PRODUCT'}, {'entity': 'Business under the caption \"Industry Overview\"', 'category': 'WORK_OF_ART'}, {'entity': 'Environmental Matters\" below for summary of our environmental reserve activity', 'category': 'WORK_OF_ART'}, {'entity': 'our tax-qualified defined benefit pension plan', 'category': 'WORK_OF_ART'}, {'entity': 'the performance of our plan assets', 'category': 'WORK_OF_ART'}, {'entity': 'Exoatmospheric Kill Vehicle \"RKV\" program', 'category': 'WORK_OF_ART'}, {'entity': '25', 'category': 'CARDINAL'}, {'entity': '23', 'category': 'CARDINAL'}, {'entity': '19', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '96', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '18', 'category': 'CARDINAL'}, {'entity': '17', 'category': 'CARDINAL'}, {'entity': '13', 'category': 'CARDINAL'}, {'entity': '11', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '34', 'category': 'CARDINAL'}, {'entity': '33', 'category': 'CARDINAL'}, {'entity': '21', 'category': 'CARDINAL'}, {'entity': '21', 'category': 'CARDINAL'}, {'entity': '17', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '82', 'category': 'CARDINAL'}, {'entity': '94', 'category': 'CARDINAL'}, {'entity': '43', 'category': 'CARDINAL'}, {'entity': '65', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  9\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVMvRMrcvv1XH6sU8kL6lbhfBLJ6\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701566129,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#2013#9.4#1.6#7.8#6.3#15.5#20.2#26.3#30.1#35.7#42.5#50.9#23.6#21#41.1#14.6#26.5#21#43.3#53.9#60.5#64.8#0.1#0.1#53.7#37.1#36.6#26.1#34#45#2,069.4#1,974.0#275.6#269.3#13.3#13.6#45.1#38.4#3.3#7.5#1.8#2.1#6.7#5.4#1.8#32#2.2#24#44#3.0#2.1#3.7#3.3#6.7#5.4\\n\\nDATE#June 2013#Year Ended December 31, 2020#Year Ended December 31, 2019#Year Ended December 31, 2020#Year Ended December 31, 2019#Year Ended December 31, 2020#Year Ended December 31, 2019#Year Ended December 31, 2020#Year Ended December 31, 2019#Year Ended December 31, 2020#Year Ended December 31, 2019#Year Ended December 31, 2020#Year Ended December 31, 2019#during the fourth quarter of 2020#As of December 31, 2020#Year Ended December 31, 2020#Year Ended December 31, 2019#Year Ended December 31, 2020#Year Ended December 31, 2019#As of December 31#2020#2019#As of December 31, 2020#As of December 31, 2019\\n\\nEVENT#\\n\\nFAC#\\n\\nGPE#\\n\\nLANGUAGE#\\n\\nLAW#\\n\\nLOC#\\n\\nMONEY#$7.8 million#$6.1#0.5#$5.6#$41.1 million#14.6 million#$25 million\\n\\nNORP#\\n\\nORDINAL#first#second\\n\\nORG#Senior Credit Facility#IRS#Applicable Financial Statement#Company's#Real Estate Segment#COVID-19\\n\\nPERCENT#23.6%#21%#26.5%#32%#24%#44%\\n\\nPERSON#\\n\\nPRODUCT#RS-25#MRBM#GMLRS#Commercial Crew Development program#RKV program#Standard Missile program#AJ-60 solid rocket motor#RS-68#THAAD\\n\\nQUANTITY#\\n\\nTIME#\\n\\nWORK_OF_ART#Unfunded backlog#Funded backlog}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2511,\n",
      "    \"completion_tokens\": 598,\n",
      "    \"total_tokens\": 3109\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'June 2013', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2020', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2019', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2020', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2019', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2020', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2019', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2020', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2019', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2020', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2019', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2020', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2019', 'category': 'DATE'}, {'entity': 'during the fourth quarter of 2020', 'category': 'DATE'}, {'entity': 'As of December 31, 2020', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2020', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2019', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2020', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2019', 'category': 'DATE'}, {'entity': 'As of December 31', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': 'As of December 31, 2020', 'category': 'DATE'}, {'entity': 'As of December 31, 2019', 'category': 'DATE'}, {'entity': '$7.8 million', 'category': 'MONEY'}, {'entity': '$6.1', 'category': 'MONEY'}, {'entity': '0.5', 'category': 'MONEY'}, {'entity': '$5.6', 'category': 'MONEY'}, {'entity': '$41.1 million', 'category': 'MONEY'}, {'entity': '14.6 million', 'category': 'MONEY'}, {'entity': '$25 million', 'category': 'MONEY'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': 'IRS', 'category': 'ORG'}, {'entity': 'Applicable Financial Statement', 'category': 'ORG'}, {'entity': 'Companys', 'category': 'ORG'}, {'entity': 'Real Estate Segment', 'category': 'ORG'}, {'entity': 'COVID-19', 'category': 'ORG'}, {'entity': '23.6%', 'category': 'PERCENT'}, {'entity': '21%', 'category': 'PERCENT'}, {'entity': '26.5%', 'category': 'PERCENT'}, {'entity': '32%', 'category': 'PERCENT'}, {'entity': '24%', 'category': 'PERCENT'}, {'entity': '44%', 'category': 'PERCENT'}, {'entity': 'RS-25', 'category': 'PRODUCT'}, {'entity': 'MRBM', 'category': 'PRODUCT'}, {'entity': 'GMLRS', 'category': 'PRODUCT'}, {'entity': 'Commercial Crew Development program', 'category': 'PRODUCT'}, {'entity': 'RKV program', 'category': 'PRODUCT'}, {'entity': 'Standard Missile program', 'category': 'PRODUCT'}, {'entity': 'AJ-60 solid rocket motor', 'category': 'PRODUCT'}, {'entity': 'RS-68', 'category': 'PRODUCT'}, {'entity': 'THAAD', 'category': 'PRODUCT'}, {'entity': 'Unfunded backlog', 'category': 'WORK_OF_ART'}, {'entity': 'Funded backlog', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'second', 'category': 'ORDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '9.4', 'category': 'CARDINAL'}, {'entity': '1.6', 'category': 'CARDINAL'}, {'entity': '7.8', 'category': 'CARDINAL'}, {'entity': '6.3', 'category': 'CARDINAL'}, {'entity': '15.5', 'category': 'CARDINAL'}, {'entity': '20.2', 'category': 'CARDINAL'}, {'entity': '26.3', 'category': 'CARDINAL'}, {'entity': '30.1', 'category': 'CARDINAL'}, {'entity': '35.7', 'category': 'CARDINAL'}, {'entity': '42.5', 'category': 'CARDINAL'}, {'entity': '50.9', 'category': 'CARDINAL'}, {'entity': '23.6', 'category': 'CARDINAL'}, {'entity': '21', 'category': 'CARDINAL'}, {'entity': '41.1', 'category': 'CARDINAL'}, {'entity': '14.6', 'category': 'CARDINAL'}, {'entity': '26.5', 'category': 'CARDINAL'}, {'entity': '21', 'category': 'CARDINAL'}, {'entity': '43.3', 'category': 'CARDINAL'}, {'entity': '53.9', 'category': 'CARDINAL'}, {'entity': '60.5', 'category': 'CARDINAL'}, {'entity': '64.8', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '53.7', 'category': 'CARDINAL'}, {'entity': '37.1', 'category': 'CARDINAL'}, {'entity': '36.6', 'category': 'CARDINAL'}, {'entity': '26.1', 'category': 'CARDINAL'}, {'entity': '34', 'category': 'CARDINAL'}, {'entity': '45', 'category': 'CARDINAL'}, {'entity': '2,069.4', 'category': 'CARDINAL'}, {'entity': '1,974.0', 'category': 'CARDINAL'}, {'entity': '275.6', 'category': 'CARDINAL'}, {'entity': '269.3', 'category': 'CARDINAL'}, {'entity': '13.3', 'category': 'CARDINAL'}, {'entity': '13.6', 'category': 'CARDINAL'}, {'entity': '45.1', 'category': 'CARDINAL'}, {'entity': '38.4', 'category': 'CARDINAL'}, {'entity': '3.3', 'category': 'CARDINAL'}, {'entity': '7.5', 'category': 'CARDINAL'}, {'entity': '1.8', 'category': 'CARDINAL'}, {'entity': '2.1', 'category': 'CARDINAL'}, {'entity': '6.7', 'category': 'CARDINAL'}, {'entity': '5.4', 'category': 'CARDINAL'}, {'entity': '1.8', 'category': 'CARDINAL'}, {'entity': '32', 'category': 'CARDINAL'}, {'entity': '2.2', 'category': 'CARDINAL'}, {'entity': '24', 'category': 'CARDINAL'}, {'entity': '44', 'category': 'CARDINAL'}, {'entity': '3.0', 'category': 'CARDINAL'}, {'entity': '2.1', 'category': 'CARDINAL'}, {'entity': '3.7', 'category': 'CARDINAL'}, {'entity': '3.3', 'category': 'CARDINAL'}, {'entity': '6.7', 'category': 'CARDINAL'}, {'entity': '5.4', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  9\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVNjET1XC5ZupmzByspBPj3IK55X\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701566179,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#137.7#141.0#30.1#35.7#6.3#15.5#42.5#50.9#65.3#74.5#36.6#26.1#43.8#41.3#8.1#0.3#270.2#271.7#6.6#7.1#13.0#13.7#138.4#130.1#1.66#1.69#0.01#1.67#1.56#81.9#81.7#363.8#261.2#54.6#42.9#309.2#218.3#183.4#208.4#331.4#67.0#76.2#91.9#10.6#21.1#0.8#5.4#6.7#261.8#300.6#451.1#46.5#6.0#5.3#309.2#327.9#32.4#16.7#41.0#35.4#300.6#309.2#32.4#13.7#10.2#3.2#5.3#16.7#10.0#4.1#1.9#0.7\\n\\nDATE#Year Ended December 31, 2020#2019#Year Ended December 31, 2020#2019#Year Ended December 31#2020#2019#as of December 31, 2020#in the 1950s and 1960s#in 2020 and 2019#through the term of the project agreement, which expires in May 2027#Year Ended December 31,\\t2020#2019\\n\\nEVENT#our U.S. government contracts#our U.S. government contracts#Additional operations and maintenance#remediation#operable treatment units\\n\\nFAC#Aerojet Rocketdyne - Sacramento#Baldwin Park Operable Unit (\\\"BPOU\\\")#Other Aerojet Rocketdyne sites#Other sites\\n\\nGPE#U.S.#GAAP#the federal#state\\n\\nLAW#the Non-GAAP#GAAP#the Non-GAAP#in accordance with GAAP#GAAP#GAAP#with environmental laws and regulations#according to GAAP\\n\\nLOC#Sacramento#BPOU\\n\\nMONEY#137.7#141.0#30.1#35.7#6.3#15.5#42.5#50.9#65.3#74.5#36.6#26.1#43.8#41.3#8.1#0.3#270.2#271.7#137.7#141.0#36.6#26.1#43.8#41.3#8.1#0.3#138.4#130.1#81.9#81.7#363.8#261.2#54.6#42.9#309.2#218.3#183.4#208.4#331.4#67.0#76.2#91.9#10.6#21.1#0.8#5.4#6.7#261.8#300.6#451.1#46.5#6.0#5.3#309.2#327.9#32.4#16.7#41.0#35.4#300.6#309.2#32.4#13.7#10.2#3.2#5.3#16.7#10.0#4.1#1.9#0.7\\n\\nORG#Net Income#Adjusted Net Income#Adjusted EPS#Free Cash Flow#stakeholders#the investment community#the Non-GAAP#Northrop#Environmental Reserves#Aerojet Rocketdyne#Baldwin Park Operable Unit\\n\\nPERCENT#6.6#7.1#13.0#13.7\\n\\nPERSON#Free Cash Flow#Free Cash Flow\\n\\nPRODUCT#Free Cash Flow#Free Cash Flow\\n\\nQUANTITY#15 years\\n\\nTIME#May 2027}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2488,\n",
      "    \"completion_tokens\": 910,\n",
      "    \"total_tokens\": 3398\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'Year Ended December 31, 2020', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2020', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': 'as of December 31, 2020', 'category': 'DATE'}, {'entity': 'in the 1950s and 1960s', 'category': 'DATE'}, {'entity': 'in 2020 and 2019', 'category': 'DATE'}, {'entity': 'through the term of the project agreement, which expires in May 2027', 'category': 'DATE'}, {'entity': 'Year Ended December 31,\\t2020', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': 'our U.S. government contracts', 'category': 'EVENT'}, {'entity': 'our U.S. government contracts', 'category': 'EVENT'}, {'entity': 'Additional operations and maintenance', 'category': 'EVENT'}, {'entity': 'remediation', 'category': 'EVENT'}, {'entity': 'operable treatment units', 'category': 'EVENT'}, {'entity': 'Aerojet Rocketdyne - Sacramento', 'category': 'FAC'}, {'entity': 'Baldwin Park Operable Unit \"BPOU\"', 'category': 'FAC'}, {'entity': 'Other Aerojet Rocketdyne sites', 'category': 'FAC'}, {'entity': 'Other sites', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'GAAP', 'category': 'GPE'}, {'entity': 'the federal', 'category': 'GPE'}, {'entity': 'state', 'category': 'GPE'}, {'entity': 'the Non-GAAP', 'category': 'LAW'}, {'entity': 'GAAP', 'category': 'LAW'}, {'entity': 'the Non-GAAP', 'category': 'LAW'}, {'entity': 'in accordance with GAAP', 'category': 'LAW'}, {'entity': 'GAAP', 'category': 'LAW'}, {'entity': 'GAAP', 'category': 'LAW'}, {'entity': 'with environmental laws and regulations', 'category': 'LAW'}, {'entity': 'according to GAAP', 'category': 'LAW'}, {'entity': 'Sacramento', 'category': 'LOC'}, {'entity': 'BPOU', 'category': 'LOC'}, {'entity': '137.7', 'category': 'MONEY'}, {'entity': '141.0', 'category': 'MONEY'}, {'entity': '30.1', 'category': 'MONEY'}, {'entity': '35.7', 'category': 'MONEY'}, {'entity': '6.3', 'category': 'MONEY'}, {'entity': '15.5', 'category': 'MONEY'}, {'entity': '42.5', 'category': 'MONEY'}, {'entity': '50.9', 'category': 'MONEY'}, {'entity': '65.3', 'category': 'MONEY'}, {'entity': '74.5', 'category': 'MONEY'}, {'entity': '36.6', 'category': 'MONEY'}, {'entity': '26.1', 'category': 'MONEY'}, {'entity': '43.8', 'category': 'MONEY'}, {'entity': '41.3', 'category': 'MONEY'}, {'entity': '8.1', 'category': 'MONEY'}, {'entity': '0.3', 'category': 'MONEY'}, {'entity': '270.2', 'category': 'MONEY'}, {'entity': '271.7', 'category': 'MONEY'}, {'entity': '137.7', 'category': 'MONEY'}, {'entity': '141.0', 'category': 'MONEY'}, {'entity': '36.6', 'category': 'MONEY'}, {'entity': '26.1', 'category': 'MONEY'}, {'entity': '43.8', 'category': 'MONEY'}, {'entity': '41.3', 'category': 'MONEY'}, {'entity': '8.1', 'category': 'MONEY'}, {'entity': '0.3', 'category': 'MONEY'}, {'entity': '138.4', 'category': 'MONEY'}, {'entity': '130.1', 'category': 'MONEY'}, {'entity': '81.9', 'category': 'MONEY'}, {'entity': '81.7', 'category': 'MONEY'}, {'entity': '363.8', 'category': 'MONEY'}, {'entity': '261.2', 'category': 'MONEY'}, {'entity': '54.6', 'category': 'MONEY'}, {'entity': '42.9', 'category': 'MONEY'}, {'entity': '309.2', 'category': 'MONEY'}, {'entity': '218.3', 'category': 'MONEY'}, {'entity': '183.4', 'category': 'MONEY'}, {'entity': '208.4', 'category': 'MONEY'}, {'entity': '331.4', 'category': 'MONEY'}, {'entity': '67.0', 'category': 'MONEY'}, {'entity': '76.2', 'category': 'MONEY'}, {'entity': '91.9', 'category': 'MONEY'}, {'entity': '10.6', 'category': 'MONEY'}, {'entity': '21.1', 'category': 'MONEY'}, {'entity': '0.8', 'category': 'MONEY'}, {'entity': '5.4', 'category': 'MONEY'}, {'entity': '6.7', 'category': 'MONEY'}, {'entity': '261.8', 'category': 'MONEY'}, {'entity': '300.6', 'category': 'MONEY'}, {'entity': '451.1', 'category': 'MONEY'}, {'entity': '46.5', 'category': 'MONEY'}, {'entity': '6.0', 'category': 'MONEY'}, {'entity': '5.3', 'category': 'MONEY'}, {'entity': '309.2', 'category': 'MONEY'}, {'entity': '327.9', 'category': 'MONEY'}, {'entity': '32.4', 'category': 'MONEY'}, {'entity': '16.7', 'category': 'MONEY'}, {'entity': '41.0', 'category': 'MONEY'}, {'entity': '35.4', 'category': 'MONEY'}, {'entity': '300.6', 'category': 'MONEY'}, {'entity': '309.2', 'category': 'MONEY'}, {'entity': '32.4', 'category': 'MONEY'}, {'entity': '13.7', 'category': 'MONEY'}, {'entity': '10.2', 'category': 'MONEY'}, {'entity': '3.2', 'category': 'MONEY'}, {'entity': '5.3', 'category': 'MONEY'}, {'entity': '16.7', 'category': 'MONEY'}, {'entity': '10.0', 'category': 'MONEY'}, {'entity': '4.1', 'category': 'MONEY'}, {'entity': '1.9', 'category': 'MONEY'}, {'entity': '0.7', 'category': 'MONEY'}, {'entity': 'Net Income', 'category': 'ORG'}, {'entity': 'Adjusted Net Income', 'category': 'ORG'}, {'entity': 'Adjusted EPS', 'category': 'ORG'}, {'entity': 'Free Cash Flow', 'category': 'ORG'}, {'entity': 'stakeholders', 'category': 'ORG'}, {'entity': 'the investment community', 'category': 'ORG'}, {'entity': 'the Non-GAAP', 'category': 'ORG'}, {'entity': 'Northrop', 'category': 'ORG'}, {'entity': 'Environmental Reserves', 'category': 'ORG'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': 'Baldwin Park Operable Unit', 'category': 'ORG'}, {'entity': '6.6', 'category': 'PERCENT'}, {'entity': '7.1', 'category': 'PERCENT'}, {'entity': '13.0', 'category': 'PERCENT'}, {'entity': '13.7', 'category': 'PERCENT'}, {'entity': 'Free Cash Flow', 'category': 'PERSON'}, {'entity': 'Free Cash Flow', 'category': 'PERSON'}, {'entity': 'Free Cash Flow', 'category': 'PRODUCT'}, {'entity': 'Free Cash Flow', 'category': 'PRODUCT'}, {'entity': '15 years', 'category': 'QUANTITY'}, {'entity': 'May 2027', 'category': 'TIME'}, {'entity': '137.7', 'category': 'CARDINAL'}, {'entity': '141.0', 'category': 'CARDINAL'}, {'entity': '30.1', 'category': 'CARDINAL'}, {'entity': '35.7', 'category': 'CARDINAL'}, {'entity': '6.3', 'category': 'CARDINAL'}, {'entity': '15.5', 'category': 'CARDINAL'}, {'entity': '42.5', 'category': 'CARDINAL'}, {'entity': '50.9', 'category': 'CARDINAL'}, {'entity': '65.3', 'category': 'CARDINAL'}, {'entity': '74.5', 'category': 'CARDINAL'}, {'entity': '36.6', 'category': 'CARDINAL'}, {'entity': '26.1', 'category': 'CARDINAL'}, {'entity': '43.8', 'category': 'CARDINAL'}, {'entity': '41.3', 'category': 'CARDINAL'}, {'entity': '8.1', 'category': 'CARDINAL'}, {'entity': '0.3', 'category': 'CARDINAL'}, {'entity': '270.2', 'category': 'CARDINAL'}, {'entity': '271.7', 'category': 'CARDINAL'}, {'entity': '6.6', 'category': 'CARDINAL'}, {'entity': '7.1', 'category': 'CARDINAL'}, {'entity': '13.0', 'category': 'CARDINAL'}, {'entity': '13.7', 'category': 'CARDINAL'}, {'entity': '138.4', 'category': 'CARDINAL'}, {'entity': '130.1', 'category': 'CARDINAL'}, {'entity': '1.66', 'category': 'CARDINAL'}, {'entity': '1.69', 'category': 'CARDINAL'}, {'entity': '0.01', 'category': 'CARDINAL'}, {'entity': '1.67', 'category': 'CARDINAL'}, {'entity': '1.56', 'category': 'CARDINAL'}, {'entity': '81.9', 'category': 'CARDINAL'}, {'entity': '81.7', 'category': 'CARDINAL'}, {'entity': '363.8', 'category': 'CARDINAL'}, {'entity': '261.2', 'category': 'CARDINAL'}, {'entity': '54.6', 'category': 'CARDINAL'}, {'entity': '42.9', 'category': 'CARDINAL'}, {'entity': '309.2', 'category': 'CARDINAL'}, {'entity': '218.3', 'category': 'CARDINAL'}, {'entity': '183.4', 'category': 'CARDINAL'}, {'entity': '208.4', 'category': 'CARDINAL'}, {'entity': '331.4', 'category': 'CARDINAL'}, {'entity': '67.0', 'category': 'CARDINAL'}, {'entity': '76.2', 'category': 'CARDINAL'}, {'entity': '91.9', 'category': 'CARDINAL'}, {'entity': '10.6', 'category': 'CARDINAL'}, {'entity': '21.1', 'category': 'CARDINAL'}, {'entity': '0.8', 'category': 'CARDINAL'}, {'entity': '5.4', 'category': 'CARDINAL'}, {'entity': '6.7', 'category': 'CARDINAL'}, {'entity': '261.8', 'category': 'CARDINAL'}, {'entity': '300.6', 'category': 'CARDINAL'}, {'entity': '451.1', 'category': 'CARDINAL'}, {'entity': '46.5', 'category': 'CARDINAL'}, {'entity': '6.0', 'category': 'CARDINAL'}, {'entity': '5.3', 'category': 'CARDINAL'}, {'entity': '309.2', 'category': 'CARDINAL'}, {'entity': '327.9', 'category': 'CARDINAL'}, {'entity': '32.4', 'category': 'CARDINAL'}, {'entity': '16.7', 'category': 'CARDINAL'}, {'entity': '41.0', 'category': 'CARDINAL'}, {'entity': '35.4', 'category': 'CARDINAL'}, {'entity': '300.6', 'category': 'CARDINAL'}, {'entity': '309.2', 'category': 'CARDINAL'}, {'entity': '32.4', 'category': 'CARDINAL'}, {'entity': '13.7', 'category': 'CARDINAL'}, {'entity': '10.2', 'category': 'CARDINAL'}, {'entity': '3.2', 'category': 'CARDINAL'}, {'entity': '5.3', 'category': 'CARDINAL'}, {'entity': '16.7', 'category': 'CARDINAL'}, {'entity': '10.0', 'category': 'CARDINAL'}, {'entity': '4.1', 'category': 'CARDINAL'}, {'entity': '1.9', 'category': 'CARDINAL'}, {'entity': '0.7', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  9\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVOdUuQNG3XEcYjfIY3ee2fyQfch\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701566235,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#12%\\n\\nDATE#Year Ended December 31, 2020#Year Ended December 31, 2019#December 31, 2019#December 31, 2020#March 27, 2020#December 31, 2017\\n\\nEVENT#the COVID-19 pandemic#the Global Settlement#the Merger#the Pre-Closing Period\\n\\nGPE#U.S.\\n\\nLAW#the CARES Act#the Merger Agreement\\n\\nMONEY#$322.0 #$344.1 #$28.3 #$14.5 #$36.0#$30.6#$6.0#$308.3#$322.0#$4.3#$2.1#$363.8#$261.2#$61.0#$41.8#$85.9#$24.1#$216.9#$195.3#$102.6 million#$54.6 million#$42.9 million#$6.7 million#$21.7 million#$20.8 million#$51.7 million#$12.5 million#$3.3 million#$328.1 #$19.6#$308.5 #$300.0#$47.7 #$2.1#$45.6#$675.8 #$21.7#$654.1 #$1,149.5 million #$622.4 million\\n\\nORG#Aerojet Rocketdyne#Northrop#Senior Credit Facility#Board of Directors\\n\\nPERCENT#2 1/4%#2\\u00bc%\\n\\nPERSON#COVID-19\\n\\nPRODUCT#RS-25 program\\n\\nTIME#this Report\\n\\nWORK_OF_ART#Note 1 in the consolidated financial statements in Item 8}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2338,\n",
      "    \"completion_tokens\": 345,\n",
      "    \"total_tokens\": 2683\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'Year Ended December 31, 2020', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2019', 'category': 'DATE'}, {'entity': 'December 31, 2019', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'March 27, 2020', 'category': 'DATE'}, {'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': 'the COVID-19 pandemic', 'category': 'EVENT'}, {'entity': 'the Global Settlement', 'category': 'EVENT'}, {'entity': 'the Merger', 'category': 'EVENT'}, {'entity': 'the Pre-Closing Period', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'the CARES Act', 'category': 'LAW'}, {'entity': 'the Merger Agreement', 'category': 'LAW'}, {'entity': '$322.0', 'category': 'MONEY'}, {'entity': '$344.1', 'category': 'MONEY'}, {'entity': '$28.3', 'category': 'MONEY'}, {'entity': '$14.5', 'category': 'MONEY'}, {'entity': '$36.0', 'category': 'MONEY'}, {'entity': '$30.6', 'category': 'MONEY'}, {'entity': '$6.0', 'category': 'MONEY'}, {'entity': '$308.3', 'category': 'MONEY'}, {'entity': '$322.0', 'category': 'MONEY'}, {'entity': '$4.3', 'category': 'MONEY'}, {'entity': '$2.1', 'category': 'MONEY'}, {'entity': '$363.8', 'category': 'MONEY'}, {'entity': '$261.2', 'category': 'MONEY'}, {'entity': '$61.0', 'category': 'MONEY'}, {'entity': '$41.8', 'category': 'MONEY'}, {'entity': '$85.9', 'category': 'MONEY'}, {'entity': '$24.1', 'category': 'MONEY'}, {'entity': '$216.9', 'category': 'MONEY'}, {'entity': '$195.3', 'category': 'MONEY'}, {'entity': '$102.6 million', 'category': 'MONEY'}, {'entity': '$54.6 million', 'category': 'MONEY'}, {'entity': '$42.9 million', 'category': 'MONEY'}, {'entity': '$6.7 million', 'category': 'MONEY'}, {'entity': '$21.7 million', 'category': 'MONEY'}, {'entity': '$20.8 million', 'category': 'MONEY'}, {'entity': '$51.7 million', 'category': 'MONEY'}, {'entity': '$12.5 million', 'category': 'MONEY'}, {'entity': '$3.3 million', 'category': 'MONEY'}, {'entity': '$328.1', 'category': 'MONEY'}, {'entity': '$19.6', 'category': 'MONEY'}, {'entity': '$308.5', 'category': 'MONEY'}, {'entity': '$300.0', 'category': 'MONEY'}, {'entity': '$47.7', 'category': 'MONEY'}, {'entity': '$2.1', 'category': 'MONEY'}, {'entity': '$45.6', 'category': 'MONEY'}, {'entity': '$675.8', 'category': 'MONEY'}, {'entity': '$21.7', 'category': 'MONEY'}, {'entity': '$654.1', 'category': 'MONEY'}, {'entity': '$1,149.5 million', 'category': 'MONEY'}, {'entity': '$622.4 million', 'category': 'MONEY'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': 'Northrop', 'category': 'ORG'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': 'Board of Directors', 'category': 'ORG'}, {'entity': '2 1/4%', 'category': 'PERCENT'}, {'entity': '2¼%', 'category': 'PERCENT'}, {'entity': 'COVID-19', 'category': 'PERSON'}, {'entity': 'RS-25 program', 'category': 'PRODUCT'}, {'entity': 'this Report', 'category': 'TIME'}, {'entity': 'Note 1 in the consolidated financial statements in Item 8', 'category': 'WORK_OF_ART'}, {'entity': '12%', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  9\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVPFLU41UDLJ00mr4itfGx7Z1NjT\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701566273,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#100 million#18#1.3 million#51.7 million#48.3 million#8#a#8#308.5#26.3#282.2#300.0#300.0#45.6#2.1#3.2#3.0#37.3#63.1#15.0#27.1#4.6#16.4#21.0#3.4#5.7#4.5#7.4#56.4#14.9#19.6#5.9#16.0#1,352.8#863.9#485.3#3.0#0.6#51.4#21.5#1.4#28.5#2,198.8#1,225.6#844.6#22.4#106.2#2\\u00bc#33.80#20#30#2\\u00bc#6#15#94 \\n\\nDATE#March 13, 2020#December 31, 2020#January 1, 2021#March 31, 2021#December 31, 2020#10 years#2021\\n\\nEVENT#Merger#share repurchase program\\n\\nFAC#Board of Directors#Senior Credit Facility\\n\\nGPE#U.S.\\n\\nLAW#Item 8#Risk Factors#Part I, Item 1A. Risk Factors#Item 8#Item 8#Item 8\\n\\nMONEY#$100 million#$51.7 million#$48.3 million#$308.5#$26.3#$282.2#$300.0#$45.6#$2.1#$3.2#$3.0#$37.3#$63.1#$15.0#$27.1#$4.6#$16.4#$21.0#$3.4#$5.7#$4.5#$7.4#$56.4#$14.9#$19.6#$5.9#$16.0#$1,352.8#$863.9#$485.3#$3.0#$0.6#$51.4#$21.5#$1.4#$28.5#$2,198.8#$1,225.6#$844.6#$22.4#$106.2\\n\\nORG#Board of Directors#Senior Credit Facility#U.S. government#Aerospace and Defense segment#CAS#Aerospace and Defense\\n\\nPERCENT#2\\u00bc%#2\\u00bc%\\n\\nQUANTITY#1.3 million#2\\u00bc\\n\\nTIME#20 days#30 day\\n\\nWORK_OF_ART#Risk Factors#Part I, Item 1A. Risk Factors#Note 8(d)#Note 1}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2287,\n",
      "    \"completion_tokens\": 579,\n",
      "    \"total_tokens\": 2866\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'March 13, 2020', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'January 1, 2021', 'category': 'DATE'}, {'entity': 'March 31, 2021', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': '10 years', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': 'Merger', 'category': 'EVENT'}, {'entity': 'share repurchase program', 'category': 'EVENT'}, {'entity': 'Board of Directors', 'category': 'FAC'}, {'entity': 'Senior Credit Facility', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Item 8', 'category': 'LAW'}, {'entity': 'Risk Factors', 'category': 'LAW'}, {'entity': 'Part I, Item 1A. Risk Factors', 'category': 'LAW'}, {'entity': 'Item 8', 'category': 'LAW'}, {'entity': 'Item 8', 'category': 'LAW'}, {'entity': 'Item 8', 'category': 'LAW'}, {'entity': '$100 million', 'category': 'MONEY'}, {'entity': '$51.7 million', 'category': 'MONEY'}, {'entity': '$48.3 million', 'category': 'MONEY'}, {'entity': '$308.5', 'category': 'MONEY'}, {'entity': '$26.3', 'category': 'MONEY'}, {'entity': '$282.2', 'category': 'MONEY'}, {'entity': '$300.0', 'category': 'MONEY'}, {'entity': '$45.6', 'category': 'MONEY'}, {'entity': '$2.1', 'category': 'MONEY'}, {'entity': '$3.2', 'category': 'MONEY'}, {'entity': '$3.0', 'category': 'MONEY'}, {'entity': '$37.3', 'category': 'MONEY'}, {'entity': '$63.1', 'category': 'MONEY'}, {'entity': '$15.0', 'category': 'MONEY'}, {'entity': '$27.1', 'category': 'MONEY'}, {'entity': '$4.6', 'category': 'MONEY'}, {'entity': '$16.4', 'category': 'MONEY'}, {'entity': '$21.0', 'category': 'MONEY'}, {'entity': '$3.4', 'category': 'MONEY'}, {'entity': '$5.7', 'category': 'MONEY'}, {'entity': '$4.5', 'category': 'MONEY'}, {'entity': '$7.4', 'category': 'MONEY'}, {'entity': '$56.4', 'category': 'MONEY'}, {'entity': '$14.9', 'category': 'MONEY'}, {'entity': '$19.6', 'category': 'MONEY'}, {'entity': '$5.9', 'category': 'MONEY'}, {'entity': '$16.0', 'category': 'MONEY'}, {'entity': '$1,352.8', 'category': 'MONEY'}, {'entity': '$863.9', 'category': 'MONEY'}, {'entity': '$485.3', 'category': 'MONEY'}, {'entity': '$3.0', 'category': 'MONEY'}, {'entity': '$0.6', 'category': 'MONEY'}, {'entity': '$51.4', 'category': 'MONEY'}, {'entity': '$21.5', 'category': 'MONEY'}, {'entity': '$1.4', 'category': 'MONEY'}, {'entity': '$28.5', 'category': 'MONEY'}, {'entity': '$2,198.8', 'category': 'MONEY'}, {'entity': '$1,225.6', 'category': 'MONEY'}, {'entity': '$844.6', 'category': 'MONEY'}, {'entity': '$22.4', 'category': 'MONEY'}, {'entity': '$106.2', 'category': 'MONEY'}, {'entity': 'Board of Directors', 'category': 'ORG'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'Aerospace and Defense segment', 'category': 'ORG'}, {'entity': 'CAS', 'category': 'ORG'}, {'entity': 'Aerospace and Defense', 'category': 'ORG'}, {'entity': '2¼%', 'category': 'PERCENT'}, {'entity': '2¼%', 'category': 'PERCENT'}, {'entity': '1.3 million', 'category': 'QUANTITY'}, {'entity': '2¼', 'category': 'QUANTITY'}, {'entity': '20 days', 'category': 'TIME'}, {'entity': '30 day', 'category': 'TIME'}, {'entity': 'Risk Factors', 'category': 'WORK_OF_ART'}, {'entity': 'Part I, Item 1A. Risk Factors', 'category': 'WORK_OF_ART'}, {'entity': 'Note 8d', 'category': 'WORK_OF_ART'}, {'entity': 'Note 1', 'category': 'WORK_OF_ART'}, {'entity': '100 million', 'category': 'CARDINAL'}, {'entity': '18', 'category': 'CARDINAL'}, {'entity': '1.3 million', 'category': 'CARDINAL'}, {'entity': '51.7 million', 'category': 'CARDINAL'}, {'entity': '48.3 million', 'category': 'CARDINAL'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': 'a', 'category': 'CARDINAL'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': '308.5', 'category': 'CARDINAL'}, {'entity': '26.3', 'category': 'CARDINAL'}, {'entity': '282.2', 'category': 'CARDINAL'}, {'entity': '300.0', 'category': 'CARDINAL'}, {'entity': '300.0', 'category': 'CARDINAL'}, {'entity': '45.6', 'category': 'CARDINAL'}, {'entity': '2.1', 'category': 'CARDINAL'}, {'entity': '3.2', 'category': 'CARDINAL'}, {'entity': '3.0', 'category': 'CARDINAL'}, {'entity': '37.3', 'category': 'CARDINAL'}, {'entity': '63.1', 'category': 'CARDINAL'}, {'entity': '15.0', 'category': 'CARDINAL'}, {'entity': '27.1', 'category': 'CARDINAL'}, {'entity': '4.6', 'category': 'CARDINAL'}, {'entity': '16.4', 'category': 'CARDINAL'}, {'entity': '21.0', 'category': 'CARDINAL'}, {'entity': '3.4', 'category': 'CARDINAL'}, {'entity': '5.7', 'category': 'CARDINAL'}, {'entity': '4.5', 'category': 'CARDINAL'}, {'entity': '7.4', 'category': 'CARDINAL'}, {'entity': '56.4', 'category': 'CARDINAL'}, {'entity': '14.9', 'category': 'CARDINAL'}, {'entity': '19.6', 'category': 'CARDINAL'}, {'entity': '5.9', 'category': 'CARDINAL'}, {'entity': '16.0', 'category': 'CARDINAL'}, {'entity': '1,352.8', 'category': 'CARDINAL'}, {'entity': '863.9', 'category': 'CARDINAL'}, {'entity': '485.3', 'category': 'CARDINAL'}, {'entity': '3.0', 'category': 'CARDINAL'}, {'entity': '0.6', 'category': 'CARDINAL'}, {'entity': '51.4', 'category': 'CARDINAL'}, {'entity': '21.5', 'category': 'CARDINAL'}, {'entity': '1.4', 'category': 'CARDINAL'}, {'entity': '28.5', 'category': 'CARDINAL'}, {'entity': '2,198.8', 'category': 'CARDINAL'}, {'entity': '1,225.6', 'category': 'CARDINAL'}, {'entity': '844.6', 'category': 'CARDINAL'}, {'entity': '22.4', 'category': 'CARDINAL'}, {'entity': '106.2', 'category': 'CARDINAL'}, {'entity': '2¼', 'category': 'CARDINAL'}, {'entity': '33.80', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '30', 'category': 'CARDINAL'}, {'entity': '2¼', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '15', 'category': 'CARDINAL'}, {'entity': '94', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  9\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVQ0KPEO1AV0dIFSndndmX8Q25u4\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701566320,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#2009#401 \\n\\nDATE#Year Ended December 31, 2020#Year Ended December 31, 2019 \\n\\nEVENT#Retirement Benefit Plans\\n\\nFAC#Aerospace and Defense\\n\\nMONEY#$38.5#$38.6#45.1#38.4\\n\\nORDINAL#first \\n\\nORG#U.S. government#Cost-based pricing\\n\\nPERCENT#0.44#0.36#0.42#0.34 \\n\\nPERSON#DCAA\\n\\nPRODUCT#contract overhead costs\\n\\nQUANTITY#34.5#28.2\\n\\nTIME#\\n\\nWORK_OF_ART#}\\n\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2007,\n",
      "    \"completion_tokens\": 130,\n",
      "    \"total_tokens\": 2137\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'Year Ended December 31, 2020', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2019', 'category': 'DATE'}, {'entity': 'Retirement Benefit Plans', 'category': 'EVENT'}, {'entity': 'Aerospace and Defense', 'category': 'FAC'}, {'entity': '$38.5', 'category': 'MONEY'}, {'entity': '$38.6', 'category': 'MONEY'}, {'entity': '45.1', 'category': 'MONEY'}, {'entity': '38.4', 'category': 'MONEY'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'Cost-based pricing', 'category': 'ORG'}, {'entity': '0.44', 'category': 'PERCENT'}, {'entity': '0.36', 'category': 'PERCENT'}, {'entity': '0.42', 'category': 'PERCENT'}, {'entity': '0.34', 'category': 'PERCENT'}, {'entity': 'DCAA', 'category': 'PERSON'}, {'entity': 'contract overhead costs', 'category': 'PRODUCT'}, {'entity': '34.5', 'category': 'QUANTITY'}, {'entity': '28.2', 'category': 'QUANTITY'}, {'entity': '', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '2009', 'category': 'CARDINAL'}, {'entity': '401', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  9\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVQVLJZ4yZPiNUJECkN6T7Vzz3Lt\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701566351,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#1 \\n\\nDATE#December 31#December 31, 2020#Year Ended December 31#2020#2019\\n\\nFAC#Global Settlement\\n\\nGPE#U.S.\\n\\nMONEY#$18.3#$150.5#$8.6#$(0.1)#$(0.3)#$(15.7)#$(126.0)#$(8.7)\\n\\nORG#GAAP#U.S. government\\n\\nPERCENT#2.52 %#3.28 %#2.28 %#3.19 %#3.28 %#4.27 %#3.19 %#4.09 %#7.00 %#7.00 %\\n\\nPERSON#Item 8\\n\\nQUANTITY#one-percentage-point\\n\\nTIME#three years\\n\\nWORK_OF_ART#Environmental Matters#Notes 8(b) and 8(c)}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2169,\n",
      "    \"completion_tokens\": 182,\n",
      "    \"total_tokens\": 2351\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': 'Global Settlement', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '$18.3', 'category': 'MONEY'}, {'entity': '$150.5', 'category': 'MONEY'}, {'entity': '$8.6', 'category': 'MONEY'}, {'entity': '$0.1', 'category': 'MONEY'}, {'entity': '$0.3', 'category': 'MONEY'}, {'entity': '$15.7', 'category': 'MONEY'}, {'entity': '$126.0', 'category': 'MONEY'}, {'entity': '$8.7', 'category': 'MONEY'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': '2.52 %', 'category': 'PERCENT'}, {'entity': '3.28 %', 'category': 'PERCENT'}, {'entity': '2.28 %', 'category': 'PERCENT'}, {'entity': '3.19 %', 'category': 'PERCENT'}, {'entity': '3.28 %', 'category': 'PERCENT'}, {'entity': '4.27 %', 'category': 'PERCENT'}, {'entity': '3.19 %', 'category': 'PERCENT'}, {'entity': '4.09 %', 'category': 'PERCENT'}, {'entity': '7.00 %', 'category': 'PERCENT'}, {'entity': '7.00 %', 'category': 'PERCENT'}, {'entity': 'Item 8', 'category': 'PERSON'}, {'entity': 'one-percentage-point', 'category': 'QUANTITY'}, {'entity': 'three years', 'category': 'TIME'}, {'entity': 'Environmental Matters', 'category': 'WORK_OF_ART'}, {'entity': 'Notes 8b and 8c', 'category': 'WORK_OF_ART'}, {'entity': '1', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  9\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVR1gof1vozV9kBg7FAlXMDk84YC\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701566383,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#50%#49%#51%#2.25%#1.90% \\n\\nDATE#December 31, 2020#December 31, 2019#December 31, 2020#December 31, 2019#past three years\\n\\nLAW#Senior Credit Facility\\n\\nMONEY#$608.5 million#$300.0 million#$308.5 million\\n\\nORG#Retirement Benefit Plans\\n\\nPERCENT#2.25%#1.90%\\n\\nQUANTITY#$608.5 million\\n\\nTIME#three years}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 1453,\n",
      "    \"completion_tokens\": 118,\n",
      "    \"total_tokens\": 1571\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'December 31, 2019', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'December 31, 2019', 'category': 'DATE'}, {'entity': 'past three years', 'category': 'DATE'}, {'entity': 'Senior Credit Facility', 'category': 'LAW'}, {'entity': '$608.5 million', 'category': 'MONEY'}, {'entity': '$300.0 million', 'category': 'MONEY'}, {'entity': '$308.5 million', 'category': 'MONEY'}, {'entity': 'Retirement Benefit Plans', 'category': 'ORG'}, {'entity': '2.25%', 'category': 'PERCENT'}, {'entity': '1.90%', 'category': 'PERCENT'}, {'entity': '$608.5 million', 'category': 'QUANTITY'}, {'entity': 'three years', 'category': 'TIME'}, {'entity': '50%', 'category': 'CARDINAL'}, {'entity': '49%', 'category': 'CARDINAL'}, {'entity': '51%', 'category': 'CARDINAL'}, {'entity': '2.25%', 'category': 'CARDINAL'}, {'entity': '1.90%', 'category': 'CARDINAL'}]\n",
      "/home/damir/Dropbox/Documents/Teaching/2023/L715/l715_23/data/10-Ks/Aerojet_Rocketdyne_Holdings_Inc./2018/Management.txt\n",
      "Length of chunks:  12\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVRURCFjlfrGjjM5w8PVrOozYdTB\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701566412,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#7#8#6#2017#2016#1#1#35#21#2018#64.6#74.4#27#29#225.4#201.9#205.4#188.4#212.8#158.7#183.4#111.1#4.6#4.5#2.1#2.3 \\n\\nDATE#December 22, 2017#December 31, 2017#December 31, 2016#April 6, 2017#December 31, 2015#November 30, 2015\\n\\nEVENT#Management\\u2019s Discussion and Analysis of Financial Condition and Results of Operations#Tax Cuts and Jobs Act#CIP \\n\\nFAC#Phase I#Phase II\\n\\nGPE#U.S.\\n\\nLAW#the \\u201cTax Act\\u201d#Consolidated Financial Statements#Supplementary Data of this Report\\n\\nMONEY#$1,877.2 million#$1,761.3 million#$18.0 million#$0.27#$(9.2) million#$(0.13)#$201.9 million#$188.4 million#$158.7 million#$111.1 million#$4.5 billion#$2.3 billion#$230 million#$235.1 million#$60.5 million#$79.5 million#$32.5 million\\n\\nORDINAL#first#second\\n\\nORG#Net#NASA#Missile Defense Agency#U.S. Army#U.S. Air Force#U.S. Navy#U.S. government#Lockheed Martin#ULA#Raytheon#Board of Directors#Sacramento#California#Gainesville#Virginia#Huntsville#Alabama\\n\\nPERCENT#74.4%#27%#29%#92 %#91 %#90 %#85 %#30 %#23 %#16 %#12 %#9 %#2 %#8 %#100 %#14 %#12 %#10 %#24 %#27 %#29 %#24 %#22 %#21 %#19 %#28 %#17 %#20 %#20 %#19 \\n\\nPERSON#\\n\\nPRODUCT#\\n\\nQUANTITY#\\n\\nTIME#\\n\\nWORK_OF_ART#}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2429,\n",
      "    \"completion_tokens\": 442,\n",
      "    \"total_tokens\": 2871\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 22, 2017', 'category': 'DATE'}, {'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'April 6, 2017', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': 'Management’s Discussion and Analysis of Financial Condition and Results of Operations', 'category': 'EVENT'}, {'entity': 'Tax Cuts and Jobs Act', 'category': 'EVENT'}, {'entity': 'CIP', 'category': 'EVENT'}, {'entity': 'Phase I', 'category': 'FAC'}, {'entity': 'Phase II', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'the “Tax Act”', 'category': 'LAW'}, {'entity': 'Consolidated Financial Statements', 'category': 'LAW'}, {'entity': 'Supplementary Data of this Report', 'category': 'LAW'}, {'entity': '$1,877.2 million', 'category': 'MONEY'}, {'entity': '$1,761.3 million', 'category': 'MONEY'}, {'entity': '$18.0 million', 'category': 'MONEY'}, {'entity': '$0.27', 'category': 'MONEY'}, {'entity': '$9.2 million', 'category': 'MONEY'}, {'entity': '$0.13', 'category': 'MONEY'}, {'entity': '$201.9 million', 'category': 'MONEY'}, {'entity': '$188.4 million', 'category': 'MONEY'}, {'entity': '$158.7 million', 'category': 'MONEY'}, {'entity': '$111.1 million', 'category': 'MONEY'}, {'entity': '$4.5 billion', 'category': 'MONEY'}, {'entity': '$2.3 billion', 'category': 'MONEY'}, {'entity': '$230 million', 'category': 'MONEY'}, {'entity': '$235.1 million', 'category': 'MONEY'}, {'entity': '$60.5 million', 'category': 'MONEY'}, {'entity': '$79.5 million', 'category': 'MONEY'}, {'entity': '$32.5 million', 'category': 'MONEY'}, {'entity': 'Net', 'category': 'ORG'}, {'entity': 'NASA', 'category': 'ORG'}, {'entity': 'Missile Defense Agency', 'category': 'ORG'}, {'entity': 'U.S. Army', 'category': 'ORG'}, {'entity': 'U.S. Air Force', 'category': 'ORG'}, {'entity': 'U.S. Navy', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'Lockheed Martin', 'category': 'ORG'}, {'entity': 'ULA', 'category': 'ORG'}, {'entity': 'Raytheon', 'category': 'ORG'}, {'entity': 'Board of Directors', 'category': 'ORG'}, {'entity': 'Sacramento', 'category': 'ORG'}, {'entity': 'California', 'category': 'ORG'}, {'entity': 'Gainesville', 'category': 'ORG'}, {'entity': 'Virginia', 'category': 'ORG'}, {'entity': 'Huntsville', 'category': 'ORG'}, {'entity': 'Alabama', 'category': 'ORG'}, {'entity': '74.4%', 'category': 'PERCENT'}, {'entity': '27%', 'category': 'PERCENT'}, {'entity': '29%', 'category': 'PERCENT'}, {'entity': '92 %', 'category': 'PERCENT'}, {'entity': '91 %', 'category': 'PERCENT'}, {'entity': '90 %', 'category': 'PERCENT'}, {'entity': '85 %', 'category': 'PERCENT'}, {'entity': '30 %', 'category': 'PERCENT'}, {'entity': '23 %', 'category': 'PERCENT'}, {'entity': '16 %', 'category': 'PERCENT'}, {'entity': '12 %', 'category': 'PERCENT'}, {'entity': '9 %', 'category': 'PERCENT'}, {'entity': '2 %', 'category': 'PERCENT'}, {'entity': '8 %', 'category': 'PERCENT'}, {'entity': '100 %', 'category': 'PERCENT'}, {'entity': '14 %', 'category': 'PERCENT'}, {'entity': '12 %', 'category': 'PERCENT'}, {'entity': '10 %', 'category': 'PERCENT'}, {'entity': '24 %', 'category': 'PERCENT'}, {'entity': '27 %', 'category': 'PERCENT'}, {'entity': '29 %', 'category': 'PERCENT'}, {'entity': '24 %', 'category': 'PERCENT'}, {'entity': '22 %', 'category': 'PERCENT'}, {'entity': '21 %', 'category': 'PERCENT'}, {'entity': '19 %', 'category': 'PERCENT'}, {'entity': '28 %', 'category': 'PERCENT'}, {'entity': '17 %', 'category': 'PERCENT'}, {'entity': '20 %', 'category': 'PERCENT'}, {'entity': '20 %', 'category': 'PERCENT'}, {'entity': '19', 'category': 'PERCENT'}, {'entity': '', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'second', 'category': 'ORDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '2017', 'category': 'CARDINAL'}, {'entity': '2016', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '35', 'category': 'CARDINAL'}, {'entity': '21', 'category': 'CARDINAL'}, {'entity': '2018', 'category': 'CARDINAL'}, {'entity': '64.6', 'category': 'CARDINAL'}, {'entity': '74.4', 'category': 'CARDINAL'}, {'entity': '27', 'category': 'CARDINAL'}, {'entity': '29', 'category': 'CARDINAL'}, {'entity': '225.4', 'category': 'CARDINAL'}, {'entity': '201.9', 'category': 'CARDINAL'}, {'entity': '205.4', 'category': 'CARDINAL'}, {'entity': '188.4', 'category': 'CARDINAL'}, {'entity': '212.8', 'category': 'CARDINAL'}, {'entity': '158.7', 'category': 'CARDINAL'}, {'entity': '183.4', 'category': 'CARDINAL'}, {'entity': '111.1', 'category': 'CARDINAL'}, {'entity': '4.6', 'category': 'CARDINAL'}, {'entity': '4.5', 'category': 'CARDINAL'}, {'entity': '2.1', 'category': 'CARDINAL'}, {'entity': '2.3', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  12\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVS7ZPGDUKCZ3r7HnOXtE4BQ99rs\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701566451,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#670.9#42.0#37.5#4.5#75.8#33.7#42.1#158.0#36.5#32.2#95.0#37.2#42.0#36.8#32.2#26.1#26.4#32.4#96.3 \\n\\nDATE#December 31, 2017#fiscal 2018#fiscal 2017#December 31, 2016#December 31, 2015#fiscal 2016#fiscal 2015#fiscal 2016#December 31, 2015\\n\\nEVENT#\\n\\nFAC#\\n\\nGPE#U.S.#Sacramento\\n\\nLANGUAGE#\\n\\nLAW#CAS#PPA#IRS regulations\\n\\nLOC#\\n\\nMONEY#$158.0 million#$36.5 million#$32.2 million#$115.9 million#$1,761.3 million#$1,708.3 million#$95.0 million#$37.2 million#$42.0 million#$36.8 million#$32.2 million#$96.3 million#$26.4 million#$32.4 million\\n\\nNORP#U.S. \\n\\nORDINAL#\\n\\nORG#Notes#Aerojet Rocketdyne#Commercial Crew Development program#Atlas V program#THAAD#Standard Missile programs#Coleman Aerospace#RS-25 program#SLS development program#RL10 program#PAC-3 contracts\\n\\nPERSON#\\n\\nPERCENT#\\n\\nPRODUCT#\\n\\nQUANTITY#750 acres\\n\\nTIME#\\n\\nWORK_OF_ART#}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2459,\n",
      "    \"completion_tokens\": 332,\n",
      "    \"total_tokens\": 2791\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': 'fiscal 2018', 'category': 'DATE'}, {'entity': 'fiscal 2017', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'fiscal 2016', 'category': 'DATE'}, {'entity': 'fiscal 2015', 'category': 'DATE'}, {'entity': 'fiscal 2016', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Sacramento', 'category': 'GPE'}, {'entity': 'CAS', 'category': 'LAW'}, {'entity': 'PPA', 'category': 'LAW'}, {'entity': 'IRS regulations', 'category': 'LAW'}, {'entity': '$158.0 million', 'category': 'MONEY'}, {'entity': '$36.5 million', 'category': 'MONEY'}, {'entity': '$32.2 million', 'category': 'MONEY'}, {'entity': '$115.9 million', 'category': 'MONEY'}, {'entity': '$1,761.3 million', 'category': 'MONEY'}, {'entity': '$1,708.3 million', 'category': 'MONEY'}, {'entity': '$95.0 million', 'category': 'MONEY'}, {'entity': '$37.2 million', 'category': 'MONEY'}, {'entity': '$42.0 million', 'category': 'MONEY'}, {'entity': '$36.8 million', 'category': 'MONEY'}, {'entity': '$32.2 million', 'category': 'MONEY'}, {'entity': '$96.3 million', 'category': 'MONEY'}, {'entity': '$26.4 million', 'category': 'MONEY'}, {'entity': '$32.4 million', 'category': 'MONEY'}, {'entity': 'U.S.', 'category': 'NORP'}, {'entity': 'Notes', 'category': 'ORG'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': 'Commercial Crew Development program', 'category': 'ORG'}, {'entity': 'Atlas V program', 'category': 'ORG'}, {'entity': 'THAAD', 'category': 'ORG'}, {'entity': 'Standard Missile programs', 'category': 'ORG'}, {'entity': 'Coleman Aerospace', 'category': 'ORG'}, {'entity': 'RS-25 program', 'category': 'ORG'}, {'entity': 'SLS development program', 'category': 'ORG'}, {'entity': 'RL10 program', 'category': 'ORG'}, {'entity': 'PAC-3 contracts', 'category': 'ORG'}, {'entity': '750 acres', 'category': 'QUANTITY'}, {'entity': '', 'category': 'WORK_OF_ART'}, {'entity': '670.9', 'category': 'CARDINAL'}, {'entity': '42.0', 'category': 'CARDINAL'}, {'entity': '37.5', 'category': 'CARDINAL'}, {'entity': '4.5', 'category': 'CARDINAL'}, {'entity': '75.8', 'category': 'CARDINAL'}, {'entity': '33.7', 'category': 'CARDINAL'}, {'entity': '42.1', 'category': 'CARDINAL'}, {'entity': '158.0', 'category': 'CARDINAL'}, {'entity': '36.5', 'category': 'CARDINAL'}, {'entity': '32.2', 'category': 'CARDINAL'}, {'entity': '95.0', 'category': 'CARDINAL'}, {'entity': '37.2', 'category': 'CARDINAL'}, {'entity': '42.0', 'category': 'CARDINAL'}, {'entity': '36.8', 'category': 'CARDINAL'}, {'entity': '32.2', 'category': 'CARDINAL'}, {'entity': '26.1', 'category': 'CARDINAL'}, {'entity': '26.4', 'category': 'CARDINAL'}, {'entity': '32.4', 'category': 'CARDINAL'}, {'entity': '96.3', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  12\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVShWfyAJLq0mmcQ9r8OrLF5ThAN\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701566487,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#7.125#460.0#24.6#9.5#13.0\\n\\nDATE#July 18, 2016#May 30, 2017#June 30, 2017\\n\\nEVENT#registered rescission offer\\n\\nFAC#SEC\\n\\nGPE#U.S.\\n\\nMONEY#$2.0 million#$3.5 million#$1.0 million#$34.1 million\\n\\nORG#Aerospace and Defense#Coleman Aerospace#L3 Technologies, Inc.#Second-Priority Senior Secured Notes#Executive Chairman\\n\\nPERCENT#3.6#3.0#1.3#1.2\\n\\nPERSON#\\n\\nPRODUCT#401(k)\\n\\nTIME#the third quarter of fiscal 2017#the first quarter of fiscal 2016\\n\\nWORK_OF_ART#}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 3025,\n",
      "    \"completion_tokens\": 171,\n",
      "    \"total_tokens\": 3196\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'July 18, 2016', 'category': 'DATE'}, {'entity': 'May 30, 2017', 'category': 'DATE'}, {'entity': 'June 30, 2017', 'category': 'DATE'}, {'entity': 'registered rescission offer', 'category': 'EVENT'}, {'entity': 'SEC', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '$2.0 million', 'category': 'MONEY'}, {'entity': '$3.5 million', 'category': 'MONEY'}, {'entity': '$1.0 million', 'category': 'MONEY'}, {'entity': '$34.1 million', 'category': 'MONEY'}, {'entity': 'Aerospace and Defense', 'category': 'ORG'}, {'entity': 'Coleman Aerospace', 'category': 'ORG'}, {'entity': 'L3 Technologies, Inc.', 'category': 'ORG'}, {'entity': 'Second-Priority Senior Secured Notes', 'category': 'ORG'}, {'entity': 'Executive Chairman', 'category': 'ORG'}, {'entity': '3.6', 'category': 'PERCENT'}, {'entity': '3.0', 'category': 'PERCENT'}, {'entity': '1.3', 'category': 'PERCENT'}, {'entity': '1.2', 'category': 'PERCENT'}, {'entity': '401k', 'category': 'PRODUCT'}, {'entity': 'the third quarter of fiscal 2017', 'category': 'TIME'}, {'entity': 'the first quarter of fiscal 2016', 'category': 'TIME'}, {'entity': '', 'category': 'WORK_OF_ART'}, {'entity': '7.125', 'category': 'CARDINAL'}, {'entity': '460.0', 'category': 'CARDINAL'}, {'entity': '24.6', 'category': 'CARDINAL'}, {'entity': '9.5', 'category': 'CARDINAL'}, {'entity': '13.0', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  12\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVTB0jtXBW08EaFXP3wDQlPrompI\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701566517,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#20#76.0#1.9#0.4#3.5#0.6#2.9#22.4#30.2#8.5#2.3#30.9#32.5#32.5#50.4#7 1/8#4 1/16#3.82#2 1/4#5.8#3.02#96.1#11.2#110.6#86.9#35.0#21#64.6#74.4#36.2#35#27#29#1.7#2.8#15.0#14.0#10.8#59.1#66.0#65.5#64.5#70.1#88.1#0.1#1.1#63.7#60.1#80.5#73.2#68.9#67.6#60\\n\\nDATE#Fiscal 2015#October 28, 2014#December 2015#December 31, 2017#December 31, 2016#December 31, 2015#the first quarter of fiscal 2016#the third quarter of fiscal 2016#December 31, 2015#fiscal 2017#fiscal 2016#fiscal 2015#fiscal 2018\\n\\nEVENT#the Antares program\\n\\nFAC#the Senior Credit Facility\\n\\nGPE#ORB#December\\n\\nLAW#Settlement and Mutual Release Agreement#the Contract#the Tax Act of 2017#the IRS code\\n\\nMONEY#$50.0 million#$76.0 million#$1.9 million#$0.4 million#$3.5 million#$22.4 million#$30.2 million#$8.5 million#$2.3 million#$30.9 million#$32.5 million#$50.4 million#$96.1 million#$11.2 million#$86.9 million#$64.6 million#$1.7 million#$2.8 million\\n\\nNORP#federal#state#state#federal#state#state\\n\\nORG#Aerojet Rocketdyne#Orbital Sciences Corporation#Orbital\\n\\nPERSON#Senior\\n\\nPRODUCT#AJ-26 liquid propulsion rocket engines#Antares#Cygnus ORB-3 service and cargo module#SEC#the 401(k)#the 7 1/8% Senior Secured Notes#the 4 1/16% Convertible Subordinated Debentures#the 2 1/4% Notes#R&D#IRS#R&D#R&D#R&D}\\n\\nQUANTITY#20 AJ-26\\n\\nTIME#one month#one month\\n\\nWORK_OF_ART#Critical Accounting Policies - Retirement Benefit Plans}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2628,\n",
      "    \"completion_tokens\": 599,\n",
      "    \"total_tokens\": 3227\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'Fiscal 2015', 'category': 'DATE'}, {'entity': 'October 28, 2014', 'category': 'DATE'}, {'entity': 'December 2015', 'category': 'DATE'}, {'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'the first quarter of fiscal 2016', 'category': 'DATE'}, {'entity': 'the third quarter of fiscal 2016', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'fiscal 2017', 'category': 'DATE'}, {'entity': 'fiscal 2016', 'category': 'DATE'}, {'entity': 'fiscal 2015', 'category': 'DATE'}, {'entity': 'fiscal 2018', 'category': 'DATE'}, {'entity': 'the Antares program', 'category': 'EVENT'}, {'entity': 'the Senior Credit Facility', 'category': 'FAC'}, {'entity': 'ORB', 'category': 'GPE'}, {'entity': 'December', 'category': 'GPE'}, {'entity': 'Settlement and Mutual Release Agreement', 'category': 'LAW'}, {'entity': 'the Contract', 'category': 'LAW'}, {'entity': 'the Tax Act of 2017', 'category': 'LAW'}, {'entity': 'the IRS code', 'category': 'LAW'}, {'entity': '$50.0 million', 'category': 'MONEY'}, {'entity': '$76.0 million', 'category': 'MONEY'}, {'entity': '$1.9 million', 'category': 'MONEY'}, {'entity': '$0.4 million', 'category': 'MONEY'}, {'entity': '$3.5 million', 'category': 'MONEY'}, {'entity': '$22.4 million', 'category': 'MONEY'}, {'entity': '$30.2 million', 'category': 'MONEY'}, {'entity': '$8.5 million', 'category': 'MONEY'}, {'entity': '$2.3 million', 'category': 'MONEY'}, {'entity': '$30.9 million', 'category': 'MONEY'}, {'entity': '$32.5 million', 'category': 'MONEY'}, {'entity': '$50.4 million', 'category': 'MONEY'}, {'entity': '$96.1 million', 'category': 'MONEY'}, {'entity': '$11.2 million', 'category': 'MONEY'}, {'entity': '$86.9 million', 'category': 'MONEY'}, {'entity': '$64.6 million', 'category': 'MONEY'}, {'entity': '$1.7 million', 'category': 'MONEY'}, {'entity': '$2.8 million', 'category': 'MONEY'}, {'entity': 'federal', 'category': 'NORP'}, {'entity': 'state', 'category': 'NORP'}, {'entity': 'state', 'category': 'NORP'}, {'entity': 'federal', 'category': 'NORP'}, {'entity': 'state', 'category': 'NORP'}, {'entity': 'state', 'category': 'NORP'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': 'Orbital Sciences Corporation', 'category': 'ORG'}, {'entity': 'Orbital', 'category': 'ORG'}, {'entity': 'Senior', 'category': 'PERSON'}, {'entity': 'AJ-26 liquid propulsion rocket engines', 'category': 'PRODUCT'}, {'entity': 'Antares', 'category': 'PRODUCT'}, {'entity': 'Cygnus ORB-3 service and cargo module', 'category': 'PRODUCT'}, {'entity': 'SEC', 'category': 'PRODUCT'}, {'entity': 'the 401k', 'category': 'PRODUCT'}, {'entity': 'the 7 1/8% Senior Secured Notes', 'category': 'PRODUCT'}, {'entity': 'the 4 1/16% Convertible Subordinated Debentures', 'category': 'PRODUCT'}, {'entity': 'the 2 1/4% Notes', 'category': 'PRODUCT'}, {'entity': 'R&D', 'category': 'PRODUCT'}, {'entity': 'IRS', 'category': 'PRODUCT'}, {'entity': 'R&D', 'category': 'PRODUCT'}, {'entity': 'R&D', 'category': 'PRODUCT'}, {'entity': 'R&D', 'category': 'PRODUCT'}, {'entity': '20 AJ-26', 'category': 'QUANTITY'}, {'entity': 'one month', 'category': 'TIME'}, {'entity': 'one month', 'category': 'TIME'}, {'entity': 'Critical Accounting Policies - Retirement Benefit Plans', 'category': 'WORK_OF_ART'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '76.0', 'category': 'CARDINAL'}, {'entity': '1.9', 'category': 'CARDINAL'}, {'entity': '0.4', 'category': 'CARDINAL'}, {'entity': '3.5', 'category': 'CARDINAL'}, {'entity': '0.6', 'category': 'CARDINAL'}, {'entity': '2.9', 'category': 'CARDINAL'}, {'entity': '22.4', 'category': 'CARDINAL'}, {'entity': '30.2', 'category': 'CARDINAL'}, {'entity': '8.5', 'category': 'CARDINAL'}, {'entity': '2.3', 'category': 'CARDINAL'}, {'entity': '30.9', 'category': 'CARDINAL'}, {'entity': '32.5', 'category': 'CARDINAL'}, {'entity': '32.5', 'category': 'CARDINAL'}, {'entity': '50.4', 'category': 'CARDINAL'}, {'entity': '7 1/8', 'category': 'CARDINAL'}, {'entity': '4 1/16', 'category': 'CARDINAL'}, {'entity': '3.82', 'category': 'CARDINAL'}, {'entity': '2 1/4', 'category': 'CARDINAL'}, {'entity': '5.8', 'category': 'CARDINAL'}, {'entity': '3.02', 'category': 'CARDINAL'}, {'entity': '96.1', 'category': 'CARDINAL'}, {'entity': '11.2', 'category': 'CARDINAL'}, {'entity': '110.6', 'category': 'CARDINAL'}, {'entity': '86.9', 'category': 'CARDINAL'}, {'entity': '35.0', 'category': 'CARDINAL'}, {'entity': '21', 'category': 'CARDINAL'}, {'entity': '64.6', 'category': 'CARDINAL'}, {'entity': '74.4', 'category': 'CARDINAL'}, {'entity': '36.2', 'category': 'CARDINAL'}, {'entity': '35', 'category': 'CARDINAL'}, {'entity': '27', 'category': 'CARDINAL'}, {'entity': '29', 'category': 'CARDINAL'}, {'entity': '1.7', 'category': 'CARDINAL'}, {'entity': '2.8', 'category': 'CARDINAL'}, {'entity': '15.0', 'category': 'CARDINAL'}, {'entity': '14.0', 'category': 'CARDINAL'}, {'entity': '10.8', 'category': 'CARDINAL'}, {'entity': '59.1', 'category': 'CARDINAL'}, {'entity': '66.0', 'category': 'CARDINAL'}, {'entity': '65.5', 'category': 'CARDINAL'}, {'entity': '64.5', 'category': 'CARDINAL'}, {'entity': '70.1', 'category': 'CARDINAL'}, {'entity': '88.1', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '1.1', 'category': 'CARDINAL'}, {'entity': '63.7', 'category': 'CARDINAL'}, {'entity': '60.1', 'category': 'CARDINAL'}, {'entity': '80.5', 'category': 'CARDINAL'}, {'entity': '73.2', 'category': 'CARDINAL'}, {'entity': '68.9', 'category': 'CARDINAL'}, {'entity': '67.6', 'category': 'CARDINAL'}, {'entity': '60', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  12\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVTtbasf50ATfO2R9KrSXL8Ayg9Q\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701566561,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#1.5#2.0#2.1#2.2#4.6#4.5#1.7#6.4#7.4#550 \\n\\nDATE#December 31#November 30#2017#2016#2015##Year Ended#one year#53 weeks#52 weeks#month ended December 31\\n\\nEVENT#Aerospace and Defense Segment#Real Estate Segment\\n\\nMONEY#$1,870.8#$1,753.9#$116.9#$1,660.0#$93.9#$177.9#$143.3#$34.6#$202.9#$184.1#$18.8#$165.7#$18.4#$33.7 million#$27.5 million#$158.0 million#$36.5 million#$32.2 million#$95.0 million#$37.2 million#$36.8 million#$8.1 million#$95.8 million#$32.4 million#$26.4 million#$26.1 million\\n\\nORG#U.S. government\\n\\nPERCENT#9.5#8.2#10.8#10.5#10.0#15.9#20.5\\n\\nPRODUCT#Atlas V\\n\\nQUANTITY#50.0\\n\\nWORK_OF_ART#Antares AJ-26 Settlement Agreement}\\n\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2622,\n",
      "    \"completion_tokens\": 280,\n",
      "    \"total_tokens\": 2902\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': 'Year Ended', 'category': 'DATE'}, {'entity': 'one year', 'category': 'DATE'}, {'entity': '53 weeks', 'category': 'DATE'}, {'entity': '52 weeks', 'category': 'DATE'}, {'entity': 'month ended December 31', 'category': 'DATE'}, {'entity': 'Aerospace and Defense Segment', 'category': 'EVENT'}, {'entity': 'Real Estate Segment', 'category': 'EVENT'}, {'entity': '$1,870.8', 'category': 'MONEY'}, {'entity': '$1,753.9', 'category': 'MONEY'}, {'entity': '$116.9', 'category': 'MONEY'}, {'entity': '$1,660.0', 'category': 'MONEY'}, {'entity': '$93.9', 'category': 'MONEY'}, {'entity': '$177.9', 'category': 'MONEY'}, {'entity': '$143.3', 'category': 'MONEY'}, {'entity': '$34.6', 'category': 'MONEY'}, {'entity': '$202.9', 'category': 'MONEY'}, {'entity': '$184.1', 'category': 'MONEY'}, {'entity': '$18.8', 'category': 'MONEY'}, {'entity': '$165.7', 'category': 'MONEY'}, {'entity': '$18.4', 'category': 'MONEY'}, {'entity': '$33.7 million', 'category': 'MONEY'}, {'entity': '$27.5 million', 'category': 'MONEY'}, {'entity': '$158.0 million', 'category': 'MONEY'}, {'entity': '$36.5 million', 'category': 'MONEY'}, {'entity': '$32.2 million', 'category': 'MONEY'}, {'entity': '$95.0 million', 'category': 'MONEY'}, {'entity': '$37.2 million', 'category': 'MONEY'}, {'entity': '$36.8 million', 'category': 'MONEY'}, {'entity': '$8.1 million', 'category': 'MONEY'}, {'entity': '$95.8 million', 'category': 'MONEY'}, {'entity': '$32.4 million', 'category': 'MONEY'}, {'entity': '$26.4 million', 'category': 'MONEY'}, {'entity': '$26.1 million', 'category': 'MONEY'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': '9.5', 'category': 'PERCENT'}, {'entity': '8.2', 'category': 'PERCENT'}, {'entity': '10.8', 'category': 'PERCENT'}, {'entity': '10.5', 'category': 'PERCENT'}, {'entity': '10.0', 'category': 'PERCENT'}, {'entity': '15.9', 'category': 'PERCENT'}, {'entity': '20.5', 'category': 'PERCENT'}, {'entity': 'Atlas V', 'category': 'PRODUCT'}, {'entity': '50.0', 'category': 'QUANTITY'}, {'entity': 'Antares AJ-26 Settlement Agreement', 'category': 'WORK_OF_ART'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '2.0', 'category': 'CARDINAL'}, {'entity': '2.1', 'category': 'CARDINAL'}, {'entity': '2.2', 'category': 'CARDINAL'}, {'entity': '4.6', 'category': 'CARDINAL'}, {'entity': '4.5', 'category': 'CARDINAL'}, {'entity': '1.7', 'category': 'CARDINAL'}, {'entity': '6.4', 'category': 'CARDINAL'}, {'entity': '7.4', 'category': 'CARDINAL'}, {'entity': '550', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  12\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVUUcaPXTXBhc6HMtwUshK1Z1PrK\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701566598,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#550#30.6#0.5#0.2#96.1#11.2#0.3#2.0#30.9#32.5#50.4#3.8#72.6#64.9#65.1#5.1#39.5#41.4#67.6#5.6#1.0#34.5#51.9#0.4#225.4#201.9#218.8#23.9#12.0#11.5#12.8#24.8#0.5#1.0#0.9#7.3#33.7#27.5#212.8#158.7#67.6#0.1#29.4#47.6#36.8#1.2#183.4#111.1#30.8#1.1#1950s#1960s#2017#2016#2015#December 31, 2017#156.6#206.5#325.2#88.2#116.4#152.5#11.2#13.7#19.2#0.7#4.8#6.5#256.7#341.4#503.4#64.5#15\\n\\nDATE#One month ended December 31, 2015#Year Ended#One month ended December 31, 2017#December 31, 2016#December 31, 2015#November 30#year#fiscal 2017#fiscal 2016#May 2027#quarterly\\n\\nEVENT#Adjusted EBITDAP#operational performance#remediation of environmental conditions#PRP\\n\\nGPE#U.S.\\n\\nLAW#GAAP#Non-GAAP\\n\\nMONEY#$30.6 million#$0.5$0.2#$96.1#$11.2#$0.3#$2.0#$30.9#$32.5#$50.4#$3.8#$72.6#$64.9#$65.1#$5.1#$39.5#$41.4#$67.6#$5.6#-$1.0#$34.5#$51.9#$0.4#$225.4#$201.9#$218.8#$23.9#$212.8#$158.7#$67.6#-$29.4#-$47.6#-$36.8#-$1.2#$183.4#$111.1#$30.8#-$1.1#$33.7 million#$27.5 million#$156.6#$206.5#$325.2#$88.2#$116.4#$152.5#$11.2#$13.7#$19.2#$0.7#$4.8#$6.5#$256.7#$341.4#$503.4#$64.5 million \\n\\nORG#Non-GAAP Financial Measures#Adjusted EBITDAP#GAAP#Aerojet Rocketdyne - Sacramento#Aerojet Rocketdyne - Baldwin Park Operable Unit (\\\"BPOU\\\")#Northrop#Notes to Consolidated Financial Statements\\n\\nPERCENT#12.0 %#11.5 %#12.8 %#24.8 %#0.5 #%#1.0 %#0.9 #%#7.3 %\\n\\nPRODUCT#operational performance\\n\\nTIME#fifteen year\\n\\nWORK_OF_ART#Notes 8(c)#8(d)}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2525,\n",
      "    \"completion_tokens\": 758,\n",
      "    \"total_tokens\": 3283\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'One month ended December 31, 2015', 'category': 'DATE'}, {'entity': 'Year Ended', 'category': 'DATE'}, {'entity': 'One month ended December 31, 2017', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': 'year', 'category': 'DATE'}, {'entity': 'fiscal 2017', 'category': 'DATE'}, {'entity': 'fiscal 2016', 'category': 'DATE'}, {'entity': 'May 2027', 'category': 'DATE'}, {'entity': 'quarterly', 'category': 'DATE'}, {'entity': 'Adjusted EBITDAP', 'category': 'EVENT'}, {'entity': 'operational performance', 'category': 'EVENT'}, {'entity': 'remediation of environmental conditions', 'category': 'EVENT'}, {'entity': 'PRP', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'GAAP', 'category': 'LAW'}, {'entity': 'Non-GAAP', 'category': 'LAW'}, {'entity': '$30.6 million', 'category': 'MONEY'}, {'entity': '$0.5$0.2', 'category': 'MONEY'}, {'entity': '$96.1', 'category': 'MONEY'}, {'entity': '$11.2', 'category': 'MONEY'}, {'entity': '$0.3', 'category': 'MONEY'}, {'entity': '$2.0', 'category': 'MONEY'}, {'entity': '$30.9', 'category': 'MONEY'}, {'entity': '$32.5', 'category': 'MONEY'}, {'entity': '$50.4', 'category': 'MONEY'}, {'entity': '$3.8', 'category': 'MONEY'}, {'entity': '$72.6', 'category': 'MONEY'}, {'entity': '$64.9', 'category': 'MONEY'}, {'entity': '$65.1', 'category': 'MONEY'}, {'entity': '$5.1', 'category': 'MONEY'}, {'entity': '$39.5', 'category': 'MONEY'}, {'entity': '$41.4', 'category': 'MONEY'}, {'entity': '$67.6', 'category': 'MONEY'}, {'entity': '$5.6', 'category': 'MONEY'}, {'entity': '-$1.0', 'category': 'MONEY'}, {'entity': '$34.5', 'category': 'MONEY'}, {'entity': '$51.9', 'category': 'MONEY'}, {'entity': '$0.4', 'category': 'MONEY'}, {'entity': '$225.4', 'category': 'MONEY'}, {'entity': '$201.9', 'category': 'MONEY'}, {'entity': '$218.8', 'category': 'MONEY'}, {'entity': '$23.9', 'category': 'MONEY'}, {'entity': '$212.8', 'category': 'MONEY'}, {'entity': '$158.7', 'category': 'MONEY'}, {'entity': '$67.6', 'category': 'MONEY'}, {'entity': '-$29.4', 'category': 'MONEY'}, {'entity': '-$47.6', 'category': 'MONEY'}, {'entity': '-$36.8', 'category': 'MONEY'}, {'entity': '-$1.2', 'category': 'MONEY'}, {'entity': '$183.4', 'category': 'MONEY'}, {'entity': '$111.1', 'category': 'MONEY'}, {'entity': '$30.8', 'category': 'MONEY'}, {'entity': '-$1.1', 'category': 'MONEY'}, {'entity': '$33.7 million', 'category': 'MONEY'}, {'entity': '$27.5 million', 'category': 'MONEY'}, {'entity': '$156.6', 'category': 'MONEY'}, {'entity': '$206.5', 'category': 'MONEY'}, {'entity': '$325.2', 'category': 'MONEY'}, {'entity': '$88.2', 'category': 'MONEY'}, {'entity': '$116.4', 'category': 'MONEY'}, {'entity': '$152.5', 'category': 'MONEY'}, {'entity': '$11.2', 'category': 'MONEY'}, {'entity': '$13.7', 'category': 'MONEY'}, {'entity': '$19.2', 'category': 'MONEY'}, {'entity': '$0.7', 'category': 'MONEY'}, {'entity': '$4.8', 'category': 'MONEY'}, {'entity': '$6.5', 'category': 'MONEY'}, {'entity': '$256.7', 'category': 'MONEY'}, {'entity': '$341.4', 'category': 'MONEY'}, {'entity': '$503.4', 'category': 'MONEY'}, {'entity': '$64.5 million', 'category': 'MONEY'}, {'entity': 'Non-GAAP Financial Measures', 'category': 'ORG'}, {'entity': 'Adjusted EBITDAP', 'category': 'ORG'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': 'Aerojet Rocketdyne - Sacramento', 'category': 'ORG'}, {'entity': 'Aerojet Rocketdyne - Baldwin Park Operable Unit \"BPOU\"', 'category': 'ORG'}, {'entity': 'Northrop', 'category': 'ORG'}, {'entity': 'Notes to Consolidated Financial Statements', 'category': 'ORG'}, {'entity': '12.0 %', 'category': 'PERCENT'}, {'entity': '11.5 %', 'category': 'PERCENT'}, {'entity': '12.8 %', 'category': 'PERCENT'}, {'entity': '24.8 %', 'category': 'PERCENT'}, {'entity': '0.5', 'category': 'PERCENT'}, {'entity': '%', 'category': 'PERCENT'}, {'entity': '1.0 %', 'category': 'PERCENT'}, {'entity': '0.9', 'category': 'PERCENT'}, {'entity': '%', 'category': 'PERCENT'}, {'entity': '7.3 %', 'category': 'PERCENT'}, {'entity': 'operational performance', 'category': 'PRODUCT'}, {'entity': 'fifteen year', 'category': 'TIME'}, {'entity': 'Notes 8c', 'category': 'WORK_OF_ART'}, {'entity': '8d', 'category': 'WORK_OF_ART'}, {'entity': '550', 'category': 'CARDINAL'}, {'entity': '30.6', 'category': 'CARDINAL'}, {'entity': '0.5', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '96.1', 'category': 'CARDINAL'}, {'entity': '11.2', 'category': 'CARDINAL'}, {'entity': '0.3', 'category': 'CARDINAL'}, {'entity': '2.0', 'category': 'CARDINAL'}, {'entity': '30.9', 'category': 'CARDINAL'}, {'entity': '32.5', 'category': 'CARDINAL'}, {'entity': '50.4', 'category': 'CARDINAL'}, {'entity': '3.8', 'category': 'CARDINAL'}, {'entity': '72.6', 'category': 'CARDINAL'}, {'entity': '64.9', 'category': 'CARDINAL'}, {'entity': '65.1', 'category': 'CARDINAL'}, {'entity': '5.1', 'category': 'CARDINAL'}, {'entity': '39.5', 'category': 'CARDINAL'}, {'entity': '41.4', 'category': 'CARDINAL'}, {'entity': '67.6', 'category': 'CARDINAL'}, {'entity': '5.6', 'category': 'CARDINAL'}, {'entity': '1.0', 'category': 'CARDINAL'}, {'entity': '34.5', 'category': 'CARDINAL'}, {'entity': '51.9', 'category': 'CARDINAL'}, {'entity': '0.4', 'category': 'CARDINAL'}, {'entity': '225.4', 'category': 'CARDINAL'}, {'entity': '201.9', 'category': 'CARDINAL'}, {'entity': '218.8', 'category': 'CARDINAL'}, {'entity': '23.9', 'category': 'CARDINAL'}, {'entity': '12.0', 'category': 'CARDINAL'}, {'entity': '11.5', 'category': 'CARDINAL'}, {'entity': '12.8', 'category': 'CARDINAL'}, {'entity': '24.8', 'category': 'CARDINAL'}, {'entity': '0.5', 'category': 'CARDINAL'}, {'entity': '1.0', 'category': 'CARDINAL'}, {'entity': '0.9', 'category': 'CARDINAL'}, {'entity': '7.3', 'category': 'CARDINAL'}, {'entity': '33.7', 'category': 'CARDINAL'}, {'entity': '27.5', 'category': 'CARDINAL'}, {'entity': '212.8', 'category': 'CARDINAL'}, {'entity': '158.7', 'category': 'CARDINAL'}, {'entity': '67.6', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '29.4', 'category': 'CARDINAL'}, {'entity': '47.6', 'category': 'CARDINAL'}, {'entity': '36.8', 'category': 'CARDINAL'}, {'entity': '1.2', 'category': 'CARDINAL'}, {'entity': '183.4', 'category': 'CARDINAL'}, {'entity': '111.1', 'category': 'CARDINAL'}, {'entity': '30.8', 'category': 'CARDINAL'}, {'entity': '1.1', 'category': 'CARDINAL'}, {'entity': '1950s', 'category': 'CARDINAL'}, {'entity': '1960s', 'category': 'CARDINAL'}, {'entity': '2017', 'category': 'CARDINAL'}, {'entity': '2016', 'category': 'CARDINAL'}, {'entity': '2015', 'category': 'CARDINAL'}, {'entity': 'December 31, 2017', 'category': 'CARDINAL'}, {'entity': '156.6', 'category': 'CARDINAL'}, {'entity': '206.5', 'category': 'CARDINAL'}, {'entity': '325.2', 'category': 'CARDINAL'}, {'entity': '88.2', 'category': 'CARDINAL'}, {'entity': '116.4', 'category': 'CARDINAL'}, {'entity': '152.5', 'category': 'CARDINAL'}, {'entity': '11.2', 'category': 'CARDINAL'}, {'entity': '13.7', 'category': 'CARDINAL'}, {'entity': '19.2', 'category': 'CARDINAL'}, {'entity': '0.7', 'category': 'CARDINAL'}, {'entity': '4.8', 'category': 'CARDINAL'}, {'entity': '6.5', 'category': 'CARDINAL'}, {'entity': '256.7', 'category': 'CARDINAL'}, {'entity': '341.4', 'category': 'CARDINAL'}, {'entity': '503.4', 'category': 'CARDINAL'}, {'entity': '64.5', 'category': 'CARDINAL'}, {'entity': '15', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  12\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVVHMKq3o1PoflYiNVPxAiCrwjmh\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701566647,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#349.7#302.3#166.0#306.1#31.3#87.4#176.6#0.5#39.6#40.0#36.5#4.3#341.4#349.7#306.1#302.3#31.3#13.4#6.7#2.3#8.9#87.4#59.4#10.4#5.9#2.7#9.0#0.5#176.6#126.3#13.8#13.5#5.2#17.8#24#333.0#300.4#181.4#303.1#21.4#67.3#133.6#0.4#31.5#35.1#31.2#3.8#1.8#1.6#25.4#0.2#3.5#1.2#6.1#0.5#321.2#333.0#303.1#300.4#31.3#87.4#176.6#0.5#212.8#158.7#67.6#0.1#66.4#47.1#35.8#1.2#21.7#90.2#86.6#1.5#124.7#201.8#54.8#2.6#212.8#263.9#19.9#75.8#158.7#213.2#32.8#37.4#28.9#33.1#67.6\\n\\nDATE#Year ended#One month ended#December 31, 2017#December 31, 2016#November 30, 2015#December 31, 2015#December 31, 2017#December 31, 2016#November 30, 2015#December 31, 2015#fiscal 2017#fiscal 2016#December 31, 2015#fiscal 2015#the current period#15 year#fiscal 2016#Year ended#One month ended#December 31, 2017#December 31, 2016#November 30, 2015#December 31, 2015#Year Ended#One month ended#December 31, 2017#December 31, 2016#November 30, 2015#December 31, 2015#Note 1(w)#Year Ended#One month ended#December 31, 2017#December 31, 2016#November 30, 2015#December 31, 2015#fiscal 2017#fiscal 2016\\n\\nEVENT#environmental reserve additions#environmental clean-up matters\\n\\nGPE#Camden, Arkansas#U.S.#Sacramento\\n\\nMONEY#31.3 million#31.3 million#13.4 million#6.7 million#2.3 million#8.9 million#87.4 million#59.4 million#10.4 million#5.9 million#2.7 million#9.0 million#0.5 million#176.6 million#126.3 million#13.8 million#13.5 million#5.2 million#17.8 million#341.4#333.0#21.4#67.3#133.6#0.4#31.5#35.1#31.2#3.8#1.8#1.6#25.4#0.2#3.5#1.2#6.1#0.5#321.2#333.0#263.9 million#19.9 million#75.8 million#213.2 million#32.8 million#37.4 million#28.9 million#33.1 million \\n\\nORG#Aerojet Rocketdyne#Aerospace and Defense segment#U.S. government#Northrop Agreement and Global Settlement#U.S. government#Northrop#Aerojet Rocketdyne#U.S. government#Atlas V and Standard Missile programs\\n\\nPERCENT#24%}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2587,\n",
      "    \"completion_tokens\": 914,\n",
      "    \"total_tokens\": 3501\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'Year ended', 'category': 'DATE'}, {'entity': 'One month ended', 'category': 'DATE'}, {'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'fiscal 2017', 'category': 'DATE'}, {'entity': 'fiscal 2016', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'fiscal 2015', 'category': 'DATE'}, {'entity': 'the current period', 'category': 'DATE'}, {'entity': '15 year', 'category': 'DATE'}, {'entity': 'fiscal 2016', 'category': 'DATE'}, {'entity': 'Year ended', 'category': 'DATE'}, {'entity': 'One month ended', 'category': 'DATE'}, {'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'Year Ended', 'category': 'DATE'}, {'entity': 'One month ended', 'category': 'DATE'}, {'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'Note 1w', 'category': 'DATE'}, {'entity': 'Year Ended', 'category': 'DATE'}, {'entity': 'One month ended', 'category': 'DATE'}, {'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'fiscal 2017', 'category': 'DATE'}, {'entity': 'fiscal 2016', 'category': 'DATE'}, {'entity': 'environmental reserve additions', 'category': 'EVENT'}, {'entity': 'environmental clean-up matters', 'category': 'EVENT'}, {'entity': 'Camden, Arkansas', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Sacramento', 'category': 'GPE'}, {'entity': '31.3 million', 'category': 'MONEY'}, {'entity': '31.3 million', 'category': 'MONEY'}, {'entity': '13.4 million', 'category': 'MONEY'}, {'entity': '6.7 million', 'category': 'MONEY'}, {'entity': '2.3 million', 'category': 'MONEY'}, {'entity': '8.9 million', 'category': 'MONEY'}, {'entity': '87.4 million', 'category': 'MONEY'}, {'entity': '59.4 million', 'category': 'MONEY'}, {'entity': '10.4 million', 'category': 'MONEY'}, {'entity': '5.9 million', 'category': 'MONEY'}, {'entity': '2.7 million', 'category': 'MONEY'}, {'entity': '9.0 million', 'category': 'MONEY'}, {'entity': '0.5 million', 'category': 'MONEY'}, {'entity': '176.6 million', 'category': 'MONEY'}, {'entity': '126.3 million', 'category': 'MONEY'}, {'entity': '13.8 million', 'category': 'MONEY'}, {'entity': '13.5 million', 'category': 'MONEY'}, {'entity': '5.2 million', 'category': 'MONEY'}, {'entity': '17.8 million', 'category': 'MONEY'}, {'entity': '341.4', 'category': 'MONEY'}, {'entity': '333.0', 'category': 'MONEY'}, {'entity': '21.4', 'category': 'MONEY'}, {'entity': '67.3', 'category': 'MONEY'}, {'entity': '133.6', 'category': 'MONEY'}, {'entity': '0.4', 'category': 'MONEY'}, {'entity': '31.5', 'category': 'MONEY'}, {'entity': '35.1', 'category': 'MONEY'}, {'entity': '31.2', 'category': 'MONEY'}, {'entity': '3.8', 'category': 'MONEY'}, {'entity': '1.8', 'category': 'MONEY'}, {'entity': '1.6', 'category': 'MONEY'}, {'entity': '25.4', 'category': 'MONEY'}, {'entity': '0.2', 'category': 'MONEY'}, {'entity': '3.5', 'category': 'MONEY'}, {'entity': '1.2', 'category': 'MONEY'}, {'entity': '6.1', 'category': 'MONEY'}, {'entity': '0.5', 'category': 'MONEY'}, {'entity': '321.2', 'category': 'MONEY'}, {'entity': '333.0', 'category': 'MONEY'}, {'entity': '263.9 million', 'category': 'MONEY'}, {'entity': '19.9 million', 'category': 'MONEY'}, {'entity': '75.8 million', 'category': 'MONEY'}, {'entity': '213.2 million', 'category': 'MONEY'}, {'entity': '32.8 million', 'category': 'MONEY'}, {'entity': '37.4 million', 'category': 'MONEY'}, {'entity': '28.9 million', 'category': 'MONEY'}, {'entity': '33.1 million', 'category': 'MONEY'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': 'Aerospace and Defense segment', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'Northrop Agreement and Global Settlement', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'Northrop', 'category': 'ORG'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'Atlas V and Standard Missile programs', 'category': 'ORG'}, {'entity': '24%', 'category': 'PERCENT'}, {'entity': '349.7', 'category': 'CARDINAL'}, {'entity': '302.3', 'category': 'CARDINAL'}, {'entity': '166.0', 'category': 'CARDINAL'}, {'entity': '306.1', 'category': 'CARDINAL'}, {'entity': '31.3', 'category': 'CARDINAL'}, {'entity': '87.4', 'category': 'CARDINAL'}, {'entity': '176.6', 'category': 'CARDINAL'}, {'entity': '0.5', 'category': 'CARDINAL'}, {'entity': '39.6', 'category': 'CARDINAL'}, {'entity': '40.0', 'category': 'CARDINAL'}, {'entity': '36.5', 'category': 'CARDINAL'}, {'entity': '4.3', 'category': 'CARDINAL'}, {'entity': '341.4', 'category': 'CARDINAL'}, {'entity': '349.7', 'category': 'CARDINAL'}, {'entity': '306.1', 'category': 'CARDINAL'}, {'entity': '302.3', 'category': 'CARDINAL'}, {'entity': '31.3', 'category': 'CARDINAL'}, {'entity': '13.4', 'category': 'CARDINAL'}, {'entity': '6.7', 'category': 'CARDINAL'}, {'entity': '2.3', 'category': 'CARDINAL'}, {'entity': '8.9', 'category': 'CARDINAL'}, {'entity': '87.4', 'category': 'CARDINAL'}, {'entity': '59.4', 'category': 'CARDINAL'}, {'entity': '10.4', 'category': 'CARDINAL'}, {'entity': '5.9', 'category': 'CARDINAL'}, {'entity': '2.7', 'category': 'CARDINAL'}, {'entity': '9.0', 'category': 'CARDINAL'}, {'entity': '0.5', 'category': 'CARDINAL'}, {'entity': '176.6', 'category': 'CARDINAL'}, {'entity': '126.3', 'category': 'CARDINAL'}, {'entity': '13.8', 'category': 'CARDINAL'}, {'entity': '13.5', 'category': 'CARDINAL'}, {'entity': '5.2', 'category': 'CARDINAL'}, {'entity': '17.8', 'category': 'CARDINAL'}, {'entity': '24', 'category': 'CARDINAL'}, {'entity': '333.0', 'category': 'CARDINAL'}, {'entity': '300.4', 'category': 'CARDINAL'}, {'entity': '181.4', 'category': 'CARDINAL'}, {'entity': '303.1', 'category': 'CARDINAL'}, {'entity': '21.4', 'category': 'CARDINAL'}, {'entity': '67.3', 'category': 'CARDINAL'}, {'entity': '133.6', 'category': 'CARDINAL'}, {'entity': '0.4', 'category': 'CARDINAL'}, {'entity': '31.5', 'category': 'CARDINAL'}, {'entity': '35.1', 'category': 'CARDINAL'}, {'entity': '31.2', 'category': 'CARDINAL'}, {'entity': '3.8', 'category': 'CARDINAL'}, {'entity': '1.8', 'category': 'CARDINAL'}, {'entity': '1.6', 'category': 'CARDINAL'}, {'entity': '25.4', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '3.5', 'category': 'CARDINAL'}, {'entity': '1.2', 'category': 'CARDINAL'}, {'entity': '6.1', 'category': 'CARDINAL'}, {'entity': '0.5', 'category': 'CARDINAL'}, {'entity': '321.2', 'category': 'CARDINAL'}, {'entity': '333.0', 'category': 'CARDINAL'}, {'entity': '303.1', 'category': 'CARDINAL'}, {'entity': '300.4', 'category': 'CARDINAL'}, {'entity': '31.3', 'category': 'CARDINAL'}, {'entity': '87.4', 'category': 'CARDINAL'}, {'entity': '176.6', 'category': 'CARDINAL'}, {'entity': '0.5', 'category': 'CARDINAL'}, {'entity': '212.8', 'category': 'CARDINAL'}, {'entity': '158.7', 'category': 'CARDINAL'}, {'entity': '67.6', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '66.4', 'category': 'CARDINAL'}, {'entity': '47.1', 'category': 'CARDINAL'}, {'entity': '35.8', 'category': 'CARDINAL'}, {'entity': '1.2', 'category': 'CARDINAL'}, {'entity': '21.7', 'category': 'CARDINAL'}, {'entity': '90.2', 'category': 'CARDINAL'}, {'entity': '86.6', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '124.7', 'category': 'CARDINAL'}, {'entity': '201.8', 'category': 'CARDINAL'}, {'entity': '54.8', 'category': 'CARDINAL'}, {'entity': '2.6', 'category': 'CARDINAL'}, {'entity': '212.8', 'category': 'CARDINAL'}, {'entity': '263.9', 'category': 'CARDINAL'}, {'entity': '19.9', 'category': 'CARDINAL'}, {'entity': '75.8', 'category': 'CARDINAL'}, {'entity': '158.7', 'category': 'CARDINAL'}, {'entity': '213.2', 'category': 'CARDINAL'}, {'entity': '32.8', 'category': 'CARDINAL'}, {'entity': '37.4', 'category': 'CARDINAL'}, {'entity': '28.9', 'category': 'CARDINAL'}, {'entity': '33.1', 'category': 'CARDINAL'}, {'entity': '67.6', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  12\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVWFLnLkJsH0Lj7gXGO12ME0s78Y\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701566707,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#2015#129.7#18.8#19.5#7.8#0.1#2017#2016#29.4#47.6#36.8#1.2#17.0#20.0#20.0#700.6#800.0#81.2#20.0#34.7#670.9#3.00#1.00#3.75#1.00#3.50#1.00#0.50#1.00#3.25#1.00#10.13#1.00#3.00#1.00#2.64#1.00#3.75#1.00#535.0#20.0#311.4#2\\u00bc \\n\\nDATE#fiscal 2015#December 2015#fiscal 2017#fiscal 2016#fiscal 2015#December 31, 2015#December 31, 2016#December 31, 2017#September 30, 2018#December 31, 2018#as ofDecember 31, 2017#for the next twelve months#As of December 31, 2017#as of December 31, 2017#as of December 31, 2017 \\n\\nEVENT#CIP Phase I and Phase II#AR1 engine development \\n\\nMONEY#$129.7 million#$18.8 million#$19.5 million#$7.8 million#$0.1 million#$29.4 million#$47.6 million#$36.8 million#$1.2 million#$17.0 million#$20.0 million#$20.0 million#$700.6 million#$800.0 million#$81.2 million#$390.0#$370.0#300.0#35.6#725.6#670.9#$535.0 million#$20.0 million#$311.4 million\\n\\nORG#CIP#UTC#Transition Service Agreements#PAC-3#Standard Missile#Coleman Aerospace#Senior Credit Facility#2\\u00bc% Notes \\n\\nPERSON#Non-cash Activity \\n\\nPRODUCT#the CIP, cost reduction initiatives \\n\\nQUANTITY#2\\u00bc% \\n\\nTIME#one month \\n\\nWORK_OF_ART#Notes 8(b) and 8(c)}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2402,\n",
      "    \"completion_tokens\": 496,\n",
      "    \"total_tokens\": 2898\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'fiscal 2015', 'category': 'DATE'}, {'entity': 'December 2015', 'category': 'DATE'}, {'entity': 'fiscal 2017', 'category': 'DATE'}, {'entity': 'fiscal 2016', 'category': 'DATE'}, {'entity': 'fiscal 2015', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': 'September 30, 2018', 'category': 'DATE'}, {'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': 'as ofDecember 31, 2017', 'category': 'DATE'}, {'entity': 'for the next twelve months', 'category': 'DATE'}, {'entity': 'As of December 31, 2017', 'category': 'DATE'}, {'entity': 'as of December 31, 2017', 'category': 'DATE'}, {'entity': 'as of December 31, 2017', 'category': 'DATE'}, {'entity': 'CIP Phase I and Phase II', 'category': 'EVENT'}, {'entity': 'AR1 engine development', 'category': 'EVENT'}, {'entity': '$129.7 million', 'category': 'MONEY'}, {'entity': '$18.8 million', 'category': 'MONEY'}, {'entity': '$19.5 million', 'category': 'MONEY'}, {'entity': '$7.8 million', 'category': 'MONEY'}, {'entity': '$0.1 million', 'category': 'MONEY'}, {'entity': '$29.4 million', 'category': 'MONEY'}, {'entity': '$47.6 million', 'category': 'MONEY'}, {'entity': '$36.8 million', 'category': 'MONEY'}, {'entity': '$1.2 million', 'category': 'MONEY'}, {'entity': '$17.0 million', 'category': 'MONEY'}, {'entity': '$20.0 million', 'category': 'MONEY'}, {'entity': '$20.0 million', 'category': 'MONEY'}, {'entity': '$700.6 million', 'category': 'MONEY'}, {'entity': '$800.0 million', 'category': 'MONEY'}, {'entity': '$81.2 million', 'category': 'MONEY'}, {'entity': '$390.0', 'category': 'MONEY'}, {'entity': '$370.0', 'category': 'MONEY'}, {'entity': '300.0', 'category': 'MONEY'}, {'entity': '35.6', 'category': 'MONEY'}, {'entity': '725.6', 'category': 'MONEY'}, {'entity': '670.9', 'category': 'MONEY'}, {'entity': '$535.0 million', 'category': 'MONEY'}, {'entity': '$20.0 million', 'category': 'MONEY'}, {'entity': '$311.4 million', 'category': 'MONEY'}, {'entity': 'CIP', 'category': 'ORG'}, {'entity': 'UTC', 'category': 'ORG'}, {'entity': 'Transition Service Agreements', 'category': 'ORG'}, {'entity': 'PAC-3', 'category': 'ORG'}, {'entity': 'Standard Missile', 'category': 'ORG'}, {'entity': 'Coleman Aerospace', 'category': 'ORG'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': '2¼% Notes', 'category': 'ORG'}, {'entity': 'Non-cash Activity', 'category': 'PERSON'}, {'entity': 'the CIP', 'category': 'PRODUCT'}, {'entity': 'cost reduction initiatives', 'category': 'PRODUCT'}, {'entity': '2¼%', 'category': 'QUANTITY'}, {'entity': 'one month', 'category': 'TIME'}, {'entity': 'Notes 8b and 8c', 'category': 'WORK_OF_ART'}, {'entity': '2015', 'category': 'CARDINAL'}, {'entity': '129.7', 'category': 'CARDINAL'}, {'entity': '18.8', 'category': 'CARDINAL'}, {'entity': '19.5', 'category': 'CARDINAL'}, {'entity': '7.8', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '2017', 'category': 'CARDINAL'}, {'entity': '2016', 'category': 'CARDINAL'}, {'entity': '29.4', 'category': 'CARDINAL'}, {'entity': '47.6', 'category': 'CARDINAL'}, {'entity': '36.8', 'category': 'CARDINAL'}, {'entity': '1.2', 'category': 'CARDINAL'}, {'entity': '17.0', 'category': 'CARDINAL'}, {'entity': '20.0', 'category': 'CARDINAL'}, {'entity': '20.0', 'category': 'CARDINAL'}, {'entity': '700.6', 'category': 'CARDINAL'}, {'entity': '800.0', 'category': 'CARDINAL'}, {'entity': '81.2', 'category': 'CARDINAL'}, {'entity': '20.0', 'category': 'CARDINAL'}, {'entity': '34.7', 'category': 'CARDINAL'}, {'entity': '670.9', 'category': 'CARDINAL'}, {'entity': '3.00', 'category': 'CARDINAL'}, {'entity': '1.00', 'category': 'CARDINAL'}, {'entity': '3.75', 'category': 'CARDINAL'}, {'entity': '1.00', 'category': 'CARDINAL'}, {'entity': '3.50', 'category': 'CARDINAL'}, {'entity': '1.00', 'category': 'CARDINAL'}, {'entity': '0.50', 'category': 'CARDINAL'}, {'entity': '1.00', 'category': 'CARDINAL'}, {'entity': '3.25', 'category': 'CARDINAL'}, {'entity': '1.00', 'category': 'CARDINAL'}, {'entity': '10.13', 'category': 'CARDINAL'}, {'entity': '1.00', 'category': 'CARDINAL'}, {'entity': '3.00', 'category': 'CARDINAL'}, {'entity': '1.00', 'category': 'CARDINAL'}, {'entity': '2.64', 'category': 'CARDINAL'}, {'entity': '1.00', 'category': 'CARDINAL'}, {'entity': '3.75', 'category': 'CARDINAL'}, {'entity': '1.00', 'category': 'CARDINAL'}, {'entity': '535.0', 'category': 'CARDINAL'}, {'entity': '20.0', 'category': 'CARDINAL'}, {'entity': '311.4', 'category': 'CARDINAL'}, {'entity': '2¼', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  12\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVWvCztyQYpDiW9R3GuKZ2PfoUTQ\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701566749,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#370.0#25.0#65.0#280.0#300.0#0.9#0.2#0.4#0.3#84.5#20.7#38.2#19.1#6.5#83.1#2.2#7.4#7.5#66.0#121.9#29.4#52.7#39.8#33.6#4.8#8.7#7.4#12.7#95.1#15.1#28.7#27.4#23.9#44.0#1.3#2.6#17.6#22.5#1,133.1#98.7#203.7#399.1#431.6#10#42.0#37.5#4.5#38.6#52.8#120.0#121.9#83.1#1\\n\\nDATE#December 31, 2017#fiscal 2018\\n\\nEVENT#environmental remediation#Aerospace and Defense segment#Outsourced information technology commitment#Postretirement medical and life insurance benefits#Operating leases\\n\\nFAC#Huntsville building\\n\\nGPE#Huntsville#Alabama#U.S.\\n\\nLOC#\\n\\nMONEY# \\n\\nORG#Aerojet Rocketdyne\\n\\nPERCENT#\\n\\nPERSON#\\n\\nPRODUCT#Senior Credit Facility\\n\\nQUANTITY#\\n\\nTIME#\\n\\nWORK_OF_ART#}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2216,\n",
      "    \"completion_tokens\": 319,\n",
      "    \"total_tokens\": 2535\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': 'fiscal 2018', 'category': 'DATE'}, {'entity': 'environmental remediation', 'category': 'EVENT'}, {'entity': 'Aerospace and Defense segment', 'category': 'EVENT'}, {'entity': 'Outsourced information technology commitment', 'category': 'EVENT'}, {'entity': 'Postretirement medical and life insurance benefits', 'category': 'EVENT'}, {'entity': 'Operating leases', 'category': 'EVENT'}, {'entity': 'Huntsville building', 'category': 'FAC'}, {'entity': 'Huntsville', 'category': 'GPE'}, {'entity': 'Alabama', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': 'Senior Credit Facility', 'category': 'PRODUCT'}, {'entity': '', 'category': 'WORK_OF_ART'}, {'entity': '370.0', 'category': 'CARDINAL'}, {'entity': '25.0', 'category': 'CARDINAL'}, {'entity': '65.0', 'category': 'CARDINAL'}, {'entity': '280.0', 'category': 'CARDINAL'}, {'entity': '300.0', 'category': 'CARDINAL'}, {'entity': '0.9', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '0.4', 'category': 'CARDINAL'}, {'entity': '0.3', 'category': 'CARDINAL'}, {'entity': '84.5', 'category': 'CARDINAL'}, {'entity': '20.7', 'category': 'CARDINAL'}, {'entity': '38.2', 'category': 'CARDINAL'}, {'entity': '19.1', 'category': 'CARDINAL'}, {'entity': '6.5', 'category': 'CARDINAL'}, {'entity': '83.1', 'category': 'CARDINAL'}, {'entity': '2.2', 'category': 'CARDINAL'}, {'entity': '7.4', 'category': 'CARDINAL'}, {'entity': '7.5', 'category': 'CARDINAL'}, {'entity': '66.0', 'category': 'CARDINAL'}, {'entity': '121.9', 'category': 'CARDINAL'}, {'entity': '29.4', 'category': 'CARDINAL'}, {'entity': '52.7', 'category': 'CARDINAL'}, {'entity': '39.8', 'category': 'CARDINAL'}, {'entity': '33.6', 'category': 'CARDINAL'}, {'entity': '4.8', 'category': 'CARDINAL'}, {'entity': '8.7', 'category': 'CARDINAL'}, {'entity': '7.4', 'category': 'CARDINAL'}, {'entity': '12.7', 'category': 'CARDINAL'}, {'entity': '95.1', 'category': 'CARDINAL'}, {'entity': '15.1', 'category': 'CARDINAL'}, {'entity': '28.7', 'category': 'CARDINAL'}, {'entity': '27.4', 'category': 'CARDINAL'}, {'entity': '23.9', 'category': 'CARDINAL'}, {'entity': '44.0', 'category': 'CARDINAL'}, {'entity': '1.3', 'category': 'CARDINAL'}, {'entity': '2.6', 'category': 'CARDINAL'}, {'entity': '17.6', 'category': 'CARDINAL'}, {'entity': '22.5', 'category': 'CARDINAL'}, {'entity': '1,133.1', 'category': 'CARDINAL'}, {'entity': '98.7', 'category': 'CARDINAL'}, {'entity': '203.7', 'category': 'CARDINAL'}, {'entity': '399.1', 'category': 'CARDINAL'}, {'entity': '431.6', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '42.0', 'category': 'CARDINAL'}, {'entity': '37.5', 'category': 'CARDINAL'}, {'entity': '4.5', 'category': 'CARDINAL'}, {'entity': '38.6', 'category': 'CARDINAL'}, {'entity': '52.8', 'category': 'CARDINAL'}, {'entity': '120.0', 'category': 'CARDINAL'}, {'entity': '121.9', 'category': 'CARDINAL'}, {'entity': '83.1', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  12\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVXWACr2Q68OgRKo0qVMGG5YFXqK\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701566786,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#37.2#14.1#41.2#11.7#22.3#8.5#24.7#7.0#0.31#0.13#0.40#0.11#0.31#0.11#0.40#0.09\\n\\nDATE#December 31, 2017#December 31, 2016#December 31, 2015#November 30, \\n\\nEVENT#THAAD program#J-2X program \\n\\nFAC#\\n\\nGPE#\\n\\nLANGUAGE#\\n\\nLAW#FAR#CAS \\n\\nLOC#\\n\\nMONEY#\\n\\nNORP#\\n\\nORDINAL#one\\n\\nORG#Aerospace and Defense segment#U.S. government#DCAA\\n\\nPERCENT#\\n\\nPERSON#\\n\\nPRODUCT#electric propulsion contracts#space launch systems#missile defense programs \\n\\nQUANTITY#\\n\\nTIME#\\n\\nWORK_OF_ART#\\n\\n}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2078,\n",
      "    \"completion_tokens\": 188,\n",
      "    \"total_tokens\": 2266\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'November 30,', 'category': 'DATE'}, {'entity': 'THAAD program', 'category': 'EVENT'}, {'entity': 'J-2X program', 'category': 'EVENT'}, {'entity': 'FAR', 'category': 'LAW'}, {'entity': 'CAS', 'category': 'LAW'}, {'entity': 'Aerospace and Defense segment', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'DCAA', 'category': 'ORG'}, {'entity': 'electric propulsion contracts', 'category': 'PRODUCT'}, {'entity': 'space launch systems', 'category': 'PRODUCT'}, {'entity': 'missile defense programs', 'category': 'PRODUCT'}, {'entity': 'one', 'category': 'ORDINAL'}, {'entity': '37.2', 'category': 'CARDINAL'}, {'entity': '14.1', 'category': 'CARDINAL'}, {'entity': '41.2', 'category': 'CARDINAL'}, {'entity': '11.7', 'category': 'CARDINAL'}, {'entity': '22.3', 'category': 'CARDINAL'}, {'entity': '8.5', 'category': 'CARDINAL'}, {'entity': '24.7', 'category': 'CARDINAL'}, {'entity': '7.0', 'category': 'CARDINAL'}, {'entity': '0.31', 'category': 'CARDINAL'}, {'entity': '0.13', 'category': 'CARDINAL'}, {'entity': '0.40', 'category': 'CARDINAL'}, {'entity': '0.11', 'category': 'CARDINAL'}, {'entity': '0.31', 'category': 'CARDINAL'}, {'entity': '0.11', 'category': 'CARDINAL'}, {'entity': '0.40', 'category': 'CARDINAL'}, {'entity': '0.09', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  12\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVY27LuunkYGSWrOlYSGn1Kuf5hA\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701566818,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{ORG#Aerospace and Defense#U.S. government\\n\\nDATE#October 1, 2017#October 1, 2016#September 1, 2016#fiscal 2009#December 31, 2017#December 31, 2016#December 31, 2017#December 31, 2016#Year Ended#One month ended#December 31, 2017#November 30, 2016#November 30, 2015#December 31, 2015#December 31, 2017#November 30, 2016#November 30, 2015#December 31, 2015#December 31, 2017\\n\\nCARDINAL#50%#401#one#three#one\\n\\nPERCENT#3.59%#4.02%#3.37%#3.68%#4.02%#4.36%#3.96%#4.26%#3.68%#3.99%#3.54%#3.87%#7.00%#7.00%#8.00%#7.00%\\n\\nMONEY#$21.7 million#$153.5 million#$9.2 million#$18.5 million#$128.9 million#$9.2 million\\n\\nEVENT#Step Zero analysis#Step One analysis\\n\\nORDINAL#first#fourth\\n\\nTIME#the first day of our fourth quarter\\n\\nQUANTITY#more than 50%#one-fifth}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2290,\n",
      "    \"completion_tokens\": 327,\n",
      "    \"total_tokens\": 2617\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'October 1, 2017', 'category': 'DATE'}, {'entity': 'October 1, 2016', 'category': 'DATE'}, {'entity': 'September 1, 2016', 'category': 'DATE'}, {'entity': 'fiscal 2009', 'category': 'DATE'}, {'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'Year Ended', 'category': 'DATE'}, {'entity': 'One month ended', 'category': 'DATE'}, {'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': 'November 30, 2016', 'category': 'DATE'}, {'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': 'November 30, 2016', 'category': 'DATE'}, {'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': 'Step Zero analysis', 'category': 'EVENT'}, {'entity': 'Step One analysis', 'category': 'EVENT'}, {'entity': '$21.7 million', 'category': 'MONEY'}, {'entity': '$153.5 million', 'category': 'MONEY'}, {'entity': '$9.2 million', 'category': 'MONEY'}, {'entity': '$18.5 million', 'category': 'MONEY'}, {'entity': '$128.9 million', 'category': 'MONEY'}, {'entity': '$9.2 million', 'category': 'MONEY'}, {'entity': 'Aerospace and Defense', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': '3.59%', 'category': 'PERCENT'}, {'entity': '4.02%', 'category': 'PERCENT'}, {'entity': '3.37%', 'category': 'PERCENT'}, {'entity': '3.68%', 'category': 'PERCENT'}, {'entity': '4.02%', 'category': 'PERCENT'}, {'entity': '4.36%', 'category': 'PERCENT'}, {'entity': '3.96%', 'category': 'PERCENT'}, {'entity': '4.26%', 'category': 'PERCENT'}, {'entity': '3.68%', 'category': 'PERCENT'}, {'entity': '3.99%', 'category': 'PERCENT'}, {'entity': '3.54%', 'category': 'PERCENT'}, {'entity': '3.87%', 'category': 'PERCENT'}, {'entity': '7.00%', 'category': 'PERCENT'}, {'entity': '7.00%', 'category': 'PERCENT'}, {'entity': '8.00%', 'category': 'PERCENT'}, {'entity': '7.00%', 'category': 'PERCENT'}, {'entity': 'more than 50%', 'category': 'QUANTITY'}, {'entity': 'one-fifth', 'category': 'QUANTITY'}, {'entity': 'the first day of our fourth quarter', 'category': 'TIME'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'fourth', 'category': 'ORDINAL'}, {'entity': '50%', 'category': 'CARDINAL'}, {'entity': '401', 'category': 'CARDINAL'}, {'entity': 'one', 'category': 'CARDINAL'}, {'entity': 'three', 'category': 'CARDINAL'}, {'entity': 'one', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  12\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVYfajPaMEEpVyXsWmFOLZXFrpFW\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701566857,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#8#100#35#21#64.6#74.4#50#670.9#300.9#45#2.26#370.0#55#3.82 \\n\\nDATE#December 22, 2017#December 31, 2017#December 31, 2016 \\n\\nFAC#Senior Credit Facility \\n\\nGPE#U.S.\\n\\nLAW#Tax Act of 2017\\n\\nMONEY#$64.6 million \\n\\nORG#Global Settlement#Northrop Agreement#U.S. government \\n\\nPERCENT#35%#21%#74.4%#45%#55%\\n\\nPERSON#\\n\\nPRODUCT#2 1/4% Notes#4 1/16% Debentures\\n\\nTIME#\\n\\nWORK_OF_ART#}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2150,\n",
      "    \"completion_tokens\": 165,\n",
      "    \"total_tokens\": 2315\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 22, 2017', 'category': 'DATE'}, {'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'Senior Credit Facility', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Tax Act of 2017', 'category': 'LAW'}, {'entity': '$64.6 million', 'category': 'MONEY'}, {'entity': 'Global Settlement', 'category': 'ORG'}, {'entity': 'Northrop Agreement', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': '35%', 'category': 'PERCENT'}, {'entity': '21%', 'category': 'PERCENT'}, {'entity': '74.4%', 'category': 'PERCENT'}, {'entity': '45%', 'category': 'PERCENT'}, {'entity': '55%', 'category': 'PERCENT'}, {'entity': '2 1/4% Notes', 'category': 'PRODUCT'}, {'entity': '4 1/16% Debentures', 'category': 'PRODUCT'}, {'entity': '', 'category': 'WORK_OF_ART'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '35', 'category': 'CARDINAL'}, {'entity': '21', 'category': 'CARDINAL'}, {'entity': '64.6', 'category': 'CARDINAL'}, {'entity': '74.4', 'category': 'CARDINAL'}, {'entity': '50', 'category': 'CARDINAL'}, {'entity': '670.9', 'category': 'CARDINAL'}, {'entity': '300.9', 'category': 'CARDINAL'}, {'entity': '45', 'category': 'CARDINAL'}, {'entity': '2.26', 'category': 'CARDINAL'}, {'entity': '370.0', 'category': 'CARDINAL'}, {'entity': '55', 'category': 'CARDINAL'}, {'entity': '3.82', 'category': 'CARDINAL'}]\n",
      "/home/damir/Dropbox/Documents/Teaching/2023/L715/l715_23/data/10-Ks/Aerojet_Rocketdyne_Holdings_Inc./2020/Management.txt\n",
      "Length of chunks:  8\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVZAVjH7kEhSqFg8uYUdAZHVhIH4\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701566888,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#7#8#1#130.1#1.56#151.5#1.93#271.7#304.9#261.2#252.7#218.3#209.5#5.4#4.1#230.0#197.0#60.5#235.0#170.4#53.5#637.0#932.5#1,349.8#417.3#83#46.0#13.9#32.1 \\n\\nDATE#December 31, 2018#the fiscal year ended December 31, 2018#February 19, 2019#December 31, 2017#the year ended December 31, 2017#2019#2018#December 31, 2019#December 31, 2018#2015#April 6, 2017#the last measurement date at December 31, 2019#2020\\n\\nEVENT#Competitive Improvement Program#Phase I#Phase II\\n\\nFAC#\\n\\nGPE#U.S.#Sacramento#California#Gainesville#Virginia#Huntsville#Alabama\\n\\nLOC#\\n\\nMONEY#$1,981.5 million#$1,895.9 million#$141.0 million#$137.3 million#$1.69#$1.75#$5.4 billion#$4.1 billion\\n\\nNORP#U.S.\\n\\nORDINAL#first#I#II\\n\\nORG#NASA#U.S. Air Force#U.S. Army#MDA#U.S. Navy#U.S. government#Lockheed Martin#Raytheon#ULA#Aerojet Rocketdyne\\n\\nPERCENT#96#94#18#27#14#19#23#6#7#4#100#33#18#17#10#83\\n\\nPERSON#\\n\\nPRODUCT#\\n\\nQUANTITY#\\n\\nTIME#\\n\\nWORK_OF_ART#Management\\u2019s Discussion and Analysis of Financial Condition and Results of Operations#Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations#Management\\u2019s Discussion and Analysis#Adjusted EBITDAP#Free cash flow\\n}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2361,\n",
      "    \"completion_tokens\": 453,\n",
      "    \"total_tokens\": 2814\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': 'the fiscal year ended December 31, 2018', 'category': 'DATE'}, {'entity': 'February 19, 2019', 'category': 'DATE'}, {'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': 'the year ended December 31, 2017', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': '2018', 'category': 'DATE'}, {'entity': 'December 31, 2019', 'category': 'DATE'}, {'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': 'April 6, 2017', 'category': 'DATE'}, {'entity': 'the last measurement date at December 31, 2019', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': 'Competitive Improvement Program', 'category': 'EVENT'}, {'entity': 'Phase I', 'category': 'EVENT'}, {'entity': 'Phase II', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Sacramento', 'category': 'GPE'}, {'entity': 'California', 'category': 'GPE'}, {'entity': 'Gainesville', 'category': 'GPE'}, {'entity': 'Virginia', 'category': 'GPE'}, {'entity': 'Huntsville', 'category': 'GPE'}, {'entity': 'Alabama', 'category': 'GPE'}, {'entity': '$1,981.5 million', 'category': 'MONEY'}, {'entity': '$1,895.9 million', 'category': 'MONEY'}, {'entity': '$141.0 million', 'category': 'MONEY'}, {'entity': '$137.3 million', 'category': 'MONEY'}, {'entity': '$1.69', 'category': 'MONEY'}, {'entity': '$1.75', 'category': 'MONEY'}, {'entity': '$5.4 billion', 'category': 'MONEY'}, {'entity': '$4.1 billion', 'category': 'MONEY'}, {'entity': 'U.S.', 'category': 'NORP'}, {'entity': 'NASA', 'category': 'ORG'}, {'entity': 'U.S. Air Force', 'category': 'ORG'}, {'entity': 'U.S. Army', 'category': 'ORG'}, {'entity': 'MDA', 'category': 'ORG'}, {'entity': 'U.S. Navy', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'Lockheed Martin', 'category': 'ORG'}, {'entity': 'Raytheon', 'category': 'ORG'}, {'entity': 'ULA', 'category': 'ORG'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': '96', 'category': 'PERCENT'}, {'entity': '94', 'category': 'PERCENT'}, {'entity': '18', 'category': 'PERCENT'}, {'entity': '27', 'category': 'PERCENT'}, {'entity': '14', 'category': 'PERCENT'}, {'entity': '19', 'category': 'PERCENT'}, {'entity': '23', 'category': 'PERCENT'}, {'entity': '6', 'category': 'PERCENT'}, {'entity': '7', 'category': 'PERCENT'}, {'entity': '4', 'category': 'PERCENT'}, {'entity': '100', 'category': 'PERCENT'}, {'entity': '33', 'category': 'PERCENT'}, {'entity': '18', 'category': 'PERCENT'}, {'entity': '17', 'category': 'PERCENT'}, {'entity': '10', 'category': 'PERCENT'}, {'entity': '83', 'category': 'PERCENT'}, {'entity': 'Management’s Discussion and Analysis of Financial Condition and Results of Operations', 'category': 'WORK_OF_ART'}, {'entity': 'Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations', 'category': 'WORK_OF_ART'}, {'entity': 'Management’s Discussion and Analysis', 'category': 'WORK_OF_ART'}, {'entity': 'Adjusted EBITDAP', 'category': 'WORK_OF_ART'}, {'entity': 'Free cash flow', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'I', 'category': 'ORDINAL'}, {'entity': 'II', 'category': 'ORDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '130.1', 'category': 'CARDINAL'}, {'entity': '1.56', 'category': 'CARDINAL'}, {'entity': '151.5', 'category': 'CARDINAL'}, {'entity': '1.93', 'category': 'CARDINAL'}, {'entity': '271.7', 'category': 'CARDINAL'}, {'entity': '304.9', 'category': 'CARDINAL'}, {'entity': '261.2', 'category': 'CARDINAL'}, {'entity': '252.7', 'category': 'CARDINAL'}, {'entity': '218.3', 'category': 'CARDINAL'}, {'entity': '209.5', 'category': 'CARDINAL'}, {'entity': '5.4', 'category': 'CARDINAL'}, {'entity': '4.1', 'category': 'CARDINAL'}, {'entity': '230.0', 'category': 'CARDINAL'}, {'entity': '197.0', 'category': 'CARDINAL'}, {'entity': '60.5', 'category': 'CARDINAL'}, {'entity': '235.0', 'category': 'CARDINAL'}, {'entity': '170.4', 'category': 'CARDINAL'}, {'entity': '53.5', 'category': 'CARDINAL'}, {'entity': '637.0', 'category': 'CARDINAL'}, {'entity': '932.5', 'category': 'CARDINAL'}, {'entity': '1,349.8', 'category': 'CARDINAL'}, {'entity': '417.3', 'category': 'CARDINAL'}, {'entity': '83', 'category': 'CARDINAL'}, {'entity': '46.0', 'category': 'CARDINAL'}, {'entity': '13.9', 'category': 'CARDINAL'}, {'entity': '32.1', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  8\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVZt5KDfsEMwrrGN0ernKUDEM0hI\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701566933,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#1#3#120.6#34.7#64.2#81.4#81.7#2.7#2.3#1.3#2#74.5#72.3#2.2#1.6#41.8#43.0#15.5#10.0#5.5#26.3#9.4#35.7#34.4#1.3#50.9#51.3#26.5#21#27.2#21#49.1#53.9#50.9#3.0#64.8#60.1#4.7#37.1#66.9#29.8#26.1#57.6#31.5#37#48\\n\\nDATE#Year Ended December 31, 2019#Year Ended December 31, 2018#Year Ended December 31#December 31, 2019#December 31, 2018\\n\\nEVENT#Commercial Crew Development program\\n\\nGPE#Huntsville#Alabama\\n\\nMONEY#$1,981.5#$1,895.9#$85.6#$1,613.6#$1,549.4#$26.3#$23.3#$3.0#$27.3#$20.5#$6.8#$53.6#$43.8#$9.8#$58.1#$56.1#$2.0#$13.6#$13.7#0.1#74.5#$72.3#$2.2#$1.6#40.2#41.8#$43.0#$15.5#$10.0#$5.5#$26.3#$25.5#$0.8#$9.4#$8.9#$0.5#$35.7#$34.4#$1.3#$50.9#$51.3\\n\\nORG#PAC-3#GMLRS#RS-68#AJ-60#RS-25#Commercial Crew Development#SG&A#U.S. government#Global Settlement#Senior Credit Facility#Company's\\n\\nPERCENT#81.4#81.7#2.7#2.3#1.3\\n\\nPRODUCT#hypersonic booster\\n\\nTIME#early 2019\\n\\nWORK_OF_ART#Environmental Matters}\\\"Critical Accounting Policies - Retirement Benefit Plans}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2527,\n",
      "    \"completion_tokens\": 505,\n",
      "    \"total_tokens\": 3032\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'Year Ended December 31, 2019', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2018', 'category': 'DATE'}, {'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': 'December 31, 2019', 'category': 'DATE'}, {'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': 'Commercial Crew Development program', 'category': 'EVENT'}, {'entity': 'Huntsville', 'category': 'GPE'}, {'entity': 'Alabama', 'category': 'GPE'}, {'entity': '$1,981.5', 'category': 'MONEY'}, {'entity': '$1,895.9', 'category': 'MONEY'}, {'entity': '$85.6', 'category': 'MONEY'}, {'entity': '$1,613.6', 'category': 'MONEY'}, {'entity': '$1,549.4', 'category': 'MONEY'}, {'entity': '$26.3', 'category': 'MONEY'}, {'entity': '$23.3', 'category': 'MONEY'}, {'entity': '$3.0', 'category': 'MONEY'}, {'entity': '$27.3', 'category': 'MONEY'}, {'entity': '$20.5', 'category': 'MONEY'}, {'entity': '$6.8', 'category': 'MONEY'}, {'entity': '$53.6', 'category': 'MONEY'}, {'entity': '$43.8', 'category': 'MONEY'}, {'entity': '$9.8', 'category': 'MONEY'}, {'entity': '$58.1', 'category': 'MONEY'}, {'entity': '$56.1', 'category': 'MONEY'}, {'entity': '$2.0', 'category': 'MONEY'}, {'entity': '$13.6', 'category': 'MONEY'}, {'entity': '$13.7', 'category': 'MONEY'}, {'entity': '0.1', 'category': 'MONEY'}, {'entity': '74.5', 'category': 'MONEY'}, {'entity': '$72.3', 'category': 'MONEY'}, {'entity': '$2.2', 'category': 'MONEY'}, {'entity': '$1.6', 'category': 'MONEY'}, {'entity': '40.2', 'category': 'MONEY'}, {'entity': '41.8', 'category': 'MONEY'}, {'entity': '$43.0', 'category': 'MONEY'}, {'entity': '$15.5', 'category': 'MONEY'}, {'entity': '$10.0', 'category': 'MONEY'}, {'entity': '$5.5', 'category': 'MONEY'}, {'entity': '$26.3', 'category': 'MONEY'}, {'entity': '$25.5', 'category': 'MONEY'}, {'entity': '$0.8', 'category': 'MONEY'}, {'entity': '$9.4', 'category': 'MONEY'}, {'entity': '$8.9', 'category': 'MONEY'}, {'entity': '$0.5', 'category': 'MONEY'}, {'entity': '$35.7', 'category': 'MONEY'}, {'entity': '$34.4', 'category': 'MONEY'}, {'entity': '$1.3', 'category': 'MONEY'}, {'entity': '$50.9', 'category': 'MONEY'}, {'entity': '$51.3', 'category': 'MONEY'}, {'entity': 'PAC-3', 'category': 'ORG'}, {'entity': 'GMLRS', 'category': 'ORG'}, {'entity': 'RS-68', 'category': 'ORG'}, {'entity': 'AJ-60', 'category': 'ORG'}, {'entity': 'RS-25', 'category': 'ORG'}, {'entity': 'Commercial Crew Development', 'category': 'ORG'}, {'entity': 'SG&A', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'Global Settlement', 'category': 'ORG'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': 'Companys', 'category': 'ORG'}, {'entity': '81.4', 'category': 'PERCENT'}, {'entity': '81.7', 'category': 'PERCENT'}, {'entity': '2.7', 'category': 'PERCENT'}, {'entity': '2.3', 'category': 'PERCENT'}, {'entity': '1.3', 'category': 'PERCENT'}, {'entity': 'hypersonic booster', 'category': 'PRODUCT'}, {'entity': 'early 2019', 'category': 'TIME'}, {'entity': 'Environmental Matters\"Critical Accounting Policies - Retirement Benefit Plans', 'category': 'WORK_OF_ART'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '120.6', 'category': 'CARDINAL'}, {'entity': '34.7', 'category': 'CARDINAL'}, {'entity': '64.2', 'category': 'CARDINAL'}, {'entity': '81.4', 'category': 'CARDINAL'}, {'entity': '81.7', 'category': 'CARDINAL'}, {'entity': '2.7', 'category': 'CARDINAL'}, {'entity': '2.3', 'category': 'CARDINAL'}, {'entity': '1.3', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '74.5', 'category': 'CARDINAL'}, {'entity': '72.3', 'category': 'CARDINAL'}, {'entity': '2.2', 'category': 'CARDINAL'}, {'entity': '1.6', 'category': 'CARDINAL'}, {'entity': '41.8', 'category': 'CARDINAL'}, {'entity': '43.0', 'category': 'CARDINAL'}, {'entity': '15.5', 'category': 'CARDINAL'}, {'entity': '10.0', 'category': 'CARDINAL'}, {'entity': '5.5', 'category': 'CARDINAL'}, {'entity': '26.3', 'category': 'CARDINAL'}, {'entity': '9.4', 'category': 'CARDINAL'}, {'entity': '35.7', 'category': 'CARDINAL'}, {'entity': '34.4', 'category': 'CARDINAL'}, {'entity': '1.3', 'category': 'CARDINAL'}, {'entity': '50.9', 'category': 'CARDINAL'}, {'entity': '51.3', 'category': 'CARDINAL'}, {'entity': '26.5', 'category': 'CARDINAL'}, {'entity': '21', 'category': 'CARDINAL'}, {'entity': '27.2', 'category': 'CARDINAL'}, {'entity': '21', 'category': 'CARDINAL'}, {'entity': '49.1', 'category': 'CARDINAL'}, {'entity': '53.9', 'category': 'CARDINAL'}, {'entity': '50.9', 'category': 'CARDINAL'}, {'entity': '3.0', 'category': 'CARDINAL'}, {'entity': '64.8', 'category': 'CARDINAL'}, {'entity': '60.1', 'category': 'CARDINAL'}, {'entity': '4.7', 'category': 'CARDINAL'}, {'entity': '37.1', 'category': 'CARDINAL'}, {'entity': '66.9', 'category': 'CARDINAL'}, {'entity': '29.8', 'category': 'CARDINAL'}, {'entity': '26.1', 'category': 'CARDINAL'}, {'entity': '57.6', 'category': 'CARDINAL'}, {'entity': '31.5', 'category': 'CARDINAL'}, {'entity': '37', 'category': 'CARDINAL'}, {'entity': '48', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  8\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVaY6ccJgdJnaPNZszyX4Hz9zLun\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701566974,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{DATE#Year Ended December 31, 2019#Year Ended December 31, 2018#2018#2019\\n\\nCARDINAL#1,974.0#1,888.1#85.9#269.3#264.6#4.7#13.6#14.0#120.6#34.7#43.0#1.9#4.6#38.4#59.1#7.5#7.8#2.1#2.8#1.4#57#31, 2019#5.4#4.1#36#2.0#23#41#31, 2019#2018#2.1#1.9#3.3#2.2#5.4#4.1#31, 2019#2018#141.0#137.3#35.7#34.4#15.5#10.0#50.9#51.3#74.5#72.3#26.1#57.6#41.3#38.2#271.7#304.9#7.1#7.2#13.7#16.1#26.1#57.6#41.3#38.2#4.0#5.4#130.1#151.5#1.69#1.75#0.13#0.18#1.56#1.93#81.7#76.8#261.2#252.7#42.9#43.2#218.3#209.5\\n\\nEVENT#Global Settlement#Commercial Crew Development program\\n\\nFAC#Sacramento Land\\n\\nGPE#U.S.\\n\\nMONEY#$120.6 million#$34.7 million#$43.0 million#$4.6 million#$38.4 million#$59.1 million\\n\\nORG#Aerospace and Defense Segment#PAC-3#GMLRS#RS-68#AJ-60#RS-25#Real Estate Segment#Standard Missile#THAAD\\n\\nPERCENT#13.6%#14.0%#1.9%#36%#23%#7.1%#7.2%#13.7%#16.1%\\n\\nPERSON#Net\\n\\nPRODUCT#GAAP\\n\\nWORK_OF_ART#THAAD#PAC-3#THAAD#RS-68#RL10}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2520,\n",
      "    \"completion_tokens\": 522,\n",
      "    \"total_tokens\": 3042\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'Year Ended December 31, 2019', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2018', 'category': 'DATE'}, {'entity': '2018', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': 'Global Settlement', 'category': 'EVENT'}, {'entity': 'Commercial Crew Development program', 'category': 'EVENT'}, {'entity': 'Sacramento Land', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '$120.6 million', 'category': 'MONEY'}, {'entity': '$34.7 million', 'category': 'MONEY'}, {'entity': '$43.0 million', 'category': 'MONEY'}, {'entity': '$4.6 million', 'category': 'MONEY'}, {'entity': '$38.4 million', 'category': 'MONEY'}, {'entity': '$59.1 million', 'category': 'MONEY'}, {'entity': 'Aerospace and Defense Segment', 'category': 'ORG'}, {'entity': 'PAC-3', 'category': 'ORG'}, {'entity': 'GMLRS', 'category': 'ORG'}, {'entity': 'RS-68', 'category': 'ORG'}, {'entity': 'AJ-60', 'category': 'ORG'}, {'entity': 'RS-25', 'category': 'ORG'}, {'entity': 'Real Estate Segment', 'category': 'ORG'}, {'entity': 'Standard Missile', 'category': 'ORG'}, {'entity': 'THAAD', 'category': 'ORG'}, {'entity': '13.6%', 'category': 'PERCENT'}, {'entity': '14.0%', 'category': 'PERCENT'}, {'entity': '1.9%', 'category': 'PERCENT'}, {'entity': '36%', 'category': 'PERCENT'}, {'entity': '23%', 'category': 'PERCENT'}, {'entity': '7.1%', 'category': 'PERCENT'}, {'entity': '7.2%', 'category': 'PERCENT'}, {'entity': '13.7%', 'category': 'PERCENT'}, {'entity': '16.1%', 'category': 'PERCENT'}, {'entity': 'Net', 'category': 'PERSON'}, {'entity': 'GAAP', 'category': 'PRODUCT'}, {'entity': 'THAAD', 'category': 'WORK_OF_ART'}, {'entity': 'PAC-3', 'category': 'WORK_OF_ART'}, {'entity': 'THAAD', 'category': 'WORK_OF_ART'}, {'entity': 'RS-68', 'category': 'WORK_OF_ART'}, {'entity': 'RL10', 'category': 'WORK_OF_ART'}, {'entity': '1,974.0', 'category': 'CARDINAL'}, {'entity': '1,888.1', 'category': 'CARDINAL'}, {'entity': '85.9', 'category': 'CARDINAL'}, {'entity': '269.3', 'category': 'CARDINAL'}, {'entity': '264.6', 'category': 'CARDINAL'}, {'entity': '4.7', 'category': 'CARDINAL'}, {'entity': '13.6', 'category': 'CARDINAL'}, {'entity': '14.0', 'category': 'CARDINAL'}, {'entity': '120.6', 'category': 'CARDINAL'}, {'entity': '34.7', 'category': 'CARDINAL'}, {'entity': '43.0', 'category': 'CARDINAL'}, {'entity': '1.9', 'category': 'CARDINAL'}, {'entity': '4.6', 'category': 'CARDINAL'}, {'entity': '38.4', 'category': 'CARDINAL'}, {'entity': '59.1', 'category': 'CARDINAL'}, {'entity': '7.5', 'category': 'CARDINAL'}, {'entity': '7.8', 'category': 'CARDINAL'}, {'entity': '2.1', 'category': 'CARDINAL'}, {'entity': '2.8', 'category': 'CARDINAL'}, {'entity': '1.4', 'category': 'CARDINAL'}, {'entity': '57', 'category': 'CARDINAL'}, {'entity': '31, 2019', 'category': 'CARDINAL'}, {'entity': '5.4', 'category': 'CARDINAL'}, {'entity': '4.1', 'category': 'CARDINAL'}, {'entity': '36', 'category': 'CARDINAL'}, {'entity': '2.0', 'category': 'CARDINAL'}, {'entity': '23', 'category': 'CARDINAL'}, {'entity': '41', 'category': 'CARDINAL'}, {'entity': '31, 2019', 'category': 'CARDINAL'}, {'entity': '2018', 'category': 'CARDINAL'}, {'entity': '2.1', 'category': 'CARDINAL'}, {'entity': '1.9', 'category': 'CARDINAL'}, {'entity': '3.3', 'category': 'CARDINAL'}, {'entity': '2.2', 'category': 'CARDINAL'}, {'entity': '5.4', 'category': 'CARDINAL'}, {'entity': '4.1', 'category': 'CARDINAL'}, {'entity': '31, 2019', 'category': 'CARDINAL'}, {'entity': '2018', 'category': 'CARDINAL'}, {'entity': '141.0', 'category': 'CARDINAL'}, {'entity': '137.3', 'category': 'CARDINAL'}, {'entity': '35.7', 'category': 'CARDINAL'}, {'entity': '34.4', 'category': 'CARDINAL'}, {'entity': '15.5', 'category': 'CARDINAL'}, {'entity': '10.0', 'category': 'CARDINAL'}, {'entity': '50.9', 'category': 'CARDINAL'}, {'entity': '51.3', 'category': 'CARDINAL'}, {'entity': '74.5', 'category': 'CARDINAL'}, {'entity': '72.3', 'category': 'CARDINAL'}, {'entity': '26.1', 'category': 'CARDINAL'}, {'entity': '57.6', 'category': 'CARDINAL'}, {'entity': '41.3', 'category': 'CARDINAL'}, {'entity': '38.2', 'category': 'CARDINAL'}, {'entity': '271.7', 'category': 'CARDINAL'}, {'entity': '304.9', 'category': 'CARDINAL'}, {'entity': '7.1', 'category': 'CARDINAL'}, {'entity': '7.2', 'category': 'CARDINAL'}, {'entity': '13.7', 'category': 'CARDINAL'}, {'entity': '16.1', 'category': 'CARDINAL'}, {'entity': '26.1', 'category': 'CARDINAL'}, {'entity': '57.6', 'category': 'CARDINAL'}, {'entity': '41.3', 'category': 'CARDINAL'}, {'entity': '38.2', 'category': 'CARDINAL'}, {'entity': '4.0', 'category': 'CARDINAL'}, {'entity': '5.4', 'category': 'CARDINAL'}, {'entity': '130.1', 'category': 'CARDINAL'}, {'entity': '151.5', 'category': 'CARDINAL'}, {'entity': '1.69', 'category': 'CARDINAL'}, {'entity': '1.75', 'category': 'CARDINAL'}, {'entity': '0.13', 'category': 'CARDINAL'}, {'entity': '0.18', 'category': 'CARDINAL'}, {'entity': '1.56', 'category': 'CARDINAL'}, {'entity': '1.93', 'category': 'CARDINAL'}, {'entity': '81.7', 'category': 'CARDINAL'}, {'entity': '76.8', 'category': 'CARDINAL'}, {'entity': '261.2', 'category': 'CARDINAL'}, {'entity': '252.7', 'category': 'CARDINAL'}, {'entity': '42.9', 'category': 'CARDINAL'}, {'entity': '43.2', 'category': 'CARDINAL'}, {'entity': '218.3', 'category': 'CARDINAL'}, {'entity': '209.5', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  8\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVbFg3d97jXB3MA7LXPPjvZTn0hh\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701567017,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#1950s#1960s#5.3 million#5.9 million#2019#2018#1#52.5 million#15#2027#327.9#341.4#16.7#23.3#35.4#36.8#309.2#327.9#16.7#10.0 million#4.1 million#1.9 million#0.7 million#23.3#8.8 million#4.6 million#3.8 million#2.2 million#3.9 million#12%\\n\\nDATE#December 31, 2019#Year Ended December 31, 2019#Year Ended December 31, 2018\\n\\nEVENT#Generally Accepted Manufacturing and Disposal Practices\\n\\nFAC#Aerojet Rocketdyne - Sacramento#Aerojet Rocketdyne - Baldwin Park Operable Unit (\\\"BPOU\\\")\\n\\nGPE#US\\n\\nLOC#\\n\\nMONEY#325.8#106.1#22.3#5.6#309.2#459.8#344.1#321.2#18.2#28.1#32.8#344.1\\n\\nNORP#\\n\\nORDINAL#\\n\\nORG#PRP#Northrop#Aerojet Rocketdyne#Global Settlement#U.S. government#Aerospace and Defense segment\\n\\nPERCENT#100%\\n\\nPERSON#\\n\\nPRODUCT#\\n\\nQUANTITY#\\n\\nTIME#\\n\\nWORK_OF_ART#}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2297,\n",
      "    \"completion_tokens\": 310,\n",
      "    \"total_tokens\": 2607\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2019', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2019', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2018', 'category': 'DATE'}, {'entity': 'Generally Accepted Manufacturing and Disposal Practices', 'category': 'EVENT'}, {'entity': 'Aerojet Rocketdyne - Sacramento', 'category': 'FAC'}, {'entity': 'Aerojet Rocketdyne - Baldwin Park Operable Unit \"BPOU\"', 'category': 'FAC'}, {'entity': 'US', 'category': 'GPE'}, {'entity': '325.8', 'category': 'MONEY'}, {'entity': '106.1', 'category': 'MONEY'}, {'entity': '22.3', 'category': 'MONEY'}, {'entity': '5.6', 'category': 'MONEY'}, {'entity': '309.2', 'category': 'MONEY'}, {'entity': '459.8', 'category': 'MONEY'}, {'entity': '344.1', 'category': 'MONEY'}, {'entity': '321.2', 'category': 'MONEY'}, {'entity': '18.2', 'category': 'MONEY'}, {'entity': '28.1', 'category': 'MONEY'}, {'entity': '32.8', 'category': 'MONEY'}, {'entity': '344.1', 'category': 'MONEY'}, {'entity': 'PRP', 'category': 'ORG'}, {'entity': 'Northrop', 'category': 'ORG'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': 'Global Settlement', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'Aerospace and Defense segment', 'category': 'ORG'}, {'entity': '100%', 'category': 'PERCENT'}, {'entity': '', 'category': 'WORK_OF_ART'}, {'entity': '1950s', 'category': 'CARDINAL'}, {'entity': '1960s', 'category': 'CARDINAL'}, {'entity': '5.3 million', 'category': 'CARDINAL'}, {'entity': '5.9 million', 'category': 'CARDINAL'}, {'entity': '2019', 'category': 'CARDINAL'}, {'entity': '2018', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '52.5 million', 'category': 'CARDINAL'}, {'entity': '15', 'category': 'CARDINAL'}, {'entity': '2027', 'category': 'CARDINAL'}, {'entity': '327.9', 'category': 'CARDINAL'}, {'entity': '341.4', 'category': 'CARDINAL'}, {'entity': '16.7', 'category': 'CARDINAL'}, {'entity': '23.3', 'category': 'CARDINAL'}, {'entity': '35.4', 'category': 'CARDINAL'}, {'entity': '36.8', 'category': 'CARDINAL'}, {'entity': '309.2', 'category': 'CARDINAL'}, {'entity': '327.9', 'category': 'CARDINAL'}, {'entity': '16.7', 'category': 'CARDINAL'}, {'entity': '10.0 million', 'category': 'CARDINAL'}, {'entity': '4.1 million', 'category': 'CARDINAL'}, {'entity': '1.9 million', 'category': 'CARDINAL'}, {'entity': '0.7 million', 'category': 'CARDINAL'}, {'entity': '23.3', 'category': 'CARDINAL'}, {'entity': '8.8 million', 'category': 'CARDINAL'}, {'entity': '4.6 million', 'category': 'CARDINAL'}, {'entity': '3.8 million', 'category': 'CARDINAL'}, {'entity': '2.2 million', 'category': 'CARDINAL'}, {'entity': '3.9 million', 'category': 'CARDINAL'}, {'entity': '12%', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  8\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVboUd5p0XLsKxqR6UP6ayc19ZIM\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701567052,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#261.2#252.7#41.8#20.9#24.1#26.5#195.3#205.3#8.5#43.0#42.9#43.2#20.4#20.8#25.3#345.6#17.5#328.1#300.0#27.2#3.3#23.8#47.7#672.8#20.8#23.8#675.8#932.6#620.3#33.80#328.1#19.7#54.7#253.7#300.0#300.0#47.7#2.1#3.9#2.8#38.9#96.2#20.9#38.9#17.8#18.6#22.9#3.5#6.1#5.0#8.3#59.2#14.2#24.1#7.4#13.5#889.2#603.1#254.6#31.5#51.4#0.1#9.3#13.4#28.6#1,794.7#963.6#391.6#331.6#107.9 \\n\\nDATE#Year Ended December 31, 2019#2018#December 31, 2018#December 31, 2019#January 1, 2020#through March 31, 2020#December 31, 2019#December 31, 2019#the next 10 years  \\n\\nEVENT#OutlookShort-term\\n\\nFAC#Senior Credit Facility#Senior Credit Facility#Senior Credit Facility\\n\\nGPE#U.S.\\n\\nMONEY#$43.0 million#$42.9 million#$43.2 million#$20.4 million#$20.8 million#$25.3 million#$345.6#$328.1#300.0#300.0#27.2#3.3#23.8#47.7#$672.8#$675.8#$932.6 million#$620.3 million#300.0#$328.1#$300.0#$47.7#$96.2#$22.9#$59.2#$889.2#$51.4#$1,794.7\\n\\nORG#Operating ActivitiesThe#Net Cash Provided by Operating ActivitiesThe#Net Cash Used in Investing ActivitiesDuring#Net Cash Used in Financing ActivitiesDuring#Item 8#Contractual Obligations:We#Item 8 \\n\\nPERCENT#2 1/4%\\n\\nPERSON#Risk Factors\\n\\nPRODUCT# 2\\u00bc% Notes#2\\u00bc% Notes#2\\u00bc% Notes#2\\u00bc% Notes#2\\u00bc% Notes#2\\u00bc% Notes#2\\u00bc% Notes}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2499,\n",
      "    \"completion_tokens\": 607,\n",
      "    \"total_tokens\": 3106\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'Year Ended December 31, 2019', 'category': 'DATE'}, {'entity': '2018', 'category': 'DATE'}, {'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': 'December 31, 2019', 'category': 'DATE'}, {'entity': 'January 1, 2020', 'category': 'DATE'}, {'entity': 'through March 31, 2020', 'category': 'DATE'}, {'entity': 'December 31, 2019', 'category': 'DATE'}, {'entity': 'December 31, 2019', 'category': 'DATE'}, {'entity': 'the next 10 years', 'category': 'DATE'}, {'entity': 'OutlookShort-term', 'category': 'EVENT'}, {'entity': 'Senior Credit Facility', 'category': 'FAC'}, {'entity': 'Senior Credit Facility', 'category': 'FAC'}, {'entity': 'Senior Credit Facility', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '$43.0 million', 'category': 'MONEY'}, {'entity': '$42.9 million', 'category': 'MONEY'}, {'entity': '$43.2 million', 'category': 'MONEY'}, {'entity': '$20.4 million', 'category': 'MONEY'}, {'entity': '$20.8 million', 'category': 'MONEY'}, {'entity': '$25.3 million', 'category': 'MONEY'}, {'entity': '$345.6', 'category': 'MONEY'}, {'entity': '$328.1', 'category': 'MONEY'}, {'entity': '300.0', 'category': 'MONEY'}, {'entity': '300.0', 'category': 'MONEY'}, {'entity': '27.2', 'category': 'MONEY'}, {'entity': '3.3', 'category': 'MONEY'}, {'entity': '23.8', 'category': 'MONEY'}, {'entity': '47.7', 'category': 'MONEY'}, {'entity': '$672.8', 'category': 'MONEY'}, {'entity': '$675.8', 'category': 'MONEY'}, {'entity': '$932.6 million', 'category': 'MONEY'}, {'entity': '$620.3 million', 'category': 'MONEY'}, {'entity': '300.0', 'category': 'MONEY'}, {'entity': '$328.1', 'category': 'MONEY'}, {'entity': '$300.0', 'category': 'MONEY'}, {'entity': '$47.7', 'category': 'MONEY'}, {'entity': '$96.2', 'category': 'MONEY'}, {'entity': '$22.9', 'category': 'MONEY'}, {'entity': '$59.2', 'category': 'MONEY'}, {'entity': '$889.2', 'category': 'MONEY'}, {'entity': '$51.4', 'category': 'MONEY'}, {'entity': '$1,794.7', 'category': 'MONEY'}, {'entity': 'Operating ActivitiesThe', 'category': 'ORG'}, {'entity': 'Net Cash Provided by Operating ActivitiesThe', 'category': 'ORG'}, {'entity': 'Net Cash Used in Investing ActivitiesDuring', 'category': 'ORG'}, {'entity': 'Net Cash Used in Financing ActivitiesDuring', 'category': 'ORG'}, {'entity': 'Item 8', 'category': 'ORG'}, {'entity': 'Contractual ObligationsWe', 'category': 'ORG'}, {'entity': 'Item 8', 'category': 'ORG'}, {'entity': '2 1/4%', 'category': 'PERCENT'}, {'entity': 'Risk Factors', 'category': 'PERSON'}, {'entity': '2¼% Notes', 'category': 'PRODUCT'}, {'entity': '2¼% Notes', 'category': 'PRODUCT'}, {'entity': '2¼% Notes', 'category': 'PRODUCT'}, {'entity': '2¼% Notes', 'category': 'PRODUCT'}, {'entity': '2¼% Notes', 'category': 'PRODUCT'}, {'entity': '2¼% Notes', 'category': 'PRODUCT'}, {'entity': '2¼% Notes', 'category': 'PRODUCT'}, {'entity': '261.2', 'category': 'CARDINAL'}, {'entity': '252.7', 'category': 'CARDINAL'}, {'entity': '41.8', 'category': 'CARDINAL'}, {'entity': '20.9', 'category': 'CARDINAL'}, {'entity': '24.1', 'category': 'CARDINAL'}, {'entity': '26.5', 'category': 'CARDINAL'}, {'entity': '195.3', 'category': 'CARDINAL'}, {'entity': '205.3', 'category': 'CARDINAL'}, {'entity': '8.5', 'category': 'CARDINAL'}, {'entity': '43.0', 'category': 'CARDINAL'}, {'entity': '42.9', 'category': 'CARDINAL'}, {'entity': '43.2', 'category': 'CARDINAL'}, {'entity': '20.4', 'category': 'CARDINAL'}, {'entity': '20.8', 'category': 'CARDINAL'}, {'entity': '25.3', 'category': 'CARDINAL'}, {'entity': '345.6', 'category': 'CARDINAL'}, {'entity': '17.5', 'category': 'CARDINAL'}, {'entity': '328.1', 'category': 'CARDINAL'}, {'entity': '300.0', 'category': 'CARDINAL'}, {'entity': '27.2', 'category': 'CARDINAL'}, {'entity': '3.3', 'category': 'CARDINAL'}, {'entity': '23.8', 'category': 'CARDINAL'}, {'entity': '47.7', 'category': 'CARDINAL'}, {'entity': '672.8', 'category': 'CARDINAL'}, {'entity': '20.8', 'category': 'CARDINAL'}, {'entity': '23.8', 'category': 'CARDINAL'}, {'entity': '675.8', 'category': 'CARDINAL'}, {'entity': '932.6', 'category': 'CARDINAL'}, {'entity': '620.3', 'category': 'CARDINAL'}, {'entity': '33.80', 'category': 'CARDINAL'}, {'entity': '328.1', 'category': 'CARDINAL'}, {'entity': '19.7', 'category': 'CARDINAL'}, {'entity': '54.7', 'category': 'CARDINAL'}, {'entity': '253.7', 'category': 'CARDINAL'}, {'entity': '300.0', 'category': 'CARDINAL'}, {'entity': '300.0', 'category': 'CARDINAL'}, {'entity': '47.7', 'category': 'CARDINAL'}, {'entity': '2.1', 'category': 'CARDINAL'}, {'entity': '3.9', 'category': 'CARDINAL'}, {'entity': '2.8', 'category': 'CARDINAL'}, {'entity': '38.9', 'category': 'CARDINAL'}, {'entity': '96.2', 'category': 'CARDINAL'}, {'entity': '20.9', 'category': 'CARDINAL'}, {'entity': '38.9', 'category': 'CARDINAL'}, {'entity': '17.8', 'category': 'CARDINAL'}, {'entity': '18.6', 'category': 'CARDINAL'}, {'entity': '22.9', 'category': 'CARDINAL'}, {'entity': '3.5', 'category': 'CARDINAL'}, {'entity': '6.1', 'category': 'CARDINAL'}, {'entity': '5.0', 'category': 'CARDINAL'}, {'entity': '8.3', 'category': 'CARDINAL'}, {'entity': '59.2', 'category': 'CARDINAL'}, {'entity': '14.2', 'category': 'CARDINAL'}, {'entity': '24.1', 'category': 'CARDINAL'}, {'entity': '7.4', 'category': 'CARDINAL'}, {'entity': '13.5', 'category': 'CARDINAL'}, {'entity': '889.2', 'category': 'CARDINAL'}, {'entity': '603.1', 'category': 'CARDINAL'}, {'entity': '254.6', 'category': 'CARDINAL'}, {'entity': '31.5', 'category': 'CARDINAL'}, {'entity': '51.4', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '9.3', 'category': 'CARDINAL'}, {'entity': '13.4', 'category': 'CARDINAL'}, {'entity': '28.6', 'category': 'CARDINAL'}, {'entity': '1,794.7', 'category': 'CARDINAL'}, {'entity': '963.6', 'category': 'CARDINAL'}, {'entity': '391.6', 'category': 'CARDINAL'}, {'entity': '331.6', 'category': 'CARDINAL'}, {'entity': '107.9', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  8\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVcc96qn4bWyFF6jD6kA6FkqBmMT\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701567102,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#13.9 \\n\\nDATE#Year Ended December 31, 2019#2018\\n\\nMONEY#$13.9 million\\n\\nORG#U.S. government#Aerospace and Defense\\n\\nPERSON#GAAP\\n\\nPRODUCT#U.S. government contracts#long-lived assets#pension funding rules\\n\\nWORK_OF_ART#Note 9(d)#Note 1#Item 8 of this Report#the consolidated financial statements}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 1952,\n",
      "    \"completion_tokens\": 91,\n",
      "    \"total_tokens\": 2043\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'Year Ended December 31, 2019', 'category': 'DATE'}, {'entity': '2018', 'category': 'DATE'}, {'entity': '$13.9 million', 'category': 'MONEY'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'Aerospace and Defense', 'category': 'ORG'}, {'entity': 'GAAP', 'category': 'PERSON'}, {'entity': 'U.S. government contracts', 'category': 'PRODUCT'}, {'entity': 'long-lived assets', 'category': 'PRODUCT'}, {'entity': 'pension funding rules', 'category': 'PRODUCT'}, {'entity': 'Note 9d', 'category': 'WORK_OF_ART'}, {'entity': 'Note 1', 'category': 'WORK_OF_ART'}, {'entity': 'Item 8 of this Report', 'category': 'WORK_OF_ART'}, {'entity': 'the consolidated financial statements', 'category': 'WORK_OF_ART'}, {'entity': '13.9', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  8\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVd4GIdAuAAP6Zkb9xsfjkWSKn79\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701567130,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#38.6#68.2#38.4#59.1#28.2#43.1#0.36#0.56#0.34#0.55#401#2009#1\\n\\nDATE#December 31, 2019#December 31, 2018#Year Ended December 31, 2019#Year Ended December 31, 2018\\n\\nEVENT#changes in contract estimates\\n\\nLAW#Note 1(r)#FAR and CAS\\n\\nMONEY#$\\t38.6#$\\t68.2\\n\\nORG#Aerospace and Defense segment#U.S. government#DCAA\\n\\nPERCENT#3.28%#4.27%#3.19%#4.09%#3.59%#4.09%#7.00%#3.37%\\n\\nPERSON#Net PeriodicBenefit\\n\\nPRODUCT#Retirement Benefit Plans\\n\\nQUANTITY#one-percentage-point\\n\\nTIME#Item 8 of this Report\\n\\nWORK_OF_ART#Environmental Reserves and Estimated Recoveries}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2218,\n",
      "    \"completion_tokens\": 225,\n",
      "    \"total_tokens\": 2443\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2019', 'category': 'DATE'}, {'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2019', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2018', 'category': 'DATE'}, {'entity': 'changes in contract estimates', 'category': 'EVENT'}, {'entity': 'Note 1r', 'category': 'LAW'}, {'entity': 'FAR and CAS', 'category': 'LAW'}, {'entity': '$\\t38.6', 'category': 'MONEY'}, {'entity': '$\\t68.2', 'category': 'MONEY'}, {'entity': 'Aerospace and Defense segment', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'DCAA', 'category': 'ORG'}, {'entity': '3.28%', 'category': 'PERCENT'}, {'entity': '4.27%', 'category': 'PERCENT'}, {'entity': '3.19%', 'category': 'PERCENT'}, {'entity': '4.09%', 'category': 'PERCENT'}, {'entity': '3.59%', 'category': 'PERCENT'}, {'entity': '4.09%', 'category': 'PERCENT'}, {'entity': '7.00%', 'category': 'PERCENT'}, {'entity': '3.37%', 'category': 'PERCENT'}, {'entity': 'Net PeriodicBenefit', 'category': 'PERSON'}, {'entity': 'Retirement Benefit Plans', 'category': 'PRODUCT'}, {'entity': 'one-percentage-point', 'category': 'QUANTITY'}, {'entity': 'Item 8 of this Report', 'category': 'TIME'}, {'entity': 'Environmental Reserves and Estimated Recoveries', 'category': 'WORK_OF_ART'}, {'entity': '38.6', 'category': 'CARDINAL'}, {'entity': '68.2', 'category': 'CARDINAL'}, {'entity': '38.4', 'category': 'CARDINAL'}, {'entity': '59.1', 'category': 'CARDINAL'}, {'entity': '28.2', 'category': 'CARDINAL'}, {'entity': '43.1', 'category': 'CARDINAL'}, {'entity': '0.36', 'category': 'CARDINAL'}, {'entity': '0.56', 'category': 'CARDINAL'}, {'entity': '0.34', 'category': 'CARDINAL'}, {'entity': '0.55', 'category': 'CARDINAL'}, {'entity': '401', 'category': 'CARDINAL'}, {'entity': '2009', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  8\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVdcTL8DkrY7EO2Xu9J7RCyGG7ND\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701567164,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#100%#50%\\n\\nDATE#December 31, 2019#the past three years\\n\\nEVENT#Global Settlement\\n\\nGPE#U.S.\\n\\nLAW#U.S. federal income tax\\n\\nMONEY#$628.1 million#$300.0 million#$328.1 million\\n\\nORG#Company#Senior Credit Facility\\n\\nPERCENT#2.25%#3.55%\\n\\nPERSON#\\n\\nPRODUCT#\\n\\nQUANTITY#\\n\\nTIME#\\n\\nWORK_OF_ART#}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 1940,\n",
      "    \"completion_tokens\": 97,\n",
      "    \"total_tokens\": 2037\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2019', 'category': 'DATE'}, {'entity': 'the past three years', 'category': 'DATE'}, {'entity': 'Global Settlement', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S. federal income tax', 'category': 'LAW'}, {'entity': '$628.1 million', 'category': 'MONEY'}, {'entity': '$300.0 million', 'category': 'MONEY'}, {'entity': '$328.1 million', 'category': 'MONEY'}, {'entity': 'Company', 'category': 'ORG'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': '2.25%', 'category': 'PERCENT'}, {'entity': '3.55%', 'category': 'PERCENT'}, {'entity': '', 'category': 'WORK_OF_ART'}, {'entity': '100%', 'category': 'CARDINAL'}, {'entity': '50%', 'category': 'CARDINAL'}]\n",
      "/home/damir/Dropbox/Documents/Teaching/2023/L715/l715_23/data/10-Ks/Aerojet_Rocketdyne_Holdings_Inc./2015/Management.txt\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVe40szKLR1bycssMnq62Cn304RA\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701567192,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#7#10#8#1#1A#1#6#8#2#12,000#50#2014#1,597.4#1,383.1#2013#12#5#53.0#92#167.9#2.11#23.6#60.6#59.6#4#193.9#174.2#10.9#155.6#11.3#145.5#151.4#150.4#77.6#94.1#107.0#14.4#2.2#1.7#516.3#501.6#30#2014#2013#27.8#2012#550#10#1976#12#14#411#50#12#12, 2014#2015#5#2014#38.5\\n\\nDATE#November 30#last Saturday of November#first quarter of fiscal 2013#first quarter of fiscal 2014#July 2012#June 10, 2013#June 12, 2013#June 14, 2013#June 12, 2014#June 12, 2015#December 2014#three months through March 2015#November 30, 2014\\n\\nEVENT#Annual Report#Rocketdyne Business operating results (see below)#Antares AJ-26 program#Acquisition#RDA Acquisition\\n\\nFAC#Amended and Restated Purchase Agreement#RD Amross\\n\\nGPE#United States of America#United States#Sacramento#Sacramento Land#California\\n\\nLANGUAGE#GAAP\\n\\nLAW#Hart-Scott-Rodino Antitrust Improvements Act of 1976\\n\\nMONEY#$1,597.4 million#$1,383.1 million#$23.6 million#$60.6 million#$59.6 million#4 1/16%#$193.9 million#$174.2 million#$155.6 million#$145.5 million#$151.4 million#$150.4 million#$77.6 million#$94.1 million#$107.0 million#$14.4 million#$2.2 billion#$1.7 billion#$516.3 million#$501.6 million#$550 million#50% #%$411 million\\n\\nORG#GenCorp Inc.#GAAP#Consolidated Financial Statements#Supplementary Data#Risk Factors#Aerojet Rocketdyne#DoD#NASA#major aerospace and defense prime contractors#Easton Development Company, LLC#FTC#UTC#Rocketdyne Business#RD Amross#U.S. government\\n\\nPERSON#Management\\u2019s Discussion and Analysis of Financial Condition and Results of Operations\\n\\nQUANTITY#12,000 acres\\n\\nTIME#fiscal 2014#fiscal 2013#first quarter of fiscal 2013#first quarter of fiscal 2014\\n\\nWORK_OF_ART#Original Purchase Agreement#Amended and Restated Purchase Agreement}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2319,\n",
      "    \"completion_tokens\": 630,\n",
      "    \"total_tokens\": 2949\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'November 30', 'category': 'DATE'}, {'entity': 'last Saturday of November', 'category': 'DATE'}, {'entity': 'first quarter of fiscal 2013', 'category': 'DATE'}, {'entity': 'first quarter of fiscal 2014', 'category': 'DATE'}, {'entity': 'July 2012', 'category': 'DATE'}, {'entity': 'June 10, 2013', 'category': 'DATE'}, {'entity': 'June 12, 2013', 'category': 'DATE'}, {'entity': 'June 14, 2013', 'category': 'DATE'}, {'entity': 'June 12, 2014', 'category': 'DATE'}, {'entity': 'June 12, 2015', 'category': 'DATE'}, {'entity': 'December 2014', 'category': 'DATE'}, {'entity': 'three months through March 2015', 'category': 'DATE'}, {'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'Annual Report', 'category': 'EVENT'}, {'entity': 'Rocketdyne Business operating results see below', 'category': 'EVENT'}, {'entity': 'Antares AJ-26 program', 'category': 'EVENT'}, {'entity': 'Acquisition', 'category': 'EVENT'}, {'entity': 'RDA Acquisition', 'category': 'EVENT'}, {'entity': 'Amended and Restated Purchase Agreement', 'category': 'FAC'}, {'entity': 'RD Amross', 'category': 'FAC'}, {'entity': 'United States of America', 'category': 'GPE'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'Sacramento', 'category': 'GPE'}, {'entity': 'Sacramento Land', 'category': 'GPE'}, {'entity': 'California', 'category': 'GPE'}, {'entity': 'GAAP', 'category': 'LANGUAGE'}, {'entity': 'Hart-Scott-Rodino Antitrust Improvements Act of 1976', 'category': 'LAW'}, {'entity': '$1,597.4 million', 'category': 'MONEY'}, {'entity': '$1,383.1 million', 'category': 'MONEY'}, {'entity': '$23.6 million', 'category': 'MONEY'}, {'entity': '$60.6 million', 'category': 'MONEY'}, {'entity': '$59.6 million', 'category': 'MONEY'}, {'entity': '4 1/16%', 'category': 'MONEY'}, {'entity': '$193.9 million', 'category': 'MONEY'}, {'entity': '$174.2 million', 'category': 'MONEY'}, {'entity': '$155.6 million', 'category': 'MONEY'}, {'entity': '$145.5 million', 'category': 'MONEY'}, {'entity': '$151.4 million', 'category': 'MONEY'}, {'entity': '$150.4 million', 'category': 'MONEY'}, {'entity': '$77.6 million', 'category': 'MONEY'}, {'entity': '$94.1 million', 'category': 'MONEY'}, {'entity': '$107.0 million', 'category': 'MONEY'}, {'entity': '$14.4 million', 'category': 'MONEY'}, {'entity': '$2.2 billion', 'category': 'MONEY'}, {'entity': '$1.7 billion', 'category': 'MONEY'}, {'entity': '$516.3 million', 'category': 'MONEY'}, {'entity': '$501.6 million', 'category': 'MONEY'}, {'entity': '$550 million', 'category': 'MONEY'}, {'entity': '50%', 'category': 'MONEY'}, {'entity': '%$411 million', 'category': 'MONEY'}, {'entity': 'GenCorp Inc.', 'category': 'ORG'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': 'Consolidated Financial Statements', 'category': 'ORG'}, {'entity': 'Supplementary Data', 'category': 'ORG'}, {'entity': 'Risk Factors', 'category': 'ORG'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': 'DoD', 'category': 'ORG'}, {'entity': 'NASA', 'category': 'ORG'}, {'entity': 'major aerospace and defense prime contractors', 'category': 'ORG'}, {'entity': 'Easton Development Company, LLC', 'category': 'ORG'}, {'entity': 'FTC', 'category': 'ORG'}, {'entity': 'UTC', 'category': 'ORG'}, {'entity': 'Rocketdyne Business', 'category': 'ORG'}, {'entity': 'RD Amross', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'Management’s Discussion and Analysis of Financial Condition and Results of Operations', 'category': 'PERSON'}, {'entity': '12', 'category': 'QUANTITY'}, {'entity': '000 acres', 'category': 'QUANTITY'}, {'entity': 'fiscal 2014', 'category': 'TIME'}, {'entity': 'fiscal 2013', 'category': 'TIME'}, {'entity': 'first quarter of fiscal 2013', 'category': 'TIME'}, {'entity': 'first quarter of fiscal 2014', 'category': 'TIME'}, {'entity': 'Original Purchase Agreement', 'category': 'WORK_OF_ART'}, {'entity': 'Amended and Restated Purchase Agreement', 'category': 'WORK_OF_ART'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1A', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '12,000', 'category': 'CARDINAL'}, {'entity': '50', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '1,597.4', 'category': 'CARDINAL'}, {'entity': '1,383.1', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '5', 'category': 'CARDINAL'}, {'entity': '53.0', 'category': 'CARDINAL'}, {'entity': '92', 'category': 'CARDINAL'}, {'entity': '167.9', 'category': 'CARDINAL'}, {'entity': '2.11', 'category': 'CARDINAL'}, {'entity': '23.6', 'category': 'CARDINAL'}, {'entity': '60.6', 'category': 'CARDINAL'}, {'entity': '59.6', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '193.9', 'category': 'CARDINAL'}, {'entity': '174.2', 'category': 'CARDINAL'}, {'entity': '10.9', 'category': 'CARDINAL'}, {'entity': '155.6', 'category': 'CARDINAL'}, {'entity': '11.3', 'category': 'CARDINAL'}, {'entity': '145.5', 'category': 'CARDINAL'}, {'entity': '151.4', 'category': 'CARDINAL'}, {'entity': '150.4', 'category': 'CARDINAL'}, {'entity': '77.6', 'category': 'CARDINAL'}, {'entity': '94.1', 'category': 'CARDINAL'}, {'entity': '107.0', 'category': 'CARDINAL'}, {'entity': '14.4', 'category': 'CARDINAL'}, {'entity': '2.2', 'category': 'CARDINAL'}, {'entity': '1.7', 'category': 'CARDINAL'}, {'entity': '516.3', 'category': 'CARDINAL'}, {'entity': '501.6', 'category': 'CARDINAL'}, {'entity': '30', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '27.8', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '550', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '1976', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '14', 'category': 'CARDINAL'}, {'entity': '411', 'category': 'CARDINAL'}, {'entity': '50', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '12, 2014', 'category': 'CARDINAL'}, {'entity': '2015', 'category': 'CARDINAL'}, {'entity': '5', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '38.5', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVeqqJHYw7UglGsHuQCfLX6Qemmt\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701567240,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#two#two#two#2015#one#1,383.1#994.9#1,762.7#1,694.0#167.9#2.6#30.7#38.2#2.76#0.04#0.50#0.64#2.11#0.04#0.47#0.56#28#23#32#25#18#17#32#37#11#10#2014#1,473.8#92#2013#1,311.0#95#2012#936.9#94#12#22#25#12#4#5#2013#2014#2015#1.0#490.2#3.3#64.0#18.0#0.5#0.4#2016#2012#2014\\n\\nDATE#December 2014#fiscal 2015#2013#2012#Year Ended  2013#2012#Year Ended \\t2014#2013#2012#GFY 2014#2015#GFY 2015#January 2016\\n\\nEVENT#the Acquisition\\n\\nFAC#\\n\\nGPE#U.S.\\n\\nLANGUAGE#\\n\\nLAW#the Bipartisan Budget Act of 2013#the President\\u2019s Budget Request for GFY 2015#the Department of Homeland Security\\n\\nLOC#\\n\\nMONEY#$\\t1,694.0#$\\t167.9#$\\t2.76#$\\t0.04#$\\t0.64#$\\t0.04#$\\t0.47#$\\t$1.0 trillion#$490.2 billion#$3.3 billion#$64.0 billion#$18.0 billion#$0.5 billion#$0.4 billion\\n\\nNORP#\\n\\nORDINAL#\\n\\nORG#DCAA#DCMA#the Under Secretary of Defense#Rocketdyne Business#NASA#the Missile Defense Agency#Lockheed Martin#ULA#Raytheon#U.S. Congress#DoD#GFY#Commerce, Justice, Science#CR\\n\\nPERCENT#10%#92%#95%#94%\\n\\nPERSON#\\n\\nPRODUCT#\\n\\nQUANTITY#\\n\\nTIME#\\n\\nWORK_OF_ART#}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2398,\n",
      "    \"completion_tokens\": 471,\n",
      "    \"total_tokens\": 2869\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 2014', 'category': 'DATE'}, {'entity': 'fiscal 2015', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': 'Year Ended  2013', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': 'Year Ended \\t2014', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': 'GFY 2014', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': 'GFY 2015', 'category': 'DATE'}, {'entity': 'January 2016', 'category': 'DATE'}, {'entity': 'the Acquisition', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'the Bipartisan Budget Act of 2013', 'category': 'LAW'}, {'entity': 'the President’s Budget Request for GFY 2015', 'category': 'LAW'}, {'entity': 'the Department of Homeland Security', 'category': 'LAW'}, {'entity': '$\\t1,694.0', 'category': 'MONEY'}, {'entity': '$\\t167.9', 'category': 'MONEY'}, {'entity': '$\\t2.76', 'category': 'MONEY'}, {'entity': '$\\t0.04', 'category': 'MONEY'}, {'entity': '$\\t0.64', 'category': 'MONEY'}, {'entity': '$\\t0.04', 'category': 'MONEY'}, {'entity': '$\\t0.47', 'category': 'MONEY'}, {'entity': '$\\t$1.0 trillion', 'category': 'MONEY'}, {'entity': '$490.2 billion', 'category': 'MONEY'}, {'entity': '$3.3 billion', 'category': 'MONEY'}, {'entity': '$64.0 billion', 'category': 'MONEY'}, {'entity': '$18.0 billion', 'category': 'MONEY'}, {'entity': '$0.5 billion', 'category': 'MONEY'}, {'entity': '$0.4 billion', 'category': 'MONEY'}, {'entity': 'DCAA', 'category': 'ORG'}, {'entity': 'DCMA', 'category': 'ORG'}, {'entity': 'the Under Secretary of Defense', 'category': 'ORG'}, {'entity': 'Rocketdyne Business', 'category': 'ORG'}, {'entity': 'NASA', 'category': 'ORG'}, {'entity': 'the Missile Defense Agency', 'category': 'ORG'}, {'entity': 'Lockheed Martin', 'category': 'ORG'}, {'entity': 'ULA', 'category': 'ORG'}, {'entity': 'Raytheon', 'category': 'ORG'}, {'entity': 'U.S. Congress', 'category': 'ORG'}, {'entity': 'DoD', 'category': 'ORG'}, {'entity': 'GFY', 'category': 'ORG'}, {'entity': 'Commerce, Justice, Science', 'category': 'ORG'}, {'entity': 'CR', 'category': 'ORG'}, {'entity': '10%', 'category': 'PERCENT'}, {'entity': '92%', 'category': 'PERCENT'}, {'entity': '95%', 'category': 'PERCENT'}, {'entity': '94%', 'category': 'PERCENT'}, {'entity': '', 'category': 'WORK_OF_ART'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': '2015', 'category': 'CARDINAL'}, {'entity': 'one', 'category': 'CARDINAL'}, {'entity': '1,383.1', 'category': 'CARDINAL'}, {'entity': '994.9', 'category': 'CARDINAL'}, {'entity': '1,762.7', 'category': 'CARDINAL'}, {'entity': '1,694.0', 'category': 'CARDINAL'}, {'entity': '167.9', 'category': 'CARDINAL'}, {'entity': '2.6', 'category': 'CARDINAL'}, {'entity': '30.7', 'category': 'CARDINAL'}, {'entity': '38.2', 'category': 'CARDINAL'}, {'entity': '2.76', 'category': 'CARDINAL'}, {'entity': '0.04', 'category': 'CARDINAL'}, {'entity': '0.50', 'category': 'CARDINAL'}, {'entity': '0.64', 'category': 'CARDINAL'}, {'entity': '2.11', 'category': 'CARDINAL'}, {'entity': '0.04', 'category': 'CARDINAL'}, {'entity': '0.47', 'category': 'CARDINAL'}, {'entity': '0.56', 'category': 'CARDINAL'}, {'entity': '28', 'category': 'CARDINAL'}, {'entity': '23', 'category': 'CARDINAL'}, {'entity': '32', 'category': 'CARDINAL'}, {'entity': '25', 'category': 'CARDINAL'}, {'entity': '18', 'category': 'CARDINAL'}, {'entity': '17', 'category': 'CARDINAL'}, {'entity': '32', 'category': 'CARDINAL'}, {'entity': '37', 'category': 'CARDINAL'}, {'entity': '11', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '1,473.8', 'category': 'CARDINAL'}, {'entity': '92', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '1,311.0', 'category': 'CARDINAL'}, {'entity': '95', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '936.9', 'category': 'CARDINAL'}, {'entity': '94', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '22', 'category': 'CARDINAL'}, {'entity': '25', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '5', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2015', 'category': 'CARDINAL'}, {'entity': '1.0', 'category': 'CARDINAL'}, {'entity': '490.2', 'category': 'CARDINAL'}, {'entity': '3.3', 'category': 'CARDINAL'}, {'entity': '64.0', 'category': 'CARDINAL'}, {'entity': '18.0', 'category': 'CARDINAL'}, {'entity': '0.5', 'category': 'CARDINAL'}, {'entity': '0.4', 'category': 'CARDINAL'}, {'entity': '2016', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVfVdDUoXLHIHZDWVsg7KJg9YdWS\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701567281,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#782.2#920.4#86#74.8#2016#2015 \\n\\nDATE#November 30, 2014#January 1, 2015\\n\\nFAC#Aerojet Rocketdyne - Sacramento#Aerojet Rocketdyne - BPOU\\n\\nGPE#U.S.\\n\\nLAW#NASA Authorization Act#Internal Revenue Service\\n\\nMONEY#$84.1 million#$130.4 million#$211.3 million#$14.0 million#$21.7 million#$35.6 million#$7.8 million#$8.1 million#$20.0 million#$0.7 million#$5.8 million#$8.0 million#$106.6 million#$166.0 million#$274.9 million\\n\\nORG#QDR#Missile Defense#Space#Nuclear Deterrence#Precision Strike#DoD#NASA#SLS#Congress#Russian Soyuz#ISS#ATK#Aerospace#Defense#SpaceX#Blue Origin#Northrop#Aerojet Rocketdyne#PPA\\n\\nPERCENT#15%\\n\\nPRODUCT#rocket motors#liquid engines#liquid fuel propulsion capabilities#propulsion systems\\n\\nTIME#decade\\n\\nEVENT#retirement of the space shuttle fleet\\n\\nWORK_OF_ART#Aerojet Rocketdyne Business ERP Integration\\n}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2454,\n",
      "    \"completion_tokens\": 276,\n",
      "    \"total_tokens\": 2730\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'January 1, 2015', 'category': 'DATE'}, {'entity': 'retirement of the space shuttle fleet', 'category': 'EVENT'}, {'entity': 'Aerojet Rocketdyne - Sacramento', 'category': 'FAC'}, {'entity': 'Aerojet Rocketdyne - BPOU', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'NASA Authorization Act', 'category': 'LAW'}, {'entity': 'Internal Revenue Service', 'category': 'LAW'}, {'entity': '$84.1 million', 'category': 'MONEY'}, {'entity': '$130.4 million', 'category': 'MONEY'}, {'entity': '$211.3 million', 'category': 'MONEY'}, {'entity': '$14.0 million', 'category': 'MONEY'}, {'entity': '$21.7 million', 'category': 'MONEY'}, {'entity': '$35.6 million', 'category': 'MONEY'}, {'entity': '$7.8 million', 'category': 'MONEY'}, {'entity': '$8.1 million', 'category': 'MONEY'}, {'entity': '$20.0 million', 'category': 'MONEY'}, {'entity': '$0.7 million', 'category': 'MONEY'}, {'entity': '$5.8 million', 'category': 'MONEY'}, {'entity': '$8.0 million', 'category': 'MONEY'}, {'entity': '$106.6 million', 'category': 'MONEY'}, {'entity': '$166.0 million', 'category': 'MONEY'}, {'entity': '$274.9 million', 'category': 'MONEY'}, {'entity': 'QDR', 'category': 'ORG'}, {'entity': 'Missile Defense', 'category': 'ORG'}, {'entity': 'Space', 'category': 'ORG'}, {'entity': 'Nuclear Deterrence', 'category': 'ORG'}, {'entity': 'Precision Strike', 'category': 'ORG'}, {'entity': 'DoD', 'category': 'ORG'}, {'entity': 'NASA', 'category': 'ORG'}, {'entity': 'SLS', 'category': 'ORG'}, {'entity': 'Congress', 'category': 'ORG'}, {'entity': 'Russian Soyuz', 'category': 'ORG'}, {'entity': 'ISS', 'category': 'ORG'}, {'entity': 'ATK', 'category': 'ORG'}, {'entity': 'Aerospace', 'category': 'ORG'}, {'entity': 'Defense', 'category': 'ORG'}, {'entity': 'SpaceX', 'category': 'ORG'}, {'entity': 'Blue Origin', 'category': 'ORG'}, {'entity': 'Northrop', 'category': 'ORG'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': 'PPA', 'category': 'ORG'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': 'rocket motors', 'category': 'PRODUCT'}, {'entity': 'liquid engines', 'category': 'PRODUCT'}, {'entity': 'liquid fuel propulsion capabilities', 'category': 'PRODUCT'}, {'entity': 'propulsion systems', 'category': 'PRODUCT'}, {'entity': 'decade', 'category': 'TIME'}, {'entity': 'Aerojet Rocketdyne Business ERP Integration', 'category': 'WORK_OF_ART'}, {'entity': '782.2', 'category': 'CARDINAL'}, {'entity': '920.4', 'category': 'CARDINAL'}, {'entity': '86', 'category': 'CARDINAL'}, {'entity': '74.8', 'category': 'CARDINAL'}, {'entity': '2016', 'category': 'CARDINAL'}, {'entity': '2015', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVg3Nxi1HdhB2iDiXUafVIIjf1MS\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701567315,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#1,000,000#12#360.0#71.9#113.9#27.8#21.7#26.4#24.6#192.7#306.6#113.9#114.3#95.4#18.9#69.4#41.7#27.7#43.1#17.8#25.3#18.2#39.9#21.7#7.9#34.3#26.4#0.6#25.2#24.6#27.8#465.6#469.3#3.7#679.4#319.4#360.0#6.2#5.7#0.5#1,597.4#1,383.1#214.3#319.4#53.7#21.0#16.1#16.0#53#52#27.8#50#46#52#43#7#5#6#100#100#100#1,408.1#1,229.6#178.5#1,229.6#994.9#360.0#88.1#88.9#88.9#87.4#86.4#85.5#85.5#85.5#1,380.4#1,183.2#197.2#1,183.2#850.7#332.5#3.2#2.2#1.0#2.2#24.5#44.2#19.7#44.2#18.9#25.3#1,408.1#1,229.6#178.5#1,229.6#994.9#360.0#23.6#1.5#37.9#53.6#15.7#53.6#41.9#11.7#2.4#3.9#3.9#4.2#1.3#1.4#1.4#1.3#21.1#18.7#2.4#18.7#13.3#5.4#5.7#14.1#8.4#14.1#6.5#7.6#11.1#20.8#9.7#20.8#22.1#1.3#37.9#53.6#15.7#53.6#41.9#11.7#7.6#63.7#43.8#19.9#43.8#22.3#21.5#48.5#35.8#12.7#35.8#19.3#16.5#13.5#6.5#7.0#6.5#1.5#5.0#1.7#1.5#0.2#1.5#1.5#10.4#7.0#3.1 \\n\\nDATE#June 14, 2013#fiscal 2013#fiscal 2014 and 2013#Fiscal 2014#2013#fiscal 2013#June 14, 2013#November 30 \\n\\nEVENT#Acquisition\\n\\nFAC#Rocketdyne Business \\n\\nMONEY#$360.0 million#$1.5 million \\n\\nORG#Rocketdyne#End of Year in Millions#Antares#Antares AJ-26 \\n\\nPERSON#Aerojet Rocketdyne \\n\\nPRODUCT#Standard Missile#Standard Missile-3 Block IB#Standard Missile-3 Block IIA#Standard Missile-1 Regrain#Bomb Live Unit - 129B, \\u201cBLU-129B\\\"#Standard Missile contracts \\n\\nTIME#12 months and 51/2 months \\n\\nWORK_OF_ART#Standard Missile-3 Block IIA contract#Standard Missile-1 Regrain contract#Atlas V program}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 3064,\n",
      "    \"completion_tokens\": 848,\n",
      "    \"total_tokens\": 3912\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'June 14, 2013', 'category': 'DATE'}, {'entity': 'fiscal 2013', 'category': 'DATE'}, {'entity': 'fiscal 2014 and 2013', 'category': 'DATE'}, {'entity': 'Fiscal 2014', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': 'fiscal 2013', 'category': 'DATE'}, {'entity': 'June 14, 2013', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': 'Acquisition', 'category': 'EVENT'}, {'entity': 'Rocketdyne Business', 'category': 'FAC'}, {'entity': '$360.0 million', 'category': 'MONEY'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': 'Rocketdyne', 'category': 'ORG'}, {'entity': 'End of Year in Millions', 'category': 'ORG'}, {'entity': 'Antares', 'category': 'ORG'}, {'entity': 'Antares AJ-26', 'category': 'ORG'}, {'entity': 'Aerojet Rocketdyne', 'category': 'PERSON'}, {'entity': 'Standard Missile', 'category': 'PRODUCT'}, {'entity': 'Standard Missile-3 Block IB', 'category': 'PRODUCT'}, {'entity': 'Standard Missile-3 Block IIA', 'category': 'PRODUCT'}, {'entity': 'Standard Missile-1 Regrain', 'category': 'PRODUCT'}, {'entity': 'Bomb Live Unit - 129B, “BLU-129B\"', 'category': 'PRODUCT'}, {'entity': 'Standard Missile contracts', 'category': 'PRODUCT'}, {'entity': '12 months and 51/2 months', 'category': 'TIME'}, {'entity': 'Standard Missile-3 Block IIA contract', 'category': 'WORK_OF_ART'}, {'entity': 'Standard Missile-1 Regrain contract', 'category': 'WORK_OF_ART'}, {'entity': 'Atlas V program', 'category': 'WORK_OF_ART'}, {'entity': '1,000,000', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '360.0', 'category': 'CARDINAL'}, {'entity': '71.9', 'category': 'CARDINAL'}, {'entity': '113.9', 'category': 'CARDINAL'}, {'entity': '27.8', 'category': 'CARDINAL'}, {'entity': '21.7', 'category': 'CARDINAL'}, {'entity': '26.4', 'category': 'CARDINAL'}, {'entity': '24.6', 'category': 'CARDINAL'}, {'entity': '192.7', 'category': 'CARDINAL'}, {'entity': '306.6', 'category': 'CARDINAL'}, {'entity': '113.9', 'category': 'CARDINAL'}, {'entity': '114.3', 'category': 'CARDINAL'}, {'entity': '95.4', 'category': 'CARDINAL'}, {'entity': '18.9', 'category': 'CARDINAL'}, {'entity': '69.4', 'category': 'CARDINAL'}, {'entity': '41.7', 'category': 'CARDINAL'}, {'entity': '27.7', 'category': 'CARDINAL'}, {'entity': '43.1', 'category': 'CARDINAL'}, {'entity': '17.8', 'category': 'CARDINAL'}, {'entity': '25.3', 'category': 'CARDINAL'}, {'entity': '18.2', 'category': 'CARDINAL'}, {'entity': '39.9', 'category': 'CARDINAL'}, {'entity': '21.7', 'category': 'CARDINAL'}, {'entity': '7.9', 'category': 'CARDINAL'}, {'entity': '34.3', 'category': 'CARDINAL'}, {'entity': '26.4', 'category': 'CARDINAL'}, {'entity': '0.6', 'category': 'CARDINAL'}, {'entity': '25.2', 'category': 'CARDINAL'}, {'entity': '24.6', 'category': 'CARDINAL'}, {'entity': '27.8', 'category': 'CARDINAL'}, {'entity': '465.6', 'category': 'CARDINAL'}, {'entity': '469.3', 'category': 'CARDINAL'}, {'entity': '3.7', 'category': 'CARDINAL'}, {'entity': '679.4', 'category': 'CARDINAL'}, {'entity': '319.4', 'category': 'CARDINAL'}, {'entity': '360.0', 'category': 'CARDINAL'}, {'entity': '6.2', 'category': 'CARDINAL'}, {'entity': '5.7', 'category': 'CARDINAL'}, {'entity': '0.5', 'category': 'CARDINAL'}, {'entity': '1,597.4', 'category': 'CARDINAL'}, {'entity': '1,383.1', 'category': 'CARDINAL'}, {'entity': '214.3', 'category': 'CARDINAL'}, {'entity': '319.4', 'category': 'CARDINAL'}, {'entity': '53.7', 'category': 'CARDINAL'}, {'entity': '21.0', 'category': 'CARDINAL'}, {'entity': '16.1', 'category': 'CARDINAL'}, {'entity': '16.0', 'category': 'CARDINAL'}, {'entity': '53', 'category': 'CARDINAL'}, {'entity': '52', 'category': 'CARDINAL'}, {'entity': '27.8', 'category': 'CARDINAL'}, {'entity': '50', 'category': 'CARDINAL'}, {'entity': '46', 'category': 'CARDINAL'}, {'entity': '52', 'category': 'CARDINAL'}, {'entity': '43', 'category': 'CARDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '1,408.1', 'category': 'CARDINAL'}, {'entity': '1,229.6', 'category': 'CARDINAL'}, {'entity': '178.5', 'category': 'CARDINAL'}, {'entity': '1,229.6', 'category': 'CARDINAL'}, {'entity': '994.9', 'category': 'CARDINAL'}, {'entity': '360.0', 'category': 'CARDINAL'}, {'entity': '88.1', 'category': 'CARDINAL'}, {'entity': '88.9', 'category': 'CARDINAL'}, {'entity': '88.9', 'category': 'CARDINAL'}, {'entity': '87.4', 'category': 'CARDINAL'}, {'entity': '86.4', 'category': 'CARDINAL'}, {'entity': '85.5', 'category': 'CARDINAL'}, {'entity': '85.5', 'category': 'CARDINAL'}, {'entity': '85.5', 'category': 'CARDINAL'}, {'entity': '1,380.4', 'category': 'CARDINAL'}, {'entity': '1,183.2', 'category': 'CARDINAL'}, {'entity': '197.2', 'category': 'CARDINAL'}, {'entity': '1,183.2', 'category': 'CARDINAL'}, {'entity': '850.7', 'category': 'CARDINAL'}, {'entity': '332.5', 'category': 'CARDINAL'}, {'entity': '3.2', 'category': 'CARDINAL'}, {'entity': '2.2', 'category': 'CARDINAL'}, {'entity': '1.0', 'category': 'CARDINAL'}, {'entity': '2.2', 'category': 'CARDINAL'}, {'entity': '24.5', 'category': 'CARDINAL'}, {'entity': '44.2', 'category': 'CARDINAL'}, {'entity': '19.7', 'category': 'CARDINAL'}, {'entity': '44.2', 'category': 'CARDINAL'}, {'entity': '18.9', 'category': 'CARDINAL'}, {'entity': '25.3', 'category': 'CARDINAL'}, {'entity': '1,408.1', 'category': 'CARDINAL'}, {'entity': '1,229.6', 'category': 'CARDINAL'}, {'entity': '178.5', 'category': 'CARDINAL'}, {'entity': '1,229.6', 'category': 'CARDINAL'}, {'entity': '994.9', 'category': 'CARDINAL'}, {'entity': '360.0', 'category': 'CARDINAL'}, {'entity': '23.6', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '37.9', 'category': 'CARDINAL'}, {'entity': '53.6', 'category': 'CARDINAL'}, {'entity': '15.7', 'category': 'CARDINAL'}, {'entity': '53.6', 'category': 'CARDINAL'}, {'entity': '41.9', 'category': 'CARDINAL'}, {'entity': '11.7', 'category': 'CARDINAL'}, {'entity': '2.4', 'category': 'CARDINAL'}, {'entity': '3.9', 'category': 'CARDINAL'}, {'entity': '3.9', 'category': 'CARDINAL'}, {'entity': '4.2', 'category': 'CARDINAL'}, {'entity': '1.3', 'category': 'CARDINAL'}, {'entity': '1.4', 'category': 'CARDINAL'}, {'entity': '1.4', 'category': 'CARDINAL'}, {'entity': '1.3', 'category': 'CARDINAL'}, {'entity': '21.1', 'category': 'CARDINAL'}, {'entity': '18.7', 'category': 'CARDINAL'}, {'entity': '2.4', 'category': 'CARDINAL'}, {'entity': '18.7', 'category': 'CARDINAL'}, {'entity': '13.3', 'category': 'CARDINAL'}, {'entity': '5.4', 'category': 'CARDINAL'}, {'entity': '5.7', 'category': 'CARDINAL'}, {'entity': '14.1', 'category': 'CARDINAL'}, {'entity': '8.4', 'category': 'CARDINAL'}, {'entity': '14.1', 'category': 'CARDINAL'}, {'entity': '6.5', 'category': 'CARDINAL'}, {'entity': '7.6', 'category': 'CARDINAL'}, {'entity': '11.1', 'category': 'CARDINAL'}, {'entity': '20.8', 'category': 'CARDINAL'}, {'entity': '9.7', 'category': 'CARDINAL'}, {'entity': '20.8', 'category': 'CARDINAL'}, {'entity': '22.1', 'category': 'CARDINAL'}, {'entity': '1.3', 'category': 'CARDINAL'}, {'entity': '37.9', 'category': 'CARDINAL'}, {'entity': '53.6', 'category': 'CARDINAL'}, {'entity': '15.7', 'category': 'CARDINAL'}, {'entity': '53.6', 'category': 'CARDINAL'}, {'entity': '41.9', 'category': 'CARDINAL'}, {'entity': '11.7', 'category': 'CARDINAL'}, {'entity': '7.6', 'category': 'CARDINAL'}, {'entity': '63.7', 'category': 'CARDINAL'}, {'entity': '43.8', 'category': 'CARDINAL'}, {'entity': '19.9', 'category': 'CARDINAL'}, {'entity': '43.8', 'category': 'CARDINAL'}, {'entity': '22.3', 'category': 'CARDINAL'}, {'entity': '21.5', 'category': 'CARDINAL'}, {'entity': '48.5', 'category': 'CARDINAL'}, {'entity': '35.8', 'category': 'CARDINAL'}, {'entity': '12.7', 'category': 'CARDINAL'}, {'entity': '35.8', 'category': 'CARDINAL'}, {'entity': '19.3', 'category': 'CARDINAL'}, {'entity': '16.5', 'category': 'CARDINAL'}, {'entity': '13.5', 'category': 'CARDINAL'}, {'entity': '6.5', 'category': 'CARDINAL'}, {'entity': '7.0', 'category': 'CARDINAL'}, {'entity': '6.5', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '5.0', 'category': 'CARDINAL'}, {'entity': '1.7', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '10.4', 'category': 'CARDINAL'}, {'entity': '7.0', 'category': 'CARDINAL'}, {'entity': '3.1', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVgu5PX0JCCqTsoqDm3CWStDnEdn\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701567368,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#15.2#10.3#5.0#74.5#33.8#40.7#33.8#26.2#7.6#37.2#2.8#2.4#11.8#3.2#1.5#2014#2013#2012#0.9#1.6#60.8#22.9#12.0#4#1/16#59.6#119.9#0.3#60.6#0.2#0.9#0.5#1.0#20.0#1.4#5.2#10.1#0.1#5.0#0.7#2.0#75.0#100#0.4#0.1#0.2#0.6#52.7#48.7#4.0#48.7#22.3#26.4#49.1#44.2#4.9#44.2#19.4#24.8#3.6#4.5#89.0#12.9#193.9#18.9#13.8#9.2#4.6#3.7#1.9#0.2#7.7#0.3#1.5#178.4#0.1#0.2#2.3#2.8#21.1#1.7#3.1#1.3#1.2#10.0#1.9#0.3#32.7#39.4#35#740.1#26.2#282.4#178.7 \\n\\nDATE#Year Ended 2014#Year Ended 2013\\n\\nEVENT#Rocketdyne Business acquisition\\n\\nMONEY#$15.2 million#$10.3 million#$5.0 million#$74.5#$33.8#$40.7#$33.8#$26.2#$7.6#$37.2#$2.8 million#$2.4 million#$11.8 million#$3.2 million#$1.5 million#0.9 million#$60.8 million#$61.7 million#$24.5 million#$12.7 million#$59.6 million#119.9 million#0.2 million#0.5 million#1.0#20.0 million#5.2 million#10.1 million#0.1 million#5.0 million#0.7 million#$11.6 million#$75.0 million#0.4 million#0.1 million#0.6#26.4#52.7 million#$48.7 million#4.0 million#$48.7 million#$22.3 million#26.4 million#49.1 million#44.2 million#4.9 million#44.2 million#19.4 million#24.8 million#3.6 million#4.5 million#89.0 million#26.4 million#12.9 million#193.9 million#18.9 million#13.8 million#9.2 million#4.6 million#3.7 million#1.9#0.2#7.7 million#0.3 million#1.5 million#178.4 million#0.2 million#2.3 million#2.8 million#21.1 million#1.7 million#3.1 million#1.3 million#1.2 million#10.0 million#1.9 million#0.3 million#32.7%#39.4 million#35%#740.1%#26.2 million#282.4 million#178.7 million\\n\\nORG#Rocketdyne Business#U.S. government contracts#Senior Credit Facility#SEC#Research and Development#R&D\\n\\nPERCENT#32.7%#35%#740.1%#35%\\n\\nPERSON#Fiscal 2014#Fiscal 2013#Fiscal 2012#We}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2901,\n",
      "    \"completion_tokens\": 868,\n",
      "    \"total_tokens\": 3769\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'Year Ended 2014', 'category': 'DATE'}, {'entity': 'Year Ended 2013', 'category': 'DATE'}, {'entity': 'Rocketdyne Business acquisition', 'category': 'EVENT'}, {'entity': '$15.2 million', 'category': 'MONEY'}, {'entity': '$10.3 million', 'category': 'MONEY'}, {'entity': '$5.0 million', 'category': 'MONEY'}, {'entity': '$74.5', 'category': 'MONEY'}, {'entity': '$33.8', 'category': 'MONEY'}, {'entity': '$40.7', 'category': 'MONEY'}, {'entity': '$33.8', 'category': 'MONEY'}, {'entity': '$26.2', 'category': 'MONEY'}, {'entity': '$7.6', 'category': 'MONEY'}, {'entity': '$37.2', 'category': 'MONEY'}, {'entity': '$2.8 million', 'category': 'MONEY'}, {'entity': '$2.4 million', 'category': 'MONEY'}, {'entity': '$11.8 million', 'category': 'MONEY'}, {'entity': '$3.2 million', 'category': 'MONEY'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': '0.9 million', 'category': 'MONEY'}, {'entity': '$60.8 million', 'category': 'MONEY'}, {'entity': '$61.7 million', 'category': 'MONEY'}, {'entity': '$24.5 million', 'category': 'MONEY'}, {'entity': '$12.7 million', 'category': 'MONEY'}, {'entity': '$59.6 million', 'category': 'MONEY'}, {'entity': '119.9 million', 'category': 'MONEY'}, {'entity': '0.2 million', 'category': 'MONEY'}, {'entity': '0.5 million', 'category': 'MONEY'}, {'entity': '1.0', 'category': 'MONEY'}, {'entity': '20.0 million', 'category': 'MONEY'}, {'entity': '5.2 million', 'category': 'MONEY'}, {'entity': '10.1 million', 'category': 'MONEY'}, {'entity': '0.1 million', 'category': 'MONEY'}, {'entity': '5.0 million', 'category': 'MONEY'}, {'entity': '0.7 million', 'category': 'MONEY'}, {'entity': '$11.6 million', 'category': 'MONEY'}, {'entity': '$75.0 million', 'category': 'MONEY'}, {'entity': '0.4 million', 'category': 'MONEY'}, {'entity': '0.1 million', 'category': 'MONEY'}, {'entity': '0.6', 'category': 'MONEY'}, {'entity': '26.4', 'category': 'MONEY'}, {'entity': '52.7 million', 'category': 'MONEY'}, {'entity': '$48.7 million', 'category': 'MONEY'}, {'entity': '4.0 million', 'category': 'MONEY'}, {'entity': '$48.7 million', 'category': 'MONEY'}, {'entity': '$22.3 million', 'category': 'MONEY'}, {'entity': '26.4 million', 'category': 'MONEY'}, {'entity': '49.1 million', 'category': 'MONEY'}, {'entity': '44.2 million', 'category': 'MONEY'}, {'entity': '4.9 million', 'category': 'MONEY'}, {'entity': '44.2 million', 'category': 'MONEY'}, {'entity': '19.4 million', 'category': 'MONEY'}, {'entity': '24.8 million', 'category': 'MONEY'}, {'entity': '3.6 million', 'category': 'MONEY'}, {'entity': '4.5 million', 'category': 'MONEY'}, {'entity': '89.0 million', 'category': 'MONEY'}, {'entity': '26.4 million', 'category': 'MONEY'}, {'entity': '12.9 million', 'category': 'MONEY'}, {'entity': '193.9 million', 'category': 'MONEY'}, {'entity': '18.9 million', 'category': 'MONEY'}, {'entity': '13.8 million', 'category': 'MONEY'}, {'entity': '9.2 million', 'category': 'MONEY'}, {'entity': '4.6 million', 'category': 'MONEY'}, {'entity': '3.7 million', 'category': 'MONEY'}, {'entity': '1.9', 'category': 'MONEY'}, {'entity': '0.2', 'category': 'MONEY'}, {'entity': '7.7 million', 'category': 'MONEY'}, {'entity': '0.3 million', 'category': 'MONEY'}, {'entity': '1.5 million', 'category': 'MONEY'}, {'entity': '178.4 million', 'category': 'MONEY'}, {'entity': '0.2 million', 'category': 'MONEY'}, {'entity': '2.3 million', 'category': 'MONEY'}, {'entity': '2.8 million', 'category': 'MONEY'}, {'entity': '21.1 million', 'category': 'MONEY'}, {'entity': '1.7 million', 'category': 'MONEY'}, {'entity': '3.1 million', 'category': 'MONEY'}, {'entity': '1.3 million', 'category': 'MONEY'}, {'entity': '1.2 million', 'category': 'MONEY'}, {'entity': '10.0 million', 'category': 'MONEY'}, {'entity': '1.9 million', 'category': 'MONEY'}, {'entity': '0.3 million', 'category': 'MONEY'}, {'entity': '32.7%', 'category': 'MONEY'}, {'entity': '39.4 million', 'category': 'MONEY'}, {'entity': '35%', 'category': 'MONEY'}, {'entity': '740.1%', 'category': 'MONEY'}, {'entity': '26.2 million', 'category': 'MONEY'}, {'entity': '282.4 million', 'category': 'MONEY'}, {'entity': '178.7 million', 'category': 'MONEY'}, {'entity': 'Rocketdyne Business', 'category': 'ORG'}, {'entity': 'U.S. government contracts', 'category': 'ORG'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'Research and Development', 'category': 'ORG'}, {'entity': 'R&D', 'category': 'ORG'}, {'entity': '32.7%', 'category': 'PERCENT'}, {'entity': '35%', 'category': 'PERCENT'}, {'entity': '740.1%', 'category': 'PERCENT'}, {'entity': '35%', 'category': 'PERCENT'}, {'entity': 'Fiscal 2014', 'category': 'PERSON'}, {'entity': 'Fiscal 2013', 'category': 'PERSON'}, {'entity': 'Fiscal 2012', 'category': 'PERSON'}, {'entity': 'We', 'category': 'PERSON'}, {'entity': '15.2', 'category': 'CARDINAL'}, {'entity': '10.3', 'category': 'CARDINAL'}, {'entity': '5.0', 'category': 'CARDINAL'}, {'entity': '74.5', 'category': 'CARDINAL'}, {'entity': '33.8', 'category': 'CARDINAL'}, {'entity': '40.7', 'category': 'CARDINAL'}, {'entity': '33.8', 'category': 'CARDINAL'}, {'entity': '26.2', 'category': 'CARDINAL'}, {'entity': '7.6', 'category': 'CARDINAL'}, {'entity': '37.2', 'category': 'CARDINAL'}, {'entity': '2.8', 'category': 'CARDINAL'}, {'entity': '2.4', 'category': 'CARDINAL'}, {'entity': '11.8', 'category': 'CARDINAL'}, {'entity': '3.2', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '0.9', 'category': 'CARDINAL'}, {'entity': '1.6', 'category': 'CARDINAL'}, {'entity': '60.8', 'category': 'CARDINAL'}, {'entity': '22.9', 'category': 'CARDINAL'}, {'entity': '12.0', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '1/16', 'category': 'CARDINAL'}, {'entity': '59.6', 'category': 'CARDINAL'}, {'entity': '119.9', 'category': 'CARDINAL'}, {'entity': '0.3', 'category': 'CARDINAL'}, {'entity': '60.6', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '0.9', 'category': 'CARDINAL'}, {'entity': '0.5', 'category': 'CARDINAL'}, {'entity': '1.0', 'category': 'CARDINAL'}, {'entity': '20.0', 'category': 'CARDINAL'}, {'entity': '1.4', 'category': 'CARDINAL'}, {'entity': '5.2', 'category': 'CARDINAL'}, {'entity': '10.1', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '5.0', 'category': 'CARDINAL'}, {'entity': '0.7', 'category': 'CARDINAL'}, {'entity': '2.0', 'category': 'CARDINAL'}, {'entity': '75.0', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '0.4', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '0.6', 'category': 'CARDINAL'}, {'entity': '52.7', 'category': 'CARDINAL'}, {'entity': '48.7', 'category': 'CARDINAL'}, {'entity': '4.0', 'category': 'CARDINAL'}, {'entity': '48.7', 'category': 'CARDINAL'}, {'entity': '22.3', 'category': 'CARDINAL'}, {'entity': '26.4', 'category': 'CARDINAL'}, {'entity': '49.1', 'category': 'CARDINAL'}, {'entity': '44.2', 'category': 'CARDINAL'}, {'entity': '4.9', 'category': 'CARDINAL'}, {'entity': '44.2', 'category': 'CARDINAL'}, {'entity': '19.4', 'category': 'CARDINAL'}, {'entity': '24.8', 'category': 'CARDINAL'}, {'entity': '3.6', 'category': 'CARDINAL'}, {'entity': '4.5', 'category': 'CARDINAL'}, {'entity': '89.0', 'category': 'CARDINAL'}, {'entity': '12.9', 'category': 'CARDINAL'}, {'entity': '193.9', 'category': 'CARDINAL'}, {'entity': '18.9', 'category': 'CARDINAL'}, {'entity': '13.8', 'category': 'CARDINAL'}, {'entity': '9.2', 'category': 'CARDINAL'}, {'entity': '4.6', 'category': 'CARDINAL'}, {'entity': '3.7', 'category': 'CARDINAL'}, {'entity': '1.9', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '7.7', 'category': 'CARDINAL'}, {'entity': '0.3', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '178.4', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '2.3', 'category': 'CARDINAL'}, {'entity': '2.8', 'category': 'CARDINAL'}, {'entity': '21.1', 'category': 'CARDINAL'}, {'entity': '1.7', 'category': 'CARDINAL'}, {'entity': '3.1', 'category': 'CARDINAL'}, {'entity': '1.3', 'category': 'CARDINAL'}, {'entity': '1.2', 'category': 'CARDINAL'}, {'entity': '10.0', 'category': 'CARDINAL'}, {'entity': '1.9', 'category': 'CARDINAL'}, {'entity': '0.3', 'category': 'CARDINAL'}, {'entity': '32.7', 'category': 'CARDINAL'}, {'entity': '39.4', 'category': 'CARDINAL'}, {'entity': '35', 'category': 'CARDINAL'}, {'entity': '740.1', 'category': 'CARDINAL'}, {'entity': '26.2', 'category': 'CARDINAL'}, {'entity': '282.4', 'category': 'CARDINAL'}, {'entity': '178.7', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVhjZ4k6pHaZaO7CDIBPLZNlBqIc\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701567419,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#$439.5 million#$401.1 million#three#$1.6 million#$6.6 million#4.54%#3.68%#$67 million#$35.6 million#4.54%#3.96%\\n \\nDATE#November 30, 2014#fiscal 2015#Bipartisan Budget Act of 2013#November 30, 2013#fiscal 2013#fourth quarter of fiscal 2013#During fiscal 2014#year end#Tax Increase Prevention Act of 2014#December 2014#first quarter of fiscal 2015#August 31, 2004#November 30, 2005#fiscal 2014#2013#November 30, 2014#November 30, 2013\\n\\nEVENT#Rocketdyne acquisition integration\\n\\nFAC#Congressional\\n\\nGPE#U.S.\\n\\nLAW#Tax Increase Prevention Act of 2014\\n\\nMONEY#$178.7 million#$1.1 million#$102.6 million\\n\\nORG#Rocketdyne Business#Rocketdyne\\n\\nPERCENT#12.5%#8%\\n\\nPERSON#Congressional\\n\\nPRODUCT#R&D credit\\n\\nTIME#three year\\n\\nYEAR#2014#2013}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2317,\n",
      "    \"completion_tokens\": 270,\n",
      "    \"total_tokens\": 2587\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'fiscal 2015', 'category': 'DATE'}, {'entity': 'Bipartisan Budget Act of 2013', 'category': 'DATE'}, {'entity': 'November 30, 2013', 'category': 'DATE'}, {'entity': 'fiscal 2013', 'category': 'DATE'}, {'entity': 'fourth quarter of fiscal 2013', 'category': 'DATE'}, {'entity': 'During fiscal 2014', 'category': 'DATE'}, {'entity': 'year end', 'category': 'DATE'}, {'entity': 'Tax Increase Prevention Act of 2014', 'category': 'DATE'}, {'entity': 'December 2014', 'category': 'DATE'}, {'entity': 'first quarter of fiscal 2015', 'category': 'DATE'}, {'entity': 'August 31, 2004', 'category': 'DATE'}, {'entity': 'November 30, 2005', 'category': 'DATE'}, {'entity': 'fiscal 2014', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'November 30, 2013', 'category': 'DATE'}, {'entity': 'Rocketdyne acquisition integration', 'category': 'EVENT'}, {'entity': 'Congressional', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Tax Increase Prevention Act of 2014', 'category': 'LAW'}, {'entity': '$178.7 million', 'category': 'MONEY'}, {'entity': '$1.1 million', 'category': 'MONEY'}, {'entity': '$102.6 million', 'category': 'MONEY'}, {'entity': 'Rocketdyne Business', 'category': 'ORG'}, {'entity': 'Rocketdyne', 'category': 'ORG'}, {'entity': '12.5%', 'category': 'PERCENT'}, {'entity': '8%', 'category': 'PERCENT'}, {'entity': 'Congressional', 'category': 'PERSON'}, {'entity': 'R&D credit', 'category': 'PRODUCT'}, {'entity': 'three year', 'category': 'TIME'}, {'entity': '$439.5 million', 'category': 'CARDINAL'}, {'entity': '$401.1 million', 'category': 'CARDINAL'}, {'entity': 'three', 'category': 'CARDINAL'}, {'entity': '$1.6 million', 'category': 'CARDINAL'}, {'entity': '$6.6 million', 'category': 'CARDINAL'}, {'entity': '4.54%', 'category': 'CARDINAL'}, {'entity': '3.68%', 'category': 'CARDINAL'}, {'entity': '$67 million', 'category': 'CARDINAL'}, {'entity': '$35.6 million', 'category': 'CARDINAL'}, {'entity': '4.54%', 'category': 'CARDINAL'}, {'entity': '3.96%', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RViIkpcRNn6pBce6rBevER4zlHjN\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701567454,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#24.4#14.7#10.8#2014#2013#2012#360.0#71.9#113.9#27.8#21.7#26.4#24.6#192.7#306.6#114.3#95.4#7.9#34.3#43.1#17.8#0.6#25.2#69.4#41.7#18.2#39.9#465.6#469.3#679.4#319.4#53.7#16.0#52\\n\\nDATE#fiscal 2014#fiscal 2013#fiscal 2012\\n\\nEVENT#Rocketdyne purchase accounting adjustments#net sales from the acquired Rocketdyne Business\\n\\nFAC#Rocketdyne Business \\n\\nGPE#U.S.\\n\\nLAW#401(k) plan\\n\\nMONEY#$24.4 million#$14.7 million#$10.8 million\\n\\nORG#Aerospace and Defense#Standard Missile#Atlas V#Antares#Orion#GEM-T#THAAD#T3 IIA and IIB#Aerojet programs#Rocketdyne \\n\\nPERCENT#6.7#7.1#12.0#11.7#1.5\\n\\nPRODUCT#pension plans#net sales \\n\\nTIME#three years\\n\\nWORK_OF_ART#Antares AJ-26 program}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2748,\n",
      "    \"completion_tokens\": 306,\n",
      "    \"total_tokens\": 3054\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'fiscal 2014', 'category': 'DATE'}, {'entity': 'fiscal 2013', 'category': 'DATE'}, {'entity': 'fiscal 2012', 'category': 'DATE'}, {'entity': 'Rocketdyne purchase accounting adjustments', 'category': 'EVENT'}, {'entity': 'net sales from the acquired Rocketdyne Business', 'category': 'EVENT'}, {'entity': 'Rocketdyne Business', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '401k plan', 'category': 'LAW'}, {'entity': '$24.4 million', 'category': 'MONEY'}, {'entity': '$14.7 million', 'category': 'MONEY'}, {'entity': '$10.8 million', 'category': 'MONEY'}, {'entity': 'Aerospace and Defense', 'category': 'ORG'}, {'entity': 'Standard Missile', 'category': 'ORG'}, {'entity': 'Atlas V', 'category': 'ORG'}, {'entity': 'Antares', 'category': 'ORG'}, {'entity': 'Orion', 'category': 'ORG'}, {'entity': 'GEM-T', 'category': 'ORG'}, {'entity': 'THAAD', 'category': 'ORG'}, {'entity': 'T3 IIA and IIB', 'category': 'ORG'}, {'entity': 'Aerojet programs', 'category': 'ORG'}, {'entity': 'Rocketdyne', 'category': 'ORG'}, {'entity': '6.7', 'category': 'PERCENT'}, {'entity': '7.1', 'category': 'PERCENT'}, {'entity': '12.0', 'category': 'PERCENT'}, {'entity': '11.7', 'category': 'PERCENT'}, {'entity': '1.5', 'category': 'PERCENT'}, {'entity': 'pension plans', 'category': 'PRODUCT'}, {'entity': 'net sales', 'category': 'PRODUCT'}, {'entity': 'three years', 'category': 'TIME'}, {'entity': 'Antares AJ-26 program', 'category': 'WORK_OF_ART'}, {'entity': '24.4', 'category': 'CARDINAL'}, {'entity': '14.7', 'category': 'CARDINAL'}, {'entity': '10.8', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '360.0', 'category': 'CARDINAL'}, {'entity': '71.9', 'category': 'CARDINAL'}, {'entity': '113.9', 'category': 'CARDINAL'}, {'entity': '27.8', 'category': 'CARDINAL'}, {'entity': '21.7', 'category': 'CARDINAL'}, {'entity': '26.4', 'category': 'CARDINAL'}, {'entity': '24.6', 'category': 'CARDINAL'}, {'entity': '192.7', 'category': 'CARDINAL'}, {'entity': '306.6', 'category': 'CARDINAL'}, {'entity': '114.3', 'category': 'CARDINAL'}, {'entity': '95.4', 'category': 'CARDINAL'}, {'entity': '7.9', 'category': 'CARDINAL'}, {'entity': '34.3', 'category': 'CARDINAL'}, {'entity': '43.1', 'category': 'CARDINAL'}, {'entity': '17.8', 'category': 'CARDINAL'}, {'entity': '0.6', 'category': 'CARDINAL'}, {'entity': '25.2', 'category': 'CARDINAL'}, {'entity': '69.4', 'category': 'CARDINAL'}, {'entity': '41.7', 'category': 'CARDINAL'}, {'entity': '18.2', 'category': 'CARDINAL'}, {'entity': '39.9', 'category': 'CARDINAL'}, {'entity': '465.6', 'category': 'CARDINAL'}, {'entity': '469.3', 'category': 'CARDINAL'}, {'entity': '679.4', 'category': 'CARDINAL'}, {'entity': '319.4', 'category': 'CARDINAL'}, {'entity': '53.7', 'category': 'CARDINAL'}, {'entity': '16.0', 'category': 'CARDINAL'}, {'entity': '52', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RViqvhz6a35AIC0kWoZprs7dRs0L\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701567488,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#27.8#2013#2012#30, 2014#30,2013#2.2#1.7#0.9#0.8#3.1#2.5#30, 2013#68#27#48#1.5#2014#2013#2012#6.2#5.7#0.5#5.7#8.8#4.2#3.8#0.4#3.8#3.7#0.1#39.4#26.2#13.2#52.7#48.7#22.3#0.1#0.2#0.6#63.7#43.8#22.3#35.6#65.0#41.0#61.7#24.5#12.7#174.2#155.6#110.9#10.9#11.3#11.1#2014#2013#2012#150.4#77.6#86.2#43.4#63.2#37.2#107.0#14.4#49.0#1#30, 2014#30, 2013#782.2#699.2#265.9#197.6#516.3#501.6#1950s#1960s#7.1#2014#4.9#2013#6.3#2012#30, 2014#84.1#130.4#211.3#14.0#21.7#35.6#7.8#8.1#20.0#0.7#5.8#8.0#106.6#166.0#274.9#74.8#30, 2014#15\\n\\nDATE#first quarter of fiscal 2013#November 30, 2014#November 30,2013#one year#Year Ended#Year Ended#Year Ended#Year Ended\\n\\nGPE#RS-68, RS-27, Atlas V#Sacramento\\n\\nMONEY#$27.8 million#2.2#1.7#0.9#0.8#3.1#2.5#1.5 billion#6.2#5.7#0.5#5.7#8.8#4.2#3.8#0.4#3.8#3.7#0.1#39.4#26.2#13.2#52.7#48.7#22.3#0.1#0.2#0.6#63.7#43.8#22.3#35.6#65.0#41.0#61.7#24.5#12.7#174.2#155.6#110.9#150.4#77.6#86.2#43.4#63.2#37.2#107.0#14.4#49.0#782.2#699.2#265.9#197.6#516.3#501.6#7.1#4.9#6.3#84.1#130.4#211.3#14.0#21.7#35.6#7.8#8.1#20.0#0.7#5.8#8.0#106.6#166.0#274.9#74.8\\n\\nORG#Rocketdyne#Non-GAAP#GAAP\\n\\nPERCENT#48%\\n\\nPERSON#EBITDAP#Aerojet Rocketdyne\\n\\nPRODUCT#RS-68#RS-27#Atlas V#THAAD\\n\\nWORK_OF_ART#Environmental Matters#Free Cash Flow}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2548,\n",
      "    \"completion_tokens\": 821,\n",
      "    \"total_tokens\": 3369\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'first quarter of fiscal 2013', 'category': 'DATE'}, {'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'November 30,2013', 'category': 'DATE'}, {'entity': 'one year', 'category': 'DATE'}, {'entity': 'Year Ended', 'category': 'DATE'}, {'entity': 'Year Ended', 'category': 'DATE'}, {'entity': 'Year Ended', 'category': 'DATE'}, {'entity': 'Year Ended', 'category': 'DATE'}, {'entity': 'RS-68, RS-27, Atlas V', 'category': 'GPE'}, {'entity': 'Sacramento', 'category': 'GPE'}, {'entity': '$27.8 million', 'category': 'MONEY'}, {'entity': '2.2', 'category': 'MONEY'}, {'entity': '1.7', 'category': 'MONEY'}, {'entity': '0.9', 'category': 'MONEY'}, {'entity': '0.8', 'category': 'MONEY'}, {'entity': '3.1', 'category': 'MONEY'}, {'entity': '2.5', 'category': 'MONEY'}, {'entity': '1.5 billion', 'category': 'MONEY'}, {'entity': '6.2', 'category': 'MONEY'}, {'entity': '5.7', 'category': 'MONEY'}, {'entity': '0.5', 'category': 'MONEY'}, {'entity': '5.7', 'category': 'MONEY'}, {'entity': '8.8', 'category': 'MONEY'}, {'entity': '4.2', 'category': 'MONEY'}, {'entity': '3.8', 'category': 'MONEY'}, {'entity': '0.4', 'category': 'MONEY'}, {'entity': '3.8', 'category': 'MONEY'}, {'entity': '3.7', 'category': 'MONEY'}, {'entity': '0.1', 'category': 'MONEY'}, {'entity': '39.4', 'category': 'MONEY'}, {'entity': '26.2', 'category': 'MONEY'}, {'entity': '13.2', 'category': 'MONEY'}, {'entity': '52.7', 'category': 'MONEY'}, {'entity': '48.7', 'category': 'MONEY'}, {'entity': '22.3', 'category': 'MONEY'}, {'entity': '0.1', 'category': 'MONEY'}, {'entity': '0.2', 'category': 'MONEY'}, {'entity': '0.6', 'category': 'MONEY'}, {'entity': '63.7', 'category': 'MONEY'}, {'entity': '43.8', 'category': 'MONEY'}, {'entity': '22.3', 'category': 'MONEY'}, {'entity': '35.6', 'category': 'MONEY'}, {'entity': '65.0', 'category': 'MONEY'}, {'entity': '41.0', 'category': 'MONEY'}, {'entity': '61.7', 'category': 'MONEY'}, {'entity': '24.5', 'category': 'MONEY'}, {'entity': '12.7', 'category': 'MONEY'}, {'entity': '174.2', 'category': 'MONEY'}, {'entity': '155.6', 'category': 'MONEY'}, {'entity': '110.9', 'category': 'MONEY'}, {'entity': '150.4', 'category': 'MONEY'}, {'entity': '77.6', 'category': 'MONEY'}, {'entity': '86.2', 'category': 'MONEY'}, {'entity': '43.4', 'category': 'MONEY'}, {'entity': '63.2', 'category': 'MONEY'}, {'entity': '37.2', 'category': 'MONEY'}, {'entity': '107.0', 'category': 'MONEY'}, {'entity': '14.4', 'category': 'MONEY'}, {'entity': '49.0', 'category': 'MONEY'}, {'entity': '782.2', 'category': 'MONEY'}, {'entity': '699.2', 'category': 'MONEY'}, {'entity': '265.9', 'category': 'MONEY'}, {'entity': '197.6', 'category': 'MONEY'}, {'entity': '516.3', 'category': 'MONEY'}, {'entity': '501.6', 'category': 'MONEY'}, {'entity': '7.1', 'category': 'MONEY'}, {'entity': '4.9', 'category': 'MONEY'}, {'entity': '6.3', 'category': 'MONEY'}, {'entity': '84.1', 'category': 'MONEY'}, {'entity': '130.4', 'category': 'MONEY'}, {'entity': '211.3', 'category': 'MONEY'}, {'entity': '14.0', 'category': 'MONEY'}, {'entity': '21.7', 'category': 'MONEY'}, {'entity': '35.6', 'category': 'MONEY'}, {'entity': '7.8', 'category': 'MONEY'}, {'entity': '8.1', 'category': 'MONEY'}, {'entity': '20.0', 'category': 'MONEY'}, {'entity': '0.7', 'category': 'MONEY'}, {'entity': '5.8', 'category': 'MONEY'}, {'entity': '8.0', 'category': 'MONEY'}, {'entity': '106.6', 'category': 'MONEY'}, {'entity': '166.0', 'category': 'MONEY'}, {'entity': '274.9', 'category': 'MONEY'}, {'entity': '74.8', 'category': 'MONEY'}, {'entity': 'Rocketdyne', 'category': 'ORG'}, {'entity': 'Non-GAAP', 'category': 'ORG'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': '48%', 'category': 'PERCENT'}, {'entity': 'EBITDAP', 'category': 'PERSON'}, {'entity': 'Aerojet Rocketdyne', 'category': 'PERSON'}, {'entity': 'RS-68', 'category': 'PRODUCT'}, {'entity': 'RS-27', 'category': 'PRODUCT'}, {'entity': 'Atlas V', 'category': 'PRODUCT'}, {'entity': 'THAAD', 'category': 'PRODUCT'}, {'entity': 'Environmental Matters', 'category': 'WORK_OF_ART'}, {'entity': 'Free Cash Flow', 'category': 'WORK_OF_ART'}, {'entity': '27.8', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '30, 2014', 'category': 'CARDINAL'}, {'entity': '30,2013', 'category': 'CARDINAL'}, {'entity': '2.2', 'category': 'CARDINAL'}, {'entity': '1.7', 'category': 'CARDINAL'}, {'entity': '0.9', 'category': 'CARDINAL'}, {'entity': '0.8', 'category': 'CARDINAL'}, {'entity': '3.1', 'category': 'CARDINAL'}, {'entity': '2.5', 'category': 'CARDINAL'}, {'entity': '30, 2013', 'category': 'CARDINAL'}, {'entity': '68', 'category': 'CARDINAL'}, {'entity': '27', 'category': 'CARDINAL'}, {'entity': '48', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '6.2', 'category': 'CARDINAL'}, {'entity': '5.7', 'category': 'CARDINAL'}, {'entity': '0.5', 'category': 'CARDINAL'}, {'entity': '5.7', 'category': 'CARDINAL'}, {'entity': '8.8', 'category': 'CARDINAL'}, {'entity': '4.2', 'category': 'CARDINAL'}, {'entity': '3.8', 'category': 'CARDINAL'}, {'entity': '0.4', 'category': 'CARDINAL'}, {'entity': '3.8', 'category': 'CARDINAL'}, {'entity': '3.7', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '39.4', 'category': 'CARDINAL'}, {'entity': '26.2', 'category': 'CARDINAL'}, {'entity': '13.2', 'category': 'CARDINAL'}, {'entity': '52.7', 'category': 'CARDINAL'}, {'entity': '48.7', 'category': 'CARDINAL'}, {'entity': '22.3', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '0.6', 'category': 'CARDINAL'}, {'entity': '63.7', 'category': 'CARDINAL'}, {'entity': '43.8', 'category': 'CARDINAL'}, {'entity': '22.3', 'category': 'CARDINAL'}, {'entity': '35.6', 'category': 'CARDINAL'}, {'entity': '65.0', 'category': 'CARDINAL'}, {'entity': '41.0', 'category': 'CARDINAL'}, {'entity': '61.7', 'category': 'CARDINAL'}, {'entity': '24.5', 'category': 'CARDINAL'}, {'entity': '12.7', 'category': 'CARDINAL'}, {'entity': '174.2', 'category': 'CARDINAL'}, {'entity': '155.6', 'category': 'CARDINAL'}, {'entity': '110.9', 'category': 'CARDINAL'}, {'entity': '10.9', 'category': 'CARDINAL'}, {'entity': '11.3', 'category': 'CARDINAL'}, {'entity': '11.1', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '150.4', 'category': 'CARDINAL'}, {'entity': '77.6', 'category': 'CARDINAL'}, {'entity': '86.2', 'category': 'CARDINAL'}, {'entity': '43.4', 'category': 'CARDINAL'}, {'entity': '63.2', 'category': 'CARDINAL'}, {'entity': '37.2', 'category': 'CARDINAL'}, {'entity': '107.0', 'category': 'CARDINAL'}, {'entity': '14.4', 'category': 'CARDINAL'}, {'entity': '49.0', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '30, 2014', 'category': 'CARDINAL'}, {'entity': '30, 2013', 'category': 'CARDINAL'}, {'entity': '782.2', 'category': 'CARDINAL'}, {'entity': '699.2', 'category': 'CARDINAL'}, {'entity': '265.9', 'category': 'CARDINAL'}, {'entity': '197.6', 'category': 'CARDINAL'}, {'entity': '516.3', 'category': 'CARDINAL'}, {'entity': '501.6', 'category': 'CARDINAL'}, {'entity': '1950s', 'category': 'CARDINAL'}, {'entity': '1960s', 'category': 'CARDINAL'}, {'entity': '7.1', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '4.9', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '6.3', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '30, 2014', 'category': 'CARDINAL'}, {'entity': '84.1', 'category': 'CARDINAL'}, {'entity': '130.4', 'category': 'CARDINAL'}, {'entity': '211.3', 'category': 'CARDINAL'}, {'entity': '14.0', 'category': 'CARDINAL'}, {'entity': '21.7', 'category': 'CARDINAL'}, {'entity': '35.6', 'category': 'CARDINAL'}, {'entity': '7.8', 'category': 'CARDINAL'}, {'entity': '8.1', 'category': 'CARDINAL'}, {'entity': '20.0', 'category': 'CARDINAL'}, {'entity': '0.7', 'category': 'CARDINAL'}, {'entity': '5.8', 'category': 'CARDINAL'}, {'entity': '8.0', 'category': 'CARDINAL'}, {'entity': '106.6', 'category': 'CARDINAL'}, {'entity': '166.0', 'category': 'CARDINAL'}, {'entity': '274.9', 'category': 'CARDINAL'}, {'entity': '74.8', 'category': 'CARDINAL'}, {'entity': '30, 2014', 'category': 'CARDINAL'}, {'entity': '15', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVjhByjvtN74xbACTMtWrwDpJzKy\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701567541,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#15#2017#130.7#38.6#12.1#181.4#9.2#190.6#24.5#5.9#3.8#34.2#0.5#34.7#14.7#13.3#5.1#33.1#2.7#35.8#140.5#31.2#10.8#182.5#7#189.5#9.8#5.1#0.1#15#3.8#18.8#22.3#9.4#2.7#34.4#2.6#37#128#26.9#8.2#163.1#8.2#171.3#24#4.5#3.3#31.8#1.9#33.7#21.6#9.7#3.4#34.7#4.3#39#130.4#21.7#8.1#160.2#5.8#166#33.7#8.1#5.8#4#3#1.5#11.3#18.8#6.6#4.4#2.3#1.5#4#34.7#15.3#6.7#3.5#1.4#7.8#20#17.4#2.6#20#12#37\\n\\nDATE#November 30, 2011#November 30, 2012#November 30, 2013#November 30, 2014#January 12, 1999#December 1, 1998\\n\\nEVENT#Global Settlement\\n\\nFAC#AerojetRocketdyne-BPOU#AerojetRocketdyne-Sacramento\\n\\nGPE#Camden, Arkansas#Toledo, Ohio#Sacramento and Azusa#U.S.\\n\\nLAW#the Global Settlement resolving certain prior environmental and facility disagreements#Northrop Agreement\\n\\nMONEY#$33.7 million#$18.8 million#$34.7 million#$20.0 million\\n\\nORG#Aerojet Rocketdyne#Atlantic Research Corporation#ARC#BPOU#Northrop\\n\\nPERSON#AerojetRocketdyne\\n\\nPRODUCT#the ARC propulsion#the EIS business\\n\\nQUANTITY#fifteen year period\\n\\nTIME#third quarter of fiscal 2010\\n\\nWORK_OF_ART#TotalEnvironmentalReserve \\t(In millions)#Pre-Close Environmental Costs}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2467,\n",
      "    \"completion_tokens\": 542,\n",
      "    \"total_tokens\": 3009\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'November 30, 2011', 'category': 'DATE'}, {'entity': 'November 30, 2012', 'category': 'DATE'}, {'entity': 'November 30, 2013', 'category': 'DATE'}, {'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'January 12, 1999', 'category': 'DATE'}, {'entity': 'December 1, 1998', 'category': 'DATE'}, {'entity': 'Global Settlement', 'category': 'EVENT'}, {'entity': 'AerojetRocketdyne-BPOU', 'category': 'FAC'}, {'entity': 'AerojetRocketdyne-Sacramento', 'category': 'FAC'}, {'entity': 'Camden, Arkansas', 'category': 'GPE'}, {'entity': 'Toledo, Ohio', 'category': 'GPE'}, {'entity': 'Sacramento and Azusa', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'the Global Settlement resolving certain prior environmental and facility disagreements', 'category': 'LAW'}, {'entity': 'Northrop Agreement', 'category': 'LAW'}, {'entity': '$33.7 million', 'category': 'MONEY'}, {'entity': '$18.8 million', 'category': 'MONEY'}, {'entity': '$34.7 million', 'category': 'MONEY'}, {'entity': '$20.0 million', 'category': 'MONEY'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': 'Atlantic Research Corporation', 'category': 'ORG'}, {'entity': 'ARC', 'category': 'ORG'}, {'entity': 'BPOU', 'category': 'ORG'}, {'entity': 'Northrop', 'category': 'ORG'}, {'entity': 'AerojetRocketdyne', 'category': 'PERSON'}, {'entity': 'the ARC propulsion', 'category': 'PRODUCT'}, {'entity': 'the EIS business', 'category': 'PRODUCT'}, {'entity': 'fifteen year period', 'category': 'QUANTITY'}, {'entity': 'third quarter of fiscal 2010', 'category': 'TIME'}, {'entity': 'TotalEnvironmentalReserve \\tIn millions', 'category': 'WORK_OF_ART'}, {'entity': 'Pre-Close Environmental Costs', 'category': 'WORK_OF_ART'}, {'entity': '15', 'category': 'CARDINAL'}, {'entity': '2017', 'category': 'CARDINAL'}, {'entity': '130.7', 'category': 'CARDINAL'}, {'entity': '38.6', 'category': 'CARDINAL'}, {'entity': '12.1', 'category': 'CARDINAL'}, {'entity': '181.4', 'category': 'CARDINAL'}, {'entity': '9.2', 'category': 'CARDINAL'}, {'entity': '190.6', 'category': 'CARDINAL'}, {'entity': '24.5', 'category': 'CARDINAL'}, {'entity': '5.9', 'category': 'CARDINAL'}, {'entity': '3.8', 'category': 'CARDINAL'}, {'entity': '34.2', 'category': 'CARDINAL'}, {'entity': '0.5', 'category': 'CARDINAL'}, {'entity': '34.7', 'category': 'CARDINAL'}, {'entity': '14.7', 'category': 'CARDINAL'}, {'entity': '13.3', 'category': 'CARDINAL'}, {'entity': '5.1', 'category': 'CARDINAL'}, {'entity': '33.1', 'category': 'CARDINAL'}, {'entity': '2.7', 'category': 'CARDINAL'}, {'entity': '35.8', 'category': 'CARDINAL'}, {'entity': '140.5', 'category': 'CARDINAL'}, {'entity': '31.2', 'category': 'CARDINAL'}, {'entity': '10.8', 'category': 'CARDINAL'}, {'entity': '182.5', 'category': 'CARDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '189.5', 'category': 'CARDINAL'}, {'entity': '9.8', 'category': 'CARDINAL'}, {'entity': '5.1', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '15', 'category': 'CARDINAL'}, {'entity': '3.8', 'category': 'CARDINAL'}, {'entity': '18.8', 'category': 'CARDINAL'}, {'entity': '22.3', 'category': 'CARDINAL'}, {'entity': '9.4', 'category': 'CARDINAL'}, {'entity': '2.7', 'category': 'CARDINAL'}, {'entity': '34.4', 'category': 'CARDINAL'}, {'entity': '2.6', 'category': 'CARDINAL'}, {'entity': '37', 'category': 'CARDINAL'}, {'entity': '128', 'category': 'CARDINAL'}, {'entity': '26.9', 'category': 'CARDINAL'}, {'entity': '8.2', 'category': 'CARDINAL'}, {'entity': '163.1', 'category': 'CARDINAL'}, {'entity': '8.2', 'category': 'CARDINAL'}, {'entity': '171.3', 'category': 'CARDINAL'}, {'entity': '24', 'category': 'CARDINAL'}, {'entity': '4.5', 'category': 'CARDINAL'}, {'entity': '3.3', 'category': 'CARDINAL'}, {'entity': '31.8', 'category': 'CARDINAL'}, {'entity': '1.9', 'category': 'CARDINAL'}, {'entity': '33.7', 'category': 'CARDINAL'}, {'entity': '21.6', 'category': 'CARDINAL'}, {'entity': '9.7', 'category': 'CARDINAL'}, {'entity': '3.4', 'category': 'CARDINAL'}, {'entity': '34.7', 'category': 'CARDINAL'}, {'entity': '4.3', 'category': 'CARDINAL'}, {'entity': '39', 'category': 'CARDINAL'}, {'entity': '130.4', 'category': 'CARDINAL'}, {'entity': '21.7', 'category': 'CARDINAL'}, {'entity': '8.1', 'category': 'CARDINAL'}, {'entity': '160.2', 'category': 'CARDINAL'}, {'entity': '5.8', 'category': 'CARDINAL'}, {'entity': '166', 'category': 'CARDINAL'}, {'entity': '33.7', 'category': 'CARDINAL'}, {'entity': '8.1', 'category': 'CARDINAL'}, {'entity': '5.8', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '11.3', 'category': 'CARDINAL'}, {'entity': '18.8', 'category': 'CARDINAL'}, {'entity': '6.6', 'category': 'CARDINAL'}, {'entity': '4.4', 'category': 'CARDINAL'}, {'entity': '2.3', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '34.7', 'category': 'CARDINAL'}, {'entity': '15.3', 'category': 'CARDINAL'}, {'entity': '6.7', 'category': 'CARDINAL'}, {'entity': '3.5', 'category': 'CARDINAL'}, {'entity': '1.4', 'category': 'CARDINAL'}, {'entity': '7.8', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '17.4', 'category': 'CARDINAL'}, {'entity': '2.6', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '37', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVkQu3enSmMIWS6mT957tfAK7mmL\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701567586,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#189.7#107.2#82.5#74.8#7.7#30.5#6.0#111.2#98.8#210.0#21.7#22.7#1.3#3.0#111.5#94.0#205.5#8.7#22.6#1.6#2.7#99.2#87.9#187.1#21.4#23.2#1.7#2.8#99.1#82.3#181.4#0.2#0.6#82.5#88.5#5.1#3.7#2.5#1.9#1.5#6.7#31.0#12.6#8.1#2.7#1.7#1.3#4.6#8.7#3.9#2.6#0.9#1.3#30.5#11.5#9.3#2.1#1.6#6.0#21.7#9.0#4.3#3.3#0.8#4.3#29.7#14.7#7.1#1.8#1.3#4.8#22.9#10.4#23.1#10.8#8.4#11.6#33.7#18.8#34.7\\n\\nDATE#November 30, 2014#the third quarter of fiscal 2010#November 30, 2011#November 30, 2012#November 30, 2013#November 30, 2014#November 30, 2013#November 30, 2014#November 30, 2013#Year Ended 2014#2013#2012#July 2013\\n\\nMONEY#$189.7 million#$6.0 million#$31.0 million\\n\\nORG#Aerojet Rocketdyne#Northrop#the U.S. government#Sacramento site#BPOU site#the U.S. government#the Financial Accounting Standards Board#FASB\\n\\nPERSON#Northrop\\n\\nWORK_OF_ART#Northrop Agreement}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2585,\n",
      "    \"completion_tokens\": 490,\n",
      "    \"total_tokens\": 3075\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'the third quarter of fiscal 2010', 'category': 'DATE'}, {'entity': 'November 30, 2011', 'category': 'DATE'}, {'entity': 'November 30, 2012', 'category': 'DATE'}, {'entity': 'November 30, 2013', 'category': 'DATE'}, {'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'November 30, 2013', 'category': 'DATE'}, {'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'November 30, 2013', 'category': 'DATE'}, {'entity': 'Year Ended 2014', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': 'July 2013', 'category': 'DATE'}, {'entity': '$189.7 million', 'category': 'MONEY'}, {'entity': '$6.0 million', 'category': 'MONEY'}, {'entity': '$31.0 million', 'category': 'MONEY'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': 'Northrop', 'category': 'ORG'}, {'entity': 'the U.S. government', 'category': 'ORG'}, {'entity': 'Sacramento site', 'category': 'ORG'}, {'entity': 'BPOU site', 'category': 'ORG'}, {'entity': 'the U.S. government', 'category': 'ORG'}, {'entity': 'the Financial Accounting Standards Board', 'category': 'ORG'}, {'entity': 'FASB', 'category': 'ORG'}, {'entity': 'Northrop', 'category': 'PERSON'}, {'entity': 'Northrop Agreement', 'category': 'WORK_OF_ART'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '82.5', 'category': 'CARDINAL'}, {'entity': '74.8', 'category': 'CARDINAL'}, {'entity': '7.7', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6.0', 'category': 'CARDINAL'}, {'entity': '111.2', 'category': 'CARDINAL'}, {'entity': '98.8', 'category': 'CARDINAL'}, {'entity': '210.0', 'category': 'CARDINAL'}, {'entity': '21.7', 'category': 'CARDINAL'}, {'entity': '22.7', 'category': 'CARDINAL'}, {'entity': '1.3', 'category': 'CARDINAL'}, {'entity': '3.0', 'category': 'CARDINAL'}, {'entity': '111.5', 'category': 'CARDINAL'}, {'entity': '94.0', 'category': 'CARDINAL'}, {'entity': '205.5', 'category': 'CARDINAL'}, {'entity': '8.7', 'category': 'CARDINAL'}, {'entity': '22.6', 'category': 'CARDINAL'}, {'entity': '1.6', 'category': 'CARDINAL'}, {'entity': '2.7', 'category': 'CARDINAL'}, {'entity': '99.2', 'category': 'CARDINAL'}, {'entity': '87.9', 'category': 'CARDINAL'}, {'entity': '187.1', 'category': 'CARDINAL'}, {'entity': '21.4', 'category': 'CARDINAL'}, {'entity': '23.2', 'category': 'CARDINAL'}, {'entity': '1.7', 'category': 'CARDINAL'}, {'entity': '2.8', 'category': 'CARDINAL'}, {'entity': '99.1', 'category': 'CARDINAL'}, {'entity': '82.3', 'category': 'CARDINAL'}, {'entity': '181.4', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '0.6', 'category': 'CARDINAL'}, {'entity': '82.5', 'category': 'CARDINAL'}, {'entity': '88.5', 'category': 'CARDINAL'}, {'entity': '5.1', 'category': 'CARDINAL'}, {'entity': '3.7', 'category': 'CARDINAL'}, {'entity': '2.5', 'category': 'CARDINAL'}, {'entity': '1.9', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '6.7', 'category': 'CARDINAL'}, {'entity': '31.0', 'category': 'CARDINAL'}, {'entity': '12.6', 'category': 'CARDINAL'}, {'entity': '8.1', 'category': 'CARDINAL'}, {'entity': '2.7', 'category': 'CARDINAL'}, {'entity': '1.7', 'category': 'CARDINAL'}, {'entity': '1.3', 'category': 'CARDINAL'}, {'entity': '4.6', 'category': 'CARDINAL'}, {'entity': '8.7', 'category': 'CARDINAL'}, {'entity': '3.9', 'category': 'CARDINAL'}, {'entity': '2.6', 'category': 'CARDINAL'}, {'entity': '0.9', 'category': 'CARDINAL'}, {'entity': '1.3', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '11.5', 'category': 'CARDINAL'}, {'entity': '9.3', 'category': 'CARDINAL'}, {'entity': '2.1', 'category': 'CARDINAL'}, {'entity': '1.6', 'category': 'CARDINAL'}, {'entity': '6.0', 'category': 'CARDINAL'}, {'entity': '21.7', 'category': 'CARDINAL'}, {'entity': '9.0', 'category': 'CARDINAL'}, {'entity': '4.3', 'category': 'CARDINAL'}, {'entity': '3.3', 'category': 'CARDINAL'}, {'entity': '0.8', 'category': 'CARDINAL'}, {'entity': '4.3', 'category': 'CARDINAL'}, {'entity': '29.7', 'category': 'CARDINAL'}, {'entity': '14.7', 'category': 'CARDINAL'}, {'entity': '7.1', 'category': 'CARDINAL'}, {'entity': '1.8', 'category': 'CARDINAL'}, {'entity': '1.3', 'category': 'CARDINAL'}, {'entity': '4.8', 'category': 'CARDINAL'}, {'entity': '22.9', 'category': 'CARDINAL'}, {'entity': '10.4', 'category': 'CARDINAL'}, {'entity': '23.1', 'category': 'CARDINAL'}, {'entity': '10.8', 'category': 'CARDINAL'}, {'entity': '8.4', 'category': 'CARDINAL'}, {'entity': '11.6', 'category': 'CARDINAL'}, {'entity': '33.7', 'category': 'CARDINAL'}, {'entity': '18.8', 'category': 'CARDINAL'}, {'entity': '34.7', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVl6GNkDOt6hv3of3uBQAZid65Nf\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701567628,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#2#7 1/8#4 1/16#2 1/4\\n\\nDATE#November 30, 2014#November 30,2013#fiscal 2014#fiscal 2013#fiscal 2012#August 2014#May 2014#April 2014#the first quarter of fiscal 2018#the fourth quarter of fiscal 2014#the first quarter of fiscal 2014\\n\\nEVENT#Rocketdyne Business integration\\n\\nMONEY#$189.0 million#$166.3 million#$64.5 million#$60.3 million#$460.0 million#$12.8 million#$14.9 million\\n\\nORG#ERP#FASB#Rocketdyne Business\\n\\nPERCENT#7 1/8%#4 1/16%#2 1/4%\\n\\nPERSON#\\n\\nQUANTITY#3.5 million#411.2 million\\n\\nTIME#}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2446,\n",
      "    \"completion_tokens\": 201,\n",
      "    \"total_tokens\": 2647\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'November 30,2013', 'category': 'DATE'}, {'entity': 'fiscal 2014', 'category': 'DATE'}, {'entity': 'fiscal 2013', 'category': 'DATE'}, {'entity': 'fiscal 2012', 'category': 'DATE'}, {'entity': 'August 2014', 'category': 'DATE'}, {'entity': 'May 2014', 'category': 'DATE'}, {'entity': 'April 2014', 'category': 'DATE'}, {'entity': 'the first quarter of fiscal 2018', 'category': 'DATE'}, {'entity': 'the fourth quarter of fiscal 2014', 'category': 'DATE'}, {'entity': 'the first quarter of fiscal 2014', 'category': 'DATE'}, {'entity': 'Rocketdyne Business integration', 'category': 'EVENT'}, {'entity': '$189.0 million', 'category': 'MONEY'}, {'entity': '$166.3 million', 'category': 'MONEY'}, {'entity': '$64.5 million', 'category': 'MONEY'}, {'entity': '$60.3 million', 'category': 'MONEY'}, {'entity': '$460.0 million', 'category': 'MONEY'}, {'entity': '$12.8 million', 'category': 'MONEY'}, {'entity': '$14.9 million', 'category': 'MONEY'}, {'entity': 'ERP', 'category': 'ORG'}, {'entity': 'FASB', 'category': 'ORG'}, {'entity': 'Rocketdyne Business', 'category': 'ORG'}, {'entity': '7 1/8%', 'category': 'PERCENT'}, {'entity': '4 1/16%', 'category': 'PERCENT'}, {'entity': '2 1/4%', 'category': 'PERCENT'}, {'entity': '3.5 million', 'category': 'QUANTITY'}, {'entity': '411.2 million', 'category': 'QUANTITY'}, {'entity': '', 'category': 'TIME'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '7 1/8', 'category': 'CARDINAL'}, {'entity': '4 1/16', 'category': 'CARDINAL'}, {'entity': '2 1/4', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVlczogUxEnL1t8Z9IdeELz4q6zC\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701567660,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#4.50#1.00#4.25#1.00#4.00#1.00#2.40#1.00#3.57#1.00#2.40#1.00#3.53#1.00#4.50#1.00#164.2#7#1/8#4#1/16#50#55.0#98.8#5.0#10.0#83.8#460.0#133.8#133.6#0.2#89.6#0.3#0.3#89.0#291.5#48.4#91.6#88.9#62.6#50.2#6.4#12.1#10.8#20.9#105.2#19.2#29.7#20.5#35.8#24.4#3.5#20.9#0.6#0.6#1,254.1#213.5#143.7#207.7#689.2#1,000#133.6#14.8#6.2 \\n\\nDATE#November 30, 2015#November 30, 2017#November 30, 2014#November 30, 2014#November 30, 2014#next twelve months#November 30, 2014#November 30, 2014#December 31, 2014#November 30, 2014#November 30, 2014#December 31, 2014#November 30, 2014#November 30, 2014#next 10 years#November 30, 2014#November 30, 2014\\n\\nMONEY#$150.0 million#$164.2 million#$55.0 million#$98.8#$460.0#$133.8#$89.6#$291.5#$50.2#$105.2#$24.4#$0.6#$1,254.1#$6.2 million\\n\\nORG#Financial Covenant#Rocketdyne Business#Senior Credit Facility#Senior Credit Facility#Senior Credit Facility#Board of Directors#RD Amross#UTC#Part I, Item 1A. Risk Factors#Aerospace#Defense segment\\n\\nPERSON#Senior#Debentures \\n\\nTIME#ofNovember#4 1/16#4 1/16#4 1/16#4 1/16#4 1/16#4 1/16}\\n\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2497,\n",
      "    \"completion_tokens\": 552,\n",
      "    \"total_tokens\": 3049\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': 'November 30, 2017', 'category': 'DATE'}, {'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'next twelve months', 'category': 'DATE'}, {'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'December 31, 2014', 'category': 'DATE'}, {'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'December 31, 2014', 'category': 'DATE'}, {'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'next 10 years', 'category': 'DATE'}, {'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': '$150.0 million', 'category': 'MONEY'}, {'entity': '$164.2 million', 'category': 'MONEY'}, {'entity': '$55.0 million', 'category': 'MONEY'}, {'entity': '$98.8', 'category': 'MONEY'}, {'entity': '$460.0', 'category': 'MONEY'}, {'entity': '$133.8', 'category': 'MONEY'}, {'entity': '$89.6', 'category': 'MONEY'}, {'entity': '$291.5', 'category': 'MONEY'}, {'entity': '$50.2', 'category': 'MONEY'}, {'entity': '$105.2', 'category': 'MONEY'}, {'entity': '$24.4', 'category': 'MONEY'}, {'entity': '$0.6', 'category': 'MONEY'}, {'entity': '$1,254.1', 'category': 'MONEY'}, {'entity': '$6.2 million', 'category': 'MONEY'}, {'entity': 'Financial Covenant', 'category': 'ORG'}, {'entity': 'Rocketdyne Business', 'category': 'ORG'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': 'Board of Directors', 'category': 'ORG'}, {'entity': 'RD Amross', 'category': 'ORG'}, {'entity': 'UTC', 'category': 'ORG'}, {'entity': 'Part I, Item 1A. Risk Factors', 'category': 'ORG'}, {'entity': 'Aerospace', 'category': 'ORG'}, {'entity': 'Defense segment', 'category': 'ORG'}, {'entity': 'Senior', 'category': 'PERSON'}, {'entity': 'Debentures', 'category': 'PERSON'}, {'entity': 'ofNovember', 'category': 'TIME'}, {'entity': '4 1/16', 'category': 'TIME'}, {'entity': '4 1/16', 'category': 'TIME'}, {'entity': '4 1/16', 'category': 'TIME'}, {'entity': '4 1/16', 'category': 'TIME'}, {'entity': '4 1/16', 'category': 'TIME'}, {'entity': '4 1/16', 'category': 'TIME'}, {'entity': '4.50', 'category': 'CARDINAL'}, {'entity': '1.00', 'category': 'CARDINAL'}, {'entity': '4.25', 'category': 'CARDINAL'}, {'entity': '1.00', 'category': 'CARDINAL'}, {'entity': '4.00', 'category': 'CARDINAL'}, {'entity': '1.00', 'category': 'CARDINAL'}, {'entity': '2.40', 'category': 'CARDINAL'}, {'entity': '1.00', 'category': 'CARDINAL'}, {'entity': '3.57', 'category': 'CARDINAL'}, {'entity': '1.00', 'category': 'CARDINAL'}, {'entity': '2.40', 'category': 'CARDINAL'}, {'entity': '1.00', 'category': 'CARDINAL'}, {'entity': '3.53', 'category': 'CARDINAL'}, {'entity': '1.00', 'category': 'CARDINAL'}, {'entity': '4.50', 'category': 'CARDINAL'}, {'entity': '1.00', 'category': 'CARDINAL'}, {'entity': '164.2', 'category': 'CARDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '1/8', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '1/16', 'category': 'CARDINAL'}, {'entity': '50', 'category': 'CARDINAL'}, {'entity': '55.0', 'category': 'CARDINAL'}, {'entity': '98.8', 'category': 'CARDINAL'}, {'entity': '5.0', 'category': 'CARDINAL'}, {'entity': '10.0', 'category': 'CARDINAL'}, {'entity': '83.8', 'category': 'CARDINAL'}, {'entity': '460.0', 'category': 'CARDINAL'}, {'entity': '133.8', 'category': 'CARDINAL'}, {'entity': '133.6', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '89.6', 'category': 'CARDINAL'}, {'entity': '0.3', 'category': 'CARDINAL'}, {'entity': '0.3', 'category': 'CARDINAL'}, {'entity': '89.0', 'category': 'CARDINAL'}, {'entity': '291.5', 'category': 'CARDINAL'}, {'entity': '48.4', 'category': 'CARDINAL'}, {'entity': '91.6', 'category': 'CARDINAL'}, {'entity': '88.9', 'category': 'CARDINAL'}, {'entity': '62.6', 'category': 'CARDINAL'}, {'entity': '50.2', 'category': 'CARDINAL'}, {'entity': '6.4', 'category': 'CARDINAL'}, {'entity': '12.1', 'category': 'CARDINAL'}, {'entity': '10.8', 'category': 'CARDINAL'}, {'entity': '20.9', 'category': 'CARDINAL'}, {'entity': '105.2', 'category': 'CARDINAL'}, {'entity': '19.2', 'category': 'CARDINAL'}, {'entity': '29.7', 'category': 'CARDINAL'}, {'entity': '20.5', 'category': 'CARDINAL'}, {'entity': '35.8', 'category': 'CARDINAL'}, {'entity': '24.4', 'category': 'CARDINAL'}, {'entity': '3.5', 'category': 'CARDINAL'}, {'entity': '20.9', 'category': 'CARDINAL'}, {'entity': '0.6', 'category': 'CARDINAL'}, {'entity': '0.6', 'category': 'CARDINAL'}, {'entity': '1,254.1', 'category': 'CARDINAL'}, {'entity': '213.5', 'category': 'CARDINAL'}, {'entity': '143.7', 'category': 'CARDINAL'}, {'entity': '207.7', 'category': 'CARDINAL'}, {'entity': '689.2', 'category': 'CARDINAL'}, {'entity': '1,000', 'category': 'CARDINAL'}, {'entity': '133.6', 'category': 'CARDINAL'}, {'entity': '14.8', 'category': 'CARDINAL'}, {'entity': '6.2', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVmKdH50hJxALltXAwc3ky5DWI6E\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701567704,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#50 \\n\\nDATE#November 30, 2014#October 2015#fiscal years#Year Ended#2014#2013#2012#fiscal 2014#fiscal 2013\\n\\nEVENT#pending future acquisition\\n\\nMONEY#$46.8 million#$43.9 million#$120.0 million#$55.0 million\\n\\nORG#GenCorp#Aerojet Rocketdyne#UTC#RD Amross#Senior Credit Facility#7 1/8% Notes#GAAP#SEC#Antares AJ-26#Antares AJ-26#Atlas V\\n\\nPRODUCT#7 1/8% Notes\\n\\nQUANTITY#75% \\n\\nTIME#one-year\\n\\nWORK_OF_ART#Note 1 of the Notes to Consolidated Financial Statements\\n}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2086,\n",
      "    \"completion_tokens\": 166,\n",
      "    \"total_tokens\": 2252\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'October 2015', 'category': 'DATE'}, {'entity': 'fiscal years', 'category': 'DATE'}, {'entity': 'Year Ended', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': 'fiscal 2014', 'category': 'DATE'}, {'entity': 'fiscal 2013', 'category': 'DATE'}, {'entity': 'pending future acquisition', 'category': 'EVENT'}, {'entity': '$46.8 million', 'category': 'MONEY'}, {'entity': '$43.9 million', 'category': 'MONEY'}, {'entity': '$120.0 million', 'category': 'MONEY'}, {'entity': '$55.0 million', 'category': 'MONEY'}, {'entity': 'GenCorp', 'category': 'ORG'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': 'UTC', 'category': 'ORG'}, {'entity': 'RD Amross', 'category': 'ORG'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': '7 1/8% Notes', 'category': 'ORG'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'Antares AJ-26', 'category': 'ORG'}, {'entity': 'Antares AJ-26', 'category': 'ORG'}, {'entity': 'Atlas V', 'category': 'ORG'}, {'entity': '7 1/8% Notes', 'category': 'PRODUCT'}, {'entity': '75%', 'category': 'QUANTITY'}, {'entity': 'one-year', 'category': 'TIME'}, {'entity': 'Note 1 of the Notes to Consolidated Financial Statements', 'category': 'WORK_OF_ART'}, {'entity': '50', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVmqUrIRMf7vtUOaSm9nuFWti7lK\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701567736,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#50%\\n\\nDATE#September 1, 2014#September 1, 2013\\n\\nEVENT#real estate asset sales\\n\\nFAC#\\n\\nGPE#U.S.\\n\\nLOC#\\n\\nMONEY#\\n\\nNORP#U.S. government\\n\\nORDINAL#first\\n\\nORG#Aerospace and Defense#U.S. government#DCAA\\n\\nPERCENT#\\n\\nPERSON#\\n\\nPRODUCT#\\n\\nQUANTITY#five-year\\n\\nTIME#\\n\\nWORK_OF_ART#}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2016,\n",
      "    \"completion_tokens\": 95,\n",
      "    \"total_tokens\": 2111\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'September 1, 2014', 'category': 'DATE'}, {'entity': 'September 1, 2013', 'category': 'DATE'}, {'entity': 'real estate asset sales', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S. government', 'category': 'NORP'}, {'entity': 'Aerospace and Defense', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'DCAA', 'category': 'ORG'}, {'entity': 'five-year', 'category': 'QUANTITY'}, {'entity': '', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '50%', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVnI9xsIoqLx8EwZSVYkQ6xSG37i\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701567764,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL:22.5#187.5#11.6#0.4#1.8#19.3#156.6#11.6#401\\n\\nDATE: November 30, 2014#fiscal 2014#fiscal 2009\\n\\nEVENT:Retirement Benefit Plans\\n\\nLAW:GAAP\\n\\nMONEY:$22.5 million#$187.5 million#$11.6 million#$0.4 million#$1.8 million#$(19.3 million)#$(156.6 million)#$(11.6 million)\\n\\nORG:Consolidated Financial Statements#U.S. Government\\n\\nPERCENT:3.96#4.54#3.54#3.98#4.54#3.68#4.95#3.98#3.24#4.58#8.00\\n\\nPERSON:see Notes 8\\n\\nQUANTITY:one percentage point\\n\\nTIME:three years#future years\\n\\nWORK_OF_ART:Notes 8(b) and 8(c)}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2205,\n",
      "    \"completion_tokens\": 215,\n",
      "    \"total_tokens\": 2420\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'fiscal 2014', 'category': 'DATE'}, {'entity': 'fiscal 2009', 'category': 'DATE'}, {'entity': 'Retirement Benefit Plans', 'category': 'EVENT'}, {'entity': 'GAAP', 'category': 'LAW'}, {'entity': '$22.5 million', 'category': 'MONEY'}, {'entity': '$187.5 million', 'category': 'MONEY'}, {'entity': '$11.6 million', 'category': 'MONEY'}, {'entity': '$0.4 million', 'category': 'MONEY'}, {'entity': '$1.8 million', 'category': 'MONEY'}, {'entity': '$19.3 million', 'category': 'MONEY'}, {'entity': '$156.6 million', 'category': 'MONEY'}, {'entity': '$11.6 million', 'category': 'MONEY'}, {'entity': 'Consolidated Financial Statements', 'category': 'ORG'}, {'entity': 'U.S. Government', 'category': 'ORG'}, {'entity': '3.96', 'category': 'PERCENT'}, {'entity': '4.54', 'category': 'PERCENT'}, {'entity': '3.54', 'category': 'PERCENT'}, {'entity': '3.98', 'category': 'PERCENT'}, {'entity': '4.54', 'category': 'PERCENT'}, {'entity': '3.68', 'category': 'PERCENT'}, {'entity': '4.95', 'category': 'PERCENT'}, {'entity': '3.98', 'category': 'PERCENT'}, {'entity': '3.24', 'category': 'PERCENT'}, {'entity': '4.58', 'category': 'PERCENT'}, {'entity': '8.00', 'category': 'PERCENT'}, {'entity': 'see Notes 8', 'category': 'PERSON'}, {'entity': 'one percentage point', 'category': 'QUANTITY'}, {'entity': 'three years', 'category': 'TIME'}, {'entity': 'future years', 'category': 'TIME'}, {'entity': 'Notes 8b and 8c', 'category': 'WORK_OF_ART'}, {'entity': '22.5', 'category': 'CARDINAL'}, {'entity': '187.5', 'category': 'CARDINAL'}, {'entity': '11.6', 'category': 'CARDINAL'}, {'entity': '0.4', 'category': 'CARDINAL'}, {'entity': '1.8', 'category': 'CARDINAL'}, {'entity': '19.3', 'category': 'CARDINAL'}, {'entity': '156.6', 'category': 'CARDINAL'}, {'entity': '11.6', 'category': 'CARDINAL'}, {'entity': '401', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVnpeWtNmolu7fsXQZ8wHsoojq5H\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701567797,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#782.2#594.4#76#187.8#24#5.94#98.8#45.0#7#483.6#494.5#460.0#460.0#4#248.2#398.1#133.6#193.2#89.0#0.8#1.0#920.4#938.6\\n\\nDATE#three fiscal years#November 30, 2014#November 30, 2013#November 30, 2014#November 30, 2013\\n\\nEVENT#Global Settlement Agreement\\n\\nLAW#Global Settlement Agreement#Northrop Agreement\\n\\nMONEY#$782.2 million#$594.4 million#$187.8 million#$98.8 million#$45.0 million#$483.6 million#$494.5 million#$460.0 million#$460.0 million#$248.2 million#$398.1 million#$133.6 million#$193.2 million#$89.0 million#$0.8 million#$1.0 million#$920.4 million#$938.6 million\\n\\nORG#U.S. government#Company#Subordinated Credit Facility#Senior Credit Facility\\n\\nPERSON#Northrop\\n\\nTIME#present\\n\\nWORK_OF_ART#Item 7A.}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 1909,\n",
      "    \"completion_tokens\": 273,\n",
      "    \"total_tokens\": 2182\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'three fiscal years', 'category': 'DATE'}, {'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'November 30, 2013', 'category': 'DATE'}, {'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'November 30, 2013', 'category': 'DATE'}, {'entity': 'Global Settlement Agreement', 'category': 'EVENT'}, {'entity': 'Global Settlement Agreement', 'category': 'LAW'}, {'entity': 'Northrop Agreement', 'category': 'LAW'}, {'entity': '$782.2 million', 'category': 'MONEY'}, {'entity': '$594.4 million', 'category': 'MONEY'}, {'entity': '$187.8 million', 'category': 'MONEY'}, {'entity': '$98.8 million', 'category': 'MONEY'}, {'entity': '$45.0 million', 'category': 'MONEY'}, {'entity': '$483.6 million', 'category': 'MONEY'}, {'entity': '$494.5 million', 'category': 'MONEY'}, {'entity': '$460.0 million', 'category': 'MONEY'}, {'entity': '$460.0 million', 'category': 'MONEY'}, {'entity': '$248.2 million', 'category': 'MONEY'}, {'entity': '$398.1 million', 'category': 'MONEY'}, {'entity': '$133.6 million', 'category': 'MONEY'}, {'entity': '$193.2 million', 'category': 'MONEY'}, {'entity': '$89.0 million', 'category': 'MONEY'}, {'entity': '$0.8 million', 'category': 'MONEY'}, {'entity': '$1.0 million', 'category': 'MONEY'}, {'entity': '$920.4 million', 'category': 'MONEY'}, {'entity': '$938.6 million', 'category': 'MONEY'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'Company', 'category': 'ORG'}, {'entity': 'Subordinated Credit Facility', 'category': 'ORG'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': 'Northrop', 'category': 'PERSON'}, {'entity': 'present', 'category': 'TIME'}, {'entity': 'Item 7A.', 'category': 'WORK_OF_ART'}, {'entity': '782.2', 'category': 'CARDINAL'}, {'entity': '594.4', 'category': 'CARDINAL'}, {'entity': '76', 'category': 'CARDINAL'}, {'entity': '187.8', 'category': 'CARDINAL'}, {'entity': '24', 'category': 'CARDINAL'}, {'entity': '5.94', 'category': 'CARDINAL'}, {'entity': '98.8', 'category': 'CARDINAL'}, {'entity': '45.0', 'category': 'CARDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '483.6', 'category': 'CARDINAL'}, {'entity': '494.5', 'category': 'CARDINAL'}, {'entity': '460.0', 'category': 'CARDINAL'}, {'entity': '460.0', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '248.2', 'category': 'CARDINAL'}, {'entity': '398.1', 'category': 'CARDINAL'}, {'entity': '133.6', 'category': 'CARDINAL'}, {'entity': '193.2', 'category': 'CARDINAL'}, {'entity': '89.0', 'category': 'CARDINAL'}, {'entity': '0.8', 'category': 'CARDINAL'}, {'entity': '1.0', 'category': 'CARDINAL'}, {'entity': '920.4', 'category': 'CARDINAL'}, {'entity': '938.6', 'category': 'CARDINAL'}]\n",
      "/home/damir/Dropbox/Documents/Teaching/2023/L715/l715_23/data/10-Ks/Aerojet_Rocketdyne_Holdings_Inc./2019/Management.txt\n",
      "Length of chunks:  11\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVoPL0WPT13625Won9ET4TFPQNlz\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701567833,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#7#8#1#1A#1#2018#1,895.9#1,877.2#2017#137.3#1.75#9.2#0.13#151.5#1.93#76.0#1.02#304.9#222.9#236.2#202.9#252.7#212.8#209.5#183.4#2018#37.6#578.0#1#4.1#4.6#2014#1#2018#2018#8#1#14#94#92#91#25#18#15#24#7#5#94#6#100#14#14#12#13#9#12#11#9#13#30#24#27#19#17#20#18#17#13#17#2015#1#6#2017#230#210.0#60.5#235.0#131.4#48.1#31#8#625.4\\n\\nDATE#2018#2017#2018#2017#January 1, 2018#January 1, 2018#December 31, 2018#December 31, 2017#May 2014#January 1, 2018#January 1 ,2018#December 31, 2018#2018#2017#2016#2018#2017#2016#December 31, 2018#2015#April 6, 2017#December 31, 2018#December 31, 2018\\n\\nEVENT#Management\\u2019s Discussion and Analysis\\n\\nFAC#\\n\\nGPE#Sacramento#California#Gainesville#Virginia#Huntsville#Alabama\\n\\nLANGUAGE#\\n\\nLAW#Operating Segment Information#Use of Non-GAAP Financial Measures\\n\\nLOCA#\\n\\nMONEY#$1,895.9 million#$1,877.2 million#$137.3 million#$151.5 million#$76.0 million#$304.9 million#$222.9 million#$252.7 million#$212.8 million#$209.5 million#$183.4 million#$37.6 million#$578.0 million#$4.1 billion#$4.6 billion#$230 million#$210.0 million#$235.0 million#$131.4 million#$48.1 million#$625.4 million\\n\\nNORP#U.S.\\n\\nORDINAL#\\n\\nORG#Financial Accounting Standards Board (FASB)#NASA#Missile Defense Agency#Lockheed Martin#Raytheon#ULA#Notable Program#Industry UpdateInformation#Business#Board of Directors\\n\\nPERCENT#94%#92%#91%#25%#18%#15%#24%#7%#5%#94%#6%#100%#14%#14%#12%#13%#9%#12%#11%#9%#13%#30%#24%#27%#19%#17%#20%#18%#17%#13%#17%\\n\\nPERSON#\\n\\nPRODUCT#Net sales#Adjusted Net Income (Non-GAAP measure*)#EPS#Adjusted EPS (Non-GAAP measure*)#Adjusted EBITDAP (Non-GAAP measure*)#Standard Missile program#THAAD program#RS-25 program#Capital Structure\\n\\nQUANTITY#$4.1 billion\\n\\nTIME#\\n\\nWORK_OF_ART#Operating Segment Information#Use of Non-GAAP Financial Measures}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2372,\n",
      "    \"completion_tokens\": 753,\n",
      "    \"total_tokens\": 3125\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': '2018', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': '2018', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': 'January 1, 2018', 'category': 'DATE'}, {'entity': 'January 1, 2018', 'category': 'DATE'}, {'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': 'May 2014', 'category': 'DATE'}, {'entity': 'January 1, 2018', 'category': 'DATE'}, {'entity': 'January 1 ,2018', 'category': 'DATE'}, {'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': '2018', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2018', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': 'April 6, 2017', 'category': 'DATE'}, {'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': 'Management’s Discussion and Analysis', 'category': 'EVENT'}, {'entity': 'Sacramento', 'category': 'GPE'}, {'entity': 'California', 'category': 'GPE'}, {'entity': 'Gainesville', 'category': 'GPE'}, {'entity': 'Virginia', 'category': 'GPE'}, {'entity': 'Huntsville', 'category': 'GPE'}, {'entity': 'Alabama', 'category': 'GPE'}, {'entity': 'Operating Segment Information', 'category': 'LAW'}, {'entity': 'Use of Non-GAAP Financial Measures', 'category': 'LAW'}, {'entity': '$1,895.9 million', 'category': 'MONEY'}, {'entity': '$1,877.2 million', 'category': 'MONEY'}, {'entity': '$137.3 million', 'category': 'MONEY'}, {'entity': '$151.5 million', 'category': 'MONEY'}, {'entity': '$76.0 million', 'category': 'MONEY'}, {'entity': '$304.9 million', 'category': 'MONEY'}, {'entity': '$222.9 million', 'category': 'MONEY'}, {'entity': '$252.7 million', 'category': 'MONEY'}, {'entity': '$212.8 million', 'category': 'MONEY'}, {'entity': '$209.5 million', 'category': 'MONEY'}, {'entity': '$183.4 million', 'category': 'MONEY'}, {'entity': '$37.6 million', 'category': 'MONEY'}, {'entity': '$578.0 million', 'category': 'MONEY'}, {'entity': '$4.1 billion', 'category': 'MONEY'}, {'entity': '$4.6 billion', 'category': 'MONEY'}, {'entity': '$230 million', 'category': 'MONEY'}, {'entity': '$210.0 million', 'category': 'MONEY'}, {'entity': '$235.0 million', 'category': 'MONEY'}, {'entity': '$131.4 million', 'category': 'MONEY'}, {'entity': '$48.1 million', 'category': 'MONEY'}, {'entity': '$625.4 million', 'category': 'MONEY'}, {'entity': 'U.S.', 'category': 'NORP'}, {'entity': 'Financial Accounting Standards Board FASB', 'category': 'ORG'}, {'entity': 'NASA', 'category': 'ORG'}, {'entity': 'Missile Defense Agency', 'category': 'ORG'}, {'entity': 'Lockheed Martin', 'category': 'ORG'}, {'entity': 'Raytheon', 'category': 'ORG'}, {'entity': 'ULA', 'category': 'ORG'}, {'entity': 'Notable Program', 'category': 'ORG'}, {'entity': 'Industry UpdateInformation', 'category': 'ORG'}, {'entity': 'Business', 'category': 'ORG'}, {'entity': 'Board of Directors', 'category': 'ORG'}, {'entity': '94%', 'category': 'PERCENT'}, {'entity': '92%', 'category': 'PERCENT'}, {'entity': '91%', 'category': 'PERCENT'}, {'entity': '25%', 'category': 'PERCENT'}, {'entity': '18%', 'category': 'PERCENT'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': '24%', 'category': 'PERCENT'}, {'entity': '7%', 'category': 'PERCENT'}, {'entity': '5%', 'category': 'PERCENT'}, {'entity': '94%', 'category': 'PERCENT'}, {'entity': '6%', 'category': 'PERCENT'}, {'entity': '100%', 'category': 'PERCENT'}, {'entity': '14%', 'category': 'PERCENT'}, {'entity': '14%', 'category': 'PERCENT'}, {'entity': '12%', 'category': 'PERCENT'}, {'entity': '13%', 'category': 'PERCENT'}, {'entity': '9%', 'category': 'PERCENT'}, {'entity': '12%', 'category': 'PERCENT'}, {'entity': '11%', 'category': 'PERCENT'}, {'entity': '9%', 'category': 'PERCENT'}, {'entity': '13%', 'category': 'PERCENT'}, {'entity': '30%', 'category': 'PERCENT'}, {'entity': '24%', 'category': 'PERCENT'}, {'entity': '27%', 'category': 'PERCENT'}, {'entity': '19%', 'category': 'PERCENT'}, {'entity': '17%', 'category': 'PERCENT'}, {'entity': '20%', 'category': 'PERCENT'}, {'entity': '18%', 'category': 'PERCENT'}, {'entity': '17%', 'category': 'PERCENT'}, {'entity': '13%', 'category': 'PERCENT'}, {'entity': '17%', 'category': 'PERCENT'}, {'entity': 'Net sales', 'category': 'PRODUCT'}, {'entity': 'Adjusted Net Income Non-GAAP measure*', 'category': 'PRODUCT'}, {'entity': 'EPS', 'category': 'PRODUCT'}, {'entity': 'Adjusted EPS Non-GAAP measure*', 'category': 'PRODUCT'}, {'entity': 'Adjusted EBITDAP Non-GAAP measure*', 'category': 'PRODUCT'}, {'entity': 'Standard Missile program', 'category': 'PRODUCT'}, {'entity': 'THAAD program', 'category': 'PRODUCT'}, {'entity': 'RS-25 program', 'category': 'PRODUCT'}, {'entity': 'Capital Structure', 'category': 'PRODUCT'}, {'entity': '$4.1 billion', 'category': 'QUANTITY'}, {'entity': 'Operating Segment Information', 'category': 'WORK_OF_ART'}, {'entity': 'Use of Non-GAAP Financial Measures', 'category': 'WORK_OF_ART'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1A', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '2018', 'category': 'CARDINAL'}, {'entity': '1,895.9', 'category': 'CARDINAL'}, {'entity': '1,877.2', 'category': 'CARDINAL'}, {'entity': '2017', 'category': 'CARDINAL'}, {'entity': '137.3', 'category': 'CARDINAL'}, {'entity': '1.75', 'category': 'CARDINAL'}, {'entity': '9.2', 'category': 'CARDINAL'}, {'entity': '0.13', 'category': 'CARDINAL'}, {'entity': '151.5', 'category': 'CARDINAL'}, {'entity': '1.93', 'category': 'CARDINAL'}, {'entity': '76.0', 'category': 'CARDINAL'}, {'entity': '1.02', 'category': 'CARDINAL'}, {'entity': '304.9', 'category': 'CARDINAL'}, {'entity': '222.9', 'category': 'CARDINAL'}, {'entity': '236.2', 'category': 'CARDINAL'}, {'entity': '202.9', 'category': 'CARDINAL'}, {'entity': '252.7', 'category': 'CARDINAL'}, {'entity': '212.8', 'category': 'CARDINAL'}, {'entity': '209.5', 'category': 'CARDINAL'}, {'entity': '183.4', 'category': 'CARDINAL'}, {'entity': '2018', 'category': 'CARDINAL'}, {'entity': '37.6', 'category': 'CARDINAL'}, {'entity': '578.0', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '4.1', 'category': 'CARDINAL'}, {'entity': '4.6', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '2018', 'category': 'CARDINAL'}, {'entity': '2018', 'category': 'CARDINAL'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '14', 'category': 'CARDINAL'}, {'entity': '94', 'category': 'CARDINAL'}, {'entity': '92', 'category': 'CARDINAL'}, {'entity': '91', 'category': 'CARDINAL'}, {'entity': '25', 'category': 'CARDINAL'}, {'entity': '18', 'category': 'CARDINAL'}, {'entity': '15', 'category': 'CARDINAL'}, {'entity': '24', 'category': 'CARDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '5', 'category': 'CARDINAL'}, {'entity': '94', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '14', 'category': 'CARDINAL'}, {'entity': '14', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '13', 'category': 'CARDINAL'}, {'entity': '9', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '11', 'category': 'CARDINAL'}, {'entity': '9', 'category': 'CARDINAL'}, {'entity': '13', 'category': 'CARDINAL'}, {'entity': '30', 'category': 'CARDINAL'}, {'entity': '24', 'category': 'CARDINAL'}, {'entity': '27', 'category': 'CARDINAL'}, {'entity': '19', 'category': 'CARDINAL'}, {'entity': '17', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '18', 'category': 'CARDINAL'}, {'entity': '17', 'category': 'CARDINAL'}, {'entity': '13', 'category': 'CARDINAL'}, {'entity': '17', 'category': 'CARDINAL'}, {'entity': '2015', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '2017', 'category': 'CARDINAL'}, {'entity': '230', 'category': 'CARDINAL'}, {'entity': '210.0', 'category': 'CARDINAL'}, {'entity': '60.5', 'category': 'CARDINAL'}, {'entity': '235.0', 'category': 'CARDINAL'}, {'entity': '131.4', 'category': 'CARDINAL'}, {'entity': '48.1', 'category': 'CARDINAL'}, {'entity': '31', 'category': 'CARDINAL'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': '625.4', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  11\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVpCnroYe2gX9dFfbCHhFnVAJm6i\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701567882,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#625.4#894.8#1,288.7#393.9#82#2.7#95.0#37.0#2017#2016#1,895.9#1,877.2#18.7#1,877.2#1,761.3#115.9#1,910.0#32.8#126.0#94.6#42.6#89.1#158.0#36.5#32.2#1,549.4#1,562.2#12.8#1,562.2#1,477.4#84.8#81.7#83.2#83.2#83.9#23.3#25.0#1.7#25.0#21.8#3.2#20.5#22.0#1.5#22.0#12.9#9.1#43.8#47.0#3.2#47.0#34.7#12.3#2.3#2.5#2.5#2.0#1.2#1.3#1.3#1.2#22#27\\n\\nDATE#2018#December 31, 2018#September 10, 2018#2019#2017#2016#Year Ended December 31#Year Ended December 31\\n\\nEVENT#Industrial bond transaction#Retirement Benefits#Cyber Security#Net Sales#Revenue recognition guidance\\n\\nFAC#Tax-qualified defined benefit pension plan\\n\\nGPE#U.S.\\n\\nLAW#CAS#pension funding rules\\n\\nMONEY#$625.4 million#$894.8 million#$1,288.7 million#$393.9 million#2.7 million treasury stock#$95.0 million#$37.0 million#$1,895.9#$1,877.2#$18.7#$1,877.2#$1,761.3#$115.9#$1,910.0 million#$32.8 million#$126.0 million#$94.6 million#$42.6 million#1,549.4#$1,562.2\\n\\nORG#Aerojet Rocketdyne#Coleman Aerospace#Commercial Crew Development#Atlas V program#RS-25#SLS#the THAAD#Standard Missile#RS-68#Executive Chairman\\n\\nPERCENT#82%#81.7%#83.2%\\n\\nPERSON#\\n\\nPRODUCT#Standard Missile#PAC-3#RS-25#SLS#Commercial Crew Development#Atlas V\\n\\nWORK_OF_ART#Net sales:\\t$\\t1,895.9\\t\\t \\t$\\t1,877.2}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2469,\n",
      "    \"completion_tokens\": 579,\n",
      "    \"total_tokens\": 3048\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': '2018', 'category': 'DATE'}, {'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': 'September 10, 2018', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': 'Industrial bond transaction', 'category': 'EVENT'}, {'entity': 'Retirement Benefits', 'category': 'EVENT'}, {'entity': 'Cyber Security', 'category': 'EVENT'}, {'entity': 'Net Sales', 'category': 'EVENT'}, {'entity': 'Revenue recognition guidance', 'category': 'EVENT'}, {'entity': 'Tax-qualified defined benefit pension plan', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'CAS', 'category': 'LAW'}, {'entity': 'pension funding rules', 'category': 'LAW'}, {'entity': '$625.4 million', 'category': 'MONEY'}, {'entity': '$894.8 million', 'category': 'MONEY'}, {'entity': '$1,288.7 million', 'category': 'MONEY'}, {'entity': '$393.9 million', 'category': 'MONEY'}, {'entity': '2.7 million treasury stock', 'category': 'MONEY'}, {'entity': '$95.0 million', 'category': 'MONEY'}, {'entity': '$37.0 million', 'category': 'MONEY'}, {'entity': '$1,895.9', 'category': 'MONEY'}, {'entity': '$1,877.2', 'category': 'MONEY'}, {'entity': '$18.7', 'category': 'MONEY'}, {'entity': '$1,877.2', 'category': 'MONEY'}, {'entity': '$1,761.3', 'category': 'MONEY'}, {'entity': '$115.9', 'category': 'MONEY'}, {'entity': '$1,910.0 million', 'category': 'MONEY'}, {'entity': '$32.8 million', 'category': 'MONEY'}, {'entity': '$126.0 million', 'category': 'MONEY'}, {'entity': '$94.6 million', 'category': 'MONEY'}, {'entity': '$42.6 million', 'category': 'MONEY'}, {'entity': '1,549.4', 'category': 'MONEY'}, {'entity': '$1,562.2', 'category': 'MONEY'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': 'Coleman Aerospace', 'category': 'ORG'}, {'entity': 'Commercial Crew Development', 'category': 'ORG'}, {'entity': 'Atlas V program', 'category': 'ORG'}, {'entity': 'RS-25', 'category': 'ORG'}, {'entity': 'SLS', 'category': 'ORG'}, {'entity': 'the THAAD', 'category': 'ORG'}, {'entity': 'Standard Missile', 'category': 'ORG'}, {'entity': 'RS-68', 'category': 'ORG'}, {'entity': 'Executive Chairman', 'category': 'ORG'}, {'entity': '82%', 'category': 'PERCENT'}, {'entity': '81.7%', 'category': 'PERCENT'}, {'entity': '83.2%', 'category': 'PERCENT'}, {'entity': 'Standard Missile', 'category': 'PRODUCT'}, {'entity': 'PAC-3', 'category': 'PRODUCT'}, {'entity': 'RS-25', 'category': 'PRODUCT'}, {'entity': 'SLS', 'category': 'PRODUCT'}, {'entity': 'Commercial Crew Development', 'category': 'PRODUCT'}, {'entity': 'Atlas V', 'category': 'PRODUCT'}, {'entity': 'Net sales\\t$\\t1', 'category': 'WORK_OF_ART'}, {'entity': '895.9\\t\\t \\t$\\t1', 'category': 'WORK_OF_ART'}, {'entity': '877.2', 'category': 'WORK_OF_ART'}, {'entity': '625.4', 'category': 'CARDINAL'}, {'entity': '894.8', 'category': 'CARDINAL'}, {'entity': '1,288.7', 'category': 'CARDINAL'}, {'entity': '393.9', 'category': 'CARDINAL'}, {'entity': '82', 'category': 'CARDINAL'}, {'entity': '2.7', 'category': 'CARDINAL'}, {'entity': '95.0', 'category': 'CARDINAL'}, {'entity': '37.0', 'category': 'CARDINAL'}, {'entity': '2017', 'category': 'CARDINAL'}, {'entity': '2016', 'category': 'CARDINAL'}, {'entity': '1,895.9', 'category': 'CARDINAL'}, {'entity': '1,877.2', 'category': 'CARDINAL'}, {'entity': '18.7', 'category': 'CARDINAL'}, {'entity': '1,877.2', 'category': 'CARDINAL'}, {'entity': '1,761.3', 'category': 'CARDINAL'}, {'entity': '115.9', 'category': 'CARDINAL'}, {'entity': '1,910.0', 'category': 'CARDINAL'}, {'entity': '32.8', 'category': 'CARDINAL'}, {'entity': '126.0', 'category': 'CARDINAL'}, {'entity': '94.6', 'category': 'CARDINAL'}, {'entity': '42.6', 'category': 'CARDINAL'}, {'entity': '89.1', 'category': 'CARDINAL'}, {'entity': '158.0', 'category': 'CARDINAL'}, {'entity': '36.5', 'category': 'CARDINAL'}, {'entity': '32.2', 'category': 'CARDINAL'}, {'entity': '1,549.4', 'category': 'CARDINAL'}, {'entity': '1,562.2', 'category': 'CARDINAL'}, {'entity': '12.8', 'category': 'CARDINAL'}, {'entity': '1,562.2', 'category': 'CARDINAL'}, {'entity': '1,477.4', 'category': 'CARDINAL'}, {'entity': '84.8', 'category': 'CARDINAL'}, {'entity': '81.7', 'category': 'CARDINAL'}, {'entity': '83.2', 'category': 'CARDINAL'}, {'entity': '83.2', 'category': 'CARDINAL'}, {'entity': '83.9', 'category': 'CARDINAL'}, {'entity': '23.3', 'category': 'CARDINAL'}, {'entity': '25.0', 'category': 'CARDINAL'}, {'entity': '1.7', 'category': 'CARDINAL'}, {'entity': '25.0', 'category': 'CARDINAL'}, {'entity': '21.8', 'category': 'CARDINAL'}, {'entity': '3.2', 'category': 'CARDINAL'}, {'entity': '20.5', 'category': 'CARDINAL'}, {'entity': '22.0', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '22.0', 'category': 'CARDINAL'}, {'entity': '12.9', 'category': 'CARDINAL'}, {'entity': '9.1', 'category': 'CARDINAL'}, {'entity': '43.8', 'category': 'CARDINAL'}, {'entity': '47.0', 'category': 'CARDINAL'}, {'entity': '3.2', 'category': 'CARDINAL'}, {'entity': '47.0', 'category': 'CARDINAL'}, {'entity': '34.7', 'category': 'CARDINAL'}, {'entity': '12.3', 'category': 'CARDINAL'}, {'entity': '2.3', 'category': 'CARDINAL'}, {'entity': '2.5', 'category': 'CARDINAL'}, {'entity': '2.5', 'category': 'CARDINAL'}, {'entity': '2.0', 'category': 'CARDINAL'}, {'entity': '1.2', 'category': 'CARDINAL'}, {'entity': '1.3', 'category': 'CARDINAL'}, {'entity': '1.3', 'category': 'CARDINAL'}, {'entity': '1.2', 'category': 'CARDINAL'}, {'entity': '22', 'category': 'CARDINAL'}, {'entity': '27', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  11\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVptuWht3TyIdvdBTsAMslpiVYEz\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701567925,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#2018#2017#2016#56.1#56.7#0.6#56.7#49.6#7.1#13.7#13.7#13.3#0.4#2.5#2.2#0.3#2.2#2.0#0.2#72.3#72.6#0.3#72.6#64.9#2.0#43.0#40.2#7.9#48.1#7.9#54.3#46.4#35.5#10.1#13.0#0.3#105.344#34.1#24.6#10.0#3.5#6.5#25.5#22.4#3.1#8.9#8.5#0.4#34.4#30.9#3.5#3.82#4.52#32.5#1.6#3.82#5.8#51.3#96.1#11.2#27.2#21#110.6#35.0#35#21#64.6#74.4#36.2#127.7#31#1\\n\\nDATE#December 31\\n\\nEVENT#change#change\\n\\nMONEY#$56.1 million#$56.7 million#$7.1 million\\n\\nORG#CIP#U.S. government#Global Settlement#SEC#Senior Credit Facility#Coleman Aerospace#L3 Technologies, Inc.#Senior Credit Facility#Tax Cuts and Jobs Act#Tax Act\\n\\nPERSON#Environmental Matters#Environmental Matters\\n\\nPRODUCT#Senior Secured Notes\\n\\nWORK_OF_ART#depreciation and amortization expense#Senior Credit Facility#Senior Credit Facility}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2766,\n",
      "    \"completion_tokens\": 387,\n",
      "    \"total_tokens\": 3153\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31', 'category': 'DATE'}, {'entity': 'change', 'category': 'EVENT'}, {'entity': 'change', 'category': 'EVENT'}, {'entity': '$56.1 million', 'category': 'MONEY'}, {'entity': '$56.7 million', 'category': 'MONEY'}, {'entity': '$7.1 million', 'category': 'MONEY'}, {'entity': 'CIP', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'Global Settlement', 'category': 'ORG'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': 'Coleman Aerospace', 'category': 'ORG'}, {'entity': 'L3 Technologies, Inc.', 'category': 'ORG'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': 'Tax Cuts and Jobs Act', 'category': 'ORG'}, {'entity': 'Tax Act', 'category': 'ORG'}, {'entity': 'Environmental Matters', 'category': 'PERSON'}, {'entity': 'Environmental Matters', 'category': 'PERSON'}, {'entity': 'Senior Secured Notes', 'category': 'PRODUCT'}, {'entity': 'depreciation and amortization expense', 'category': 'WORK_OF_ART'}, {'entity': 'Senior Credit Facility', 'category': 'WORK_OF_ART'}, {'entity': 'Senior Credit Facility', 'category': 'WORK_OF_ART'}, {'entity': '2018', 'category': 'CARDINAL'}, {'entity': '2017', 'category': 'CARDINAL'}, {'entity': '2016', 'category': 'CARDINAL'}, {'entity': '56.1', 'category': 'CARDINAL'}, {'entity': '56.7', 'category': 'CARDINAL'}, {'entity': '0.6', 'category': 'CARDINAL'}, {'entity': '56.7', 'category': 'CARDINAL'}, {'entity': '49.6', 'category': 'CARDINAL'}, {'entity': '7.1', 'category': 'CARDINAL'}, {'entity': '13.7', 'category': 'CARDINAL'}, {'entity': '13.7', 'category': 'CARDINAL'}, {'entity': '13.3', 'category': 'CARDINAL'}, {'entity': '0.4', 'category': 'CARDINAL'}, {'entity': '2.5', 'category': 'CARDINAL'}, {'entity': '2.2', 'category': 'CARDINAL'}, {'entity': '0.3', 'category': 'CARDINAL'}, {'entity': '2.2', 'category': 'CARDINAL'}, {'entity': '2.0', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '72.3', 'category': 'CARDINAL'}, {'entity': '72.6', 'category': 'CARDINAL'}, {'entity': '0.3', 'category': 'CARDINAL'}, {'entity': '72.6', 'category': 'CARDINAL'}, {'entity': '64.9', 'category': 'CARDINAL'}, {'entity': '2.0', 'category': 'CARDINAL'}, {'entity': '43.0', 'category': 'CARDINAL'}, {'entity': '40.2', 'category': 'CARDINAL'}, {'entity': '7.9', 'category': 'CARDINAL'}, {'entity': '48.1', 'category': 'CARDINAL'}, {'entity': '7.9', 'category': 'CARDINAL'}, {'entity': '54.3', 'category': 'CARDINAL'}, {'entity': '46.4', 'category': 'CARDINAL'}, {'entity': '35.5', 'category': 'CARDINAL'}, {'entity': '10.1', 'category': 'CARDINAL'}, {'entity': '13.0', 'category': 'CARDINAL'}, {'entity': '0.3', 'category': 'CARDINAL'}, {'entity': '105.344', 'category': 'CARDINAL'}, {'entity': '34.1', 'category': 'CARDINAL'}, {'entity': '24.6', 'category': 'CARDINAL'}, {'entity': '10.0', 'category': 'CARDINAL'}, {'entity': '3.5', 'category': 'CARDINAL'}, {'entity': '6.5', 'category': 'CARDINAL'}, {'entity': '25.5', 'category': 'CARDINAL'}, {'entity': '22.4', 'category': 'CARDINAL'}, {'entity': '3.1', 'category': 'CARDINAL'}, {'entity': '8.9', 'category': 'CARDINAL'}, {'entity': '8.5', 'category': 'CARDINAL'}, {'entity': '0.4', 'category': 'CARDINAL'}, {'entity': '34.4', 'category': 'CARDINAL'}, {'entity': '30.9', 'category': 'CARDINAL'}, {'entity': '3.5', 'category': 'CARDINAL'}, {'entity': '3.82', 'category': 'CARDINAL'}, {'entity': '4.52', 'category': 'CARDINAL'}, {'entity': '32.5', 'category': 'CARDINAL'}, {'entity': '1.6', 'category': 'CARDINAL'}, {'entity': '3.82', 'category': 'CARDINAL'}, {'entity': '5.8', 'category': 'CARDINAL'}, {'entity': '51.3', 'category': 'CARDINAL'}, {'entity': '96.1', 'category': 'CARDINAL'}, {'entity': '11.2', 'category': 'CARDINAL'}, {'entity': '27.2', 'category': 'CARDINAL'}, {'entity': '21', 'category': 'CARDINAL'}, {'entity': '110.6', 'category': 'CARDINAL'}, {'entity': '35.0', 'category': 'CARDINAL'}, {'entity': '35', 'category': 'CARDINAL'}, {'entity': '21', 'category': 'CARDINAL'}, {'entity': '64.6', 'category': 'CARDINAL'}, {'entity': '74.4', 'category': 'CARDINAL'}, {'entity': '36.2', 'category': 'CARDINAL'}, {'entity': '127.7', 'category': 'CARDINAL'}, {'entity': '31', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  11\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVqUk5kCSLA3XMyxV5LYIHTsnhTb\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701567962,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#2018#19.8#31#2018#5.9#26#2018#2017#2017#2016#50.9#59.1#8.2#59.1#66.0#6.9#60.1#49.5#10.6#49.5#56.1#6.6#0.1#0.1#66.9#63.7#3.2#63.7#60.1#3.6#57.6#73.2#15.6#73.2#68.9#4.3#2018#2017#17.3#2017#2016#116.9#264.6#177.9#86.7#177.9#143.3#34.6#14.0#9.5#9.5#8.2#12.4#10.7#10.7#10.4#233.4#200.4#33.0#200.4#182.1#18.3#37.2#7.5#44.7#7.5#18.3#10.8#6.0#17.0#11.0#17.0#20.5#3.5#2.0#2.0#2.0#264.6#177.9#86.7#177.9#143.3#34.6#1,888.1#1,870.8#2018#43.0#2018#31.4#2017#126.0#94.6#42.6#2018#89.1#2018#59.1#37.2#2017#158.0#36.5#32.2#2016#2017 \\n\\nDATE#December 31, 2018#December 31, 2018#Year Ended December 31,#Year Ended December 31,#January 1, 2018#December 31,#Year Ended December 31,#Year Ended December 31,#January 1, 2018#December 31\\n\\nEVENT#Global Settlement\\n\\nGPE#U.S.\\n\\nMONEY#$19.8 million#$5.9 million#$26 million#$50.9$59.1#$60.1$49.5$57.6$73.2#$1,888.1#$1,870.8\\n\\nORG#PAC-3#Atlas V#Atlas V#Commercial Crew Development#RS-68#Aerospace and Defense#Commercial Crew Development#THAAD#Aerojet Rocketdyne#Coleman Aerospace\\n\\nPERCENT#14.0%#9.5%#9.5%#8.2%#12.4%#10.7%#10.7%#10.4%\\n\\nPRODUCT#GAAP/CAS\\n\\nTIME#53 weeks#fourth quarter#52 weeks}\\n\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2575,\n",
      "    \"completion_tokens\": 637,\n",
      "    \"total_tokens\": 3212\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': 'Year Ended December 31,', 'category': 'DATE'}, {'entity': 'Year Ended December 31,', 'category': 'DATE'}, {'entity': 'January 1, 2018', 'category': 'DATE'}, {'entity': 'December 31,', 'category': 'DATE'}, {'entity': 'Year Ended December 31,', 'category': 'DATE'}, {'entity': 'Year Ended December 31,', 'category': 'DATE'}, {'entity': 'January 1, 2018', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': 'Global Settlement', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '$19.8 million', 'category': 'MONEY'}, {'entity': '$5.9 million', 'category': 'MONEY'}, {'entity': '$26 million', 'category': 'MONEY'}, {'entity': '$50.9$59.1', 'category': 'MONEY'}, {'entity': '$60.1$49.5$57.6$73.2', 'category': 'MONEY'}, {'entity': '$1,888.1', 'category': 'MONEY'}, {'entity': '$1,870.8', 'category': 'MONEY'}, {'entity': 'PAC-3', 'category': 'ORG'}, {'entity': 'Atlas V', 'category': 'ORG'}, {'entity': 'Atlas V', 'category': 'ORG'}, {'entity': 'Commercial Crew Development', 'category': 'ORG'}, {'entity': 'RS-68', 'category': 'ORG'}, {'entity': 'Aerospace and Defense', 'category': 'ORG'}, {'entity': 'Commercial Crew Development', 'category': 'ORG'}, {'entity': 'THAAD', 'category': 'ORG'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': 'Coleman Aerospace', 'category': 'ORG'}, {'entity': '14.0%', 'category': 'PERCENT'}, {'entity': '9.5%', 'category': 'PERCENT'}, {'entity': '9.5%', 'category': 'PERCENT'}, {'entity': '8.2%', 'category': 'PERCENT'}, {'entity': '12.4%', 'category': 'PERCENT'}, {'entity': '10.7%', 'category': 'PERCENT'}, {'entity': '10.7%', 'category': 'PERCENT'}, {'entity': '10.4%', 'category': 'PERCENT'}, {'entity': 'GAAP/CAS', 'category': 'PRODUCT'}, {'entity': '53 weeks', 'category': 'TIME'}, {'entity': 'fourth quarter', 'category': 'TIME'}, {'entity': '52 weeks', 'category': 'TIME'}, {'entity': '2018', 'category': 'CARDINAL'}, {'entity': '19.8', 'category': 'CARDINAL'}, {'entity': '31', 'category': 'CARDINAL'}, {'entity': '2018', 'category': 'CARDINAL'}, {'entity': '5.9', 'category': 'CARDINAL'}, {'entity': '26', 'category': 'CARDINAL'}, {'entity': '2018', 'category': 'CARDINAL'}, {'entity': '2017', 'category': 'CARDINAL'}, {'entity': '2017', 'category': 'CARDINAL'}, {'entity': '2016', 'category': 'CARDINAL'}, {'entity': '50.9', 'category': 'CARDINAL'}, {'entity': '59.1', 'category': 'CARDINAL'}, {'entity': '8.2', 'category': 'CARDINAL'}, {'entity': '59.1', 'category': 'CARDINAL'}, {'entity': '66.0', 'category': 'CARDINAL'}, {'entity': '6.9', 'category': 'CARDINAL'}, {'entity': '60.1', 'category': 'CARDINAL'}, {'entity': '49.5', 'category': 'CARDINAL'}, {'entity': '10.6', 'category': 'CARDINAL'}, {'entity': '49.5', 'category': 'CARDINAL'}, {'entity': '56.1', 'category': 'CARDINAL'}, {'entity': '6.6', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '66.9', 'category': 'CARDINAL'}, {'entity': '63.7', 'category': 'CARDINAL'}, {'entity': '3.2', 'category': 'CARDINAL'}, {'entity': '63.7', 'category': 'CARDINAL'}, {'entity': '60.1', 'category': 'CARDINAL'}, {'entity': '3.6', 'category': 'CARDINAL'}, {'entity': '57.6', 'category': 'CARDINAL'}, {'entity': '73.2', 'category': 'CARDINAL'}, {'entity': '15.6', 'category': 'CARDINAL'}, {'entity': '73.2', 'category': 'CARDINAL'}, {'entity': '68.9', 'category': 'CARDINAL'}, {'entity': '4.3', 'category': 'CARDINAL'}, {'entity': '2018', 'category': 'CARDINAL'}, {'entity': '2017', 'category': 'CARDINAL'}, {'entity': '17.3', 'category': 'CARDINAL'}, {'entity': '2017', 'category': 'CARDINAL'}, {'entity': '2016', 'category': 'CARDINAL'}, {'entity': '116.9', 'category': 'CARDINAL'}, {'entity': '264.6', 'category': 'CARDINAL'}, {'entity': '177.9', 'category': 'CARDINAL'}, {'entity': '86.7', 'category': 'CARDINAL'}, {'entity': '177.9', 'category': 'CARDINAL'}, {'entity': '143.3', 'category': 'CARDINAL'}, {'entity': '34.6', 'category': 'CARDINAL'}, {'entity': '14.0', 'category': 'CARDINAL'}, {'entity': '9.5', 'category': 'CARDINAL'}, {'entity': '9.5', 'category': 'CARDINAL'}, {'entity': '8.2', 'category': 'CARDINAL'}, {'entity': '12.4', 'category': 'CARDINAL'}, {'entity': '10.7', 'category': 'CARDINAL'}, {'entity': '10.7', 'category': 'CARDINAL'}, {'entity': '10.4', 'category': 'CARDINAL'}, {'entity': '233.4', 'category': 'CARDINAL'}, {'entity': '200.4', 'category': 'CARDINAL'}, {'entity': '33.0', 'category': 'CARDINAL'}, {'entity': '200.4', 'category': 'CARDINAL'}, {'entity': '182.1', 'category': 'CARDINAL'}, {'entity': '18.3', 'category': 'CARDINAL'}, {'entity': '37.2', 'category': 'CARDINAL'}, {'entity': '7.5', 'category': 'CARDINAL'}, {'entity': '44.7', 'category': 'CARDINAL'}, {'entity': '7.5', 'category': 'CARDINAL'}, {'entity': '18.3', 'category': 'CARDINAL'}, {'entity': '10.8', 'category': 'CARDINAL'}, {'entity': '6.0', 'category': 'CARDINAL'}, {'entity': '17.0', 'category': 'CARDINAL'}, {'entity': '11.0', 'category': 'CARDINAL'}, {'entity': '17.0', 'category': 'CARDINAL'}, {'entity': '20.5', 'category': 'CARDINAL'}, {'entity': '3.5', 'category': 'CARDINAL'}, {'entity': '2.0', 'category': 'CARDINAL'}, {'entity': '2.0', 'category': 'CARDINAL'}, {'entity': '2.0', 'category': 'CARDINAL'}, {'entity': '264.6', 'category': 'CARDINAL'}, {'entity': '177.9', 'category': 'CARDINAL'}, {'entity': '86.7', 'category': 'CARDINAL'}, {'entity': '177.9', 'category': 'CARDINAL'}, {'entity': '143.3', 'category': 'CARDINAL'}, {'entity': '34.6', 'category': 'CARDINAL'}, {'entity': '1,888.1', 'category': 'CARDINAL'}, {'entity': '1,870.8', 'category': 'CARDINAL'}, {'entity': '2018', 'category': 'CARDINAL'}, {'entity': '43.0', 'category': 'CARDINAL'}, {'entity': '2018', 'category': 'CARDINAL'}, {'entity': '31.4', 'category': 'CARDINAL'}, {'entity': '2017', 'category': 'CARDINAL'}, {'entity': '126.0', 'category': 'CARDINAL'}, {'entity': '94.6', 'category': 'CARDINAL'}, {'entity': '42.6', 'category': 'CARDINAL'}, {'entity': '2018', 'category': 'CARDINAL'}, {'entity': '89.1', 'category': 'CARDINAL'}, {'entity': '2018', 'category': 'CARDINAL'}, {'entity': '59.1', 'category': 'CARDINAL'}, {'entity': '37.2', 'category': 'CARDINAL'}, {'entity': '2017', 'category': 'CARDINAL'}, {'entity': '158.0', 'category': 'CARDINAL'}, {'entity': '36.5', 'category': 'CARDINAL'}, {'entity': '32.2', 'category': 'CARDINAL'}, {'entity': '2016', 'category': 'CARDINAL'}, {'entity': '2017', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  11\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVrFPmWaPudtfNk8g2wpSc9Anqww\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701568009,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#7.8#6.4#1.4#6.4#7.4#(1.0#2.8#2.5#0.3#2.5#4.3#(1.8#1.4#57#2017#2016#4.1#45%#1.8#29%#26#4.1#4.6#0.6#4.1#4.6#137.3#(9.2#18.0#34.4#30.9#32.5#10.0#3.5#0.6#51.3#96.1#11.2#72.3#72.6#64.9#57.6#73.2#68.9#38.2#36.2#29.5#0.2#1.0#34.5#304.9#222.9#199.9#16.1#11.9#11.3#7.2#0.5#1.0#137.3#(9.2#18.0#57.6#73.2#68.9#38.2#36.2#29.5#0.2#1.0#34.5#5.4#15.4#34.0#151.5#76.0#57.9#1.75#(0.13#0.27#0.18#1.15#0.54#1.93#1.02#0.81#76.8#73.0#65.7#0.1#7.1#76.8#73.1#72.8#252.7#212.8#158.7#43.2#29.4#47.6#209.5#183.4#111.1\\n\\nDATE#2018#2017#2016#December 31, 2018#twelve months#the next twelve months#the following twelve months#December 31, 2017#Year Ended December 31, 2018#2017#2016#Year Ended December 31, 2018#2017#2016#December 31, 2018\\n\\nMONEY#$1.4 million#$4.1 billion#$1.8 billion#$4.1 billion#$4.6 billion#$0.6 billion#$137.3#$9.2#$18.0#$34.4#$30.9#$32.5#$10.0#$3.5#$0.6#$51.3#$96.1#$11.2#$72.3#$72.6#$64.9#$57.6#$73.2#$68.9#$38.2#$36.2#$29.5#$0.2#$1.0#$34.5#$304.9#$222.9#$199.9#$137.3#$9.2#$18.0#$57.6#$73.2#$68.9#$38.2#$36.2#$29.5#$0.2#$1.0#$34.5#$5.4#$15.4#$34.0#$151.5#$76.0#$57.9#$1.75#$0.13#$0.27#$0.18#$1.15#$0.54#$1.93#$1.02#$0.81#$252.7#$212.8#$158.7#$43.2#$29.4#$47.6#$209.5#$183.4#$111.1\\n\\nORG#Net#Segment performance#the Sacramento Land#rental#New Revenue#Funded backlog#Unfunded backlog#GAAP#Adjusted EBITDAP#Adjusted Net Income#Adjusted EPS#GAAP#Adjusted Net Income#Adjusted EPS#GAAP#Net income (##GAAP#CASH Flow#GAAP#Hazardous\\n\\nPERCENT#45%#29%#26%#16.1%#11.9 %#11.3%#7.2%#(0.5%)#1.0%\\n\\nPERSON#Aerojet Rocketdyne\\n\\nPRODUCT#Net sales#segment performance#backlog#income#net sales#net income#Interest expense#interest income#Depreciation and amortization#retirement benefits#net income#Adjusted EBITDAP#financial measure#Free Cash Flow#cash flow from operating activities#residual cash flow\\n\\nQUANTITY#57 acres\\n\\nTIME#twelve months}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2642,\n",
      "    \"completion_tokens\": 978,\n",
      "    \"total_tokens\": 3620\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': '2018', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': 'twelve months', 'category': 'DATE'}, {'entity': 'the next twelve months', 'category': 'DATE'}, {'entity': 'the following twelve months', 'category': 'DATE'}, {'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2018', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2018', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': '$1.4 million', 'category': 'MONEY'}, {'entity': '$4.1 billion', 'category': 'MONEY'}, {'entity': '$1.8 billion', 'category': 'MONEY'}, {'entity': '$4.1 billion', 'category': 'MONEY'}, {'entity': '$4.6 billion', 'category': 'MONEY'}, {'entity': '$0.6 billion', 'category': 'MONEY'}, {'entity': '$137.3', 'category': 'MONEY'}, {'entity': '$9.2', 'category': 'MONEY'}, {'entity': '$18.0', 'category': 'MONEY'}, {'entity': '$34.4', 'category': 'MONEY'}, {'entity': '$30.9', 'category': 'MONEY'}, {'entity': '$32.5', 'category': 'MONEY'}, {'entity': '$10.0', 'category': 'MONEY'}, {'entity': '$3.5', 'category': 'MONEY'}, {'entity': '$0.6', 'category': 'MONEY'}, {'entity': '$51.3', 'category': 'MONEY'}, {'entity': '$96.1', 'category': 'MONEY'}, {'entity': '$11.2', 'category': 'MONEY'}, {'entity': '$72.3', 'category': 'MONEY'}, {'entity': '$72.6', 'category': 'MONEY'}, {'entity': '$64.9', 'category': 'MONEY'}, {'entity': '$57.6', 'category': 'MONEY'}, {'entity': '$73.2', 'category': 'MONEY'}, {'entity': '$68.9', 'category': 'MONEY'}, {'entity': '$38.2', 'category': 'MONEY'}, {'entity': '$36.2', 'category': 'MONEY'}, {'entity': '$29.5', 'category': 'MONEY'}, {'entity': '$0.2', 'category': 'MONEY'}, {'entity': '$1.0', 'category': 'MONEY'}, {'entity': '$34.5', 'category': 'MONEY'}, {'entity': '$304.9', 'category': 'MONEY'}, {'entity': '$222.9', 'category': 'MONEY'}, {'entity': '$199.9', 'category': 'MONEY'}, {'entity': '$137.3', 'category': 'MONEY'}, {'entity': '$9.2', 'category': 'MONEY'}, {'entity': '$18.0', 'category': 'MONEY'}, {'entity': '$57.6', 'category': 'MONEY'}, {'entity': '$73.2', 'category': 'MONEY'}, {'entity': '$68.9', 'category': 'MONEY'}, {'entity': '$38.2', 'category': 'MONEY'}, {'entity': '$36.2', 'category': 'MONEY'}, {'entity': '$29.5', 'category': 'MONEY'}, {'entity': '$0.2', 'category': 'MONEY'}, {'entity': '$1.0', 'category': 'MONEY'}, {'entity': '$34.5', 'category': 'MONEY'}, {'entity': '$5.4', 'category': 'MONEY'}, {'entity': '$15.4', 'category': 'MONEY'}, {'entity': '$34.0', 'category': 'MONEY'}, {'entity': '$151.5', 'category': 'MONEY'}, {'entity': '$76.0', 'category': 'MONEY'}, {'entity': '$57.9', 'category': 'MONEY'}, {'entity': '$1.75', 'category': 'MONEY'}, {'entity': '$0.13', 'category': 'MONEY'}, {'entity': '$0.27', 'category': 'MONEY'}, {'entity': '$0.18', 'category': 'MONEY'}, {'entity': '$1.15', 'category': 'MONEY'}, {'entity': '$0.54', 'category': 'MONEY'}, {'entity': '$1.93', 'category': 'MONEY'}, {'entity': '$1.02', 'category': 'MONEY'}, {'entity': '$0.81', 'category': 'MONEY'}, {'entity': '$252.7', 'category': 'MONEY'}, {'entity': '$212.8', 'category': 'MONEY'}, {'entity': '$158.7', 'category': 'MONEY'}, {'entity': '$43.2', 'category': 'MONEY'}, {'entity': '$29.4', 'category': 'MONEY'}, {'entity': '$47.6', 'category': 'MONEY'}, {'entity': '$209.5', 'category': 'MONEY'}, {'entity': '$183.4', 'category': 'MONEY'}, {'entity': '$111.1', 'category': 'MONEY'}, {'entity': 'Net', 'category': 'ORG'}, {'entity': 'Segment performance', 'category': 'ORG'}, {'entity': 'the Sacramento Land', 'category': 'ORG'}, {'entity': 'rental', 'category': 'ORG'}, {'entity': 'New Revenue', 'category': 'ORG'}, {'entity': 'Funded backlog', 'category': 'ORG'}, {'entity': 'Unfunded backlog', 'category': 'ORG'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': 'Adjusted EBITDAP', 'category': 'ORG'}, {'entity': 'Adjusted Net Income', 'category': 'ORG'}, {'entity': 'Adjusted EPS', 'category': 'ORG'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': 'Adjusted Net Income', 'category': 'ORG'}, {'entity': 'Adjusted EPS', 'category': 'ORG'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': 'Net income', 'category': 'ORG'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': 'CASH Flow', 'category': 'ORG'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': 'Hazardous', 'category': 'ORG'}, {'entity': '45%', 'category': 'PERCENT'}, {'entity': '29%', 'category': 'PERCENT'}, {'entity': '26%', 'category': 'PERCENT'}, {'entity': '16.1%', 'category': 'PERCENT'}, {'entity': '11.9 %', 'category': 'PERCENT'}, {'entity': '11.3%', 'category': 'PERCENT'}, {'entity': '7.2%', 'category': 'PERCENT'}, {'entity': '0.5%', 'category': 'PERCENT'}, {'entity': '1.0%', 'category': 'PERCENT'}, {'entity': 'Aerojet Rocketdyne', 'category': 'PERSON'}, {'entity': 'Net sales', 'category': 'PRODUCT'}, {'entity': 'segment performance', 'category': 'PRODUCT'}, {'entity': 'backlog', 'category': 'PRODUCT'}, {'entity': 'income', 'category': 'PRODUCT'}, {'entity': 'net sales', 'category': 'PRODUCT'}, {'entity': 'net income', 'category': 'PRODUCT'}, {'entity': 'Interest expense', 'category': 'PRODUCT'}, {'entity': 'interest income', 'category': 'PRODUCT'}, {'entity': 'Depreciation and amortization', 'category': 'PRODUCT'}, {'entity': 'retirement benefits', 'category': 'PRODUCT'}, {'entity': 'net income', 'category': 'PRODUCT'}, {'entity': 'Adjusted EBITDAP', 'category': 'PRODUCT'}, {'entity': 'financial measure', 'category': 'PRODUCT'}, {'entity': 'Free Cash Flow', 'category': 'PRODUCT'}, {'entity': 'cash flow from operating activities', 'category': 'PRODUCT'}, {'entity': 'residual cash flow', 'category': 'PRODUCT'}, {'entity': '57 acres', 'category': 'QUANTITY'}, {'entity': 'twelve months', 'category': 'TIME'}, {'entity': '7.8', 'category': 'CARDINAL'}, {'entity': '6.4', 'category': 'CARDINAL'}, {'entity': '1.4', 'category': 'CARDINAL'}, {'entity': '6.4', 'category': 'CARDINAL'}, {'entity': '7.4', 'category': 'CARDINAL'}, {'entity': '1.0', 'category': 'CARDINAL'}, {'entity': '2.8', 'category': 'CARDINAL'}, {'entity': '2.5', 'category': 'CARDINAL'}, {'entity': '0.3', 'category': 'CARDINAL'}, {'entity': '2.5', 'category': 'CARDINAL'}, {'entity': '4.3', 'category': 'CARDINAL'}, {'entity': '1.8', 'category': 'CARDINAL'}, {'entity': '1.4', 'category': 'CARDINAL'}, {'entity': '57', 'category': 'CARDINAL'}, {'entity': '2017', 'category': 'CARDINAL'}, {'entity': '2016', 'category': 'CARDINAL'}, {'entity': '4.1', 'category': 'CARDINAL'}, {'entity': '45%', 'category': 'CARDINAL'}, {'entity': '1.8', 'category': 'CARDINAL'}, {'entity': '29%', 'category': 'CARDINAL'}, {'entity': '26', 'category': 'CARDINAL'}, {'entity': '4.1', 'category': 'CARDINAL'}, {'entity': '4.6', 'category': 'CARDINAL'}, {'entity': '0.6', 'category': 'CARDINAL'}, {'entity': '4.1', 'category': 'CARDINAL'}, {'entity': '4.6', 'category': 'CARDINAL'}, {'entity': '137.3', 'category': 'CARDINAL'}, {'entity': '9.2', 'category': 'CARDINAL'}, {'entity': '18.0', 'category': 'CARDINAL'}, {'entity': '34.4', 'category': 'CARDINAL'}, {'entity': '30.9', 'category': 'CARDINAL'}, {'entity': '32.5', 'category': 'CARDINAL'}, {'entity': '10.0', 'category': 'CARDINAL'}, {'entity': '3.5', 'category': 'CARDINAL'}, {'entity': '0.6', 'category': 'CARDINAL'}, {'entity': '51.3', 'category': 'CARDINAL'}, {'entity': '96.1', 'category': 'CARDINAL'}, {'entity': '11.2', 'category': 'CARDINAL'}, {'entity': '72.3', 'category': 'CARDINAL'}, {'entity': '72.6', 'category': 'CARDINAL'}, {'entity': '64.9', 'category': 'CARDINAL'}, {'entity': '57.6', 'category': 'CARDINAL'}, {'entity': '73.2', 'category': 'CARDINAL'}, {'entity': '68.9', 'category': 'CARDINAL'}, {'entity': '38.2', 'category': 'CARDINAL'}, {'entity': '36.2', 'category': 'CARDINAL'}, {'entity': '29.5', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '1.0', 'category': 'CARDINAL'}, {'entity': '34.5', 'category': 'CARDINAL'}, {'entity': '304.9', 'category': 'CARDINAL'}, {'entity': '222.9', 'category': 'CARDINAL'}, {'entity': '199.9', 'category': 'CARDINAL'}, {'entity': '16.1', 'category': 'CARDINAL'}, {'entity': '11.9', 'category': 'CARDINAL'}, {'entity': '11.3', 'category': 'CARDINAL'}, {'entity': '7.2', 'category': 'CARDINAL'}, {'entity': '0.5', 'category': 'CARDINAL'}, {'entity': '1.0', 'category': 'CARDINAL'}, {'entity': '137.3', 'category': 'CARDINAL'}, {'entity': '9.2', 'category': 'CARDINAL'}, {'entity': '18.0', 'category': 'CARDINAL'}, {'entity': '57.6', 'category': 'CARDINAL'}, {'entity': '73.2', 'category': 'CARDINAL'}, {'entity': '68.9', 'category': 'CARDINAL'}, {'entity': '38.2', 'category': 'CARDINAL'}, {'entity': '36.2', 'category': 'CARDINAL'}, {'entity': '29.5', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '1.0', 'category': 'CARDINAL'}, {'entity': '34.5', 'category': 'CARDINAL'}, {'entity': '5.4', 'category': 'CARDINAL'}, {'entity': '15.4', 'category': 'CARDINAL'}, {'entity': '34.0', 'category': 'CARDINAL'}, {'entity': '151.5', 'category': 'CARDINAL'}, {'entity': '76.0', 'category': 'CARDINAL'}, {'entity': '57.9', 'category': 'CARDINAL'}, {'entity': '1.75', 'category': 'CARDINAL'}, {'entity': '0.13', 'category': 'CARDINAL'}, {'entity': '0.27', 'category': 'CARDINAL'}, {'entity': '0.18', 'category': 'CARDINAL'}, {'entity': '1.15', 'category': 'CARDINAL'}, {'entity': '0.54', 'category': 'CARDINAL'}, {'entity': '1.93', 'category': 'CARDINAL'}, {'entity': '1.02', 'category': 'CARDINAL'}, {'entity': '0.81', 'category': 'CARDINAL'}, {'entity': '76.8', 'category': 'CARDINAL'}, {'entity': '73.0', 'category': 'CARDINAL'}, {'entity': '65.7', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '7.1', 'category': 'CARDINAL'}, {'entity': '76.8', 'category': 'CARDINAL'}, {'entity': '73.1', 'category': 'CARDINAL'}, {'entity': '72.8', 'category': 'CARDINAL'}, {'entity': '252.7', 'category': 'CARDINAL'}, {'entity': '212.8', 'category': 'CARDINAL'}, {'entity': '158.7', 'category': 'CARDINAL'}, {'entity': '43.2', 'category': 'CARDINAL'}, {'entity': '29.4', 'category': 'CARDINAL'}, {'entity': '47.6', 'category': 'CARDINAL'}, {'entity': '209.5', 'category': 'CARDINAL'}, {'entity': '183.4', 'category': 'CARDINAL'}, {'entity': '111.1', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  11\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVsAlqnBQPBm7n7F4Yx82eOfytpS\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701568066,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#39.9#39.7#12#22.0#4.3#285.6#327.9#327.9#472.1#1#58.5#31#2027#341.4#349.7#302.3#23.3#31.3#87.4#36.8#39.6#40.0#327.9#341.4#349.7#23.3#8.8#4.6#3.8#2.2#3.9#31.3#13.4#6.7#2.3#8.9#87.4#59.4#15#10.4#5.9#2.7#9.0#12#321.2#333.0#300.4#18.2#21.4#67.3#28.1#31.5#35.1#1#32.8#344.1#321.2#333.0#36.9#8.2#18.3#1#252.7#212.8#158.7#20.9#66.4#47.1#26.5#21.7#90.2#205.3#124.7#201.8#39.9 \\n\\nDATE#December 31, 2018#May 2027#Year Ended December 31, 2018#Year Ended December 31, 2017#Year Ended December 31, 2016#Year Ended December 31, 2018#Year Ended December 31, 2017#Year Ended December 31, 2016#Year Ended December 31, 2018#Year Ended December 31, 2017#Year Ended December 31, 2016\\n\\nEVENT#Global Settlement\\n\\nFAC#Baldwin Park Operable Unit#Sacramento\\n\\nMONEY#$207.4#$311.7#$91.3#$103.8#$132.6#$11.1#$12.4#$207.4#$285.6#$327.9#$472.1#$58.5 million#$341.4#$349.7#$302.3#$23.3#$31.3#$87.4#$36.8#$39.6#$40.0#$327.9#$341.4#$349.7#$23.3#$8.8#$4.6#$3.8#$2.2#$3.9#$31.3#$13.4#$6.7#$2.3#$8.9#$87.4#$59.4#$10.4#$5.9#$2.7#$9.0#$321.2#$333.0#$300.4#$18.2#$21.4#$67.3#$28.1#$31.5#$35.1#$32.8#$344.1#$321.2#$333.0#$36.9#$8.2#$18.3#$252.7#$212.8#$158.7#$20.9#$66.4#$47.1#$26.5#$21.7#$90.2#$205.3#$124.7#$201.8\\n\\nGPE#Sacramento#Northrop#Camden#Arkansas\\n\\nORG#Rocketdyne#Aerojet Rocketdyne#Aerospace and Defense\\n\\nWORK_OF_ART#BPOU}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2454,\n",
      "    \"completion_tokens\": 735,\n",
      "    \"total_tokens\": 3189\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': 'May 2027', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2018', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2017', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2016', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2018', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2017', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2016', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2018', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2017', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2016', 'category': 'DATE'}, {'entity': 'Global Settlement', 'category': 'EVENT'}, {'entity': 'Baldwin Park Operable Unit', 'category': 'FAC'}, {'entity': 'Sacramento', 'category': 'FAC'}, {'entity': 'Sacramento', 'category': 'GPE'}, {'entity': 'Northrop', 'category': 'GPE'}, {'entity': 'Camden', 'category': 'GPE'}, {'entity': 'Arkansas', 'category': 'GPE'}, {'entity': '$207.4', 'category': 'MONEY'}, {'entity': '$311.7', 'category': 'MONEY'}, {'entity': '$91.3', 'category': 'MONEY'}, {'entity': '$103.8', 'category': 'MONEY'}, {'entity': '$132.6', 'category': 'MONEY'}, {'entity': '$11.1', 'category': 'MONEY'}, {'entity': '$12.4', 'category': 'MONEY'}, {'entity': '$207.4', 'category': 'MONEY'}, {'entity': '$285.6', 'category': 'MONEY'}, {'entity': '$327.9', 'category': 'MONEY'}, {'entity': '$472.1', 'category': 'MONEY'}, {'entity': '$58.5 million', 'category': 'MONEY'}, {'entity': '$341.4', 'category': 'MONEY'}, {'entity': '$349.7', 'category': 'MONEY'}, {'entity': '$302.3', 'category': 'MONEY'}, {'entity': '$23.3', 'category': 'MONEY'}, {'entity': '$31.3', 'category': 'MONEY'}, {'entity': '$87.4', 'category': 'MONEY'}, {'entity': '$36.8', 'category': 'MONEY'}, {'entity': '$39.6', 'category': 'MONEY'}, {'entity': '$40.0', 'category': 'MONEY'}, {'entity': '$327.9', 'category': 'MONEY'}, {'entity': '$341.4', 'category': 'MONEY'}, {'entity': '$349.7', 'category': 'MONEY'}, {'entity': '$23.3', 'category': 'MONEY'}, {'entity': '$8.8', 'category': 'MONEY'}, {'entity': '$4.6', 'category': 'MONEY'}, {'entity': '$3.8', 'category': 'MONEY'}, {'entity': '$2.2', 'category': 'MONEY'}, {'entity': '$3.9', 'category': 'MONEY'}, {'entity': '$31.3', 'category': 'MONEY'}, {'entity': '$13.4', 'category': 'MONEY'}, {'entity': '$6.7', 'category': 'MONEY'}, {'entity': '$2.3', 'category': 'MONEY'}, {'entity': '$8.9', 'category': 'MONEY'}, {'entity': '$87.4', 'category': 'MONEY'}, {'entity': '$59.4', 'category': 'MONEY'}, {'entity': '$10.4', 'category': 'MONEY'}, {'entity': '$5.9', 'category': 'MONEY'}, {'entity': '$2.7', 'category': 'MONEY'}, {'entity': '$9.0', 'category': 'MONEY'}, {'entity': '$321.2', 'category': 'MONEY'}, {'entity': '$333.0', 'category': 'MONEY'}, {'entity': '$300.4', 'category': 'MONEY'}, {'entity': '$18.2', 'category': 'MONEY'}, {'entity': '$21.4', 'category': 'MONEY'}, {'entity': '$67.3', 'category': 'MONEY'}, {'entity': '$28.1', 'category': 'MONEY'}, {'entity': '$31.5', 'category': 'MONEY'}, {'entity': '$35.1', 'category': 'MONEY'}, {'entity': '$32.8', 'category': 'MONEY'}, {'entity': '$344.1', 'category': 'MONEY'}, {'entity': '$321.2', 'category': 'MONEY'}, {'entity': '$333.0', 'category': 'MONEY'}, {'entity': '$36.9', 'category': 'MONEY'}, {'entity': '$8.2', 'category': 'MONEY'}, {'entity': '$18.3', 'category': 'MONEY'}, {'entity': '$252.7', 'category': 'MONEY'}, {'entity': '$212.8', 'category': 'MONEY'}, {'entity': '$158.7', 'category': 'MONEY'}, {'entity': '$20.9', 'category': 'MONEY'}, {'entity': '$66.4', 'category': 'MONEY'}, {'entity': '$47.1', 'category': 'MONEY'}, {'entity': '$26.5', 'category': 'MONEY'}, {'entity': '$21.7', 'category': 'MONEY'}, {'entity': '$90.2', 'category': 'MONEY'}, {'entity': '$205.3', 'category': 'MONEY'}, {'entity': '$124.7', 'category': 'MONEY'}, {'entity': '$201.8', 'category': 'MONEY'}, {'entity': 'Rocketdyne', 'category': 'ORG'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': 'Aerospace and Defense', 'category': 'ORG'}, {'entity': 'BPOU', 'category': 'WORK_OF_ART'}, {'entity': '39.9', 'category': 'CARDINAL'}, {'entity': '39.7', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '22.0', 'category': 'CARDINAL'}, {'entity': '4.3', 'category': 'CARDINAL'}, {'entity': '285.6', 'category': 'CARDINAL'}, {'entity': '327.9', 'category': 'CARDINAL'}, {'entity': '327.9', 'category': 'CARDINAL'}, {'entity': '472.1', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '58.5', 'category': 'CARDINAL'}, {'entity': '31', 'category': 'CARDINAL'}, {'entity': '2027', 'category': 'CARDINAL'}, {'entity': '341.4', 'category': 'CARDINAL'}, {'entity': '349.7', 'category': 'CARDINAL'}, {'entity': '302.3', 'category': 'CARDINAL'}, {'entity': '23.3', 'category': 'CARDINAL'}, {'entity': '31.3', 'category': 'CARDINAL'}, {'entity': '87.4', 'category': 'CARDINAL'}, {'entity': '36.8', 'category': 'CARDINAL'}, {'entity': '39.6', 'category': 'CARDINAL'}, {'entity': '40.0', 'category': 'CARDINAL'}, {'entity': '327.9', 'category': 'CARDINAL'}, {'entity': '341.4', 'category': 'CARDINAL'}, {'entity': '349.7', 'category': 'CARDINAL'}, {'entity': '23.3', 'category': 'CARDINAL'}, {'entity': '8.8', 'category': 'CARDINAL'}, {'entity': '4.6', 'category': 'CARDINAL'}, {'entity': '3.8', 'category': 'CARDINAL'}, {'entity': '2.2', 'category': 'CARDINAL'}, {'entity': '3.9', 'category': 'CARDINAL'}, {'entity': '31.3', 'category': 'CARDINAL'}, {'entity': '13.4', 'category': 'CARDINAL'}, {'entity': '6.7', 'category': 'CARDINAL'}, {'entity': '2.3', 'category': 'CARDINAL'}, {'entity': '8.9', 'category': 'CARDINAL'}, {'entity': '87.4', 'category': 'CARDINAL'}, {'entity': '59.4', 'category': 'CARDINAL'}, {'entity': '15', 'category': 'CARDINAL'}, {'entity': '10.4', 'category': 'CARDINAL'}, {'entity': '5.9', 'category': 'CARDINAL'}, {'entity': '2.7', 'category': 'CARDINAL'}, {'entity': '9.0', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '321.2', 'category': 'CARDINAL'}, {'entity': '333.0', 'category': 'CARDINAL'}, {'entity': '300.4', 'category': 'CARDINAL'}, {'entity': '18.2', 'category': 'CARDINAL'}, {'entity': '21.4', 'category': 'CARDINAL'}, {'entity': '67.3', 'category': 'CARDINAL'}, {'entity': '28.1', 'category': 'CARDINAL'}, {'entity': '31.5', 'category': 'CARDINAL'}, {'entity': '35.1', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '32.8', 'category': 'CARDINAL'}, {'entity': '344.1', 'category': 'CARDINAL'}, {'entity': '321.2', 'category': 'CARDINAL'}, {'entity': '333.0', 'category': 'CARDINAL'}, {'entity': '36.9', 'category': 'CARDINAL'}, {'entity': '8.2', 'category': 'CARDINAL'}, {'entity': '18.3', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '252.7', 'category': 'CARDINAL'}, {'entity': '212.8', 'category': 'CARDINAL'}, {'entity': '158.7', 'category': 'CARDINAL'}, {'entity': '20.9', 'category': 'CARDINAL'}, {'entity': '66.4', 'category': 'CARDINAL'}, {'entity': '47.1', 'category': 'CARDINAL'}, {'entity': '26.5', 'category': 'CARDINAL'}, {'entity': '21.7', 'category': 'CARDINAL'}, {'entity': '90.2', 'category': 'CARDINAL'}, {'entity': '205.3', 'category': 'CARDINAL'}, {'entity': '124.7', 'category': 'CARDINAL'}, {'entity': '201.8', 'category': 'CARDINAL'}, {'entity': '39.9', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  11\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVszfKDeM3gVpKd7fzdpAI3NaO43\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701568117,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#47.3#38.7#39.4#39.7#54.1#43.0#43.2#29.4#47.6#1.9#20.4#17.0#20.0#25.3#20.0#700.6#800.0#345.6#300.0#0.9#27.2#670.9#25.3#27.2#1.0#735.3#620.6#17.0#46.0#282.1#300.0#0.8#1.9#1.4#23.1#93.4#23.9#31.4#23.8#14.3#32.2#1.6#3.2#3.2#24.2#29.4#4.4#7.8#6.4#10.8#79.4#15.9#29.6#19.5#14.4#927.7#600.1#326.3#1.2#0.1#46.0#4.3#17.6#24.1#1,880.9#964.2#450.5#355.2#111.0#33.80#20 \\n\\nDATE#2017#2016#2018#20 days in the 30 day period prior to December 31, 2018 \\n\\nEVENT#Atlas V and PAC-3 contracts\\n\\nFAC#Senior Credit Facility \\n\\nGPE#Huntsville \\n\\nMONEY#$47.3 million#$38.7 million#$39.4 million#$39.7 million#$54.1 million#43.0 million#$43.2 million#$29.4 million#$47.6 million#$1.9 million#$20.4 million#$17.0 million#$20.0 million#$25.3 million#20.0 million#$700.6 million#$800.0 million#$345.6#300.0#$0.9#27.2#$670.9#25.3#27.2#1.0 billion#$735.3 million#$620.6 million#$17.0 million#$46.0#$282.1#300.0#$0.8#1.9#1.4#23.1#93.4#23.9#31.4#23.8#14.3#32.2#1.6#3.2#3.2#24.2#29.4#4.4#7.8#6.4#10.8#79.4#15.9#29.6#19.5#14.4#927.7#600.1#326.3#1.2#0.1#46.0#4.3#17.6#24.1#$1,880.9#$964.2#$450.5#$355.2#$111.0\\n\\nORG#Coleman Aerospace \\n\\nPERCENT#2 1/4% \\n\\nPERSON#January 1#March 31 \\n\\nTIME#2019#2019 \\n\\nWORK_OF_ART#2\\u00bc% Notes#2\\u00bc% Notes#2\\u00bc% Notes#2\\u00bc% Notes}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2506,\n",
      "    \"completion_tokens\": 701,\n",
      "    \"total_tokens\": 3207\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': '2017', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2018', 'category': 'DATE'}, {'entity': '20 days in the 30 day period prior to December 31, 2018', 'category': 'DATE'}, {'entity': 'Atlas V and PAC-3 contracts', 'category': 'EVENT'}, {'entity': 'Senior Credit Facility', 'category': 'FAC'}, {'entity': 'Huntsville', 'category': 'GPE'}, {'entity': '$47.3 million', 'category': 'MONEY'}, {'entity': '$38.7 million', 'category': 'MONEY'}, {'entity': '$39.4 million', 'category': 'MONEY'}, {'entity': '$39.7 million', 'category': 'MONEY'}, {'entity': '$54.1 million', 'category': 'MONEY'}, {'entity': '43.0 million', 'category': 'MONEY'}, {'entity': '$43.2 million', 'category': 'MONEY'}, {'entity': '$29.4 million', 'category': 'MONEY'}, {'entity': '$47.6 million', 'category': 'MONEY'}, {'entity': '$1.9 million', 'category': 'MONEY'}, {'entity': '$20.4 million', 'category': 'MONEY'}, {'entity': '$17.0 million', 'category': 'MONEY'}, {'entity': '$20.0 million', 'category': 'MONEY'}, {'entity': '$25.3 million', 'category': 'MONEY'}, {'entity': '20.0 million', 'category': 'MONEY'}, {'entity': '$700.6 million', 'category': 'MONEY'}, {'entity': '$800.0 million', 'category': 'MONEY'}, {'entity': '$345.6', 'category': 'MONEY'}, {'entity': '300.0', 'category': 'MONEY'}, {'entity': '$0.9', 'category': 'MONEY'}, {'entity': '27.2', 'category': 'MONEY'}, {'entity': '$670.9', 'category': 'MONEY'}, {'entity': '25.3', 'category': 'MONEY'}, {'entity': '27.2', 'category': 'MONEY'}, {'entity': '1.0 billion', 'category': 'MONEY'}, {'entity': '$735.3 million', 'category': 'MONEY'}, {'entity': '$620.6 million', 'category': 'MONEY'}, {'entity': '$17.0 million', 'category': 'MONEY'}, {'entity': '$46.0', 'category': 'MONEY'}, {'entity': '$282.1', 'category': 'MONEY'}, {'entity': '300.0', 'category': 'MONEY'}, {'entity': '$0.8', 'category': 'MONEY'}, {'entity': '1.9', 'category': 'MONEY'}, {'entity': '1.4', 'category': 'MONEY'}, {'entity': '23.1', 'category': 'MONEY'}, {'entity': '93.4', 'category': 'MONEY'}, {'entity': '23.9', 'category': 'MONEY'}, {'entity': '31.4', 'category': 'MONEY'}, {'entity': '23.8', 'category': 'MONEY'}, {'entity': '14.3', 'category': 'MONEY'}, {'entity': '32.2', 'category': 'MONEY'}, {'entity': '1.6', 'category': 'MONEY'}, {'entity': '3.2', 'category': 'MONEY'}, {'entity': '3.2', 'category': 'MONEY'}, {'entity': '24.2', 'category': 'MONEY'}, {'entity': '29.4', 'category': 'MONEY'}, {'entity': '4.4', 'category': 'MONEY'}, {'entity': '7.8', 'category': 'MONEY'}, {'entity': '6.4', 'category': 'MONEY'}, {'entity': '10.8', 'category': 'MONEY'}, {'entity': '79.4', 'category': 'MONEY'}, {'entity': '15.9', 'category': 'MONEY'}, {'entity': '29.6', 'category': 'MONEY'}, {'entity': '19.5', 'category': 'MONEY'}, {'entity': '14.4', 'category': 'MONEY'}, {'entity': '927.7', 'category': 'MONEY'}, {'entity': '600.1', 'category': 'MONEY'}, {'entity': '326.3', 'category': 'MONEY'}, {'entity': '1.2', 'category': 'MONEY'}, {'entity': '0.1', 'category': 'MONEY'}, {'entity': '46.0', 'category': 'MONEY'}, {'entity': '4.3', 'category': 'MONEY'}, {'entity': '17.6', 'category': 'MONEY'}, {'entity': '24.1', 'category': 'MONEY'}, {'entity': '$1,880.9', 'category': 'MONEY'}, {'entity': '$964.2', 'category': 'MONEY'}, {'entity': '$450.5', 'category': 'MONEY'}, {'entity': '$355.2', 'category': 'MONEY'}, {'entity': '$111.0', 'category': 'MONEY'}, {'entity': 'Coleman Aerospace', 'category': 'ORG'}, {'entity': '2 1/4%', 'category': 'PERCENT'}, {'entity': 'January 1', 'category': 'PERSON'}, {'entity': 'March 31', 'category': 'PERSON'}, {'entity': '2019', 'category': 'TIME'}, {'entity': '2019', 'category': 'TIME'}, {'entity': '2¼% Notes', 'category': 'WORK_OF_ART'}, {'entity': '2¼% Notes', 'category': 'WORK_OF_ART'}, {'entity': '2¼% Notes', 'category': 'WORK_OF_ART'}, {'entity': '2¼% Notes', 'category': 'WORK_OF_ART'}, {'entity': '47.3', 'category': 'CARDINAL'}, {'entity': '38.7', 'category': 'CARDINAL'}, {'entity': '39.4', 'category': 'CARDINAL'}, {'entity': '39.7', 'category': 'CARDINAL'}, {'entity': '54.1', 'category': 'CARDINAL'}, {'entity': '43.0', 'category': 'CARDINAL'}, {'entity': '43.2', 'category': 'CARDINAL'}, {'entity': '29.4', 'category': 'CARDINAL'}, {'entity': '47.6', 'category': 'CARDINAL'}, {'entity': '1.9', 'category': 'CARDINAL'}, {'entity': '20.4', 'category': 'CARDINAL'}, {'entity': '17.0', 'category': 'CARDINAL'}, {'entity': '20.0', 'category': 'CARDINAL'}, {'entity': '25.3', 'category': 'CARDINAL'}, {'entity': '20.0', 'category': 'CARDINAL'}, {'entity': '700.6', 'category': 'CARDINAL'}, {'entity': '800.0', 'category': 'CARDINAL'}, {'entity': '345.6', 'category': 'CARDINAL'}, {'entity': '300.0', 'category': 'CARDINAL'}, {'entity': '0.9', 'category': 'CARDINAL'}, {'entity': '27.2', 'category': 'CARDINAL'}, {'entity': '670.9', 'category': 'CARDINAL'}, {'entity': '25.3', 'category': 'CARDINAL'}, {'entity': '27.2', 'category': 'CARDINAL'}, {'entity': '1.0', 'category': 'CARDINAL'}, {'entity': '735.3', 'category': 'CARDINAL'}, {'entity': '620.6', 'category': 'CARDINAL'}, {'entity': '17.0', 'category': 'CARDINAL'}, {'entity': '46.0', 'category': 'CARDINAL'}, {'entity': '282.1', 'category': 'CARDINAL'}, {'entity': '300.0', 'category': 'CARDINAL'}, {'entity': '0.8', 'category': 'CARDINAL'}, {'entity': '1.9', 'category': 'CARDINAL'}, {'entity': '1.4', 'category': 'CARDINAL'}, {'entity': '23.1', 'category': 'CARDINAL'}, {'entity': '93.4', 'category': 'CARDINAL'}, {'entity': '23.9', 'category': 'CARDINAL'}, {'entity': '31.4', 'category': 'CARDINAL'}, {'entity': '23.8', 'category': 'CARDINAL'}, {'entity': '14.3', 'category': 'CARDINAL'}, {'entity': '32.2', 'category': 'CARDINAL'}, {'entity': '1.6', 'category': 'CARDINAL'}, {'entity': '3.2', 'category': 'CARDINAL'}, {'entity': '3.2', 'category': 'CARDINAL'}, {'entity': '24.2', 'category': 'CARDINAL'}, {'entity': '29.4', 'category': 'CARDINAL'}, {'entity': '4.4', 'category': 'CARDINAL'}, {'entity': '7.8', 'category': 'CARDINAL'}, {'entity': '6.4', 'category': 'CARDINAL'}, {'entity': '10.8', 'category': 'CARDINAL'}, {'entity': '79.4', 'category': 'CARDINAL'}, {'entity': '15.9', 'category': 'CARDINAL'}, {'entity': '29.6', 'category': 'CARDINAL'}, {'entity': '19.5', 'category': 'CARDINAL'}, {'entity': '14.4', 'category': 'CARDINAL'}, {'entity': '927.7', 'category': 'CARDINAL'}, {'entity': '600.1', 'category': 'CARDINAL'}, {'entity': '326.3', 'category': 'CARDINAL'}, {'entity': '1.2', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '46.0', 'category': 'CARDINAL'}, {'entity': '4.3', 'category': 'CARDINAL'}, {'entity': '17.6', 'category': 'CARDINAL'}, {'entity': '24.1', 'category': 'CARDINAL'}, {'entity': '1,880.9', 'category': 'CARDINAL'}, {'entity': '964.2', 'category': 'CARDINAL'}, {'entity': '450.5', 'category': 'CARDINAL'}, {'entity': '355.2', 'category': 'CARDINAL'}, {'entity': '111.0', 'category': 'CARDINAL'}, {'entity': '33.80', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  11\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVtkX1Rj4svP440l1Mu2KpQBpXPo\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701568164,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#8#6#37.0 \\n\\nDATE#December 31, 2018#2019\\n\\nFAC#Item 8\\n\\nMONEY#$37.0 million\\n\\nORG#U.S. government#U.S. government#U.S. government#U.S. government#U.S. government#Aerospace and Defense#U.S. government#GAAP\\n\\nPERCENT#10 years\\n\\nPERSON#Note 6\\n\\nPRODUCT#benefit pension plan#benefit pension plan#benefit pension plan#benefit pension plan\\n\\nTIME#annually#quarterly\\n}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 1967,\n",
      "    \"completion_tokens\": 124,\n",
      "    \"total_tokens\": 2091\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': 'Item 8', 'category': 'FAC'}, {'entity': '$37.0 million', 'category': 'MONEY'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'Aerospace and Defense', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': '10 years', 'category': 'PERCENT'}, {'entity': 'Note 6', 'category': 'PERSON'}, {'entity': 'benefit pension plan', 'category': 'PRODUCT'}, {'entity': 'benefit pension plan', 'category': 'PRODUCT'}, {'entity': 'benefit pension plan', 'category': 'PRODUCT'}, {'entity': 'benefit pension plan', 'category': 'PRODUCT'}, {'entity': 'annually', 'category': 'TIME'}, {'entity': 'quarterly', 'category': 'TIME'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '37.0', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  11\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVuEBjFHDt6f125AXBtcAj3rI5oJ\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701568194,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#68.2#33.7#2.7#59.1#37.2#14.1#43.1#22.3#8.5#0.56#0.31#0.13#0.55#0.31#0.11 \\n\\nDATE#Year Ended December 31, 2018#Year Ended December 31, 2017#Year Ended December 31, 2016#October 1, 2018#October 1, 2017#As of December 31, 2018#As of December 31, 2017\\n \\nLAW#FAR and CAS\\n\\nORG#Aerospace and Defense#DCAA#U.S. government\\n\\nPERCENT#4.27 #%3.59 #%4.09 #%3.37 #%3.59 #%4.02 #%4.36 #%3.37 #%3.68 #%3.99 #%7.00 #%7.00 #%7.00 #\\n}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2220,\n",
      "    \"completion_tokens\": 212,\n",
      "    \"total_tokens\": 2432\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'Year Ended December 31, 2018', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2017', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2016', 'category': 'DATE'}, {'entity': 'October 1, 2018', 'category': 'DATE'}, {'entity': 'October 1, 2017', 'category': 'DATE'}, {'entity': 'As of December 31, 2018', 'category': 'DATE'}, {'entity': 'As of December 31, 2017', 'category': 'DATE'}, {'entity': 'FAR and CAS', 'category': 'LAW'}, {'entity': 'Aerospace and Defense', 'category': 'ORG'}, {'entity': 'DCAA', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': '4.27', 'category': 'PERCENT'}, {'entity': '%3.59', 'category': 'PERCENT'}, {'entity': '%4.09', 'category': 'PERCENT'}, {'entity': '%3.37', 'category': 'PERCENT'}, {'entity': '%3.59', 'category': 'PERCENT'}, {'entity': '%4.02', 'category': 'PERCENT'}, {'entity': '%4.36', 'category': 'PERCENT'}, {'entity': '%3.37', 'category': 'PERCENT'}, {'entity': '%3.68', 'category': 'PERCENT'}, {'entity': '%3.99', 'category': 'PERCENT'}, {'entity': '%7.00', 'category': 'PERCENT'}, {'entity': '%7.00', 'category': 'PERCENT'}, {'entity': '%7.00', 'category': 'PERCENT'}, {'entity': '68.2', 'category': 'CARDINAL'}, {'entity': '33.7', 'category': 'CARDINAL'}, {'entity': '2.7', 'category': 'CARDINAL'}, {'entity': '59.1', 'category': 'CARDINAL'}, {'entity': '37.2', 'category': 'CARDINAL'}, {'entity': '14.1', 'category': 'CARDINAL'}, {'entity': '43.1', 'category': 'CARDINAL'}, {'entity': '22.3', 'category': 'CARDINAL'}, {'entity': '8.5', 'category': 'CARDINAL'}, {'entity': '0.56', 'category': 'CARDINAL'}, {'entity': '0.31', 'category': 'CARDINAL'}, {'entity': '0.13', 'category': 'CARDINAL'}, {'entity': '0.55', 'category': 'CARDINAL'}, {'entity': '0.31', 'category': 'CARDINAL'}, {'entity': '0.11', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  11\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVukFemquRKn6TiNd1WTbdRT8vvK\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701568226,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#one#three#1\\n\\nDATE#December 31, 2018\\n\\nFAC#Global Settlement\\n\\nGPE#U.S.\\n\\nMONEY#$20.5#$128.0#$8.6#$(0.2)#$(0.5)#$(17.5)#$(108.5)#$0.2#$0.6\\n\\nORG#U.S. government#Company\\n\\nPERCENT#1%#50%\\n\\nPERSON#Item 8\\n\\nPRODUCT#Net PeriodicBenefit Expense#ProjectedBenefitObligation#Net Periodic PensionBenefit Expense#Net PeriodicMedical and LifeInsurance Benefit Expense#AccumulatedBenefitObligation\\n\\nWORK_OF_ART#Notes 8(b)#Notes 8(c)#Notes 8(d)#Item 8}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2079,\n",
      "    \"completion_tokens\": 165,\n",
      "    \"total_tokens\": 2244\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31', 'category': 'DATE'}, {'entity': '2018', 'category': 'DATE'}, {'entity': 'Global Settlement', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '$20.5', 'category': 'MONEY'}, {'entity': '$128.0', 'category': 'MONEY'}, {'entity': '$8.6', 'category': 'MONEY'}, {'entity': '$0.2', 'category': 'MONEY'}, {'entity': '$0.5', 'category': 'MONEY'}, {'entity': '$17.5', 'category': 'MONEY'}, {'entity': '$108.5', 'category': 'MONEY'}, {'entity': '$0.2', 'category': 'MONEY'}, {'entity': '$0.6', 'category': 'MONEY'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'Company', 'category': 'ORG'}, {'entity': '1%', 'category': 'PERCENT'}, {'entity': '50%', 'category': 'PERCENT'}, {'entity': 'Item 8', 'category': 'PERSON'}, {'entity': 'Net PeriodicBenefit Expense', 'category': 'PRODUCT'}, {'entity': 'ProjectedBenefitObligation', 'category': 'PRODUCT'}, {'entity': 'Net Periodic PensionBenefit Expense', 'category': 'PRODUCT'}, {'entity': 'Net PeriodicMedical and LifeInsurance Benefit Expense', 'category': 'PRODUCT'}, {'entity': 'AccumulatedBenefitObligation', 'category': 'PRODUCT'}, {'entity': 'Notes 8b', 'category': 'WORK_OF_ART'}, {'entity': 'Notes 8c', 'category': 'WORK_OF_ART'}, {'entity': 'Notes 8d', 'category': 'WORK_OF_ART'}, {'entity': 'Item 8', 'category': 'WORK_OF_ART'}, {'entity': 'one', 'category': 'CARDINAL'}, {'entity': 'three', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  11\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVvEfasRf9mmiGT9cZUMmzpBqoyJ\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701568256,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL:$645.6 million#$300.0 million#46%#$345.6 million#54%#4.52%#$370.0#2\\u00bc%#$441.1#415.3#300.0#$786.7#$785.3#$645.6#$670.0\\n\\nDATE:the past three years#December 31, 2018#December 31, 2017\\n\\nFAC:Senior Credit Facility\\n\\nLAW:Retirement Benefit Plans\\n\\nMONEY:2.25%\\n\\nORG:Term loan\\n\\nPERCENT:2\\u00bc%\\n\\nPERSON:Interest Rate Risk\\n\\nPRODUCT:2\\u00bc% Notes\\n\\nQUANTITY:Level 2\\n\\nTIME:As of December 31,}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 1119,\n",
      "    \"completion_tokens\": 151,\n",
      "    \"total_tokens\": 1270\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'the past three years', 'category': 'DATE'}, {'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': 'Senior Credit Facility', 'category': 'FAC'}, {'entity': 'Retirement Benefit Plans', 'category': 'LAW'}, {'entity': '2.25%', 'category': 'MONEY'}, {'entity': 'Term loan', 'category': 'ORG'}, {'entity': '2¼%', 'category': 'PERCENT'}, {'entity': 'Interest Rate Risk', 'category': 'PERSON'}, {'entity': '2¼% Notes', 'category': 'PRODUCT'}, {'entity': 'Level 2', 'category': 'QUANTITY'}, {'entity': 'As of December 31', 'category': 'TIME'}, {'entity': '', 'category': 'TIME'}, {'entity': '$645.6 million', 'category': 'CARDINAL'}, {'entity': '$300.0 million', 'category': 'CARDINAL'}, {'entity': '46%', 'category': 'CARDINAL'}, {'entity': '$345.6 million', 'category': 'CARDINAL'}, {'entity': '54%', 'category': 'CARDINAL'}, {'entity': '4.52%', 'category': 'CARDINAL'}, {'entity': '$370.0', 'category': 'CARDINAL'}, {'entity': '2¼%', 'category': 'CARDINAL'}, {'entity': '$441.1', 'category': 'CARDINAL'}, {'entity': '415.3', 'category': 'CARDINAL'}, {'entity': '300.0', 'category': 'CARDINAL'}, {'entity': '$786.7', 'category': 'CARDINAL'}, {'entity': '$785.3', 'category': 'CARDINAL'}, {'entity': '$645.6', 'category': 'CARDINAL'}, {'entity': '$670.0', 'category': 'CARDINAL'}]\n",
      "/home/damir/Dropbox/Documents/Teaching/2023/L715/l715_23/data/10-Ks/Aerojet_Rocketdyne_Holdings_Inc./2017/Management.txt\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVvj9nyd0IfWeyDSFpPWMgam6E3c\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701568287,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#7#10#53#52#32.2#1,761.3#1,708.3#18.0#0.27#16.2#0.27#202.0#11.5#217.9#12.8#188.4#200.1#158.4#65.1#110.8#28.3#2.3#2.4#4.5#4.0#315.3#442.1#91#90#92#85#12#14#13#27#29#28#24#21#19#25#28#20#17#19#13#11#10 \\n\\nDATE#January 2016#December 2015#December 31, 2015#December 31, 2014#December 31, 2016#November 30, 2015#2014#December 31, 2015\\n\\nEVENT#\\n\\nFAC#\\n\\nGPE#United States\\n\\nLOC#\\n\\nMONEY#$1.5 million\\n\\nNORP#GAAP\\n\\nORDINAL#\\n\\nORG#Aerojet Rocketdyne Holdings, Inc.#NASA#DoD#Easton#Aerojet Rocketdyne#Standard Missile program#THAAD program#ULA#Raytheon\\n\\nPERCENT#15%\\n\\nPERSON#\\n\\nPRODUCT#Form 10-K\\n\\nQUANTITY#\\n\\nTIME#\\n\\nWORK_OF_ART#\\n\\nLAW#Form 10-K\\n\\nLANGUAGE#\\n\\nNATIONALITIES OR RELIGIOUS OR POLITICAL GROUPS#}\\n\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2443,\n",
      "    \"completion_tokens\": 323,\n",
      "    \"total_tokens\": 2766\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'January 2016', 'category': 'DATE'}, {'entity': 'December 2015', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'December 31, 2014', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'Form 10-K', 'category': 'LAW'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': 'GAAP', 'category': 'NORP'}, {'entity': 'Aerojet Rocketdyne Holdings, Inc.', 'category': 'ORG'}, {'entity': 'NASA', 'category': 'ORG'}, {'entity': 'DoD', 'category': 'ORG'}, {'entity': 'Easton', 'category': 'ORG'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': 'Standard Missile program', 'category': 'ORG'}, {'entity': 'THAAD program', 'category': 'ORG'}, {'entity': 'ULA', 'category': 'ORG'}, {'entity': 'Raytheon', 'category': 'ORG'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': 'Form 10-K', 'category': 'PRODUCT'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '53', 'category': 'CARDINAL'}, {'entity': '52', 'category': 'CARDINAL'}, {'entity': '32.2', 'category': 'CARDINAL'}, {'entity': '1,761.3', 'category': 'CARDINAL'}, {'entity': '1,708.3', 'category': 'CARDINAL'}, {'entity': '18.0', 'category': 'CARDINAL'}, {'entity': '0.27', 'category': 'CARDINAL'}, {'entity': '16.2', 'category': 'CARDINAL'}, {'entity': '0.27', 'category': 'CARDINAL'}, {'entity': '202.0', 'category': 'CARDINAL'}, {'entity': '11.5', 'category': 'CARDINAL'}, {'entity': '217.9', 'category': 'CARDINAL'}, {'entity': '12.8', 'category': 'CARDINAL'}, {'entity': '188.4', 'category': 'CARDINAL'}, {'entity': '200.1', 'category': 'CARDINAL'}, {'entity': '158.4', 'category': 'CARDINAL'}, {'entity': '65.1', 'category': 'CARDINAL'}, {'entity': '110.8', 'category': 'CARDINAL'}, {'entity': '28.3', 'category': 'CARDINAL'}, {'entity': '2.3', 'category': 'CARDINAL'}, {'entity': '2.4', 'category': 'CARDINAL'}, {'entity': '4.5', 'category': 'CARDINAL'}, {'entity': '4.0', 'category': 'CARDINAL'}, {'entity': '315.3', 'category': 'CARDINAL'}, {'entity': '442.1', 'category': 'CARDINAL'}, {'entity': '91', 'category': 'CARDINAL'}, {'entity': '90', 'category': 'CARDINAL'}, {'entity': '92', 'category': 'CARDINAL'}, {'entity': '85', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '14', 'category': 'CARDINAL'}, {'entity': '13', 'category': 'CARDINAL'}, {'entity': '27', 'category': 'CARDINAL'}, {'entity': '29', 'category': 'CARDINAL'}, {'entity': '28', 'category': 'CARDINAL'}, {'entity': '24', 'category': 'CARDINAL'}, {'entity': '21', 'category': 'CARDINAL'}, {'entity': '19', 'category': 'CARDINAL'}, {'entity': '25', 'category': 'CARDINAL'}, {'entity': '28', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '17', 'category': 'CARDINAL'}, {'entity': '19', 'category': 'CARDINAL'}, {'entity': '13', 'category': 'CARDINAL'}, {'entity': '11', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVwLwv3m70pqn5mLMkipxpZAZ16F\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701568325,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#500#82 million#31 million#145 million#25 million#19 million#38 million#18.4 million#28.9 million\\n\\nDATE#March 2015#December 31, 2016#December 9, 2016#October 1, 2016#April 28, 2017#GFY 2017#2014\\n\\nEVENT#U.S. presidential election#Trum Administration#federal spending#nuclear modernization#missile defense#SLS program#defense industry#government outlays#aerospace \\n\\nFAC#U.S. Congress\\n\\nGPE#U.S.\\n\\nLAW#public policy\\n\\nMONEY#$145 million#$82 million#$31 million#$25 million#$19 million\\n\\nORG#DoD#NASA#Congress#Trump Administration#Aerojet Rocketdyne#Boeing\\u2019s CST-100 Starliner#CIP#Russian Soyuz#CR#SpaceX#Blue Origin\\n\\nPERSON#Trump\\n\\nPRODUCT#propulsion systems#space shuttle fleet#liquid fuel propulsion capabilities#new SLS vehicle#CST-100 Starliner\\n\\nTIME#four-year\\n\\nWORK_OF_ART#\\u201cSpace Taxi\\u201d}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2109,\n",
      "    \"completion_tokens\": 247,\n",
      "    \"total_tokens\": 2356\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'March 2015', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'December 9, 2016', 'category': 'DATE'}, {'entity': 'October 1, 2016', 'category': 'DATE'}, {'entity': 'April 28, 2017', 'category': 'DATE'}, {'entity': 'GFY 2017', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': 'U.S. presidential election', 'category': 'EVENT'}, {'entity': 'Trum Administration', 'category': 'EVENT'}, {'entity': 'federal spending', 'category': 'EVENT'}, {'entity': 'nuclear modernization', 'category': 'EVENT'}, {'entity': 'missile defense', 'category': 'EVENT'}, {'entity': 'SLS program', 'category': 'EVENT'}, {'entity': 'defense industry', 'category': 'EVENT'}, {'entity': 'government outlays', 'category': 'EVENT'}, {'entity': 'aerospace', 'category': 'EVENT'}, {'entity': 'U.S. Congress', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'public policy', 'category': 'LAW'}, {'entity': '$145 million', 'category': 'MONEY'}, {'entity': '$82 million', 'category': 'MONEY'}, {'entity': '$31 million', 'category': 'MONEY'}, {'entity': '$25 million', 'category': 'MONEY'}, {'entity': '$19 million', 'category': 'MONEY'}, {'entity': 'DoD', 'category': 'ORG'}, {'entity': 'NASA', 'category': 'ORG'}, {'entity': 'Congress', 'category': 'ORG'}, {'entity': 'Trump Administration', 'category': 'ORG'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': 'Boeing’s CST-100 Starliner', 'category': 'ORG'}, {'entity': 'CIP', 'category': 'ORG'}, {'entity': 'Russian Soyuz', 'category': 'ORG'}, {'entity': 'CR', 'category': 'ORG'}, {'entity': 'SpaceX', 'category': 'ORG'}, {'entity': 'Blue Origin', 'category': 'ORG'}, {'entity': 'Trump', 'category': 'PERSON'}, {'entity': 'propulsion systems', 'category': 'PRODUCT'}, {'entity': 'space shuttle fleet', 'category': 'PRODUCT'}, {'entity': 'liquid fuel propulsion capabilities', 'category': 'PRODUCT'}, {'entity': 'new SLS vehicle', 'category': 'PRODUCT'}, {'entity': 'CST-100 Starliner', 'category': 'PRODUCT'}, {'entity': 'four-year', 'category': 'TIME'}, {'entity': '“Space Taxi”', 'category': 'WORK_OF_ART'}, {'entity': '500', 'category': 'CARDINAL'}, {'entity': '82 million', 'category': 'CARDINAL'}, {'entity': '31 million', 'category': 'CARDINAL'}, {'entity': '145 million', 'category': 'CARDINAL'}, {'entity': '25 million', 'category': 'CARDINAL'}, {'entity': '19 million', 'category': 'CARDINAL'}, {'entity': '38 million', 'category': 'CARDINAL'}, {'entity': '18.4 million', 'category': 'CARDINAL'}, {'entity': '28.9 million', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVwt3DE5hbsr9zcYRdIU4pjJtPUP\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701568359,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#31#2016#1#159.6#210.1#210.1#326.0#96.3#126.8#126.8#178.3#8.5#8.5#8.5#14.4#264.4#345.4#345.4#518.7#0.6#4.3#4.3#6.3#265.0#349.7#349.7#525.0#68.0#725.6#37.0#35.0#32.8#27.5#5.3#72.0#18.0#16.2#50.0#7.0#0.27#0.28#0.85#0.11#0.27#0.01#0.11#65.6#61.1#57.9#62.9#65.7#61.1#57.9#72.5#1,761.3#1,708.3#1,602.2#96.3#1,527.4#1,459.5#1,406.2#75.4#53.6#49.0#38.2#2.8#64.9#65.1#63.7#5.1#34.5#1.9#60.8#19.7#17.4#13.7#0.2#1,700.1#1,675.0#1,582.6#83.5#61.2#33.3#19.6#12.8#0.6#0.3#0.1#32.5#50.4#52.7#3.8#31.9#50.1#52.6#3.8#29.3#16.8#33.0#9.0#11.2#0.3#16.3#2.0#0.1#0.9#0.7#1,761.3#1,708.3#53.0#1,708.3#1,602.2#106.1#95.0#37.2#42.0#36.8#53#32.2#84.3#80.3#109.7#84.3#80.3#109.7#550\\n\\nDATE#December 31, 2016#December 31, 2016#fiscal 2017#fiscal 2017#During fiscal 2016#fiscal 2016#fiscal 2017#December 31,  2016#December 31,  2015#November 30,  2015#November 30,  2014#December 31, 2016#November 30, 2015#November 30, 2014#December 31,  2015#November 30,  2014#November 30,  2015#fiscal 2015#December 31,  2015#December 31,  2015#fiscal 2015#fiscal 2016#fiscal 2015#fiscal 2016#2016 calendar#fiscal 2016#fiscal 2015#December 31,  2015\\n\\nEVENT#Commercial Crew Development program#Standard Missile-3 Block IB contract#Standard Missile MK72 booster contract#RS-25 program#SLS development program#Orion program#J-2X program#THAAD and Standard Missile programs#Antares AJ-26 program \\n\\nFAC#Aerojet Rocketdyne - Sacramento#Aerojet Rocketdyne - BPOU#Other Aerojet Rocketdyne sites\\n\\nGPE#Sacramento#U.S.#U.S.#U.S.#U.S.#U.S.#U.S.\\n\\nLAW#Note 7(c) and (d)\\n\\nMONEY#$95.0 million#$37.2 million#$42.0 million#$36.8 million#$550 acres#550 acres#$32.2 million#$84.3 million#$80.3 million#$32.2 million#$109.7 million\\n\\nORG#Aerojet Rocketdyne#Aerospace and Defense segment#U.S. government#Northrop#U.S. government#Aerojet Rocketdyne#Aerojet Rocketdyne#U.S. government#U.S. government#IRS#Aerojet Rocketdyne#PPA#U.S. government#Aerojet Rocketdyne#RL10 program#PAC-3 contracts#RS-25 program#SLS development program#Orion program#J-2X program#THAAD and Standard Missile programs#Antares AJ-26 program\\n\\nPERCENT#15%\\n\\nTIME#around 5PM#7PM\\n\\nQUANTITY#68.0 million\\n\\nWORK_OF_ART#Environmental Matters}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2894,\n",
      "    \"completion_tokens\": 1061,\n",
      "    \"total_tokens\": 3955\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'fiscal 2017', 'category': 'DATE'}, {'entity': 'fiscal 2017', 'category': 'DATE'}, {'entity': 'During fiscal 2016', 'category': 'DATE'}, {'entity': 'fiscal 2016', 'category': 'DATE'}, {'entity': 'fiscal 2017', 'category': 'DATE'}, {'entity': 'December 31,  2016', 'category': 'DATE'}, {'entity': 'December 31,  2015', 'category': 'DATE'}, {'entity': 'November 30,  2015', 'category': 'DATE'}, {'entity': 'November 30,  2014', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'December 31,  2015', 'category': 'DATE'}, {'entity': 'November 30,  2014', 'category': 'DATE'}, {'entity': 'November 30,  2015', 'category': 'DATE'}, {'entity': 'fiscal 2015', 'category': 'DATE'}, {'entity': 'December 31,  2015', 'category': 'DATE'}, {'entity': 'December 31,  2015', 'category': 'DATE'}, {'entity': 'fiscal 2015', 'category': 'DATE'}, {'entity': 'fiscal 2016', 'category': 'DATE'}, {'entity': 'fiscal 2015', 'category': 'DATE'}, {'entity': 'fiscal 2016', 'category': 'DATE'}, {'entity': '2016 calendar', 'category': 'DATE'}, {'entity': 'fiscal 2016', 'category': 'DATE'}, {'entity': 'fiscal 2015', 'category': 'DATE'}, {'entity': 'December 31,  2015', 'category': 'DATE'}, {'entity': 'Commercial Crew Development program', 'category': 'EVENT'}, {'entity': 'Standard Missile-3 Block IB contract', 'category': 'EVENT'}, {'entity': 'Standard Missile MK72 booster contract', 'category': 'EVENT'}, {'entity': 'RS-25 program', 'category': 'EVENT'}, {'entity': 'SLS development program', 'category': 'EVENT'}, {'entity': 'Orion program', 'category': 'EVENT'}, {'entity': 'J-2X program', 'category': 'EVENT'}, {'entity': 'THAAD and Standard Missile programs', 'category': 'EVENT'}, {'entity': 'Antares AJ-26 program', 'category': 'EVENT'}, {'entity': 'Aerojet Rocketdyne - Sacramento', 'category': 'FAC'}, {'entity': 'Aerojet Rocketdyne - BPOU', 'category': 'FAC'}, {'entity': 'Other Aerojet Rocketdyne sites', 'category': 'FAC'}, {'entity': 'Sacramento', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Note 7c and d', 'category': 'LAW'}, {'entity': '$95.0 million', 'category': 'MONEY'}, {'entity': '$37.2 million', 'category': 'MONEY'}, {'entity': '$42.0 million', 'category': 'MONEY'}, {'entity': '$36.8 million', 'category': 'MONEY'}, {'entity': '$550 acres', 'category': 'MONEY'}, {'entity': '550 acres', 'category': 'MONEY'}, {'entity': '$32.2 million', 'category': 'MONEY'}, {'entity': '$84.3 million', 'category': 'MONEY'}, {'entity': '$80.3 million', 'category': 'MONEY'}, {'entity': '$32.2 million', 'category': 'MONEY'}, {'entity': '$109.7 million', 'category': 'MONEY'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': 'Aerospace and Defense segment', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'Northrop', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'IRS', 'category': 'ORG'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': 'PPA', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': 'RL10 program', 'category': 'ORG'}, {'entity': 'PAC-3 contracts', 'category': 'ORG'}, {'entity': 'RS-25 program', 'category': 'ORG'}, {'entity': 'SLS development program', 'category': 'ORG'}, {'entity': 'Orion program', 'category': 'ORG'}, {'entity': 'J-2X program', 'category': 'ORG'}, {'entity': 'THAAD and Standard Missile programs', 'category': 'ORG'}, {'entity': 'Antares AJ-26 program', 'category': 'ORG'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': '68.0 million', 'category': 'QUANTITY'}, {'entity': 'around 5PM', 'category': 'TIME'}, {'entity': '7PM', 'category': 'TIME'}, {'entity': 'Environmental Matters', 'category': 'WORK_OF_ART'}, {'entity': '31', 'category': 'CARDINAL'}, {'entity': '2016', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '159.6', 'category': 'CARDINAL'}, {'entity': '210.1', 'category': 'CARDINAL'}, {'entity': '210.1', 'category': 'CARDINAL'}, {'entity': '326.0', 'category': 'CARDINAL'}, {'entity': '96.3', 'category': 'CARDINAL'}, {'entity': '126.8', 'category': 'CARDINAL'}, {'entity': '126.8', 'category': 'CARDINAL'}, {'entity': '178.3', 'category': 'CARDINAL'}, {'entity': '8.5', 'category': 'CARDINAL'}, {'entity': '8.5', 'category': 'CARDINAL'}, {'entity': '8.5', 'category': 'CARDINAL'}, {'entity': '14.4', 'category': 'CARDINAL'}, {'entity': '264.4', 'category': 'CARDINAL'}, {'entity': '345.4', 'category': 'CARDINAL'}, {'entity': '345.4', 'category': 'CARDINAL'}, {'entity': '518.7', 'category': 'CARDINAL'}, {'entity': '0.6', 'category': 'CARDINAL'}, {'entity': '4.3', 'category': 'CARDINAL'}, {'entity': '4.3', 'category': 'CARDINAL'}, {'entity': '6.3', 'category': 'CARDINAL'}, {'entity': '265.0', 'category': 'CARDINAL'}, {'entity': '349.7', 'category': 'CARDINAL'}, {'entity': '349.7', 'category': 'CARDINAL'}, {'entity': '525.0', 'category': 'CARDINAL'}, {'entity': '68.0', 'category': 'CARDINAL'}, {'entity': '725.6', 'category': 'CARDINAL'}, {'entity': '37.0', 'category': 'CARDINAL'}, {'entity': '35.0', 'category': 'CARDINAL'}, {'entity': '32.8', 'category': 'CARDINAL'}, {'entity': '27.5', 'category': 'CARDINAL'}, {'entity': '5.3', 'category': 'CARDINAL'}, {'entity': '72.0', 'category': 'CARDINAL'}, {'entity': '18.0', 'category': 'CARDINAL'}, {'entity': '16.2', 'category': 'CARDINAL'}, {'entity': '50.0', 'category': 'CARDINAL'}, {'entity': '7.0', 'category': 'CARDINAL'}, {'entity': '0.27', 'category': 'CARDINAL'}, {'entity': '0.28', 'category': 'CARDINAL'}, {'entity': '0.85', 'category': 'CARDINAL'}, {'entity': '0.11', 'category': 'CARDINAL'}, {'entity': '0.27', 'category': 'CARDINAL'}, {'entity': '0.01', 'category': 'CARDINAL'}, {'entity': '0.11', 'category': 'CARDINAL'}, {'entity': '65.6', 'category': 'CARDINAL'}, {'entity': '61.1', 'category': 'CARDINAL'}, {'entity': '57.9', 'category': 'CARDINAL'}, {'entity': '62.9', 'category': 'CARDINAL'}, {'entity': '65.7', 'category': 'CARDINAL'}, {'entity': '61.1', 'category': 'CARDINAL'}, {'entity': '57.9', 'category': 'CARDINAL'}, {'entity': '72.5', 'category': 'CARDINAL'}, {'entity': '1,761.3', 'category': 'CARDINAL'}, {'entity': '1,708.3', 'category': 'CARDINAL'}, {'entity': '1,602.2', 'category': 'CARDINAL'}, {'entity': '96.3', 'category': 'CARDINAL'}, {'entity': '1,527.4', 'category': 'CARDINAL'}, {'entity': '1,459.5', 'category': 'CARDINAL'}, {'entity': '1,406.2', 'category': 'CARDINAL'}, {'entity': '75.4', 'category': 'CARDINAL'}, {'entity': '53.6', 'category': 'CARDINAL'}, {'entity': '49.0', 'category': 'CARDINAL'}, {'entity': '38.2', 'category': 'CARDINAL'}, {'entity': '2.8', 'category': 'CARDINAL'}, {'entity': '64.9', 'category': 'CARDINAL'}, {'entity': '65.1', 'category': 'CARDINAL'}, {'entity': '63.7', 'category': 'CARDINAL'}, {'entity': '5.1', 'category': 'CARDINAL'}, {'entity': '34.5', 'category': 'CARDINAL'}, {'entity': '1.9', 'category': 'CARDINAL'}, {'entity': '60.8', 'category': 'CARDINAL'}, {'entity': '19.7', 'category': 'CARDINAL'}, {'entity': '17.4', 'category': 'CARDINAL'}, {'entity': '13.7', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '1,700.1', 'category': 'CARDINAL'}, {'entity': '1,675.0', 'category': 'CARDINAL'}, {'entity': '1,582.6', 'category': 'CARDINAL'}, {'entity': '83.5', 'category': 'CARDINAL'}, {'entity': '61.2', 'category': 'CARDINAL'}, {'entity': '33.3', 'category': 'CARDINAL'}, {'entity': '19.6', 'category': 'CARDINAL'}, {'entity': '12.8', 'category': 'CARDINAL'}, {'entity': '0.6', 'category': 'CARDINAL'}, {'entity': '0.3', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '32.5', 'category': 'CARDINAL'}, {'entity': '50.4', 'category': 'CARDINAL'}, {'entity': '52.7', 'category': 'CARDINAL'}, {'entity': '3.8', 'category': 'CARDINAL'}, {'entity': '31.9', 'category': 'CARDINAL'}, {'entity': '50.1', 'category': 'CARDINAL'}, {'entity': '52.6', 'category': 'CARDINAL'}, {'entity': '3.8', 'category': 'CARDINAL'}, {'entity': '29.3', 'category': 'CARDINAL'}, {'entity': '16.8', 'category': 'CARDINAL'}, {'entity': '33.0', 'category': 'CARDINAL'}, {'entity': '9.0', 'category': 'CARDINAL'}, {'entity': '11.2', 'category': 'CARDINAL'}, {'entity': '0.3', 'category': 'CARDINAL'}, {'entity': '16.3', 'category': 'CARDINAL'}, {'entity': '2.0', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '0.9', 'category': 'CARDINAL'}, {'entity': '0.7', 'category': 'CARDINAL'}, {'entity': '1,761.3', 'category': 'CARDINAL'}, {'entity': '1,708.3', 'category': 'CARDINAL'}, {'entity': '53.0', 'category': 'CARDINAL'}, {'entity': '1,708.3', 'category': 'CARDINAL'}, {'entity': '1,602.2', 'category': 'CARDINAL'}, {'entity': '106.1', 'category': 'CARDINAL'}, {'entity': '95.0', 'category': 'CARDINAL'}, {'entity': '37.2', 'category': 'CARDINAL'}, {'entity': '42.0', 'category': 'CARDINAL'}, {'entity': '36.8', 'category': 'CARDINAL'}, {'entity': '53', 'category': 'CARDINAL'}, {'entity': '32.2', 'category': 'CARDINAL'}, {'entity': '84.3', 'category': 'CARDINAL'}, {'entity': '80.3', 'category': 'CARDINAL'}, {'entity': '109.7', 'category': 'CARDINAL'}, {'entity': '84.3', 'category': 'CARDINAL'}, {'entity': '80.3', 'category': 'CARDINAL'}, {'entity': '109.7', 'category': 'CARDINAL'}, {'entity': '550', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVxvkz5BP20gVRFAC3UJqDrB30iF\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701568423,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#550#20#50.0#550#30.6#20#50.0#1#2.7#1.2#1.3#1.3#1#2.8#1 \\n\\nDATE#December 31, 2015#Year Ended#November 30, 2016#2015#Change*#2015#2014#Change**#November 30, 2015#Year Ended#December 31, 2016#2015#Change*#2015#2014#Change*#December 31, 2016#2015#2015#November 30, 2016#Change*#2015#2014#Change**#December 31, 2015\\n\\nEVENT#Acquisition#Aj-26 program\\n\\nGPE#Sacramento#U.S.\\n\\nLAW#Settlement and Mutual Release Agreement\\n\\nMONEY#$96.3#$32.4 million#$26.4 million#$26.1 million#$1,527.4#$1,459.5#$67.9#$1,459.5#$1,406.2#$53.3#85.4%#83.9%#82.5%#82.5%#86.0%#$1,477.2#$1,409.0#$68.2#$1,409.0#$1,377.8#$31.2#0.1#25.0#$25.2#$1,527.4#$1,459.5#$67.9#$1,459.5#$1,406.2#$53.3#$30.6 million#$30.6 million#85.4%#87.8%#$50.0 million#78.3%#73.9%#$21.8#$23.0#1.8#$8.6#$5.7#$17.4#$11.3#$4.6#$49.0#$38.2\\n\\nORG#THAAD#Standard Missile#RL10#Atlas V#Commercial Crew Development#RS-25#SLS#Aerojet Rocketdyne#Orbital Sciences Corporation#Antares#Cygnus ORB-3 service and cargo module#AR1#U.S. government#Rocketdyne\\n\\nPERCENT#86.7#85.4#85.4#87.8#83.9#82.5#82.5#86.0#78.3#73.9\\n\\nPERSON#Orbital\\n\\nPRODUCT#AR1#liquid propulsion rocket engines\\n\\nWORK_OF_ART#AR1 R&D costs\\n}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2992,\n",
      "    \"completion_tokens\": 556,\n",
      "    \"total_tokens\": 3548\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'Year Ended', 'category': 'DATE'}, {'entity': 'November 30, 2016', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': 'Change*', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': 'Change**', 'category': 'DATE'}, {'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': 'Year Ended', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': 'Change*', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': 'Change*', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': 'November 30, 2016', 'category': 'DATE'}, {'entity': 'Change*', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': 'Change**', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'Acquisition', 'category': 'EVENT'}, {'entity': 'Aj-26 program', 'category': 'EVENT'}, {'entity': 'Sacramento', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Settlement and Mutual Release Agreement', 'category': 'LAW'}, {'entity': '$96.3', 'category': 'MONEY'}, {'entity': '$32.4 million', 'category': 'MONEY'}, {'entity': '$26.4 million', 'category': 'MONEY'}, {'entity': '$26.1 million', 'category': 'MONEY'}, {'entity': '$1,527.4', 'category': 'MONEY'}, {'entity': '$1,459.5', 'category': 'MONEY'}, {'entity': '$67.9', 'category': 'MONEY'}, {'entity': '$1,459.5', 'category': 'MONEY'}, {'entity': '$1,406.2', 'category': 'MONEY'}, {'entity': '$53.3', 'category': 'MONEY'}, {'entity': '85.4%', 'category': 'MONEY'}, {'entity': '83.9%', 'category': 'MONEY'}, {'entity': '82.5%', 'category': 'MONEY'}, {'entity': '82.5%', 'category': 'MONEY'}, {'entity': '86.0%', 'category': 'MONEY'}, {'entity': '$1,477.2', 'category': 'MONEY'}, {'entity': '$1,409.0', 'category': 'MONEY'}, {'entity': '$68.2', 'category': 'MONEY'}, {'entity': '$1,409.0', 'category': 'MONEY'}, {'entity': '$1,377.8', 'category': 'MONEY'}, {'entity': '$31.2', 'category': 'MONEY'}, {'entity': '0.1', 'category': 'MONEY'}, {'entity': '25.0', 'category': 'MONEY'}, {'entity': '$25.2', 'category': 'MONEY'}, {'entity': '$1,527.4', 'category': 'MONEY'}, {'entity': '$1,459.5', 'category': 'MONEY'}, {'entity': '$67.9', 'category': 'MONEY'}, {'entity': '$1,459.5', 'category': 'MONEY'}, {'entity': '$1,406.2', 'category': 'MONEY'}, {'entity': '$53.3', 'category': 'MONEY'}, {'entity': '$30.6 million', 'category': 'MONEY'}, {'entity': '$30.6 million', 'category': 'MONEY'}, {'entity': '85.4%', 'category': 'MONEY'}, {'entity': '87.8%', 'category': 'MONEY'}, {'entity': '$50.0 million', 'category': 'MONEY'}, {'entity': '78.3%', 'category': 'MONEY'}, {'entity': '73.9%', 'category': 'MONEY'}, {'entity': '$21.8', 'category': 'MONEY'}, {'entity': '$23.0', 'category': 'MONEY'}, {'entity': '1.8', 'category': 'MONEY'}, {'entity': '$8.6', 'category': 'MONEY'}, {'entity': '$5.7', 'category': 'MONEY'}, {'entity': '$17.4', 'category': 'MONEY'}, {'entity': '$11.3', 'category': 'MONEY'}, {'entity': '$4.6', 'category': 'MONEY'}, {'entity': '$49.0', 'category': 'MONEY'}, {'entity': '$38.2', 'category': 'MONEY'}, {'entity': 'THAAD', 'category': 'ORG'}, {'entity': 'Standard Missile', 'category': 'ORG'}, {'entity': 'RL10', 'category': 'ORG'}, {'entity': 'Atlas V', 'category': 'ORG'}, {'entity': 'Commercial Crew Development', 'category': 'ORG'}, {'entity': 'RS-25', 'category': 'ORG'}, {'entity': 'SLS', 'category': 'ORG'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': 'Orbital Sciences Corporation', 'category': 'ORG'}, {'entity': 'Antares', 'category': 'ORG'}, {'entity': 'Cygnus ORB-3 service and cargo module', 'category': 'ORG'}, {'entity': 'AR1', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'Rocketdyne', 'category': 'ORG'}, {'entity': '86.7', 'category': 'PERCENT'}, {'entity': '85.4', 'category': 'PERCENT'}, {'entity': '85.4', 'category': 'PERCENT'}, {'entity': '87.8', 'category': 'PERCENT'}, {'entity': '83.9', 'category': 'PERCENT'}, {'entity': '82.5', 'category': 'PERCENT'}, {'entity': '82.5', 'category': 'PERCENT'}, {'entity': '86.0', 'category': 'PERCENT'}, {'entity': '78.3', 'category': 'PERCENT'}, {'entity': '73.9', 'category': 'PERCENT'}, {'entity': 'Orbital', 'category': 'PERSON'}, {'entity': 'AR1', 'category': 'PRODUCT'}, {'entity': 'liquid propulsion rocket engines', 'category': 'PRODUCT'}, {'entity': 'AR1 R&D costs', 'category': 'WORK_OF_ART'}, {'entity': '550', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '50.0', 'category': 'CARDINAL'}, {'entity': '550', 'category': 'CARDINAL'}, {'entity': '30.6', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '50.0', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '2.7', 'category': 'CARDINAL'}, {'entity': '1.2', 'category': 'CARDINAL'}, {'entity': '1.3', 'category': 'CARDINAL'}, {'entity': '1.3', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '2.8', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVybV7oVzq4xNlIExHYmI6jfgQ2G\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701568465,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#64.9#65.1#0.2#65.1#63.7#1.4#49.6#49.8#0.2#49.8#48.5#1.3#13.3#13.4#0.1#13.4#13.5#0.1#2.0#1.9#0.1#1.9#1.7#0.2#64.9#65.1#0.2#65.1#63.7#1.4#54.2#69.3#15.1#69.3#74.5#5.2#0.2#34.5#51.9#61.7#0.4#460.0#7.125#105.344#34.1#24.6#9.5#13.0#0.3#0.1#50.0#76.0#1.9#0.9#4.1/16#59.6#119.9#0.3#60.6#0.1#0.4#0.6#0.3#0.3#0.3#0.1#0.2#32.5#50.4#17.9#50.4#52.7#2.3#30.2#47.7#17.5#47.7#49.1#1.4#2.3#2.7#0.4#2.7#3.6#0.9#32.5#50.4#17.9#50.4#52.7#2.3#3.02#5.8#49.0#5.5#3.8#3.6#0.2#3.8#11.2#0.3#16.3#2.0#10.3#5.9#11.5#3.1#0.7#2.7#3.7#0.4#3.9#3.2#0.2#0.3#0.4\\n\\n DATE#Year Ended#Year Ended#Year Ended#December 31#November 30#November 30#November 30#2016#2015#Change*#2015#2014#Change**#One month ended December 31#2015#Year Ended#Year Ended#December 31#November 30#November 30#November 30#2016#2015#Change*#2015#2014#Change**#One month ended December 31#2015#Year Ended#One month ended#December 31#November 30#November 30#December 31#2016#2015#2014#2015#Fiscal 2016 Activity:On July 18, 2016#Fiscal 2015 Activity#Fiscal 2014 Activity#December 2015 Activity#Year Ended#Year Ended#December 31#November 30#November 30#November 30#2016#2015#Change*#2015#2014#Change*#Year Ended#Year Ended#December 31#November 30#November 30#November 30#2016#2015#Change*#2015#2014#Change**#One month ended December 31#2015#Year Ended#One month ended#December 31#November 30#November 30#December 31#2016#2015#2014#2015#Year Ended#One month ended#December 31#November 30#November 30#December 31#2016#2015#2014#2015 \\n\\n EVENT#the product launch \\n\\n MONEY#$1.5 million#49.8#48.5#1.3#13.3#13.4#0.1#13.4#13.#0.1#2.0#1.9#64.9#65.1#0.2#65.1#63.7#1.4#54.2#69.3#15.1#69.3#74.5#5.2#34.5#51.9#61.7#0.4#460.0 million#7.125% Second-Priority Senior Secured Notes#105.344% of the principal amount#34.1 million#24.6 million#$9.5 million#$13.0 million principal#0.3 million #$0.1 million #$50.0 million#76.0 million principal amount#$1.9 million#0.9 million for realized losses#$59.6#119.9#0.2 million#0.4 million for realized losses#0.6#0.3#0.3#0.3#0.1#0.2#32.5#50.4#17.9#50.4#52.7#2.3#30.2#47.7#17.5#47.7#49.1#1.4#3.01/16% Debentures#59.6#119.9#60.6#0.1#2.0#10.3#5.9#11.5#3.1#0.7#2.7#3.7#0.4#3.9#3.2#0.2#0.3#0.4 \\n\\n ORG#CIP#Aerojet Rocketdyne#U.S. government#Senior Credit Facility#SEC#4 1/16% Convertible Subordinated Debentures#SEC \\n\\n QUANTITY#2.0#1.9#0.1#1.9#1.7#0.2#0.2 \\n\\n TIME#month ended December 31#One month ended December 31#month ended December 31#month ended December 31#month ended December 31#One month ended December 31#One month ended December 31}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 3143,\n",
      "    \"completion_tokens\": 1300,\n",
      "    \"total_tokens\": 4443\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'Year Ended', 'category': 'DATE'}, {'entity': 'Year Ended', 'category': 'DATE'}, {'entity': 'Year Ended', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': 'Change*', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': 'Change**', 'category': 'DATE'}, {'entity': 'One month ended December 31', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': 'Year Ended', 'category': 'DATE'}, {'entity': 'Year Ended', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': 'Change*', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': 'Change**', 'category': 'DATE'}, {'entity': 'One month ended December 31', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': 'Year Ended', 'category': 'DATE'}, {'entity': 'One month ended', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': 'Fiscal 2016 ActivityOn July 18, 2016', 'category': 'DATE'}, {'entity': 'Fiscal 2015 Activity', 'category': 'DATE'}, {'entity': 'Fiscal 2014 Activity', 'category': 'DATE'}, {'entity': 'December 2015 Activity', 'category': 'DATE'}, {'entity': 'Year Ended', 'category': 'DATE'}, {'entity': 'Year Ended', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': 'Change*', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': 'Change*', 'category': 'DATE'}, {'entity': 'Year Ended', 'category': 'DATE'}, {'entity': 'Year Ended', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': 'Change*', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': 'Change**', 'category': 'DATE'}, {'entity': 'One month ended December 31', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': 'Year Ended', 'category': 'DATE'}, {'entity': 'One month ended', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': 'Year Ended', 'category': 'DATE'}, {'entity': 'One month ended', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': 'the product launch', 'category': 'EVENT'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': '49.8', 'category': 'MONEY'}, {'entity': '48.5', 'category': 'MONEY'}, {'entity': '1.3', 'category': 'MONEY'}, {'entity': '13.3', 'category': 'MONEY'}, {'entity': '13.4', 'category': 'MONEY'}, {'entity': '0.1', 'category': 'MONEY'}, {'entity': '13.4', 'category': 'MONEY'}, {'entity': '13.', 'category': 'MONEY'}, {'entity': '0.1', 'category': 'MONEY'}, {'entity': '2.0', 'category': 'MONEY'}, {'entity': '1.9', 'category': 'MONEY'}, {'entity': '64.9', 'category': 'MONEY'}, {'entity': '65.1', 'category': 'MONEY'}, {'entity': '0.2', 'category': 'MONEY'}, {'entity': '65.1', 'category': 'MONEY'}, {'entity': '63.7', 'category': 'MONEY'}, {'entity': '1.4', 'category': 'MONEY'}, {'entity': '54.2', 'category': 'MONEY'}, {'entity': '69.3', 'category': 'MONEY'}, {'entity': '15.1', 'category': 'MONEY'}, {'entity': '69.3', 'category': 'MONEY'}, {'entity': '74.5', 'category': 'MONEY'}, {'entity': '5.2', 'category': 'MONEY'}, {'entity': '34.5', 'category': 'MONEY'}, {'entity': '51.9', 'category': 'MONEY'}, {'entity': '61.7', 'category': 'MONEY'}, {'entity': '0.4', 'category': 'MONEY'}, {'entity': '460.0 million', 'category': 'MONEY'}, {'entity': '7.125% Second-Priority Senior Secured Notes', 'category': 'MONEY'}, {'entity': '105.344% of the principal amount', 'category': 'MONEY'}, {'entity': '34.1 million', 'category': 'MONEY'}, {'entity': '24.6 million', 'category': 'MONEY'}, {'entity': '$9.5 million', 'category': 'MONEY'}, {'entity': '$13.0 million principal', 'category': 'MONEY'}, {'entity': '0.3 million', 'category': 'MONEY'}, {'entity': '$0.1 million', 'category': 'MONEY'}, {'entity': '$50.0 million', 'category': 'MONEY'}, {'entity': '76.0 million principal amount', 'category': 'MONEY'}, {'entity': '$1.9 million', 'category': 'MONEY'}, {'entity': '0.9 million for realized losses', 'category': 'MONEY'}, {'entity': '$59.6', 'category': 'MONEY'}, {'entity': '119.9', 'category': 'MONEY'}, {'entity': '0.2 million', 'category': 'MONEY'}, {'entity': '0.4 million for realized losses', 'category': 'MONEY'}, {'entity': '0.6', 'category': 'MONEY'}, {'entity': '0.3', 'category': 'MONEY'}, {'entity': '0.3', 'category': 'MONEY'}, {'entity': '0.3', 'category': 'MONEY'}, {'entity': '0.1', 'category': 'MONEY'}, {'entity': '0.2', 'category': 'MONEY'}, {'entity': '32.5', 'category': 'MONEY'}, {'entity': '50.4', 'category': 'MONEY'}, {'entity': '17.9', 'category': 'MONEY'}, {'entity': '50.4', 'category': 'MONEY'}, {'entity': '52.7', 'category': 'MONEY'}, {'entity': '2.3', 'category': 'MONEY'}, {'entity': '30.2', 'category': 'MONEY'}, {'entity': '47.7', 'category': 'MONEY'}, {'entity': '17.5', 'category': 'MONEY'}, {'entity': '47.7', 'category': 'MONEY'}, {'entity': '49.1', 'category': 'MONEY'}, {'entity': '1.4', 'category': 'MONEY'}, {'entity': '3.01/16% Debentures', 'category': 'MONEY'}, {'entity': '59.6', 'category': 'MONEY'}, {'entity': '119.9', 'category': 'MONEY'}, {'entity': '60.6', 'category': 'MONEY'}, {'entity': '0.1', 'category': 'MONEY'}, {'entity': '2.0', 'category': 'MONEY'}, {'entity': '10.3', 'category': 'MONEY'}, {'entity': '5.9', 'category': 'MONEY'}, {'entity': '11.5', 'category': 'MONEY'}, {'entity': '3.1', 'category': 'MONEY'}, {'entity': '0.7', 'category': 'MONEY'}, {'entity': '2.7', 'category': 'MONEY'}, {'entity': '3.7', 'category': 'MONEY'}, {'entity': '0.4', 'category': 'MONEY'}, {'entity': '3.9', 'category': 'MONEY'}, {'entity': '3.2', 'category': 'MONEY'}, {'entity': '0.2', 'category': 'MONEY'}, {'entity': '0.3', 'category': 'MONEY'}, {'entity': '0.4', 'category': 'MONEY'}, {'entity': 'CIP', 'category': 'ORG'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': '4 1/16% Convertible Subordinated Debentures', 'category': 'ORG'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': '2.0', 'category': 'QUANTITY'}, {'entity': '1.9', 'category': 'QUANTITY'}, {'entity': '0.1', 'category': 'QUANTITY'}, {'entity': '1.9', 'category': 'QUANTITY'}, {'entity': '1.7', 'category': 'QUANTITY'}, {'entity': '0.2', 'category': 'QUANTITY'}, {'entity': '0.2', 'category': 'QUANTITY'}, {'entity': 'month ended December 31', 'category': 'TIME'}, {'entity': 'One month ended December 31', 'category': 'TIME'}, {'entity': 'month ended December 31', 'category': 'TIME'}, {'entity': 'month ended December 31', 'category': 'TIME'}, {'entity': 'month ended December 31', 'category': 'TIME'}, {'entity': 'One month ended December 31', 'category': 'TIME'}, {'entity': 'One month ended December 31', 'category': 'TIME'}, {'entity': '64.9', 'category': 'CARDINAL'}, {'entity': '65.1', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '65.1', 'category': 'CARDINAL'}, {'entity': '63.7', 'category': 'CARDINAL'}, {'entity': '1.4', 'category': 'CARDINAL'}, {'entity': '49.6', 'category': 'CARDINAL'}, {'entity': '49.8', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '49.8', 'category': 'CARDINAL'}, {'entity': '48.5', 'category': 'CARDINAL'}, {'entity': '1.3', 'category': 'CARDINAL'}, {'entity': '13.3', 'category': 'CARDINAL'}, {'entity': '13.4', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '13.4', 'category': 'CARDINAL'}, {'entity': '13.5', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '2.0', 'category': 'CARDINAL'}, {'entity': '1.9', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '1.9', 'category': 'CARDINAL'}, {'entity': '1.7', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '64.9', 'category': 'CARDINAL'}, {'entity': '65.1', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '65.1', 'category': 'CARDINAL'}, {'entity': '63.7', 'category': 'CARDINAL'}, {'entity': '1.4', 'category': 'CARDINAL'}, {'entity': '54.2', 'category': 'CARDINAL'}, {'entity': '69.3', 'category': 'CARDINAL'}, {'entity': '15.1', 'category': 'CARDINAL'}, {'entity': '69.3', 'category': 'CARDINAL'}, {'entity': '74.5', 'category': 'CARDINAL'}, {'entity': '5.2', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '34.5', 'category': 'CARDINAL'}, {'entity': '51.9', 'category': 'CARDINAL'}, {'entity': '61.7', 'category': 'CARDINAL'}, {'entity': '0.4', 'category': 'CARDINAL'}, {'entity': '460.0', 'category': 'CARDINAL'}, {'entity': '7.125', 'category': 'CARDINAL'}, {'entity': '105.344', 'category': 'CARDINAL'}, {'entity': '34.1', 'category': 'CARDINAL'}, {'entity': '24.6', 'category': 'CARDINAL'}, {'entity': '9.5', 'category': 'CARDINAL'}, {'entity': '13.0', 'category': 'CARDINAL'}, {'entity': '0.3', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '50.0', 'category': 'CARDINAL'}, {'entity': '76.0', 'category': 'CARDINAL'}, {'entity': '1.9', 'category': 'CARDINAL'}, {'entity': '0.9', 'category': 'CARDINAL'}, {'entity': '4.1/16', 'category': 'CARDINAL'}, {'entity': '59.6', 'category': 'CARDINAL'}, {'entity': '119.9', 'category': 'CARDINAL'}, {'entity': '0.3', 'category': 'CARDINAL'}, {'entity': '60.6', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '0.4', 'category': 'CARDINAL'}, {'entity': '0.6', 'category': 'CARDINAL'}, {'entity': '0.3', 'category': 'CARDINAL'}, {'entity': '0.3', 'category': 'CARDINAL'}, {'entity': '0.3', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '32.5', 'category': 'CARDINAL'}, {'entity': '50.4', 'category': 'CARDINAL'}, {'entity': '17.9', 'category': 'CARDINAL'}, {'entity': '50.4', 'category': 'CARDINAL'}, {'entity': '52.7', 'category': 'CARDINAL'}, {'entity': '2.3', 'category': 'CARDINAL'}, {'entity': '30.2', 'category': 'CARDINAL'}, {'entity': '47.7', 'category': 'CARDINAL'}, {'entity': '17.5', 'category': 'CARDINAL'}, {'entity': '47.7', 'category': 'CARDINAL'}, {'entity': '49.1', 'category': 'CARDINAL'}, {'entity': '1.4', 'category': 'CARDINAL'}, {'entity': '2.3', 'category': 'CARDINAL'}, {'entity': '2.7', 'category': 'CARDINAL'}, {'entity': '0.4', 'category': 'CARDINAL'}, {'entity': '2.7', 'category': 'CARDINAL'}, {'entity': '3.6', 'category': 'CARDINAL'}, {'entity': '0.9', 'category': 'CARDINAL'}, {'entity': '32.5', 'category': 'CARDINAL'}, {'entity': '50.4', 'category': 'CARDINAL'}, {'entity': '17.9', 'category': 'CARDINAL'}, {'entity': '50.4', 'category': 'CARDINAL'}, {'entity': '52.7', 'category': 'CARDINAL'}, {'entity': '2.3', 'category': 'CARDINAL'}, {'entity': '3.02', 'category': 'CARDINAL'}, {'entity': '5.8', 'category': 'CARDINAL'}, {'entity': '49.0', 'category': 'CARDINAL'}, {'entity': '5.5', 'category': 'CARDINAL'}, {'entity': '3.8', 'category': 'CARDINAL'}, {'entity': '3.6', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '3.8', 'category': 'CARDINAL'}, {'entity': '11.2', 'category': 'CARDINAL'}, {'entity': '0.3', 'category': 'CARDINAL'}, {'entity': '16.3', 'category': 'CARDINAL'}, {'entity': '2.0', 'category': 'CARDINAL'}, {'entity': '10.3', 'category': 'CARDINAL'}, {'entity': '5.9', 'category': 'CARDINAL'}, {'entity': '11.5', 'category': 'CARDINAL'}, {'entity': '3.1', 'category': 'CARDINAL'}, {'entity': '0.7', 'category': 'CARDINAL'}, {'entity': '2.7', 'category': 'CARDINAL'}, {'entity': '3.7', 'category': 'CARDINAL'}, {'entity': '0.4', 'category': 'CARDINAL'}, {'entity': '3.9', 'category': 'CARDINAL'}, {'entity': '3.2', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '0.3', 'category': 'CARDINAL'}, {'entity': '0.4', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RVzgZyBeC7Fy0ofvdbjPxE7DAjyp\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701568532,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#0.4#0.3#0.1#0.3#0.8#1.4#2.3#0.1#21.1#4.1#1.3#0.2#1.9#1.7#0.5#1.0#1.4#0.6#0.8#0.6#0.4#0.7#0.4#0.8#0.5#0.2#11.2#0.3#16.3#2.0#439.7#343.7#31#2016#2015#14.0#10.8#8.9#1.1#66.0#65.5#69.6#5.5#70.1#88.1#92.6#6.0#1.1#1.1#0.9#0.1#60.1#80.5#51.5#5.1#68.9#67.6#36.5#5.6#73\\n\\nDATE#December 31, 2015#December 31, 2016\\n\\nEVENT#Rocketdyne Business acquisition integration#Competitive Improvement Program\\n\\nGPE#U.S.\\n\\nLAW#Section 199 of the IRS code\\n\\nMONEY#$343.7 million\\n\\nORG#IRS#Competitive Improvement Program#CAS\\n\\nPERCENT#more-likely-than-not\\n\\nPERSON#Positive results\\n\\nPRODUCT#retirement benefit plan payments\\n\\nTIME#fiscal 2016#fiscal 2015#fiscal 2014#fiscal 2017\\n\\nWORK_OF_ART#Non-deductible convertible subordinated notes interest#Non-deductible premiums on repurchase of convertible subordinated notes}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2418,\n",
      "    \"completion_tokens\": 382,\n",
      "    \"total_tokens\": 2800\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'Rocketdyne Business acquisition integration', 'category': 'EVENT'}, {'entity': 'Competitive Improvement Program', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Section 199 of the IRS code', 'category': 'LAW'}, {'entity': '$343.7 million', 'category': 'MONEY'}, {'entity': 'IRS', 'category': 'ORG'}, {'entity': 'Competitive Improvement Program', 'category': 'ORG'}, {'entity': 'CAS', 'category': 'ORG'}, {'entity': 'more-likely-than-not', 'category': 'PERCENT'}, {'entity': 'Positive results', 'category': 'PERSON'}, {'entity': 'retirement benefit plan payments', 'category': 'PRODUCT'}, {'entity': 'fiscal 2016', 'category': 'TIME'}, {'entity': 'fiscal 2015', 'category': 'TIME'}, {'entity': 'fiscal 2014', 'category': 'TIME'}, {'entity': 'fiscal 2017', 'category': 'TIME'}, {'entity': 'Non-deductible convertible subordinated notes interest', 'category': 'WORK_OF_ART'}, {'entity': 'Non-deductible premiums on repurchase of convertible subordinated notes', 'category': 'WORK_OF_ART'}, {'entity': '0.4', 'category': 'CARDINAL'}, {'entity': '0.3', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '0.3', 'category': 'CARDINAL'}, {'entity': '0.8', 'category': 'CARDINAL'}, {'entity': '1.4', 'category': 'CARDINAL'}, {'entity': '2.3', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '21.1', 'category': 'CARDINAL'}, {'entity': '4.1', 'category': 'CARDINAL'}, {'entity': '1.3', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '1.9', 'category': 'CARDINAL'}, {'entity': '1.7', 'category': 'CARDINAL'}, {'entity': '0.5', 'category': 'CARDINAL'}, {'entity': '1.0', 'category': 'CARDINAL'}, {'entity': '1.4', 'category': 'CARDINAL'}, {'entity': '0.6', 'category': 'CARDINAL'}, {'entity': '0.8', 'category': 'CARDINAL'}, {'entity': '0.6', 'category': 'CARDINAL'}, {'entity': '0.4', 'category': 'CARDINAL'}, {'entity': '0.7', 'category': 'CARDINAL'}, {'entity': '0.4', 'category': 'CARDINAL'}, {'entity': '0.8', 'category': 'CARDINAL'}, {'entity': '0.5', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '11.2', 'category': 'CARDINAL'}, {'entity': '0.3', 'category': 'CARDINAL'}, {'entity': '16.3', 'category': 'CARDINAL'}, {'entity': '2.0', 'category': 'CARDINAL'}, {'entity': '439.7', 'category': 'CARDINAL'}, {'entity': '343.7', 'category': 'CARDINAL'}, {'entity': '31', 'category': 'CARDINAL'}, {'entity': '2016', 'category': 'CARDINAL'}, {'entity': '2015', 'category': 'CARDINAL'}, {'entity': '14.0', 'category': 'CARDINAL'}, {'entity': '10.8', 'category': 'CARDINAL'}, {'entity': '8.9', 'category': 'CARDINAL'}, {'entity': '1.1', 'category': 'CARDINAL'}, {'entity': '66.0', 'category': 'CARDINAL'}, {'entity': '65.5', 'category': 'CARDINAL'}, {'entity': '69.6', 'category': 'CARDINAL'}, {'entity': '5.5', 'category': 'CARDINAL'}, {'entity': '70.1', 'category': 'CARDINAL'}, {'entity': '88.1', 'category': 'CARDINAL'}, {'entity': '92.6', 'category': 'CARDINAL'}, {'entity': '6.0', 'category': 'CARDINAL'}, {'entity': '1.1', 'category': 'CARDINAL'}, {'entity': '1.1', 'category': 'CARDINAL'}, {'entity': '0.9', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '60.1', 'category': 'CARDINAL'}, {'entity': '80.5', 'category': 'CARDINAL'}, {'entity': '51.5', 'category': 'CARDINAL'}, {'entity': '5.1', 'category': 'CARDINAL'}, {'entity': '68.9', 'category': 'CARDINAL'}, {'entity': '67.6', 'category': 'CARDINAL'}, {'entity': '36.5', 'category': 'CARDINAL'}, {'entity': '5.6', 'category': 'CARDINAL'}, {'entity': '73', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RW0Ij4i9hjJA6sEVVpVoLipoRNoI\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701568570,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#1#203.1#189.2#13.9#143.3#48.9#94.4#27.5#95.0#37.2#36.8#32.2#84.3#80.3#109.7#50.0#32.1 \\n\\nDATE#December 31#November 30#2016#2015#2014\\n\\nEVENT#Commercial Crew Development program#Antares AJ-26 Settlement Agreement#SLS development program#Orion program#J-2X program#THAAD program#Standard Missile programs#RL10 program#RS-68 programs#Antares AJ-26 program close-out#AR1 program\\n\\nFAC#Rocketdyne Business\\n\\nGPE#U.S.\\n\\nMONEY#$1,753.9#$1,660.0#$93.9#$64.0#$143.3#$48.9#$94.4#$189.2#$177.3#$11.9#$50.0#$95.8#$15.2#$21.3\\n\\nORDINAL#third#fourth\\n\\nORG#Aerojet Rocketdyne#Space Launch\\n\\nPERCENT#8.2#2.9#7.1#11.6#11.4#11.1#15.9#22.2\\n\\nPERSON#PAC-3\\n\\nPRODUCT#AJ-26\\n\\nQUANTITY#53#52#68\\n\\nTIME#52 weeks#53 weeks\\n\\nWORK_OF_ART#Segment margin before environmental remediation provision adjustments, retirement benefit expense, Rocketdyne purchase accounting adjustments, and unusual items}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2676,\n",
      "    \"completion_tokens\": 339,\n",
      "    \"total_tokens\": 3015\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': 'Commercial Crew Development program', 'category': 'EVENT'}, {'entity': 'Antares AJ-26 Settlement Agreement', 'category': 'EVENT'}, {'entity': 'SLS development program', 'category': 'EVENT'}, {'entity': 'Orion program', 'category': 'EVENT'}, {'entity': 'J-2X program', 'category': 'EVENT'}, {'entity': 'THAAD program', 'category': 'EVENT'}, {'entity': 'Standard Missile programs', 'category': 'EVENT'}, {'entity': 'RL10 program', 'category': 'EVENT'}, {'entity': 'RS-68 programs', 'category': 'EVENT'}, {'entity': 'Antares AJ-26 program close-out', 'category': 'EVENT'}, {'entity': 'AR1 program', 'category': 'EVENT'}, {'entity': 'Rocketdyne Business', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '$1,753.9', 'category': 'MONEY'}, {'entity': '$1,660.0', 'category': 'MONEY'}, {'entity': '$93.9', 'category': 'MONEY'}, {'entity': '$64.0', 'category': 'MONEY'}, {'entity': '$143.3', 'category': 'MONEY'}, {'entity': '$48.9', 'category': 'MONEY'}, {'entity': '$94.4', 'category': 'MONEY'}, {'entity': '$189.2', 'category': 'MONEY'}, {'entity': '$177.3', 'category': 'MONEY'}, {'entity': '$11.9', 'category': 'MONEY'}, {'entity': '$50.0', 'category': 'MONEY'}, {'entity': '$95.8', 'category': 'MONEY'}, {'entity': '$15.2', 'category': 'MONEY'}, {'entity': '$21.3', 'category': 'MONEY'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': 'Space Launch', 'category': 'ORG'}, {'entity': '8.2', 'category': 'PERCENT'}, {'entity': '2.9', 'category': 'PERCENT'}, {'entity': '7.1', 'category': 'PERCENT'}, {'entity': '11.6', 'category': 'PERCENT'}, {'entity': '11.4', 'category': 'PERCENT'}, {'entity': '11.1', 'category': 'PERCENT'}, {'entity': '15.9', 'category': 'PERCENT'}, {'entity': '22.2', 'category': 'PERCENT'}, {'entity': 'PAC-3', 'category': 'PERSON'}, {'entity': 'AJ-26', 'category': 'PRODUCT'}, {'entity': '53', 'category': 'QUANTITY'}, {'entity': '52', 'category': 'QUANTITY'}, {'entity': '68', 'category': 'QUANTITY'}, {'entity': '52 weeks', 'category': 'TIME'}, {'entity': '53 weeks', 'category': 'TIME'}, {'entity': 'Segment margin before environmental remediation provision adjustments', 'category': 'WORK_OF_ART'}, {'entity': 'retirement benefit expense', 'category': 'WORK_OF_ART'}, {'entity': 'Rocketdyne purchase accounting adjustments', 'category': 'WORK_OF_ART'}, {'entity': 'and unusual items', 'category': 'WORK_OF_ART'}, {'entity': 'third', 'category': 'ORDINAL'}, {'entity': 'fourth', 'category': 'ORDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '203.1', 'category': 'CARDINAL'}, {'entity': '189.2', 'category': 'CARDINAL'}, {'entity': '13.9', 'category': 'CARDINAL'}, {'entity': '143.3', 'category': 'CARDINAL'}, {'entity': '48.9', 'category': 'CARDINAL'}, {'entity': '94.4', 'category': 'CARDINAL'}, {'entity': '27.5', 'category': 'CARDINAL'}, {'entity': '95.0', 'category': 'CARDINAL'}, {'entity': '37.2', 'category': 'CARDINAL'}, {'entity': '36.8', 'category': 'CARDINAL'}, {'entity': '32.2', 'category': 'CARDINAL'}, {'entity': '84.3', 'category': 'CARDINAL'}, {'entity': '80.3', 'category': 'CARDINAL'}, {'entity': '109.7', 'category': 'CARDINAL'}, {'entity': '50.0', 'category': 'CARDINAL'}, {'entity': '32.1', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RW0tAuXFfHFGSb5fkH1WUpYppiVg\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701568607,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#31#32.4#26.4#26.1#2.3#2.4#2.2#1.6#4.5#4.0#1.7#1.6#2016#2015#2014#7.4#48.3#40.9#42.0#550#30.6#0.5#0.2#29.3#16.8#33.0#9.0#32.5#50.4#52.7#3.8#64.9#65.1#63.7#5.1#41.4#67.6#36.5#5.6#34.5#51.9#61.7#0.4#202.0#217.9#181.5#23.9#27.5#158.4#65.1#150.6#2.3#47.6#36.8#43.4#1.2#110.8#28.3#107.2#3.5#315.3#442.1#725.6#650.6#410.3#208.5#1950s#1960s\\n\\nDATE#December 31, 2016#2015#2014#One month ended December 31, 2015#As of December 31, 2016#Year Ended#November 30,#2015#2014#Year Ended#December 31, 2016\\n\\nMONEY#$32.4 million#$26.4 million#$26.1 million#millions#$2.3#$2.4#$4.5#$4.0#$1.7#$1.6#$7.4#$48.3#$(40.9)#$42.0 million#$30.6 million#$(16.8)#$9.0#$(0.6)#$(0.3)#$(0.1)#$64.9#$65.1#$63.7#$(0.1)#$41.4#$67.6#$36.5#$(0.4)#$202.0#$(0.4)#$217.9#$181.5#$(0.4)#$23.9#$(0.4)#$158.4#$65.1#$150.6#$(2.3)#$(1.2)#$(0.1)#$315.3#$442.1#$(0.6)#$725.6#$650.6#$(410.3)#$(208.5)\\n\\nORG#Rocketdyne#Commercial Crew Development#RS-25#SLS#Real Estate Segment\\n\\nPRODUCT#Standard Missile#THAAD#RL10#Atlas V\\n\\nTIME#One month\\n\\nWORK_OF_ART#Adjusted EBITDAP}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2561,\n",
      "    \"completion_tokens\": 605,\n",
      "    \"total_tokens\": 3166\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': 'One month ended December 31, 2015', 'category': 'DATE'}, {'entity': 'As of December 31, 2016', 'category': 'DATE'}, {'entity': 'Year Ended', 'category': 'DATE'}, {'entity': 'November 30,', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': 'Year Ended', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': '$32.4 million', 'category': 'MONEY'}, {'entity': '$26.4 million', 'category': 'MONEY'}, {'entity': '$26.1 million', 'category': 'MONEY'}, {'entity': 'millions', 'category': 'MONEY'}, {'entity': '$2.3', 'category': 'MONEY'}, {'entity': '$2.4', 'category': 'MONEY'}, {'entity': '$4.5', 'category': 'MONEY'}, {'entity': '$4.0', 'category': 'MONEY'}, {'entity': '$1.7', 'category': 'MONEY'}, {'entity': '$1.6', 'category': 'MONEY'}, {'entity': '$7.4', 'category': 'MONEY'}, {'entity': '$48.3', 'category': 'MONEY'}, {'entity': '$40.9', 'category': 'MONEY'}, {'entity': '$42.0 million', 'category': 'MONEY'}, {'entity': '$30.6 million', 'category': 'MONEY'}, {'entity': '$16.8', 'category': 'MONEY'}, {'entity': '$9.0', 'category': 'MONEY'}, {'entity': '$0.6', 'category': 'MONEY'}, {'entity': '$0.3', 'category': 'MONEY'}, {'entity': '$0.1', 'category': 'MONEY'}, {'entity': '$64.9', 'category': 'MONEY'}, {'entity': '$65.1', 'category': 'MONEY'}, {'entity': '$63.7', 'category': 'MONEY'}, {'entity': '$0.1', 'category': 'MONEY'}, {'entity': '$41.4', 'category': 'MONEY'}, {'entity': '$67.6', 'category': 'MONEY'}, {'entity': '$36.5', 'category': 'MONEY'}, {'entity': '$0.4', 'category': 'MONEY'}, {'entity': '$202.0', 'category': 'MONEY'}, {'entity': '$0.4', 'category': 'MONEY'}, {'entity': '$217.9', 'category': 'MONEY'}, {'entity': '$181.5', 'category': 'MONEY'}, {'entity': '$0.4', 'category': 'MONEY'}, {'entity': '$23.9', 'category': 'MONEY'}, {'entity': '$0.4', 'category': 'MONEY'}, {'entity': '$158.4', 'category': 'MONEY'}, {'entity': '$65.1', 'category': 'MONEY'}, {'entity': '$150.6', 'category': 'MONEY'}, {'entity': '$2.3', 'category': 'MONEY'}, {'entity': '$1.2', 'category': 'MONEY'}, {'entity': '$0.1', 'category': 'MONEY'}, {'entity': '$315.3', 'category': 'MONEY'}, {'entity': '$442.1', 'category': 'MONEY'}, {'entity': '$0.6', 'category': 'MONEY'}, {'entity': '$725.6', 'category': 'MONEY'}, {'entity': '$650.6', 'category': 'MONEY'}, {'entity': '$410.3', 'category': 'MONEY'}, {'entity': '$208.5', 'category': 'MONEY'}, {'entity': 'Rocketdyne', 'category': 'ORG'}, {'entity': 'Commercial Crew Development', 'category': 'ORG'}, {'entity': 'RS-25', 'category': 'ORG'}, {'entity': 'SLS', 'category': 'ORG'}, {'entity': 'Real Estate Segment', 'category': 'ORG'}, {'entity': 'Standard Missile', 'category': 'PRODUCT'}, {'entity': 'THAAD', 'category': 'PRODUCT'}, {'entity': 'RL10', 'category': 'PRODUCT'}, {'entity': 'Atlas V', 'category': 'PRODUCT'}, {'entity': 'One month', 'category': 'TIME'}, {'entity': 'Adjusted EBITDAP', 'category': 'WORK_OF_ART'}, {'entity': '31', 'category': 'CARDINAL'}, {'entity': '32.4', 'category': 'CARDINAL'}, {'entity': '26.4', 'category': 'CARDINAL'}, {'entity': '26.1', 'category': 'CARDINAL'}, {'entity': '2.3', 'category': 'CARDINAL'}, {'entity': '2.4', 'category': 'CARDINAL'}, {'entity': '2.2', 'category': 'CARDINAL'}, {'entity': '1.6', 'category': 'CARDINAL'}, {'entity': '4.5', 'category': 'CARDINAL'}, {'entity': '4.0', 'category': 'CARDINAL'}, {'entity': '1.7', 'category': 'CARDINAL'}, {'entity': '1.6', 'category': 'CARDINAL'}, {'entity': '2016', 'category': 'CARDINAL'}, {'entity': '2015', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '7.4', 'category': 'CARDINAL'}, {'entity': '48.3', 'category': 'CARDINAL'}, {'entity': '40.9', 'category': 'CARDINAL'}, {'entity': '42.0', 'category': 'CARDINAL'}, {'entity': '550', 'category': 'CARDINAL'}, {'entity': '30.6', 'category': 'CARDINAL'}, {'entity': '0.5', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '29.3', 'category': 'CARDINAL'}, {'entity': '16.8', 'category': 'CARDINAL'}, {'entity': '33.0', 'category': 'CARDINAL'}, {'entity': '9.0', 'category': 'CARDINAL'}, {'entity': '32.5', 'category': 'CARDINAL'}, {'entity': '50.4', 'category': 'CARDINAL'}, {'entity': '52.7', 'category': 'CARDINAL'}, {'entity': '3.8', 'category': 'CARDINAL'}, {'entity': '64.9', 'category': 'CARDINAL'}, {'entity': '65.1', 'category': 'CARDINAL'}, {'entity': '63.7', 'category': 'CARDINAL'}, {'entity': '5.1', 'category': 'CARDINAL'}, {'entity': '41.4', 'category': 'CARDINAL'}, {'entity': '67.6', 'category': 'CARDINAL'}, {'entity': '36.5', 'category': 'CARDINAL'}, {'entity': '5.6', 'category': 'CARDINAL'}, {'entity': '34.5', 'category': 'CARDINAL'}, {'entity': '51.9', 'category': 'CARDINAL'}, {'entity': '61.7', 'category': 'CARDINAL'}, {'entity': '0.4', 'category': 'CARDINAL'}, {'entity': '202.0', 'category': 'CARDINAL'}, {'entity': '217.9', 'category': 'CARDINAL'}, {'entity': '181.5', 'category': 'CARDINAL'}, {'entity': '23.9', 'category': 'CARDINAL'}, {'entity': '27.5', 'category': 'CARDINAL'}, {'entity': '158.4', 'category': 'CARDINAL'}, {'entity': '65.1', 'category': 'CARDINAL'}, {'entity': '150.6', 'category': 'CARDINAL'}, {'entity': '2.3', 'category': 'CARDINAL'}, {'entity': '47.6', 'category': 'CARDINAL'}, {'entity': '36.8', 'category': 'CARDINAL'}, {'entity': '43.4', 'category': 'CARDINAL'}, {'entity': '1.2', 'category': 'CARDINAL'}, {'entity': '110.8', 'category': 'CARDINAL'}, {'entity': '28.3', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '3.5', 'category': 'CARDINAL'}, {'entity': '315.3', 'category': 'CARDINAL'}, {'entity': '442.1', 'category': 'CARDINAL'}, {'entity': '725.6', 'category': 'CARDINAL'}, {'entity': '650.6', 'category': 'CARDINAL'}, {'entity': '410.3', 'category': 'CARDINAL'}, {'entity': '208.5', 'category': 'CARDINAL'}, {'entity': '1950s', 'category': 'CARDINAL'}, {'entity': '1960s', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RW1eMXG1IX6qusfYaMrKcGyxvkBb\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701568654,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#6.5#5.5#7.1#0.3#159.6#210.1#210.1#326.0#96.3#126.8#126.8#178.3#8.5#8.5#14.4#264.4#345.4#345.4#518.7#0.6#4.3#4.3#6.3#265.0#349.7#349.7#525.0#68.0#15#128.0#26.9#8.2#163.1#8.2#171.3#24.0#4.5#3.3#31.8#1.9#33.7#21.6#9.7#3.4#34.7#4.3#39.0#130.4#21.7#8.1#160.2#5.8#166.0#44.3#129.7#2.0#176.0#0.6#176.6#21.7#11.3#2.3#35.3#1.2#36.5#153.0#140.1#7.8#300.9#5.2#306.1#0.5#0.9#3.4#4.3#152.6#136.7#7.8#297.1#5.2#302.3#80.0#3.5#3.9#87.4#22.5#13.4#3.2#39.1#0.9#40.0#210.1#126.8#8.5#345.4#4.3#349.7#87.4#59.4#10.4#5.9#2.7#9.0#0.5#176.6#126.3#13.8#13.5#5.2#17.8#33.7#8.1#5.8#4.0#3.0#1.5#11.3#20.0#20.0#19.9#0.1\\n\\nDATE#fiscal 2016#fiscal 2015#fiscal 2014#December 31, 2015#December 31, 2016#November 30, 2013#November 30, 2014#November 30, 2015#December 31, 2015#December 31, 2016#May 6, 2016#fiscal 2017\\n\\nEVENT#Aerojet Rocketdyne - Sacramento#Aerojet Rocketdyne - BPOU#Other Aerojet Rocketdyne sites#Total Aerojet Rocketdyne#Other sites#AerojetRocketdyne-Sacramento#AerojetRocketdyne-BPOU#OtherAerojetRocketdyneSites#TotalAerojetRocketdyne#Other#TotalEnvironmentalReserve\\n\\nMONEY#$6.5 million#$5.5 million#$7.1 million#$0.3 million#$159.6#$210.1#$210.1 - $326.0#$96.3#$126.8#$126.8 - $178.3#$8.5#$8.5 - $14.4#$264.4#$345.4#$345.4 - $518.7#$0.6#$4.3#$4.3 - $6.3#$265.0#$349.7#$349.7 - $525.0#$68.0 million#$128.0#$26.9#$8.2#$163.1#$8.2#$171.3#$24.0#$4.5#$3.3#$31.8#$1.9#$33.7#$21.6#$9.7#$3.4#$34.7#$4.3#$39.0#130.4#$21.7#$8.1#$160.2#$5.8#$166.0#44.3#129.7#2.0#176.0#0.6#176.6#21.7#11.3#2.3#35.3#1.2#36.5#153.0#140.1#7.8#300.9#5.2#306.1#0.5#0.9#3.4#4.3#152.6#136.7#7.8#297.1#5.2#302.3#80.0#3.5#3.9#87.4#22.5#13.4#3.2#39.1#0.9#40.0#210.1#126.8#8.5#345.4#4.3#349.7#87.4#59.4#10.4#5.9#2.7#9.0#0.5#176.6#126.3#13.8#13.5#5.2#17.8#33.7#8.1#5.8#4.0#3.0#1.5#11.3#20.0#20.0#19.9#0.1\\n\\nORG#Northrop Agreement#Atlantic Research Corporation#ARC#Aerojet Rocketdyne#U.S. government#Environmental Reserve\\n\\nPRODUCT#Pre-Close Environmental Costs\\n\\nQUANTITY#one month#fifteen year\\n\\nTIME#quarterly}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2699,\n",
      "    \"completion_tokens\": 1205,\n",
      "    \"total_tokens\": 3904\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'fiscal 2016', 'category': 'DATE'}, {'entity': 'fiscal 2015', 'category': 'DATE'}, {'entity': 'fiscal 2014', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'November 30, 2013', 'category': 'DATE'}, {'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'May 6, 2016', 'category': 'DATE'}, {'entity': 'fiscal 2017', 'category': 'DATE'}, {'entity': 'Aerojet Rocketdyne - Sacramento', 'category': 'EVENT'}, {'entity': 'Aerojet Rocketdyne - BPOU', 'category': 'EVENT'}, {'entity': 'Other Aerojet Rocketdyne sites', 'category': 'EVENT'}, {'entity': 'Total Aerojet Rocketdyne', 'category': 'EVENT'}, {'entity': 'Other sites', 'category': 'EVENT'}, {'entity': 'AerojetRocketdyne-Sacramento', 'category': 'EVENT'}, {'entity': 'AerojetRocketdyne-BPOU', 'category': 'EVENT'}, {'entity': 'OtherAerojetRocketdyneSites', 'category': 'EVENT'}, {'entity': 'TotalAerojetRocketdyne', 'category': 'EVENT'}, {'entity': 'Other', 'category': 'EVENT'}, {'entity': 'TotalEnvironmentalReserve', 'category': 'EVENT'}, {'entity': '$6.5 million', 'category': 'MONEY'}, {'entity': '$5.5 million', 'category': 'MONEY'}, {'entity': '$7.1 million', 'category': 'MONEY'}, {'entity': '$0.3 million', 'category': 'MONEY'}, {'entity': '$159.6', 'category': 'MONEY'}, {'entity': '$210.1', 'category': 'MONEY'}, {'entity': '$210.1 - $326.0', 'category': 'MONEY'}, {'entity': '$96.3', 'category': 'MONEY'}, {'entity': '$126.8', 'category': 'MONEY'}, {'entity': '$126.8 - $178.3', 'category': 'MONEY'}, {'entity': '$8.5', 'category': 'MONEY'}, {'entity': '$8.5 - $14.4', 'category': 'MONEY'}, {'entity': '$264.4', 'category': 'MONEY'}, {'entity': '$345.4', 'category': 'MONEY'}, {'entity': '$345.4 - $518.7', 'category': 'MONEY'}, {'entity': '$0.6', 'category': 'MONEY'}, {'entity': '$4.3', 'category': 'MONEY'}, {'entity': '$4.3 - $6.3', 'category': 'MONEY'}, {'entity': '$265.0', 'category': 'MONEY'}, {'entity': '$349.7', 'category': 'MONEY'}, {'entity': '$349.7 - $525.0', 'category': 'MONEY'}, {'entity': '$68.0 million', 'category': 'MONEY'}, {'entity': '$128.0', 'category': 'MONEY'}, {'entity': '$26.9', 'category': 'MONEY'}, {'entity': '$8.2', 'category': 'MONEY'}, {'entity': '$163.1', 'category': 'MONEY'}, {'entity': '$8.2', 'category': 'MONEY'}, {'entity': '$171.3', 'category': 'MONEY'}, {'entity': '$24.0', 'category': 'MONEY'}, {'entity': '$4.5', 'category': 'MONEY'}, {'entity': '$3.3', 'category': 'MONEY'}, {'entity': '$31.8', 'category': 'MONEY'}, {'entity': '$1.9', 'category': 'MONEY'}, {'entity': '$33.7', 'category': 'MONEY'}, {'entity': '$21.6', 'category': 'MONEY'}, {'entity': '$9.7', 'category': 'MONEY'}, {'entity': '$3.4', 'category': 'MONEY'}, {'entity': '$34.7', 'category': 'MONEY'}, {'entity': '$4.3', 'category': 'MONEY'}, {'entity': '$39.0', 'category': 'MONEY'}, {'entity': '130.4', 'category': 'MONEY'}, {'entity': '$21.7', 'category': 'MONEY'}, {'entity': '$8.1', 'category': 'MONEY'}, {'entity': '$160.2', 'category': 'MONEY'}, {'entity': '$5.8', 'category': 'MONEY'}, {'entity': '$166.0', 'category': 'MONEY'}, {'entity': '44.3', 'category': 'MONEY'}, {'entity': '129.7', 'category': 'MONEY'}, {'entity': '2.0', 'category': 'MONEY'}, {'entity': '176.0', 'category': 'MONEY'}, {'entity': '0.6', 'category': 'MONEY'}, {'entity': '176.6', 'category': 'MONEY'}, {'entity': '21.7', 'category': 'MONEY'}, {'entity': '11.3', 'category': 'MONEY'}, {'entity': '2.3', 'category': 'MONEY'}, {'entity': '35.3', 'category': 'MONEY'}, {'entity': '1.2', 'category': 'MONEY'}, {'entity': '36.5', 'category': 'MONEY'}, {'entity': '153.0', 'category': 'MONEY'}, {'entity': '140.1', 'category': 'MONEY'}, {'entity': '7.8', 'category': 'MONEY'}, {'entity': '300.9', 'category': 'MONEY'}, {'entity': '5.2', 'category': 'MONEY'}, {'entity': '306.1', 'category': 'MONEY'}, {'entity': '0.5', 'category': 'MONEY'}, {'entity': '0.9', 'category': 'MONEY'}, {'entity': '3.4', 'category': 'MONEY'}, {'entity': '4.3', 'category': 'MONEY'}, {'entity': '152.6', 'category': 'MONEY'}, {'entity': '136.7', 'category': 'MONEY'}, {'entity': '7.8', 'category': 'MONEY'}, {'entity': '297.1', 'category': 'MONEY'}, {'entity': '5.2', 'category': 'MONEY'}, {'entity': '302.3', 'category': 'MONEY'}, {'entity': '80.0', 'category': 'MONEY'}, {'entity': '3.5', 'category': 'MONEY'}, {'entity': '3.9', 'category': 'MONEY'}, {'entity': '87.4', 'category': 'MONEY'}, {'entity': '22.5', 'category': 'MONEY'}, {'entity': '13.4', 'category': 'MONEY'}, {'entity': '3.2', 'category': 'MONEY'}, {'entity': '39.1', 'category': 'MONEY'}, {'entity': '0.9', 'category': 'MONEY'}, {'entity': '40.0', 'category': 'MONEY'}, {'entity': '210.1', 'category': 'MONEY'}, {'entity': '126.8', 'category': 'MONEY'}, {'entity': '8.5', 'category': 'MONEY'}, {'entity': '345.4', 'category': 'MONEY'}, {'entity': '4.3', 'category': 'MONEY'}, {'entity': '349.7', 'category': 'MONEY'}, {'entity': '87.4', 'category': 'MONEY'}, {'entity': '59.4', 'category': 'MONEY'}, {'entity': '10.4', 'category': 'MONEY'}, {'entity': '5.9', 'category': 'MONEY'}, {'entity': '2.7', 'category': 'MONEY'}, {'entity': '9.0', 'category': 'MONEY'}, {'entity': '0.5', 'category': 'MONEY'}, {'entity': '176.6', 'category': 'MONEY'}, {'entity': '126.3', 'category': 'MONEY'}, {'entity': '13.8', 'category': 'MONEY'}, {'entity': '13.5', 'category': 'MONEY'}, {'entity': '5.2', 'category': 'MONEY'}, {'entity': '17.8', 'category': 'MONEY'}, {'entity': '33.7', 'category': 'MONEY'}, {'entity': '8.1', 'category': 'MONEY'}, {'entity': '5.8', 'category': 'MONEY'}, {'entity': '4.0', 'category': 'MONEY'}, {'entity': '3.0', 'category': 'MONEY'}, {'entity': '1.5', 'category': 'MONEY'}, {'entity': '11.3', 'category': 'MONEY'}, {'entity': '20.0', 'category': 'MONEY'}, {'entity': '20.0', 'category': 'MONEY'}, {'entity': '19.9', 'category': 'MONEY'}, {'entity': '0.1', 'category': 'MONEY'}, {'entity': 'Northrop Agreement', 'category': 'ORG'}, {'entity': 'Atlantic Research Corporation', 'category': 'ORG'}, {'entity': 'ARC', 'category': 'ORG'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'Environmental Reserve', 'category': 'ORG'}, {'entity': 'Pre-Close Environmental Costs', 'category': 'PRODUCT'}, {'entity': 'one month', 'category': 'QUANTITY'}, {'entity': 'fifteen year', 'category': 'QUANTITY'}, {'entity': 'quarterly', 'category': 'TIME'}, {'entity': '6.5', 'category': 'CARDINAL'}, {'entity': '5.5', 'category': 'CARDINAL'}, {'entity': '7.1', 'category': 'CARDINAL'}, {'entity': '0.3', 'category': 'CARDINAL'}, {'entity': '159.6', 'category': 'CARDINAL'}, {'entity': '210.1', 'category': 'CARDINAL'}, {'entity': '210.1', 'category': 'CARDINAL'}, {'entity': '326.0', 'category': 'CARDINAL'}, {'entity': '96.3', 'category': 'CARDINAL'}, {'entity': '126.8', 'category': 'CARDINAL'}, {'entity': '126.8', 'category': 'CARDINAL'}, {'entity': '178.3', 'category': 'CARDINAL'}, {'entity': '8.5', 'category': 'CARDINAL'}, {'entity': '8.5', 'category': 'CARDINAL'}, {'entity': '14.4', 'category': 'CARDINAL'}, {'entity': '264.4', 'category': 'CARDINAL'}, {'entity': '345.4', 'category': 'CARDINAL'}, {'entity': '345.4', 'category': 'CARDINAL'}, {'entity': '518.7', 'category': 'CARDINAL'}, {'entity': '0.6', 'category': 'CARDINAL'}, {'entity': '4.3', 'category': 'CARDINAL'}, {'entity': '4.3', 'category': 'CARDINAL'}, {'entity': '6.3', 'category': 'CARDINAL'}, {'entity': '265.0', 'category': 'CARDINAL'}, {'entity': '349.7', 'category': 'CARDINAL'}, {'entity': '349.7', 'category': 'CARDINAL'}, {'entity': '525.0', 'category': 'CARDINAL'}, {'entity': '68.0', 'category': 'CARDINAL'}, {'entity': '15', 'category': 'CARDINAL'}, {'entity': '128.0', 'category': 'CARDINAL'}, {'entity': '26.9', 'category': 'CARDINAL'}, {'entity': '8.2', 'category': 'CARDINAL'}, {'entity': '163.1', 'category': 'CARDINAL'}, {'entity': '8.2', 'category': 'CARDINAL'}, {'entity': '171.3', 'category': 'CARDINAL'}, {'entity': '24.0', 'category': 'CARDINAL'}, {'entity': '4.5', 'category': 'CARDINAL'}, {'entity': '3.3', 'category': 'CARDINAL'}, {'entity': '31.8', 'category': 'CARDINAL'}, {'entity': '1.9', 'category': 'CARDINAL'}, {'entity': '33.7', 'category': 'CARDINAL'}, {'entity': '21.6', 'category': 'CARDINAL'}, {'entity': '9.7', 'category': 'CARDINAL'}, {'entity': '3.4', 'category': 'CARDINAL'}, {'entity': '34.7', 'category': 'CARDINAL'}, {'entity': '4.3', 'category': 'CARDINAL'}, {'entity': '39.0', 'category': 'CARDINAL'}, {'entity': '130.4', 'category': 'CARDINAL'}, {'entity': '21.7', 'category': 'CARDINAL'}, {'entity': '8.1', 'category': 'CARDINAL'}, {'entity': '160.2', 'category': 'CARDINAL'}, {'entity': '5.8', 'category': 'CARDINAL'}, {'entity': '166.0', 'category': 'CARDINAL'}, {'entity': '44.3', 'category': 'CARDINAL'}, {'entity': '129.7', 'category': 'CARDINAL'}, {'entity': '2.0', 'category': 'CARDINAL'}, {'entity': '176.0', 'category': 'CARDINAL'}, {'entity': '0.6', 'category': 'CARDINAL'}, {'entity': '176.6', 'category': 'CARDINAL'}, {'entity': '21.7', 'category': 'CARDINAL'}, {'entity': '11.3', 'category': 'CARDINAL'}, {'entity': '2.3', 'category': 'CARDINAL'}, {'entity': '35.3', 'category': 'CARDINAL'}, {'entity': '1.2', 'category': 'CARDINAL'}, {'entity': '36.5', 'category': 'CARDINAL'}, {'entity': '153.0', 'category': 'CARDINAL'}, {'entity': '140.1', 'category': 'CARDINAL'}, {'entity': '7.8', 'category': 'CARDINAL'}, {'entity': '300.9', 'category': 'CARDINAL'}, {'entity': '5.2', 'category': 'CARDINAL'}, {'entity': '306.1', 'category': 'CARDINAL'}, {'entity': '0.5', 'category': 'CARDINAL'}, {'entity': '0.9', 'category': 'CARDINAL'}, {'entity': '3.4', 'category': 'CARDINAL'}, {'entity': '4.3', 'category': 'CARDINAL'}, {'entity': '152.6', 'category': 'CARDINAL'}, {'entity': '136.7', 'category': 'CARDINAL'}, {'entity': '7.8', 'category': 'CARDINAL'}, {'entity': '297.1', 'category': 'CARDINAL'}, {'entity': '5.2', 'category': 'CARDINAL'}, {'entity': '302.3', 'category': 'CARDINAL'}, {'entity': '80.0', 'category': 'CARDINAL'}, {'entity': '3.5', 'category': 'CARDINAL'}, {'entity': '3.9', 'category': 'CARDINAL'}, {'entity': '87.4', 'category': 'CARDINAL'}, {'entity': '22.5', 'category': 'CARDINAL'}, {'entity': '13.4', 'category': 'CARDINAL'}, {'entity': '3.2', 'category': 'CARDINAL'}, {'entity': '39.1', 'category': 'CARDINAL'}, {'entity': '0.9', 'category': 'CARDINAL'}, {'entity': '40.0', 'category': 'CARDINAL'}, {'entity': '210.1', 'category': 'CARDINAL'}, {'entity': '126.8', 'category': 'CARDINAL'}, {'entity': '8.5', 'category': 'CARDINAL'}, {'entity': '345.4', 'category': 'CARDINAL'}, {'entity': '4.3', 'category': 'CARDINAL'}, {'entity': '349.7', 'category': 'CARDINAL'}, {'entity': '87.4', 'category': 'CARDINAL'}, {'entity': '59.4', 'category': 'CARDINAL'}, {'entity': '10.4', 'category': 'CARDINAL'}, {'entity': '5.9', 'category': 'CARDINAL'}, {'entity': '2.7', 'category': 'CARDINAL'}, {'entity': '9.0', 'category': 'CARDINAL'}, {'entity': '0.5', 'category': 'CARDINAL'}, {'entity': '176.6', 'category': 'CARDINAL'}, {'entity': '126.3', 'category': 'CARDINAL'}, {'entity': '13.8', 'category': 'CARDINAL'}, {'entity': '13.5', 'category': 'CARDINAL'}, {'entity': '5.2', 'category': 'CARDINAL'}, {'entity': '17.8', 'category': 'CARDINAL'}, {'entity': '33.7', 'category': 'CARDINAL'}, {'entity': '8.1', 'category': 'CARDINAL'}, {'entity': '5.8', 'category': 'CARDINAL'}, {'entity': '4.0', 'category': 'CARDINAL'}, {'entity': '3.0', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '11.3', 'category': 'CARDINAL'}, {'entity': '20.0', 'category': 'CARDINAL'}, {'entity': '20.0', 'category': 'CARDINAL'}, {'entity': '19.9', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RW2i2sKSsMF9xc3atsOfrMTHA6fC\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701568720,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#20#12#1#68.0#24#189.7#119.2#70.5#68.0#2.5#99.2#87.9#187.1#21.4#23.2#1.7#3.2#99.1#82.3#181.4#133.6#27.2#21.1#6.1#226.6#76.5#303.1#0.4#3.3#0.2#0.5#223.9#76.5#300.4#67.3#30.7#2.0#1.2#262.5#70.5#333.0#67.3#45.0#7.8#5.1#2.0#7.4#35.1#15.7#3.8#3.6#2.7#2.1#7.2#3.8#3.6#133.6#95.6#10.5#10.2#3.9#13.4#31.2#13.8#6.8#3.4#2.8#1.1#3.3#25.4#24#21.4#5.1#3.7#2.5#1.9#1.5#6.7\\n\\nDATE#January 12, 1999#December 1, 1998#2001#December 31, 2016#November 30, 2013#November 30, 2014#November 30, 2015#December 31, 2015#December 31, 2016\\n\\nLAW#Northrop Agreement#Global Settlement\\n\\nMONEY#$20 million#$68.0 million#$189.7 million\\n\\nORG#Aerojet Rocketdyne#U.S. government#Aerospace and Defense#Northrop\\n\\nPERCENT#24%\\n\\nPERSON#Northrop#Aerojet Rocketdyne\\n\\nPRODUCT#Pre-Close Environmental Costs#EIS business\\n\\nTIME#one month}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2581,\n",
      "    \"completion_tokens\": 458,\n",
      "    \"total_tokens\": 3039\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'January 12, 1999', 'category': 'DATE'}, {'entity': 'December 1, 1998', 'category': 'DATE'}, {'entity': '2001', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'November 30, 2013', 'category': 'DATE'}, {'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'Northrop Agreement', 'category': 'LAW'}, {'entity': 'Global Settlement', 'category': 'LAW'}, {'entity': '$20 million', 'category': 'MONEY'}, {'entity': '$68.0 million', 'category': 'MONEY'}, {'entity': '$189.7 million', 'category': 'MONEY'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'Aerospace and Defense', 'category': 'ORG'}, {'entity': 'Northrop', 'category': 'ORG'}, {'entity': '24%', 'category': 'PERCENT'}, {'entity': 'Northrop', 'category': 'PERSON'}, {'entity': 'Aerojet Rocketdyne', 'category': 'PERSON'}, {'entity': 'Pre-Close Environmental Costs', 'category': 'PRODUCT'}, {'entity': 'EIS business', 'category': 'PRODUCT'}, {'entity': 'one month', 'category': 'TIME'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '68.0', 'category': 'CARDINAL'}, {'entity': '24', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '119.2', 'category': 'CARDINAL'}, {'entity': '70.5', 'category': 'CARDINAL'}, {'entity': '68.0', 'category': 'CARDINAL'}, {'entity': '2.5', 'category': 'CARDINAL'}, {'entity': '99.2', 'category': 'CARDINAL'}, {'entity': '87.9', 'category': 'CARDINAL'}, {'entity': '187.1', 'category': 'CARDINAL'}, {'entity': '21.4', 'category': 'CARDINAL'}, {'entity': '23.2', 'category': 'CARDINAL'}, {'entity': '1.7', 'category': 'CARDINAL'}, {'entity': '3.2', 'category': 'CARDINAL'}, {'entity': '99.1', 'category': 'CARDINAL'}, {'entity': '82.3', 'category': 'CARDINAL'}, {'entity': '181.4', 'category': 'CARDINAL'}, {'entity': '133.6', 'category': 'CARDINAL'}, {'entity': '27.2', 'category': 'CARDINAL'}, {'entity': '21.1', 'category': 'CARDINAL'}, {'entity': '6.1', 'category': 'CARDINAL'}, {'entity': '226.6', 'category': 'CARDINAL'}, {'entity': '76.5', 'category': 'CARDINAL'}, {'entity': '303.1', 'category': 'CARDINAL'}, {'entity': '0.4', 'category': 'CARDINAL'}, {'entity': '3.3', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '0.5', 'category': 'CARDINAL'}, {'entity': '223.9', 'category': 'CARDINAL'}, {'entity': '76.5', 'category': 'CARDINAL'}, {'entity': '300.4', 'category': 'CARDINAL'}, {'entity': '67.3', 'category': 'CARDINAL'}, {'entity': '30.7', 'category': 'CARDINAL'}, {'entity': '2.0', 'category': 'CARDINAL'}, {'entity': '1.2', 'category': 'CARDINAL'}, {'entity': '262.5', 'category': 'CARDINAL'}, {'entity': '70.5', 'category': 'CARDINAL'}, {'entity': '333.0', 'category': 'CARDINAL'}, {'entity': '67.3', 'category': 'CARDINAL'}, {'entity': '45.0', 'category': 'CARDINAL'}, {'entity': '7.8', 'category': 'CARDINAL'}, {'entity': '5.1', 'category': 'CARDINAL'}, {'entity': '2.0', 'category': 'CARDINAL'}, {'entity': '7.4', 'category': 'CARDINAL'}, {'entity': '35.1', 'category': 'CARDINAL'}, {'entity': '15.7', 'category': 'CARDINAL'}, {'entity': '3.8', 'category': 'CARDINAL'}, {'entity': '3.6', 'category': 'CARDINAL'}, {'entity': '2.7', 'category': 'CARDINAL'}, {'entity': '2.1', 'category': 'CARDINAL'}, {'entity': '7.2', 'category': 'CARDINAL'}, {'entity': '3.8', 'category': 'CARDINAL'}, {'entity': '3.6', 'category': 'CARDINAL'}, {'entity': '133.6', 'category': 'CARDINAL'}, {'entity': '95.6', 'category': 'CARDINAL'}, {'entity': '10.5', 'category': 'CARDINAL'}, {'entity': '10.2', 'category': 'CARDINAL'}, {'entity': '3.9', 'category': 'CARDINAL'}, {'entity': '13.4', 'category': 'CARDINAL'}, {'entity': '31.2', 'category': 'CARDINAL'}, {'entity': '13.8', 'category': 'CARDINAL'}, {'entity': '6.8', 'category': 'CARDINAL'}, {'entity': '3.4', 'category': 'CARDINAL'}, {'entity': '2.8', 'category': 'CARDINAL'}, {'entity': '1.1', 'category': 'CARDINAL'}, {'entity': '3.3', 'category': 'CARDINAL'}, {'entity': '25.4', 'category': 'CARDINAL'}, {'entity': '24', 'category': 'CARDINAL'}, {'entity': '21.4', 'category': 'CARDINAL'}, {'entity': '5.1', 'category': 'CARDINAL'}, {'entity': '3.7', 'category': 'CARDINAL'}, {'entity': '2.5', 'category': 'CARDINAL'}, {'entity': '1.9', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '6.7', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RW3MplPggs1tjzAzT5Ru5bW41lNf\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701568760,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#31.0#12.6#8.1#2.7#1.7#1.3#4.6#69.1#159.3#22.9#0.6#18.3#17.3#10.8#87.4#176.6#33.7#0.5#158.4#65.1#150.6#2.3#47.6#36.8#43.4#1.2#700.6#800.0#81.2#64.5#189.0#166.3#4.2#92.5#400.0#102.5#100.0#460.0#484.6#24.6#84.6#49.0#300.0#0.2#13.0#0.3#650.6#800.0#700.6#24.4#725.6#3.00#4.00#3.75#3.50#0.50#3.25#44.0#37.5#28.9#33.1#120.5#17.8#19.5#7.8#127.4#69.6#96.9#4.9#41.0#27.2#16.9\\n\\nDATE#Fiscal 2014#Year Ended#December 31, 2016#December 31, 2015#November 30, 2014#November 30, 2015#December 31, 2016#December 31, 2015#November 30, 2014#November 30, 2015#fiscal 2016#fiscal 2015#fiscal 2014#December 31, 2015#fiscal 2016#2015#2014#December 31, 2015#fiscal 2016#fiscal 2015#fiscal 2014#December 31, 2015#fiscal 2016#fiscal 2015#December 31, 2015#December 31, 2015#December 31, 2016#December 31, 2016#December 31, 2018#December 31, 2017#September 30, 2018#December 31, 2018#December 31, 2016\\n\\nMONEY#$31.0 million#$12.6 million#$8.1 million#$2.7 million#$1.7 million#$1.3 million#$4.6 million#$69.1 million#$159.3 million#$22.9 million#$87.4 million#$176.6 million#$33.7 Million#$158.4 million#$65.1 million#$150.6 million#$2.3 million#$47.6 million#$36.8 million#$43.4 million#$1.2 million#$700.6 million#$800.0 million#$81.2 million#$64.5 million#$189.0 million#$166.3 million#$4.2 million#$92.5 million#$400.0 million#$102.5 million#$100.0 million#$460.0 million#$484.6 million#$84.6 million#$49.0 million#$300.0 million#$13.0 million#$650.6 million\\n\\nORG#Camden, Arkansas#Summarized#Northrop#U.S. government#Income#Cash#PAC-3#Atlas V#Standard Missile#Rocketdyne Business#Debt Activity and Covenants#Senior Credit Facility#Capital ResourcesNet\\n\\nPERSON#ii#UTC#Transition Service Agreements\\n\\nPRODUCT#Atlas\\n\\nTIME#One month\\n\\nWORK_OF_ART#Standard Missile programs#Competitive Improvement Plan}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2711,\n",
      "    \"completion_tokens\": 809,\n",
      "    \"total_tokens\": 3520\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'Fiscal 2014', 'category': 'DATE'}, {'entity': 'Year Ended', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': 'fiscal 2016', 'category': 'DATE'}, {'entity': 'fiscal 2015', 'category': 'DATE'}, {'entity': 'fiscal 2014', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'fiscal 2016', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'fiscal 2016', 'category': 'DATE'}, {'entity': 'fiscal 2015', 'category': 'DATE'}, {'entity': 'fiscal 2014', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'fiscal 2016', 'category': 'DATE'}, {'entity': 'fiscal 2015', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': 'September 30, 2018', 'category': 'DATE'}, {'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': '$31.0 million', 'category': 'MONEY'}, {'entity': '$12.6 million', 'category': 'MONEY'}, {'entity': '$8.1 million', 'category': 'MONEY'}, {'entity': '$2.7 million', 'category': 'MONEY'}, {'entity': '$1.7 million', 'category': 'MONEY'}, {'entity': '$1.3 million', 'category': 'MONEY'}, {'entity': '$4.6 million', 'category': 'MONEY'}, {'entity': '$69.1 million', 'category': 'MONEY'}, {'entity': '$159.3 million', 'category': 'MONEY'}, {'entity': '$22.9 million', 'category': 'MONEY'}, {'entity': '$87.4 million', 'category': 'MONEY'}, {'entity': '$176.6 million', 'category': 'MONEY'}, {'entity': '$33.7 Million', 'category': 'MONEY'}, {'entity': '$158.4 million', 'category': 'MONEY'}, {'entity': '$65.1 million', 'category': 'MONEY'}, {'entity': '$150.6 million', 'category': 'MONEY'}, {'entity': '$2.3 million', 'category': 'MONEY'}, {'entity': '$47.6 million', 'category': 'MONEY'}, {'entity': '$36.8 million', 'category': 'MONEY'}, {'entity': '$43.4 million', 'category': 'MONEY'}, {'entity': '$1.2 million', 'category': 'MONEY'}, {'entity': '$700.6 million', 'category': 'MONEY'}, {'entity': '$800.0 million', 'category': 'MONEY'}, {'entity': '$81.2 million', 'category': 'MONEY'}, {'entity': '$64.5 million', 'category': 'MONEY'}, {'entity': '$189.0 million', 'category': 'MONEY'}, {'entity': '$166.3 million', 'category': 'MONEY'}, {'entity': '$4.2 million', 'category': 'MONEY'}, {'entity': '$92.5 million', 'category': 'MONEY'}, {'entity': '$400.0 million', 'category': 'MONEY'}, {'entity': '$102.5 million', 'category': 'MONEY'}, {'entity': '$100.0 million', 'category': 'MONEY'}, {'entity': '$460.0 million', 'category': 'MONEY'}, {'entity': '$484.6 million', 'category': 'MONEY'}, {'entity': '$84.6 million', 'category': 'MONEY'}, {'entity': '$49.0 million', 'category': 'MONEY'}, {'entity': '$300.0 million', 'category': 'MONEY'}, {'entity': '$13.0 million', 'category': 'MONEY'}, {'entity': '$650.6 million', 'category': 'MONEY'}, {'entity': 'Camden, Arkansas', 'category': 'ORG'}, {'entity': 'Summarized', 'category': 'ORG'}, {'entity': 'Northrop', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'Income', 'category': 'ORG'}, {'entity': 'Cash', 'category': 'ORG'}, {'entity': 'PAC-3', 'category': 'ORG'}, {'entity': 'Atlas V', 'category': 'ORG'}, {'entity': 'Standard Missile', 'category': 'ORG'}, {'entity': 'Rocketdyne Business', 'category': 'ORG'}, {'entity': 'Debt Activity and Covenants', 'category': 'ORG'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': 'Capital ResourcesNet', 'category': 'ORG'}, {'entity': 'ii', 'category': 'PERSON'}, {'entity': 'UTC', 'category': 'PERSON'}, {'entity': 'Transition Service Agreements', 'category': 'PERSON'}, {'entity': 'Atlas', 'category': 'PRODUCT'}, {'entity': 'One month', 'category': 'TIME'}, {'entity': 'Standard Missile programs', 'category': 'WORK_OF_ART'}, {'entity': 'Competitive Improvement Plan', 'category': 'WORK_OF_ART'}, {'entity': '31.0', 'category': 'CARDINAL'}, {'entity': '12.6', 'category': 'CARDINAL'}, {'entity': '8.1', 'category': 'CARDINAL'}, {'entity': '2.7', 'category': 'CARDINAL'}, {'entity': '1.7', 'category': 'CARDINAL'}, {'entity': '1.3', 'category': 'CARDINAL'}, {'entity': '4.6', 'category': 'CARDINAL'}, {'entity': '69.1', 'category': 'CARDINAL'}, {'entity': '159.3', 'category': 'CARDINAL'}, {'entity': '22.9', 'category': 'CARDINAL'}, {'entity': '0.6', 'category': 'CARDINAL'}, {'entity': '18.3', 'category': 'CARDINAL'}, {'entity': '17.3', 'category': 'CARDINAL'}, {'entity': '10.8', 'category': 'CARDINAL'}, {'entity': '87.4', 'category': 'CARDINAL'}, {'entity': '176.6', 'category': 'CARDINAL'}, {'entity': '33.7', 'category': 'CARDINAL'}, {'entity': '0.5', 'category': 'CARDINAL'}, {'entity': '158.4', 'category': 'CARDINAL'}, {'entity': '65.1', 'category': 'CARDINAL'}, {'entity': '150.6', 'category': 'CARDINAL'}, {'entity': '2.3', 'category': 'CARDINAL'}, {'entity': '47.6', 'category': 'CARDINAL'}, {'entity': '36.8', 'category': 'CARDINAL'}, {'entity': '43.4', 'category': 'CARDINAL'}, {'entity': '1.2', 'category': 'CARDINAL'}, {'entity': '700.6', 'category': 'CARDINAL'}, {'entity': '800.0', 'category': 'CARDINAL'}, {'entity': '81.2', 'category': 'CARDINAL'}, {'entity': '64.5', 'category': 'CARDINAL'}, {'entity': '189.0', 'category': 'CARDINAL'}, {'entity': '166.3', 'category': 'CARDINAL'}, {'entity': '4.2', 'category': 'CARDINAL'}, {'entity': '92.5', 'category': 'CARDINAL'}, {'entity': '400.0', 'category': 'CARDINAL'}, {'entity': '102.5', 'category': 'CARDINAL'}, {'entity': '100.0', 'category': 'CARDINAL'}, {'entity': '460.0', 'category': 'CARDINAL'}, {'entity': '484.6', 'category': 'CARDINAL'}, {'entity': '24.6', 'category': 'CARDINAL'}, {'entity': '84.6', 'category': 'CARDINAL'}, {'entity': '49.0', 'category': 'CARDINAL'}, {'entity': '300.0', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '13.0', 'category': 'CARDINAL'}, {'entity': '0.3', 'category': 'CARDINAL'}, {'entity': '650.6', 'category': 'CARDINAL'}, {'entity': '800.0', 'category': 'CARDINAL'}, {'entity': '700.6', 'category': 'CARDINAL'}, {'entity': '24.4', 'category': 'CARDINAL'}, {'entity': '725.6', 'category': 'CARDINAL'}, {'entity': '3.00', 'category': 'CARDINAL'}, {'entity': '4.00', 'category': 'CARDINAL'}, {'entity': '3.75', 'category': 'CARDINAL'}, {'entity': '3.50', 'category': 'CARDINAL'}, {'entity': '0.50', 'category': 'CARDINAL'}, {'entity': '3.25', 'category': 'CARDINAL'}, {'entity': '44.0', 'category': 'CARDINAL'}, {'entity': '37.5', 'category': 'CARDINAL'}, {'entity': '28.9', 'category': 'CARDINAL'}, {'entity': '33.1', 'category': 'CARDINAL'}, {'entity': '120.5', 'category': 'CARDINAL'}, {'entity': '17.8', 'category': 'CARDINAL'}, {'entity': '19.5', 'category': 'CARDINAL'}, {'entity': '7.8', 'category': 'CARDINAL'}, {'entity': '127.4', 'category': 'CARDINAL'}, {'entity': '69.6', 'category': 'CARDINAL'}, {'entity': '96.9', 'category': 'CARDINAL'}, {'entity': '4.9', 'category': 'CARDINAL'}, {'entity': '41.0', 'category': 'CARDINAL'}, {'entity': '27.2', 'category': 'CARDINAL'}, {'entity': '16.9', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RW4EqsbSctdXI6TEge0BjDJvJQD9\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701568814,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#11.07 to 1.00#3.00 to 1.00#2.59 to 1.00#4.00 to 1.00#$304.7 million#3.9 million#$35.6 million#$72.0 million\\n\\nDATE#the next twelve months#December 31, 2016#December 2016#February 3, 2017#January 2017#as of December 31, 2016#10 years#as of December 31, 2016\\n\\nEVENT#conversion of Debentures to common stock\\n\\nFAC#Senior Credit Facility\\n\\nMONEY#100% of the principal#100% of the principal amount\\n\\nNORP#U.S. government#U.S.\\n\\nORG#lenders#Senior Credit Facility#2\\u00bc% Notes\\n\\nPERCENT#100%\\n\\nPERSON#Notes 7(b) and 7(c)\\n\\nPRODUCT#4 1/16% Debentures#common stock#equity securities\\n\\nTIME#the next 12 months\\n\\nWORK_OF_ART#Part I, Item 1A. Risk Factors}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2404,\n",
      "    \"completion_tokens\": 235,\n",
      "    \"total_tokens\": 2639\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'the next twelve months', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'December 2016', 'category': 'DATE'}, {'entity': 'February 3, 2017', 'category': 'DATE'}, {'entity': 'January 2017', 'category': 'DATE'}, {'entity': 'as of December 31, 2016', 'category': 'DATE'}, {'entity': '10 years', 'category': 'DATE'}, {'entity': 'as of December 31, 2016', 'category': 'DATE'}, {'entity': 'conversion of Debentures to common stock', 'category': 'EVENT'}, {'entity': 'Senior Credit Facility', 'category': 'FAC'}, {'entity': '100% of the principal', 'category': 'MONEY'}, {'entity': '100% of the principal amount', 'category': 'MONEY'}, {'entity': 'U.S. government', 'category': 'NORP'}, {'entity': 'U.S.', 'category': 'NORP'}, {'entity': 'lenders', 'category': 'ORG'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': '2¼% Notes', 'category': 'ORG'}, {'entity': '100%', 'category': 'PERCENT'}, {'entity': 'Notes 7b and 7c', 'category': 'PERSON'}, {'entity': '4 1/16% Debentures', 'category': 'PRODUCT'}, {'entity': 'common stock', 'category': 'PRODUCT'}, {'entity': 'equity securities', 'category': 'PRODUCT'}, {'entity': 'the next 12 months', 'category': 'TIME'}, {'entity': 'Part I', 'category': 'WORK_OF_ART'}, {'entity': 'Item 1A. Risk Factors', 'category': 'WORK_OF_ART'}, {'entity': '11.07 to 1.00', 'category': 'CARDINAL'}, {'entity': '3.00 to 1.00', 'category': 'CARDINAL'}, {'entity': '2.59 to 1.00', 'category': 'CARDINAL'}, {'entity': '4.00 to 1.00', 'category': 'CARDINAL'}, {'entity': '$304.7 million', 'category': 'CARDINAL'}, {'entity': '3.9 million', 'category': 'CARDINAL'}, {'entity': '$35.6 million', 'category': 'CARDINAL'}, {'entity': '$72.0 million', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RW4mIwxnMv6G65eDCqTgYqG9OJRv\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701568848,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#37.0 million#35.0 million#45.3 million#44.5 million#120.0 million#one-year\\n\\nDATE#fiscal 2017#December 31, 2016#2017\\n\\nGPE#U.S.\\n\\nMONEY#$37.0 million#$35.0 million#$45.3 million#$44.5 million#$120.0 million\\n\\nORG#Aerojet Rocketdyne#Senior Credit Facility#GAAP#SEC\\n\\nPERSON#us\\n\\nPRODUCT#product warranties\\n\\nWORK_OF_ART#Off-Balance Sheet Risk}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 1994,\n",
      "    \"completion_tokens\": 122,\n",
      "    \"total_tokens\": 2116\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'fiscal 2017', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '$37.0 million', 'category': 'MONEY'}, {'entity': '$35.0 million', 'category': 'MONEY'}, {'entity': '$45.3 million', 'category': 'MONEY'}, {'entity': '$44.5 million', 'category': 'MONEY'}, {'entity': '$120.0 million', 'category': 'MONEY'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'us', 'category': 'PERSON'}, {'entity': 'product warranties', 'category': 'PRODUCT'}, {'entity': 'Off-Balance Sheet Risk', 'category': 'WORK_OF_ART'}, {'entity': '37.0 million', 'category': 'CARDINAL'}, {'entity': '35.0 million', 'category': 'CARDINAL'}, {'entity': '45.3 million', 'category': 'CARDINAL'}, {'entity': '44.5 million', 'category': 'CARDINAL'}, {'entity': '120.0 million', 'category': 'CARDINAL'}, {'entity': 'one-year', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RW5GJRIKUw1OhdXvt58GOihPHMnO\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701568878,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL:94#14.1#41.2#9.2#11.7#8.5#24.7#5.5#7.0#0.13#0.40#0.10#0.11#0.11#0.40#0.10#0.09#50 \\n\\nDATE:the last three fiscal years and one month ended December 31, 2015#Year Ended#One month ended#December 31#November 30#November 30#December 31#2016#2015#2014#2015#October 1, 2016#September 1, 2016#September 1, 2015\\n\\nEVENT:space launch systems\\n\\nORG:Aerospace and Defense#U.S. government#DCAA\\n\\nPERSON:Antares AJ-26}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2138,\n",
      "    \"completion_tokens\": 179,\n",
      "    \"total_tokens\": 2317\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'the last three fiscal years and one month ended December 31, 2015', 'category': 'DATE'}, {'entity': 'Year Ended', 'category': 'DATE'}, {'entity': 'One month ended', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': 'October 1, 2016', 'category': 'DATE'}, {'entity': 'September 1, 2016', 'category': 'DATE'}, {'entity': 'September 1, 2015', 'category': 'DATE'}, {'entity': 'space launch systems', 'category': 'EVENT'}, {'entity': 'Aerospace and Defense', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'DCAA', 'category': 'ORG'}, {'entity': 'Antares AJ-26', 'category': 'PERSON'}, {'entity': '94', 'category': 'CARDINAL'}, {'entity': '14.1', 'category': 'CARDINAL'}, {'entity': '41.2', 'category': 'CARDINAL'}, {'entity': '9.2', 'category': 'CARDINAL'}, {'entity': '11.7', 'category': 'CARDINAL'}, {'entity': '8.5', 'category': 'CARDINAL'}, {'entity': '24.7', 'category': 'CARDINAL'}, {'entity': '5.5', 'category': 'CARDINAL'}, {'entity': '7.0', 'category': 'CARDINAL'}, {'entity': '0.13', 'category': 'CARDINAL'}, {'entity': '0.40', 'category': 'CARDINAL'}, {'entity': '0.10', 'category': 'CARDINAL'}, {'entity': '0.11', 'category': 'CARDINAL'}, {'entity': '0.11', 'category': 'CARDINAL'}, {'entity': '0.40', 'category': 'CARDINAL'}, {'entity': '0.10', 'category': 'CARDINAL'}, {'entity': '0.09', 'category': 'CARDINAL'}, {'entity': '50', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RW5mot2vfbEIbMBIVjpFvN1hPI0j\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701568910,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#1%#2016#2015#2014#8.0%#7.0%#1 \\n\\nDATE#December 31, 2016#November 30#September 1#October 1#September 1, 2016#October 1, 2016#fiscal 2009#December 31#December 31, 2016#December 31, 2015#November 30, 2015#December 31, 2015#December 1, 2015#three years#December 31, 2016#fiscal 2016\\n\\nEVENT#annual test of goodwill impairment#change in fiscal year end#annual impairment testing date#long-range planning cycle#Retirement Benefit Plans#Retirement benefits\\n\\nFAC#\\n\\nGPE#U.S.\\n\\nLANGUAGE#\\n\\nLAW#GAAP\\n\\nLOC#\\n\\nMONEY#\\n\\nNORP#\\n\\nORDINAL#first \\n\\nORG#Retirement Benefit Plans\\n\\nPERCENT#4.02 %#4.36 %#3.68 %#3.99 %#4.36 %#3.96 %#4.54 %#4.26 %#3.99 %#3.54 %#3.98 %#3.87 %#7.00 %#8.00 %#8.00 %#7.00 %\\n\\nPERSON#\\n\\nPRODUCT#\\n\\nQUANTITY#One month \\n\\nTIME#\\n\\nWORK_OF_ART#\\n\\n}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2293,\n",
      "    \"completion_tokens\": 288,\n",
      "    \"total_tokens\": 2581\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': 'September 1', 'category': 'DATE'}, {'entity': 'October 1', 'category': 'DATE'}, {'entity': 'September 1, 2016', 'category': 'DATE'}, {'entity': 'October 1, 2016', 'category': 'DATE'}, {'entity': 'fiscal 2009', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'December 1, 2015', 'category': 'DATE'}, {'entity': 'three years', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'fiscal 2016', 'category': 'DATE'}, {'entity': 'annual test of goodwill impairment', 'category': 'EVENT'}, {'entity': 'change in fiscal year end', 'category': 'EVENT'}, {'entity': 'annual impairment testing date', 'category': 'EVENT'}, {'entity': 'long-range planning cycle', 'category': 'EVENT'}, {'entity': 'Retirement Benefit Plans', 'category': 'EVENT'}, {'entity': 'Retirement benefits', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'GAAP', 'category': 'LAW'}, {'entity': 'Retirement Benefit Plans', 'category': 'ORG'}, {'entity': '4.02 %', 'category': 'PERCENT'}, {'entity': '4.36 %', 'category': 'PERCENT'}, {'entity': '3.68 %', 'category': 'PERCENT'}, {'entity': '3.99 %', 'category': 'PERCENT'}, {'entity': '4.36 %', 'category': 'PERCENT'}, {'entity': '3.96 %', 'category': 'PERCENT'}, {'entity': '4.54 %', 'category': 'PERCENT'}, {'entity': '4.26 %', 'category': 'PERCENT'}, {'entity': '3.99 %', 'category': 'PERCENT'}, {'entity': '3.54 %', 'category': 'PERCENT'}, {'entity': '3.98 %', 'category': 'PERCENT'}, {'entity': '3.87 %', 'category': 'PERCENT'}, {'entity': '7.00 %', 'category': 'PERCENT'}, {'entity': '8.00 %', 'category': 'PERCENT'}, {'entity': '8.00 %', 'category': 'PERCENT'}, {'entity': '7.00 %', 'category': 'PERCENT'}, {'entity': 'One month', 'category': 'QUANTITY'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '1%', 'category': 'CARDINAL'}, {'entity': '2016', 'category': 'CARDINAL'}, {'entity': '2015', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '8.0%', 'category': 'CARDINAL'}, {'entity': '7.0%', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RW6KHvo1xiEZnLIzNQwsCjNUYDG0\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701568944,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#100%#50%#46%#54%#335.6 million#2.44%#390.0 million#3.02%#725.6 million#7 1/8%#294.9#300.0#4 1/16%#70.8#149.5#35.6#84.6#13.0#0.6#755.7#735.2#650.6#3.9 million\\n\\nDATE#December 31, 2016#as of December 31, 2016#on February 3, 2017#In January 2017#December 31, 2015\\n\\nEVENT#Global Settlement#Northrop Agreement\\n\\nFAC#Senior Credit Facility\\n\\nGPE#U.S.\\n\\nLAW#U.S. federal income tax return\\n\\nMONEY#$725.6 million#$335.6 million#$390.0 million\\n\\nORG#the Company#U.S. government#world resources#taxing authorities\\n\\nPERCENT#100%#50%#46%#54%\\n\\nPERSON#third party\\n\\nTIME#the past three fiscal years\\n\\nWORK_OF_ART#Term loan#7 1/8% Notes#2 1/4% Notes#4 1/16% Debentures#Delayed draw term loan#Other debt}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2090,\n",
      "    \"completion_tokens\": 283,\n",
      "    \"total_tokens\": 2373\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'as of December 31, 2016', 'category': 'DATE'}, {'entity': 'on February 3, 2017', 'category': 'DATE'}, {'entity': 'In January 2017', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'Global Settlement', 'category': 'EVENT'}, {'entity': 'Northrop Agreement', 'category': 'EVENT'}, {'entity': 'Senior Credit Facility', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S. federal income tax return', 'category': 'LAW'}, {'entity': '$725.6 million', 'category': 'MONEY'}, {'entity': '$335.6 million', 'category': 'MONEY'}, {'entity': '$390.0 million', 'category': 'MONEY'}, {'entity': 'the Company', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'world resources', 'category': 'ORG'}, {'entity': 'taxing authorities', 'category': 'ORG'}, {'entity': '100%', 'category': 'PERCENT'}, {'entity': '50%', 'category': 'PERCENT'}, {'entity': '46%', 'category': 'PERCENT'}, {'entity': '54%', 'category': 'PERCENT'}, {'entity': 'third party', 'category': 'PERSON'}, {'entity': 'the past three fiscal years', 'category': 'TIME'}, {'entity': 'Term loan', 'category': 'WORK_OF_ART'}, {'entity': '7 1/8% Notes', 'category': 'WORK_OF_ART'}, {'entity': '2 1/4% Notes', 'category': 'WORK_OF_ART'}, {'entity': '4 1/16% Debentures', 'category': 'WORK_OF_ART'}, {'entity': 'Delayed draw term loan', 'category': 'WORK_OF_ART'}, {'entity': 'Other debt', 'category': 'WORK_OF_ART'}, {'entity': '100%', 'category': 'CARDINAL'}, {'entity': '50%', 'category': 'CARDINAL'}, {'entity': '46%', 'category': 'CARDINAL'}, {'entity': '54%', 'category': 'CARDINAL'}, {'entity': '335.6 million', 'category': 'CARDINAL'}, {'entity': '2.44%', 'category': 'CARDINAL'}, {'entity': '390.0 million', 'category': 'CARDINAL'}, {'entity': '3.02%', 'category': 'CARDINAL'}, {'entity': '725.6 million', 'category': 'CARDINAL'}, {'entity': '7 1/8%', 'category': 'CARDINAL'}, {'entity': '294.9', 'category': 'CARDINAL'}, {'entity': '300.0', 'category': 'CARDINAL'}, {'entity': '4 1/16%', 'category': 'CARDINAL'}, {'entity': '70.8', 'category': 'CARDINAL'}, {'entity': '149.5', 'category': 'CARDINAL'}, {'entity': '35.6', 'category': 'CARDINAL'}, {'entity': '84.6', 'category': 'CARDINAL'}, {'entity': '13.0', 'category': 'CARDINAL'}, {'entity': '0.6', 'category': 'CARDINAL'}, {'entity': '755.7', 'category': 'CARDINAL'}, {'entity': '735.2', 'category': 'CARDINAL'}, {'entity': '650.6', 'category': 'CARDINAL'}, {'entity': '3.9 million', 'category': 'CARDINAL'}]\n",
      "/home/damir/Dropbox/Documents/Teaching/2023/L715/l715_23/data/10-Ks/Aerojet_Rocketdyne_Holdings_Inc./2013/Management.txt\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RW6u9nbbC77hOYECu7Wp44iHolqp\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701568980,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#7#10#8#6#1#2#6#138.4#1,018#902#550#20.0#50#28#460.0#21#15#13#34.3 \\n\\nDATE#November 30, 2012#November 30, 2011#July 2012#the first half of 2013#January 28, 2013#July 21, 2013#August 16, 2012#November 30, 2012\\n\\nEVENT#Management\\u2019s Discussion and Analysis of Financial Condition and Results of Operations\\n\\nFAC#Rocketdyne Business\\n\\nGPE#U.S.\\n\\nLOC#NASA\\u2019s#the United States of America\\n\\nMONEY#$994.9 million#$918.1 million#($2.6) million#($0.04) loss#$2.9 million#$0.05#$110.9 million#$115.4 million#$119.2 million#$114.2 million#$86.2 million#$76.8 million#$49.0 million#$55.7 million#$86.6 million#$86.6 million in net debt#$138.4 million#$1,018 million#$902 million#$550 million#$550 million#$20.0 million#$460.0 million#$50 million#$11.6 million#$34.3 million\\n\\nORDINAL#first\\n\\nORG#GenCorp Inc.#GAAP#UTC#NASA#the Rocketdyne Business#the Securities Act#the Consolidated Financial Statements#our Senior Credit Facility#LDACS\\n\\nPERCENT#11.1%#12.6%\\n\\nPERSON#\\n\\nPRODUCT#\\n\\nTIME#\\n\\nWORK_OF_ART#Form 10-K#Item 1A. Risk Factors#Item 8. Consolidated Financial Statements and Supplementary Data#Annual Report#Report#7 1/8% Notes#Form 10-K#the 7 1/8% Notes#See Note 15 in Notes to the Consolidated Financial Statements#the Rocketdyne Business#Rule 144A#Regulation S#the 7 1/8% Notes#7 1/8% Notes#the Rocketdyne Business#the proposed Acquisition#the proposed acquisition#the 7 1/8% Notes#the Acquisition#the Acquisition#the Rocketdyne Business#the proposed acquisition#the Rocketdyne Business#LDACS#the Consolidated Financial Statements#the LDACS program#Note 13 in Notes to the Consolidated Financial Statements\\n}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2300,\n",
      "    \"completion_tokens\": 522,\n",
      "    \"total_tokens\": 2822\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'November 30, 2012', 'category': 'DATE'}, {'entity': 'November 30, 2011', 'category': 'DATE'}, {'entity': 'July 2012', 'category': 'DATE'}, {'entity': 'the first half of 2013', 'category': 'DATE'}, {'entity': 'January 28, 2013', 'category': 'DATE'}, {'entity': 'July 21, 2013', 'category': 'DATE'}, {'entity': 'August 16, 2012', 'category': 'DATE'}, {'entity': 'November 30, 2012', 'category': 'DATE'}, {'entity': 'Management’s Discussion and Analysis of Financial Condition and Results of Operations', 'category': 'EVENT'}, {'entity': 'Rocketdyne Business', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'NASA’s', 'category': 'LOC'}, {'entity': 'the United States of America', 'category': 'LOC'}, {'entity': '$994.9 million', 'category': 'MONEY'}, {'entity': '$918.1 million', 'category': 'MONEY'}, {'entity': '$2.6 million', 'category': 'MONEY'}, {'entity': '$0.04 loss', 'category': 'MONEY'}, {'entity': '$2.9 million', 'category': 'MONEY'}, {'entity': '$0.05', 'category': 'MONEY'}, {'entity': '$110.9 million', 'category': 'MONEY'}, {'entity': '$115.4 million', 'category': 'MONEY'}, {'entity': '$119.2 million', 'category': 'MONEY'}, {'entity': '$114.2 million', 'category': 'MONEY'}, {'entity': '$86.2 million', 'category': 'MONEY'}, {'entity': '$76.8 million', 'category': 'MONEY'}, {'entity': '$49.0 million', 'category': 'MONEY'}, {'entity': '$55.7 million', 'category': 'MONEY'}, {'entity': '$86.6 million', 'category': 'MONEY'}, {'entity': '$86.6 million in net debt', 'category': 'MONEY'}, {'entity': '$138.4 million', 'category': 'MONEY'}, {'entity': '$1,018 million', 'category': 'MONEY'}, {'entity': '$902 million', 'category': 'MONEY'}, {'entity': '$550 million', 'category': 'MONEY'}, {'entity': '$550 million', 'category': 'MONEY'}, {'entity': '$20.0 million', 'category': 'MONEY'}, {'entity': '$460.0 million', 'category': 'MONEY'}, {'entity': '$50 million', 'category': 'MONEY'}, {'entity': '$11.6 million', 'category': 'MONEY'}, {'entity': '$34.3 million', 'category': 'MONEY'}, {'entity': 'GenCorp Inc.', 'category': 'ORG'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': 'UTC', 'category': 'ORG'}, {'entity': 'NASA', 'category': 'ORG'}, {'entity': 'the Rocketdyne Business', 'category': 'ORG'}, {'entity': 'the Securities Act', 'category': 'ORG'}, {'entity': 'the Consolidated Financial Statements', 'category': 'ORG'}, {'entity': 'our Senior Credit Facility', 'category': 'ORG'}, {'entity': 'LDACS', 'category': 'ORG'}, {'entity': '11.1%', 'category': 'PERCENT'}, {'entity': '12.6%', 'category': 'PERCENT'}, {'entity': 'Form 10-K', 'category': 'WORK_OF_ART'}, {'entity': 'Item 1A. Risk Factors', 'category': 'WORK_OF_ART'}, {'entity': 'Item 8. Consolidated Financial Statements and Supplementary Data', 'category': 'WORK_OF_ART'}, {'entity': 'Annual Report', 'category': 'WORK_OF_ART'}, {'entity': 'Report', 'category': 'WORK_OF_ART'}, {'entity': '7 1/8% Notes', 'category': 'WORK_OF_ART'}, {'entity': 'Form 10-K', 'category': 'WORK_OF_ART'}, {'entity': 'the 7 1/8% Notes', 'category': 'WORK_OF_ART'}, {'entity': 'See Note 15 in Notes to the Consolidated Financial Statements', 'category': 'WORK_OF_ART'}, {'entity': 'the Rocketdyne Business', 'category': 'WORK_OF_ART'}, {'entity': 'Rule 144A', 'category': 'WORK_OF_ART'}, {'entity': 'Regulation S', 'category': 'WORK_OF_ART'}, {'entity': 'the 7 1/8% Notes', 'category': 'WORK_OF_ART'}, {'entity': '7 1/8% Notes', 'category': 'WORK_OF_ART'}, {'entity': 'the Rocketdyne Business', 'category': 'WORK_OF_ART'}, {'entity': 'the proposed Acquisition', 'category': 'WORK_OF_ART'}, {'entity': 'the proposed acquisition', 'category': 'WORK_OF_ART'}, {'entity': 'the 7 1/8% Notes', 'category': 'WORK_OF_ART'}, {'entity': 'the Acquisition', 'category': 'WORK_OF_ART'}, {'entity': 'the Acquisition', 'category': 'WORK_OF_ART'}, {'entity': 'the Rocketdyne Business', 'category': 'WORK_OF_ART'}, {'entity': 'the proposed acquisition', 'category': 'WORK_OF_ART'}, {'entity': 'the Rocketdyne Business', 'category': 'WORK_OF_ART'}, {'entity': 'LDACS', 'category': 'WORK_OF_ART'}, {'entity': 'the Consolidated Financial Statements', 'category': 'WORK_OF_ART'}, {'entity': 'the LDACS program', 'category': 'WORK_OF_ART'}, {'entity': 'Note 13 in Notes to the Consolidated Financial Statements', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '138.4', 'category': 'CARDINAL'}, {'entity': '1,018', 'category': 'CARDINAL'}, {'entity': '902', 'category': 'CARDINAL'}, {'entity': '550', 'category': 'CARDINAL'}, {'entity': '20.0', 'category': 'CARDINAL'}, {'entity': '50', 'category': 'CARDINAL'}, {'entity': '28', 'category': 'CARDINAL'}, {'entity': '460.0', 'category': 'CARDINAL'}, {'entity': '21', 'category': 'CARDINAL'}, {'entity': '15', 'category': 'CARDINAL'}, {'entity': '13', 'category': 'CARDINAL'}, {'entity': '34.3', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RW7cOwVGJshkRBVA8t3qiG2fJO35\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701569024,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#37#36#32#28#27#94#93#92#25#24#26#2013#1.2#2012#525.4#45#5.2#259#487#17.7#140.5#220.5#31.2#63.5#10.8#25.8#7.0#11.1#189.5#320.9#69.3#12\\n\\nDATE#Year Ended 2012#Year Ended 2011#Year Ended 2010#GFY ended September 30, 2012#February 13, 2012#January 2, 2013#November 30, 2012#third quarter of fiscal 2010\\n\\nEVENT#American Taxpayer Relief Act of 2012#Budget Control Act of 2011#Budget Control Act\\n\\nFAC#Baldwin Park Operable Unit#Sacramento\\n\\nGPE#U.S.\\n\\nLAW#the American Taxpayer Relief Act of 2012#Budget Control Act of 2011\\n\\nMONEY#$525.4 billion#$45 billion#$5.2 billion#$259 billion#$487 billion#$17.7 billion#$140.5 million#$220.5 million#$31.2 million#$63.5 million#$10.8 million#$25.8 million#$7.0 million#$11.1 million#$189.5 million#$320.9 million#$69.3 million\\n\\nNORP#Congressional Joint Select Committee on Deficit Reduction#Congress\\n\\nORG#U.S. government#NASA#DoD#Executive Branch#GFY#Congress#Northrop Agreement#Northrop#Aerospace and Defense segment\\n\\nPERCENT#10%#37%#36%#32%#28%#27%#94%#93%#92%#25%#24%#26%#37\\n\\nPRODUCT#Standard Missile program#ERP system\\n\\nWORK_OF_ART#Rocketdyne Business}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2310,\n",
      "    \"completion_tokens\": 420,\n",
      "    \"total_tokens\": 2730\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'Year Ended 2012', 'category': 'DATE'}, {'entity': 'Year Ended 2011', 'category': 'DATE'}, {'entity': 'Year Ended 2010', 'category': 'DATE'}, {'entity': 'GFY ended September 30, 2012', 'category': 'DATE'}, {'entity': 'February 13, 2012', 'category': 'DATE'}, {'entity': 'January 2, 2013', 'category': 'DATE'}, {'entity': 'November 30, 2012', 'category': 'DATE'}, {'entity': 'third quarter of fiscal 2010', 'category': 'DATE'}, {'entity': 'American Taxpayer Relief Act of 2012', 'category': 'EVENT'}, {'entity': 'Budget Control Act of 2011', 'category': 'EVENT'}, {'entity': 'Budget Control Act', 'category': 'EVENT'}, {'entity': 'Baldwin Park Operable Unit', 'category': 'FAC'}, {'entity': 'Sacramento', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'the American Taxpayer Relief Act of 2012', 'category': 'LAW'}, {'entity': 'Budget Control Act of 2011', 'category': 'LAW'}, {'entity': '$525.4 billion', 'category': 'MONEY'}, {'entity': '$45 billion', 'category': 'MONEY'}, {'entity': '$5.2 billion', 'category': 'MONEY'}, {'entity': '$259 billion', 'category': 'MONEY'}, {'entity': '$487 billion', 'category': 'MONEY'}, {'entity': '$17.7 billion', 'category': 'MONEY'}, {'entity': '$140.5 million', 'category': 'MONEY'}, {'entity': '$220.5 million', 'category': 'MONEY'}, {'entity': '$31.2 million', 'category': 'MONEY'}, {'entity': '$63.5 million', 'category': 'MONEY'}, {'entity': '$10.8 million', 'category': 'MONEY'}, {'entity': '$25.8 million', 'category': 'MONEY'}, {'entity': '$7.0 million', 'category': 'MONEY'}, {'entity': '$11.1 million', 'category': 'MONEY'}, {'entity': '$189.5 million', 'category': 'MONEY'}, {'entity': '$320.9 million', 'category': 'MONEY'}, {'entity': '$69.3 million', 'category': 'MONEY'}, {'entity': 'Congressional Joint Select Committee on Deficit Reduction', 'category': 'NORP'}, {'entity': 'Congress', 'category': 'NORP'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'NASA', 'category': 'ORG'}, {'entity': 'DoD', 'category': 'ORG'}, {'entity': 'Executive Branch', 'category': 'ORG'}, {'entity': 'GFY', 'category': 'ORG'}, {'entity': 'Congress', 'category': 'ORG'}, {'entity': 'Northrop Agreement', 'category': 'ORG'}, {'entity': 'Northrop', 'category': 'ORG'}, {'entity': 'Aerospace and Defense segment', 'category': 'ORG'}, {'entity': '10%', 'category': 'PERCENT'}, {'entity': '37%', 'category': 'PERCENT'}, {'entity': '36%', 'category': 'PERCENT'}, {'entity': '32%', 'category': 'PERCENT'}, {'entity': '28%', 'category': 'PERCENT'}, {'entity': '27%', 'category': 'PERCENT'}, {'entity': '94%', 'category': 'PERCENT'}, {'entity': '93%', 'category': 'PERCENT'}, {'entity': '92%', 'category': 'PERCENT'}, {'entity': '25%', 'category': 'PERCENT'}, {'entity': '24%', 'category': 'PERCENT'}, {'entity': '26%', 'category': 'PERCENT'}, {'entity': '37', 'category': 'PERCENT'}, {'entity': 'Standard Missile program', 'category': 'PRODUCT'}, {'entity': 'ERP system', 'category': 'PRODUCT'}, {'entity': 'Rocketdyne Business', 'category': 'WORK_OF_ART'}, {'entity': '37', 'category': 'CARDINAL'}, {'entity': '36', 'category': 'CARDINAL'}, {'entity': '32', 'category': 'CARDINAL'}, {'entity': '28', 'category': 'CARDINAL'}, {'entity': '27', 'category': 'CARDINAL'}, {'entity': '94', 'category': 'CARDINAL'}, {'entity': '93', 'category': 'CARDINAL'}, {'entity': '92', 'category': 'CARDINAL'}, {'entity': '25', 'category': 'CARDINAL'}, {'entity': '24', 'category': 'CARDINAL'}, {'entity': '26', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '1.2', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '525.4', 'category': 'CARDINAL'}, {'entity': '45', 'category': 'CARDINAL'}, {'entity': '5.2', 'category': 'CARDINAL'}, {'entity': '259', 'category': 'CARDINAL'}, {'entity': '487', 'category': 'CARDINAL'}, {'entity': '17.7', 'category': 'CARDINAL'}, {'entity': '140.5', 'category': 'CARDINAL'}, {'entity': '220.5', 'category': 'CARDINAL'}, {'entity': '31.2', 'category': 'CARDINAL'}, {'entity': '63.5', 'category': 'CARDINAL'}, {'entity': '10.8', 'category': 'CARDINAL'}, {'entity': '25.8', 'category': 'CARDINAL'}, {'entity': '7.0', 'category': 'CARDINAL'}, {'entity': '11.1', 'category': 'CARDINAL'}, {'entity': '189.5', 'category': 'CARDINAL'}, {'entity': '320.9', 'category': 'CARDINAL'}, {'entity': '69.3', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RW8GxmZsaISaT5aWaUygRAlLnjRG\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701569064,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#510#460#50#2015#84#64#32#37#29.0#23.4#918.1#857.9#869.6#799.3#753.9#41.9#40.9#26.7#22.3#24.6#27.9#26.2#14.5#11.9#960.0#879.3#820.4#34.9#38.8#37.5#22.3#30.8#37.0#0.6#1.0#1.6#21.7#29.8#35.4#13.2#9.0#2.1#18.9#6.1#3.9#5.7#2.9#6.0#3.1#2.6#2.9#6.8#994.9#918.1#76.8#918.1#857.9#60.2#39.6#34.5#17.7#24.9#27.7#24.8#22.2#22.0 \\n\\nDATE#fiscal 2012#November 30, 2012#January 28, 2013#fiscal year end 2011#fiscal year end 2012#November 30, 2012#July 6, 2012#fiscal 2015#fiscal 2013#November 2012#fiscal 2010#fiscal 2011\\n\\nEVENT#the proposed acquisition of the Rocketdyne Business#the sale of the 7 1/8% Note#MAP-21\\n\\nFAC#the Senior Credit Facility#the Office of Federal Procurement Policy\\n\\nGPE#U.S.\\n\\nLAW#Internal Revenue Service regulations\\n\\nMONEY#$248.7 million#$759 million#$454.5 million#$1,243.1 million#$32 million to $37 million#$29.0 million#$23.4 million\\n\\nORG#Standard Missile#T3#Hawk#SSST#Orion\\n\\nPERCENT#7 1/8%#84%\\n\\nPRODUCT#ERP system#Oracle Business Suite\\n\\nTIME#first quarter of fiscal 2012\\n\\nWORK_OF_ART#Note 15 in Notes to the Consolidated Financial Statements}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2477,\n",
      "    \"completion_tokens\": 501,\n",
      "    \"total_tokens\": 2978\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'fiscal 2012', 'category': 'DATE'}, {'entity': 'November 30, 2012', 'category': 'DATE'}, {'entity': 'January 28, 2013', 'category': 'DATE'}, {'entity': 'fiscal year end 2011', 'category': 'DATE'}, {'entity': 'fiscal year end 2012', 'category': 'DATE'}, {'entity': 'November 30, 2012', 'category': 'DATE'}, {'entity': 'July 6, 2012', 'category': 'DATE'}, {'entity': 'fiscal 2015', 'category': 'DATE'}, {'entity': 'fiscal 2013', 'category': 'DATE'}, {'entity': 'November 2012', 'category': 'DATE'}, {'entity': 'fiscal 2010', 'category': 'DATE'}, {'entity': 'fiscal 2011', 'category': 'DATE'}, {'entity': 'the proposed acquisition of the Rocketdyne Business', 'category': 'EVENT'}, {'entity': 'the sale of the 7 1/8% Note', 'category': 'EVENT'}, {'entity': 'MAP-21', 'category': 'EVENT'}, {'entity': 'the Senior Credit Facility', 'category': 'FAC'}, {'entity': 'the Office of Federal Procurement Policy', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Internal Revenue Service regulations', 'category': 'LAW'}, {'entity': '$248.7 million', 'category': 'MONEY'}, {'entity': '$759 million', 'category': 'MONEY'}, {'entity': '$454.5 million', 'category': 'MONEY'}, {'entity': '$1,243.1 million', 'category': 'MONEY'}, {'entity': '$32 million to $37 million', 'category': 'MONEY'}, {'entity': '$29.0 million', 'category': 'MONEY'}, {'entity': '$23.4 million', 'category': 'MONEY'}, {'entity': 'Standard Missile', 'category': 'ORG'}, {'entity': 'T3', 'category': 'ORG'}, {'entity': 'Hawk', 'category': 'ORG'}, {'entity': 'SSST', 'category': 'ORG'}, {'entity': 'Orion', 'category': 'ORG'}, {'entity': '7 1/8%', 'category': 'PERCENT'}, {'entity': '84%', 'category': 'PERCENT'}, {'entity': 'ERP system', 'category': 'PRODUCT'}, {'entity': 'Oracle Business Suite', 'category': 'PRODUCT'}, {'entity': 'first quarter of fiscal 2012', 'category': 'TIME'}, {'entity': 'Note 15 in Notes to the Consolidated Financial Statements', 'category': 'WORK_OF_ART'}, {'entity': '510', 'category': 'CARDINAL'}, {'entity': '460', 'category': 'CARDINAL'}, {'entity': '50', 'category': 'CARDINAL'}, {'entity': '2015', 'category': 'CARDINAL'}, {'entity': '84', 'category': 'CARDINAL'}, {'entity': '64', 'category': 'CARDINAL'}, {'entity': '32', 'category': 'CARDINAL'}, {'entity': '37', 'category': 'CARDINAL'}, {'entity': '29.0', 'category': 'CARDINAL'}, {'entity': '23.4', 'category': 'CARDINAL'}, {'entity': '918.1', 'category': 'CARDINAL'}, {'entity': '857.9', 'category': 'CARDINAL'}, {'entity': '869.6', 'category': 'CARDINAL'}, {'entity': '799.3', 'category': 'CARDINAL'}, {'entity': '753.9', 'category': 'CARDINAL'}, {'entity': '41.9', 'category': 'CARDINAL'}, {'entity': '40.9', 'category': 'CARDINAL'}, {'entity': '26.7', 'category': 'CARDINAL'}, {'entity': '22.3', 'category': 'CARDINAL'}, {'entity': '24.6', 'category': 'CARDINAL'}, {'entity': '27.9', 'category': 'CARDINAL'}, {'entity': '26.2', 'category': 'CARDINAL'}, {'entity': '14.5', 'category': 'CARDINAL'}, {'entity': '11.9', 'category': 'CARDINAL'}, {'entity': '960.0', 'category': 'CARDINAL'}, {'entity': '879.3', 'category': 'CARDINAL'}, {'entity': '820.4', 'category': 'CARDINAL'}, {'entity': '34.9', 'category': 'CARDINAL'}, {'entity': '38.8', 'category': 'CARDINAL'}, {'entity': '37.5', 'category': 'CARDINAL'}, {'entity': '22.3', 'category': 'CARDINAL'}, {'entity': '30.8', 'category': 'CARDINAL'}, {'entity': '37.0', 'category': 'CARDINAL'}, {'entity': '0.6', 'category': 'CARDINAL'}, {'entity': '1.0', 'category': 'CARDINAL'}, {'entity': '1.6', 'category': 'CARDINAL'}, {'entity': '21.7', 'category': 'CARDINAL'}, {'entity': '29.8', 'category': 'CARDINAL'}, {'entity': '35.4', 'category': 'CARDINAL'}, {'entity': '13.2', 'category': 'CARDINAL'}, {'entity': '9.0', 'category': 'CARDINAL'}, {'entity': '2.1', 'category': 'CARDINAL'}, {'entity': '18.9', 'category': 'CARDINAL'}, {'entity': '6.1', 'category': 'CARDINAL'}, {'entity': '3.9', 'category': 'CARDINAL'}, {'entity': '5.7', 'category': 'CARDINAL'}, {'entity': '2.9', 'category': 'CARDINAL'}, {'entity': '6.0', 'category': 'CARDINAL'}, {'entity': '3.1', 'category': 'CARDINAL'}, {'entity': '2.6', 'category': 'CARDINAL'}, {'entity': '2.9', 'category': 'CARDINAL'}, {'entity': '6.8', 'category': 'CARDINAL'}, {'entity': '994.9', 'category': 'CARDINAL'}, {'entity': '918.1', 'category': 'CARDINAL'}, {'entity': '76.8', 'category': 'CARDINAL'}, {'entity': '918.1', 'category': 'CARDINAL'}, {'entity': '857.9', 'category': 'CARDINAL'}, {'entity': '60.2', 'category': 'CARDINAL'}, {'entity': '39.6', 'category': 'CARDINAL'}, {'entity': '34.5', 'category': 'CARDINAL'}, {'entity': '17.7', 'category': 'CARDINAL'}, {'entity': '24.9', 'category': 'CARDINAL'}, {'entity': '27.7', 'category': 'CARDINAL'}, {'entity': '24.8', 'category': 'CARDINAL'}, {'entity': '22.2', 'category': 'CARDINAL'}, {'entity': '22.0', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RW8xaN6Q6ukSp09HV39iYcHJIcFz\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701569107,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#869.6#799.3#70.3#753.9#45.4#850.7#778.3#72.4#724.6#53.7#18.9#21.0#21.0#29.3#2.1#8.3#41.9#40.9#1.0#26.7#14.2#13.3#11.8#1.5#13.7#22.1#25.4#3.3#6.5#3.7#2.8#24.6#22.3#2.3#27.9#3.3#1.6#26.2#14.5#11.7#11.9#2.6#7.1#3.0#1.5#2.2#0.7#4.1#2.8#11.6#0.4#0.2#1.2#1.3#0.7#2.7#12.0#1.5#0.6#12.7#5.6#3.4#75.0#9 1/2#100#3.3#0.8\\nDATE#2012#2011#2010#2010#July 2012\\nMONEY#$869.6#$799.3#$70.3#$799.3#$753.9#$45.4#$850.7#$778.3#$72.4#$778.3#$724.6#$53.7#$21.0#$21.0#$29.3#$45.4#$41.9#$40.9#$1.0#$40.9#$26.7#$14.2#$13.3#$11.8#$1.5#$11.8#$13.7#$22.1#$25.4#($3.3)#$6.5#$3.7#$2.8#$24.6#$22.3#($2.3)#$24.6#$27.9#$26.2#$14.5#$11.7#$14.5#$11.9#$7.1#$3.0#$1.5#$2.2#$7 million#$4.1 million#$2.8 million#$11.6 million#$0.4 million#$0.2 million#$1.2 million#$1.3 million#$2.7 million#$12.0 million#$1.5 million#$0.6 million#$12.7 million#$5.6 million#$3.4 million#$3.3 million#$0.8 million\\nORG#NASA#SEC#Rocketdyne Business\\nPERCENT#52#53#50#42#41#43#6#6#7#100#100#100#87.4#87.1#87.1#87.9#4.2#4.5#4.5#3.1\\nWORK_OF_ART#9 1/2% Senior Subordinated Notes}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 3024,\n",
      "    \"completion_tokens\": 654,\n",
      "    \"total_tokens\": 3678\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': '2012', 'category': 'DATE'}, {'entity': '2011', 'category': 'DATE'}, {'entity': '2010', 'category': 'DATE'}, {'entity': '2010', 'category': 'DATE'}, {'entity': 'July 2012', 'category': 'DATE'}, {'entity': '$869.6', 'category': 'MONEY'}, {'entity': '$799.3', 'category': 'MONEY'}, {'entity': '$70.3', 'category': 'MONEY'}, {'entity': '$799.3', 'category': 'MONEY'}, {'entity': '$753.9', 'category': 'MONEY'}, {'entity': '$45.4', 'category': 'MONEY'}, {'entity': '$850.7', 'category': 'MONEY'}, {'entity': '$778.3', 'category': 'MONEY'}, {'entity': '$72.4', 'category': 'MONEY'}, {'entity': '$778.3', 'category': 'MONEY'}, {'entity': '$724.6', 'category': 'MONEY'}, {'entity': '$53.7', 'category': 'MONEY'}, {'entity': '$21.0', 'category': 'MONEY'}, {'entity': '$21.0', 'category': 'MONEY'}, {'entity': '$29.3', 'category': 'MONEY'}, {'entity': '$45.4', 'category': 'MONEY'}, {'entity': '$41.9', 'category': 'MONEY'}, {'entity': '$40.9', 'category': 'MONEY'}, {'entity': '$1.0', 'category': 'MONEY'}, {'entity': '$40.9', 'category': 'MONEY'}, {'entity': '$26.7', 'category': 'MONEY'}, {'entity': '$14.2', 'category': 'MONEY'}, {'entity': '$13.3', 'category': 'MONEY'}, {'entity': '$11.8', 'category': 'MONEY'}, {'entity': '$1.5', 'category': 'MONEY'}, {'entity': '$11.8', 'category': 'MONEY'}, {'entity': '$13.7', 'category': 'MONEY'}, {'entity': '$22.1', 'category': 'MONEY'}, {'entity': '$25.4', 'category': 'MONEY'}, {'entity': '$3.3', 'category': 'MONEY'}, {'entity': '$6.5', 'category': 'MONEY'}, {'entity': '$3.7', 'category': 'MONEY'}, {'entity': '$2.8', 'category': 'MONEY'}, {'entity': '$24.6', 'category': 'MONEY'}, {'entity': '$22.3', 'category': 'MONEY'}, {'entity': '$2.3', 'category': 'MONEY'}, {'entity': '$24.6', 'category': 'MONEY'}, {'entity': '$27.9', 'category': 'MONEY'}, {'entity': '$26.2', 'category': 'MONEY'}, {'entity': '$14.5', 'category': 'MONEY'}, {'entity': '$11.7', 'category': 'MONEY'}, {'entity': '$14.5', 'category': 'MONEY'}, {'entity': '$11.9', 'category': 'MONEY'}, {'entity': '$7.1', 'category': 'MONEY'}, {'entity': '$3.0', 'category': 'MONEY'}, {'entity': '$1.5', 'category': 'MONEY'}, {'entity': '$2.2', 'category': 'MONEY'}, {'entity': '$7 million', 'category': 'MONEY'}, {'entity': '$4.1 million', 'category': 'MONEY'}, {'entity': '$2.8 million', 'category': 'MONEY'}, {'entity': '$11.6 million', 'category': 'MONEY'}, {'entity': '$0.4 million', 'category': 'MONEY'}, {'entity': '$0.2 million', 'category': 'MONEY'}, {'entity': '$1.2 million', 'category': 'MONEY'}, {'entity': '$1.3 million', 'category': 'MONEY'}, {'entity': '$2.7 million', 'category': 'MONEY'}, {'entity': '$12.0 million', 'category': 'MONEY'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': '$0.6 million', 'category': 'MONEY'}, {'entity': '$12.7 million', 'category': 'MONEY'}, {'entity': '$5.6 million', 'category': 'MONEY'}, {'entity': '$3.4 million', 'category': 'MONEY'}, {'entity': '$3.3 million', 'category': 'MONEY'}, {'entity': '$0.8 million', 'category': 'MONEY'}, {'entity': 'NASA', 'category': 'ORG'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'Rocketdyne Business', 'category': 'ORG'}, {'entity': '52', 'category': 'PERCENT'}, {'entity': '53', 'category': 'PERCENT'}, {'entity': '50', 'category': 'PERCENT'}, {'entity': '42', 'category': 'PERCENT'}, {'entity': '41', 'category': 'PERCENT'}, {'entity': '43', 'category': 'PERCENT'}, {'entity': '6', 'category': 'PERCENT'}, {'entity': '6', 'category': 'PERCENT'}, {'entity': '7', 'category': 'PERCENT'}, {'entity': '100', 'category': 'PERCENT'}, {'entity': '100', 'category': 'PERCENT'}, {'entity': '100', 'category': 'PERCENT'}, {'entity': '87.4', 'category': 'PERCENT'}, {'entity': '87.1', 'category': 'PERCENT'}, {'entity': '87.1', 'category': 'PERCENT'}, {'entity': '87.9', 'category': 'PERCENT'}, {'entity': '4.2', 'category': 'PERCENT'}, {'entity': '4.5', 'category': 'PERCENT'}, {'entity': '4.5', 'category': 'PERCENT'}, {'entity': '3.1', 'category': 'PERCENT'}, {'entity': '9 1/2% Senior Subordinated Notes', 'category': 'WORK_OF_ART'}, {'entity': '869.6', 'category': 'CARDINAL'}, {'entity': '799.3', 'category': 'CARDINAL'}, {'entity': '70.3', 'category': 'CARDINAL'}, {'entity': '753.9', 'category': 'CARDINAL'}, {'entity': '45.4', 'category': 'CARDINAL'}, {'entity': '850.7', 'category': 'CARDINAL'}, {'entity': '778.3', 'category': 'CARDINAL'}, {'entity': '72.4', 'category': 'CARDINAL'}, {'entity': '724.6', 'category': 'CARDINAL'}, {'entity': '53.7', 'category': 'CARDINAL'}, {'entity': '18.9', 'category': 'CARDINAL'}, {'entity': '21.0', 'category': 'CARDINAL'}, {'entity': '21.0', 'category': 'CARDINAL'}, {'entity': '29.3', 'category': 'CARDINAL'}, {'entity': '2.1', 'category': 'CARDINAL'}, {'entity': '8.3', 'category': 'CARDINAL'}, {'entity': '41.9', 'category': 'CARDINAL'}, {'entity': '40.9', 'category': 'CARDINAL'}, {'entity': '1.0', 'category': 'CARDINAL'}, {'entity': '26.7', 'category': 'CARDINAL'}, {'entity': '14.2', 'category': 'CARDINAL'}, {'entity': '13.3', 'category': 'CARDINAL'}, {'entity': '11.8', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '13.7', 'category': 'CARDINAL'}, {'entity': '22.1', 'category': 'CARDINAL'}, {'entity': '25.4', 'category': 'CARDINAL'}, {'entity': '3.3', 'category': 'CARDINAL'}, {'entity': '6.5', 'category': 'CARDINAL'}, {'entity': '3.7', 'category': 'CARDINAL'}, {'entity': '2.8', 'category': 'CARDINAL'}, {'entity': '24.6', 'category': 'CARDINAL'}, {'entity': '22.3', 'category': 'CARDINAL'}, {'entity': '2.3', 'category': 'CARDINAL'}, {'entity': '27.9', 'category': 'CARDINAL'}, {'entity': '3.3', 'category': 'CARDINAL'}, {'entity': '1.6', 'category': 'CARDINAL'}, {'entity': '26.2', 'category': 'CARDINAL'}, {'entity': '14.5', 'category': 'CARDINAL'}, {'entity': '11.7', 'category': 'CARDINAL'}, {'entity': '11.9', 'category': 'CARDINAL'}, {'entity': '2.6', 'category': 'CARDINAL'}, {'entity': '7.1', 'category': 'CARDINAL'}, {'entity': '3.0', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '2.2', 'category': 'CARDINAL'}, {'entity': '0.7', 'category': 'CARDINAL'}, {'entity': '4.1', 'category': 'CARDINAL'}, {'entity': '2.8', 'category': 'CARDINAL'}, {'entity': '11.6', 'category': 'CARDINAL'}, {'entity': '0.4', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '1.2', 'category': 'CARDINAL'}, {'entity': '1.3', 'category': 'CARDINAL'}, {'entity': '0.7', 'category': 'CARDINAL'}, {'entity': '2.7', 'category': 'CARDINAL'}, {'entity': '12.0', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '0.6', 'category': 'CARDINAL'}, {'entity': '12.7', 'category': 'CARDINAL'}, {'entity': '5.6', 'category': 'CARDINAL'}, {'entity': '3.4', 'category': 'CARDINAL'}, {'entity': '75.0', 'category': 'CARDINAL'}, {'entity': '9 1/2', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '3.3', 'category': 'CARDINAL'}, {'entity': '0.8', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RW9ljm0erjV3LihLt3eVlQtOJKWS\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701569157,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#22.0#2#1/4#99.0#99.6#0.2#1.3#2010#1.4#1.9#0.9#2.7#0.7#77.8#93.0#98.975#4#1/16#2009#3.5#0.4#0.3#22.5#102#4#1/16#2009#0.4#0.9#22.3#30.8#8.5#30.8#37.0#6.2#19.4#24.1#4.7#24.1#26.5#2.4#3.5#3.5#6.7#3.2#3.2#3.8#0.6#68.4#2#1/4#75.0#9#1/2#22.5#77.8#9#1/2#2#1/4#0.6#1.0#0.4#1.0#1.6#0.6#18.9#6.1#3.9#30#2012#2011#4.6#3.2#0.7#2.7#2.7#2.0#2.8#0.1#13.0#4.0#3.1#0.2#0.3#0.3#2.8#2.8#2.5#3.1#0.2#10.0#1.3#1.0#0.5#0.1#18.9#6.1#3.9#30#2012#2011#288.1#211.1#three#30 \\n\\nDATE#fiscal 2011#Fiscal 2010#fiscal 2010#fiscal 2010#December 2009#fiscal 2010#fiscal 2010#fiscal 2012#fiscal 2011#fiscal 2011#fiscal 2012#fiscal 2011#fiscal 2011#fiscal 2010#fiscal 2012#fiscal 2011#fiscal 2010#fiscal 2011#fiscal 2010#Year Ended 2012#Year Ended 2011#Year Ended 2010#Year Ended 2012#Year Ended 2011#Year Ended 2010#November 30, 2012#2011#November 30, 2012#2011\\n\\nEVENT#\\n\\nFAC#\\n\\nGPE#U.S.#U.S.\\n\\nLANGUAGE#\\n\\nLAW#\\n\\nLOC#\\n\\nMONEY#$22.0 million#$0.2 million#$1.3 million#$1.4 million#$1.9 million#$0.9 million#$2.7 million#$0.7 million#$77.8 million#(74.3 )#$3.5#(6.3 )#2.9#(0.4 )#(0.3 )#$22.5 million#(23.0 )#(0.4 )#(0.9 )#22.3#$30.8#(8.5 )#30.8#37.0#(6.2 )#19.4#24.1#(4.7 )#24.1#26.5#(2.4 )#3.5#3.5#6.7#(3.2 )#3.2#3.8#(0.6 )#$68.4 million#$75.0 million#$0.6#$1.0#(0.4 )#1.0#1.6#(0.6 )#18.9#6.1#(3.9 )#4.6#3.2#0.7#2.7#2.7#2.0#2.8#0.1#13.0#(4.0 )#(3.1 )#0.2#0.3#0.3#2.8#2.8#2.5#3.1#0.2#(10.0 )#(1.3 )#1.0#0.5#(0.1 )#18.9#6.1#(3.9 )#$288.1 million#$211.1 million\\n\\nNORP#Senior#Senior#U.S.#U.S.\\n\\nORDINAL#first#second\\n\\nORG#the Senior Credit Facility#the Senior Credit Facility#the Rocketdyne Business\\n\\nPERCENT#99.0%#99.6%#93.0%#98.975%#102%\\n\\nPERSON#\\n\\nPRODUCT#\\n\\nQUANTITY#\\n\\nTIME#\\n\\nWORK_OF_ART#}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2839,\n",
      "    \"completion_tokens\": 1042,\n",
      "    \"total_tokens\": 3881\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'fiscal 2011', 'category': 'DATE'}, {'entity': 'Fiscal 2010', 'category': 'DATE'}, {'entity': 'fiscal 2010', 'category': 'DATE'}, {'entity': 'fiscal 2010', 'category': 'DATE'}, {'entity': 'December 2009', 'category': 'DATE'}, {'entity': 'fiscal 2010', 'category': 'DATE'}, {'entity': 'fiscal 2010', 'category': 'DATE'}, {'entity': 'fiscal 2012', 'category': 'DATE'}, {'entity': 'fiscal 2011', 'category': 'DATE'}, {'entity': 'fiscal 2011', 'category': 'DATE'}, {'entity': 'fiscal 2012', 'category': 'DATE'}, {'entity': 'fiscal 2011', 'category': 'DATE'}, {'entity': 'fiscal 2011', 'category': 'DATE'}, {'entity': 'fiscal 2010', 'category': 'DATE'}, {'entity': 'fiscal 2012', 'category': 'DATE'}, {'entity': 'fiscal 2011', 'category': 'DATE'}, {'entity': 'fiscal 2010', 'category': 'DATE'}, {'entity': 'fiscal 2011', 'category': 'DATE'}, {'entity': 'fiscal 2010', 'category': 'DATE'}, {'entity': 'Year Ended 2012', 'category': 'DATE'}, {'entity': 'Year Ended 2011', 'category': 'DATE'}, {'entity': 'Year Ended 2010', 'category': 'DATE'}, {'entity': 'Year Ended 2012', 'category': 'DATE'}, {'entity': 'Year Ended 2011', 'category': 'DATE'}, {'entity': 'Year Ended 2010', 'category': 'DATE'}, {'entity': 'November 30, 2012', 'category': 'DATE'}, {'entity': '2011', 'category': 'DATE'}, {'entity': 'November 30, 2012', 'category': 'DATE'}, {'entity': '2011', 'category': 'DATE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '$22.0 million', 'category': 'MONEY'}, {'entity': '$0.2 million', 'category': 'MONEY'}, {'entity': '$1.3 million', 'category': 'MONEY'}, {'entity': '$1.4 million', 'category': 'MONEY'}, {'entity': '$1.9 million', 'category': 'MONEY'}, {'entity': '$0.9 million', 'category': 'MONEY'}, {'entity': '$2.7 million', 'category': 'MONEY'}, {'entity': '$0.7 million', 'category': 'MONEY'}, {'entity': '$77.8 million', 'category': 'MONEY'}, {'entity': '74.3', 'category': 'MONEY'}, {'entity': '$3.5', 'category': 'MONEY'}, {'entity': '6.3', 'category': 'MONEY'}, {'entity': '2.9', 'category': 'MONEY'}, {'entity': '0.4', 'category': 'MONEY'}, {'entity': '0.3', 'category': 'MONEY'}, {'entity': '$22.5 million', 'category': 'MONEY'}, {'entity': '23.0', 'category': 'MONEY'}, {'entity': '0.4', 'category': 'MONEY'}, {'entity': '0.9', 'category': 'MONEY'}, {'entity': '22.3', 'category': 'MONEY'}, {'entity': '$30.8', 'category': 'MONEY'}, {'entity': '8.5', 'category': 'MONEY'}, {'entity': '30.8', 'category': 'MONEY'}, {'entity': '37.0', 'category': 'MONEY'}, {'entity': '6.2', 'category': 'MONEY'}, {'entity': '19.4', 'category': 'MONEY'}, {'entity': '24.1', 'category': 'MONEY'}, {'entity': '4.7', 'category': 'MONEY'}, {'entity': '24.1', 'category': 'MONEY'}, {'entity': '26.5', 'category': 'MONEY'}, {'entity': '2.4', 'category': 'MONEY'}, {'entity': '3.5', 'category': 'MONEY'}, {'entity': '3.5', 'category': 'MONEY'}, {'entity': '6.7', 'category': 'MONEY'}, {'entity': '3.2', 'category': 'MONEY'}, {'entity': '3.2', 'category': 'MONEY'}, {'entity': '3.8', 'category': 'MONEY'}, {'entity': '0.6', 'category': 'MONEY'}, {'entity': '$68.4 million', 'category': 'MONEY'}, {'entity': '$75.0 million', 'category': 'MONEY'}, {'entity': '$0.6', 'category': 'MONEY'}, {'entity': '$1.0', 'category': 'MONEY'}, {'entity': '0.4', 'category': 'MONEY'}, {'entity': '1.0', 'category': 'MONEY'}, {'entity': '1.6', 'category': 'MONEY'}, {'entity': '0.6', 'category': 'MONEY'}, {'entity': '18.9', 'category': 'MONEY'}, {'entity': '6.1', 'category': 'MONEY'}, {'entity': '3.9', 'category': 'MONEY'}, {'entity': '4.6', 'category': 'MONEY'}, {'entity': '3.2', 'category': 'MONEY'}, {'entity': '0.7', 'category': 'MONEY'}, {'entity': '2.7', 'category': 'MONEY'}, {'entity': '2.7', 'category': 'MONEY'}, {'entity': '2.0', 'category': 'MONEY'}, {'entity': '2.8', 'category': 'MONEY'}, {'entity': '0.1', 'category': 'MONEY'}, {'entity': '13.0', 'category': 'MONEY'}, {'entity': '4.0', 'category': 'MONEY'}, {'entity': '3.1', 'category': 'MONEY'}, {'entity': '0.2', 'category': 'MONEY'}, {'entity': '0.3', 'category': 'MONEY'}, {'entity': '0.3', 'category': 'MONEY'}, {'entity': '2.8', 'category': 'MONEY'}, {'entity': '2.8', 'category': 'MONEY'}, {'entity': '2.5', 'category': 'MONEY'}, {'entity': '3.1', 'category': 'MONEY'}, {'entity': '0.2', 'category': 'MONEY'}, {'entity': '10.0', 'category': 'MONEY'}, {'entity': '1.3', 'category': 'MONEY'}, {'entity': '1.0', 'category': 'MONEY'}, {'entity': '0.5', 'category': 'MONEY'}, {'entity': '0.1', 'category': 'MONEY'}, {'entity': '18.9', 'category': 'MONEY'}, {'entity': '6.1', 'category': 'MONEY'}, {'entity': '3.9', 'category': 'MONEY'}, {'entity': '$288.1 million', 'category': 'MONEY'}, {'entity': '$211.1 million', 'category': 'MONEY'}, {'entity': 'Senior', 'category': 'NORP'}, {'entity': 'Senior', 'category': 'NORP'}, {'entity': 'U.S.', 'category': 'NORP'}, {'entity': 'U.S.', 'category': 'NORP'}, {'entity': 'the Senior Credit Facility', 'category': 'ORG'}, {'entity': 'the Senior Credit Facility', 'category': 'ORG'}, {'entity': 'the Rocketdyne Business', 'category': 'ORG'}, {'entity': '99.0%', 'category': 'PERCENT'}, {'entity': '99.6%', 'category': 'PERCENT'}, {'entity': '93.0%', 'category': 'PERCENT'}, {'entity': '98.975%', 'category': 'PERCENT'}, {'entity': '102%', 'category': 'PERCENT'}, {'entity': '', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'second', 'category': 'ORDINAL'}, {'entity': '22.0', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '1/4', 'category': 'CARDINAL'}, {'entity': '99.0', 'category': 'CARDINAL'}, {'entity': '99.6', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '1.3', 'category': 'CARDINAL'}, {'entity': '2010', 'category': 'CARDINAL'}, {'entity': '1.4', 'category': 'CARDINAL'}, {'entity': '1.9', 'category': 'CARDINAL'}, {'entity': '0.9', 'category': 'CARDINAL'}, {'entity': '2.7', 'category': 'CARDINAL'}, {'entity': '0.7', 'category': 'CARDINAL'}, {'entity': '77.8', 'category': 'CARDINAL'}, {'entity': '93.0', 'category': 'CARDINAL'}, {'entity': '98.975', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '1/16', 'category': 'CARDINAL'}, {'entity': '2009', 'category': 'CARDINAL'}, {'entity': '3.5', 'category': 'CARDINAL'}, {'entity': '0.4', 'category': 'CARDINAL'}, {'entity': '0.3', 'category': 'CARDINAL'}, {'entity': '22.5', 'category': 'CARDINAL'}, {'entity': '102', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '1/16', 'category': 'CARDINAL'}, {'entity': '2009', 'category': 'CARDINAL'}, {'entity': '0.4', 'category': 'CARDINAL'}, {'entity': '0.9', 'category': 'CARDINAL'}, {'entity': '22.3', 'category': 'CARDINAL'}, {'entity': '30.8', 'category': 'CARDINAL'}, {'entity': '8.5', 'category': 'CARDINAL'}, {'entity': '30.8', 'category': 'CARDINAL'}, {'entity': '37.0', 'category': 'CARDINAL'}, {'entity': '6.2', 'category': 'CARDINAL'}, {'entity': '19.4', 'category': 'CARDINAL'}, {'entity': '24.1', 'category': 'CARDINAL'}, {'entity': '4.7', 'category': 'CARDINAL'}, {'entity': '24.1', 'category': 'CARDINAL'}, {'entity': '26.5', 'category': 'CARDINAL'}, {'entity': '2.4', 'category': 'CARDINAL'}, {'entity': '3.5', 'category': 'CARDINAL'}, {'entity': '3.5', 'category': 'CARDINAL'}, {'entity': '6.7', 'category': 'CARDINAL'}, {'entity': '3.2', 'category': 'CARDINAL'}, {'entity': '3.2', 'category': 'CARDINAL'}, {'entity': '3.8', 'category': 'CARDINAL'}, {'entity': '0.6', 'category': 'CARDINAL'}, {'entity': '68.4', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '1/4', 'category': 'CARDINAL'}, {'entity': '75.0', 'category': 'CARDINAL'}, {'entity': '9', 'category': 'CARDINAL'}, {'entity': '1/2', 'category': 'CARDINAL'}, {'entity': '22.5', 'category': 'CARDINAL'}, {'entity': '77.8', 'category': 'CARDINAL'}, {'entity': '9', 'category': 'CARDINAL'}, {'entity': '1/2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '1/4', 'category': 'CARDINAL'}, {'entity': '0.6', 'category': 'CARDINAL'}, {'entity': '1.0', 'category': 'CARDINAL'}, {'entity': '0.4', 'category': 'CARDINAL'}, {'entity': '1.0', 'category': 'CARDINAL'}, {'entity': '1.6', 'category': 'CARDINAL'}, {'entity': '0.6', 'category': 'CARDINAL'}, {'entity': '18.9', 'category': 'CARDINAL'}, {'entity': '6.1', 'category': 'CARDINAL'}, {'entity': '3.9', 'category': 'CARDINAL'}, {'entity': '30', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '2011', 'category': 'CARDINAL'}, {'entity': '4.6', 'category': 'CARDINAL'}, {'entity': '3.2', 'category': 'CARDINAL'}, {'entity': '0.7', 'category': 'CARDINAL'}, {'entity': '2.7', 'category': 'CARDINAL'}, {'entity': '2.7', 'category': 'CARDINAL'}, {'entity': '2.0', 'category': 'CARDINAL'}, {'entity': '2.8', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '13.0', 'category': 'CARDINAL'}, {'entity': '4.0', 'category': 'CARDINAL'}, {'entity': '3.1', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '0.3', 'category': 'CARDINAL'}, {'entity': '0.3', 'category': 'CARDINAL'}, {'entity': '2.8', 'category': 'CARDINAL'}, {'entity': '2.8', 'category': 'CARDINAL'}, {'entity': '2.5', 'category': 'CARDINAL'}, {'entity': '3.1', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '10.0', 'category': 'CARDINAL'}, {'entity': '1.3', 'category': 'CARDINAL'}, {'entity': '1.0', 'category': 'CARDINAL'}, {'entity': '0.5', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '18.9', 'category': 'CARDINAL'}, {'entity': '6.1', 'category': 'CARDINAL'}, {'entity': '3.9', 'category': 'CARDINAL'}, {'entity': '30', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '2011', 'category': 'CARDINAL'}, {'entity': '288.1', 'category': 'CARDINAL'}, {'entity': '211.1', 'category': 'CARDINAL'}, {'entity': 'three', 'category': 'CARDINAL'}, {'entity': '30', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWAkBYXxM3fYiLBb1RiDvkdLfcxD\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701569218,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#1.0#3.8#2.9#1.0#2.6#0.5#3.1#0.4#1.7#4.6#76.8#99.2#0.1#58.9#41.0#46.4#41.9#64.0#10.8#9.9#3.7\\n\\nDATE#November 30, 2012#January 2013#August 31, 2004#November 30, 2005#November 2003#June 2004#fiscal 2009#fiscal 2012#fiscal 2013#fiscal 2012#fiscal 2011#fiscal 2010\\n\\nEVENT#American Taxpayer Relief Act of 2012\\n\\nLAW#Budget Control Act of 2011\\n\\nLOC#Chartres\\n\\nMONEY#$1.0 million#$3.8 million#\\u20ac2.9 million ($3.8 million)#$1.0 million#$3.8 million#$1.0 million\\n\\nORG#GDX Automotive#Fine Chemicals#Snappon SA#Paris Commercial Court#PPA\\n\\nPERSON#American Taxpayer\\n\\nPRODUCT#GDX manufacturing facility\\n\\nWORK_OF_ART#Note 7(b)\\n}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2339,\n",
      "    \"completion_tokens\": 277,\n",
      "    \"total_tokens\": 2616\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'November 30, 2012', 'category': 'DATE'}, {'entity': 'January 2013', 'category': 'DATE'}, {'entity': 'August 31, 2004', 'category': 'DATE'}, {'entity': 'November 30, 2005', 'category': 'DATE'}, {'entity': 'November 2003', 'category': 'DATE'}, {'entity': 'June 2004', 'category': 'DATE'}, {'entity': 'fiscal 2009', 'category': 'DATE'}, {'entity': 'fiscal 2012', 'category': 'DATE'}, {'entity': 'fiscal 2013', 'category': 'DATE'}, {'entity': 'fiscal 2012', 'category': 'DATE'}, {'entity': 'fiscal 2011', 'category': 'DATE'}, {'entity': 'fiscal 2010', 'category': 'DATE'}, {'entity': 'American Taxpayer Relief Act of 2012', 'category': 'EVENT'}, {'entity': 'Budget Control Act of 2011', 'category': 'LAW'}, {'entity': 'Chartres', 'category': 'LOC'}, {'entity': '$1.0 million', 'category': 'MONEY'}, {'entity': '$3.8 million', 'category': 'MONEY'}, {'entity': '€2.9 million $3.8 million', 'category': 'MONEY'}, {'entity': '$1.0 million', 'category': 'MONEY'}, {'entity': '$3.8 million', 'category': 'MONEY'}, {'entity': '$1.0 million', 'category': 'MONEY'}, {'entity': 'GDX Automotive', 'category': 'ORG'}, {'entity': 'Fine Chemicals', 'category': 'ORG'}, {'entity': 'Snappon SA', 'category': 'ORG'}, {'entity': 'Paris Commercial Court', 'category': 'ORG'}, {'entity': 'PPA', 'category': 'ORG'}, {'entity': 'American Taxpayer', 'category': 'PERSON'}, {'entity': 'GDX manufacturing facility', 'category': 'PRODUCT'}, {'entity': 'Note 7b', 'category': 'WORK_OF_ART'}, {'entity': '1.0', 'category': 'CARDINAL'}, {'entity': '3.8', 'category': 'CARDINAL'}, {'entity': '2.9', 'category': 'CARDINAL'}, {'entity': '1.0', 'category': 'CARDINAL'}, {'entity': '2.6', 'category': 'CARDINAL'}, {'entity': '0.5', 'category': 'CARDINAL'}, {'entity': '3.1', 'category': 'CARDINAL'}, {'entity': '0.4', 'category': 'CARDINAL'}, {'entity': '1.7', 'category': 'CARDINAL'}, {'entity': '4.6', 'category': 'CARDINAL'}, {'entity': '76.8', 'category': 'CARDINAL'}, {'entity': '99.2', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '58.9', 'category': 'CARDINAL'}, {'entity': '41.0', 'category': 'CARDINAL'}, {'entity': '46.4', 'category': 'CARDINAL'}, {'entity': '41.9', 'category': 'CARDINAL'}, {'entity': '64.0', 'category': 'CARDINAL'}, {'entity': '10.8', 'category': 'CARDINAL'}, {'entity': '9.9', 'category': 'CARDINAL'}, {'entity': '3.7', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWBIfgzsdshmLqo5S2Yz5dSArNXs\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701569252,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#2011#2010#986.1#909.7#76.4#909.7#850.7#59.0#84.5#74.6#9.9#74.6#67.3#7.3#8.6#8.2#8.2#7.9#11.7#11.9#11.9#11.7#115.5#108.6#6.9#108.6#99.6#9.0#11.4#8.9#2.5#8.9#0.2#8.7#18.9#21.0#2.1#21.0#29.3#8.3#0.7#4.1#3.4#4.1#2.8#1.3#84.5#74.6#9.9#74.6#67.3#7.3#39.6#34.5#17.7#24.9#11.7#11.9#27.7#24.8#22.2#22.0#11.9#11.7#8.3#8.7#6.4#6.8#2012#2011#8.8#8.4#0.4#8.4#7.2#1.2#3.7#1.9#1.7#1.2#13.2#9.0#2.1#22.3#30.8#37.0#0.6#1.0#1.6#22.3#24.6#27.9#41.0#46.4#41.9#1.4#11.6#0.7#4.1#2.8#0.7#0.4#0.2#1.2#2.7#110.9#115.4#110.7#11.1#12.6#12.9#86.2#76.8#148.1#37.2#21.1#16.9#49.0#55.7#131.2#November 30\\n\\nDATE#2012#2011#2010#fiscal 2012#fiscal 2011#fiscal 2010#fiscal 2012#fiscal 2011#Year Ended 2012#Year Ended 2011#Year Ended 2010#As of November 30\\n\\nMONEY#$986.1#$909.7#$76.4#$909.7#$850.7#$59.0#$84.5#$74.6#$9.9#$74.6#$67.3#$7.3#$115.5#$108.6#$6.9#$108.6#$99.6#$9.0#11.4 million#8.9 million#2.5 million#8.9 million#18.9 million#21.0 million#21.0 million#29.3 million#0.7 million#4.1 million#3.4 million#4.1 million#2.8 million#1.3 million#84.5 million#74.6 million#9.9 million#74.6 million#67.3 million#7.3 million#39.6 million#$34.5 million#$17.7 million#$24.9 million#27.7 million#24.8 million#22.2 million#22.0 million#8.3 million#8.7 million#6.4 million#6.8 million#8.4 million#8.4 million#7.2 million#1.2 million#3.7 million#13.2 million#9.0 million#2.1 million#22.3 million#30.8 million#37.0 million#22.3 million#24.6 million#27.9 million#41.0 million#46.4 million#41.9 million#11.6 million#0.7 million#4.1 million#2.8 million#0.7 million#0.4 million#0.2 million#1.2 million#110.9 million#115.4 million#110.7 million#86.2 million#76.8 million#148.1 million#37.2 million#21.1 million#16.9 million#49.0 million#55.7 million#131.2 million\\n\\nORG#Non-GAAP#GAAP\\n\\nPERCENT#8.6#8.2#8.2#7.9#11.7#11.9#11.9#11.7#11.1#12.6#12.9 \\n\\nPRODUCT#Aerospace and Defense#T3#Hawk#NASA#THAAD#Standard Missile#SSST#Bomb Live Unit#Orion#Rocketdyne Business}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2919,\n",
      "    \"completion_tokens\": 1062,\n",
      "    \"total_tokens\": 3981\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': '2012', 'category': 'DATE'}, {'entity': '2011', 'category': 'DATE'}, {'entity': '2010', 'category': 'DATE'}, {'entity': 'fiscal 2012', 'category': 'DATE'}, {'entity': 'fiscal 2011', 'category': 'DATE'}, {'entity': 'fiscal 2010', 'category': 'DATE'}, {'entity': 'fiscal 2012', 'category': 'DATE'}, {'entity': 'fiscal 2011', 'category': 'DATE'}, {'entity': 'Year Ended 2012', 'category': 'DATE'}, {'entity': 'Year Ended 2011', 'category': 'DATE'}, {'entity': 'Year Ended 2010', 'category': 'DATE'}, {'entity': 'As of November 30', 'category': 'DATE'}, {'entity': '$986.1', 'category': 'MONEY'}, {'entity': '$909.7', 'category': 'MONEY'}, {'entity': '$76.4', 'category': 'MONEY'}, {'entity': '$909.7', 'category': 'MONEY'}, {'entity': '$850.7', 'category': 'MONEY'}, {'entity': '$59.0', 'category': 'MONEY'}, {'entity': '$84.5', 'category': 'MONEY'}, {'entity': '$74.6', 'category': 'MONEY'}, {'entity': '$9.9', 'category': 'MONEY'}, {'entity': '$74.6', 'category': 'MONEY'}, {'entity': '$67.3', 'category': 'MONEY'}, {'entity': '$7.3', 'category': 'MONEY'}, {'entity': '$115.5', 'category': 'MONEY'}, {'entity': '$108.6', 'category': 'MONEY'}, {'entity': '$6.9', 'category': 'MONEY'}, {'entity': '$108.6', 'category': 'MONEY'}, {'entity': '$99.6', 'category': 'MONEY'}, {'entity': '$9.0', 'category': 'MONEY'}, {'entity': '11.4 million', 'category': 'MONEY'}, {'entity': '8.9 million', 'category': 'MONEY'}, {'entity': '2.5 million', 'category': 'MONEY'}, {'entity': '8.9 million', 'category': 'MONEY'}, {'entity': '18.9 million', 'category': 'MONEY'}, {'entity': '21.0 million', 'category': 'MONEY'}, {'entity': '21.0 million', 'category': 'MONEY'}, {'entity': '29.3 million', 'category': 'MONEY'}, {'entity': '0.7 million', 'category': 'MONEY'}, {'entity': '4.1 million', 'category': 'MONEY'}, {'entity': '3.4 million', 'category': 'MONEY'}, {'entity': '4.1 million', 'category': 'MONEY'}, {'entity': '2.8 million', 'category': 'MONEY'}, {'entity': '1.3 million', 'category': 'MONEY'}, {'entity': '84.5 million', 'category': 'MONEY'}, {'entity': '74.6 million', 'category': 'MONEY'}, {'entity': '9.9 million', 'category': 'MONEY'}, {'entity': '74.6 million', 'category': 'MONEY'}, {'entity': '67.3 million', 'category': 'MONEY'}, {'entity': '7.3 million', 'category': 'MONEY'}, {'entity': '39.6 million', 'category': 'MONEY'}, {'entity': '$34.5 million', 'category': 'MONEY'}, {'entity': '$17.7 million', 'category': 'MONEY'}, {'entity': '$24.9 million', 'category': 'MONEY'}, {'entity': '27.7 million', 'category': 'MONEY'}, {'entity': '24.8 million', 'category': 'MONEY'}, {'entity': '22.2 million', 'category': 'MONEY'}, {'entity': '22.0 million', 'category': 'MONEY'}, {'entity': '8.3 million', 'category': 'MONEY'}, {'entity': '8.7 million', 'category': 'MONEY'}, {'entity': '6.4 million', 'category': 'MONEY'}, {'entity': '6.8 million', 'category': 'MONEY'}, {'entity': '8.4 million', 'category': 'MONEY'}, {'entity': '8.4 million', 'category': 'MONEY'}, {'entity': '7.2 million', 'category': 'MONEY'}, {'entity': '1.2 million', 'category': 'MONEY'}, {'entity': '3.7 million', 'category': 'MONEY'}, {'entity': '13.2 million', 'category': 'MONEY'}, {'entity': '9.0 million', 'category': 'MONEY'}, {'entity': '2.1 million', 'category': 'MONEY'}, {'entity': '22.3 million', 'category': 'MONEY'}, {'entity': '30.8 million', 'category': 'MONEY'}, {'entity': '37.0 million', 'category': 'MONEY'}, {'entity': '22.3 million', 'category': 'MONEY'}, {'entity': '24.6 million', 'category': 'MONEY'}, {'entity': '27.9 million', 'category': 'MONEY'}, {'entity': '41.0 million', 'category': 'MONEY'}, {'entity': '46.4 million', 'category': 'MONEY'}, {'entity': '41.9 million', 'category': 'MONEY'}, {'entity': '11.6 million', 'category': 'MONEY'}, {'entity': '0.7 million', 'category': 'MONEY'}, {'entity': '4.1 million', 'category': 'MONEY'}, {'entity': '2.8 million', 'category': 'MONEY'}, {'entity': '0.7 million', 'category': 'MONEY'}, {'entity': '0.4 million', 'category': 'MONEY'}, {'entity': '0.2 million', 'category': 'MONEY'}, {'entity': '1.2 million', 'category': 'MONEY'}, {'entity': '110.9 million', 'category': 'MONEY'}, {'entity': '115.4 million', 'category': 'MONEY'}, {'entity': '110.7 million', 'category': 'MONEY'}, {'entity': '86.2 million', 'category': 'MONEY'}, {'entity': '76.8 million', 'category': 'MONEY'}, {'entity': '148.1 million', 'category': 'MONEY'}, {'entity': '37.2 million', 'category': 'MONEY'}, {'entity': '21.1 million', 'category': 'MONEY'}, {'entity': '16.9 million', 'category': 'MONEY'}, {'entity': '49.0 million', 'category': 'MONEY'}, {'entity': '55.7 million', 'category': 'MONEY'}, {'entity': '131.2 million', 'category': 'MONEY'}, {'entity': 'Non-GAAP', 'category': 'ORG'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': '8.6', 'category': 'PERCENT'}, {'entity': '8.2', 'category': 'PERCENT'}, {'entity': '8.2', 'category': 'PERCENT'}, {'entity': '7.9', 'category': 'PERCENT'}, {'entity': '11.7', 'category': 'PERCENT'}, {'entity': '11.9', 'category': 'PERCENT'}, {'entity': '11.9', 'category': 'PERCENT'}, {'entity': '11.7', 'category': 'PERCENT'}, {'entity': '11.1', 'category': 'PERCENT'}, {'entity': '12.6', 'category': 'PERCENT'}, {'entity': '12.9', 'category': 'PERCENT'}, {'entity': 'Aerospace and Defense', 'category': 'PRODUCT'}, {'entity': 'T3', 'category': 'PRODUCT'}, {'entity': 'Hawk', 'category': 'PRODUCT'}, {'entity': 'NASA', 'category': 'PRODUCT'}, {'entity': 'THAAD', 'category': 'PRODUCT'}, {'entity': 'Standard Missile', 'category': 'PRODUCT'}, {'entity': 'SSST', 'category': 'PRODUCT'}, {'entity': 'Bomb Live Unit', 'category': 'PRODUCT'}, {'entity': 'Orion', 'category': 'PRODUCT'}, {'entity': 'Rocketdyne Business', 'category': 'PRODUCT'}, {'entity': '2011', 'category': 'CARDINAL'}, {'entity': '2010', 'category': 'CARDINAL'}, {'entity': '986.1', 'category': 'CARDINAL'}, {'entity': '909.7', 'category': 'CARDINAL'}, {'entity': '76.4', 'category': 'CARDINAL'}, {'entity': '909.7', 'category': 'CARDINAL'}, {'entity': '850.7', 'category': 'CARDINAL'}, {'entity': '59.0', 'category': 'CARDINAL'}, {'entity': '84.5', 'category': 'CARDINAL'}, {'entity': '74.6', 'category': 'CARDINAL'}, {'entity': '9.9', 'category': 'CARDINAL'}, {'entity': '74.6', 'category': 'CARDINAL'}, {'entity': '67.3', 'category': 'CARDINAL'}, {'entity': '7.3', 'category': 'CARDINAL'}, {'entity': '8.6', 'category': 'CARDINAL'}, {'entity': '8.2', 'category': 'CARDINAL'}, {'entity': '8.2', 'category': 'CARDINAL'}, {'entity': '7.9', 'category': 'CARDINAL'}, {'entity': '11.7', 'category': 'CARDINAL'}, {'entity': '11.9', 'category': 'CARDINAL'}, {'entity': '11.9', 'category': 'CARDINAL'}, {'entity': '11.7', 'category': 'CARDINAL'}, {'entity': '115.5', 'category': 'CARDINAL'}, {'entity': '108.6', 'category': 'CARDINAL'}, {'entity': '6.9', 'category': 'CARDINAL'}, {'entity': '108.6', 'category': 'CARDINAL'}, {'entity': '99.6', 'category': 'CARDINAL'}, {'entity': '9.0', 'category': 'CARDINAL'}, {'entity': '11.4', 'category': 'CARDINAL'}, {'entity': '8.9', 'category': 'CARDINAL'}, {'entity': '2.5', 'category': 'CARDINAL'}, {'entity': '8.9', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '8.7', 'category': 'CARDINAL'}, {'entity': '18.9', 'category': 'CARDINAL'}, {'entity': '21.0', 'category': 'CARDINAL'}, {'entity': '2.1', 'category': 'CARDINAL'}, {'entity': '21.0', 'category': 'CARDINAL'}, {'entity': '29.3', 'category': 'CARDINAL'}, {'entity': '8.3', 'category': 'CARDINAL'}, {'entity': '0.7', 'category': 'CARDINAL'}, {'entity': '4.1', 'category': 'CARDINAL'}, {'entity': '3.4', 'category': 'CARDINAL'}, {'entity': '4.1', 'category': 'CARDINAL'}, {'entity': '2.8', 'category': 'CARDINAL'}, {'entity': '1.3', 'category': 'CARDINAL'}, {'entity': '84.5', 'category': 'CARDINAL'}, {'entity': '74.6', 'category': 'CARDINAL'}, {'entity': '9.9', 'category': 'CARDINAL'}, {'entity': '74.6', 'category': 'CARDINAL'}, {'entity': '67.3', 'category': 'CARDINAL'}, {'entity': '7.3', 'category': 'CARDINAL'}, {'entity': '39.6', 'category': 'CARDINAL'}, {'entity': '34.5', 'category': 'CARDINAL'}, {'entity': '17.7', 'category': 'CARDINAL'}, {'entity': '24.9', 'category': 'CARDINAL'}, {'entity': '11.7', 'category': 'CARDINAL'}, {'entity': '11.9', 'category': 'CARDINAL'}, {'entity': '27.7', 'category': 'CARDINAL'}, {'entity': '24.8', 'category': 'CARDINAL'}, {'entity': '22.2', 'category': 'CARDINAL'}, {'entity': '22.0', 'category': 'CARDINAL'}, {'entity': '11.9', 'category': 'CARDINAL'}, {'entity': '11.7', 'category': 'CARDINAL'}, {'entity': '8.3', 'category': 'CARDINAL'}, {'entity': '8.7', 'category': 'CARDINAL'}, {'entity': '6.4', 'category': 'CARDINAL'}, {'entity': '6.8', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '2011', 'category': 'CARDINAL'}, {'entity': '8.8', 'category': 'CARDINAL'}, {'entity': '8.4', 'category': 'CARDINAL'}, {'entity': '0.4', 'category': 'CARDINAL'}, {'entity': '8.4', 'category': 'CARDINAL'}, {'entity': '7.2', 'category': 'CARDINAL'}, {'entity': '1.2', 'category': 'CARDINAL'}, {'entity': '3.7', 'category': 'CARDINAL'}, {'entity': '1.9', 'category': 'CARDINAL'}, {'entity': '1.7', 'category': 'CARDINAL'}, {'entity': '1.2', 'category': 'CARDINAL'}, {'entity': '13.2', 'category': 'CARDINAL'}, {'entity': '9.0', 'category': 'CARDINAL'}, {'entity': '2.1', 'category': 'CARDINAL'}, {'entity': '22.3', 'category': 'CARDINAL'}, {'entity': '30.8', 'category': 'CARDINAL'}, {'entity': '37.0', 'category': 'CARDINAL'}, {'entity': '0.6', 'category': 'CARDINAL'}, {'entity': '1.0', 'category': 'CARDINAL'}, {'entity': '1.6', 'category': 'CARDINAL'}, {'entity': '22.3', 'category': 'CARDINAL'}, {'entity': '24.6', 'category': 'CARDINAL'}, {'entity': '27.9', 'category': 'CARDINAL'}, {'entity': '41.0', 'category': 'CARDINAL'}, {'entity': '46.4', 'category': 'CARDINAL'}, {'entity': '41.9', 'category': 'CARDINAL'}, {'entity': '1.4', 'category': 'CARDINAL'}, {'entity': '11.6', 'category': 'CARDINAL'}, {'entity': '0.7', 'category': 'CARDINAL'}, {'entity': '4.1', 'category': 'CARDINAL'}, {'entity': '2.8', 'category': 'CARDINAL'}, {'entity': '0.7', 'category': 'CARDINAL'}, {'entity': '0.4', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '1.2', 'category': 'CARDINAL'}, {'entity': '2.7', 'category': 'CARDINAL'}, {'entity': '110.9', 'category': 'CARDINAL'}, {'entity': '115.4', 'category': 'CARDINAL'}, {'entity': '110.7', 'category': 'CARDINAL'}, {'entity': '11.1', 'category': 'CARDINAL'}, {'entity': '12.6', 'category': 'CARDINAL'}, {'entity': '12.9', 'category': 'CARDINAL'}, {'entity': '86.2', 'category': 'CARDINAL'}, {'entity': '76.8', 'category': 'CARDINAL'}, {'entity': '148.1', 'category': 'CARDINAL'}, {'entity': '37.2', 'category': 'CARDINAL'}, {'entity': '21.1', 'category': 'CARDINAL'}, {'entity': '16.9', 'category': 'CARDINAL'}, {'entity': '49.0', 'category': 'CARDINAL'}, {'entity': '55.7', 'category': 'CARDINAL'}, {'entity': '131.2', 'category': 'CARDINAL'}, {'entity': 'November 30', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWCFn049mmoTGXT3biJjUZlZffYE\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701569311,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#248.7#326.4#396.7#162.1#188.0#181.5#26.7#86.6#138.4#188.5#6.3#7.1#8.8#15#2017#152.5#47.8#10.8#211.1#11.6#222.7#6.7#9.5#11.7#27.9#8.6#36.5#19.4#11.2#2.4#33.0#8.5#41.5#139.8#46.1#20.1#206.0#11.7#217.7#21.2#5.9#5.9#33.0#0.1#32.9#30.3#13.4#13.9#57.6#2.4#60.0#130.7#38.6#12.1#181.4#9.2#190.6#24.5#5.9#3.8#34.2#0.5#34.7#14.7#13.3#5.1#33.1#2.7#35.8#140.5#31.2#10.8#182.5#7.0#189.5#34.7#15.3#6.7#3.5#1.4#7.8#32.9#9.0#7.6#2.6#2.5#2.4#8.8#36.5#13.7#9.8#4.6#1.5#1.2#5.7\\n\\nDATE#November 30, 2012#2011#2010#November 30, 2009#November 30, 2010#November 30, 2011#November 30, 2012#fifteen years\\n\\nEVENT#environmental remediation#remediation of environmental pollution#environmental conditions\\n\\nGPE#Camden#Arkansas#Fullerton#California#Toledo#Ohio\\n\\nMONEY#$6.3 million in fiscal 2012#$7.1 million in fiscal 2011#$8.8 million in fiscal 2010#$34.7 million in fiscal 2012#$32.9 million in fiscal 2011#$36.5 million in fiscal 2010\\n\\nORG#GAAP#BPOU#Aerojet-Sacramento#Aerojet-BPOU#OtherAerojetSites#TotalAerojet#TotalEnvironmentalReserve\\n\\nTIME#fifteen year period#quarterly}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2630,\n",
      "    \"completion_tokens\": 584,\n",
      "    \"total_tokens\": 3214\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'November 30, 2012', 'category': 'DATE'}, {'entity': '2011', 'category': 'DATE'}, {'entity': '2010', 'category': 'DATE'}, {'entity': 'November 30, 2009', 'category': 'DATE'}, {'entity': 'November 30, 2010', 'category': 'DATE'}, {'entity': 'November 30, 2011', 'category': 'DATE'}, {'entity': 'November 30, 2012', 'category': 'DATE'}, {'entity': 'fifteen years', 'category': 'DATE'}, {'entity': 'environmental remediation', 'category': 'EVENT'}, {'entity': 'remediation of environmental pollution', 'category': 'EVENT'}, {'entity': 'environmental conditions', 'category': 'EVENT'}, {'entity': 'Camden', 'category': 'GPE'}, {'entity': 'Arkansas', 'category': 'GPE'}, {'entity': 'Fullerton', 'category': 'GPE'}, {'entity': 'California', 'category': 'GPE'}, {'entity': 'Toledo', 'category': 'GPE'}, {'entity': 'Ohio', 'category': 'GPE'}, {'entity': '$6.3 million in fiscal 2012', 'category': 'MONEY'}, {'entity': '$7.1 million in fiscal 2011', 'category': 'MONEY'}, {'entity': '$8.8 million in fiscal 2010', 'category': 'MONEY'}, {'entity': '$34.7 million in fiscal 2012', 'category': 'MONEY'}, {'entity': '$32.9 million in fiscal 2011', 'category': 'MONEY'}, {'entity': '$36.5 million in fiscal 2010', 'category': 'MONEY'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': 'BPOU', 'category': 'ORG'}, {'entity': 'Aerojet-Sacramento', 'category': 'ORG'}, {'entity': 'Aerojet-BPOU', 'category': 'ORG'}, {'entity': 'OtherAerojetSites', 'category': 'ORG'}, {'entity': 'TotalAerojet', 'category': 'ORG'}, {'entity': 'TotalEnvironmentalReserve', 'category': 'ORG'}, {'entity': 'fifteen year period', 'category': 'TIME'}, {'entity': 'quarterly', 'category': 'TIME'}, {'entity': '248.7', 'category': 'CARDINAL'}, {'entity': '326.4', 'category': 'CARDINAL'}, {'entity': '396.7', 'category': 'CARDINAL'}, {'entity': '162.1', 'category': 'CARDINAL'}, {'entity': '188.0', 'category': 'CARDINAL'}, {'entity': '181.5', 'category': 'CARDINAL'}, {'entity': '26.7', 'category': 'CARDINAL'}, {'entity': '86.6', 'category': 'CARDINAL'}, {'entity': '138.4', 'category': 'CARDINAL'}, {'entity': '188.5', 'category': 'CARDINAL'}, {'entity': '6.3', 'category': 'CARDINAL'}, {'entity': '7.1', 'category': 'CARDINAL'}, {'entity': '8.8', 'category': 'CARDINAL'}, {'entity': '15', 'category': 'CARDINAL'}, {'entity': '2017', 'category': 'CARDINAL'}, {'entity': '152.5', 'category': 'CARDINAL'}, {'entity': '47.8', 'category': 'CARDINAL'}, {'entity': '10.8', 'category': 'CARDINAL'}, {'entity': '211.1', 'category': 'CARDINAL'}, {'entity': '11.6', 'category': 'CARDINAL'}, {'entity': '222.7', 'category': 'CARDINAL'}, {'entity': '6.7', 'category': 'CARDINAL'}, {'entity': '9.5', 'category': 'CARDINAL'}, {'entity': '11.7', 'category': 'CARDINAL'}, {'entity': '27.9', 'category': 'CARDINAL'}, {'entity': '8.6', 'category': 'CARDINAL'}, {'entity': '36.5', 'category': 'CARDINAL'}, {'entity': '19.4', 'category': 'CARDINAL'}, {'entity': '11.2', 'category': 'CARDINAL'}, {'entity': '2.4', 'category': 'CARDINAL'}, {'entity': '33.0', 'category': 'CARDINAL'}, {'entity': '8.5', 'category': 'CARDINAL'}, {'entity': '41.5', 'category': 'CARDINAL'}, {'entity': '139.8', 'category': 'CARDINAL'}, {'entity': '46.1', 'category': 'CARDINAL'}, {'entity': '20.1', 'category': 'CARDINAL'}, {'entity': '206.0', 'category': 'CARDINAL'}, {'entity': '11.7', 'category': 'CARDINAL'}, {'entity': '217.7', 'category': 'CARDINAL'}, {'entity': '21.2', 'category': 'CARDINAL'}, {'entity': '5.9', 'category': 'CARDINAL'}, {'entity': '5.9', 'category': 'CARDINAL'}, {'entity': '33.0', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '32.9', 'category': 'CARDINAL'}, {'entity': '30.3', 'category': 'CARDINAL'}, {'entity': '13.4', 'category': 'CARDINAL'}, {'entity': '13.9', 'category': 'CARDINAL'}, {'entity': '57.6', 'category': 'CARDINAL'}, {'entity': '2.4', 'category': 'CARDINAL'}, {'entity': '60.0', 'category': 'CARDINAL'}, {'entity': '130.7', 'category': 'CARDINAL'}, {'entity': '38.6', 'category': 'CARDINAL'}, {'entity': '12.1', 'category': 'CARDINAL'}, {'entity': '181.4', 'category': 'CARDINAL'}, {'entity': '9.2', 'category': 'CARDINAL'}, {'entity': '190.6', 'category': 'CARDINAL'}, {'entity': '24.5', 'category': 'CARDINAL'}, {'entity': '5.9', 'category': 'CARDINAL'}, {'entity': '3.8', 'category': 'CARDINAL'}, {'entity': '34.2', 'category': 'CARDINAL'}, {'entity': '0.5', 'category': 'CARDINAL'}, {'entity': '34.7', 'category': 'CARDINAL'}, {'entity': '14.7', 'category': 'CARDINAL'}, {'entity': '13.3', 'category': 'CARDINAL'}, {'entity': '5.1', 'category': 'CARDINAL'}, {'entity': '33.1', 'category': 'CARDINAL'}, {'entity': '2.7', 'category': 'CARDINAL'}, {'entity': '35.8', 'category': 'CARDINAL'}, {'entity': '140.5', 'category': 'CARDINAL'}, {'entity': '31.2', 'category': 'CARDINAL'}, {'entity': '10.8', 'category': 'CARDINAL'}, {'entity': '182.5', 'category': 'CARDINAL'}, {'entity': '7.0', 'category': 'CARDINAL'}, {'entity': '189.5', 'category': 'CARDINAL'}, {'entity': '34.7', 'category': 'CARDINAL'}, {'entity': '15.3', 'category': 'CARDINAL'}, {'entity': '6.7', 'category': 'CARDINAL'}, {'entity': '3.5', 'category': 'CARDINAL'}, {'entity': '1.4', 'category': 'CARDINAL'}, {'entity': '7.8', 'category': 'CARDINAL'}, {'entity': '32.9', 'category': 'CARDINAL'}, {'entity': '9.0', 'category': 'CARDINAL'}, {'entity': '7.6', 'category': 'CARDINAL'}, {'entity': '2.6', 'category': 'CARDINAL'}, {'entity': '2.5', 'category': 'CARDINAL'}, {'entity': '2.4', 'category': 'CARDINAL'}, {'entity': '8.8', 'category': 'CARDINAL'}, {'entity': '36.5', 'category': 'CARDINAL'}, {'entity': '13.7', 'category': 'CARDINAL'}, {'entity': '9.8', 'category': 'CARDINAL'}, {'entity': '4.6', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '1.2', 'category': 'CARDINAL'}, {'entity': '5.7', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWCyJwPmJ4nvARPbmmYvYDBds0JA\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701569356,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#20.0#13.9#4.5#1.6#12#37#189.7#93.7#96.0#69.3#26.7#6.0#18.2#125.3#103.4#228.7#20.7#2.8#23.5#20.2#7.6#27.8#2.6#0.8#1.8#5.2#128.4#103.0#231.4#21.5#10.9#21.5#52.3#111.2#98.8#210.0#21.7#7.0#29.7#1.3#3.0#111.5#94.0#205.5\\n\\nDATE#October 2003#November 30, 2012#January 12, 1999#December 1, 1998#third quarter of fiscal 2010#third quarter of fiscal 2010#November 30, 2009#November 30, 2010#November 30, 2011#November 30, 2012\\n\\nEVENT#Global Settlement\\n\\nGPE#U.S.#Sacramento#Azusa#Northrop\\n\\nMONEY#$20.0 million\\n\\nORG#Atlantic Research Corporation#Aerojet#ARC#U.S. government#EIS#Northrop\\n\\nPERCENT#12%#37%}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2500,\n",
      "    \"completion_tokens\": 315,\n",
      "    \"total_tokens\": 2815\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'October 2003', 'category': 'DATE'}, {'entity': 'November 30, 2012', 'category': 'DATE'}, {'entity': 'January 12, 1999', 'category': 'DATE'}, {'entity': 'December 1, 1998', 'category': 'DATE'}, {'entity': 'third quarter of fiscal 2010', 'category': 'DATE'}, {'entity': 'third quarter of fiscal 2010', 'category': 'DATE'}, {'entity': 'November 30, 2009', 'category': 'DATE'}, {'entity': 'November 30, 2010', 'category': 'DATE'}, {'entity': 'November 30, 2011', 'category': 'DATE'}, {'entity': 'November 30, 2012', 'category': 'DATE'}, {'entity': 'Global Settlement', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Sacramento', 'category': 'GPE'}, {'entity': 'Azusa', 'category': 'GPE'}, {'entity': 'Northrop', 'category': 'GPE'}, {'entity': '$20.0 million', 'category': 'MONEY'}, {'entity': 'Atlantic Research Corporation', 'category': 'ORG'}, {'entity': 'Aerojet', 'category': 'ORG'}, {'entity': 'ARC', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'EIS', 'category': 'ORG'}, {'entity': 'Northrop', 'category': 'ORG'}, {'entity': '12%', 'category': 'PERCENT'}, {'entity': '37%', 'category': 'PERCENT'}, {'entity': '20.0', 'category': 'CARDINAL'}, {'entity': '13.9', 'category': 'CARDINAL'}, {'entity': '4.5', 'category': 'CARDINAL'}, {'entity': '1.6', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '37', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '93.7', 'category': 'CARDINAL'}, {'entity': '96.0', 'category': 'CARDINAL'}, {'entity': '69.3', 'category': 'CARDINAL'}, {'entity': '26.7', 'category': 'CARDINAL'}, {'entity': '6.0', 'category': 'CARDINAL'}, {'entity': '18.2', 'category': 'CARDINAL'}, {'entity': '125.3', 'category': 'CARDINAL'}, {'entity': '103.4', 'category': 'CARDINAL'}, {'entity': '228.7', 'category': 'CARDINAL'}, {'entity': '20.7', 'category': 'CARDINAL'}, {'entity': '2.8', 'category': 'CARDINAL'}, {'entity': '23.5', 'category': 'CARDINAL'}, {'entity': '20.2', 'category': 'CARDINAL'}, {'entity': '7.6', 'category': 'CARDINAL'}, {'entity': '27.8', 'category': 'CARDINAL'}, {'entity': '2.6', 'category': 'CARDINAL'}, {'entity': '0.8', 'category': 'CARDINAL'}, {'entity': '1.8', 'category': 'CARDINAL'}, {'entity': '5.2', 'category': 'CARDINAL'}, {'entity': '128.4', 'category': 'CARDINAL'}, {'entity': '103.0', 'category': 'CARDINAL'}, {'entity': '231.4', 'category': 'CARDINAL'}, {'entity': '21.5', 'category': 'CARDINAL'}, {'entity': '10.9', 'category': 'CARDINAL'}, {'entity': '21.5', 'category': 'CARDINAL'}, {'entity': '52.3', 'category': 'CARDINAL'}, {'entity': '111.2', 'category': 'CARDINAL'}, {'entity': '98.8', 'category': 'CARDINAL'}, {'entity': '210.0', 'category': 'CARDINAL'}, {'entity': '21.7', 'category': 'CARDINAL'}, {'entity': '7.0', 'category': 'CARDINAL'}, {'entity': '29.7', 'category': 'CARDINAL'}, {'entity': '1.3', 'category': 'CARDINAL'}, {'entity': '3.0', 'category': 'CARDINAL'}, {'entity': '111.5', 'category': 'CARDINAL'}, {'entity': '94.0', 'category': 'CARDINAL'}, {'entity': '205.5', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWDYOxvFHItMG8IQmAMgUV5NzXYD\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701569392,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#9.0#4.3#3.3#0.8#4.3#29.7#14.7#7.1#1.8#1.3#4.8#21.5#5.3#4.4#2.5#2.4#1.5#5.4#52.3#17.2#14.7#7.6#6.8#6.0#23.5#11.4#9.4#1.3#1.0#0.4#27.8#13.8#4.4#3.8#2.1#1.3#2.4#2.8#24.9#27.7#8.8#36.5#18.2#1#3#1#50%\\n\\nDATE#Fiscal 2012#Fiscal 2011#Fiscal 2010#November 30, 2012#January 2010#December 1, 2011#September 1, 2011#December 2010#May 2011#second quarter of fiscal 2012#June 2011\\n\\nGPE#Camden#Arkansas#Fullerton#California#U.S.\\n\\nMONEY#$9.0 million#$4.3 million#$3.3 million#$0.8 million#$4.3 million#$29.7 million#$14.7 million#$7.1 million#$1.8 million#$1.3 million#$4.8 million#$21.5 million#$5.3 million#$4.4 million#$2.5 million#$2.4 million#$1.5 million#$5.4 million#$52.3 million#$17.2 million#$14.7 million#$7.6 million#$6.8 million#$6.0 million#$23.5 million#$11.4 million#$9.4 million#$1.3 million#$1.0 million#$0.4 million#$27.8 million#$13.8 million#$4.4 million#$3.8 million#$2.1 million#$1.3 million#$2.4 million#$24.3 million#$32.9 million#$36.5 million#$18.2 million\\n\\nORG#U.S. Government#Northrop#Financial Accounting Standards Board#FASB \\n\\nTIME#As of September 1, 2011}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2336,\n",
      "    \"completion_tokens\": 512,\n",
      "    \"total_tokens\": 2848\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'Fiscal 2012', 'category': 'DATE'}, {'entity': 'Fiscal 2011', 'category': 'DATE'}, {'entity': 'Fiscal 2010', 'category': 'DATE'}, {'entity': 'November 30, 2012', 'category': 'DATE'}, {'entity': 'January 2010', 'category': 'DATE'}, {'entity': 'December 1, 2011', 'category': 'DATE'}, {'entity': 'September 1, 2011', 'category': 'DATE'}, {'entity': 'December 2010', 'category': 'DATE'}, {'entity': 'May 2011', 'category': 'DATE'}, {'entity': 'second quarter of fiscal 2012', 'category': 'DATE'}, {'entity': 'June 2011', 'category': 'DATE'}, {'entity': 'Camden', 'category': 'GPE'}, {'entity': 'Arkansas', 'category': 'GPE'}, {'entity': 'Fullerton', 'category': 'GPE'}, {'entity': 'California', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '$9.0 million', 'category': 'MONEY'}, {'entity': '$4.3 million', 'category': 'MONEY'}, {'entity': '$3.3 million', 'category': 'MONEY'}, {'entity': '$0.8 million', 'category': 'MONEY'}, {'entity': '$4.3 million', 'category': 'MONEY'}, {'entity': '$29.7 million', 'category': 'MONEY'}, {'entity': '$14.7 million', 'category': 'MONEY'}, {'entity': '$7.1 million', 'category': 'MONEY'}, {'entity': '$1.8 million', 'category': 'MONEY'}, {'entity': '$1.3 million', 'category': 'MONEY'}, {'entity': '$4.8 million', 'category': 'MONEY'}, {'entity': '$21.5 million', 'category': 'MONEY'}, {'entity': '$5.3 million', 'category': 'MONEY'}, {'entity': '$4.4 million', 'category': 'MONEY'}, {'entity': '$2.5 million', 'category': 'MONEY'}, {'entity': '$2.4 million', 'category': 'MONEY'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': '$5.4 million', 'category': 'MONEY'}, {'entity': '$52.3 million', 'category': 'MONEY'}, {'entity': '$17.2 million', 'category': 'MONEY'}, {'entity': '$14.7 million', 'category': 'MONEY'}, {'entity': '$7.6 million', 'category': 'MONEY'}, {'entity': '$6.8 million', 'category': 'MONEY'}, {'entity': '$6.0 million', 'category': 'MONEY'}, {'entity': '$23.5 million', 'category': 'MONEY'}, {'entity': '$11.4 million', 'category': 'MONEY'}, {'entity': '$9.4 million', 'category': 'MONEY'}, {'entity': '$1.3 million', 'category': 'MONEY'}, {'entity': '$1.0 million', 'category': 'MONEY'}, {'entity': '$0.4 million', 'category': 'MONEY'}, {'entity': '$27.8 million', 'category': 'MONEY'}, {'entity': '$13.8 million', 'category': 'MONEY'}, {'entity': '$4.4 million', 'category': 'MONEY'}, {'entity': '$3.8 million', 'category': 'MONEY'}, {'entity': '$2.1 million', 'category': 'MONEY'}, {'entity': '$1.3 million', 'category': 'MONEY'}, {'entity': '$2.4 million', 'category': 'MONEY'}, {'entity': '$24.3 million', 'category': 'MONEY'}, {'entity': '$32.9 million', 'category': 'MONEY'}, {'entity': '$36.5 million', 'category': 'MONEY'}, {'entity': '$18.2 million', 'category': 'MONEY'}, {'entity': 'U.S. Government', 'category': 'ORG'}, {'entity': 'Northrop', 'category': 'ORG'}, {'entity': 'Financial Accounting Standards Board', 'category': 'ORG'}, {'entity': 'FASB', 'category': 'ORG'}, {'entity': 'As of September 1', 'category': 'TIME'}, {'entity': '2011', 'category': 'TIME'}, {'entity': '9.0', 'category': 'CARDINAL'}, {'entity': '4.3', 'category': 'CARDINAL'}, {'entity': '3.3', 'category': 'CARDINAL'}, {'entity': '0.8', 'category': 'CARDINAL'}, {'entity': '4.3', 'category': 'CARDINAL'}, {'entity': '29.7', 'category': 'CARDINAL'}, {'entity': '14.7', 'category': 'CARDINAL'}, {'entity': '7.1', 'category': 'CARDINAL'}, {'entity': '1.8', 'category': 'CARDINAL'}, {'entity': '1.3', 'category': 'CARDINAL'}, {'entity': '4.8', 'category': 'CARDINAL'}, {'entity': '21.5', 'category': 'CARDINAL'}, {'entity': '5.3', 'category': 'CARDINAL'}, {'entity': '4.4', 'category': 'CARDINAL'}, {'entity': '2.5', 'category': 'CARDINAL'}, {'entity': '2.4', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '5.4', 'category': 'CARDINAL'}, {'entity': '52.3', 'category': 'CARDINAL'}, {'entity': '17.2', 'category': 'CARDINAL'}, {'entity': '14.7', 'category': 'CARDINAL'}, {'entity': '7.6', 'category': 'CARDINAL'}, {'entity': '6.8', 'category': 'CARDINAL'}, {'entity': '6.0', 'category': 'CARDINAL'}, {'entity': '23.5', 'category': 'CARDINAL'}, {'entity': '11.4', 'category': 'CARDINAL'}, {'entity': '9.4', 'category': 'CARDINAL'}, {'entity': '1.3', 'category': 'CARDINAL'}, {'entity': '1.0', 'category': 'CARDINAL'}, {'entity': '0.4', 'category': 'CARDINAL'}, {'entity': '27.8', 'category': 'CARDINAL'}, {'entity': '13.8', 'category': 'CARDINAL'}, {'entity': '4.4', 'category': 'CARDINAL'}, {'entity': '3.8', 'category': 'CARDINAL'}, {'entity': '2.1', 'category': 'CARDINAL'}, {'entity': '1.3', 'category': 'CARDINAL'}, {'entity': '2.4', 'category': 'CARDINAL'}, {'entity': '2.8', 'category': 'CARDINAL'}, {'entity': '24.9', 'category': 'CARDINAL'}, {'entity': '27.7', 'category': 'CARDINAL'}, {'entity': '8.8', 'category': 'CARDINAL'}, {'entity': '36.5', 'category': 'CARDINAL'}, {'entity': '18.2', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '50%', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWECJMjKjcgFOJA8FkvzhIlT7ZCk\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701569432,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#300.0#100.0#5.0#47.5#44.8 \\n\\nDATE#November 30,2012#November 30,2011#May 30, 2012#August 16, 2012#January 14, 2013#first quarter of fiscal 2013#fiscal 2012#fiscal 2011#fiscal 2010#December 2009#November 18, 2011\\n\\nEVENT#Acquisition\\n\\nMONEY#$86.2 million#$76.8 million#$148.1 million#$74.8 million#$44.0 million#$64.1 million#$22.3 million#$85.6 million#$14.2 million#$90.1 million#$37.2 million#$14.9 million#$21.1 million#$16.9 million#$0.6 million#$26.7 million#$26.6 million#$77.7 million#$2.2 million#$70.1 million#$1.8 million#$4.2 million#$200.0 million#$240.2 million#$7.7 million#$1.5 million#$50.0 million#$326.4 million#$248.7 million#$30.0 million#$20.0 million#$510 million#$50 million\\n\\nORG#Wells Fargo Bank, National Association#Aerojet\\n\\nPERCENT#350 basis points\\n\\nTIME#5-year}\\n\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2539,\n",
      "    \"completion_tokens\": 298,\n",
      "    \"total_tokens\": 2837\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'November 30,2012', 'category': 'DATE'}, {'entity': 'November 30,2011', 'category': 'DATE'}, {'entity': 'May 30, 2012', 'category': 'DATE'}, {'entity': 'August 16, 2012', 'category': 'DATE'}, {'entity': 'January 14, 2013', 'category': 'DATE'}, {'entity': 'first quarter of fiscal 2013', 'category': 'DATE'}, {'entity': 'fiscal 2012', 'category': 'DATE'}, {'entity': 'fiscal 2011', 'category': 'DATE'}, {'entity': 'fiscal 2010', 'category': 'DATE'}, {'entity': 'December 2009', 'category': 'DATE'}, {'entity': 'November 18, 2011', 'category': 'DATE'}, {'entity': 'Acquisition', 'category': 'EVENT'}, {'entity': '$86.2 million', 'category': 'MONEY'}, {'entity': '$76.8 million', 'category': 'MONEY'}, {'entity': '$148.1 million', 'category': 'MONEY'}, {'entity': '$74.8 million', 'category': 'MONEY'}, {'entity': '$44.0 million', 'category': 'MONEY'}, {'entity': '$64.1 million', 'category': 'MONEY'}, {'entity': '$22.3 million', 'category': 'MONEY'}, {'entity': '$85.6 million', 'category': 'MONEY'}, {'entity': '$14.2 million', 'category': 'MONEY'}, {'entity': '$90.1 million', 'category': 'MONEY'}, {'entity': '$37.2 million', 'category': 'MONEY'}, {'entity': '$14.9 million', 'category': 'MONEY'}, {'entity': '$21.1 million', 'category': 'MONEY'}, {'entity': '$16.9 million', 'category': 'MONEY'}, {'entity': '$0.6 million', 'category': 'MONEY'}, {'entity': '$26.7 million', 'category': 'MONEY'}, {'entity': '$26.6 million', 'category': 'MONEY'}, {'entity': '$77.7 million', 'category': 'MONEY'}, {'entity': '$2.2 million', 'category': 'MONEY'}, {'entity': '$70.1 million', 'category': 'MONEY'}, {'entity': '$1.8 million', 'category': 'MONEY'}, {'entity': '$4.2 million', 'category': 'MONEY'}, {'entity': '$200.0 million', 'category': 'MONEY'}, {'entity': '$240.2 million', 'category': 'MONEY'}, {'entity': '$7.7 million', 'category': 'MONEY'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': '$50.0 million', 'category': 'MONEY'}, {'entity': '$326.4 million', 'category': 'MONEY'}, {'entity': '$248.7 million', 'category': 'MONEY'}, {'entity': '$30.0 million', 'category': 'MONEY'}, {'entity': '$20.0 million', 'category': 'MONEY'}, {'entity': '$510 million', 'category': 'MONEY'}, {'entity': '$50 million', 'category': 'MONEY'}, {'entity': 'Wells Fargo Bank, National Association', 'category': 'ORG'}, {'entity': 'Aerojet', 'category': 'ORG'}, {'entity': '350 basis points', 'category': 'PERCENT'}, {'entity': '5-year', 'category': 'TIME'}, {'entity': '300.0', 'category': 'CARDINAL'}, {'entity': '100.0', 'category': 'CARDINAL'}, {'entity': '5.0', 'category': 'CARDINAL'}, {'entity': '47.5', 'category': 'CARDINAL'}, {'entity': '44.8', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWElLmezXmwYXbdSTwFoCMxkl5EK\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701569467,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#350#250#50#350#25#66#100#100.0#2.40#3.50#6.05#1.30#3.50#15#7#100#1#2#3#5#4 \\n\\nDATE#November 30, 2012#July 2012#January 28, 2013#July 21, 2013#November 30, 2012\\n\\nGPE#Orange#Virginia#Redmond#Washington#California\\n\\nLAW#Rule 144A#Regulation S\\n\\nMONEY#$100.0 million#$550 million#$460.0 million\\n\\nNORP#U.S.\\n\\nORG#Senior Credit Facility#Aerojet#Easton#Rocketdyne Business#UTC#Acquisition#Consolidated Financial Statements\\n\\nPERSON#Medicare\\n\\nPRODUCT#7 1/8% Notes\\n\\nTIME#the next twelve months#the first half of 2013#the next 10 years\\n\\nWORK_OF_ART#Notes 7(b) and 7(c) of Notes to Consolidated Financial Statements}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2455,\n",
      "    \"completion_tokens\": 233,\n",
      "    \"total_tokens\": 2688\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'November 30, 2012', 'category': 'DATE'}, {'entity': 'July 2012', 'category': 'DATE'}, {'entity': 'January 28, 2013', 'category': 'DATE'}, {'entity': 'July 21, 2013', 'category': 'DATE'}, {'entity': 'November 30, 2012', 'category': 'DATE'}, {'entity': 'Orange', 'category': 'GPE'}, {'entity': 'Virginia', 'category': 'GPE'}, {'entity': 'Redmond', 'category': 'GPE'}, {'entity': 'Washington', 'category': 'GPE'}, {'entity': 'California', 'category': 'GPE'}, {'entity': 'Rule 144A', 'category': 'LAW'}, {'entity': 'Regulation S', 'category': 'LAW'}, {'entity': '$100.0 million', 'category': 'MONEY'}, {'entity': '$550 million', 'category': 'MONEY'}, {'entity': '$460.0 million', 'category': 'MONEY'}, {'entity': 'U.S.', 'category': 'NORP'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': 'Aerojet', 'category': 'ORG'}, {'entity': 'Easton', 'category': 'ORG'}, {'entity': 'Rocketdyne Business', 'category': 'ORG'}, {'entity': 'UTC', 'category': 'ORG'}, {'entity': 'Acquisition', 'category': 'ORG'}, {'entity': 'Consolidated Financial Statements', 'category': 'ORG'}, {'entity': 'Medicare', 'category': 'PERSON'}, {'entity': '7 1/8% Notes', 'category': 'PRODUCT'}, {'entity': 'the next twelve months', 'category': 'TIME'}, {'entity': 'the first half of 2013', 'category': 'TIME'}, {'entity': 'the next 10 years', 'category': 'TIME'}, {'entity': 'Notes 7b and 7c of Notes to Consolidated Financial Statements', 'category': 'WORK_OF_ART'}, {'entity': '350', 'category': 'CARDINAL'}, {'entity': '250', 'category': 'CARDINAL'}, {'entity': '50', 'category': 'CARDINAL'}, {'entity': '350', 'category': 'CARDINAL'}, {'entity': '25', 'category': 'CARDINAL'}, {'entity': '66', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '100.0', 'category': 'CARDINAL'}, {'entity': '2.40', 'category': 'CARDINAL'}, {'entity': '3.50', 'category': 'CARDINAL'}, {'entity': '6.05', 'category': 'CARDINAL'}, {'entity': '1.30', 'category': 'CARDINAL'}, {'entity': '3.50', 'category': 'CARDINAL'}, {'entity': '15', 'category': 'CARDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '5', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWFLA3796GTJc25CLaUGl0BOlVS9\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701569503,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#4.4 million#44.8 million#39.3 million#120.0 million#one-year\\n\\nDATE#November 30, 2012\\n\\nMONEY#$4.4 million#$44.8 million#$39.3 million#$120.0 million\\n\\nORG#GAAP#SEC#GenCorp#Aerojet#U.S. government\\n\\nPERSON#Senior Credit Facility\\n\\nTIME#twelve months\\n\\nWORK_OF_ART#Critical Accounting PoliciesOur}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 1988,\n",
      "    \"completion_tokens\": 100,\n",
      "    \"total_tokens\": 2088\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'November 30', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': '$4.4 million', 'category': 'MONEY'}, {'entity': '$44.8 million', 'category': 'MONEY'}, {'entity': '$39.3 million', 'category': 'MONEY'}, {'entity': '$120.0 million', 'category': 'MONEY'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'GenCorp', 'category': 'ORG'}, {'entity': 'Aerojet', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'Senior Credit Facility', 'category': 'PERSON'}, {'entity': 'twelve months', 'category': 'TIME'}, {'entity': 'Critical Accounting PoliciesOur', 'category': 'WORK_OF_ART'}, {'entity': '4.4 million', 'category': 'CARDINAL'}, {'entity': '44.8 million', 'category': 'CARDINAL'}, {'entity': '39.3 million', 'category': 'CARDINAL'}, {'entity': '120.0 million', 'category': 'CARDINAL'}, {'entity': 'one-year', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWFoDuEE2zY3IUvG1kaHjAIEM5lM\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701569532,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#1#50 \\n\\nDATE#January 1, 1997#September 1, 2012#September 1, 2011 \\n\\nEVENT#Retirement Benefit Plans#Goodwill \\n\\nORG#the U.S. government#DCAA#Aerospace and Defense \\n\\nPERSON#Goodwill \\n\\nPRODUCT#401\\n\\nLAW#FAR and CAS#PPA\\n\\nWORK_OF_ART#Step Zero analysis#Step One \\n\\nMONEY#401(k)\\n\\nTIME#Annual}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2024,\n",
      "    \"completion_tokens\": 102,\n",
      "    \"total_tokens\": 2126\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'January 1, 1997', 'category': 'DATE'}, {'entity': 'September 1, 2012', 'category': 'DATE'}, {'entity': 'September 1, 2011', 'category': 'DATE'}, {'entity': 'Retirement Benefit Plans', 'category': 'EVENT'}, {'entity': 'Goodwill', 'category': 'EVENT'}, {'entity': 'FAR and CAS', 'category': 'LAW'}, {'entity': 'PPA', 'category': 'LAW'}, {'entity': '401k', 'category': 'MONEY'}, {'entity': 'the U.S. government', 'category': 'ORG'}, {'entity': 'DCAA', 'category': 'ORG'}, {'entity': 'Aerospace and Defense', 'category': 'ORG'}, {'entity': 'Goodwill', 'category': 'PERSON'}, {'entity': '401', 'category': 'PRODUCT'}, {'entity': 'Annual', 'category': 'TIME'}, {'entity': 'Step Zero analysis', 'category': 'WORK_OF_ART'}, {'entity': 'Step One', 'category': 'WORK_OF_ART'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '50', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWGGr75jsTXdEGBENDt1ALKPYn7U\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701569560,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#2012#2011#2012#2011#3.68#4.95#3.24#4.58#4.95#5.21#4.58#4.65#8.00#8.00#8.00#1#3#1#1#\\n\\nDATE#November 30, 2012#future years#fiscal 2012#any particular quarterly or annual period#\\n\\nEVENT#pension obligations#Expected long-term rate of return on plan assets#future investment performance of the plan\\u2019s assets#Market conditions and interest rates significantly affect assets and liabilities of our pension plans. Pension accounting permits market gains and losses to be deferred and recognized over a period of years. This \\u201csmoothing\\u201d results in the creation of other accumulated income or loss which will be amortized to pension costs in future years. The accounting method we utilize recognizes one-fifth of the unamortized gains and losses in the market-related value of pension assets and all other gains and losses including changes in the discount rate used to calculate benefit costs each year. Investment gains or losses for this purpose are the difference between the expected return and the actual return on the market-related value of assets which smoothes asset values over three years. Although the smoothing period mitigates some volatility in the calculation of annual pension costs, future pension costs are impacted by changes in the market value of pension plan assets and changes in interest rates.In addition, we maintain medical and life benefits other than pensions that are not funded.A one percentage point change in the key assumptions would have the following effects on the projected benefit obligations as of November 30, 2012 and on expense for fiscal 2012#Net PeriodicBenefit Expense#ProjectedBenefitObligation#Net Periodic PensionBenefit Expense#Net PeriodicMedical and LifeBenefit Expense#AccumulatedBenefitObligation#1% decrease#22.9#193.5#12.4#2.0#1% increase#19.7#161.7#12.4#0.5#2.2#\\n\\nFAC#our pension plans#\\n\\nGPE#U.S.#\\n\\nLOC#\\n\\nMONEY#\\n\\nNORP#U.S. government#\\n\\nORG#U.S. government#\\n\\nPERCENT#3.68 %#4.95 %#3.24 %#4.58 %#4.95 %#5.21 %#4.58 %#4.65 %#8.00 %#8.00 %#8.00 #%\\n\\nPERSON#\\n\\nPRODUCT#\\n\\nTIME#\\n\\nWORK_OF_ART#}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2199,\n",
      "    \"completion_tokens\": 528,\n",
      "    \"total_tokens\": 2727\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'November 30, 2012', 'category': 'DATE'}, {'entity': 'future years', 'category': 'DATE'}, {'entity': 'fiscal 2012', 'category': 'DATE'}, {'entity': 'any particular quarterly or annual period', 'category': 'DATE'}, {'entity': 'pension obligations', 'category': 'EVENT'}, {'entity': 'Expected long-term rate of return on plan assets', 'category': 'EVENT'}, {'entity': 'future investment performance of the plan’s assets', 'category': 'EVENT'}, {'entity': 'Market conditions and interest rates significantly affect assets and liabilities of our pension plans. Pension accounting permits market gains and losses to be deferred and recognized over a period of years. This “smoothing” results in the creation of other accumulated income or loss which will be amortized to pension costs in future years. The accounting method we utilize recognizes one-fifth of the unamortized gains and losses in the market-related value of pension assets and all other gains and losses including changes in the discount rate used to calculate benefit costs each year. Investment gains or losses for this purpose are the difference between the expected return and the actual return on the market-related value of assets which smoothes asset values over three years. Although the smoothing period mitigates some volatility in the calculation of annual pension costs, future pension costs are impacted by changes in the market value of pension plan assets and changes in interest rates.In addition, we maintain medical and life benefits other than pensions that are not funded.A one percentage point change in the key assumptions would have the following effects on the projected benefit obligations as of November 30, 2012 and on expense for fiscal 2012', 'category': 'EVENT'}, {'entity': 'Net PeriodicBenefit Expense', 'category': 'EVENT'}, {'entity': 'ProjectedBenefitObligation', 'category': 'EVENT'}, {'entity': 'Net Periodic PensionBenefit Expense', 'category': 'EVENT'}, {'entity': 'Net PeriodicMedical and LifeBenefit Expense', 'category': 'EVENT'}, {'entity': 'AccumulatedBenefitObligation', 'category': 'EVENT'}, {'entity': '1% decrease', 'category': 'EVENT'}, {'entity': '22.9', 'category': 'EVENT'}, {'entity': '193.5', 'category': 'EVENT'}, {'entity': '12.4', 'category': 'EVENT'}, {'entity': '2.0', 'category': 'EVENT'}, {'entity': '1% increase', 'category': 'EVENT'}, {'entity': '19.7', 'category': 'EVENT'}, {'entity': '161.7', 'category': 'EVENT'}, {'entity': '12.4', 'category': 'EVENT'}, {'entity': '0.5', 'category': 'EVENT'}, {'entity': '2.2', 'category': 'EVENT'}, {'entity': 'our pension plans', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S. government', 'category': 'NORP'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': '3.68 %', 'category': 'PERCENT'}, {'entity': '4.95 %', 'category': 'PERCENT'}, {'entity': '3.24 %', 'category': 'PERCENT'}, {'entity': '4.58 %', 'category': 'PERCENT'}, {'entity': '4.95 %', 'category': 'PERCENT'}, {'entity': '5.21 %', 'category': 'PERCENT'}, {'entity': '4.58 %', 'category': 'PERCENT'}, {'entity': '4.65 %', 'category': 'PERCENT'}, {'entity': '8.00 %', 'category': 'PERCENT'}, {'entity': '8.00 %', 'category': 'PERCENT'}, {'entity': '8.00', 'category': 'PERCENT'}, {'entity': '%', 'category': 'PERCENT'}, {'entity': '', 'category': 'WORK_OF_ART'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '2011', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '2011', 'category': 'CARDINAL'}, {'entity': '3.68', 'category': 'CARDINAL'}, {'entity': '4.95', 'category': 'CARDINAL'}, {'entity': '3.24', 'category': 'CARDINAL'}, {'entity': '4.58', 'category': 'CARDINAL'}, {'entity': '4.95', 'category': 'CARDINAL'}, {'entity': '5.21', 'category': 'CARDINAL'}, {'entity': '4.58', 'category': 'CARDINAL'}, {'entity': '4.65', 'category': 'CARDINAL'}, {'entity': '8.00', 'category': 'CARDINAL'}, {'entity': '8.00', 'category': 'CARDINAL'}, {'entity': '8.00', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWGx9bW1GCt9wwSfLx8rdqMbA6gW\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701569603,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#50% \\n\\nDATE#November 30, 2012#November 30, 2011\\n\\nLAW#Senior Credit Facility\\n\\nMONEY#$248.7 million#$201.2 million#4.09%#$47.5 million#3.71%\\n\\nORG#Quantitative and Qualitative Disclosures\\n\\nPERCENT#81%#19%\\n\\nQUANTITY#three fiscal years\\n\\nTIME#past three fiscal years\\n\\nWORK_OF_ART#9 1/2% Notes#4 1/16% Debentures\\n}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 1590,\n",
      "    \"completion_tokens\": 114,\n",
      "    \"total_tokens\": 1704\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'November 30, 2012', 'category': 'DATE'}, {'entity': 'November 30, 2011', 'category': 'DATE'}, {'entity': 'Senior Credit Facility', 'category': 'LAW'}, {'entity': '$248.7 million', 'category': 'MONEY'}, {'entity': '$201.2 million', 'category': 'MONEY'}, {'entity': '4.09%', 'category': 'MONEY'}, {'entity': '$47.5 million', 'category': 'MONEY'}, {'entity': '3.71%', 'category': 'MONEY'}, {'entity': 'Quantitative and Qualitative Disclosures', 'category': 'ORG'}, {'entity': '81%', 'category': 'PERCENT'}, {'entity': '19%', 'category': 'PERCENT'}, {'entity': 'three fiscal years', 'category': 'QUANTITY'}, {'entity': 'past three fiscal years', 'category': 'TIME'}, {'entity': '9 1/2% Notes', 'category': 'WORK_OF_ART'}, {'entity': '4 1/16% Debentures', 'category': 'WORK_OF_ART'}, {'entity': '50%', 'category': 'CARDINAL'}]\n",
      "/home/damir/Dropbox/Documents/Teaching/2023/L715/l715_23/data/10-Ks/Aerojet_Rocketdyne_Holdings_Inc./2023/Management.txt\n",
      "Length of chunks:  8\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWHQaOtF08zdjspWtkxUHFf4F50c\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701569632,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#7#1#1#1#1#58.00#17#2023#0.0025#20#2020#56.00#5.00#25#2022#14#2022#2022#2021#2,237.6#2,188.0#74.0#146.6#3.3#6.7#115.0#164.5#5.1#7.5#0.90#1.78#1.39#2.00#238.8#298.5#10.7#13.6#48.7#199.6#89.4#162.3#95#96#25#21#20#12#10#7#95#5#100#15#17#12#10#32#32#19#20#19#17#9.8 \\n\\n DATE#December 31, 2020#December 31, 2021#February 18, 2022#December 17, 2022#September 17, 2023#December 20, 2020#March 2021#January 25, 2022#February 13, 2022#February 14, 2022#Year Ended December 31, 2022#December 31, 2022#December 31, 2022\\n\\n EVENT#Management\\u2019s Discussion and Analysis of Financial Condition and Results of Operations#Merger#Lockheed Terminated Merger Agreement\\n\\n FAC#to paragraph 303(b) of Regulation S-K\\n\\n GPE#Russia#Ukraine#putin#Baldwin Park\\n\\n LAW#Merger Agreement#Regulation S-K#HSR Act#Lockheed Terminated Merger Agreement\\n\\n MONEY#$58.00#$0.0025#$51.00#$56.00#$5.00\\n\\n ORDINAL#first\\n\\n ORG#Aerospace and Defense#Real Estate#SEC#L3Harris#Merger Sub.#Company#FTC#U.S. government#NASA#Missile Defense Agency#MDA#U.S. Army#U.S. Air Force#U.S. Navy#RS-25 program#Standard Missile program#PAC-3 program#Lockheed Martin#Raytheon#Aerojet Rocketdyne - Sacramento#Aerojet Rocketdyne - Baldwin Park Operable Unit\\\"\\n\\n PERCENT#3.3%#6.7%#5.1%#7.5%#10.7%#13.6%#95%#96%#25%#21%#20%#12%#10%#7%#95%#5%#100%#15%#32%#32%#19%#20%#19%#17%\\n\\n PERSON#Lockheed Martin#Mizar Sub, Inc.}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2436,\n",
      "    \"completion_tokens\": 608,\n",
      "    \"total_tokens\": 3044\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': 'February 18, 2022', 'category': 'DATE'}, {'entity': 'December 17, 2022', 'category': 'DATE'}, {'entity': 'September 17, 2023', 'category': 'DATE'}, {'entity': 'December 20, 2020', 'category': 'DATE'}, {'entity': 'March 2021', 'category': 'DATE'}, {'entity': 'January 25, 2022', 'category': 'DATE'}, {'entity': 'February 13, 2022', 'category': 'DATE'}, {'entity': 'February 14, 2022', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2022', 'category': 'DATE'}, {'entity': 'December 31, 2022', 'category': 'DATE'}, {'entity': 'December 31, 2022', 'category': 'DATE'}, {'entity': 'Management’s Discussion and Analysis of Financial Condition and Results of Operations', 'category': 'EVENT'}, {'entity': 'Merger', 'category': 'EVENT'}, {'entity': 'Lockheed Terminated Merger Agreement', 'category': 'EVENT'}, {'entity': 'to paragraph 303b of Regulation S-K', 'category': 'FAC'}, {'entity': 'Russia', 'category': 'GPE'}, {'entity': 'Ukraine', 'category': 'GPE'}, {'entity': 'putin', 'category': 'GPE'}, {'entity': 'Baldwin Park', 'category': 'GPE'}, {'entity': 'Merger Agreement', 'category': 'LAW'}, {'entity': 'Regulation S-K', 'category': 'LAW'}, {'entity': 'HSR Act', 'category': 'LAW'}, {'entity': 'Lockheed Terminated Merger Agreement', 'category': 'LAW'}, {'entity': '$58.00', 'category': 'MONEY'}, {'entity': '$0.0025', 'category': 'MONEY'}, {'entity': '$51.00', 'category': 'MONEY'}, {'entity': '$56.00', 'category': 'MONEY'}, {'entity': '$5.00', 'category': 'MONEY'}, {'entity': 'Aerospace and Defense', 'category': 'ORG'}, {'entity': 'Real Estate', 'category': 'ORG'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'L3Harris', 'category': 'ORG'}, {'entity': 'Merger Sub.', 'category': 'ORG'}, {'entity': 'Company', 'category': 'ORG'}, {'entity': 'FTC', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'NASA', 'category': 'ORG'}, {'entity': 'Missile Defense Agency', 'category': 'ORG'}, {'entity': 'MDA', 'category': 'ORG'}, {'entity': 'U.S. Army', 'category': 'ORG'}, {'entity': 'U.S. Air Force', 'category': 'ORG'}, {'entity': 'U.S. Navy', 'category': 'ORG'}, {'entity': 'RS-25 program', 'category': 'ORG'}, {'entity': 'Standard Missile program', 'category': 'ORG'}, {'entity': 'PAC-3 program', 'category': 'ORG'}, {'entity': 'Lockheed Martin', 'category': 'ORG'}, {'entity': 'Raytheon', 'category': 'ORG'}, {'entity': 'Aerojet Rocketdyne - Sacramento', 'category': 'ORG'}, {'entity': 'Aerojet Rocketdyne - Baldwin Park Operable Unit\"', 'category': 'ORG'}, {'entity': '3.3%', 'category': 'PERCENT'}, {'entity': '6.7%', 'category': 'PERCENT'}, {'entity': '5.1%', 'category': 'PERCENT'}, {'entity': '7.5%', 'category': 'PERCENT'}, {'entity': '10.7%', 'category': 'PERCENT'}, {'entity': '13.6%', 'category': 'PERCENT'}, {'entity': '95%', 'category': 'PERCENT'}, {'entity': '96%', 'category': 'PERCENT'}, {'entity': '25%', 'category': 'PERCENT'}, {'entity': '21%', 'category': 'PERCENT'}, {'entity': '20%', 'category': 'PERCENT'}, {'entity': '12%', 'category': 'PERCENT'}, {'entity': '10%', 'category': 'PERCENT'}, {'entity': '7%', 'category': 'PERCENT'}, {'entity': '95%', 'category': 'PERCENT'}, {'entity': '5%', 'category': 'PERCENT'}, {'entity': '100%', 'category': 'PERCENT'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': '32%', 'category': 'PERCENT'}, {'entity': '32%', 'category': 'PERCENT'}, {'entity': '19%', 'category': 'PERCENT'}, {'entity': '20%', 'category': 'PERCENT'}, {'entity': '19%', 'category': 'PERCENT'}, {'entity': '17%', 'category': 'PERCENT'}, {'entity': 'Lockheed Martin', 'category': 'PERSON'}, {'entity': 'Mizar Sub, Inc.', 'category': 'PERSON'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '58.00', 'category': 'CARDINAL'}, {'entity': '17', 'category': 'CARDINAL'}, {'entity': '2023', 'category': 'CARDINAL'}, {'entity': '0.0025', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '2020', 'category': 'CARDINAL'}, {'entity': '56.00', 'category': 'CARDINAL'}, {'entity': '5.00', 'category': 'CARDINAL'}, {'entity': '25', 'category': 'CARDINAL'}, {'entity': '2022', 'category': 'CARDINAL'}, {'entity': '14', 'category': 'CARDINAL'}, {'entity': '2022', 'category': 'CARDINAL'}, {'entity': '2022', 'category': 'CARDINAL'}, {'entity': '2021', 'category': 'CARDINAL'}, {'entity': '2,237.6', 'category': 'CARDINAL'}, {'entity': '2,188.0', 'category': 'CARDINAL'}, {'entity': '74.0', 'category': 'CARDINAL'}, {'entity': '146.6', 'category': 'CARDINAL'}, {'entity': '3.3', 'category': 'CARDINAL'}, {'entity': '6.7', 'category': 'CARDINAL'}, {'entity': '115.0', 'category': 'CARDINAL'}, {'entity': '164.5', 'category': 'CARDINAL'}, {'entity': '5.1', 'category': 'CARDINAL'}, {'entity': '7.5', 'category': 'CARDINAL'}, {'entity': '0.90', 'category': 'CARDINAL'}, {'entity': '1.78', 'category': 'CARDINAL'}, {'entity': '1.39', 'category': 'CARDINAL'}, {'entity': '2.00', 'category': 'CARDINAL'}, {'entity': '238.8', 'category': 'CARDINAL'}, {'entity': '298.5', 'category': 'CARDINAL'}, {'entity': '10.7', 'category': 'CARDINAL'}, {'entity': '13.6', 'category': 'CARDINAL'}, {'entity': '48.7', 'category': 'CARDINAL'}, {'entity': '199.6', 'category': 'CARDINAL'}, {'entity': '89.4', 'category': 'CARDINAL'}, {'entity': '162.3', 'category': 'CARDINAL'}, {'entity': '95', 'category': 'CARDINAL'}, {'entity': '96', 'category': 'CARDINAL'}, {'entity': '25', 'category': 'CARDINAL'}, {'entity': '21', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '95', 'category': 'CARDINAL'}, {'entity': '5', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '15', 'category': 'CARDINAL'}, {'entity': '17', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '32', 'category': 'CARDINAL'}, {'entity': '32', 'category': 'CARDINAL'}, {'entity': '19', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '19', 'category': 'CARDINAL'}, {'entity': '17', 'category': 'CARDINAL'}, {'entity': '9.8', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  8\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWIDdkZl2LwuC1qPIxSjb3vVX7qJ\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701569681,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#50.8#62.6#10.8#20.9#0.9#5.3#6.6#253.1#290.5#447.1#34.5#303.1#706.9#949.7#242.8#83#7#10.6#2,237.6#2,188.0#49.6#42.3#1,906.2#1,800.1#106.1#85.2#82.3#29.9#25.3#4.6#26.6#20.7#5.9#56.5#46.0#10.5#2.5#2.1#1.3#1.2#48.1#48.8#0.7#6.6#9.9#3.3#2.6#2.7#0.1#57.3#61.4#4.1#27.8#25.3#15.7\\n\\nDATE#December 31, 2022#March 11, 2021#2023#December 31, 2017#2020#January 2023#Year Ended December 31, 2022#Year Ended December 31, 2021#Year Ended December 31, 2022#Year Ended December 31, 2022#Year Ended December 31, 2022#Year Ended December 31, 2022#Year Ended December 31, 2022#Year Ended December 31, 2022#Year Ended December 31, 2022#Year Ended December 31, 2022\\n\\nEVENT#Russia's invasion of Ukraine\\n\\nFAC#Aerojet Rocketdyne\\n\\nGPE#Ukraine#U.S.\\n\\nLAW#ARPA#CARES Act#Internal Revenue Service regulations\\n\\nMONEY#$34.5 million#$303.1 million#$706.9 million#$949.7 million#$242.8 million#$7 million#$10.6 million\\n\\nORG#Aerojet Rocketdyne#Northrop#U.S. government#Internal Revenue Service#United Technologies Corporation\\n\\nPERCENT#83%\\n\\nPERSON#Rocketdyne\\n\\nPRODUCT#NGI program#RS-25 program#Standard Missile program#RS-68 program#Rocketdyne Business\\n\\nWORK_OF_ART#Item 8 of this Report}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2472,\n",
      "    \"completion_tokens\": 516,\n",
      "    \"total_tokens\": 2988\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2022', 'category': 'DATE'}, {'entity': 'March 11, 2021', 'category': 'DATE'}, {'entity': '2023', 'category': 'DATE'}, {'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': 'January 2023', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2022', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2021', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2022', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2022', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2022', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2022', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2022', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2022', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2022', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2022', 'category': 'DATE'}, {'entity': 'Russias invasion of Ukraine', 'category': 'EVENT'}, {'entity': 'Aerojet Rocketdyne', 'category': 'FAC'}, {'entity': 'Ukraine', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'ARPA', 'category': 'LAW'}, {'entity': 'CARES Act', 'category': 'LAW'}, {'entity': 'Internal Revenue Service regulations', 'category': 'LAW'}, {'entity': '$34.5 million', 'category': 'MONEY'}, {'entity': '$303.1 million', 'category': 'MONEY'}, {'entity': '$706.9 million', 'category': 'MONEY'}, {'entity': '$949.7 million', 'category': 'MONEY'}, {'entity': '$242.8 million', 'category': 'MONEY'}, {'entity': '$7 million', 'category': 'MONEY'}, {'entity': '$10.6 million', 'category': 'MONEY'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': 'Northrop', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'Internal Revenue Service', 'category': 'ORG'}, {'entity': 'United Technologies Corporation', 'category': 'ORG'}, {'entity': '83%', 'category': 'PERCENT'}, {'entity': 'Rocketdyne', 'category': 'PERSON'}, {'entity': 'NGI program', 'category': 'PRODUCT'}, {'entity': 'RS-25 program', 'category': 'PRODUCT'}, {'entity': 'Standard Missile program', 'category': 'PRODUCT'}, {'entity': 'RS-68 program', 'category': 'PRODUCT'}, {'entity': 'Rocketdyne Business', 'category': 'PRODUCT'}, {'entity': 'Item 8 of this Report', 'category': 'WORK_OF_ART'}, {'entity': '50.8', 'category': 'CARDINAL'}, {'entity': '62.6', 'category': 'CARDINAL'}, {'entity': '10.8', 'category': 'CARDINAL'}, {'entity': '20.9', 'category': 'CARDINAL'}, {'entity': '0.9', 'category': 'CARDINAL'}, {'entity': '5.3', 'category': 'CARDINAL'}, {'entity': '6.6', 'category': 'CARDINAL'}, {'entity': '253.1', 'category': 'CARDINAL'}, {'entity': '290.5', 'category': 'CARDINAL'}, {'entity': '447.1', 'category': 'CARDINAL'}, {'entity': '34.5', 'category': 'CARDINAL'}, {'entity': '303.1', 'category': 'CARDINAL'}, {'entity': '706.9', 'category': 'CARDINAL'}, {'entity': '949.7', 'category': 'CARDINAL'}, {'entity': '242.8', 'category': 'CARDINAL'}, {'entity': '83', 'category': 'CARDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '10.6', 'category': 'CARDINAL'}, {'entity': '2,237.6', 'category': 'CARDINAL'}, {'entity': '2,188.0', 'category': 'CARDINAL'}, {'entity': '49.6', 'category': 'CARDINAL'}, {'entity': '42.3', 'category': 'CARDINAL'}, {'entity': '1,906.2', 'category': 'CARDINAL'}, {'entity': '1,800.1', 'category': 'CARDINAL'}, {'entity': '106.1', 'category': 'CARDINAL'}, {'entity': '85.2', 'category': 'CARDINAL'}, {'entity': '82.3', 'category': 'CARDINAL'}, {'entity': '29.9', 'category': 'CARDINAL'}, {'entity': '25.3', 'category': 'CARDINAL'}, {'entity': '4.6', 'category': 'CARDINAL'}, {'entity': '26.6', 'category': 'CARDINAL'}, {'entity': '20.7', 'category': 'CARDINAL'}, {'entity': '5.9', 'category': 'CARDINAL'}, {'entity': '56.5', 'category': 'CARDINAL'}, {'entity': '46.0', 'category': 'CARDINAL'}, {'entity': '10.5', 'category': 'CARDINAL'}, {'entity': '2.5', 'category': 'CARDINAL'}, {'entity': '2.1', 'category': 'CARDINAL'}, {'entity': '1.3', 'category': 'CARDINAL'}, {'entity': '1.2', 'category': 'CARDINAL'}, {'entity': '48.1', 'category': 'CARDINAL'}, {'entity': '48.8', 'category': 'CARDINAL'}, {'entity': '0.7', 'category': 'CARDINAL'}, {'entity': '6.6', 'category': 'CARDINAL'}, {'entity': '9.9', 'category': 'CARDINAL'}, {'entity': '3.3', 'category': 'CARDINAL'}, {'entity': '2.6', 'category': 'CARDINAL'}, {'entity': '2.7', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '57.3', 'category': 'CARDINAL'}, {'entity': '61.4', 'category': 'CARDINAL'}, {'entity': '4.1', 'category': 'CARDINAL'}, {'entity': '27.8', 'category': 'CARDINAL'}, {'entity': '25.3', 'category': 'CARDINAL'}, {'entity': '15.7', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  8\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWIu7Jgack4KmvJ7oTDrtnvSn1uV\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701569724,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#15.7#2.5#18.9#16.4#1.0#4.6#3.6#72.3#23.5#48.8#27.8#25.3#15.7#16.4#11#8#22.7#10.5#12.2#2\\u00bc#22.6#0.1#6#8#154.1#2.9#5.4#2.5#2.9#17.1#14.2#2.9#1.5#5.9#4.4#18.6#20.1#1.5#1#34.3#48.4#31.7#21#21#151.3#24.8#21#16#36.1#34.0#2.1#62.8#61.4#1.4#0.1#0.1#27.7#61.2#33.5#1.1#33.9#32.8#10#32#2,235.2#2,179.3#55.9#252.9#285.9#33.0#11.3#13.1#53#52#42.3#55#57#45#43#33.8#31.2#2.4#8.7#6.3#1.0#2.9#3.9\\n\\nDATE#Year Ended December 31, 2022#Year Ended December 31, 2021#Year Ended December 31, 2021#Year Ended December 31, 2022#Year Ended December 31, 2022#Year Ended December 31, 2022#Year Ended December 31, 2021#In 2022#January 1, 2022#December 31, 2022#Year Ended December 31, 2022#In 2022#As of December 31, 2022#In 2021#On August 16, 2022#In 2022#Year Ended December 31, 2022#Year Ended December 31, 2022#December 31, 2021#In 2023#2023#Year Ended December 31, 2022#Year Ended December 31, 2022#Year Ended December 31, 2022#Year Ended December 31, 2021#Year Ended December 31, 2022#During 2022#Year Ended December 31, 2022\\n\\nEVENT#proxy contest\\n\\nLAW#Inflation Reduction Act\\n\\nMONEY#$27.8 million#$25.3 million#15.7 million#16.4 million#$22.7#10.5#12.2#$22.6 million#$0.1 million#$154.1 million#$10.5 million#5.4#2.5#2.9#17.1#14.2#2.9#1.5#5.9#4.4#18.6#20.1#1.5#34.3#48.4#21#$151.3 million#21#$10 million#$32 million#2,235.2#2,179.3#55.9#252.9#285.9#33.0#42.3 million#33.8 million#31.2 million#2.4#8.7#6.3\\n\\nORG#Senior Credit Facility#the \\\"Inflation Reduction Act\\\"#NGI#RS-25#Aerojet Rocketdyne\\n\\nPERCENT#31.7%#21%#24.8%#21%#11.3 %\\n\\nPRODUCT#Senior Credit Facility#Inflation Reduction Act#Retirement Benefit Plans#Aerospace and Defense Segment#Real Estate Segment\\n\\nTIME#fourth quarter of 2022\\n\\nWORK_OF_ART#Critical Accounting Policies and Estimates - Retirement Benefit Plans}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2580,\n",
      "    \"completion_tokens\": 854,\n",
      "    \"total_tokens\": 3434\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'Year Ended December 31, 2022', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2021', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2021', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2022', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2022', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2022', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2021', 'category': 'DATE'}, {'entity': 'In 2022', 'category': 'DATE'}, {'entity': 'January 1, 2022', 'category': 'DATE'}, {'entity': 'December 31, 2022', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2022', 'category': 'DATE'}, {'entity': 'In 2022', 'category': 'DATE'}, {'entity': 'As of December 31, 2022', 'category': 'DATE'}, {'entity': 'In 2021', 'category': 'DATE'}, {'entity': 'On August 16, 2022', 'category': 'DATE'}, {'entity': 'In 2022', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2022', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2022', 'category': 'DATE'}, {'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': 'In 2023', 'category': 'DATE'}, {'entity': '2023', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2022', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2022', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2022', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2021', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2022', 'category': 'DATE'}, {'entity': 'During 2022', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2022', 'category': 'DATE'}, {'entity': 'proxy contest', 'category': 'EVENT'}, {'entity': 'Inflation Reduction Act', 'category': 'LAW'}, {'entity': '$27.8 million', 'category': 'MONEY'}, {'entity': '$25.3 million', 'category': 'MONEY'}, {'entity': '15.7 million', 'category': 'MONEY'}, {'entity': '16.4 million', 'category': 'MONEY'}, {'entity': '$22.7', 'category': 'MONEY'}, {'entity': '10.5', 'category': 'MONEY'}, {'entity': '12.2', 'category': 'MONEY'}, {'entity': '$22.6 million', 'category': 'MONEY'}, {'entity': '$0.1 million', 'category': 'MONEY'}, {'entity': '$154.1 million', 'category': 'MONEY'}, {'entity': '$10.5 million', 'category': 'MONEY'}, {'entity': '5.4', 'category': 'MONEY'}, {'entity': '2.5', 'category': 'MONEY'}, {'entity': '2.9', 'category': 'MONEY'}, {'entity': '17.1', 'category': 'MONEY'}, {'entity': '14.2', 'category': 'MONEY'}, {'entity': '2.9', 'category': 'MONEY'}, {'entity': '1.5', 'category': 'MONEY'}, {'entity': '5.9', 'category': 'MONEY'}, {'entity': '4.4', 'category': 'MONEY'}, {'entity': '18.6', 'category': 'MONEY'}, {'entity': '20.1', 'category': 'MONEY'}, {'entity': '1.5', 'category': 'MONEY'}, {'entity': '34.3', 'category': 'MONEY'}, {'entity': '48.4', 'category': 'MONEY'}, {'entity': '21', 'category': 'MONEY'}, {'entity': '$151.3 million', 'category': 'MONEY'}, {'entity': '21', 'category': 'MONEY'}, {'entity': '$10 million', 'category': 'MONEY'}, {'entity': '$32 million', 'category': 'MONEY'}, {'entity': '2,235.2', 'category': 'MONEY'}, {'entity': '2,179.3', 'category': 'MONEY'}, {'entity': '55.9', 'category': 'MONEY'}, {'entity': '252.9', 'category': 'MONEY'}, {'entity': '285.9', 'category': 'MONEY'}, {'entity': '33.0', 'category': 'MONEY'}, {'entity': '42.3 million', 'category': 'MONEY'}, {'entity': '33.8 million', 'category': 'MONEY'}, {'entity': '31.2 million', 'category': 'MONEY'}, {'entity': '2.4', 'category': 'MONEY'}, {'entity': '8.7', 'category': 'MONEY'}, {'entity': '6.3', 'category': 'MONEY'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': 'the \"Inflation Reduction Act\"', 'category': 'ORG'}, {'entity': 'NGI', 'category': 'ORG'}, {'entity': 'RS-25', 'category': 'ORG'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': '31.7%', 'category': 'PERCENT'}, {'entity': '21%', 'category': 'PERCENT'}, {'entity': '24.8%', 'category': 'PERCENT'}, {'entity': '21%', 'category': 'PERCENT'}, {'entity': '11.3 %', 'category': 'PERCENT'}, {'entity': 'Senior Credit Facility', 'category': 'PRODUCT'}, {'entity': 'Inflation Reduction Act', 'category': 'PRODUCT'}, {'entity': 'Retirement Benefit Plans', 'category': 'PRODUCT'}, {'entity': 'Aerospace and Defense Segment', 'category': 'PRODUCT'}, {'entity': 'Real Estate Segment', 'category': 'PRODUCT'}, {'entity': 'fourth quarter of 2022', 'category': 'TIME'}, {'entity': 'Critical Accounting Policies and Estimates - Retirement Benefit Plans', 'category': 'WORK_OF_ART'}, {'entity': '15.7', 'category': 'CARDINAL'}, {'entity': '2.5', 'category': 'CARDINAL'}, {'entity': '18.9', 'category': 'CARDINAL'}, {'entity': '16.4', 'category': 'CARDINAL'}, {'entity': '1.0', 'category': 'CARDINAL'}, {'entity': '4.6', 'category': 'CARDINAL'}, {'entity': '3.6', 'category': 'CARDINAL'}, {'entity': '72.3', 'category': 'CARDINAL'}, {'entity': '23.5', 'category': 'CARDINAL'}, {'entity': '48.8', 'category': 'CARDINAL'}, {'entity': '27.8', 'category': 'CARDINAL'}, {'entity': '25.3', 'category': 'CARDINAL'}, {'entity': '15.7', 'category': 'CARDINAL'}, {'entity': '16.4', 'category': 'CARDINAL'}, {'entity': '11', 'category': 'CARDINAL'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': '22.7', 'category': 'CARDINAL'}, {'entity': '10.5', 'category': 'CARDINAL'}, {'entity': '12.2', 'category': 'CARDINAL'}, {'entity': '2¼', 'category': 'CARDINAL'}, {'entity': '22.6', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': '154.1', 'category': 'CARDINAL'}, {'entity': '2.9', 'category': 'CARDINAL'}, {'entity': '5.4', 'category': 'CARDINAL'}, {'entity': '2.5', 'category': 'CARDINAL'}, {'entity': '2.9', 'category': 'CARDINAL'}, {'entity': '17.1', 'category': 'CARDINAL'}, {'entity': '14.2', 'category': 'CARDINAL'}, {'entity': '2.9', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '5.9', 'category': 'CARDINAL'}, {'entity': '4.4', 'category': 'CARDINAL'}, {'entity': '18.6', 'category': 'CARDINAL'}, {'entity': '20.1', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '34.3', 'category': 'CARDINAL'}, {'entity': '48.4', 'category': 'CARDINAL'}, {'entity': '31.7', 'category': 'CARDINAL'}, {'entity': '21', 'category': 'CARDINAL'}, {'entity': '21', 'category': 'CARDINAL'}, {'entity': '151.3', 'category': 'CARDINAL'}, {'entity': '24.8', 'category': 'CARDINAL'}, {'entity': '21', 'category': 'CARDINAL'}, {'entity': '16', 'category': 'CARDINAL'}, {'entity': '36.1', 'category': 'CARDINAL'}, {'entity': '34.0', 'category': 'CARDINAL'}, {'entity': '2.1', 'category': 'CARDINAL'}, {'entity': '62.8', 'category': 'CARDINAL'}, {'entity': '61.4', 'category': 'CARDINAL'}, {'entity': '1.4', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '27.7', 'category': 'CARDINAL'}, {'entity': '61.2', 'category': 'CARDINAL'}, {'entity': '33.5', 'category': 'CARDINAL'}, {'entity': '1.1', 'category': 'CARDINAL'}, {'entity': '33.9', 'category': 'CARDINAL'}, {'entity': '32.8', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '32', 'category': 'CARDINAL'}, {'entity': '2,235.2', 'category': 'CARDINAL'}, {'entity': '2,179.3', 'category': 'CARDINAL'}, {'entity': '55.9', 'category': 'CARDINAL'}, {'entity': '252.9', 'category': 'CARDINAL'}, {'entity': '285.9', 'category': 'CARDINAL'}, {'entity': '33.0', 'category': 'CARDINAL'}, {'entity': '11.3', 'category': 'CARDINAL'}, {'entity': '13.1', 'category': 'CARDINAL'}, {'entity': '53', 'category': 'CARDINAL'}, {'entity': '52', 'category': 'CARDINAL'}, {'entity': '42.3', 'category': 'CARDINAL'}, {'entity': '55', 'category': 'CARDINAL'}, {'entity': '57', 'category': 'CARDINAL'}, {'entity': '45', 'category': 'CARDINAL'}, {'entity': '43', 'category': 'CARDINAL'}, {'entity': '33.8', 'category': 'CARDINAL'}, {'entity': '31.2', 'category': 'CARDINAL'}, {'entity': '2.4', 'category': 'CARDINAL'}, {'entity': '8.7', 'category': 'CARDINAL'}, {'entity': '6.3', 'category': 'CARDINAL'}, {'entity': '1.0', 'category': 'CARDINAL'}, {'entity': '2.9', 'category': 'CARDINAL'}, {'entity': '3.9', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  8\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWJjnVURzl4D7X50jAMUfBxVXKMZ\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701569775,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#33%#27%#40%#6.8#74.0#146.6#3.3#6.7#10.7#13.6#115.0#164.5#0.90#1.78#83.3#81.7#48.7#199.6#89.4#162.3\\n\\nDATE#2022#2021#December 31, 2022#Year Ended December 31#Year Ended December 31\\n\\nEVENT#industrial land sale#funding delays#program restructurings/cancellations\\n\\nFAC#Senior Credit Facility\\n\\nGPE#U.S.\\n\\nMONEY#$6.2 million#$2.3 million#$6.8 billion#$2.3 billion#3.1#3.7#18.6#20.1#34.3#48.4#57.3#61.4#1.1#33.9#(35.1)#(38.8)#$238.8#$298.5#(19.0)#(6.6)#$115.0#$164.5#(5.4)#(2.5)#45.0#29.4#$322.1 million#$621.1 million\\n\\nORDINAL#first#second\\n\\nORG#Non-GAAP#GAAP#CAS#Audit Committee#Board of Directors#Company\\n\\nPERCENT#net income as a percentage of net sales#Adjusted EBITDAP as a percentage of net sales\\n\\nTIME#the next twelve months#the following twelve months#the next twelve months\\n\\nWORK_OF_ART#Merger}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2447,\n",
      "    \"completion_tokens\": 346,\n",
      "    \"total_tokens\": 2793\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': '2022', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': 'December 31, 2022', 'category': 'DATE'}, {'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': 'industrial land sale', 'category': 'EVENT'}, {'entity': 'funding delays', 'category': 'EVENT'}, {'entity': 'program restructurings/cancellations', 'category': 'EVENT'}, {'entity': 'Senior Credit Facility', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '$6.2 million', 'category': 'MONEY'}, {'entity': '$2.3 million', 'category': 'MONEY'}, {'entity': '$6.8 billion', 'category': 'MONEY'}, {'entity': '$2.3 billion', 'category': 'MONEY'}, {'entity': '3.1', 'category': 'MONEY'}, {'entity': '3.7', 'category': 'MONEY'}, {'entity': '18.6', 'category': 'MONEY'}, {'entity': '20.1', 'category': 'MONEY'}, {'entity': '34.3', 'category': 'MONEY'}, {'entity': '48.4', 'category': 'MONEY'}, {'entity': '57.3', 'category': 'MONEY'}, {'entity': '61.4', 'category': 'MONEY'}, {'entity': '1.1', 'category': 'MONEY'}, {'entity': '33.9', 'category': 'MONEY'}, {'entity': '35.1', 'category': 'MONEY'}, {'entity': '38.8', 'category': 'MONEY'}, {'entity': '$238.8', 'category': 'MONEY'}, {'entity': '$298.5', 'category': 'MONEY'}, {'entity': '19.0', 'category': 'MONEY'}, {'entity': '6.6', 'category': 'MONEY'}, {'entity': '$115.0', 'category': 'MONEY'}, {'entity': '$164.5', 'category': 'MONEY'}, {'entity': '5.4', 'category': 'MONEY'}, {'entity': '2.5', 'category': 'MONEY'}, {'entity': '45.0', 'category': 'MONEY'}, {'entity': '29.4', 'category': 'MONEY'}, {'entity': '$322.1 million', 'category': 'MONEY'}, {'entity': '$621.1 million', 'category': 'MONEY'}, {'entity': 'Non-GAAP', 'category': 'ORG'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': 'CAS', 'category': 'ORG'}, {'entity': 'Audit Committee', 'category': 'ORG'}, {'entity': 'Board of Directors', 'category': 'ORG'}, {'entity': 'Company', 'category': 'ORG'}, {'entity': 'net income as a percentage of net sales', 'category': 'PERCENT'}, {'entity': 'Adjusted EBITDAP as a percentage of net sales', 'category': 'PERCENT'}, {'entity': 'the next twelve months', 'category': 'TIME'}, {'entity': 'the following twelve months', 'category': 'TIME'}, {'entity': 'the next twelve months', 'category': 'TIME'}, {'entity': 'Merger', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'second', 'category': 'ORDINAL'}, {'entity': '33%', 'category': 'CARDINAL'}, {'entity': '27%', 'category': 'CARDINAL'}, {'entity': '40%', 'category': 'CARDINAL'}, {'entity': '6.8', 'category': 'CARDINAL'}, {'entity': '74.0', 'category': 'CARDINAL'}, {'entity': '146.6', 'category': 'CARDINAL'}, {'entity': '3.3', 'category': 'CARDINAL'}, {'entity': '6.7', 'category': 'CARDINAL'}, {'entity': '10.7', 'category': 'CARDINAL'}, {'entity': '13.6', 'category': 'CARDINAL'}, {'entity': '115.0', 'category': 'CARDINAL'}, {'entity': '164.5', 'category': 'CARDINAL'}, {'entity': '0.90', 'category': 'CARDINAL'}, {'entity': '1.78', 'category': 'CARDINAL'}, {'entity': '83.3', 'category': 'CARDINAL'}, {'entity': '81.7', 'category': 'CARDINAL'}, {'entity': '48.7', 'category': 'CARDINAL'}, {'entity': '199.6', 'category': 'CARDINAL'}, {'entity': '89.4', 'category': 'CARDINAL'}, {'entity': '162.3', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  8\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWKMQurho3PG6QKnqFmLl3riibfb\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701569814,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#42.4#40.7#1.7#287.1#263.8#18.9#1.7#2.7#650.0#269.1#10#175#250#5.0#31#262.3#13.5#248.8#41.7#15.9#25.8#65.0#3.7#7.6#7.8#45.9#65.1#11.8#17.4#15.3#20.6#14.9#2.4#4.0#3.2#5.3#1,353.8#845.9#470.1#37.8#57.4#19.0#1.5#3.4#33.5#1,860.2#912.2#775.2#67.5#105.3#7#10#8\\n\\nDATE#2022#September 20, 2025#December 31, 2022#December 31, 2022#2023#Next 10 years\\n\\nMONEY#$42.4 million#$40.7 million#$1.7 million#$287.1 million#$263.8 million#$18.9 million#$1.7 million#$2.7 million#$650.0 million#$269.1 million#262.3#13.5#248.8#41.7#15.9#25.8#65.0#3.7#7.6#7.8#45.9#65.1#11.8#17.4#15.3#20.6#14.9#2.4#4.0#3.2#5.3#1,353.8#845.9#470.1#37.8#57.4#19.0#1.5#3.4#33.5#1,860.2#912.2#775.2#67.5#105.3#7 million\\n\\nORG#Senior Credit Facility#Company#U.S. government#SEC#GAAP\\n\\nPERCENT#10 basis points#175 to 250 basis points#5.0% per annum\\n\\nTIME#15 years}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2274,\n",
      "    \"completion_tokens\": 487,\n",
      "    \"total_tokens\": 2761\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': '2022', 'category': 'DATE'}, {'entity': 'September 20, 2025', 'category': 'DATE'}, {'entity': 'December 31, 2022', 'category': 'DATE'}, {'entity': 'December 31, 2022', 'category': 'DATE'}, {'entity': '2023', 'category': 'DATE'}, {'entity': 'Next 10 years', 'category': 'DATE'}, {'entity': '$42.4 million', 'category': 'MONEY'}, {'entity': '$40.7 million', 'category': 'MONEY'}, {'entity': '$1.7 million', 'category': 'MONEY'}, {'entity': '$287.1 million', 'category': 'MONEY'}, {'entity': '$263.8 million', 'category': 'MONEY'}, {'entity': '$18.9 million', 'category': 'MONEY'}, {'entity': '$1.7 million', 'category': 'MONEY'}, {'entity': '$2.7 million', 'category': 'MONEY'}, {'entity': '$650.0 million', 'category': 'MONEY'}, {'entity': '$269.1 million', 'category': 'MONEY'}, {'entity': '262.3', 'category': 'MONEY'}, {'entity': '13.5', 'category': 'MONEY'}, {'entity': '248.8', 'category': 'MONEY'}, {'entity': '41.7', 'category': 'MONEY'}, {'entity': '15.9', 'category': 'MONEY'}, {'entity': '25.8', 'category': 'MONEY'}, {'entity': '65.0', 'category': 'MONEY'}, {'entity': '3.7', 'category': 'MONEY'}, {'entity': '7.6', 'category': 'MONEY'}, {'entity': '7.8', 'category': 'MONEY'}, {'entity': '45.9', 'category': 'MONEY'}, {'entity': '65.1', 'category': 'MONEY'}, {'entity': '11.8', 'category': 'MONEY'}, {'entity': '17.4', 'category': 'MONEY'}, {'entity': '15.3', 'category': 'MONEY'}, {'entity': '20.6', 'category': 'MONEY'}, {'entity': '14.9', 'category': 'MONEY'}, {'entity': '2.4', 'category': 'MONEY'}, {'entity': '4.0', 'category': 'MONEY'}, {'entity': '3.2', 'category': 'MONEY'}, {'entity': '5.3', 'category': 'MONEY'}, {'entity': '1,353.8', 'category': 'MONEY'}, {'entity': '845.9', 'category': 'MONEY'}, {'entity': '470.1', 'category': 'MONEY'}, {'entity': '37.8', 'category': 'MONEY'}, {'entity': '57.4', 'category': 'MONEY'}, {'entity': '19.0', 'category': 'MONEY'}, {'entity': '1.5', 'category': 'MONEY'}, {'entity': '3.4', 'category': 'MONEY'}, {'entity': '33.5', 'category': 'MONEY'}, {'entity': '1,860.2', 'category': 'MONEY'}, {'entity': '912.2', 'category': 'MONEY'}, {'entity': '775.2', 'category': 'MONEY'}, {'entity': '67.5', 'category': 'MONEY'}, {'entity': '105.3', 'category': 'MONEY'}, {'entity': '7 million', 'category': 'MONEY'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': 'Company', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': '10 basis points', 'category': 'PERCENT'}, {'entity': '175 to 250 basis points', 'category': 'PERCENT'}, {'entity': '5.0% per annum', 'category': 'PERCENT'}, {'entity': '15 years', 'category': 'TIME'}, {'entity': '42.4', 'category': 'CARDINAL'}, {'entity': '40.7', 'category': 'CARDINAL'}, {'entity': '1.7', 'category': 'CARDINAL'}, {'entity': '287.1', 'category': 'CARDINAL'}, {'entity': '263.8', 'category': 'CARDINAL'}, {'entity': '18.9', 'category': 'CARDINAL'}, {'entity': '1.7', 'category': 'CARDINAL'}, {'entity': '2.7', 'category': 'CARDINAL'}, {'entity': '650.0', 'category': 'CARDINAL'}, {'entity': '269.1', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '175', 'category': 'CARDINAL'}, {'entity': '250', 'category': 'CARDINAL'}, {'entity': '5.0', 'category': 'CARDINAL'}, {'entity': '31', 'category': 'CARDINAL'}, {'entity': '262.3', 'category': 'CARDINAL'}, {'entity': '13.5', 'category': 'CARDINAL'}, {'entity': '248.8', 'category': 'CARDINAL'}, {'entity': '41.7', 'category': 'CARDINAL'}, {'entity': '15.9', 'category': 'CARDINAL'}, {'entity': '25.8', 'category': 'CARDINAL'}, {'entity': '65.0', 'category': 'CARDINAL'}, {'entity': '3.7', 'category': 'CARDINAL'}, {'entity': '7.6', 'category': 'CARDINAL'}, {'entity': '7.8', 'category': 'CARDINAL'}, {'entity': '45.9', 'category': 'CARDINAL'}, {'entity': '65.1', 'category': 'CARDINAL'}, {'entity': '11.8', 'category': 'CARDINAL'}, {'entity': '17.4', 'category': 'CARDINAL'}, {'entity': '15.3', 'category': 'CARDINAL'}, {'entity': '20.6', 'category': 'CARDINAL'}, {'entity': '14.9', 'category': 'CARDINAL'}, {'entity': '2.4', 'category': 'CARDINAL'}, {'entity': '4.0', 'category': 'CARDINAL'}, {'entity': '3.2', 'category': 'CARDINAL'}, {'entity': '5.3', 'category': 'CARDINAL'}, {'entity': '1,353.8', 'category': 'CARDINAL'}, {'entity': '845.9', 'category': 'CARDINAL'}, {'entity': '470.1', 'category': 'CARDINAL'}, {'entity': '37.8', 'category': 'CARDINAL'}, {'entity': '57.4', 'category': 'CARDINAL'}, {'entity': '19.0', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '3.4', 'category': 'CARDINAL'}, {'entity': '33.5', 'category': 'CARDINAL'}, {'entity': '1,860.2', 'category': 'CARDINAL'}, {'entity': '912.2', 'category': 'CARDINAL'}, {'entity': '775.2', 'category': 'CARDINAL'}, {'entity': '67.5', 'category': 'CARDINAL'}, {'entity': '105.3', 'category': 'CARDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '8', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  8\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWL1wi9hioUBMtbL4KB8tj77rJYr\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701569855,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#2022#2021#34.8#31.2#23.1#23.5#0.29#0.29#8#401#5.56#2.90#5.66#2.77#2.90#2.52#2.77#2.28#7.00#7.00 \\n\\nDATE#Year Ended December 31\\n\\nFAC#U.S. government \\n\\nGPE#U.S.\\n\\nMONEY#$(21.4)#$(33.8)#$(23.1)\\n\\nORG#Aerospace and Defense\\n\\nPERCENT#2.90%#2.52%#2.77%#2.28%#7.00%#7.00% \\n\\nPRODUCT#defined benefit pension plans }\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2135,\n",
      "    \"completion_tokens\": 166,\n",
      "    \"total_tokens\": 2301\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': 'U.S. government', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '$21.4', 'category': 'MONEY'}, {'entity': '$33.8', 'category': 'MONEY'}, {'entity': '$23.1', 'category': 'MONEY'}, {'entity': 'Aerospace and Defense', 'category': 'ORG'}, {'entity': '2.90%', 'category': 'PERCENT'}, {'entity': '2.52%', 'category': 'PERCENT'}, {'entity': '2.77%', 'category': 'PERCENT'}, {'entity': '2.28%', 'category': 'PERCENT'}, {'entity': '7.00%', 'category': 'PERCENT'}, {'entity': '7.00%', 'category': 'PERCENT'}, {'entity': 'defined benefit pension plans', 'category': 'PRODUCT'}, {'entity': '2022', 'category': 'CARDINAL'}, {'entity': '2021', 'category': 'CARDINAL'}, {'entity': '34.8', 'category': 'CARDINAL'}, {'entity': '31.2', 'category': 'CARDINAL'}, {'entity': '23.1', 'category': 'CARDINAL'}, {'entity': '23.5', 'category': 'CARDINAL'}, {'entity': '0.29', 'category': 'CARDINAL'}, {'entity': '0.29', 'category': 'CARDINAL'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': '401', 'category': 'CARDINAL'}, {'entity': '5.56', 'category': 'CARDINAL'}, {'entity': '2.90', 'category': 'CARDINAL'}, {'entity': '5.66', 'category': 'CARDINAL'}, {'entity': '2.77', 'category': 'CARDINAL'}, {'entity': '2.90', 'category': 'CARDINAL'}, {'entity': '2.52', 'category': 'CARDINAL'}, {'entity': '2.77', 'category': 'CARDINAL'}, {'entity': '2.28', 'category': 'CARDINAL'}, {'entity': '7.00', 'category': 'CARDINAL'}, {'entity': '7.00', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  8\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWLX2A7RR7AWs1rMNohspHxPzsf6\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701569887,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#three#one#one#1#1#1#1 \\n\\nDATE#January 1, 2022#December 31, 2022#December 31, 2022#January 1, 2022#December 31, 2022#2022\\n\\nGPE#U.S.#Rancho Cordova#U.S.\\n\\nMONEY#$16.5#$80.7#$9.0#$(0.1)#{-14.2}#(69.7)#$(9.0)#$0.1#$296.4#$33.8#$(39.7)#$290.5#$33.8#$13.9#$13.0#$3.9#$3.0#298.9#$29.6#$(34.9)#$(6.0)#$287.6#$4.1\\n\\nORG#Northrop\\n\\nPERSON#Company\\n\\nTIME#three years#annual#future#future#most#currently#future#future#future#associated\\n\\n}\\n\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2165,\n",
      "    \"completion_tokens\": 218,\n",
      "    \"total_tokens\": 2383\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'January 1, 2022', 'category': 'DATE'}, {'entity': 'December 31, 2022', 'category': 'DATE'}, {'entity': 'December 31, 2022', 'category': 'DATE'}, {'entity': 'January 1, 2022', 'category': 'DATE'}, {'entity': 'December 31, 2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Rancho Cordova', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '$16.5', 'category': 'MONEY'}, {'entity': '$80.7', 'category': 'MONEY'}, {'entity': '$9.0', 'category': 'MONEY'}, {'entity': '$0.1', 'category': 'MONEY'}, {'entity': '-14.2', 'category': 'MONEY'}, {'entity': '69.7', 'category': 'MONEY'}, {'entity': '$9.0', 'category': 'MONEY'}, {'entity': '$0.1', 'category': 'MONEY'}, {'entity': '$296.4', 'category': 'MONEY'}, {'entity': '$33.8', 'category': 'MONEY'}, {'entity': '$39.7', 'category': 'MONEY'}, {'entity': '$290.5', 'category': 'MONEY'}, {'entity': '$33.8', 'category': 'MONEY'}, {'entity': '$13.9', 'category': 'MONEY'}, {'entity': '$13.0', 'category': 'MONEY'}, {'entity': '$3.9', 'category': 'MONEY'}, {'entity': '$3.0', 'category': 'MONEY'}, {'entity': '298.9', 'category': 'MONEY'}, {'entity': '$29.6', 'category': 'MONEY'}, {'entity': '$34.9', 'category': 'MONEY'}, {'entity': '$6.0', 'category': 'MONEY'}, {'entity': '$287.6', 'category': 'MONEY'}, {'entity': '$4.1', 'category': 'MONEY'}, {'entity': 'Northrop', 'category': 'ORG'}, {'entity': 'Company', 'category': 'PERSON'}, {'entity': 'three years', 'category': 'TIME'}, {'entity': 'annual', 'category': 'TIME'}, {'entity': 'future', 'category': 'TIME'}, {'entity': 'future', 'category': 'TIME'}, {'entity': 'most', 'category': 'TIME'}, {'entity': 'currently', 'category': 'TIME'}, {'entity': 'future', 'category': 'TIME'}, {'entity': 'future', 'category': 'TIME'}, {'entity': 'future', 'category': 'TIME'}, {'entity': 'associated', 'category': 'TIME'}, {'entity': 'three', 'category': 'CARDINAL'}, {'entity': 'one', 'category': 'CARDINAL'}, {'entity': 'one', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  8\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWM3TF4hbaO2rnsr0q0NsgqmJKP5\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701569919,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#three#6.17 \\n\\nDATE#December 31, 2022#December 31, 2022\\n\\nMONEY#$261.5 million#$259.4 million\\n\\nORG#Retirement Benefit Plans\\n\\nPERCENT#6.17%\\n\\nPERSON#Item 8}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 931,\n",
      "    \"completion_tokens\": 61,\n",
      "    \"total_tokens\": 992\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2022', 'category': 'DATE'}, {'entity': 'December 31, 2022', 'category': 'DATE'}, {'entity': '$261.5 million', 'category': 'MONEY'}, {'entity': '$259.4 million', 'category': 'MONEY'}, {'entity': 'Retirement Benefit Plans', 'category': 'ORG'}, {'entity': '6.17%', 'category': 'PERCENT'}, {'entity': 'Item 8', 'category': 'PERSON'}, {'entity': 'three', 'category': 'CARDINAL'}, {'entity': '6.17', 'category': 'CARDINAL'}]\n",
      "/home/damir/Dropbox/Documents/Teaching/2023/L715/l715_23/data/10-Ks/Aerojet_Rocketdyne_Holdings_Inc./2022/Management.txt\n",
      "Length of chunks:  8\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWMUq1FqD3CBuBJPZZ30eZOMBGwJ\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701569946,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#7#1#303#8#1A#1#51.00#56.00#5.00#25#13#14#31#2021#2020#2,188.0#2,072.7#143.7#137.7#6.6#161.6#138.4#7.4#6.7#1.75#1.66#1.97#1.67#298.5#270.2#13.6#13.0#199.6#363.8#162.3#309.2#21.2#27 \\n\\nDATE#fiscal year ended December 31, 2019#December 31, 2020#February 18, 2021#December 20, 2020#January 25, 2022#February 13, 2022#February 14, 2022#the years ended December 31, 2021 and 2020#During 2020#March 27, 2020#as of December 31, 2021#after December 31, 2017\\n\\nFAC#U.S. federal court \\n\\nGPE#U.S.#the United States \\n\\nLAW#the Merger Agreement#Regulation S-K#Item 7 \\u201cManagement\\u2019s Discussion and Analysis of Financial Condition and Results of Operations\\u201d#the FTC Litigation#the Administrative Complaint#the U.S. Federal Court Complaint#The CARES Act#The American Rescue Plan Act of 2021 (\\\"ARPA\\\") \\n\\nMONEY#$51.00#$56.00#$5.00#In millions#162.3 \\n\\nORG#Lockheed Martin#Mizar Sub, Inc.#the SEC#Lockheed Martin and Mizar Sub, Inc.#The Company\\n\\nPERCENT#6.6 %#6.7 %#13.6 %#13.0 %\\n\\nPERSON#\\n\\nTIME#\\n\\nWORK_OF_ART#}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2258,\n",
      "    \"completion_tokens\": 410,\n",
      "    \"total_tokens\": 2668\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'fiscal year ended December 31, 2019', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'February 18, 2021', 'category': 'DATE'}, {'entity': 'December 20, 2020', 'category': 'DATE'}, {'entity': 'January 25, 2022', 'category': 'DATE'}, {'entity': 'February 13, 2022', 'category': 'DATE'}, {'entity': 'February 14, 2022', 'category': 'DATE'}, {'entity': 'the years ended December 31, 2021 and 2020', 'category': 'DATE'}, {'entity': 'During 2020', 'category': 'DATE'}, {'entity': 'March 27, 2020', 'category': 'DATE'}, {'entity': 'as of December 31, 2021', 'category': 'DATE'}, {'entity': 'after December 31, 2017', 'category': 'DATE'}, {'entity': 'U.S. federal court', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'the United States', 'category': 'GPE'}, {'entity': 'the Merger Agreement', 'category': 'LAW'}, {'entity': 'Regulation S-K', 'category': 'LAW'}, {'entity': 'Item 7 “Management’s Discussion and Analysis of Financial Condition and Results of Operations”', 'category': 'LAW'}, {'entity': 'the FTC Litigation', 'category': 'LAW'}, {'entity': 'the Administrative Complaint', 'category': 'LAW'}, {'entity': 'the U.S. Federal Court Complaint', 'category': 'LAW'}, {'entity': 'The CARES Act', 'category': 'LAW'}, {'entity': 'The American Rescue Plan Act of 2021 \"ARPA\"', 'category': 'LAW'}, {'entity': '$51.00', 'category': 'MONEY'}, {'entity': '$56.00', 'category': 'MONEY'}, {'entity': '$5.00', 'category': 'MONEY'}, {'entity': 'In millions', 'category': 'MONEY'}, {'entity': '162.3', 'category': 'MONEY'}, {'entity': 'Lockheed Martin', 'category': 'ORG'}, {'entity': 'Mizar Sub, Inc.', 'category': 'ORG'}, {'entity': 'the SEC', 'category': 'ORG'}, {'entity': 'Lockheed Martin and Mizar Sub, Inc.', 'category': 'ORG'}, {'entity': 'The Company', 'category': 'ORG'}, {'entity': '6.6 %', 'category': 'PERCENT'}, {'entity': '6.7 %', 'category': 'PERCENT'}, {'entity': '13.6 %', 'category': 'PERCENT'}, {'entity': '13.0 %', 'category': 'PERCENT'}, {'entity': '', 'category': 'WORK_OF_ART'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '303', 'category': 'CARDINAL'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': '1A', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '51.00', 'category': 'CARDINAL'}, {'entity': '56.00', 'category': 'CARDINAL'}, {'entity': '5.00', 'category': 'CARDINAL'}, {'entity': '25', 'category': 'CARDINAL'}, {'entity': '13', 'category': 'CARDINAL'}, {'entity': '14', 'category': 'CARDINAL'}, {'entity': '31', 'category': 'CARDINAL'}, {'entity': '2021', 'category': 'CARDINAL'}, {'entity': '2020', 'category': 'CARDINAL'}, {'entity': '2,188.0', 'category': 'CARDINAL'}, {'entity': '2,072.7', 'category': 'CARDINAL'}, {'entity': '143.7', 'category': 'CARDINAL'}, {'entity': '137.7', 'category': 'CARDINAL'}, {'entity': '6.6', 'category': 'CARDINAL'}, {'entity': '161.6', 'category': 'CARDINAL'}, {'entity': '138.4', 'category': 'CARDINAL'}, {'entity': '7.4', 'category': 'CARDINAL'}, {'entity': '6.7', 'category': 'CARDINAL'}, {'entity': '1.75', 'category': 'CARDINAL'}, {'entity': '1.66', 'category': 'CARDINAL'}, {'entity': '1.97', 'category': 'CARDINAL'}, {'entity': '1.67', 'category': 'CARDINAL'}, {'entity': '298.5', 'category': 'CARDINAL'}, {'entity': '270.2', 'category': 'CARDINAL'}, {'entity': '13.6', 'category': 'CARDINAL'}, {'entity': '13.0', 'category': 'CARDINAL'}, {'entity': '199.6', 'category': 'CARDINAL'}, {'entity': '363.8', 'category': 'CARDINAL'}, {'entity': '162.3', 'category': 'CARDINAL'}, {'entity': '309.2', 'category': 'CARDINAL'}, {'entity': '21.2', 'category': 'CARDINAL'}, {'entity': '27', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  8\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWN9WsYWhsGK7oRzm2kapcA2SebI\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701569987,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#96#96#24#22#20#14#11#5#96#4#100#17#18#12#13#10#10#8#11#32#34#20#21#17#17#10.4#188.9#214.7#347.7#56.9#64.7#78.0#11.8#11.8#21.5#0.8#5.2#6.6#258.4#296.4#453.8#40.5#461.3#1,005.0#1,279.3#274.3#87#15#115.3\\n\\nDATE#Year Ended December 31#Year Ended December 31#Year Ended December 31#Year Ended December 31#Year Ended December 31#Year Ended December 31#December 31, 2021#December 31, 2021#December 31, 2021#December 31, 2021#March 11, 2021#Year Ended December 31#Year Ended December 31\\n\\nEVENT#the COVID-19 pandemic\\n\\nFAC#Aerojet Rocketdyne - Sacramento#Baldwin Park Operable Unit (\\\"BPOU\\\")#Aerojet Rocketdyne - Baldwin Park Operable Unit\\n\\nGPE#U.S.#U.S.#U.S.#U.S.#U.S.#U.S.#U.S.#U.S.\\n\\nLAW#ARPA\\n\\nLOC#Sacramento\\n\\nMONEY#$10.4 million#$188.9 #$214.7 #$347.7#$56.9 #$64.7 #$78.0#$11.8 #$11.8 #$21.5#$0.8 #$5.2 #$6.6#$258.4 #$296.4 #$453.8#$40.5 million#$461.3 million#$1,005.0 million#$1,279.3 million#$274.3 million#$15 million#$2,188.0 #$2,072.7\\n\\nNORP#NASA#U.S. Army#U.S. Air Force#U.S. Navy#Other U.S. government#Total U.S. government customers#Other customers#Total#RS-25 program#Standard Missile program#PAC-3 program#THAAD program#Lockheed Martin#NASA#Raytheon#Aerojet Rocketdyne#Aerojet Rocketdyne\\n\\nORG#U.S. aerospace#defense#U.S. government agencies#the military services#NASA#the Missile Defense Agency#Government#environment#Internal Revenue Service\\n\\nPERCENT#96 %#96 %#96 %#17 %#18 %#10 %#11 %#32 %#34 %#20 %#21 %#17 %#17 %#87%\\n\\nPRODUCT#GBSD#ATACMS#THAAD and RS-68\\n\\nQUANTITY#10% of net sales\\n\\nTIME#the last measurement date at December 31, 2021\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2320,\n",
      "    \"completion_tokens\": 623,\n",
      "    \"total_tokens\": 2943\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': 'March 11, 2021', 'category': 'DATE'}, {'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': 'the COVID-19 pandemic', 'category': 'EVENT'}, {'entity': 'Aerojet Rocketdyne - Sacramento', 'category': 'FAC'}, {'entity': 'Baldwin Park Operable Unit \"BPOU\"', 'category': 'FAC'}, {'entity': 'Aerojet Rocketdyne - Baldwin Park Operable Unit', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'ARPA', 'category': 'LAW'}, {'entity': 'Sacramento', 'category': 'LOC'}, {'entity': '$10.4 million', 'category': 'MONEY'}, {'entity': '$188.9', 'category': 'MONEY'}, {'entity': '$214.7', 'category': 'MONEY'}, {'entity': '$347.7', 'category': 'MONEY'}, {'entity': '$56.9', 'category': 'MONEY'}, {'entity': '$64.7', 'category': 'MONEY'}, {'entity': '$78.0', 'category': 'MONEY'}, {'entity': '$11.8', 'category': 'MONEY'}, {'entity': '$11.8', 'category': 'MONEY'}, {'entity': '$21.5', 'category': 'MONEY'}, {'entity': '$0.8', 'category': 'MONEY'}, {'entity': '$5.2', 'category': 'MONEY'}, {'entity': '$6.6', 'category': 'MONEY'}, {'entity': '$258.4', 'category': 'MONEY'}, {'entity': '$296.4', 'category': 'MONEY'}, {'entity': '$453.8', 'category': 'MONEY'}, {'entity': '$40.5 million', 'category': 'MONEY'}, {'entity': '$461.3 million', 'category': 'MONEY'}, {'entity': '$1,005.0 million', 'category': 'MONEY'}, {'entity': '$1,279.3 million', 'category': 'MONEY'}, {'entity': '$274.3 million', 'category': 'MONEY'}, {'entity': '$15 million', 'category': 'MONEY'}, {'entity': '$2,188.0', 'category': 'MONEY'}, {'entity': '$2,072.7', 'category': 'MONEY'}, {'entity': 'NASA', 'category': 'NORP'}, {'entity': 'U.S. Army', 'category': 'NORP'}, {'entity': 'U.S. Air Force', 'category': 'NORP'}, {'entity': 'U.S. Navy', 'category': 'NORP'}, {'entity': 'Other U.S. government', 'category': 'NORP'}, {'entity': 'Total U.S. government customers', 'category': 'NORP'}, {'entity': 'Other customers', 'category': 'NORP'}, {'entity': 'Total', 'category': 'NORP'}, {'entity': 'RS-25 program', 'category': 'NORP'}, {'entity': 'Standard Missile program', 'category': 'NORP'}, {'entity': 'PAC-3 program', 'category': 'NORP'}, {'entity': 'THAAD program', 'category': 'NORP'}, {'entity': 'Lockheed Martin', 'category': 'NORP'}, {'entity': 'NASA', 'category': 'NORP'}, {'entity': 'Raytheon', 'category': 'NORP'}, {'entity': 'Aerojet Rocketdyne', 'category': 'NORP'}, {'entity': 'Aerojet Rocketdyne', 'category': 'NORP'}, {'entity': 'U.S. aerospace', 'category': 'ORG'}, {'entity': 'defense', 'category': 'ORG'}, {'entity': 'U.S. government agencies', 'category': 'ORG'}, {'entity': 'the military services', 'category': 'ORG'}, {'entity': 'NASA', 'category': 'ORG'}, {'entity': 'the Missile Defense Agency', 'category': 'ORG'}, {'entity': 'Government', 'category': 'ORG'}, {'entity': 'environment', 'category': 'ORG'}, {'entity': 'Internal Revenue Service', 'category': 'ORG'}, {'entity': '96 %', 'category': 'PERCENT'}, {'entity': '96 %', 'category': 'PERCENT'}, {'entity': '96 %', 'category': 'PERCENT'}, {'entity': '17 %', 'category': 'PERCENT'}, {'entity': '18 %', 'category': 'PERCENT'}, {'entity': '10 %', 'category': 'PERCENT'}, {'entity': '11 %', 'category': 'PERCENT'}, {'entity': '32 %', 'category': 'PERCENT'}, {'entity': '34 %', 'category': 'PERCENT'}, {'entity': '20 %', 'category': 'PERCENT'}, {'entity': '21 %', 'category': 'PERCENT'}, {'entity': '17 %', 'category': 'PERCENT'}, {'entity': '17 %', 'category': 'PERCENT'}, {'entity': '87%', 'category': 'PERCENT'}, {'entity': 'GBSD', 'category': 'PRODUCT'}, {'entity': 'ATACMS', 'category': 'PRODUCT'}, {'entity': 'THAAD and RS-68', 'category': 'PRODUCT'}, {'entity': '10% of net sales', 'category': 'QUANTITY'}, {'entity': 'the last measurement date at December 31', 'category': 'TIME'}, {'entity': '2021', 'category': 'TIME'}, {'entity': '96', 'category': 'CARDINAL'}, {'entity': '96', 'category': 'CARDINAL'}, {'entity': '24', 'category': 'CARDINAL'}, {'entity': '22', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '14', 'category': 'CARDINAL'}, {'entity': '11', 'category': 'CARDINAL'}, {'entity': '5', 'category': 'CARDINAL'}, {'entity': '96', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '17', 'category': 'CARDINAL'}, {'entity': '18', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '13', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': '11', 'category': 'CARDINAL'}, {'entity': '32', 'category': 'CARDINAL'}, {'entity': '34', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '21', 'category': 'CARDINAL'}, {'entity': '17', 'category': 'CARDINAL'}, {'entity': '17', 'category': 'CARDINAL'}, {'entity': '10.4', 'category': 'CARDINAL'}, {'entity': '188.9', 'category': 'CARDINAL'}, {'entity': '214.7', 'category': 'CARDINAL'}, {'entity': '347.7', 'category': 'CARDINAL'}, {'entity': '56.9', 'category': 'CARDINAL'}, {'entity': '64.7', 'category': 'CARDINAL'}, {'entity': '78.0', 'category': 'CARDINAL'}, {'entity': '11.8', 'category': 'CARDINAL'}, {'entity': '11.8', 'category': 'CARDINAL'}, {'entity': '21.5', 'category': 'CARDINAL'}, {'entity': '0.8', 'category': 'CARDINAL'}, {'entity': '5.2', 'category': 'CARDINAL'}, {'entity': '6.6', 'category': 'CARDINAL'}, {'entity': '258.4', 'category': 'CARDINAL'}, {'entity': '296.4', 'category': 'CARDINAL'}, {'entity': '453.8', 'category': 'CARDINAL'}, {'entity': '40.5', 'category': 'CARDINAL'}, {'entity': '461.3', 'category': 'CARDINAL'}, {'entity': '1,005.0', 'category': 'CARDINAL'}, {'entity': '1,279.3', 'category': 'CARDINAL'}, {'entity': '274.3', 'category': 'CARDINAL'}, {'entity': '87', 'category': 'CARDINAL'}, {'entity': '15', 'category': 'CARDINAL'}, {'entity': '115.3', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  8\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWNrjmeJcr4G71VkfxHsEx8Gii4K\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701570031,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#154.1#2.9#2#2.1#1.2#1.2#154.1#1\\n\\nDATE#Year Ended December 31, 2021#Year Ended December 31, 2020#Year Ended December 31#December 31, 2020#December 31, 2021\\n\\nEVENT#Merger\\n\\nGPE#United States\\n\\nLAW#Note 9(e)#Item 8#Note 11\\n\\nMONEY#$1,800.1#$1,701.3#$98.8#$25.3#$24.7#$0.6#$20.7#$31.4#$46.0#$56.1#$48.8#$49.2#$9.9#$13.4#$2.7#$61.4#$65.3#$23.5#$9.4#$14.1#$10.5#$2.5#$6.3#$14.2#$20.2#$5.9#$9.9#$20.1#$30.1#$51.3#$42.5#$20.0#$34.0#$43.3#$61.4#$60.5#$0.1#$61.2#$53.7#$33.9#$36.6#$154.1#$1#$38#$2,179.3#$2,069.4#$109.9#$285.9#$275.6#$31.2#$45.1\\n\\nORG#Rocketdyne Business from United Technologies Corporation#Aerospace and Defense Segment#Real Estate Segment#GBSD and ATACMS#THAAD and RS-68#U.S. government\\n\\nPERCENT#82.3 %#82.1 %#2.1 %#1.2 %#1.2 %#26.3%#21%#23.6%#13.1 %#13.3 %#57 %#61 %#43 %#39 %\\n\\nPERSON#Merger\\n\\nPRODUCT#2\\u00bc% Notes#Senior Credit Facility#2\\u00bc% Notes\\n\\nQUANTITY#2\\u00bc\\n\\nTIME#Year Ended December 31, 2021#Year Ended December 31, 2020\\n\\nWORK_OF_ART#Item 8 of this Report}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2656,\n",
      "    \"completion_tokens\": 467,\n",
      "    \"total_tokens\": 3123\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'Year Ended December 31, 2021', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2020', 'category': 'DATE'}, {'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': 'Merger', 'category': 'EVENT'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'Note 9e', 'category': 'LAW'}, {'entity': 'Item 8', 'category': 'LAW'}, {'entity': 'Note 11', 'category': 'LAW'}, {'entity': '$1,800.1', 'category': 'MONEY'}, {'entity': '$1,701.3', 'category': 'MONEY'}, {'entity': '$98.8', 'category': 'MONEY'}, {'entity': '$25.3', 'category': 'MONEY'}, {'entity': '$24.7', 'category': 'MONEY'}, {'entity': '$0.6', 'category': 'MONEY'}, {'entity': '$20.7', 'category': 'MONEY'}, {'entity': '$31.4', 'category': 'MONEY'}, {'entity': '$46.0', 'category': 'MONEY'}, {'entity': '$56.1', 'category': 'MONEY'}, {'entity': '$48.8', 'category': 'MONEY'}, {'entity': '$49.2', 'category': 'MONEY'}, {'entity': '$9.9', 'category': 'MONEY'}, {'entity': '$13.4', 'category': 'MONEY'}, {'entity': '$2.7', 'category': 'MONEY'}, {'entity': '$61.4', 'category': 'MONEY'}, {'entity': '$65.3', 'category': 'MONEY'}, {'entity': '$23.5', 'category': 'MONEY'}, {'entity': '$9.4', 'category': 'MONEY'}, {'entity': '$14.1', 'category': 'MONEY'}, {'entity': '$10.5', 'category': 'MONEY'}, {'entity': '$2.5', 'category': 'MONEY'}, {'entity': '$6.3', 'category': 'MONEY'}, {'entity': '$14.2', 'category': 'MONEY'}, {'entity': '$20.2', 'category': 'MONEY'}, {'entity': '$5.9', 'category': 'MONEY'}, {'entity': '$9.9', 'category': 'MONEY'}, {'entity': '$20.1', 'category': 'MONEY'}, {'entity': '$30.1', 'category': 'MONEY'}, {'entity': '$51.3', 'category': 'MONEY'}, {'entity': '$42.5', 'category': 'MONEY'}, {'entity': '$20.0', 'category': 'MONEY'}, {'entity': '$34.0', 'category': 'MONEY'}, {'entity': '$43.3', 'category': 'MONEY'}, {'entity': '$61.4', 'category': 'MONEY'}, {'entity': '$60.5', 'category': 'MONEY'}, {'entity': '$0.1', 'category': 'MONEY'}, {'entity': '$61.2', 'category': 'MONEY'}, {'entity': '$53.7', 'category': 'MONEY'}, {'entity': '$33.9', 'category': 'MONEY'}, {'entity': '$36.6', 'category': 'MONEY'}, {'entity': '$154.1', 'category': 'MONEY'}, {'entity': '$1', 'category': 'MONEY'}, {'entity': '$38', 'category': 'MONEY'}, {'entity': '$2,179.3', 'category': 'MONEY'}, {'entity': '$2,069.4', 'category': 'MONEY'}, {'entity': '$109.9', 'category': 'MONEY'}, {'entity': '$285.9', 'category': 'MONEY'}, {'entity': '$275.6', 'category': 'MONEY'}, {'entity': '$31.2', 'category': 'MONEY'}, {'entity': '$45.1', 'category': 'MONEY'}, {'entity': 'Rocketdyne Business from United Technologies Corporation', 'category': 'ORG'}, {'entity': 'Aerospace and Defense Segment', 'category': 'ORG'}, {'entity': 'Real Estate Segment', 'category': 'ORG'}, {'entity': 'GBSD and ATACMS', 'category': 'ORG'}, {'entity': 'THAAD and RS-68', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': '82.3 %', 'category': 'PERCENT'}, {'entity': '82.1 %', 'category': 'PERCENT'}, {'entity': '2.1 %', 'category': 'PERCENT'}, {'entity': '1.2 %', 'category': 'PERCENT'}, {'entity': '1.2 %', 'category': 'PERCENT'}, {'entity': '26.3%', 'category': 'PERCENT'}, {'entity': '21%', 'category': 'PERCENT'}, {'entity': '23.6%', 'category': 'PERCENT'}, {'entity': '13.1 %', 'category': 'PERCENT'}, {'entity': '13.3 %', 'category': 'PERCENT'}, {'entity': '57 %', 'category': 'PERCENT'}, {'entity': '61 %', 'category': 'PERCENT'}, {'entity': '43 %', 'category': 'PERCENT'}, {'entity': '39 %', 'category': 'PERCENT'}, {'entity': 'Merger', 'category': 'PERSON'}, {'entity': '2¼% Notes', 'category': 'PRODUCT'}, {'entity': 'Senior Credit Facility', 'category': 'PRODUCT'}, {'entity': '2¼% Notes', 'category': 'PRODUCT'}, {'entity': '2¼', 'category': 'QUANTITY'}, {'entity': 'Year Ended December 31, 2021', 'category': 'TIME'}, {'entity': 'Year Ended December 31, 2020', 'category': 'TIME'}, {'entity': 'Item 8 of this Report', 'category': 'WORK_OF_ART'}, {'entity': '154.1', 'category': 'CARDINAL'}, {'entity': '2.9', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2.1', 'category': 'CARDINAL'}, {'entity': '1.2', 'category': 'CARDINAL'}, {'entity': '1.2', 'category': 'CARDINAL'}, {'entity': '154.1', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  8\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWOWGGoht9MGY2jh04bdRUpJvxyf\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701570072,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#2.9#1.8#4.7#6.2#2.3#34#2.3#28#38#3.1#3.0#3.7#3.7#6.8#6.7#143.7#137.7#20.1#30.1#2.5#6.3#51.3#42.5#61.4#65.3#33.9#36.6#38.8#43.8#29.4#8.1#298.5#270.2#6.6#6.6#13.6#13.0#161.6#138.4#1.75#1.66#0.22#0.01#1.97#1.67#81.7#81.9#199.6#363.8#37.3#54.6#162.3#309.2#700.4#622.2#449.1 \\n\\nDATE#Year Ended December 31, 2021#During 2021#During 2020#December 31, 2021#Year Ended December 31, 2021#As of December 31, 2021#the next twelve months#the following twelve months#Year Ended December 31, 2021#Year Ended December 31, 2021#As of December 31, 2021\\n\\nFAC#Senior Credit Facility\\n\\nGPE#U.S.\\n\\nMONEY#$8.7#$3.3#$5.4#$6.2 million#$2.3 million#$6.8 billion#$2.3 billion#$3.1#$3.0#$3.7#$3.7#$6.8#$6.7#$143.7 #$137.7#$20.1#$30.1#-$2.5#-$6.3#$51.3#$42.5#$61.4#$65.3#$33.9#$36.6#-$38.8#-$43.8#$29.4#$8.1#$298.5#$270.2#$161.6#$138.4#$1.75#$1.66#$0.22#$0.01#$1.97#$1.67#$199.6#$363.8#-$37.3#-$54.6#$162.3#$309.2#$700.4 million#$622.2 million#-$449.1 million\\n\\nORG#Lockheed Martin#Audit Committee#Board of Directors\\n\\nPERCENT#34%#28%#38%\\n\\nPRODUCT#Adjusted EBITDAP, Adjusted Net Income, and Adjusted EPS\\n\\nTIME#the next twelve months#the following twelve months}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2463,\n",
      "    \"completion_tokens\": 588,\n",
      "    \"total_tokens\": 3051\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'Year Ended December 31, 2021', 'category': 'DATE'}, {'entity': 'During 2021', 'category': 'DATE'}, {'entity': 'During 2020', 'category': 'DATE'}, {'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2021', 'category': 'DATE'}, {'entity': 'As of December 31, 2021', 'category': 'DATE'}, {'entity': 'the next twelve months', 'category': 'DATE'}, {'entity': 'the following twelve months', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2021', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2021', 'category': 'DATE'}, {'entity': 'As of December 31, 2021', 'category': 'DATE'}, {'entity': 'Senior Credit Facility', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '$8.7', 'category': 'MONEY'}, {'entity': '$3.3', 'category': 'MONEY'}, {'entity': '$5.4', 'category': 'MONEY'}, {'entity': '$6.2 million', 'category': 'MONEY'}, {'entity': '$2.3 million', 'category': 'MONEY'}, {'entity': '$6.8 billion', 'category': 'MONEY'}, {'entity': '$2.3 billion', 'category': 'MONEY'}, {'entity': '$3.1', 'category': 'MONEY'}, {'entity': '$3.0', 'category': 'MONEY'}, {'entity': '$3.7', 'category': 'MONEY'}, {'entity': '$3.7', 'category': 'MONEY'}, {'entity': '$6.8', 'category': 'MONEY'}, {'entity': '$6.7', 'category': 'MONEY'}, {'entity': '$143.7', 'category': 'MONEY'}, {'entity': '$137.7', 'category': 'MONEY'}, {'entity': '$20.1', 'category': 'MONEY'}, {'entity': '$30.1', 'category': 'MONEY'}, {'entity': '-$2.5', 'category': 'MONEY'}, {'entity': '-$6.3', 'category': 'MONEY'}, {'entity': '$51.3', 'category': 'MONEY'}, {'entity': '$42.5', 'category': 'MONEY'}, {'entity': '$61.4', 'category': 'MONEY'}, {'entity': '$65.3', 'category': 'MONEY'}, {'entity': '$33.9', 'category': 'MONEY'}, {'entity': '$36.6', 'category': 'MONEY'}, {'entity': '-$38.8', 'category': 'MONEY'}, {'entity': '-$43.8', 'category': 'MONEY'}, {'entity': '$29.4', 'category': 'MONEY'}, {'entity': '$8.1', 'category': 'MONEY'}, {'entity': '$298.5', 'category': 'MONEY'}, {'entity': '$270.2', 'category': 'MONEY'}, {'entity': '$161.6', 'category': 'MONEY'}, {'entity': '$138.4', 'category': 'MONEY'}, {'entity': '$1.75', 'category': 'MONEY'}, {'entity': '$1.66', 'category': 'MONEY'}, {'entity': '$0.22', 'category': 'MONEY'}, {'entity': '$0.01', 'category': 'MONEY'}, {'entity': '$1.97', 'category': 'MONEY'}, {'entity': '$1.67', 'category': 'MONEY'}, {'entity': '$199.6', 'category': 'MONEY'}, {'entity': '$363.8', 'category': 'MONEY'}, {'entity': '-$37.3', 'category': 'MONEY'}, {'entity': '-$54.6', 'category': 'MONEY'}, {'entity': '$162.3', 'category': 'MONEY'}, {'entity': '$309.2', 'category': 'MONEY'}, {'entity': '$700.4 million', 'category': 'MONEY'}, {'entity': '$622.2 million', 'category': 'MONEY'}, {'entity': '-$449.1 million', 'category': 'MONEY'}, {'entity': 'Lockheed Martin', 'category': 'ORG'}, {'entity': 'Audit Committee', 'category': 'ORG'}, {'entity': 'Board of Directors', 'category': 'ORG'}, {'entity': '34%', 'category': 'PERCENT'}, {'entity': '28%', 'category': 'PERCENT'}, {'entity': '38%', 'category': 'PERCENT'}, {'entity': 'Adjusted EBITDAP', 'category': 'PRODUCT'}, {'entity': 'Adjusted Net Income', 'category': 'PRODUCT'}, {'entity': 'and Adjusted EPS', 'category': 'PRODUCT'}, {'entity': 'the next twelve months', 'category': 'TIME'}, {'entity': 'the following twelve months', 'category': 'TIME'}, {'entity': '2.9', 'category': 'CARDINAL'}, {'entity': '1.8', 'category': 'CARDINAL'}, {'entity': '4.7', 'category': 'CARDINAL'}, {'entity': '6.2', 'category': 'CARDINAL'}, {'entity': '2.3', 'category': 'CARDINAL'}, {'entity': '34', 'category': 'CARDINAL'}, {'entity': '2.3', 'category': 'CARDINAL'}, {'entity': '28', 'category': 'CARDINAL'}, {'entity': '38', 'category': 'CARDINAL'}, {'entity': '3.1', 'category': 'CARDINAL'}, {'entity': '3.0', 'category': 'CARDINAL'}, {'entity': '3.7', 'category': 'CARDINAL'}, {'entity': '3.7', 'category': 'CARDINAL'}, {'entity': '6.8', 'category': 'CARDINAL'}, {'entity': '6.7', 'category': 'CARDINAL'}, {'entity': '143.7', 'category': 'CARDINAL'}, {'entity': '137.7', 'category': 'CARDINAL'}, {'entity': '20.1', 'category': 'CARDINAL'}, {'entity': '30.1', 'category': 'CARDINAL'}, {'entity': '2.5', 'category': 'CARDINAL'}, {'entity': '6.3', 'category': 'CARDINAL'}, {'entity': '51.3', 'category': 'CARDINAL'}, {'entity': '42.5', 'category': 'CARDINAL'}, {'entity': '61.4', 'category': 'CARDINAL'}, {'entity': '65.3', 'category': 'CARDINAL'}, {'entity': '33.9', 'category': 'CARDINAL'}, {'entity': '36.6', 'category': 'CARDINAL'}, {'entity': '38.8', 'category': 'CARDINAL'}, {'entity': '43.8', 'category': 'CARDINAL'}, {'entity': '29.4', 'category': 'CARDINAL'}, {'entity': '8.1', 'category': 'CARDINAL'}, {'entity': '298.5', 'category': 'CARDINAL'}, {'entity': '270.2', 'category': 'CARDINAL'}, {'entity': '6.6', 'category': 'CARDINAL'}, {'entity': '6.6', 'category': 'CARDINAL'}, {'entity': '13.6', 'category': 'CARDINAL'}, {'entity': '13.0', 'category': 'CARDINAL'}, {'entity': '161.6', 'category': 'CARDINAL'}, {'entity': '138.4', 'category': 'CARDINAL'}, {'entity': '1.75', 'category': 'CARDINAL'}, {'entity': '1.66', 'category': 'CARDINAL'}, {'entity': '0.22', 'category': 'CARDINAL'}, {'entity': '0.01', 'category': 'CARDINAL'}, {'entity': '1.97', 'category': 'CARDINAL'}, {'entity': '1.67', 'category': 'CARDINAL'}, {'entity': '81.7', 'category': 'CARDINAL'}, {'entity': '81.9', 'category': 'CARDINAL'}, {'entity': '199.6', 'category': 'CARDINAL'}, {'entity': '363.8', 'category': 'CARDINAL'}, {'entity': '37.3', 'category': 'CARDINAL'}, {'entity': '54.6', 'category': 'CARDINAL'}, {'entity': '162.3', 'category': 'CARDINAL'}, {'entity': '309.2', 'category': 'CARDINAL'}, {'entity': '700.4', 'category': 'CARDINAL'}, {'entity': '622.2', 'category': 'CARDINAL'}, {'entity': '449.1', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  8\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWPEuPDK8TTMabS9gcciK2EgeonK\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701570116,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#449.1#703.4#1,152.5#2021#199.6#2021#39.2#37.3#1.9#2021#609.5#428.8#182.6#308.5#26.3#282.2#2#1/4#300.0#154.1#145.9#45.6#2.2#43.4#654.1#182.6#471.5#650.0#350.0#175#250#7.5#2021#10.0#2022#282.2#28.4#253.8#145.9#145.9#15.0#8.3#6.7#69.4#4.4#7.5#7.7#49.8#62.9#15.2#15.0#9.8#22.9#16.8#2.7#4.5#3.6#6.0#1,409.6#921.4#483.7#3.9#0.6#51.8#19.8#1.5#30.5#2,053.6#1,126.3#791.0#26.5#109.8#20#30#2022#2022#33.80#20#30#2021#10#15\\n\\nDATE#December 31,2020#December 31, 2021#September 20, 2023#December 31, 2022#December 31, 2021#January 1, 2022#March 31, 2022#December 31, 2021\\n\\nEVENT#Pre-Closing Dividend \\n\\nFAC#Senior Credit Facility\\n\\nLOC#U.S.\\n\\nMONEY#$37.3 million#$1.9 million#$609.5 million#$428.8 million#$182.6 million#$650.0 million#$350.0 million\\n\\nORG#Total debt activity#Company#U.S. government#U.S. government#Aerospace and Defense#SEC#GAAP\\n\\nPERCENT#175 to 250 basis points#7.5% per annum#10.0% per annum#175 to 250 basis points per annum#30 to 45 basis points per annum\\n\\nTIME#quarterly\\n\\nWORK_OF_ART#2 1/4% Notes#2\\u00bc% Notes#2\\u00bc% Notes}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2442,\n",
      "    \"completion_tokens\": 535,\n",
      "    \"total_tokens\": 2977\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31,2020', 'category': 'DATE'}, {'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': 'September 20, 2023', 'category': 'DATE'}, {'entity': 'December 31, 2022', 'category': 'DATE'}, {'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': 'January 1, 2022', 'category': 'DATE'}, {'entity': 'March 31, 2022', 'category': 'DATE'}, {'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': 'Pre-Closing Dividend', 'category': 'EVENT'}, {'entity': 'Senior Credit Facility', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': '$37.3 million', 'category': 'MONEY'}, {'entity': '$1.9 million', 'category': 'MONEY'}, {'entity': '$609.5 million', 'category': 'MONEY'}, {'entity': '$428.8 million', 'category': 'MONEY'}, {'entity': '$182.6 million', 'category': 'MONEY'}, {'entity': '$650.0 million', 'category': 'MONEY'}, {'entity': '$350.0 million', 'category': 'MONEY'}, {'entity': 'Total debt activity', 'category': 'ORG'}, {'entity': 'Company', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'Aerospace and Defense', 'category': 'ORG'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': '175 to 250 basis points', 'category': 'PERCENT'}, {'entity': '7.5% per annum', 'category': 'PERCENT'}, {'entity': '10.0% per annum', 'category': 'PERCENT'}, {'entity': '175 to 250 basis points per annum', 'category': 'PERCENT'}, {'entity': '30 to 45 basis points per annum', 'category': 'PERCENT'}, {'entity': 'quarterly', 'category': 'TIME'}, {'entity': '2 1/4% Notes', 'category': 'WORK_OF_ART'}, {'entity': '2¼% Notes', 'category': 'WORK_OF_ART'}, {'entity': '2¼% Notes', 'category': 'WORK_OF_ART'}, {'entity': '449.1', 'category': 'CARDINAL'}, {'entity': '703.4', 'category': 'CARDINAL'}, {'entity': '1,152.5', 'category': 'CARDINAL'}, {'entity': '2021', 'category': 'CARDINAL'}, {'entity': '199.6', 'category': 'CARDINAL'}, {'entity': '2021', 'category': 'CARDINAL'}, {'entity': '39.2', 'category': 'CARDINAL'}, {'entity': '37.3', 'category': 'CARDINAL'}, {'entity': '1.9', 'category': 'CARDINAL'}, {'entity': '2021', 'category': 'CARDINAL'}, {'entity': '609.5', 'category': 'CARDINAL'}, {'entity': '428.8', 'category': 'CARDINAL'}, {'entity': '182.6', 'category': 'CARDINAL'}, {'entity': '308.5', 'category': 'CARDINAL'}, {'entity': '26.3', 'category': 'CARDINAL'}, {'entity': '282.2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '1/4', 'category': 'CARDINAL'}, {'entity': '300.0', 'category': 'CARDINAL'}, {'entity': '154.1', 'category': 'CARDINAL'}, {'entity': '145.9', 'category': 'CARDINAL'}, {'entity': '45.6', 'category': 'CARDINAL'}, {'entity': '2.2', 'category': 'CARDINAL'}, {'entity': '43.4', 'category': 'CARDINAL'}, {'entity': '654.1', 'category': 'CARDINAL'}, {'entity': '182.6', 'category': 'CARDINAL'}, {'entity': '471.5', 'category': 'CARDINAL'}, {'entity': '650.0', 'category': 'CARDINAL'}, {'entity': '350.0', 'category': 'CARDINAL'}, {'entity': '175', 'category': 'CARDINAL'}, {'entity': '250', 'category': 'CARDINAL'}, {'entity': '7.5', 'category': 'CARDINAL'}, {'entity': '2021', 'category': 'CARDINAL'}, {'entity': '10.0', 'category': 'CARDINAL'}, {'entity': '2022', 'category': 'CARDINAL'}, {'entity': '282.2', 'category': 'CARDINAL'}, {'entity': '28.4', 'category': 'CARDINAL'}, {'entity': '253.8', 'category': 'CARDINAL'}, {'entity': '145.9', 'category': 'CARDINAL'}, {'entity': '145.9', 'category': 'CARDINAL'}, {'entity': '15.0', 'category': 'CARDINAL'}, {'entity': '8.3', 'category': 'CARDINAL'}, {'entity': '6.7', 'category': 'CARDINAL'}, {'entity': '69.4', 'category': 'CARDINAL'}, {'entity': '4.4', 'category': 'CARDINAL'}, {'entity': '7.5', 'category': 'CARDINAL'}, {'entity': '7.7', 'category': 'CARDINAL'}, {'entity': '49.8', 'category': 'CARDINAL'}, {'entity': '62.9', 'category': 'CARDINAL'}, {'entity': '15.2', 'category': 'CARDINAL'}, {'entity': '15.0', 'category': 'CARDINAL'}, {'entity': '9.8', 'category': 'CARDINAL'}, {'entity': '22.9', 'category': 'CARDINAL'}, {'entity': '16.8', 'category': 'CARDINAL'}, {'entity': '2.7', 'category': 'CARDINAL'}, {'entity': '4.5', 'category': 'CARDINAL'}, {'entity': '3.6', 'category': 'CARDINAL'}, {'entity': '6.0', 'category': 'CARDINAL'}, {'entity': '1,409.6', 'category': 'CARDINAL'}, {'entity': '921.4', 'category': 'CARDINAL'}, {'entity': '483.7', 'category': 'CARDINAL'}, {'entity': '3.9', 'category': 'CARDINAL'}, {'entity': '0.6', 'category': 'CARDINAL'}, {'entity': '51.8', 'category': 'CARDINAL'}, {'entity': '19.8', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '2,053.6', 'category': 'CARDINAL'}, {'entity': '1,126.3', 'category': 'CARDINAL'}, {'entity': '791.0', 'category': 'CARDINAL'}, {'entity': '26.5', 'category': 'CARDINAL'}, {'entity': '109.8', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '30', 'category': 'CARDINAL'}, {'entity': '2022', 'category': 'CARDINAL'}, {'entity': '2022', 'category': 'CARDINAL'}, {'entity': '33.80', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '30', 'category': 'CARDINAL'}, {'entity': '2021', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '15', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  8\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWPuxOYbORDwpa8f6SLKj0ETuiad\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701570158,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#2009 \\n\\nDATE#Year Ended December 31#As of December 31 \\n\\nEVENT#Retirement \\n\\nFAC#\\n\\nGPE#\\n\\nLANGUAGE#English \\n\\nLAW#the contract value\\n\\nLOC#\\n\\nMONEY#$38.5#45.1#34.0 \\n\\nNORP#\\n\\nORDINAL#\\n\\nORG#Aerospace and Defense segment \\n\\nPERCENT#0.29#0.44#0.28#0.42#2.90%#2.52%#2.77%#2.28%#2.52%#3.28%#2.28%#3.19%#7.00%\\n\\nPERSON#\\n\\nPRODUCT#Report \\n\\nQUANTITY#\\n\\nTIME#\\n\\nWORK_OF_ART#\\n}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2109,\n",
      "    \"completion_tokens\": 155,\n",
      "    \"total_tokens\": 2264\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': 'As of December 31', 'category': 'DATE'}, {'entity': 'Retirement', 'category': 'EVENT'}, {'entity': 'English', 'category': 'LANGUAGE'}, {'entity': 'the contract value', 'category': 'LAW'}, {'entity': '$38.5', 'category': 'MONEY'}, {'entity': '45.1', 'category': 'MONEY'}, {'entity': '34.0', 'category': 'MONEY'}, {'entity': 'Aerospace and Defense segment', 'category': 'ORG'}, {'entity': '0.29', 'category': 'PERCENT'}, {'entity': '0.44', 'category': 'PERCENT'}, {'entity': '0.28', 'category': 'PERCENT'}, {'entity': '0.42', 'category': 'PERCENT'}, {'entity': '2.90%', 'category': 'PERCENT'}, {'entity': '2.52%', 'category': 'PERCENT'}, {'entity': '2.77%', 'category': 'PERCENT'}, {'entity': '2.28%', 'category': 'PERCENT'}, {'entity': '2.52%', 'category': 'PERCENT'}, {'entity': '3.28%', 'category': 'PERCENT'}, {'entity': '2.28%', 'category': 'PERCENT'}, {'entity': '3.19%', 'category': 'PERCENT'}, {'entity': '7.00%', 'category': 'PERCENT'}, {'entity': 'Report', 'category': 'PRODUCT'}, {'entity': '2009', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  8\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWQO4OYesMaT0leONvoM86E2AhF4\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701570188,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#1 \\n\\nDATE#December 31, 2021#2021#January 1, 2021#December 31, 2021\\n\\nEVENT#Global Settlement\\n\\nFAC#\\n\\nGPE#U.S.\\n\\nLOC#\\n\\nMONEY#$18.9#$132.3#$8.8#$(0.1)#$(0.2)#(16.1)#(111.5)#(8.8)#0.1#0.2#300.6#35.3#(39.5)#296.4#35.3#13.7#13.2#8.4#308.3#31.2#(34.6)#(6.0)#298.9#4.1\\n\\nNORP#\\n\\nORDINAL#\\n\\nORG#Northrop\\n\\nPERCENT#1%\\n\\nPERSON#\\n\\nPRODUCT#\\n\\nQUANTITY#\\n\\nTIME#\\n\\nWORK_OF_ART#}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2161,\n",
      "    \"completion_tokens\": 189,\n",
      "    \"total_tokens\": 2350\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': 'January 1, 2021', 'category': 'DATE'}, {'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': 'Global Settlement', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '$18.9', 'category': 'MONEY'}, {'entity': '$132.3', 'category': 'MONEY'}, {'entity': '$8.8', 'category': 'MONEY'}, {'entity': '$0.1', 'category': 'MONEY'}, {'entity': '$0.2', 'category': 'MONEY'}, {'entity': '16.1', 'category': 'MONEY'}, {'entity': '111.5', 'category': 'MONEY'}, {'entity': '8.8', 'category': 'MONEY'}, {'entity': '0.1', 'category': 'MONEY'}, {'entity': '0.2', 'category': 'MONEY'}, {'entity': '300.6', 'category': 'MONEY'}, {'entity': '35.3', 'category': 'MONEY'}, {'entity': '39.5', 'category': 'MONEY'}, {'entity': '296.4', 'category': 'MONEY'}, {'entity': '35.3', 'category': 'MONEY'}, {'entity': '13.7', 'category': 'MONEY'}, {'entity': '13.2', 'category': 'MONEY'}, {'entity': '8.4', 'category': 'MONEY'}, {'entity': '308.3', 'category': 'MONEY'}, {'entity': '31.2', 'category': 'MONEY'}, {'entity': '34.6', 'category': 'MONEY'}, {'entity': '6.0', 'category': 'MONEY'}, {'entity': '298.9', 'category': 'MONEY'}, {'entity': '4.1', 'category': 'MONEY'}, {'entity': 'Northrop', 'category': 'ORG'}, {'entity': '1%', 'category': 'PERCENT'}, {'entity': '', 'category': 'WORK_OF_ART'}, {'entity': '1', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  8\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWQu0bR3gl8mplSjSV15EnKYpnt4\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701570220,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#428.1#145.9#34#2.25#282.2#66#1.85#275.8#306.5#282.2#308.5#266.1#609.5#145.9#300#541.9#916#428.1#608.5\\n\\nDATE#December 31, 2021#December 31, 2020#three years#December 31, 2021#December 31, 2020\\n\\nMONEY#$428.1 million#$145.9 million#$282.2 million#$275.8#$306.5#$282.2#$308.5#$266.1#$609.5#$145.9#$300#541.9#916#428.1#608.5\\n\\nORG#Senior Credit Facility#Retirement Benefit Plans\\n\\nPERCENT#34%#66% \\n\\nTIME#the past three years\\n\\nWORK_OF_ART#Item 7A. Quantitative and Qualitative Disclosures About Market RiskPolicies and Procedures}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 1320,\n",
      "    \"completion_tokens\": 222,\n",
      "    \"total_tokens\": 1542\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'three years', 'category': 'DATE'}, {'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': '$428.1 million', 'category': 'MONEY'}, {'entity': '$145.9 million', 'category': 'MONEY'}, {'entity': '$282.2 million', 'category': 'MONEY'}, {'entity': '$275.8', 'category': 'MONEY'}, {'entity': '$306.5', 'category': 'MONEY'}, {'entity': '$282.2', 'category': 'MONEY'}, {'entity': '$308.5', 'category': 'MONEY'}, {'entity': '$266.1', 'category': 'MONEY'}, {'entity': '$609.5', 'category': 'MONEY'}, {'entity': '$145.9', 'category': 'MONEY'}, {'entity': '$300', 'category': 'MONEY'}, {'entity': '541.9', 'category': 'MONEY'}, {'entity': '916', 'category': 'MONEY'}, {'entity': '428.1', 'category': 'MONEY'}, {'entity': '608.5', 'category': 'MONEY'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': 'Retirement Benefit Plans', 'category': 'ORG'}, {'entity': '34%', 'category': 'PERCENT'}, {'entity': '66%', 'category': 'PERCENT'}, {'entity': 'the past three years', 'category': 'TIME'}, {'entity': 'Item 7A. Quantitative and Qualitative Disclosures About Market RiskPolicies and Procedures', 'category': 'WORK_OF_ART'}, {'entity': '428.1', 'category': 'CARDINAL'}, {'entity': '145.9', 'category': 'CARDINAL'}, {'entity': '34', 'category': 'CARDINAL'}, {'entity': '2.25', 'category': 'CARDINAL'}, {'entity': '282.2', 'category': 'CARDINAL'}, {'entity': '66', 'category': 'CARDINAL'}, {'entity': '1.85', 'category': 'CARDINAL'}, {'entity': '275.8', 'category': 'CARDINAL'}, {'entity': '306.5', 'category': 'CARDINAL'}, {'entity': '282.2', 'category': 'CARDINAL'}, {'entity': '308.5', 'category': 'CARDINAL'}, {'entity': '266.1', 'category': 'CARDINAL'}, {'entity': '609.5', 'category': 'CARDINAL'}, {'entity': '145.9', 'category': 'CARDINAL'}, {'entity': '300', 'category': 'CARDINAL'}, {'entity': '541.9', 'category': 'CARDINAL'}, {'entity': '916', 'category': 'CARDINAL'}, {'entity': '428.1', 'category': 'CARDINAL'}, {'entity': '608.5', 'category': 'CARDINAL'}]\n",
      "/home/damir/Dropbox/Documents/Teaching/2023/L715/l715_23/data/10-Ks/Bristol-Myers_Squibb_Company/2016/Management.txt\n",
      "Length of chunks:  17\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWRQ7R1vQ7l4ryNztrAOCEVLwyxi\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701570252,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#7#4#100#20#1#3\\n\\nDATE#2015#2014#December 2015#November 2015#October 2015#July 2015#June 2015#March 2015#September 2015#December 2014#December 31\\n\\nEVENT#MANAGEMENT\\u2019S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS#divestiture of our pipeline of investigational human immunodeficiency\\n\\nFAC#Japanese Ministry of Health, Labour and Welfare#U.S. Food and Drug Administration (FDA)\\n\\nGPE#U.S.#EU#France#Japan\\n\\nMONEY#$16,560#$15,879#$16,385#$1.9 billion#$900 million\\n\\nORG#Bristol-Myers Squibb Company#Bristol-Myers Squibb#BMS#Hepatitis C Franchise#Opdivo#Eliquis#Flexus Biosciences, Inc.#Flexus#Cardioxyl Pharmaceuticals, Inc.#Cardioxyl#Ono Pharmaceutical Co., Ltd.#FDA#Ono#U.S. Food and Drug Administration#BRAF#RCC#SQ NSCLC#melanoma#Revlimid*#Hepatitis C Portfolio - Daklinza#HCV genotype 3#BMS\\n\\nPERCENT#21.5%#14.8%#10.8%\\n\\nPERSON#Opdivo+Yervoy (ipilimumab)#Yervoy#Empliciti (elotuzumab)\\n\\nPRODUCT#Abilify* (aripiprazole)#Baraclude (entecavir)#Reyataz (atazanavir sulfate)#Sustiva (efavirenz)#Hepatitis C Franchise#Opdivo (nivolumab)#Eliquis (apixaban)#Flexus#Cardioxyl#Opdivo#Yervoy (ipilimumab)#Empliciti (elotuzumab)#Daklinza (daclatasvir)#Orencia (abatacept)#Eliquis#Daklinza#Sustiva Franchise\\n\\nQUANTITY#446#352#311#1,565#2,004#2,563#3,378#3,085#3,019#8,930#11,843#8,272\\n\\nTIME#12 months#end of 2015\\n\\nWORK_OF_ART#Yervoy, our first immuno-oncology agent}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2468,\n",
      "    \"completion_tokens\": 530,\n",
      "    \"total_tokens\": 2998\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': 'December 2015', 'category': 'DATE'}, {'entity': 'November 2015', 'category': 'DATE'}, {'entity': 'October 2015', 'category': 'DATE'}, {'entity': 'July 2015', 'category': 'DATE'}, {'entity': 'June 2015', 'category': 'DATE'}, {'entity': 'March 2015', 'category': 'DATE'}, {'entity': 'September 2015', 'category': 'DATE'}, {'entity': 'December 2014', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': 'MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS', 'category': 'EVENT'}, {'entity': 'divestiture of our pipeline of investigational human immunodeficiency', 'category': 'EVENT'}, {'entity': 'Japanese Ministry of Health, Labour and Welfare', 'category': 'FAC'}, {'entity': 'U.S. Food and Drug Administration FDA', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'EU', 'category': 'GPE'}, {'entity': 'France', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': '$16,560', 'category': 'MONEY'}, {'entity': '$15,879', 'category': 'MONEY'}, {'entity': '$16,385', 'category': 'MONEY'}, {'entity': '$1.9 billion', 'category': 'MONEY'}, {'entity': '$900 million', 'category': 'MONEY'}, {'entity': 'Bristol-Myers Squibb Company', 'category': 'ORG'}, {'entity': 'Bristol-Myers Squibb', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Hepatitis C Franchise', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'Flexus Biosciences, Inc.', 'category': 'ORG'}, {'entity': 'Flexus', 'category': 'ORG'}, {'entity': 'Cardioxyl Pharmaceuticals, Inc.', 'category': 'ORG'}, {'entity': 'Cardioxyl', 'category': 'ORG'}, {'entity': 'Ono Pharmaceutical Co., Ltd.', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'Ono', 'category': 'ORG'}, {'entity': 'U.S. Food and Drug Administration', 'category': 'ORG'}, {'entity': 'BRAF', 'category': 'ORG'}, {'entity': 'RCC', 'category': 'ORG'}, {'entity': 'SQ NSCLC', 'category': 'ORG'}, {'entity': 'melanoma', 'category': 'ORG'}, {'entity': 'Revlimid*', 'category': 'ORG'}, {'entity': 'Hepatitis C Portfolio - Daklinza', 'category': 'ORG'}, {'entity': 'HCV genotype 3', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': '21.5%', 'category': 'PERCENT'}, {'entity': '14.8%', 'category': 'PERCENT'}, {'entity': '10.8%', 'category': 'PERCENT'}, {'entity': 'Opdivo+Yervoy ipilimumab', 'category': 'PERSON'}, {'entity': 'Yervoy', 'category': 'PERSON'}, {'entity': 'Empliciti elotuzumab', 'category': 'PERSON'}, {'entity': 'Abilify* aripiprazole', 'category': 'PRODUCT'}, {'entity': 'Baraclude entecavir', 'category': 'PRODUCT'}, {'entity': 'Reyataz atazanavir sulfate', 'category': 'PRODUCT'}, {'entity': 'Sustiva efavirenz', 'category': 'PRODUCT'}, {'entity': 'Hepatitis C Franchise', 'category': 'PRODUCT'}, {'entity': 'Opdivo nivolumab', 'category': 'PRODUCT'}, {'entity': 'Eliquis apixaban', 'category': 'PRODUCT'}, {'entity': 'Flexus', 'category': 'PRODUCT'}, {'entity': 'Cardioxyl', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Yervoy ipilimumab', 'category': 'PRODUCT'}, {'entity': 'Empliciti elotuzumab', 'category': 'PRODUCT'}, {'entity': 'Daklinza daclatasvir', 'category': 'PRODUCT'}, {'entity': 'Orencia abatacept', 'category': 'PRODUCT'}, {'entity': 'Eliquis', 'category': 'PRODUCT'}, {'entity': 'Daklinza', 'category': 'PRODUCT'}, {'entity': 'Sustiva Franchise', 'category': 'PRODUCT'}, {'entity': '446', 'category': 'QUANTITY'}, {'entity': '352', 'category': 'QUANTITY'}, {'entity': '311', 'category': 'QUANTITY'}, {'entity': '1,565', 'category': 'QUANTITY'}, {'entity': '2,004', 'category': 'QUANTITY'}, {'entity': '2,563', 'category': 'QUANTITY'}, {'entity': '3,378', 'category': 'QUANTITY'}, {'entity': '3,085', 'category': 'QUANTITY'}, {'entity': '3,019', 'category': 'QUANTITY'}, {'entity': '8,930', 'category': 'QUANTITY'}, {'entity': '11,843', 'category': 'QUANTITY'}, {'entity': '8,272', 'category': 'QUANTITY'}, {'entity': '12 months', 'category': 'TIME'}, {'entity': 'end of 2015', 'category': 'TIME'}, {'entity': 'Yervoy', 'category': 'WORK_OF_ART'}, {'entity': 'our first immuno-oncology agent', 'category': 'WORK_OF_ART'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  17\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWS9c3Y3FoDDzEGr0a1Fff6WvtOm\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701570297,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#2.4#9.9#19.9#10\\n\\nDATE# December 2015# November 2015# September 2015# May 2015# August 2015# April 2015# March 2015# February 2015# January 2015# Year Ended December 31# 2015 vs. 2014# 2014 vs. 2013# 2015# 2014# 2013\\n\\nEVENT# Acquisition and Licensing Arrangements\\n\\nFAC#California Institute for Biomedical Research\\n\\nGPE#U.S.#Europe#United States\\n\\nLAW# license agreement\\n\\nMONEY# 2.4 million\\n\\nNORP#Japanese#U.S.#European\\n\\nORG#ViiV Healthcare#Kyorin Pharmaceutical Co#BMS#Cardioxyl#Five Prime Therapeutics#Promedior#uniQure N.V.#Flexus#Novo Nordisk A/S# Bavarian Nordic A/S#Rigel Pharmaceuticals#California Institute for Biomedical Research# Calibr\\n\\nPERSON#\\n\\nPRODUCT#HIV medicines#FPR2 agonist program#CXL-1427#FPA008#PRM-151#S100A1#F001287#Prostvac\\n\\nQUANTITY#\\n\\nTIME#\\n\\nWORK_OF_ART#}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2400,\n",
      "    \"completion_tokens\": 275,\n",
      "    \"total_tokens\": 2675\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 2015', 'category': 'DATE'}, {'entity': 'November 2015', 'category': 'DATE'}, {'entity': 'September 2015', 'category': 'DATE'}, {'entity': 'May 2015', 'category': 'DATE'}, {'entity': 'August 2015', 'category': 'DATE'}, {'entity': 'April 2015', 'category': 'DATE'}, {'entity': 'March 2015', 'category': 'DATE'}, {'entity': 'February 2015', 'category': 'DATE'}, {'entity': 'January 2015', 'category': 'DATE'}, {'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': '2015 vs. 2014', 'category': 'DATE'}, {'entity': '2014 vs. 2013', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': 'Acquisition and Licensing Arrangements', 'category': 'EVENT'}, {'entity': 'California Institute for Biomedical Research', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Europe', 'category': 'GPE'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'license agreement', 'category': 'LAW'}, {'entity': '2.4 million', 'category': 'MONEY'}, {'entity': 'Japanese', 'category': 'NORP'}, {'entity': 'U.S.', 'category': 'NORP'}, {'entity': 'European', 'category': 'NORP'}, {'entity': 'ViiV Healthcare', 'category': 'ORG'}, {'entity': 'Kyorin Pharmaceutical Co', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Cardioxyl', 'category': 'ORG'}, {'entity': 'Five Prime Therapeutics', 'category': 'ORG'}, {'entity': 'Promedior', 'category': 'ORG'}, {'entity': 'uniQure N.V.', 'category': 'ORG'}, {'entity': 'Flexus', 'category': 'ORG'}, {'entity': 'Novo Nordisk A/S', 'category': 'ORG'}, {'entity': 'Bavarian Nordic A/S', 'category': 'ORG'}, {'entity': 'Rigel Pharmaceuticals', 'category': 'ORG'}, {'entity': 'California Institute for Biomedical Research', 'category': 'ORG'}, {'entity': 'Calibr', 'category': 'ORG'}, {'entity': 'HIV medicines', 'category': 'PRODUCT'}, {'entity': 'FPR2 agonist program', 'category': 'PRODUCT'}, {'entity': 'CXL-1427', 'category': 'PRODUCT'}, {'entity': 'FPA008', 'category': 'PRODUCT'}, {'entity': 'PRM-151', 'category': 'PRODUCT'}, {'entity': 'S100A1', 'category': 'PRODUCT'}, {'entity': 'F001287', 'category': 'PRODUCT'}, {'entity': 'Prostvac', 'category': 'PRODUCT'}, {'entity': '', 'category': 'WORK_OF_ART'}, {'entity': '2.4', 'category': 'CARDINAL'}, {'entity': '9.9', 'category': 'CARDINAL'}, {'entity': '19.9', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  17\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWSi8OmJInI52JGEXyT850bjqHfo\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701570332,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#3#3#170#1.1#1.6#1.3#49#286#279#324#938#755#574#94#776#2,199#748#570#105#711#2,134#56#267#232#352#907#1,043#878#109#1,206#3,236#1,002#688#85#782#2,557#97#434#181#709#1,421#17,166#13,793#14,391#1,043#755#717#859#551#490#36#61#62#1,183#766#818#3,121#2,133#2,087#14,045#11,660#12,304#63#30#22#180#1,312#1,441#1,527#135#215#289#1,177#1,226#1,238#1,603#256#323#1,280#1,139#1,362#1,551#591#689#769#548#673#782#1,252#1,444#1,614#1,041#1,118#1,092#211#326#522#3 \\nDATE#February 2014#June 2014#third quarter of 2014#April 2015#January 1, 2014#December 31, 2014#December 31, 2015#Year Ended December 31, 2015#Year Ended December 31, 2014#Year Ended December 31, 2013#December 31, 2015#March 31, 2015 \\nEVENT#diabetes business divestiture#diabetes business divestiture \\nGPE#U.S.#Europe#EU#France#Japan#France#U.S.#U.S.#Non-U.S.#U.S.#U.S.#Non-U.S.#U.S.#U.S.#U.S.#Non-U.S.#U.S.#U.S.#Non-U.S.#Non-U.S.#Non-U.S.#U.S.#U.S.#U.S.#U.S.#U.S.#U.S.#Non-U.S.#Non-U.S.#Non-U.S.#U.S.#U.S.#U.S.#U.S.#U.S.#U.S.#U.S.#U.S.#U.S.#Non-U.S.#Non-U.S.#U.S.#U.S.#U.S.#U.S.#Non-U.S.#U.S.#U.S.#U.S.#U.S.#U.S.#U.S.#Non-U.S.#Non-U.S.#Non-U.S.#U.S.#U.S.#U.S.#U.S.#U.S.#U.S.#U.S.#U.S.#Non-U.S.#Non-U.S.#Non-U.S.#U.S.\\nLANGUAGE#English \\nMONEY#$170 million#$1.1 billion#$1.6 billion#$1.3 billion#$1.1 billion in 2015,#$1.6 billion in 2014#$1.3 billion in 2013#Dollars in Millions#Charge-Backs and Cash Discounts#Medicaid and Medicare Rebates#Other Rebates, Discounts and Adjustments#Dollars in Millions#Dollars in Millions#$14,391#Gross-to-Net Adjustments#Discounts#Net product sales#$63 million in 2015,#$30 million in 2014#$22 million in 2013#$180 million#Dollars in Millions\\nORG#Daklinza#EU#Daklinza#France#Eliquis#Yervoy and Sprycel#Atripla#Atripla#Rebates#Daklinza#France#Plavix\\nPERCENT#3%#3%#10%#10%#10%\\nPERSON#Eliquis, Yervoy and Sprycel#Eliquis#Eliquis#Eliquis, Yervoy and Sprycel#Eliquis#Eliquis#Eliquis#Yervoy#Sprycel#Eliquis, Yervoy#Sprycel#Eliquis and Opdivo#Eliquis\\nPRODUCT#Abilify*#Erbitux*#Abilify*#Abilify*#Abilify*#Abilify*#Abilify* and Atripla*#Abilify* and Atripla*\\nWORK_OF_ART#\\\"\\u2014Product Sales Discussion\\\"#Item 8. Financial Statements\\u2014Note 3. Alliances}\\n\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 3038,\n",
      "    \"completion_tokens\": 974,\n",
      "    \"total_tokens\": 4012\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'February 2014', 'category': 'DATE'}, {'entity': 'June 2014', 'category': 'DATE'}, {'entity': 'third quarter of 2014', 'category': 'DATE'}, {'entity': 'April 2015', 'category': 'DATE'}, {'entity': 'January 1, 2014', 'category': 'DATE'}, {'entity': 'December 31, 2014', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2015', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2014', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2013', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'March 31, 2015', 'category': 'DATE'}, {'entity': 'diabetes business divestiture', 'category': 'EVENT'}, {'entity': 'diabetes business divestiture', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Europe', 'category': 'GPE'}, {'entity': 'EU', 'category': 'GPE'}, {'entity': 'France', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'France', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Non-U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Non-U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Non-U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Non-U.S.', 'category': 'GPE'}, {'entity': 'Non-U.S.', 'category': 'GPE'}, {'entity': 'Non-U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Non-U.S.', 'category': 'GPE'}, {'entity': 'Non-U.S.', 'category': 'GPE'}, {'entity': 'Non-U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Non-U.S.', 'category': 'GPE'}, {'entity': 'Non-U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Non-U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Non-U.S.', 'category': 'GPE'}, {'entity': 'Non-U.S.', 'category': 'GPE'}, {'entity': 'Non-U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Non-U.S.', 'category': 'GPE'}, {'entity': 'Non-U.S.', 'category': 'GPE'}, {'entity': 'Non-U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'English', 'category': 'LANGUAGE'}, {'entity': '$170 million', 'category': 'MONEY'}, {'entity': '$1.1 billion', 'category': 'MONEY'}, {'entity': '$1.6 billion', 'category': 'MONEY'}, {'entity': '$1.3 billion', 'category': 'MONEY'}, {'entity': '$1.1 billion in 2015,', 'category': 'MONEY'}, {'entity': '$1.6 billion in 2014', 'category': 'MONEY'}, {'entity': '$1.3 billion in 2013', 'category': 'MONEY'}, {'entity': 'Dollars in Millions', 'category': 'MONEY'}, {'entity': 'Charge-Backs and Cash Discounts', 'category': 'MONEY'}, {'entity': 'Medicaid and Medicare Rebates', 'category': 'MONEY'}, {'entity': 'Other Rebates, Discounts and Adjustments', 'category': 'MONEY'}, {'entity': 'Dollars in Millions', 'category': 'MONEY'}, {'entity': 'Dollars in Millions', 'category': 'MONEY'}, {'entity': '$14,391', 'category': 'MONEY'}, {'entity': 'Gross-to-Net Adjustments', 'category': 'MONEY'}, {'entity': 'Discounts', 'category': 'MONEY'}, {'entity': 'Net product sales', 'category': 'MONEY'}, {'entity': '$63 million in 2015,', 'category': 'MONEY'}, {'entity': '$30 million in 2014', 'category': 'MONEY'}, {'entity': '$22 million in 2013', 'category': 'MONEY'}, {'entity': '$180 million', 'category': 'MONEY'}, {'entity': 'Dollars in Millions', 'category': 'MONEY'}, {'entity': 'Daklinza', 'category': 'ORG'}, {'entity': 'EU', 'category': 'ORG'}, {'entity': 'Daklinza', 'category': 'ORG'}, {'entity': 'France', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'Yervoy and Sprycel', 'category': 'ORG'}, {'entity': 'Atripla', 'category': 'ORG'}, {'entity': 'Atripla', 'category': 'ORG'}, {'entity': 'Rebates', 'category': 'ORG'}, {'entity': 'Daklinza', 'category': 'ORG'}, {'entity': 'France', 'category': 'ORG'}, {'entity': 'Plavix', 'category': 'ORG'}, {'entity': '3%', 'category': 'PERCENT'}, {'entity': '3%', 'category': 'PERCENT'}, {'entity': '10%', 'category': 'PERCENT'}, {'entity': '10%', 'category': 'PERCENT'}, {'entity': '10%', 'category': 'PERCENT'}, {'entity': 'Eliquis, Yervoy and Sprycel', 'category': 'PERSON'}, {'entity': 'Eliquis', 'category': 'PERSON'}, {'entity': 'Eliquis', 'category': 'PERSON'}, {'entity': 'Eliquis, Yervoy and Sprycel', 'category': 'PERSON'}, {'entity': 'Eliquis', 'category': 'PERSON'}, {'entity': 'Eliquis', 'category': 'PERSON'}, {'entity': 'Eliquis', 'category': 'PERSON'}, {'entity': 'Yervoy', 'category': 'PERSON'}, {'entity': 'Sprycel', 'category': 'PERSON'}, {'entity': 'Eliquis, Yervoy', 'category': 'PERSON'}, {'entity': 'Sprycel', 'category': 'PERSON'}, {'entity': 'Eliquis and Opdivo', 'category': 'PERSON'}, {'entity': 'Eliquis', 'category': 'PERSON'}, {'entity': 'Abilify*', 'category': 'PRODUCT'}, {'entity': 'Erbitux*', 'category': 'PRODUCT'}, {'entity': 'Abilify*', 'category': 'PRODUCT'}, {'entity': 'Abilify*', 'category': 'PRODUCT'}, {'entity': 'Abilify*', 'category': 'PRODUCT'}, {'entity': 'Abilify*', 'category': 'PRODUCT'}, {'entity': 'Abilify* and Atripla*', 'category': 'PRODUCT'}, {'entity': 'Abilify* and Atripla*', 'category': 'PRODUCT'}, {'entity': '\"—Product Sales Discussion\"', 'category': 'WORK_OF_ART'}, {'entity': 'Item 8. Financial Statements—Note 3. Alliances', 'category': 'WORK_OF_ART'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '170', 'category': 'CARDINAL'}, {'entity': '1.1', 'category': 'CARDINAL'}, {'entity': '1.6', 'category': 'CARDINAL'}, {'entity': '1.3', 'category': 'CARDINAL'}, {'entity': '49', 'category': 'CARDINAL'}, {'entity': '286', 'category': 'CARDINAL'}, {'entity': '279', 'category': 'CARDINAL'}, {'entity': '324', 'category': 'CARDINAL'}, {'entity': '938', 'category': 'CARDINAL'}, {'entity': '755', 'category': 'CARDINAL'}, {'entity': '574', 'category': 'CARDINAL'}, {'entity': '94', 'category': 'CARDINAL'}, {'entity': '776', 'category': 'CARDINAL'}, {'entity': '2,199', 'category': 'CARDINAL'}, {'entity': '748', 'category': 'CARDINAL'}, {'entity': '570', 'category': 'CARDINAL'}, {'entity': '105', 'category': 'CARDINAL'}, {'entity': '711', 'category': 'CARDINAL'}, {'entity': '2,134', 'category': 'CARDINAL'}, {'entity': '56', 'category': 'CARDINAL'}, {'entity': '267', 'category': 'CARDINAL'}, {'entity': '232', 'category': 'CARDINAL'}, {'entity': '352', 'category': 'CARDINAL'}, {'entity': '907', 'category': 'CARDINAL'}, {'entity': '1,043', 'category': 'CARDINAL'}, {'entity': '878', 'category': 'CARDINAL'}, {'entity': '109', 'category': 'CARDINAL'}, {'entity': '1,206', 'category': 'CARDINAL'}, {'entity': '3,236', 'category': 'CARDINAL'}, {'entity': '1,002', 'category': 'CARDINAL'}, {'entity': '688', 'category': 'CARDINAL'}, {'entity': '85', 'category': 'CARDINAL'}, {'entity': '782', 'category': 'CARDINAL'}, {'entity': '2,557', 'category': 'CARDINAL'}, {'entity': '97', 'category': 'CARDINAL'}, {'entity': '434', 'category': 'CARDINAL'}, {'entity': '181', 'category': 'CARDINAL'}, {'entity': '709', 'category': 'CARDINAL'}, {'entity': '1,421', 'category': 'CARDINAL'}, {'entity': '17,166', 'category': 'CARDINAL'}, {'entity': '13,793', 'category': 'CARDINAL'}, {'entity': '14,391', 'category': 'CARDINAL'}, {'entity': '1,043', 'category': 'CARDINAL'}, {'entity': '755', 'category': 'CARDINAL'}, {'entity': '717', 'category': 'CARDINAL'}, {'entity': '859', 'category': 'CARDINAL'}, {'entity': '551', 'category': 'CARDINAL'}, {'entity': '490', 'category': 'CARDINAL'}, {'entity': '36', 'category': 'CARDINAL'}, {'entity': '61', 'category': 'CARDINAL'}, {'entity': '62', 'category': 'CARDINAL'}, {'entity': '1,183', 'category': 'CARDINAL'}, {'entity': '766', 'category': 'CARDINAL'}, {'entity': '818', 'category': 'CARDINAL'}, {'entity': '3,121', 'category': 'CARDINAL'}, {'entity': '2,133', 'category': 'CARDINAL'}, {'entity': '2,087', 'category': 'CARDINAL'}, {'entity': '14,045', 'category': 'CARDINAL'}, {'entity': '11,660', 'category': 'CARDINAL'}, {'entity': '12,304', 'category': 'CARDINAL'}, {'entity': '63', 'category': 'CARDINAL'}, {'entity': '30', 'category': 'CARDINAL'}, {'entity': '22', 'category': 'CARDINAL'}, {'entity': '180', 'category': 'CARDINAL'}, {'entity': '1,312', 'category': 'CARDINAL'}, {'entity': '1,441', 'category': 'CARDINAL'}, {'entity': '1,527', 'category': 'CARDINAL'}, {'entity': '135', 'category': 'CARDINAL'}, {'entity': '215', 'category': 'CARDINAL'}, {'entity': '289', 'category': 'CARDINAL'}, {'entity': '1,177', 'category': 'CARDINAL'}, {'entity': '1,226', 'category': 'CARDINAL'}, {'entity': '1,238', 'category': 'CARDINAL'}, {'entity': '1,603', 'category': 'CARDINAL'}, {'entity': '256', 'category': 'CARDINAL'}, {'entity': '323', 'category': 'CARDINAL'}, {'entity': '1,280', 'category': 'CARDINAL'}, {'entity': '1,139', 'category': 'CARDINAL'}, {'entity': '1,362', 'category': 'CARDINAL'}, {'entity': '1,551', 'category': 'CARDINAL'}, {'entity': '591', 'category': 'CARDINAL'}, {'entity': '689', 'category': 'CARDINAL'}, {'entity': '769', 'category': 'CARDINAL'}, {'entity': '548', 'category': 'CARDINAL'}, {'entity': '673', 'category': 'CARDINAL'}, {'entity': '782', 'category': 'CARDINAL'}, {'entity': '1,252', 'category': 'CARDINAL'}, {'entity': '1,444', 'category': 'CARDINAL'}, {'entity': '1,614', 'category': 'CARDINAL'}, {'entity': '1,041', 'category': 'CARDINAL'}, {'entity': '1,118', 'category': 'CARDINAL'}, {'entity': '1,092', 'category': 'CARDINAL'}, {'entity': '211', 'category': 'CARDINAL'}, {'entity': '326', 'category': 'CARDINAL'}, {'entity': '522', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  17\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWTh8qrzFDiksoMZNXvlhl4HRaDn\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701570393,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#501#723#696#31#4#487#682#682#29#14#66#3#942#6#823#1#119#5#1,620#1,493#1,280#9#17#8#2#829#671#541#24#24#791#822#739#4#11#16#5#1,126#1,308#960#14#36#7#2#602#709#577#15#23#524#599#383#13#56#16#4#746#2,020#2,289#63#12#1#600#1,572#1,519#62#3#146#448#770#67#42#4#1,885#1,652#1,444#14#14#6#2#1,271#1,064#954#19#12#614#588#490#4#20#18#6#1,860#774#146#1,023#404#97#837#370#49#2,571#3,400#4,878#24#30#6#1#460#591#1,798#22#67#2,111#2,809#3,080#25#9#7#2#100#1,315#201#288#55 \\n\\nDATE#September 2014#2015#2014#July 2015#2016#third quarter of 2014#2015#2014#third quarter of 2014#2015#2016#December 2015#October 2015#December 2014#September 2014#June 2015#July 2015#2015#2014#April 2015#2014#2013#June 2014\\n\\nGPE#U.S.#Germany#EU#Japan#France#Japan#Europe\\n\\nMONEY#$170 million \\n\\nORG#BMS#Eli Lilly#NSQ#SQ NSCLC#RCC#EU#Advanced SQ NSCLC#Philadelphia chromosome-positive chronic myeloid leukemia#Gleevec*#Otsuka Pharmaceutical Co., Ltd.#RA \\n\\nPERSON#Daklinza#Sunvepra#Daklinza#Daklinza#Sunvepra#Reyataz#Evotaz#Sustiva#Atripla*#Sustiva#Atripla*#Empliciti#Erbitux*#Epidermal Growth Factor Receptor#Opdivo#Opdivo#Opdivo#Sprycel#Yervoy#Opdivo#Abilify*#Orencia\\n\\nPRODUCT#Hepatitis C Franchise#Reyataz Franchise#Sustiva Franchise#Empliciti#Erbitux*#Sprycel#Yervoy#Abilify*#Orencia\\n}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2962,\n",
      "    \"completion_tokens\": 630,\n",
      "    \"total_tokens\": 3592\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'September 2014', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': 'July 2015', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': 'third quarter of 2014', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': 'third quarter of 2014', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': 'December 2015', 'category': 'DATE'}, {'entity': 'October 2015', 'category': 'DATE'}, {'entity': 'December 2014', 'category': 'DATE'}, {'entity': 'September 2014', 'category': 'DATE'}, {'entity': 'June 2015', 'category': 'DATE'}, {'entity': 'July 2015', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': 'April 2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': 'June 2014', 'category': 'DATE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Germany', 'category': 'GPE'}, {'entity': 'EU', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'France', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'Europe', 'category': 'GPE'}, {'entity': '$170 million', 'category': 'MONEY'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Eli Lilly', 'category': 'ORG'}, {'entity': 'NSQ', 'category': 'ORG'}, {'entity': 'SQ NSCLC', 'category': 'ORG'}, {'entity': 'RCC', 'category': 'ORG'}, {'entity': 'EU', 'category': 'ORG'}, {'entity': 'Advanced SQ NSCLC', 'category': 'ORG'}, {'entity': 'Philadelphia chromosome-positive chronic myeloid leukemia', 'category': 'ORG'}, {'entity': 'Gleevec*', 'category': 'ORG'}, {'entity': 'Otsuka Pharmaceutical Co., Ltd.', 'category': 'ORG'}, {'entity': 'RA', 'category': 'ORG'}, {'entity': 'Daklinza', 'category': 'PERSON'}, {'entity': 'Sunvepra', 'category': 'PERSON'}, {'entity': 'Daklinza', 'category': 'PERSON'}, {'entity': 'Daklinza', 'category': 'PERSON'}, {'entity': 'Sunvepra', 'category': 'PERSON'}, {'entity': 'Reyataz', 'category': 'PERSON'}, {'entity': 'Evotaz', 'category': 'PERSON'}, {'entity': 'Sustiva', 'category': 'PERSON'}, {'entity': 'Atripla*', 'category': 'PERSON'}, {'entity': 'Sustiva', 'category': 'PERSON'}, {'entity': 'Atripla*', 'category': 'PERSON'}, {'entity': 'Empliciti', 'category': 'PERSON'}, {'entity': 'Erbitux*', 'category': 'PERSON'}, {'entity': 'Epidermal Growth Factor Receptor', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Sprycel', 'category': 'PERSON'}, {'entity': 'Yervoy', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Abilify*', 'category': 'PERSON'}, {'entity': 'Orencia', 'category': 'PERSON'}, {'entity': 'Hepatitis C Franchise', 'category': 'PRODUCT'}, {'entity': 'Reyataz Franchise', 'category': 'PRODUCT'}, {'entity': 'Sustiva Franchise', 'category': 'PRODUCT'}, {'entity': 'Empliciti', 'category': 'PRODUCT'}, {'entity': 'Erbitux*', 'category': 'PRODUCT'}, {'entity': 'Sprycel', 'category': 'PRODUCT'}, {'entity': 'Yervoy', 'category': 'PRODUCT'}, {'entity': 'Abilify*', 'category': 'PRODUCT'}, {'entity': 'Orencia', 'category': 'PRODUCT'}, {'entity': '501', 'category': 'CARDINAL'}, {'entity': '723', 'category': 'CARDINAL'}, {'entity': '696', 'category': 'CARDINAL'}, {'entity': '31', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '487', 'category': 'CARDINAL'}, {'entity': '682', 'category': 'CARDINAL'}, {'entity': '682', 'category': 'CARDINAL'}, {'entity': '29', 'category': 'CARDINAL'}, {'entity': '14', 'category': 'CARDINAL'}, {'entity': '66', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '942', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '823', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '119', 'category': 'CARDINAL'}, {'entity': '5', 'category': 'CARDINAL'}, {'entity': '1,620', 'category': 'CARDINAL'}, {'entity': '1,493', 'category': 'CARDINAL'}, {'entity': '1,280', 'category': 'CARDINAL'}, {'entity': '9', 'category': 'CARDINAL'}, {'entity': '17', 'category': 'CARDINAL'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '829', 'category': 'CARDINAL'}, {'entity': '671', 'category': 'CARDINAL'}, {'entity': '541', 'category': 'CARDINAL'}, {'entity': '24', 'category': 'CARDINAL'}, {'entity': '24', 'category': 'CARDINAL'}, {'entity': '791', 'category': 'CARDINAL'}, {'entity': '822', 'category': 'CARDINAL'}, {'entity': '739', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '11', 'category': 'CARDINAL'}, {'entity': '16', 'category': 'CARDINAL'}, {'entity': '5', 'category': 'CARDINAL'}, {'entity': '1,126', 'category': 'CARDINAL'}, {'entity': '1,308', 'category': 'CARDINAL'}, {'entity': '960', 'category': 'CARDINAL'}, {'entity': '14', 'category': 'CARDINAL'}, {'entity': '36', 'category': 'CARDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '602', 'category': 'CARDINAL'}, {'entity': '709', 'category': 'CARDINAL'}, {'entity': '577', 'category': 'CARDINAL'}, {'entity': '15', 'category': 'CARDINAL'}, {'entity': '23', 'category': 'CARDINAL'}, {'entity': '524', 'category': 'CARDINAL'}, {'entity': '599', 'category': 'CARDINAL'}, {'entity': '383', 'category': 'CARDINAL'}, {'entity': '13', 'category': 'CARDINAL'}, {'entity': '56', 'category': 'CARDINAL'}, {'entity': '16', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '746', 'category': 'CARDINAL'}, {'entity': '2,020', 'category': 'CARDINAL'}, {'entity': '2,289', 'category': 'CARDINAL'}, {'entity': '63', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '600', 'category': 'CARDINAL'}, {'entity': '1,572', 'category': 'CARDINAL'}, {'entity': '1,519', 'category': 'CARDINAL'}, {'entity': '62', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '146', 'category': 'CARDINAL'}, {'entity': '448', 'category': 'CARDINAL'}, {'entity': '770', 'category': 'CARDINAL'}, {'entity': '67', 'category': 'CARDINAL'}, {'entity': '42', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '1,885', 'category': 'CARDINAL'}, {'entity': '1,652', 'category': 'CARDINAL'}, {'entity': '1,444', 'category': 'CARDINAL'}, {'entity': '14', 'category': 'CARDINAL'}, {'entity': '14', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '1,271', 'category': 'CARDINAL'}, {'entity': '1,064', 'category': 'CARDINAL'}, {'entity': '954', 'category': 'CARDINAL'}, {'entity': '19', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '614', 'category': 'CARDINAL'}, {'entity': '588', 'category': 'CARDINAL'}, {'entity': '490', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '18', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '1,860', 'category': 'CARDINAL'}, {'entity': '774', 'category': 'CARDINAL'}, {'entity': '146', 'category': 'CARDINAL'}, {'entity': '1,023', 'category': 'CARDINAL'}, {'entity': '404', 'category': 'CARDINAL'}, {'entity': '97', 'category': 'CARDINAL'}, {'entity': '837', 'category': 'CARDINAL'}, {'entity': '370', 'category': 'CARDINAL'}, {'entity': '49', 'category': 'CARDINAL'}, {'entity': '2,571', 'category': 'CARDINAL'}, {'entity': '3,400', 'category': 'CARDINAL'}, {'entity': '4,878', 'category': 'CARDINAL'}, {'entity': '24', 'category': 'CARDINAL'}, {'entity': '30', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '460', 'category': 'CARDINAL'}, {'entity': '591', 'category': 'CARDINAL'}, {'entity': '1,798', 'category': 'CARDINAL'}, {'entity': '22', 'category': 'CARDINAL'}, {'entity': '67', 'category': 'CARDINAL'}, {'entity': '2,111', 'category': 'CARDINAL'}, {'entity': '2,809', 'category': 'CARDINAL'}, {'entity': '3,080', 'category': 'CARDINAL'}, {'entity': '25', 'category': 'CARDINAL'}, {'entity': '9', 'category': 'CARDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '1,315', 'category': 'CARDINAL'}, {'entity': '201', 'category': 'CARDINAL'}, {'entity': '288', 'category': 'CARDINAL'}, {'entity': '55', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  17\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWUSSliauqvFCWTSEBDTJ3IB84LI\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701570440,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#1.1#1.2#1.4#2.9#3.1#6.4#4.8#95#100\\n\\nDATE#February 2014#December 31, 2015#September 30, 2015#June 30, 2015#the year ended December 31, 2015\\n\\nEVENT#diabetes business divestiture#diabetes business divestiture\\n\\nGPE#U.S.#France#Greece#Russia#Europe \\n\\nLAW#SEC Consent Order\\n\\nLOC#Europe\\n\\nMONEY#$1.1 billion#$290 million \\n\\nNORP#non-U.S.\\n\\nORDINAL#1.1#1.2#1.4#2.9#3.1#4.8#6.4\\n\\nORG#U.S. Securities and Exchange Commission#Eliquis\\n\\nPERSON#Donormyl#Dafalgan#Fervex#Efferalgan\\n\\nPRODUCT#Form 10-Q#Form 10-K#diabetic aid\\n\\nTIME#one month}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2248,\n",
      "    \"completion_tokens\": 225,\n",
      "    \"total_tokens\": 2473\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'February 2014', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'September 30, 2015', 'category': 'DATE'}, {'entity': 'June 30, 2015', 'category': 'DATE'}, {'entity': 'the year ended December 31, 2015', 'category': 'DATE'}, {'entity': 'diabetes business divestiture', 'category': 'EVENT'}, {'entity': 'diabetes business divestiture', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'France', 'category': 'GPE'}, {'entity': 'Greece', 'category': 'GPE'}, {'entity': 'Russia', 'category': 'GPE'}, {'entity': 'Europe', 'category': 'GPE'}, {'entity': 'SEC Consent Order', 'category': 'LAW'}, {'entity': 'Europe', 'category': 'LOC'}, {'entity': '$1.1 billion', 'category': 'MONEY'}, {'entity': '$290 million', 'category': 'MONEY'}, {'entity': 'non-U.S.', 'category': 'NORP'}, {'entity': 'U.S. Securities and Exchange Commission', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'Donormyl', 'category': 'PERSON'}, {'entity': 'Dafalgan', 'category': 'PERSON'}, {'entity': 'Fervex', 'category': 'PERSON'}, {'entity': 'Efferalgan', 'category': 'PERSON'}, {'entity': 'Form 10-Q', 'category': 'PRODUCT'}, {'entity': 'Form 10-K', 'category': 'PRODUCT'}, {'entity': 'diabetic aid', 'category': 'PRODUCT'}, {'entity': 'one month', 'category': 'TIME'}, {'entity': '1.1', 'category': 'ORDINAL'}, {'entity': '1.2', 'category': 'ORDINAL'}, {'entity': '1.4', 'category': 'ORDINAL'}, {'entity': '2.9', 'category': 'ORDINAL'}, {'entity': '3.1', 'category': 'ORDINAL'}, {'entity': '4.8', 'category': 'ORDINAL'}, {'entity': '6.4', 'category': 'ORDINAL'}, {'entity': '1.1', 'category': 'CARDINAL'}, {'entity': '1.2', 'category': 'CARDINAL'}, {'entity': '1.4', 'category': 'CARDINAL'}, {'entity': '2.9', 'category': 'CARDINAL'}, {'entity': '3.1', 'category': 'CARDINAL'}, {'entity': '6.4', 'category': 'CARDINAL'}, {'entity': '4.8', 'category': 'CARDINAL'}, {'entity': '95', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  17\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWUzxF8qfFCLAh3FO7aqwMxsLHdw\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701570473,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#96#500#800#167#350#160#343#310#148#130#184#203#199#101#118#163#226#159#23#20#83#107#166#13#29#196#564#2#628#404#148#160#877#165#180#7#210#205#90#123#713\\n\\nDATE#Year Ended December 31#July 28, 2014#2015#2014#2013\\n\\nEVENT#diabetes business divestiture\\n\\nFAC#Mount Vernon\\n\\nGPE#Indiana#North America#Switzerland#Ireland#Puerto Rico\\n\\nLAW#Affordable Care Act\\n\\nMONEY#$96 million#$500 million#$800 million#$167 million#$350 million#$160 million#$343 million#$310 million#148 million#$130 million#184 million#$203 million#$199 million#$101 million#$118 million#$163 million#$226 million#$159 million#$23 million#$20 million#$83 million#$107 million#$166 million#$13 million#$29 million#$196 million#$564 million#$2 million#$614 million#$404 million#$148 million#160 million#$877 million#$165 million#$180 million#$7 million#210 million#$205 million#$90 million#$123 million\\n\\nORG#IRS#Eliquis#Opdivo#Hepatitis C Franchise#BMS#Flexus#Cardioxyl#Five Prime#LPA1 antagonist#IPRD#iPierian#Inc.#iPierian#Erbitux#Reckitt Benckiser Group plc#Reckitt#The Prudential Insurance Company of America#Amylin\\n\\nPERSON#Ixempra#Alliances\\n\\nPRODUCT#Branded Prescription Drug Fee\\n\\nTIME#the fourth quarter of 2015#the third quarter of 2014\\n\\nWORK_OF_ART#Item 8. Financial#Item 8. Financial Statements\\u2014Note 3. Alliances, Note 4. Acquisitions and Other Divestitures and Note 14. Goodwill and Other Intangible Assets#Item 8. Financial Statements\\u2014Note 19. Pension, Postretirement and Postemployment#Item 8. Financial Statements\\u2014Note 10. Financial Instruments}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2347,\n",
      "    \"completion_tokens\": 473,\n",
      "    \"total_tokens\": 2820\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': 'July 28, 2014', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': 'diabetes business divestiture', 'category': 'EVENT'}, {'entity': 'Mount Vernon', 'category': 'FAC'}, {'entity': 'Indiana', 'category': 'GPE'}, {'entity': 'North America', 'category': 'GPE'}, {'entity': 'Switzerland', 'category': 'GPE'}, {'entity': 'Ireland', 'category': 'GPE'}, {'entity': 'Puerto Rico', 'category': 'GPE'}, {'entity': 'Affordable Care Act', 'category': 'LAW'}, {'entity': '$96 million', 'category': 'MONEY'}, {'entity': '$500 million', 'category': 'MONEY'}, {'entity': '$800 million', 'category': 'MONEY'}, {'entity': '$167 million', 'category': 'MONEY'}, {'entity': '$350 million', 'category': 'MONEY'}, {'entity': '$160 million', 'category': 'MONEY'}, {'entity': '$343 million', 'category': 'MONEY'}, {'entity': '$310 million', 'category': 'MONEY'}, {'entity': '148 million', 'category': 'MONEY'}, {'entity': '$130 million', 'category': 'MONEY'}, {'entity': '184 million', 'category': 'MONEY'}, {'entity': '$203 million', 'category': 'MONEY'}, {'entity': '$199 million', 'category': 'MONEY'}, {'entity': '$101 million', 'category': 'MONEY'}, {'entity': '$118 million', 'category': 'MONEY'}, {'entity': '$163 million', 'category': 'MONEY'}, {'entity': '$226 million', 'category': 'MONEY'}, {'entity': '$159 million', 'category': 'MONEY'}, {'entity': '$23 million', 'category': 'MONEY'}, {'entity': '$20 million', 'category': 'MONEY'}, {'entity': '$83 million', 'category': 'MONEY'}, {'entity': '$107 million', 'category': 'MONEY'}, {'entity': '$166 million', 'category': 'MONEY'}, {'entity': '$13 million', 'category': 'MONEY'}, {'entity': '$29 million', 'category': 'MONEY'}, {'entity': '$196 million', 'category': 'MONEY'}, {'entity': '$564 million', 'category': 'MONEY'}, {'entity': '$2 million', 'category': 'MONEY'}, {'entity': '$614 million', 'category': 'MONEY'}, {'entity': '$404 million', 'category': 'MONEY'}, {'entity': '$148 million', 'category': 'MONEY'}, {'entity': '160 million', 'category': 'MONEY'}, {'entity': '$877 million', 'category': 'MONEY'}, {'entity': '$165 million', 'category': 'MONEY'}, {'entity': '$180 million', 'category': 'MONEY'}, {'entity': '$7 million', 'category': 'MONEY'}, {'entity': '210 million', 'category': 'MONEY'}, {'entity': '$205 million', 'category': 'MONEY'}, {'entity': '$90 million', 'category': 'MONEY'}, {'entity': '$123 million', 'category': 'MONEY'}, {'entity': 'IRS', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Hepatitis C Franchise', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Flexus', 'category': 'ORG'}, {'entity': 'Cardioxyl', 'category': 'ORG'}, {'entity': 'Five Prime', 'category': 'ORG'}, {'entity': 'LPA1 antagonist', 'category': 'ORG'}, {'entity': 'IPRD', 'category': 'ORG'}, {'entity': 'iPierian', 'category': 'ORG'}, {'entity': 'Inc.', 'category': 'ORG'}, {'entity': 'iPierian', 'category': 'ORG'}, {'entity': 'Erbitux', 'category': 'ORG'}, {'entity': 'Reckitt Benckiser Group plc', 'category': 'ORG'}, {'entity': 'Reckitt', 'category': 'ORG'}, {'entity': 'The Prudential Insurance Company of America', 'category': 'ORG'}, {'entity': 'Amylin', 'category': 'ORG'}, {'entity': 'Ixempra', 'category': 'PERSON'}, {'entity': 'Alliances', 'category': 'PERSON'}, {'entity': 'Branded Prescription Drug Fee', 'category': 'PRODUCT'}, {'entity': 'the fourth quarter of 2015', 'category': 'TIME'}, {'entity': 'the third quarter of 2014', 'category': 'TIME'}, {'entity': 'Item 8. Financial', 'category': 'WORK_OF_ART'}, {'entity': 'Item 8. Financial Statements—Note 3. Alliances, Note 4. Acquisitions and Other Divestitures and Note 14. Goodwill and Other Intangible Assets', 'category': 'WORK_OF_ART'}, {'entity': 'Item 8. Financial Statements—Note 19. Pension, Postretirement and Postemployment', 'category': 'WORK_OF_ART'}, {'entity': 'Item 8. Financial Statements—Note 10. Financial Instruments', 'category': 'WORK_OF_ART'}, {'entity': '96', 'category': 'CARDINAL'}, {'entity': '500', 'category': 'CARDINAL'}, {'entity': '800', 'category': 'CARDINAL'}, {'entity': '167', 'category': 'CARDINAL'}, {'entity': '350', 'category': 'CARDINAL'}, {'entity': '160', 'category': 'CARDINAL'}, {'entity': '343', 'category': 'CARDINAL'}, {'entity': '310', 'category': 'CARDINAL'}, {'entity': '148', 'category': 'CARDINAL'}, {'entity': '130', 'category': 'CARDINAL'}, {'entity': '184', 'category': 'CARDINAL'}, {'entity': '203', 'category': 'CARDINAL'}, {'entity': '199', 'category': 'CARDINAL'}, {'entity': '101', 'category': 'CARDINAL'}, {'entity': '118', 'category': 'CARDINAL'}, {'entity': '163', 'category': 'CARDINAL'}, {'entity': '226', 'category': 'CARDINAL'}, {'entity': '159', 'category': 'CARDINAL'}, {'entity': '23', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '83', 'category': 'CARDINAL'}, {'entity': '107', 'category': 'CARDINAL'}, {'entity': '166', 'category': 'CARDINAL'}, {'entity': '13', 'category': 'CARDINAL'}, {'entity': '29', 'category': 'CARDINAL'}, {'entity': '196', 'category': 'CARDINAL'}, {'entity': '564', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '628', 'category': 'CARDINAL'}, {'entity': '404', 'category': 'CARDINAL'}, {'entity': '148', 'category': 'CARDINAL'}, {'entity': '160', 'category': 'CARDINAL'}, {'entity': '877', 'category': 'CARDINAL'}, {'entity': '165', 'category': 'CARDINAL'}, {'entity': '180', 'category': 'CARDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '210', 'category': 'CARDINAL'}, {'entity': '205', 'category': 'CARDINAL'}, {'entity': '90', 'category': 'CARDINAL'}, {'entity': '123', 'category': 'CARDINAL'}, {'entity': '713', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  17\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWVfJDVvXANHk3c8aIHepxFNgjLy\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701570515,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#2013#8#84#151#36#549#273#14#84#151#326#96#10#9#16#10#105#16#1,679#278#16#160#343#1,883#621#16#115#163#226#187#559#160#877#161#123#72#10#158#27#23#13#11#180#316#626#340#2,293#1,503#698#480#545#242#480#422#242#1,813#1,081#456#16#1,565#2,004#2,563#1,813#1,081#456#3,378#3,085#3,019#1,679#1,670#1,662#0.93#1.20#1.54#1.08#0.65#0.28#2.01#1.85#1.82#2,385#5,571#1,885#1,864#4,660#4,408#8,930#11,843#139#590#6,550#7,242#2,241#4,011#1.7#7.2#1.3#2.0#254#0.16#755#2.5#2.4#2.3#800#500#500#1.3#1.0#2019#1.5#2015#2014\\n\\nDATE#Year Ended December 31#Year Ended December 31#December 31, 2015#the next few years#2015#2014#2013#2015#2014#2013#2016#2017#December 31, 2015#December 31, 2015#2014\\n\\nLAW#Item 8. Financial Statements\\u2014Note 8. Income Taxes#Item 8. Financial Statements\\u2014Note 10. Financial Instruments and Fair Value Measurements#Item 8. Financial Statements\\u2014Note 10. Financial Instruments and Fair Value Measurements\\n\\nMONEY#$84#$151#$36#$549#$273#$14#$84#$151#$326#$96#$10#$9#$16#$10#$105#$16#$1,679#$278#$16#$160#$343#$1,883#$621#$16#$115#$163#$226#187#559#$160#$877#$161#$123#$72#$10#158#27#23#13#11#180#316#626#340#$2,293#$1,503#$698#$480#$545#$242#$480#$422#$242#$1,813#$1,081#$456#$16#$1,565#$2,004#$2,563#$1,813#$1,081#$456#$3,378#$3,085#$3,019#$0.93#$1.20#$1.54#$1.08#$0.65#$0.28#$2.01#$1.85#$1.82#$2,385#$5,571#$1,885#$1,864#$4,660#$4,408#$8,930#$11,843#$139#$590#$6,550#$7,242#$2,241#$4,011#$1.7#$7.2#$1.3#$2.0#$254#$755#$2.5#$2.4#$2.3#$800#$500#$500#$1.3#$1.0#$1.5 \\n\\nORG#GAAP#BMS#U.S.\\n\\nPERCENT#0.16% \\n\\nPRODUCT#commercial paper\\n\\nWORK_OF_ART#Item 8. Financial Statements\\u2014Note 8. Income Taxes#Item 8. Financial Statements\\u2014Note 10. Financial Instruments and Fair Value Measurements#Item 8. Financial Statements\\u2014Note 10. Financial Instruments and Fair Value Measurements}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2560,\n",
      "    \"completion_tokens\": 834,\n",
      "    \"total_tokens\": 3394\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'the next few years', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': 'Item 8. Financial Statements—Note 8. Income Taxes', 'category': 'LAW'}, {'entity': 'Item 8. Financial Statements—Note 10. Financial Instruments and Fair Value Measurements', 'category': 'LAW'}, {'entity': 'Item 8. Financial Statements—Note 10. Financial Instruments and Fair Value Measurements', 'category': 'LAW'}, {'entity': '$84', 'category': 'MONEY'}, {'entity': '$151', 'category': 'MONEY'}, {'entity': '$36', 'category': 'MONEY'}, {'entity': '$549', 'category': 'MONEY'}, {'entity': '$273', 'category': 'MONEY'}, {'entity': '$14', 'category': 'MONEY'}, {'entity': '$84', 'category': 'MONEY'}, {'entity': '$151', 'category': 'MONEY'}, {'entity': '$326', 'category': 'MONEY'}, {'entity': '$96', 'category': 'MONEY'}, {'entity': '$10', 'category': 'MONEY'}, {'entity': '$9', 'category': 'MONEY'}, {'entity': '$16', 'category': 'MONEY'}, {'entity': '$10', 'category': 'MONEY'}, {'entity': '$105', 'category': 'MONEY'}, {'entity': '$16', 'category': 'MONEY'}, {'entity': '$1,679', 'category': 'MONEY'}, {'entity': '$278', 'category': 'MONEY'}, {'entity': '$16', 'category': 'MONEY'}, {'entity': '$160', 'category': 'MONEY'}, {'entity': '$343', 'category': 'MONEY'}, {'entity': '$1,883', 'category': 'MONEY'}, {'entity': '$621', 'category': 'MONEY'}, {'entity': '$16', 'category': 'MONEY'}, {'entity': '$115', 'category': 'MONEY'}, {'entity': '$163', 'category': 'MONEY'}, {'entity': '$226', 'category': 'MONEY'}, {'entity': '187', 'category': 'MONEY'}, {'entity': '559', 'category': 'MONEY'}, {'entity': '$160', 'category': 'MONEY'}, {'entity': '$877', 'category': 'MONEY'}, {'entity': '$161', 'category': 'MONEY'}, {'entity': '$123', 'category': 'MONEY'}, {'entity': '$72', 'category': 'MONEY'}, {'entity': '$10', 'category': 'MONEY'}, {'entity': '158', 'category': 'MONEY'}, {'entity': '27', 'category': 'MONEY'}, {'entity': '23', 'category': 'MONEY'}, {'entity': '13', 'category': 'MONEY'}, {'entity': '11', 'category': 'MONEY'}, {'entity': '180', 'category': 'MONEY'}, {'entity': '316', 'category': 'MONEY'}, {'entity': '626', 'category': 'MONEY'}, {'entity': '340', 'category': 'MONEY'}, {'entity': '$2,293', 'category': 'MONEY'}, {'entity': '$1,503', 'category': 'MONEY'}, {'entity': '$698', 'category': 'MONEY'}, {'entity': '$480', 'category': 'MONEY'}, {'entity': '$545', 'category': 'MONEY'}, {'entity': '$242', 'category': 'MONEY'}, {'entity': '$480', 'category': 'MONEY'}, {'entity': '$422', 'category': 'MONEY'}, {'entity': '$242', 'category': 'MONEY'}, {'entity': '$1,813', 'category': 'MONEY'}, {'entity': '$1,081', 'category': 'MONEY'}, {'entity': '$456', 'category': 'MONEY'}, {'entity': '$16', 'category': 'MONEY'}, {'entity': '$1,565', 'category': 'MONEY'}, {'entity': '$2,004', 'category': 'MONEY'}, {'entity': '$2,563', 'category': 'MONEY'}, {'entity': '$1,813', 'category': 'MONEY'}, {'entity': '$1,081', 'category': 'MONEY'}, {'entity': '$456', 'category': 'MONEY'}, {'entity': '$3,378', 'category': 'MONEY'}, {'entity': '$3,085', 'category': 'MONEY'}, {'entity': '$3,019', 'category': 'MONEY'}, {'entity': '$0.93', 'category': 'MONEY'}, {'entity': '$1.20', 'category': 'MONEY'}, {'entity': '$1.54', 'category': 'MONEY'}, {'entity': '$1.08', 'category': 'MONEY'}, {'entity': '$0.65', 'category': 'MONEY'}, {'entity': '$0.28', 'category': 'MONEY'}, {'entity': '$2.01', 'category': 'MONEY'}, {'entity': '$1.85', 'category': 'MONEY'}, {'entity': '$1.82', 'category': 'MONEY'}, {'entity': '$2,385', 'category': 'MONEY'}, {'entity': '$5,571', 'category': 'MONEY'}, {'entity': '$1,885', 'category': 'MONEY'}, {'entity': '$1,864', 'category': 'MONEY'}, {'entity': '$4,660', 'category': 'MONEY'}, {'entity': '$4,408', 'category': 'MONEY'}, {'entity': '$8,930', 'category': 'MONEY'}, {'entity': '$11,843', 'category': 'MONEY'}, {'entity': '$139', 'category': 'MONEY'}, {'entity': '$590', 'category': 'MONEY'}, {'entity': '$6,550', 'category': 'MONEY'}, {'entity': '$7,242', 'category': 'MONEY'}, {'entity': '$2,241', 'category': 'MONEY'}, {'entity': '$4,011', 'category': 'MONEY'}, {'entity': '$1.7', 'category': 'MONEY'}, {'entity': '$7.2', 'category': 'MONEY'}, {'entity': '$1.3', 'category': 'MONEY'}, {'entity': '$2.0', 'category': 'MONEY'}, {'entity': '$254', 'category': 'MONEY'}, {'entity': '$755', 'category': 'MONEY'}, {'entity': '$2.5', 'category': 'MONEY'}, {'entity': '$2.4', 'category': 'MONEY'}, {'entity': '$2.3', 'category': 'MONEY'}, {'entity': '$800', 'category': 'MONEY'}, {'entity': '$500', 'category': 'MONEY'}, {'entity': '$500', 'category': 'MONEY'}, {'entity': '$1.3', 'category': 'MONEY'}, {'entity': '$1.0', 'category': 'MONEY'}, {'entity': '$1.5', 'category': 'MONEY'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'U.S.', 'category': 'ORG'}, {'entity': '0.16%', 'category': 'PERCENT'}, {'entity': 'commercial paper', 'category': 'PRODUCT'}, {'entity': 'Item 8. Financial Statements—Note 8. Income Taxes', 'category': 'WORK_OF_ART'}, {'entity': 'Item 8. Financial Statements—Note 10. Financial Instruments and Fair Value Measurements', 'category': 'WORK_OF_ART'}, {'entity': 'Item 8. Financial Statements—Note 10. Financial Instruments and Fair Value Measurements', 'category': 'WORK_OF_ART'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': '84', 'category': 'CARDINAL'}, {'entity': '151', 'category': 'CARDINAL'}, {'entity': '36', 'category': 'CARDINAL'}, {'entity': '549', 'category': 'CARDINAL'}, {'entity': '273', 'category': 'CARDINAL'}, {'entity': '14', 'category': 'CARDINAL'}, {'entity': '84', 'category': 'CARDINAL'}, {'entity': '151', 'category': 'CARDINAL'}, {'entity': '326', 'category': 'CARDINAL'}, {'entity': '96', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '9', 'category': 'CARDINAL'}, {'entity': '16', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '105', 'category': 'CARDINAL'}, {'entity': '16', 'category': 'CARDINAL'}, {'entity': '1,679', 'category': 'CARDINAL'}, {'entity': '278', 'category': 'CARDINAL'}, {'entity': '16', 'category': 'CARDINAL'}, {'entity': '160', 'category': 'CARDINAL'}, {'entity': '343', 'category': 'CARDINAL'}, {'entity': '1,883', 'category': 'CARDINAL'}, {'entity': '621', 'category': 'CARDINAL'}, {'entity': '16', 'category': 'CARDINAL'}, {'entity': '115', 'category': 'CARDINAL'}, {'entity': '163', 'category': 'CARDINAL'}, {'entity': '226', 'category': 'CARDINAL'}, {'entity': '187', 'category': 'CARDINAL'}, {'entity': '559', 'category': 'CARDINAL'}, {'entity': '160', 'category': 'CARDINAL'}, {'entity': '877', 'category': 'CARDINAL'}, {'entity': '161', 'category': 'CARDINAL'}, {'entity': '123', 'category': 'CARDINAL'}, {'entity': '72', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '158', 'category': 'CARDINAL'}, {'entity': '27', 'category': 'CARDINAL'}, {'entity': '23', 'category': 'CARDINAL'}, {'entity': '13', 'category': 'CARDINAL'}, {'entity': '11', 'category': 'CARDINAL'}, {'entity': '180', 'category': 'CARDINAL'}, {'entity': '316', 'category': 'CARDINAL'}, {'entity': '626', 'category': 'CARDINAL'}, {'entity': '340', 'category': 'CARDINAL'}, {'entity': '2,293', 'category': 'CARDINAL'}, {'entity': '1,503', 'category': 'CARDINAL'}, {'entity': '698', 'category': 'CARDINAL'}, {'entity': '480', 'category': 'CARDINAL'}, {'entity': '545', 'category': 'CARDINAL'}, {'entity': '242', 'category': 'CARDINAL'}, {'entity': '480', 'category': 'CARDINAL'}, {'entity': '422', 'category': 'CARDINAL'}, {'entity': '242', 'category': 'CARDINAL'}, {'entity': '1,813', 'category': 'CARDINAL'}, {'entity': '1,081', 'category': 'CARDINAL'}, {'entity': '456', 'category': 'CARDINAL'}, {'entity': '16', 'category': 'CARDINAL'}, {'entity': '1,565', 'category': 'CARDINAL'}, {'entity': '2,004', 'category': 'CARDINAL'}, {'entity': '2,563', 'category': 'CARDINAL'}, {'entity': '1,813', 'category': 'CARDINAL'}, {'entity': '1,081', 'category': 'CARDINAL'}, {'entity': '456', 'category': 'CARDINAL'}, {'entity': '3,378', 'category': 'CARDINAL'}, {'entity': '3,085', 'category': 'CARDINAL'}, {'entity': '3,019', 'category': 'CARDINAL'}, {'entity': '1,679', 'category': 'CARDINAL'}, {'entity': '1,670', 'category': 'CARDINAL'}, {'entity': '1,662', 'category': 'CARDINAL'}, {'entity': '0.93', 'category': 'CARDINAL'}, {'entity': '1.20', 'category': 'CARDINAL'}, {'entity': '1.54', 'category': 'CARDINAL'}, {'entity': '1.08', 'category': 'CARDINAL'}, {'entity': '0.65', 'category': 'CARDINAL'}, {'entity': '0.28', 'category': 'CARDINAL'}, {'entity': '2.01', 'category': 'CARDINAL'}, {'entity': '1.85', 'category': 'CARDINAL'}, {'entity': '1.82', 'category': 'CARDINAL'}, {'entity': '2,385', 'category': 'CARDINAL'}, {'entity': '5,571', 'category': 'CARDINAL'}, {'entity': '1,885', 'category': 'CARDINAL'}, {'entity': '1,864', 'category': 'CARDINAL'}, {'entity': '4,660', 'category': 'CARDINAL'}, {'entity': '4,408', 'category': 'CARDINAL'}, {'entity': '8,930', 'category': 'CARDINAL'}, {'entity': '11,843', 'category': 'CARDINAL'}, {'entity': '139', 'category': 'CARDINAL'}, {'entity': '590', 'category': 'CARDINAL'}, {'entity': '6,550', 'category': 'CARDINAL'}, {'entity': '7,242', 'category': 'CARDINAL'}, {'entity': '2,241', 'category': 'CARDINAL'}, {'entity': '4,011', 'category': 'CARDINAL'}, {'entity': '1.7', 'category': 'CARDINAL'}, {'entity': '7.2', 'category': 'CARDINAL'}, {'entity': '1.3', 'category': 'CARDINAL'}, {'entity': '2.0', 'category': 'CARDINAL'}, {'entity': '254', 'category': 'CARDINAL'}, {'entity': '0.16', 'category': 'CARDINAL'}, {'entity': '755', 'category': 'CARDINAL'}, {'entity': '2.5', 'category': 'CARDINAL'}, {'entity': '2.4', 'category': 'CARDINAL'}, {'entity': '2.3', 'category': 'CARDINAL'}, {'entity': '800', 'category': 'CARDINAL'}, {'entity': '500', 'category': 'CARDINAL'}, {'entity': '500', 'category': 'CARDINAL'}, {'entity': '1.3', 'category': 'CARDINAL'}, {'entity': '1.0', 'category': 'CARDINAL'}, {'entity': '2019', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '2015', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  17\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWWXvyw3HWimyes90sKH68V00ls6\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701570569,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#476 million#454 million#509 million#358 million#522 million#1,832#3,148#3,545#1,572#1,216#572#3,351#2,437#1,068#1.3 billion#700 million#600 million#400 million#397 million#600 million#485 million#400 million#44#2.8 billion#2.9 billion#700 million#3.6 billion#800 million#200 million#300 million#1.3 billion#175 million#1.8 billion#3.5 billion#1.6 billion#175 million#914 million#700 million#1.4 billion#1.6 billion#676 million#892 million#288 million#564 million#433 million#139#6,339#750#500#5,089#4,308#187#194#192#186#185#3,364#822#134#111#99#78#62#338#2,809#1,226#491#381#284#228#199#75#75#480#101#33#31#263#14,972#1,761#1,647#724#1,081#506#9,253\\nDATE#2015#2014#2013#April 2015\\nEVENT#\\nFAC#\\nGPE#Italy#Portugal#Spain#Japan#Europe#EU\\nLANGUAGE#\\nLAW#\\nLOC#\\nMONEY#$476 million#$454 million#$509 million#$358 million#$522 million\\nNORP#European\\nORDINAL#first\\nORG#Moody's Investors Service#Standard & Poor's#Fitch#Reckitt#Flexus#Cardioxyl#iPierian\\nPERCENT#\\nPERSON#BMS\\nPRODUCT#Abilify\\nQUANTITY#\\nTIME#\\nWORK_OF_ART#}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2430,\n",
      "    \"completion_tokens\": 396,\n",
      "    \"total_tokens\": 2826\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': 'April 2015', 'category': 'DATE'}, {'entity': 'Italy', 'category': 'GPE'}, {'entity': 'Portugal', 'category': 'GPE'}, {'entity': 'Spain', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'Europe', 'category': 'GPE'}, {'entity': 'EU', 'category': 'GPE'}, {'entity': '$476 million', 'category': 'MONEY'}, {'entity': '$454 million', 'category': 'MONEY'}, {'entity': '$509 million', 'category': 'MONEY'}, {'entity': '$358 million', 'category': 'MONEY'}, {'entity': '$522 million', 'category': 'MONEY'}, {'entity': 'European', 'category': 'NORP'}, {'entity': 'Moodys Investors Service', 'category': 'ORG'}, {'entity': 'Standard & Poors', 'category': 'ORG'}, {'entity': 'Fitch', 'category': 'ORG'}, {'entity': 'Reckitt', 'category': 'ORG'}, {'entity': 'Flexus', 'category': 'ORG'}, {'entity': 'Cardioxyl', 'category': 'ORG'}, {'entity': 'iPierian', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'PERSON'}, {'entity': 'Abilify', 'category': 'PRODUCT'}, {'entity': '', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '476 million', 'category': 'CARDINAL'}, {'entity': '454 million', 'category': 'CARDINAL'}, {'entity': '509 million', 'category': 'CARDINAL'}, {'entity': '358 million', 'category': 'CARDINAL'}, {'entity': '522 million', 'category': 'CARDINAL'}, {'entity': '1,832', 'category': 'CARDINAL'}, {'entity': '3,148', 'category': 'CARDINAL'}, {'entity': '3,545', 'category': 'CARDINAL'}, {'entity': '1,572', 'category': 'CARDINAL'}, {'entity': '1,216', 'category': 'CARDINAL'}, {'entity': '572', 'category': 'CARDINAL'}, {'entity': '3,351', 'category': 'CARDINAL'}, {'entity': '2,437', 'category': 'CARDINAL'}, {'entity': '1,068', 'category': 'CARDINAL'}, {'entity': '1.3 billion', 'category': 'CARDINAL'}, {'entity': '700 million', 'category': 'CARDINAL'}, {'entity': '600 million', 'category': 'CARDINAL'}, {'entity': '400 million', 'category': 'CARDINAL'}, {'entity': '397 million', 'category': 'CARDINAL'}, {'entity': '600 million', 'category': 'CARDINAL'}, {'entity': '485 million', 'category': 'CARDINAL'}, {'entity': '400 million', 'category': 'CARDINAL'}, {'entity': '44', 'category': 'CARDINAL'}, {'entity': '2.8 billion', 'category': 'CARDINAL'}, {'entity': '2.9 billion', 'category': 'CARDINAL'}, {'entity': '700 million', 'category': 'CARDINAL'}, {'entity': '3.6 billion', 'category': 'CARDINAL'}, {'entity': '800 million', 'category': 'CARDINAL'}, {'entity': '200 million', 'category': 'CARDINAL'}, {'entity': '300 million', 'category': 'CARDINAL'}, {'entity': '1.3 billion', 'category': 'CARDINAL'}, {'entity': '175 million', 'category': 'CARDINAL'}, {'entity': '1.8 billion', 'category': 'CARDINAL'}, {'entity': '3.5 billion', 'category': 'CARDINAL'}, {'entity': '1.6 billion', 'category': 'CARDINAL'}, {'entity': '175 million', 'category': 'CARDINAL'}, {'entity': '914 million', 'category': 'CARDINAL'}, {'entity': '700 million', 'category': 'CARDINAL'}, {'entity': '1.4 billion', 'category': 'CARDINAL'}, {'entity': '1.6 billion', 'category': 'CARDINAL'}, {'entity': '676 million', 'category': 'CARDINAL'}, {'entity': '892 million', 'category': 'CARDINAL'}, {'entity': '288 million', 'category': 'CARDINAL'}, {'entity': '564 million', 'category': 'CARDINAL'}, {'entity': '433 million', 'category': 'CARDINAL'}, {'entity': '139', 'category': 'CARDINAL'}, {'entity': '6,339', 'category': 'CARDINAL'}, {'entity': '750', 'category': 'CARDINAL'}, {'entity': '500', 'category': 'CARDINAL'}, {'entity': '5,089', 'category': 'CARDINAL'}, {'entity': '4,308', 'category': 'CARDINAL'}, {'entity': '187', 'category': 'CARDINAL'}, {'entity': '194', 'category': 'CARDINAL'}, {'entity': '192', 'category': 'CARDINAL'}, {'entity': '186', 'category': 'CARDINAL'}, {'entity': '185', 'category': 'CARDINAL'}, {'entity': '3,364', 'category': 'CARDINAL'}, {'entity': '822', 'category': 'CARDINAL'}, {'entity': '134', 'category': 'CARDINAL'}, {'entity': '111', 'category': 'CARDINAL'}, {'entity': '99', 'category': 'CARDINAL'}, {'entity': '78', 'category': 'CARDINAL'}, {'entity': '62', 'category': 'CARDINAL'}, {'entity': '338', 'category': 'CARDINAL'}, {'entity': '2,809', 'category': 'CARDINAL'}, {'entity': '1,226', 'category': 'CARDINAL'}, {'entity': '491', 'category': 'CARDINAL'}, {'entity': '381', 'category': 'CARDINAL'}, {'entity': '284', 'category': 'CARDINAL'}, {'entity': '228', 'category': 'CARDINAL'}, {'entity': '199', 'category': 'CARDINAL'}, {'entity': '75', 'category': 'CARDINAL'}, {'entity': '75', 'category': 'CARDINAL'}, {'entity': '480', 'category': 'CARDINAL'}, {'entity': '101', 'category': 'CARDINAL'}, {'entity': '33', 'category': 'CARDINAL'}, {'entity': '31', 'category': 'CARDINAL'}, {'entity': '263', 'category': 'CARDINAL'}, {'entity': '14,972', 'category': 'CARDINAL'}, {'entity': '1,761', 'category': 'CARDINAL'}, {'entity': '1,647', 'category': 'CARDINAL'}, {'entity': '724', 'category': 'CARDINAL'}, {'entity': '1,081', 'category': 'CARDINAL'}, {'entity': '506', 'category': 'CARDINAL'}, {'entity': '9,253', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  17\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWX8ztTVZKKGwuSZbEXiZVsiks6G\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701570606,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#2.6 billion#6.7 billion#2.3 billion#100%#95%#300 million#2014#2015 \\n\\nDATE#August 4, 2004#October 2015\\n\\nLAW#Foreign Corrupt Practices Act\\n\\nMONEY#$2.6 billion#$6.7 billion#$2.3 billion#$14.7 million#$300 million\\n\\nORG#SEC#BMS\\n\\nPERCENT#100%#95%\\n\\nTIME#weekly#two-year\\n\\nWORK_OF_ART#Item 8. Financial Statements\\u2014Note 3. Alliances#Item 8. Financial Statements\\u2014Note 8. Income Taxes#Item 8. Financial Statements\\u2014Note 10. Financial Instruments and Fair Value Measurements#Item 8. Financial Statements\\u2014Note 19. Pension, Postretirement and Postemployment Liabilities#Item 8. Financial Statements\\u2014Note 21. Leases#Item 8. Financial Statements\\u2014Note 1. Accounting Policies\\u2014Recently Issued Accounting Standards\\n\\n}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2045,\n",
      "    \"completion_tokens\": 213,\n",
      "    \"total_tokens\": 2258\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'August 4, 2004', 'category': 'DATE'}, {'entity': 'October 2015', 'category': 'DATE'}, {'entity': 'Foreign Corrupt Practices Act', 'category': 'LAW'}, {'entity': '$2.6 billion', 'category': 'MONEY'}, {'entity': '$6.7 billion', 'category': 'MONEY'}, {'entity': '$2.3 billion', 'category': 'MONEY'}, {'entity': '$14.7 million', 'category': 'MONEY'}, {'entity': '$300 million', 'category': 'MONEY'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': '100%', 'category': 'PERCENT'}, {'entity': '95%', 'category': 'PERCENT'}, {'entity': 'weekly', 'category': 'TIME'}, {'entity': 'two-year', 'category': 'TIME'}, {'entity': 'Item 8. Financial Statements—Note 3. Alliances', 'category': 'WORK_OF_ART'}, {'entity': 'Item 8. Financial Statements—Note 8. Income Taxes', 'category': 'WORK_OF_ART'}, {'entity': 'Item 8. Financial Statements—Note 10. Financial Instruments and Fair Value Measurements', 'category': 'WORK_OF_ART'}, {'entity': 'Item 8. Financial Statements—Note 19. Pension, Postretirement and Postemployment Liabilities', 'category': 'WORK_OF_ART'}, {'entity': 'Item 8. Financial Statements—Note 21. Leases', 'category': 'WORK_OF_ART'}, {'entity': 'Item 8. Financial Statements—Note 1. Accounting Policies—Recently Issued Accounting Standards', 'category': 'WORK_OF_ART'}, {'entity': '2.6 billion', 'category': 'CARDINAL'}, {'entity': '6.7 billion', 'category': 'CARDINAL'}, {'entity': '2.3 billion', 'category': 'CARDINAL'}, {'entity': '100%', 'category': 'CARDINAL'}, {'entity': '95%', 'category': 'CARDINAL'}, {'entity': '300 million', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2015', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  17\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWXepqzlorTHMsvxpq6ApnQSuxJF\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701570638,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#2#1#1#50%#1#2#1#1#2#1#4.0%#4.2%#1%#1%#1.0 billion#600 million\\n\\nDATE#December 31, 2015#September 30, 2014#2015#2015\\n\\nEVENT#Society of Actuaries\\n\\nFAC#\\n\\nGPE#U.S.\\n\\nLAW#\\\"340B Drug Pricing Program\\n\\nMONEY#$9 million\\n\\nNORP#\\n\\nORG#U.S. Department of Defense#U.S. Department of Veterans Affairs#Medicaid#Medicare#Centers for Medicare & Medicaid Services#Medicare Part D#Citigroup\\n\\nPERCENT#\\n\\nPERSON#\\n\\nPRODUCT#\\n\\nQUANTITY#\\n\\nTIME#twelve months#one month#six months\\n\\nWORK_OF_ART#}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2039,\n",
      "    \"completion_tokens\": 176,\n",
      "    \"total_tokens\": 2215\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'September 30, 2014', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': 'Society of Actuaries', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '\"340B Drug Pricing Program', 'category': 'LAW'}, {'entity': '$9 million', 'category': 'MONEY'}, {'entity': 'U.S. Department of Defense', 'category': 'ORG'}, {'entity': 'U.S. Department of Veterans Affairs', 'category': 'ORG'}, {'entity': 'Medicaid', 'category': 'ORG'}, {'entity': 'Medicare', 'category': 'ORG'}, {'entity': 'Centers for Medicare & Medicaid Services', 'category': 'ORG'}, {'entity': 'Medicare Part D', 'category': 'ORG'}, {'entity': 'Citigroup', 'category': 'ORG'}, {'entity': 'twelve months', 'category': 'TIME'}, {'entity': 'one month', 'category': 'TIME'}, {'entity': 'six months', 'category': 'TIME'}, {'entity': '', 'category': 'WORK_OF_ART'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '50%', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '4.0%', 'category': 'CARDINAL'}, {'entity': '4.2%', 'category': 'CARDINAL'}, {'entity': '1%', 'category': 'CARDINAL'}, {'entity': '1%', 'category': 'CARDINAL'}, {'entity': '1.0 billion', 'category': 'CARDINAL'}, {'entity': '600 million', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  17\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWYBCOTrtzxCvyb1RS9K8pr0y48g\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701570671,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#1%#26%#73#600 \\n\\nDATE#2015#2014\\n\\nEVENT#Cardioxyl and Flexus acquisition#iPierian acquisition#Erbitux divestiture#Ixempra divestiture#alliances with The Medicines Company and Valeant Pharmaceuticals International, Inc.#divestiture of diabetes business to AstraZeneca\\n\\nFAC#ASC 805 - Business Combinations\\n\\nGPE#U.S.\\n\\nMONEY#$39 million#$8.3 billion#$1.4 billion#$266 million#$758 million#$275 million#$120 million#$160 million#$343 million#$310 million#$115 million#$151 million#$36 million\\n\\nORG#AstraZeneca PLC#BMS\\n\\nPERSON#Promedior\\n\\nPRODUCT#BMS-986020#peginterferon lambda#IPRD#Erbitux#Ixempra\\n\\nWORK_OF_ART#\\u201cItem 8. Financial Statements\\u2014Note 19. Pension, Postretirement and Postemployment Liabilities.\\u201d#\\\\\\\"Item 8. Financial Statements\\u2014Note 4. Acquisitions and Other Divestitures\\\\\\\"#\\\\\\\"Item 8. Financial Statements\\u2014Note 3. Alliances\\\\\\\"#\\u201cItem 8. Financial Statements\\u2014Note 14. Goodwill and Other Intangible Assets.\\\\\\\"#\\u201cItem 8. Financial Statements\\u2014Note 1. Accounting Policies\\u2014Contingencies,\\u201d \\u201c\\u2014Note 8. Income Taxes\\u201d and \\u201c\\u2014Note 22. Legal Proceedings and Contingencies.\\u201d}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2141,\n",
      "    \"completion_tokens\": 313,\n",
      "    \"total_tokens\": 2454\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': 'Cardioxyl and Flexus acquisition', 'category': 'EVENT'}, {'entity': 'iPierian acquisition', 'category': 'EVENT'}, {'entity': 'Erbitux divestiture', 'category': 'EVENT'}, {'entity': 'Ixempra divestiture', 'category': 'EVENT'}, {'entity': 'alliances with The Medicines Company and Valeant Pharmaceuticals International, Inc.', 'category': 'EVENT'}, {'entity': 'divestiture of diabetes business to AstraZeneca', 'category': 'EVENT'}, {'entity': 'ASC 805 - Business Combinations', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '$39 million', 'category': 'MONEY'}, {'entity': '$8.3 billion', 'category': 'MONEY'}, {'entity': '$1.4 billion', 'category': 'MONEY'}, {'entity': '$266 million', 'category': 'MONEY'}, {'entity': '$758 million', 'category': 'MONEY'}, {'entity': '$275 million', 'category': 'MONEY'}, {'entity': '$120 million', 'category': 'MONEY'}, {'entity': '$160 million', 'category': 'MONEY'}, {'entity': '$343 million', 'category': 'MONEY'}, {'entity': '$310 million', 'category': 'MONEY'}, {'entity': '$115 million', 'category': 'MONEY'}, {'entity': '$151 million', 'category': 'MONEY'}, {'entity': '$36 million', 'category': 'MONEY'}, {'entity': 'AstraZeneca PLC', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Promedior', 'category': 'PERSON'}, {'entity': 'BMS-986020', 'category': 'PRODUCT'}, {'entity': 'peginterferon lambda', 'category': 'PRODUCT'}, {'entity': 'IPRD', 'category': 'PRODUCT'}, {'entity': 'Erbitux', 'category': 'PRODUCT'}, {'entity': 'Ixempra', 'category': 'PRODUCT'}, {'entity': '“Item 8. Financial Statements—Note 19. Pension, Postretirement and Postemployment Liabilities.”', 'category': 'WORK_OF_ART'}, {'entity': '\\\\\"Item 8. Financial Statements—Note 4. Acquisitions and Other Divestitures\\\\\"', 'category': 'WORK_OF_ART'}, {'entity': '\\\\\"Item 8. Financial Statements—Note 3. Alliances\\\\\"', 'category': 'WORK_OF_ART'}, {'entity': '“Item 8. Financial Statements—Note 14. Goodwill and Other Intangible Assets.\\\\\"', 'category': 'WORK_OF_ART'}, {'entity': '“Item 8. Financial Statements—Note 1. Accounting Policies—Contingencies,” “—Note 8. Income Taxes” and “—Note 22. Legal Proceedings and Contingencies.”', 'category': 'WORK_OF_ART'}, {'entity': '1%', 'category': 'CARDINAL'}, {'entity': '26%', 'category': 'CARDINAL'}, {'entity': '73', 'category': 'CARDINAL'}, {'entity': '600', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  17\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWYl5ZDidHC5M26xrOYDAlkcpbzS\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701570707,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#4.1 billion#3.5 billion#3.8 billion#4.3 billion#146 million#27 million#6 million#244 million#123 million#30-45%#10%\\n\\nDATE#December 31, 2015#December 31, 2014#December 31, 2015#2022#2017#2009#2014#2008 through 2014#January 2016#January 2016#January 2016\\n\\nEVENT#Mead Johnson Nutrition Company (Mead Johnson) split-off#exchange offer#IPO\\n\\nFAC#\\n\\nGPE#U.S.\\n\\nLOC#\\n\\nMONEY#\\n\\nNORP#U.S. Federal\\n\\nORDINAL#\\n\\nORG#Mead Johnson#Mead Johnson & Company#Internal Revenue Service#Mead Johnson Class B#IRS\\n\\nPERCENT#\\n\\nPERSON#\\n\\nPRODUCT#Opdivo#Yervoy\\n\\nQUANTITY#\\n\\nTIME#four year\\n\\nWORK_OF_ART#CheckMate-067 trial\\n\\nLAW#Internal Revenue Code\\n\\nLANGUAGE#}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2178,\n",
      "    \"completion_tokens\": 220,\n",
      "    \"total_tokens\": 2398\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'December 31, 2014', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': '2009', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2008 through 2014', 'category': 'DATE'}, {'entity': 'January 2016', 'category': 'DATE'}, {'entity': 'January 2016', 'category': 'DATE'}, {'entity': 'January 2016', 'category': 'DATE'}, {'entity': 'Mead Johnson Nutrition Company Mead Johnson split-off', 'category': 'EVENT'}, {'entity': 'exchange offer', 'category': 'EVENT'}, {'entity': 'IPO', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '', 'category': 'LANGUAGE'}, {'entity': 'Internal Revenue Code', 'category': 'LAW'}, {'entity': 'U.S. Federal', 'category': 'NORP'}, {'entity': 'Mead Johnson', 'category': 'ORG'}, {'entity': 'Mead Johnson & Company', 'category': 'ORG'}, {'entity': 'Internal Revenue Service', 'category': 'ORG'}, {'entity': 'Mead Johnson Class B', 'category': 'ORG'}, {'entity': 'IRS', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Yervoy', 'category': 'PRODUCT'}, {'entity': 'four year', 'category': 'TIME'}, {'entity': 'CheckMate-067 trial', 'category': 'WORK_OF_ART'}, {'entity': '4.1 billion', 'category': 'CARDINAL'}, {'entity': '3.5 billion', 'category': 'CARDINAL'}, {'entity': '3.8 billion', 'category': 'CARDINAL'}, {'entity': '4.3 billion', 'category': 'CARDINAL'}, {'entity': '146 million', 'category': 'CARDINAL'}, {'entity': '27 million', 'category': 'CARDINAL'}, {'entity': '6 million', 'category': 'CARDINAL'}, {'entity': '244 million', 'category': 'CARDINAL'}, {'entity': '123 million', 'category': 'CARDINAL'}, {'entity': '30-45%', 'category': 'CARDINAL'}, {'entity': '10%', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  17\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWZKkI1P1wCNz1RPbKR2zgXoWBxE\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701570742,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#57.7#26.7#68#11.5#6.9#2.9#58#43#74#95.5#82.1#86.2#61#11#22#39#13#6.2#16.6#4.9#10.6 \\n\\nDATE#November 2015#September 2015#July 2015#June 2015#May 2015#April 2015#December 2015#October 2015#18 month\\n\\nEVENT#CheckMate-066#Study 004#CheckMate-067#CheckMate-069 \\n\\nFAC#European Commission \\n\\nGPE#Japan#Europe \\n\\nLAW#European Marketing Authorization Application \\n\\nMONEY#0.42#0.57 \\n\\nORG#FDA#Company#Ono#BMS#Opdivo European Marketing Authorization#Yervoy#Nivolumab BMS#EMA#EC \\n\\nPERCENT#99.5% \\n\\nPERSON#Phase III#the European Medicines Agency#the European Commission \\n\\nPRODUCT#Opdivo#BRAF V600 wild-type unresectable #metastatic melanoma#tumor response rate#Opdivo+Yervoy regimen#CheckMate-063#Opdivo monotherapy#Yervoy monotherapy#Opdivo+Yervoy#Opdivo European Marketing Authorization Application#Opdivo in Japan#Nivolumab BMS#SQ NSCLC#NFC NSCLC#Opdivo+Yervoy arms#CheckMate-012 \\n\\nWORK_OF_ART#CheckMate-067#CheckMate-069 \\n\\nQUANTITY#28 Member\\n\\nTIME#two years#three-year#99.5% CI#95.5% CI#0.42#0.57}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2524,\n",
      "    \"completion_tokens\": 381,\n",
      "    \"total_tokens\": 2905\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'November 2015', 'category': 'DATE'}, {'entity': 'September 2015', 'category': 'DATE'}, {'entity': 'July 2015', 'category': 'DATE'}, {'entity': 'June 2015', 'category': 'DATE'}, {'entity': 'May 2015', 'category': 'DATE'}, {'entity': 'April 2015', 'category': 'DATE'}, {'entity': 'December 2015', 'category': 'DATE'}, {'entity': 'October 2015', 'category': 'DATE'}, {'entity': '18 month', 'category': 'DATE'}, {'entity': 'CheckMate-066', 'category': 'EVENT'}, {'entity': 'Study 004', 'category': 'EVENT'}, {'entity': 'CheckMate-067', 'category': 'EVENT'}, {'entity': 'CheckMate-069', 'category': 'EVENT'}, {'entity': 'European Commission', 'category': 'FAC'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'Europe', 'category': 'GPE'}, {'entity': 'European Marketing Authorization Application', 'category': 'LAW'}, {'entity': '0.42', 'category': 'MONEY'}, {'entity': '0.57', 'category': 'MONEY'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'Company', 'category': 'ORG'}, {'entity': 'Ono', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Opdivo European Marketing Authorization', 'category': 'ORG'}, {'entity': 'Yervoy', 'category': 'ORG'}, {'entity': 'Nivolumab BMS', 'category': 'ORG'}, {'entity': 'EMA', 'category': 'ORG'}, {'entity': 'EC', 'category': 'ORG'}, {'entity': '99.5%', 'category': 'PERCENT'}, {'entity': 'Phase III', 'category': 'PERSON'}, {'entity': 'the European Medicines Agency', 'category': 'PERSON'}, {'entity': 'the European Commission', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'BRAF V600 wild-type unresectable', 'category': 'PRODUCT'}, {'entity': 'metastatic melanoma', 'category': 'PRODUCT'}, {'entity': 'tumor response rate', 'category': 'PRODUCT'}, {'entity': 'Opdivo+Yervoy regimen', 'category': 'PRODUCT'}, {'entity': 'CheckMate-063', 'category': 'PRODUCT'}, {'entity': 'Opdivo monotherapy', 'category': 'PRODUCT'}, {'entity': 'Yervoy monotherapy', 'category': 'PRODUCT'}, {'entity': 'Opdivo+Yervoy', 'category': 'PRODUCT'}, {'entity': 'Opdivo European Marketing Authorization Application', 'category': 'PRODUCT'}, {'entity': 'Opdivo in Japan', 'category': 'PRODUCT'}, {'entity': 'Nivolumab BMS', 'category': 'PRODUCT'}, {'entity': 'SQ NSCLC', 'category': 'PRODUCT'}, {'entity': 'NFC NSCLC', 'category': 'PRODUCT'}, {'entity': 'Opdivo+Yervoy arms', 'category': 'PRODUCT'}, {'entity': 'CheckMate-012', 'category': 'PRODUCT'}, {'entity': '28 Member', 'category': 'QUANTITY'}, {'entity': 'two years', 'category': 'TIME'}, {'entity': 'three-year', 'category': 'TIME'}, {'entity': '99.5% CI', 'category': 'TIME'}, {'entity': '95.5% CI', 'category': 'TIME'}, {'entity': '0.42', 'category': 'TIME'}, {'entity': '0.57', 'category': 'TIME'}, {'entity': 'CheckMate-067', 'category': 'WORK_OF_ART'}, {'entity': 'CheckMate-069', 'category': 'WORK_OF_ART'}, {'entity': '57.7', 'category': 'CARDINAL'}, {'entity': '26.7', 'category': 'CARDINAL'}, {'entity': '68', 'category': 'CARDINAL'}, {'entity': '11.5', 'category': 'CARDINAL'}, {'entity': '6.9', 'category': 'CARDINAL'}, {'entity': '2.9', 'category': 'CARDINAL'}, {'entity': '58', 'category': 'CARDINAL'}, {'entity': '43', 'category': 'CARDINAL'}, {'entity': '74', 'category': 'CARDINAL'}, {'entity': '95.5', 'category': 'CARDINAL'}, {'entity': '82.1', 'category': 'CARDINAL'}, {'entity': '86.2', 'category': 'CARDINAL'}, {'entity': '61', 'category': 'CARDINAL'}, {'entity': '11', 'category': 'CARDINAL'}, {'entity': '22', 'category': 'CARDINAL'}, {'entity': '39', 'category': 'CARDINAL'}, {'entity': '13', 'category': 'CARDINAL'}, {'entity': '6.2', 'category': 'CARDINAL'}, {'entity': '16.6', 'category': 'CARDINAL'}, {'entity': '4.9', 'category': 'CARDINAL'}, {'entity': '10.6', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  17\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWZxiOjt7KMAtZtPjcQ1NIqpxcCZ\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701570781,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#3#10#42#24#9.2#6#41#0.59#95#0.44-0.79#0.00025#27#28#0.73#96#0.59-0.89#0.0015#10#54#0.59#95#0.44#0.79#0.00025#9.2#6#25#19.6#62#12#0.73#95#0.60#0.89#0.0014#0.70#95#0.57#0.85#0.0004#70#95#0.57#0.85#0.0004#30#68#57#41#27#79#74#83#66#60#71#1.9#1.4#2.8#0.0002\\n\\nDATE#September 2015#July 2015#July 2015#May 2015#May 2015#March 2015#November 2015#November 2015#September 2015#July 2015#May 2015#January 2016#December 2015#November 2015#June 2015\\n\\nEVENT#CheckMate-017#CheckMate-063#Phase III CheckMate-057 study#Checkmate-057#CheckMate-025#CheckMate-025#CA209-040#ELOQUENT-2\\n\\nFAC#EMA\\n\\nGPE#EU\\n\\nLOC#tumor types\\n\\nMONEY#\\n\\nNORP#\\n\\nORDINAL#first\\n\\nORG#Opdivo Yervoy cohorts#Company#EMA#EC#Nivolumab BMS#FDA#EMA#RCC#CheckMate-025#EMA#RCC #Company#AbbVie Inc. (AbbVie)#Committee for Medicinal Products for Human Use (CHMP)#EC#FDA#Company#AbbVie#ELOQUENT-2#FDA#Company#AbbVie#ELOQUENT-2\\n\\nPERCENT#27%#28%#27%#95%#54%#95%#95%#10%#96%#62%#74%#83%#66%#71%\\n\\nPERSON#\\n\\nPRODUCT#Opdivo#Opdivo#CheckMate-017#CheckMate-063#Opdivo#Opdivo#Opdivo#Opdivo#Opdivo#Opdivo#Opdivo#Opdivo#Opdivo#Opdivo#Opdivo#everolimus#Opdivo#Opdivo#Opdivo#Empliciti#Empliciti#Empliciti#Empliciti#Empliciti#Empliciti#Empliciti#Empliciti#Empliciti#Empliciti\\n\\nQUANTITY#\\n\\nTIME#\\n\\nWORK_OF_ART#hepatocellular carcinoma (HCC)}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2615,\n",
      "    \"completion_tokens\": 628,\n",
      "    \"total_tokens\": 3243\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'September 2015', 'category': 'DATE'}, {'entity': 'July 2015', 'category': 'DATE'}, {'entity': 'July 2015', 'category': 'DATE'}, {'entity': 'May 2015', 'category': 'DATE'}, {'entity': 'May 2015', 'category': 'DATE'}, {'entity': 'March 2015', 'category': 'DATE'}, {'entity': 'November 2015', 'category': 'DATE'}, {'entity': 'November 2015', 'category': 'DATE'}, {'entity': 'September 2015', 'category': 'DATE'}, {'entity': 'July 2015', 'category': 'DATE'}, {'entity': 'May 2015', 'category': 'DATE'}, {'entity': 'January 2016', 'category': 'DATE'}, {'entity': 'December 2015', 'category': 'DATE'}, {'entity': 'November 2015', 'category': 'DATE'}, {'entity': 'June 2015', 'category': 'DATE'}, {'entity': 'CheckMate-017', 'category': 'EVENT'}, {'entity': 'CheckMate-063', 'category': 'EVENT'}, {'entity': 'Phase III CheckMate-057 study', 'category': 'EVENT'}, {'entity': 'Checkmate-057', 'category': 'EVENT'}, {'entity': 'CheckMate-025', 'category': 'EVENT'}, {'entity': 'CheckMate-025', 'category': 'EVENT'}, {'entity': 'CA209-040', 'category': 'EVENT'}, {'entity': 'ELOQUENT-2', 'category': 'EVENT'}, {'entity': 'EMA', 'category': 'FAC'}, {'entity': 'EU', 'category': 'GPE'}, {'entity': 'tumor types', 'category': 'LOC'}, {'entity': 'Opdivo Yervoy cohorts', 'category': 'ORG'}, {'entity': 'Company', 'category': 'ORG'}, {'entity': 'EMA', 'category': 'ORG'}, {'entity': 'EC', 'category': 'ORG'}, {'entity': 'Nivolumab BMS', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'EMA', 'category': 'ORG'}, {'entity': 'RCC', 'category': 'ORG'}, {'entity': 'CheckMate-025', 'category': 'ORG'}, {'entity': 'EMA', 'category': 'ORG'}, {'entity': 'RCC', 'category': 'ORG'}, {'entity': 'Company', 'category': 'ORG'}, {'entity': 'AbbVie Inc. AbbVie', 'category': 'ORG'}, {'entity': 'Committee for Medicinal Products for Human Use CHMP', 'category': 'ORG'}, {'entity': 'EC', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'Company', 'category': 'ORG'}, {'entity': 'AbbVie', 'category': 'ORG'}, {'entity': 'ELOQUENT-2', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'Company', 'category': 'ORG'}, {'entity': 'AbbVie', 'category': 'ORG'}, {'entity': 'ELOQUENT-2', 'category': 'ORG'}, {'entity': '27%', 'category': 'PERCENT'}, {'entity': '28%', 'category': 'PERCENT'}, {'entity': '27%', 'category': 'PERCENT'}, {'entity': '95%', 'category': 'PERCENT'}, {'entity': '54%', 'category': 'PERCENT'}, {'entity': '95%', 'category': 'PERCENT'}, {'entity': '95%', 'category': 'PERCENT'}, {'entity': '10%', 'category': 'PERCENT'}, {'entity': '96%', 'category': 'PERCENT'}, {'entity': '62%', 'category': 'PERCENT'}, {'entity': '74%', 'category': 'PERCENT'}, {'entity': '83%', 'category': 'PERCENT'}, {'entity': '66%', 'category': 'PERCENT'}, {'entity': '71%', 'category': 'PERCENT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'CheckMate-017', 'category': 'PRODUCT'}, {'entity': 'CheckMate-063', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'everolimus', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Empliciti', 'category': 'PRODUCT'}, {'entity': 'Empliciti', 'category': 'PRODUCT'}, {'entity': 'Empliciti', 'category': 'PRODUCT'}, {'entity': 'Empliciti', 'category': 'PRODUCT'}, {'entity': 'Empliciti', 'category': 'PRODUCT'}, {'entity': 'Empliciti', 'category': 'PRODUCT'}, {'entity': 'Empliciti', 'category': 'PRODUCT'}, {'entity': 'Empliciti', 'category': 'PRODUCT'}, {'entity': 'Empliciti', 'category': 'PRODUCT'}, {'entity': 'Empliciti', 'category': 'PRODUCT'}, {'entity': 'hepatocellular carcinoma HCC', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '42', 'category': 'CARDINAL'}, {'entity': '24', 'category': 'CARDINAL'}, {'entity': '9.2', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '41', 'category': 'CARDINAL'}, {'entity': '0.59', 'category': 'CARDINAL'}, {'entity': '95', 'category': 'CARDINAL'}, {'entity': '0.44-0.79', 'category': 'CARDINAL'}, {'entity': '0.00025', 'category': 'CARDINAL'}, {'entity': '27', 'category': 'CARDINAL'}, {'entity': '28', 'category': 'CARDINAL'}, {'entity': '0.73', 'category': 'CARDINAL'}, {'entity': '96', 'category': 'CARDINAL'}, {'entity': '0.59-0.89', 'category': 'CARDINAL'}, {'entity': '0.0015', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '54', 'category': 'CARDINAL'}, {'entity': '0.59', 'category': 'CARDINAL'}, {'entity': '95', 'category': 'CARDINAL'}, {'entity': '0.44', 'category': 'CARDINAL'}, {'entity': '0.79', 'category': 'CARDINAL'}, {'entity': '0.00025', 'category': 'CARDINAL'}, {'entity': '9.2', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '25', 'category': 'CARDINAL'}, {'entity': '19.6', 'category': 'CARDINAL'}, {'entity': '62', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '0.73', 'category': 'CARDINAL'}, {'entity': '95', 'category': 'CARDINAL'}, {'entity': '0.60', 'category': 'CARDINAL'}, {'entity': '0.89', 'category': 'CARDINAL'}, {'entity': '0.0014', 'category': 'CARDINAL'}, {'entity': '0.70', 'category': 'CARDINAL'}, {'entity': '95', 'category': 'CARDINAL'}, {'entity': '0.57', 'category': 'CARDINAL'}, {'entity': '0.85', 'category': 'CARDINAL'}, {'entity': '0.0004', 'category': 'CARDINAL'}, {'entity': '70', 'category': 'CARDINAL'}, {'entity': '95', 'category': 'CARDINAL'}, {'entity': '0.57', 'category': 'CARDINAL'}, {'entity': '0.85', 'category': 'CARDINAL'}, {'entity': '0.0004', 'category': 'CARDINAL'}, {'entity': '30', 'category': 'CARDINAL'}, {'entity': '68', 'category': 'CARDINAL'}, {'entity': '57', 'category': 'CARDINAL'}, {'entity': '41', 'category': 'CARDINAL'}, {'entity': '27', 'category': 'CARDINAL'}, {'entity': '79', 'category': 'CARDINAL'}, {'entity': '74', 'category': 'CARDINAL'}, {'entity': '83', 'category': 'CARDINAL'}, {'entity': '66', 'category': 'CARDINAL'}, {'entity': '60', 'category': 'CARDINAL'}, {'entity': '71', 'category': 'CARDINAL'}, {'entity': '1.9', 'category': 'CARDINAL'}, {'entity': '1.4', 'category': 'CARDINAL'}, {'entity': '2.8', 'category': 'CARDINAL'}, {'entity': '0.0002', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  17\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWahomlEJRlJhJmFmzaUhfAG4f9H\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701570827,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#1#3#100%#83%#89%#214,000#100,000#12#16#1#3#4 \\n\\nDATE#August 2015#October 2015#July 2015#January 2016#November 2015#September 2015#May 2015#April 2015#February 2015\\n\\nEVENT#Study-104#Study-095#Study-156#ALLY-3+ trial#ALLY-1#ALLY-2\\n\\nFAC#Philadelphia chromosome\\n\\nGPE#United States#Europe#England#Wales#UK#EU\\n\\nLANGUAGE#Japanese\\n\\nLAW#FDA\\n\\nMONEY# million.\\n\\nORDINAL#first#second\\n\\nORG#Philadelphia#Otsuka Pharmaceutical Co., Ltd#Otsuka#Company#FDA#Gleevec#Hepatitis C Portfolio#Yervoy#Gilead Sciences, Inc.#National Institute for Health and Care Excellence\\n\\nPERCENT#15%\\n\\nPERSON#Mary#Shakespeare#Peter#Lisa\\n\\nPRODUCT#Sprycel#Daklinza#Sunvepra#Beclabuvir\\n\\nTIME#5PM#7PM\\n\\nWORK_OF_ART#Hamlet\\n}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2483,\n",
      "    \"completion_tokens\": 256,\n",
      "    \"total_tokens\": 2739\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'August 2015', 'category': 'DATE'}, {'entity': 'October 2015', 'category': 'DATE'}, {'entity': 'July 2015', 'category': 'DATE'}, {'entity': 'January 2016', 'category': 'DATE'}, {'entity': 'November 2015', 'category': 'DATE'}, {'entity': 'September 2015', 'category': 'DATE'}, {'entity': 'May 2015', 'category': 'DATE'}, {'entity': 'April 2015', 'category': 'DATE'}, {'entity': 'February 2015', 'category': 'DATE'}, {'entity': 'Study-104', 'category': 'EVENT'}, {'entity': 'Study-095', 'category': 'EVENT'}, {'entity': 'Study-156', 'category': 'EVENT'}, {'entity': 'ALLY-3+ trial', 'category': 'EVENT'}, {'entity': 'ALLY-1', 'category': 'EVENT'}, {'entity': 'ALLY-2', 'category': 'EVENT'}, {'entity': 'Philadelphia chromosome', 'category': 'FAC'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'Europe', 'category': 'GPE'}, {'entity': 'England', 'category': 'GPE'}, {'entity': 'Wales', 'category': 'GPE'}, {'entity': 'UK', 'category': 'GPE'}, {'entity': 'EU', 'category': 'GPE'}, {'entity': 'Japanese', 'category': 'LANGUAGE'}, {'entity': 'FDA', 'category': 'LAW'}, {'entity': 'million.', 'category': 'MONEY'}, {'entity': 'Philadelphia', 'category': 'ORG'}, {'entity': 'Otsuka Pharmaceutical Co., Ltd', 'category': 'ORG'}, {'entity': 'Otsuka', 'category': 'ORG'}, {'entity': 'Company', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'Gleevec', 'category': 'ORG'}, {'entity': 'Hepatitis C Portfolio', 'category': 'ORG'}, {'entity': 'Yervoy', 'category': 'ORG'}, {'entity': 'Gilead Sciences, Inc.', 'category': 'ORG'}, {'entity': 'National Institute for Health and Care Excellence', 'category': 'ORG'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': 'Mary', 'category': 'PERSON'}, {'entity': 'Shakespeare', 'category': 'PERSON'}, {'entity': 'Peter', 'category': 'PERSON'}, {'entity': 'Lisa', 'category': 'PERSON'}, {'entity': 'Sprycel', 'category': 'PRODUCT'}, {'entity': 'Daklinza', 'category': 'PRODUCT'}, {'entity': 'Sunvepra', 'category': 'PRODUCT'}, {'entity': 'Beclabuvir', 'category': 'PRODUCT'}, {'entity': '5PM', 'category': 'TIME'}, {'entity': '7PM', 'category': 'TIME'}, {'entity': 'Hamlet', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'second', 'category': 'ORDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '100%', 'category': 'CARDINAL'}, {'entity': '83%', 'category': 'CARDINAL'}, {'entity': '89%', 'category': 'CARDINAL'}, {'entity': '214,000', 'category': 'CARDINAL'}, {'entity': '100,000', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '16', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  17\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWbGLbeBdusr46lAnWV3neKGxMN8\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701570862,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#10%#144 million\\n\\nDATE#December 2015#December 31, 2015#January 2015#June 2015#July 2015#September 2015\\n\\nEVENT#AMPLIFY trial#AVERT and AMPLE trials\\n\\nFAC#\\n\\nGPE#U.S.#EU\\n\\nLANGUAGE#\\n\\nLAW#Section 27A of the Securities Act of 1933#Section 21E of the Securities Exchange Act of 1934#Form 10-K#Item 1A. Risk Factors#Item 7A#Item 8. Financial Statements\\u2014Note 10. Financial Instruments and Fair Value Measurements\\n\\nLOC#\\n\\nMONEY#\\n\\nNORP#Japanese#Chinese#Canadian#South Korean\\n\\nORDINAL#\\n\\nORG#Company#Gilead#Reyataz Franchise#FDA#EC#EMA#AbbVie#Pfizer, Inc.#Securities Act of 1933#Securities Exchange Act of 1934\\n\\nPERCENT#\\n\\nPERSON#\\n\\nPRODUCT#HCV.Reyataz#HIV#Evotaz#atazanavir 300 mg#cobicistat 150 mg#Tybost#Orencia#RA#methotrexate#anti-citrullinated protein antibody#adalimumab#ClickJect Pre-Filled Pen#Eliquis#NVAF#VTE#Phase III AMPLIFY trial#warfarin#AUGUSTUS#Form 10-K\\n\\nQUANTITY#2.0 to 3.0#7, 21 and 90 days\\n\\nTIME#once-daily#\\n\\nWORK_OF_ART#}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2217,\n",
      "    \"completion_tokens\": 340,\n",
      "    \"total_tokens\": 2557\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 2015', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'January 2015', 'category': 'DATE'}, {'entity': 'June 2015', 'category': 'DATE'}, {'entity': 'July 2015', 'category': 'DATE'}, {'entity': 'September 2015', 'category': 'DATE'}, {'entity': 'AMPLIFY trial', 'category': 'EVENT'}, {'entity': 'AVERT and AMPLE trials', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'EU', 'category': 'GPE'}, {'entity': 'Section 27A of the Securities Act of 1933', 'category': 'LAW'}, {'entity': 'Section 21E of the Securities Exchange Act of 1934', 'category': 'LAW'}, {'entity': 'Form 10-K', 'category': 'LAW'}, {'entity': 'Item 1A. Risk Factors', 'category': 'LAW'}, {'entity': 'Item 7A', 'category': 'LAW'}, {'entity': 'Item 8. Financial Statements—Note 10. Financial Instruments and Fair Value Measurements', 'category': 'LAW'}, {'entity': 'Japanese', 'category': 'NORP'}, {'entity': 'Chinese', 'category': 'NORP'}, {'entity': 'Canadian', 'category': 'NORP'}, {'entity': 'South Korean', 'category': 'NORP'}, {'entity': 'Company', 'category': 'ORG'}, {'entity': 'Gilead', 'category': 'ORG'}, {'entity': 'Reyataz Franchise', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'EC', 'category': 'ORG'}, {'entity': 'EMA', 'category': 'ORG'}, {'entity': 'AbbVie', 'category': 'ORG'}, {'entity': 'Pfizer, Inc.', 'category': 'ORG'}, {'entity': 'Securities Act of 1933', 'category': 'ORG'}, {'entity': 'Securities Exchange Act of 1934', 'category': 'ORG'}, {'entity': 'HCV.Reyataz', 'category': 'PRODUCT'}, {'entity': 'HIV', 'category': 'PRODUCT'}, {'entity': 'Evotaz', 'category': 'PRODUCT'}, {'entity': 'atazanavir 300 mg', 'category': 'PRODUCT'}, {'entity': 'cobicistat 150 mg', 'category': 'PRODUCT'}, {'entity': 'Tybost', 'category': 'PRODUCT'}, {'entity': 'Orencia', 'category': 'PRODUCT'}, {'entity': 'RA', 'category': 'PRODUCT'}, {'entity': 'methotrexate', 'category': 'PRODUCT'}, {'entity': 'anti-citrullinated protein antibody', 'category': 'PRODUCT'}, {'entity': 'adalimumab', 'category': 'PRODUCT'}, {'entity': 'ClickJect Pre-Filled Pen', 'category': 'PRODUCT'}, {'entity': 'Eliquis', 'category': 'PRODUCT'}, {'entity': 'NVAF', 'category': 'PRODUCT'}, {'entity': 'VTE', 'category': 'PRODUCT'}, {'entity': 'Phase III AMPLIFY trial', 'category': 'PRODUCT'}, {'entity': 'warfarin', 'category': 'PRODUCT'}, {'entity': 'AUGUSTUS', 'category': 'PRODUCT'}, {'entity': 'Form 10-K', 'category': 'PRODUCT'}, {'entity': '2.0 to 3.0', 'category': 'QUANTITY'}, {'entity': '7, 21 and 90 days', 'category': 'QUANTITY'}, {'entity': 'once-daily', 'category': 'TIME'}, {'entity': '', 'category': 'WORK_OF_ART'}, {'entity': '10%', 'category': 'CARDINAL'}, {'entity': '144 million', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  17\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWbtzBcSnerQvaNUhh0jSquZwTF2\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701570901,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#100#58#100#122#100#591#100#123\\n\\nDATE#\\n\\nEVENT#\\n\\nFAC#\\n\\nGPE#Greece#Portugal#Italy#Spain#Europe\\n\\nLOC#\\n\\nMONEY#$58 million#$122 million#$591 million#$123 million\\n\\nNORP#European\\n\\nORDINAL#\\n\\nORG#Financial Instruments and Fair Value Measurements\\n\\nPERCENT#\\n\\nPERSON#\\n\\nPRODUCT#forward starting interest rate swap contracts#interest rate swap contracts#debt security portfolio#derivative instrument contract#derivative instruments\\n\\nTIME#\\n\\nWORK_OF_ART#Item 8}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 1138,\n",
      "    \"completion_tokens\": 120,\n",
      "    \"total_tokens\": 1258\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'Greece', 'category': 'GPE'}, {'entity': 'Portugal', 'category': 'GPE'}, {'entity': 'Italy', 'category': 'GPE'}, {'entity': 'Spain', 'category': 'GPE'}, {'entity': 'Europe', 'category': 'GPE'}, {'entity': '$58 million', 'category': 'MONEY'}, {'entity': '$122 million', 'category': 'MONEY'}, {'entity': '$591 million', 'category': 'MONEY'}, {'entity': '$123 million', 'category': 'MONEY'}, {'entity': 'European', 'category': 'NORP'}, {'entity': 'Financial Instruments and Fair Value Measurements', 'category': 'ORG'}, {'entity': 'forward starting interest rate swap contracts', 'category': 'PRODUCT'}, {'entity': 'interest rate swap contracts', 'category': 'PRODUCT'}, {'entity': 'debt security portfolio', 'category': 'PRODUCT'}, {'entity': 'derivative instrument contract', 'category': 'PRODUCT'}, {'entity': 'derivative instruments', 'category': 'PRODUCT'}, {'entity': 'Item 8', 'category': 'WORK_OF_ART'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '58', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '122', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '591', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '123', 'category': 'CARDINAL'}]\n",
      "/home/damir/Dropbox/Documents/Teaching/2023/L715/l715_23/data/10-Ks/Bristol-Myers_Squibb_Company/2021/Management.txt\n",
      "Length of chunks:  17\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWcNTpi8fnPiCtsdh3LCJmyYbqhf\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701570931,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#7#13#2020#2019#2019#2020#60#2.01#1.75#2020#2019#42,518#26,145 \\n\\nDATE#November 20, 2019#November 17, 2020#December 31\\n\\nMONEY#$13.1 billion#$15.7 billion \\n\\nORG#Bristol-Myers Squibb Company#Celgene#MyoKardia#Otezla\\n\\nPERSON#Eliquis#Opdivo#Yervoy#Revlimid#Pomalyst#Zeposia#Onureg#liso-cel#berdomide#CC-92480#BCMA#deucravacitinib#mavacamten \\n\\nWORK_OF_ART#Form 10-K#Form 10-K#Summary of Abbreviated Terms#Form 10-K#Economic and Market Factors#COVID-19#Non-GAAP Financial Measures\\n\\nLAW#Item 7\\n\\nEVENT#Celgene transaction#COVID-19 pandemic\\n\\nPERCENT#63%}\\n\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2214,\n",
      "    \"completion_tokens\": 232,\n",
      "    \"total_tokens\": 2446\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'November 20, 2019', 'category': 'DATE'}, {'entity': 'November 17, 2020', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': 'Celgene transaction', 'category': 'EVENT'}, {'entity': 'COVID-19 pandemic', 'category': 'EVENT'}, {'entity': 'Item 7', 'category': 'LAW'}, {'entity': '$13.1 billion', 'category': 'MONEY'}, {'entity': '$15.7 billion', 'category': 'MONEY'}, {'entity': 'Bristol-Myers Squibb Company', 'category': 'ORG'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': 'MyoKardia', 'category': 'ORG'}, {'entity': 'Otezla', 'category': 'ORG'}, {'entity': '63%', 'category': 'PERCENT'}, {'entity': 'Eliquis', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Yervoy', 'category': 'PERSON'}, {'entity': 'Revlimid', 'category': 'PERSON'}, {'entity': 'Pomalyst', 'category': 'PERSON'}, {'entity': 'Zeposia', 'category': 'PERSON'}, {'entity': 'Onureg', 'category': 'PERSON'}, {'entity': 'liso-cel', 'category': 'PERSON'}, {'entity': 'berdomide', 'category': 'PERSON'}, {'entity': 'CC-92480', 'category': 'PERSON'}, {'entity': 'BCMA', 'category': 'PERSON'}, {'entity': 'deucravacitinib', 'category': 'PERSON'}, {'entity': 'mavacamten', 'category': 'PERSON'}, {'entity': 'Form 10-K', 'category': 'WORK_OF_ART'}, {'entity': 'Form 10-K', 'category': 'WORK_OF_ART'}, {'entity': 'Summary of Abbreviated Terms', 'category': 'WORK_OF_ART'}, {'entity': 'Form 10-K', 'category': 'WORK_OF_ART'}, {'entity': 'Economic and Market Factors', 'category': 'WORK_OF_ART'}, {'entity': 'COVID-19', 'category': 'WORK_OF_ART'}, {'entity': 'Non-GAAP Financial Measures', 'category': 'WORK_OF_ART'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '13', 'category': 'CARDINAL'}, {'entity': '2020', 'category': 'CARDINAL'}, {'entity': '2019', 'category': 'CARDINAL'}, {'entity': '2019', 'category': 'CARDINAL'}, {'entity': '2020', 'category': 'CARDINAL'}, {'entity': '60', 'category': 'CARDINAL'}, {'entity': '2.01', 'category': 'CARDINAL'}, {'entity': '1.75', 'category': 'CARDINAL'}, {'entity': '2020', 'category': 'CARDINAL'}, {'entity': '2019', 'category': 'CARDINAL'}, {'entity': '42,518', 'category': 'CARDINAL'}, {'entity': '26,145', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  17\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWcwGCem4u3QCqxBIBpZIr35Mr7N\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701570966,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#53 billion \\n\\nDATE#first quarter of 2020#December 31, 2020#January 31, 2020#November 2020#September 2020#June 2020#April 2020#2020#2021#the fourth quarter\\n\\nEVENT#COVID-19 pandemic#Organisation for Economic Co-operation and Development\\n\\nFAC#\\n\\nGPE#U.S.#Canada#UK#EU\\n\\nLANGUAGE#\\n\\nLAW#\\n\\nLOC#\\n\\nMONEY#\\n\\nNORP#European\\n\\nORDINAL#\\n\\nORG#FDA\\n\\nPERCENT#3%\\n\\nPERSON#\\n\\nPRODUCT#Zeposia#Reblozyl#Onureg#BMS#Medicare Part B#Medicare Part D#Opdivo#Yervoy\\n\\nQUANTITY#\\n\\nTIME#the first months\\n\\nWORK_OF_ART#\\n}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2131,\n",
      "    \"completion_tokens\": 174,\n",
      "    \"total_tokens\": 2305\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'first quarter of 2020', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'January 31, 2020', 'category': 'DATE'}, {'entity': 'November 2020', 'category': 'DATE'}, {'entity': 'September 2020', 'category': 'DATE'}, {'entity': 'June 2020', 'category': 'DATE'}, {'entity': 'April 2020', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': 'the fourth quarter', 'category': 'DATE'}, {'entity': 'COVID-19 pandemic', 'category': 'EVENT'}, {'entity': 'Organisation for Economic Co-operation and Development', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Canada', 'category': 'GPE'}, {'entity': 'UK', 'category': 'GPE'}, {'entity': 'EU', 'category': 'GPE'}, {'entity': 'European', 'category': 'NORP'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': '3%', 'category': 'PERCENT'}, {'entity': 'Zeposia', 'category': 'PRODUCT'}, {'entity': 'Reblozyl', 'category': 'PRODUCT'}, {'entity': 'Onureg', 'category': 'PRODUCT'}, {'entity': 'BMS', 'category': 'PRODUCT'}, {'entity': 'Medicare Part B', 'category': 'PRODUCT'}, {'entity': 'Medicare Part D', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Yervoy', 'category': 'PRODUCT'}, {'entity': 'the first months', 'category': 'TIME'}, {'entity': '53 billion', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  17\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWdTas1dowisrRXg8FQYwWS3A4HZ\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701570999,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#two#one#two \\n\\nDATE#June 2020#May 2020#April 2020#March 2020#December 29, 2020#January 2021#February 2021#2020#2021\\n\\nEVENT#FDA approval of Opdivo#EC approval of Zeposia#FDA approval of Opdivo+Yervoy#FDA approval of Pomalyst#FDA approval of Reblozyl#FDA approval of Zeposia#FDA approval of Opdivo+Yervoy#FDA approval of Opdivo \\n\\nFAC#FDA \\n\\nGPE#U.S.#HIV \\n\\nNORP#American \\n\\nORG#Opdivo#Zeposia#Opdivo+Yervoy#Pomalyst#Reblozyl#Cabometyx#Breyanzi#Inrebic#RCC#Janus Associated Kinase#BMS#EC#SCLC#HCC#RBC#RMS#ALK#PD-L1#NSCLC#ESCC#RRMS#lisocabtagene maraleucel#oncology#hematology#immunology#fibrosis#cardiovascular#Opdivo+Yervoy#Eliquis#Revlimid#Pomalyst#Orencia#Sprycel#Reblozyl#multiple myeloma#RA#Inrebic#Zeposia#Onureg#MDS#R&D\\n\\nPERSON#Cabometyx }\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2260,\n",
      "    \"completion_tokens\": 322,\n",
      "    \"total_tokens\": 2582\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'June 2020', 'category': 'DATE'}, {'entity': 'May 2020', 'category': 'DATE'}, {'entity': 'April 2020', 'category': 'DATE'}, {'entity': 'March 2020', 'category': 'DATE'}, {'entity': 'December 29, 2020', 'category': 'DATE'}, {'entity': 'January 2021', 'category': 'DATE'}, {'entity': 'February 2021', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': 'FDA approval of Opdivo', 'category': 'EVENT'}, {'entity': 'EC approval of Zeposia', 'category': 'EVENT'}, {'entity': 'FDA approval of Opdivo+Yervoy', 'category': 'EVENT'}, {'entity': 'FDA approval of Pomalyst', 'category': 'EVENT'}, {'entity': 'FDA approval of Reblozyl', 'category': 'EVENT'}, {'entity': 'FDA approval of Zeposia', 'category': 'EVENT'}, {'entity': 'FDA approval of Opdivo+Yervoy', 'category': 'EVENT'}, {'entity': 'FDA approval of Opdivo', 'category': 'EVENT'}, {'entity': 'FDA', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'HIV', 'category': 'GPE'}, {'entity': 'American', 'category': 'NORP'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Zeposia', 'category': 'ORG'}, {'entity': 'Opdivo+Yervoy', 'category': 'ORG'}, {'entity': 'Pomalyst', 'category': 'ORG'}, {'entity': 'Reblozyl', 'category': 'ORG'}, {'entity': 'Cabometyx', 'category': 'ORG'}, {'entity': 'Breyanzi', 'category': 'ORG'}, {'entity': 'Inrebic', 'category': 'ORG'}, {'entity': 'RCC', 'category': 'ORG'}, {'entity': 'Janus Associated Kinase', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'EC', 'category': 'ORG'}, {'entity': 'SCLC', 'category': 'ORG'}, {'entity': 'HCC', 'category': 'ORG'}, {'entity': 'RBC', 'category': 'ORG'}, {'entity': 'RMS', 'category': 'ORG'}, {'entity': 'ALK', 'category': 'ORG'}, {'entity': 'PD-L1', 'category': 'ORG'}, {'entity': 'NSCLC', 'category': 'ORG'}, {'entity': 'ESCC', 'category': 'ORG'}, {'entity': 'RRMS', 'category': 'ORG'}, {'entity': 'lisocabtagene maraleucel', 'category': 'ORG'}, {'entity': 'oncology', 'category': 'ORG'}, {'entity': 'hematology', 'category': 'ORG'}, {'entity': 'immunology', 'category': 'ORG'}, {'entity': 'fibrosis', 'category': 'ORG'}, {'entity': 'cardiovascular', 'category': 'ORG'}, {'entity': 'Opdivo+Yervoy', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'Revlimid', 'category': 'ORG'}, {'entity': 'Pomalyst', 'category': 'ORG'}, {'entity': 'Orencia', 'category': 'ORG'}, {'entity': 'Sprycel', 'category': 'ORG'}, {'entity': 'Reblozyl', 'category': 'ORG'}, {'entity': 'multiple myeloma', 'category': 'ORG'}, {'entity': 'RA', 'category': 'ORG'}, {'entity': 'Inrebic', 'category': 'ORG'}, {'entity': 'Zeposia', 'category': 'ORG'}, {'entity': 'Onureg', 'category': 'ORG'}, {'entity': 'MDS', 'category': 'ORG'}, {'entity': 'R&D', 'category': 'ORG'}, {'entity': 'Cabometyx', 'category': 'PERSON'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': 'one', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  17\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWe32eP6ZbqSKy5gqKLW0ITDnQEo\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701571035,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#3.0#2022\\n\\nDATE#2020#first quarter of 2021#December 31, 2020#December 31, 2020#2020#2019#2020 vs. 2019#2020#2019#2020 vs. 2019#2020#2019#2020 vs. 2019#2020#2019#2020 vs. 2019#2020#2019#2020 vs. 2019#2020#2019#December 31, 2020#December 31, 2020#2020#2019#2020 vs. 2019#2020#2019#2020 vs. 2019#2020#2019#December 31, 2020#2020#2019#2020 vs. 2019#2020#2019#2020 vs. 2019#2020#2019#2020 vs. 2019#2020#2019#2020 vs. 2019#2020#2019#December 31, 2020#2020#2019#2020#2019#December 31, 2020#2020#2019#2020 vs. 2019#2020#2019#December 31, 2020#2020#2019#2020#2019#2020#2020 vs. 2019#2020#2019#2020 vs. 2019#2020#2019#2020 vs. 2019#2020#2019#2020#2019#2020 vs. 2019#2020#2019#2020 vs. 2019#2020#2019#2020 vs. 2019#2020#2019#2020 vs. 2019#2020#2019#2020 vs. 2019#2020#2019#2020 vs. 2019#2020#2019#2020 vs. 2019#2020#2019#2020 vs. 2019#2020#2019#2020 vs. 201\\n \\nEVENT#Celgene acquisition restructuring activities#biopharma strategy#Dragonfly\\u2019s interleukin-12 (IL-12) investigational immunotherapy program#TGF-beta program\\n\\nMONEY#$3.0 billion#$1.7 billion\\n\\nORG#our Celgene#Company#Our business#Celgene hematology brands#United States\\u2022Europe\\n\\nPERCENT#69%#1%#52%#43%#31%#32%#(1)%#37%#40%#(3)%#16%#15%#1%\\n\\nPERSON#MyoKardia#mavacamten#Dragonfly#Forbius\\n\\nPRODUCT#commercial and research and development area#prioritized brands#mand and administrative, manufacturing, R&D, procurement and streamlining the Company's pricing and information technology infrastructure#Revlimid, Pomalyst/Imnovid#Eliquis, Opdivo#product launches#Eliquis\\n\\nWORK_OF_ART#Note 3. Alliances#Note 4. Acquisitions}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 3104,\n",
      "    \"completion_tokens\": 688,\n",
      "    \"total_tokens\": 3792\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': '2020', 'category': 'DATE'}, {'entity': 'first quarter of 2021', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': '2020 vs. 2019', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': '2020 vs. 2019', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': '2020 vs. 2019', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': '2020 vs. 2019', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': '2020 vs. 2019', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': '2020 vs. 2019', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': '2020 vs. 2019', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': '2020 vs. 2019', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': '2020 vs. 2019', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': '2020 vs. 2019', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': '2020 vs. 2019', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': '2020 vs. 2019', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2020 vs. 2019', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': '2020 vs. 2019', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': '2020 vs. 2019', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': '2020 vs. 2019', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': '2020 vs. 2019', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': '2020 vs. 2019', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': '2020 vs. 2019', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': '2020 vs. 2019', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': '2020 vs. 2019', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': '2020 vs. 2019', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': '2020 vs. 2019', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': '2020 vs. 201', 'category': 'DATE'}, {'entity': 'Celgene acquisition restructuring activities', 'category': 'EVENT'}, {'entity': 'biopharma strategy', 'category': 'EVENT'}, {'entity': 'Dragonfly’s interleukin-12 IL-12 investigational immunotherapy program', 'category': 'EVENT'}, {'entity': 'TGF-beta program', 'category': 'EVENT'}, {'entity': '$3.0 billion', 'category': 'MONEY'}, {'entity': '$1.7 billion', 'category': 'MONEY'}, {'entity': 'our Celgene', 'category': 'ORG'}, {'entity': 'Company', 'category': 'ORG'}, {'entity': 'Our business', 'category': 'ORG'}, {'entity': 'Celgene hematology brands', 'category': 'ORG'}, {'entity': 'United States•Europe', 'category': 'ORG'}, {'entity': '69%', 'category': 'PERCENT'}, {'entity': '1%', 'category': 'PERCENT'}, {'entity': '52%', 'category': 'PERCENT'}, {'entity': '43%', 'category': 'PERCENT'}, {'entity': '31%', 'category': 'PERCENT'}, {'entity': '32%', 'category': 'PERCENT'}, {'entity': '1%', 'category': 'PERCENT'}, {'entity': '37%', 'category': 'PERCENT'}, {'entity': '40%', 'category': 'PERCENT'}, {'entity': '3%', 'category': 'PERCENT'}, {'entity': '16%', 'category': 'PERCENT'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': '1%', 'category': 'PERCENT'}, {'entity': 'MyoKardia', 'category': 'PERSON'}, {'entity': 'mavacamten', 'category': 'PERSON'}, {'entity': 'Dragonfly', 'category': 'PERSON'}, {'entity': 'Forbius', 'category': 'PERSON'}, {'entity': 'commercial and research and development area', 'category': 'PRODUCT'}, {'entity': 'prioritized brands', 'category': 'PRODUCT'}, {'entity': 'mand and administrative, manufacturing, R&D, procurement and streamlining the Companys pricing and information technology infrastructure', 'category': 'PRODUCT'}, {'entity': 'Revlimid, Pomalyst/Imnovid', 'category': 'PRODUCT'}, {'entity': 'Eliquis, Opdivo', 'category': 'PRODUCT'}, {'entity': 'product launches', 'category': 'PRODUCT'}, {'entity': 'Eliquis', 'category': 'PRODUCT'}, {'entity': 'Note 3. Alliances', 'category': 'WORK_OF_ART'}, {'entity': 'Note 4. Acquisitions', 'category': 'WORK_OF_ART'}, {'entity': '3.0', 'category': 'CARDINAL'}, {'entity': '2022', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  17\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWepBwFiPiFjhPbwBV5eLi4yxsZF\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701571083,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#1.5#2020#2.2 \\n\\nDATE#December 31, 2020#November 2019#April 2020#September 2020#June 2020#2020#2019\\n\\nGPE#U.S.#Europe\\n\\nLANGUAGE#English\\n\\nLOC#Philadelphia\\n\\nMONEY#$295 million#$27 million\\n\\nORG#FDA#SEC#UPSA#Celgene\\n\\nPERCENT#15%#10%#16%#9%#7%#6%#8%#12%#19%\\n\\nPERSON#Reblozyl\\n\\nPRODUCT#Inrebic#Onureg#Zeposia#Vidaza#Baraclude\\n\\nTIME#one month\\n\\nWORK_OF_ART#Opdivo+Yervoy#Opdivo+Yervoy#Opdivo+Yervoy}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2365,\n",
      "    \"completion_tokens\": 180,\n",
      "    \"total_tokens\": 2545\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'November 2019', 'category': 'DATE'}, {'entity': 'April 2020', 'category': 'DATE'}, {'entity': 'September 2020', 'category': 'DATE'}, {'entity': 'June 2020', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Europe', 'category': 'GPE'}, {'entity': 'English', 'category': 'LANGUAGE'}, {'entity': 'Philadelphia', 'category': 'LOC'}, {'entity': '$295 million', 'category': 'MONEY'}, {'entity': '$27 million', 'category': 'MONEY'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'UPSA', 'category': 'ORG'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': '10%', 'category': 'PERCENT'}, {'entity': '16%', 'category': 'PERCENT'}, {'entity': '9%', 'category': 'PERCENT'}, {'entity': '7%', 'category': 'PERCENT'}, {'entity': '6%', 'category': 'PERCENT'}, {'entity': '8%', 'category': 'PERCENT'}, {'entity': '12%', 'category': 'PERCENT'}, {'entity': '19%', 'category': 'PERCENT'}, {'entity': 'Reblozyl', 'category': 'PERSON'}, {'entity': 'Inrebic', 'category': 'PRODUCT'}, {'entity': 'Onureg', 'category': 'PRODUCT'}, {'entity': 'Zeposia', 'category': 'PRODUCT'}, {'entity': 'Vidaza', 'category': 'PRODUCT'}, {'entity': 'Baraclude', 'category': 'PRODUCT'}, {'entity': 'one month', 'category': 'TIME'}, {'entity': 'Opdivo+Yervoy', 'category': 'WORK_OF_ART'}, {'entity': 'Opdivo+Yervoy', 'category': 'WORK_OF_ART'}, {'entity': 'Opdivo+Yervoy', 'category': 'WORK_OF_ART'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '2020', 'category': 'CARDINAL'}, {'entity': '2.2', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  17\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWfMGLHE4nLvLB5DtEMqPQSnj6Se\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701571116,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#3#75#2020#46#7,661#57#11,143#81#11,438#9,688#11,773#8,078#49,389#21,170\\n\\nDATE#September 30, 2020#the year ended December 31, 2020#the year ended December 31, 2020\\n\\nEVENT#product launch#new product launches#MyoKardia acquisition\\n\\nGPE#Germany#U.S.\\n\\nLAW#2020 Form 10-K\\n\\nMONEY#$11,773#$8,078#$49,389#$21,170#$3.7 billion#$2.0 billion#$650 million#$600 million#$575 million#$2.8 billion#$241 million#$5.0 billion#$3.3 billion#$1.0 billion#$470 million\\n\\nORG#three largest wholesalers#Revlimid REMS#Pomalyst REMS#Revlimid#Imnovid#Inrebic#Celgene\\n\\nPERCENT#75%#46%#57%#81%\\n\\nPERSON#Eliquis\\n\\nPRODUCT#Revlimid#Pomalyst#Imnovid\\n\\nWORK_OF_ART#Form 10-Q#Form 10-K\\n\\nTIME#monthly#year#quarterly}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2176,\n",
      "    \"completion_tokens\": 269,\n",
      "    \"total_tokens\": 2445\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'September 30, 2020', 'category': 'DATE'}, {'entity': 'the year ended December 31, 2020', 'category': 'DATE'}, {'entity': 'the year ended December 31, 2020', 'category': 'DATE'}, {'entity': 'product launch', 'category': 'EVENT'}, {'entity': 'new product launches', 'category': 'EVENT'}, {'entity': 'MyoKardia acquisition', 'category': 'EVENT'}, {'entity': 'Germany', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '2020 Form 10-K', 'category': 'LAW'}, {'entity': '$11,773', 'category': 'MONEY'}, {'entity': '$8,078', 'category': 'MONEY'}, {'entity': '$49,389', 'category': 'MONEY'}, {'entity': '$21,170', 'category': 'MONEY'}, {'entity': '$3.7 billion', 'category': 'MONEY'}, {'entity': '$2.0 billion', 'category': 'MONEY'}, {'entity': '$650 million', 'category': 'MONEY'}, {'entity': '$600 million', 'category': 'MONEY'}, {'entity': '$575 million', 'category': 'MONEY'}, {'entity': '$2.8 billion', 'category': 'MONEY'}, {'entity': '$241 million', 'category': 'MONEY'}, {'entity': '$5.0 billion', 'category': 'MONEY'}, {'entity': '$3.3 billion', 'category': 'MONEY'}, {'entity': '$1.0 billion', 'category': 'MONEY'}, {'entity': '$470 million', 'category': 'MONEY'}, {'entity': 'three largest wholesalers', 'category': 'ORG'}, {'entity': 'Revlimid REMS', 'category': 'ORG'}, {'entity': 'Pomalyst REMS', 'category': 'ORG'}, {'entity': 'Revlimid', 'category': 'ORG'}, {'entity': 'Imnovid', 'category': 'ORG'}, {'entity': 'Inrebic', 'category': 'ORG'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': '75%', 'category': 'PERCENT'}, {'entity': '46%', 'category': 'PERCENT'}, {'entity': '57%', 'category': 'PERCENT'}, {'entity': '81%', 'category': 'PERCENT'}, {'entity': 'Eliquis', 'category': 'PERSON'}, {'entity': 'Revlimid', 'category': 'PRODUCT'}, {'entity': 'Pomalyst', 'category': 'PRODUCT'}, {'entity': 'Imnovid', 'category': 'PRODUCT'}, {'entity': 'monthly', 'category': 'TIME'}, {'entity': 'year', 'category': 'TIME'}, {'entity': 'quarterly', 'category': 'TIME'}, {'entity': 'Form 10-Q', 'category': 'WORK_OF_ART'}, {'entity': 'Form 10-K', 'category': 'WORK_OF_ART'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '75', 'category': 'CARDINAL'}, {'entity': '2020', 'category': 'CARDINAL'}, {'entity': '46', 'category': 'CARDINAL'}, {'entity': '7,661', 'category': 'CARDINAL'}, {'entity': '57', 'category': 'CARDINAL'}, {'entity': '11,143', 'category': 'CARDINAL'}, {'entity': '81', 'category': 'CARDINAL'}, {'entity': '11,438', 'category': 'CARDINAL'}, {'entity': '9,688', 'category': 'CARDINAL'}, {'entity': '11,773', 'category': 'CARDINAL'}, {'entity': '8,078', 'category': 'CARDINAL'}, {'entity': '49,389', 'category': 'CARDINAL'}, {'entity': '21,170', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  17\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWfu3rCN2c5ZN1W7ZXMR7k8kj7sI\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701571150,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#2020#19.0#19.9#72#80#1.4#3.0#197#1.2#1.5#853#266#81#140#170 \\n\\nDATE#May 2019#January 2021#December 31, 2020#Year Ended December 31\\n\\nEVENT#Celgene acquisition#Bristol-Myers Squibb Retirement Income Plan termination\\n\\nMONEY#$1,420#(1,757)#523#(1,527)#(1,360)#(1,228)#275#717#415#530#301#(194)#77#(149)#37#(121)#464#76#(55)#1,168#21#15#(13)#1,599#(34)#1#(2,314)#938#(6,871)#4,975#2,124#1,515\\n\\nORG#FDA#Celgene#Sanofi#UPSA\\n\\nPERCENT#30.9%#30.5%#46.5%#(-15.7%)#15.6%#14.8%\\n\\nPERSON#MyoKardia\\n\\nPRODUCT#liso-cel (JCAR017)#Keytruda#Tecentriq#Otezla\\n\\nTIME#2022}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2376,\n",
      "    \"completion_tokens\": 280,\n",
      "    \"total_tokens\": 2656\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'May 2019', 'category': 'DATE'}, {'entity': 'January 2021', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': 'Celgene acquisition', 'category': 'EVENT'}, {'entity': 'Bristol-Myers Squibb Retirement Income Plan termination', 'category': 'EVENT'}, {'entity': '$1,420', 'category': 'MONEY'}, {'entity': '1,757', 'category': 'MONEY'}, {'entity': '523', 'category': 'MONEY'}, {'entity': '1,527', 'category': 'MONEY'}, {'entity': '1,360', 'category': 'MONEY'}, {'entity': '1,228', 'category': 'MONEY'}, {'entity': '275', 'category': 'MONEY'}, {'entity': '717', 'category': 'MONEY'}, {'entity': '415', 'category': 'MONEY'}, {'entity': '530', 'category': 'MONEY'}, {'entity': '301', 'category': 'MONEY'}, {'entity': '194', 'category': 'MONEY'}, {'entity': '77', 'category': 'MONEY'}, {'entity': '149', 'category': 'MONEY'}, {'entity': '37', 'category': 'MONEY'}, {'entity': '121', 'category': 'MONEY'}, {'entity': '464', 'category': 'MONEY'}, {'entity': '76', 'category': 'MONEY'}, {'entity': '55', 'category': 'MONEY'}, {'entity': '1,168', 'category': 'MONEY'}, {'entity': '21', 'category': 'MONEY'}, {'entity': '15', 'category': 'MONEY'}, {'entity': '13', 'category': 'MONEY'}, {'entity': '1,599', 'category': 'MONEY'}, {'entity': '34', 'category': 'MONEY'}, {'entity': '1', 'category': 'MONEY'}, {'entity': '2,314', 'category': 'MONEY'}, {'entity': '938', 'category': 'MONEY'}, {'entity': '6,871', 'category': 'MONEY'}, {'entity': '4,975', 'category': 'MONEY'}, {'entity': '2,124', 'category': 'MONEY'}, {'entity': '1,515', 'category': 'MONEY'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': 'Sanofi', 'category': 'ORG'}, {'entity': 'UPSA', 'category': 'ORG'}, {'entity': '30.9%', 'category': 'PERCENT'}, {'entity': '30.5%', 'category': 'PERCENT'}, {'entity': '46.5%', 'category': 'PERCENT'}, {'entity': '-15.7%', 'category': 'PERCENT'}, {'entity': '15.6%', 'category': 'PERCENT'}, {'entity': '14.8%', 'category': 'PERCENT'}, {'entity': 'MyoKardia', 'category': 'PERSON'}, {'entity': 'liso-cel JCAR017', 'category': 'PRODUCT'}, {'entity': 'Keytruda', 'category': 'PRODUCT'}, {'entity': 'Tecentriq', 'category': 'PRODUCT'}, {'entity': 'Otezla', 'category': 'PRODUCT'}, {'entity': '2022', 'category': 'TIME'}, {'entity': '2020', 'category': 'CARDINAL'}, {'entity': '19.0', 'category': 'CARDINAL'}, {'entity': '19.9', 'category': 'CARDINAL'}, {'entity': '72', 'category': 'CARDINAL'}, {'entity': '80', 'category': 'CARDINAL'}, {'entity': '1.4', 'category': 'CARDINAL'}, {'entity': '3.0', 'category': 'CARDINAL'}, {'entity': '197', 'category': 'CARDINAL'}, {'entity': '1.2', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '853', 'category': 'CARDINAL'}, {'entity': '266', 'category': 'CARDINAL'}, {'entity': '81', 'category': 'CARDINAL'}, {'entity': '140', 'category': 'CARDINAL'}, {'entity': '170', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  17\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWgTgcshBPechbpE4DxlO30M1lfS\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701571185,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#99.2#8\\n\\nDATE#February 4, 2021#Year Ended December 31#2020#2019\\n\\nEVENT#MyoKardia acquisition\\n\\nMONEY#$2,688#$660#$575#$4#$33#$197#$3,300#$858#$275#$27#$4#$9#$279#$1,003#$25#$470#$32#$36#$282#$115#$1,906#$11,438#$9,688#$159#$1,757#$168#$1,156#$717#$415#$530#$301#$239#$75#$76#$55#$1,635#$657#$2#$2,211#$2,262#$24,400#$4,475#$1,733#$687#$266#$808#$853#$614#$121#$23,786#$4,596#$9,015#$3,439#$23,786#$4,596#$14,771#$8,035#$2,258#$1,712#$35#$2,293#$3.99#$2.01#$10.43#$2.68#$6.44#$4.69#$14,546#$12,346#$1,285#$3,047#$433#$767#$16,264#$16,160#$2,340#$3,346#$48,336#$43,387#$34,412#$30,573#$15.8 billion#2024#$1.0 billion#December 31, 2019#$5.0 billion#February 2020#$6.0 billion#$7 billion#27 million#$1.6 billion#December 31, 2020#$4.4 billion#$2.0 billion#$4.1 billion#$2.7 billion#$2.6 billion#$750 million#$800 million#$1.0 billion#$1.3 billion#$1.2 billion#$5 billion\\n\\nORG#BMS#Celgene#GAAP#Board of Directors#Exchange Act#ASR#Item 8. Financial Statements and Supplementary Data\\u2014Note 16. Equity\\n\\nPERSON#Otezla\\n\\nPRODUCT#common stock\\n\\nQUANTITY#366 days\\n\\nTIME#January 2021\\n\\nWORK_OF_ART#Form 8-K#EPS}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2543,\n",
      "    \"completion_tokens\": 469,\n",
      "    \"total_tokens\": 3012\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'February 4, 2021', 'category': 'DATE'}, {'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': 'MyoKardia acquisition', 'category': 'EVENT'}, {'entity': '$2,688', 'category': 'MONEY'}, {'entity': '$660', 'category': 'MONEY'}, {'entity': '$575', 'category': 'MONEY'}, {'entity': '$4', 'category': 'MONEY'}, {'entity': '$33', 'category': 'MONEY'}, {'entity': '$197', 'category': 'MONEY'}, {'entity': '$3,300', 'category': 'MONEY'}, {'entity': '$858', 'category': 'MONEY'}, {'entity': '$275', 'category': 'MONEY'}, {'entity': '$27', 'category': 'MONEY'}, {'entity': '$4', 'category': 'MONEY'}, {'entity': '$9', 'category': 'MONEY'}, {'entity': '$279', 'category': 'MONEY'}, {'entity': '$1,003', 'category': 'MONEY'}, {'entity': '$25', 'category': 'MONEY'}, {'entity': '$470', 'category': 'MONEY'}, {'entity': '$32', 'category': 'MONEY'}, {'entity': '$36', 'category': 'MONEY'}, {'entity': '$282', 'category': 'MONEY'}, {'entity': '$115', 'category': 'MONEY'}, {'entity': '$1,906', 'category': 'MONEY'}, {'entity': '$11,438', 'category': 'MONEY'}, {'entity': '$9,688', 'category': 'MONEY'}, {'entity': '$159', 'category': 'MONEY'}, {'entity': '$1,757', 'category': 'MONEY'}, {'entity': '$168', 'category': 'MONEY'}, {'entity': '$1,156', 'category': 'MONEY'}, {'entity': '$717', 'category': 'MONEY'}, {'entity': '$415', 'category': 'MONEY'}, {'entity': '$530', 'category': 'MONEY'}, {'entity': '$301', 'category': 'MONEY'}, {'entity': '$239', 'category': 'MONEY'}, {'entity': '$75', 'category': 'MONEY'}, {'entity': '$76', 'category': 'MONEY'}, {'entity': '$55', 'category': 'MONEY'}, {'entity': '$1,635', 'category': 'MONEY'}, {'entity': '$657', 'category': 'MONEY'}, {'entity': '$2', 'category': 'MONEY'}, {'entity': '$2,211', 'category': 'MONEY'}, {'entity': '$2,262', 'category': 'MONEY'}, {'entity': '$24,400', 'category': 'MONEY'}, {'entity': '$4,475', 'category': 'MONEY'}, {'entity': '$1,733', 'category': 'MONEY'}, {'entity': '$687', 'category': 'MONEY'}, {'entity': '$266', 'category': 'MONEY'}, {'entity': '$808', 'category': 'MONEY'}, {'entity': '$853', 'category': 'MONEY'}, {'entity': '$614', 'category': 'MONEY'}, {'entity': '$121', 'category': 'MONEY'}, {'entity': '$23,786', 'category': 'MONEY'}, {'entity': '$4,596', 'category': 'MONEY'}, {'entity': '$9,015', 'category': 'MONEY'}, {'entity': '$3,439', 'category': 'MONEY'}, {'entity': '$23,786', 'category': 'MONEY'}, {'entity': '$4,596', 'category': 'MONEY'}, {'entity': '$14,771', 'category': 'MONEY'}, {'entity': '$8,035', 'category': 'MONEY'}, {'entity': '$2,258', 'category': 'MONEY'}, {'entity': '$1,712', 'category': 'MONEY'}, {'entity': '$35', 'category': 'MONEY'}, {'entity': '$2,293', 'category': 'MONEY'}, {'entity': '$3.99', 'category': 'MONEY'}, {'entity': '$2.01', 'category': 'MONEY'}, {'entity': '$10.43', 'category': 'MONEY'}, {'entity': '$2.68', 'category': 'MONEY'}, {'entity': '$6.44', 'category': 'MONEY'}, {'entity': '$4.69', 'category': 'MONEY'}, {'entity': '$14,546', 'category': 'MONEY'}, {'entity': '$12,346', 'category': 'MONEY'}, {'entity': '$1,285', 'category': 'MONEY'}, {'entity': '$3,047', 'category': 'MONEY'}, {'entity': '$433', 'category': 'MONEY'}, {'entity': '$767', 'category': 'MONEY'}, {'entity': '$16,264', 'category': 'MONEY'}, {'entity': '$16,160', 'category': 'MONEY'}, {'entity': '$2,340', 'category': 'MONEY'}, {'entity': '$3,346', 'category': 'MONEY'}, {'entity': '$48,336', 'category': 'MONEY'}, {'entity': '$43,387', 'category': 'MONEY'}, {'entity': '$34,412', 'category': 'MONEY'}, {'entity': '$30,573', 'category': 'MONEY'}, {'entity': '$15.8 billion', 'category': 'MONEY'}, {'entity': '2024', 'category': 'MONEY'}, {'entity': '$1.0 billion', 'category': 'MONEY'}, {'entity': 'December 31, 2019', 'category': 'MONEY'}, {'entity': '$5.0 billion', 'category': 'MONEY'}, {'entity': 'February 2020', 'category': 'MONEY'}, {'entity': '$6.0 billion', 'category': 'MONEY'}, {'entity': '$7 billion', 'category': 'MONEY'}, {'entity': '27 million', 'category': 'MONEY'}, {'entity': '$1.6 billion', 'category': 'MONEY'}, {'entity': 'December 31, 2020', 'category': 'MONEY'}, {'entity': '$4.4 billion', 'category': 'MONEY'}, {'entity': '$2.0 billion', 'category': 'MONEY'}, {'entity': '$4.1 billion', 'category': 'MONEY'}, {'entity': '$2.7 billion', 'category': 'MONEY'}, {'entity': '$2.6 billion', 'category': 'MONEY'}, {'entity': '$750 million', 'category': 'MONEY'}, {'entity': '$800 million', 'category': 'MONEY'}, {'entity': '$1.0 billion', 'category': 'MONEY'}, {'entity': '$1.3 billion', 'category': 'MONEY'}, {'entity': '$1.2 billion', 'category': 'MONEY'}, {'entity': '$5 billion', 'category': 'MONEY'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': 'Board of Directors', 'category': 'ORG'}, {'entity': 'Exchange Act', 'category': 'ORG'}, {'entity': 'ASR', 'category': 'ORG'}, {'entity': 'Item 8. Financial Statements and Supplementary Data—Note 16. Equity', 'category': 'ORG'}, {'entity': 'Otezla', 'category': 'PERSON'}, {'entity': 'common stock', 'category': 'PRODUCT'}, {'entity': '366 days', 'category': 'QUANTITY'}, {'entity': 'January 2021', 'category': 'TIME'}, {'entity': 'Form 8-K', 'category': 'WORK_OF_ART'}, {'entity': 'EPS', 'category': 'WORK_OF_ART'}, {'entity': '99.2', 'category': 'CARDINAL'}, {'entity': '8', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  17\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWh90UzD0JYobJmDd0XP6HWRta7W\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701571227,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#four#364#2.0#2021#three#1.0#2022#two#1.5#2021#2024#2025#1.0#1.5#364#2.0#2022#4.0#2.0#2.0#9#2021#7.0#3#30#8#2021#1#2020#2019#75#2020#90#2019#5.8#1.2#1.9#1.1#500#946#90#15.0#11.7#2.3#8.8#13.3#1.4#5.8#7.0#340#2,000#4,750#4,767#4,286#4,201#28,707#1,573#1,522#1,389#1,280#1,169#14,902#196#189\\n\\nDATE#December 31, 2020#December 31, 2020#September 2024#July 2025#December 31, 2020#December 31, 2019#January 2021#January 2022#November 2020#April 9, 2021#December 31, 2020#February 2021#November 2020#Year Ended December 31, 2020#Year Ended December 31, 2019#the first quarter of the subsequent year#annually#December 31, 2020\\n\\nEVENT#Celgene acquisition#debt maturities\\n\\nFAC#Moody\\u2019s Investors Service#Standard & Poor\\u2019s\\n\\nMONEY#$6.0 billion#$2.0 billion#$1.0 billion#$1.5 billion#$1.0 billion#$1.5 billion#$2.0 billion#$4.0 billion#$2.0 billion#$2.0 billion#$7.0 billion#$14,052#$8,210#10,859#9,913#1,151#7,621#$1.2 billion#$1.9 billion#$1.1 billion#$500 million#$15.0 billion#$11.7 billion#$2.3 billion#$13.3 billion#$1.4 billion#$5.8 billion#$7.0 billion#$340#$48,711#$21,835\\n\\nORG#MyoKardia#UPSA#Opdivo#Yervoy#Empliciti#MyoKardia#Celgene\\n\\nPERCENT#30 years\\n\\nQUANTITY#A2#Prime-1#A+#A-1\\n\\nTIME#364-day\\n\\nWORK_OF_ART#Item 8. Financial Statements and Supplementary Data\\u2014Note 9. Financial Instruments and Fair Value Measurements}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2360,\n",
      "    \"completion_tokens\": 591,\n",
      "    \"total_tokens\": 2951\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'September 2024', 'category': 'DATE'}, {'entity': 'July 2025', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'December 31, 2019', 'category': 'DATE'}, {'entity': 'January 2021', 'category': 'DATE'}, {'entity': 'January 2022', 'category': 'DATE'}, {'entity': 'November 2020', 'category': 'DATE'}, {'entity': 'April 9, 2021', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'February 2021', 'category': 'DATE'}, {'entity': 'November 2020', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2020', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2019', 'category': 'DATE'}, {'entity': 'the first quarter of the subsequent year', 'category': 'DATE'}, {'entity': 'annually', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'Celgene acquisition', 'category': 'EVENT'}, {'entity': 'debt maturities', 'category': 'EVENT'}, {'entity': 'Moody’s Investors Service', 'category': 'FAC'}, {'entity': 'Standard & Poor’s', 'category': 'FAC'}, {'entity': '$6.0 billion', 'category': 'MONEY'}, {'entity': '$2.0 billion', 'category': 'MONEY'}, {'entity': '$1.0 billion', 'category': 'MONEY'}, {'entity': '$1.5 billion', 'category': 'MONEY'}, {'entity': '$1.0 billion', 'category': 'MONEY'}, {'entity': '$1.5 billion', 'category': 'MONEY'}, {'entity': '$2.0 billion', 'category': 'MONEY'}, {'entity': '$4.0 billion', 'category': 'MONEY'}, {'entity': '$2.0 billion', 'category': 'MONEY'}, {'entity': '$2.0 billion', 'category': 'MONEY'}, {'entity': '$7.0 billion', 'category': 'MONEY'}, {'entity': '$14,052', 'category': 'MONEY'}, {'entity': '$8,210', 'category': 'MONEY'}, {'entity': '10,859', 'category': 'MONEY'}, {'entity': '9,913', 'category': 'MONEY'}, {'entity': '1,151', 'category': 'MONEY'}, {'entity': '7,621', 'category': 'MONEY'}, {'entity': '$1.2 billion', 'category': 'MONEY'}, {'entity': '$1.9 billion', 'category': 'MONEY'}, {'entity': '$1.1 billion', 'category': 'MONEY'}, {'entity': '$500 million', 'category': 'MONEY'}, {'entity': '$15.0 billion', 'category': 'MONEY'}, {'entity': '$11.7 billion', 'category': 'MONEY'}, {'entity': '$2.3 billion', 'category': 'MONEY'}, {'entity': '$13.3 billion', 'category': 'MONEY'}, {'entity': '$1.4 billion', 'category': 'MONEY'}, {'entity': '$5.8 billion', 'category': 'MONEY'}, {'entity': '$7.0 billion', 'category': 'MONEY'}, {'entity': '$340', 'category': 'MONEY'}, {'entity': '$48,711', 'category': 'MONEY'}, {'entity': '$21,835', 'category': 'MONEY'}, {'entity': 'MyoKardia', 'category': 'ORG'}, {'entity': 'UPSA', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Yervoy', 'category': 'ORG'}, {'entity': 'Empliciti', 'category': 'ORG'}, {'entity': 'MyoKardia', 'category': 'ORG'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': '30 years', 'category': 'PERCENT'}, {'entity': 'A2', 'category': 'QUANTITY'}, {'entity': 'Prime-1', 'category': 'QUANTITY'}, {'entity': 'A+', 'category': 'QUANTITY'}, {'entity': 'A-1', 'category': 'QUANTITY'}, {'entity': '364-day', 'category': 'TIME'}, {'entity': 'Item 8. Financial Statements and Supplementary Data—Note 9. Financial Instruments and Fair Value Measurements', 'category': 'WORK_OF_ART'}, {'entity': 'four', 'category': 'CARDINAL'}, {'entity': '364', 'category': 'CARDINAL'}, {'entity': '2.0', 'category': 'CARDINAL'}, {'entity': '2021', 'category': 'CARDINAL'}, {'entity': 'three', 'category': 'CARDINAL'}, {'entity': '1.0', 'category': 'CARDINAL'}, {'entity': '2022', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '2021', 'category': 'CARDINAL'}, {'entity': '2024', 'category': 'CARDINAL'}, {'entity': '2025', 'category': 'CARDINAL'}, {'entity': '1.0', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '364', 'category': 'CARDINAL'}, {'entity': '2.0', 'category': 'CARDINAL'}, {'entity': '2022', 'category': 'CARDINAL'}, {'entity': '4.0', 'category': 'CARDINAL'}, {'entity': '2.0', 'category': 'CARDINAL'}, {'entity': '2.0', 'category': 'CARDINAL'}, {'entity': '9', 'category': 'CARDINAL'}, {'entity': '2021', 'category': 'CARDINAL'}, {'entity': '7.0', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '30', 'category': 'CARDINAL'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': '2021', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '2020', 'category': 'CARDINAL'}, {'entity': '2019', 'category': 'CARDINAL'}, {'entity': '75', 'category': 'CARDINAL'}, {'entity': '2020', 'category': 'CARDINAL'}, {'entity': '90', 'category': 'CARDINAL'}, {'entity': '2019', 'category': 'CARDINAL'}, {'entity': '5.8', 'category': 'CARDINAL'}, {'entity': '1.2', 'category': 'CARDINAL'}, {'entity': '1.9', 'category': 'CARDINAL'}, {'entity': '1.1', 'category': 'CARDINAL'}, {'entity': '500', 'category': 'CARDINAL'}, {'entity': '946', 'category': 'CARDINAL'}, {'entity': '90', 'category': 'CARDINAL'}, {'entity': '15.0', 'category': 'CARDINAL'}, {'entity': '11.7', 'category': 'CARDINAL'}, {'entity': '2.3', 'category': 'CARDINAL'}, {'entity': '8.8', 'category': 'CARDINAL'}, {'entity': '13.3', 'category': 'CARDINAL'}, {'entity': '1.4', 'category': 'CARDINAL'}, {'entity': '5.8', 'category': 'CARDINAL'}, {'entity': '7.0', 'category': 'CARDINAL'}, {'entity': '340', 'category': 'CARDINAL'}, {'entity': '2,000', 'category': 'CARDINAL'}, {'entity': '4,750', 'category': 'CARDINAL'}, {'entity': '4,767', 'category': 'CARDINAL'}, {'entity': '4,286', 'category': 'CARDINAL'}, {'entity': '4,201', 'category': 'CARDINAL'}, {'entity': '28,707', 'category': 'CARDINAL'}, {'entity': '1,573', 'category': 'CARDINAL'}, {'entity': '1,522', 'category': 'CARDINAL'}, {'entity': '1,389', 'category': 'CARDINAL'}, {'entity': '1,280', 'category': 'CARDINAL'}, {'entity': '1,169', 'category': 'CARDINAL'}, {'entity': '14,902', 'category': 'CARDINAL'}, {'entity': '196', 'category': 'CARDINAL'}, {'entity': '189', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  17\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWhuFtTNtDw81mUp7PtJYPi3lBdz\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701571274,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#189#193#158#136#1,044#5,306#2,027#953#703#629#472#522#87#87#3,295#81,490#6,562#7,753#7,619#7,151#6,986#45,419#22.0#8.1#13.9#14.7#9.00#31#100#75 \\n\\nDATE#January 2021#December 31, 2020#March 31, 2021#August 4, 2004#September 30, 2004\\n\\nEVENT#Celgene acquisition#SEC Consent Order / FCPA Settlement\\n\\nFAC#FDA\\n\\nGPE#U.S.\\n\\nLAW#Item 8. Financial Statements and Supplementary Data\\u2014Note 13. Leases#Exhibit 10#Form 10-Q\\n\\nMONEY#$22.0 billion#$8.1 billion#$13.9 billion#$14.7 billion#$9.00\\n\\nORG#SEC#FDA#Medicare#Medicaid\\n\\nPERCENT#100%#75%\\n\\nPERSON#ii#iii\\n\\nPRODUCT#ozanimod#liso-cel#JCAR017#ide-cel#bb2121\\n\\nWORK_OF_ART#Item 8. Financial Statements and Supplementary Data\\u2014Note 3. Alliances#\\u201cItem 8. Financial Statements and Supplementary Data\\u2014Note 1. Accounting Policies and Recently Issued Accounting Standards.\\u201d}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2165,\n",
      "    \"completion_tokens\": 313,\n",
      "    \"total_tokens\": 2478\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'January 2021', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'March 31, 2021', 'category': 'DATE'}, {'entity': 'August 4, 2004', 'category': 'DATE'}, {'entity': 'September 30, 2004', 'category': 'DATE'}, {'entity': 'Celgene acquisition', 'category': 'EVENT'}, {'entity': 'SEC Consent Order / FCPA Settlement', 'category': 'EVENT'}, {'entity': 'FDA', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Item 8. Financial Statements and Supplementary Data—Note 13. Leases', 'category': 'LAW'}, {'entity': 'Exhibit 10', 'category': 'LAW'}, {'entity': 'Form 10-Q', 'category': 'LAW'}, {'entity': '$22.0 billion', 'category': 'MONEY'}, {'entity': '$8.1 billion', 'category': 'MONEY'}, {'entity': '$13.9 billion', 'category': 'MONEY'}, {'entity': '$14.7 billion', 'category': 'MONEY'}, {'entity': '$9.00', 'category': 'MONEY'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'Medicare', 'category': 'ORG'}, {'entity': 'Medicaid', 'category': 'ORG'}, {'entity': '100%', 'category': 'PERCENT'}, {'entity': '75%', 'category': 'PERCENT'}, {'entity': 'ii', 'category': 'PERSON'}, {'entity': 'iii', 'category': 'PERSON'}, {'entity': 'ozanimod', 'category': 'PRODUCT'}, {'entity': 'liso-cel', 'category': 'PRODUCT'}, {'entity': 'JCAR017', 'category': 'PRODUCT'}, {'entity': 'ide-cel', 'category': 'PRODUCT'}, {'entity': 'bb2121', 'category': 'PRODUCT'}, {'entity': 'Item 8. Financial Statements and Supplementary Data—Note 3. Alliances', 'category': 'WORK_OF_ART'}, {'entity': '“Item 8. Financial Statements and Supplementary Data—Note 1. Accounting Policies and Recently Issued Accounting Standards.”', 'category': 'WORK_OF_ART'}, {'entity': '189', 'category': 'CARDINAL'}, {'entity': '193', 'category': 'CARDINAL'}, {'entity': '158', 'category': 'CARDINAL'}, {'entity': '136', 'category': 'CARDINAL'}, {'entity': '1,044', 'category': 'CARDINAL'}, {'entity': '5,306', 'category': 'CARDINAL'}, {'entity': '2,027', 'category': 'CARDINAL'}, {'entity': '953', 'category': 'CARDINAL'}, {'entity': '703', 'category': 'CARDINAL'}, {'entity': '629', 'category': 'CARDINAL'}, {'entity': '472', 'category': 'CARDINAL'}, {'entity': '522', 'category': 'CARDINAL'}, {'entity': '87', 'category': 'CARDINAL'}, {'entity': '87', 'category': 'CARDINAL'}, {'entity': '3,295', 'category': 'CARDINAL'}, {'entity': '81,490', 'category': 'CARDINAL'}, {'entity': '6,562', 'category': 'CARDINAL'}, {'entity': '7,753', 'category': 'CARDINAL'}, {'entity': '7,619', 'category': 'CARDINAL'}, {'entity': '7,151', 'category': 'CARDINAL'}, {'entity': '6,986', 'category': 'CARDINAL'}, {'entity': '45,419', 'category': 'CARDINAL'}, {'entity': '22.0', 'category': 'CARDINAL'}, {'entity': '8.1', 'category': 'CARDINAL'}, {'entity': '13.9', 'category': 'CARDINAL'}, {'entity': '14.7', 'category': 'CARDINAL'}, {'entity': '9.00', 'category': 'CARDINAL'}, {'entity': '31', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '75', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  17\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWiTHC881ww1cVcFb9PoDAquQu9i\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701571309,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL:2%#70%#53.2 billion#64.0 billion\\n\\nDATE:December 31, 2020#December 31, 2019\\n\\nEVENT:Celgene acquisition\\n\\nGPE:U.S.\\n\\nLAW:340B Drug Pricing Program#Medicare Part D\\n\\nORG:U.S. Department of Defense#U.S. Department of Veterans Affairs#CMS#Medicaid\\n\\nPERCENT:2%\\n\\nPERSON:LOE\\n\\nPRODUCT:commercially marketed products#IPRD assets\\n\\nQUANTITY:two to four week\\n\\nTIME:one month\\n\\nWORK_OF_ART:Item 8. Financial Statements and Supplementary Data\\u2014Note 2. Revenue\\n}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2008,\n",
      "    \"completion_tokens\": 141,\n",
      "    \"total_tokens\": 2149\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'December 31, 2019', 'category': 'DATE'}, {'entity': 'Celgene acquisition', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '340B Drug Pricing Program', 'category': 'LAW'}, {'entity': 'Medicare Part D', 'category': 'LAW'}, {'entity': 'U.S. Department of Defense', 'category': 'ORG'}, {'entity': 'U.S. Department of Veterans Affairs', 'category': 'ORG'}, {'entity': 'CMS', 'category': 'ORG'}, {'entity': 'Medicaid', 'category': 'ORG'}, {'entity': '2%', 'category': 'PERCENT'}, {'entity': 'LOE', 'category': 'PERSON'}, {'entity': 'commercially marketed products', 'category': 'PRODUCT'}, {'entity': 'IPRD assets', 'category': 'PRODUCT'}, {'entity': 'two to four week', 'category': 'QUANTITY'}, {'entity': 'one month', 'category': 'TIME'}, {'entity': 'Item 8. Financial Statements and Supplementary Data—Note 2. Revenue', 'category': 'WORK_OF_ART'}, {'entity': '2%', 'category': 'CARDINAL'}, {'entity': '70%', 'category': 'CARDINAL'}, {'entity': '53.2 billion', 'category': 'CARDINAL'}, {'entity': '64.0 billion', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  17\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWixISGsk0onAVmDi0fRfNIPRtCn\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701571339,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#575#470#20.5#22.5#3.5#2.8#2.1#2.8#1.5#50#244#40\\n\\nDATE#December 31, 2020#December 31, 2019#2022#2021#2009\\n\\nEVENT#Mead Johnson split-off\\n\\nGPE#U.S.\\n\\nLAW#Section 382 of the Internal Revenue Code\\n\\nMONEY#$575 million#$470 million#$20.5 billion#$22.5 billion#$3.5 billion#$2.1 billion\\n\\nORG#Inrebic#orva-cel#Celgene#Mead Johnson#Mead Johnson & Company#Internal Revenue Service \\n\\nPERCENT#40%\\n\\nPERSON#Mead Johnson\\n\\nPRODUCT#Goodwill}\\n\\nNote: No entities were found for the categories - DATE, EVENT, FAC, LANGUAGE, LOC, NORP, ORDINAL, QUANTITY, TIME, and WORK_OF_ART.\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2122,\n",
      "    \"completion_tokens\": 204,\n",
      "    \"total_tokens\": 2326\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'December 31, 2019', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2009', 'category': 'DATE'}, {'entity': 'EVENT', 'category': 'DATE'}, {'entity': 'FAC', 'category': 'DATE'}, {'entity': 'LANGUAGE', 'category': 'DATE'}, {'entity': 'LOC', 'category': 'DATE'}, {'entity': 'NORP', 'category': 'DATE'}, {'entity': 'ORDINAL', 'category': 'DATE'}, {'entity': 'QUANTITY', 'category': 'DATE'}, {'entity': 'TIME', 'category': 'DATE'}, {'entity': 'and WORK_OF_ART.', 'category': 'DATE'}, {'entity': 'Mead Johnson split-off', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Section 382 of the Internal Revenue Code', 'category': 'LAW'}, {'entity': '$575 million', 'category': 'MONEY'}, {'entity': '$470 million', 'category': 'MONEY'}, {'entity': '$20.5 billion', 'category': 'MONEY'}, {'entity': '$22.5 billion', 'category': 'MONEY'}, {'entity': '$3.5 billion', 'category': 'MONEY'}, {'entity': '$2.1 billion', 'category': 'MONEY'}, {'entity': 'Inrebic', 'category': 'ORG'}, {'entity': 'orva-cel', 'category': 'ORG'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': 'Mead Johnson', 'category': 'ORG'}, {'entity': 'Mead Johnson & Company', 'category': 'ORG'}, {'entity': 'Internal Revenue Service', 'category': 'ORG'}, {'entity': '40%', 'category': 'PERCENT'}, {'entity': 'Mead Johnson', 'category': 'PERSON'}, {'entity': 'Goodwill', 'category': 'PRODUCT'}, {'entity': '575', 'category': 'CARDINAL'}, {'entity': '470', 'category': 'CARDINAL'}, {'entity': '20.5', 'category': 'CARDINAL'}, {'entity': '22.5', 'category': 'CARDINAL'}, {'entity': '3.5', 'category': 'CARDINAL'}, {'entity': '2.8', 'category': 'CARDINAL'}, {'entity': '2.1', 'category': 'CARDINAL'}, {'entity': '2.8', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '50', 'category': 'CARDINAL'}, {'entity': '244', 'category': 'CARDINAL'}, {'entity': '40', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  17\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWjV4FUfXUry3i7xw8M0wO4DpP9X\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701571373,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#10\\n\\nDATE#February 2020#October 2020#August 2020#January 2021#April 2020#December 2020#November 2020#September 2020#June 2020#May 2020#March 2020\\n\\nEVENT#Phase III CheckMate-816 trial#Phase III clinical study TASUKI-52#Phase III CheckMate-9ER trial#Phase III Checkmate-025 study#Phase III CheckMate-577 trial#Phase III Checkmate-649 trial#Phase II/III clinical study#Phase III CheckMate-577 trial#Phase III ATTRACTION-3 trial\\n\\nLAW#sBLA#PDUFA#MAA\\n\\nMONEY#10%\\n\\nORG#FDA#EMA#EC#NMPA#CheckMate -9ER#CheckMate-025\\n\\nPERSON#Opdivo#Revlimid#Ono#Cabometyx#Exelixis#CheckMate -649#TASUKI-52#ONO-4538-12#ATTRACTION-3#fluoropyrimidine\\n\\nPRODUCT#Cabometyx\\n\\nTIME#three years#five-year}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2306,\n",
      "    \"completion_tokens\": 250,\n",
      "    \"total_tokens\": 2556\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'February 2020', 'category': 'DATE'}, {'entity': 'October 2020', 'category': 'DATE'}, {'entity': 'August 2020', 'category': 'DATE'}, {'entity': 'January 2021', 'category': 'DATE'}, {'entity': 'April 2020', 'category': 'DATE'}, {'entity': 'December 2020', 'category': 'DATE'}, {'entity': 'November 2020', 'category': 'DATE'}, {'entity': 'September 2020', 'category': 'DATE'}, {'entity': 'June 2020', 'category': 'DATE'}, {'entity': 'May 2020', 'category': 'DATE'}, {'entity': 'March 2020', 'category': 'DATE'}, {'entity': 'Phase III CheckMate-816 trial', 'category': 'EVENT'}, {'entity': 'Phase III clinical study TASUKI-52', 'category': 'EVENT'}, {'entity': 'Phase III CheckMate-9ER trial', 'category': 'EVENT'}, {'entity': 'Phase III Checkmate-025 study', 'category': 'EVENT'}, {'entity': 'Phase III CheckMate-577 trial', 'category': 'EVENT'}, {'entity': 'Phase III Checkmate-649 trial', 'category': 'EVENT'}, {'entity': 'Phase II/III clinical study', 'category': 'EVENT'}, {'entity': 'Phase III CheckMate-577 trial', 'category': 'EVENT'}, {'entity': 'Phase III ATTRACTION-3 trial', 'category': 'EVENT'}, {'entity': 'sBLA', 'category': 'LAW'}, {'entity': 'PDUFA', 'category': 'LAW'}, {'entity': 'MAA', 'category': 'LAW'}, {'entity': '10%', 'category': 'MONEY'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'EMA', 'category': 'ORG'}, {'entity': 'EC', 'category': 'ORG'}, {'entity': 'NMPA', 'category': 'ORG'}, {'entity': 'CheckMate -9ER', 'category': 'ORG'}, {'entity': 'CheckMate-025', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Revlimid', 'category': 'PERSON'}, {'entity': 'Ono', 'category': 'PERSON'}, {'entity': 'Cabometyx', 'category': 'PERSON'}, {'entity': 'Exelixis', 'category': 'PERSON'}, {'entity': 'CheckMate -649', 'category': 'PERSON'}, {'entity': 'TASUKI-52', 'category': 'PERSON'}, {'entity': 'ONO-4538-12', 'category': 'PERSON'}, {'entity': 'ATTRACTION-3', 'category': 'PERSON'}, {'entity': 'fluoropyrimidine', 'category': 'PERSON'}, {'entity': 'Cabometyx', 'category': 'PRODUCT'}, {'entity': 'three years', 'category': 'TIME'}, {'entity': 'five-year', 'category': 'TIME'}, {'entity': '10', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  17\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWk2KcAcBjtN8hrDSNWb2DNuqphG\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701571406,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#half#four\\n\\nDATE#December 2020#February 2020#December 2020#February 2021#January 2020#November 2020#November 2020#May 2020#May 2020#May 2020#January 2020#October 2020#October 2020#October 2020#September 2020#April 2020#September 2020\\n\\nEVENT#trial#CheckMate-032#CheckMate-451#CheckMate-331#CheckMate-142#CheckMate-548#CheckMate-274#ONO-4538-23#Opdivo+Yervoy#Phase III CheckMate-227#CheckMate-915#Phase III CheckMate-743#CheckMate-743\\n\\nFAC#FDA#MHLW\\n\\nGPE#Japan\\n\\nLAW#MSI-H\\n\\nLOC#CRC\\n\\nMONEY#\\n\\nNORP#\\n\\nORDINAL#first#second#third\\n\\nORG#Ono#BMS#Opdivo#SCLC#ESCC#MHLW#CheckMate-142#BMS#Opdivo#FDA#HSI-H#DMC#NSCLC#Opdivo#Opdivo#Opdivo#\\n\\nPERCENT#\\n\\nPERSON#EC \\n\\nPRODUCT#Opdivo#Yervoy\\n\\nQUANTITY#\\n\\nTIME#\\n\\nWORK_OF_ART#Opdivo+Yervoy}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2330,\n",
      "    \"completion_tokens\": 303,\n",
      "    \"total_tokens\": 2633\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 2020', 'category': 'DATE'}, {'entity': 'February 2020', 'category': 'DATE'}, {'entity': 'December 2020', 'category': 'DATE'}, {'entity': 'February 2021', 'category': 'DATE'}, {'entity': 'January 2020', 'category': 'DATE'}, {'entity': 'November 2020', 'category': 'DATE'}, {'entity': 'November 2020', 'category': 'DATE'}, {'entity': 'May 2020', 'category': 'DATE'}, {'entity': 'May 2020', 'category': 'DATE'}, {'entity': 'May 2020', 'category': 'DATE'}, {'entity': 'January 2020', 'category': 'DATE'}, {'entity': 'October 2020', 'category': 'DATE'}, {'entity': 'October 2020', 'category': 'DATE'}, {'entity': 'October 2020', 'category': 'DATE'}, {'entity': 'September 2020', 'category': 'DATE'}, {'entity': 'April 2020', 'category': 'DATE'}, {'entity': 'September 2020', 'category': 'DATE'}, {'entity': 'trial', 'category': 'EVENT'}, {'entity': 'CheckMate-032', 'category': 'EVENT'}, {'entity': 'CheckMate-451', 'category': 'EVENT'}, {'entity': 'CheckMate-331', 'category': 'EVENT'}, {'entity': 'CheckMate-142', 'category': 'EVENT'}, {'entity': 'CheckMate-548', 'category': 'EVENT'}, {'entity': 'CheckMate-274', 'category': 'EVENT'}, {'entity': 'ONO-4538-23', 'category': 'EVENT'}, {'entity': 'Opdivo+Yervoy', 'category': 'EVENT'}, {'entity': 'Phase III CheckMate-227', 'category': 'EVENT'}, {'entity': 'CheckMate-915', 'category': 'EVENT'}, {'entity': 'Phase III CheckMate-743', 'category': 'EVENT'}, {'entity': 'CheckMate-743', 'category': 'EVENT'}, {'entity': 'FDA', 'category': 'FAC'}, {'entity': 'MHLW', 'category': 'FAC'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'MSI-H', 'category': 'LAW'}, {'entity': 'CRC', 'category': 'LOC'}, {'entity': 'Ono', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'SCLC', 'category': 'ORG'}, {'entity': 'ESCC', 'category': 'ORG'}, {'entity': 'MHLW', 'category': 'ORG'}, {'entity': 'CheckMate-142', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'HSI-H', 'category': 'ORG'}, {'entity': 'DMC', 'category': 'ORG'}, {'entity': 'NSCLC', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'EC', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Yervoy', 'category': 'PRODUCT'}, {'entity': 'Opdivo+Yervoy', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'second', 'category': 'ORDINAL'}, {'entity': 'third', 'category': 'ORDINAL'}, {'entity': 'half', 'category': 'CARDINAL'}, {'entity': 'four', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  17\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWkbhZkkzqPBAUkD3bM2CrR0EKgt\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701571441,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{DATE#February 2020#September 2020#March 2020#June 2020#April 2020#December 2020#February 2021#May 2020#May 30, 2021#September 2020#May 2021\\n\\nEVENT#Phase III CheckMate-214 study#American Society of Clinical Oncology 2020 Genitourinary Cancers Symposium#Phase I/II CheckMate-040 trial#Phase IV exploratory biomarker study#Phase III ELOQUENT-1 trial\\n\\nFAC#FDA\\n\\nGPE#San Francisco#Japan\\n\\nMONEY#1mg/kg#3 mg/kg\\n\\nORG#Ono#FDA#EMA#Zeposia#EC#RMS\\n\\nPERSON#Pomalyst#Revlimid#Empliciti#Inrebic#Onureg#Breyanzi\\n\\nPRODUCT#Opdivo+Yervoy#sunitinib#Opdivo 1mg/kg#Yervoy 3 mg/kg#sorafenib#Orencia#aduluimab#Pomalyst#Kaposi sarcoma#Empliciti+Revlimid#dexamethasone#Reblozyl#Zeposia#Inrebic#Onureg#Breyanzi\\n\\nWORK_OF_ART#Orencia for Intravenous Infusion 250mg#Orencia for Subcutaneous Injection 125mg Syringe 1mL#Orencia for Subcutaneous Injection 125mg Auto-injector 1mL\\n\\nCARDINAL#250mg#125mg#1mL\\n\\nORDINAL#first}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2416,\n",
      "    \"completion_tokens\": 347,\n",
      "    \"total_tokens\": 2763\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'February 2020', 'category': 'DATE'}, {'entity': 'September 2020', 'category': 'DATE'}, {'entity': 'March 2020', 'category': 'DATE'}, {'entity': 'June 2020', 'category': 'DATE'}, {'entity': 'April 2020', 'category': 'DATE'}, {'entity': 'December 2020', 'category': 'DATE'}, {'entity': 'February 2021', 'category': 'DATE'}, {'entity': 'May 2020', 'category': 'DATE'}, {'entity': 'May 30, 2021', 'category': 'DATE'}, {'entity': 'September 2020', 'category': 'DATE'}, {'entity': 'May 2021', 'category': 'DATE'}, {'entity': 'Phase III CheckMate-214 study', 'category': 'EVENT'}, {'entity': 'American Society of Clinical Oncology 2020 Genitourinary Cancers Symposium', 'category': 'EVENT'}, {'entity': 'Phase I/II CheckMate-040 trial', 'category': 'EVENT'}, {'entity': 'Phase IV exploratory biomarker study', 'category': 'EVENT'}, {'entity': 'Phase III ELOQUENT-1 trial', 'category': 'EVENT'}, {'entity': 'FDA', 'category': 'FAC'}, {'entity': 'San Francisco', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': '1mg/kg', 'category': 'MONEY'}, {'entity': '3 mg/kg', 'category': 'MONEY'}, {'entity': 'Ono', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'EMA', 'category': 'ORG'}, {'entity': 'Zeposia', 'category': 'ORG'}, {'entity': 'EC', 'category': 'ORG'}, {'entity': 'RMS', 'category': 'ORG'}, {'entity': 'Pomalyst', 'category': 'PERSON'}, {'entity': 'Revlimid', 'category': 'PERSON'}, {'entity': 'Empliciti', 'category': 'PERSON'}, {'entity': 'Inrebic', 'category': 'PERSON'}, {'entity': 'Onureg', 'category': 'PERSON'}, {'entity': 'Breyanzi', 'category': 'PERSON'}, {'entity': 'Opdivo+Yervoy', 'category': 'PRODUCT'}, {'entity': 'sunitinib', 'category': 'PRODUCT'}, {'entity': 'Opdivo 1mg/kg', 'category': 'PRODUCT'}, {'entity': 'Yervoy 3 mg/kg', 'category': 'PRODUCT'}, {'entity': 'sorafenib', 'category': 'PRODUCT'}, {'entity': 'Orencia', 'category': 'PRODUCT'}, {'entity': 'aduluimab', 'category': 'PRODUCT'}, {'entity': 'Pomalyst', 'category': 'PRODUCT'}, {'entity': 'Kaposi sarcoma', 'category': 'PRODUCT'}, {'entity': 'Empliciti+Revlimid', 'category': 'PRODUCT'}, {'entity': 'dexamethasone', 'category': 'PRODUCT'}, {'entity': 'Reblozyl', 'category': 'PRODUCT'}, {'entity': 'Zeposia', 'category': 'PRODUCT'}, {'entity': 'Inrebic', 'category': 'PRODUCT'}, {'entity': 'Onureg', 'category': 'PRODUCT'}, {'entity': 'Breyanzi', 'category': 'PRODUCT'}, {'entity': 'Orencia for Intravenous Infusion 250mg', 'category': 'WORK_OF_ART'}, {'entity': 'Orencia for Subcutaneous Injection 125mg Syringe 1mL', 'category': 'WORK_OF_ART'}, {'entity': 'Orencia for Subcutaneous Injection 125mg Auto-injector 1mL', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '250mg', 'category': 'CARDINAL'}, {'entity': '125mg', 'category': 'CARDINAL'}, {'entity': '1mL', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  17\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWlCbCvRp1CLChiy3cBXjhJlIlQ7\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701571478,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#2#3#16#75#2#3#73#33#50#2#150#1#75#16#2020\\n\\nDATE#July 2020#September 2020#May 2020#February 2021#November 2020#August 2020#March 27, 2021\\n\\nEVENT#POETYK PSO-2#Phase II KarMMa study#Phase III POETYK PSO-1 trial#Phase III IDHENTIFY study\\n\\nFAC#the FDA\\n\\nGPE#B-cell lymphoma#adult patients#plaque psoriasis#moderate to severe plaque psoriasis\\n\\nLAW#Section 27A of the Securities Act, and Section 21E of the Exchange Act\\n\\nMONEY#6 mg\\n\\nORG#Breyanzi#EMA#liso-cel#CAR T cell therapy#FDA#Priority Review#BLA#ide-cel#proteasome inhibitor#anti-CD38 antibody#bluebird#Accelerated Assessment status#EMA#KarMMa#deucravacitinib#BMS-986165#Plaque Psoriasis#POETYK PSO-2#Otezla#Phase III#AML#Idhifa#Celgene#MyoKardia#COVID-19#Exchange Act\\n\\nPERSON#Tyrosine kinase#Physician\\n\\nPRODUCT#Breyanzi (lisocabtagene maraleucel; liso-cel)#Ide-cel#deucravacitinib(BMS-986165)#Idhifa\\n\\nTIME#16 weeks\\n\\nQUANTITY#bb2121}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2350,\n",
      "    \"completion_tokens\": 345,\n",
      "    \"total_tokens\": 2695\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'July 2020', 'category': 'DATE'}, {'entity': 'September 2020', 'category': 'DATE'}, {'entity': 'May 2020', 'category': 'DATE'}, {'entity': 'February 2021', 'category': 'DATE'}, {'entity': 'November 2020', 'category': 'DATE'}, {'entity': 'August 2020', 'category': 'DATE'}, {'entity': 'March 27, 2021', 'category': 'DATE'}, {'entity': 'POETYK PSO-2', 'category': 'EVENT'}, {'entity': 'Phase II KarMMa study', 'category': 'EVENT'}, {'entity': 'Phase III POETYK PSO-1 trial', 'category': 'EVENT'}, {'entity': 'Phase III IDHENTIFY study', 'category': 'EVENT'}, {'entity': 'the FDA', 'category': 'FAC'}, {'entity': 'B-cell lymphoma', 'category': 'GPE'}, {'entity': 'adult patients', 'category': 'GPE'}, {'entity': 'plaque psoriasis', 'category': 'GPE'}, {'entity': 'moderate to severe plaque psoriasis', 'category': 'GPE'}, {'entity': 'Section 27A of the Securities Act', 'category': 'LAW'}, {'entity': 'and Section 21E of the Exchange Act', 'category': 'LAW'}, {'entity': '6 mg', 'category': 'MONEY'}, {'entity': 'Breyanzi', 'category': 'ORG'}, {'entity': 'EMA', 'category': 'ORG'}, {'entity': 'liso-cel', 'category': 'ORG'}, {'entity': 'CAR T cell therapy', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'Priority Review', 'category': 'ORG'}, {'entity': 'BLA', 'category': 'ORG'}, {'entity': 'ide-cel', 'category': 'ORG'}, {'entity': 'proteasome inhibitor', 'category': 'ORG'}, {'entity': 'anti-CD38 antibody', 'category': 'ORG'}, {'entity': 'bluebird', 'category': 'ORG'}, {'entity': 'Accelerated Assessment status', 'category': 'ORG'}, {'entity': 'EMA', 'category': 'ORG'}, {'entity': 'KarMMa', 'category': 'ORG'}, {'entity': 'deucravacitinib', 'category': 'ORG'}, {'entity': 'BMS-986165', 'category': 'ORG'}, {'entity': 'Plaque Psoriasis', 'category': 'ORG'}, {'entity': 'POETYK PSO-2', 'category': 'ORG'}, {'entity': 'Otezla', 'category': 'ORG'}, {'entity': 'Phase III', 'category': 'ORG'}, {'entity': 'AML', 'category': 'ORG'}, {'entity': 'Idhifa', 'category': 'ORG'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': 'MyoKardia', 'category': 'ORG'}, {'entity': 'COVID-19', 'category': 'ORG'}, {'entity': 'Exchange Act', 'category': 'ORG'}, {'entity': 'Tyrosine kinase', 'category': 'PERSON'}, {'entity': 'Physician', 'category': 'PERSON'}, {'entity': 'Breyanzi lisocabtagene maraleucel; liso-cel', 'category': 'PRODUCT'}, {'entity': 'Ide-cel', 'category': 'PRODUCT'}, {'entity': 'deucravacitinibBMS-986165', 'category': 'PRODUCT'}, {'entity': 'Idhifa', 'category': 'PRODUCT'}, {'entity': 'bb2121', 'category': 'QUANTITY'}, {'entity': '16 weeks', 'category': 'TIME'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '16', 'category': 'CARDINAL'}, {'entity': '75', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '73', 'category': 'CARDINAL'}, {'entity': '33', 'category': 'CARDINAL'}, {'entity': '50', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '150', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '75', 'category': 'CARDINAL'}, {'entity': '16', 'category': 'CARDINAL'}, {'entity': '2020', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  17\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWlmCDRd2imwxGE6gXyRagScJoTm\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701571514,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#10#742 million#358 million#100\\n\\nDATE#December 31, 2020#December 31, 2019\\n\\nGPE#U.S.#Japan\\n\\nLANGUAGE#Japanese#non-U.S.\\n\\nMONEY#$742 million#$358 million#$4.7 billion#$3.8 billion\\n\\nORG#Company's\\n\\nPERSON#Accumulated\\n\\nQUANTITY#100 basis points\\n\\nTIME#year-end\\n\\nWORK_OF_ART#Item 8. Financial Statements and Supplementary Data\\u2014Note 9. Financial Instruments and Fair Value Measurements}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 1299,\n",
      "    \"completion_tokens\": 115,\n",
      "    \"total_tokens\": 1414\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'December 31, 2019', 'category': 'DATE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'Japanese', 'category': 'LANGUAGE'}, {'entity': 'non-U.S.', 'category': 'LANGUAGE'}, {'entity': '$742 million', 'category': 'MONEY'}, {'entity': '$358 million', 'category': 'MONEY'}, {'entity': '$4.7 billion', 'category': 'MONEY'}, {'entity': '$3.8 billion', 'category': 'MONEY'}, {'entity': 'Companys', 'category': 'ORG'}, {'entity': 'Accumulated', 'category': 'PERSON'}, {'entity': '100 basis points', 'category': 'QUANTITY'}, {'entity': 'year-end', 'category': 'TIME'}, {'entity': 'Item 8. Financial Statements and Supplementary Data—Note 9. Financial Instruments and Fair Value Measurements', 'category': 'WORK_OF_ART'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '742 million', 'category': 'CARDINAL'}, {'entity': '358 million', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}]\n",
      "/home/damir/Dropbox/Documents/Teaching/2023/L715/l715_23/data/10-Ks/Bristol-Myers_Squibb_Company/2018/Management.txt\n",
      "Length of chunks:  15\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWmF1ZW8bWfdNZf2uLAs6OBTtnpd\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701571543,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#7#15#17#35#7#17#2017\\n\\nDATE#Year Ended December 31#December 2017#September 2017#August 2017#June 2017#April 2017#March 2017#February 2017#July 2017#March 2017#November 2017#July 2017#April 2017#2017#early 2018\\n\\nEVENT#EXECUTIVE SUMMARY#Significant Product and Pipeline Approvals#\\n\\nFAC#\\n\\nGPE#U.S.#EU#Japan#China#North America#\\n\\nLANGUAGE#\\n\\nLAW#2017 Form 10-K#\\n\\nLOC#\\n\\nMONEY#$2.04#$1.76#$0.18#20,776#19,427#16,560#\\n\\nNORP#\\n\\nORDINAL#\\n\\nORG#MANAGEMENT\\u2019S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS#Bristol-Myers Squibb Company#Opdivo#Yervoy#our IO#FGF21#TYK-2#Daklinza#GAAP#non-GAAP#Abilify*#Erbitux*#Reyataz#Sustiva#Baraclude#Diluted Earnings Per Share#GAAP Non-GAAP#\\u2014Non-GAAP Financial Measures\\n\\nPERCENT#\\n\\nPERSON#\\n\\nPRODUCT#Eliquis\\n\\nQUANTITY#\\n\\nTIME#\\n\\nWORK_OF_ART#TREATMENT OF OPERATIONS\\n}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2293,\n",
      "    \"completion_tokens\": 312,\n",
      "    \"total_tokens\": 2605\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': 'December 2017', 'category': 'DATE'}, {'entity': 'September 2017', 'category': 'DATE'}, {'entity': 'August 2017', 'category': 'DATE'}, {'entity': 'June 2017', 'category': 'DATE'}, {'entity': 'April 2017', 'category': 'DATE'}, {'entity': 'March 2017', 'category': 'DATE'}, {'entity': 'February 2017', 'category': 'DATE'}, {'entity': 'July 2017', 'category': 'DATE'}, {'entity': 'March 2017', 'category': 'DATE'}, {'entity': 'November 2017', 'category': 'DATE'}, {'entity': 'July 2017', 'category': 'DATE'}, {'entity': 'April 2017', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': 'early 2018', 'category': 'DATE'}, {'entity': 'EXECUTIVE SUMMARY', 'category': 'EVENT'}, {'entity': 'Significant Product and Pipeline Approvals', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'EU', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'China', 'category': 'GPE'}, {'entity': 'North America', 'category': 'GPE'}, {'entity': '2017 Form 10-K', 'category': 'LAW'}, {'entity': '$2.04', 'category': 'MONEY'}, {'entity': '$1.76', 'category': 'MONEY'}, {'entity': '$0.18', 'category': 'MONEY'}, {'entity': '20,776', 'category': 'MONEY'}, {'entity': '19,427', 'category': 'MONEY'}, {'entity': '16,560', 'category': 'MONEY'}, {'entity': 'MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS', 'category': 'ORG'}, {'entity': 'Bristol-Myers Squibb Company', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Yervoy', 'category': 'ORG'}, {'entity': 'our IO', 'category': 'ORG'}, {'entity': 'FGF21', 'category': 'ORG'}, {'entity': 'TYK-2', 'category': 'ORG'}, {'entity': 'Daklinza', 'category': 'ORG'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': 'non-GAAP', 'category': 'ORG'}, {'entity': 'Abilify*', 'category': 'ORG'}, {'entity': 'Erbitux*', 'category': 'ORG'}, {'entity': 'Reyataz', 'category': 'ORG'}, {'entity': 'Sustiva', 'category': 'ORG'}, {'entity': 'Baraclude', 'category': 'ORG'}, {'entity': 'Diluted Earnings Per Share', 'category': 'ORG'}, {'entity': 'GAAP Non-GAAP', 'category': 'ORG'}, {'entity': '—Non-GAAP Financial Measures', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'PRODUCT'}, {'entity': 'TREATMENT OF OPERATIONS', 'category': 'WORK_OF_ART'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '15', 'category': 'CARDINAL'}, {'entity': '17', 'category': 'CARDINAL'}, {'entity': '35', 'category': 'CARDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '17', 'category': 'CARDINAL'}, {'entity': '2017', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  15\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWmptQsNGsUZEWjfEQvcGk0iO01U\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701571579,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#2017#2016#2015#10\\n\\nDATE#the past three years\\n\\nEVENT#acquisition and licensing arrangements#commercial model evolution#operating model transformation\\n\\nGPE#U.S.#Japan#South Korea#Taiwan#China#ASEAN \\n\\nLOC#Duchenne\\n\\nMONEY#2015\\n\\nORG#Opdivo#Yervoy#Eliquis#Orencia#Sprycel#Ono#Halozyme#IFM#Biogen#Roche#CytomX#PsiOxus#Padlock#Cormorant#Nitto Denko#Flexus#Cardioxyl#Five Prime#Promedior#Bavarian Nordic#uniQure\\n\\nPERSON#\\n\\nPRODUCT#ONO-4578#Prostaglandin E2 receptor 4#ENHANZE#STING#NLRP3#BMS-986168#eTau#BMS-986089#myostatin adnectin#Probody#NG-348#PAD inhibitor#HuMax-IL8#monoclonal antibody#HSP47#ND-L02-s0201#F001287#IDO1-inhibitor#IDO#TDO#CXL-1427#nitroxyl prodrug#cabiralizumab#CSF1R#PRM-151#IPF#MF#Prostvac#prostate-specific antigen#S100A1#gene therapy\\n\\nQUANTITY#\\n\\nTIME#\\n\\nWORK_OF_ART#}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2208,\n",
      "    \"completion_tokens\": 315,\n",
      "    \"total_tokens\": 2523\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'the past three years', 'category': 'DATE'}, {'entity': 'acquisition and licensing arrangements', 'category': 'EVENT'}, {'entity': 'commercial model evolution', 'category': 'EVENT'}, {'entity': 'operating model transformation', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'South Korea', 'category': 'GPE'}, {'entity': 'Taiwan', 'category': 'GPE'}, {'entity': 'China', 'category': 'GPE'}, {'entity': 'ASEAN', 'category': 'GPE'}, {'entity': 'Duchenne', 'category': 'LOC'}, {'entity': '2015', 'category': 'MONEY'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Yervoy', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'Orencia', 'category': 'ORG'}, {'entity': 'Sprycel', 'category': 'ORG'}, {'entity': 'Ono', 'category': 'ORG'}, {'entity': 'Halozyme', 'category': 'ORG'}, {'entity': 'IFM', 'category': 'ORG'}, {'entity': 'Biogen', 'category': 'ORG'}, {'entity': 'Roche', 'category': 'ORG'}, {'entity': 'CytomX', 'category': 'ORG'}, {'entity': 'PsiOxus', 'category': 'ORG'}, {'entity': 'Padlock', 'category': 'ORG'}, {'entity': 'Cormorant', 'category': 'ORG'}, {'entity': 'Nitto Denko', 'category': 'ORG'}, {'entity': 'Flexus', 'category': 'ORG'}, {'entity': 'Cardioxyl', 'category': 'ORG'}, {'entity': 'Five Prime', 'category': 'ORG'}, {'entity': 'Promedior', 'category': 'ORG'}, {'entity': 'Bavarian Nordic', 'category': 'ORG'}, {'entity': 'uniQure', 'category': 'ORG'}, {'entity': 'ONO-4578', 'category': 'PRODUCT'}, {'entity': 'Prostaglandin E2 receptor 4', 'category': 'PRODUCT'}, {'entity': 'ENHANZE', 'category': 'PRODUCT'}, {'entity': 'STING', 'category': 'PRODUCT'}, {'entity': 'NLRP3', 'category': 'PRODUCT'}, {'entity': 'BMS-986168', 'category': 'PRODUCT'}, {'entity': 'eTau', 'category': 'PRODUCT'}, {'entity': 'BMS-986089', 'category': 'PRODUCT'}, {'entity': 'myostatin adnectin', 'category': 'PRODUCT'}, {'entity': 'Probody', 'category': 'PRODUCT'}, {'entity': 'NG-348', 'category': 'PRODUCT'}, {'entity': 'PAD inhibitor', 'category': 'PRODUCT'}, {'entity': 'HuMax-IL8', 'category': 'PRODUCT'}, {'entity': 'monoclonal antibody', 'category': 'PRODUCT'}, {'entity': 'HSP47', 'category': 'PRODUCT'}, {'entity': 'ND-L02-s0201', 'category': 'PRODUCT'}, {'entity': 'F001287', 'category': 'PRODUCT'}, {'entity': 'IDO1-inhibitor', 'category': 'PRODUCT'}, {'entity': 'IDO', 'category': 'PRODUCT'}, {'entity': 'TDO', 'category': 'PRODUCT'}, {'entity': 'CXL-1427', 'category': 'PRODUCT'}, {'entity': 'nitroxyl prodrug', 'category': 'PRODUCT'}, {'entity': 'cabiralizumab', 'category': 'PRODUCT'}, {'entity': 'CSF1R', 'category': 'PRODUCT'}, {'entity': 'PRM-151', 'category': 'PRODUCT'}, {'entity': 'IPF', 'category': 'PRODUCT'}, {'entity': 'MF', 'category': 'PRODUCT'}, {'entity': 'Prostvac', 'category': 'PRODUCT'}, {'entity': 'prostate-specific antigen', 'category': 'PRODUCT'}, {'entity': 'S100A1', 'category': 'PRODUCT'}, {'entity': 'gene therapy', 'category': 'PRODUCT'}, {'entity': '', 'category': 'WORK_OF_ART'}, {'entity': '2017', 'category': 'CARDINAL'}, {'entity': '2016', 'category': 'CARDINAL'}, {'entity': '2015', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  15\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWnO6u6Wr6xEOVcODWZpaJEmcjjh\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701571614,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#7#6#18#1#21#2#2#5#10#2#5#7#2#14#30#24#31#13#10#2#31#13#1#5#6#10#14#1#5#18#54#7#10#18#10#1#10#12#20#32#12#23#74#87#60#7#6#8#9#3#1#9 \\n\\nDATE#Year Ended December 31, 2017#Year Ended December 31, 2016#Year Ended December 31, 2015#Balance at January 1, 2016#Balance at December 31, 2016#Balance at December 31, 2017\\n\\nEVENT#the changes in revenues#Product Revenues\\n\\nGPE#United States#Europe#Japan#Latin America\\n\\nMONEY#4, 988#10, 720#11, 358#3, 964#3, 877#528#553#739#19, 427#20, 776#8, 188#16, 560#10#52#2, 772#2, 066#2, 834#1, 297#2, 807\\n\\nORG#NKT#PD-1\\n\\nPERCENT#50%#1%#2%#5%#10%#31%#18%\\n\\nPRODUCT#Eliquis#Opdivo#Daklinza#HIV brands#Opdivo and Daklinza#Erbitux#Yervoy#Hepatitis C Franchise#Abilify\\n\\nQUANTITY#10% of total revenues#2% higher#5% higher#2% higher\\n\\nTIME#2017 vs. 2016#2016 vs. 2015}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 3503,\n",
      "    \"completion_tokens\": 394,\n",
      "    \"total_tokens\": 3897\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'Year Ended December 31, 2017', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2016', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2015', 'category': 'DATE'}, {'entity': 'Balance at January 1, 2016', 'category': 'DATE'}, {'entity': 'Balance at December 31, 2016', 'category': 'DATE'}, {'entity': 'Balance at December 31, 2017', 'category': 'DATE'}, {'entity': 'the changes in revenues', 'category': 'EVENT'}, {'entity': 'Product Revenues', 'category': 'EVENT'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'Europe', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'Latin America', 'category': 'GPE'}, {'entity': '4, 988', 'category': 'MONEY'}, {'entity': '10, 720', 'category': 'MONEY'}, {'entity': '11, 358', 'category': 'MONEY'}, {'entity': '3, 964', 'category': 'MONEY'}, {'entity': '3, 877', 'category': 'MONEY'}, {'entity': '528', 'category': 'MONEY'}, {'entity': '553', 'category': 'MONEY'}, {'entity': '739', 'category': 'MONEY'}, {'entity': '19, 427', 'category': 'MONEY'}, {'entity': '20, 776', 'category': 'MONEY'}, {'entity': '8, 188', 'category': 'MONEY'}, {'entity': '16, 560', 'category': 'MONEY'}, {'entity': '10', 'category': 'MONEY'}, {'entity': '52', 'category': 'MONEY'}, {'entity': '2, 772', 'category': 'MONEY'}, {'entity': '2, 066', 'category': 'MONEY'}, {'entity': '2, 834', 'category': 'MONEY'}, {'entity': '1, 297', 'category': 'MONEY'}, {'entity': '2, 807', 'category': 'MONEY'}, {'entity': 'NKT', 'category': 'ORG'}, {'entity': 'PD-1', 'category': 'ORG'}, {'entity': '50%', 'category': 'PERCENT'}, {'entity': '1%', 'category': 'PERCENT'}, {'entity': '2%', 'category': 'PERCENT'}, {'entity': '5%', 'category': 'PERCENT'}, {'entity': '10%', 'category': 'PERCENT'}, {'entity': '31%', 'category': 'PERCENT'}, {'entity': '18%', 'category': 'PERCENT'}, {'entity': 'Eliquis', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Daklinza', 'category': 'PRODUCT'}, {'entity': 'HIV brands', 'category': 'PRODUCT'}, {'entity': 'Opdivo and Daklinza', 'category': 'PRODUCT'}, {'entity': 'Erbitux', 'category': 'PRODUCT'}, {'entity': 'Yervoy', 'category': 'PRODUCT'}, {'entity': 'Hepatitis C Franchise', 'category': 'PRODUCT'}, {'entity': 'Abilify', 'category': 'PRODUCT'}, {'entity': '10% of total revenues', 'category': 'QUANTITY'}, {'entity': '2% higher', 'category': 'QUANTITY'}, {'entity': '5% higher', 'category': 'QUANTITY'}, {'entity': '2% higher', 'category': 'QUANTITY'}, {'entity': '2017 vs. 2016', 'category': 'TIME'}, {'entity': '2016 vs. 2015', 'category': 'TIME'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '18', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '21', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '5', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '5', 'category': 'CARDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '14', 'category': 'CARDINAL'}, {'entity': '30', 'category': 'CARDINAL'}, {'entity': '24', 'category': 'CARDINAL'}, {'entity': '31', 'category': 'CARDINAL'}, {'entity': '13', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '31', 'category': 'CARDINAL'}, {'entity': '13', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '14', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '5', 'category': 'CARDINAL'}, {'entity': '18', 'category': 'CARDINAL'}, {'entity': '54', 'category': 'CARDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '18', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '32', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '23', 'category': 'CARDINAL'}, {'entity': '74', 'category': 'CARDINAL'}, {'entity': '87', 'category': 'CARDINAL'}, {'entity': '60', 'category': 'CARDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': '9', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '9', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  15\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWo1LMbrUP5eyeYKHRv887vT1s0d\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701571653,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#1.2#3.0#2.6#95 \\n\\nDATE#September 30, 2017#June 30, 2017#December 31, 2017#December 2015#May 2016#September 2016#December 2017#July 2015#April 2015#October 2015\\n\\nEVENT#SEC Consent Order\\n\\nGPE#U.S.#Europe#France#Gulf Countries#Japan#Canada\\n\\nLANGUAGE#English\\n\\nLAW_DOCUMENT#Item 8. Financial Statements\\u2014Note 3. Alliances\\n\\nORG#Opdivo#Eliquis#Orencia#Sprycel#Gleevec#Yervoy#Empliciti#Baraclude#Sustiva#Atripla#Gilead#BMS#Reyataz#Tybost#Hepatitis C Franchise#Daklinza#Sunvepra#Erbitux#Lilly#SEC#Dafalgan#Efferalgan#Fervex#Perfalgan\\n\\nPERSON#Abilify\\n\\nPRODUCT#Philadelphia chromosome\\n\\nTIME#1.7 months\\n\\nWORK_OF_ART#Philadelphia chromosome-positive chronic myeloid leukemia}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2373,\n",
      "    \"completion_tokens\": 259,\n",
      "    \"total_tokens\": 2632\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'September 30, 2017', 'category': 'DATE'}, {'entity': 'June 30, 2017', 'category': 'DATE'}, {'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': 'December 2015', 'category': 'DATE'}, {'entity': 'May 2016', 'category': 'DATE'}, {'entity': 'September 2016', 'category': 'DATE'}, {'entity': 'December 2017', 'category': 'DATE'}, {'entity': 'July 2015', 'category': 'DATE'}, {'entity': 'April 2015', 'category': 'DATE'}, {'entity': 'October 2015', 'category': 'DATE'}, {'entity': 'SEC Consent Order', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Europe', 'category': 'GPE'}, {'entity': 'France', 'category': 'GPE'}, {'entity': 'Gulf Countries', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'Canada', 'category': 'GPE'}, {'entity': 'English', 'category': 'LANGUAGE'}, {'entity': 'DOCUMENT', 'category': 'LAW'}, {'entity': 'Item 8. Financial Statements—Note 3. Alliances', 'category': 'LAW'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'Orencia', 'category': 'ORG'}, {'entity': 'Sprycel', 'category': 'ORG'}, {'entity': 'Gleevec', 'category': 'ORG'}, {'entity': 'Yervoy', 'category': 'ORG'}, {'entity': 'Empliciti', 'category': 'ORG'}, {'entity': 'Baraclude', 'category': 'ORG'}, {'entity': 'Sustiva', 'category': 'ORG'}, {'entity': 'Atripla', 'category': 'ORG'}, {'entity': 'Gilead', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Reyataz', 'category': 'ORG'}, {'entity': 'Tybost', 'category': 'ORG'}, {'entity': 'Hepatitis C Franchise', 'category': 'ORG'}, {'entity': 'Daklinza', 'category': 'ORG'}, {'entity': 'Sunvepra', 'category': 'ORG'}, {'entity': 'Erbitux', 'category': 'ORG'}, {'entity': 'Lilly', 'category': 'ORG'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'Dafalgan', 'category': 'ORG'}, {'entity': 'Efferalgan', 'category': 'ORG'}, {'entity': 'Fervex', 'category': 'ORG'}, {'entity': 'Perfalgan', 'category': 'ORG'}, {'entity': 'Abilify', 'category': 'PERSON'}, {'entity': 'Philadelphia chromosome', 'category': 'PRODUCT'}, {'entity': '1.7 months', 'category': 'TIME'}, {'entity': 'Philadelphia chromosome-positive chronic myeloid leukemia', 'category': 'WORK_OF_ART'}, {'entity': '1.2', 'category': 'CARDINAL'}, {'entity': '3.0', 'category': 'CARDINAL'}, {'entity': '2.6', 'category': 'CARDINAL'}, {'entity': '95', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  15\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWoZ430ta5w9ighgjRRmdHi321VY\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701571687,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#100#800#167#350#60#50#439#1,679#160#160#1,883#2020\\n\\nDATE#year ended December 31, 2017#2017#2016#2015\\n\\nGPE#U.S.#Ireland#Puerto Rico\\n\\nMONEY#$6,066#$4,946#$3,909#$719 million#$146 million#$700 million\\n\\nNORP#annual\\n\\nORG#Form 10-K#Form 10-Q#Eliquis#Daklinza#Opdivo#IFM#CytomX#Halozyme#Flexus#Cardioxyl#PsiOxus#Ono#Padlock#Cormorant#Nitto Denko#Five Prime#Promedior#Bavarian Nordic#uniQure#F-Star Alpha#LPA1 Antagonist#Connecticut\\n\\nPERCENT#23#27#18#16#100%\\n\\nPERSON#Walllingford\\n\\nPRODUCT#R&D\\n\\nTIME#through 2020\\n\\nWORK_OF_ART#Item 8. Financial Statements\\u2014Note 4. Acquisitions, Divestitures and Licensing Arrangements}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2447,\n",
      "    \"completion_tokens\": 250,\n",
      "    \"total_tokens\": 2697\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'year ended December 31, 2017', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Ireland', 'category': 'GPE'}, {'entity': 'Puerto Rico', 'category': 'GPE'}, {'entity': '$6,066', 'category': 'MONEY'}, {'entity': '$4,946', 'category': 'MONEY'}, {'entity': '$3,909', 'category': 'MONEY'}, {'entity': '$719 million', 'category': 'MONEY'}, {'entity': '$146 million', 'category': 'MONEY'}, {'entity': '$700 million', 'category': 'MONEY'}, {'entity': 'annual', 'category': 'NORP'}, {'entity': 'Form 10-K', 'category': 'ORG'}, {'entity': 'Form 10-Q', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'Daklinza', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'IFM', 'category': 'ORG'}, {'entity': 'CytomX', 'category': 'ORG'}, {'entity': 'Halozyme', 'category': 'ORG'}, {'entity': 'Flexus', 'category': 'ORG'}, {'entity': 'Cardioxyl', 'category': 'ORG'}, {'entity': 'PsiOxus', 'category': 'ORG'}, {'entity': 'Ono', 'category': 'ORG'}, {'entity': 'Padlock', 'category': 'ORG'}, {'entity': 'Cormorant', 'category': 'ORG'}, {'entity': 'Nitto Denko', 'category': 'ORG'}, {'entity': 'Five Prime', 'category': 'ORG'}, {'entity': 'Promedior', 'category': 'ORG'}, {'entity': 'Bavarian Nordic', 'category': 'ORG'}, {'entity': 'uniQure', 'category': 'ORG'}, {'entity': 'F-Star Alpha', 'category': 'ORG'}, {'entity': 'LPA1 Antagonist', 'category': 'ORG'}, {'entity': 'Connecticut', 'category': 'ORG'}, {'entity': '23', 'category': 'PERCENT'}, {'entity': '27', 'category': 'PERCENT'}, {'entity': '18', 'category': 'PERCENT'}, {'entity': '16', 'category': 'PERCENT'}, {'entity': '100%', 'category': 'PERCENT'}, {'entity': 'Walllingford', 'category': 'PERSON'}, {'entity': 'R&D', 'category': 'PRODUCT'}, {'entity': 'through 2020', 'category': 'TIME'}, {'entity': 'Item 8. Financial Statements—Note 4. Acquisitions', 'category': 'WORK_OF_ART'}, {'entity': 'Divestitures and Licensing Arrangements', 'category': 'WORK_OF_ART'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '800', 'category': 'CARDINAL'}, {'entity': '167', 'category': 'CARDINAL'}, {'entity': '350', 'category': 'CARDINAL'}, {'entity': '60', 'category': 'CARDINAL'}, {'entity': '50', 'category': 'CARDINAL'}, {'entity': '439', 'category': 'CARDINAL'}, {'entity': '1,679', 'category': 'CARDINAL'}, {'entity': '160', 'category': 'CARDINAL'}, {'entity': '160', 'category': 'CARDINAL'}, {'entity': '1,883', 'category': 'CARDINAL'}, {'entity': '2020', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  15\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWp9jFzjS3kgAlfPpfjo2dVz9QP7\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701571723,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#2017#2016#2015#826 \\n\\nDATE#Year Ended December 31\\n\\nEVENT#Merck's PD-1 antibody Keytruda*#patent-infringement settlement\\n\\nFAC#Mount Vernon, Indiana manufacturing facility#Reckitt alliance\\n\\nGPE#U.S.#Switzerland#Ireland#Puerto Rico\\n\\nLANGUAGE#English\\n\\nLAW#Tax Cuts and Jobs Act of 2017#the Act\\n\\nLOC#Erbitux*\\n\\nMONEY#$196#$167#$184#$293#$109#$118#$487#$75#$77#$83#$164#$576#$196#$1,351#$719#$383#$37#$238#$122#$162#$91#$160#$15#$13#$5#$45#$109#$16#$44#$7#$1,519#$1,285#$187#$625#$481#$5,131#$5,915#$2,077#$4,156#$1,408#$446#$2.9 billion#$2.6 billion#$285 million#15.5%#8.0%#21%#56.7%#3.3%#1.8%#0.3%\\n\\nORG#Company#BMS#BMS#Merck#Ono#Reckitt alliance\\n\\nPERCENT#6.5%#2.5%#75/25 percent#81.0%#23.8%#21.5%#35%#21%\\n\\nPERSON#Ixempra*#Amylin#IFM#Cormorant#Padlock#Cardioxyl#Flexus#Promedior\\n\\nPRODUCT#diabetes business#diabetes and investigational HIV medicines businesses#U.S. pension plan#merck patent infringement settlement#Erbitux* and diabetes business divestitures#Amylin product sales#written option liability\\n\\nTIME#January 1, 2017 through December 31, 2023#January 1, 2024 through December 31, 2026#fourth quarter of 2017#post-1986 \\n\\nWORK_OF_ART#Tax Cuts and Jobs Act of 2017}\\n\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2478,\n",
      "    \"completion_tokens\": 449,\n",
      "    \"total_tokens\": 2927\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': 'Mercks PD-1 antibody Keytruda*', 'category': 'EVENT'}, {'entity': 'patent-infringement settlement', 'category': 'EVENT'}, {'entity': 'Mount Vernon, Indiana manufacturing facility', 'category': 'FAC'}, {'entity': 'Reckitt alliance', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Switzerland', 'category': 'GPE'}, {'entity': 'Ireland', 'category': 'GPE'}, {'entity': 'Puerto Rico', 'category': 'GPE'}, {'entity': 'English', 'category': 'LANGUAGE'}, {'entity': 'Tax Cuts and Jobs Act of 2017', 'category': 'LAW'}, {'entity': 'the Act', 'category': 'LAW'}, {'entity': 'Erbitux*', 'category': 'LOC'}, {'entity': '$196', 'category': 'MONEY'}, {'entity': '$167', 'category': 'MONEY'}, {'entity': '$184', 'category': 'MONEY'}, {'entity': '$293', 'category': 'MONEY'}, {'entity': '$109', 'category': 'MONEY'}, {'entity': '$118', 'category': 'MONEY'}, {'entity': '$487', 'category': 'MONEY'}, {'entity': '$75', 'category': 'MONEY'}, {'entity': '$77', 'category': 'MONEY'}, {'entity': '$83', 'category': 'MONEY'}, {'entity': '$164', 'category': 'MONEY'}, {'entity': '$576', 'category': 'MONEY'}, {'entity': '$196', 'category': 'MONEY'}, {'entity': '$1,351', 'category': 'MONEY'}, {'entity': '$719', 'category': 'MONEY'}, {'entity': '$383', 'category': 'MONEY'}, {'entity': '$37', 'category': 'MONEY'}, {'entity': '$238', 'category': 'MONEY'}, {'entity': '$122', 'category': 'MONEY'}, {'entity': '$162', 'category': 'MONEY'}, {'entity': '$91', 'category': 'MONEY'}, {'entity': '$160', 'category': 'MONEY'}, {'entity': '$15', 'category': 'MONEY'}, {'entity': '$13', 'category': 'MONEY'}, {'entity': '$5', 'category': 'MONEY'}, {'entity': '$45', 'category': 'MONEY'}, {'entity': '$109', 'category': 'MONEY'}, {'entity': '$16', 'category': 'MONEY'}, {'entity': '$44', 'category': 'MONEY'}, {'entity': '$7', 'category': 'MONEY'}, {'entity': '$1,519', 'category': 'MONEY'}, {'entity': '$1,285', 'category': 'MONEY'}, {'entity': '$187', 'category': 'MONEY'}, {'entity': '$625', 'category': 'MONEY'}, {'entity': '$481', 'category': 'MONEY'}, {'entity': '$5,131', 'category': 'MONEY'}, {'entity': '$5,915', 'category': 'MONEY'}, {'entity': '$2,077', 'category': 'MONEY'}, {'entity': '$4,156', 'category': 'MONEY'}, {'entity': '$1,408', 'category': 'MONEY'}, {'entity': '$446', 'category': 'MONEY'}, {'entity': '$2.9 billion', 'category': 'MONEY'}, {'entity': '$2.6 billion', 'category': 'MONEY'}, {'entity': '$285 million', 'category': 'MONEY'}, {'entity': '15.5%', 'category': 'MONEY'}, {'entity': '8.0%', 'category': 'MONEY'}, {'entity': '21%', 'category': 'MONEY'}, {'entity': '56.7%', 'category': 'MONEY'}, {'entity': '3.3%', 'category': 'MONEY'}, {'entity': '1.8%', 'category': 'MONEY'}, {'entity': '0.3%', 'category': 'MONEY'}, {'entity': 'Company', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Merck', 'category': 'ORG'}, {'entity': 'Ono', 'category': 'ORG'}, {'entity': 'Reckitt alliance', 'category': 'ORG'}, {'entity': '6.5%', 'category': 'PERCENT'}, {'entity': '2.5%', 'category': 'PERCENT'}, {'entity': '75/25 percent', 'category': 'PERCENT'}, {'entity': '81.0%', 'category': 'PERCENT'}, {'entity': '23.8%', 'category': 'PERCENT'}, {'entity': '21.5%', 'category': 'PERCENT'}, {'entity': '35%', 'category': 'PERCENT'}, {'entity': '21%', 'category': 'PERCENT'}, {'entity': 'Ixempra*', 'category': 'PERSON'}, {'entity': 'Amylin', 'category': 'PERSON'}, {'entity': 'IFM', 'category': 'PERSON'}, {'entity': 'Cormorant', 'category': 'PERSON'}, {'entity': 'Padlock', 'category': 'PERSON'}, {'entity': 'Cardioxyl', 'category': 'PERSON'}, {'entity': 'Flexus', 'category': 'PERSON'}, {'entity': 'Promedior', 'category': 'PERSON'}, {'entity': 'diabetes business', 'category': 'PRODUCT'}, {'entity': 'diabetes and investigational HIV medicines businesses', 'category': 'PRODUCT'}, {'entity': 'U.S. pension plan', 'category': 'PRODUCT'}, {'entity': 'merck patent infringement settlement', 'category': 'PRODUCT'}, {'entity': 'Erbitux* and diabetes business divestitures', 'category': 'PRODUCT'}, {'entity': 'Amylin product sales', 'category': 'PRODUCT'}, {'entity': 'written option liability', 'category': 'PRODUCT'}, {'entity': 'January 1, 2017 through December 31, 2023', 'category': 'TIME'}, {'entity': 'January 1, 2024 through December 31, 2026', 'category': 'TIME'}, {'entity': 'fourth quarter of 2017', 'category': 'TIME'}, {'entity': 'post-1986', 'category': 'TIME'}, {'entity': 'Tax Cuts and Jobs Act of 2017', 'category': 'WORK_OF_ART'}, {'entity': '2017', 'category': 'CARDINAL'}, {'entity': '2016', 'category': 'CARDINAL'}, {'entity': '2015', 'category': 'CARDINAL'}, {'entity': '826', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  15\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWpnLozoYPt9j7xDwcQX8cJEyFBR\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701571763,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#1#2.6#1.17#2.5#1.1#1.2#800#1.0#850#389#2.5#5.2#4.1#2017\\n\\nDATE#2017#2018#2019#Year Ended December 31#December 31, 2017\\n\\nEVENT#U.S. tax reform\\n\\nGPE#U.S.#Puerto Rico#Ireland\\n\\nMONEY#$1.5 billion#1.3 billion#2.911 billion#2.6 billion#2.5 billion\\n\\nORG#BMS\\n\\nPERCENT#15%\\n\\nPERSON#\\n\\nPRODUCT#\\n\\nTIME#\\n\\nWORK_OF_ART#Item 8. Financial Statements\\u2014Note 7. Income Taxes#Item 8. Financial Statements\\u2014Note 9. Financial Instruments and Fair Value Measurements and Note 15. Equity\\n\\nLOC#\\n\\nFAC#\\n\\nNORP#\\n\\nLAW#\\n\\nLANGUAGE#}\\n\\nNote that since there are no entities in the following categories: NORP, LAW, FAC, LOC, PRODUCT, PERSON, TIME, and LANGUAGE, these categories are not mentioned in the final output.\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2569,\n",
      "    \"completion_tokens\": 238,\n",
      "    \"total_tokens\": 2807\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': '2017', 'category': 'DATE'}, {'entity': '2018', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': 'U.S. tax reform', 'category': 'EVENT'}, {'entity': 'LOC', 'category': 'FAC'}, {'entity': 'PRODUCT', 'category': 'FAC'}, {'entity': 'PERSON', 'category': 'FAC'}, {'entity': 'TIME', 'category': 'FAC'}, {'entity': 'and LANGUAGE', 'category': 'FAC'}, {'entity': 'these categories are not mentioned in the final output.', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Puerto Rico', 'category': 'GPE'}, {'entity': 'Ireland', 'category': 'GPE'}, {'entity': '', 'category': 'LANGUAGE'}, {'entity': '$1.5 billion', 'category': 'MONEY'}, {'entity': '1.3 billion', 'category': 'MONEY'}, {'entity': '2.911 billion', 'category': 'MONEY'}, {'entity': '2.6 billion', 'category': 'MONEY'}, {'entity': '2.5 billion', 'category': 'MONEY'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': 'Item 8. Financial Statements—Note 7. Income Taxes', 'category': 'WORK_OF_ART'}, {'entity': 'Item 8. Financial Statements—Note 9. Financial Instruments and Fair Value Measurements and Note 15. Equity', 'category': 'WORK_OF_ART'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '2.6', 'category': 'CARDINAL'}, {'entity': '1.17', 'category': 'CARDINAL'}, {'entity': '2.5', 'category': 'CARDINAL'}, {'entity': '1.1', 'category': 'CARDINAL'}, {'entity': '1.2', 'category': 'CARDINAL'}, {'entity': '800', 'category': 'CARDINAL'}, {'entity': '1.0', 'category': 'CARDINAL'}, {'entity': '850', 'category': 'CARDINAL'}, {'entity': '389', 'category': 'CARDINAL'}, {'entity': '2.5', 'category': 'CARDINAL'}, {'entity': '5.2', 'category': 'CARDINAL'}, {'entity': '4.1', 'category': 'CARDINAL'}, {'entity': '2017', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  15\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWqKEtSlTDbqJMIMfMlT8R76Tw5y\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701571796,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#three#364#two#two#five#one#31#2017#2016#2.2#1.5#470#481#400#300#1.0#700#600#1.4#1.5#745#600#350#3.1#2.1#800#600#400#1.4#2.2#880#1.0#1.3#200 \\n\\nDATE#March 2018#October 2021#July 2022#December 31, 2017#2017#2016#2015#90 days#2017#2015 \\n\\nEVENT#Financial Statements\\u2014Note 9. Financial Instruments and Fair Value Measurements#healthcare reform initiatives \\n\\nFAC#Moody's Investors Service#Standard & Poor's#Fitch \\n\\nGPE#U.S.#European \\n\\nMONEY#$5.0 billion#$2.0 billion#$1.5 billion#$1.5 billion#approximately $1.5 billion#$470 million#$481 million#approximately $400 million#approximately $300 million#approximately $700 million#approximately $600 million#approximately $1.4 billion#approximately $600 million#approximately $350 million#approximately $2.1 billion#approximately $800 million#approximately $600 million#approximately $400 million#approximately $2.2 billion#approximately $1.3 billion#approximately $200 million \\n\\nORG#BMS#the Biogen and Roche#Merck's PD-1 antibody Keytruda#CytomX#Halozyme#Nitto Denko#the Abilify#Five-Prime#Promedior \\n\\nPERSON#Opdivo#Yervoy#Empliciti#IFM \\n\\nPRODUCT#the CytomX#Halozyme#Nitto Denko \\n\\nQUANTITY#364 day \\n\\nWORK_OF_ART#Abilify#Item 8. Financial Statements\\u2014Note 9. Financial Instruments and Fair Value Measurements#Opdivo#Yervoy#Empliciti#Abilify#Five-Prime#Promedior#Ixempra}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2253,\n",
      "    \"completion_tokens\": 443,\n",
      "    \"total_tokens\": 2696\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'March 2018', 'category': 'DATE'}, {'entity': 'October 2021', 'category': 'DATE'}, {'entity': 'July 2022', 'category': 'DATE'}, {'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '90 days', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': 'Financial Statements—Note 9. Financial Instruments and Fair Value Measurements', 'category': 'EVENT'}, {'entity': 'healthcare reform initiatives', 'category': 'EVENT'}, {'entity': 'Moodys Investors Service', 'category': 'FAC'}, {'entity': 'Standard & Poors', 'category': 'FAC'}, {'entity': 'Fitch', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'European', 'category': 'GPE'}, {'entity': '$5.0 billion', 'category': 'MONEY'}, {'entity': '$2.0 billion', 'category': 'MONEY'}, {'entity': '$1.5 billion', 'category': 'MONEY'}, {'entity': '$1.5 billion', 'category': 'MONEY'}, {'entity': 'approximately $1.5 billion', 'category': 'MONEY'}, {'entity': '$470 million', 'category': 'MONEY'}, {'entity': '$481 million', 'category': 'MONEY'}, {'entity': 'approximately $400 million', 'category': 'MONEY'}, {'entity': 'approximately $300 million', 'category': 'MONEY'}, {'entity': 'approximately $700 million', 'category': 'MONEY'}, {'entity': 'approximately $600 million', 'category': 'MONEY'}, {'entity': 'approximately $1.4 billion', 'category': 'MONEY'}, {'entity': 'approximately $600 million', 'category': 'MONEY'}, {'entity': 'approximately $350 million', 'category': 'MONEY'}, {'entity': 'approximately $2.1 billion', 'category': 'MONEY'}, {'entity': 'approximately $800 million', 'category': 'MONEY'}, {'entity': 'approximately $600 million', 'category': 'MONEY'}, {'entity': 'approximately $400 million', 'category': 'MONEY'}, {'entity': 'approximately $2.2 billion', 'category': 'MONEY'}, {'entity': 'approximately $1.3 billion', 'category': 'MONEY'}, {'entity': 'approximately $200 million', 'category': 'MONEY'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'the Biogen and Roche', 'category': 'ORG'}, {'entity': 'Mercks PD-1 antibody Keytruda', 'category': 'ORG'}, {'entity': 'CytomX', 'category': 'ORG'}, {'entity': 'Halozyme', 'category': 'ORG'}, {'entity': 'Nitto Denko', 'category': 'ORG'}, {'entity': 'the Abilify', 'category': 'ORG'}, {'entity': 'Five-Prime', 'category': 'ORG'}, {'entity': 'Promedior', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Yervoy', 'category': 'PERSON'}, {'entity': 'Empliciti', 'category': 'PERSON'}, {'entity': 'IFM', 'category': 'PERSON'}, {'entity': 'the CytomX', 'category': 'PRODUCT'}, {'entity': 'Halozyme', 'category': 'PRODUCT'}, {'entity': 'Nitto Denko', 'category': 'PRODUCT'}, {'entity': '364 day', 'category': 'QUANTITY'}, {'entity': 'Abilify', 'category': 'WORK_OF_ART'}, {'entity': 'Item 8. Financial Statements—Note 9. Financial Instruments and Fair Value Measurements', 'category': 'WORK_OF_ART'}, {'entity': 'Opdivo', 'category': 'WORK_OF_ART'}, {'entity': 'Yervoy', 'category': 'WORK_OF_ART'}, {'entity': 'Empliciti', 'category': 'WORK_OF_ART'}, {'entity': 'Abilify', 'category': 'WORK_OF_ART'}, {'entity': 'Five-Prime', 'category': 'WORK_OF_ART'}, {'entity': 'Promedior', 'category': 'WORK_OF_ART'}, {'entity': 'Ixempra', 'category': 'WORK_OF_ART'}, {'entity': 'three', 'category': 'CARDINAL'}, {'entity': '364', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': 'five', 'category': 'CARDINAL'}, {'entity': 'one', 'category': 'CARDINAL'}, {'entity': '31', 'category': 'CARDINAL'}, {'entity': '2017', 'category': 'CARDINAL'}, {'entity': '2016', 'category': 'CARDINAL'}, {'entity': '2.2', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '470', 'category': 'CARDINAL'}, {'entity': '481', 'category': 'CARDINAL'}, {'entity': '400', 'category': 'CARDINAL'}, {'entity': '300', 'category': 'CARDINAL'}, {'entity': '1.0', 'category': 'CARDINAL'}, {'entity': '700', 'category': 'CARDINAL'}, {'entity': '600', 'category': 'CARDINAL'}, {'entity': '1.4', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '745', 'category': 'CARDINAL'}, {'entity': '600', 'category': 'CARDINAL'}, {'entity': '350', 'category': 'CARDINAL'}, {'entity': '3.1', 'category': 'CARDINAL'}, {'entity': '2.1', 'category': 'CARDINAL'}, {'entity': '800', 'category': 'CARDINAL'}, {'entity': '600', 'category': 'CARDINAL'}, {'entity': '400', 'category': 'CARDINAL'}, {'entity': '1.4', 'category': 'CARDINAL'}, {'entity': '2.2', 'category': 'CARDINAL'}, {'entity': '880', 'category': 'CARDINAL'}, {'entity': '1.0', 'category': 'CARDINAL'}, {'entity': '1.3', 'category': 'CARDINAL'}, {'entity': '200', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  15\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWqyJPYig9hwhFPGTf3jKWMYa7sg\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701571836,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#17.0#3.1#10.4#3.5#100#95\\n\\nDATE#December 31, 2017#August 4, 2004#September 30, 2004#October 2015#October 2017\\n\\nEVENT#FCPA Settlement#Deemed repatriation transition tax\\n\\nLAW#\\u201cItem 8. Financial Statements\\u2014Note 3. Alliances\\u201d#\\u201cItem 8. Financial Statements\\u2014Note 1. Accounting Policies\\u2014Recently Issued Accounting Standards\\u201d#FCPA\\n\\nMONEY#$17.0 billion#$3.1 billion#$10.4 billion#$3.5 billion#$14.7 million\\n\\nORG#SEC#our U.S. pharmaceutical wholesalers\\n\\nPERCENT#100%#95%\\n\\nPERSON#Note 3. Alliances#Note 1. Accounting Policies\\n\\nPRODUCT#DSAs\\n\\nQUANTITY#one month\\n\\nTIME#weekly#two-year\\n\\nWORK_OF_ART#Item 8. Financial Statements\\u2014Note 3. Alliances#Item 8. Financial Statements\\u2014Note 1. Accounting Policies\\u2014Recently Issued Accounting Standards#Form 10-Q}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2221,\n",
      "    \"completion_tokens\": 242,\n",
      "    \"total_tokens\": 2463\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': 'August 4, 2004', 'category': 'DATE'}, {'entity': 'September 30, 2004', 'category': 'DATE'}, {'entity': 'October 2015', 'category': 'DATE'}, {'entity': 'October 2017', 'category': 'DATE'}, {'entity': 'FCPA Settlement', 'category': 'EVENT'}, {'entity': 'Deemed repatriation transition tax', 'category': 'EVENT'}, {'entity': '“Item 8. Financial Statements—Note 3. Alliances”', 'category': 'LAW'}, {'entity': '“Item 8. Financial Statements—Note 1. Accounting Policies—Recently Issued Accounting Standards”', 'category': 'LAW'}, {'entity': 'FCPA', 'category': 'LAW'}, {'entity': '$17.0 billion', 'category': 'MONEY'}, {'entity': '$3.1 billion', 'category': 'MONEY'}, {'entity': '$10.4 billion', 'category': 'MONEY'}, {'entity': '$3.5 billion', 'category': 'MONEY'}, {'entity': '$14.7 million', 'category': 'MONEY'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'our U.S. pharmaceutical wholesalers', 'category': 'ORG'}, {'entity': '100%', 'category': 'PERCENT'}, {'entity': '95%', 'category': 'PERCENT'}, {'entity': 'Note 3. Alliances', 'category': 'PERSON'}, {'entity': 'Note 1. Accounting Policies', 'category': 'PERSON'}, {'entity': 'DSAs', 'category': 'PRODUCT'}, {'entity': 'one month', 'category': 'QUANTITY'}, {'entity': 'weekly', 'category': 'TIME'}, {'entity': 'two-year', 'category': 'TIME'}, {'entity': 'Item 8. Financial Statements—Note 3. Alliances', 'category': 'WORK_OF_ART'}, {'entity': 'Item 8. Financial Statements—Note 1. Accounting Policies—Recently Issued Accounting Standards', 'category': 'WORK_OF_ART'}, {'entity': 'Form 10-Q', 'category': 'WORK_OF_ART'}, {'entity': '17.0', 'category': 'CARDINAL'}, {'entity': '3.1', 'category': 'CARDINAL'}, {'entity': '10.4', 'category': 'CARDINAL'}, {'entity': '3.5', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '95', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  15\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWrVsONnLrHk4Rar49HPSVpglvMx\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701571869,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#2#340B#2#50#47\\n\\nDATE#December 31, 2017\\n\\nEVENT#Medicaid and Medicare rebates#Other rebates, returns, discounts and adjustments#Retirement Benefits#Business Combinations and Divestitures\\n\\nFAC#Citi Pension Discount\\n\\nGPE#U.S.\\n\\nMONEY#$950 million#$40 million#$8.1 billion\\n\\nORG#Department of Defense#Department of Veterans Affairs#Centers for Medicare & Medicaid Services\\n\\nPERCENT#2%#1%\\n\\nPERSON#\\n\\nPRODUCT#\\n\\nQUANTITY#\\n\\nTIME#one month#two to four week\\n\\nWORK_OF_ART#\\n\\n}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2026,\n",
      "    \"completion_tokens\": 133,\n",
      "    \"total_tokens\": 2159\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': 'Medicaid and Medicare rebates', 'category': 'EVENT'}, {'entity': 'Other rebates, returns, discounts and adjustments', 'category': 'EVENT'}, {'entity': 'Retirement Benefits', 'category': 'EVENT'}, {'entity': 'Business Combinations and Divestitures', 'category': 'EVENT'}, {'entity': 'Citi Pension Discount', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '$950 million', 'category': 'MONEY'}, {'entity': '$40 million', 'category': 'MONEY'}, {'entity': '$8.1 billion', 'category': 'MONEY'}, {'entity': 'Department of Defense', 'category': 'ORG'}, {'entity': 'Department of Veterans Affairs', 'category': 'ORG'}, {'entity': 'Centers for Medicare & Medicaid Services', 'category': 'ORG'}, {'entity': '2%', 'category': 'PERCENT'}, {'entity': '1%', 'category': 'PERCENT'}, {'entity': 'one month', 'category': 'TIME'}, {'entity': 'two to four week', 'category': 'TIME'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '340B', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '50', 'category': 'CARDINAL'}, {'entity': '47', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  15\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWs0c5GGPP7glSUnfNZV78z0mfOl\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701571900,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#1#2#3#4#6#13 \\n\\nDATE#one year#the past three years#the fourth quarter of 2016#December 31, 2017#2017#2015#2016\\n\\nEVENT#the transactions were accounted for as asset acquisitions#the transactions were accounted for as sales of businesses#the divestitures of our small molecule manufacturing operations#our sale of our R&D facility in Wallingford\\n\\nFAC#R&D facility in Wallingford\\n\\nGPE#Ireland#Connecticut\\n\\nLAW#ASC 805 - Business Combinations\\n\\nMONEY#$1.2 billion#$254 million#$152 million#$565 million#$359 million#$32 million#$75 million#$160 million#$146 million#$79 million#$533 million#$104 million#$115 million\\n\\nORG#IFM#Cormorant#Padlock#Cardioxyl#Flexus#Reckitt#the Medicines Company#Valeant Pharmaceuticals International#Erbitux*#Ixempra*#Biogen#Roche#BMS-986020#F-Star Alpha's FS102#\\u201cItem 8. Financial Statements\\u2014Note 13. Goodwill and Other Intangible Assets.\\\"#the Company\\u2019s\\n\\nPERSON#\\n\\nPRODUCT#\\n\\nQUANTITY#\\n\\nTIME#\\n\\nWORK_OF_ART#}\\n\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2135,\n",
      "    \"completion_tokens\": 273,\n",
      "    \"total_tokens\": 2408\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'one year', 'category': 'DATE'}, {'entity': 'the past three years', 'category': 'DATE'}, {'entity': 'the fourth quarter of 2016', 'category': 'DATE'}, {'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': 'the transactions were accounted for as asset acquisitions', 'category': 'EVENT'}, {'entity': 'the transactions were accounted for as sales of businesses', 'category': 'EVENT'}, {'entity': 'the divestitures of our small molecule manufacturing operations', 'category': 'EVENT'}, {'entity': 'our sale of our R&D facility in Wallingford', 'category': 'EVENT'}, {'entity': 'R&D facility in Wallingford', 'category': 'FAC'}, {'entity': 'Ireland', 'category': 'GPE'}, {'entity': 'Connecticut', 'category': 'GPE'}, {'entity': 'ASC 805 - Business Combinations', 'category': 'LAW'}, {'entity': '$1.2 billion', 'category': 'MONEY'}, {'entity': '$254 million', 'category': 'MONEY'}, {'entity': '$152 million', 'category': 'MONEY'}, {'entity': '$565 million', 'category': 'MONEY'}, {'entity': '$359 million', 'category': 'MONEY'}, {'entity': '$32 million', 'category': 'MONEY'}, {'entity': '$75 million', 'category': 'MONEY'}, {'entity': '$160 million', 'category': 'MONEY'}, {'entity': '$146 million', 'category': 'MONEY'}, {'entity': '$79 million', 'category': 'MONEY'}, {'entity': '$533 million', 'category': 'MONEY'}, {'entity': '$104 million', 'category': 'MONEY'}, {'entity': '$115 million', 'category': 'MONEY'}, {'entity': 'IFM', 'category': 'ORG'}, {'entity': 'Cormorant', 'category': 'ORG'}, {'entity': 'Padlock', 'category': 'ORG'}, {'entity': 'Cardioxyl', 'category': 'ORG'}, {'entity': 'Flexus', 'category': 'ORG'}, {'entity': 'Reckitt', 'category': 'ORG'}, {'entity': 'the Medicines Company', 'category': 'ORG'}, {'entity': 'Valeant Pharmaceuticals International', 'category': 'ORG'}, {'entity': 'Erbitux*', 'category': 'ORG'}, {'entity': 'Ixempra*', 'category': 'ORG'}, {'entity': 'Biogen', 'category': 'ORG'}, {'entity': 'Roche', 'category': 'ORG'}, {'entity': 'BMS-986020', 'category': 'ORG'}, {'entity': 'F-Star Alphas FS102', 'category': 'ORG'}, {'entity': '“Item 8. Financial Statements—Note 13. Goodwill and Other Intangible Assets.\"', 'category': 'ORG'}, {'entity': 'the Company’s', 'category': 'ORG'}, {'entity': '', 'category': 'WORK_OF_ART'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '13', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  15\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWsYyP3JFujPnMugMzdu8le9vAnM\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701571934,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#2.3 billion#2.8 billion#4.3 billion#3.1 billion#317 million#2.6 billion#50%#244 million#30-45%#10%\\n\\nDATE#December 31, 2017#December 31, 2016#2022#2018#2009\\n\\nEVENT#Mead Johnson split-off#one-time deemed repatriation tax#internal spin-off of Mead Johnson shares#conversion of Mead Johnson Class B shares to Class A shares#conversion of Mead Johnson & Company to a limited liability company#exchange offer#completion of the IPO#restructuring to facilitate the IPO\\n\\nFAC#\\n\\nGPE#\\n\\nLANGUAGE#\\n\\nLAW#Section 382 of the Internal Revenue Code#Internal Revenue Code#tax-exempt transactions under the Internal Revenue Code\\n\\nLOC#\\n\\nMONEY#\\n\\nNORP#U.S. Federal\\n\\nORDINAL#fourth\\n\\nORG#Mead Johnson Class B#Mead Johnson & Company#IRS#Seattle Genetics, Inc.#CheckMate-205#Adcetris  \\n\\nPERCENT#\\n\\nPERSON#Mead Johnson \\n\\nPRODUCT#Opdivo#Opdivo was the only investigational compound or marketed product\\n\\nQUANTITY#\\n\\nTIME#\\n\\nWORK_OF_ART#}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2186,\n",
      "    \"completion_tokens\": 261,\n",
      "    \"total_tokens\": 2447\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2018', 'category': 'DATE'}, {'entity': '2009', 'category': 'DATE'}, {'entity': 'Mead Johnson split-off', 'category': 'EVENT'}, {'entity': 'one-time deemed repatriation tax', 'category': 'EVENT'}, {'entity': 'internal spin-off of Mead Johnson shares', 'category': 'EVENT'}, {'entity': 'conversion of Mead Johnson Class B shares to Class A shares', 'category': 'EVENT'}, {'entity': 'conversion of Mead Johnson & Company to a limited liability company', 'category': 'EVENT'}, {'entity': 'exchange offer', 'category': 'EVENT'}, {'entity': 'completion of the IPO', 'category': 'EVENT'}, {'entity': 'restructuring to facilitate the IPO', 'category': 'EVENT'}, {'entity': 'Section 382 of the Internal Revenue Code', 'category': 'LAW'}, {'entity': 'Internal Revenue Code', 'category': 'LAW'}, {'entity': 'tax-exempt transactions under the Internal Revenue Code', 'category': 'LAW'}, {'entity': 'U.S. Federal', 'category': 'NORP'}, {'entity': 'Mead Johnson Class B', 'category': 'ORG'}, {'entity': 'Mead Johnson & Company', 'category': 'ORG'}, {'entity': 'IRS', 'category': 'ORG'}, {'entity': 'Seattle Genetics, Inc.', 'category': 'ORG'}, {'entity': 'CheckMate-205', 'category': 'ORG'}, {'entity': 'Adcetris', 'category': 'ORG'}, {'entity': 'Mead Johnson', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Opdivo was the only investigational compound or marketed product', 'category': 'PRODUCT'}, {'entity': '', 'category': 'WORK_OF_ART'}, {'entity': 'fourth', 'category': 'ORDINAL'}, {'entity': '2.3 billion', 'category': 'CARDINAL'}, {'entity': '2.8 billion', 'category': 'CARDINAL'}, {'entity': '4.3 billion', 'category': 'CARDINAL'}, {'entity': '3.1 billion', 'category': 'CARDINAL'}, {'entity': '317 million', 'category': 'CARDINAL'}, {'entity': '2.6 billion', 'category': 'CARDINAL'}, {'entity': '50%', 'category': 'CARDINAL'}, {'entity': '244 million', 'category': 'CARDINAL'}, {'entity': '30-45%', 'category': 'CARDINAL'}, {'entity': '10%', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  15\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWt8w2Nf8Il2HLtk0AL7NeM5dVNs\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701571970,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#III#three#III#III#I/II#I#III#III#III#l#I#III#III#II#II#III#III#II#III\\n\\nDATE#April 2017#September 2017#January 2017#April 2017#September 2017#April 2017#March 2017#June 2017#August 2017#December 2017#October 2017#September 2017#July 2017#June 2017#June 2017#February 2017#December 2017#September 2017#November 2017#September 2017#April 2017#June 2017#July 2017#March 5, 2018#April 2017#January 2018#June 2017#April 2017#June 2017#February 2018#December 2017#April 16, 2018#November 2017#September 2017\\n\\nEVENT#CheckMate-143#Checkmate-078#CheckMate-017 and CheckMate-057#CA209-003#CheckMate-025#CheckMate-039 and CA204142#CheckMate-602, CheckMate-039 and CA204142#CheckMate-142#CheckMate-204#CheckMate-067#IFCT-1501 MAPS-2#CheckMate-227#CheckMate-214\\n\\nFAC#China Food and Drug Administration\\n\\nGPE#Japan#China\\n\\nORG#FDA#Opdivo#Ono#GBM#HCC#HNC#HPV#mCRC#mUC#NSCLC#RCC#Clovis Oncology, Inc.#BMS#EMA#CFDA#Incyte\\n\\nPERSON#\\n\\nPRODUCT#Adcetris*(brentuximab vedotin)#Opdivo#cHL#Gastric#ONO-4538-12#Opdivo#CheckMate-143#Opdivo#HCC#sorafenib#SCCHN#HNC#Ono#HPV#CheckMate-358#Opdivo#MSI-H#dMMR mCRC#fluoropyrimidine#oxaliplatin#irinotecan#Opdivo#Yervoy#Opdivo#BMS-986016#anti-LAG-3#anti-PD-1/PD-L1#mUC#Opdivo#Opdivo#Opdivo#pembrolizumab#Opdivo#Checkmate-078#Opdivo#docetaxel#NSCLC#CFDA#CheckMate-017 and CheckMate-057#Opdivo#docetaxel#NSCLC#CA209-003#Opdivo#NSCLC#CheckMate-025#Opdivo#everolimus#RCC#Opdivo#Rubraca*(rucaparib)#Opdivo#Opdivo#epacadostat#Opdivo#CheckMate-142#Opdivo#Yervoy#dMMR or MSI-H metastatic CRC#CheckMate-204#Opdivo+Yervoy#Opdivo+Yervoy#Opdivo#Yervoy#Opdivo+Yervoy#Opdivo+Yervoy#CheckMate-227#Opdivo+Yervoy#Opdivo+Yervoy#Opdivo+Yervoy#Opdivo+Yervoy#Opdivo+Yervoy#sunitinib#Opdivo+Yervoy\\n\\nTIME#30 minutes\\n\\nWORK_OF_ART#}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2442,\n",
      "    \"completion_tokens\": 786,\n",
      "    \"total_tokens\": 3228\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'April 2017', 'category': 'DATE'}, {'entity': 'September 2017', 'category': 'DATE'}, {'entity': 'January 2017', 'category': 'DATE'}, {'entity': 'April 2017', 'category': 'DATE'}, {'entity': 'September 2017', 'category': 'DATE'}, {'entity': 'April 2017', 'category': 'DATE'}, {'entity': 'March 2017', 'category': 'DATE'}, {'entity': 'June 2017', 'category': 'DATE'}, {'entity': 'August 2017', 'category': 'DATE'}, {'entity': 'December 2017', 'category': 'DATE'}, {'entity': 'October 2017', 'category': 'DATE'}, {'entity': 'September 2017', 'category': 'DATE'}, {'entity': 'July 2017', 'category': 'DATE'}, {'entity': 'June 2017', 'category': 'DATE'}, {'entity': 'June 2017', 'category': 'DATE'}, {'entity': 'February 2017', 'category': 'DATE'}, {'entity': 'December 2017', 'category': 'DATE'}, {'entity': 'September 2017', 'category': 'DATE'}, {'entity': 'November 2017', 'category': 'DATE'}, {'entity': 'September 2017', 'category': 'DATE'}, {'entity': 'April 2017', 'category': 'DATE'}, {'entity': 'June 2017', 'category': 'DATE'}, {'entity': 'July 2017', 'category': 'DATE'}, {'entity': 'March 5, 2018', 'category': 'DATE'}, {'entity': 'April 2017', 'category': 'DATE'}, {'entity': 'January 2018', 'category': 'DATE'}, {'entity': 'June 2017', 'category': 'DATE'}, {'entity': 'April 2017', 'category': 'DATE'}, {'entity': 'June 2017', 'category': 'DATE'}, {'entity': 'February 2018', 'category': 'DATE'}, {'entity': 'December 2017', 'category': 'DATE'}, {'entity': 'April 16, 2018', 'category': 'DATE'}, {'entity': 'November 2017', 'category': 'DATE'}, {'entity': 'September 2017', 'category': 'DATE'}, {'entity': 'CheckMate-143', 'category': 'EVENT'}, {'entity': 'Checkmate-078', 'category': 'EVENT'}, {'entity': 'CheckMate-017 and CheckMate-057', 'category': 'EVENT'}, {'entity': 'CA209-003', 'category': 'EVENT'}, {'entity': 'CheckMate-025', 'category': 'EVENT'}, {'entity': 'CheckMate-039 and CA204142', 'category': 'EVENT'}, {'entity': 'CheckMate-602, CheckMate-039 and CA204142', 'category': 'EVENT'}, {'entity': 'CheckMate-142', 'category': 'EVENT'}, {'entity': 'CheckMate-204', 'category': 'EVENT'}, {'entity': 'CheckMate-067', 'category': 'EVENT'}, {'entity': 'IFCT-1501 MAPS-2', 'category': 'EVENT'}, {'entity': 'CheckMate-227', 'category': 'EVENT'}, {'entity': 'CheckMate-214', 'category': 'EVENT'}, {'entity': 'China Food and Drug Administration', 'category': 'FAC'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'China', 'category': 'GPE'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Ono', 'category': 'ORG'}, {'entity': 'GBM', 'category': 'ORG'}, {'entity': 'HCC', 'category': 'ORG'}, {'entity': 'HNC', 'category': 'ORG'}, {'entity': 'HPV', 'category': 'ORG'}, {'entity': 'mCRC', 'category': 'ORG'}, {'entity': 'mUC', 'category': 'ORG'}, {'entity': 'NSCLC', 'category': 'ORG'}, {'entity': 'RCC', 'category': 'ORG'}, {'entity': 'Clovis Oncology, Inc.', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'EMA', 'category': 'ORG'}, {'entity': 'CFDA', 'category': 'ORG'}, {'entity': 'Incyte', 'category': 'ORG'}, {'entity': 'Adcetris*brentuximab vedotin', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'cHL', 'category': 'PRODUCT'}, {'entity': 'Gastric', 'category': 'PRODUCT'}, {'entity': 'ONO-4538-12', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'CheckMate-143', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'HCC', 'category': 'PRODUCT'}, {'entity': 'sorafenib', 'category': 'PRODUCT'}, {'entity': 'SCCHN', 'category': 'PRODUCT'}, {'entity': 'HNC', 'category': 'PRODUCT'}, {'entity': 'Ono', 'category': 'PRODUCT'}, {'entity': 'HPV', 'category': 'PRODUCT'}, {'entity': 'CheckMate-358', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'MSI-H', 'category': 'PRODUCT'}, {'entity': 'dMMR mCRC', 'category': 'PRODUCT'}, {'entity': 'fluoropyrimidine', 'category': 'PRODUCT'}, {'entity': 'oxaliplatin', 'category': 'PRODUCT'}, {'entity': 'irinotecan', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Yervoy', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'BMS-986016', 'category': 'PRODUCT'}, {'entity': 'anti-LAG-3', 'category': 'PRODUCT'}, {'entity': 'anti-PD-1/PD-L1', 'category': 'PRODUCT'}, {'entity': 'mUC', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'pembrolizumab', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Checkmate-078', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'docetaxel', 'category': 'PRODUCT'}, {'entity': 'NSCLC', 'category': 'PRODUCT'}, {'entity': 'CFDA', 'category': 'PRODUCT'}, {'entity': 'CheckMate-017 and CheckMate-057', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'docetaxel', 'category': 'PRODUCT'}, {'entity': 'NSCLC', 'category': 'PRODUCT'}, {'entity': 'CA209-003', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'NSCLC', 'category': 'PRODUCT'}, {'entity': 'CheckMate-025', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'everolimus', 'category': 'PRODUCT'}, {'entity': 'RCC', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Rubraca*rucaparib', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'epacadostat', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'CheckMate-142', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Yervoy', 'category': 'PRODUCT'}, {'entity': 'dMMR or MSI-H metastatic CRC', 'category': 'PRODUCT'}, {'entity': 'CheckMate-204', 'category': 'PRODUCT'}, {'entity': 'Opdivo+Yervoy', 'category': 'PRODUCT'}, {'entity': 'Opdivo+Yervoy', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Yervoy', 'category': 'PRODUCT'}, {'entity': 'Opdivo+Yervoy', 'category': 'PRODUCT'}, {'entity': 'Opdivo+Yervoy', 'category': 'PRODUCT'}, {'entity': 'CheckMate-227', 'category': 'PRODUCT'}, {'entity': 'Opdivo+Yervoy', 'category': 'PRODUCT'}, {'entity': 'Opdivo+Yervoy', 'category': 'PRODUCT'}, {'entity': 'Opdivo+Yervoy', 'category': 'PRODUCT'}, {'entity': 'Opdivo+Yervoy', 'category': 'PRODUCT'}, {'entity': 'Opdivo+Yervoy', 'category': 'PRODUCT'}, {'entity': 'sunitinib', 'category': 'PRODUCT'}, {'entity': 'Opdivo+Yervoy', 'category': 'PRODUCT'}, {'entity': '30 minutes', 'category': 'TIME'}, {'entity': '', 'category': 'WORK_OF_ART'}, {'entity': 'III', 'category': 'CARDINAL'}, {'entity': 'three', 'category': 'CARDINAL'}, {'entity': 'III', 'category': 'CARDINAL'}, {'entity': 'III', 'category': 'CARDINAL'}, {'entity': 'I/II', 'category': 'CARDINAL'}, {'entity': 'I', 'category': 'CARDINAL'}, {'entity': 'III', 'category': 'CARDINAL'}, {'entity': 'III', 'category': 'CARDINAL'}, {'entity': 'III', 'category': 'CARDINAL'}, {'entity': 'l', 'category': 'CARDINAL'}, {'entity': 'I', 'category': 'CARDINAL'}, {'entity': 'III', 'category': 'CARDINAL'}, {'entity': 'III', 'category': 'CARDINAL'}, {'entity': 'II', 'category': 'CARDINAL'}, {'entity': 'II', 'category': 'CARDINAL'}, {'entity': 'III', 'category': 'CARDINAL'}, {'entity': 'III', 'category': 'CARDINAL'}, {'entity': 'II', 'category': 'CARDINAL'}, {'entity': 'III', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  15\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWu4ftrT5oPi2cgLEESrlimtHsrt\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701572028,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{DATE#August 2017#July 2017#October 2017#February 2017#March 2017#December 2017#November 2017#June 2017#May 2017#January 2018#April 2017#September 2017\\n\\nEVENT#CheckMate-214#Phase III CheckMate 9ER study#Phase I/II CheckMate-032 study#Phase IV study#Phase II CA180-372 study#Phase II CA180-226 study#Phase III CA184-029 study#Phase III study#Phase III PROSPECT study\\n\\nMONEY#Form 10-K\\n\\nORG#Data Monitoring Committee#BMS#Exelixis, Inc.#Opdivo#Yervoy#Cabometyx#FDA#EMA#Sprycel#Philadelphia chromosome-positive ALL#Philadelphia chromosome-positive CML#CheckMate#U.S. Medicare#Eliquis#U.S. Humana#Orencia#PsA#ALL#CML#Yervoy#Empliciti#lenalidomide/dexamethasone#China FDA#Daklinza#Sunvepra#Bavarian Nordic A/S#Prostvac#HCV#Securities Act of 1933#Securities Exchange Act of 1934\\n\\nPERSON#Humana\\n\\nPRODUCT#Opdivo#Yervoy\\n\\nWORK_OF_ART#Form 10-K}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2316,\n",
      "    \"completion_tokens\": 299,\n",
      "    \"total_tokens\": 2615\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'August 2017', 'category': 'DATE'}, {'entity': 'July 2017', 'category': 'DATE'}, {'entity': 'October 2017', 'category': 'DATE'}, {'entity': 'February 2017', 'category': 'DATE'}, {'entity': 'March 2017', 'category': 'DATE'}, {'entity': 'December 2017', 'category': 'DATE'}, {'entity': 'November 2017', 'category': 'DATE'}, {'entity': 'June 2017', 'category': 'DATE'}, {'entity': 'May 2017', 'category': 'DATE'}, {'entity': 'January 2018', 'category': 'DATE'}, {'entity': 'April 2017', 'category': 'DATE'}, {'entity': 'September 2017', 'category': 'DATE'}, {'entity': 'CheckMate-214', 'category': 'EVENT'}, {'entity': 'Phase III CheckMate 9ER study', 'category': 'EVENT'}, {'entity': 'Phase I/II CheckMate-032 study', 'category': 'EVENT'}, {'entity': 'Phase IV study', 'category': 'EVENT'}, {'entity': 'Phase II CA180-372 study', 'category': 'EVENT'}, {'entity': 'Phase II CA180-226 study', 'category': 'EVENT'}, {'entity': 'Phase III CA184-029 study', 'category': 'EVENT'}, {'entity': 'Phase III study', 'category': 'EVENT'}, {'entity': 'Phase III PROSPECT study', 'category': 'EVENT'}, {'entity': 'Form 10-K', 'category': 'MONEY'}, {'entity': 'Data Monitoring Committee', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Exelixis, Inc.', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Yervoy', 'category': 'ORG'}, {'entity': 'Cabometyx', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'EMA', 'category': 'ORG'}, {'entity': 'Sprycel', 'category': 'ORG'}, {'entity': 'Philadelphia chromosome-positive ALL', 'category': 'ORG'}, {'entity': 'Philadelphia chromosome-positive CML', 'category': 'ORG'}, {'entity': 'CheckMate', 'category': 'ORG'}, {'entity': 'U.S. Medicare', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'U.S. Humana', 'category': 'ORG'}, {'entity': 'Orencia', 'category': 'ORG'}, {'entity': 'PsA', 'category': 'ORG'}, {'entity': 'ALL', 'category': 'ORG'}, {'entity': 'CML', 'category': 'ORG'}, {'entity': 'Yervoy', 'category': 'ORG'}, {'entity': 'Empliciti', 'category': 'ORG'}, {'entity': 'lenalidomide/dexamethasone', 'category': 'ORG'}, {'entity': 'China FDA', 'category': 'ORG'}, {'entity': 'Daklinza', 'category': 'ORG'}, {'entity': 'Sunvepra', 'category': 'ORG'}, {'entity': 'Bavarian Nordic A/S', 'category': 'ORG'}, {'entity': 'Prostvac', 'category': 'ORG'}, {'entity': 'HCV', 'category': 'ORG'}, {'entity': 'Securities Act of 1933', 'category': 'ORG'}, {'entity': 'Securities Exchange Act of 1934', 'category': 'ORG'}, {'entity': 'Humana', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Yervoy', 'category': 'PRODUCT'}, {'entity': 'Form 10-K', 'category': 'WORK_OF_ART'}]\n",
      "Length of chunks:  15\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWufbtX8gpvOexHwEFdwQ5a4Mv2R\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701572065,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#10#100#100#100\\n\\nDATE#December 31, 2017\\n\\nEVENT#QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK\\n\\nGPE#U.S.\\n\\nLANGUAGE#Japanese\\n\\nMONEY#$175 million#$25 million#$569 million#$70 million\\n\\nORG#Financial Instruments and Fair Value Measurements\\n\\nPERCENT#10%\\n\\nPRODUCT#euro\\n\\nWORK_OF_ART#Item 7A#Item 8}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 1375,\n",
      "    \"completion_tokens\": 99,\n",
      "    \"total_tokens\": 1474\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': 'QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Japanese', 'category': 'LANGUAGE'}, {'entity': '$175 million', 'category': 'MONEY'}, {'entity': '$25 million', 'category': 'MONEY'}, {'entity': '$569 million', 'category': 'MONEY'}, {'entity': '$70 million', 'category': 'MONEY'}, {'entity': 'Financial Instruments and Fair Value Measurements', 'category': 'ORG'}, {'entity': '10%', 'category': 'PERCENT'}, {'entity': 'euro', 'category': 'PRODUCT'}, {'entity': 'Item 7A', 'category': 'WORK_OF_ART'}, {'entity': 'Item 8', 'category': 'WORK_OF_ART'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}]\n",
      "/home/damir/Dropbox/Documents/Teaching/2023/L715/l715_23/data/10-Ks/Bristol-Myers_Squibb_Company/2020/Management.txt\n",
      "Length of chunks:  15\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWv8U0rdLRWMqOECRyDncxPZ0jYq\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701572094,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#7#2019#10#4#2019#2018#2017#31#25#2019#20#2019#24#2#16#2#1#1.00#0.71 \\n\\nDATE#December 31, 2018#November 20, 2019#March 2019#January 2019#April 2019#February 2019#August 2019#November 2019\\n\\nEVENT#Celgene transaction#Opdivo#Eliquis#Opdivo+Yervoy combinations#product launch#acquisition date\\n\\nFAC#\\n\\nGPE#U.S.#EU#Japan\\n\\nLOC#\\n\\nMONEY#$1.9 billion\\n\\nNORP#\\n\\nORDINAL#first\\n\\nORG#Bristol-Myers Squibb Company#Celgene#BMS#FDA#EC#CheckMate-067#RCC#ALL#RRMM#Philadelphia\\n\\nPERCENT#\\n\\nPERSON#\\n\\nPRODUCT#Revlimid#Pomalyst#Reblozyl#Inrebic#Orencia#Sprycel#Empliciti#rituximab#Inrebic\\n\\nQUANTITY#\\n\\nTIME#\\n\\nWORK_OF_ART#Form 10-K#\\u201cItem 7. Management's Discussion and Analysis of Financial Condition and Results of Operations\\u201d#\\u201cItem 8. Financial Statements\\u2014Note 4. Acquisition, Divestitures, Licensing and Other Arrangements\\u201d\\n}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2329,\n",
      "    \"completion_tokens\": 303,\n",
      "    \"total_tokens\": 2632\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': 'November 20, 2019', 'category': 'DATE'}, {'entity': 'March 2019', 'category': 'DATE'}, {'entity': 'January 2019', 'category': 'DATE'}, {'entity': 'April 2019', 'category': 'DATE'}, {'entity': 'February 2019', 'category': 'DATE'}, {'entity': 'August 2019', 'category': 'DATE'}, {'entity': 'November 2019', 'category': 'DATE'}, {'entity': 'Celgene transaction', 'category': 'EVENT'}, {'entity': 'Opdivo', 'category': 'EVENT'}, {'entity': 'Eliquis', 'category': 'EVENT'}, {'entity': 'Opdivo+Yervoy combinations', 'category': 'EVENT'}, {'entity': 'product launch', 'category': 'EVENT'}, {'entity': 'acquisition date', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'EU', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': '$1.9 billion', 'category': 'MONEY'}, {'entity': 'Bristol-Myers Squibb Company', 'category': 'ORG'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'EC', 'category': 'ORG'}, {'entity': 'CheckMate-067', 'category': 'ORG'}, {'entity': 'RCC', 'category': 'ORG'}, {'entity': 'ALL', 'category': 'ORG'}, {'entity': 'RRMM', 'category': 'ORG'}, {'entity': 'Philadelphia', 'category': 'ORG'}, {'entity': 'Revlimid', 'category': 'PRODUCT'}, {'entity': 'Pomalyst', 'category': 'PRODUCT'}, {'entity': 'Reblozyl', 'category': 'PRODUCT'}, {'entity': 'Inrebic', 'category': 'PRODUCT'}, {'entity': 'Orencia', 'category': 'PRODUCT'}, {'entity': 'Sprycel', 'category': 'PRODUCT'}, {'entity': 'Empliciti', 'category': 'PRODUCT'}, {'entity': 'rituximab', 'category': 'PRODUCT'}, {'entity': 'Inrebic', 'category': 'PRODUCT'}, {'entity': 'Form 10-K', 'category': 'WORK_OF_ART'}, {'entity': '“Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations”', 'category': 'WORK_OF_ART'}, {'entity': '“Item 8. Financial Statements—Note 4. Acquisition, Divestitures, Licensing and Other Arrangements”', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '2019', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '2019', 'category': 'CARDINAL'}, {'entity': '2018', 'category': 'CARDINAL'}, {'entity': '2017', 'category': 'CARDINAL'}, {'entity': '31', 'category': 'CARDINAL'}, {'entity': '25', 'category': 'CARDINAL'}, {'entity': '2019', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '2019', 'category': 'CARDINAL'}, {'entity': '24', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '16', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1.00', 'category': 'CARDINAL'}, {'entity': '0.71', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  15\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWvjnRJzuE92JFiDco7RywjZxwm2\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701572131,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#2.5 \\n\\nDATE#Year Ended December 31, 2019#Year Ended December 31\\n\\nEVENT#Celgene acquisition \\n\\nFAC#U.S.#Europe#Rest of World\\n\\nMONEY#$2.5 billion#$397 million#$210 million#$1.3 billion \\n\\nORG#Amgen#BMS#Celgene#Taisho Pharmaceutical Co.#UPSA \\n\\nPRODUCT#Eliquis#Opdivo#Otezla#Revlimid\\n\\nWORK_OF_ART#Reblozyl and Inrebic}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2345,\n",
      "    \"completion_tokens\": 115,\n",
      "    \"total_tokens\": 2460\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'Year Ended December 31, 2019', 'category': 'DATE'}, {'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': 'Celgene acquisition', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'FAC'}, {'entity': 'Europe', 'category': 'FAC'}, {'entity': 'Rest of World', 'category': 'FAC'}, {'entity': '$2.5 billion', 'category': 'MONEY'}, {'entity': '$397 million', 'category': 'MONEY'}, {'entity': '$210 million', 'category': 'MONEY'}, {'entity': '$1.3 billion', 'category': 'MONEY'}, {'entity': 'Amgen', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': 'Taisho Pharmaceutical Co.', 'category': 'ORG'}, {'entity': 'UPSA', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Otezla', 'category': 'PRODUCT'}, {'entity': 'Revlimid', 'category': 'PRODUCT'}, {'entity': 'Reblozyl and Inrebic', 'category': 'WORK_OF_ART'}, {'entity': '2.5', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  15\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWwD9EP8fqiN3FgHwUAv5r3XZbKV\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701572161,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#1,859#2,416#4,666#37,206#30,174#23#3,675#2,735#34#4,941#3,225#53#3,416#2,633#30#12,032#8,593#40#25,174#21,581#17#32#28#4#40#15#13#2#1,299#899#400#7,929#6,438#23#4,755#3,760#26#3,174#2,678#19#7,204#6,735#7#4,344#4,239#2#2,860#2,496#15#2,977#2,710#10#2,146#1,875#14#831#835#322#226#96#2,110#2,000#6#1,191#1,091#9#919#909#1#1,489#1,330#12#1,004#941#7#485#389#25#166#122#44#357#247#45#246#164#50#111#83#34#5#555#744#25#20#32#38#535#712#1,674#2,357#29#383#484#21#1,291#1,873#31#26,145#22,561#16#15,342#12,586#22#10,803#9,975#8#50#70#24#37#2#22#5#60\\n\\nDATE#Year Ended December 31, 2019#Year Ended December 31, 2018#2019 vs. 2018#2019 vs. 2018#In August 2019#In November 2019\\n\\nEVENT#product sales#Medicaid and Medicare rebates#Product Revenues#treatment of patients with beta thalassemia\\n\\nFAC#\\n\\nGPE#United States#Europe#Asia#Europe#Asia#Japan\\n\\nLANGUAGE#\\n\\nLAW_Document#\\n\\nLOC#\\n\\nMONEY#\\n\\nNORP#\\n\\nORDINAL#first#prior#second#additional\\n\\nORG#Philadelphia chromosome-positive CML#Medicare Part D#Gleevec#FDA#Vidaza\\n\\nPERCENT#23%#34%#53%#30%#40%#17%#23%#26%#19%#7%#2%#15%#10%#14%#23%#19%#7%#2%#15%#6%#9%#1%#14%#7%#25%#29%#21%#31%#16%#22%#50%\\n\\nPERSON#Eliquis#Revlimid#Opdivo#Orencia#Pomalyst/Imnovid#Sprycel#Yervoy#Abraxane#Inrebic#Reblozyl#Baraclude#Vidaza\\n\\nQUANTITY#\\n\\nTIME#\\n\\nWORK_OF_ART#Reblozyl (luspatercept-aamt)}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2912,\n",
      "    \"completion_tokens\": 670,\n",
      "    \"total_tokens\": 3582\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'Year Ended December 31, 2019', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2018', 'category': 'DATE'}, {'entity': '2019 vs. 2018', 'category': 'DATE'}, {'entity': '2019 vs. 2018', 'category': 'DATE'}, {'entity': 'In August 2019', 'category': 'DATE'}, {'entity': 'In November 2019', 'category': 'DATE'}, {'entity': 'product sales', 'category': 'EVENT'}, {'entity': 'Medicaid and Medicare rebates', 'category': 'EVENT'}, {'entity': 'Product Revenues', 'category': 'EVENT'}, {'entity': 'treatment of patients with beta thalassemia', 'category': 'EVENT'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'Europe', 'category': 'GPE'}, {'entity': 'Asia', 'category': 'GPE'}, {'entity': 'Europe', 'category': 'GPE'}, {'entity': 'Asia', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'Document', 'category': 'LAW'}, {'entity': 'Philadelphia chromosome-positive CML', 'category': 'ORG'}, {'entity': 'Medicare Part D', 'category': 'ORG'}, {'entity': 'Gleevec', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'Vidaza', 'category': 'ORG'}, {'entity': '23%', 'category': 'PERCENT'}, {'entity': '34%', 'category': 'PERCENT'}, {'entity': '53%', 'category': 'PERCENT'}, {'entity': '30%', 'category': 'PERCENT'}, {'entity': '40%', 'category': 'PERCENT'}, {'entity': '17%', 'category': 'PERCENT'}, {'entity': '23%', 'category': 'PERCENT'}, {'entity': '26%', 'category': 'PERCENT'}, {'entity': '19%', 'category': 'PERCENT'}, {'entity': '7%', 'category': 'PERCENT'}, {'entity': '2%', 'category': 'PERCENT'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': '10%', 'category': 'PERCENT'}, {'entity': '14%', 'category': 'PERCENT'}, {'entity': '23%', 'category': 'PERCENT'}, {'entity': '19%', 'category': 'PERCENT'}, {'entity': '7%', 'category': 'PERCENT'}, {'entity': '2%', 'category': 'PERCENT'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': '6%', 'category': 'PERCENT'}, {'entity': '9%', 'category': 'PERCENT'}, {'entity': '1%', 'category': 'PERCENT'}, {'entity': '14%', 'category': 'PERCENT'}, {'entity': '7%', 'category': 'PERCENT'}, {'entity': '25%', 'category': 'PERCENT'}, {'entity': '29%', 'category': 'PERCENT'}, {'entity': '21%', 'category': 'PERCENT'}, {'entity': '31%', 'category': 'PERCENT'}, {'entity': '16%', 'category': 'PERCENT'}, {'entity': '22%', 'category': 'PERCENT'}, {'entity': '50%', 'category': 'PERCENT'}, {'entity': 'Eliquis', 'category': 'PERSON'}, {'entity': 'Revlimid', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Orencia', 'category': 'PERSON'}, {'entity': 'Pomalyst/Imnovid', 'category': 'PERSON'}, {'entity': 'Sprycel', 'category': 'PERSON'}, {'entity': 'Yervoy', 'category': 'PERSON'}, {'entity': 'Abraxane', 'category': 'PERSON'}, {'entity': 'Inrebic', 'category': 'PERSON'}, {'entity': 'Reblozyl', 'category': 'PERSON'}, {'entity': 'Baraclude', 'category': 'PERSON'}, {'entity': 'Vidaza', 'category': 'PERSON'}, {'entity': 'Reblozyl luspatercept-aamt', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'prior', 'category': 'ORDINAL'}, {'entity': 'second', 'category': 'ORDINAL'}, {'entity': 'additional', 'category': 'ORDINAL'}, {'entity': '1,859', 'category': 'CARDINAL'}, {'entity': '2,416', 'category': 'CARDINAL'}, {'entity': '4,666', 'category': 'CARDINAL'}, {'entity': '37,206', 'category': 'CARDINAL'}, {'entity': '30,174', 'category': 'CARDINAL'}, {'entity': '23', 'category': 'CARDINAL'}, {'entity': '3,675', 'category': 'CARDINAL'}, {'entity': '2,735', 'category': 'CARDINAL'}, {'entity': '34', 'category': 'CARDINAL'}, {'entity': '4,941', 'category': 'CARDINAL'}, {'entity': '3,225', 'category': 'CARDINAL'}, {'entity': '53', 'category': 'CARDINAL'}, {'entity': '3,416', 'category': 'CARDINAL'}, {'entity': '2,633', 'category': 'CARDINAL'}, {'entity': '30', 'category': 'CARDINAL'}, {'entity': '12,032', 'category': 'CARDINAL'}, {'entity': '8,593', 'category': 'CARDINAL'}, {'entity': '40', 'category': 'CARDINAL'}, {'entity': '25,174', 'category': 'CARDINAL'}, {'entity': '21,581', 'category': 'CARDINAL'}, {'entity': '17', 'category': 'CARDINAL'}, {'entity': '32', 'category': 'CARDINAL'}, {'entity': '28', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '40', 'category': 'CARDINAL'}, {'entity': '15', 'category': 'CARDINAL'}, {'entity': '13', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '1,299', 'category': 'CARDINAL'}, {'entity': '899', 'category': 'CARDINAL'}, {'entity': '400', 'category': 'CARDINAL'}, {'entity': '7,929', 'category': 'CARDINAL'}, {'entity': '6,438', 'category': 'CARDINAL'}, {'entity': '23', 'category': 'CARDINAL'}, {'entity': '4,755', 'category': 'CARDINAL'}, {'entity': '3,760', 'category': 'CARDINAL'}, {'entity': '26', 'category': 'CARDINAL'}, {'entity': '3,174', 'category': 'CARDINAL'}, {'entity': '2,678', 'category': 'CARDINAL'}, {'entity': '19', 'category': 'CARDINAL'}, {'entity': '7,204', 'category': 'CARDINAL'}, {'entity': '6,735', 'category': 'CARDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '4,344', 'category': 'CARDINAL'}, {'entity': '4,239', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2,860', 'category': 'CARDINAL'}, {'entity': '2,496', 'category': 'CARDINAL'}, {'entity': '15', 'category': 'CARDINAL'}, {'entity': '2,977', 'category': 'CARDINAL'}, {'entity': '2,710', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '2,146', 'category': 'CARDINAL'}, {'entity': '1,875', 'category': 'CARDINAL'}, {'entity': '14', 'category': 'CARDINAL'}, {'entity': '831', 'category': 'CARDINAL'}, {'entity': '835', 'category': 'CARDINAL'}, {'entity': '322', 'category': 'CARDINAL'}, {'entity': '226', 'category': 'CARDINAL'}, {'entity': '96', 'category': 'CARDINAL'}, {'entity': '2,110', 'category': 'CARDINAL'}, {'entity': '2,000', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '1,191', 'category': 'CARDINAL'}, {'entity': '1,091', 'category': 'CARDINAL'}, {'entity': '9', 'category': 'CARDINAL'}, {'entity': '919', 'category': 'CARDINAL'}, {'entity': '909', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1,489', 'category': 'CARDINAL'}, {'entity': '1,330', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '1,004', 'category': 'CARDINAL'}, {'entity': '941', 'category': 'CARDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '485', 'category': 'CARDINAL'}, {'entity': '389', 'category': 'CARDINAL'}, {'entity': '25', 'category': 'CARDINAL'}, {'entity': '166', 'category': 'CARDINAL'}, {'entity': '122', 'category': 'CARDINAL'}, {'entity': '44', 'category': 'CARDINAL'}, {'entity': '357', 'category': 'CARDINAL'}, {'entity': '247', 'category': 'CARDINAL'}, {'entity': '45', 'category': 'CARDINAL'}, {'entity': '246', 'category': 'CARDINAL'}, {'entity': '164', 'category': 'CARDINAL'}, {'entity': '50', 'category': 'CARDINAL'}, {'entity': '111', 'category': 'CARDINAL'}, {'entity': '83', 'category': 'CARDINAL'}, {'entity': '34', 'category': 'CARDINAL'}, {'entity': '5', 'category': 'CARDINAL'}, {'entity': '555', 'category': 'CARDINAL'}, {'entity': '744', 'category': 'CARDINAL'}, {'entity': '25', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '32', 'category': 'CARDINAL'}, {'entity': '38', 'category': 'CARDINAL'}, {'entity': '535', 'category': 'CARDINAL'}, {'entity': '712', 'category': 'CARDINAL'}, {'entity': '1,674', 'category': 'CARDINAL'}, {'entity': '2,357', 'category': 'CARDINAL'}, {'entity': '29', 'category': 'CARDINAL'}, {'entity': '383', 'category': 'CARDINAL'}, {'entity': '484', 'category': 'CARDINAL'}, {'entity': '21', 'category': 'CARDINAL'}, {'entity': '1,291', 'category': 'CARDINAL'}, {'entity': '1,873', 'category': 'CARDINAL'}, {'entity': '31', 'category': 'CARDINAL'}, {'entity': '26,145', 'category': 'CARDINAL'}, {'entity': '22,561', 'category': 'CARDINAL'}, {'entity': '16', 'category': 'CARDINAL'}, {'entity': '15,342', 'category': 'CARDINAL'}, {'entity': '12,586', 'category': 'CARDINAL'}, {'entity': '22', 'category': 'CARDINAL'}, {'entity': '10,803', 'category': 'CARDINAL'}, {'entity': '9,975', 'category': 'CARDINAL'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': '50', 'category': 'CARDINAL'}, {'entity': '70', 'category': 'CARDINAL'}, {'entity': '24', 'category': 'CARDINAL'}, {'entity': '37', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '22', 'category': 'CARDINAL'}, {'entity': '5', 'category': 'CARDINAL'}, {'entity': '60', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  15\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWx3Ocu1mM9xvT0L9y4LCyEGO0Yl\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701572213,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#2.6#2.5#93#25#7 \\n\\nDATE#June 30, 2019#December 31#2019\\n\\nEVENT#sale of the Anagni manufacturing plant#SEC Consent Order\\n\\nFAC#Anagni manufacturing plant\\n\\nGPE#U.S.#Gulf Countries#U.S.\\n\\nLAW#2019 Form 10-K#SEC Consent Order\\n\\nMONEY#$1.6 billion#$702 million#$660 million#$126 million#$400 million#$320 million# $500 million\\n\\nORG#Catalent Inc.#SEC#UPSA \\n\\nPERCENT#93%#100%#2%\\n\\nPERSON#Pomalyst#Nektar#Revlimid#REMS#Inrebic#Vidaza#Eliquis#Abraxane\\n\\nPRODUCT#Perfalgan\\n\\nTIME#one month\\n\\nWORK_OF_ART#Form 10-Q\\n\\n}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2145,\n",
      "    \"completion_tokens\": 191,\n",
      "    \"total_tokens\": 2336\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'June 30, 2019', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': 'sale of the Anagni manufacturing plant', 'category': 'EVENT'}, {'entity': 'SEC Consent Order', 'category': 'EVENT'}, {'entity': 'Anagni manufacturing plant', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Gulf Countries', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '2019 Form 10-K', 'category': 'LAW'}, {'entity': 'SEC Consent Order', 'category': 'LAW'}, {'entity': '$1.6 billion', 'category': 'MONEY'}, {'entity': '$702 million', 'category': 'MONEY'}, {'entity': '$660 million', 'category': 'MONEY'}, {'entity': '$126 million', 'category': 'MONEY'}, {'entity': '$400 million', 'category': 'MONEY'}, {'entity': '$320 million', 'category': 'MONEY'}, {'entity': '$500 million', 'category': 'MONEY'}, {'entity': 'Catalent Inc.', 'category': 'ORG'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'UPSA', 'category': 'ORG'}, {'entity': '93%', 'category': 'PERCENT'}, {'entity': '100%', 'category': 'PERCENT'}, {'entity': '2%', 'category': 'PERCENT'}, {'entity': 'Pomalyst', 'category': 'PERSON'}, {'entity': 'Nektar', 'category': 'PERSON'}, {'entity': 'Revlimid', 'category': 'PERSON'}, {'entity': 'REMS', 'category': 'PERSON'}, {'entity': 'Inrebic', 'category': 'PERSON'}, {'entity': 'Vidaza', 'category': 'PERSON'}, {'entity': 'Eliquis', 'category': 'PERSON'}, {'entity': 'Abraxane', 'category': 'PERSON'}, {'entity': 'Perfalgan', 'category': 'PRODUCT'}, {'entity': 'one month', 'category': 'TIME'}, {'entity': 'Form 10-Q', 'category': 'WORK_OF_ART'}, {'entity': '2.6', 'category': 'CARDINAL'}, {'entity': '2.5', 'category': 'CARDINAL'}, {'entity': '93', 'category': 'CARDINAL'}, {'entity': '25', 'category': 'CARDINAL'}, {'entity': '7', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  15\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWxY6mai41WBHkoolxSvBUzhXC7S\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701572244,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#1#1.1#60#25#1#2#1.6#1.2#$19.0#$340#19.9#18#650#661#545#343#145#50#25#135#278#244#197#45#$131#$256#145#$80#$75#70#$64#4,975#5,968#1,515#1,021#15.7#2.3#81#119\\n\\nDATE#Year Ended December 31#2019#2018#May 2019\\n\\nEVENT#Termination of the Bristol-Myers Squibb Retirement Income Plan#divestiture of the UPSA business#termination of our Europe and Asia partnership with Sanofi\\n\\nFAC#R&D sites\\n\\nGPE#U.S.#Bristol#Europe#Asia\\n\\nMONEY#$1,135#32#$257#$1,214#1.1 billion#79 million#85 million#$1.0 billion#1.8 billion#2.0 billion#656#183#1,599#$360#$1,168#657#523#464#415#301#$938#19.0 billion#19.9 billion#Celgene#1.6#650 million#661 million#545 million#343 million#145 million#50 million#25 million#135 million#278 million#244 million#197 million#45 million#131 million#256 million#145 million#80 million#75 million#70 million#64 million\\n\\nORG#Nektar#Cormorant Pharmaceuticals#IFM Therapeutics Inc.#Medarex#Acquisitions#Divestitures#Licensing and Collaboration Arrangements#Celgene#Bristol-Myers Squibb Retirement Income Plan#UPSA#Keytruda#Erbitux#ZymoGenetics Inc.#uniQure N.V.#Sanofi\\n\\nPERCENT#30.5%#17.1%\\n\\nPERSON#UPSA\\n\\nPRODUCT#Otezla\\n\\nTIME#2019}\\n\\nNote: There were no entities found for the following categories: FAC, LANGUAGE, LAW, NORP, ORDINAL, QUANTITY, TIME, WORK_OF_ART. Therefore these categories are not mentioned in the final output.\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2473,\n",
      "    \"completion_tokens\": 473,\n",
      "    \"total_tokens\": 2946\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': '2018', 'category': 'DATE'}, {'entity': 'May 2019', 'category': 'DATE'}, {'entity': 'Termination of the Bristol-Myers Squibb Retirement Income Plan', 'category': 'EVENT'}, {'entity': 'divestiture of the UPSA business', 'category': 'EVENT'}, {'entity': 'termination of our Europe and Asia partnership with Sanofi', 'category': 'EVENT'}, {'entity': 'R&D sites', 'category': 'FAC'}, {'entity': 'LANGUAGE', 'category': 'FAC'}, {'entity': 'LAW', 'category': 'FAC'}, {'entity': 'NORP', 'category': 'FAC'}, {'entity': 'ORDINAL', 'category': 'FAC'}, {'entity': 'QUANTITY', 'category': 'FAC'}, {'entity': 'TIME', 'category': 'FAC'}, {'entity': 'WORK_OF_ART. Therefore these categories are not mentioned in the final output.', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Bristol', 'category': 'GPE'}, {'entity': 'Europe', 'category': 'GPE'}, {'entity': 'Asia', 'category': 'GPE'}, {'entity': '$1,135', 'category': 'MONEY'}, {'entity': '32', 'category': 'MONEY'}, {'entity': '$257', 'category': 'MONEY'}, {'entity': '$1,214', 'category': 'MONEY'}, {'entity': '1.1 billion', 'category': 'MONEY'}, {'entity': '79 million', 'category': 'MONEY'}, {'entity': '85 million', 'category': 'MONEY'}, {'entity': '$1.0 billion', 'category': 'MONEY'}, {'entity': '1.8 billion', 'category': 'MONEY'}, {'entity': '2.0 billion', 'category': 'MONEY'}, {'entity': '656', 'category': 'MONEY'}, {'entity': '183', 'category': 'MONEY'}, {'entity': '1,599', 'category': 'MONEY'}, {'entity': '$360', 'category': 'MONEY'}, {'entity': '$1,168', 'category': 'MONEY'}, {'entity': '657', 'category': 'MONEY'}, {'entity': '523', 'category': 'MONEY'}, {'entity': '464', 'category': 'MONEY'}, {'entity': '415', 'category': 'MONEY'}, {'entity': '301', 'category': 'MONEY'}, {'entity': '$938', 'category': 'MONEY'}, {'entity': '19.0 billion', 'category': 'MONEY'}, {'entity': '19.9 billion', 'category': 'MONEY'}, {'entity': 'Celgene', 'category': 'MONEY'}, {'entity': '1.6', 'category': 'MONEY'}, {'entity': '650 million', 'category': 'MONEY'}, {'entity': '661 million', 'category': 'MONEY'}, {'entity': '545 million', 'category': 'MONEY'}, {'entity': '343 million', 'category': 'MONEY'}, {'entity': '145 million', 'category': 'MONEY'}, {'entity': '50 million', 'category': 'MONEY'}, {'entity': '25 million', 'category': 'MONEY'}, {'entity': '135 million', 'category': 'MONEY'}, {'entity': '278 million', 'category': 'MONEY'}, {'entity': '244 million', 'category': 'MONEY'}, {'entity': '197 million', 'category': 'MONEY'}, {'entity': '45 million', 'category': 'MONEY'}, {'entity': '131 million', 'category': 'MONEY'}, {'entity': '256 million', 'category': 'MONEY'}, {'entity': '145 million', 'category': 'MONEY'}, {'entity': '80 million', 'category': 'MONEY'}, {'entity': '75 million', 'category': 'MONEY'}, {'entity': '70 million', 'category': 'MONEY'}, {'entity': '64 million', 'category': 'MONEY'}, {'entity': 'Nektar', 'category': 'ORG'}, {'entity': 'Cormorant Pharmaceuticals', 'category': 'ORG'}, {'entity': 'IFM Therapeutics Inc.', 'category': 'ORG'}, {'entity': 'Medarex', 'category': 'ORG'}, {'entity': 'Acquisitions', 'category': 'ORG'}, {'entity': 'Divestitures', 'category': 'ORG'}, {'entity': 'Licensing and Collaboration Arrangements', 'category': 'ORG'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': 'Bristol-Myers Squibb Retirement Income Plan', 'category': 'ORG'}, {'entity': 'UPSA', 'category': 'ORG'}, {'entity': 'Keytruda', 'category': 'ORG'}, {'entity': 'Erbitux', 'category': 'ORG'}, {'entity': 'ZymoGenetics Inc.', 'category': 'ORG'}, {'entity': 'uniQure N.V.', 'category': 'ORG'}, {'entity': 'Sanofi', 'category': 'ORG'}, {'entity': '30.5%', 'category': 'PERCENT'}, {'entity': '17.1%', 'category': 'PERCENT'}, {'entity': 'UPSA', 'category': 'PERSON'}, {'entity': 'Otezla', 'category': 'PRODUCT'}, {'entity': '2019', 'category': 'TIME'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1.1', 'category': 'CARDINAL'}, {'entity': '60', 'category': 'CARDINAL'}, {'entity': '25', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '1.6', 'category': 'CARDINAL'}, {'entity': '1.2', 'category': 'CARDINAL'}, {'entity': '$19.0', 'category': 'CARDINAL'}, {'entity': '$340', 'category': 'CARDINAL'}, {'entity': '19.9', 'category': 'CARDINAL'}, {'entity': '18', 'category': 'CARDINAL'}, {'entity': '650', 'category': 'CARDINAL'}, {'entity': '661', 'category': 'CARDINAL'}, {'entity': '545', 'category': 'CARDINAL'}, {'entity': '343', 'category': 'CARDINAL'}, {'entity': '145', 'category': 'CARDINAL'}, {'entity': '50', 'category': 'CARDINAL'}, {'entity': '25', 'category': 'CARDINAL'}, {'entity': '135', 'category': 'CARDINAL'}, {'entity': '278', 'category': 'CARDINAL'}, {'entity': '244', 'category': 'CARDINAL'}, {'entity': '197', 'category': 'CARDINAL'}, {'entity': '45', 'category': 'CARDINAL'}, {'entity': '$131', 'category': 'CARDINAL'}, {'entity': '$256', 'category': 'CARDINAL'}, {'entity': '145', 'category': 'CARDINAL'}, {'entity': '$80', 'category': 'CARDINAL'}, {'entity': '$75', 'category': 'CARDINAL'}, {'entity': '70', 'category': 'CARDINAL'}, {'entity': '$64', 'category': 'CARDINAL'}, {'entity': '4,975', 'category': 'CARDINAL'}, {'entity': '5,968', 'category': 'CARDINAL'}, {'entity': '1,515', 'category': 'CARDINAL'}, {'entity': '1,021', 'category': 'CARDINAL'}, {'entity': '15.7', 'category': 'CARDINAL'}, {'entity': '2.3', 'category': 'CARDINAL'}, {'entity': '81', 'category': 'CARDINAL'}, {'entity': '119', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  15\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWyGDdVPQj9bemZQZfI1IFI2ysxM\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701572288,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#6#7#8#9#10#11#12#99.2#8#1#97#2018#2019#660#197#197#58#58#27#9#36#25#32#33#167#257#1,062#322#1,635#24#1,168#657#523#197#415#301#279#75#2#2,262#4,475#687#808#121#324#4,596#1,712#2.01#2.68#4.69#12,346#6,911#3,047#1,848#767#1,775#16,160#10,534#3,346#1,703#43,387#5,646#30,573#3,185#13.6#2.8#105#5.9#99#5.6#5#5.9#6.0#2.7#2.6#2.6#800#1.0#1.1#900#1.3\\n\\nDATE#February 6, 2020#December 31#Year Ended December 31#December 31,#2018#Year Ended December 31,#2018#December 31,#2019#2019#2018#2017#2020#2021#January 2020\\n\\nEVENT#U.S. tax reform\\n\\nGPE#U.S.\\n\\nMONEY#$97 million\\n\\nORG#BMS#Celgene#FDA#EU\\n\\nPERCENT#PRIOR#(177\\n\\nPRODUCT#Otezla#\\n\\nWORK_OF_ART#Exhibit 99.2}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2492,\n",
      "    \"completion_tokens\": 362,\n",
      "    \"total_tokens\": 2854\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'February 6, 2020', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': 'December 31,', 'category': 'DATE'}, {'entity': '2018', 'category': 'DATE'}, {'entity': 'Year Ended December 31,', 'category': 'DATE'}, {'entity': '2018', 'category': 'DATE'}, {'entity': 'December 31,', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': '2018', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': 'January 2020', 'category': 'DATE'}, {'entity': 'U.S. tax reform', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '$97 million', 'category': 'MONEY'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'EU', 'category': 'ORG'}, {'entity': 'PRIOR', 'category': 'PERCENT'}, {'entity': '177', 'category': 'PERCENT'}, {'entity': 'Otezla', 'category': 'PRODUCT'}, {'entity': 'Exhibit 99.2', 'category': 'WORK_OF_ART'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': '9', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '11', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '99.2', 'category': 'CARDINAL'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '97', 'category': 'CARDINAL'}, {'entity': '2018', 'category': 'CARDINAL'}, {'entity': '2019', 'category': 'CARDINAL'}, {'entity': '660', 'category': 'CARDINAL'}, {'entity': '197', 'category': 'CARDINAL'}, {'entity': '197', 'category': 'CARDINAL'}, {'entity': '58', 'category': 'CARDINAL'}, {'entity': '58', 'category': 'CARDINAL'}, {'entity': '27', 'category': 'CARDINAL'}, {'entity': '9', 'category': 'CARDINAL'}, {'entity': '36', 'category': 'CARDINAL'}, {'entity': '25', 'category': 'CARDINAL'}, {'entity': '32', 'category': 'CARDINAL'}, {'entity': '33', 'category': 'CARDINAL'}, {'entity': '167', 'category': 'CARDINAL'}, {'entity': '257', 'category': 'CARDINAL'}, {'entity': '1,062', 'category': 'CARDINAL'}, {'entity': '322', 'category': 'CARDINAL'}, {'entity': '1,635', 'category': 'CARDINAL'}, {'entity': '24', 'category': 'CARDINAL'}, {'entity': '1,168', 'category': 'CARDINAL'}, {'entity': '657', 'category': 'CARDINAL'}, {'entity': '523', 'category': 'CARDINAL'}, {'entity': '197', 'category': 'CARDINAL'}, {'entity': '415', 'category': 'CARDINAL'}, {'entity': '301', 'category': 'CARDINAL'}, {'entity': '279', 'category': 'CARDINAL'}, {'entity': '75', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2,262', 'category': 'CARDINAL'}, {'entity': '4,475', 'category': 'CARDINAL'}, {'entity': '687', 'category': 'CARDINAL'}, {'entity': '808', 'category': 'CARDINAL'}, {'entity': '121', 'category': 'CARDINAL'}, {'entity': '324', 'category': 'CARDINAL'}, {'entity': '4,596', 'category': 'CARDINAL'}, {'entity': '1,712', 'category': 'CARDINAL'}, {'entity': '2.01', 'category': 'CARDINAL'}, {'entity': '2.68', 'category': 'CARDINAL'}, {'entity': '4.69', 'category': 'CARDINAL'}, {'entity': '12,346', 'category': 'CARDINAL'}, {'entity': '6,911', 'category': 'CARDINAL'}, {'entity': '3,047', 'category': 'CARDINAL'}, {'entity': '1,848', 'category': 'CARDINAL'}, {'entity': '767', 'category': 'CARDINAL'}, {'entity': '1,775', 'category': 'CARDINAL'}, {'entity': '16,160', 'category': 'CARDINAL'}, {'entity': '10,534', 'category': 'CARDINAL'}, {'entity': '3,346', 'category': 'CARDINAL'}, {'entity': '1,703', 'category': 'CARDINAL'}, {'entity': '43,387', 'category': 'CARDINAL'}, {'entity': '5,646', 'category': 'CARDINAL'}, {'entity': '30,573', 'category': 'CARDINAL'}, {'entity': '3,185', 'category': 'CARDINAL'}, {'entity': '13.6', 'category': 'CARDINAL'}, {'entity': '2.8', 'category': 'CARDINAL'}, {'entity': '105', 'category': 'CARDINAL'}, {'entity': '5.9', 'category': 'CARDINAL'}, {'entity': '99', 'category': 'CARDINAL'}, {'entity': '5.6', 'category': 'CARDINAL'}, {'entity': '5', 'category': 'CARDINAL'}, {'entity': '5.9', 'category': 'CARDINAL'}, {'entity': '6.0', 'category': 'CARDINAL'}, {'entity': '2.7', 'category': 'CARDINAL'}, {'entity': '2.6', 'category': 'CARDINAL'}, {'entity': '2.6', 'category': 'CARDINAL'}, {'entity': '800', 'category': 'CARDINAL'}, {'entity': '1.0', 'category': 'CARDINAL'}, {'entity': '1.1', 'category': 'CARDINAL'}, {'entity': '900', 'category': 'CARDINAL'}, {'entity': '1.3', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  15\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWytYWnmXLSPcsVoV8xFfOMzX0lU\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701572327,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#366#4#364#1#30#3#90#120#2.1#3.0#1.0#750#1.1#8.9#23.4#14.6#11.2 \\n\\nDATE#December 31, 2019#January 2021#January 2022#September 2023#July 2024#December 31, 2019#December 31, 2018#May 2019#January 31, 2020#December 31, 2020#November 2019#Year Ended December 31,2019#2018#90 days in 2019#90 to 120 days in 2018\\n\\nEVENT#the Celgene transaction#the acquisition of Celgene#the divestitures of Otezla* and UPSA consumer health business\\n\\nFAC#Facilities\\n\\nGPE#U.S.#UK#EU\\n\\nMONEY#$5 billion#$6.0 billion#$2.0 billion#$1.0 billion#$1.5 billion#$19.0 billion#$19.9 billion#less than 3% of our total revenues\\n\\nORG#Moody's#S&P#Celgene#Moody's Investors Service#Standard & Poor's#BMS\\n\\nPERCENT#a negative long-term credit outlook\\n\\nPERSON#\\n\\nPRODUCT#senior notes#commercial paper borrowings#our commercial and clinical medicines\\n\\nQUANTITY#\\n\\nTIME#\\n\\nWORK_OF_ART#\\u201cItem 8. Financial Statements and Supplementary Data\\u2014Note 9. Financial Instruments and Fair Value Measurements\\u201d#Opdivo, Yervoy and Empliciti}\\n\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2180,\n",
      "    \"completion_tokens\": 345,\n",
      "    \"total_tokens\": 2525\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2019', 'category': 'DATE'}, {'entity': 'January 2021', 'category': 'DATE'}, {'entity': 'January 2022', 'category': 'DATE'}, {'entity': 'September 2023', 'category': 'DATE'}, {'entity': 'July 2024', 'category': 'DATE'}, {'entity': 'December 31, 2019', 'category': 'DATE'}, {'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': 'May 2019', 'category': 'DATE'}, {'entity': 'January 31, 2020', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'November 2019', 'category': 'DATE'}, {'entity': 'Year Ended December 31,2019', 'category': 'DATE'}, {'entity': '2018', 'category': 'DATE'}, {'entity': '90 days in 2019', 'category': 'DATE'}, {'entity': '90 to 120 days in 2018', 'category': 'DATE'}, {'entity': 'the Celgene transaction', 'category': 'EVENT'}, {'entity': 'the acquisition of Celgene', 'category': 'EVENT'}, {'entity': 'the divestitures of Otezla* and UPSA consumer health business', 'category': 'EVENT'}, {'entity': 'Facilities', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'UK', 'category': 'GPE'}, {'entity': 'EU', 'category': 'GPE'}, {'entity': '$5 billion', 'category': 'MONEY'}, {'entity': '$6.0 billion', 'category': 'MONEY'}, {'entity': '$2.0 billion', 'category': 'MONEY'}, {'entity': '$1.0 billion', 'category': 'MONEY'}, {'entity': '$1.5 billion', 'category': 'MONEY'}, {'entity': '$19.0 billion', 'category': 'MONEY'}, {'entity': '$19.9 billion', 'category': 'MONEY'}, {'entity': 'less than 3% of our total revenues', 'category': 'MONEY'}, {'entity': 'Moodys', 'category': 'ORG'}, {'entity': 'S&P', 'category': 'ORG'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': 'Moodys Investors Service', 'category': 'ORG'}, {'entity': 'Standard & Poors', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'a negative long-term credit outlook', 'category': 'PERCENT'}, {'entity': 'senior notes', 'category': 'PRODUCT'}, {'entity': 'commercial paper borrowings', 'category': 'PRODUCT'}, {'entity': 'our commercial and clinical medicines', 'category': 'PRODUCT'}, {'entity': '“Item 8. Financial Statements and Supplementary Data—Note 9. Financial Instruments and Fair Value Measurements”', 'category': 'WORK_OF_ART'}, {'entity': 'Opdivo, Yervoy and Empliciti', 'category': 'WORK_OF_ART'}, {'entity': '366', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '364', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '30', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '90', 'category': 'CARDINAL'}, {'entity': '120', 'category': 'CARDINAL'}, {'entity': '2.1', 'category': 'CARDINAL'}, {'entity': '3.0', 'category': 'CARDINAL'}, {'entity': '1.0', 'category': 'CARDINAL'}, {'entity': '750', 'category': 'CARDINAL'}, {'entity': '1.1', 'category': 'CARDINAL'}, {'entity': '8.9', 'category': 'CARDINAL'}, {'entity': '23.4', 'category': 'CARDINAL'}, {'entity': '14.6', 'category': 'CARDINAL'}, {'entity': '11.2', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  15\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RWzUZaBh8Ennu3EFSBbq95FChtXI\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701572364,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#18.2#7.0#20.7#6.9#13.8#14.7#9.00#6.8#100#93 \\n\\nDATE#December 31, 2019#December 31, 2020#March 31, 2021#August 4, 2004#September 30, 2004\\n\\nEVENT#Celgene acquisition#FCPA Settlement\\n\\nMONEY#$18.2 billion#$7.0 billion#$20.7 billion#$6.9 billion#$13.8 billion#$14.7 billion#$9.00#$6.8 billion\\n\\nORG#SEC#FDA#CVR\\n\\nPERSON#Item 8\\n\\nPRODUCT#ozanimod#liso-cel (JCAR017)#ide-cel (bb2121)\\n\\nTIME#20 business days\\n\\nWORK_OF_ART#Form 10-Q#Note 3. Alliances#Note 1. Accounting Policies and Recently Issued Accounting Standards}\\n\\nNote: Since there are no entities present in the following categories: FAC, GPE, LAW, LOC, NORP, ORDINAL, PERCENT, QUANTITY; these categories are not mentioned in the final output. No language has been mentioned in the text.\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2276,\n",
      "    \"completion_tokens\": 260,\n",
      "    \"total_tokens\": 2536\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2019', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'March 31, 2021', 'category': 'DATE'}, {'entity': 'August 4, 2004', 'category': 'DATE'}, {'entity': 'September 30, 2004', 'category': 'DATE'}, {'entity': 'Celgene acquisition', 'category': 'EVENT'}, {'entity': 'FCPA Settlement', 'category': 'EVENT'}, {'entity': 'GPE', 'category': 'FAC'}, {'entity': 'LAW', 'category': 'FAC'}, {'entity': 'LOC', 'category': 'FAC'}, {'entity': 'NORP', 'category': 'FAC'}, {'entity': 'ORDINAL', 'category': 'FAC'}, {'entity': 'PERCENT', 'category': 'FAC'}, {'entity': 'QUANTITY; these categories are not mentioned in the final output. No language has been mentioned in the text.', 'category': 'FAC'}, {'entity': '$18.2 billion', 'category': 'MONEY'}, {'entity': '$7.0 billion', 'category': 'MONEY'}, {'entity': '$20.7 billion', 'category': 'MONEY'}, {'entity': '$6.9 billion', 'category': 'MONEY'}, {'entity': '$13.8 billion', 'category': 'MONEY'}, {'entity': '$14.7 billion', 'category': 'MONEY'}, {'entity': '$9.00', 'category': 'MONEY'}, {'entity': '$6.8 billion', 'category': 'MONEY'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'CVR', 'category': 'ORG'}, {'entity': 'Item 8', 'category': 'PERSON'}, {'entity': 'ozanimod', 'category': 'PRODUCT'}, {'entity': 'liso-cel JCAR017', 'category': 'PRODUCT'}, {'entity': 'ide-cel bb2121', 'category': 'PRODUCT'}, {'entity': '20 business days', 'category': 'TIME'}, {'entity': 'Form 10-Q', 'category': 'WORK_OF_ART'}, {'entity': 'Note 3. Alliances', 'category': 'WORK_OF_ART'}, {'entity': 'Note 1. Accounting Policies and Recently Issued Accounting Standards', 'category': 'WORK_OF_ART'}, {'entity': '18.2', 'category': 'CARDINAL'}, {'entity': '7.0', 'category': 'CARDINAL'}, {'entity': '20.7', 'category': 'CARDINAL'}, {'entity': '6.9', 'category': 'CARDINAL'}, {'entity': '13.8', 'category': 'CARDINAL'}, {'entity': '14.7', 'category': 'CARDINAL'}, {'entity': '9.00', 'category': 'CARDINAL'}, {'entity': '6.8', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '93', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  15\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RX03iCr24bZ6cqar26Gwshbx6vAJ\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701572399,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#4#5#2#70#64.0#1.1 \\n\\nDATE#December 31, 2019#December 31, 2018\\n\\nFAC#Celgene\\n\\nGPE#U.S.\\n\\nLAW#340B Drug Pricing Program#Medicare Part D\\n\\nORG#U.S. Department of Defense#U.S. Department of Veterans Affairs#Medicaid#Medicare#CMS#Federal and state government\\n\\nPERCENT#2% \\n\\nPERSON#Medicare Advantage}\\n\\nNote: There are no entities in the categories: DATE, EVENT, LANGUAGE, NORP, ORDINAL, PERCENT, PERSON, PRODUCT, QUANTITY, TIME, WORK_OF_ART. Hence, they are not mentioned in the output above.\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2012,\n",
      "    \"completion_tokens\": 155,\n",
      "    \"total_tokens\": 2167\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2019', 'category': 'DATE'}, {'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': 'EVENT', 'category': 'DATE'}, {'entity': 'LANGUAGE', 'category': 'DATE'}, {'entity': 'NORP', 'category': 'DATE'}, {'entity': 'ORDINAL', 'category': 'DATE'}, {'entity': 'PERCENT', 'category': 'DATE'}, {'entity': 'PERSON', 'category': 'DATE'}, {'entity': 'PRODUCT', 'category': 'DATE'}, {'entity': 'QUANTITY', 'category': 'DATE'}, {'entity': 'TIME', 'category': 'DATE'}, {'entity': 'WORK_OF_ART. Hence', 'category': 'DATE'}, {'entity': 'they are not mentioned in the output above.', 'category': 'DATE'}, {'entity': 'Celgene', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '340B Drug Pricing Program', 'category': 'LAW'}, {'entity': 'Medicare Part D', 'category': 'LAW'}, {'entity': 'U.S. Department of Defense', 'category': 'ORG'}, {'entity': 'U.S. Department of Veterans Affairs', 'category': 'ORG'}, {'entity': 'Medicaid', 'category': 'ORG'}, {'entity': 'Medicare', 'category': 'ORG'}, {'entity': 'CMS', 'category': 'ORG'}, {'entity': 'Federal and state government', 'category': 'ORG'}, {'entity': '2%', 'category': 'PERCENT'}, {'entity': 'Medicare Advantage', 'category': 'PERSON'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '5', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '70', 'category': 'CARDINAL'}, {'entity': '64.0', 'category': 'CARDINAL'}, {'entity': '1.1', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  15\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RX0ZBblLLnva0qVJg42xYLcHFuS7\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701572431,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#22.5 billion#6.5 billion#2.1 billion#1.6 billion#216 million#21%#2.6 billion#56 million#50%#two#four#one#244 million\\n\\nDATE#December 31, 2019#2018#December 31, 2018#December 31, 2017#2017#2022#2019#fourth quarter of 2017#2009\\n\\nEVENT#Mead Johnson split-off\\n\\nFAC#\\n\\nGPE#\\n\\nLANGUAGE#\\n\\nLAW#Section 382 of the Internal Revenue Code\\n\\nLOC#U.S.\\n\\nMONEY#2.1 billion#$2.8 billion#$1.6 billion#$3.2 billion#$216 million#$2.6 billion#$56 million#$244 million\\n\\nNORP#federal\\n\\nORDINAL#\\n\\nORG#Mead Johnson\\n\\nPERCENT#21%\\n\\nPERSON#\\n\\nPRODUCT#\\n\\nQUANTITY#\\n\\nTIME#one year#long-range\\n\\nWORK_OF_ART#}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2142,\n",
      "    \"completion_tokens\": 210,\n",
      "    \"total_tokens\": 2352\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2019', 'category': 'DATE'}, {'entity': '2018', 'category': 'DATE'}, {'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': 'fourth quarter of 2017', 'category': 'DATE'}, {'entity': '2009', 'category': 'DATE'}, {'entity': 'Mead Johnson split-off', 'category': 'EVENT'}, {'entity': 'Section 382 of the Internal Revenue Code', 'category': 'LAW'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': '2.1 billion', 'category': 'MONEY'}, {'entity': '$2.8 billion', 'category': 'MONEY'}, {'entity': '$1.6 billion', 'category': 'MONEY'}, {'entity': '$3.2 billion', 'category': 'MONEY'}, {'entity': '$216 million', 'category': 'MONEY'}, {'entity': '$2.6 billion', 'category': 'MONEY'}, {'entity': '$56 million', 'category': 'MONEY'}, {'entity': '$244 million', 'category': 'MONEY'}, {'entity': 'federal', 'category': 'NORP'}, {'entity': 'Mead Johnson', 'category': 'ORG'}, {'entity': '21%', 'category': 'PERCENT'}, {'entity': 'one year', 'category': 'TIME'}, {'entity': 'long-range', 'category': 'TIME'}, {'entity': '', 'category': 'WORK_OF_ART'}, {'entity': '22.5 billion', 'category': 'CARDINAL'}, {'entity': '6.5 billion', 'category': 'CARDINAL'}, {'entity': '2.1 billion', 'category': 'CARDINAL'}, {'entity': '1.6 billion', 'category': 'CARDINAL'}, {'entity': '216 million', 'category': 'CARDINAL'}, {'entity': '21%', 'category': 'CARDINAL'}, {'entity': '2.6 billion', 'category': 'CARDINAL'}, {'entity': '56 million', 'category': 'CARDINAL'}, {'entity': '50%', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': 'four', 'category': 'CARDINAL'}, {'entity': 'one', 'category': 'CARDINAL'}, {'entity': '244 million', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  15\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RX17psxlpWFBwhIizXxPmIK1FvGL\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701572465,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#40-50%#10%\\n\\nDATE#December 2019#September 2019#March 2019#November 2019\\n\\nEVENT#NAXOS#AUGUSTUS trial#American Society of Hematology Annual Meeting#GUARD-AF#CheckMate-142 study#ATTRACTION-3 trial#CheckMate-548 trial#CheckMate-498 trial#CheckMate-459\\n\\nFAC#European Society of Cardiology Congress 2019\\n\\nGPE#France#Orlando, Florida#U.S.#Japan\\n\\nLAW#Item 8. Financial Statements and Supplementary Data\\u2014Note 1. Accounting Policies and Recently Issued Accounting Standards\\u2014Income Taxes#\\u2014Note 7. Income Taxes#Item 8. Financial Statements and Supplementary Data\\u2014Note 1. Accounting Policies and Recently Issued Accounting Standards\\u2014Contingencies#\\u2014Note 7. Income Taxes#\\u2014Note 19. Legal Proceedings and Contingencies\\n\\nMONEY#10% of our R&D expenses\\n\\nORG#EC#R2#NAXOS#VKAs#LMWH#BMS-Pfizer#MSI-H#dMMR#GBM#MGMT-methylated#MGMT-unmethylated#HCC#EC\\n\\nPERCENT#40-50%#10%\\n\\nPERSON#Opdivo#Revlimid#Eliquis#Opdivo#Opdivo#Opdivo#Opdivo#Opdivo#Opdivo\\n\\nPRODUCT#NAXOS (EvaluatioN of ApiXaban in strOke and Systemic embolism prevention in patients with nonvalvular atrial fibrillation in the real-life setting in France)#vitamin K antagonist#a vitamin K antagonist#VTE#atrial fibrillation#Opdivo in Japan#fluoropyrimidine anticancer drugs#Phase II CheckMate-142 study#Phase III ATTRACTION-3 trial#fluoropyrimidine and platinum-based drugs#Phase III CheckMate-548 trial#temozolomide#radiation therapy#Phase III CheckMate-498 trial#MGMT-unmethylated GBM#CheckMate-459#Opdivo flat dosing schedule#Phase III CheckMate-238\\n\\nTIME#approximately 40-50%#the next few years#six months#at least 70 years}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2258,\n",
      "    \"completion_tokens\": 492,\n",
      "    \"total_tokens\": 2750\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 2019', 'category': 'DATE'}, {'entity': 'September 2019', 'category': 'DATE'}, {'entity': 'March 2019', 'category': 'DATE'}, {'entity': 'November 2019', 'category': 'DATE'}, {'entity': 'NAXOS', 'category': 'EVENT'}, {'entity': 'AUGUSTUS trial', 'category': 'EVENT'}, {'entity': 'American Society of Hematology Annual Meeting', 'category': 'EVENT'}, {'entity': 'GUARD-AF', 'category': 'EVENT'}, {'entity': 'CheckMate-142 study', 'category': 'EVENT'}, {'entity': 'ATTRACTION-3 trial', 'category': 'EVENT'}, {'entity': 'CheckMate-548 trial', 'category': 'EVENT'}, {'entity': 'CheckMate-498 trial', 'category': 'EVENT'}, {'entity': 'CheckMate-459', 'category': 'EVENT'}, {'entity': 'European Society of Cardiology Congress 2019', 'category': 'FAC'}, {'entity': 'France', 'category': 'GPE'}, {'entity': 'Orlando, Florida', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'Item 8. Financial Statements and Supplementary Data—Note 1. Accounting Policies and Recently Issued Accounting Standards—Income Taxes', 'category': 'LAW'}, {'entity': '—Note 7. Income Taxes', 'category': 'LAW'}, {'entity': 'Item 8. Financial Statements and Supplementary Data—Note 1. Accounting Policies and Recently Issued Accounting Standards—Contingencies', 'category': 'LAW'}, {'entity': '—Note 7. Income Taxes', 'category': 'LAW'}, {'entity': '—Note 19. Legal Proceedings and Contingencies', 'category': 'LAW'}, {'entity': '10% of our R&D expenses', 'category': 'MONEY'}, {'entity': 'EC', 'category': 'ORG'}, {'entity': 'R2', 'category': 'ORG'}, {'entity': 'NAXOS', 'category': 'ORG'}, {'entity': 'VKAs', 'category': 'ORG'}, {'entity': 'LMWH', 'category': 'ORG'}, {'entity': 'BMS-Pfizer', 'category': 'ORG'}, {'entity': 'MSI-H', 'category': 'ORG'}, {'entity': 'dMMR', 'category': 'ORG'}, {'entity': 'GBM', 'category': 'ORG'}, {'entity': 'MGMT-methylated', 'category': 'ORG'}, {'entity': 'MGMT-unmethylated', 'category': 'ORG'}, {'entity': 'HCC', 'category': 'ORG'}, {'entity': 'EC', 'category': 'ORG'}, {'entity': '40-50%', 'category': 'PERCENT'}, {'entity': '10%', 'category': 'PERCENT'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Revlimid', 'category': 'PERSON'}, {'entity': 'Eliquis', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'NAXOS EvaluatioN of ApiXaban in strOke and Systemic embolism prevention in patients with nonvalvular atrial fibrillation in the real-life setting in France', 'category': 'PRODUCT'}, {'entity': 'vitamin K antagonist', 'category': 'PRODUCT'}, {'entity': 'a vitamin K antagonist', 'category': 'PRODUCT'}, {'entity': 'VTE', 'category': 'PRODUCT'}, {'entity': 'atrial fibrillation', 'category': 'PRODUCT'}, {'entity': 'Opdivo in Japan', 'category': 'PRODUCT'}, {'entity': 'fluoropyrimidine anticancer drugs', 'category': 'PRODUCT'}, {'entity': 'Phase II CheckMate-142 study', 'category': 'PRODUCT'}, {'entity': 'Phase III ATTRACTION-3 trial', 'category': 'PRODUCT'}, {'entity': 'fluoropyrimidine and platinum-based drugs', 'category': 'PRODUCT'}, {'entity': 'Phase III CheckMate-548 trial', 'category': 'PRODUCT'}, {'entity': 'temozolomide', 'category': 'PRODUCT'}, {'entity': 'radiation therapy', 'category': 'PRODUCT'}, {'entity': 'Phase III CheckMate-498 trial', 'category': 'PRODUCT'}, {'entity': 'MGMT-unmethylated GBM', 'category': 'PRODUCT'}, {'entity': 'CheckMate-459', 'category': 'PRODUCT'}, {'entity': 'Opdivo flat dosing schedule', 'category': 'PRODUCT'}, {'entity': 'Phase III CheckMate-238', 'category': 'PRODUCT'}, {'entity': 'approximately 40-50%', 'category': 'TIME'}, {'entity': 'the next few years', 'category': 'TIME'}, {'entity': 'six months', 'category': 'TIME'}, {'entity': 'at least 70 years', 'category': 'TIME'}, {'entity': '40-50%', 'category': 'CARDINAL'}, {'entity': '10%', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  15\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RX1pH03924MbXISh3jm0RaKLh7ov\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701572509,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#3#10#58%#45%#13.4%#2.6%#14%#19%#11%#1%#31%#25%#10%#32#30#52%#44%#26%#57%#67#4#1\\n\\nDATE#three years#August 2019#September 2019#April 2019#January 2019#November 2019#March 10, 2020#June 2019#February 2019#five years#60 months#43.1 months#March 2019#January 2020#2018\\n\\nEVENT#CheckMate-238 study#2019 American Society of Clinical Oncology Annual Meeting#Phase III CheckMate-017#CheckMate-057 studies#PIVOT-02 Phase I/II clinical study#Phase II CheckMate-650 trial#CheckMate-915#CheckMate-067 clinical trial#Phase I CA209-004 study#CheckMate-067#Phase 3 CheckMate -227 trial\\n\\nFAC#\\n\\nGPE#China\\n\\nLOC#\\n\\nMONEY#\\n\\nNORP#American#Chinese\\n\\nORDINAL#first#third#second\\n\\nORG#FDA#Nektar#Phase III CheckMate-017#CheckMate-057#NSCLC#SCCHN#sBLA#HCC#CheckMate-040#mCRPC#CheckMate-650#Melanoma#CheckMate-915#Phase III CheckMate-067#Phase I CA209-004#Opdivo+Yervoy.March#Company's#EU#CheckMate-227#Committee for Medicinal Products for Human Use#\\u201cCHMP\\n\\nPERCENT#58%#45%#13.4%#2.6%#19%#11%#31%#25%#10%#52%#44%#26%#57% \\n\\nPERSON#Yervoy#sorafenib\\n\\nPRODUCT#Opdivo#Yervoy#bempegaldesleukin#NKTR-214#docetaxel#sBLA\\n\\nQUANTITY#10 mg/kg#3 mg/kg\\n\\nTIME#three years#five years#28 months#11.9 months#13.5 months#four years\\n\\nWORK_OF_ART#}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2416,\n",
      "    \"completion_tokens\": 491,\n",
      "    \"total_tokens\": 2907\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'three years', 'category': 'DATE'}, {'entity': 'August 2019', 'category': 'DATE'}, {'entity': 'September 2019', 'category': 'DATE'}, {'entity': 'April 2019', 'category': 'DATE'}, {'entity': 'January 2019', 'category': 'DATE'}, {'entity': 'November 2019', 'category': 'DATE'}, {'entity': 'March 10, 2020', 'category': 'DATE'}, {'entity': 'June 2019', 'category': 'DATE'}, {'entity': 'February 2019', 'category': 'DATE'}, {'entity': 'five years', 'category': 'DATE'}, {'entity': '60 months', 'category': 'DATE'}, {'entity': '43.1 months', 'category': 'DATE'}, {'entity': 'March 2019', 'category': 'DATE'}, {'entity': 'January 2020', 'category': 'DATE'}, {'entity': '2018', 'category': 'DATE'}, {'entity': 'CheckMate-238 study', 'category': 'EVENT'}, {'entity': '2019 American Society of Clinical Oncology Annual Meeting', 'category': 'EVENT'}, {'entity': 'Phase III CheckMate-017', 'category': 'EVENT'}, {'entity': 'CheckMate-057 studies', 'category': 'EVENT'}, {'entity': 'PIVOT-02 Phase I/II clinical study', 'category': 'EVENT'}, {'entity': 'Phase II CheckMate-650 trial', 'category': 'EVENT'}, {'entity': 'CheckMate-915', 'category': 'EVENT'}, {'entity': 'CheckMate-067 clinical trial', 'category': 'EVENT'}, {'entity': 'Phase I CA209-004 study', 'category': 'EVENT'}, {'entity': 'CheckMate-067', 'category': 'EVENT'}, {'entity': 'Phase 3 CheckMate -227 trial', 'category': 'EVENT'}, {'entity': 'China', 'category': 'GPE'}, {'entity': 'American', 'category': 'NORP'}, {'entity': 'Chinese', 'category': 'NORP'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'Nektar', 'category': 'ORG'}, {'entity': 'Phase III CheckMate-017', 'category': 'ORG'}, {'entity': 'CheckMate-057', 'category': 'ORG'}, {'entity': 'NSCLC', 'category': 'ORG'}, {'entity': 'SCCHN', 'category': 'ORG'}, {'entity': 'sBLA', 'category': 'ORG'}, {'entity': 'HCC', 'category': 'ORG'}, {'entity': 'CheckMate-040', 'category': 'ORG'}, {'entity': 'mCRPC', 'category': 'ORG'}, {'entity': 'CheckMate-650', 'category': 'ORG'}, {'entity': 'Melanoma', 'category': 'ORG'}, {'entity': 'CheckMate-915', 'category': 'ORG'}, {'entity': 'Phase III CheckMate-067', 'category': 'ORG'}, {'entity': 'Phase I CA209-004', 'category': 'ORG'}, {'entity': 'Opdivo+Yervoy.March', 'category': 'ORG'}, {'entity': 'Companys', 'category': 'ORG'}, {'entity': 'EU', 'category': 'ORG'}, {'entity': 'CheckMate-227', 'category': 'ORG'}, {'entity': 'Committee for Medicinal Products for Human Use', 'category': 'ORG'}, {'entity': '“CHMP', 'category': 'ORG'}, {'entity': '58%', 'category': 'PERCENT'}, {'entity': '45%', 'category': 'PERCENT'}, {'entity': '13.4%', 'category': 'PERCENT'}, {'entity': '2.6%', 'category': 'PERCENT'}, {'entity': '19%', 'category': 'PERCENT'}, {'entity': '11%', 'category': 'PERCENT'}, {'entity': '31%', 'category': 'PERCENT'}, {'entity': '25%', 'category': 'PERCENT'}, {'entity': '10%', 'category': 'PERCENT'}, {'entity': '52%', 'category': 'PERCENT'}, {'entity': '44%', 'category': 'PERCENT'}, {'entity': '26%', 'category': 'PERCENT'}, {'entity': '57%', 'category': 'PERCENT'}, {'entity': 'Yervoy', 'category': 'PERSON'}, {'entity': 'sorafenib', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Yervoy', 'category': 'PRODUCT'}, {'entity': 'bempegaldesleukin', 'category': 'PRODUCT'}, {'entity': 'NKTR-214', 'category': 'PRODUCT'}, {'entity': 'docetaxel', 'category': 'PRODUCT'}, {'entity': 'sBLA', 'category': 'PRODUCT'}, {'entity': '10 mg/kg', 'category': 'QUANTITY'}, {'entity': '3 mg/kg', 'category': 'QUANTITY'}, {'entity': 'three years', 'category': 'TIME'}, {'entity': 'five years', 'category': 'TIME'}, {'entity': '28 months', 'category': 'TIME'}, {'entity': '11.9 months', 'category': 'TIME'}, {'entity': '13.5 months', 'category': 'TIME'}, {'entity': 'four years', 'category': 'TIME'}, {'entity': '', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'third', 'category': 'ORDINAL'}, {'entity': 'second', 'category': 'ORDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '58%', 'category': 'CARDINAL'}, {'entity': '45%', 'category': 'CARDINAL'}, {'entity': '13.4%', 'category': 'CARDINAL'}, {'entity': '2.6%', 'category': 'CARDINAL'}, {'entity': '14%', 'category': 'CARDINAL'}, {'entity': '19%', 'category': 'CARDINAL'}, {'entity': '11%', 'category': 'CARDINAL'}, {'entity': '1%', 'category': 'CARDINAL'}, {'entity': '31%', 'category': 'CARDINAL'}, {'entity': '25%', 'category': 'CARDINAL'}, {'entity': '10%', 'category': 'CARDINAL'}, {'entity': '32', 'category': 'CARDINAL'}, {'entity': '30', 'category': 'CARDINAL'}, {'entity': '52%', 'category': 'CARDINAL'}, {'entity': '44%', 'category': 'CARDINAL'}, {'entity': '26%', 'category': 'CARDINAL'}, {'entity': '57%', 'category': 'CARDINAL'}, {'entity': '67', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  15\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RX2UIn0AK3K62A4q4t2Q5X50VXMP\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701572550,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#2#1 \\n\\nDATE#May 15, 2020#October 2019#September 2019#July 2019#January 2019#February 2019#April 2019#December 2019#June 2019#March 2019#November 2019#August 2019\\n\\nEVENT#Part 2 of the Phase III CheckMate-227 study#Phase II CheckMate-714 trial#Phase IV mechanistic study\\n\\nFAC#\\n\\nGPE#Japan#Europe\\n\\nLANGUAGE#\\n\\nLAW#Prescription Drug User Fee Act\\n\\nLOC#\\n\\nMONEY#\\n\\nNORP#\\n\\nORDINAL#first#first-line\\n\\nORG#FDA#PDUFA#Yervoy#Opdivo#NSCLC#CheckMate-9LA#CheckMate-227#TMB#CheckMate-214#RCC#EC#SCCHN#CheckMate-714#GvHD#Orencia#JIA#RA#adalimumab#Annual European Congress of Rheumatology#Sprycel#ALL#Empliciti#MM#sJNDA#Japan Ministry of Health, Labour and Welfare#ELOQUENT-3#Pd#Poster display#Revlimid#Acceleron Pharma Inc.#ODAC#Reblozyl#BMS\\n\\nPERCENT#40%#33%#23%\\n\\nPERSON#\\n\\nPRODUCT#Opdivo plus low-dose Yervoy#Opdivo+Yervoy#immunotherapy and chemotherapy components#Company's sBLA#Orencia solution for subcutaneous injection in pre-filled syringe extension application (50 mg & 87.5 mg strength)#Opdivo 125mg Syringe for Subcutaneous Injection 1mL#Orencia 125mg Autoinjector for Subcutaneous Injection 1mL#anti-citrullinated protein antibody and rheumatoid factor#Empliciti plus pomalidomide and dexamethasone (EPd)#Empliciti plus pomalidomide and low-dose dexamethasone (EPd)#ELOQUENT-3\\n\\nQUANTITY#10 mutations per megabase\\n\\nTIME#\\n\\nWORK_OF_ART#\\n\\nMONEY#\\n}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2416,\n",
      "    \"completion_tokens\": 470,\n",
      "    \"total_tokens\": 2886\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'May 15, 2020', 'category': 'DATE'}, {'entity': 'October 2019', 'category': 'DATE'}, {'entity': 'September 2019', 'category': 'DATE'}, {'entity': 'July 2019', 'category': 'DATE'}, {'entity': 'January 2019', 'category': 'DATE'}, {'entity': 'February 2019', 'category': 'DATE'}, {'entity': 'April 2019', 'category': 'DATE'}, {'entity': 'December 2019', 'category': 'DATE'}, {'entity': 'June 2019', 'category': 'DATE'}, {'entity': 'March 2019', 'category': 'DATE'}, {'entity': 'November 2019', 'category': 'DATE'}, {'entity': 'August 2019', 'category': 'DATE'}, {'entity': 'Part 2 of the Phase III CheckMate-227 study', 'category': 'EVENT'}, {'entity': 'Phase II CheckMate-714 trial', 'category': 'EVENT'}, {'entity': 'Phase IV mechanistic study', 'category': 'EVENT'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'Europe', 'category': 'GPE'}, {'entity': 'Prescription Drug User Fee Act', 'category': 'LAW'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'PDUFA', 'category': 'ORG'}, {'entity': 'Yervoy', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'NSCLC', 'category': 'ORG'}, {'entity': 'CheckMate-9LA', 'category': 'ORG'}, {'entity': 'CheckMate-227', 'category': 'ORG'}, {'entity': 'TMB', 'category': 'ORG'}, {'entity': 'CheckMate-214', 'category': 'ORG'}, {'entity': 'RCC', 'category': 'ORG'}, {'entity': 'EC', 'category': 'ORG'}, {'entity': 'SCCHN', 'category': 'ORG'}, {'entity': 'CheckMate-714', 'category': 'ORG'}, {'entity': 'GvHD', 'category': 'ORG'}, {'entity': 'Orencia', 'category': 'ORG'}, {'entity': 'JIA', 'category': 'ORG'}, {'entity': 'RA', 'category': 'ORG'}, {'entity': 'adalimumab', 'category': 'ORG'}, {'entity': 'Annual European Congress of Rheumatology', 'category': 'ORG'}, {'entity': 'Sprycel', 'category': 'ORG'}, {'entity': 'ALL', 'category': 'ORG'}, {'entity': 'Empliciti', 'category': 'ORG'}, {'entity': 'MM', 'category': 'ORG'}, {'entity': 'sJNDA', 'category': 'ORG'}, {'entity': 'Japan Ministry of Health, Labour and Welfare', 'category': 'ORG'}, {'entity': 'ELOQUENT-3', 'category': 'ORG'}, {'entity': 'Pd', 'category': 'ORG'}, {'entity': 'Poster display', 'category': 'ORG'}, {'entity': 'Revlimid', 'category': 'ORG'}, {'entity': 'Acceleron Pharma Inc.', 'category': 'ORG'}, {'entity': 'ODAC', 'category': 'ORG'}, {'entity': 'Reblozyl', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': '40%', 'category': 'PERCENT'}, {'entity': '33%', 'category': 'PERCENT'}, {'entity': '23%', 'category': 'PERCENT'}, {'entity': 'Opdivo plus low-dose Yervoy', 'category': 'PRODUCT'}, {'entity': 'Opdivo+Yervoy', 'category': 'PRODUCT'}, {'entity': 'immunotherapy and chemotherapy components', 'category': 'PRODUCT'}, {'entity': 'Companys sBLA', 'category': 'PRODUCT'}, {'entity': 'Orencia solution for subcutaneous injection in pre-filled syringe extension application 50 mg & 87.5 mg strength', 'category': 'PRODUCT'}, {'entity': 'Opdivo 125mg Syringe for Subcutaneous Injection 1mL', 'category': 'PRODUCT'}, {'entity': 'Orencia 125mg Autoinjector for Subcutaneous Injection 1mL', 'category': 'PRODUCT'}, {'entity': 'anti-citrullinated protein antibody and rheumatoid factor', 'category': 'PRODUCT'}, {'entity': 'Empliciti plus pomalidomide and dexamethasone EPd', 'category': 'PRODUCT'}, {'entity': 'Empliciti plus pomalidomide and low-dose dexamethasone EPd', 'category': 'PRODUCT'}, {'entity': 'ELOQUENT-3', 'category': 'PRODUCT'}, {'entity': '10 mutations per megabase', 'category': 'QUANTITY'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'first-line', 'category': 'ORDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  15\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RX3AaTDMowAMWQ70JRs7N7KFc3Uz\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701572592,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#100 \\n\\nDATE#December 31, 2019#December 31, 2018#February 2020#August 17, 2020\\n\\nEVENT#FDA\\n\\nGPE#U.S.#Japan\\n\\nLAW#Prescription Drug User Fee Act#Section 27A of the Securities Act of 1933#Section 21E of the Exchange Act\\n\\nMONEY#$358 million#$231 million#$3.8 billion#$482 million\\n\\nORG#FDA#EMA#Celgene#Exchange Act\\n\\nPERCENT#10%\\n\\nPERSON#form 10-K\\n\\nPRODUCT#liso-cel#Lymphoma\\n\\nTIME#2020\\n\\nWORK_OF_ART#2019 Form 10-K\\n}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2164,\n",
      "    \"completion_tokens\": 150,\n",
      "    \"total_tokens\": 2314\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2019', 'category': 'DATE'}, {'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': 'February 2020', 'category': 'DATE'}, {'entity': 'August 17, 2020', 'category': 'DATE'}, {'entity': 'FDA', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'Prescription Drug User Fee Act', 'category': 'LAW'}, {'entity': 'Section 27A of the Securities Act of 1933', 'category': 'LAW'}, {'entity': 'Section 21E of the Exchange Act', 'category': 'LAW'}, {'entity': '$358 million', 'category': 'MONEY'}, {'entity': '$231 million', 'category': 'MONEY'}, {'entity': '$3.8 billion', 'category': 'MONEY'}, {'entity': '$482 million', 'category': 'MONEY'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'EMA', 'category': 'ORG'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': 'Exchange Act', 'category': 'ORG'}, {'entity': '10%', 'category': 'PERCENT'}, {'entity': 'form 10-K', 'category': 'PERSON'}, {'entity': 'liso-cel', 'category': 'PRODUCT'}, {'entity': 'Lymphoma', 'category': 'PRODUCT'}, {'entity': '2020', 'category': 'TIME'}, {'entity': '2019 Form 10-K', 'category': 'WORK_OF_ART'}, {'entity': '100', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  15\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RX3fuzhD0FeehMHnAauHKDE2u6Gx\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701572623,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 656,\n",
      "    \"completion_tokens\": 1,\n",
      "    \"total_tokens\": 657\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[]\n",
      "/home/damir/Dropbox/Documents/Teaching/2023/L715/l715_23/data/10-Ks/Bristol-Myers_Squibb_Company/2015/Management.txt\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RX44KWl9hsDbkMurEG3j5QtY61Is\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701572648,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#7 \\n\\nDATE#2014#2013#2012#\\n\\nEVENT#diabetes business divestiture\\n\\nFAC#Devens#Massachusetts\\n\\nGPE#Japan#U.S.#Ireland#EU#European Union#U.S.\\n\\nMONEY#$1.54#$1.20#$1.82#$1.85#$3.5 billion#$628 million#$348 million#$256 million#$1.3 billion#$1.7 billion\\n\\nORG#Bristol-Myers Squibb Company#Bristol-Myers Squibb#BMS#Opdivo#Eliquis#Hepatitis C Franchise#Daklinza#Sunvepra#Yervoy#Sprycel#Erbitux#Pfizer, Inc#Reyataz#Baraclude#Daklinza \\n\\nPERCENT#3%#36%#14.8%#10.8%#30-45%\\n\\nPERSON#\\n\\nPRODUCT#Orencia\\n\\nQUANTITY#\\n\\nTIME#\\n\\nWORK_OF_ART#}\\n\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2360,\n",
      "    \"completion_tokens\": 218,\n",
      "    \"total_tokens\": 2578\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': '2014', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': 'diabetes business divestiture', 'category': 'EVENT'}, {'entity': 'Devens', 'category': 'FAC'}, {'entity': 'Massachusetts', 'category': 'FAC'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Ireland', 'category': 'GPE'}, {'entity': 'EU', 'category': 'GPE'}, {'entity': 'European Union', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '$1.54', 'category': 'MONEY'}, {'entity': '$1.20', 'category': 'MONEY'}, {'entity': '$1.82', 'category': 'MONEY'}, {'entity': '$1.85', 'category': 'MONEY'}, {'entity': '$3.5 billion', 'category': 'MONEY'}, {'entity': '$628 million', 'category': 'MONEY'}, {'entity': '$348 million', 'category': 'MONEY'}, {'entity': '$256 million', 'category': 'MONEY'}, {'entity': '$1.3 billion', 'category': 'MONEY'}, {'entity': '$1.7 billion', 'category': 'MONEY'}, {'entity': 'Bristol-Myers Squibb Company', 'category': 'ORG'}, {'entity': 'Bristol-Myers Squibb', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'Hepatitis C Franchise', 'category': 'ORG'}, {'entity': 'Daklinza', 'category': 'ORG'}, {'entity': 'Sunvepra', 'category': 'ORG'}, {'entity': 'Yervoy', 'category': 'ORG'}, {'entity': 'Sprycel', 'category': 'ORG'}, {'entity': 'Erbitux', 'category': 'ORG'}, {'entity': 'Pfizer, Inc', 'category': 'ORG'}, {'entity': 'Reyataz', 'category': 'ORG'}, {'entity': 'Baraclude', 'category': 'ORG'}, {'entity': 'Daklinza', 'category': 'ORG'}, {'entity': '3%', 'category': 'PERCENT'}, {'entity': '36%', 'category': 'PERCENT'}, {'entity': '14.8%', 'category': 'PERCENT'}, {'entity': '10.8%', 'category': 'PERCENT'}, {'entity': '30-45%', 'category': 'PERCENT'}, {'entity': 'Orencia', 'category': 'PRODUCT'}, {'entity': '', 'category': 'WORK_OF_ART'}, {'entity': '7', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RX4bFdynOWg34MFCNX6nrdPCPc9K\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701572681,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#1#3#418#58#0.42#0.0001#120#11#4#23#47#6#1#107#48#41#65#3#117#11#15#8.7#22.2#41#31.6#49.7#8.2#6.05#10.91#24#129#45#37#15#3#23#87#20#13\\n\\nDATE#December 2014#November 2014#September 2014#June 2014#May 2014#January 2015#October 2014#April 2014\\n\\nEVENT#CheckMate-066#CheckMate-037#CheckMate-069#CheckMate-016#CheckMate-012#Study 063#CheckMate-039#Study-004#CheckMate-067\\n\\nFAC#U.S. Food and Drug Administration#European Medicines Agency#EMA\\u2019s Committee for Medicinal Products for Human Use#Data Monitoring Committee\\n\\nGPE#Europe\\n\\nORG#Opdivo#Company#FDA#EMA#CHMP#DMC#RECIST\\n\\nPERCENT#73%#42%#32%#95% CI = 24, 41#11%#95% CI = 4, 23#94%#88%#41%#95% CI = 31.6, 49.7#24%#45%#50%#20%#63-72\\n\\nPERSON#BRAF#Yervoy#DTIC#DAC#HL\\n\\nPRODUCT#nivolumab#BRAF inhibitor\\n\\nQUANTITY#3 mg/kg\\n\\nTIME#one-year#two-year\\n\\nWORK_OF_ART#Programmed death receptor-1#Advanced melanoma}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2494,\n",
      "    \"completion_tokens\": 378,\n",
      "    \"total_tokens\": 2872\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 2014', 'category': 'DATE'}, {'entity': 'November 2014', 'category': 'DATE'}, {'entity': 'September 2014', 'category': 'DATE'}, {'entity': 'June 2014', 'category': 'DATE'}, {'entity': 'May 2014', 'category': 'DATE'}, {'entity': 'January 2015', 'category': 'DATE'}, {'entity': 'October 2014', 'category': 'DATE'}, {'entity': 'April 2014', 'category': 'DATE'}, {'entity': 'CheckMate-066', 'category': 'EVENT'}, {'entity': 'CheckMate-037', 'category': 'EVENT'}, {'entity': 'CheckMate-069', 'category': 'EVENT'}, {'entity': 'CheckMate-016', 'category': 'EVENT'}, {'entity': 'CheckMate-012', 'category': 'EVENT'}, {'entity': 'Study 063', 'category': 'EVENT'}, {'entity': 'CheckMate-039', 'category': 'EVENT'}, {'entity': 'Study-004', 'category': 'EVENT'}, {'entity': 'CheckMate-067', 'category': 'EVENT'}, {'entity': 'U.S. Food and Drug Administration', 'category': 'FAC'}, {'entity': 'European Medicines Agency', 'category': 'FAC'}, {'entity': 'EMA’s Committee for Medicinal Products for Human Use', 'category': 'FAC'}, {'entity': 'Data Monitoring Committee', 'category': 'FAC'}, {'entity': 'Europe', 'category': 'GPE'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Company', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'EMA', 'category': 'ORG'}, {'entity': 'CHMP', 'category': 'ORG'}, {'entity': 'DMC', 'category': 'ORG'}, {'entity': 'RECIST', 'category': 'ORG'}, {'entity': '73%', 'category': 'PERCENT'}, {'entity': '42%', 'category': 'PERCENT'}, {'entity': '32%', 'category': 'PERCENT'}, {'entity': '95% CI = 24, 41', 'category': 'PERCENT'}, {'entity': '11%', 'category': 'PERCENT'}, {'entity': '95% CI = 4, 23', 'category': 'PERCENT'}, {'entity': '94%', 'category': 'PERCENT'}, {'entity': '88%', 'category': 'PERCENT'}, {'entity': '41%', 'category': 'PERCENT'}, {'entity': '95% CI = 31.6, 49.7', 'category': 'PERCENT'}, {'entity': '24%', 'category': 'PERCENT'}, {'entity': '45%', 'category': 'PERCENT'}, {'entity': '50%', 'category': 'PERCENT'}, {'entity': '20%', 'category': 'PERCENT'}, {'entity': '63-72', 'category': 'PERCENT'}, {'entity': 'BRAF', 'category': 'PERSON'}, {'entity': 'Yervoy', 'category': 'PERSON'}, {'entity': 'DTIC', 'category': 'PERSON'}, {'entity': 'DAC', 'category': 'PERSON'}, {'entity': 'HL', 'category': 'PERSON'}, {'entity': 'nivolumab', 'category': 'PRODUCT'}, {'entity': 'BRAF inhibitor', 'category': 'PRODUCT'}, {'entity': '3 mg/kg', 'category': 'QUANTITY'}, {'entity': 'one-year', 'category': 'TIME'}, {'entity': 'two-year', 'category': 'TIME'}, {'entity': 'Programmed death receptor-1', 'category': 'WORK_OF_ART'}, {'entity': 'Advanced melanoma', 'category': 'WORK_OF_ART'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '418', 'category': 'CARDINAL'}, {'entity': '58', 'category': 'CARDINAL'}, {'entity': '0.42', 'category': 'CARDINAL'}, {'entity': '0.0001', 'category': 'CARDINAL'}, {'entity': '120', 'category': 'CARDINAL'}, {'entity': '11', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '23', 'category': 'CARDINAL'}, {'entity': '47', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '107', 'category': 'CARDINAL'}, {'entity': '48', 'category': 'CARDINAL'}, {'entity': '41', 'category': 'CARDINAL'}, {'entity': '65', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '117', 'category': 'CARDINAL'}, {'entity': '11', 'category': 'CARDINAL'}, {'entity': '15', 'category': 'CARDINAL'}, {'entity': '8.7', 'category': 'CARDINAL'}, {'entity': '22.2', 'category': 'CARDINAL'}, {'entity': '41', 'category': 'CARDINAL'}, {'entity': '31.6', 'category': 'CARDINAL'}, {'entity': '49.7', 'category': 'CARDINAL'}, {'entity': '8.2', 'category': 'CARDINAL'}, {'entity': '6.05', 'category': 'CARDINAL'}, {'entity': '10.91', 'category': 'CARDINAL'}, {'entity': '24', 'category': 'CARDINAL'}, {'entity': '129', 'category': 'CARDINAL'}, {'entity': '45', 'category': 'CARDINAL'}, {'entity': '37', 'category': 'CARDINAL'}, {'entity': '15', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '23', 'category': 'CARDINAL'}, {'entity': '87', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '13', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RX5ECO8ctXlrpl8EzVIdRjIEHqMk\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701572720,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#1#3#1#12#100%#1#12#90%#86%#1b#1#12#24#48#100%#1#1#10#3#25%#46.5%#34.8%#37 percent#42 percent#22.4 percent#27.6 percent#25.0 percent#12\\n\\nDATE#February 2015#November 2014#November 2014#November 2014#October 2014#August 2014#July 2014#May 2014#January 2015#October 2014#June 2014#November 2014#June 2014\\n\\nEVENT#Breakthrough Therapy Designation#UNITY Trial#ALLY Trial\\n\\nFAC#European Commission\\n\\nGPE#EU#U.S.#Japan#U.S.\\n\\nLANGUAGE#Japanese\\n\\nLAW#New Drug Application\\n\\nMONEY#300 mg\\n\\nORG#FDA#BMS#Gilead Sciences, Inc.#Gilead#Japanese Ministry of Health, Labor and Welfare#AbbVie Inc.#AbbVie\\n\\nPERCENT#64-65%#100%#90%#86%#100%\\n\\nPERSON#Hepatitis C\\n\\nPRODUCT#Daklinza#Daclatasvir (DCV)#Sunvepra (Asunaprevir (ASV))#Beclabuvir (BCV)#BMS#DCV-TRIO#Sofosbuvir (SOF)#Gilead#DCV#ASV#Elotuzumab#AbbVie#Reyataz (atazanavir sulfate)#Evotaz (atazanavir 300 mg and cobicistat 150 mg)#Gilead#Sustiva (efavirenz)#Atripla* (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg)#Gilead#Yervoy (ipilimumab)#Orencia (abatacept)#methotrexate (MTX)\\n\\nWORK_OF_ART#Breakthrough Therapy Designation}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2512,\n",
      "    \"completion_tokens\": 459,\n",
      "    \"total_tokens\": 2971\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'February 2015', 'category': 'DATE'}, {'entity': 'November 2014', 'category': 'DATE'}, {'entity': 'November 2014', 'category': 'DATE'}, {'entity': 'November 2014', 'category': 'DATE'}, {'entity': 'October 2014', 'category': 'DATE'}, {'entity': 'August 2014', 'category': 'DATE'}, {'entity': 'July 2014', 'category': 'DATE'}, {'entity': 'May 2014', 'category': 'DATE'}, {'entity': 'January 2015', 'category': 'DATE'}, {'entity': 'October 2014', 'category': 'DATE'}, {'entity': 'June 2014', 'category': 'DATE'}, {'entity': 'November 2014', 'category': 'DATE'}, {'entity': 'June 2014', 'category': 'DATE'}, {'entity': 'Breakthrough Therapy Designation', 'category': 'EVENT'}, {'entity': 'UNITY Trial', 'category': 'EVENT'}, {'entity': 'ALLY Trial', 'category': 'EVENT'}, {'entity': 'European Commission', 'category': 'FAC'}, {'entity': 'EU', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Japanese', 'category': 'LANGUAGE'}, {'entity': 'New Drug Application', 'category': 'LAW'}, {'entity': '300 mg', 'category': 'MONEY'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Gilead Sciences, Inc.', 'category': 'ORG'}, {'entity': 'Gilead', 'category': 'ORG'}, {'entity': 'Japanese Ministry of Health, Labor and Welfare', 'category': 'ORG'}, {'entity': 'AbbVie Inc.', 'category': 'ORG'}, {'entity': 'AbbVie', 'category': 'ORG'}, {'entity': '64-65%', 'category': 'PERCENT'}, {'entity': '100%', 'category': 'PERCENT'}, {'entity': '90%', 'category': 'PERCENT'}, {'entity': '86%', 'category': 'PERCENT'}, {'entity': '100%', 'category': 'PERCENT'}, {'entity': 'Hepatitis C', 'category': 'PERSON'}, {'entity': 'Daklinza', 'category': 'PRODUCT'}, {'entity': 'Daclatasvir DCV', 'category': 'PRODUCT'}, {'entity': 'Sunvepra Asunaprevir ASV', 'category': 'PRODUCT'}, {'entity': 'Beclabuvir BCV', 'category': 'PRODUCT'}, {'entity': 'BMS', 'category': 'PRODUCT'}, {'entity': 'DCV-TRIO', 'category': 'PRODUCT'}, {'entity': 'Sofosbuvir SOF', 'category': 'PRODUCT'}, {'entity': 'Gilead', 'category': 'PRODUCT'}, {'entity': 'DCV', 'category': 'PRODUCT'}, {'entity': 'ASV', 'category': 'PRODUCT'}, {'entity': 'Elotuzumab', 'category': 'PRODUCT'}, {'entity': 'AbbVie', 'category': 'PRODUCT'}, {'entity': 'Reyataz atazanavir sulfate', 'category': 'PRODUCT'}, {'entity': 'Evotaz atazanavir 300 mg and cobicistat 150 mg', 'category': 'PRODUCT'}, {'entity': 'Gilead', 'category': 'PRODUCT'}, {'entity': 'Sustiva efavirenz', 'category': 'PRODUCT'}, {'entity': 'Atripla* efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg', 'category': 'PRODUCT'}, {'entity': 'Gilead', 'category': 'PRODUCT'}, {'entity': 'Yervoy ipilimumab', 'category': 'PRODUCT'}, {'entity': 'Orencia abatacept', 'category': 'PRODUCT'}, {'entity': 'methotrexate MTX', 'category': 'PRODUCT'}, {'entity': 'Breakthrough Therapy Designation', 'category': 'WORK_OF_ART'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '100%', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '90%', 'category': 'CARDINAL'}, {'entity': '86%', 'category': 'CARDINAL'}, {'entity': '1b', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '24', 'category': 'CARDINAL'}, {'entity': '48', 'category': 'CARDINAL'}, {'entity': '100%', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '25%', 'category': 'CARDINAL'}, {'entity': '46.5%', 'category': 'CARDINAL'}, {'entity': '34.8%', 'category': 'CARDINAL'}, {'entity': '37 percent', 'category': 'CARDINAL'}, {'entity': '42 percent', 'category': 'CARDINAL'}, {'entity': '22.4 percent', 'category': 'CARDINAL'}, {'entity': '27.6 percent', 'category': 'CARDINAL'}, {'entity': '25.0 percent', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RX5wC6R7zaOwuE3fZ6h1jj5rsZLQ\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701572764,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#94 \\n\\nDATE#November 2014#August 2014#July 2014#March 2014#February 2014#2014 vs. 2013#2013 vs. 2012#Year Ended December 31, 2014#2013#2012 \\n\\nEVENT#Phase 3 ANNEXA\\u2122-A#Phase IV clinical trial EMANATE#Phase III ARISTOTLE \\n\\nFAC#FDA \\n\\nGPE#United States#Europe \\n\\nMONEY#$400 million \\n\\nNORP#Japanese \\n\\nORDINAL#first \\n\\nORG#Pfizer#Portola Pharmaceuticals#EC \\n\\nPERCENT#94 percent \\n\\nPERSON#Eliquis \\n\\nPRODUCT#Eliquis(Apixaban)#Andexanet alfa \\n\\nQUANTITY#12-month \\n\\nTIME#50 to 75 \\n\\nWORK_OF_ART#Phase 3 ANNEXA\\u2122-A (Andexanet Alfa a Novel Antidote to the Anticoagulant Effects of fXA Inhibitors \\u2013 Apixaban)\\n}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2585,\n",
      "    \"completion_tokens\": 219,\n",
      "    \"total_tokens\": 2804\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'November 2014', 'category': 'DATE'}, {'entity': 'August 2014', 'category': 'DATE'}, {'entity': 'July 2014', 'category': 'DATE'}, {'entity': 'March 2014', 'category': 'DATE'}, {'entity': 'February 2014', 'category': 'DATE'}, {'entity': '2014 vs. 2013', 'category': 'DATE'}, {'entity': '2013 vs. 2012', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2014', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': 'Phase 3 ANNEXA™-A', 'category': 'EVENT'}, {'entity': 'Phase IV clinical trial EMANATE', 'category': 'EVENT'}, {'entity': 'Phase III ARISTOTLE', 'category': 'EVENT'}, {'entity': 'FDA', 'category': 'FAC'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'Europe', 'category': 'GPE'}, {'entity': '$400 million', 'category': 'MONEY'}, {'entity': 'Japanese', 'category': 'NORP'}, {'entity': 'Pfizer', 'category': 'ORG'}, {'entity': 'Portola Pharmaceuticals', 'category': 'ORG'}, {'entity': 'EC', 'category': 'ORG'}, {'entity': '94 percent', 'category': 'PERCENT'}, {'entity': 'Eliquis', 'category': 'PERSON'}, {'entity': 'EliquisApixaban', 'category': 'PRODUCT'}, {'entity': 'Andexanet alfa', 'category': 'PRODUCT'}, {'entity': '12-month', 'category': 'QUANTITY'}, {'entity': '50 to 75', 'category': 'TIME'}, {'entity': 'Phase 3 ANNEXA™-A Andexanet Alfa a Novel Antidote to the Anticoagulant Effects of fXA Inhibitors – Apixaban', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '94', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RX6T9c3qv4WCCN56Rl2CJc6rLOld\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701572797,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#1.6#1.3#1.5#2013#41#13#175#351#345#183#1,108#563#154#504#360#114#540#2,235#5#85#52#6#148#565#153#477#388#107#479#2,169#2#2#48#11#20#1#84#2#4#37#12#147#227#279#236#938#614#141#398#394#94#558#2,199#1#24#33#10#66#610#138#394#400#105#483#2,130#4#4#3#23#34#41#15#148#193#232#278#907#2014#2013#2012#13,793#14,391#15,849#614#563#651#141#154#192#399#499#284#370#275#386#61#62#248#548#534#434#2,133#2,087#2,195#11,660#12,304#13,654#100#1,441#1,527#1,388#6#10#2#3#215#289#241#26#20#1,226#1,238#1,147#1#8#256#362#1,551#1,521#12#2#1#1#689#769#783#10#2#673#782#738#14#6#3#2#1,444#1,614#1,527#11#6#1,118#1,092#1,016#7#326#522#511#38#2#1#1#723#696#702#4#1#682#682#688#1#41#14#14#6#1#1,493#1,280#1,019#17#26#2#4#671#541#404#24#34#822#739#615#11#20#5#7#1,308#960#706#36#36#2#709#577#503#23#15#599#383#203#56#89#4#2,020#2,289#2,827#12#19#1,572#1,519#2,102#3#28#448#770#725#42#6#1#1,652#1,444#1,176#14#23#2#2#1,064#954#797#12#20#588#490#379#20#29#6#8#774#146#2#404#97#370#49#2#295#1,683#972#82#73#110#1,242#774#91#60#185#441#198#58#3,105#3,195#5,781#3#45#1#481#556#3,076#13#82#2,624#2,639#2,705#1#2#2#1\\nDATE#2014#2013#2012#January 1, 2013#Current period#Prior period#December 31, 2013#Current period#Prior period#December 31, 2014#Year Ended December 31,#2014#2013#2012#Current period#Prior period#Year Ended December 31,#2014\\nEVENT#diabetes business divestiture in February 2014\\nGPE#U.S.#non-U.S.#Teva Pharmaceutical Industries Ltd.\\nNORP#Government\\nORG#Alliances#Critical Accounting Policies#Abilify#Atripla#Assets/related liabilities#Balance#Company#Baraclude\\nMONEY#$1.6 billion#$1.3 billion#$1.5 billion#$41#$13#$175#$351#$345#$183#$1,108#$563#$154#$504#$360#$114#$540#$2,235#$(5)#$(85)#$(52)#$(6)#$(148)#$(565)#$(153)#$(477)#$(388)#$(107)#$(479)#$(2,169)#$(2)#$(2)#$(48)#$(11)#$(20)#$(1)#$(84)#$(2)#$(4)#$(37)#$(12)#$(147)#$(227)#$(279)#$(236)#$(938)#$(614)#$(141)#$(398)#$(394)#$(94)#$(558)#$(2,199)#$(1)#$(24)#$(33)#$(10)#$(66)#$(610)#$(138)#$(394)#$(400)#$(105)#$(483)#$(2,130)#$(4)#$(4)#$(3)#$(23)#$(34)#$(41)#$(15)#$(148)#$(193)#$(232)#$(278)#$(907)#$(13,793)#$(14,391)#$(15,849)#$(614)#$(563)#$(651)#$(141)#$(154)#$(192)#$(399)#$(499)#$(284)#$(370)#$(275)#$(386)#$(61)#$(62)#$(248)#$(548)#$(534)#$(434)#$(2,133)#$(2,087)#$(2,195)#$(11,660)#$(12,304)#$(13,654)\\nPERCENT#100%#(6%)#10%#(2%)#(3%)#(26%)#20%#(1%)#8%#(2%)#(3%)#(12%)#2%#(1%)#(1%)#(10%)#(14%)#6%#(3%)#(2%)#(38%)#2%#(42%)#6%#(2%)#14%#23%#(2%)#(2%)#12%#20%#20%#29%#(6%)#(8%)#**#(82%)#73%#(91%)#60%#(58%)#(3%)#(45%)#(1%)#(13%)#(82%)#(1%)#(2%)#(2%)#(1%)\\nPRODUCT#Abilify*#Atripla*#CashDiscounts#Managed HealthcareRebates andOtherContractDiscounts#MedicaidRebates#SalesReturns#OtherAdjustments#TotalBalance#Abilify*#Eliquis\\nWORK_OF_ART#Critical Accounting Policies#Balance\\n}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 3708,\n",
      "    \"completion_tokens\": 1413,\n",
      "    \"total_tokens\": 5121\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': '2014', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': 'January 1, 2013', 'category': 'DATE'}, {'entity': 'Current period', 'category': 'DATE'}, {'entity': 'Prior period', 'category': 'DATE'}, {'entity': 'December 31, 2013', 'category': 'DATE'}, {'entity': 'Current period', 'category': 'DATE'}, {'entity': 'Prior period', 'category': 'DATE'}, {'entity': 'December 31, 2014', 'category': 'DATE'}, {'entity': 'Year Ended December 31,', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': 'Current period', 'category': 'DATE'}, {'entity': 'Prior period', 'category': 'DATE'}, {'entity': 'Year Ended December 31,', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': 'diabetes business divestiture in February 2014', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'non-U.S.', 'category': 'GPE'}, {'entity': 'Teva Pharmaceutical Industries Ltd.', 'category': 'GPE'}, {'entity': '$1.6 billion', 'category': 'MONEY'}, {'entity': '$1.3 billion', 'category': 'MONEY'}, {'entity': '$1.5 billion', 'category': 'MONEY'}, {'entity': '$41', 'category': 'MONEY'}, {'entity': '$13', 'category': 'MONEY'}, {'entity': '$175', 'category': 'MONEY'}, {'entity': '$351', 'category': 'MONEY'}, {'entity': '$345', 'category': 'MONEY'}, {'entity': '$183', 'category': 'MONEY'}, {'entity': '$1,108', 'category': 'MONEY'}, {'entity': '$563', 'category': 'MONEY'}, {'entity': '$154', 'category': 'MONEY'}, {'entity': '$504', 'category': 'MONEY'}, {'entity': '$360', 'category': 'MONEY'}, {'entity': '$114', 'category': 'MONEY'}, {'entity': '$540', 'category': 'MONEY'}, {'entity': '$2,235', 'category': 'MONEY'}, {'entity': '$5', 'category': 'MONEY'}, {'entity': '$85', 'category': 'MONEY'}, {'entity': '$52', 'category': 'MONEY'}, {'entity': '$6', 'category': 'MONEY'}, {'entity': '$148', 'category': 'MONEY'}, {'entity': '$565', 'category': 'MONEY'}, {'entity': '$153', 'category': 'MONEY'}, {'entity': '$477', 'category': 'MONEY'}, {'entity': '$388', 'category': 'MONEY'}, {'entity': '$107', 'category': 'MONEY'}, {'entity': '$479', 'category': 'MONEY'}, {'entity': '$2,169', 'category': 'MONEY'}, {'entity': '$2', 'category': 'MONEY'}, {'entity': '$2', 'category': 'MONEY'}, {'entity': '$48', 'category': 'MONEY'}, {'entity': '$11', 'category': 'MONEY'}, {'entity': '$20', 'category': 'MONEY'}, {'entity': '$1', 'category': 'MONEY'}, {'entity': '$84', 'category': 'MONEY'}, {'entity': '$2', 'category': 'MONEY'}, {'entity': '$4', 'category': 'MONEY'}, {'entity': '$37', 'category': 'MONEY'}, {'entity': '$12', 'category': 'MONEY'}, {'entity': '$147', 'category': 'MONEY'}, {'entity': '$227', 'category': 'MONEY'}, {'entity': '$279', 'category': 'MONEY'}, {'entity': '$236', 'category': 'MONEY'}, {'entity': '$938', 'category': 'MONEY'}, {'entity': '$614', 'category': 'MONEY'}, {'entity': '$141', 'category': 'MONEY'}, {'entity': '$398', 'category': 'MONEY'}, {'entity': '$394', 'category': 'MONEY'}, {'entity': '$94', 'category': 'MONEY'}, {'entity': '$558', 'category': 'MONEY'}, {'entity': '$2,199', 'category': 'MONEY'}, {'entity': '$1', 'category': 'MONEY'}, {'entity': '$24', 'category': 'MONEY'}, {'entity': '$33', 'category': 'MONEY'}, {'entity': '$10', 'category': 'MONEY'}, {'entity': '$66', 'category': 'MONEY'}, {'entity': '$610', 'category': 'MONEY'}, {'entity': '$138', 'category': 'MONEY'}, {'entity': '$394', 'category': 'MONEY'}, {'entity': '$400', 'category': 'MONEY'}, {'entity': '$105', 'category': 'MONEY'}, {'entity': '$483', 'category': 'MONEY'}, {'entity': '$2,130', 'category': 'MONEY'}, {'entity': '$4', 'category': 'MONEY'}, {'entity': '$4', 'category': 'MONEY'}, {'entity': '$3', 'category': 'MONEY'}, {'entity': '$23', 'category': 'MONEY'}, {'entity': '$34', 'category': 'MONEY'}, {'entity': '$41', 'category': 'MONEY'}, {'entity': '$15', 'category': 'MONEY'}, {'entity': '$148', 'category': 'MONEY'}, {'entity': '$193', 'category': 'MONEY'}, {'entity': '$232', 'category': 'MONEY'}, {'entity': '$278', 'category': 'MONEY'}, {'entity': '$907', 'category': 'MONEY'}, {'entity': '$13,793', 'category': 'MONEY'}, {'entity': '$14,391', 'category': 'MONEY'}, {'entity': '$15,849', 'category': 'MONEY'}, {'entity': '$614', 'category': 'MONEY'}, {'entity': '$563', 'category': 'MONEY'}, {'entity': '$651', 'category': 'MONEY'}, {'entity': '$141', 'category': 'MONEY'}, {'entity': '$154', 'category': 'MONEY'}, {'entity': '$192', 'category': 'MONEY'}, {'entity': '$399', 'category': 'MONEY'}, {'entity': '$499', 'category': 'MONEY'}, {'entity': '$284', 'category': 'MONEY'}, {'entity': '$370', 'category': 'MONEY'}, {'entity': '$275', 'category': 'MONEY'}, {'entity': '$386', 'category': 'MONEY'}, {'entity': '$61', 'category': 'MONEY'}, {'entity': '$62', 'category': 'MONEY'}, {'entity': '$248', 'category': 'MONEY'}, {'entity': '$548', 'category': 'MONEY'}, {'entity': '$534', 'category': 'MONEY'}, {'entity': '$434', 'category': 'MONEY'}, {'entity': '$2,133', 'category': 'MONEY'}, {'entity': '$2,087', 'category': 'MONEY'}, {'entity': '$2,195', 'category': 'MONEY'}, {'entity': '$11,660', 'category': 'MONEY'}, {'entity': '$12,304', 'category': 'MONEY'}, {'entity': '$13,654', 'category': 'MONEY'}, {'entity': 'Government', 'category': 'NORP'}, {'entity': 'Alliances', 'category': 'ORG'}, {'entity': 'Critical Accounting Policies', 'category': 'ORG'}, {'entity': 'Abilify', 'category': 'ORG'}, {'entity': 'Atripla', 'category': 'ORG'}, {'entity': 'Assets/related liabilities', 'category': 'ORG'}, {'entity': 'Balance', 'category': 'ORG'}, {'entity': 'Company', 'category': 'ORG'}, {'entity': 'Baraclude', 'category': 'ORG'}, {'entity': '100%', 'category': 'PERCENT'}, {'entity': '6%', 'category': 'PERCENT'}, {'entity': '10%', 'category': 'PERCENT'}, {'entity': '2%', 'category': 'PERCENT'}, {'entity': '3%', 'category': 'PERCENT'}, {'entity': '26%', 'category': 'PERCENT'}, {'entity': '20%', 'category': 'PERCENT'}, {'entity': '1%', 'category': 'PERCENT'}, {'entity': '8%', 'category': 'PERCENT'}, {'entity': '2%', 'category': 'PERCENT'}, {'entity': '3%', 'category': 'PERCENT'}, {'entity': '12%', 'category': 'PERCENT'}, {'entity': '2%', 'category': 'PERCENT'}, {'entity': '1%', 'category': 'PERCENT'}, {'entity': '1%', 'category': 'PERCENT'}, {'entity': '10%', 'category': 'PERCENT'}, {'entity': '14%', 'category': 'PERCENT'}, {'entity': '6%', 'category': 'PERCENT'}, {'entity': '3%', 'category': 'PERCENT'}, {'entity': '2%', 'category': 'PERCENT'}, {'entity': '38%', 'category': 'PERCENT'}, {'entity': '2%', 'category': 'PERCENT'}, {'entity': '42%', 'category': 'PERCENT'}, {'entity': '6%', 'category': 'PERCENT'}, {'entity': '2%', 'category': 'PERCENT'}, {'entity': '14%', 'category': 'PERCENT'}, {'entity': '23%', 'category': 'PERCENT'}, {'entity': '2%', 'category': 'PERCENT'}, {'entity': '2%', 'category': 'PERCENT'}, {'entity': '12%', 'category': 'PERCENT'}, {'entity': '20%', 'category': 'PERCENT'}, {'entity': '20%', 'category': 'PERCENT'}, {'entity': '29%', 'category': 'PERCENT'}, {'entity': '6%', 'category': 'PERCENT'}, {'entity': '8%', 'category': 'PERCENT'}, {'entity': '**', 'category': 'PERCENT'}, {'entity': '82%', 'category': 'PERCENT'}, {'entity': '73%', 'category': 'PERCENT'}, {'entity': '91%', 'category': 'PERCENT'}, {'entity': '60%', 'category': 'PERCENT'}, {'entity': '58%', 'category': 'PERCENT'}, {'entity': '3%', 'category': 'PERCENT'}, {'entity': '45%', 'category': 'PERCENT'}, {'entity': '1%', 'category': 'PERCENT'}, {'entity': '13%', 'category': 'PERCENT'}, {'entity': '82%', 'category': 'PERCENT'}, {'entity': '1%', 'category': 'PERCENT'}, {'entity': '2%', 'category': 'PERCENT'}, {'entity': '2%', 'category': 'PERCENT'}, {'entity': '1%', 'category': 'PERCENT'}, {'entity': 'Abilify*', 'category': 'PRODUCT'}, {'entity': 'Atripla*', 'category': 'PRODUCT'}, {'entity': 'CashDiscounts', 'category': 'PRODUCT'}, {'entity': 'Managed HealthcareRebates andOtherContractDiscounts', 'category': 'PRODUCT'}, {'entity': 'MedicaidRebates', 'category': 'PRODUCT'}, {'entity': 'SalesReturns', 'category': 'PRODUCT'}, {'entity': 'OtherAdjustments', 'category': 'PRODUCT'}, {'entity': 'TotalBalance', 'category': 'PRODUCT'}, {'entity': 'Abilify*', 'category': 'PRODUCT'}, {'entity': 'Eliquis', 'category': 'PRODUCT'}, {'entity': 'Critical Accounting Policies', 'category': 'WORK_OF_ART'}, {'entity': 'Balance', 'category': 'WORK_OF_ART'}, {'entity': '1.6', 'category': 'CARDINAL'}, {'entity': '1.3', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '41', 'category': 'CARDINAL'}, {'entity': '13', 'category': 'CARDINAL'}, {'entity': '175', 'category': 'CARDINAL'}, {'entity': '351', 'category': 'CARDINAL'}, {'entity': '345', 'category': 'CARDINAL'}, {'entity': '183', 'category': 'CARDINAL'}, {'entity': '1,108', 'category': 'CARDINAL'}, {'entity': '563', 'category': 'CARDINAL'}, {'entity': '154', 'category': 'CARDINAL'}, {'entity': '504', 'category': 'CARDINAL'}, {'entity': '360', 'category': 'CARDINAL'}, {'entity': '114', 'category': 'CARDINAL'}, {'entity': '540', 'category': 'CARDINAL'}, {'entity': '2,235', 'category': 'CARDINAL'}, {'entity': '5', 'category': 'CARDINAL'}, {'entity': '85', 'category': 'CARDINAL'}, {'entity': '52', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '148', 'category': 'CARDINAL'}, {'entity': '565', 'category': 'CARDINAL'}, {'entity': '153', 'category': 'CARDINAL'}, {'entity': '477', 'category': 'CARDINAL'}, {'entity': '388', 'category': 'CARDINAL'}, {'entity': '107', 'category': 'CARDINAL'}, {'entity': '479', 'category': 'CARDINAL'}, {'entity': '2,169', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '48', 'category': 'CARDINAL'}, {'entity': '11', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '84', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '37', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '147', 'category': 'CARDINAL'}, {'entity': '227', 'category': 'CARDINAL'}, {'entity': '279', 'category': 'CARDINAL'}, {'entity': '236', 'category': 'CARDINAL'}, {'entity': '938', 'category': 'CARDINAL'}, {'entity': '614', 'category': 'CARDINAL'}, {'entity': '141', 'category': 'CARDINAL'}, {'entity': '398', 'category': 'CARDINAL'}, {'entity': '394', 'category': 'CARDINAL'}, {'entity': '94', 'category': 'CARDINAL'}, {'entity': '558', 'category': 'CARDINAL'}, {'entity': '2,199', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '24', 'category': 'CARDINAL'}, {'entity': '33', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '66', 'category': 'CARDINAL'}, {'entity': '610', 'category': 'CARDINAL'}, {'entity': '138', 'category': 'CARDINAL'}, {'entity': '394', 'category': 'CARDINAL'}, {'entity': '400', 'category': 'CARDINAL'}, {'entity': '105', 'category': 'CARDINAL'}, {'entity': '483', 'category': 'CARDINAL'}, {'entity': '2,130', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '23', 'category': 'CARDINAL'}, {'entity': '34', 'category': 'CARDINAL'}, {'entity': '41', 'category': 'CARDINAL'}, {'entity': '15', 'category': 'CARDINAL'}, {'entity': '148', 'category': 'CARDINAL'}, {'entity': '193', 'category': 'CARDINAL'}, {'entity': '232', 'category': 'CARDINAL'}, {'entity': '278', 'category': 'CARDINAL'}, {'entity': '907', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '13,793', 'category': 'CARDINAL'}, {'entity': '14,391', 'category': 'CARDINAL'}, {'entity': '15,849', 'category': 'CARDINAL'}, {'entity': '614', 'category': 'CARDINAL'}, {'entity': '563', 'category': 'CARDINAL'}, {'entity': '651', 'category': 'CARDINAL'}, {'entity': '141', 'category': 'CARDINAL'}, {'entity': '154', 'category': 'CARDINAL'}, {'entity': '192', 'category': 'CARDINAL'}, {'entity': '399', 'category': 'CARDINAL'}, {'entity': '499', 'category': 'CARDINAL'}, {'entity': '284', 'category': 'CARDINAL'}, {'entity': '370', 'category': 'CARDINAL'}, {'entity': '275', 'category': 'CARDINAL'}, {'entity': '386', 'category': 'CARDINAL'}, {'entity': '61', 'category': 'CARDINAL'}, {'entity': '62', 'category': 'CARDINAL'}, {'entity': '248', 'category': 'CARDINAL'}, {'entity': '548', 'category': 'CARDINAL'}, {'entity': '534', 'category': 'CARDINAL'}, {'entity': '434', 'category': 'CARDINAL'}, {'entity': '2,133', 'category': 'CARDINAL'}, {'entity': '2,087', 'category': 'CARDINAL'}, {'entity': '2,195', 'category': 'CARDINAL'}, {'entity': '11,660', 'category': 'CARDINAL'}, {'entity': '12,304', 'category': 'CARDINAL'}, {'entity': '13,654', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '1,441', 'category': 'CARDINAL'}, {'entity': '1,527', 'category': 'CARDINAL'}, {'entity': '1,388', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '215', 'category': 'CARDINAL'}, {'entity': '289', 'category': 'CARDINAL'}, {'entity': '241', 'category': 'CARDINAL'}, {'entity': '26', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '1,226', 'category': 'CARDINAL'}, {'entity': '1,238', 'category': 'CARDINAL'}, {'entity': '1,147', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': '256', 'category': 'CARDINAL'}, {'entity': '362', 'category': 'CARDINAL'}, {'entity': '1,551', 'category': 'CARDINAL'}, {'entity': '1,521', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '689', 'category': 'CARDINAL'}, {'entity': '769', 'category': 'CARDINAL'}, {'entity': '783', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '673', 'category': 'CARDINAL'}, {'entity': '782', 'category': 'CARDINAL'}, {'entity': '738', 'category': 'CARDINAL'}, {'entity': '14', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '1,444', 'category': 'CARDINAL'}, {'entity': '1,614', 'category': 'CARDINAL'}, {'entity': '1,527', 'category': 'CARDINAL'}, {'entity': '11', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '1,118', 'category': 'CARDINAL'}, {'entity': '1,092', 'category': 'CARDINAL'}, {'entity': '1,016', 'category': 'CARDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '326', 'category': 'CARDINAL'}, {'entity': '522', 'category': 'CARDINAL'}, {'entity': '511', 'category': 'CARDINAL'}, {'entity': '38', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '723', 'category': 'CARDINAL'}, {'entity': '696', 'category': 'CARDINAL'}, {'entity': '702', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '682', 'category': 'CARDINAL'}, {'entity': '682', 'category': 'CARDINAL'}, {'entity': '688', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '41', 'category': 'CARDINAL'}, {'entity': '14', 'category': 'CARDINAL'}, {'entity': '14', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1,493', 'category': 'CARDINAL'}, {'entity': '1,280', 'category': 'CARDINAL'}, {'entity': '1,019', 'category': 'CARDINAL'}, {'entity': '17', 'category': 'CARDINAL'}, {'entity': '26', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '671', 'category': 'CARDINAL'}, {'entity': '541', 'category': 'CARDINAL'}, {'entity': '404', 'category': 'CARDINAL'}, {'entity': '24', 'category': 'CARDINAL'}, {'entity': '34', 'category': 'CARDINAL'}, {'entity': '822', 'category': 'CARDINAL'}, {'entity': '739', 'category': 'CARDINAL'}, {'entity': '615', 'category': 'CARDINAL'}, {'entity': '11', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '5', 'category': 'CARDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '1,308', 'category': 'CARDINAL'}, {'entity': '960', 'category': 'CARDINAL'}, {'entity': '706', 'category': 'CARDINAL'}, {'entity': '36', 'category': 'CARDINAL'}, {'entity': '36', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '709', 'category': 'CARDINAL'}, {'entity': '577', 'category': 'CARDINAL'}, {'entity': '503', 'category': 'CARDINAL'}, {'entity': '23', 'category': 'CARDINAL'}, {'entity': '15', 'category': 'CARDINAL'}, {'entity': '599', 'category': 'CARDINAL'}, {'entity': '383', 'category': 'CARDINAL'}, {'entity': '203', 'category': 'CARDINAL'}, {'entity': '56', 'category': 'CARDINAL'}, {'entity': '89', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '2,020', 'category': 'CARDINAL'}, {'entity': '2,289', 'category': 'CARDINAL'}, {'entity': '2,827', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '19', 'category': 'CARDINAL'}, {'entity': '1,572', 'category': 'CARDINAL'}, {'entity': '1,519', 'category': 'CARDINAL'}, {'entity': '2,102', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '28', 'category': 'CARDINAL'}, {'entity': '448', 'category': 'CARDINAL'}, {'entity': '770', 'category': 'CARDINAL'}, {'entity': '725', 'category': 'CARDINAL'}, {'entity': '42', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1,652', 'category': 'CARDINAL'}, {'entity': '1,444', 'category': 'CARDINAL'}, {'entity': '1,176', 'category': 'CARDINAL'}, {'entity': '14', 'category': 'CARDINAL'}, {'entity': '23', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '1,064', 'category': 'CARDINAL'}, {'entity': '954', 'category': 'CARDINAL'}, {'entity': '797', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '588', 'category': 'CARDINAL'}, {'entity': '490', 'category': 'CARDINAL'}, {'entity': '379', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '29', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': '774', 'category': 'CARDINAL'}, {'entity': '146', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '404', 'category': 'CARDINAL'}, {'entity': '97', 'category': 'CARDINAL'}, {'entity': '370', 'category': 'CARDINAL'}, {'entity': '49', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '295', 'category': 'CARDINAL'}, {'entity': '1,683', 'category': 'CARDINAL'}, {'entity': '972', 'category': 'CARDINAL'}, {'entity': '82', 'category': 'CARDINAL'}, {'entity': '73', 'category': 'CARDINAL'}, {'entity': '110', 'category': 'CARDINAL'}, {'entity': '1,242', 'category': 'CARDINAL'}, {'entity': '774', 'category': 'CARDINAL'}, {'entity': '91', 'category': 'CARDINAL'}, {'entity': '60', 'category': 'CARDINAL'}, {'entity': '185', 'category': 'CARDINAL'}, {'entity': '441', 'category': 'CARDINAL'}, {'entity': '198', 'category': 'CARDINAL'}, {'entity': '58', 'category': 'CARDINAL'}, {'entity': '3,105', 'category': 'CARDINAL'}, {'entity': '3,195', 'category': 'CARDINAL'}, {'entity': '5,781', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '45', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '481', 'category': 'CARDINAL'}, {'entity': '556', 'category': 'CARDINAL'}, {'entity': '3,076', 'category': 'CARDINAL'}, {'entity': '13', 'category': 'CARDINAL'}, {'entity': '82', 'category': 'CARDINAL'}, {'entity': '2,624', 'category': 'CARDINAL'}, {'entity': '2,639', 'category': 'CARDINAL'}, {'entity': '2,705', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RX7lBk0G24kW8U8jBJxNzLqc0c1e\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701572877,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#1.3#1.1\\n\\nDATE#September 2014#2013#September 2014#November 2013#2014#2013#2012#April 20, 2015#June 2014#February 2014#August 2012#2013#September 30, 2014#June 30, 2014#September 30, 2014#June 30, 2014\\n\\nEVENT#SEC Consent Order\\n\\nFAC#\\n\\nGPE#Germany#Japan#Europe#U.S.\\n\\nLANGUAGE#\\n\\nLAW#\\n\\nLOC#\\n\\nMONEY#approximately $400 million\\n\\nNORP#EU\\n\\nORDINAL#first#both\\n\\nORG#Hepatitis C Franchise#Industries Ltd.#U.S. Securities and Exchange Commission#Otsuka Pharmaceutical Co., Ltd#AstraZeneca#Sanofi\\n\\nPERCENT#34%#33%#51.5%#34.0%\\n\\nPERSON#\\n\\nPRODUCT#Daklinza#Opdivo#Sustiva#Atripla#Sunvepra#Reyataz#Erbitux#Sprycel#Gleevec#Yervoy#Abilify#Orencia#Eliquis#Myalept#Plavix#Avapro/Avalide#Farxiga#Onglyza/Kombiglyze#Bydureon#Byetta#Symlin#Efferalgan\\n\\nQUANTITY#\\n\\nTIME#both periods\\n\\nWORK_OF_ART#\\n}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2373,\n",
      "    \"completion_tokens\": 320,\n",
      "    \"total_tokens\": 2693\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'September 2014', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': 'September 2014', 'category': 'DATE'}, {'entity': 'November 2013', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': 'April 20, 2015', 'category': 'DATE'}, {'entity': 'June 2014', 'category': 'DATE'}, {'entity': 'February 2014', 'category': 'DATE'}, {'entity': 'August 2012', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': 'September 30, 2014', 'category': 'DATE'}, {'entity': 'June 30, 2014', 'category': 'DATE'}, {'entity': 'September 30, 2014', 'category': 'DATE'}, {'entity': 'June 30, 2014', 'category': 'DATE'}, {'entity': 'SEC Consent Order', 'category': 'EVENT'}, {'entity': 'Germany', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'Europe', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'approximately $400 million', 'category': 'MONEY'}, {'entity': 'EU', 'category': 'NORP'}, {'entity': 'Hepatitis C Franchise', 'category': 'ORG'}, {'entity': 'Industries Ltd.', 'category': 'ORG'}, {'entity': 'U.S. Securities and Exchange Commission', 'category': 'ORG'}, {'entity': 'Otsuka Pharmaceutical Co., Ltd', 'category': 'ORG'}, {'entity': 'AstraZeneca', 'category': 'ORG'}, {'entity': 'Sanofi', 'category': 'ORG'}, {'entity': '34%', 'category': 'PERCENT'}, {'entity': '33%', 'category': 'PERCENT'}, {'entity': '51.5%', 'category': 'PERCENT'}, {'entity': '34.0%', 'category': 'PERCENT'}, {'entity': 'Daklinza', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Sustiva', 'category': 'PRODUCT'}, {'entity': 'Atripla', 'category': 'PRODUCT'}, {'entity': 'Sunvepra', 'category': 'PRODUCT'}, {'entity': 'Reyataz', 'category': 'PRODUCT'}, {'entity': 'Erbitux', 'category': 'PRODUCT'}, {'entity': 'Sprycel', 'category': 'PRODUCT'}, {'entity': 'Gleevec', 'category': 'PRODUCT'}, {'entity': 'Yervoy', 'category': 'PRODUCT'}, {'entity': 'Abilify', 'category': 'PRODUCT'}, {'entity': 'Orencia', 'category': 'PRODUCT'}, {'entity': 'Eliquis', 'category': 'PRODUCT'}, {'entity': 'Myalept', 'category': 'PRODUCT'}, {'entity': 'Plavix', 'category': 'PRODUCT'}, {'entity': 'Avapro/Avalide', 'category': 'PRODUCT'}, {'entity': 'Farxiga', 'category': 'PRODUCT'}, {'entity': 'Onglyza/Kombiglyze', 'category': 'PRODUCT'}, {'entity': 'Bydureon', 'category': 'PRODUCT'}, {'entity': 'Byetta', 'category': 'PRODUCT'}, {'entity': 'Symlin', 'category': 'PRODUCT'}, {'entity': 'Efferalgan', 'category': 'PRODUCT'}, {'entity': 'both periods', 'category': 'TIME'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'both', 'category': 'ORDINAL'}, {'entity': '1.3', 'category': 'CARDINAL'}, {'entity': '1.1', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RX8KwQADOQqZ3UopesIFlJYMxVaN\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701572912,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#90%#100%#15\\t#3\\t#14#22#4\\t#100#2\\t#24.8%#28.2%#26.2%#147#120#27 \\n\\nDATE#December 31, 2014#2014#2013#2012\\n\\nGPE#France#U.S.\\n\\nMONEY#$\\t3,932#$\\t4,619#$\\t4,610#$\\t4,088#$\\t4,084#$\\t4,220#$\\t734#$\\t855#$\\t797#$\\t4,534#$\\t3,731#$\\t3,904#$\\t13,498#$\\t13,494#$\\t15,281#$1.1 billion\\n\\nORG#Amylin#Pfizer#Eliquis#Plavix#Avapro#/Avalide#Avalide#IRS#Branded Prescription Drug Fee#Affordable Care Act#Yervoy#Opdivo#Hepatitis C Franchise\\n\\nPRODUCT#Form 10-K#Form 10-Q#BMS-986094\\n\\nTIME#one month\\n\\nWORK_OF_ART#diabetes business divestiture\\n}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2211,\n",
      "    \"completion_tokens\": 244,\n",
      "    \"total_tokens\": 2455\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2014', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': 'France', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '$\\t3,932', 'category': 'MONEY'}, {'entity': '$\\t4,619', 'category': 'MONEY'}, {'entity': '$\\t4,610', 'category': 'MONEY'}, {'entity': '$\\t4,088', 'category': 'MONEY'}, {'entity': '$\\t4,084', 'category': 'MONEY'}, {'entity': '$\\t4,220', 'category': 'MONEY'}, {'entity': '$\\t734', 'category': 'MONEY'}, {'entity': '$\\t855', 'category': 'MONEY'}, {'entity': '$\\t797', 'category': 'MONEY'}, {'entity': '$\\t4,534', 'category': 'MONEY'}, {'entity': '$\\t3,731', 'category': 'MONEY'}, {'entity': '$\\t3,904', 'category': 'MONEY'}, {'entity': '$\\t13,498', 'category': 'MONEY'}, {'entity': '$\\t13,494', 'category': 'MONEY'}, {'entity': '$\\t15,281', 'category': 'MONEY'}, {'entity': '$1.1 billion', 'category': 'MONEY'}, {'entity': 'Amylin', 'category': 'ORG'}, {'entity': 'Pfizer', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'Plavix', 'category': 'ORG'}, {'entity': 'Avapro', 'category': 'ORG'}, {'entity': '/Avalide', 'category': 'ORG'}, {'entity': 'Avalide', 'category': 'ORG'}, {'entity': 'IRS', 'category': 'ORG'}, {'entity': 'Branded Prescription Drug Fee', 'category': 'ORG'}, {'entity': 'Affordable Care Act', 'category': 'ORG'}, {'entity': 'Yervoy', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Hepatitis C Franchise', 'category': 'ORG'}, {'entity': 'Form 10-K', 'category': 'PRODUCT'}, {'entity': 'Form 10-Q', 'category': 'PRODUCT'}, {'entity': 'BMS-986094', 'category': 'PRODUCT'}, {'entity': 'one month', 'category': 'TIME'}, {'entity': 'diabetes business divestiture', 'category': 'WORK_OF_ART'}, {'entity': '90%', 'category': 'CARDINAL'}, {'entity': '100%', 'category': 'CARDINAL'}, {'entity': '15', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '14', 'category': 'CARDINAL'}, {'entity': '22', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '24.8%', 'category': 'CARDINAL'}, {'entity': '28.2%', 'category': 'CARDINAL'}, {'entity': '26.2%', 'category': 'CARDINAL'}, {'entity': '147', 'category': 'CARDINAL'}, {'entity': '120', 'category': 'CARDINAL'}, {'entity': '27', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RX8rSytZDi8C9AiInPStiYK3EvLj\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701572945,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#$2.3 billion#$2.2 billion#$1.9 billion#approximately $100 million#1.8 billion\\n\\nDATE#2014#2013#2012#December 31\\n\\nEVENT#development of BMS-986094\\n\\nFAC#BMS-986094\\n\\nGPE#Ireland#Puerto Rico#U.S.#Europe#Asia\\n\\nLANGUAGE#English\\n\\nLAW#2012 R&D credit legislation\\n\\nMONEY#$343 million# $310 million# $148 million# $130 million# $142 million# $27 million# $47 million# $172 million# $713 million\\n\\nNORP#European#Asian\\n\\nORG#iPierian#Sanofi#Medarex#ZymoGenetics, Inc.#Prudential\\n\\nPERCENT#14.8 #%#10.8 #%#(6.9 %)\\n\\nPERSON#Amylin\\n\\nPRODUCT#BMS-986094#INX-189\\n\\nTIME#Year\\n\\nWORK_OF_ART#Item 8. Financial Statements \\u2014Note 4. Acquisitions and Note 14. Goodwill and other intangible assets#Item 8. Financial Statements \\u2014Note 14. Goodwill and Other Intangible Assets#Item 8. Financial Statements \\u2014Note 19. Pension, Postretirement and Postemployment Liabilities#Item 8. Financial Statements \\u2014Note 3. Alliances#Item 8. Financial Statements\\u2014Note 8. Income Taxes#Item 8. Financial Statements\\u2014Note 3. Alliances\\n}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2399,\n",
      "    \"completion_tokens\": 321,\n",
      "    \"total_tokens\": 2720\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': '2014', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': 'development of BMS-986094', 'category': 'EVENT'}, {'entity': 'BMS-986094', 'category': 'FAC'}, {'entity': 'Ireland', 'category': 'GPE'}, {'entity': 'Puerto Rico', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Europe', 'category': 'GPE'}, {'entity': 'Asia', 'category': 'GPE'}, {'entity': 'English', 'category': 'LANGUAGE'}, {'entity': '2012 R&D credit legislation', 'category': 'LAW'}, {'entity': '$343 million', 'category': 'MONEY'}, {'entity': '$310 million', 'category': 'MONEY'}, {'entity': '$148 million', 'category': 'MONEY'}, {'entity': '$130 million', 'category': 'MONEY'}, {'entity': '$142 million', 'category': 'MONEY'}, {'entity': '$27 million', 'category': 'MONEY'}, {'entity': '$47 million', 'category': 'MONEY'}, {'entity': '$172 million', 'category': 'MONEY'}, {'entity': '$713 million', 'category': 'MONEY'}, {'entity': 'European', 'category': 'NORP'}, {'entity': 'Asian', 'category': 'NORP'}, {'entity': 'iPierian', 'category': 'ORG'}, {'entity': 'Sanofi', 'category': 'ORG'}, {'entity': 'Medarex', 'category': 'ORG'}, {'entity': 'ZymoGenetics, Inc.', 'category': 'ORG'}, {'entity': 'Prudential', 'category': 'ORG'}, {'entity': '14.8', 'category': 'PERCENT'}, {'entity': '%', 'category': 'PERCENT'}, {'entity': '10.8', 'category': 'PERCENT'}, {'entity': '%', 'category': 'PERCENT'}, {'entity': '6.9 %', 'category': 'PERCENT'}, {'entity': 'Amylin', 'category': 'PERSON'}, {'entity': 'BMS-986094', 'category': 'PRODUCT'}, {'entity': 'INX-189', 'category': 'PRODUCT'}, {'entity': 'Year', 'category': 'TIME'}, {'entity': 'Item 8. Financial Statements —Note 4. Acquisitions and Note 14. Goodwill and other intangible assets', 'category': 'WORK_OF_ART'}, {'entity': 'Item 8. Financial Statements —Note 14. Goodwill and Other Intangible Assets', 'category': 'WORK_OF_ART'}, {'entity': 'Item 8. Financial Statements —Note 19. Pension, Postretirement and Postemployment Liabilities', 'category': 'WORK_OF_ART'}, {'entity': 'Item 8. Financial Statements —Note 3. Alliances', 'category': 'WORK_OF_ART'}, {'entity': 'Item 8. Financial Statements—Note 8. Income Taxes', 'category': 'WORK_OF_ART'}, {'entity': 'Item 8. Financial Statements—Note 3. Alliances', 'category': 'WORK_OF_ART'}, {'entity': '$2.3 billion', 'category': 'CARDINAL'}, {'entity': '$2.2 billion', 'category': 'CARDINAL'}, {'entity': '$1.9 billion', 'category': 'CARDINAL'}, {'entity': 'approximately $100 million', 'category': 'CARDINAL'}, {'entity': '1.8 billion', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RX9RNUW5eurVmm5qwuvNypVyUCqS\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701572981,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#2012#2012#2014#2013#2012#38#36#844#9#1#14#47#37#858#22#20#317#25#17#541#2014#2013#2012#151#36#147#14#23#151#326#285#96#9#16#18#105#16#85#278#16#47#343#621#16#216#1,830#163#226#174#559#877#161#151#72#10#43#27#23#45#45#38#10#14#10#626#340#327#1,503#698#2,743#545#242#947#123#422#242#1,339#1,081#456#1,404#16#2014#2014#2012#2014#2013#2012#2,004#2,563#1,960#2,004#2,563#1,959#2,004#2,563#1,960#1,081#456#1,404#3,085#3,019#3,364#3,085#3,019#3,363#1,670#1,662#1,688#1.20#1.54#1.16#0.65#0.28#0.83#1.85#1.82#1.99#2014#2013#5,571#3,586#1,864#939#4,408#3,747#11,843#8,272#590#359#7,242#7,981#4,011#68#2.5#9.3#2014#2.4#2.3#2.3#500#1.0#2019#2014#2018#582#31#2014\\n\\nDATE#May 2012#March 2012#Year Ended December 31,#Year Ended December 31,#February 2014\\n\\nEVENT#Net earnings attributable#the discovery#development#licensing#manufacturing#marketing#distribution#sale#financial performance\\n\\nFAC#BMS-986094#Ireland\\n\\nGPE#U.S.#U.S.\\n\\nMONEY#$38#$36#$844#$9#$1#$14#$47#$37#$858#$22#20#$317#$25#17#$541#$151#$36#$147#$326#$285#$96#$9#$16#$18#$105#$16#85#$278#16#47#$343#$226#$174#559#$877#161#151#$27#23|45#$38#$1,503#698#$2,743#$545#$242#$947#$16#$2,004#2,563#$1,960#$2,004#2,563#1,959#$2,004#2,563#1,960#$1,081#456#$1,404#$3,085#3,019#3,364#$3,085#3,019#3,363#$5,571#3,586#$1,864#939#4,408#3,747#11,843#8,272#590#359#7,242#7,981#4,011#2.5\\n\\nORG#Sanofi partnerships#Amylin#Amylin#aAmylin#Amylin #BMS#AstraZeneca\\n\\nPRODUCT#Pharmaceutical products\\n\\nTIME#the third quarter of 2014#one year\\n\\nWORK_OF_ART#Net Earnings Attributable to BMS \\u2014 GAAP#Diluted EPS Attributable to BMS \\u2014 Non-GAAP}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2742,\n",
      "    \"completion_tokens\": 798,\n",
      "    \"total_tokens\": 3540\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'May 2012', 'category': 'DATE'}, {'entity': 'March 2012', 'category': 'DATE'}, {'entity': 'Year Ended December 31,', 'category': 'DATE'}, {'entity': 'Year Ended December 31,', 'category': 'DATE'}, {'entity': 'February 2014', 'category': 'DATE'}, {'entity': 'Net earnings attributable', 'category': 'EVENT'}, {'entity': 'the discovery', 'category': 'EVENT'}, {'entity': 'development', 'category': 'EVENT'}, {'entity': 'licensing', 'category': 'EVENT'}, {'entity': 'manufacturing', 'category': 'EVENT'}, {'entity': 'marketing', 'category': 'EVENT'}, {'entity': 'distribution', 'category': 'EVENT'}, {'entity': 'sale', 'category': 'EVENT'}, {'entity': 'financial performance', 'category': 'EVENT'}, {'entity': 'BMS-986094', 'category': 'FAC'}, {'entity': 'Ireland', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '$38', 'category': 'MONEY'}, {'entity': '$36', 'category': 'MONEY'}, {'entity': '$844', 'category': 'MONEY'}, {'entity': '$9', 'category': 'MONEY'}, {'entity': '$1', 'category': 'MONEY'}, {'entity': '$14', 'category': 'MONEY'}, {'entity': '$47', 'category': 'MONEY'}, {'entity': '$37', 'category': 'MONEY'}, {'entity': '$858', 'category': 'MONEY'}, {'entity': '$22', 'category': 'MONEY'}, {'entity': '20', 'category': 'MONEY'}, {'entity': '$317', 'category': 'MONEY'}, {'entity': '$25', 'category': 'MONEY'}, {'entity': '17', 'category': 'MONEY'}, {'entity': '$541', 'category': 'MONEY'}, {'entity': '$151', 'category': 'MONEY'}, {'entity': '$36', 'category': 'MONEY'}, {'entity': '$147', 'category': 'MONEY'}, {'entity': '$326', 'category': 'MONEY'}, {'entity': '$285', 'category': 'MONEY'}, {'entity': '$96', 'category': 'MONEY'}, {'entity': '$9', 'category': 'MONEY'}, {'entity': '$16', 'category': 'MONEY'}, {'entity': '$18', 'category': 'MONEY'}, {'entity': '$105', 'category': 'MONEY'}, {'entity': '$16', 'category': 'MONEY'}, {'entity': '85', 'category': 'MONEY'}, {'entity': '$278', 'category': 'MONEY'}, {'entity': '16', 'category': 'MONEY'}, {'entity': '47', 'category': 'MONEY'}, {'entity': '$343', 'category': 'MONEY'}, {'entity': '$226', 'category': 'MONEY'}, {'entity': '$174', 'category': 'MONEY'}, {'entity': '559', 'category': 'MONEY'}, {'entity': '$877', 'category': 'MONEY'}, {'entity': '161', 'category': 'MONEY'}, {'entity': '151', 'category': 'MONEY'}, {'entity': '$27', 'category': 'MONEY'}, {'entity': '23|45', 'category': 'MONEY'}, {'entity': '$38', 'category': 'MONEY'}, {'entity': '$1,503', 'category': 'MONEY'}, {'entity': '698', 'category': 'MONEY'}, {'entity': '$2,743', 'category': 'MONEY'}, {'entity': '$545', 'category': 'MONEY'}, {'entity': '$242', 'category': 'MONEY'}, {'entity': '$947', 'category': 'MONEY'}, {'entity': '$16', 'category': 'MONEY'}, {'entity': '$2,004', 'category': 'MONEY'}, {'entity': '2,563', 'category': 'MONEY'}, {'entity': '$1,960', 'category': 'MONEY'}, {'entity': '$2,004', 'category': 'MONEY'}, {'entity': '2,563', 'category': 'MONEY'}, {'entity': '1,959', 'category': 'MONEY'}, {'entity': '$2,004', 'category': 'MONEY'}, {'entity': '2,563', 'category': 'MONEY'}, {'entity': '1,960', 'category': 'MONEY'}, {'entity': '$1,081', 'category': 'MONEY'}, {'entity': '456', 'category': 'MONEY'}, {'entity': '$1,404', 'category': 'MONEY'}, {'entity': '$3,085', 'category': 'MONEY'}, {'entity': '3,019', 'category': 'MONEY'}, {'entity': '3,364', 'category': 'MONEY'}, {'entity': '$3,085', 'category': 'MONEY'}, {'entity': '3,019', 'category': 'MONEY'}, {'entity': '3,363', 'category': 'MONEY'}, {'entity': '$5,571', 'category': 'MONEY'}, {'entity': '3,586', 'category': 'MONEY'}, {'entity': '$1,864', 'category': 'MONEY'}, {'entity': '939', 'category': 'MONEY'}, {'entity': '4,408', 'category': 'MONEY'}, {'entity': '3,747', 'category': 'MONEY'}, {'entity': '11,843', 'category': 'MONEY'}, {'entity': '8,272', 'category': 'MONEY'}, {'entity': '590', 'category': 'MONEY'}, {'entity': '359', 'category': 'MONEY'}, {'entity': '7,242', 'category': 'MONEY'}, {'entity': '7,981', 'category': 'MONEY'}, {'entity': '4,011', 'category': 'MONEY'}, {'entity': '2.5', 'category': 'MONEY'}, {'entity': 'Sanofi partnerships', 'category': 'ORG'}, {'entity': 'Amylin', 'category': 'ORG'}, {'entity': 'Amylin', 'category': 'ORG'}, {'entity': 'aAmylin', 'category': 'ORG'}, {'entity': 'Amylin', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'AstraZeneca', 'category': 'ORG'}, {'entity': 'Pharmaceutical products', 'category': 'PRODUCT'}, {'entity': 'the third quarter of 2014', 'category': 'TIME'}, {'entity': 'one year', 'category': 'TIME'}, {'entity': 'Net Earnings Attributable to BMS — GAAP', 'category': 'WORK_OF_ART'}, {'entity': 'Diluted EPS Attributable to BMS — Non-GAAP', 'category': 'WORK_OF_ART'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '38', 'category': 'CARDINAL'}, {'entity': '36', 'category': 'CARDINAL'}, {'entity': '844', 'category': 'CARDINAL'}, {'entity': '9', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '14', 'category': 'CARDINAL'}, {'entity': '47', 'category': 'CARDINAL'}, {'entity': '37', 'category': 'CARDINAL'}, {'entity': '858', 'category': 'CARDINAL'}, {'entity': '22', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '317', 'category': 'CARDINAL'}, {'entity': '25', 'category': 'CARDINAL'}, {'entity': '17', 'category': 'CARDINAL'}, {'entity': '541', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '151', 'category': 'CARDINAL'}, {'entity': '36', 'category': 'CARDINAL'}, {'entity': '147', 'category': 'CARDINAL'}, {'entity': '14', 'category': 'CARDINAL'}, {'entity': '23', 'category': 'CARDINAL'}, {'entity': '151', 'category': 'CARDINAL'}, {'entity': '326', 'category': 'CARDINAL'}, {'entity': '285', 'category': 'CARDINAL'}, {'entity': '96', 'category': 'CARDINAL'}, {'entity': '9', 'category': 'CARDINAL'}, {'entity': '16', 'category': 'CARDINAL'}, {'entity': '18', 'category': 'CARDINAL'}, {'entity': '105', 'category': 'CARDINAL'}, {'entity': '16', 'category': 'CARDINAL'}, {'entity': '85', 'category': 'CARDINAL'}, {'entity': '278', 'category': 'CARDINAL'}, {'entity': '16', 'category': 'CARDINAL'}, {'entity': '47', 'category': 'CARDINAL'}, {'entity': '343', 'category': 'CARDINAL'}, {'entity': '621', 'category': 'CARDINAL'}, {'entity': '16', 'category': 'CARDINAL'}, {'entity': '216', 'category': 'CARDINAL'}, {'entity': '1,830', 'category': 'CARDINAL'}, {'entity': '163', 'category': 'CARDINAL'}, {'entity': '226', 'category': 'CARDINAL'}, {'entity': '174', 'category': 'CARDINAL'}, {'entity': '559', 'category': 'CARDINAL'}, {'entity': '877', 'category': 'CARDINAL'}, {'entity': '161', 'category': 'CARDINAL'}, {'entity': '151', 'category': 'CARDINAL'}, {'entity': '72', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '43', 'category': 'CARDINAL'}, {'entity': '27', 'category': 'CARDINAL'}, {'entity': '23', 'category': 'CARDINAL'}, {'entity': '45', 'category': 'CARDINAL'}, {'entity': '45', 'category': 'CARDINAL'}, {'entity': '38', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '14', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '626', 'category': 'CARDINAL'}, {'entity': '340', 'category': 'CARDINAL'}, {'entity': '327', 'category': 'CARDINAL'}, {'entity': '1,503', 'category': 'CARDINAL'}, {'entity': '698', 'category': 'CARDINAL'}, {'entity': '2,743', 'category': 'CARDINAL'}, {'entity': '545', 'category': 'CARDINAL'}, {'entity': '242', 'category': 'CARDINAL'}, {'entity': '947', 'category': 'CARDINAL'}, {'entity': '123', 'category': 'CARDINAL'}, {'entity': '422', 'category': 'CARDINAL'}, {'entity': '242', 'category': 'CARDINAL'}, {'entity': '1,339', 'category': 'CARDINAL'}, {'entity': '1,081', 'category': 'CARDINAL'}, {'entity': '456', 'category': 'CARDINAL'}, {'entity': '1,404', 'category': 'CARDINAL'}, {'entity': '16', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '2,004', 'category': 'CARDINAL'}, {'entity': '2,563', 'category': 'CARDINAL'}, {'entity': '1,960', 'category': 'CARDINAL'}, {'entity': '2,004', 'category': 'CARDINAL'}, {'entity': '2,563', 'category': 'CARDINAL'}, {'entity': '1,959', 'category': 'CARDINAL'}, {'entity': '2,004', 'category': 'CARDINAL'}, {'entity': '2,563', 'category': 'CARDINAL'}, {'entity': '1,960', 'category': 'CARDINAL'}, {'entity': '1,081', 'category': 'CARDINAL'}, {'entity': '456', 'category': 'CARDINAL'}, {'entity': '1,404', 'category': 'CARDINAL'}, {'entity': '3,085', 'category': 'CARDINAL'}, {'entity': '3,019', 'category': 'CARDINAL'}, {'entity': '3,364', 'category': 'CARDINAL'}, {'entity': '3,085', 'category': 'CARDINAL'}, {'entity': '3,019', 'category': 'CARDINAL'}, {'entity': '3,363', 'category': 'CARDINAL'}, {'entity': '1,670', 'category': 'CARDINAL'}, {'entity': '1,662', 'category': 'CARDINAL'}, {'entity': '1,688', 'category': 'CARDINAL'}, {'entity': '1.20', 'category': 'CARDINAL'}, {'entity': '1.54', 'category': 'CARDINAL'}, {'entity': '1.16', 'category': 'CARDINAL'}, {'entity': '0.65', 'category': 'CARDINAL'}, {'entity': '0.28', 'category': 'CARDINAL'}, {'entity': '0.83', 'category': 'CARDINAL'}, {'entity': '1.85', 'category': 'CARDINAL'}, {'entity': '1.82', 'category': 'CARDINAL'}, {'entity': '1.99', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '5,571', 'category': 'CARDINAL'}, {'entity': '3,586', 'category': 'CARDINAL'}, {'entity': '1,864', 'category': 'CARDINAL'}, {'entity': '939', 'category': 'CARDINAL'}, {'entity': '4,408', 'category': 'CARDINAL'}, {'entity': '3,747', 'category': 'CARDINAL'}, {'entity': '11,843', 'category': 'CARDINAL'}, {'entity': '8,272', 'category': 'CARDINAL'}, {'entity': '590', 'category': 'CARDINAL'}, {'entity': '359', 'category': 'CARDINAL'}, {'entity': '7,242', 'category': 'CARDINAL'}, {'entity': '7,981', 'category': 'CARDINAL'}, {'entity': '4,011', 'category': 'CARDINAL'}, {'entity': '68', 'category': 'CARDINAL'}, {'entity': '2.5', 'category': 'CARDINAL'}, {'entity': '9.3', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2.4', 'category': 'CARDINAL'}, {'entity': '2.3', 'category': 'CARDINAL'}, {'entity': '2.3', 'category': 'CARDINAL'}, {'entity': '500', 'category': 'CARDINAL'}, {'entity': '1.0', 'category': 'CARDINAL'}, {'entity': '2019', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2018', 'category': 'CARDINAL'}, {'entity': '582', 'category': 'CARDINAL'}, {'entity': '31', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXAGbhsS2eBGSncgZbEz4C8dSp6E\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701573032,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#$1.5 billion#five#December 31, 2014#2013#one#two#five#two#2014#$509 million#2013#$322 million#2012#Japan#$358 million#2014#$522 million#2013#$634 million#2012#2014#2013#2014#2013#2012#2014#2013#2012#2014#2013#2012#2014#$676 million#2014#$892 million#2013#$288 million#2014#$564 million#2013#$2.0 billion#2012#$433 million#2013#$2.4 billion#2012#$1.1 billion#$892 million#2013#$563 million#2012#$590 million#2015#611#2017#500#4,943#5,100#2018#2019#3,890#572#136#121#2018#57#81#2,296#2018#2019#142#2019\\n\\nDATE#December 31, 2014#2013#December 31, 2014#December 31, 2013#2014#2013#2012#December 31, 2014#2015#2016#2017#2018#2019#Later Years\\n\\nEVENT#credit outlook#credit outlook#credit outlook#long-term credit outlook#business divestiture#dividends\\n\\nFAC#Moody\\u2019s Investors Service#Standard & Poor\\u2019s#Fitch's#Amylin\\n\\nGPE#U.S.#European#Italy#Portugal#Spain#Japan\\n\\nMONEY#$1.5 billion#$454 million#$509 million#$322 million#$358 million#$522 million#$634 million#Dollars in Millions#December 31, 2014#December 31, 2013#$2,100#$1,690#1,560#1,498#(2,487)#(2,559)#$1,173#1,069#A2#Prime-1#A+#A-1+#A-#F2#iPierian#Inhibitex\\n\\nORG#European Union#Moody\\u2019s Investors Service#Standard & Poor\\u2019s#Fitch's#Reckitt#Amylin#Plavix* and Avapro*/Avalide\\n\\nPERCENT#90 days\\n\\nPERSON#Amylin\\n\\nWORK_OF_ART#Fair Value Measurements\\n}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2460,\n",
      "    \"completion_tokens\": 520,\n",
      "    \"total_tokens\": 2980\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2014', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': 'December 31, 2014', 'category': 'DATE'}, {'entity': 'December 31, 2013', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': 'December 31, 2014', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': '2018', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': 'Later Years', 'category': 'DATE'}, {'entity': 'credit outlook', 'category': 'EVENT'}, {'entity': 'credit outlook', 'category': 'EVENT'}, {'entity': 'credit outlook', 'category': 'EVENT'}, {'entity': 'long-term credit outlook', 'category': 'EVENT'}, {'entity': 'business divestiture', 'category': 'EVENT'}, {'entity': 'dividends', 'category': 'EVENT'}, {'entity': 'Moody’s Investors Service', 'category': 'FAC'}, {'entity': 'Standard & Poor’s', 'category': 'FAC'}, {'entity': 'Fitchs', 'category': 'FAC'}, {'entity': 'Amylin', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'European', 'category': 'GPE'}, {'entity': 'Italy', 'category': 'GPE'}, {'entity': 'Portugal', 'category': 'GPE'}, {'entity': 'Spain', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': '$1.5 billion', 'category': 'MONEY'}, {'entity': '$454 million', 'category': 'MONEY'}, {'entity': '$509 million', 'category': 'MONEY'}, {'entity': '$322 million', 'category': 'MONEY'}, {'entity': '$358 million', 'category': 'MONEY'}, {'entity': '$522 million', 'category': 'MONEY'}, {'entity': '$634 million', 'category': 'MONEY'}, {'entity': 'Dollars in Millions', 'category': 'MONEY'}, {'entity': 'December 31, 2014', 'category': 'MONEY'}, {'entity': 'December 31, 2013', 'category': 'MONEY'}, {'entity': '$2,100', 'category': 'MONEY'}, {'entity': '$1,690', 'category': 'MONEY'}, {'entity': '1,560', 'category': 'MONEY'}, {'entity': '1,498', 'category': 'MONEY'}, {'entity': '2,487', 'category': 'MONEY'}, {'entity': '2,559', 'category': 'MONEY'}, {'entity': '$1,173', 'category': 'MONEY'}, {'entity': '1,069', 'category': 'MONEY'}, {'entity': 'A2', 'category': 'MONEY'}, {'entity': 'Prime-1', 'category': 'MONEY'}, {'entity': 'A+', 'category': 'MONEY'}, {'entity': 'A-1+', 'category': 'MONEY'}, {'entity': 'A-', 'category': 'MONEY'}, {'entity': 'F2', 'category': 'MONEY'}, {'entity': 'iPierian', 'category': 'MONEY'}, {'entity': 'Inhibitex', 'category': 'MONEY'}, {'entity': 'European Union', 'category': 'ORG'}, {'entity': 'Moody’s Investors Service', 'category': 'ORG'}, {'entity': 'Standard & Poor’s', 'category': 'ORG'}, {'entity': 'Fitchs', 'category': 'ORG'}, {'entity': 'Reckitt', 'category': 'ORG'}, {'entity': 'Amylin', 'category': 'ORG'}, {'entity': 'Plavix* and Avapro*/Avalide', 'category': 'ORG'}, {'entity': '90 days', 'category': 'PERCENT'}, {'entity': 'Amylin', 'category': 'PERSON'}, {'entity': 'Fair Value Measurements', 'category': 'WORK_OF_ART'}, {'entity': '$1.5 billion', 'category': 'CARDINAL'}, {'entity': 'five', 'category': 'CARDINAL'}, {'entity': 'December 31, 2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': 'one', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': 'five', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '$509 million', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '$322 million', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': 'Japan', 'category': 'CARDINAL'}, {'entity': '$358 million', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '$522 million', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '$634 million', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '$676 million', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '$892 million', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '$288 million', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '$564 million', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '$2.0 billion', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '$433 million', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '$2.4 billion', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '$1.1 billion', 'category': 'CARDINAL'}, {'entity': '$892 million', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '$563 million', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '$590 million', 'category': 'CARDINAL'}, {'entity': '2015', 'category': 'CARDINAL'}, {'entity': '611', 'category': 'CARDINAL'}, {'entity': '2017', 'category': 'CARDINAL'}, {'entity': '500', 'category': 'CARDINAL'}, {'entity': '4,943', 'category': 'CARDINAL'}, {'entity': '5,100', 'category': 'CARDINAL'}, {'entity': '2018', 'category': 'CARDINAL'}, {'entity': '2019', 'category': 'CARDINAL'}, {'entity': '3,890', 'category': 'CARDINAL'}, {'entity': '572', 'category': 'CARDINAL'}, {'entity': '136', 'category': 'CARDINAL'}, {'entity': '121', 'category': 'CARDINAL'}, {'entity': '2018', 'category': 'CARDINAL'}, {'entity': '57', 'category': 'CARDINAL'}, {'entity': '81', 'category': 'CARDINAL'}, {'entity': '2,296', 'category': 'CARDINAL'}, {'entity': '2018', 'category': 'CARDINAL'}, {'entity': '2019', 'category': 'CARDINAL'}, {'entity': '142', 'category': 'CARDINAL'}, {'entity': '2019', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXAzdyL0YhnbwG6FzjAm0gEFTFe1\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701573077,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#618#211#45#30#33#299#16,122#1,743#1,592#1,453#661#1,048#9,625#3.8 billion#900 million#2.9 billion#1.2 billion#100%#90%\\n\\nDATE#August 4, 2004#September 30, 2004\\n\\nEVENT#final settlement\\n\\nFAC#SEC\\n\\nGPE#U.S.\\n\\nLAW#SEC Consent Order#Item 8. Financial Statements\\u2014Note 3. Alliances#Item 8. Financial Statements\\u2014Note 8. Income Taxes#Item 8. Financial Statements\\u2014Note 10. Financial Instruments and Fair Value Measurements#Item 8. Financial Statements\\u2014Note 19. Pension, Postretirement and Postemployment Liabilities#Item 8. Financial Statements\\u2014Note 21. Leases\\n\\nMONEY#$3.8 billion#$900 million#$2.9 billion#$1.2 billion\\n\\nORG#SEC#IMAs#Audit Committee of the Board of Directors\\n\\nPERCENT#100%#90%\\n\\nPERSON#\\n\\nPRODUCT#\\n\\nTIME#\\n\\nWORK_OF_ART#Exhibit 10}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2086,\n",
      "    \"completion_tokens\": 247,\n",
      "    \"total_tokens\": 2333\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'August 4, 2004', 'category': 'DATE'}, {'entity': 'September 30, 2004', 'category': 'DATE'}, {'entity': 'final settlement', 'category': 'EVENT'}, {'entity': 'SEC', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'SEC Consent Order', 'category': 'LAW'}, {'entity': 'Item 8. Financial Statements—Note 3. Alliances', 'category': 'LAW'}, {'entity': 'Item 8. Financial Statements—Note 8. Income Taxes', 'category': 'LAW'}, {'entity': 'Item 8. Financial Statements—Note 10. Financial Instruments and Fair Value Measurements', 'category': 'LAW'}, {'entity': 'Item 8. Financial Statements—Note 19. Pension, Postretirement and Postemployment Liabilities', 'category': 'LAW'}, {'entity': 'Item 8. Financial Statements—Note 21. Leases', 'category': 'LAW'}, {'entity': '$3.8 billion', 'category': 'MONEY'}, {'entity': '$900 million', 'category': 'MONEY'}, {'entity': '$2.9 billion', 'category': 'MONEY'}, {'entity': '$1.2 billion', 'category': 'MONEY'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'IMAs', 'category': 'ORG'}, {'entity': 'Audit Committee of the Board of Directors', 'category': 'ORG'}, {'entity': '100%', 'category': 'PERCENT'}, {'entity': '90%', 'category': 'PERCENT'}, {'entity': 'Exhibit 10', 'category': 'WORK_OF_ART'}, {'entity': '618', 'category': 'CARDINAL'}, {'entity': '211', 'category': 'CARDINAL'}, {'entity': '45', 'category': 'CARDINAL'}, {'entity': '30', 'category': 'CARDINAL'}, {'entity': '33', 'category': 'CARDINAL'}, {'entity': '299', 'category': 'CARDINAL'}, {'entity': '16,122', 'category': 'CARDINAL'}, {'entity': '1,743', 'category': 'CARDINAL'}, {'entity': '1,592', 'category': 'CARDINAL'}, {'entity': '1,453', 'category': 'CARDINAL'}, {'entity': '661', 'category': 'CARDINAL'}, {'entity': '1,048', 'category': 'CARDINAL'}, {'entity': '9,625', 'category': 'CARDINAL'}, {'entity': '3.8 billion', 'category': 'CARDINAL'}, {'entity': '900 million', 'category': 'CARDINAL'}, {'entity': '2.9 billion', 'category': 'CARDINAL'}, {'entity': '1.2 billion', 'category': 'CARDINAL'}, {'entity': '100%', 'category': 'CARDINAL'}, {'entity': '90%', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXBXFXRyRTQKUGfNo05ywUWc6xiJ\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701573111,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#2#2#67#2011#24#2014#85#2013#37#2012#86#147#1.1 \\n\\nDATE#six months#twelve months#September 30, 2014#December 31, 2014#December 31, 2013#December 31, 2014\\n\\nGPE#U.S.\\n\\nMONEY#$24 million#$85 million#$37 million#$86 million#$147 million#$9 million#$1.1 billion#$600 million\\n\\nNORP#Federal\\n\\nORDINAL#third\\n\\nORG#BMS#U.S. Department of Defense#the U.S. Department of Veterans Affairs#Medicare#Medicare Part D#Department of Defense TRICARE Retail Pharmacy Refund Program#Medicaid#Plavix#Avapro#Avalide#Citigroup\\n\\nPERSON#Avalide\\n}\\n\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2052,\n",
      "    \"completion_tokens\": 188,\n",
      "    \"total_tokens\": 2240\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'six months', 'category': 'DATE'}, {'entity': 'twelve months', 'category': 'DATE'}, {'entity': 'September 30, 2014', 'category': 'DATE'}, {'entity': 'December 31, 2014', 'category': 'DATE'}, {'entity': 'December 31, 2013', 'category': 'DATE'}, {'entity': 'December 31, 2014', 'category': 'DATE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '$24 million', 'category': 'MONEY'}, {'entity': '$85 million', 'category': 'MONEY'}, {'entity': '$37 million', 'category': 'MONEY'}, {'entity': '$86 million', 'category': 'MONEY'}, {'entity': '$147 million', 'category': 'MONEY'}, {'entity': '$9 million', 'category': 'MONEY'}, {'entity': '$1.1 billion', 'category': 'MONEY'}, {'entity': '$600 million', 'category': 'MONEY'}, {'entity': 'Federal', 'category': 'NORP'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'U.S. Department of Defense', 'category': 'ORG'}, {'entity': 'the U.S. Department of Veterans Affairs', 'category': 'ORG'}, {'entity': 'Medicare', 'category': 'ORG'}, {'entity': 'Medicare Part D', 'category': 'ORG'}, {'entity': 'Department of Defense TRICARE Retail Pharmacy Refund Program', 'category': 'ORG'}, {'entity': 'Medicaid', 'category': 'ORG'}, {'entity': 'Plavix', 'category': 'ORG'}, {'entity': 'Avapro', 'category': 'ORG'}, {'entity': 'Avalide', 'category': 'ORG'}, {'entity': 'Citigroup', 'category': 'ORG'}, {'entity': 'Avalide', 'category': 'PERSON'}, {'entity': 'third', 'category': 'ORDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '67', 'category': 'CARDINAL'}, {'entity': '2011', 'category': 'CARDINAL'}, {'entity': '24', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '85', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '37', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '86', 'category': 'CARDINAL'}, {'entity': '147', 'category': 'CARDINAL'}, {'entity': '1.1', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXC3e0aYjmFhREtjO5yqzqoxYbLo\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701573143,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#1%#26%#148#$550 million#$600 million#8.1 \\n\\nDATE#2014#December 31, 2014\\n\\nEVENT#business combinations#divestitures\\n\\nGPE#U.S.\\n\\nMONEY#$8.8 billion#$49 million\\n\\nORG#U.S. plans#ASC 805 - Business Combinations#iPierian#AstraZeneca#BMS#Amylin#Inhibitex\\n\\nPERCENT#8.1%#1%#26%\\n\\nPRODUCT#IPRD#lead investigational compound#Bydureon\\n\\nQUANTITY#one-year\\n\\nWORK_OF_ART#\\u201cItem 8. Financial Statements\\u2014Note 19. Pension, Postretirement and Postemployment Liabilities.\\u201d#\\u201cItem 8. Financial Statements\\u2014Note 4. Acquisitions\\u201d}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2074,\n",
      "    \"completion_tokens\": 174,\n",
      "    \"total_tokens\": 2248\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': '2014', 'category': 'DATE'}, {'entity': 'December 31, 2014', 'category': 'DATE'}, {'entity': 'business combinations', 'category': 'EVENT'}, {'entity': 'divestitures', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '$8.8 billion', 'category': 'MONEY'}, {'entity': '$49 million', 'category': 'MONEY'}, {'entity': 'U.S. plans', 'category': 'ORG'}, {'entity': 'ASC 805 - Business Combinations', 'category': 'ORG'}, {'entity': 'iPierian', 'category': 'ORG'}, {'entity': 'AstraZeneca', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Amylin', 'category': 'ORG'}, {'entity': 'Inhibitex', 'category': 'ORG'}, {'entity': '8.1%', 'category': 'PERCENT'}, {'entity': '1%', 'category': 'PERCENT'}, {'entity': '26%', 'category': 'PERCENT'}, {'entity': 'IPRD', 'category': 'PRODUCT'}, {'entity': 'lead investigational compound', 'category': 'PRODUCT'}, {'entity': 'Bydureon', 'category': 'PRODUCT'}, {'entity': 'one-year', 'category': 'QUANTITY'}, {'entity': '“Item 8. Financial Statements—Note 19. Pension, Postretirement and Postemployment Liabilities.”', 'category': 'WORK_OF_ART'}, {'entity': '“Item 8. Financial Statements—Note 4. Acquisitions”', 'category': 'WORK_OF_ART'}, {'entity': '1%', 'category': 'CARDINAL'}, {'entity': '26%', 'category': 'CARDINAL'}, {'entity': '148', 'category': 'CARDINAL'}, {'entity': '$550 million', 'category': 'CARDINAL'}, {'entity': '$600 million', 'category': 'CARDINAL'}, {'entity': '8.1', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXCZ7KITBQD5o2mtNjsB0mJbxzz0\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701573175,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#5,260#11.1#13#770#10.0#7#310#9#1,830#12.0#120#12.0#7.0#1.8#382#849#242#280#343#310#2.1#1.8#120#151#36#147#3.8#4.3#4.8#4.6#135#26#562\\n\\nDATE#December 31, 2014#2017#2014#2012#December 31, 2014#December 31, 2013#2022#2017\\n\\nEVENT#divestiture of the diabetes business#IPRD impairment charges\\n\\nFAC#manufacturing facility\\n\\nGPE#U.S.\\n\\nLAW#Item 8. Financial Statements\\u2014Note 3. Alliances#Item 8. Financial Statements\\u2014Note 1. Accounting Policies\\u2014Goodwill, Acquired In-Process Research and Development and Other Intangible Assets#Item 8. Financial Statements\\u2014Note 14. Goodwill#Item 8. Financial Statements\\u2014Note 1. Accounting Policies\\u2014Contingencies##Note 8. Income Taxes#Note 22. Legal Proceedings and Contingencies\\n\\nMONEY#$7.0 billion#$1.8 billion#$382 million#$849 million#$242 million#$343 million#$2.1 billion#$1.8 billion#$120 million#$151 million#$36 million#$147 million#$3.8 billion#$4.3 billion#$4.8 billion#$4.6 billion#$135 million#$26 million#$562 million\\n\\nORG#AstraZeneca#BMS\\n\\nPERCENT#38.0%#75.0%\\n\\nPERSON#BMS-986094#INX-189#Note 3#Alliances#Note 1#Goodwill#Research and Development#Note 14#Note 1#Contingencies\\n\\nPRODUCT#Byetta#Symlin#Myalept#BMS-986094#peginterferon lambda\\n\\nTIME#annually\\n\\nWORK_OF_ART#IPRD\\n}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2249,\n",
      "    \"completion_tokens\": 443,\n",
      "    \"total_tokens\": 2692\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2014', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': 'December 31, 2014', 'category': 'DATE'}, {'entity': 'December 31, 2013', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': 'divestiture of the diabetes business', 'category': 'EVENT'}, {'entity': 'IPRD impairment charges', 'category': 'EVENT'}, {'entity': 'manufacturing facility', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Item 8. Financial Statements—Note 3. Alliances', 'category': 'LAW'}, {'entity': 'Item 8. Financial Statements—Note 1. Accounting Policies—Goodwill, Acquired In-Process Research and Development and Other Intangible Assets', 'category': 'LAW'}, {'entity': 'Item 8. Financial Statements—Note 14. Goodwill', 'category': 'LAW'}, {'entity': 'Item 8. Financial Statements—Note 1. Accounting Policies—Contingencies', 'category': 'LAW'}, {'entity': 'Note 8. Income Taxes', 'category': 'LAW'}, {'entity': 'Note 22. Legal Proceedings and Contingencies', 'category': 'LAW'}, {'entity': '$7.0 billion', 'category': 'MONEY'}, {'entity': '$1.8 billion', 'category': 'MONEY'}, {'entity': '$382 million', 'category': 'MONEY'}, {'entity': '$849 million', 'category': 'MONEY'}, {'entity': '$242 million', 'category': 'MONEY'}, {'entity': '$343 million', 'category': 'MONEY'}, {'entity': '$2.1 billion', 'category': 'MONEY'}, {'entity': '$1.8 billion', 'category': 'MONEY'}, {'entity': '$120 million', 'category': 'MONEY'}, {'entity': '$151 million', 'category': 'MONEY'}, {'entity': '$36 million', 'category': 'MONEY'}, {'entity': '$147 million', 'category': 'MONEY'}, {'entity': '$3.8 billion', 'category': 'MONEY'}, {'entity': '$4.3 billion', 'category': 'MONEY'}, {'entity': '$4.8 billion', 'category': 'MONEY'}, {'entity': '$4.6 billion', 'category': 'MONEY'}, {'entity': '$135 million', 'category': 'MONEY'}, {'entity': '$26 million', 'category': 'MONEY'}, {'entity': '$562 million', 'category': 'MONEY'}, {'entity': 'AstraZeneca', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': '38.0%', 'category': 'PERCENT'}, {'entity': '75.0%', 'category': 'PERCENT'}, {'entity': 'BMS-986094', 'category': 'PERSON'}, {'entity': 'INX-189', 'category': 'PERSON'}, {'entity': 'Note 3', 'category': 'PERSON'}, {'entity': 'Alliances', 'category': 'PERSON'}, {'entity': 'Note 1', 'category': 'PERSON'}, {'entity': 'Goodwill', 'category': 'PERSON'}, {'entity': 'Research and Development', 'category': 'PERSON'}, {'entity': 'Note 14', 'category': 'PERSON'}, {'entity': 'Note 1', 'category': 'PERSON'}, {'entity': 'Contingencies', 'category': 'PERSON'}, {'entity': 'Byetta', 'category': 'PRODUCT'}, {'entity': 'Symlin', 'category': 'PRODUCT'}, {'entity': 'Myalept', 'category': 'PRODUCT'}, {'entity': 'BMS-986094', 'category': 'PRODUCT'}, {'entity': 'peginterferon lambda', 'category': 'PRODUCT'}, {'entity': 'annually', 'category': 'TIME'}, {'entity': 'IPRD', 'category': 'WORK_OF_ART'}, {'entity': '5,260', 'category': 'CARDINAL'}, {'entity': '11.1', 'category': 'CARDINAL'}, {'entity': '13', 'category': 'CARDINAL'}, {'entity': '770', 'category': 'CARDINAL'}, {'entity': '10.0', 'category': 'CARDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '310', 'category': 'CARDINAL'}, {'entity': '9', 'category': 'CARDINAL'}, {'entity': '1,830', 'category': 'CARDINAL'}, {'entity': '12.0', 'category': 'CARDINAL'}, {'entity': '120', 'category': 'CARDINAL'}, {'entity': '12.0', 'category': 'CARDINAL'}, {'entity': '7.0', 'category': 'CARDINAL'}, {'entity': '1.8', 'category': 'CARDINAL'}, {'entity': '382', 'category': 'CARDINAL'}, {'entity': '849', 'category': 'CARDINAL'}, {'entity': '242', 'category': 'CARDINAL'}, {'entity': '280', 'category': 'CARDINAL'}, {'entity': '343', 'category': 'CARDINAL'}, {'entity': '310', 'category': 'CARDINAL'}, {'entity': '2.1', 'category': 'CARDINAL'}, {'entity': '1.8', 'category': 'CARDINAL'}, {'entity': '120', 'category': 'CARDINAL'}, {'entity': '151', 'category': 'CARDINAL'}, {'entity': '36', 'category': 'CARDINAL'}, {'entity': '147', 'category': 'CARDINAL'}, {'entity': '3.8', 'category': 'CARDINAL'}, {'entity': '4.3', 'category': 'CARDINAL'}, {'entity': '4.8', 'category': 'CARDINAL'}, {'entity': '4.6', 'category': 'CARDINAL'}, {'entity': '135', 'category': 'CARDINAL'}, {'entity': '26', 'category': 'CARDINAL'}, {'entity': '562', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXDFcWrWSZpBAqgossUJGyDbzvek\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701573217,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#10%#50% \\n\\nDATE#December 31, 2014#2009#2014 \\n\\nEVENT#Mead Johnson Nutrition Company (Mead Johnson) split-off\\n\\nFAC#Mead Johnson & Company\\n\\nGPE#South Korean\\n\\nLAW#Internal Revenue Code#Section 27A of the Securities Act of 1933#Section 21E of the Securities Exchange Act of 1934#\\u201cItem 8. Financial Statements\\u2014Note 1. Accounting Policies\\u2014Income Taxes\\u201d and \\u201c\\u2014Note 8. Income Taxes.\\u201d\\n\\nMONEY#$436 million#$244 million#$123 million\\n\\nORG#Mead Johnson#Mead Johnson Nutrition Company#Internal Revenue Service#IRS\\n\\nPERCENT#50%\\n\\nPERSON#Form 10-K\\n\\nPRODUCT#IPO\\n\\nTIME#four year period\\n\\nWORK_OF_ART#Form 10-K#Annual Report on Form 10-K}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2121,\n",
      "    \"completion_tokens\": 188,\n",
      "    \"total_tokens\": 2309\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2014', 'category': 'DATE'}, {'entity': '2009', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': 'Mead Johnson Nutrition Company Mead Johnson split-off', 'category': 'EVENT'}, {'entity': 'Mead Johnson & Company', 'category': 'FAC'}, {'entity': 'South Korean', 'category': 'GPE'}, {'entity': 'Internal Revenue Code', 'category': 'LAW'}, {'entity': 'Section 27A of the Securities Act of 1933', 'category': 'LAW'}, {'entity': 'Section 21E of the Securities Exchange Act of 1934', 'category': 'LAW'}, {'entity': '“Item 8. Financial Statements—Note 1. Accounting Policies—Income Taxes” and “—Note 8. Income Taxes.”', 'category': 'LAW'}, {'entity': '$436 million', 'category': 'MONEY'}, {'entity': '$244 million', 'category': 'MONEY'}, {'entity': '$123 million', 'category': 'MONEY'}, {'entity': 'Mead Johnson', 'category': 'ORG'}, {'entity': 'Mead Johnson Nutrition Company', 'category': 'ORG'}, {'entity': 'Internal Revenue Service', 'category': 'ORG'}, {'entity': 'IRS', 'category': 'ORG'}, {'entity': '50%', 'category': 'PERCENT'}, {'entity': 'Form 10-K', 'category': 'PERSON'}, {'entity': 'IPO', 'category': 'PRODUCT'}, {'entity': 'four year period', 'category': 'TIME'}, {'entity': 'Form 10-K', 'category': 'WORK_OF_ART'}, {'entity': 'Annual Report on Form 10-K', 'category': 'WORK_OF_ART'}, {'entity': '10%', 'category': 'CARDINAL'}, {'entity': '50%', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXDkwYrhkzV4P6bO0c6eGS1c36GX\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701573248,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#100#100#100#80 \\n\\nDATE#December 31, 2014 \\n\\nGPE#Europe#Greece#Portugal#Italy#Spain \\n\\nLAW#Item 8. Financial Statements\\u2014Note 10. Financial Instruments and Fair Value Measurements \\n\\nMONEY#$85 million#$634 million#$123 million#$130 million \\n\\nORG#U.S. \\n\\nPERCENT#100 basis points#100 basis points#100 basis points \\n\\nQUANTITY#approximately 80%\\n}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 1258,\n",
      "    \"completion_tokens\": 102,\n",
      "    \"total_tokens\": 1360\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': 'Europe', 'category': 'GPE'}, {'entity': 'Greece', 'category': 'GPE'}, {'entity': 'Portugal', 'category': 'GPE'}, {'entity': 'Italy', 'category': 'GPE'}, {'entity': 'Spain', 'category': 'GPE'}, {'entity': 'Item 8. Financial Statements—Note 10. Financial Instruments and Fair Value Measurements', 'category': 'LAW'}, {'entity': '$85 million', 'category': 'MONEY'}, {'entity': '$634 million', 'category': 'MONEY'}, {'entity': '$123 million', 'category': 'MONEY'}, {'entity': '$130 million', 'category': 'MONEY'}, {'entity': 'U.S.', 'category': 'ORG'}, {'entity': '100 basis points', 'category': 'PERCENT'}, {'entity': '100 basis points', 'category': 'PERCENT'}, {'entity': '100 basis points', 'category': 'PERCENT'}, {'entity': 'approximately 80%', 'category': 'QUANTITY'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '80', 'category': 'CARDINAL'}]\n",
      "/home/damir/Dropbox/Documents/Teaching/2023/L715/l715_23/data/10-Ks/Bristol-Myers_Squibb_Company/2019/Management.txt\n",
      "Length of chunks:  14\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXEDBuOj9GLz6ZIpYrQpro4hbpfl\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701573277,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#7#14#17#9#2.40#0.97#3#3.01#0.61#2.65#3.98#14#12\\n\\nDATE#2018#Year Ended December 31#2017#2016#January 3, 2019#August 2018#July 2018#June 2018#May 2018#April 2018#February 2018#November 2018#December 2018\\n\\nEVENT#tax reform\\n\\nFAC#\\n\\nGPE#U.S.#EU#Japan#China\\n\\nLANGUAGE#\\n\\nLAW#Item 1A. Risk Factors\\n\\nLOC#\\n\\nMONEY#$22,561#$20,776#$19,427\\n\\nNORP#\\n\\nORDINAL#first\\n\\nORG#Bristol-Myers Squibb Company#Summary of Abbreviated Terms#TYK2#Factor XIa#Janssen#PEG-FGF21#Celgene#MSI-H#dMMR mCRC#Philadelphia chromosome-positive ALL#Philadelphia chromosome-positive CML\\n\\nPERCENT#\\n\\nPERSON#\\n\\nPRODUCT#Opdivo#Eliquis#HIV brands#Daklinza#Opdivo+Yervoy#Pegbelfermin#Yervoy#Orencia#Empliciti#Sprycel\\n\\nQUANTITY#\\n\\nTIME#\\n\\nWORK_OF_ART#2018 Form 10-K}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2341,\n",
      "    \"completion_tokens\": 297,\n",
      "    \"total_tokens\": 2638\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': '2018', 'category': 'DATE'}, {'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': 'January 3, 2019', 'category': 'DATE'}, {'entity': 'August 2018', 'category': 'DATE'}, {'entity': 'July 2018', 'category': 'DATE'}, {'entity': 'June 2018', 'category': 'DATE'}, {'entity': 'May 2018', 'category': 'DATE'}, {'entity': 'April 2018', 'category': 'DATE'}, {'entity': 'February 2018', 'category': 'DATE'}, {'entity': 'November 2018', 'category': 'DATE'}, {'entity': 'December 2018', 'category': 'DATE'}, {'entity': 'tax reform', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'EU', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'China', 'category': 'GPE'}, {'entity': 'Item 1A. Risk Factors', 'category': 'LAW'}, {'entity': '$22,561', 'category': 'MONEY'}, {'entity': '$20,776', 'category': 'MONEY'}, {'entity': '$19,427', 'category': 'MONEY'}, {'entity': 'Bristol-Myers Squibb Company', 'category': 'ORG'}, {'entity': 'Summary of Abbreviated Terms', 'category': 'ORG'}, {'entity': 'TYK2', 'category': 'ORG'}, {'entity': 'Factor XIa', 'category': 'ORG'}, {'entity': 'Janssen', 'category': 'ORG'}, {'entity': 'PEG-FGF21', 'category': 'ORG'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': 'MSI-H', 'category': 'ORG'}, {'entity': 'dMMR mCRC', 'category': 'ORG'}, {'entity': 'Philadelphia chromosome-positive ALL', 'category': 'ORG'}, {'entity': 'Philadelphia chromosome-positive CML', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Eliquis', 'category': 'PRODUCT'}, {'entity': 'HIV brands', 'category': 'PRODUCT'}, {'entity': 'Daklinza', 'category': 'PRODUCT'}, {'entity': 'Opdivo+Yervoy', 'category': 'PRODUCT'}, {'entity': 'Pegbelfermin', 'category': 'PRODUCT'}, {'entity': 'Yervoy', 'category': 'PRODUCT'}, {'entity': 'Orencia', 'category': 'PRODUCT'}, {'entity': 'Empliciti', 'category': 'PRODUCT'}, {'entity': 'Sprycel', 'category': 'PRODUCT'}, {'entity': '2018 Form 10-K', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '14', 'category': 'CARDINAL'}, {'entity': '17', 'category': 'CARDINAL'}, {'entity': '9', 'category': 'CARDINAL'}, {'entity': '2.40', 'category': 'CARDINAL'}, {'entity': '0.97', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '3.01', 'category': 'CARDINAL'}, {'entity': '0.61', 'category': 'CARDINAL'}, {'entity': '2.65', 'category': 'CARDINAL'}, {'entity': '3.98', 'category': 'CARDINAL'}, {'entity': '14', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  14\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXEnSKwfXAGdn4PKeSF01Ip5HpAp\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701573313,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#1#2#4 \\n\\nDATE#three years#2018#2015#2017#2016\\n\\nEVENT#Acquisitions#Divestitures#Licensing#Collaboration Arrangements\\n\\nMONEY#\\n\\nORG#Celgene#Opdivo#Yervoy#Eliquis#Orencia#Sprycel#Nektar#Janssen#Promedior#Rigel Pharmaceuticals#Bavarian Nordic#Ono#Halozyme#IFM#Biogen#Roche#CytomX#PsiOxus#Padlock#Cormorant#Nitto Denko#BMS\\n\\nPERSON#\\n\\nPRODUCT#NKTR-214#BMS-986177#Prostvac#ONO-4578#ENHANZE#STING#NLRP3#BMS-986168#eTau#Progressive Supranuclear Palsy#BMS-986089#myostatin adnectin#Duchenne Muscular Dystrophy#Probody#NG-348#PAD inhibitor#HuMax-IL8#siRNA#heat shock protein 47#HSP47#ND-L02-s0201\\n\\nTIME#}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2183,\n",
      "    \"completion_tokens\": 252,\n",
      "    \"total_tokens\": 2435\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'three years', 'category': 'DATE'}, {'entity': '2018', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': 'Acquisitions', 'category': 'EVENT'}, {'entity': 'Divestitures', 'category': 'EVENT'}, {'entity': 'Licensing', 'category': 'EVENT'}, {'entity': 'Collaboration Arrangements', 'category': 'EVENT'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Yervoy', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'Orencia', 'category': 'ORG'}, {'entity': 'Sprycel', 'category': 'ORG'}, {'entity': 'Nektar', 'category': 'ORG'}, {'entity': 'Janssen', 'category': 'ORG'}, {'entity': 'Promedior', 'category': 'ORG'}, {'entity': 'Rigel Pharmaceuticals', 'category': 'ORG'}, {'entity': 'Bavarian Nordic', 'category': 'ORG'}, {'entity': 'Ono', 'category': 'ORG'}, {'entity': 'Halozyme', 'category': 'ORG'}, {'entity': 'IFM', 'category': 'ORG'}, {'entity': 'Biogen', 'category': 'ORG'}, {'entity': 'Roche', 'category': 'ORG'}, {'entity': 'CytomX', 'category': 'ORG'}, {'entity': 'PsiOxus', 'category': 'ORG'}, {'entity': 'Padlock', 'category': 'ORG'}, {'entity': 'Cormorant', 'category': 'ORG'}, {'entity': 'Nitto Denko', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'NKTR-214', 'category': 'PRODUCT'}, {'entity': 'BMS-986177', 'category': 'PRODUCT'}, {'entity': 'Prostvac', 'category': 'PRODUCT'}, {'entity': 'ONO-4578', 'category': 'PRODUCT'}, {'entity': 'ENHANZE', 'category': 'PRODUCT'}, {'entity': 'STING', 'category': 'PRODUCT'}, {'entity': 'NLRP3', 'category': 'PRODUCT'}, {'entity': 'BMS-986168', 'category': 'PRODUCT'}, {'entity': 'eTau', 'category': 'PRODUCT'}, {'entity': 'Progressive Supranuclear Palsy', 'category': 'PRODUCT'}, {'entity': 'BMS-986089', 'category': 'PRODUCT'}, {'entity': 'myostatin adnectin', 'category': 'PRODUCT'}, {'entity': 'Duchenne Muscular Dystrophy', 'category': 'PRODUCT'}, {'entity': 'Probody', 'category': 'PRODUCT'}, {'entity': 'NG-348', 'category': 'PRODUCT'}, {'entity': 'PAD inhibitor', 'category': 'PRODUCT'}, {'entity': 'HuMax-IL8', 'category': 'PRODUCT'}, {'entity': 'siRNA', 'category': 'PRODUCT'}, {'entity': 'heat shock protein 47', 'category': 'PRODUCT'}, {'entity': 'HSP47', 'category': 'PRODUCT'}, {'entity': 'ND-L02-s0201', 'category': 'PRODUCT'}, {'entity': '', 'category': 'TIME'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  14\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXFLaM8cdl3IE6P40UWjpK9j1Dcv\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701573347,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#2018#2017#2016#11#6#13#3#18#1#4#2#5#28#36#13#2#100\\n\\nDATE#Year Ended December 31#January 1, 2017#December 31, 2017#December 31, 2018\\n\\nGPE#United States#U.S.#Europe#Non-U.S.\\n\\nMONEY#$12,586#$11,358#$10,720#$5,658#$4,988#$4,215#$3,733#$3,877#$3,964#$584#$553#$528#$22,561#$20,776#$19,427#$126#$520#$1,160#$1,806#$2,087#$2,090#$2,135#$6,312#$2,004#$1,810#$2,107#$5,921#$3#$209#$796#$1,228#$2,233#$2,738#$3,258#$2,693#$8,689#$2,695#$2,960#$2,424#$8,079#$245#$1,061#$1,356#$2,662#$30,174#$25,499#$22,364#$2,735#$2,084#$1,582#$3,225#$2,086#$1,382#$2,633#$2,071#$1,698#$8,593#$6,241#$4,662#$21,581#$19,258#$17,702#$6,735#$4,948#$3,774#$4,239#$3,102#$2,664#$2,496#$1,846#$1,110#$6,438#$4,872#$3,343#$3,760#$2,887#$1,963#$2,678#$1,985#$1,380#$2,710#$2,479#$2,265#$1,875#$1,704#$1,532#$835#$775#$733#$2,000#$2,005#$1,824#$1,091#$1,105#$969#$909#$900#$855#$1,330#$1,244#$1,053#$941#$908#$802#$389#$336#$251#$247#$231#$150#$164#$151#$133#$83#$80#$17#$744#$1,052#$1,192#$32#$53#$66#$712#$999#$1,126#$427#$698#$912#$157#$327#$484#$270#$371#$428#$283#$729#$1,065#$27#$622#$901#$256#$107#$164#$17#$406#$1,578#$109#$827#$33#$297#$751#$1,630#$2,112#$2,271#$316#$390#$379#$1,314#$1,722#$1,892#$22,561#$20,776#$19,427#$12,586#$11,358#$10,720#$9,975#$9,418#$8,707\\n\\nORG#Opdivo#Eliquis#HIV#Europe#GTN#Critical Accounting Policies#Daklinza#HIV#Daklinza#GTN Adjustments\\n\\nPERCENT#9%#1%#7%#31%#32%#55%#51%#27%#22%#38%#34%#12%#9%#28%#24%#21%#4%#3%#36%#31%#5%#31%#16%#66%#32%#46%#30%#47%#35%#44%#9%#10%#11%#8%#6%#7%#18%#4%#13%#16%#34%#7%#54%#9%#14%#4%#29%#12%#40%#20%#29%#11%#39%#23%#52%#32%#27%#13%#61%#32%#96%#31%#35%#96%#74%#87%#89%#60%#23%#7%#19%#3%#24%#9%#6%#8%\\n\\nPRODUCT#Opdivo#Eliquis#Daklinza#Eliquis#Opdivo#Opdivo#Eliquis#Opdivo#Eliquis#Eliquis#Opdivo#Opdivo#Eliquis#Daklinza#Opdivo#Eliquis#Opdivo#Eliquis\\n\\nQUANTITY#10%#10%#10%#10%#10%#10%#100%\\n\\nTIME#Current period#Prior period#Current period#Prior period#Current period#Prior period}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 3500,\n",
      "    \"completion_tokens\": 1028,\n",
      "    \"total_tokens\": 4528\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': 'January 1, 2017', 'category': 'DATE'}, {'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Europe', 'category': 'GPE'}, {'entity': 'Non-U.S.', 'category': 'GPE'}, {'entity': '$12,586', 'category': 'MONEY'}, {'entity': '$11,358', 'category': 'MONEY'}, {'entity': '$10,720', 'category': 'MONEY'}, {'entity': '$5,658', 'category': 'MONEY'}, {'entity': '$4,988', 'category': 'MONEY'}, {'entity': '$4,215', 'category': 'MONEY'}, {'entity': '$3,733', 'category': 'MONEY'}, {'entity': '$3,877', 'category': 'MONEY'}, {'entity': '$3,964', 'category': 'MONEY'}, {'entity': '$584', 'category': 'MONEY'}, {'entity': '$553', 'category': 'MONEY'}, {'entity': '$528', 'category': 'MONEY'}, {'entity': '$22,561', 'category': 'MONEY'}, {'entity': '$20,776', 'category': 'MONEY'}, {'entity': '$19,427', 'category': 'MONEY'}, {'entity': '$126', 'category': 'MONEY'}, {'entity': '$520', 'category': 'MONEY'}, {'entity': '$1,160', 'category': 'MONEY'}, {'entity': '$1,806', 'category': 'MONEY'}, {'entity': '$2,087', 'category': 'MONEY'}, {'entity': '$2,090', 'category': 'MONEY'}, {'entity': '$2,135', 'category': 'MONEY'}, {'entity': '$6,312', 'category': 'MONEY'}, {'entity': '$2,004', 'category': 'MONEY'}, {'entity': '$1,810', 'category': 'MONEY'}, {'entity': '$2,107', 'category': 'MONEY'}, {'entity': '$5,921', 'category': 'MONEY'}, {'entity': '$3', 'category': 'MONEY'}, {'entity': '$209', 'category': 'MONEY'}, {'entity': '$796', 'category': 'MONEY'}, {'entity': '$1,228', 'category': 'MONEY'}, {'entity': '$2,233', 'category': 'MONEY'}, {'entity': '$2,738', 'category': 'MONEY'}, {'entity': '$3,258', 'category': 'MONEY'}, {'entity': '$2,693', 'category': 'MONEY'}, {'entity': '$8,689', 'category': 'MONEY'}, {'entity': '$2,695', 'category': 'MONEY'}, {'entity': '$2,960', 'category': 'MONEY'}, {'entity': '$2,424', 'category': 'MONEY'}, {'entity': '$8,079', 'category': 'MONEY'}, {'entity': '$245', 'category': 'MONEY'}, {'entity': '$1,061', 'category': 'MONEY'}, {'entity': '$1,356', 'category': 'MONEY'}, {'entity': '$2,662', 'category': 'MONEY'}, {'entity': '$30,174', 'category': 'MONEY'}, {'entity': '$25,499', 'category': 'MONEY'}, {'entity': '$22,364', 'category': 'MONEY'}, {'entity': '$2,735', 'category': 'MONEY'}, {'entity': '$2,084', 'category': 'MONEY'}, {'entity': '$1,582', 'category': 'MONEY'}, {'entity': '$3,225', 'category': 'MONEY'}, {'entity': '$2,086', 'category': 'MONEY'}, {'entity': '$1,382', 'category': 'MONEY'}, {'entity': '$2,633', 'category': 'MONEY'}, {'entity': '$2,071', 'category': 'MONEY'}, {'entity': '$1,698', 'category': 'MONEY'}, {'entity': '$8,593', 'category': 'MONEY'}, {'entity': '$6,241', 'category': 'MONEY'}, {'entity': '$4,662', 'category': 'MONEY'}, {'entity': '$21,581', 'category': 'MONEY'}, {'entity': '$19,258', 'category': 'MONEY'}, {'entity': '$17,702', 'category': 'MONEY'}, {'entity': '$6,735', 'category': 'MONEY'}, {'entity': '$4,948', 'category': 'MONEY'}, {'entity': '$3,774', 'category': 'MONEY'}, {'entity': '$4,239', 'category': 'MONEY'}, {'entity': '$3,102', 'category': 'MONEY'}, {'entity': '$2,664', 'category': 'MONEY'}, {'entity': '$2,496', 'category': 'MONEY'}, {'entity': '$1,846', 'category': 'MONEY'}, {'entity': '$1,110', 'category': 'MONEY'}, {'entity': '$6,438', 'category': 'MONEY'}, {'entity': '$4,872', 'category': 'MONEY'}, {'entity': '$3,343', 'category': 'MONEY'}, {'entity': '$3,760', 'category': 'MONEY'}, {'entity': '$2,887', 'category': 'MONEY'}, {'entity': '$1,963', 'category': 'MONEY'}, {'entity': '$2,678', 'category': 'MONEY'}, {'entity': '$1,985', 'category': 'MONEY'}, {'entity': '$1,380', 'category': 'MONEY'}, {'entity': '$2,710', 'category': 'MONEY'}, {'entity': '$2,479', 'category': 'MONEY'}, {'entity': '$2,265', 'category': 'MONEY'}, {'entity': '$1,875', 'category': 'MONEY'}, {'entity': '$1,704', 'category': 'MONEY'}, {'entity': '$1,532', 'category': 'MONEY'}, {'entity': '$835', 'category': 'MONEY'}, {'entity': '$775', 'category': 'MONEY'}, {'entity': '$733', 'category': 'MONEY'}, {'entity': '$2,000', 'category': 'MONEY'}, {'entity': '$2,005', 'category': 'MONEY'}, {'entity': '$1,824', 'category': 'MONEY'}, {'entity': '$1,091', 'category': 'MONEY'}, {'entity': '$1,105', 'category': 'MONEY'}, {'entity': '$969', 'category': 'MONEY'}, {'entity': '$909', 'category': 'MONEY'}, {'entity': '$900', 'category': 'MONEY'}, {'entity': '$855', 'category': 'MONEY'}, {'entity': '$1,330', 'category': 'MONEY'}, {'entity': '$1,244', 'category': 'MONEY'}, {'entity': '$1,053', 'category': 'MONEY'}, {'entity': '$941', 'category': 'MONEY'}, {'entity': '$908', 'category': 'MONEY'}, {'entity': '$802', 'category': 'MONEY'}, {'entity': '$389', 'category': 'MONEY'}, {'entity': '$336', 'category': 'MONEY'}, {'entity': '$251', 'category': 'MONEY'}, {'entity': '$247', 'category': 'MONEY'}, {'entity': '$231', 'category': 'MONEY'}, {'entity': '$150', 'category': 'MONEY'}, {'entity': '$164', 'category': 'MONEY'}, {'entity': '$151', 'category': 'MONEY'}, {'entity': '$133', 'category': 'MONEY'}, {'entity': '$83', 'category': 'MONEY'}, {'entity': '$80', 'category': 'MONEY'}, {'entity': '$17', 'category': 'MONEY'}, {'entity': '$744', 'category': 'MONEY'}, {'entity': '$1,052', 'category': 'MONEY'}, {'entity': '$1,192', 'category': 'MONEY'}, {'entity': '$32', 'category': 'MONEY'}, {'entity': '$53', 'category': 'MONEY'}, {'entity': '$66', 'category': 'MONEY'}, {'entity': '$712', 'category': 'MONEY'}, {'entity': '$999', 'category': 'MONEY'}, {'entity': '$1,126', 'category': 'MONEY'}, {'entity': '$427', 'category': 'MONEY'}, {'entity': '$698', 'category': 'MONEY'}, {'entity': '$912', 'category': 'MONEY'}, {'entity': '$157', 'category': 'MONEY'}, {'entity': '$327', 'category': 'MONEY'}, {'entity': '$484', 'category': 'MONEY'}, {'entity': '$270', 'category': 'MONEY'}, {'entity': '$371', 'category': 'MONEY'}, {'entity': '$428', 'category': 'MONEY'}, {'entity': '$283', 'category': 'MONEY'}, {'entity': '$729', 'category': 'MONEY'}, {'entity': '$1,065', 'category': 'MONEY'}, {'entity': '$27', 'category': 'MONEY'}, {'entity': '$622', 'category': 'MONEY'}, {'entity': '$901', 'category': 'MONEY'}, {'entity': '$256', 'category': 'MONEY'}, {'entity': '$107', 'category': 'MONEY'}, {'entity': '$164', 'category': 'MONEY'}, {'entity': '$17', 'category': 'MONEY'}, {'entity': '$406', 'category': 'MONEY'}, {'entity': '$1,578', 'category': 'MONEY'}, {'entity': '$109', 'category': 'MONEY'}, {'entity': '$827', 'category': 'MONEY'}, {'entity': '$33', 'category': 'MONEY'}, {'entity': '$297', 'category': 'MONEY'}, {'entity': '$751', 'category': 'MONEY'}, {'entity': '$1,630', 'category': 'MONEY'}, {'entity': '$2,112', 'category': 'MONEY'}, {'entity': '$2,271', 'category': 'MONEY'}, {'entity': '$316', 'category': 'MONEY'}, {'entity': '$390', 'category': 'MONEY'}, {'entity': '$379', 'category': 'MONEY'}, {'entity': '$1,314', 'category': 'MONEY'}, {'entity': '$1,722', 'category': 'MONEY'}, {'entity': '$1,892', 'category': 'MONEY'}, {'entity': '$22,561', 'category': 'MONEY'}, {'entity': '$20,776', 'category': 'MONEY'}, {'entity': '$19,427', 'category': 'MONEY'}, {'entity': '$12,586', 'category': 'MONEY'}, {'entity': '$11,358', 'category': 'MONEY'}, {'entity': '$10,720', 'category': 'MONEY'}, {'entity': '$9,975', 'category': 'MONEY'}, {'entity': '$9,418', 'category': 'MONEY'}, {'entity': '$8,707', 'category': 'MONEY'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'HIV', 'category': 'ORG'}, {'entity': 'Europe', 'category': 'ORG'}, {'entity': 'GTN', 'category': 'ORG'}, {'entity': 'Critical Accounting Policies', 'category': 'ORG'}, {'entity': 'Daklinza', 'category': 'ORG'}, {'entity': 'HIV', 'category': 'ORG'}, {'entity': 'Daklinza', 'category': 'ORG'}, {'entity': 'GTN Adjustments', 'category': 'ORG'}, {'entity': '9%', 'category': 'PERCENT'}, {'entity': '1%', 'category': 'PERCENT'}, {'entity': '7%', 'category': 'PERCENT'}, {'entity': '31%', 'category': 'PERCENT'}, {'entity': '32%', 'category': 'PERCENT'}, {'entity': '55%', 'category': 'PERCENT'}, {'entity': '51%', 'category': 'PERCENT'}, {'entity': '27%', 'category': 'PERCENT'}, {'entity': '22%', 'category': 'PERCENT'}, {'entity': '38%', 'category': 'PERCENT'}, {'entity': '34%', 'category': 'PERCENT'}, {'entity': '12%', 'category': 'PERCENT'}, {'entity': '9%', 'category': 'PERCENT'}, {'entity': '28%', 'category': 'PERCENT'}, {'entity': '24%', 'category': 'PERCENT'}, {'entity': '21%', 'category': 'PERCENT'}, {'entity': '4%', 'category': 'PERCENT'}, {'entity': '3%', 'category': 'PERCENT'}, {'entity': '36%', 'category': 'PERCENT'}, {'entity': '31%', 'category': 'PERCENT'}, {'entity': '5%', 'category': 'PERCENT'}, {'entity': '31%', 'category': 'PERCENT'}, {'entity': '16%', 'category': 'PERCENT'}, {'entity': '66%', 'category': 'PERCENT'}, {'entity': '32%', 'category': 'PERCENT'}, {'entity': '46%', 'category': 'PERCENT'}, {'entity': '30%', 'category': 'PERCENT'}, {'entity': '47%', 'category': 'PERCENT'}, {'entity': '35%', 'category': 'PERCENT'}, {'entity': '44%', 'category': 'PERCENT'}, {'entity': '9%', 'category': 'PERCENT'}, {'entity': '10%', 'category': 'PERCENT'}, {'entity': '11%', 'category': 'PERCENT'}, {'entity': '8%', 'category': 'PERCENT'}, {'entity': '6%', 'category': 'PERCENT'}, {'entity': '7%', 'category': 'PERCENT'}, {'entity': '18%', 'category': 'PERCENT'}, {'entity': '4%', 'category': 'PERCENT'}, {'entity': '13%', 'category': 'PERCENT'}, {'entity': '16%', 'category': 'PERCENT'}, {'entity': '34%', 'category': 'PERCENT'}, {'entity': '7%', 'category': 'PERCENT'}, {'entity': '54%', 'category': 'PERCENT'}, {'entity': '9%', 'category': 'PERCENT'}, {'entity': '14%', 'category': 'PERCENT'}, {'entity': '4%', 'category': 'PERCENT'}, {'entity': '29%', 'category': 'PERCENT'}, {'entity': '12%', 'category': 'PERCENT'}, {'entity': '40%', 'category': 'PERCENT'}, {'entity': '20%', 'category': 'PERCENT'}, {'entity': '29%', 'category': 'PERCENT'}, {'entity': '11%', 'category': 'PERCENT'}, {'entity': '39%', 'category': 'PERCENT'}, {'entity': '23%', 'category': 'PERCENT'}, {'entity': '52%', 'category': 'PERCENT'}, {'entity': '32%', 'category': 'PERCENT'}, {'entity': '27%', 'category': 'PERCENT'}, {'entity': '13%', 'category': 'PERCENT'}, {'entity': '61%', 'category': 'PERCENT'}, {'entity': '32%', 'category': 'PERCENT'}, {'entity': '96%', 'category': 'PERCENT'}, {'entity': '31%', 'category': 'PERCENT'}, {'entity': '35%', 'category': 'PERCENT'}, {'entity': '96%', 'category': 'PERCENT'}, {'entity': '74%', 'category': 'PERCENT'}, {'entity': '87%', 'category': 'PERCENT'}, {'entity': '89%', 'category': 'PERCENT'}, {'entity': '60%', 'category': 'PERCENT'}, {'entity': '23%', 'category': 'PERCENT'}, {'entity': '7%', 'category': 'PERCENT'}, {'entity': '19%', 'category': 'PERCENT'}, {'entity': '3%', 'category': 'PERCENT'}, {'entity': '24%', 'category': 'PERCENT'}, {'entity': '9%', 'category': 'PERCENT'}, {'entity': '6%', 'category': 'PERCENT'}, {'entity': '8%', 'category': 'PERCENT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Eliquis', 'category': 'PRODUCT'}, {'entity': 'Daklinza', 'category': 'PRODUCT'}, {'entity': 'Eliquis', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Eliquis', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Eliquis', 'category': 'PRODUCT'}, {'entity': 'Eliquis', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Eliquis', 'category': 'PRODUCT'}, {'entity': 'Daklinza', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Eliquis', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Eliquis', 'category': 'PRODUCT'}, {'entity': '10%', 'category': 'QUANTITY'}, {'entity': '10%', 'category': 'QUANTITY'}, {'entity': '10%', 'category': 'QUANTITY'}, {'entity': '10%', 'category': 'QUANTITY'}, {'entity': '10%', 'category': 'QUANTITY'}, {'entity': '10%', 'category': 'QUANTITY'}, {'entity': '100%', 'category': 'QUANTITY'}, {'entity': 'Current period', 'category': 'TIME'}, {'entity': 'Prior period', 'category': 'TIME'}, {'entity': 'Current period', 'category': 'TIME'}, {'entity': 'Prior period', 'category': 'TIME'}, {'entity': 'Current period', 'category': 'TIME'}, {'entity': 'Prior period', 'category': 'TIME'}, {'entity': '2018', 'category': 'CARDINAL'}, {'entity': '2017', 'category': 'CARDINAL'}, {'entity': '2016', 'category': 'CARDINAL'}, {'entity': '11', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '13', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '18', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '5', 'category': 'CARDINAL'}, {'entity': '28', 'category': 'CARDINAL'}, {'entity': '36', 'category': 'CARDINAL'}, {'entity': '13', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  14\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXGNTDwBl1wS17ussaHEA5HGoVSM\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701573411,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#2018#97% \\n\\nDATE#December 31, 2018#September 30, 2018#June 30, 2018\\n\\nEVENT#SEC Consent Order\\n\\nGPE#Europe#France#Canada#U.S.\\n\\nLAW#SEC Consent Order\\n\\nMONEY#204 million\\n\\nNORP#Canadian\\n\\nORG#Opdivo+Yervoy#Eliquis#Sprycel#U.S.#International#Gleevec#Yervoy#Baraclude#Reyataz#Tybost#Sustiva#Atripla#BMS#Daklinza#Sunvepra#OTC#Plavix#Abilify#Dafalgan#Efferalgan#Fervex\\n\\nPRODUCT#Opdivo+Yervoy combination#Gleevec#Opdivo+Yervoy combination therapy#Reyataz and Tybost#Sustiva#generic version of Sustiva#U.S. Atripla* royalty#Daklinza#Dafalgan#Efferalgan#Fervex\\n\\nTIME#2018\\n\\nWORK_OF_ART#Item 8. Financial Statements\\u2014Note 3. Alliances\\n}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2384,\n",
      "    \"completion_tokens\": 261,\n",
      "    \"total_tokens\": 2645\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': 'September 30, 2018', 'category': 'DATE'}, {'entity': 'June 30, 2018', 'category': 'DATE'}, {'entity': 'SEC Consent Order', 'category': 'EVENT'}, {'entity': 'Europe', 'category': 'GPE'}, {'entity': 'France', 'category': 'GPE'}, {'entity': 'Canada', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'SEC Consent Order', 'category': 'LAW'}, {'entity': '204 million', 'category': 'MONEY'}, {'entity': 'Canadian', 'category': 'NORP'}, {'entity': 'Opdivo+Yervoy', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'Sprycel', 'category': 'ORG'}, {'entity': 'U.S.', 'category': 'ORG'}, {'entity': 'International', 'category': 'ORG'}, {'entity': 'Gleevec', 'category': 'ORG'}, {'entity': 'Yervoy', 'category': 'ORG'}, {'entity': 'Baraclude', 'category': 'ORG'}, {'entity': 'Reyataz', 'category': 'ORG'}, {'entity': 'Tybost', 'category': 'ORG'}, {'entity': 'Sustiva', 'category': 'ORG'}, {'entity': 'Atripla', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Daklinza', 'category': 'ORG'}, {'entity': 'Sunvepra', 'category': 'ORG'}, {'entity': 'OTC', 'category': 'ORG'}, {'entity': 'Plavix', 'category': 'ORG'}, {'entity': 'Abilify', 'category': 'ORG'}, {'entity': 'Dafalgan', 'category': 'ORG'}, {'entity': 'Efferalgan', 'category': 'ORG'}, {'entity': 'Fervex', 'category': 'ORG'}, {'entity': 'Opdivo+Yervoy combination', 'category': 'PRODUCT'}, {'entity': 'Gleevec', 'category': 'PRODUCT'}, {'entity': 'Opdivo+Yervoy combination therapy', 'category': 'PRODUCT'}, {'entity': 'Reyataz and Tybost', 'category': 'PRODUCT'}, {'entity': 'Sustiva', 'category': 'PRODUCT'}, {'entity': 'generic version of Sustiva', 'category': 'PRODUCT'}, {'entity': 'U.S. Atripla* royalty', 'category': 'PRODUCT'}, {'entity': 'Daklinza', 'category': 'PRODUCT'}, {'entity': 'Dafalgan', 'category': 'PRODUCT'}, {'entity': 'Efferalgan', 'category': 'PRODUCT'}, {'entity': 'Fervex', 'category': 'PRODUCT'}, {'entity': '2018', 'category': 'TIME'}, {'entity': 'Item 8. Financial Statements—Note 3. Alliances', 'category': 'WORK_OF_ART'}, {'entity': '2018', 'category': 'CARDINAL'}, {'entity': '97%', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  14\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXGw8fh6DpsVmTIguEjZj5vaMCx8\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701573446,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#6,547#6,094#4,969#4,551#4,751#4,979#6,345#6,482#5,012#16,593#15,645#13,512#905#146#753#1,050#60#25#1,135#75#79#1,214#1,588#535\\n\\nDATE#the year ended December 31, 2018\\n\\nFAC#R&D facility in Wallingford, Connecticut\\n\\nGPE#Swords#Ireland\\n\\nMONEY#$905 million#$146 million#$753 million\\n\\nORG#Eliquis#Daklinza#Nektar#Cormorant#IFM#CytomX#Halozyme#Flexus#Cardioxyl#PsiOxus#Ono#Padlock#Nitto Denko#F-Star\\n\\nPERSON#BMS\\n\\nPRODUCT#Opdivo#NKTR-214#IO\\n\\nTIME#2020\\n\\nWORK_OF_ART#2018 Form 10-K}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2390,\n",
      "    \"completion_tokens\": 223,\n",
      "    \"total_tokens\": 2613\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'the year ended December 31', 'category': 'DATE'}, {'entity': '2018', 'category': 'DATE'}, {'entity': 'R&D facility in Wallingford', 'category': 'FAC'}, {'entity': 'Connecticut', 'category': 'FAC'}, {'entity': 'Swords', 'category': 'GPE'}, {'entity': 'Ireland', 'category': 'GPE'}, {'entity': '$905 million', 'category': 'MONEY'}, {'entity': '$146 million', 'category': 'MONEY'}, {'entity': '$753 million', 'category': 'MONEY'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'Daklinza', 'category': 'ORG'}, {'entity': 'Nektar', 'category': 'ORG'}, {'entity': 'Cormorant', 'category': 'ORG'}, {'entity': 'IFM', 'category': 'ORG'}, {'entity': 'CytomX', 'category': 'ORG'}, {'entity': 'Halozyme', 'category': 'ORG'}, {'entity': 'Flexus', 'category': 'ORG'}, {'entity': 'Cardioxyl', 'category': 'ORG'}, {'entity': 'PsiOxus', 'category': 'ORG'}, {'entity': 'Ono', 'category': 'ORG'}, {'entity': 'Padlock', 'category': 'ORG'}, {'entity': 'Nitto Denko', 'category': 'ORG'}, {'entity': 'F-Star', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'NKTR-214', 'category': 'PRODUCT'}, {'entity': 'IO', 'category': 'PRODUCT'}, {'entity': '2020', 'category': 'TIME'}, {'entity': '2018 Form 10-K', 'category': 'WORK_OF_ART'}, {'entity': '6,547', 'category': 'CARDINAL'}, {'entity': '6,094', 'category': 'CARDINAL'}, {'entity': '4,969', 'category': 'CARDINAL'}, {'entity': '4,551', 'category': 'CARDINAL'}, {'entity': '4,751', 'category': 'CARDINAL'}, {'entity': '4,979', 'category': 'CARDINAL'}, {'entity': '6,345', 'category': 'CARDINAL'}, {'entity': '6,482', 'category': 'CARDINAL'}, {'entity': '5,012', 'category': 'CARDINAL'}, {'entity': '16,593', 'category': 'CARDINAL'}, {'entity': '15,645', 'category': 'CARDINAL'}, {'entity': '13,512', 'category': 'CARDINAL'}, {'entity': '905', 'category': 'CARDINAL'}, {'entity': '146', 'category': 'CARDINAL'}, {'entity': '753', 'category': 'CARDINAL'}, {'entity': '1,050', 'category': 'CARDINAL'}, {'entity': '60', 'category': 'CARDINAL'}, {'entity': '25', 'category': 'CARDINAL'}, {'entity': '1,135', 'category': 'CARDINAL'}, {'entity': '75', 'category': 'CARDINAL'}, {'entity': '79', 'category': 'CARDINAL'}, {'entity': '1,214', 'category': 'CARDINAL'}, {'entity': '1,588', 'category': 'CARDINAL'}, {'entity': '535', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  14\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXHUBInMf5pPX3LN6Gld1OLqrUmr\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701573480,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#183#196#167#173#126#97#512#23#37#131#293#109#76#487#47#93#75#77#178#164#576#1,353#1,351#719#12#37#238#27#1#72#64#20#16#44#850#1,682#1,448#534#268#826#481#70#42#50#25#121#162#92#64#109#5,968#5,131#5,915#1,021#4,156#1,408#17.1#81.0#23.8#60.0#1.8#35#21#2.9#56.7#2.6#15.5#8.0#285#21#56#0.9#3.3#1.8#3.9#1.0#7#8 \\n\\nDATE#Year Ended December 31#2018#2017#2016#December 22, 2017#the fourth quarter of 2017#December 31, 2017#2018\\n\\nEVENT#Tax Cuts and Jobs Act of 2017\\n\\nGPE#U.S.\\n\\nLAW#the Act#the Tax Cuts and Jobs Act of 2017\\n\\nMONEY#$534 million#$268 million#$826 million#$481 million#$70 million#$42 million#$50 million#$25 million#$121 million#$162 million#$92 million#$64 million#$109 million#$5,968 million#$5,131 million#$5,915 million#$1,021 million#$4,156 million#$1,408 million\\n \\nORG#Company#Nektar#BMS#Merck#Keytruda*#Biogen#Roche#Erbitux* #diabetes#HIV\\n\\nPERCENT#15%\\n\\nPERSON#ZymoGenetics}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2478,\n",
      "    \"completion_tokens\": 412,\n",
      "    \"total_tokens\": 2890\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': '2018', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': 'December 22, 2017', 'category': 'DATE'}, {'entity': 'the fourth quarter of 2017', 'category': 'DATE'}, {'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': '2018', 'category': 'DATE'}, {'entity': 'Tax Cuts and Jobs Act of 2017', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'the Act', 'category': 'LAW'}, {'entity': 'the Tax Cuts and Jobs Act of 2017', 'category': 'LAW'}, {'entity': '$534 million', 'category': 'MONEY'}, {'entity': '$268 million', 'category': 'MONEY'}, {'entity': '$826 million', 'category': 'MONEY'}, {'entity': '$481 million', 'category': 'MONEY'}, {'entity': '$70 million', 'category': 'MONEY'}, {'entity': '$42 million', 'category': 'MONEY'}, {'entity': '$50 million', 'category': 'MONEY'}, {'entity': '$25 million', 'category': 'MONEY'}, {'entity': '$121 million', 'category': 'MONEY'}, {'entity': '$162 million', 'category': 'MONEY'}, {'entity': '$92 million', 'category': 'MONEY'}, {'entity': '$64 million', 'category': 'MONEY'}, {'entity': '$109 million', 'category': 'MONEY'}, {'entity': '$5,968 million', 'category': 'MONEY'}, {'entity': '$5,131 million', 'category': 'MONEY'}, {'entity': '$5,915 million', 'category': 'MONEY'}, {'entity': '$1,021 million', 'category': 'MONEY'}, {'entity': '$4,156 million', 'category': 'MONEY'}, {'entity': '$1,408 million', 'category': 'MONEY'}, {'entity': 'Company', 'category': 'ORG'}, {'entity': 'Nektar', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Merck', 'category': 'ORG'}, {'entity': 'Keytruda*', 'category': 'ORG'}, {'entity': 'Biogen', 'category': 'ORG'}, {'entity': 'Roche', 'category': 'ORG'}, {'entity': 'Erbitux*', 'category': 'ORG'}, {'entity': 'diabetes', 'category': 'ORG'}, {'entity': 'HIV', 'category': 'ORG'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': 'ZymoGenetics', 'category': 'PERSON'}, {'entity': '183', 'category': 'CARDINAL'}, {'entity': '196', 'category': 'CARDINAL'}, {'entity': '167', 'category': 'CARDINAL'}, {'entity': '173', 'category': 'CARDINAL'}, {'entity': '126', 'category': 'CARDINAL'}, {'entity': '97', 'category': 'CARDINAL'}, {'entity': '512', 'category': 'CARDINAL'}, {'entity': '23', 'category': 'CARDINAL'}, {'entity': '37', 'category': 'CARDINAL'}, {'entity': '131', 'category': 'CARDINAL'}, {'entity': '293', 'category': 'CARDINAL'}, {'entity': '109', 'category': 'CARDINAL'}, {'entity': '76', 'category': 'CARDINAL'}, {'entity': '487', 'category': 'CARDINAL'}, {'entity': '47', 'category': 'CARDINAL'}, {'entity': '93', 'category': 'CARDINAL'}, {'entity': '75', 'category': 'CARDINAL'}, {'entity': '77', 'category': 'CARDINAL'}, {'entity': '178', 'category': 'CARDINAL'}, {'entity': '164', 'category': 'CARDINAL'}, {'entity': '576', 'category': 'CARDINAL'}, {'entity': '1,353', 'category': 'CARDINAL'}, {'entity': '1,351', 'category': 'CARDINAL'}, {'entity': '719', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '37', 'category': 'CARDINAL'}, {'entity': '238', 'category': 'CARDINAL'}, {'entity': '27', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '72', 'category': 'CARDINAL'}, {'entity': '64', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '16', 'category': 'CARDINAL'}, {'entity': '44', 'category': 'CARDINAL'}, {'entity': '850', 'category': 'CARDINAL'}, {'entity': '1,682', 'category': 'CARDINAL'}, {'entity': '1,448', 'category': 'CARDINAL'}, {'entity': '534', 'category': 'CARDINAL'}, {'entity': '268', 'category': 'CARDINAL'}, {'entity': '826', 'category': 'CARDINAL'}, {'entity': '481', 'category': 'CARDINAL'}, {'entity': '70', 'category': 'CARDINAL'}, {'entity': '42', 'category': 'CARDINAL'}, {'entity': '50', 'category': 'CARDINAL'}, {'entity': '25', 'category': 'CARDINAL'}, {'entity': '121', 'category': 'CARDINAL'}, {'entity': '162', 'category': 'CARDINAL'}, {'entity': '92', 'category': 'CARDINAL'}, {'entity': '64', 'category': 'CARDINAL'}, {'entity': '109', 'category': 'CARDINAL'}, {'entity': '5,968', 'category': 'CARDINAL'}, {'entity': '5,131', 'category': 'CARDINAL'}, {'entity': '5,915', 'category': 'CARDINAL'}, {'entity': '1,021', 'category': 'CARDINAL'}, {'entity': '4,156', 'category': 'CARDINAL'}, {'entity': '1,408', 'category': 'CARDINAL'}, {'entity': '17.1', 'category': 'CARDINAL'}, {'entity': '81.0', 'category': 'CARDINAL'}, {'entity': '23.8', 'category': 'CARDINAL'}, {'entity': '60.0', 'category': 'CARDINAL'}, {'entity': '1.8', 'category': 'CARDINAL'}, {'entity': '35', 'category': 'CARDINAL'}, {'entity': '21', 'category': 'CARDINAL'}, {'entity': '2.9', 'category': 'CARDINAL'}, {'entity': '56.7', 'category': 'CARDINAL'}, {'entity': '2.6', 'category': 'CARDINAL'}, {'entity': '15.5', 'category': 'CARDINAL'}, {'entity': '8.0', 'category': 'CARDINAL'}, {'entity': '285', 'category': 'CARDINAL'}, {'entity': '21', 'category': 'CARDINAL'}, {'entity': '56', 'category': 'CARDINAL'}, {'entity': '0.9', 'category': 'CARDINAL'}, {'entity': '3.3', 'category': 'CARDINAL'}, {'entity': '1.8', 'category': 'CARDINAL'}, {'entity': '3.9', 'category': 'CARDINAL'}, {'entity': '1.0', 'category': 'CARDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '8', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  14\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXIAlfht2mVMXiQoauOk394WqsWU\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701573522,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#1#2#33.5#8#1#4#3#364\\nDATE#Year Ended December 31#2018#2017#2016#2018#2017#2016#Year Ended December 31#2018#2017#2016#December 31, 2018#December 31, 2018#December 31, 2018#year#2018#2018#December 31, 2018\\nEVENT#U.S. tax reform\\nGPE#U.S.#Ireland\\nMONEY#$\\t17#$\\t146#$\\t41#$\\t21#$\\t58#$\\t149#$\\t21#$\\t1,135#$\\t1,130#$\\t439#$\\t512#$\\t131#$\\t293#$\\t109#$\\t70#481#40#177#126#559#75#497#10#121#162#91#64#15#109#646#540#314#1,920#1,198#242#268#87#51#56#2,911#324#2,824#51#1,596#4,022#293#3,963#293#4,920#1,007#4,457#1,596#3,963#293#6,516#4,970#4,750#1,652#1,680#3.01#0.61#2.65#0.97#2.40#0.18#3.98#3.01#2.83#6,911#5,421#1,973#1,391#1,775#2,480#10,659#9,292#1,703#987#5,646#6,975#3,310#1,330#9.3 billion#1.4 billion#2019#1.3 billion#19 million#1.27%#300 million#2.6 billion#2.5 billion#1.0 billion#1.1 billion#1.2 billion#800 million#600 million#1.85 billion#8.3 million#4.8%#5.0 billion#2.0 billion#1.5 billion#1.5 billion#33.5 billion#8 billion#1 billion#4 billion#3 billion\\nORG#BMS#U.S.#GAAP#GAAP#GAAP#Board of Directors#Nektar#Item 8. Financial Statements and Supplementary Data\\u2014Note 9. Financial Instruments and Fair Value Measurements#GAAP#Celgene\\nPERCENT#1.27%\\nTIME#364-day#364-day#five-year#five-year#364-day#364-day#three-year#five-year\\nWORK_OF_ART#Diluted Non-GAAP}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2610,\n",
      "    \"completion_tokens\": 592,\n",
      "    \"total_tokens\": 3202\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': '2018', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2018', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': '2018', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': 'year', 'category': 'DATE'}, {'entity': '2018', 'category': 'DATE'}, {'entity': '2018', 'category': 'DATE'}, {'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': 'U.S. tax reform', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Ireland', 'category': 'GPE'}, {'entity': '$\\t17', 'category': 'MONEY'}, {'entity': '$\\t146', 'category': 'MONEY'}, {'entity': '$\\t41', 'category': 'MONEY'}, {'entity': '$\\t21', 'category': 'MONEY'}, {'entity': '$\\t58', 'category': 'MONEY'}, {'entity': '$\\t149', 'category': 'MONEY'}, {'entity': '$\\t21', 'category': 'MONEY'}, {'entity': '$\\t1,135', 'category': 'MONEY'}, {'entity': '$\\t1,130', 'category': 'MONEY'}, {'entity': '$\\t439', 'category': 'MONEY'}, {'entity': '$\\t512', 'category': 'MONEY'}, {'entity': '$\\t131', 'category': 'MONEY'}, {'entity': '$\\t293', 'category': 'MONEY'}, {'entity': '$\\t109', 'category': 'MONEY'}, {'entity': '$\\t70', 'category': 'MONEY'}, {'entity': '481', 'category': 'MONEY'}, {'entity': '40', 'category': 'MONEY'}, {'entity': '177', 'category': 'MONEY'}, {'entity': '126', 'category': 'MONEY'}, {'entity': '559', 'category': 'MONEY'}, {'entity': '75', 'category': 'MONEY'}, {'entity': '497', 'category': 'MONEY'}, {'entity': '10', 'category': 'MONEY'}, {'entity': '121', 'category': 'MONEY'}, {'entity': '162', 'category': 'MONEY'}, {'entity': '91', 'category': 'MONEY'}, {'entity': '64', 'category': 'MONEY'}, {'entity': '15', 'category': 'MONEY'}, {'entity': '109', 'category': 'MONEY'}, {'entity': '646', 'category': 'MONEY'}, {'entity': '540', 'category': 'MONEY'}, {'entity': '314', 'category': 'MONEY'}, {'entity': '1,920', 'category': 'MONEY'}, {'entity': '1,198', 'category': 'MONEY'}, {'entity': '242', 'category': 'MONEY'}, {'entity': '268', 'category': 'MONEY'}, {'entity': '87', 'category': 'MONEY'}, {'entity': '51', 'category': 'MONEY'}, {'entity': '56', 'category': 'MONEY'}, {'entity': '2,911', 'category': 'MONEY'}, {'entity': '324', 'category': 'MONEY'}, {'entity': '2,824', 'category': 'MONEY'}, {'entity': '51', 'category': 'MONEY'}, {'entity': '1,596', 'category': 'MONEY'}, {'entity': '4,022', 'category': 'MONEY'}, {'entity': '293', 'category': 'MONEY'}, {'entity': '3,963', 'category': 'MONEY'}, {'entity': '293', 'category': 'MONEY'}, {'entity': '4,920', 'category': 'MONEY'}, {'entity': '1,007', 'category': 'MONEY'}, {'entity': '4,457', 'category': 'MONEY'}, {'entity': '1,596', 'category': 'MONEY'}, {'entity': '3,963', 'category': 'MONEY'}, {'entity': '293', 'category': 'MONEY'}, {'entity': '6,516', 'category': 'MONEY'}, {'entity': '4,970', 'category': 'MONEY'}, {'entity': '4,750', 'category': 'MONEY'}, {'entity': '1,652', 'category': 'MONEY'}, {'entity': '1,680', 'category': 'MONEY'}, {'entity': '3.01', 'category': 'MONEY'}, {'entity': '0.61', 'category': 'MONEY'}, {'entity': '2.65', 'category': 'MONEY'}, {'entity': '0.97', 'category': 'MONEY'}, {'entity': '2.40', 'category': 'MONEY'}, {'entity': '0.18', 'category': 'MONEY'}, {'entity': '3.98', 'category': 'MONEY'}, {'entity': '3.01', 'category': 'MONEY'}, {'entity': '2.83', 'category': 'MONEY'}, {'entity': '6,911', 'category': 'MONEY'}, {'entity': '5,421', 'category': 'MONEY'}, {'entity': '1,973', 'category': 'MONEY'}, {'entity': '1,391', 'category': 'MONEY'}, {'entity': '1,775', 'category': 'MONEY'}, {'entity': '2,480', 'category': 'MONEY'}, {'entity': '10,659', 'category': 'MONEY'}, {'entity': '9,292', 'category': 'MONEY'}, {'entity': '1,703', 'category': 'MONEY'}, {'entity': '987', 'category': 'MONEY'}, {'entity': '5,646', 'category': 'MONEY'}, {'entity': '6,975', 'category': 'MONEY'}, {'entity': '3,310', 'category': 'MONEY'}, {'entity': '1,330', 'category': 'MONEY'}, {'entity': '9.3 billion', 'category': 'MONEY'}, {'entity': '1.4 billion', 'category': 'MONEY'}, {'entity': '2019', 'category': 'MONEY'}, {'entity': '1.3 billion', 'category': 'MONEY'}, {'entity': '19 million', 'category': 'MONEY'}, {'entity': '1.27%', 'category': 'MONEY'}, {'entity': '300 million', 'category': 'MONEY'}, {'entity': '2.6 billion', 'category': 'MONEY'}, {'entity': '2.5 billion', 'category': 'MONEY'}, {'entity': '1.0 billion', 'category': 'MONEY'}, {'entity': '1.1 billion', 'category': 'MONEY'}, {'entity': '1.2 billion', 'category': 'MONEY'}, {'entity': '800 million', 'category': 'MONEY'}, {'entity': '600 million', 'category': 'MONEY'}, {'entity': '1.85 billion', 'category': 'MONEY'}, {'entity': '8.3 million', 'category': 'MONEY'}, {'entity': '4.8%', 'category': 'MONEY'}, {'entity': '5.0 billion', 'category': 'MONEY'}, {'entity': '2.0 billion', 'category': 'MONEY'}, {'entity': '1.5 billion', 'category': 'MONEY'}, {'entity': '1.5 billion', 'category': 'MONEY'}, {'entity': '33.5 billion', 'category': 'MONEY'}, {'entity': '8 billion', 'category': 'MONEY'}, {'entity': '1 billion', 'category': 'MONEY'}, {'entity': '4 billion', 'category': 'MONEY'}, {'entity': '3 billion', 'category': 'MONEY'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'U.S.', 'category': 'ORG'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': 'Board of Directors', 'category': 'ORG'}, {'entity': 'Nektar', 'category': 'ORG'}, {'entity': 'Item 8. Financial Statements and Supplementary Data—Note 9. Financial Instruments and Fair Value Measurements', 'category': 'ORG'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': '1.27%', 'category': 'PERCENT'}, {'entity': '364-day', 'category': 'TIME'}, {'entity': '364-day', 'category': 'TIME'}, {'entity': 'five-year', 'category': 'TIME'}, {'entity': 'five-year', 'category': 'TIME'}, {'entity': '364-day', 'category': 'TIME'}, {'entity': '364-day', 'category': 'TIME'}, {'entity': 'three-year', 'category': 'TIME'}, {'entity': 'five-year', 'category': 'TIME'}, {'entity': 'Diluted Non-GAAP', 'category': 'WORK_OF_ART'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '33.5', 'category': 'CARDINAL'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '364', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  14\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXIvZgoH458hh6FuLzF4dyzQwPSG\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701573569,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL:$25.5 billion#$3.0 billion#364-day $2.0 billion#three-year $1.0 billion#February 25, 2019#$7.6 billion#10 and 30 years#less than 3%#$5,940#$5,275#$3,058#(874)#(66)#1,480#(3,535)#(4,077)#(2,653)#90 days to 120 days#$700 million#$2.2 billion#approximately $600 million#$500 million#$400 million#$2.2 billion#approximately $400 million#$1.5 billion#$500 million#$500 million#approximately $400 million#approximately $300 million#$800 million#$900 million#$500 million#8.3 million\\n\\nDATE:January 2019#January 2020#January 2022#June 2016#2018#2017#2016\\n\\nEVENT:the UK voted to depart from the EU\\n\\nFAC:the bridge facility#under the bridge\\n\\nGPE:U.S.#EU#UK#Ireland\\n\\nMONEY:$1.0 billion#two $1.5 billion\\n\\nNORP:BMS's\\n\\nORG:Moody's#Standard & Poor's#Moody's Investors Service#BMS#Celgene#A2 and Prime-1#A+ and A-1+\\n\\nPERCENT:Prime-1\\n\\nPRODUCT:the bridge loan#the term loan#the pending acquisition of Celgene#two new revolving credit facilities#the new 364-day facility#commercial paper borrowings#interest rate swap option contracts (swaptions)#interest rate risk#interest rate#credit ratings#long-term and short-term credit ratings#long-term debt#acquisition of Celgene#credit rating downgrade#interest rate of any debt#fair market value of existing debt#cash flows#Operating ActivitiesCash flow#investing activities#financing activities#operating activities#net earnings#noncontrolling interest#non-cash operating items#gains and losses#operating assets and liabilities#cash collections from customers#alliance partners#payments to suppliers#customer discounts and rebates#tax payments#cash flow from operating activities#higher cash collections#timing of payments#ordinary course of business#R&D licensing#collaboration payments#Nektar transaction#litigation settlement proceeds#Merck settlement#out-license proceeds#Biogen and Roche transactions#income tax payments#pension plans contributions#CytomX#Halozyme#Nitto Denko transactions#cash requirements from investing activities#cash used for acquisitions#manufacturing and facility-related capital expenditures#business divestitures#include royalties#sales and maturities of marketable securities#business divestiture proceeds#divestiture of manufacturing operations#Swords, Ireland#mature brands\\n\\nPERSON:BMS's\\n\\nTIME:first quarter}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2226,\n",
      "    \"completion_tokens\": 594,\n",
      "    \"total_tokens\": 2820\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'January 2019', 'category': 'DATE'}, {'entity': 'January 2020', 'category': 'DATE'}, {'entity': 'January 2022', 'category': 'DATE'}, {'entity': 'June 2016', 'category': 'DATE'}, {'entity': '2018', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': 'the UK voted to depart from the EU', 'category': 'EVENT'}, {'entity': 'the bridge facility', 'category': 'FAC'}, {'entity': 'under the bridge', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'EU', 'category': 'GPE'}, {'entity': 'UK', 'category': 'GPE'}, {'entity': 'Ireland', 'category': 'GPE'}, {'entity': '$1.0 billion', 'category': 'MONEY'}, {'entity': 'two $1.5 billion', 'category': 'MONEY'}, {'entity': 'BMSs', 'category': 'NORP'}, {'entity': 'Moodys', 'category': 'ORG'}, {'entity': 'Standard & Poors', 'category': 'ORG'}, {'entity': 'Moodys Investors Service', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': 'A2 and Prime-1', 'category': 'ORG'}, {'entity': 'A+ and A-1+', 'category': 'ORG'}, {'entity': 'Prime-1', 'category': 'PERCENT'}, {'entity': 'BMSs', 'category': 'PERSON'}, {'entity': 'the bridge loan', 'category': 'PRODUCT'}, {'entity': 'the term loan', 'category': 'PRODUCT'}, {'entity': 'the pending acquisition of Celgene', 'category': 'PRODUCT'}, {'entity': 'two new revolving credit facilities', 'category': 'PRODUCT'}, {'entity': 'the new 364-day facility', 'category': 'PRODUCT'}, {'entity': 'commercial paper borrowings', 'category': 'PRODUCT'}, {'entity': 'interest rate swap option contracts swaptions', 'category': 'PRODUCT'}, {'entity': 'interest rate risk', 'category': 'PRODUCT'}, {'entity': 'interest rate', 'category': 'PRODUCT'}, {'entity': 'credit ratings', 'category': 'PRODUCT'}, {'entity': 'long-term and short-term credit ratings', 'category': 'PRODUCT'}, {'entity': 'long-term debt', 'category': 'PRODUCT'}, {'entity': 'acquisition of Celgene', 'category': 'PRODUCT'}, {'entity': 'credit rating downgrade', 'category': 'PRODUCT'}, {'entity': 'interest rate of any debt', 'category': 'PRODUCT'}, {'entity': 'fair market value of existing debt', 'category': 'PRODUCT'}, {'entity': 'cash flows', 'category': 'PRODUCT'}, {'entity': 'Operating ActivitiesCash flow', 'category': 'PRODUCT'}, {'entity': 'investing activities', 'category': 'PRODUCT'}, {'entity': 'financing activities', 'category': 'PRODUCT'}, {'entity': 'operating activities', 'category': 'PRODUCT'}, {'entity': 'net earnings', 'category': 'PRODUCT'}, {'entity': 'noncontrolling interest', 'category': 'PRODUCT'}, {'entity': 'non-cash operating items', 'category': 'PRODUCT'}, {'entity': 'gains and losses', 'category': 'PRODUCT'}, {'entity': 'operating assets and liabilities', 'category': 'PRODUCT'}, {'entity': 'cash collections from customers', 'category': 'PRODUCT'}, {'entity': 'alliance partners', 'category': 'PRODUCT'}, {'entity': 'payments to suppliers', 'category': 'PRODUCT'}, {'entity': 'customer discounts and rebates', 'category': 'PRODUCT'}, {'entity': 'tax payments', 'category': 'PRODUCT'}, {'entity': 'cash flow from operating activities', 'category': 'PRODUCT'}, {'entity': 'higher cash collections', 'category': 'PRODUCT'}, {'entity': 'timing of payments', 'category': 'PRODUCT'}, {'entity': 'ordinary course of business', 'category': 'PRODUCT'}, {'entity': 'R&D licensing', 'category': 'PRODUCT'}, {'entity': 'collaboration payments', 'category': 'PRODUCT'}, {'entity': 'Nektar transaction', 'category': 'PRODUCT'}, {'entity': 'litigation settlement proceeds', 'category': 'PRODUCT'}, {'entity': 'Merck settlement', 'category': 'PRODUCT'}, {'entity': 'out-license proceeds', 'category': 'PRODUCT'}, {'entity': 'Biogen and Roche transactions', 'category': 'PRODUCT'}, {'entity': 'income tax payments', 'category': 'PRODUCT'}, {'entity': 'pension plans contributions', 'category': 'PRODUCT'}, {'entity': 'CytomX', 'category': 'PRODUCT'}, {'entity': 'Halozyme', 'category': 'PRODUCT'}, {'entity': 'Nitto Denko transactions', 'category': 'PRODUCT'}, {'entity': 'cash requirements from investing activities', 'category': 'PRODUCT'}, {'entity': 'cash used for acquisitions', 'category': 'PRODUCT'}, {'entity': 'manufacturing and facility-related capital expenditures', 'category': 'PRODUCT'}, {'entity': 'business divestitures', 'category': 'PRODUCT'}, {'entity': 'include royalties', 'category': 'PRODUCT'}, {'entity': 'sales and maturities of marketable securities', 'category': 'PRODUCT'}, {'entity': 'business divestiture proceeds', 'category': 'PRODUCT'}, {'entity': 'divestiture of manufacturing operations', 'category': 'PRODUCT'}, {'entity': 'Swords, Ireland', 'category': 'PRODUCT'}, {'entity': 'mature brands', 'category': 'PRODUCT'}, {'entity': 'first quarter', 'category': 'TIME'}, {'entity': '$25.5 billion', 'category': 'CARDINAL'}, {'entity': '$3.0 billion', 'category': 'CARDINAL'}, {'entity': '364-day $2.0 billion', 'category': 'CARDINAL'}, {'entity': 'three-year $1.0 billion', 'category': 'CARDINAL'}, {'entity': 'February 25, 2019', 'category': 'CARDINAL'}, {'entity': '$7.6 billion', 'category': 'CARDINAL'}, {'entity': '10 and 30 years', 'category': 'CARDINAL'}, {'entity': 'less than 3%', 'category': 'CARDINAL'}, {'entity': '$5,940', 'category': 'CARDINAL'}, {'entity': '$5,275', 'category': 'CARDINAL'}, {'entity': '$3,058', 'category': 'CARDINAL'}, {'entity': '874', 'category': 'CARDINAL'}, {'entity': '66', 'category': 'CARDINAL'}, {'entity': '1,480', 'category': 'CARDINAL'}, {'entity': '3,535', 'category': 'CARDINAL'}, {'entity': '4,077', 'category': 'CARDINAL'}, {'entity': '2,653', 'category': 'CARDINAL'}, {'entity': '90 days to 120 days', 'category': 'CARDINAL'}, {'entity': '$700 million', 'category': 'CARDINAL'}, {'entity': '$2.2 billion', 'category': 'CARDINAL'}, {'entity': 'approximately $600 million', 'category': 'CARDINAL'}, {'entity': '$500 million', 'category': 'CARDINAL'}, {'entity': '$400 million', 'category': 'CARDINAL'}, {'entity': '$2.2 billion', 'category': 'CARDINAL'}, {'entity': 'approximately $400 million', 'category': 'CARDINAL'}, {'entity': '$1.5 billion', 'category': 'CARDINAL'}, {'entity': '$500 million', 'category': 'CARDINAL'}, {'entity': '$500 million', 'category': 'CARDINAL'}, {'entity': 'approximately $400 million', 'category': 'CARDINAL'}, {'entity': 'approximately $300 million', 'category': 'CARDINAL'}, {'entity': '$800 million', 'category': 'CARDINAL'}, {'entity': '$900 million', 'category': 'CARDINAL'}, {'entity': '$500 million', 'category': 'CARDINAL'}, {'entity': '8.3 million', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  14\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXJgDMDVH9mIcPaGH2a1z0LrjTCY\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701573616,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#500#2.1#1.5#1.4#2.2#900#14.0#5.5#8.5#4.4#100#97\\n\\nDATE#2016#2017#December 31, 2018#August 4, 2004#September 30, 2004\\n\\nFAC#SEC Consent Order\\n\\nGPE#U.S.\\n\\nMONEY#$300 million#$500 million#$2.1 billion#$1.5 billion#$1.4 billion#$2.2 billion#$900 million#$14.0 billion#$5.5 billion#$8.5 billion#$4.4 billion\\n\\nORG#IFM#SEC#Alliances\\n\\nPERSON#\\n\\nTIME#\\n\\nDATE#\\n\\nWORK_OF_ART#\\u201cItem 8. Financial Statements and Supplementary Data\\u2014Note 3. Alliances\\u201d#\\u201cItem 8. Financial Statements and Supplementary Data\\u2014Note 1. Accounting Policies and Recently Issued Accounting Standards.\\n\\nLAW#FCPA Settlement\\n\\nPRODUCT#HIV medicines\\n\\nEVENT#accelerated share repurchase agreements\\n\\nPERCENT#\\n\\nNORP#DSAs\\n\\nLOC#\\n\\nFAC##}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2255,\n",
      "    \"completion_tokens\": 243,\n",
      "    \"total_tokens\": 2498\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': '2016', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': 'August 4, 2004', 'category': 'DATE'}, {'entity': 'September 30, 2004', 'category': 'DATE'}, {'entity': 'accelerated share repurchase agreements', 'category': 'EVENT'}, {'entity': 'SEC Consent Order', 'category': 'FAC'}, {'entity': '', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'FCPA Settlement', 'category': 'LAW'}, {'entity': '$300 million', 'category': 'MONEY'}, {'entity': '$500 million', 'category': 'MONEY'}, {'entity': '$2.1 billion', 'category': 'MONEY'}, {'entity': '$1.5 billion', 'category': 'MONEY'}, {'entity': '$1.4 billion', 'category': 'MONEY'}, {'entity': '$2.2 billion', 'category': 'MONEY'}, {'entity': '$900 million', 'category': 'MONEY'}, {'entity': '$14.0 billion', 'category': 'MONEY'}, {'entity': '$5.5 billion', 'category': 'MONEY'}, {'entity': '$8.5 billion', 'category': 'MONEY'}, {'entity': '$4.4 billion', 'category': 'MONEY'}, {'entity': 'DSAs', 'category': 'NORP'}, {'entity': 'IFM', 'category': 'ORG'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'Alliances', 'category': 'ORG'}, {'entity': 'HIV medicines', 'category': 'PRODUCT'}, {'entity': '“Item 8. Financial Statements and Supplementary Data—Note 3. Alliances”', 'category': 'WORK_OF_ART'}, {'entity': '“Item 8. Financial Statements and Supplementary Data—Note 1. Accounting Policies and Recently Issued Accounting Standards.', 'category': 'WORK_OF_ART'}, {'entity': '500', 'category': 'CARDINAL'}, {'entity': '2.1', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '1.4', 'category': 'CARDINAL'}, {'entity': '2.2', 'category': 'CARDINAL'}, {'entity': '900', 'category': 'CARDINAL'}, {'entity': '14.0', 'category': 'CARDINAL'}, {'entity': '5.5', 'category': 'CARDINAL'}, {'entity': '8.5', 'category': 'CARDINAL'}, {'entity': '4.4', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '97', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  14\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXKEx1vDMvRSyAdMzXdrYuVgLd1M\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701573650,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#1#2#3#4#5#2%#50%#1%#$500 million#6.6%#7.8% \\n\\nDATE#December 31, 2018\\n\\nEVENT#GTN Adjustments#Pension Benefits\\n\\nFAC#Citi Pension Discount\\n\\nGPE#U.S.\\n\\nLAW#340B Drug Pricing Program#Medicare Part D\\n\\nORG#U.S. Department of Defense#U.S. Department of Veterans Affairs#Medicaid#Medicare#CMS#Bristol-Myers Squibb Retirement Income Plan\\n\\nPERCENT#2%#50%#1% \\n\\nPRODUCT#Retail#Mail\\n\\nQUANTITY#two to four week#one month \\n\\nTIME#:}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2034,\n",
      "    \"completion_tokens\": 154,\n",
      "    \"total_tokens\": 2188\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31', 'category': 'DATE'}, {'entity': '2018', 'category': 'DATE'}, {'entity': 'GTN Adjustments', 'category': 'EVENT'}, {'entity': 'Pension Benefits', 'category': 'EVENT'}, {'entity': 'Citi Pension Discount', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '340B Drug Pricing Program', 'category': 'LAW'}, {'entity': 'Medicare Part D', 'category': 'LAW'}, {'entity': 'U.S. Department of Defense', 'category': 'ORG'}, {'entity': 'U.S. Department of Veterans Affairs', 'category': 'ORG'}, {'entity': 'Medicaid', 'category': 'ORG'}, {'entity': 'Medicare', 'category': 'ORG'}, {'entity': 'CMS', 'category': 'ORG'}, {'entity': 'Bristol-Myers Squibb Retirement Income Plan', 'category': 'ORG'}, {'entity': '2%', 'category': 'PERCENT'}, {'entity': '50%', 'category': 'PERCENT'}, {'entity': '1%', 'category': 'PERCENT'}, {'entity': 'Retail', 'category': 'PRODUCT'}, {'entity': 'Mail', 'category': 'PRODUCT'}, {'entity': 'two to four week', 'category': 'QUANTITY'}, {'entity': 'one month', 'category': 'QUANTITY'}, {'entity': '', 'category': 'TIME'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '5', 'category': 'CARDINAL'}, {'entity': '2%', 'category': 'CARDINAL'}, {'entity': '50%', 'category': 'CARDINAL'}, {'entity': '1%', 'category': 'CARDINAL'}, {'entity': '$500 million', 'category': 'CARDINAL'}, {'entity': '6.6%', 'category': 'CARDINAL'}, {'entity': '7.8%', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  14\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXKjkYIyit6M82DWC4BMTqRhujoG\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701573681,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#$42 million#$1.1 billion#$192 million#$84 million#$501 million#$366 million#$32 million#$137 million#$533 million#$104 million#$479 million#$152 million#$2.1 billion#$3.2 billion#$2.3 billion#$2.8 billion#$206 million#$2.6 billion#$56 million#50%\\n\\nDATE#December 31, 2018#2016#December 31, 2018#2022#2018#December 31, 2017#fourth quarter of 2017#December 31, 2017#December 31, 2018#2009#four year#two years\\n\\nEVENT#Mead Johnson split-off\\n\\nFAC#UPSA\\n\\nGPE#France\\n\\nLAW#\\u201cItem 8. Financial Statements and Supplementary Data\\u2014Note 16. Retirement Benefits.\\u201d#\\u201cItem 8. Financial Statements and Supplementary Data\\u2014Note 7. Income Taxes\\u201d#Section 382 of the Internal Revenue Code#Internal Revenue Code#Internal Revenue Service\\n\\nMONEY#$192 million#$84 million#$501 million#$366 million#$32 million#$137 million#$533 million#$104 million#$479 million#$152 million#$2.1 billion#$3.2 billion#$2.3 billion#$2.8 billion#$206 million#$2.6 billion#$56 million\\n\\nNORP#U.S. Federal\\n\\nORG#BMS#Mead Johnson & Company#IRS\\n\\nPERSON#Mead Johnson\\n\\nPRODUCT#Mead Johnson shares\\n\\nQUANTITY#one year\\n\\nTIME#near and long-term\\n\\nWORK_OF_ART#Mead Johnson Class B shares to Class A shares}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2178,\n",
      "    \"completion_tokens\": 347,\n",
      "    \"total_tokens\": 2525\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2018', 'category': 'DATE'}, {'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': 'fourth quarter of 2017', 'category': 'DATE'}, {'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': '2009', 'category': 'DATE'}, {'entity': 'four year', 'category': 'DATE'}, {'entity': 'two years', 'category': 'DATE'}, {'entity': 'Mead Johnson split-off', 'category': 'EVENT'}, {'entity': 'UPSA', 'category': 'FAC'}, {'entity': 'France', 'category': 'GPE'}, {'entity': '“Item 8. Financial Statements and Supplementary Data—Note 16. Retirement Benefits.”', 'category': 'LAW'}, {'entity': '“Item 8. Financial Statements and Supplementary Data—Note 7. Income Taxes”', 'category': 'LAW'}, {'entity': 'Section 382 of the Internal Revenue Code', 'category': 'LAW'}, {'entity': 'Internal Revenue Code', 'category': 'LAW'}, {'entity': 'Internal Revenue Service', 'category': 'LAW'}, {'entity': '$192 million', 'category': 'MONEY'}, {'entity': '$84 million', 'category': 'MONEY'}, {'entity': '$501 million', 'category': 'MONEY'}, {'entity': '$366 million', 'category': 'MONEY'}, {'entity': '$32 million', 'category': 'MONEY'}, {'entity': '$137 million', 'category': 'MONEY'}, {'entity': '$533 million', 'category': 'MONEY'}, {'entity': '$104 million', 'category': 'MONEY'}, {'entity': '$479 million', 'category': 'MONEY'}, {'entity': '$152 million', 'category': 'MONEY'}, {'entity': '$2.1 billion', 'category': 'MONEY'}, {'entity': '$3.2 billion', 'category': 'MONEY'}, {'entity': '$2.3 billion', 'category': 'MONEY'}, {'entity': '$2.8 billion', 'category': 'MONEY'}, {'entity': '$206 million', 'category': 'MONEY'}, {'entity': '$2.6 billion', 'category': 'MONEY'}, {'entity': '$56 million', 'category': 'MONEY'}, {'entity': 'U.S. Federal', 'category': 'NORP'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Mead Johnson & Company', 'category': 'ORG'}, {'entity': 'IRS', 'category': 'ORG'}, {'entity': 'Mead Johnson', 'category': 'PERSON'}, {'entity': 'Mead Johnson shares', 'category': 'PRODUCT'}, {'entity': 'one year', 'category': 'QUANTITY'}, {'entity': 'near and long-term', 'category': 'TIME'}, {'entity': 'Mead Johnson Class B shares to Class A shares', 'category': 'WORK_OF_ART'}, {'entity': '$42 million', 'category': 'CARDINAL'}, {'entity': '$1.1 billion', 'category': 'CARDINAL'}, {'entity': '$192 million', 'category': 'CARDINAL'}, {'entity': '$84 million', 'category': 'CARDINAL'}, {'entity': '$501 million', 'category': 'CARDINAL'}, {'entity': '$366 million', 'category': 'CARDINAL'}, {'entity': '$32 million', 'category': 'CARDINAL'}, {'entity': '$137 million', 'category': 'CARDINAL'}, {'entity': '$533 million', 'category': 'CARDINAL'}, {'entity': '$104 million', 'category': 'CARDINAL'}, {'entity': '$479 million', 'category': 'CARDINAL'}, {'entity': '$152 million', 'category': 'CARDINAL'}, {'entity': '$2.1 billion', 'category': 'CARDINAL'}, {'entity': '$3.2 billion', 'category': 'CARDINAL'}, {'entity': '$2.3 billion', 'category': 'CARDINAL'}, {'entity': '$2.8 billion', 'category': 'CARDINAL'}, {'entity': '$206 million', 'category': 'CARDINAL'}, {'entity': '$2.6 billion', 'category': 'CARDINAL'}, {'entity': '$56 million', 'category': 'CARDINAL'}, {'entity': '50%', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  14\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXLLS9DyX5g4b8IFk5mGEDPqcTyA\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701573719,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#244\\n\\nDATE#2009\\n\\nGPE#China#Japan\\n\\nLAW#tax sharing agreement\\n\\nMONEY#$244 million\\n\\nORG#Mead Johnson#FDA#EC#PIVOT Phase I#II Study#American Society of Clinical Oncology#EU\\n\\nPERCENT#10%#35-45%\\n\\nPERSON#Opdivo\\n\\nPRODUCT#CheckMate-238#CheckMate-602#CheckMate-078#CheckMate-141#CheckMate-331#NKTR-214#CheckMate-142#CheckMate-650\\n\\nTIME#30 minute\\n\\nWORK_OF_ART#Item 8. Financial Statements#Supplementary Data\\u2014Note 1. Accounting Policies#Recently Issued Accounting Standards\\u2014Income Taxes#Supplementary Data\\u2014Note 1. Accounting Policies#Recently Issued Accounting Standards\\u2014Contingencies#treatment of adjuvant melanoma}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2299,\n",
      "    \"completion_tokens\": 183,\n",
      "    \"total_tokens\": 2482\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': '2009', 'category': 'DATE'}, {'entity': 'China', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'tax sharing agreement', 'category': 'LAW'}, {'entity': '$244 million', 'category': 'MONEY'}, {'entity': 'Mead Johnson', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'EC', 'category': 'ORG'}, {'entity': 'PIVOT Phase I', 'category': 'ORG'}, {'entity': 'II Study', 'category': 'ORG'}, {'entity': 'American Society of Clinical Oncology', 'category': 'ORG'}, {'entity': 'EU', 'category': 'ORG'}, {'entity': '10%', 'category': 'PERCENT'}, {'entity': '35-45%', 'category': 'PERCENT'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'CheckMate-238', 'category': 'PRODUCT'}, {'entity': 'CheckMate-602', 'category': 'PRODUCT'}, {'entity': 'CheckMate-078', 'category': 'PRODUCT'}, {'entity': 'CheckMate-141', 'category': 'PRODUCT'}, {'entity': 'CheckMate-331', 'category': 'PRODUCT'}, {'entity': 'NKTR-214', 'category': 'PRODUCT'}, {'entity': 'CheckMate-142', 'category': 'PRODUCT'}, {'entity': 'CheckMate-650', 'category': 'PRODUCT'}, {'entity': '30 minute', 'category': 'TIME'}, {'entity': 'Item 8. Financial Statements', 'category': 'WORK_OF_ART'}, {'entity': 'Supplementary Data—Note 1. Accounting Policies', 'category': 'WORK_OF_ART'}, {'entity': 'Recently Issued Accounting Standards—Income Taxes', 'category': 'WORK_OF_ART'}, {'entity': 'Supplementary Data—Note 1. Accounting Policies', 'category': 'WORK_OF_ART'}, {'entity': 'Recently Issued Accounting Standards—Contingencies', 'category': 'WORK_OF_ART'}, {'entity': 'treatment of adjuvant melanoma', 'category': 'WORK_OF_ART'}, {'entity': '244', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  14\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXLrZVyiVHm7IERhO1S2kYEEN85l\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701573751,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#13.5#10 \\n\\nDATE#October 2018#May 2018#January 2019#June 2018#February 2019#April 2018#November 2018#September 2018#July 2018#January 2018#September 2018\\n\\nEVENT#Phase III CheckMate-067 clinical trial#Phase I/II CheckMate-032 trial#Phase III CheckMate-214 study#Phase III CheckMate-451 study#Phase II study\\n\\nFAC#Company's sBLA\\n\\nGPE#Japan#EU\\n\\nLAW#Section 27A of the Securities Act of 1933#Section 21E of the Exchange Act \\n\\nMONEY#10 mutations per megabase\\n\\nNORP#Company's\\n\\nORDINAL#first-line#first-line#first-line#first-line\\n\\nORG#Opdivo+Yervoy#Yervoy#Opdivo#Opdivo1 mg/kg plus Yervoy 3 mg/kg#Opdivo 3 mg/kg plus Yervoy 1 mg/kg#CHMP#EMA#FDA#Eliquis#NVAF#Eliquis#Orencia#JIA#CHMP#Empliciti#RRMM#FDA#EMA#PI#Sprycel#ALL#EC#CML#Yervoy#TYK2 Inhibitor#BMS-986165\\n\\nPERCENT#10%\\n\\nPERSON#\\n\\nPRODUCT#Opdivo#Yervoy#sBLA#Opdivo#Yervoy#CheckMate-227#Opdivo+Yervoy#Eliquis#Eliquis#Orencia#Empliciti#Empliciti#Sprycel#Sprycel#Sprycel#Yervoy#BMS-986165#2018 Form 10-K\\n\\nQUANTITY#two years\\n\\nTIME#\\n\\nWORK_OF_ART#}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2374,\n",
      "    \"completion_tokens\": 403,\n",
      "    \"total_tokens\": 2777\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'October 2018', 'category': 'DATE'}, {'entity': 'May 2018', 'category': 'DATE'}, {'entity': 'January 2019', 'category': 'DATE'}, {'entity': 'June 2018', 'category': 'DATE'}, {'entity': 'February 2019', 'category': 'DATE'}, {'entity': 'April 2018', 'category': 'DATE'}, {'entity': 'November 2018', 'category': 'DATE'}, {'entity': 'September 2018', 'category': 'DATE'}, {'entity': 'July 2018', 'category': 'DATE'}, {'entity': 'January 2018', 'category': 'DATE'}, {'entity': 'September 2018', 'category': 'DATE'}, {'entity': 'Phase III CheckMate-067 clinical trial', 'category': 'EVENT'}, {'entity': 'Phase I/II CheckMate-032 trial', 'category': 'EVENT'}, {'entity': 'Phase III CheckMate-214 study', 'category': 'EVENT'}, {'entity': 'Phase III CheckMate-451 study', 'category': 'EVENT'}, {'entity': 'Phase II study', 'category': 'EVENT'}, {'entity': 'Companys sBLA', 'category': 'FAC'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'EU', 'category': 'GPE'}, {'entity': 'Section 27A of the Securities Act of 1933', 'category': 'LAW'}, {'entity': 'Section 21E of the Exchange Act', 'category': 'LAW'}, {'entity': '10 mutations per megabase', 'category': 'MONEY'}, {'entity': 'Companys', 'category': 'NORP'}, {'entity': 'Opdivo+Yervoy', 'category': 'ORG'}, {'entity': 'Yervoy', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Opdivo1 mg/kg plus Yervoy 3 mg/kg', 'category': 'ORG'}, {'entity': 'Opdivo 3 mg/kg plus Yervoy 1 mg/kg', 'category': 'ORG'}, {'entity': 'CHMP', 'category': 'ORG'}, {'entity': 'EMA', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'NVAF', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'Orencia', 'category': 'ORG'}, {'entity': 'JIA', 'category': 'ORG'}, {'entity': 'CHMP', 'category': 'ORG'}, {'entity': 'Empliciti', 'category': 'ORG'}, {'entity': 'RRMM', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'EMA', 'category': 'ORG'}, {'entity': 'PI', 'category': 'ORG'}, {'entity': 'Sprycel', 'category': 'ORG'}, {'entity': 'ALL', 'category': 'ORG'}, {'entity': 'EC', 'category': 'ORG'}, {'entity': 'CML', 'category': 'ORG'}, {'entity': 'Yervoy', 'category': 'ORG'}, {'entity': 'TYK2 Inhibitor', 'category': 'ORG'}, {'entity': 'BMS-986165', 'category': 'ORG'}, {'entity': '10%', 'category': 'PERCENT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Yervoy', 'category': 'PRODUCT'}, {'entity': 'sBLA', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Yervoy', 'category': 'PRODUCT'}, {'entity': 'CheckMate-227', 'category': 'PRODUCT'}, {'entity': 'Opdivo+Yervoy', 'category': 'PRODUCT'}, {'entity': 'Eliquis', 'category': 'PRODUCT'}, {'entity': 'Eliquis', 'category': 'PRODUCT'}, {'entity': 'Orencia', 'category': 'PRODUCT'}, {'entity': 'Empliciti', 'category': 'PRODUCT'}, {'entity': 'Empliciti', 'category': 'PRODUCT'}, {'entity': 'Sprycel', 'category': 'PRODUCT'}, {'entity': 'Sprycel', 'category': 'PRODUCT'}, {'entity': 'Sprycel', 'category': 'PRODUCT'}, {'entity': 'Yervoy', 'category': 'PRODUCT'}, {'entity': 'BMS-986165', 'category': 'PRODUCT'}, {'entity': '2018 Form 10-K', 'category': 'PRODUCT'}, {'entity': 'two years', 'category': 'QUANTITY'}, {'entity': '', 'category': 'WORK_OF_ART'}, {'entity': 'first-line', 'category': 'ORDINAL'}, {'entity': 'first-line', 'category': 'ORDINAL'}, {'entity': 'first-line', 'category': 'ORDINAL'}, {'entity': 'first-line', 'category': 'ORDINAL'}, {'entity': '13.5', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  14\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXMW6MVaJQIkMzQizbyzEfpbyRCH\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701573792,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL:$231 million#$175 million#$482 million#$569 million#100\\n\\nDATE:December 31, 2018#December 31, 2017\\n\\nEVENT:2018 Form 10-K\\n\\nLAW:Item 7A.#\\u201cItem 8. Financial Statements and Supplementary Data\\u2014Note 9. Financial Instruments and Fair Value Measurements.\\u201d\\n\\nMONEY:$231 million#$175 million#$482 million#$569 million\\n\\nORG:Company#Japan subsidiary\\n\\nPERCENT:10%\\n\\nPRODUCT:Financial Statements\\n\\nQUANTITY:100 basis points\\n\\nTIME:year-end}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 1501,\n",
      "    \"completion_tokens\": 119,\n",
      "    \"total_tokens\": 1620\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': '2018 Form 10-K', 'category': 'EVENT'}, {'entity': 'Item 7A.', 'category': 'LAW'}, {'entity': '“Item 8. Financial Statements and Supplementary Data—Note 9. Financial Instruments and Fair Value Measurements.”', 'category': 'LAW'}, {'entity': '$231 million', 'category': 'MONEY'}, {'entity': '$175 million', 'category': 'MONEY'}, {'entity': '$482 million', 'category': 'MONEY'}, {'entity': '$569 million', 'category': 'MONEY'}, {'entity': 'Company', 'category': 'ORG'}, {'entity': 'Japan subsidiary', 'category': 'ORG'}, {'entity': '10%', 'category': 'PERCENT'}, {'entity': 'Financial Statements', 'category': 'PRODUCT'}, {'entity': '100 basis points', 'category': 'QUANTITY'}, {'entity': 'year-end', 'category': 'TIME'}, {'entity': '$231 million', 'category': 'CARDINAL'}, {'entity': '$175 million', 'category': 'CARDINAL'}, {'entity': '$482 million', 'category': 'CARDINAL'}, {'entity': '$569 million', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}]\n",
      "/home/damir/Dropbox/Documents/Teaching/2023/L715/l715_23/data/10-Ks/Bristol-Myers_Squibb_Company/2014/Management.txt\n",
      "Length of chunks:  17\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXN0ypUedxxVj9cjiZfV4XuRaGQS\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701573822,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#7#51.5#34.0#1.8#2.7#600#800#2025#8#16,385#17,621#21,244#13,494#15,281#14,263#2,891#2,340#6,981#311#161#1,721#10.8#6.9#24.7#2,563#1,960#3,709#3,019#3,364#3,921#1.54#1.16#2.16#1.82#1.99#2.28#8,272#6,352#11,642#2010#3590 \\n\\nDATE#Year Ended December 31#2013#2012#2011#February 2014\\n\\nEVENT#MANAGEMENT\\u2019S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS\\n\\nFAC#Financial Statements\\n\\nGPE#U.S.#United Kingdom#Germany\\n\\nLAW#Patient Protection and Affordable Care Act\\n\\nMONEY#$2.7 billion#$600 million#$800 million\\n\\nNORP#European\\n\\nORDINAL#second\\n\\nORG#Bristol-Myers Squibb Company#Bristol-Myers Squibb#BMS#AstraZeneca#Amylin#Farxiga#Managed Care Organizations#MCOs#Item 8\\n\\nPERCENT#51.5%#34%\\n\\nWORK_OF_ART#Item 7#Avapro*/Avalide#Onglyza#Forxiga#Bydureon#Byetta#Symlin#metreleptin#Item 8#Biologics License Application#BLA#Note 5. Assets Held-For-Sale#Patient Protection and Affordable Care Act#HR 3590\\n}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2310,\n",
      "    \"completion_tokens\": 385,\n",
      "    \"total_tokens\": 2695\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': '2011', 'category': 'DATE'}, {'entity': 'February 2014', 'category': 'DATE'}, {'entity': 'MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS', 'category': 'EVENT'}, {'entity': 'Financial Statements', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'United Kingdom', 'category': 'GPE'}, {'entity': 'Germany', 'category': 'GPE'}, {'entity': 'Patient Protection and Affordable Care Act', 'category': 'LAW'}, {'entity': '$2.7 billion', 'category': 'MONEY'}, {'entity': '$600 million', 'category': 'MONEY'}, {'entity': '$800 million', 'category': 'MONEY'}, {'entity': 'European', 'category': 'NORP'}, {'entity': 'Bristol-Myers Squibb Company', 'category': 'ORG'}, {'entity': 'Bristol-Myers Squibb', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'AstraZeneca', 'category': 'ORG'}, {'entity': 'Amylin', 'category': 'ORG'}, {'entity': 'Farxiga', 'category': 'ORG'}, {'entity': 'Managed Care Organizations', 'category': 'ORG'}, {'entity': 'MCOs', 'category': 'ORG'}, {'entity': 'Item 8', 'category': 'ORG'}, {'entity': '51.5%', 'category': 'PERCENT'}, {'entity': '34%', 'category': 'PERCENT'}, {'entity': 'Item 7', 'category': 'WORK_OF_ART'}, {'entity': 'Avapro*/Avalide', 'category': 'WORK_OF_ART'}, {'entity': 'Onglyza', 'category': 'WORK_OF_ART'}, {'entity': 'Forxiga', 'category': 'WORK_OF_ART'}, {'entity': 'Bydureon', 'category': 'WORK_OF_ART'}, {'entity': 'Byetta', 'category': 'WORK_OF_ART'}, {'entity': 'Symlin', 'category': 'WORK_OF_ART'}, {'entity': 'metreleptin', 'category': 'WORK_OF_ART'}, {'entity': 'Item 8', 'category': 'WORK_OF_ART'}, {'entity': 'Biologics License Application', 'category': 'WORK_OF_ART'}, {'entity': 'BLA', 'category': 'WORK_OF_ART'}, {'entity': 'Note 5. Assets Held-For-Sale', 'category': 'WORK_OF_ART'}, {'entity': 'Patient Protection and Affordable Care Act', 'category': 'WORK_OF_ART'}, {'entity': 'HR 3590', 'category': 'WORK_OF_ART'}, {'entity': 'second', 'category': 'ORDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '51.5', 'category': 'CARDINAL'}, {'entity': '34.0', 'category': 'CARDINAL'}, {'entity': '1.8', 'category': 'CARDINAL'}, {'entity': '2.7', 'category': 'CARDINAL'}, {'entity': '600', 'category': 'CARDINAL'}, {'entity': '800', 'category': 'CARDINAL'}, {'entity': '2025', 'category': 'CARDINAL'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': '16,385', 'category': 'CARDINAL'}, {'entity': '17,621', 'category': 'CARDINAL'}, {'entity': '21,244', 'category': 'CARDINAL'}, {'entity': '13,494', 'category': 'CARDINAL'}, {'entity': '15,281', 'category': 'CARDINAL'}, {'entity': '14,263', 'category': 'CARDINAL'}, {'entity': '2,891', 'category': 'CARDINAL'}, {'entity': '2,340', 'category': 'CARDINAL'}, {'entity': '6,981', 'category': 'CARDINAL'}, {'entity': '311', 'category': 'CARDINAL'}, {'entity': '161', 'category': 'CARDINAL'}, {'entity': '1,721', 'category': 'CARDINAL'}, {'entity': '10.8', 'category': 'CARDINAL'}, {'entity': '6.9', 'category': 'CARDINAL'}, {'entity': '24.7', 'category': 'CARDINAL'}, {'entity': '2,563', 'category': 'CARDINAL'}, {'entity': '1,960', 'category': 'CARDINAL'}, {'entity': '3,709', 'category': 'CARDINAL'}, {'entity': '3,019', 'category': 'CARDINAL'}, {'entity': '3,364', 'category': 'CARDINAL'}, {'entity': '3,921', 'category': 'CARDINAL'}, {'entity': '1.54', 'category': 'CARDINAL'}, {'entity': '1.16', 'category': 'CARDINAL'}, {'entity': '2.16', 'category': 'CARDINAL'}, {'entity': '1.82', 'category': 'CARDINAL'}, {'entity': '1.99', 'category': 'CARDINAL'}, {'entity': '2.28', 'category': 'CARDINAL'}, {'entity': '8,272', 'category': 'CARDINAL'}, {'entity': '6,352', 'category': 'CARDINAL'}, {'entity': '11,642', 'category': 'CARDINAL'}, {'entity': '2010', 'category': 'CARDINAL'}, {'entity': '3590', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  17\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXNeIZtGz3RNTlkYmdTUPOF6ueho\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701573862,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#2013#30-45%#84.7%#94%#2015\\n\\nDATE#May 2012#February 2014#January 2014#November 2013#April 2013#December 2013#February 2013#March 2015#October 2013 \\n\\nEVENT#divesting our diabetes portfolio\\n\\nFAC#multi-product bulk biologics manufacturing facility\\n\\nGPE#United States#Japan\\n\\nLAW#\\u201cItem 8. Financial Statements\\u2014Note 22. Legal Proceedings and Contingencies.\\u201d\\n\\nMONEY#$1 billion#$3 billion#$1.4 billion\\n\\nNORP#Russian#European\\n\\nORG#FDA#BMS#European Medicines Agency#Pharmaceutical and Medical Devices Agency#European Association for the Study of the Liver \\n\\nPERCENT#30-45%\\n\\nPERSON#\\n\\nPRODUCT#Yervoy (ipilimumab)#Sprycel (dasatinib)#Erbitux (cetuximab)#Reyataz (atazanavir sulfate)#Baraclude (entecavir)#Orencia (abatacept)#Eliquis (apixaban)#Daclatasvir#Asunaprevir#BMS-791325#Sustiva (efavirenz)#Nivolumab \\n\\nWORK_OF_ART#}\\n\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2258,\n",
      "    \"completion_tokens\": 281,\n",
      "    \"total_tokens\": 2539\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'May 2012', 'category': 'DATE'}, {'entity': 'February 2014', 'category': 'DATE'}, {'entity': 'January 2014', 'category': 'DATE'}, {'entity': 'November 2013', 'category': 'DATE'}, {'entity': 'April 2013', 'category': 'DATE'}, {'entity': 'December 2013', 'category': 'DATE'}, {'entity': 'February 2013', 'category': 'DATE'}, {'entity': 'March 2015', 'category': 'DATE'}, {'entity': 'October 2013', 'category': 'DATE'}, {'entity': 'divesting our diabetes portfolio', 'category': 'EVENT'}, {'entity': 'multi-product bulk biologics manufacturing facility', 'category': 'FAC'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': '“Item 8. Financial Statements—Note 22. Legal Proceedings and Contingencies.”', 'category': 'LAW'}, {'entity': '$1 billion', 'category': 'MONEY'}, {'entity': '$3 billion', 'category': 'MONEY'}, {'entity': '$1.4 billion', 'category': 'MONEY'}, {'entity': 'Russian', 'category': 'NORP'}, {'entity': 'European', 'category': 'NORP'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'European Medicines Agency', 'category': 'ORG'}, {'entity': 'Pharmaceutical and Medical Devices Agency', 'category': 'ORG'}, {'entity': 'European Association for the Study of the Liver', 'category': 'ORG'}, {'entity': '30-45%', 'category': 'PERCENT'}, {'entity': 'Yervoy ipilimumab', 'category': 'PRODUCT'}, {'entity': 'Sprycel dasatinib', 'category': 'PRODUCT'}, {'entity': 'Erbitux cetuximab', 'category': 'PRODUCT'}, {'entity': 'Reyataz atazanavir sulfate', 'category': 'PRODUCT'}, {'entity': 'Baraclude entecavir', 'category': 'PRODUCT'}, {'entity': 'Orencia abatacept', 'category': 'PRODUCT'}, {'entity': 'Eliquis apixaban', 'category': 'PRODUCT'}, {'entity': 'Daclatasvir', 'category': 'PRODUCT'}, {'entity': 'Asunaprevir', 'category': 'PRODUCT'}, {'entity': 'BMS-791325', 'category': 'PRODUCT'}, {'entity': 'Sustiva efavirenz', 'category': 'PRODUCT'}, {'entity': 'Nivolumab', 'category': 'PRODUCT'}, {'entity': '', 'category': 'WORK_OF_ART'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '30-45%', 'category': 'CARDINAL'}, {'entity': '84.7%', 'category': 'CARDINAL'}, {'entity': '94%', 'category': 'CARDINAL'}, {'entity': '2015', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  17\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXOGn5AfxzNRU0qnCBX8gEcaYxw8\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701573900,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#129#42#24#004#1#3#80#100#400#76#63#84#64#10#67#172#65#168#043#33#20.8#10#18#17.1#27\\n\\nDATE#June 2013#December 2013#November 2013#September 2013#January 2013#June 2013#July 2013#December 2013#February 27, 2014#January 2014#September 2013#June 2013#March 2013\\n\\nEVENT#Phase III DASISION study\\n\\nGPE#Philadelphia\\n\\nLAW#Prescription Drug User Free Act\\n\\nMONEY#20 mg/kg arm\\n\\nORDINAL#first#four-year\\n\\nORG#World Health Organization#American Society of Hematology#European LeukemiaNet guidelines#EMA#European Congress#European Commission#Endocrinologic and Metabolic Drugs Advisory Committee#Company#FDA#AstraZeneca#EC#BLA#EMDAC#PDUFA#Annual Meeting of the European Association for the Study of Diabetes#EASD#Japanese Ministry of Health, Labor and Welfare\\n\\nPERCENT#42%#24%#53%#76%#63%#84%#64%#22%#92%#76%\\n\\nPERSON#Sprycel#Gleevec#Yervoy#Abilify\\n\\nPRODUCT#dasatanib#imatinib meslylate#aripiprazole#metreleptin#dapagliflozin and metformin hydrochloride\\n\\nQUANTITY#10 mg/kg\\n\\nTIME#12 weeks#three months#four years#three years#ten years#24 weeks#eight weeks#two-week#day seven}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2416,\n",
      "    \"completion_tokens\": 375,\n",
      "    \"total_tokens\": 2791\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'June 2013', 'category': 'DATE'}, {'entity': 'December 2013', 'category': 'DATE'}, {'entity': 'November 2013', 'category': 'DATE'}, {'entity': 'September 2013', 'category': 'DATE'}, {'entity': 'January 2013', 'category': 'DATE'}, {'entity': 'June 2013', 'category': 'DATE'}, {'entity': 'July 2013', 'category': 'DATE'}, {'entity': 'December 2013', 'category': 'DATE'}, {'entity': 'February 27, 2014', 'category': 'DATE'}, {'entity': 'January 2014', 'category': 'DATE'}, {'entity': 'September 2013', 'category': 'DATE'}, {'entity': 'June 2013', 'category': 'DATE'}, {'entity': 'March 2013', 'category': 'DATE'}, {'entity': 'Phase III DASISION study', 'category': 'EVENT'}, {'entity': 'Philadelphia', 'category': 'GPE'}, {'entity': 'Prescription Drug User Free Act', 'category': 'LAW'}, {'entity': '20 mg/kg arm', 'category': 'MONEY'}, {'entity': 'World Health Organization', 'category': 'ORG'}, {'entity': 'American Society of Hematology', 'category': 'ORG'}, {'entity': 'European LeukemiaNet guidelines', 'category': 'ORG'}, {'entity': 'EMA', 'category': 'ORG'}, {'entity': 'European Congress', 'category': 'ORG'}, {'entity': 'European Commission', 'category': 'ORG'}, {'entity': 'Endocrinologic and Metabolic Drugs Advisory Committee', 'category': 'ORG'}, {'entity': 'Company', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'AstraZeneca', 'category': 'ORG'}, {'entity': 'EC', 'category': 'ORG'}, {'entity': 'BLA', 'category': 'ORG'}, {'entity': 'EMDAC', 'category': 'ORG'}, {'entity': 'PDUFA', 'category': 'ORG'}, {'entity': 'Annual Meeting of the European Association for the Study of Diabetes', 'category': 'ORG'}, {'entity': 'EASD', 'category': 'ORG'}, {'entity': 'Japanese Ministry of Health, Labor and Welfare', 'category': 'ORG'}, {'entity': '42%', 'category': 'PERCENT'}, {'entity': '24%', 'category': 'PERCENT'}, {'entity': '53%', 'category': 'PERCENT'}, {'entity': '76%', 'category': 'PERCENT'}, {'entity': '63%', 'category': 'PERCENT'}, {'entity': '84%', 'category': 'PERCENT'}, {'entity': '64%', 'category': 'PERCENT'}, {'entity': '22%', 'category': 'PERCENT'}, {'entity': '92%', 'category': 'PERCENT'}, {'entity': '76%', 'category': 'PERCENT'}, {'entity': 'Sprycel', 'category': 'PERSON'}, {'entity': 'Gleevec', 'category': 'PERSON'}, {'entity': 'Yervoy', 'category': 'PERSON'}, {'entity': 'Abilify', 'category': 'PERSON'}, {'entity': 'dasatanib', 'category': 'PRODUCT'}, {'entity': 'imatinib meslylate', 'category': 'PRODUCT'}, {'entity': 'aripiprazole', 'category': 'PRODUCT'}, {'entity': 'metreleptin', 'category': 'PRODUCT'}, {'entity': 'dapagliflozin and metformin hydrochloride', 'category': 'PRODUCT'}, {'entity': '10 mg/kg', 'category': 'QUANTITY'}, {'entity': '12 weeks', 'category': 'TIME'}, {'entity': 'three months', 'category': 'TIME'}, {'entity': 'four years', 'category': 'TIME'}, {'entity': 'three years', 'category': 'TIME'}, {'entity': 'ten years', 'category': 'TIME'}, {'entity': '24 weeks', 'category': 'TIME'}, {'entity': 'eight weeks', 'category': 'TIME'}, {'entity': 'two-week', 'category': 'TIME'}, {'entity': 'day seven', 'category': 'TIME'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'four-year', 'category': 'ORDINAL'}, {'entity': '129', 'category': 'CARDINAL'}, {'entity': '42', 'category': 'CARDINAL'}, {'entity': '24', 'category': 'CARDINAL'}, {'entity': '004', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '80', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '400', 'category': 'CARDINAL'}, {'entity': '76', 'category': 'CARDINAL'}, {'entity': '63', 'category': 'CARDINAL'}, {'entity': '84', 'category': 'CARDINAL'}, {'entity': '64', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '67', 'category': 'CARDINAL'}, {'entity': '172', 'category': 'CARDINAL'}, {'entity': '65', 'category': 'CARDINAL'}, {'entity': '168', 'category': 'CARDINAL'}, {'entity': '043', 'category': 'CARDINAL'}, {'entity': '33', 'category': 'CARDINAL'}, {'entity': '20.8', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '18', 'category': 'CARDINAL'}, {'entity': '17.1', 'category': 'CARDINAL'}, {'entity': '27', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  17\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXOuCT3OBeE8kWYTaayEbpuvK74I\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701573940,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#2#2#20#19#1#26#30#4#6#7#3#2#1#6#1#2#1#2#7#5#1#1#17#17#2#2\\n\\nDATE#January 2013#February 2014#September 2013#June 2013#June 2013#December 2013#November 2013#September 2013#August 2013#July 2013#June 2013#May 2013#January#February#April 2013#January#April 2013#Year Ended December 31,\\t2013#2012#2011\\n\\nEVENT#SAVOR clinical trial#AMPLE#Phase III ARISTOTLE trial#International Society on Thrombosis and Haemostasis congress \\n\\nFAC#European Society of Cardiology#Annual Meeting of the EASD \\n\\nGPE#China#Europe#United States#Japan\\n\\nLANGUAGE#American  \\n\\nORG#China\\u2018s State Food and Drug Administration#FDA#AstraZeneca#Company#Ono Pharmaceutical Co.#Ltd.#Japanese Ministry of Health Labour and Welfare#Pfizer#European Medicines Agency#ESC#New England Journal of Medicine#American Heart Association#South Korea#Israel#Russia#Mexico#Colombia \\n\\nPERSON#American College of Rheumatology\\n\\nPRODUCT#Farxiga#Onglyza#saxagliptin#Kombiglyze#Orencia#abatacept#Humira#adalimumab#Eliquis \\n\\nTIME#one year#two years#30-day \\n\\nWORK_OF_ART#New England Journal of Medicine and presented at the International Society on Thrombosis and Haemostasis congress in Amsterdam}\\n\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2573,\n",
      "    \"completion_tokens\": 374,\n",
      "    \"total_tokens\": 2947\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'January 2013', 'category': 'DATE'}, {'entity': 'February 2014', 'category': 'DATE'}, {'entity': 'September 2013', 'category': 'DATE'}, {'entity': 'June 2013', 'category': 'DATE'}, {'entity': 'June 2013', 'category': 'DATE'}, {'entity': 'December 2013', 'category': 'DATE'}, {'entity': 'November 2013', 'category': 'DATE'}, {'entity': 'September 2013', 'category': 'DATE'}, {'entity': 'August 2013', 'category': 'DATE'}, {'entity': 'July 2013', 'category': 'DATE'}, {'entity': 'June 2013', 'category': 'DATE'}, {'entity': 'May 2013', 'category': 'DATE'}, {'entity': 'January', 'category': 'DATE'}, {'entity': 'February', 'category': 'DATE'}, {'entity': 'April 2013', 'category': 'DATE'}, {'entity': 'January', 'category': 'DATE'}, {'entity': 'April 2013', 'category': 'DATE'}, {'entity': 'Year Ended December 31,\\t2013', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': '2011', 'category': 'DATE'}, {'entity': 'SAVOR clinical trial', 'category': 'EVENT'}, {'entity': 'AMPLE', 'category': 'EVENT'}, {'entity': 'Phase III ARISTOTLE trial', 'category': 'EVENT'}, {'entity': 'International Society on Thrombosis and Haemostasis congress', 'category': 'EVENT'}, {'entity': 'European Society of Cardiology', 'category': 'FAC'}, {'entity': 'Annual Meeting of the EASD', 'category': 'FAC'}, {'entity': 'China', 'category': 'GPE'}, {'entity': 'Europe', 'category': 'GPE'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'American', 'category': 'LANGUAGE'}, {'entity': 'China‘s State Food and Drug Administration', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'AstraZeneca', 'category': 'ORG'}, {'entity': 'Company', 'category': 'ORG'}, {'entity': 'Ono Pharmaceutical Co.', 'category': 'ORG'}, {'entity': 'Ltd.', 'category': 'ORG'}, {'entity': 'Japanese Ministry of Health Labour and Welfare', 'category': 'ORG'}, {'entity': 'Pfizer', 'category': 'ORG'}, {'entity': 'European Medicines Agency', 'category': 'ORG'}, {'entity': 'ESC', 'category': 'ORG'}, {'entity': 'New England Journal of Medicine', 'category': 'ORG'}, {'entity': 'American Heart Association', 'category': 'ORG'}, {'entity': 'South Korea', 'category': 'ORG'}, {'entity': 'Israel', 'category': 'ORG'}, {'entity': 'Russia', 'category': 'ORG'}, {'entity': 'Mexico', 'category': 'ORG'}, {'entity': 'Colombia', 'category': 'ORG'}, {'entity': 'American College of Rheumatology', 'category': 'PERSON'}, {'entity': 'Farxiga', 'category': 'PRODUCT'}, {'entity': 'Onglyza', 'category': 'PRODUCT'}, {'entity': 'saxagliptin', 'category': 'PRODUCT'}, {'entity': 'Kombiglyze', 'category': 'PRODUCT'}, {'entity': 'Orencia', 'category': 'PRODUCT'}, {'entity': 'abatacept', 'category': 'PRODUCT'}, {'entity': 'Humira', 'category': 'PRODUCT'}, {'entity': 'adalimumab', 'category': 'PRODUCT'}, {'entity': 'Eliquis', 'category': 'PRODUCT'}, {'entity': 'one year', 'category': 'TIME'}, {'entity': 'two years', 'category': 'TIME'}, {'entity': '30-day', 'category': 'TIME'}, {'entity': 'New England Journal of Medicine and presented at the International Society on Thrombosis and Haemostasis congress in Amsterdam', 'category': 'WORK_OF_ART'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '19', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '26', 'category': 'CARDINAL'}, {'entity': '30', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '5', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '17', 'category': 'CARDINAL'}, {'entity': '17', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  17\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXPY5I3PX8MZQbeTQnWCvKq4PLcP\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701573980,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#1.5#34.0#51.5#2013#8#53.5#51.5#2012#1.7#1.1#1.5#1.3#2011#13#2#41#28#417#411#161#181#1,249#651#191#351#423#256#451#2,323#67#37#8#17#128#663#208#561#459#88#435#2,414#23#76#31#175#345#183#1,108#563#154#504#360#114#540#2,235#5#85#52#6#148#565#153#477#388#107#479#2,169#48#11#20#1#84#4#37#12#147#227#279#236#938#14,391#15,849#20,385#9#22#14#32#76#62#75#23#24#2,087#2,195#2,763#5#21#12,304#13,654#17,622#10#23#100\\n\\nDATE#January 1, 2012#December 31, 2012#both periods#2014#2015#2016#December 31, 2013#Year Ended December 31,\\n\\nGPE#U.S.#Europe#Japan\\n\\nMONEY#1.7 billion#1.1 billion#1.5 billion#1.3 billion\\n\\nORG#BMS#AstraZeneca#Amylin#Sanofi\\n\\nPERCENT#100%#10%#51.5%#34.0%#8%#53.5%#76%#24%#29%#20%#14%#23%\\n\\nPRODUCT#Abilify#Atripla#Plavix#Avapro/Avalide#Onglyza#Forxiga#Bydureon#Byetta#Symlin#metreleptin\\n\\nWORK_OF_ART#Item 8. Financial Statements\\u2014Note 3. Alliances#Item 8. Financial Statements\\u2014Note 5. Assets Held-For-Sale}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2826,\n",
      "    \"completion_tokens\": 481,\n",
      "    \"total_tokens\": 3307\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'January 1, 2012', 'category': 'DATE'}, {'entity': 'December 31, 2012', 'category': 'DATE'}, {'entity': 'both periods', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': 'December 31, 2013', 'category': 'DATE'}, {'entity': 'Year Ended December 31,', 'category': 'DATE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Europe', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': '1.7 billion', 'category': 'MONEY'}, {'entity': '1.1 billion', 'category': 'MONEY'}, {'entity': '1.5 billion', 'category': 'MONEY'}, {'entity': '1.3 billion', 'category': 'MONEY'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'AstraZeneca', 'category': 'ORG'}, {'entity': 'Amylin', 'category': 'ORG'}, {'entity': 'Sanofi', 'category': 'ORG'}, {'entity': '100%', 'category': 'PERCENT'}, {'entity': '10%', 'category': 'PERCENT'}, {'entity': '51.5%', 'category': 'PERCENT'}, {'entity': '34.0%', 'category': 'PERCENT'}, {'entity': '8%', 'category': 'PERCENT'}, {'entity': '53.5%', 'category': 'PERCENT'}, {'entity': '76%', 'category': 'PERCENT'}, {'entity': '24%', 'category': 'PERCENT'}, {'entity': '29%', 'category': 'PERCENT'}, {'entity': '20%', 'category': 'PERCENT'}, {'entity': '14%', 'category': 'PERCENT'}, {'entity': '23%', 'category': 'PERCENT'}, {'entity': 'Abilify', 'category': 'PRODUCT'}, {'entity': 'Atripla', 'category': 'PRODUCT'}, {'entity': 'Plavix', 'category': 'PRODUCT'}, {'entity': 'Avapro/Avalide', 'category': 'PRODUCT'}, {'entity': 'Onglyza', 'category': 'PRODUCT'}, {'entity': 'Forxiga', 'category': 'PRODUCT'}, {'entity': 'Bydureon', 'category': 'PRODUCT'}, {'entity': 'Byetta', 'category': 'PRODUCT'}, {'entity': 'Symlin', 'category': 'PRODUCT'}, {'entity': 'metreleptin', 'category': 'PRODUCT'}, {'entity': 'Item 8. Financial Statements—Note 3. Alliances', 'category': 'WORK_OF_ART'}, {'entity': 'Item 8. Financial Statements—Note 5. Assets Held-For-Sale', 'category': 'WORK_OF_ART'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '34.0', 'category': 'CARDINAL'}, {'entity': '51.5', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': '53.5', 'category': 'CARDINAL'}, {'entity': '51.5', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '1.7', 'category': 'CARDINAL'}, {'entity': '1.1', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '1.3', 'category': 'CARDINAL'}, {'entity': '2011', 'category': 'CARDINAL'}, {'entity': '13', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '41', 'category': 'CARDINAL'}, {'entity': '28', 'category': 'CARDINAL'}, {'entity': '417', 'category': 'CARDINAL'}, {'entity': '411', 'category': 'CARDINAL'}, {'entity': '161', 'category': 'CARDINAL'}, {'entity': '181', 'category': 'CARDINAL'}, {'entity': '1,249', 'category': 'CARDINAL'}, {'entity': '651', 'category': 'CARDINAL'}, {'entity': '191', 'category': 'CARDINAL'}, {'entity': '351', 'category': 'CARDINAL'}, {'entity': '423', 'category': 'CARDINAL'}, {'entity': '256', 'category': 'CARDINAL'}, {'entity': '451', 'category': 'CARDINAL'}, {'entity': '2,323', 'category': 'CARDINAL'}, {'entity': '67', 'category': 'CARDINAL'}, {'entity': '37', 'category': 'CARDINAL'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': '17', 'category': 'CARDINAL'}, {'entity': '128', 'category': 'CARDINAL'}, {'entity': '663', 'category': 'CARDINAL'}, {'entity': '208', 'category': 'CARDINAL'}, {'entity': '561', 'category': 'CARDINAL'}, {'entity': '459', 'category': 'CARDINAL'}, {'entity': '88', 'category': 'CARDINAL'}, {'entity': '435', 'category': 'CARDINAL'}, {'entity': '2,414', 'category': 'CARDINAL'}, {'entity': '23', 'category': 'CARDINAL'}, {'entity': '76', 'category': 'CARDINAL'}, {'entity': '31', 'category': 'CARDINAL'}, {'entity': '175', 'category': 'CARDINAL'}, {'entity': '345', 'category': 'CARDINAL'}, {'entity': '183', 'category': 'CARDINAL'}, {'entity': '1,108', 'category': 'CARDINAL'}, {'entity': '563', 'category': 'CARDINAL'}, {'entity': '154', 'category': 'CARDINAL'}, {'entity': '504', 'category': 'CARDINAL'}, {'entity': '360', 'category': 'CARDINAL'}, {'entity': '114', 'category': 'CARDINAL'}, {'entity': '540', 'category': 'CARDINAL'}, {'entity': '2,235', 'category': 'CARDINAL'}, {'entity': '5', 'category': 'CARDINAL'}, {'entity': '85', 'category': 'CARDINAL'}, {'entity': '52', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '148', 'category': 'CARDINAL'}, {'entity': '565', 'category': 'CARDINAL'}, {'entity': '153', 'category': 'CARDINAL'}, {'entity': '477', 'category': 'CARDINAL'}, {'entity': '388', 'category': 'CARDINAL'}, {'entity': '107', 'category': 'CARDINAL'}, {'entity': '479', 'category': 'CARDINAL'}, {'entity': '2,169', 'category': 'CARDINAL'}, {'entity': '48', 'category': 'CARDINAL'}, {'entity': '11', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '84', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '37', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '147', 'category': 'CARDINAL'}, {'entity': '227', 'category': 'CARDINAL'}, {'entity': '279', 'category': 'CARDINAL'}, {'entity': '236', 'category': 'CARDINAL'}, {'entity': '938', 'category': 'CARDINAL'}, {'entity': '14,391', 'category': 'CARDINAL'}, {'entity': '15,849', 'category': 'CARDINAL'}, {'entity': '20,385', 'category': 'CARDINAL'}, {'entity': '9', 'category': 'CARDINAL'}, {'entity': '22', 'category': 'CARDINAL'}, {'entity': '14', 'category': 'CARDINAL'}, {'entity': '32', 'category': 'CARDINAL'}, {'entity': '76', 'category': 'CARDINAL'}, {'entity': '62', 'category': 'CARDINAL'}, {'entity': '75', 'category': 'CARDINAL'}, {'entity': '23', 'category': 'CARDINAL'}, {'entity': '24', 'category': 'CARDINAL'}, {'entity': '2,087', 'category': 'CARDINAL'}, {'entity': '2,195', 'category': 'CARDINAL'}, {'entity': '2,763', 'category': 'CARDINAL'}, {'entity': '5', 'category': 'CARDINAL'}, {'entity': '21', 'category': 'CARDINAL'}, {'entity': '12,304', 'category': 'CARDINAL'}, {'entity': '13,654', 'category': 'CARDINAL'}, {'entity': '17,622', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '23', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  17\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXQJxi5JbJLQHRVhODyscaHK0CLH\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701574027,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#147#173#83#84#86#1#527#1,388#1,196#10#16#3#2#289#241#208#20#16#1,238#1,147#988#8#16#3#2#1,551#1,521#1,569#2#3#1#3#769#783#771#2#2#782#738#798#6#8#2#6#1,614#1,527#1,485#6#3#1,092#1,016#950#7#7#522#511#535#2#4#1#5#696#702#691#1#2#682#688#681#1#1#14#14#10#40#2#1,280#1,019#803#26#27#4#4#541#404#299#34#35#739#615#504#20#22#7#6#960#706#360#36#96#577#503#323#15#56#383#203#37#89#2,289#2,827#2,758#19#3#1#1,519#2,102#2,052#28#2#770#725#706#6#3#1#7#298#78#263#75#35#3#400#149#304#147#96#2#23#23#877#709#473#24#50#2#591#516#346#15#49#286#193#127#48#52#2#9#26#11#3#20#9#3#6#2#1,444#1,176#917#23#28#2#2#954#797#621#20#28#490#379#296#29#28#8#6#231#503#952#54#47#1#7#155#549#238#348#403#32#14#3#146#2#97#49#2#258#2,547#7,087#90#64#153#2,424#6,709#94#64#105#123#378#15#67#3#1#2,765#2,756#2,950#7#1#3#474#524#527#10#1#2,291#2,232#2,423#3#8#1#3\\n\\nDATE#2012#December 31, 2013#2012#2014#2013#2012#2011#2013#2012#2011#2013#2012#2011#2013#2012#2011#2013#2012#2011#2013#2012#2011#2013#2012#2011#2013#2012#2011#2013#2012#2011#2013#2012#2011#2013#2012#2011#2013#2012, 2011#2013#2012#2011#2013#2012#2011\\n\\nEVENT#product expiration\\nFAC#Federal court\\n\\nMONEY#$147 million#$173 million\\n\\nORG#Medicaid#Company#U.S.#U.S.#Non-U.S.#U.S.#Non-U.S.#U.S.#Non-U.S.#U.S.#Non-U.S.#U.S.#Non-U.S.#U.S.#Non-U.S.#U.S.#Non-U.S.#U.S.#Non-U.S.#U.S.#Non-U.S.#U.S.#Non-U.S.#U.S.#Non-U.S.#U.S.#Non-U.S.#U.S.#Non-U.S.#U.S.#Non-U.S.#U.S.#Non-U.S.#Lilly\\n\\nPERCENT#83%#84%#86%#10 %#16 %#(3 )%#(2 )%#20 %#16 %#8 %#16 %#(3 )%#(2 )%#2 %#(3 )%#(1 )%#(3 )%#6 %#(8 )%#(2 )%#(6 )%#6 %#3 %#(2 )%#(1 )%#2 %#(4 )%#1 %#(5 )%#(1 )%#2 %#26 %#27 %#(4 )%#(4 )%#34 %#35 %#20 %#22 %#(7 )%#(6 )%#36 %#96 %#15 %#56 %#89 %#19 %#3 %#(1 )%#(28 )%#2 %#6 %#3 %#1 %#(7 )%#24 %#50 %#(2 )%#15 %#49 %#48 %#52 %#(2 )%#(9 )%#23 %#28 %#(2 )%#(2 )%#20 %#28 %#29 %#28 %#(8 )%#(6 )%#(54 )%#(47 )%#(1 )%#(32 )%#(14 )%#(3 )%#(90 )%#(64 )%#(94 )%#(64 )%#(15 )%#(67 )%#3 %#(1 )%#(7 )%#(1 )%#(3 )%#(10 )%#(1 )%#3 %#(8 )%#(1 )%#(3 )%\\n\\nPRODUCT#Plavix* and Avapro*/Avalide#Baraclude (entecavir)#Reyataz (atazanavir sulfate)#Sustiva (efavirenz) Franchise#Erbitux* (cetuximab)#Sprycel (dasatinib)#Yervoy (ipilimumab)#Abilify* (aripiprazole)#Bydureon* (exenatide extended-release for injectable suspension)#Byetta* (exenatide)#Forxiga (dapagliflozin)#Onglyza/Kombiglyze(saxagliptin/saxagliptin and metformin)#Nulojix (belatacept)#Orencia (abatacept)#Avapro*/Avalide*(irbesartan/irbesartan-hydrochlorothiazide)#Eliquis (apixaban)#Plavix* (clopidogrel bisulfate)#Baraclude \\u2014 an oral antiviral agent for the treatment of chronic hepatitis B#Reyataz \\u2014 a protease inhibitor for the treatment of the HIV#Sustiva Franchise \\u2014 a non-nucleoside reverse transcriptase inhibitor for the treatment of HIV#Atripla* (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg)#Erbitux* \\u2014 a monoclonal antibody designed to exclusively target and block the Epidermal Growth Factor Receptor#Sprycel \\u2014 an oral inhibitor of multiple tyrosine kinases\\n\\nTIME#six months#twelve months}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 3600,\n",
      "    \"completion_tokens\": 1532,\n",
      "    \"total_tokens\": 5132\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': '2012', 'category': 'DATE'}, {'entity': 'December 31, 2013', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': '2011', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': '2011', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': '2011', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': '2011', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': '2011', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': '2011', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': '2011', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': '2011', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': '2011', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': '2011', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': '2011', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2012, 2011', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': '2011', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': '2011', 'category': 'DATE'}, {'entity': 'product expiration', 'category': 'EVENT'}, {'entity': 'Federal court', 'category': 'FAC'}, {'entity': '$147 million', 'category': 'MONEY'}, {'entity': '$173 million', 'category': 'MONEY'}, {'entity': 'Medicaid', 'category': 'ORG'}, {'entity': 'Company', 'category': 'ORG'}, {'entity': 'U.S.', 'category': 'ORG'}, {'entity': 'U.S.', 'category': 'ORG'}, {'entity': 'Non-U.S.', 'category': 'ORG'}, {'entity': 'U.S.', 'category': 'ORG'}, {'entity': 'Non-U.S.', 'category': 'ORG'}, {'entity': 'U.S.', 'category': 'ORG'}, {'entity': 'Non-U.S.', 'category': 'ORG'}, {'entity': 'U.S.', 'category': 'ORG'}, {'entity': 'Non-U.S.', 'category': 'ORG'}, {'entity': 'U.S.', 'category': 'ORG'}, {'entity': 'Non-U.S.', 'category': 'ORG'}, {'entity': 'U.S.', 'category': 'ORG'}, {'entity': 'Non-U.S.', 'category': 'ORG'}, {'entity': 'U.S.', 'category': 'ORG'}, {'entity': 'Non-U.S.', 'category': 'ORG'}, {'entity': 'U.S.', 'category': 'ORG'}, {'entity': 'Non-U.S.', 'category': 'ORG'}, {'entity': 'U.S.', 'category': 'ORG'}, {'entity': 'Non-U.S.', 'category': 'ORG'}, {'entity': 'U.S.', 'category': 'ORG'}, {'entity': 'Non-U.S.', 'category': 'ORG'}, {'entity': 'U.S.', 'category': 'ORG'}, {'entity': 'Non-U.S.', 'category': 'ORG'}, {'entity': 'U.S.', 'category': 'ORG'}, {'entity': 'Non-U.S.', 'category': 'ORG'}, {'entity': 'U.S.', 'category': 'ORG'}, {'entity': 'Non-U.S.', 'category': 'ORG'}, {'entity': 'U.S.', 'category': 'ORG'}, {'entity': 'Non-U.S.', 'category': 'ORG'}, {'entity': 'U.S.', 'category': 'ORG'}, {'entity': 'Non-U.S.', 'category': 'ORG'}, {'entity': 'Lilly', 'category': 'ORG'}, {'entity': '83%', 'category': 'PERCENT'}, {'entity': '84%', 'category': 'PERCENT'}, {'entity': '86%', 'category': 'PERCENT'}, {'entity': '10 %', 'category': 'PERCENT'}, {'entity': '16 %', 'category': 'PERCENT'}, {'entity': '3 %', 'category': 'PERCENT'}, {'entity': '2 %', 'category': 'PERCENT'}, {'entity': '20 %', 'category': 'PERCENT'}, {'entity': '16 %', 'category': 'PERCENT'}, {'entity': '8 %', 'category': 'PERCENT'}, {'entity': '16 %', 'category': 'PERCENT'}, {'entity': '3 %', 'category': 'PERCENT'}, {'entity': '2 %', 'category': 'PERCENT'}, {'entity': '2 %', 'category': 'PERCENT'}, {'entity': '3 %', 'category': 'PERCENT'}, {'entity': '1 %', 'category': 'PERCENT'}, {'entity': '3 %', 'category': 'PERCENT'}, {'entity': '6 %', 'category': 'PERCENT'}, {'entity': '8 %', 'category': 'PERCENT'}, {'entity': '2 %', 'category': 'PERCENT'}, {'entity': '6 %', 'category': 'PERCENT'}, {'entity': '6 %', 'category': 'PERCENT'}, {'entity': '3 %', 'category': 'PERCENT'}, {'entity': '2 %', 'category': 'PERCENT'}, {'entity': '1 %', 'category': 'PERCENT'}, {'entity': '2 %', 'category': 'PERCENT'}, {'entity': '4 %', 'category': 'PERCENT'}, {'entity': '1 %', 'category': 'PERCENT'}, {'entity': '5 %', 'category': 'PERCENT'}, {'entity': '1 %', 'category': 'PERCENT'}, {'entity': '2 %', 'category': 'PERCENT'}, {'entity': '26 %', 'category': 'PERCENT'}, {'entity': '27 %', 'category': 'PERCENT'}, {'entity': '4 %', 'category': 'PERCENT'}, {'entity': '4 %', 'category': 'PERCENT'}, {'entity': '34 %', 'category': 'PERCENT'}, {'entity': '35 %', 'category': 'PERCENT'}, {'entity': '20 %', 'category': 'PERCENT'}, {'entity': '22 %', 'category': 'PERCENT'}, {'entity': '7 %', 'category': 'PERCENT'}, {'entity': '6 %', 'category': 'PERCENT'}, {'entity': '36 %', 'category': 'PERCENT'}, {'entity': '96 %', 'category': 'PERCENT'}, {'entity': '15 %', 'category': 'PERCENT'}, {'entity': '56 %', 'category': 'PERCENT'}, {'entity': '89 %', 'category': 'PERCENT'}, {'entity': '19 %', 'category': 'PERCENT'}, {'entity': '3 %', 'category': 'PERCENT'}, {'entity': '1 %', 'category': 'PERCENT'}, {'entity': '28 %', 'category': 'PERCENT'}, {'entity': '2 %', 'category': 'PERCENT'}, {'entity': '6 %', 'category': 'PERCENT'}, {'entity': '3 %', 'category': 'PERCENT'}, {'entity': '1 %', 'category': 'PERCENT'}, {'entity': '7 %', 'category': 'PERCENT'}, {'entity': '24 %', 'category': 'PERCENT'}, {'entity': '50 %', 'category': 'PERCENT'}, {'entity': '2 %', 'category': 'PERCENT'}, {'entity': '15 %', 'category': 'PERCENT'}, {'entity': '49 %', 'category': 'PERCENT'}, {'entity': '48 %', 'category': 'PERCENT'}, {'entity': '52 %', 'category': 'PERCENT'}, {'entity': '2 %', 'category': 'PERCENT'}, {'entity': '9 %', 'category': 'PERCENT'}, {'entity': '23 %', 'category': 'PERCENT'}, {'entity': '28 %', 'category': 'PERCENT'}, {'entity': '2 %', 'category': 'PERCENT'}, {'entity': '2 %', 'category': 'PERCENT'}, {'entity': '20 %', 'category': 'PERCENT'}, {'entity': '28 %', 'category': 'PERCENT'}, {'entity': '29 %', 'category': 'PERCENT'}, {'entity': '28 %', 'category': 'PERCENT'}, {'entity': '8 %', 'category': 'PERCENT'}, {'entity': '6 %', 'category': 'PERCENT'}, {'entity': '54 %', 'category': 'PERCENT'}, {'entity': '47 %', 'category': 'PERCENT'}, {'entity': '1 %', 'category': 'PERCENT'}, {'entity': '32 %', 'category': 'PERCENT'}, {'entity': '14 %', 'category': 'PERCENT'}, {'entity': '3 %', 'category': 'PERCENT'}, {'entity': '90 %', 'category': 'PERCENT'}, {'entity': '64 %', 'category': 'PERCENT'}, {'entity': '94 %', 'category': 'PERCENT'}, {'entity': '64 %', 'category': 'PERCENT'}, {'entity': '15 %', 'category': 'PERCENT'}, {'entity': '67 %', 'category': 'PERCENT'}, {'entity': '3 %', 'category': 'PERCENT'}, {'entity': '1 %', 'category': 'PERCENT'}, {'entity': '7 %', 'category': 'PERCENT'}, {'entity': '1 %', 'category': 'PERCENT'}, {'entity': '3 %', 'category': 'PERCENT'}, {'entity': '10 %', 'category': 'PERCENT'}, {'entity': '1 %', 'category': 'PERCENT'}, {'entity': '3 %', 'category': 'PERCENT'}, {'entity': '8 %', 'category': 'PERCENT'}, {'entity': '1 %', 'category': 'PERCENT'}, {'entity': '3 %', 'category': 'PERCENT'}, {'entity': 'Plavix* and Avapro*/Avalide', 'category': 'PRODUCT'}, {'entity': 'Baraclude entecavir', 'category': 'PRODUCT'}, {'entity': 'Reyataz atazanavir sulfate', 'category': 'PRODUCT'}, {'entity': 'Sustiva efavirenz Franchise', 'category': 'PRODUCT'}, {'entity': 'Erbitux* cetuximab', 'category': 'PRODUCT'}, {'entity': 'Sprycel dasatinib', 'category': 'PRODUCT'}, {'entity': 'Yervoy ipilimumab', 'category': 'PRODUCT'}, {'entity': 'Abilify* aripiprazole', 'category': 'PRODUCT'}, {'entity': 'Bydureon* exenatide extended-release for injectable suspension', 'category': 'PRODUCT'}, {'entity': 'Byetta* exenatide', 'category': 'PRODUCT'}, {'entity': 'Forxiga dapagliflozin', 'category': 'PRODUCT'}, {'entity': 'Onglyza/Kombiglyzesaxagliptin/saxagliptin and metformin', 'category': 'PRODUCT'}, {'entity': 'Nulojix belatacept', 'category': 'PRODUCT'}, {'entity': 'Orencia abatacept', 'category': 'PRODUCT'}, {'entity': 'Avapro*/Avalide*irbesartan/irbesartan-hydrochlorothiazide', 'category': 'PRODUCT'}, {'entity': 'Eliquis apixaban', 'category': 'PRODUCT'}, {'entity': 'Plavix* clopidogrel bisulfate', 'category': 'PRODUCT'}, {'entity': 'Baraclude — an oral antiviral agent for the treatment of chronic hepatitis B', 'category': 'PRODUCT'}, {'entity': 'Reyataz — a protease inhibitor for the treatment of the HIV', 'category': 'PRODUCT'}, {'entity': 'Sustiva Franchise — a non-nucleoside reverse transcriptase inhibitor for the treatment of HIV', 'category': 'PRODUCT'}, {'entity': 'Atripla* efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg', 'category': 'PRODUCT'}, {'entity': 'Erbitux* — a monoclonal antibody designed to exclusively target and block the Epidermal Growth Factor Receptor', 'category': 'PRODUCT'}, {'entity': 'Sprycel — an oral inhibitor of multiple tyrosine kinases', 'category': 'PRODUCT'}, {'entity': 'six months', 'category': 'TIME'}, {'entity': 'twelve months', 'category': 'TIME'}, {'entity': '147', 'category': 'CARDINAL'}, {'entity': '173', 'category': 'CARDINAL'}, {'entity': '83', 'category': 'CARDINAL'}, {'entity': '84', 'category': 'CARDINAL'}, {'entity': '86', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '527', 'category': 'CARDINAL'}, {'entity': '1,388', 'category': 'CARDINAL'}, {'entity': '1,196', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '16', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '289', 'category': 'CARDINAL'}, {'entity': '241', 'category': 'CARDINAL'}, {'entity': '208', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '16', 'category': 'CARDINAL'}, {'entity': '1,238', 'category': 'CARDINAL'}, {'entity': '1,147', 'category': 'CARDINAL'}, {'entity': '988', 'category': 'CARDINAL'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': '16', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '1,551', 'category': 'CARDINAL'}, {'entity': '1,521', 'category': 'CARDINAL'}, {'entity': '1,569', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '769', 'category': 'CARDINAL'}, {'entity': '783', 'category': 'CARDINAL'}, {'entity': '771', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '782', 'category': 'CARDINAL'}, {'entity': '738', 'category': 'CARDINAL'}, {'entity': '798', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '1,614', 'category': 'CARDINAL'}, {'entity': '1,527', 'category': 'CARDINAL'}, {'entity': '1,485', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '1,092', 'category': 'CARDINAL'}, {'entity': '1,016', 'category': 'CARDINAL'}, {'entity': '950', 'category': 'CARDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '522', 'category': 'CARDINAL'}, {'entity': '511', 'category': 'CARDINAL'}, {'entity': '535', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '5', 'category': 'CARDINAL'}, {'entity': '696', 'category': 'CARDINAL'}, {'entity': '702', 'category': 'CARDINAL'}, {'entity': '691', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '682', 'category': 'CARDINAL'}, {'entity': '688', 'category': 'CARDINAL'}, {'entity': '681', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '14', 'category': 'CARDINAL'}, {'entity': '14', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '40', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '1,280', 'category': 'CARDINAL'}, {'entity': '1,019', 'category': 'CARDINAL'}, {'entity': '803', 'category': 'CARDINAL'}, {'entity': '26', 'category': 'CARDINAL'}, {'entity': '27', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '541', 'category': 'CARDINAL'}, {'entity': '404', 'category': 'CARDINAL'}, {'entity': '299', 'category': 'CARDINAL'}, {'entity': '34', 'category': 'CARDINAL'}, {'entity': '35', 'category': 'CARDINAL'}, {'entity': '739', 'category': 'CARDINAL'}, {'entity': '615', 'category': 'CARDINAL'}, {'entity': '504', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '22', 'category': 'CARDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '960', 'category': 'CARDINAL'}, {'entity': '706', 'category': 'CARDINAL'}, {'entity': '360', 'category': 'CARDINAL'}, {'entity': '36', 'category': 'CARDINAL'}, {'entity': '96', 'category': 'CARDINAL'}, {'entity': '577', 'category': 'CARDINAL'}, {'entity': '503', 'category': 'CARDINAL'}, {'entity': '323', 'category': 'CARDINAL'}, {'entity': '15', 'category': 'CARDINAL'}, {'entity': '56', 'category': 'CARDINAL'}, {'entity': '383', 'category': 'CARDINAL'}, {'entity': '203', 'category': 'CARDINAL'}, {'entity': '37', 'category': 'CARDINAL'}, {'entity': '89', 'category': 'CARDINAL'}, {'entity': '2,289', 'category': 'CARDINAL'}, {'entity': '2,827', 'category': 'CARDINAL'}, {'entity': '2,758', 'category': 'CARDINAL'}, {'entity': '19', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1,519', 'category': 'CARDINAL'}, {'entity': '2,102', 'category': 'CARDINAL'}, {'entity': '2,052', 'category': 'CARDINAL'}, {'entity': '28', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '770', 'category': 'CARDINAL'}, {'entity': '725', 'category': 'CARDINAL'}, {'entity': '706', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '298', 'category': 'CARDINAL'}, {'entity': '78', 'category': 'CARDINAL'}, {'entity': '263', 'category': 'CARDINAL'}, {'entity': '75', 'category': 'CARDINAL'}, {'entity': '35', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '400', 'category': 'CARDINAL'}, {'entity': '149', 'category': 'CARDINAL'}, {'entity': '304', 'category': 'CARDINAL'}, {'entity': '147', 'category': 'CARDINAL'}, {'entity': '96', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '23', 'category': 'CARDINAL'}, {'entity': '23', 'category': 'CARDINAL'}, {'entity': '877', 'category': 'CARDINAL'}, {'entity': '709', 'category': 'CARDINAL'}, {'entity': '473', 'category': 'CARDINAL'}, {'entity': '24', 'category': 'CARDINAL'}, {'entity': '50', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '591', 'category': 'CARDINAL'}, {'entity': '516', 'category': 'CARDINAL'}, {'entity': '346', 'category': 'CARDINAL'}, {'entity': '15', 'category': 'CARDINAL'}, {'entity': '49', 'category': 'CARDINAL'}, {'entity': '286', 'category': 'CARDINAL'}, {'entity': '193', 'category': 'CARDINAL'}, {'entity': '127', 'category': 'CARDINAL'}, {'entity': '48', 'category': 'CARDINAL'}, {'entity': '52', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '9', 'category': 'CARDINAL'}, {'entity': '26', 'category': 'CARDINAL'}, {'entity': '11', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '9', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '1,444', 'category': 'CARDINAL'}, {'entity': '1,176', 'category': 'CARDINAL'}, {'entity': '917', 'category': 'CARDINAL'}, {'entity': '23', 'category': 'CARDINAL'}, {'entity': '28', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '954', 'category': 'CARDINAL'}, {'entity': '797', 'category': 'CARDINAL'}, {'entity': '621', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '28', 'category': 'CARDINAL'}, {'entity': '490', 'category': 'CARDINAL'}, {'entity': '379', 'category': 'CARDINAL'}, {'entity': '296', 'category': 'CARDINAL'}, {'entity': '29', 'category': 'CARDINAL'}, {'entity': '28', 'category': 'CARDINAL'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '231', 'category': 'CARDINAL'}, {'entity': '503', 'category': 'CARDINAL'}, {'entity': '952', 'category': 'CARDINAL'}, {'entity': '54', 'category': 'CARDINAL'}, {'entity': '47', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '155', 'category': 'CARDINAL'}, {'entity': '549', 'category': 'CARDINAL'}, {'entity': '238', 'category': 'CARDINAL'}, {'entity': '348', 'category': 'CARDINAL'}, {'entity': '403', 'category': 'CARDINAL'}, {'entity': '32', 'category': 'CARDINAL'}, {'entity': '14', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '146', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '97', 'category': 'CARDINAL'}, {'entity': '49', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '258', 'category': 'CARDINAL'}, {'entity': '2,547', 'category': 'CARDINAL'}, {'entity': '7,087', 'category': 'CARDINAL'}, {'entity': '90', 'category': 'CARDINAL'}, {'entity': '64', 'category': 'CARDINAL'}, {'entity': '153', 'category': 'CARDINAL'}, {'entity': '2,424', 'category': 'CARDINAL'}, {'entity': '6,709', 'category': 'CARDINAL'}, {'entity': '94', 'category': 'CARDINAL'}, {'entity': '64', 'category': 'CARDINAL'}, {'entity': '105', 'category': 'CARDINAL'}, {'entity': '123', 'category': 'CARDINAL'}, {'entity': '378', 'category': 'CARDINAL'}, {'entity': '15', 'category': 'CARDINAL'}, {'entity': '67', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '2,765', 'category': 'CARDINAL'}, {'entity': '2,756', 'category': 'CARDINAL'}, {'entity': '2,950', 'category': 'CARDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '474', 'category': 'CARDINAL'}, {'entity': '524', 'category': 'CARDINAL'}, {'entity': '527', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '2,291', 'category': 'CARDINAL'}, {'entity': '2,232', 'category': 'CARDINAL'}, {'entity': '2,423', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  17\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXRa8M1Jwn2gLkZ6cEQo7MmXlX7p\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701574106,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#one\\n\\nDATE#August 2012#second quarter of 2013#fourth quarter of 2012#second quarter of 2012#January 1, 2013#March 2012#first quarter of 2013#May 2011\\n\\nEVENT#\\n\\nFAC#\\n\\nGPE#U.S.#EU#Europe#Japan#Canada#Australia\\n\\nLANGUAGE#\\n\\nLAW_DOCUMENT#\\\"Item 8. Financial Statements\\u2014Note 3. Alliances\\\"\\n\\nLOC#\\n\\nMONEY#$27 million#$62 million\\n\\nNORP#\\n\\nORDINAL#first\\n\\nORG#Philadelphia chromosome-positive chronic myeloid leukemia#Otsuka#AstraZeneca#Amylin#Lilly#Sanofi#Pfizer\\n\\nPERCENT#51.5%#34.0%\\n\\nPERSON#\\n\\nPRODUCT#Sprycel#Gleevec*#Yervoy#Abilify*#Bydureon*#Byetta*#Forxiga#Onglyza/Kombiglyze#Onglyza/Komboglyze#Nulojix#Orencia#Avapro*/Avalide*#Aprovel*/Karvea*#Eliquis#Plavix*#Symlin*\\n\\nQUANTITY#\\n\\nTIME#\\n\\nWORK_OF_ART#}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2336,\n",
      "    \"completion_tokens\": 270,\n",
      "    \"total_tokens\": 2606\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'August 2012', 'category': 'DATE'}, {'entity': 'second quarter of 2013', 'category': 'DATE'}, {'entity': 'fourth quarter of 2012', 'category': 'DATE'}, {'entity': 'second quarter of 2012', 'category': 'DATE'}, {'entity': 'January 1, 2013', 'category': 'DATE'}, {'entity': 'March 2012', 'category': 'DATE'}, {'entity': 'first quarter of 2013', 'category': 'DATE'}, {'entity': 'May 2011', 'category': 'DATE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'EU', 'category': 'GPE'}, {'entity': 'Europe', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'Canada', 'category': 'GPE'}, {'entity': 'Australia', 'category': 'GPE'}, {'entity': 'DOCUMENT', 'category': 'LAW'}, {'entity': '\"Item 8. Financial Statements—Note 3. Alliances\"', 'category': 'LAW'}, {'entity': '$27 million', 'category': 'MONEY'}, {'entity': '$62 million', 'category': 'MONEY'}, {'entity': 'Philadelphia chromosome-positive chronic myeloid leukemia', 'category': 'ORG'}, {'entity': 'Otsuka', 'category': 'ORG'}, {'entity': 'AstraZeneca', 'category': 'ORG'}, {'entity': 'Amylin', 'category': 'ORG'}, {'entity': 'Lilly', 'category': 'ORG'}, {'entity': 'Sanofi', 'category': 'ORG'}, {'entity': 'Pfizer', 'category': 'ORG'}, {'entity': '51.5%', 'category': 'PERCENT'}, {'entity': '34.0%', 'category': 'PERCENT'}, {'entity': 'Sprycel', 'category': 'PRODUCT'}, {'entity': 'Gleevec*', 'category': 'PRODUCT'}, {'entity': 'Yervoy', 'category': 'PRODUCT'}, {'entity': 'Abilify*', 'category': 'PRODUCT'}, {'entity': 'Bydureon*', 'category': 'PRODUCT'}, {'entity': 'Byetta*', 'category': 'PRODUCT'}, {'entity': 'Forxiga', 'category': 'PRODUCT'}, {'entity': 'Onglyza/Kombiglyze', 'category': 'PRODUCT'}, {'entity': 'Onglyza/Komboglyze', 'category': 'PRODUCT'}, {'entity': 'Nulojix', 'category': 'PRODUCT'}, {'entity': 'Orencia', 'category': 'PRODUCT'}, {'entity': 'Avapro*/Avalide*', 'category': 'PRODUCT'}, {'entity': 'Aprovel*/Karvea*', 'category': 'PRODUCT'}, {'entity': 'Eliquis', 'category': 'PRODUCT'}, {'entity': 'Plavix*', 'category': 'PRODUCT'}, {'entity': 'Symlin*', 'category': 'PRODUCT'}, {'entity': '', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'one', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  17\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXSBnkPesmy5LqeV9jdtT8EO723Q\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701574143,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#1.1#1.1#0.7#90#100#2013#2012#2011#13,494#15,281#14,263#100#28.2#26.2#26.4#147#120#27\\nDATE#September 30, 2013#December 31, 2012#September 30, 2013#December 31, 2012#the year ended December 31, 2013\\nGPE#Europe#France#Brazil#U.S.\\nMONEY#$4,619#$4,610#$5,598#$4,084#$4,220#$4,203#$855#$797#$957#$3,731#$3,904#$3,839#$1,830#$205#$80#$334\\nORG#Form 10-K#Form 10-Q#BMS-986094\\nPERCENT#90%-(18)%-(3)%7%-(4)%2%-(100)%-(76)%-(12)%7%\\nPRODUCT#Reyataz\\nWORK_OF_ART#Form 10-K#Form 10-Q}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2238,\n",
      "    \"completion_tokens\": 241,\n",
      "    \"total_tokens\": 2479\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'September 30, 2013', 'category': 'DATE'}, {'entity': 'December 31, 2012', 'category': 'DATE'}, {'entity': 'September 30, 2013', 'category': 'DATE'}, {'entity': 'December 31, 2012', 'category': 'DATE'}, {'entity': 'the year ended December 31, 2013', 'category': 'DATE'}, {'entity': 'Europe', 'category': 'GPE'}, {'entity': 'France', 'category': 'GPE'}, {'entity': 'Brazil', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '$4,619', 'category': 'MONEY'}, {'entity': '$4,610', 'category': 'MONEY'}, {'entity': '$5,598', 'category': 'MONEY'}, {'entity': '$4,084', 'category': 'MONEY'}, {'entity': '$4,220', 'category': 'MONEY'}, {'entity': '$4,203', 'category': 'MONEY'}, {'entity': '$855', 'category': 'MONEY'}, {'entity': '$797', 'category': 'MONEY'}, {'entity': '$957', 'category': 'MONEY'}, {'entity': '$3,731', 'category': 'MONEY'}, {'entity': '$3,904', 'category': 'MONEY'}, {'entity': '$3,839', 'category': 'MONEY'}, {'entity': '$1,830', 'category': 'MONEY'}, {'entity': '$205', 'category': 'MONEY'}, {'entity': '$80', 'category': 'MONEY'}, {'entity': '$334', 'category': 'MONEY'}, {'entity': 'Form 10-K', 'category': 'ORG'}, {'entity': 'Form 10-Q', 'category': 'ORG'}, {'entity': 'BMS-986094', 'category': 'ORG'}, {'entity': '90%-18%-3%7%-4%2%-100%-76%-12%7%', 'category': 'PERCENT'}, {'entity': 'Reyataz', 'category': 'PRODUCT'}, {'entity': 'Form 10-K', 'category': 'WORK_OF_ART'}, {'entity': 'Form 10-Q', 'category': 'WORK_OF_ART'}, {'entity': '1.1', 'category': 'CARDINAL'}, {'entity': '1.1', 'category': 'CARDINAL'}, {'entity': '0.7', 'category': 'CARDINAL'}, {'entity': '90', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '2011', 'category': 'CARDINAL'}, {'entity': '13,494', 'category': 'CARDINAL'}, {'entity': '15,281', 'category': 'CARDINAL'}, {'entity': '14,263', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '28.2', 'category': 'CARDINAL'}, {'entity': '26.2', 'category': 'CARDINAL'}, {'entity': '26.4', 'category': 'CARDINAL'}, {'entity': '147', 'category': 'CARDINAL'}, {'entity': '120', 'category': 'CARDINAL'}, {'entity': '27', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  17\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXSjBJdyAUb4tFvoERh3pO07iVPM\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701574177,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#2.2 billion#1.9 billion#2.0 billion#60 million#27 million#45 million#1.8 billion#145 million\\n\\nDATE#2013#2012#2011#Year Ended December 31#fourth quarter of 2012#2013\\n\\nEVENT#Amylin acquisition#Medarex, Inc. (Medarex) acquisition and Inhibitex, Inc (Inhibitex) acquisition\\n\\nGPE#Mexico#Europe#Asia#U.S.#Ireland#Puerto Rico\\n\\nLAW#\\u201cItem 8. Financial Statements \\u2014Note 14. Goodwill and Other Intangible Assets\\u201d#\\u201c\\u2014Critical Accounting Policies\\u201d#\\u201cItem 8. Financial Statements\\u2014Note 3. Alliances\\\"#\\u201cItem 8. Financial Statements\\u2014Note 19. Pension, Postretirement and Postemployment Liabilities\\\"\\n\\nMONEY#$2.2 billion#$1.9 billion#$2.0 billion#$60 million#$27 million#$45 million#$1.8 billion#199#182#145#226#174#116#20#45#6#166#183#281#38#2#53#37#148#312#140#165#158#10#15#67#62#205#80#334#2,891#2,340#6,981#311#161#1,721#392 million#1,830 million\\n\\nORG#BMS-986094#Inhibitex#Sanofi#Otsuka#Apotex#Plavix#Medarex#ZymoGenetics, Inc.\\n\\nPERCENT#10.8#%#6.9#%#24.7#%\\n\\nPERSON#Amylin\\n\\nPRODUCT#BMS-986094#INX-189#FV-100#a nucleoside inhibitor for the reduction of shingles-associated pain\\n\\nTIME#annual\\n\\nWORK_OF_ART#Specified Items#Non-GAAP Financial Measures\\n}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2370,\n",
      "    \"completion_tokens\": 413,\n",
      "    \"total_tokens\": 2783\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': '2013', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': '2011', 'category': 'DATE'}, {'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': 'fourth quarter of 2012', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': 'Amylin acquisition', 'category': 'EVENT'}, {'entity': 'Medarex, Inc. Medarex acquisition and Inhibitex, Inc Inhibitex acquisition', 'category': 'EVENT'}, {'entity': 'Mexico', 'category': 'GPE'}, {'entity': 'Europe', 'category': 'GPE'}, {'entity': 'Asia', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Ireland', 'category': 'GPE'}, {'entity': 'Puerto Rico', 'category': 'GPE'}, {'entity': '“Item 8. Financial Statements —Note 14. Goodwill and Other Intangible Assets”', 'category': 'LAW'}, {'entity': '“—Critical Accounting Policies”', 'category': 'LAW'}, {'entity': '“Item 8. Financial Statements—Note 3. Alliances\"', 'category': 'LAW'}, {'entity': '“Item 8. Financial Statements—Note 19. Pension, Postretirement and Postemployment Liabilities\"', 'category': 'LAW'}, {'entity': '$2.2 billion', 'category': 'MONEY'}, {'entity': '$1.9 billion', 'category': 'MONEY'}, {'entity': '$2.0 billion', 'category': 'MONEY'}, {'entity': '$60 million', 'category': 'MONEY'}, {'entity': '$27 million', 'category': 'MONEY'}, {'entity': '$45 million', 'category': 'MONEY'}, {'entity': '$1.8 billion', 'category': 'MONEY'}, {'entity': '199', 'category': 'MONEY'}, {'entity': '182', 'category': 'MONEY'}, {'entity': '145', 'category': 'MONEY'}, {'entity': '226', 'category': 'MONEY'}, {'entity': '174', 'category': 'MONEY'}, {'entity': '116', 'category': 'MONEY'}, {'entity': '20', 'category': 'MONEY'}, {'entity': '45', 'category': 'MONEY'}, {'entity': '6', 'category': 'MONEY'}, {'entity': '166', 'category': 'MONEY'}, {'entity': '183', 'category': 'MONEY'}, {'entity': '281', 'category': 'MONEY'}, {'entity': '38', 'category': 'MONEY'}, {'entity': '2', 'category': 'MONEY'}, {'entity': '53', 'category': 'MONEY'}, {'entity': '37', 'category': 'MONEY'}, {'entity': '148', 'category': 'MONEY'}, {'entity': '312', 'category': 'MONEY'}, {'entity': '140', 'category': 'MONEY'}, {'entity': '165', 'category': 'MONEY'}, {'entity': '158', 'category': 'MONEY'}, {'entity': '10', 'category': 'MONEY'}, {'entity': '15', 'category': 'MONEY'}, {'entity': '67', 'category': 'MONEY'}, {'entity': '62', 'category': 'MONEY'}, {'entity': '205', 'category': 'MONEY'}, {'entity': '80', 'category': 'MONEY'}, {'entity': '334', 'category': 'MONEY'}, {'entity': '2,891', 'category': 'MONEY'}, {'entity': '2,340', 'category': 'MONEY'}, {'entity': '6,981', 'category': 'MONEY'}, {'entity': '311', 'category': 'MONEY'}, {'entity': '161', 'category': 'MONEY'}, {'entity': '1,721', 'category': 'MONEY'}, {'entity': '392 million', 'category': 'MONEY'}, {'entity': '1,830 million', 'category': 'MONEY'}, {'entity': 'BMS-986094', 'category': 'ORG'}, {'entity': 'Inhibitex', 'category': 'ORG'}, {'entity': 'Sanofi', 'category': 'ORG'}, {'entity': 'Otsuka', 'category': 'ORG'}, {'entity': 'Apotex', 'category': 'ORG'}, {'entity': 'Plavix', 'category': 'ORG'}, {'entity': 'Medarex', 'category': 'ORG'}, {'entity': 'ZymoGenetics, Inc.', 'category': 'ORG'}, {'entity': '10.8', 'category': 'PERCENT'}, {'entity': '%', 'category': 'PERCENT'}, {'entity': '6.9', 'category': 'PERCENT'}, {'entity': '%', 'category': 'PERCENT'}, {'entity': '24.7', 'category': 'PERCENT'}, {'entity': '%', 'category': 'PERCENT'}, {'entity': 'Amylin', 'category': 'PERSON'}, {'entity': 'BMS-986094', 'category': 'PRODUCT'}, {'entity': 'INX-189', 'category': 'PRODUCT'}, {'entity': 'FV-100', 'category': 'PRODUCT'}, {'entity': 'a nucleoside inhibitor for the reduction of shingles-associated pain', 'category': 'PRODUCT'}, {'entity': 'annual', 'category': 'TIME'}, {'entity': 'Specified Items', 'category': 'WORK_OF_ART'}, {'entity': 'Non-GAAP Financial Measures', 'category': 'WORK_OF_ART'}, {'entity': '2.2 billion', 'category': 'CARDINAL'}, {'entity': '1.9 billion', 'category': 'CARDINAL'}, {'entity': '2.0 billion', 'category': 'CARDINAL'}, {'entity': '60 million', 'category': 'CARDINAL'}, {'entity': '27 million', 'category': 'CARDINAL'}, {'entity': '45 million', 'category': 'CARDINAL'}, {'entity': '1.8 billion', 'category': 'CARDINAL'}, {'entity': '145 million', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  17\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXTMV3t04YX0EgA1YAfQnVIuXTo9\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701574216,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#2.7 billion#259 million#820 million#582 million#2#two#1.5 billion#five-year\\n\\nDATE#prior to 2023#Year Ended December 31#2013#2012#2011#May 2012#March 2012#prior periods#future periods#1,662#1,688#1,717#February 2014#In January 2014\\n\\nFAC#U.S.\\n\\nGPE#Ireland#Puerto Rico#Americas#U.S.#low-tax jurisdictions#U.S.\\n\\nLANGUAGE#English\\n\\nLOC#Item 8. Financial Statements\\u2014Note 10.IT#Item 8. Financial Statements\\u2014Note 5.\\n\\nMONEY#$1,960\\n\\nORDINAL#second#two\\n\\nORG#Item 8. Financial Statements\\u2014Note 3. Alliances#Sanofi#Amylin#AstraZeneca#Financial Statements\\u2014Note 10.Financial Instruments and Fair Value Measurements.\\n\\nPERCENT#12%#100%\\n \\nPERSON#BMS#Amylin\\n\\nPRODUCT#Plavix*#Avapro*/Avalide*#Farxiga}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2767,\n",
      "    \"completion_tokens\": 242,\n",
      "    \"total_tokens\": 3009\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'prior to 2023', 'category': 'DATE'}, {'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': '2011', 'category': 'DATE'}, {'entity': 'May 2012', 'category': 'DATE'}, {'entity': 'March 2012', 'category': 'DATE'}, {'entity': 'prior periods', 'category': 'DATE'}, {'entity': 'future periods', 'category': 'DATE'}, {'entity': '1,662', 'category': 'DATE'}, {'entity': '1,688', 'category': 'DATE'}, {'entity': '1,717', 'category': 'DATE'}, {'entity': 'February 2014', 'category': 'DATE'}, {'entity': 'In January 2014', 'category': 'DATE'}, {'entity': 'U.S.', 'category': 'FAC'}, {'entity': 'Ireland', 'category': 'GPE'}, {'entity': 'Puerto Rico', 'category': 'GPE'}, {'entity': 'Americas', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'low-tax jurisdictions', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'English', 'category': 'LANGUAGE'}, {'entity': 'Item 8. Financial Statements—Note 10.IT', 'category': 'LOC'}, {'entity': 'Item 8. Financial Statements—Note 5.', 'category': 'LOC'}, {'entity': '$1', 'category': 'MONEY'}, {'entity': '960', 'category': 'MONEY'}, {'entity': 'Item 8. Financial Statements—Note 3. Alliances', 'category': 'ORG'}, {'entity': 'Sanofi', 'category': 'ORG'}, {'entity': 'Amylin', 'category': 'ORG'}, {'entity': 'AstraZeneca', 'category': 'ORG'}, {'entity': 'Financial Statements—Note 10.Financial Instruments and Fair Value Measurements.', 'category': 'ORG'}, {'entity': '12%', 'category': 'PERCENT'}, {'entity': '100%', 'category': 'PERCENT'}, {'entity': 'BMS', 'category': 'PERSON'}, {'entity': 'Amylin', 'category': 'PERSON'}, {'entity': 'Plavix*', 'category': 'PRODUCT'}, {'entity': 'Avapro*/Avalide*', 'category': 'PRODUCT'}, {'entity': 'Farxiga', 'category': 'PRODUCT'}, {'entity': 'second', 'category': 'ORDINAL'}, {'entity': 'two', 'category': 'ORDINAL'}, {'entity': '2.7 billion', 'category': 'CARDINAL'}, {'entity': '259 million', 'category': 'CARDINAL'}, {'entity': '820 million', 'category': 'CARDINAL'}, {'entity': '582 million', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': '1.5 billion', 'category': 'CARDINAL'}, {'entity': 'five-year', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  17\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXTudtT8tC5ka4VeW7wbVYew8wLF\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701574250,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL:#359#7,566 \\n\\nDATE:#December 31, 2013#October 2013#September 2013#July 2013#December 2013#May 2010#June 2012#2014#2013#2012#2011\\n\\nEVENT:#public offering#commercial paper borrowings\\n\\nMONEY:#$1.5 billion#$500 million#$509 million#$322 million#$484 million#$522 million#$634 million#$593 million#$1,690#$1,708#1,498#1,657#(2,559)#(2,202)#$629#$967 million#$3.7 billion#$3.6 billion#$700 million#$1.5 billion#$5.0 billion#$2.5 billion#360 million#44 million#$859 million#$1.3 billion#102 million#433 million#2.4 billion#$1.2 billion#$3.0 billion#2.3 billion#$1.41#$1.37#$1.33#$0.36#1.44##$2.0 billion#$597 million#5.25%#$2.0 billion#109 million#78 million#296 million#435 million#(129 million)#392 million#$71 million#554 million#(47 million)\\n\\nORG:#Moody\\u2019s Investors Service#Standard & Poor\\u2019s#Fitch#Board of Directors\\n\\nPERCENT:#1.750%#3.250%#4.500%\\n            \\nPERSON:#Amylin\\n\\n}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2495,\n",
      "    \"completion_tokens\": 314,\n",
      "    \"total_tokens\": 2809\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2013', 'category': 'DATE'}, {'entity': 'October 2013', 'category': 'DATE'}, {'entity': 'September 2013', 'category': 'DATE'}, {'entity': 'July 2013', 'category': 'DATE'}, {'entity': 'December 2013', 'category': 'DATE'}, {'entity': 'May 2010', 'category': 'DATE'}, {'entity': 'June 2012', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': '2011', 'category': 'DATE'}, {'entity': 'public offering', 'category': 'EVENT'}, {'entity': 'commercial paper borrowings', 'category': 'EVENT'}, {'entity': '$1.5 billion', 'category': 'MONEY'}, {'entity': '$500 million', 'category': 'MONEY'}, {'entity': '$509 million', 'category': 'MONEY'}, {'entity': '$322 million', 'category': 'MONEY'}, {'entity': '$484 million', 'category': 'MONEY'}, {'entity': '$522 million', 'category': 'MONEY'}, {'entity': '$634 million', 'category': 'MONEY'}, {'entity': '$593 million', 'category': 'MONEY'}, {'entity': '$1,690', 'category': 'MONEY'}, {'entity': '$1,708', 'category': 'MONEY'}, {'entity': '1,498', 'category': 'MONEY'}, {'entity': '1,657', 'category': 'MONEY'}, {'entity': '2,559', 'category': 'MONEY'}, {'entity': '2,202', 'category': 'MONEY'}, {'entity': '$629', 'category': 'MONEY'}, {'entity': '$967 million', 'category': 'MONEY'}, {'entity': '$3.7 billion', 'category': 'MONEY'}, {'entity': '$3.6 billion', 'category': 'MONEY'}, {'entity': '$700 million', 'category': 'MONEY'}, {'entity': '$1.5 billion', 'category': 'MONEY'}, {'entity': '$5.0 billion', 'category': 'MONEY'}, {'entity': '$2.5 billion', 'category': 'MONEY'}, {'entity': '360 million', 'category': 'MONEY'}, {'entity': '44 million', 'category': 'MONEY'}, {'entity': '$859 million', 'category': 'MONEY'}, {'entity': '$1.3 billion', 'category': 'MONEY'}, {'entity': '102 million', 'category': 'MONEY'}, {'entity': '433 million', 'category': 'MONEY'}, {'entity': '2.4 billion', 'category': 'MONEY'}, {'entity': '$1.2 billion', 'category': 'MONEY'}, {'entity': '$3.0 billion', 'category': 'MONEY'}, {'entity': '2.3 billion', 'category': 'MONEY'}, {'entity': '$1.41', 'category': 'MONEY'}, {'entity': '$1.37', 'category': 'MONEY'}, {'entity': '$1.33', 'category': 'MONEY'}, {'entity': '$0.36', 'category': 'MONEY'}, {'entity': '1.44', 'category': 'MONEY'}, {'entity': '$2.0 billion', 'category': 'MONEY'}, {'entity': '$597 million', 'category': 'MONEY'}, {'entity': '5.25%', 'category': 'MONEY'}, {'entity': '$2.0 billion', 'category': 'MONEY'}, {'entity': '109 million', 'category': 'MONEY'}, {'entity': '78 million', 'category': 'MONEY'}, {'entity': '296 million', 'category': 'MONEY'}, {'entity': '435 million', 'category': 'MONEY'}, {'entity': '129 million', 'category': 'MONEY'}, {'entity': '392 million', 'category': 'MONEY'}, {'entity': '$71 million', 'category': 'MONEY'}, {'entity': '554 million', 'category': 'MONEY'}, {'entity': '47 million', 'category': 'MONEY'}, {'entity': 'Moody’s Investors Service', 'category': 'ORG'}, {'entity': 'Standard & Poor’s', 'category': 'ORG'}, {'entity': 'Fitch', 'category': 'ORG'}, {'entity': 'Board of Directors', 'category': 'ORG'}, {'entity': '1.750%', 'category': 'PERCENT'}, {'entity': '3.250%', 'category': 'PERCENT'}, {'entity': '4.500%', 'category': 'PERCENT'}, {'entity': 'Amylin', 'category': 'PERSON'}, {'entity': '359', 'category': 'CARDINAL'}, {'entity': '7,566', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  17\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXUTFp279L2DFXeqdGHddV2Z51U0\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701574285,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#7,566#5,567#614#1,476#114#627#16,323#1,578#886#1,459#1,294#1,015#10,091#100#3.6#700#2.9#1.6#4#2004#10#100%#90%#250\\n\\nDATE#August 4, 2004#December 15, 2013\\n\\nLAW_DOCUMENT#SEC Consent Order\\n\\nMONEY#$3.6 billion#$700 million#$2.9 billion#$1.6 billion#$250 million\\n\\nORG#SEC#Audit Committee of the Board of Directors#Financial Accounting Standards Board\\n\\nPERSON#Form 10-Q\\n\\nPRODUCT#IMAs\\n\\nTIME#weekly#monthly\\n\\nWORK_OF_ART#Item 8. Financial Statements\\u2014Note 19. Pension, Postretirement and Postemployment Liabilities#Item 8. Financial Statements\\u2014Note 8. Income Taxes#Item 8. Financial Statements\\u2014Note 3. Alliances#Item 8. Financial Statements\\u2014Note 10. Financial Instruments and Fair Value Measurements#Item 8. Financial Statements\\u2014Note 21. Leases\\n}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2185,\n",
      "    \"completion_tokens\": 251,\n",
      "    \"total_tokens\": 2436\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'August 4, 2004', 'category': 'DATE'}, {'entity': 'December 15, 2013', 'category': 'DATE'}, {'entity': 'DOCUMENT', 'category': 'LAW'}, {'entity': 'SEC Consent Order', 'category': 'LAW'}, {'entity': '$3.6 billion', 'category': 'MONEY'}, {'entity': '$700 million', 'category': 'MONEY'}, {'entity': '$2.9 billion', 'category': 'MONEY'}, {'entity': '$1.6 billion', 'category': 'MONEY'}, {'entity': '$250 million', 'category': 'MONEY'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'Audit Committee of the Board of Directors', 'category': 'ORG'}, {'entity': 'Financial Accounting Standards Board', 'category': 'ORG'}, {'entity': 'Form 10-Q', 'category': 'PERSON'}, {'entity': 'IMAs', 'category': 'PRODUCT'}, {'entity': 'weekly', 'category': 'TIME'}, {'entity': 'monthly', 'category': 'TIME'}, {'entity': 'Item 8. Financial Statements—Note 19. Pension, Postretirement and Postemployment Liabilities', 'category': 'WORK_OF_ART'}, {'entity': 'Item 8. Financial Statements—Note 8. Income Taxes', 'category': 'WORK_OF_ART'}, {'entity': 'Item 8. Financial Statements—Note 3. Alliances', 'category': 'WORK_OF_ART'}, {'entity': 'Item 8. Financial Statements—Note 10. Financial Instruments and Fair Value Measurements', 'category': 'WORK_OF_ART'}, {'entity': 'Item 8. Financial Statements—Note 21. Leases', 'category': 'WORK_OF_ART'}, {'entity': '7,566', 'category': 'CARDINAL'}, {'entity': '5,567', 'category': 'CARDINAL'}, {'entity': '614', 'category': 'CARDINAL'}, {'entity': '1,476', 'category': 'CARDINAL'}, {'entity': '114', 'category': 'CARDINAL'}, {'entity': '627', 'category': 'CARDINAL'}, {'entity': '16,323', 'category': 'CARDINAL'}, {'entity': '1,578', 'category': 'CARDINAL'}, {'entity': '886', 'category': 'CARDINAL'}, {'entity': '1,459', 'category': 'CARDINAL'}, {'entity': '1,294', 'category': 'CARDINAL'}, {'entity': '1,015', 'category': 'CARDINAL'}, {'entity': '10,091', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '3.6', 'category': 'CARDINAL'}, {'entity': '700', 'category': 'CARDINAL'}, {'entity': '2.9', 'category': 'CARDINAL'}, {'entity': '1.6', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '2004', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '100%', 'category': 'CARDINAL'}, {'entity': '90%', 'category': 'CARDINAL'}, {'entity': '250', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  17\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXV0Z9YELFH14xfIW5kcP7GE8ttO\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701574318,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#2#50%#15.1%#23.1%#$67 million#$85 million#$37 million#$147 million#$173 million#4.15% \\n\\nDATE#January 1, 2010#2011#2012#2013#December 31, 2013#December 31, 2012\\n\\nEVENT#Medicare Part D coverage gap discounts\\n\\nGPE#U.S.\\n\\nLAW#340B Drug Pricing Program#Medicare Part D\\n\\nMONEY#2% of the sales price\\n\\nORG#U.S. Department of Defense#U.S. Department of Veterans Affairs#Medicaid#Company\\u2019s#Citigroup\\n\\nPERCENT#2%#50%#15.1%#23.1%\\n\\nPRODUCT#Plavix#Avapro#Avalide\\n\\nTIME#one month time lag#six months#twelve months\\n\\nWORK_OF_ART#Retirement BenefitsAccounting}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2026,\n",
      "    \"completion_tokens\": 195,\n",
      "    \"total_tokens\": 2221\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'January 1, 2010', 'category': 'DATE'}, {'entity': '2011', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': 'December 31, 2013', 'category': 'DATE'}, {'entity': 'December 31, 2012', 'category': 'DATE'}, {'entity': 'Medicare Part D coverage gap discounts', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '340B Drug Pricing Program', 'category': 'LAW'}, {'entity': 'Medicare Part D', 'category': 'LAW'}, {'entity': '2% of the sales price', 'category': 'MONEY'}, {'entity': 'U.S. Department of Defense', 'category': 'ORG'}, {'entity': 'U.S. Department of Veterans Affairs', 'category': 'ORG'}, {'entity': 'Medicaid', 'category': 'ORG'}, {'entity': 'Company’s', 'category': 'ORG'}, {'entity': 'Citigroup', 'category': 'ORG'}, {'entity': '2%', 'category': 'PERCENT'}, {'entity': '50%', 'category': 'PERCENT'}, {'entity': '15.1%', 'category': 'PERCENT'}, {'entity': '23.1%', 'category': 'PERCENT'}, {'entity': 'Plavix', 'category': 'PRODUCT'}, {'entity': 'Avapro', 'category': 'PRODUCT'}, {'entity': 'Avalide', 'category': 'PRODUCT'}, {'entity': 'one month time lag', 'category': 'TIME'}, {'entity': 'six months', 'category': 'TIME'}, {'entity': 'twelve months', 'category': 'TIME'}, {'entity': 'Retirement BenefitsAccounting', 'category': 'WORK_OF_ART'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '50%', 'category': 'CARDINAL'}, {'entity': '15.1%', 'category': 'CARDINAL'}, {'entity': '23.1%', 'category': 'CARDINAL'}, {'entity': '$67 million', 'category': 'CARDINAL'}, {'entity': '$85 million', 'category': 'CARDINAL'}, {'entity': '$37 million', 'category': 'CARDINAL'}, {'entity': '$147 million', 'category': 'CARDINAL'}, {'entity': '$173 million', 'category': 'CARDINAL'}, {'entity': '4.15%', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  17\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXVXAb1tSFqOZPy1lkvGExYyU9E4\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701574351,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#4.62%#1%#10 million#1%#950 million#8.63%#1%#53 million#15.6 billion#41%#6.2 billion#7.1 billion\\n\\nDATE#December 31, 2013#December 31, 2013#December 31, 2013\\n\\nMONEY#$10 million#$950 million#$15.6 billion#$6.2 billion#$7.1 billion\\n\\nORG#U.S. pension#U.S. plans#U.S. plans#BMS#Amylin#Inhibitex#Amira\\n\\nPERCENT#4.62%#1%#8.63%#1%#41%\\n\\nPERSON#BMS-986094#INX-189#Metreleptin#AM152#Bydureon#Byetta#Symlin#Recothrom}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2250,\n",
      "    \"completion_tokens\": 189,\n",
      "    \"total_tokens\": 2439\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2013', 'category': 'DATE'}, {'entity': 'December 31, 2013', 'category': 'DATE'}, {'entity': 'December 31, 2013', 'category': 'DATE'}, {'entity': '$10 million', 'category': 'MONEY'}, {'entity': '$950 million', 'category': 'MONEY'}, {'entity': '$15.6 billion', 'category': 'MONEY'}, {'entity': '$6.2 billion', 'category': 'MONEY'}, {'entity': '$7.1 billion', 'category': 'MONEY'}, {'entity': 'U.S. pension', 'category': 'ORG'}, {'entity': 'U.S. plans', 'category': 'ORG'}, {'entity': 'U.S. plans', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Amylin', 'category': 'ORG'}, {'entity': 'Inhibitex', 'category': 'ORG'}, {'entity': 'Amira', 'category': 'ORG'}, {'entity': '4.62%', 'category': 'PERCENT'}, {'entity': '1%', 'category': 'PERCENT'}, {'entity': '8.63%', 'category': 'PERCENT'}, {'entity': '1%', 'category': 'PERCENT'}, {'entity': '41%', 'category': 'PERCENT'}, {'entity': 'BMS-986094', 'category': 'PERSON'}, {'entity': 'INX-189', 'category': 'PERSON'}, {'entity': 'Metreleptin', 'category': 'PERSON'}, {'entity': 'AM152', 'category': 'PERSON'}, {'entity': 'Bydureon', 'category': 'PERSON'}, {'entity': 'Byetta', 'category': 'PERSON'}, {'entity': 'Symlin', 'category': 'PERSON'}, {'entity': 'Recothrom', 'category': 'PERSON'}, {'entity': '4.62%', 'category': 'CARDINAL'}, {'entity': '1%', 'category': 'CARDINAL'}, {'entity': '10 million', 'category': 'CARDINAL'}, {'entity': '1%', 'category': 'CARDINAL'}, {'entity': '950 million', 'category': 'CARDINAL'}, {'entity': '8.63%', 'category': 'CARDINAL'}, {'entity': '1%', 'category': 'CARDINAL'}, {'entity': '53 million', 'category': 'CARDINAL'}, {'entity': '15.6 billion', 'category': 'CARDINAL'}, {'entity': '41%', 'category': 'CARDINAL'}, {'entity': '6.2 billion', 'category': 'CARDINAL'}, {'entity': '7.1 billion', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  17\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXW3b4NVQuATvPpqJ7xZhTuIdkht\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701574383,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#2.3 billion#525 million#1.0 billion#241 million#548 million#2.1 billion#1.8 billion#30 million#120 million#310 million#160 million#4.8 billion#4.6 billion#5.1 billion#4.4 billion#138 million#23 million#784 million#383 million \\n\\nDATE#December 31, 2013#2012#2011#December 31, 2012#2022#2017\\n\\nEVENT#the discontinued development of BMS-986094#the exchange offer\\n\\nFAC#\\n\\nGPE#U.S.\\n\\nLOC#\\n\\nMONEY#\\n\\nNORP#Federal\\n\\nORDINAL#\\n\\nORG#IPRD#Medarex, Inc.#Inhibitex#Mead Johnson Nutrition Company#Mead Johnson#Mead Johnson & Company#Internal Revenue Service\\n\\nPERCENT#\\n\\nPERSON#\\n\\nPRODUCT#capitalized software\\n\\nQUANTITY#\\n\\nTIME#\\n\\nWORK_OF_ART#}\\n\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2138,\n",
      "    \"completion_tokens\": 202,\n",
      "    \"total_tokens\": 2340\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2013', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': '2011', 'category': 'DATE'}, {'entity': 'December 31, 2012', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': 'the discontinued development of BMS-986094', 'category': 'EVENT'}, {'entity': 'the exchange offer', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Federal', 'category': 'NORP'}, {'entity': 'IPRD', 'category': 'ORG'}, {'entity': 'Medarex, Inc.', 'category': 'ORG'}, {'entity': 'Inhibitex', 'category': 'ORG'}, {'entity': 'Mead Johnson Nutrition Company', 'category': 'ORG'}, {'entity': 'Mead Johnson', 'category': 'ORG'}, {'entity': 'Mead Johnson & Company', 'category': 'ORG'}, {'entity': 'Internal Revenue Service', 'category': 'ORG'}, {'entity': 'capitalized software', 'category': 'PRODUCT'}, {'entity': '', 'category': 'WORK_OF_ART'}, {'entity': '2.3 billion', 'category': 'CARDINAL'}, {'entity': '525 million', 'category': 'CARDINAL'}, {'entity': '1.0 billion', 'category': 'CARDINAL'}, {'entity': '241 million', 'category': 'CARDINAL'}, {'entity': '548 million', 'category': 'CARDINAL'}, {'entity': '2.1 billion', 'category': 'CARDINAL'}, {'entity': '1.8 billion', 'category': 'CARDINAL'}, {'entity': '30 million', 'category': 'CARDINAL'}, {'entity': '120 million', 'category': 'CARDINAL'}, {'entity': '310 million', 'category': 'CARDINAL'}, {'entity': '160 million', 'category': 'CARDINAL'}, {'entity': '4.8 billion', 'category': 'CARDINAL'}, {'entity': '4.6 billion', 'category': 'CARDINAL'}, {'entity': '5.1 billion', 'category': 'CARDINAL'}, {'entity': '4.4 billion', 'category': 'CARDINAL'}, {'entity': '138 million', 'category': 'CARDINAL'}, {'entity': '23 million', 'category': 'CARDINAL'}, {'entity': '784 million', 'category': 'CARDINAL'}, {'entity': '383 million', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  17\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXWZN13ENAReghZuRQqgqekjZPoc\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701574415,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#100 \\n\\nDATE#December 31, 2013\\n\\nFAC#Internal Revenue Code\\n\\nGPE#United States#Euro#Japanese yen#Chinese renminbi#Canadian dollar#South Korean\\n\\nLAW#Section 27A of the Securities Act of 1933#Section 21E of the Securities Exchange Act of 1934\\n\\nMONEY#$244 million#$135 million#$161 million#$697 million#$104\\n\\nNORP#U.S.\\n\\nORDINAL#10-K\\n\\nORG#Mead Johnson#IRS#Annual Report#Item 7A\\n\\nPERCENT#10%\\n\\nPERSON#Form 10-K\\n\\nPRODUCT#stock\\n\\nQUANTITY#QUANTITATIVE AND QUALITATIVE DISCLOSURES \\n\\nTIME#the next several years\\n\\nWORK_OF_ART#Item 8. Financial Statements\\u2014Note 10. Financial Instruments and Fair Value Measurements#Item 8. Financial Statements\\u2014Note 1. Accounting Policies\\u2014Income Taxes#Item 1A. Risk Factors}\\n\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2102,\n",
      "    \"completion_tokens\": 207,\n",
      "    \"total_tokens\": 2309\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': 'Internal Revenue Code', 'category': 'FAC'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'Euro', 'category': 'GPE'}, {'entity': 'Japanese yen', 'category': 'GPE'}, {'entity': 'Chinese renminbi', 'category': 'GPE'}, {'entity': 'Canadian dollar', 'category': 'GPE'}, {'entity': 'South Korean', 'category': 'GPE'}, {'entity': 'Section 27A of the Securities Act of 1933', 'category': 'LAW'}, {'entity': 'Section 21E of the Securities Exchange Act of 1934', 'category': 'LAW'}, {'entity': '$244 million', 'category': 'MONEY'}, {'entity': '$135 million', 'category': 'MONEY'}, {'entity': '$161 million', 'category': 'MONEY'}, {'entity': '$697 million', 'category': 'MONEY'}, {'entity': '$104', 'category': 'MONEY'}, {'entity': 'U.S.', 'category': 'NORP'}, {'entity': 'Mead Johnson', 'category': 'ORG'}, {'entity': 'IRS', 'category': 'ORG'}, {'entity': 'Annual Report', 'category': 'ORG'}, {'entity': 'Item 7A', 'category': 'ORG'}, {'entity': '10%', 'category': 'PERCENT'}, {'entity': 'Form 10-K', 'category': 'PERSON'}, {'entity': 'stock', 'category': 'PRODUCT'}, {'entity': 'QUANTITATIVE AND QUALITATIVE DISCLOSURES', 'category': 'QUANTITY'}, {'entity': 'the next several years', 'category': 'TIME'}, {'entity': 'Item 8. Financial Statements—Note 10. Financial Instruments and Fair Value Measurements', 'category': 'WORK_OF_ART'}, {'entity': 'Item 8. Financial Statements—Note 1. Accounting Policies—Income Taxes', 'category': 'WORK_OF_ART'}, {'entity': 'Item 1A. Risk Factors', 'category': 'WORK_OF_ART'}, {'entity': '10-K', 'category': 'ORDINAL'}, {'entity': '100', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  17\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXX519JEUTnagFXEgmmG9HEdx8dA\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701574447,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL:#104 million#80#\\n\\nDATE:#December 31, 2013\\n\\nGPE:#European#Europe#Greece#Portugal#Italy#Spain\\n\\nLAW:#Item 8. Financial Statements\\u2014Note 10. Financial Instruments and Fair Value Measurements\\n\\nMONEY:#$104 million#$172 million\\n\\nORG:#government-backed entities\\n\\nPERCENT:#80%\\n\\nWORK_OF_ART:#Credit Risk}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 945,\n",
      "    \"completion_tokens\": 85,\n",
      "    \"total_tokens\": 1030\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2013', 'category': 'DATE'}, {'entity': 'European', 'category': 'GPE'}, {'entity': 'Europe', 'category': 'GPE'}, {'entity': 'Greece', 'category': 'GPE'}, {'entity': 'Portugal', 'category': 'GPE'}, {'entity': 'Italy', 'category': 'GPE'}, {'entity': 'Spain', 'category': 'GPE'}, {'entity': 'Item 8. Financial Statements—Note 10. Financial Instruments and Fair Value Measurements', 'category': 'LAW'}, {'entity': '$104 million', 'category': 'MONEY'}, {'entity': '$172 million', 'category': 'MONEY'}, {'entity': 'government-backed entities', 'category': 'ORG'}, {'entity': '80%', 'category': 'PERCENT'}, {'entity': 'Credit Risk', 'category': 'WORK_OF_ART'}, {'entity': '104 million', 'category': 'CARDINAL'}, {'entity': '80', 'category': 'CARDINAL'}]\n",
      "/home/damir/Dropbox/Documents/Teaching/2023/L715/l715_23/data/10-Ks/Bristol-Myers_Squibb_Company/2017/Management.txt\n",
      "Length of chunks:  14\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXXYNoMvocQ3DJjZIHMdASIOpJwp\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701574476,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#19#10#17 \\n\\nDATE#2016#October 2016#December 31#December 2016#November 2016#August 2016#May 2016#April 2016#February 2016#January 2016#September 2016#July 2016#June 2016 \\n\\nEVENT#MANAGEMENT\\u2019S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS \\n\\nFAC#Marketable Securities\\n  \\nGPE#U.S.#EU#Japan#North America \\n\\nMONEY#$0.93#$2.65#$2.01#$2.83 \\n\\nORG#Bristol-Myers Squibb Company#Summary of Abbreviated Terms#CheckMate-026#Opdivo+Yervoy#Eliquis and Orencia product sales#GAAP#Dollars in Millions#FDA#RCC#HSCT#NSQ NSCLC#BRAF#Revlimid*#MTX#HCV#Ximency#Daklinza#HIV\\n\\nPERCENT#23.8#21.5#14.8\\n\\nPERSON#\\n\\nPRODUCT#Abilify*#Erbitux*#Reyataz#Sustiva#Baraclude#Opdivo#Eliquis#Orencia#Opdivo+Yervoy#Empliciti#Hepatitis C Franchise#Ximency  \\n\\nQUANTITY#\\t\\n\\nTIME#\\n\\nWORK_OF_ART#2016 Form 10-K\\n}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2458,\n",
      "    \"completion_tokens\": 321,\n",
      "    \"total_tokens\": 2779\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': '2016', 'category': 'DATE'}, {'entity': 'October 2016', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': 'December 2016', 'category': 'DATE'}, {'entity': 'November 2016', 'category': 'DATE'}, {'entity': 'August 2016', 'category': 'DATE'}, {'entity': 'May 2016', 'category': 'DATE'}, {'entity': 'April 2016', 'category': 'DATE'}, {'entity': 'February 2016', 'category': 'DATE'}, {'entity': 'January 2016', 'category': 'DATE'}, {'entity': 'September 2016', 'category': 'DATE'}, {'entity': 'July 2016', 'category': 'DATE'}, {'entity': 'June 2016', 'category': 'DATE'}, {'entity': 'MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS', 'category': 'EVENT'}, {'entity': 'Marketable Securities', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'EU', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'North America', 'category': 'GPE'}, {'entity': '$0.93', 'category': 'MONEY'}, {'entity': '$2.65', 'category': 'MONEY'}, {'entity': '$2.01', 'category': 'MONEY'}, {'entity': '$2.83', 'category': 'MONEY'}, {'entity': 'Bristol-Myers Squibb Company', 'category': 'ORG'}, {'entity': 'Summary of Abbreviated Terms', 'category': 'ORG'}, {'entity': 'CheckMate-026', 'category': 'ORG'}, {'entity': 'Opdivo+Yervoy', 'category': 'ORG'}, {'entity': 'Eliquis and Orencia product sales', 'category': 'ORG'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': 'Dollars in Millions', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'RCC', 'category': 'ORG'}, {'entity': 'HSCT', 'category': 'ORG'}, {'entity': 'NSQ NSCLC', 'category': 'ORG'}, {'entity': 'BRAF', 'category': 'ORG'}, {'entity': 'Revlimid*', 'category': 'ORG'}, {'entity': 'MTX', 'category': 'ORG'}, {'entity': 'HCV', 'category': 'ORG'}, {'entity': 'Ximency', 'category': 'ORG'}, {'entity': 'Daklinza', 'category': 'ORG'}, {'entity': 'HIV', 'category': 'ORG'}, {'entity': '23.8', 'category': 'PERCENT'}, {'entity': '21.5', 'category': 'PERCENT'}, {'entity': '14.8', 'category': 'PERCENT'}, {'entity': 'Abilify*', 'category': 'PRODUCT'}, {'entity': 'Erbitux*', 'category': 'PRODUCT'}, {'entity': 'Reyataz', 'category': 'PRODUCT'}, {'entity': 'Sustiva', 'category': 'PRODUCT'}, {'entity': 'Baraclude', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Eliquis', 'category': 'PRODUCT'}, {'entity': 'Orencia', 'category': 'PRODUCT'}, {'entity': 'Opdivo+Yervoy', 'category': 'PRODUCT'}, {'entity': 'Empliciti', 'category': 'PRODUCT'}, {'entity': 'Hepatitis C Franchise', 'category': 'PRODUCT'}, {'entity': 'Ximency', 'category': 'PRODUCT'}, {'entity': '2016 Form 10-K', 'category': 'WORK_OF_ART'}, {'entity': '19', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '17', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  14\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXY9LUO16cekWCnoMUDV49Z4GfmB\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701574513,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#2016#2015#2014#31#21#4#34#5#3#170\\n\\nDATE#February 2016#April 2016#July 2016#December 2016#in 2016#in 2014#in 2015\\n\\nEVENT#Acquisition and Licensing Arrangements#RESULTS OF OPERATIONSRegional\\n\\nFAC#California Institute for Biomedical Research\\n\\nGPE#United States#Europe#Japan#EU#France#Latin America\\n\\nLOC#\\n\\nMONEY#\\n\\nNORP#\\n\\nORDINAL#first\\n\\nORG#Yervoy#Nitto Denko#BMS#Cormorant#Padlock#Pfizer#Portola#Dual Therapeutics, LLC#Eliquis#Sprycel#Opdivo#Daklinza#Erbitux\\n\\nPERCENT#\\n\\nPERSON#\\n\\nPRODUCT#HSP47 siRNAs#HuMax-IL8#PAD\\n\\nQUANTITY#\\n\\nTIME#\\n\\nWORK_OF_ART#}\\n\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2344,\n",
      "    \"completion_tokens\": 209,\n",
      "    \"total_tokens\": 2553\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'February 2016', 'category': 'DATE'}, {'entity': 'April 2016', 'category': 'DATE'}, {'entity': 'July 2016', 'category': 'DATE'}, {'entity': 'December 2016', 'category': 'DATE'}, {'entity': 'in 2016', 'category': 'DATE'}, {'entity': 'in 2014', 'category': 'DATE'}, {'entity': 'in 2015', 'category': 'DATE'}, {'entity': 'Acquisition and Licensing Arrangements', 'category': 'EVENT'}, {'entity': 'RESULTS OF OPERATIONSRegional', 'category': 'EVENT'}, {'entity': 'California Institute for Biomedical Research', 'category': 'FAC'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'Europe', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'EU', 'category': 'GPE'}, {'entity': 'France', 'category': 'GPE'}, {'entity': 'Latin America', 'category': 'GPE'}, {'entity': 'Yervoy', 'category': 'ORG'}, {'entity': 'Nitto Denko', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Cormorant', 'category': 'ORG'}, {'entity': 'Padlock', 'category': 'ORG'}, {'entity': 'Pfizer', 'category': 'ORG'}, {'entity': 'Portola', 'category': 'ORG'}, {'entity': 'Dual Therapeutics, LLC', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'Sprycel', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Daklinza', 'category': 'ORG'}, {'entity': 'Erbitux', 'category': 'ORG'}, {'entity': 'HSP47 siRNAs', 'category': 'PRODUCT'}, {'entity': 'HuMax-IL8', 'category': 'PRODUCT'}, {'entity': 'PAD', 'category': 'PRODUCT'}, {'entity': '', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '2016', 'category': 'CARDINAL'}, {'entity': '2015', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '31', 'category': 'CARDINAL'}, {'entity': '21', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '34', 'category': 'CARDINAL'}, {'entity': '5', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '170', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  14\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXYhA0ojf8jXaGK7Expz1q2J44S1\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701574547,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#10%#10%#$460 million#$1.1 billion#$1.6 billion#22,364#17,166#13,793#30#24#(1,582)#(1,043)#(755)#52#38#(1,382)#(859)#(551)#61#56#(1,698)#(1,219)#(827)#39#47#(4,662)#(3,121)#(2,133)#49#46#17,702#14,045#11,660#26#20#3,774#942#6#1,824#1,620#1,493#13#9#1,053#1,126#1,308#(6)#(14)#3,343#1,860#774#80#2,265#1,885#1,652#20#14#1,192#1,312#1,441#(9)#1,578#1,603#256#(2)#912#1,139#1,362#(20)#(16)#1,065#1,252#1,444#(15)#(13)#128#746#2,020#(83)#(63)#2,143#2,571#3,400#(17)#(24)\\nDATE#2016#2015#2014#April 2015#January 1, 2015#December 31, 2015#December 31, 2016#Year Ended December 31,#2016 vs. 2015#2015 vs. 2014\\nGPE#Japan#U.S.#France\\nMONEY#$56#$267#$584#$907#$1,043#$878#$1,315#$3,236#$97#$434#$890#$1,421#$1,582#$1,438#$1,797#$4,817#$126#$520#$1,160#$1,806\\nNORP#Japanese#European\\nORG#Medicaid#Medicare#Daklinza#Eliquis#Opdivo#Hepatitis C#Oncology#Erbitux#Lilly#EU#Philadelphia chromosome#Gleevec\\nPERCENT#10%#10%#30%#24%#52%#38%#61%#56%#39%#47%#49%#46%#26%#20%#13%#9%#(6%)#(14%)#80%#20%#14%#(9%)#(15%)#(13%)#(83%)#(63%)#(17%)#(24%)\\nPRODUCT#Abilify*#Atripla*#Eliquis#Opdivo\\nTIME#Current period#Current period\\nWORK_OF_ART#Alliances-Note 3. Alliances\\n}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 3431,\n",
      "    \"completion_tokens\": 616,\n",
      "    \"total_tokens\": 4047\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': '2016', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': 'April 2015', 'category': 'DATE'}, {'entity': 'January 1, 2015', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'Year Ended December 31,', 'category': 'DATE'}, {'entity': '2016 vs. 2015', 'category': 'DATE'}, {'entity': '2015 vs. 2014', 'category': 'DATE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'France', 'category': 'GPE'}, {'entity': '$56', 'category': 'MONEY'}, {'entity': '$267', 'category': 'MONEY'}, {'entity': '$584', 'category': 'MONEY'}, {'entity': '$907', 'category': 'MONEY'}, {'entity': '$1,043', 'category': 'MONEY'}, {'entity': '$878', 'category': 'MONEY'}, {'entity': '$1,315', 'category': 'MONEY'}, {'entity': '$3,236', 'category': 'MONEY'}, {'entity': '$97', 'category': 'MONEY'}, {'entity': '$434', 'category': 'MONEY'}, {'entity': '$890', 'category': 'MONEY'}, {'entity': '$1,421', 'category': 'MONEY'}, {'entity': '$1,582', 'category': 'MONEY'}, {'entity': '$1,438', 'category': 'MONEY'}, {'entity': '$1,797', 'category': 'MONEY'}, {'entity': '$4,817', 'category': 'MONEY'}, {'entity': '$126', 'category': 'MONEY'}, {'entity': '$520', 'category': 'MONEY'}, {'entity': '$1,160', 'category': 'MONEY'}, {'entity': '$1,806', 'category': 'MONEY'}, {'entity': 'Japanese', 'category': 'NORP'}, {'entity': 'European', 'category': 'NORP'}, {'entity': 'Medicaid', 'category': 'ORG'}, {'entity': 'Medicare', 'category': 'ORG'}, {'entity': 'Daklinza', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Hepatitis C', 'category': 'ORG'}, {'entity': 'Oncology', 'category': 'ORG'}, {'entity': 'Erbitux', 'category': 'ORG'}, {'entity': 'Lilly', 'category': 'ORG'}, {'entity': 'EU', 'category': 'ORG'}, {'entity': 'Philadelphia chromosome', 'category': 'ORG'}, {'entity': 'Gleevec', 'category': 'ORG'}, {'entity': '10%', 'category': 'PERCENT'}, {'entity': '10%', 'category': 'PERCENT'}, {'entity': '30%', 'category': 'PERCENT'}, {'entity': '24%', 'category': 'PERCENT'}, {'entity': '52%', 'category': 'PERCENT'}, {'entity': '38%', 'category': 'PERCENT'}, {'entity': '61%', 'category': 'PERCENT'}, {'entity': '56%', 'category': 'PERCENT'}, {'entity': '39%', 'category': 'PERCENT'}, {'entity': '47%', 'category': 'PERCENT'}, {'entity': '49%', 'category': 'PERCENT'}, {'entity': '46%', 'category': 'PERCENT'}, {'entity': '26%', 'category': 'PERCENT'}, {'entity': '20%', 'category': 'PERCENT'}, {'entity': '13%', 'category': 'PERCENT'}, {'entity': '9%', 'category': 'PERCENT'}, {'entity': '6%', 'category': 'PERCENT'}, {'entity': '14%', 'category': 'PERCENT'}, {'entity': '80%', 'category': 'PERCENT'}, {'entity': '20%', 'category': 'PERCENT'}, {'entity': '14%', 'category': 'PERCENT'}, {'entity': '9%', 'category': 'PERCENT'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': '13%', 'category': 'PERCENT'}, {'entity': '83%', 'category': 'PERCENT'}, {'entity': '63%', 'category': 'PERCENT'}, {'entity': '17%', 'category': 'PERCENT'}, {'entity': '24%', 'category': 'PERCENT'}, {'entity': 'Abilify*', 'category': 'PRODUCT'}, {'entity': 'Atripla*', 'category': 'PRODUCT'}, {'entity': 'Eliquis', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Current period', 'category': 'TIME'}, {'entity': 'Current period', 'category': 'TIME'}, {'entity': 'Alliances-Note 3. Alliances', 'category': 'WORK_OF_ART'}, {'entity': '10%', 'category': 'CARDINAL'}, {'entity': '10%', 'category': 'CARDINAL'}, {'entity': '$460 million', 'category': 'CARDINAL'}, {'entity': '$1.1 billion', 'category': 'CARDINAL'}, {'entity': '$1.6 billion', 'category': 'CARDINAL'}, {'entity': '22,364', 'category': 'CARDINAL'}, {'entity': '17,166', 'category': 'CARDINAL'}, {'entity': '13,793', 'category': 'CARDINAL'}, {'entity': '30', 'category': 'CARDINAL'}, {'entity': '24', 'category': 'CARDINAL'}, {'entity': '1,582', 'category': 'CARDINAL'}, {'entity': '1,043', 'category': 'CARDINAL'}, {'entity': '755', 'category': 'CARDINAL'}, {'entity': '52', 'category': 'CARDINAL'}, {'entity': '38', 'category': 'CARDINAL'}, {'entity': '1,382', 'category': 'CARDINAL'}, {'entity': '859', 'category': 'CARDINAL'}, {'entity': '551', 'category': 'CARDINAL'}, {'entity': '61', 'category': 'CARDINAL'}, {'entity': '56', 'category': 'CARDINAL'}, {'entity': '1,698', 'category': 'CARDINAL'}, {'entity': '1,219', 'category': 'CARDINAL'}, {'entity': '827', 'category': 'CARDINAL'}, {'entity': '39', 'category': 'CARDINAL'}, {'entity': '47', 'category': 'CARDINAL'}, {'entity': '4,662', 'category': 'CARDINAL'}, {'entity': '3,121', 'category': 'CARDINAL'}, {'entity': '2,133', 'category': 'CARDINAL'}, {'entity': '49', 'category': 'CARDINAL'}, {'entity': '46', 'category': 'CARDINAL'}, {'entity': '17,702', 'category': 'CARDINAL'}, {'entity': '14,045', 'category': 'CARDINAL'}, {'entity': '11,660', 'category': 'CARDINAL'}, {'entity': '26', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '3,774', 'category': 'CARDINAL'}, {'entity': '942', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '1,824', 'category': 'CARDINAL'}, {'entity': '1,620', 'category': 'CARDINAL'}, {'entity': '1,493', 'category': 'CARDINAL'}, {'entity': '13', 'category': 'CARDINAL'}, {'entity': '9', 'category': 'CARDINAL'}, {'entity': '1,053', 'category': 'CARDINAL'}, {'entity': '1,126', 'category': 'CARDINAL'}, {'entity': '1,308', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '14', 'category': 'CARDINAL'}, {'entity': '3,343', 'category': 'CARDINAL'}, {'entity': '1,860', 'category': 'CARDINAL'}, {'entity': '774', 'category': 'CARDINAL'}, {'entity': '80', 'category': 'CARDINAL'}, {'entity': '2,265', 'category': 'CARDINAL'}, {'entity': '1,885', 'category': 'CARDINAL'}, {'entity': '1,652', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '14', 'category': 'CARDINAL'}, {'entity': '1,192', 'category': 'CARDINAL'}, {'entity': '1,312', 'category': 'CARDINAL'}, {'entity': '1,441', 'category': 'CARDINAL'}, {'entity': '9', 'category': 'CARDINAL'}, {'entity': '1,578', 'category': 'CARDINAL'}, {'entity': '1,603', 'category': 'CARDINAL'}, {'entity': '256', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '912', 'category': 'CARDINAL'}, {'entity': '1,139', 'category': 'CARDINAL'}, {'entity': '1,362', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '16', 'category': 'CARDINAL'}, {'entity': '1,065', 'category': 'CARDINAL'}, {'entity': '1,252', 'category': 'CARDINAL'}, {'entity': '1,444', 'category': 'CARDINAL'}, {'entity': '15', 'category': 'CARDINAL'}, {'entity': '13', 'category': 'CARDINAL'}, {'entity': '128', 'category': 'CARDINAL'}, {'entity': '746', 'category': 'CARDINAL'}, {'entity': '2,020', 'category': 'CARDINAL'}, {'entity': '83', 'category': 'CARDINAL'}, {'entity': '63', 'category': 'CARDINAL'}, {'entity': '2,143', 'category': 'CARDINAL'}, {'entity': '2,571', 'category': 'CARDINAL'}, {'entity': '3,400', 'category': 'CARDINAL'}, {'entity': '17', 'category': 'CARDINAL'}, {'entity': '24', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  14\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXZU1UNHdnJgo5FZaIBpwgb98dfs\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701574596,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#1.2#1.1#4.8#2.4#95 \\n\\nDATE#December 2017#December 2017#November 2013#April 2015#June 2014#September 2014#October 2015#September 30, 2016#June 30, 2016#June 30, 2016#June 30, 2016\\n\\nEVENT#SEC Consent Order\\n\\nGPE#U.S.#France#Saudi Arabia#Europe#South Korea#Japan\\n\\nMONEY#$170 million#$63 million\\n\\nORG#U.S. wholesaler distribution channel#direct customer distribution channel#diabetes alliance#OTC#SEC#Gilead#Otsuka#EU#NS5A replication complex inhibitor; Sunvepra - an NS3 protease inhibitor\\n\\nPERSON#Daklinza\\n\\nPRODUCT#Dafalgan#Efferalgan#Fervex#Perfalgan\\n\\nTIME#one month}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2281,\n",
      "    \"completion_tokens\": 209,\n",
      "    \"total_tokens\": 2490\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 2017', 'category': 'DATE'}, {'entity': 'December 2017', 'category': 'DATE'}, {'entity': 'November 2013', 'category': 'DATE'}, {'entity': 'April 2015', 'category': 'DATE'}, {'entity': 'June 2014', 'category': 'DATE'}, {'entity': 'September 2014', 'category': 'DATE'}, {'entity': 'October 2015', 'category': 'DATE'}, {'entity': 'September 30, 2016', 'category': 'DATE'}, {'entity': 'June 30, 2016', 'category': 'DATE'}, {'entity': 'June 30, 2016', 'category': 'DATE'}, {'entity': 'June 30, 2016', 'category': 'DATE'}, {'entity': 'SEC Consent Order', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'France', 'category': 'GPE'}, {'entity': 'Saudi Arabia', 'category': 'GPE'}, {'entity': 'Europe', 'category': 'GPE'}, {'entity': 'South Korea', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': '$170 million', 'category': 'MONEY'}, {'entity': '$63 million', 'category': 'MONEY'}, {'entity': 'U.S. wholesaler distribution channel', 'category': 'ORG'}, {'entity': 'direct customer distribution channel', 'category': 'ORG'}, {'entity': 'diabetes alliance', 'category': 'ORG'}, {'entity': 'OTC', 'category': 'ORG'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'Gilead', 'category': 'ORG'}, {'entity': 'Otsuka', 'category': 'ORG'}, {'entity': 'EU', 'category': 'ORG'}, {'entity': 'NS5A replication complex inhibitor; Sunvepra - an NS3 protease inhibitor', 'category': 'ORG'}, {'entity': 'Daklinza', 'category': 'PERSON'}, {'entity': 'Dafalgan', 'category': 'PRODUCT'}, {'entity': 'Efferalgan', 'category': 'PRODUCT'}, {'entity': 'Fervex', 'category': 'PRODUCT'}, {'entity': 'Perfalgan', 'category': 'PRODUCT'}, {'entity': 'one month', 'category': 'TIME'}, {'entity': '1.2', 'category': 'CARDINAL'}, {'entity': '1.1', 'category': 'CARDINAL'}, {'entity': '4.8', 'category': 'CARDINAL'}, {'entity': '2.4', 'category': 'CARDINAL'}, {'entity': '95', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  14\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXa3BfjAHTaXPGzb4eAHuhHlUAKG\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701574631,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#2016#2015#2014#27#1#4,911#4,841#4,822#1#4,940#5,920#4,534#17#31#13,512#14,483#13,498#7#100#700#532#96#439#1.7#278#374#1.3#148#100#13#160#343#310#70#29#250#1.1#397#576#196#564\\n\\nDATE#the year ended December 31, 2016\\n\\nGPE#Puerto Rico#U.S.#Indiana\\n\\nMONEY#$4,946#$3,909#$3,932#$4,940#$5,920#$4,534#$13,512#$14,483#$13,498#$700 million#$532 million#$96 million#$439 million#$1.7 billion#$278 million#$374 million#$1.3 billion#$148 million#$100 million#$13 million#$160 million#$343 million#$310 million#$70 million#$29 million#$250 million#$1.1 billion#$397 million#$576 million#$196 million#$564 million\\n\\nORG#Form 10-K#Form 10-Q#Eliquis#Opdivo#Hepatitis C Franchise#Branded Prescription Drug Fee#IRS#Padlock#Nitto Denko#Flexus#Cormorant#Cardioxyl#Five Prime#iPierian#LPA1 Antagonist#R&D#U.S.#Alliances#Financial Statements\\u2014Note 3. Alliances#Note 4. Acquisitions and Divestitures#Note 13. Goodwill and Other Intangible Assets#Non-GAAP Financial Measures\\n\\nPERCENT#27 #%1 #%31 #%7 #%100#\\n\\nPERSON#R&D}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2244,\n",
      "    \"completion_tokens\": 385,\n",
      "    \"total_tokens\": 2629\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'the year ended December 31', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': 'Puerto Rico', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Indiana', 'category': 'GPE'}, {'entity': '$4,946', 'category': 'MONEY'}, {'entity': '$3,909', 'category': 'MONEY'}, {'entity': '$3,932', 'category': 'MONEY'}, {'entity': '$4,940', 'category': 'MONEY'}, {'entity': '$5,920', 'category': 'MONEY'}, {'entity': '$4,534', 'category': 'MONEY'}, {'entity': '$13,512', 'category': 'MONEY'}, {'entity': '$14,483', 'category': 'MONEY'}, {'entity': '$13,498', 'category': 'MONEY'}, {'entity': '$700 million', 'category': 'MONEY'}, {'entity': '$532 million', 'category': 'MONEY'}, {'entity': '$96 million', 'category': 'MONEY'}, {'entity': '$439 million', 'category': 'MONEY'}, {'entity': '$1.7 billion', 'category': 'MONEY'}, {'entity': '$278 million', 'category': 'MONEY'}, {'entity': '$374 million', 'category': 'MONEY'}, {'entity': '$1.3 billion', 'category': 'MONEY'}, {'entity': '$148 million', 'category': 'MONEY'}, {'entity': '$100 million', 'category': 'MONEY'}, {'entity': '$13 million', 'category': 'MONEY'}, {'entity': '$160 million', 'category': 'MONEY'}, {'entity': '$343 million', 'category': 'MONEY'}, {'entity': '$310 million', 'category': 'MONEY'}, {'entity': '$70 million', 'category': 'MONEY'}, {'entity': '$29 million', 'category': 'MONEY'}, {'entity': '$250 million', 'category': 'MONEY'}, {'entity': '$1.1 billion', 'category': 'MONEY'}, {'entity': '$397 million', 'category': 'MONEY'}, {'entity': '$576 million', 'category': 'MONEY'}, {'entity': '$196 million', 'category': 'MONEY'}, {'entity': '$564 million', 'category': 'MONEY'}, {'entity': 'Form 10-K', 'category': 'ORG'}, {'entity': 'Form 10-Q', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Hepatitis C Franchise', 'category': 'ORG'}, {'entity': 'Branded Prescription Drug Fee', 'category': 'ORG'}, {'entity': 'IRS', 'category': 'ORG'}, {'entity': 'Padlock', 'category': 'ORG'}, {'entity': 'Nitto Denko', 'category': 'ORG'}, {'entity': 'Flexus', 'category': 'ORG'}, {'entity': 'Cormorant', 'category': 'ORG'}, {'entity': 'Cardioxyl', 'category': 'ORG'}, {'entity': 'Five Prime', 'category': 'ORG'}, {'entity': 'iPierian', 'category': 'ORG'}, {'entity': 'LPA1 Antagonist', 'category': 'ORG'}, {'entity': 'R&D', 'category': 'ORG'}, {'entity': 'U.S.', 'category': 'ORG'}, {'entity': 'Alliances', 'category': 'ORG'}, {'entity': 'Financial Statements—Note 3. Alliances', 'category': 'ORG'}, {'entity': 'Note 4. Acquisitions and Divestitures', 'category': 'ORG'}, {'entity': 'Note 13. Goodwill and Other Intangible Assets', 'category': 'ORG'}, {'entity': 'Non-GAAP Financial Measures', 'category': 'ORG'}, {'entity': '27', 'category': 'PERCENT'}, {'entity': '%1', 'category': 'PERCENT'}, {'entity': '%31', 'category': 'PERCENT'}, {'entity': '%7', 'category': 'PERCENT'}, {'entity': '%100', 'category': 'PERCENT'}, {'entity': 'R&D', 'category': 'PERSON'}, {'entity': '2016', 'category': 'CARDINAL'}, {'entity': '2015', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '27', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '4,911', 'category': 'CARDINAL'}, {'entity': '4,841', 'category': 'CARDINAL'}, {'entity': '4,822', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '4,940', 'category': 'CARDINAL'}, {'entity': '5,920', 'category': 'CARDINAL'}, {'entity': '4,534', 'category': 'CARDINAL'}, {'entity': '17', 'category': 'CARDINAL'}, {'entity': '31', 'category': 'CARDINAL'}, {'entity': '13,512', 'category': 'CARDINAL'}, {'entity': '14,483', 'category': 'CARDINAL'}, {'entity': '13,498', 'category': 'CARDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '700', 'category': 'CARDINAL'}, {'entity': '532', 'category': 'CARDINAL'}, {'entity': '96', 'category': 'CARDINAL'}, {'entity': '439', 'category': 'CARDINAL'}, {'entity': '1.7', 'category': 'CARDINAL'}, {'entity': '278', 'category': 'CARDINAL'}, {'entity': '374', 'category': 'CARDINAL'}, {'entity': '1.3', 'category': 'CARDINAL'}, {'entity': '148', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '13', 'category': 'CARDINAL'}, {'entity': '160', 'category': 'CARDINAL'}, {'entity': '343', 'category': 'CARDINAL'}, {'entity': '310', 'category': 'CARDINAL'}, {'entity': '70', 'category': 'CARDINAL'}, {'entity': '29', 'category': 'CARDINAL'}, {'entity': '250', 'category': 'CARDINAL'}, {'entity': '1.1', 'category': 'CARDINAL'}, {'entity': '397', 'category': 'CARDINAL'}, {'entity': '576', 'category': 'CARDINAL'}, {'entity': '196', 'category': 'CARDINAL'}, {'entity': '564', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  14\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXafuPtFg1sbgvc2kjgEJQBtNYzQ\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701574669,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#719#383#283#91#160#877#713#109#118#163#300#35#1.8#0.3#5.1#21#84#151#96#10#105#439#1679#278#13#160#343#83#44#21#535#1883#621#109#115#163#40#158#27#559#187#559#10#91#160#877#15#13#11#123#32#45#40#314#316#626#242#2293#1503#51#480#545#123#422#293#1813#1081#16#16#4,457#1,565#2,004\\n\\nDATE#2015#2014#2016#2015#2014#2016#2015#2014#2017#2023#2014#2016#2015#2014#2016#2015#2014#December 31,2016#December 31,2015#December 31,2014\\n\\nMONEY#$719 million#$383 million#$283 million#$91 million#$160 million#$877 million#$713 million#$109 million#$118 million#$163 million#$300 million#5,915#2,077#2,381#1,408#446#352#21#84#151#96#10#105#439#1,679#278#13#160#343#83#44#21#535#1,883#621#109#115#163#40#158#27#559#187#559#10#91#160#877#15#13#11#123#32#45#40#314#316#626#242#2,293#1,503#51#480#545#123#422#293#1,813#1,081#16#16#4,457#1,565#2,004\\n\\nORG#The Prudential Insurance Company of America#R&D#Flexus#Cormorant#Flexus#Cardioxyl#Amylin\\n\\nPERSON#Padlock#Amylin\\n\\nPRODUCT#Erbitux*#Amylin product\\n\\nTIME#2016\\n\\nWORK_OF_ART#Item 8. Financial Statements\\u2014Note 4. Acquisitions and Divestitures, Note 5. Other (Income)/Expense, Note 6. Restructuring and Note 16. Pension and Postretirement Benefit Plans\\n\\nWORK_OF_ART#Item 8. Financial Statements\\u2014Note 7. Income Taxes\\n\\nGPE#Switzerland#Ireland#Puerto Rico#U.S.#U.S.#U.S. \\n\\nPERCENT#23.8#21.5#14.8\\n\\nEVENT#business divestiture\\n\\nNORP#American}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2481,\n",
      "    \"completion_tokens\": 605,\n",
      "    \"total_tokens\": 3086\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': '2023', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': 'December 31,2016', 'category': 'DATE'}, {'entity': 'December 31,2015', 'category': 'DATE'}, {'entity': 'December 31,2014', 'category': 'DATE'}, {'entity': 'business divestiture', 'category': 'EVENT'}, {'entity': 'Switzerland', 'category': 'GPE'}, {'entity': 'Ireland', 'category': 'GPE'}, {'entity': 'Puerto Rico', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '$719 million', 'category': 'MONEY'}, {'entity': '$383 million', 'category': 'MONEY'}, {'entity': '$283 million', 'category': 'MONEY'}, {'entity': '$91 million', 'category': 'MONEY'}, {'entity': '$160 million', 'category': 'MONEY'}, {'entity': '$877 million', 'category': 'MONEY'}, {'entity': '$713 million', 'category': 'MONEY'}, {'entity': '$109 million', 'category': 'MONEY'}, {'entity': '$118 million', 'category': 'MONEY'}, {'entity': '$163 million', 'category': 'MONEY'}, {'entity': '$300 million', 'category': 'MONEY'}, {'entity': '5,915', 'category': 'MONEY'}, {'entity': '2,077', 'category': 'MONEY'}, {'entity': '2,381', 'category': 'MONEY'}, {'entity': '1,408', 'category': 'MONEY'}, {'entity': '446', 'category': 'MONEY'}, {'entity': '352', 'category': 'MONEY'}, {'entity': '21', 'category': 'MONEY'}, {'entity': '84', 'category': 'MONEY'}, {'entity': '151', 'category': 'MONEY'}, {'entity': '96', 'category': 'MONEY'}, {'entity': '10', 'category': 'MONEY'}, {'entity': '105', 'category': 'MONEY'}, {'entity': '439', 'category': 'MONEY'}, {'entity': '1,679', 'category': 'MONEY'}, {'entity': '278', 'category': 'MONEY'}, {'entity': '13', 'category': 'MONEY'}, {'entity': '160', 'category': 'MONEY'}, {'entity': '343', 'category': 'MONEY'}, {'entity': '83', 'category': 'MONEY'}, {'entity': '44', 'category': 'MONEY'}, {'entity': '21', 'category': 'MONEY'}, {'entity': '535', 'category': 'MONEY'}, {'entity': '1,883', 'category': 'MONEY'}, {'entity': '621', 'category': 'MONEY'}, {'entity': '109', 'category': 'MONEY'}, {'entity': '115', 'category': 'MONEY'}, {'entity': '163', 'category': 'MONEY'}, {'entity': '40', 'category': 'MONEY'}, {'entity': '158', 'category': 'MONEY'}, {'entity': '27', 'category': 'MONEY'}, {'entity': '559', 'category': 'MONEY'}, {'entity': '187', 'category': 'MONEY'}, {'entity': '559', 'category': 'MONEY'}, {'entity': '10', 'category': 'MONEY'}, {'entity': '91', 'category': 'MONEY'}, {'entity': '160', 'category': 'MONEY'}, {'entity': '877', 'category': 'MONEY'}, {'entity': '15', 'category': 'MONEY'}, {'entity': '13', 'category': 'MONEY'}, {'entity': '11', 'category': 'MONEY'}, {'entity': '123', 'category': 'MONEY'}, {'entity': '32', 'category': 'MONEY'}, {'entity': '45', 'category': 'MONEY'}, {'entity': '40', 'category': 'MONEY'}, {'entity': '314', 'category': 'MONEY'}, {'entity': '316', 'category': 'MONEY'}, {'entity': '626', 'category': 'MONEY'}, {'entity': '242', 'category': 'MONEY'}, {'entity': '2,293', 'category': 'MONEY'}, {'entity': '1,503', 'category': 'MONEY'}, {'entity': '51', 'category': 'MONEY'}, {'entity': '480', 'category': 'MONEY'}, {'entity': '545', 'category': 'MONEY'}, {'entity': '123', 'category': 'MONEY'}, {'entity': '422', 'category': 'MONEY'}, {'entity': '293', 'category': 'MONEY'}, {'entity': '1,813', 'category': 'MONEY'}, {'entity': '1,081', 'category': 'MONEY'}, {'entity': '16', 'category': 'MONEY'}, {'entity': '16', 'category': 'MONEY'}, {'entity': '4,457', 'category': 'MONEY'}, {'entity': '1,565', 'category': 'MONEY'}, {'entity': '2,004', 'category': 'MONEY'}, {'entity': 'American', 'category': 'NORP'}, {'entity': 'The Prudential Insurance Company of America', 'category': 'ORG'}, {'entity': 'R&D', 'category': 'ORG'}, {'entity': 'Flexus', 'category': 'ORG'}, {'entity': 'Cormorant', 'category': 'ORG'}, {'entity': 'Flexus', 'category': 'ORG'}, {'entity': 'Cardioxyl', 'category': 'ORG'}, {'entity': 'Amylin', 'category': 'ORG'}, {'entity': '23.8', 'category': 'PERCENT'}, {'entity': '21.5', 'category': 'PERCENT'}, {'entity': '14.8', 'category': 'PERCENT'}, {'entity': 'Padlock', 'category': 'PERSON'}, {'entity': 'Amylin', 'category': 'PERSON'}, {'entity': 'Erbitux*', 'category': 'PRODUCT'}, {'entity': 'Amylin product', 'category': 'PRODUCT'}, {'entity': '2016', 'category': 'TIME'}, {'entity': 'Item 8. Financial Statements—Note 4. Acquisitions and Divestitures', 'category': 'WORK_OF_ART'}, {'entity': 'Note 5. Other Income/Expense', 'category': 'WORK_OF_ART'}, {'entity': 'Note 6. Restructuring and Note 16. Pension and Postretirement Benefit Plans', 'category': 'WORK_OF_ART'}, {'entity': 'Item 8. Financial Statements—Note 7. Income Taxes', 'category': 'WORK_OF_ART'}, {'entity': '719', 'category': 'CARDINAL'}, {'entity': '383', 'category': 'CARDINAL'}, {'entity': '283', 'category': 'CARDINAL'}, {'entity': '91', 'category': 'CARDINAL'}, {'entity': '160', 'category': 'CARDINAL'}, {'entity': '877', 'category': 'CARDINAL'}, {'entity': '713', 'category': 'CARDINAL'}, {'entity': '109', 'category': 'CARDINAL'}, {'entity': '118', 'category': 'CARDINAL'}, {'entity': '163', 'category': 'CARDINAL'}, {'entity': '300', 'category': 'CARDINAL'}, {'entity': '35', 'category': 'CARDINAL'}, {'entity': '1.8', 'category': 'CARDINAL'}, {'entity': '0.3', 'category': 'CARDINAL'}, {'entity': '5.1', 'category': 'CARDINAL'}, {'entity': '21', 'category': 'CARDINAL'}, {'entity': '84', 'category': 'CARDINAL'}, {'entity': '151', 'category': 'CARDINAL'}, {'entity': '96', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '105', 'category': 'CARDINAL'}, {'entity': '439', 'category': 'CARDINAL'}, {'entity': '1679', 'category': 'CARDINAL'}, {'entity': '278', 'category': 'CARDINAL'}, {'entity': '13', 'category': 'CARDINAL'}, {'entity': '160', 'category': 'CARDINAL'}, {'entity': '343', 'category': 'CARDINAL'}, {'entity': '83', 'category': 'CARDINAL'}, {'entity': '44', 'category': 'CARDINAL'}, {'entity': '21', 'category': 'CARDINAL'}, {'entity': '535', 'category': 'CARDINAL'}, {'entity': '1883', 'category': 'CARDINAL'}, {'entity': '621', 'category': 'CARDINAL'}, {'entity': '109', 'category': 'CARDINAL'}, {'entity': '115', 'category': 'CARDINAL'}, {'entity': '163', 'category': 'CARDINAL'}, {'entity': '40', 'category': 'CARDINAL'}, {'entity': '158', 'category': 'CARDINAL'}, {'entity': '27', 'category': 'CARDINAL'}, {'entity': '559', 'category': 'CARDINAL'}, {'entity': '187', 'category': 'CARDINAL'}, {'entity': '559', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '91', 'category': 'CARDINAL'}, {'entity': '160', 'category': 'CARDINAL'}, {'entity': '877', 'category': 'CARDINAL'}, {'entity': '15', 'category': 'CARDINAL'}, {'entity': '13', 'category': 'CARDINAL'}, {'entity': '11', 'category': 'CARDINAL'}, {'entity': '123', 'category': 'CARDINAL'}, {'entity': '32', 'category': 'CARDINAL'}, {'entity': '45', 'category': 'CARDINAL'}, {'entity': '40', 'category': 'CARDINAL'}, {'entity': '314', 'category': 'CARDINAL'}, {'entity': '316', 'category': 'CARDINAL'}, {'entity': '626', 'category': 'CARDINAL'}, {'entity': '242', 'category': 'CARDINAL'}, {'entity': '2293', 'category': 'CARDINAL'}, {'entity': '1503', 'category': 'CARDINAL'}, {'entity': '51', 'category': 'CARDINAL'}, {'entity': '480', 'category': 'CARDINAL'}, {'entity': '545', 'category': 'CARDINAL'}, {'entity': '123', 'category': 'CARDINAL'}, {'entity': '422', 'category': 'CARDINAL'}, {'entity': '293', 'category': 'CARDINAL'}, {'entity': '1813', 'category': 'CARDINAL'}, {'entity': '1081', 'category': 'CARDINAL'}, {'entity': '16', 'category': 'CARDINAL'}, {'entity': '16', 'category': 'CARDINAL'}, {'entity': '4,457', 'category': 'CARDINAL'}, {'entity': '1,565', 'category': 'CARDINAL'}, {'entity': '2,004', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  14\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXbRKSn8x0v4Sz8sO729n5KSJUEj\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701574717,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#1,680#1,679#1,670#1.3#2.0#2.5#2.4#1.2#800#500#1.0#900\\n\\nDATE#2016#2015#2014#October 2016#February 2017#June 2016\\n\\nEVENT#Abilify* alliance\\n\\nFAC#\\n\\nGPE#U.S.#Ireland#UK#EU\\n\\nLOC#\\n\\nMONEY#$2.65#$0.93#$1.20#0.18#1.08#0.65#2.83#2.01#1.85#$4,237#$2,385#2,113#1,885#2,719#4,660#9,069#8,930#(992#(139#(5,716#(6,550#2,361#2,241#$1.1 billion#$8.0 billion\\n\\nNORP#\\n\\nORDINAL#\\n\\nORG#BMS \\n\\nPERCENT#2%\\n\\nPERSON#\\n\\nPRODUCT#Opdivo, Yervoy and Empliciti\\n\\nQUANTITY#\\n\\nTIME#\\n\\nWORK_OF_ART#Item 8. Financial Statements\\u2014Note 9. Financial Instruments and Fair Value Measurements#Item 8. Financial Statements\\u2014Note 15. Equity}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2344,\n",
      "    \"completion_tokens\": 276,\n",
      "    \"total_tokens\": 2620\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': '2016', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': 'October 2016', 'category': 'DATE'}, {'entity': 'February 2017', 'category': 'DATE'}, {'entity': 'June 2016', 'category': 'DATE'}, {'entity': 'Abilify* alliance', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Ireland', 'category': 'GPE'}, {'entity': 'UK', 'category': 'GPE'}, {'entity': 'EU', 'category': 'GPE'}, {'entity': '$2.65', 'category': 'MONEY'}, {'entity': '$0.93', 'category': 'MONEY'}, {'entity': '$1.20', 'category': 'MONEY'}, {'entity': '0.18', 'category': 'MONEY'}, {'entity': '1.08', 'category': 'MONEY'}, {'entity': '0.65', 'category': 'MONEY'}, {'entity': '2.83', 'category': 'MONEY'}, {'entity': '2.01', 'category': 'MONEY'}, {'entity': '1.85', 'category': 'MONEY'}, {'entity': '$4,237', 'category': 'MONEY'}, {'entity': '$2,385', 'category': 'MONEY'}, {'entity': '2,113', 'category': 'MONEY'}, {'entity': '1,885', 'category': 'MONEY'}, {'entity': '2,719', 'category': 'MONEY'}, {'entity': '4,660', 'category': 'MONEY'}, {'entity': '9,069', 'category': 'MONEY'}, {'entity': '8,930', 'category': 'MONEY'}, {'entity': '992', 'category': 'MONEY'}, {'entity': '139', 'category': 'MONEY'}, {'entity': '5,716', 'category': 'MONEY'}, {'entity': '6,550', 'category': 'MONEY'}, {'entity': '2,361', 'category': 'MONEY'}, {'entity': '2,241', 'category': 'MONEY'}, {'entity': '$1.1 billion', 'category': 'MONEY'}, {'entity': '$8.0 billion', 'category': 'MONEY'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': '2%', 'category': 'PERCENT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Yervoy and Empliciti', 'category': 'PRODUCT'}, {'entity': 'Item 8. Financial Statements—Note 9. Financial Instruments and Fair Value Measurements', 'category': 'WORK_OF_ART'}, {'entity': 'Item 8. Financial Statements—Note 15. Equity', 'category': 'WORK_OF_ART'}, {'entity': '1,680', 'category': 'CARDINAL'}, {'entity': '1,679', 'category': 'CARDINAL'}, {'entity': '1,670', 'category': 'CARDINAL'}, {'entity': '1.3', 'category': 'CARDINAL'}, {'entity': '2.0', 'category': 'CARDINAL'}, {'entity': '2.5', 'category': 'CARDINAL'}, {'entity': '2.4', 'category': 'CARDINAL'}, {'entity': '1.2', 'category': 'CARDINAL'}, {'entity': '800', 'category': 'CARDINAL'}, {'entity': '500', 'category': 'CARDINAL'}, {'entity': '1.0', 'category': 'CARDINAL'}, {'entity': '900', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  14\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXc1S28gVSAXKkd4wDfZF3TJBc8d\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701574753,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#600 million#1.4 billion#1.3 billion#700 million#600 million#400 million#3.1 billion#2.1 billion#800 million#600 million#400 million#2.8 billion#2.9 billion#900 million#300 million#1.3 billion#906 million#700 million#600 million#200 million#914 million#243#6,261#750#5,011#4,133#194#188#187#783#123#107#86#66#61#340#2,799#1,265#537#406#345#156#90#70#526#126#67#58#37#238#14,815#2,645#964#1,247#656#441#8,862#10.4 billion#3.0 billion#7.4 billion#2.5 billion\\n\\nDATE#December 31, 2016#August 4, 2004#September 30, 2004\\n\\nEVENT#product ingredient supply and Medicaid rebates for Abilify*#business divestitures#purchases of marketable securities#manufacturing and facility-related capital expenditures#sale and maturity of marketable securities#Higher net redemptions of marketable securities#Net short-term borrowings\\n\\nFAC#Mount Vernon, Indiana manufacturing facility\\n\\nGPE#Indiana\\n\\nMONEY#$600 million#$1.4 billion#$1.3 billion#$700 million#$600 million#$400 million#$3.1 billion#$2.1 billion#$800 million#$600 million#$400 million#$2.8 billion#$2.9 billion#$900 million#$300 million#$1.3 billion#$906 million#$700 million#$600 million#$200 million#$914 million#$243#$6,261#$750#$5,011#$4,133#$194#$188#$187#$783#$123#$107#$86#$66#$61#$340#$2,799#$1,265#$537#$406#$345#$156#$90#$70#$526#$126#$67#$58#$37#$238#14,815#$2,645#$964#$1,247#$656#$441#$8,862#10.4 billion#3.0 billion#7.4 billion#2.5 billion\\n\\nORG#SEC#FCPA\\n\\nPERSON#Cormorant#Padlock#Flexus#Cardioxyl#Ixempra\\n\\nPRODUCT#Abilify*#Ixempra*#OTC products#Cormorant#Padlock#Flexus#Cardioxyl#Ixempra*#OTC product\\n\\nTIME#90 days \\n\\nWORK_OF_ART#Form 10-Q}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2347,\n",
      "    \"completion_tokens\": 563,\n",
      "    \"total_tokens\": 2910\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'August 4, 2004', 'category': 'DATE'}, {'entity': 'September 30, 2004', 'category': 'DATE'}, {'entity': 'product ingredient supply and Medicaid rebates for Abilify*', 'category': 'EVENT'}, {'entity': 'business divestitures', 'category': 'EVENT'}, {'entity': 'purchases of marketable securities', 'category': 'EVENT'}, {'entity': 'manufacturing and facility-related capital expenditures', 'category': 'EVENT'}, {'entity': 'sale and maturity of marketable securities', 'category': 'EVENT'}, {'entity': 'Higher net redemptions of marketable securities', 'category': 'EVENT'}, {'entity': 'Net short-term borrowings', 'category': 'EVENT'}, {'entity': 'Mount Vernon', 'category': 'FAC'}, {'entity': 'Indiana manufacturing facility', 'category': 'FAC'}, {'entity': 'Indiana', 'category': 'GPE'}, {'entity': '$600 million', 'category': 'MONEY'}, {'entity': '$1.4 billion', 'category': 'MONEY'}, {'entity': '$1.3 billion', 'category': 'MONEY'}, {'entity': '$700 million', 'category': 'MONEY'}, {'entity': '$600 million', 'category': 'MONEY'}, {'entity': '$400 million', 'category': 'MONEY'}, {'entity': '$3.1 billion', 'category': 'MONEY'}, {'entity': '$2.1 billion', 'category': 'MONEY'}, {'entity': '$800 million', 'category': 'MONEY'}, {'entity': '$600 million', 'category': 'MONEY'}, {'entity': '$400 million', 'category': 'MONEY'}, {'entity': '$2.8 billion', 'category': 'MONEY'}, {'entity': '$2.9 billion', 'category': 'MONEY'}, {'entity': '$900 million', 'category': 'MONEY'}, {'entity': '$300 million', 'category': 'MONEY'}, {'entity': '$1.3 billion', 'category': 'MONEY'}, {'entity': '$906 million', 'category': 'MONEY'}, {'entity': '$700 million', 'category': 'MONEY'}, {'entity': '$600 million', 'category': 'MONEY'}, {'entity': '$200 million', 'category': 'MONEY'}, {'entity': '$914 million', 'category': 'MONEY'}, {'entity': '$243', 'category': 'MONEY'}, {'entity': '$6,261', 'category': 'MONEY'}, {'entity': '$750', 'category': 'MONEY'}, {'entity': '$5,011', 'category': 'MONEY'}, {'entity': '$4,133', 'category': 'MONEY'}, {'entity': '$194', 'category': 'MONEY'}, {'entity': '$188', 'category': 'MONEY'}, {'entity': '$187', 'category': 'MONEY'}, {'entity': '$783', 'category': 'MONEY'}, {'entity': '$123', 'category': 'MONEY'}, {'entity': '$107', 'category': 'MONEY'}, {'entity': '$86', 'category': 'MONEY'}, {'entity': '$66', 'category': 'MONEY'}, {'entity': '$61', 'category': 'MONEY'}, {'entity': '$340', 'category': 'MONEY'}, {'entity': '$2,799', 'category': 'MONEY'}, {'entity': '$1,265', 'category': 'MONEY'}, {'entity': '$537', 'category': 'MONEY'}, {'entity': '$406', 'category': 'MONEY'}, {'entity': '$345', 'category': 'MONEY'}, {'entity': '$156', 'category': 'MONEY'}, {'entity': '$90', 'category': 'MONEY'}, {'entity': '$70', 'category': 'MONEY'}, {'entity': '$526', 'category': 'MONEY'}, {'entity': '$126', 'category': 'MONEY'}, {'entity': '$67', 'category': 'MONEY'}, {'entity': '$58', 'category': 'MONEY'}, {'entity': '$37', 'category': 'MONEY'}, {'entity': '$238', 'category': 'MONEY'}, {'entity': '14,815', 'category': 'MONEY'}, {'entity': '$2,645', 'category': 'MONEY'}, {'entity': '$964', 'category': 'MONEY'}, {'entity': '$1,247', 'category': 'MONEY'}, {'entity': '$656', 'category': 'MONEY'}, {'entity': '$441', 'category': 'MONEY'}, {'entity': '$8,862', 'category': 'MONEY'}, {'entity': '10.4 billion', 'category': 'MONEY'}, {'entity': '3.0 billion', 'category': 'MONEY'}, {'entity': '7.4 billion', 'category': 'MONEY'}, {'entity': '2.5 billion', 'category': 'MONEY'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'FCPA', 'category': 'ORG'}, {'entity': 'Cormorant', 'category': 'PERSON'}, {'entity': 'Padlock', 'category': 'PERSON'}, {'entity': 'Flexus', 'category': 'PERSON'}, {'entity': 'Cardioxyl', 'category': 'PERSON'}, {'entity': 'Ixempra', 'category': 'PERSON'}, {'entity': 'Abilify*', 'category': 'PRODUCT'}, {'entity': 'Ixempra*', 'category': 'PRODUCT'}, {'entity': 'OTC products', 'category': 'PRODUCT'}, {'entity': 'Cormorant', 'category': 'PRODUCT'}, {'entity': 'Padlock', 'category': 'PRODUCT'}, {'entity': 'Flexus', 'category': 'PRODUCT'}, {'entity': 'Cardioxyl', 'category': 'PRODUCT'}, {'entity': 'Ixempra*', 'category': 'PRODUCT'}, {'entity': 'OTC product', 'category': 'PRODUCT'}, {'entity': '90 days', 'category': 'TIME'}, {'entity': 'Form 10-Q', 'category': 'WORK_OF_ART'}, {'entity': '600 million', 'category': 'CARDINAL'}, {'entity': '1.4 billion', 'category': 'CARDINAL'}, {'entity': '1.3 billion', 'category': 'CARDINAL'}, {'entity': '700 million', 'category': 'CARDINAL'}, {'entity': '600 million', 'category': 'CARDINAL'}, {'entity': '400 million', 'category': 'CARDINAL'}, {'entity': '3.1 billion', 'category': 'CARDINAL'}, {'entity': '2.1 billion', 'category': 'CARDINAL'}, {'entity': '800 million', 'category': 'CARDINAL'}, {'entity': '600 million', 'category': 'CARDINAL'}, {'entity': '400 million', 'category': 'CARDINAL'}, {'entity': '2.8 billion', 'category': 'CARDINAL'}, {'entity': '2.9 billion', 'category': 'CARDINAL'}, {'entity': '900 million', 'category': 'CARDINAL'}, {'entity': '300 million', 'category': 'CARDINAL'}, {'entity': '1.3 billion', 'category': 'CARDINAL'}, {'entity': '906 million', 'category': 'CARDINAL'}, {'entity': '700 million', 'category': 'CARDINAL'}, {'entity': '600 million', 'category': 'CARDINAL'}, {'entity': '200 million', 'category': 'CARDINAL'}, {'entity': '914 million', 'category': 'CARDINAL'}, {'entity': '243', 'category': 'CARDINAL'}, {'entity': '6,261', 'category': 'CARDINAL'}, {'entity': '750', 'category': 'CARDINAL'}, {'entity': '5,011', 'category': 'CARDINAL'}, {'entity': '4,133', 'category': 'CARDINAL'}, {'entity': '194', 'category': 'CARDINAL'}, {'entity': '188', 'category': 'CARDINAL'}, {'entity': '187', 'category': 'CARDINAL'}, {'entity': '783', 'category': 'CARDINAL'}, {'entity': '123', 'category': 'CARDINAL'}, {'entity': '107', 'category': 'CARDINAL'}, {'entity': '86', 'category': 'CARDINAL'}, {'entity': '66', 'category': 'CARDINAL'}, {'entity': '61', 'category': 'CARDINAL'}, {'entity': '340', 'category': 'CARDINAL'}, {'entity': '2,799', 'category': 'CARDINAL'}, {'entity': '1,265', 'category': 'CARDINAL'}, {'entity': '537', 'category': 'CARDINAL'}, {'entity': '406', 'category': 'CARDINAL'}, {'entity': '345', 'category': 'CARDINAL'}, {'entity': '156', 'category': 'CARDINAL'}, {'entity': '90', 'category': 'CARDINAL'}, {'entity': '70', 'category': 'CARDINAL'}, {'entity': '526', 'category': 'CARDINAL'}, {'entity': '126', 'category': 'CARDINAL'}, {'entity': '67', 'category': 'CARDINAL'}, {'entity': '58', 'category': 'CARDINAL'}, {'entity': '37', 'category': 'CARDINAL'}, {'entity': '238', 'category': 'CARDINAL'}, {'entity': '14,815', 'category': 'CARDINAL'}, {'entity': '2,645', 'category': 'CARDINAL'}, {'entity': '964', 'category': 'CARDINAL'}, {'entity': '1,247', 'category': 'CARDINAL'}, {'entity': '656', 'category': 'CARDINAL'}, {'entity': '441', 'category': 'CARDINAL'}, {'entity': '8,862', 'category': 'CARDINAL'}, {'entity': '10.4 billion', 'category': 'CARDINAL'}, {'entity': '3.0 billion', 'category': 'CARDINAL'}, {'entity': '7.4 billion', 'category': 'CARDINAL'}, {'entity': '2.5 billion', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  14\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXcmk4ZDMxJqlgfuLdrmlas6x6y5\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701574800,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#100%#95%#50%#300 million\\n\\nDATE#October 2015#in 2014#in 2015\\n\\nGPE#France#U.S.\\n\\nLAW#FCPA#340B Drug Pricing Program\\n\\nMONEY#$14.7 million\\n\\nORG#IMAs#the Company#SEC#BMS#U.S. Department of Defense#U.S. Department of Veterans Affairs#Medicaid#Medicare#Centers for Medicare & Medicaid Services#Medicare Part D\\n\\nPERCENT#100%#50%#2%#95%\\n\\nPRODUCT#Daklinza\\n\\nTIME#one month#weekly#two to four week#two-year}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2017,\n",
      "    \"completion_tokens\": 144,\n",
      "    \"total_tokens\": 2161\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'October 2015', 'category': 'DATE'}, {'entity': 'in 2014', 'category': 'DATE'}, {'entity': 'in 2015', 'category': 'DATE'}, {'entity': 'France', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'FCPA', 'category': 'LAW'}, {'entity': '340B Drug Pricing Program', 'category': 'LAW'}, {'entity': '$14.7 million', 'category': 'MONEY'}, {'entity': 'IMAs', 'category': 'ORG'}, {'entity': 'the Company', 'category': 'ORG'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'U.S. Department of Defense', 'category': 'ORG'}, {'entity': 'U.S. Department of Veterans Affairs', 'category': 'ORG'}, {'entity': 'Medicaid', 'category': 'ORG'}, {'entity': 'Medicare', 'category': 'ORG'}, {'entity': 'Centers for Medicare & Medicaid Services', 'category': 'ORG'}, {'entity': 'Medicare Part D', 'category': 'ORG'}, {'entity': '100%', 'category': 'PERCENT'}, {'entity': '50%', 'category': 'PERCENT'}, {'entity': '2%', 'category': 'PERCENT'}, {'entity': '95%', 'category': 'PERCENT'}, {'entity': 'Daklinza', 'category': 'PRODUCT'}, {'entity': 'one month', 'category': 'TIME'}, {'entity': 'weekly', 'category': 'TIME'}, {'entity': 'two to four week', 'category': 'TIME'}, {'entity': 'two-year', 'category': 'TIME'}, {'entity': '100%', 'category': 'CARDINAL'}, {'entity': '95%', 'category': 'CARDINAL'}, {'entity': '50%', 'category': 'CARDINAL'}, {'entity': '300 million', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  14\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXdHZyiShgnihvTPfrWEGr94sgTR\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701574831,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#4.0%#1%#$900 million#1%#$41 million#8.3 billion#25% \\n\\nDATE#December 31, 2016 \\n\\nEVENT#Retirement Benefits \\n\\nFAC#Citi Pension \\n\\nGPE#U.S.\\n\\nMONEY#$600 million#$73 million#$98 million \\n\\nORG#Cormorant#Padlock#Cardioxyl#Flexus#iPierian#AstraZeneca#Reckitt#The Medicines Company#Valeant Pharmaceuticals International, Inc.\\n\\nPERSON#Promedior \\n\\nPRODUCT#Erbitux#Ixempra#HIV medicines\\n\\nWORK_OF_ART#\\u201cItem 8. Financial Statements\\u2014Note 16. Pension, Postretirement and Postemployment Liabilities.\\u201d#ASC 805 - Business Combinations\\n}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2070,\n",
      "    \"completion_tokens\": 171,\n",
      "    \"total_tokens\": 2241\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': 'Retirement Benefits', 'category': 'EVENT'}, {'entity': 'Citi Pension', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '$600 million', 'category': 'MONEY'}, {'entity': '$73 million', 'category': 'MONEY'}, {'entity': '$98 million', 'category': 'MONEY'}, {'entity': 'Cormorant', 'category': 'ORG'}, {'entity': 'Padlock', 'category': 'ORG'}, {'entity': 'Cardioxyl', 'category': 'ORG'}, {'entity': 'Flexus', 'category': 'ORG'}, {'entity': 'iPierian', 'category': 'ORG'}, {'entity': 'AstraZeneca', 'category': 'ORG'}, {'entity': 'Reckitt', 'category': 'ORG'}, {'entity': 'The Medicines Company', 'category': 'ORG'}, {'entity': 'Valeant Pharmaceuticals International, Inc.', 'category': 'ORG'}, {'entity': 'Promedior', 'category': 'PERSON'}, {'entity': 'Erbitux', 'category': 'PRODUCT'}, {'entity': 'Ixempra', 'category': 'PRODUCT'}, {'entity': 'HIV medicines', 'category': 'PRODUCT'}, {'entity': '“Item 8. Financial Statements—Note 16. Pension, Postretirement and Postemployment Liabilities.”', 'category': 'WORK_OF_ART'}, {'entity': 'ASC 805 - Business Combinations', 'category': 'WORK_OF_ART'}, {'entity': '4.0%', 'category': 'CARDINAL'}, {'entity': '1%', 'category': 'CARDINAL'}, {'entity': '$900 million', 'category': 'CARDINAL'}, {'entity': '1%', 'category': 'CARDINAL'}, {'entity': '$41 million', 'category': 'CARDINAL'}, {'entity': '8.3 billion', 'category': 'CARDINAL'}, {'entity': '25%', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  14\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXdmK6gZXgpPwPPfrwIvPVqxc6kD\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701574862,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#1.4 billion#248 million#155 million#669 million#361 million#107 million#160 million#343 million#310 million#104 million#115 million#151 million#4.3 billion#3.1 billion#4.1 billion#3.5 billion#129 million#27 million#11 million#50%\\n\\nDATE#December 31, 2016#December 31, 2015#2022#2017#2009\\n\\nEVENT#business, supply and development agreements#IPRD impairment charges#Company\\u2019s restructuring actions\\n\\nFAC#manufacturing facility\\n\\nGPE#U.S.\\n\\nLAW#Item 8. Financial Statements\\u2014Note 3. Alliances#Item 8. Financial Statements\\u2014Note 13. Goodwill and Other Intangible Assets#Item 8. Financial Statements\\u2014Note 1. Accounting Policies\\u2014Contingencies#Item 8. Financial Statements\\u2014Note 7. Income Taxes#Item 8. Financial Statements\\u2014Note 18. Legal Proceedings and Contingencies#Internal Revenue Code\\n\\nMONEY#$1.4 billion#248 million#155 million#669 million#361 million#107 million#160 million#343 million#310 million#104 million#115 million#151 million#4.3 billion#3.1 billion#4.1 billion#3.5 billion#129 million#27 million\\n\\nORG#Mead Johnson & Company\\n\\nPERCENT#50%\\n\\nTIME#four year period\\n\\nWORK_OF_ART#Mead Johnson}\\n\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2168,\n",
      "    \"completion_tokens\": 316,\n",
      "    \"total_tokens\": 2484\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': '2009', 'category': 'DATE'}, {'entity': 'business, supply and development agreements', 'category': 'EVENT'}, {'entity': 'IPRD impairment charges', 'category': 'EVENT'}, {'entity': 'Company’s restructuring actions', 'category': 'EVENT'}, {'entity': 'manufacturing facility', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Item 8. Financial Statements—Note 3. Alliances', 'category': 'LAW'}, {'entity': 'Item 8. Financial Statements—Note 13. Goodwill and Other Intangible Assets', 'category': 'LAW'}, {'entity': 'Item 8. Financial Statements—Note 1. Accounting Policies—Contingencies', 'category': 'LAW'}, {'entity': 'Item 8. Financial Statements—Note 7. Income Taxes', 'category': 'LAW'}, {'entity': 'Item 8. Financial Statements—Note 18. Legal Proceedings and Contingencies', 'category': 'LAW'}, {'entity': 'Internal Revenue Code', 'category': 'LAW'}, {'entity': '$1.4 billion', 'category': 'MONEY'}, {'entity': '248 million', 'category': 'MONEY'}, {'entity': '155 million', 'category': 'MONEY'}, {'entity': '669 million', 'category': 'MONEY'}, {'entity': '361 million', 'category': 'MONEY'}, {'entity': '107 million', 'category': 'MONEY'}, {'entity': '160 million', 'category': 'MONEY'}, {'entity': '343 million', 'category': 'MONEY'}, {'entity': '310 million', 'category': 'MONEY'}, {'entity': '104 million', 'category': 'MONEY'}, {'entity': '115 million', 'category': 'MONEY'}, {'entity': '151 million', 'category': 'MONEY'}, {'entity': '4.3 billion', 'category': 'MONEY'}, {'entity': '3.1 billion', 'category': 'MONEY'}, {'entity': '4.1 billion', 'category': 'MONEY'}, {'entity': '3.5 billion', 'category': 'MONEY'}, {'entity': '129 million', 'category': 'MONEY'}, {'entity': '27 million', 'category': 'MONEY'}, {'entity': 'Mead Johnson & Company', 'category': 'ORG'}, {'entity': '50%', 'category': 'PERCENT'}, {'entity': 'four year period', 'category': 'TIME'}, {'entity': 'Mead Johnson', 'category': 'WORK_OF_ART'}, {'entity': '1.4 billion', 'category': 'CARDINAL'}, {'entity': '248 million', 'category': 'CARDINAL'}, {'entity': '155 million', 'category': 'CARDINAL'}, {'entity': '669 million', 'category': 'CARDINAL'}, {'entity': '361 million', 'category': 'CARDINAL'}, {'entity': '107 million', 'category': 'CARDINAL'}, {'entity': '160 million', 'category': 'CARDINAL'}, {'entity': '343 million', 'category': 'CARDINAL'}, {'entity': '310 million', 'category': 'CARDINAL'}, {'entity': '104 million', 'category': 'CARDINAL'}, {'entity': '115 million', 'category': 'CARDINAL'}, {'entity': '151 million', 'category': 'CARDINAL'}, {'entity': '4.3 billion', 'category': 'CARDINAL'}, {'entity': '3.1 billion', 'category': 'CARDINAL'}, {'entity': '4.1 billion', 'category': 'CARDINAL'}, {'entity': '3.5 billion', 'category': 'CARDINAL'}, {'entity': '129 million', 'category': 'CARDINAL'}, {'entity': '27 million', 'category': 'CARDINAL'}, {'entity': '11 million', 'category': 'CARDINAL'}, {'entity': '50%', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  14\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXeNanfnpvzu0z1GZlfgpdeYwKF0\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701574899,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#244 million#123 million#30-45%#10%\\n\\nDATE#2009#2014#2008 through 2014#2016#2015#December 2016#November 2016#October 2016#June 2016#May 2016#January 2017#January 2016#February 2017#September 2016#August 2016#April 2016#July 2016\\n\\nEVENT#disposal of Mead Johnson#IPO#restructuring#the acquisition of Mead Johnson\\u2019s stock or assets#Phase III development#the treatment of relapsed or refractory cHL#the treatment of adult patients with relapsed or refractory cHL#the treatment of patients with cHL who have relapsed or progressed#the treatment of unresectable advanced or recurrent gastric cancer#a Phase I trial evaluating Opdivo#the treatment of patients with previously treated locally advanced or mUC#the treatment of locally advanced mUC in adults after failure of prior platinum-containing therapy#a Phase I/II trial evaluating Opdivo#a Phase III trial evaluating Opdivo#the treatment of previously treated patients with metastatic NSQ NSCLC#the treatment of unresectable or metastatic RCC#the treatment of previously treated patients with SCCHN#the treatment of patients with SCCHN with disease progression on or after platinum-based therapy#the treatment of previously treated recurrent or metastatic SCCHN#the treatment of unresectable or metastatic melanoma#the treatment of previously untreated unresectable or metastatic melanoma\\n\\nFAC#Mead Johnson\\n\\nGPE#Seattle\\n\\nLAW#Internal Revenue Code\\n\\nMONEY#$244 million#$123 million\\n\\nORG#Mead Johnson#our alliance partner#BMS#FDA#EMA#Ono#JMHLW\\n\\nPERCENT#30-45%#10%\\n\\nPERSON#Opdivo#Adcetris\\n\\nPRODUCT#Opdivo#Yervoy\\n\\nWORK_OF_ART#Item 8. Financial Statements\\u2014Note 1. Accounting Policies\\u2014Income Taxes#\\u2014Note 7. Income Taxes#CA209-003#CheckMate-205#CheckMate-032#CheckMate-142#CheckMate-067#CheckMate-069}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2388,\n",
      "    \"completion_tokens\": 471,\n",
      "    \"total_tokens\": 2859\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': '2009', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2008 through 2014', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': 'December 2016', 'category': 'DATE'}, {'entity': 'November 2016', 'category': 'DATE'}, {'entity': 'October 2016', 'category': 'DATE'}, {'entity': 'June 2016', 'category': 'DATE'}, {'entity': 'May 2016', 'category': 'DATE'}, {'entity': 'January 2017', 'category': 'DATE'}, {'entity': 'January 2016', 'category': 'DATE'}, {'entity': 'February 2017', 'category': 'DATE'}, {'entity': 'September 2016', 'category': 'DATE'}, {'entity': 'August 2016', 'category': 'DATE'}, {'entity': 'April 2016', 'category': 'DATE'}, {'entity': 'July 2016', 'category': 'DATE'}, {'entity': 'disposal of Mead Johnson', 'category': 'EVENT'}, {'entity': 'IPO', 'category': 'EVENT'}, {'entity': 'restructuring', 'category': 'EVENT'}, {'entity': 'the acquisition of Mead Johnson’s stock or assets', 'category': 'EVENT'}, {'entity': 'Phase III development', 'category': 'EVENT'}, {'entity': 'the treatment of relapsed or refractory cHL', 'category': 'EVENT'}, {'entity': 'the treatment of adult patients with relapsed or refractory cHL', 'category': 'EVENT'}, {'entity': 'the treatment of patients with cHL who have relapsed or progressed', 'category': 'EVENT'}, {'entity': 'the treatment of unresectable advanced or recurrent gastric cancer', 'category': 'EVENT'}, {'entity': 'a Phase I trial evaluating Opdivo', 'category': 'EVENT'}, {'entity': 'the treatment of patients with previously treated locally advanced or mUC', 'category': 'EVENT'}, {'entity': 'the treatment of locally advanced mUC in adults after failure of prior platinum-containing therapy', 'category': 'EVENT'}, {'entity': 'a Phase I/II trial evaluating Opdivo', 'category': 'EVENT'}, {'entity': 'a Phase III trial evaluating Opdivo', 'category': 'EVENT'}, {'entity': 'the treatment of previously treated patients with metastatic NSQ NSCLC', 'category': 'EVENT'}, {'entity': 'the treatment of unresectable or metastatic RCC', 'category': 'EVENT'}, {'entity': 'the treatment of previously treated patients with SCCHN', 'category': 'EVENT'}, {'entity': 'the treatment of patients with SCCHN with disease progression on or after platinum-based therapy', 'category': 'EVENT'}, {'entity': 'the treatment of previously treated recurrent or metastatic SCCHN', 'category': 'EVENT'}, {'entity': 'the treatment of unresectable or metastatic melanoma', 'category': 'EVENT'}, {'entity': 'the treatment of previously untreated unresectable or metastatic melanoma', 'category': 'EVENT'}, {'entity': 'Mead Johnson', 'category': 'FAC'}, {'entity': 'Seattle', 'category': 'GPE'}, {'entity': 'Internal Revenue Code', 'category': 'LAW'}, {'entity': '$244 million', 'category': 'MONEY'}, {'entity': '$123 million', 'category': 'MONEY'}, {'entity': 'Mead Johnson', 'category': 'ORG'}, {'entity': 'our alliance partner', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'EMA', 'category': 'ORG'}, {'entity': 'Ono', 'category': 'ORG'}, {'entity': 'JMHLW', 'category': 'ORG'}, {'entity': '30-45%', 'category': 'PERCENT'}, {'entity': '10%', 'category': 'PERCENT'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Adcetris', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Yervoy', 'category': 'PRODUCT'}, {'entity': 'Item 8. Financial Statements—Note 1. Accounting Policies—Income Taxes', 'category': 'WORK_OF_ART'}, {'entity': '—Note 7. Income Taxes', 'category': 'WORK_OF_ART'}, {'entity': 'CA209-003', 'category': 'WORK_OF_ART'}, {'entity': 'CheckMate-205', 'category': 'WORK_OF_ART'}, {'entity': 'CheckMate-032', 'category': 'WORK_OF_ART'}, {'entity': 'CheckMate-142', 'category': 'WORK_OF_ART'}, {'entity': 'CheckMate-067', 'category': 'WORK_OF_ART'}, {'entity': 'CheckMate-069', 'category': 'WORK_OF_ART'}, {'entity': '244 million', 'category': 'CARDINAL'}, {'entity': '123 million', 'category': 'CARDINAL'}, {'entity': '30-45%', 'category': 'CARDINAL'}, {'entity': '10%', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  14\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXf2ZsbgGc4kXwk7sYW9d8MU7S4N\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701574940,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#012#016#032#1#1#3#5#10#7A#10#1A#100\\n\\nDATE#June 2016#October 2016#December 2016#September 2016#May 2016#October 2016#September 2016#July 2016#June 2016#December 2016#February 2016#February 2016#January 2016#June 2016#December 31, 2016\\n\\nEVENT#CheckMate-012#CheckMate-016#CheckMate-032#Special Note Regarding Forward-Looking Statements#QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK#Foreign Exchange Risk#Interest Rate Risk\\n\\nFAC#Ximency combination tablet\\n\\nGPE#U.S.#Chinese\\n\\nLAW#Section 27A of the Securities Act of 1933#Section 21E of the Securities Exchange Act of 1934#Item 1A. Risk Factors\\n\\nMONEY#$86 million#$36 million\\n\\nORDINAL#first#third\\n\\nORG#RCC#SCLC#JMHLW#EC#HCV#FDA#HIV#Item\\n\\nPERSON#CA184-029\\n\\nPRODUCT#Opdivo#Yervoy#NSCLC#Empliciti#Multiple Myeloma#Revlimid#lenalidomide#dexamethasone#Orencia#MTX#RA#ClickJect Autoinjector#anti-CCP#RF#Hepatitis C Portfolio#daclatasvir#asunaprevir#beclabuvir#Daklinza#sofosbuvir#Reyataz\\n\\nWORK_OF_ART#Form 10-K\\n\\nTIME#at least one prior therapy}\\n\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2238,\n",
      "    \"completion_tokens\": 383,\n",
      "    \"total_tokens\": 2621\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'June 2016', 'category': 'DATE'}, {'entity': 'October 2016', 'category': 'DATE'}, {'entity': 'December 2016', 'category': 'DATE'}, {'entity': 'September 2016', 'category': 'DATE'}, {'entity': 'May 2016', 'category': 'DATE'}, {'entity': 'October 2016', 'category': 'DATE'}, {'entity': 'September 2016', 'category': 'DATE'}, {'entity': 'July 2016', 'category': 'DATE'}, {'entity': 'June 2016', 'category': 'DATE'}, {'entity': 'December 2016', 'category': 'DATE'}, {'entity': 'February 2016', 'category': 'DATE'}, {'entity': 'February 2016', 'category': 'DATE'}, {'entity': 'January 2016', 'category': 'DATE'}, {'entity': 'June 2016', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'CheckMate-012', 'category': 'EVENT'}, {'entity': 'CheckMate-016', 'category': 'EVENT'}, {'entity': 'CheckMate-032', 'category': 'EVENT'}, {'entity': 'Special Note Regarding Forward-Looking Statements', 'category': 'EVENT'}, {'entity': 'QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK', 'category': 'EVENT'}, {'entity': 'Foreign Exchange Risk', 'category': 'EVENT'}, {'entity': 'Interest Rate Risk', 'category': 'EVENT'}, {'entity': 'Ximency combination tablet', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Chinese', 'category': 'GPE'}, {'entity': 'Section 27A of the Securities Act of 1933', 'category': 'LAW'}, {'entity': 'Section 21E of the Securities Exchange Act of 1934', 'category': 'LAW'}, {'entity': 'Item 1A. Risk Factors', 'category': 'LAW'}, {'entity': '$86 million', 'category': 'MONEY'}, {'entity': '$36 million', 'category': 'MONEY'}, {'entity': 'RCC', 'category': 'ORG'}, {'entity': 'SCLC', 'category': 'ORG'}, {'entity': 'JMHLW', 'category': 'ORG'}, {'entity': 'EC', 'category': 'ORG'}, {'entity': 'HCV', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'HIV', 'category': 'ORG'}, {'entity': 'Item', 'category': 'ORG'}, {'entity': 'CA184-029', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Yervoy', 'category': 'PRODUCT'}, {'entity': 'NSCLC', 'category': 'PRODUCT'}, {'entity': 'Empliciti', 'category': 'PRODUCT'}, {'entity': 'Multiple Myeloma', 'category': 'PRODUCT'}, {'entity': 'Revlimid', 'category': 'PRODUCT'}, {'entity': 'lenalidomide', 'category': 'PRODUCT'}, {'entity': 'dexamethasone', 'category': 'PRODUCT'}, {'entity': 'Orencia', 'category': 'PRODUCT'}, {'entity': 'MTX', 'category': 'PRODUCT'}, {'entity': 'RA', 'category': 'PRODUCT'}, {'entity': 'ClickJect Autoinjector', 'category': 'PRODUCT'}, {'entity': 'anti-CCP', 'category': 'PRODUCT'}, {'entity': 'RF', 'category': 'PRODUCT'}, {'entity': 'Hepatitis C Portfolio', 'category': 'PRODUCT'}, {'entity': 'daclatasvir', 'category': 'PRODUCT'}, {'entity': 'asunaprevir', 'category': 'PRODUCT'}, {'entity': 'beclabuvir', 'category': 'PRODUCT'}, {'entity': 'Daklinza', 'category': 'PRODUCT'}, {'entity': 'sofosbuvir', 'category': 'PRODUCT'}, {'entity': 'Reyataz', 'category': 'PRODUCT'}, {'entity': 'at least one prior therapy', 'category': 'TIME'}, {'entity': 'Form 10-K', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'third', 'category': 'ORDINAL'}, {'entity': '012', 'category': 'CARDINAL'}, {'entity': '016', 'category': 'CARDINAL'}, {'entity': '032', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '5', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '7A', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '1A', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  14\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXfemVkUWqHA58euVhDI6k2K5yaO\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701574978,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#100#100#125#513#68 \\n\\nDATE#Item 8\\n\\nGPE#Europe#Greece#Italy#Spain#Portugal\\n\\nMONEY#$125 million#$513 million#$68 million\\n\\nORG#European\\n\\nPERCENT#8\\n\\nWORK_OF_ART#Note 9. Financial Instruments and Fair Value Measurements}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 1027,\n",
      "    \"completion_tokens\": 71,\n",
      "    \"total_tokens\": 1098\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'Item 8', 'category': 'DATE'}, {'entity': 'Europe', 'category': 'GPE'}, {'entity': 'Greece', 'category': 'GPE'}, {'entity': 'Italy', 'category': 'GPE'}, {'entity': 'Spain', 'category': 'GPE'}, {'entity': 'Portugal', 'category': 'GPE'}, {'entity': '$125 million', 'category': 'MONEY'}, {'entity': '$513 million', 'category': 'MONEY'}, {'entity': '$68 million', 'category': 'MONEY'}, {'entity': 'European', 'category': 'ORG'}, {'entity': '8', 'category': 'PERCENT'}, {'entity': 'Note 9. Financial Instruments and Fair Value Measurements', 'category': 'WORK_OF_ART'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '125', 'category': 'CARDINAL'}, {'entity': '513', 'category': 'CARDINAL'}, {'entity': '68', 'category': 'CARDINAL'}]\n",
      "/home/damir/Dropbox/Documents/Teaching/2023/L715/l715_23/data/10-Ks/Bristol-Myers_Squibb_Company/2023/Management.txt\n",
      "Length of chunks:  15\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXg65Y5QaFD4J3o05grWF4fP6QNt\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701575006,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#7#18#0.17#0.54 \\n\\nDATE#Year Ended December 31#August 16, 2022#December 31, 2021#December 2022\\n\\nEVENT#MANAGEMENT\\u2019S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS\\n\\nFAC#New Jersey#Washington \\n\\nGPE#U.S., EU and Japan#Japan#U.S.#EU \\n\\nLAW#IRA\\n\\nMONEY#$46,159#$46,385 \\n\\nORG#Bristol-Myers Squibb Company#FDA#EC#Turning Point#Organization for Economic Co-operation and Development#Ministry of Health, Labour and Welfare\\n\\nPERCENT#10%#20%\\n\\nPERSON#President Biden \\n\\nPRODUCT#Opdualag#Opdivo#Abecma#Breyanzi#Sotyktu#deucravacitinib#Camzyos#Eliquis#Opdivo#Opdualag#Abecma#Reblozyl#Revlimid\\n\\nTIME#second-line treatments#third-line treatments\\n\\nWORK_OF_ART#2022 Form 10-K#2021 Form 10-K#Summary of Abbreviated Terms}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2266,\n",
      "    \"completion_tokens\": 255,\n",
      "    \"total_tokens\": 2521\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': 'August 16, 2022', 'category': 'DATE'}, {'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': 'December 2022', 'category': 'DATE'}, {'entity': 'MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS', 'category': 'EVENT'}, {'entity': 'New Jersey', 'category': 'FAC'}, {'entity': 'Washington', 'category': 'FAC'}, {'entity': 'U.S., EU and Japan', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'EU', 'category': 'GPE'}, {'entity': 'IRA', 'category': 'LAW'}, {'entity': '$46,159', 'category': 'MONEY'}, {'entity': '$46,385', 'category': 'MONEY'}, {'entity': 'Bristol-Myers Squibb Company', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'EC', 'category': 'ORG'}, {'entity': 'Turning Point', 'category': 'ORG'}, {'entity': 'Organization for Economic Co-operation and Development', 'category': 'ORG'}, {'entity': 'Ministry of Health, Labour and Welfare', 'category': 'ORG'}, {'entity': '10%', 'category': 'PERCENT'}, {'entity': '20%', 'category': 'PERCENT'}, {'entity': 'President Biden', 'category': 'PERSON'}, {'entity': 'Opdualag', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Abecma', 'category': 'PRODUCT'}, {'entity': 'Breyanzi', 'category': 'PRODUCT'}, {'entity': 'Sotyktu', 'category': 'PRODUCT'}, {'entity': 'deucravacitinib', 'category': 'PRODUCT'}, {'entity': 'Camzyos', 'category': 'PRODUCT'}, {'entity': 'Eliquis', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Opdualag', 'category': 'PRODUCT'}, {'entity': 'Abecma', 'category': 'PRODUCT'}, {'entity': 'Reblozyl', 'category': 'PRODUCT'}, {'entity': 'Revlimid', 'category': 'PRODUCT'}, {'entity': 'second-line treatments', 'category': 'TIME'}, {'entity': 'third-line treatments', 'category': 'TIME'}, {'entity': '2022 Form 10-K', 'category': 'WORK_OF_ART'}, {'entity': '2021 Form 10-K', 'category': 'WORK_OF_ART'}, {'entity': 'Summary of Abbreviated Terms', 'category': 'WORK_OF_ART'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '18', 'category': 'CARDINAL'}, {'entity': '0.17', 'category': 'CARDINAL'}, {'entity': '0.54', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  15\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXggeSU4pX6Cu98xPNWf2LOdzQuu\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701575042,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#12#1#12#12#1#1 \\n\\nDATE#September 2022#September 2022#September 2022#June 2022#May 2022#May 2022#May 2022#May 2022#April 2022#April 2022#April 2022#April 2022#April 2022#March 2022#March 2022#March 2022#January 2022#2022#2023#2022\\n\\nEVENT#FDA approval\\n\\nFAC#\\n\\nGPE#Japan\\n\\nLANGUAGE#\\n\\nLAW_DOCUMENT#\\n\\nLOCATION#\\n\\nMONEY#\\n\\nNORP#\\n\\nORDINAL#first#first#first#first#first#first\\n\\nORG#Opdualag#Japan's Ministry of Health, Labour and Welfare#FDA#FDA#EC#EC#Opdivo#Opdivo#EC#FDA#FDA#FDA#Japan's Ministry of Health, Labour and Welfare#Abecma#Japan\\u2019s Ministry of Health, Labour and Welfare#Janssen#Camzyos#Eliquis#Revlimid#Celgene\\n\\nPERCENT#1%\\n\\nPERSON#Opdualag#Breyanzi#Camzyos\\n\\nPRODUCT#Opdualag#Breyanzi#Opdivo+Yervoy#Opdivo#Opdivo+Yervoy#Opdivo#Camzyos#Breyanzi#Opdualag#Opdivo#Revlimid#Pomalyst\\n\\nQUANTITY#\\n\\nTIME#\\n\\nWORK_OF_ART#Pipeline Developments}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2382,\n",
      "    \"completion_tokens\": 332,\n",
      "    \"total_tokens\": 2714\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'September 2022', 'category': 'DATE'}, {'entity': 'September 2022', 'category': 'DATE'}, {'entity': 'September 2022', 'category': 'DATE'}, {'entity': 'June 2022', 'category': 'DATE'}, {'entity': 'May 2022', 'category': 'DATE'}, {'entity': 'May 2022', 'category': 'DATE'}, {'entity': 'May 2022', 'category': 'DATE'}, {'entity': 'May 2022', 'category': 'DATE'}, {'entity': 'April 2022', 'category': 'DATE'}, {'entity': 'April 2022', 'category': 'DATE'}, {'entity': 'April 2022', 'category': 'DATE'}, {'entity': 'April 2022', 'category': 'DATE'}, {'entity': 'April 2022', 'category': 'DATE'}, {'entity': 'March 2022', 'category': 'DATE'}, {'entity': 'March 2022', 'category': 'DATE'}, {'entity': 'March 2022', 'category': 'DATE'}, {'entity': 'January 2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2023', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': 'FDA approval', 'category': 'EVENT'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'DOCUMENT', 'category': 'LAW'}, {'entity': 'TION', 'category': 'LOC'}, {'entity': 'Opdualag', 'category': 'ORG'}, {'entity': 'Japans Ministry of Health, Labour and Welfare', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'EC', 'category': 'ORG'}, {'entity': 'EC', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'EC', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'Japans Ministry of Health, Labour and Welfare', 'category': 'ORG'}, {'entity': 'Abecma', 'category': 'ORG'}, {'entity': 'Japan’s Ministry of Health, Labour and Welfare', 'category': 'ORG'}, {'entity': 'Janssen', 'category': 'ORG'}, {'entity': 'Camzyos', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'Revlimid', 'category': 'ORG'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': '1%', 'category': 'PERCENT'}, {'entity': 'Opdualag', 'category': 'PERSON'}, {'entity': 'Breyanzi', 'category': 'PERSON'}, {'entity': 'Camzyos', 'category': 'PERSON'}, {'entity': 'Opdualag', 'category': 'PRODUCT'}, {'entity': 'Breyanzi', 'category': 'PRODUCT'}, {'entity': 'Opdivo+Yervoy', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Opdivo+Yervoy', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Camzyos', 'category': 'PRODUCT'}, {'entity': 'Breyanzi', 'category': 'PRODUCT'}, {'entity': 'Opdualag', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Revlimid', 'category': 'PRODUCT'}, {'entity': 'Pomalyst', 'category': 'PRODUCT'}, {'entity': 'Pipeline Developments', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  15\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXhHGj8opqdH3T3N0kly5r9GkRZ5\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701575079,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#3.0 billion \\n\\nDATE#2022#Year Ended December 31, 2022#January 1, 2022#December 31, 2022\\n\\nEVENT#Celgene acquisition restructuring\\n\\nGPE#United States\\n\\nMONEY#$3.0 billion\\n\\nORG#Celgene#R&D#Medicaid and Medicare#Company's#Environmental, Social and Governance (ESG)\\n\\nPERCENT#10%\\n\\nPRODUCT#Eliquis#New Product Portfolio#Opdivo#Revlimid#In-Line Products#New Product Portfolio\\n\\nQUANTITY#at least $3.0 billion\\n\\nTIME#2022 vs. 2021\\n\\nWORK_OF_ART#Item 8. Financial Statements and Supplementary Data \\u2014Note 3. Alliances#\\u2014Note 4. Acquisitions, Divestitures, Licensing and Other Arrangements.}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 3141,\n",
      "    \"completion_tokens\": 179,\n",
      "    \"total_tokens\": 3320\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': '2022', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2022', 'category': 'DATE'}, {'entity': 'January 1, 2022', 'category': 'DATE'}, {'entity': 'December 31, 2022', 'category': 'DATE'}, {'entity': 'Celgene acquisition restructuring', 'category': 'EVENT'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': '$3.0 billion', 'category': 'MONEY'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': 'R&D', 'category': 'ORG'}, {'entity': 'Medicaid and Medicare', 'category': 'ORG'}, {'entity': 'Companys', 'category': 'ORG'}, {'entity': 'Environmental, Social and Governance ESG', 'category': 'ORG'}, {'entity': '10%', 'category': 'PERCENT'}, {'entity': 'Eliquis', 'category': 'PRODUCT'}, {'entity': 'New Product Portfolio', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Revlimid', 'category': 'PRODUCT'}, {'entity': 'In-Line Products', 'category': 'PRODUCT'}, {'entity': 'New Product Portfolio', 'category': 'PRODUCT'}, {'entity': 'at least $3.0 billion', 'category': 'QUANTITY'}, {'entity': '2022 vs. 2021', 'category': 'TIME'}, {'entity': 'Item 8. Financial Statements and Supplementary Data —Note 3. Alliances', 'category': 'WORK_OF_ART'}, {'entity': '—Note 4. Acquisitions, Divestitures, Licensing and Other Arrangements.', 'category': 'WORK_OF_ART'}, {'entity': '3.0 billion', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  15\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXhoUnqAJfBLTgAxAeVgEtLpiP4u\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701575112,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#7%#11%#4%#15%#3%#14%#8%#8%#9%#3%#15%#19%#11%#8%#3%#9%#12%#21%#10%#5%#5%#22%#12 \\n\\nDATE#May 2021#2021#2026#1 year to 18 years#May 2021#March 2022#June 2020#April 2021#September 2020\\n\\nEVENT#at-risk generic launch \\n\\nGPE#Europe#United Kingdom#Netherlands#the UK#the Netherlands#U.S.#EU#Japan \\n\\nLAW#UK apixaban composition of matter patent and related SPC#our Eliquis patents#patents#method of use patents#Formulation and additional patents \\n\\nLOC#Philadelphia \\n\\nMONEY#1. Financial Statements\\u2014Note 20.\\n\\nNORP#Japanese \\n\\nORG#GTN#Eliquis#BMS#Item 1.#Legal Proceedings and Contingencies\\u2014Intellectual Property#Opdivo#NKT#RCC#HCC#MPM#Yervoy#NSCLC#CRC#Cabometyx#kidney cancer#bladder#Pomalyst/Imnovid#myeloma#lenalidomide#a proteasome inhibitor#Orencia#abatacept#RA#PsA#JIA#Sprycel#Philadelphia chromosome-positive CML#Gleevec#imatinib mesylate#lymphoid blast phase CML#Yervoy#melanoma#MPM#RCC#CRC#Empliciti#elotuzumab#OTC#mature products#Reblozyl#luspatercept-aamt#ESA#MDS#ring sideroblasts#RBC transfusions#Abecma#idecabtagene vicleucel#B-cell maturation antigen#immunomodulatory agent#proteasome inhibitor#anti-CD38 monoclonal antibody#Opdualag#relatlimab#LAG-3#Zeposia#ozanimod#relapsing-remitting disease#active secondary progressive disease#UC#Breyanzi#lisocabtagene maraleucel#CAR-T cell therapy#Onureg#azacitidine#DNA and RNA#AML#complete remission with incomplete blood count#intensive induction chemotherapy#intensive curative therapy#Inrebic#fedratinib\\n\\nPERCENT#11%#4%#15%#11%#14%#10%#3%#11%#12%#21%#5%#22%\\n\\nPERSON#Opdivo#Yervoy\\n\\nPRODUCT#Eliquis \\n\\nWORK_OF_ART#the Opdivo+Yervoy combinations for NSCLC\\n}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2364,\n",
      "    \"completion_tokens\": 611,\n",
      "    \"total_tokens\": 2975\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'May 2021', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2026', 'category': 'DATE'}, {'entity': '1 year to 18 years', 'category': 'DATE'}, {'entity': 'May 2021', 'category': 'DATE'}, {'entity': 'March 2022', 'category': 'DATE'}, {'entity': 'June 2020', 'category': 'DATE'}, {'entity': 'April 2021', 'category': 'DATE'}, {'entity': 'September 2020', 'category': 'DATE'}, {'entity': 'at-risk generic launch', 'category': 'EVENT'}, {'entity': 'Europe', 'category': 'GPE'}, {'entity': 'United Kingdom', 'category': 'GPE'}, {'entity': 'Netherlands', 'category': 'GPE'}, {'entity': 'the UK', 'category': 'GPE'}, {'entity': 'the Netherlands', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'EU', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'UK apixaban composition of matter patent and related SPC', 'category': 'LAW'}, {'entity': 'our Eliquis patents', 'category': 'LAW'}, {'entity': 'patents', 'category': 'LAW'}, {'entity': 'method of use patents', 'category': 'LAW'}, {'entity': 'Formulation and additional patents', 'category': 'LAW'}, {'entity': 'Philadelphia', 'category': 'LOC'}, {'entity': '1. Financial Statements—Note 20.', 'category': 'MONEY'}, {'entity': 'Japanese', 'category': 'NORP'}, {'entity': 'GTN', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Item 1.', 'category': 'ORG'}, {'entity': 'Legal Proceedings and Contingencies—Intellectual Property', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'NKT', 'category': 'ORG'}, {'entity': 'RCC', 'category': 'ORG'}, {'entity': 'HCC', 'category': 'ORG'}, {'entity': 'MPM', 'category': 'ORG'}, {'entity': 'Yervoy', 'category': 'ORG'}, {'entity': 'NSCLC', 'category': 'ORG'}, {'entity': 'CRC', 'category': 'ORG'}, {'entity': 'Cabometyx', 'category': 'ORG'}, {'entity': 'kidney cancer', 'category': 'ORG'}, {'entity': 'bladder', 'category': 'ORG'}, {'entity': 'Pomalyst/Imnovid', 'category': 'ORG'}, {'entity': 'myeloma', 'category': 'ORG'}, {'entity': 'lenalidomide', 'category': 'ORG'}, {'entity': 'a proteasome inhibitor', 'category': 'ORG'}, {'entity': 'Orencia', 'category': 'ORG'}, {'entity': 'abatacept', 'category': 'ORG'}, {'entity': 'RA', 'category': 'ORG'}, {'entity': 'PsA', 'category': 'ORG'}, {'entity': 'JIA', 'category': 'ORG'}, {'entity': 'Sprycel', 'category': 'ORG'}, {'entity': 'Philadelphia chromosome-positive CML', 'category': 'ORG'}, {'entity': 'Gleevec', 'category': 'ORG'}, {'entity': 'imatinib mesylate', 'category': 'ORG'}, {'entity': 'lymphoid blast phase CML', 'category': 'ORG'}, {'entity': 'Yervoy', 'category': 'ORG'}, {'entity': 'melanoma', 'category': 'ORG'}, {'entity': 'MPM', 'category': 'ORG'}, {'entity': 'RCC', 'category': 'ORG'}, {'entity': 'CRC', 'category': 'ORG'}, {'entity': 'Empliciti', 'category': 'ORG'}, {'entity': 'elotuzumab', 'category': 'ORG'}, {'entity': 'OTC', 'category': 'ORG'}, {'entity': 'mature products', 'category': 'ORG'}, {'entity': 'Reblozyl', 'category': 'ORG'}, {'entity': 'luspatercept-aamt', 'category': 'ORG'}, {'entity': 'ESA', 'category': 'ORG'}, {'entity': 'MDS', 'category': 'ORG'}, {'entity': 'ring sideroblasts', 'category': 'ORG'}, {'entity': 'RBC transfusions', 'category': 'ORG'}, {'entity': 'Abecma', 'category': 'ORG'}, {'entity': 'idecabtagene vicleucel', 'category': 'ORG'}, {'entity': 'B-cell maturation antigen', 'category': 'ORG'}, {'entity': 'immunomodulatory agent', 'category': 'ORG'}, {'entity': 'proteasome inhibitor', 'category': 'ORG'}, {'entity': 'anti-CD38 monoclonal antibody', 'category': 'ORG'}, {'entity': 'Opdualag', 'category': 'ORG'}, {'entity': 'relatlimab', 'category': 'ORG'}, {'entity': 'LAG-3', 'category': 'ORG'}, {'entity': 'Zeposia', 'category': 'ORG'}, {'entity': 'ozanimod', 'category': 'ORG'}, {'entity': 'relapsing-remitting disease', 'category': 'ORG'}, {'entity': 'active secondary progressive disease', 'category': 'ORG'}, {'entity': 'UC', 'category': 'ORG'}, {'entity': 'Breyanzi', 'category': 'ORG'}, {'entity': 'lisocabtagene maraleucel', 'category': 'ORG'}, {'entity': 'CAR-T cell therapy', 'category': 'ORG'}, {'entity': 'Onureg', 'category': 'ORG'}, {'entity': 'azacitidine', 'category': 'ORG'}, {'entity': 'DNA and RNA', 'category': 'ORG'}, {'entity': 'AML', 'category': 'ORG'}, {'entity': 'complete remission with incomplete blood count', 'category': 'ORG'}, {'entity': 'intensive induction chemotherapy', 'category': 'ORG'}, {'entity': 'intensive curative therapy', 'category': 'ORG'}, {'entity': 'Inrebic', 'category': 'ORG'}, {'entity': 'fedratinib', 'category': 'ORG'}, {'entity': '11%', 'category': 'PERCENT'}, {'entity': '4%', 'category': 'PERCENT'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': '11%', 'category': 'PERCENT'}, {'entity': '14%', 'category': 'PERCENT'}, {'entity': '10%', 'category': 'PERCENT'}, {'entity': '3%', 'category': 'PERCENT'}, {'entity': '11%', 'category': 'PERCENT'}, {'entity': '12%', 'category': 'PERCENT'}, {'entity': '21%', 'category': 'PERCENT'}, {'entity': '5%', 'category': 'PERCENT'}, {'entity': '22%', 'category': 'PERCENT'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Yervoy', 'category': 'PERSON'}, {'entity': 'Eliquis', 'category': 'PRODUCT'}, {'entity': 'the Opdivo+Yervoy combinations for NSCLC', 'category': 'WORK_OF_ART'}, {'entity': '7%', 'category': 'CARDINAL'}, {'entity': '11%', 'category': 'CARDINAL'}, {'entity': '4%', 'category': 'CARDINAL'}, {'entity': '15%', 'category': 'CARDINAL'}, {'entity': '3%', 'category': 'CARDINAL'}, {'entity': '14%', 'category': 'CARDINAL'}, {'entity': '8%', 'category': 'CARDINAL'}, {'entity': '8%', 'category': 'CARDINAL'}, {'entity': '9%', 'category': 'CARDINAL'}, {'entity': '3%', 'category': 'CARDINAL'}, {'entity': '15%', 'category': 'CARDINAL'}, {'entity': '19%', 'category': 'CARDINAL'}, {'entity': '11%', 'category': 'CARDINAL'}, {'entity': '8%', 'category': 'CARDINAL'}, {'entity': '3%', 'category': 'CARDINAL'}, {'entity': '9%', 'category': 'CARDINAL'}, {'entity': '12%', 'category': 'CARDINAL'}, {'entity': '21%', 'category': 'CARDINAL'}, {'entity': '10%', 'category': 'CARDINAL'}, {'entity': '5%', 'category': 'CARDINAL'}, {'entity': '5%', 'category': 'CARDINAL'}, {'entity': '22%', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  15\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXicBJfsHCVwumMbtPlK6nPpVXwy\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701575162,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#2#4#35#18#13#78#100\\n\\nDATE#August 2019#April 2022#September 2022#July 2022#December 31, 2022#September 30, 2022\\n\\nGPE#U.S.#European#Canada#EU#Japan\\n\\nLAW#SEC Consent Order\\n\\nMONEY#$6.5 billion\\n\\nORG#Inrebic#Camzyos#Sotyktu#Revlimid#BMS#Abraxane#Nab\\u00ae technology platform#REM#Pomalyst#Lenalidomide REMS#Pomalyst REMS\\n\\nPERCENT#4%#61%#57%#35%#15%#18%#5%#2%\\n\\nPRODUCT#lenalidomide#dexamethasone\\n\\nTIME#one month\\n\\nWORK_OF_ART#2022 Form 10-K\\n\\nNORP#American#Japanese\\n\\nEVENT#SEC Consent Order\\n\\nFAC#U.S. wholesaler distribution channel\\n\\nLOC#U.S. wholesaler distribution channel\\n\\nORDINAL#second\\n\\nQUANTITY#one month\\n\\nPERSON#U.S. products}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2297,\n",
      "    \"completion_tokens\": 247,\n",
      "    \"total_tokens\": 2544\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'August 2019', 'category': 'DATE'}, {'entity': 'April 2022', 'category': 'DATE'}, {'entity': 'September 2022', 'category': 'DATE'}, {'entity': 'July 2022', 'category': 'DATE'}, {'entity': 'December 31, 2022', 'category': 'DATE'}, {'entity': 'September 30, 2022', 'category': 'DATE'}, {'entity': 'SEC Consent Order', 'category': 'EVENT'}, {'entity': 'U.S. wholesaler distribution channel', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'European', 'category': 'GPE'}, {'entity': 'Canada', 'category': 'GPE'}, {'entity': 'EU', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'SEC Consent Order', 'category': 'LAW'}, {'entity': 'U.S. wholesaler distribution channel', 'category': 'LOC'}, {'entity': '$6.5 billion', 'category': 'MONEY'}, {'entity': 'American', 'category': 'NORP'}, {'entity': 'Japanese', 'category': 'NORP'}, {'entity': 'Inrebic', 'category': 'ORG'}, {'entity': 'Camzyos', 'category': 'ORG'}, {'entity': 'Sotyktu', 'category': 'ORG'}, {'entity': 'Revlimid', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Abraxane', 'category': 'ORG'}, {'entity': 'Nab® technology platform', 'category': 'ORG'}, {'entity': 'REM', 'category': 'ORG'}, {'entity': 'Pomalyst', 'category': 'ORG'}, {'entity': 'Lenalidomide REMS', 'category': 'ORG'}, {'entity': 'Pomalyst REMS', 'category': 'ORG'}, {'entity': '4%', 'category': 'PERCENT'}, {'entity': '61%', 'category': 'PERCENT'}, {'entity': '57%', 'category': 'PERCENT'}, {'entity': '35%', 'category': 'PERCENT'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': '18%', 'category': 'PERCENT'}, {'entity': '5%', 'category': 'PERCENT'}, {'entity': '2%', 'category': 'PERCENT'}, {'entity': 'U.S. products', 'category': 'PERSON'}, {'entity': 'lenalidomide', 'category': 'PRODUCT'}, {'entity': 'dexamethasone', 'category': 'PRODUCT'}, {'entity': 'one month', 'category': 'QUANTITY'}, {'entity': 'one month', 'category': 'TIME'}, {'entity': '2022 Form 10-K', 'category': 'WORK_OF_ART'}, {'entity': 'second', 'category': 'ORDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '35', 'category': 'CARDINAL'}, {'entity': '18', 'category': 'CARDINAL'}, {'entity': '13', 'category': 'CARDINAL'}, {'entity': '78', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  15\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXjAF1uyg4iNA8YbRnrE8BjCmShZ\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701575196,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#197#541#588#315#124#235#73#686#742#80#47#295#200#150#90#650#220#80#58#80#815#1,159#428#1.3#1,232#1,334#1,283#832#801#440#266#178#171#75#90#576#720#6.0#3.5#40#83#15#39#32#7,713#8,098#1,368#1,084\\n\\nDATE#Year Ended December 31#2022#2021#first quarter of 2026#fourth quarter of 2022\\n\\nEVENT#Turning Point unvested stock awards cash settlement#Mavacamten royalty extinguishment#Dragonfly milestone and opt-in license fee#Immatics upfront license fee#BridgeBio upfront collaboration fee#Eisai upfront collaboration fee#Agenus upfront license fee and milestone#Prothena opt-in license fee#Evotec opt-in license fee#other Acquired IPRD#Abraxane market exclusivity expiration#Pomalyst market exclusivity period expected expiration#mature product rights divestiture#licensing and supply obligation matters resolution#intellectual property and promotional practice matters#Nimbus\\u2019 TYK2 inhibitor settlement#contingent development, regulatory and sales-based milestones\\n\\nFAC#EU regulatory\\n\\nGPE#Russian Federation\\n\\nLAW_DOCUMENT#Item 8. Financial Statements and Supplementary Data\\u2014Note 15. Goodwill and Other Intangible Assets\\n\\nLOC#EU#Russian Federation\\n\\nMONEY#$197 million#$541 million#$588 million#$315 million#$124 million#$235 million#$73 million#$686 million#$742 million#$80 million#295 million#200 million#150 million#90 million#650 million#220 million#80 million#58 million#80 million#815 million#1,159 million#428 million#1.3 billion#1,232 million#1,334 million#1,283 million#832 million#801 million#440 million#266 million#178 million#171 million#75 million#90 million#576 million#720 million#6.0 billion#3.5 billion#40 million#83 million#15 million#39 million#32 million#7,713 million#8,098 million#1,368 million#1,084 million\\n\\nORG#Eliquis#Inrebic#Turning Point#BMS#Celgene#Eisai#Agenus#Prothena#Evotec#FDA#JCAR017#Nimbus#TYK2\\n\\nPERSON#Mavacamten#Dragonfly#Immatics#BridgeBio#Pomalyst#Abraxane#Keytruda\\n\\nPRODUCT#CAR-T cell therapy\\n\\nWORK_OF_ART#Item 8. Financial Statements and Supplementary Data\\u2014Note 3. Alliances\\u201d and \\u201c\\u2014Note 4. Acquisitions, Divestitures, Licensing and Other Arrangements#Item 8. Financial Statements and Supplementary Data\\u2014Note 10. \\\"Financing Arrangements#Item 8. Financial Statements and Supplementary Data\\u2014Note 9. Financial Instruments and Fair Value Measurements#Item 8. Financial Statements\\u2014Note 20. Legal Proceedings and Contingencies}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2355,\n",
      "    \"completion_tokens\": 687,\n",
      "    \"total_tokens\": 3042\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': 'first quarter of 2026', 'category': 'DATE'}, {'entity': 'fourth quarter of 2022', 'category': 'DATE'}, {'entity': 'Turning Point unvested stock awards cash settlement', 'category': 'EVENT'}, {'entity': 'Mavacamten royalty extinguishment', 'category': 'EVENT'}, {'entity': 'Dragonfly milestone and opt-in license fee', 'category': 'EVENT'}, {'entity': 'Immatics upfront license fee', 'category': 'EVENT'}, {'entity': 'BridgeBio upfront collaboration fee', 'category': 'EVENT'}, {'entity': 'Eisai upfront collaboration fee', 'category': 'EVENT'}, {'entity': 'Agenus upfront license fee and milestone', 'category': 'EVENT'}, {'entity': 'Prothena opt-in license fee', 'category': 'EVENT'}, {'entity': 'Evotec opt-in license fee', 'category': 'EVENT'}, {'entity': 'other Acquired IPRD', 'category': 'EVENT'}, {'entity': 'Abraxane market exclusivity expiration', 'category': 'EVENT'}, {'entity': 'Pomalyst market exclusivity period expected expiration', 'category': 'EVENT'}, {'entity': 'mature product rights divestiture', 'category': 'EVENT'}, {'entity': 'licensing and supply obligation matters resolution', 'category': 'EVENT'}, {'entity': 'intellectual property and promotional practice matters', 'category': 'EVENT'}, {'entity': 'Nimbus’ TYK2 inhibitor settlement', 'category': 'EVENT'}, {'entity': 'contingent development, regulatory and sales-based milestones', 'category': 'EVENT'}, {'entity': 'EU regulatory', 'category': 'FAC'}, {'entity': 'Russian Federation', 'category': 'GPE'}, {'entity': 'DOCUMENT', 'category': 'LAW'}, {'entity': 'Item 8. Financial Statements and Supplementary Data—Note 15. Goodwill and Other Intangible Assets', 'category': 'LAW'}, {'entity': 'EU', 'category': 'LOC'}, {'entity': 'Russian Federation', 'category': 'LOC'}, {'entity': '$197 million', 'category': 'MONEY'}, {'entity': '$541 million', 'category': 'MONEY'}, {'entity': '$588 million', 'category': 'MONEY'}, {'entity': '$315 million', 'category': 'MONEY'}, {'entity': '$124 million', 'category': 'MONEY'}, {'entity': '$235 million', 'category': 'MONEY'}, {'entity': '$73 million', 'category': 'MONEY'}, {'entity': '$686 million', 'category': 'MONEY'}, {'entity': '$742 million', 'category': 'MONEY'}, {'entity': '$80 million', 'category': 'MONEY'}, {'entity': '295 million', 'category': 'MONEY'}, {'entity': '200 million', 'category': 'MONEY'}, {'entity': '150 million', 'category': 'MONEY'}, {'entity': '90 million', 'category': 'MONEY'}, {'entity': '650 million', 'category': 'MONEY'}, {'entity': '220 million', 'category': 'MONEY'}, {'entity': '80 million', 'category': 'MONEY'}, {'entity': '58 million', 'category': 'MONEY'}, {'entity': '80 million', 'category': 'MONEY'}, {'entity': '815 million', 'category': 'MONEY'}, {'entity': '1,159 million', 'category': 'MONEY'}, {'entity': '428 million', 'category': 'MONEY'}, {'entity': '1.3 billion', 'category': 'MONEY'}, {'entity': '1,232 million', 'category': 'MONEY'}, {'entity': '1,334 million', 'category': 'MONEY'}, {'entity': '1,283 million', 'category': 'MONEY'}, {'entity': '832 million', 'category': 'MONEY'}, {'entity': '801 million', 'category': 'MONEY'}, {'entity': '440 million', 'category': 'MONEY'}, {'entity': '266 million', 'category': 'MONEY'}, {'entity': '178 million', 'category': 'MONEY'}, {'entity': '171 million', 'category': 'MONEY'}, {'entity': '75 million', 'category': 'MONEY'}, {'entity': '90 million', 'category': 'MONEY'}, {'entity': '576 million', 'category': 'MONEY'}, {'entity': '720 million', 'category': 'MONEY'}, {'entity': '6.0 billion', 'category': 'MONEY'}, {'entity': '3.5 billion', 'category': 'MONEY'}, {'entity': '40 million', 'category': 'MONEY'}, {'entity': '83 million', 'category': 'MONEY'}, {'entity': '15 million', 'category': 'MONEY'}, {'entity': '39 million', 'category': 'MONEY'}, {'entity': '32 million', 'category': 'MONEY'}, {'entity': '7,713 million', 'category': 'MONEY'}, {'entity': '8,098 million', 'category': 'MONEY'}, {'entity': '1,368 million', 'category': 'MONEY'}, {'entity': '1,084 million', 'category': 'MONEY'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'Inrebic', 'category': 'ORG'}, {'entity': 'Turning Point', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': 'Eisai', 'category': 'ORG'}, {'entity': 'Agenus', 'category': 'ORG'}, {'entity': 'Prothena', 'category': 'ORG'}, {'entity': 'Evotec', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'JCAR017', 'category': 'ORG'}, {'entity': 'Nimbus', 'category': 'ORG'}, {'entity': 'TYK2', 'category': 'ORG'}, {'entity': 'Mavacamten', 'category': 'PERSON'}, {'entity': 'Dragonfly', 'category': 'PERSON'}, {'entity': 'Immatics', 'category': 'PERSON'}, {'entity': 'BridgeBio', 'category': 'PERSON'}, {'entity': 'Pomalyst', 'category': 'PERSON'}, {'entity': 'Abraxane', 'category': 'PERSON'}, {'entity': 'Keytruda', 'category': 'PERSON'}, {'entity': 'CAR-T cell therapy', 'category': 'PRODUCT'}, {'entity': 'Item 8. Financial Statements and Supplementary Data—Note 3. Alliances” and “—Note 4. Acquisitions, Divestitures, Licensing and Other Arrangements', 'category': 'WORK_OF_ART'}, {'entity': 'Item 8. Financial Statements and Supplementary Data—Note 10. \"Financing Arrangements', 'category': 'WORK_OF_ART'}, {'entity': 'Item 8. Financial Statements and Supplementary Data—Note 9. Financial Instruments and Fair Value Measurements', 'category': 'WORK_OF_ART'}, {'entity': 'Item 8. Financial Statements—Note 20. Legal Proceedings and Contingencies', 'category': 'WORK_OF_ART'}, {'entity': '197', 'category': 'CARDINAL'}, {'entity': '541', 'category': 'CARDINAL'}, {'entity': '588', 'category': 'CARDINAL'}, {'entity': '315', 'category': 'CARDINAL'}, {'entity': '124', 'category': 'CARDINAL'}, {'entity': '235', 'category': 'CARDINAL'}, {'entity': '73', 'category': 'CARDINAL'}, {'entity': '686', 'category': 'CARDINAL'}, {'entity': '742', 'category': 'CARDINAL'}, {'entity': '80', 'category': 'CARDINAL'}, {'entity': '47', 'category': 'CARDINAL'}, {'entity': '295', 'category': 'CARDINAL'}, {'entity': '200', 'category': 'CARDINAL'}, {'entity': '150', 'category': 'CARDINAL'}, {'entity': '90', 'category': 'CARDINAL'}, {'entity': '650', 'category': 'CARDINAL'}, {'entity': '220', 'category': 'CARDINAL'}, {'entity': '80', 'category': 'CARDINAL'}, {'entity': '58', 'category': 'CARDINAL'}, {'entity': '80', 'category': 'CARDINAL'}, {'entity': '815', 'category': 'CARDINAL'}, {'entity': '1,159', 'category': 'CARDINAL'}, {'entity': '428', 'category': 'CARDINAL'}, {'entity': '1.3', 'category': 'CARDINAL'}, {'entity': '1,232', 'category': 'CARDINAL'}, {'entity': '1,334', 'category': 'CARDINAL'}, {'entity': '1,283', 'category': 'CARDINAL'}, {'entity': '832', 'category': 'CARDINAL'}, {'entity': '801', 'category': 'CARDINAL'}, {'entity': '440', 'category': 'CARDINAL'}, {'entity': '266', 'category': 'CARDINAL'}, {'entity': '178', 'category': 'CARDINAL'}, {'entity': '171', 'category': 'CARDINAL'}, {'entity': '75', 'category': 'CARDINAL'}, {'entity': '90', 'category': 'CARDINAL'}, {'entity': '576', 'category': 'CARDINAL'}, {'entity': '720', 'category': 'CARDINAL'}, {'entity': '6.0', 'category': 'CARDINAL'}, {'entity': '3.5', 'category': 'CARDINAL'}, {'entity': '40', 'category': 'CARDINAL'}, {'entity': '83', 'category': 'CARDINAL'}, {'entity': '15', 'category': 'CARDINAL'}, {'entity': '39', 'category': 'CARDINAL'}, {'entity': '32', 'category': 'CARDINAL'}, {'entity': '7,713', 'category': 'CARDINAL'}, {'entity': '8,098', 'category': 'CARDINAL'}, {'entity': '1,368', 'category': 'CARDINAL'}, {'entity': '1,084', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  15\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXjy2z19aJw6YfyUAaWjwRBBbef0\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701575246,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#0.7#297#2008#2012#2016#2022#2023#31#264#63#24#603#73#1#6#2#3#98#840#130#1#80#1#1#308#843#9,595#10,023#83#120#799#758#440#564#266#281#211#9#140#75#542#71#415#11,835#11,057#1,332#993#225#72#983#1,629#1,976#10,206#9,081#a#6,327#6,994#10,206#9,081#16,533#16,075#2,146#2,245#2.95#3.12#4.75#4.04#7.70#7.16#51#9,123#13,979#130#2,987#9,253#16,966#4,264#4,948#35,056#39,605#30,067#27,587\\n\\nDATE#2021#2022#February 2, 2023#first quarter of 2022#December 31, 2021#Year Ended December 31#December 31\\n\\nEVENT#Mead Johnson split-off transaction\\n\\nGPE#Mead Johnson\\n\\nLAW#Item 8. Financial Statements and Supplementary Data\\u2014Note 7. Income Taxes#Exhibit 99.2 to our Form 8-K\\n\\nMONEY#$297 million\\n\\nORG#Non-GAAP Financial Measures#Celgene#BMS#GAAP#Celgene#BMS#SEC#BMS#BMS#BMS\\n\\nPERCENT#0.7%\\n\\nPERSON#Mead Johnson\\n\\nPRODUCT#BMS 2008 to 2012 tax years\\n\\nTIME#first quarter\\n\\nWORK_OF_ART#Item 8. Financial Statements and Supplementary Data\\u2014Note 7. Income Taxes}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2422,\n",
      "    \"completion_tokens\": 425,\n",
      "    \"total_tokens\": 2847\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': '2021', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': 'February 2, 2023', 'category': 'DATE'}, {'entity': 'first quarter of 2022', 'category': 'DATE'}, {'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': 'Mead Johnson split-off transaction', 'category': 'EVENT'}, {'entity': 'Mead Johnson', 'category': 'GPE'}, {'entity': 'Item 8. Financial Statements and Supplementary Data—Note 7. Income Taxes', 'category': 'LAW'}, {'entity': 'Exhibit 99.2 to our Form 8-K', 'category': 'LAW'}, {'entity': '$297 million', 'category': 'MONEY'}, {'entity': 'Non-GAAP Financial Measures', 'category': 'ORG'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': '0.7%', 'category': 'PERCENT'}, {'entity': 'Mead Johnson', 'category': 'PERSON'}, {'entity': 'BMS 2008 to 2012 tax years', 'category': 'PRODUCT'}, {'entity': 'first quarter', 'category': 'TIME'}, {'entity': 'Item 8. Financial Statements and Supplementary Data—Note 7. Income Taxes', 'category': 'WORK_OF_ART'}, {'entity': '0.7', 'category': 'CARDINAL'}, {'entity': '297', 'category': 'CARDINAL'}, {'entity': '2008', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '2016', 'category': 'CARDINAL'}, {'entity': '2022', 'category': 'CARDINAL'}, {'entity': '2023', 'category': 'CARDINAL'}, {'entity': '31', 'category': 'CARDINAL'}, {'entity': '264', 'category': 'CARDINAL'}, {'entity': '63', 'category': 'CARDINAL'}, {'entity': '24', 'category': 'CARDINAL'}, {'entity': '603', 'category': 'CARDINAL'}, {'entity': '73', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '98', 'category': 'CARDINAL'}, {'entity': '840', 'category': 'CARDINAL'}, {'entity': '130', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '80', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '308', 'category': 'CARDINAL'}, {'entity': '843', 'category': 'CARDINAL'}, {'entity': '9,595', 'category': 'CARDINAL'}, {'entity': '10,023', 'category': 'CARDINAL'}, {'entity': '83', 'category': 'CARDINAL'}, {'entity': '120', 'category': 'CARDINAL'}, {'entity': '799', 'category': 'CARDINAL'}, {'entity': '758', 'category': 'CARDINAL'}, {'entity': '440', 'category': 'CARDINAL'}, {'entity': '564', 'category': 'CARDINAL'}, {'entity': '266', 'category': 'CARDINAL'}, {'entity': '281', 'category': 'CARDINAL'}, {'entity': '211', 'category': 'CARDINAL'}, {'entity': '9', 'category': 'CARDINAL'}, {'entity': '140', 'category': 'CARDINAL'}, {'entity': '75', 'category': 'CARDINAL'}, {'entity': '542', 'category': 'CARDINAL'}, {'entity': '71', 'category': 'CARDINAL'}, {'entity': '415', 'category': 'CARDINAL'}, {'entity': '11,835', 'category': 'CARDINAL'}, {'entity': '11,057', 'category': 'CARDINAL'}, {'entity': '1,332', 'category': 'CARDINAL'}, {'entity': '993', 'category': 'CARDINAL'}, {'entity': '225', 'category': 'CARDINAL'}, {'entity': '72', 'category': 'CARDINAL'}, {'entity': '983', 'category': 'CARDINAL'}, {'entity': '1,629', 'category': 'CARDINAL'}, {'entity': '1,976', 'category': 'CARDINAL'}, {'entity': '10,206', 'category': 'CARDINAL'}, {'entity': '9,081', 'category': 'CARDINAL'}, {'entity': 'a', 'category': 'CARDINAL'}, {'entity': '6,327', 'category': 'CARDINAL'}, {'entity': '6,994', 'category': 'CARDINAL'}, {'entity': '10,206', 'category': 'CARDINAL'}, {'entity': '9,081', 'category': 'CARDINAL'}, {'entity': '16,533', 'category': 'CARDINAL'}, {'entity': '16,075', 'category': 'CARDINAL'}, {'entity': '2,146', 'category': 'CARDINAL'}, {'entity': '2,245', 'category': 'CARDINAL'}, {'entity': '2.95', 'category': 'CARDINAL'}, {'entity': '3.12', 'category': 'CARDINAL'}, {'entity': '4.75', 'category': 'CARDINAL'}, {'entity': '4.04', 'category': 'CARDINAL'}, {'entity': '7.70', 'category': 'CARDINAL'}, {'entity': '7.16', 'category': 'CARDINAL'}, {'entity': '51', 'category': 'CARDINAL'}, {'entity': '9,123', 'category': 'CARDINAL'}, {'entity': '13,979', 'category': 'CARDINAL'}, {'entity': '130', 'category': 'CARDINAL'}, {'entity': '2,987', 'category': 'CARDINAL'}, {'entity': '9,253', 'category': 'CARDINAL'}, {'entity': '16,966', 'category': 'CARDINAL'}, {'entity': '4,264', 'category': 'CARDINAL'}, {'entity': '4,948', 'category': 'CARDINAL'}, {'entity': '35,056', 'category': 'CARDINAL'}, {'entity': '39,605', 'category': 'CARDINAL'}, {'entity': '30,067', 'category': 'CARDINAL'}, {'entity': '27,587', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  15\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXkdQ3jaiDhlVo1nIWssyS52Bl5C\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701575287,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL:$1.9 billion#$10.6 billion#$2.5 billion#$12.6 billion#$3.3 billion#109 million#$8.0 billion#69 million#$5.0 billion#$7.2 billion#4.6 billion#4.4 billion#$0.54#$5.0 billion#$6.0 billion#4.8 billion#five-year#$5.0 billion#approximately $1.1 billion#$970 million#$750 million#approximately $1.2 billion#an aggregate $22.0 billion#$7.5 billion#$14.5 billion#$17.5 billion#a low default risk#good to extremely strong capacity\\n\\nDATE:January 1, 2022#2022#2021#January 2027#December 31, 2022#2021#2022#2021#2020#2023#2024\\n\\nEVENT:commercial paper program#share repurchase program#ASR program#investment portfolio\\n\\nLAW:Tax Cuts and Jobs Act of 2017#Rule 10b-18 under the Exchange Act#Rule 10b5-1\\n\\nMONEY:$1.9 billion in U.S. tax payments#approximately $10.6 billion#$2.5 billion#$12.6 billion#the Turning Point acquisition ($3.3 billion)from operating activities ($13.1 billion)#repurchased approximately 109 million shares of our common stock for $8.0 billion#approximately 69 million shares for $5.0 billion#the share repurchase program was $7.2 billion#dividend payments were $4.6 billion#Dividend paid per common share was $0.54#maximum of $5.0 billion#we issued an aggregate principal amount of $6.0 billion#repurchased an aggregate principal amount of $6.0 billion#$4.8 billion of debt#revolving credit facility expiring in January 2027#Annual capital expenditures were approximately $1.1 billion#we enter into contracts and commitments#$22.0 billion of potential contingent future research and development milestone payments#milestones of $7.5 billion#milestones of $14.5 billion#sales-based milestones aggregating to $17.5 billion\\n\\nORG:U.S.#BMS#Moody\\u2019s Investors Service#Standard & Poor\\u2019s\\n\\nPERSON:Equity\\n\\nTIME:more than 366 days\\n\\nWORK_OF_ART:Item 8. Financial Statements and Supplementary Data\\u2014Note 17. Equity#Item 8. Financial Statements and Supplementary Data\\u2014Note 1. Accounting Policies and Recently Issued Accounting Standards#Item 8. Financial Statements and Supplementary Data\\u2014Note 10. Financing Arrangements#Item 8. Financial Statements and Supplementary Data\\u2014Note 7. Income Taxes#Item 8. Financial Statements and Supplementary Data\\u2014Note 14. Leases#Item 8. Financial Statements and Supplementary Data\\u2014Note 3. Alliances#Item 8. Financial Statements and Supplementary Data\\u2014Note 4. Acquisitions, Divestitures, Licensing and Other Arrangements}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2243,\n",
      "    \"completion_tokens\": 641,\n",
      "    \"total_tokens\": 2884\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'January 1, 2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': 'January 2027', 'category': 'DATE'}, {'entity': 'December 31, 2022', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2023', 'category': 'DATE'}, {'entity': '2024', 'category': 'DATE'}, {'entity': 'commercial paper program', 'category': 'EVENT'}, {'entity': 'share repurchase program', 'category': 'EVENT'}, {'entity': 'ASR program', 'category': 'EVENT'}, {'entity': 'investment portfolio', 'category': 'EVENT'}, {'entity': 'Tax Cuts and Jobs Act of 2017', 'category': 'LAW'}, {'entity': 'Rule 10b-18 under the Exchange Act', 'category': 'LAW'}, {'entity': 'Rule 10b5-1', 'category': 'LAW'}, {'entity': '$1.9 billion in U.S. tax payments', 'category': 'MONEY'}, {'entity': 'approximately $10.6 billion', 'category': 'MONEY'}, {'entity': '$2.5 billion', 'category': 'MONEY'}, {'entity': '$12.6 billion', 'category': 'MONEY'}, {'entity': 'the Turning Point acquisition $3.3 billionfrom operating activities $13.1 billion', 'category': 'MONEY'}, {'entity': 'repurchased approximately 109 million shares of our common stock for $8.0 billion', 'category': 'MONEY'}, {'entity': 'approximately 69 million shares for $5.0 billion', 'category': 'MONEY'}, {'entity': 'the share repurchase program was $7.2 billion', 'category': 'MONEY'}, {'entity': 'dividend payments were $4.6 billion', 'category': 'MONEY'}, {'entity': 'Dividend paid per common share was $0.54', 'category': 'MONEY'}, {'entity': 'maximum of $5.0 billion', 'category': 'MONEY'}, {'entity': 'we issued an aggregate principal amount of $6.0 billion', 'category': 'MONEY'}, {'entity': 'repurchased an aggregate principal amount of $6.0 billion', 'category': 'MONEY'}, {'entity': '$4.8 billion of debt', 'category': 'MONEY'}, {'entity': 'revolving credit facility expiring in January 2027', 'category': 'MONEY'}, {'entity': 'Annual capital expenditures were approximately $1.1 billion', 'category': 'MONEY'}, {'entity': 'we enter into contracts and commitments', 'category': 'MONEY'}, {'entity': '$22.0 billion of potential contingent future research and development milestone payments', 'category': 'MONEY'}, {'entity': 'milestones of $7.5 billion', 'category': 'MONEY'}, {'entity': 'milestones of $14.5 billion', 'category': 'MONEY'}, {'entity': 'sales-based milestones aggregating to $17.5 billion', 'category': 'MONEY'}, {'entity': 'U.S.', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Moody’s Investors Service', 'category': 'ORG'}, {'entity': 'Standard & Poor’s', 'category': 'ORG'}, {'entity': 'Equity', 'category': 'PERSON'}, {'entity': 'more than 366 days', 'category': 'TIME'}, {'entity': 'Item 8. Financial Statements and Supplementary Data—Note 17. Equity', 'category': 'WORK_OF_ART'}, {'entity': 'Item 8. Financial Statements and Supplementary Data—Note 1. Accounting Policies and Recently Issued Accounting Standards', 'category': 'WORK_OF_ART'}, {'entity': 'Item 8. Financial Statements and Supplementary Data—Note 10. Financing Arrangements', 'category': 'WORK_OF_ART'}, {'entity': 'Item 8. Financial Statements and Supplementary Data—Note 7. Income Taxes', 'category': 'WORK_OF_ART'}, {'entity': 'Item 8. Financial Statements and Supplementary Data—Note 14. Leases', 'category': 'WORK_OF_ART'}, {'entity': 'Item 8. Financial Statements and Supplementary Data—Note 3. Alliances', 'category': 'WORK_OF_ART'}, {'entity': 'Item 8. Financial Statements and Supplementary Data—Note 4. Acquisitions, Divestitures, Licensing and Other Arrangements', 'category': 'WORK_OF_ART'}, {'entity': '$1.9 billion', 'category': 'CARDINAL'}, {'entity': '$10.6 billion', 'category': 'CARDINAL'}, {'entity': '$2.5 billion', 'category': 'CARDINAL'}, {'entity': '$12.6 billion', 'category': 'CARDINAL'}, {'entity': '$3.3 billion', 'category': 'CARDINAL'}, {'entity': '109 million', 'category': 'CARDINAL'}, {'entity': '$8.0 billion', 'category': 'CARDINAL'}, {'entity': '69 million', 'category': 'CARDINAL'}, {'entity': '$5.0 billion', 'category': 'CARDINAL'}, {'entity': '$7.2 billion', 'category': 'CARDINAL'}, {'entity': '4.6 billion', 'category': 'CARDINAL'}, {'entity': '4.4 billion', 'category': 'CARDINAL'}, {'entity': '$0.54', 'category': 'CARDINAL'}, {'entity': '$5.0 billion', 'category': 'CARDINAL'}, {'entity': '$6.0 billion', 'category': 'CARDINAL'}, {'entity': '4.8 billion', 'category': 'CARDINAL'}, {'entity': 'five-year', 'category': 'CARDINAL'}, {'entity': '$5.0 billion', 'category': 'CARDINAL'}, {'entity': 'approximately $1.1 billion', 'category': 'CARDINAL'}, {'entity': '$970 million', 'category': 'CARDINAL'}, {'entity': '$750 million', 'category': 'CARDINAL'}, {'entity': 'approximately $1.2 billion', 'category': 'CARDINAL'}, {'entity': 'an aggregate $22.0 billion', 'category': 'CARDINAL'}, {'entity': '$7.5 billion', 'category': 'CARDINAL'}, {'entity': '$14.5 billion', 'category': 'CARDINAL'}, {'entity': '$17.5 billion', 'category': 'CARDINAL'}, {'entity': 'a low default risk', 'category': 'CARDINAL'}, {'entity': 'good to extremely strong capacity', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  15\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXlSC0azzQXpZcFTW21Df4d27M7q\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701575338,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#3.1 billion#524 million#738 million#871 million#100#78 \\n\\nDATE#August 4, 2004#September 30, 2004\\n\\nEVENT#Turning Point acquisition\\n\\nGPE#U.S.\\n\\nLAW#SEC Consent Order#Form 10-Q\\n\\nMONEY#$1.9 billion#$300 million#$250 million#$3.2 billion#$2.4 billion#$4.1 billion#$646 million#$557 million\\n\\nORG#SEC#U.S. Department of Defense#U.S. Department\\n\\nPERCENT#100%#78%\\n\\nTIME#weekly\\n\\nWORK_OF_ART#Item 8. Financial Statements and Supplementary Data\\u2014Note 1. Accounting Policies and Recently Issued Accounting Standards#Item 8. Financial Statements and Supplementary Data\\u2014Note 2. Revenue\\n}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2039,\n",
      "    \"completion_tokens\": 171,\n",
      "    \"total_tokens\": 2210\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'August 4, 2004', 'category': 'DATE'}, {'entity': 'September 30, 2004', 'category': 'DATE'}, {'entity': 'Turning Point acquisition', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'SEC Consent Order', 'category': 'LAW'}, {'entity': 'Form 10-Q', 'category': 'LAW'}, {'entity': '$1.9 billion', 'category': 'MONEY'}, {'entity': '$300 million', 'category': 'MONEY'}, {'entity': '$250 million', 'category': 'MONEY'}, {'entity': '$3.2 billion', 'category': 'MONEY'}, {'entity': '$2.4 billion', 'category': 'MONEY'}, {'entity': '$4.1 billion', 'category': 'MONEY'}, {'entity': '$646 million', 'category': 'MONEY'}, {'entity': '$557 million', 'category': 'MONEY'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'U.S. Department of Defense', 'category': 'ORG'}, {'entity': 'U.S. Department', 'category': 'ORG'}, {'entity': '100%', 'category': 'PERCENT'}, {'entity': '78%', 'category': 'PERCENT'}, {'entity': 'weekly', 'category': 'TIME'}, {'entity': 'Item 8. Financial Statements and Supplementary Data—Note 1. Accounting Policies and Recently Issued Accounting Standards', 'category': 'WORK_OF_ART'}, {'entity': 'Item 8. Financial Statements and Supplementary Data—Note 2. Revenue', 'category': 'WORK_OF_ART'}, {'entity': '3.1 billion', 'category': 'CARDINAL'}, {'entity': '524 million', 'category': 'CARDINAL'}, {'entity': '738 million', 'category': 'CARDINAL'}, {'entity': '871 million', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '78', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  15\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXlymVHNJXu7yKuKFjteLWF6YnXI\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701575370,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#2#70%#2022#2020#56\\n\\nDATE#within a two to four week time#within one month#in 2022\\n\\nGPE#U.S.\\n\\nLAW#340B program\\n\\nMONEY#2% of the invoiced sales price\\n\\nORG#the U.S. Department of Veterans Affairs#Medicaid#Medicare#CMS#Turning Point#MyoKardia\\n\\nPERCENT#2%#70%\\n\\nPERSON#Medicare Part D\\n\\nPRODUCT#Medicaid#Medicare\\n\\nTIME#a two to four week time\\n\\nWORK_OF_ART#MyoKardia transaction}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 1984,\n",
      "    \"completion_tokens\": 131,\n",
      "    \"total_tokens\": 2115\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'within a two to four week time', 'category': 'DATE'}, {'entity': 'within one month', 'category': 'DATE'}, {'entity': 'in 2022', 'category': 'DATE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '340B program', 'category': 'LAW'}, {'entity': '2% of the invoiced sales price', 'category': 'MONEY'}, {'entity': 'the U.S. Department of Veterans Affairs', 'category': 'ORG'}, {'entity': 'Medicaid', 'category': 'ORG'}, {'entity': 'Medicare', 'category': 'ORG'}, {'entity': 'CMS', 'category': 'ORG'}, {'entity': 'Turning Point', 'category': 'ORG'}, {'entity': 'MyoKardia', 'category': 'ORG'}, {'entity': '2%', 'category': 'PERCENT'}, {'entity': '70%', 'category': 'PERCENT'}, {'entity': 'Medicare Part D', 'category': 'PERSON'}, {'entity': 'Medicaid', 'category': 'PRODUCT'}, {'entity': 'Medicare', 'category': 'PRODUCT'}, {'entity': 'a two to four week time', 'category': 'TIME'}, {'entity': 'MyoKardia transaction', 'category': 'WORK_OF_ART'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '70%', 'category': 'CARDINAL'}, {'entity': '2022', 'category': 'CARDINAL'}, {'entity': '2020', 'category': 'CARDINAL'}, {'entity': '56', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  15\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXmRAKos0x4bFT3kKtgtpRu1egjC\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701575399,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#101 million#$1.2 billion#$1.1 billion#$4.1 billion#$873 million#$2.7 billion#$1.1 billion#$709 million#50%#$244 million\\n\\nDATE#December 31, 2022#December 31, 2021#2009#December 2022\\n\\nEVENT#Mead Johnson split-off\\n\\nFAC#Internal Revenue Service\\n\\nGPE#U.S.\\n\\nLAW#Section 382 of the Internal Revenue Code#Internal Revenue Code\\n\\nMONEY#101 million in 2022, $1.2 billion in 2021 and $1.1 billion in 2020#$4.1 billion at December 31, 2022#$873 million#$2.7 billion at December 31, 2021#1.1 billion\\n\\nORG#Mead Johnson Class B#Mead Johnson Class A#Mead Johnson & Company#Mead Johnson#Mead Johnson\\u2019s\\n\\nPERSON#Mead Johnson\\n\\nPRODUCT#initial public offering\\n\\nTIME#four year period beginning two years before the exchange offer\\n\\nWORK_OF_ART#\\u201cItem 8. Financial Statements and Supplementary Data\\u2014Note 15. Goodwill and Other Intangible Assets\\u201d#\\u201cItem 8. Financial Statements and Supplementary Data\\u2014Note 1. Accounting Policies and Recently Issued Accounting Standards\\u2014Income Taxes\\u201d#\\u201c\\u2014Note 7. Income Taxes\\u201d#\\u201cItem 8. Financial Statements and Supplementary Data\\u2014Note 1. Accounting Policies and Recently Issued Accounting Standards\\u2014Contingencies,\\u201d#\\u201c\\u2014Note 7. Income Taxes\\u201d#\\u201c\\u2014Note 20. Legal Proceedings and Contingencies.\\u201d}\\n\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2124,\n",
      "    \"completion_tokens\": 344,\n",
      "    \"total_tokens\": 2468\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2022', 'category': 'DATE'}, {'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': '2009', 'category': 'DATE'}, {'entity': 'December 2022', 'category': 'DATE'}, {'entity': 'Mead Johnson split-off', 'category': 'EVENT'}, {'entity': 'Internal Revenue Service', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Section 382 of the Internal Revenue Code', 'category': 'LAW'}, {'entity': 'Internal Revenue Code', 'category': 'LAW'}, {'entity': '101 million in 2022, $1.2 billion in 2021 and $1.1 billion in 2020', 'category': 'MONEY'}, {'entity': '$4.1 billion at December 31, 2022', 'category': 'MONEY'}, {'entity': '$873 million', 'category': 'MONEY'}, {'entity': '$2.7 billion at December 31, 2021', 'category': 'MONEY'}, {'entity': '1.1 billion', 'category': 'MONEY'}, {'entity': 'Mead Johnson Class B', 'category': 'ORG'}, {'entity': 'Mead Johnson Class A', 'category': 'ORG'}, {'entity': 'Mead Johnson & Company', 'category': 'ORG'}, {'entity': 'Mead Johnson', 'category': 'ORG'}, {'entity': 'Mead Johnson’s', 'category': 'ORG'}, {'entity': 'Mead Johnson', 'category': 'PERSON'}, {'entity': 'initial public offering', 'category': 'PRODUCT'}, {'entity': 'four year period beginning two years before the exchange offer', 'category': 'TIME'}, {'entity': '“Item 8. Financial Statements and Supplementary Data—Note 15. Goodwill and Other Intangible Assets”', 'category': 'WORK_OF_ART'}, {'entity': '“Item 8. Financial Statements and Supplementary Data—Note 1. Accounting Policies and Recently Issued Accounting Standards—Income Taxes”', 'category': 'WORK_OF_ART'}, {'entity': '“—Note 7. Income Taxes”', 'category': 'WORK_OF_ART'}, {'entity': '“Item 8. Financial Statements and Supplementary Data—Note 1. Accounting Policies and Recently Issued Accounting Standards—Contingencies,”', 'category': 'WORK_OF_ART'}, {'entity': '“—Note 7. Income Taxes”', 'category': 'WORK_OF_ART'}, {'entity': '“—Note 20. Legal Proceedings and Contingencies.”', 'category': 'WORK_OF_ART'}, {'entity': '101 million', 'category': 'CARDINAL'}, {'entity': '$1.2 billion', 'category': 'CARDINAL'}, {'entity': '$1.1 billion', 'category': 'CARDINAL'}, {'entity': '$4.1 billion', 'category': 'CARDINAL'}, {'entity': '$873 million', 'category': 'CARDINAL'}, {'entity': '$2.7 billion', 'category': 'CARDINAL'}, {'entity': '$1.1 billion', 'category': 'CARDINAL'}, {'entity': '$709 million', 'category': 'CARDINAL'}, {'entity': '50%', 'category': 'CARDINAL'}, {'entity': '$244 million', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  15\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXn3fsNmUmGmaBw3AhAK5eOmpzah\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701575437,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#40%#10%#58%#37%#1%#two#first#1%\\n\\nDATE#last three years#February 2, 2023#April 2022#March 2022#May 2022#October 2022#April 2022#March 2022#February 2022#July 2022#June 2022\\n\\nEVENT#PIVOT IO-001 trial#CheckMate -76K trial#Phase III PIVOT IO-001 trial#Phase III CheckMate-9ER trial#Phase III CheckMate -914 trial#Phase III CheckMate -227 trial#Phase III CheckMate -9LA trial#Phase III CheckMate -901 trial\\n\\nGPE#Japan\\n\\nMONEY#\\n\\nNORP#\\n\\nORDINAL#\\n\\nORG#FDA#EMA#NDA#Opdivo#Nektar#BMS#EC#RCC#NSCLC#ESCC \\n\\nPERCENT#10%#40%#37%#58%#1%\\n\\nPERSON#\\n\\nPRODUCT#Opdivo#bempegaldesleukin#Opdivo#Opdivo#Cabometyx#Opdivo plus Yervoy#Opdivo plus Yervoy#Opdivo plus Yervoy\\n\\nQUANTITY#\\n\\nTIME#\\n\\nWORK_OF_ART#}\\n\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2338,\n",
      "    \"completion_tokens\": 281,\n",
      "    \"total_tokens\": 2619\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'last three years', 'category': 'DATE'}, {'entity': 'February 2, 2023', 'category': 'DATE'}, {'entity': 'April 2022', 'category': 'DATE'}, {'entity': 'March 2022', 'category': 'DATE'}, {'entity': 'May 2022', 'category': 'DATE'}, {'entity': 'October 2022', 'category': 'DATE'}, {'entity': 'April 2022', 'category': 'DATE'}, {'entity': 'March 2022', 'category': 'DATE'}, {'entity': 'February 2022', 'category': 'DATE'}, {'entity': 'July 2022', 'category': 'DATE'}, {'entity': 'June 2022', 'category': 'DATE'}, {'entity': 'PIVOT IO-001 trial', 'category': 'EVENT'}, {'entity': 'CheckMate -76K trial', 'category': 'EVENT'}, {'entity': 'Phase III PIVOT IO-001 trial', 'category': 'EVENT'}, {'entity': 'Phase III CheckMate-9ER trial', 'category': 'EVENT'}, {'entity': 'Phase III CheckMate -914 trial', 'category': 'EVENT'}, {'entity': 'Phase III CheckMate -227 trial', 'category': 'EVENT'}, {'entity': 'Phase III CheckMate -9LA trial', 'category': 'EVENT'}, {'entity': 'Phase III CheckMate -901 trial', 'category': 'EVENT'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'EMA', 'category': 'ORG'}, {'entity': 'NDA', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Nektar', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'EC', 'category': 'ORG'}, {'entity': 'RCC', 'category': 'ORG'}, {'entity': 'NSCLC', 'category': 'ORG'}, {'entity': 'ESCC', 'category': 'ORG'}, {'entity': '10%', 'category': 'PERCENT'}, {'entity': '40%', 'category': 'PERCENT'}, {'entity': '37%', 'category': 'PERCENT'}, {'entity': '58%', 'category': 'PERCENT'}, {'entity': '1%', 'category': 'PERCENT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'bempegaldesleukin', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Cabometyx', 'category': 'PRODUCT'}, {'entity': 'Opdivo plus Yervoy', 'category': 'PRODUCT'}, {'entity': 'Opdivo plus Yervoy', 'category': 'PRODUCT'}, {'entity': 'Opdivo plus Yervoy', 'category': 'PRODUCT'}, {'entity': '', 'category': 'WORK_OF_ART'}, {'entity': '40%', 'category': 'CARDINAL'}, {'entity': '10%', 'category': 'CARDINAL'}, {'entity': '58%', 'category': 'CARDINAL'}, {'entity': '37%', 'category': 'CARDINAL'}, {'entity': '1%', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': 'first', 'category': 'CARDINAL'}, {'entity': '1%', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  15\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXndhqcEIz8ZfJoP1Z5LgOVoEpXT\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701575473,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#1#60#2#3#10#92#86.1#52#12\\n\\nDATE#May 2022#April 2022#June 2022#January 2023#October 2022#August 2022#September 2022#December 2022#January 2022#March 2022\\n\\nEVENT#Phase III CheckMate -648 trial#Phase III Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV-1) immune modulators clinical trial#Phase II BEYOND trial#Phase III COMMANDS trial#Phase III KarMMa-3 trial#Phase III DAYBREAK open-label extension trial#Phase III DAYBREAK trial#Phase III RADIANCE trials#Phase III True North study#Phase II portion of the TRANSCEND CLL 004#Phase III clinical trials (JCAR017-BCM-003)#Phase II clinical trials (017006)#Phase II PILOT trial#Phase III TRANSFORM trial#Type II Variation application#Phase III TRANSFORM study#TRANSCEND WORLD trials#TRANSCEND NHL 001 trials#Phase II/III RELATIVITY -047 trial\\n\\nFAC#National Institutes of Health\\n\\nGPE#Japan#United States#Europe#EMA\\n\\nORG#FDA#EC#National Institutes of Health#Committee for Medicinal Product for Human Use (CHMP)#European Medicines Agency (EMA)#2seventy bio, Inc.#Ministry of Health, Labour and Welfare\\n\\nPERSON#\\n\\nPRODUCT#Opdivo#Opdivo plus Yervoy#Orencia#Reblozyl#Abecma#Zeposia#Breyanzi#Opdualag#nivolumab and relatlimab-rmbw\\n\\nWORK_OF_ART#Phase II BB2121-MM-001 and Phase I CRB-401 trials}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2386,\n",
      "    \"completion_tokens\": 388,\n",
      "    \"total_tokens\": 2774\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'May 2022', 'category': 'DATE'}, {'entity': 'April 2022', 'category': 'DATE'}, {'entity': 'June 2022', 'category': 'DATE'}, {'entity': 'January 2023', 'category': 'DATE'}, {'entity': 'October 2022', 'category': 'DATE'}, {'entity': 'August 2022', 'category': 'DATE'}, {'entity': 'September 2022', 'category': 'DATE'}, {'entity': 'December 2022', 'category': 'DATE'}, {'entity': 'January 2022', 'category': 'DATE'}, {'entity': 'March 2022', 'category': 'DATE'}, {'entity': 'Phase III CheckMate -648 trial', 'category': 'EVENT'}, {'entity': 'Phase III Accelerating COVID-19 Therapeutic Interventions and Vaccines ACTIV-1 immune modulators clinical trial', 'category': 'EVENT'}, {'entity': 'Phase II BEYOND trial', 'category': 'EVENT'}, {'entity': 'Phase III COMMANDS trial', 'category': 'EVENT'}, {'entity': 'Phase III KarMMa-3 trial', 'category': 'EVENT'}, {'entity': 'Phase III DAYBREAK open-label extension trial', 'category': 'EVENT'}, {'entity': 'Phase III DAYBREAK trial', 'category': 'EVENT'}, {'entity': 'Phase III RADIANCE trials', 'category': 'EVENT'}, {'entity': 'Phase III True North study', 'category': 'EVENT'}, {'entity': 'Phase II portion of the TRANSCEND CLL 004', 'category': 'EVENT'}, {'entity': 'Phase III clinical trials JCAR017-BCM-003', 'category': 'EVENT'}, {'entity': 'Phase II clinical trials 017006', 'category': 'EVENT'}, {'entity': 'Phase II PILOT trial', 'category': 'EVENT'}, {'entity': 'Phase III TRANSFORM trial', 'category': 'EVENT'}, {'entity': 'Type II Variation application', 'category': 'EVENT'}, {'entity': 'Phase III TRANSFORM study', 'category': 'EVENT'}, {'entity': 'TRANSCEND WORLD trials', 'category': 'EVENT'}, {'entity': 'TRANSCEND NHL 001 trials', 'category': 'EVENT'}, {'entity': 'Phase II/III RELATIVITY -047 trial', 'category': 'EVENT'}, {'entity': 'National Institutes of Health', 'category': 'FAC'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'Europe', 'category': 'GPE'}, {'entity': 'EMA', 'category': 'GPE'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'EC', 'category': 'ORG'}, {'entity': 'National Institutes of Health', 'category': 'ORG'}, {'entity': 'Committee for Medicinal Product for Human Use CHMP', 'category': 'ORG'}, {'entity': 'European Medicines Agency EMA', 'category': 'ORG'}, {'entity': '2seventy bio, Inc.', 'category': 'ORG'}, {'entity': 'Ministry of Health, Labour and Welfare', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Opdivo plus Yervoy', 'category': 'PRODUCT'}, {'entity': 'Orencia', 'category': 'PRODUCT'}, {'entity': 'Reblozyl', 'category': 'PRODUCT'}, {'entity': 'Abecma', 'category': 'PRODUCT'}, {'entity': 'Zeposia', 'category': 'PRODUCT'}, {'entity': 'Breyanzi', 'category': 'PRODUCT'}, {'entity': 'Opdualag', 'category': 'PRODUCT'}, {'entity': 'nivolumab and relatlimab-rmbw', 'category': 'PRODUCT'}, {'entity': 'Phase II BB2121-MM-001 and Phase I CRB-401 trials', 'category': 'WORK_OF_ART'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '60', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '92', 'category': 'CARDINAL'}, {'entity': '86.1', 'category': 'CARDINAL'}, {'entity': '52', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  15\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXoEnk5HSJ7LomkEMQCtlrs2qyYJ\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701575510,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#10#32#48#63#782#678 \\n\\nDATE#October 2022#June 16, 2023#April 2022#January 2023#September 2022#June 2022#December 31, 2022#December 31, 2021\\n\\nEVENT#Phase II/III RELATIVITY-047 trial#Phase III VALOR-HCM trial#Phase III EXPLORER-HCM trial#MAVA-LTE trial#Phase II PAISLEY trial\\n\\nFAC#CHMP of the EMA#Japan\\u2019s Ministry of Health, Labour and Welfare\\n\\nGPE#United States#Japan\\n\\nLAW#Section 27A of the Securities Act, and Section 21E of the Exchange Act#\\u201cItem 1A. Risk Factors\\n\\nMONEY#$782 million#$678 million\\n\\nORG#FDA#New York Heart Association#EC#POETYK PSO-1#POETYK PSO-2#Celgene#MyoKardia#Turning Point\\n\\nPERCENT#10%\\n\\nPERSON#\\n\\nPRODUCT#Camzyos (mavacamten)#Obstructive HCM#Sotyktu#Plaque Psoriasis#COVID-19\\n\\nQUANTITY#\\n\\nTIME#48 and 84 weeks\\n\\nWORK_OF_ART#2022 Form 10-K}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2222,\n",
      "    \"completion_tokens\": 279,\n",
      "    \"total_tokens\": 2501\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'October 2022', 'category': 'DATE'}, {'entity': 'June 16, 2023', 'category': 'DATE'}, {'entity': 'April 2022', 'category': 'DATE'}, {'entity': 'January 2023', 'category': 'DATE'}, {'entity': 'September 2022', 'category': 'DATE'}, {'entity': 'June 2022', 'category': 'DATE'}, {'entity': 'December 31, 2022', 'category': 'DATE'}, {'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': 'Phase II/III RELATIVITY-047 trial', 'category': 'EVENT'}, {'entity': 'Phase III VALOR-HCM trial', 'category': 'EVENT'}, {'entity': 'Phase III EXPLORER-HCM trial', 'category': 'EVENT'}, {'entity': 'MAVA-LTE trial', 'category': 'EVENT'}, {'entity': 'Phase II PAISLEY trial', 'category': 'EVENT'}, {'entity': 'CHMP of the EMA', 'category': 'FAC'}, {'entity': 'Japan’s Ministry of Health, Labour and Welfare', 'category': 'FAC'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'Section 27A of the Securities Act, and Section 21E of the Exchange Act', 'category': 'LAW'}, {'entity': '“Item 1A. Risk Factors', 'category': 'LAW'}, {'entity': '$782 million', 'category': 'MONEY'}, {'entity': '$678 million', 'category': 'MONEY'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'New York Heart Association', 'category': 'ORG'}, {'entity': 'EC', 'category': 'ORG'}, {'entity': 'POETYK PSO-1', 'category': 'ORG'}, {'entity': 'POETYK PSO-2', 'category': 'ORG'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': 'MyoKardia', 'category': 'ORG'}, {'entity': 'Turning Point', 'category': 'ORG'}, {'entity': '10%', 'category': 'PERCENT'}, {'entity': 'Camzyos mavacamten', 'category': 'PRODUCT'}, {'entity': 'Obstructive HCM', 'category': 'PRODUCT'}, {'entity': 'Sotyktu', 'category': 'PRODUCT'}, {'entity': 'Plaque Psoriasis', 'category': 'PRODUCT'}, {'entity': 'COVID-19', 'category': 'PRODUCT'}, {'entity': '48 and 84 weeks', 'category': 'TIME'}, {'entity': '2022 Form 10-K', 'category': 'WORK_OF_ART'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '32', 'category': 'CARDINAL'}, {'entity': '48', 'category': 'CARDINAL'}, {'entity': '63', 'category': 'CARDINAL'}, {'entity': '782', 'category': 'CARDINAL'}, {'entity': '678', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  15\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXopTJNXG99E0slkVu6HXpMKhz0X\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701575547,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL:$73 million#$58 million#1%\\n\\nDATE:December 31, 2022#December 31, 2021\\n\\nGPE:U.S.#international\\n\\nLANGUAGE:Non-U.S.\\n\\nMONEY:$2.6 billion#$3.8 billion\\n\\nORG:Company\\n\\nPERCENT:1%\\n\\nTIME:year-end\\n\\nWORK_OF_ART:\\u201cItem 8. Financial Statements and Supplementary Data\\u2014Note 9. Financial Instruments and Fair Value Measurements.\\u201d}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 1182,\n",
      "    \"completion_tokens\": 98,\n",
      "    \"total_tokens\": 1280\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2022', 'category': 'DATE'}, {'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'international', 'category': 'GPE'}, {'entity': 'Non-U.S.', 'category': 'LANGUAGE'}, {'entity': '$2.6 billion', 'category': 'MONEY'}, {'entity': '$3.8 billion', 'category': 'MONEY'}, {'entity': 'Company', 'category': 'ORG'}, {'entity': '1%', 'category': 'PERCENT'}, {'entity': 'year-end', 'category': 'TIME'}, {'entity': '“Item 8. Financial Statements and Supplementary Data—Note 9. Financial Instruments and Fair Value Measurements.”', 'category': 'WORK_OF_ART'}, {'entity': '$73 million', 'category': 'CARDINAL'}, {'entity': '$58 million', 'category': 'CARDINAL'}, {'entity': '1%', 'category': 'CARDINAL'}]\n",
      "/home/damir/Dropbox/Documents/Teaching/2023/L715/l715_23/data/10-Ks/Bristol-Myers_Squibb_Company/2022/Management.txt\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXpIYUGpUb0lIYVOD4wUtRWKFwIs\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701575576,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#7#2021#10#20#2021#2021#28#2022#2021#9#3.12#3.99#2020#2020#2021#2020#2021#1.07#46,385#42,518#3.12#3.99#7.51#6.44#2022#5#99#195 \\n\\nDATE#Year Ended December 31#February 10, 2021\\n\\nEVENT#COVID-19 pandemic\\n\\nFAC#Devens#Massachusetts#Leiden#Netherlands\\n\\nGPE#U.S.#EU#Japan#U.S.#Netherlands#U.S.#Puerto Rico#U.S.#U.S.#U.S.#Puerto Rico#U.S.\\n\\nLAW#Form 10-K#Form 10-K#2021 Form 10-K#Form 10-K\\n\\nMONEY#$3.12#$3.99\\n\\nORG#MANAGEMENT\\u2019S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.Management\\u2019s discussion and analysis of financial condition and results of operations#Bristol-Myers Squibb Company#FDA#MyoKardia#FDA#Celgene#GAAP\\n\\nPERCENT#9%\\n\\nPERSON#Breyanzi#Abecma#Opdivo#Yervoy#Zeposia#deucravacitinib#TYK2#mavacamten#COVID-19\\n\\nPRODUCT#Opdivo+Yervoy\\n\\nTIME#Year Ended December 31}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2242,\n",
      "    \"completion_tokens\": 329,\n",
      "    \"total_tokens\": 2571\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': 'February 10, 2021', 'category': 'DATE'}, {'entity': 'COVID-19 pandemic', 'category': 'EVENT'}, {'entity': 'Devens', 'category': 'FAC'}, {'entity': 'Massachusetts', 'category': 'FAC'}, {'entity': 'Leiden', 'category': 'FAC'}, {'entity': 'Netherlands', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'EU', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Netherlands', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Puerto Rico', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Puerto Rico', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Form 10-K', 'category': 'LAW'}, {'entity': 'Form 10-K', 'category': 'LAW'}, {'entity': '2021 Form 10-K', 'category': 'LAW'}, {'entity': 'Form 10-K', 'category': 'LAW'}, {'entity': '$3.12', 'category': 'MONEY'}, {'entity': '$3.99', 'category': 'MONEY'}, {'entity': 'MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.Management’s discussion and analysis of financial condition and results of operations', 'category': 'ORG'}, {'entity': 'Bristol-Myers Squibb Company', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'MyoKardia', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': '9%', 'category': 'PERCENT'}, {'entity': 'Breyanzi', 'category': 'PERSON'}, {'entity': 'Abecma', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Yervoy', 'category': 'PERSON'}, {'entity': 'Zeposia', 'category': 'PERSON'}, {'entity': 'deucravacitinib', 'category': 'PERSON'}, {'entity': 'TYK2', 'category': 'PERSON'}, {'entity': 'mavacamten', 'category': 'PERSON'}, {'entity': 'COVID-19', 'category': 'PERSON'}, {'entity': 'Opdivo+Yervoy', 'category': 'PRODUCT'}, {'entity': 'Year Ended December 31', 'category': 'TIME'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '2021', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '2021', 'category': 'CARDINAL'}, {'entity': '2021', 'category': 'CARDINAL'}, {'entity': '28', 'category': 'CARDINAL'}, {'entity': '2022', 'category': 'CARDINAL'}, {'entity': '2021', 'category': 'CARDINAL'}, {'entity': '9', 'category': 'CARDINAL'}, {'entity': '3.12', 'category': 'CARDINAL'}, {'entity': '3.99', 'category': 'CARDINAL'}, {'entity': '2020', 'category': 'CARDINAL'}, {'entity': '2020', 'category': 'CARDINAL'}, {'entity': '2021', 'category': 'CARDINAL'}, {'entity': '2020', 'category': 'CARDINAL'}, {'entity': '2021', 'category': 'CARDINAL'}, {'entity': '1.07', 'category': 'CARDINAL'}, {'entity': '46,385', 'category': 'CARDINAL'}, {'entity': '42,518', 'category': 'CARDINAL'}, {'entity': '3.12', 'category': 'CARDINAL'}, {'entity': '3.99', 'category': 'CARDINAL'}, {'entity': '7.51', 'category': 'CARDINAL'}, {'entity': '6.44', 'category': 'CARDINAL'}, {'entity': '2022', 'category': 'CARDINAL'}, {'entity': '5', 'category': 'CARDINAL'}, {'entity': '99', 'category': 'CARDINAL'}, {'entity': '195', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXpuqD2jU60cjjNqkZ6izXd3313Y\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701575614,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#2021 \\n\\nDATE#December 2021#November 2021#October 2021#September 2021#August 2021#July 2021#June 2021#May 2021#April 2021#March 2021\\n\\nGPE#the U.S.#U.S.#OECD#Puerto Rico#Japan\\n\\nORG#Bristol Myers Squibb#FDA#Japan\\u2019s Ministry of Health#Labour and Welfare#EC#Congress\\n\\nPERSON#Labour\\n\\nPRODUCT#Orencia#Opdivo#Zeposia#Abecma#Yervoy#Onureg#CABOMETYX\\n\\nWORK_OF_ART#Part I\\u2014Item 1A. Risk Factors\\u2014Product, Industry and Operational Risks\\u2014Increased pricing pressure and other restrictions in the U.S. and abroad continue to negatively affect our revenues and profit margins\\u201d and \\u201c\\u2014Changes to tax regulations could negatively impact our earnings.}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2286,\n",
      "    \"completion_tokens\": 200,\n",
      "    \"total_tokens\": 2486\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 2021', 'category': 'DATE'}, {'entity': 'November 2021', 'category': 'DATE'}, {'entity': 'October 2021', 'category': 'DATE'}, {'entity': 'September 2021', 'category': 'DATE'}, {'entity': 'August 2021', 'category': 'DATE'}, {'entity': 'July 2021', 'category': 'DATE'}, {'entity': 'June 2021', 'category': 'DATE'}, {'entity': 'May 2021', 'category': 'DATE'}, {'entity': 'April 2021', 'category': 'DATE'}, {'entity': 'March 2021', 'category': 'DATE'}, {'entity': 'the U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'OECD', 'category': 'GPE'}, {'entity': 'Puerto Rico', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'Bristol Myers Squibb', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'Japan’s Ministry of Health', 'category': 'ORG'}, {'entity': 'Labour and Welfare', 'category': 'ORG'}, {'entity': 'EC', 'category': 'ORG'}, {'entity': 'Congress', 'category': 'ORG'}, {'entity': 'Labour', 'category': 'PERSON'}, {'entity': 'Orencia', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Zeposia', 'category': 'PRODUCT'}, {'entity': 'Abecma', 'category': 'PRODUCT'}, {'entity': 'Yervoy', 'category': 'PRODUCT'}, {'entity': 'Onureg', 'category': 'PRODUCT'}, {'entity': 'CABOMETYX', 'category': 'PRODUCT'}, {'entity': 'Part I—Item 1A. Risk Factors—Product', 'category': 'WORK_OF_ART'}, {'entity': 'Industry and Operational Risks—Increased pricing pressure and other restrictions in the U.S. and abroad continue to negatively affect our revenues and profit margins” and “—Changes to tax regulations could negatively impact our earnings.', 'category': 'WORK_OF_ART'}, {'entity': '2021', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXqQYXF7ttm2V6oG2anxp0i72ZeZ\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701575646,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#four#three\\n\\nDATE#March 2021#February 2021#January 2021#January 2022#September 10, 2022#April 28, 2022#2022#2025\\n\\nEVENT#product launch \\n\\nFAC#\\n\\nGPE#Japan\\n\\nLOC#\\n\\nMONEY#$3.0 billion\\n\\nORDINAL#first\\n\\nORG#Japan\\u2019s Ministry of Health, Labour and Welfare#EC#FDA#CABOMETYX#MyoKardia#Janssen#Eliquis#Revlimid#Pomalyst#Orencia#Sprycel#Reblozyl#Inrebic#Zeposia#Onureg#Breyanzi#Abecma#Celgene\\n\\nPERCENT#\\n\\nPERSON#\\n\\nPRODUCT#Breyanzi#Inrebic#Opdivo#Abecma#relatlimab#nivolumab#deucravacitinib#milvexian#mavacamten\\n\\nQUANTITY# \\n\\nTIME#\\n\\nWORK_OF_ART#\\n}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2206,\n",
      "    \"completion_tokens\": 223,\n",
      "    \"total_tokens\": 2429\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'March 2021', 'category': 'DATE'}, {'entity': 'February 2021', 'category': 'DATE'}, {'entity': 'January 2021', 'category': 'DATE'}, {'entity': 'January 2022', 'category': 'DATE'}, {'entity': 'September 10, 2022', 'category': 'DATE'}, {'entity': 'April 28, 2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2025', 'category': 'DATE'}, {'entity': 'product launch', 'category': 'EVENT'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': '$3.0 billion', 'category': 'MONEY'}, {'entity': 'Japan’s Ministry of Health, Labour and Welfare', 'category': 'ORG'}, {'entity': 'EC', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'CABOMETYX', 'category': 'ORG'}, {'entity': 'MyoKardia', 'category': 'ORG'}, {'entity': 'Janssen', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'Revlimid', 'category': 'ORG'}, {'entity': 'Pomalyst', 'category': 'ORG'}, {'entity': 'Orencia', 'category': 'ORG'}, {'entity': 'Sprycel', 'category': 'ORG'}, {'entity': 'Reblozyl', 'category': 'ORG'}, {'entity': 'Inrebic', 'category': 'ORG'}, {'entity': 'Zeposia', 'category': 'ORG'}, {'entity': 'Onureg', 'category': 'ORG'}, {'entity': 'Breyanzi', 'category': 'ORG'}, {'entity': 'Abecma', 'category': 'ORG'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': 'Breyanzi', 'category': 'PRODUCT'}, {'entity': 'Inrebic', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Abecma', 'category': 'PRODUCT'}, {'entity': 'relatlimab', 'category': 'PRODUCT'}, {'entity': 'nivolumab', 'category': 'PRODUCT'}, {'entity': 'deucravacitinib', 'category': 'PRODUCT'}, {'entity': 'milvexian', 'category': 'PRODUCT'}, {'entity': 'mavacamten', 'category': 'PRODUCT'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'four', 'category': 'CARDINAL'}, {'entity': 'three', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXqxvBZwV7lqG5Cu5CQFVqoT2YhA\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701575679,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#2021#2020#2021\\n\\nDATE#Year Ended December 31, 2021#Year Ended December 31, 2020#first quarter of 2022#May 2021#August 2021#Year Ended December 31,\\t2021\\n\\nEVENT#product launches\\n\\nFAC#biologics manufacturing capabilities\\n\\nGPE#United States#Europe\\n\\nLAW#NIH ACTIV-2\\n\\nLOC#Europe#United States\\n\\nMONEY#$319 million#$106 million\\n\\nORG#Company's#Agenus#Eisai#Rockefeller University#U.S. regional commercial organizations#Medicaid#Medicare\\n\\nPERCENT#10 #%#8 #%#35 #%#10 #%#24 #%#22 #%#9 #%#37 #%#16 #%#2 #%#3 #%#1 #%#40 #%#5 #%#33 #%#31 #%#17 #%#35 #%#22 #%#18 #%#6 #%#20 #%#87 #%#13 #%#5 #%#1 #%#87 #%#36 #%#36 #%#20 %\\n\\nPERSON#Agenus#Eisai#Rockefeller University\\n\\nPRODUCT#AGEN1777#MORAb-202#PRX005#Revlimid#Eliquis#Opdivo/Yervoy#Pomalyst/Imnovid#Eliquis coverage gap discounts#Sprycel#Yervoy#Abraxane#Reblozyl#Empliciti#Abecma#Zeposia#Breyanzi#Inrebic#Onureg#lenalidomide\\n\\nTIME#Current period#Prior period}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 3143,\n",
      "    \"completion_tokens\": 349,\n",
      "    \"total_tokens\": 3492\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'Year Ended December 31, 2021', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2020', 'category': 'DATE'}, {'entity': 'first quarter of 2022', 'category': 'DATE'}, {'entity': 'May 2021', 'category': 'DATE'}, {'entity': 'August 2021', 'category': 'DATE'}, {'entity': 'Year Ended December 31,\\t2021', 'category': 'DATE'}, {'entity': 'product launches', 'category': 'EVENT'}, {'entity': 'biologics manufacturing capabilities', 'category': 'FAC'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'Europe', 'category': 'GPE'}, {'entity': 'NIH ACTIV-2', 'category': 'LAW'}, {'entity': 'Europe', 'category': 'LOC'}, {'entity': 'United States', 'category': 'LOC'}, {'entity': '$319 million', 'category': 'MONEY'}, {'entity': '$106 million', 'category': 'MONEY'}, {'entity': 'Companys', 'category': 'ORG'}, {'entity': 'Agenus', 'category': 'ORG'}, {'entity': 'Eisai', 'category': 'ORG'}, {'entity': 'Rockefeller University', 'category': 'ORG'}, {'entity': 'U.S. regional commercial organizations', 'category': 'ORG'}, {'entity': 'Medicaid', 'category': 'ORG'}, {'entity': 'Medicare', 'category': 'ORG'}, {'entity': '10', 'category': 'PERCENT'}, {'entity': '%', 'category': 'PERCENT'}, {'entity': '8', 'category': 'PERCENT'}, {'entity': '%', 'category': 'PERCENT'}, {'entity': '35', 'category': 'PERCENT'}, {'entity': '%', 'category': 'PERCENT'}, {'entity': '10', 'category': 'PERCENT'}, {'entity': '%', 'category': 'PERCENT'}, {'entity': '24', 'category': 'PERCENT'}, {'entity': '%', 'category': 'PERCENT'}, {'entity': '22', 'category': 'PERCENT'}, {'entity': '%', 'category': 'PERCENT'}, {'entity': '9', 'category': 'PERCENT'}, {'entity': '%', 'category': 'PERCENT'}, {'entity': '37', 'category': 'PERCENT'}, {'entity': '%', 'category': 'PERCENT'}, {'entity': '16', 'category': 'PERCENT'}, {'entity': '%', 'category': 'PERCENT'}, {'entity': '2', 'category': 'PERCENT'}, {'entity': '%', 'category': 'PERCENT'}, {'entity': '3', 'category': 'PERCENT'}, {'entity': '%', 'category': 'PERCENT'}, {'entity': '1', 'category': 'PERCENT'}, {'entity': '%', 'category': 'PERCENT'}, {'entity': '40', 'category': 'PERCENT'}, {'entity': '%', 'category': 'PERCENT'}, {'entity': '5', 'category': 'PERCENT'}, {'entity': '%', 'category': 'PERCENT'}, {'entity': '33', 'category': 'PERCENT'}, {'entity': '%', 'category': 'PERCENT'}, {'entity': '31', 'category': 'PERCENT'}, {'entity': '%', 'category': 'PERCENT'}, {'entity': '17', 'category': 'PERCENT'}, {'entity': '%', 'category': 'PERCENT'}, {'entity': '35', 'category': 'PERCENT'}, {'entity': '%', 'category': 'PERCENT'}, {'entity': '22', 'category': 'PERCENT'}, {'entity': '%', 'category': 'PERCENT'}, {'entity': '18', 'category': 'PERCENT'}, {'entity': '%', 'category': 'PERCENT'}, {'entity': '6', 'category': 'PERCENT'}, {'entity': '%', 'category': 'PERCENT'}, {'entity': '20', 'category': 'PERCENT'}, {'entity': '%', 'category': 'PERCENT'}, {'entity': '87', 'category': 'PERCENT'}, {'entity': '%', 'category': 'PERCENT'}, {'entity': '13', 'category': 'PERCENT'}, {'entity': '%', 'category': 'PERCENT'}, {'entity': '5', 'category': 'PERCENT'}, {'entity': '%', 'category': 'PERCENT'}, {'entity': '1', 'category': 'PERCENT'}, {'entity': '%', 'category': 'PERCENT'}, {'entity': '87', 'category': 'PERCENT'}, {'entity': '%', 'category': 'PERCENT'}, {'entity': '36', 'category': 'PERCENT'}, {'entity': '%', 'category': 'PERCENT'}, {'entity': '36', 'category': 'PERCENT'}, {'entity': '%', 'category': 'PERCENT'}, {'entity': '20 %', 'category': 'PERCENT'}, {'entity': 'Agenus', 'category': 'PERSON'}, {'entity': 'Eisai', 'category': 'PERSON'}, {'entity': 'Rockefeller University', 'category': 'PERSON'}, {'entity': 'AGEN1777', 'category': 'PRODUCT'}, {'entity': 'MORAb-202', 'category': 'PRODUCT'}, {'entity': 'PRX005', 'category': 'PRODUCT'}, {'entity': 'Revlimid', 'category': 'PRODUCT'}, {'entity': 'Eliquis', 'category': 'PRODUCT'}, {'entity': 'Opdivo/Yervoy', 'category': 'PRODUCT'}, {'entity': 'Pomalyst/Imnovid', 'category': 'PRODUCT'}, {'entity': 'Eliquis coverage gap discounts', 'category': 'PRODUCT'}, {'entity': 'Sprycel', 'category': 'PRODUCT'}, {'entity': 'Yervoy', 'category': 'PRODUCT'}, {'entity': 'Abraxane', 'category': 'PRODUCT'}, {'entity': 'Reblozyl', 'category': 'PRODUCT'}, {'entity': 'Empliciti', 'category': 'PRODUCT'}, {'entity': 'Abecma', 'category': 'PRODUCT'}, {'entity': 'Zeposia', 'category': 'PRODUCT'}, {'entity': 'Breyanzi', 'category': 'PRODUCT'}, {'entity': 'Inrebic', 'category': 'PRODUCT'}, {'entity': 'Onureg', 'category': 'PRODUCT'}, {'entity': 'lenalidomide', 'category': 'PRODUCT'}, {'entity': 'Current period', 'category': 'TIME'}, {'entity': 'Prior period', 'category': 'TIME'}, {'entity': '2021', 'category': 'CARDINAL'}, {'entity': '2020', 'category': 'CARDINAL'}, {'entity': '2021', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXraKS55HX5fSE7pAiojl6TW5kAv\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701575718,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#5#8#3#5#18#3#14#7#5#16#2#14#6#2#1#7#13#2#36#2#34#3#24#3#27#25#30\\n\\nDATE#March 2022#January 2022#February 2022#July 2022#2022#September 2021#August 2020#April 1, 2028#May 2021#2021#2026#April 2, 2028#first quarter 2022#March 2022#2023\\n\\nEVENT#regulatory exclusivity\\n\\nGPE#U.S.#EU#UK#France#Germany#Italy#Spain#Japan#Europe\\n\\nLAW#supplementary protection certificate#composition of matter patent#composition of matter patent and formulation patent#intellectual property\\n\\nMONEY#$9.5 billion to $10.0 billion\\n\\nNORP#European#Japanese\\n\\nORG#Bristol Myers Squibb-Pfizer Alliance#Court of Appeals for the Federal Circuit#U.S. District Court#NSCLC\\n\\nPERCENT#5%#8%#3%#5%#18%#3%#14%#7%#5%#16%#2%#14%#6%#2%#1%#7%#13%#2%#36%#2%#34%#3%#24%#3%#27%#25%#30%\\n\\nPERSON#Eliquis\\n\\nPRODUCT#generic lenalidomide#Revlimid#Eliquis#Eliquis patents#Opdivo#nivolumab#Yervoy#NKT#bladder#blood#CRC#head and neck#RCC#HCC#lung#melanoma#MPM#stomach#Opdivo+CABOMETYX*#kidney#Opdivo+Yervoy#Pomalyst/Imnovid#Pomalidomide#Orencia#abatacept#polyarticular JIA#Orencia biosimilars#Sprycel#dasatinib#Philadelphia chromosome-positive CML#Gleevec*#ipilimumab#metastatic melanoma#lenalidomide#Abraxane#paclitaxel albumin-bound particles#breast cancer#NSCLC#pancreatic cancer#Abraxane patents#Reblozyl#luspatercept-aamt\\n\\nWORK_OF_ART#\\u201cItem 1. Financial Statements\\u2014Note 19. Legal Proceedings and Contingencies\\u2014Intellectual Property\\u201d}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2337,\n",
      "    \"completion_tokens\": 562,\n",
      "    \"total_tokens\": 2899\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'March 2022', 'category': 'DATE'}, {'entity': 'January 2022', 'category': 'DATE'}, {'entity': 'February 2022', 'category': 'DATE'}, {'entity': 'July 2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': 'September 2021', 'category': 'DATE'}, {'entity': 'August 2020', 'category': 'DATE'}, {'entity': 'April 1, 2028', 'category': 'DATE'}, {'entity': 'May 2021', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2026', 'category': 'DATE'}, {'entity': 'April 2, 2028', 'category': 'DATE'}, {'entity': 'first quarter 2022', 'category': 'DATE'}, {'entity': 'March 2022', 'category': 'DATE'}, {'entity': '2023', 'category': 'DATE'}, {'entity': 'regulatory exclusivity', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'EU', 'category': 'GPE'}, {'entity': 'UK', 'category': 'GPE'}, {'entity': 'France', 'category': 'GPE'}, {'entity': 'Germany', 'category': 'GPE'}, {'entity': 'Italy', 'category': 'GPE'}, {'entity': 'Spain', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'Europe', 'category': 'GPE'}, {'entity': 'supplementary protection certificate', 'category': 'LAW'}, {'entity': 'composition of matter patent', 'category': 'LAW'}, {'entity': 'composition of matter patent and formulation patent', 'category': 'LAW'}, {'entity': 'intellectual property', 'category': 'LAW'}, {'entity': '$9.5 billion to $10.0 billion', 'category': 'MONEY'}, {'entity': 'European', 'category': 'NORP'}, {'entity': 'Japanese', 'category': 'NORP'}, {'entity': 'Bristol Myers Squibb-Pfizer Alliance', 'category': 'ORG'}, {'entity': 'Court of Appeals for the Federal Circuit', 'category': 'ORG'}, {'entity': 'U.S. District Court', 'category': 'ORG'}, {'entity': 'NSCLC', 'category': 'ORG'}, {'entity': '5%', 'category': 'PERCENT'}, {'entity': '8%', 'category': 'PERCENT'}, {'entity': '3%', 'category': 'PERCENT'}, {'entity': '5%', 'category': 'PERCENT'}, {'entity': '18%', 'category': 'PERCENT'}, {'entity': '3%', 'category': 'PERCENT'}, {'entity': '14%', 'category': 'PERCENT'}, {'entity': '7%', 'category': 'PERCENT'}, {'entity': '5%', 'category': 'PERCENT'}, {'entity': '16%', 'category': 'PERCENT'}, {'entity': '2%', 'category': 'PERCENT'}, {'entity': '14%', 'category': 'PERCENT'}, {'entity': '6%', 'category': 'PERCENT'}, {'entity': '2%', 'category': 'PERCENT'}, {'entity': '1%', 'category': 'PERCENT'}, {'entity': '7%', 'category': 'PERCENT'}, {'entity': '13%', 'category': 'PERCENT'}, {'entity': '2%', 'category': 'PERCENT'}, {'entity': '36%', 'category': 'PERCENT'}, {'entity': '2%', 'category': 'PERCENT'}, {'entity': '34%', 'category': 'PERCENT'}, {'entity': '3%', 'category': 'PERCENT'}, {'entity': '24%', 'category': 'PERCENT'}, {'entity': '3%', 'category': 'PERCENT'}, {'entity': '27%', 'category': 'PERCENT'}, {'entity': '25%', 'category': 'PERCENT'}, {'entity': '30%', 'category': 'PERCENT'}, {'entity': 'Eliquis', 'category': 'PERSON'}, {'entity': 'generic lenalidomide', 'category': 'PRODUCT'}, {'entity': 'Revlimid', 'category': 'PRODUCT'}, {'entity': 'Eliquis', 'category': 'PRODUCT'}, {'entity': 'Eliquis patents', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'nivolumab', 'category': 'PRODUCT'}, {'entity': 'Yervoy', 'category': 'PRODUCT'}, {'entity': 'NKT', 'category': 'PRODUCT'}, {'entity': 'bladder', 'category': 'PRODUCT'}, {'entity': 'blood', 'category': 'PRODUCT'}, {'entity': 'CRC', 'category': 'PRODUCT'}, {'entity': 'head and neck', 'category': 'PRODUCT'}, {'entity': 'RCC', 'category': 'PRODUCT'}, {'entity': 'HCC', 'category': 'PRODUCT'}, {'entity': 'lung', 'category': 'PRODUCT'}, {'entity': 'melanoma', 'category': 'PRODUCT'}, {'entity': 'MPM', 'category': 'PRODUCT'}, {'entity': 'stomach', 'category': 'PRODUCT'}, {'entity': 'Opdivo+CABOMETYX*', 'category': 'PRODUCT'}, {'entity': 'kidney', 'category': 'PRODUCT'}, {'entity': 'Opdivo+Yervoy', 'category': 'PRODUCT'}, {'entity': 'Pomalyst/Imnovid', 'category': 'PRODUCT'}, {'entity': 'Pomalidomide', 'category': 'PRODUCT'}, {'entity': 'Orencia', 'category': 'PRODUCT'}, {'entity': 'abatacept', 'category': 'PRODUCT'}, {'entity': 'polyarticular JIA', 'category': 'PRODUCT'}, {'entity': 'Orencia biosimilars', 'category': 'PRODUCT'}, {'entity': 'Sprycel', 'category': 'PRODUCT'}, {'entity': 'dasatinib', 'category': 'PRODUCT'}, {'entity': 'Philadelphia chromosome-positive CML', 'category': 'PRODUCT'}, {'entity': 'Gleevec*', 'category': 'PRODUCT'}, {'entity': 'ipilimumab', 'category': 'PRODUCT'}, {'entity': 'metastatic melanoma', 'category': 'PRODUCT'}, {'entity': 'lenalidomide', 'category': 'PRODUCT'}, {'entity': 'Abraxane', 'category': 'PRODUCT'}, {'entity': 'paclitaxel albumin-bound particles', 'category': 'PRODUCT'}, {'entity': 'breast cancer', 'category': 'PRODUCT'}, {'entity': 'NSCLC', 'category': 'PRODUCT'}, {'entity': 'pancreatic cancer', 'category': 'PRODUCT'}, {'entity': 'Abraxane patents', 'category': 'PRODUCT'}, {'entity': 'Reblozyl', 'category': 'PRODUCT'}, {'entity': 'luspatercept-aamt', 'category': 'PRODUCT'}, {'entity': '“Item 1. Financial Statements—Note 19. Legal Proceedings and Contingencies—Intellectual Property”', 'category': 'WORK_OF_ART'}, {'entity': '5', 'category': 'CARDINAL'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '5', 'category': 'CARDINAL'}, {'entity': '18', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '14', 'category': 'CARDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '5', 'category': 'CARDINAL'}, {'entity': '16', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '14', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '13', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '36', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '34', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '24', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '27', 'category': 'CARDINAL'}, {'entity': '25', 'category': 'CARDINAL'}, {'entity': '30', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXsHIx1vKGE3HNdZ6kEZlNop5elw\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701575761,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#1.4#1.9#76#2021 \\n\\nDATE#April 2020#May 2021#June 2020#April 2021#August 2019#September 2020#September 30, 2021#June 30, 2021#December 31, 2021#2021\\n\\nEVENT#launch of Reblozyl\\n\\nFAC#\\n\\nGPE#Latin America#U.S.\\n\\nLOC#\\n\\nMONEY#$1.8 billion#$2.4 billion\\n\\nNORP#\\n\\nORDINAL#first#second\\n\\nORG#SEC Consent Order#Lenalidomide REMS#Pomalyst REMS#MyoKardia\\n\\nPERCENT#\\n\\nPERSON#\\n\\nPRODUCT#Abecma (idecabtagene vicleucel)#Zeposia (ozanimod)#Breyanzi (lisocabtagene maraleucel)#Inrebic (fedratinib)#Onureg (azacitidine)#Revlimid#Pomalyst\\n\\nQUANTITY#\\n\\nTIME#\\n\\nWORK_OF_ART#\\n}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2278,\n",
      "    \"completion_tokens\": 227,\n",
      "    \"total_tokens\": 2505\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'April 2020', 'category': 'DATE'}, {'entity': 'May 2021', 'category': 'DATE'}, {'entity': 'June 2020', 'category': 'DATE'}, {'entity': 'April 2021', 'category': 'DATE'}, {'entity': 'August 2019', 'category': 'DATE'}, {'entity': 'September 2020', 'category': 'DATE'}, {'entity': 'September 30, 2021', 'category': 'DATE'}, {'entity': 'June 30, 2021', 'category': 'DATE'}, {'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': 'launch of Reblozyl', 'category': 'EVENT'}, {'entity': 'Latin America', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '$1.8 billion', 'category': 'MONEY'}, {'entity': '$2.4 billion', 'category': 'MONEY'}, {'entity': 'SEC Consent Order', 'category': 'ORG'}, {'entity': 'Lenalidomide REMS', 'category': 'ORG'}, {'entity': 'Pomalyst REMS', 'category': 'ORG'}, {'entity': 'MyoKardia', 'category': 'ORG'}, {'entity': 'Abecma idecabtagene vicleucel', 'category': 'PRODUCT'}, {'entity': 'Zeposia ozanimod', 'category': 'PRODUCT'}, {'entity': 'Breyanzi lisocabtagene maraleucel', 'category': 'PRODUCT'}, {'entity': 'Inrebic fedratinib', 'category': 'PRODUCT'}, {'entity': 'Onureg azacitidine', 'category': 'PRODUCT'}, {'entity': 'Revlimid', 'category': 'PRODUCT'}, {'entity': 'Pomalyst', 'category': 'PRODUCT'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'second', 'category': 'ORDINAL'}, {'entity': '1.4', 'category': 'CARDINAL'}, {'entity': '1.9', 'category': 'CARDINAL'}, {'entity': '76', 'category': 'CARDINAL'}, {'entity': '2021', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXsp9JjLITsWpsagXuNJQjJCVspD\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701575795,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#539#241#280#211#650#200#80#475#200#178#100#50#50#980#1,003#840#470#36#1#115#1,823#1,906#335#1.6#1,334#1,420#1,733#1,527#745#1,228#564#717#542#1,757#281#169#530#82#194#49#149#39#121#9#55#21#76#33#47#720#2,314#3.5#2.6#3.0#8,098#6,871#1,084#2,124 \\n\\nDATE#Year Ended December 31#2021#2020#Year Ended December 31#2021#2020#Year Ended December 31#2021#2020#December 31, 2020\\n\\nFAC#MyoKardia\\n\\nGPE#United States\\n\\nMONEY#$539 million#$241 million#$280 million#$211 million#$650#$200#$80#$475#$200#$178#$100#$50#$50#$980#$1,003#$840#$470#$36#$1#$115#$1,823#$1,906#$335 million#$1.6 billion#$1,334#$1,420#$(1,733)#$(1,527)#$(745)#$(1,228)#$564#$(542)#$(1,757)#$281#169#530#82#$(194)#$(49)#$(149)#$(39)#$(121)#$(9)#$(55)#$(33)#$(720)#$(2,314)#$3.5 billion#$2.6 billion#$3.0 billion#$8,098#$(6,871)#$1,084#$2,124\\n\\nORG#Sprycel#MyoKardia#Research and development#Eisai#Agenus#Prothena#Dragonfly#bluebird#Forbius#Cormorant#Celgene#MyoKardia#Revlimid#Pomalyst/Imnovid#FDA#JCAR017#BMS#Roche Group#PD-L1#Company\\n\\nPERCENT#1#\\n\\nPERSON#Item 8#Tecentriq*#Tecentriq*#Roche Group's PD-L1\\n\\nPRODUCT#mavacamten\\n\\nTIME#January 2021\\n\\nWORK_OF_ART#Item 8. Financial Statements and Supplementary Data\\u2014Note 3. Alliances#Item 8. Financial Statements and Supplementary Data\\u2014Note 4. Acquisitions#\\u2014Note 4. Acquisitions#Item 8. Financial Statements and Supplementary Data\\u2014Note 14. Goodwill and Other Intangible Assets#Item 8. Financial Statements and Supplementary Data\\u2014Note 9. Financial Instruments and Fair Value Measurements#Item 8. Financial Statements and Supplementary Data\\u2014Note 6. Restructuring}\\n\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2333,\n",
      "    \"completion_tokens\": 631,\n",
      "    \"total_tokens\": 2964\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'MyoKardia', 'category': 'FAC'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': '$539 million', 'category': 'MONEY'}, {'entity': '$241 million', 'category': 'MONEY'}, {'entity': '$280 million', 'category': 'MONEY'}, {'entity': '$211 million', 'category': 'MONEY'}, {'entity': '$650', 'category': 'MONEY'}, {'entity': '$200', 'category': 'MONEY'}, {'entity': '$80', 'category': 'MONEY'}, {'entity': '$475', 'category': 'MONEY'}, {'entity': '$200', 'category': 'MONEY'}, {'entity': '$178', 'category': 'MONEY'}, {'entity': '$100', 'category': 'MONEY'}, {'entity': '$50', 'category': 'MONEY'}, {'entity': '$50', 'category': 'MONEY'}, {'entity': '$980', 'category': 'MONEY'}, {'entity': '$1,003', 'category': 'MONEY'}, {'entity': '$840', 'category': 'MONEY'}, {'entity': '$470', 'category': 'MONEY'}, {'entity': '$36', 'category': 'MONEY'}, {'entity': '$1', 'category': 'MONEY'}, {'entity': '$115', 'category': 'MONEY'}, {'entity': '$1,823', 'category': 'MONEY'}, {'entity': '$1,906', 'category': 'MONEY'}, {'entity': '$335 million', 'category': 'MONEY'}, {'entity': '$1.6 billion', 'category': 'MONEY'}, {'entity': '$1,334', 'category': 'MONEY'}, {'entity': '$1,420', 'category': 'MONEY'}, {'entity': '$1,733', 'category': 'MONEY'}, {'entity': '$1,527', 'category': 'MONEY'}, {'entity': '$745', 'category': 'MONEY'}, {'entity': '$1,228', 'category': 'MONEY'}, {'entity': '$564', 'category': 'MONEY'}, {'entity': '$542', 'category': 'MONEY'}, {'entity': '$1,757', 'category': 'MONEY'}, {'entity': '$281', 'category': 'MONEY'}, {'entity': '169', 'category': 'MONEY'}, {'entity': '530', 'category': 'MONEY'}, {'entity': '82', 'category': 'MONEY'}, {'entity': '$194', 'category': 'MONEY'}, {'entity': '$49', 'category': 'MONEY'}, {'entity': '$149', 'category': 'MONEY'}, {'entity': '$39', 'category': 'MONEY'}, {'entity': '$121', 'category': 'MONEY'}, {'entity': '$9', 'category': 'MONEY'}, {'entity': '$55', 'category': 'MONEY'}, {'entity': '$33', 'category': 'MONEY'}, {'entity': '$720', 'category': 'MONEY'}, {'entity': '$2,314', 'category': 'MONEY'}, {'entity': '$3.5 billion', 'category': 'MONEY'}, {'entity': '$2.6 billion', 'category': 'MONEY'}, {'entity': '$3.0 billion', 'category': 'MONEY'}, {'entity': '$8,098', 'category': 'MONEY'}, {'entity': '$6,871', 'category': 'MONEY'}, {'entity': '$1,084', 'category': 'MONEY'}, {'entity': '$2,124', 'category': 'MONEY'}, {'entity': 'Sprycel', 'category': 'ORG'}, {'entity': 'MyoKardia', 'category': 'ORG'}, {'entity': 'Research and development', 'category': 'ORG'}, {'entity': 'Eisai', 'category': 'ORG'}, {'entity': 'Agenus', 'category': 'ORG'}, {'entity': 'Prothena', 'category': 'ORG'}, {'entity': 'Dragonfly', 'category': 'ORG'}, {'entity': 'bluebird', 'category': 'ORG'}, {'entity': 'Forbius', 'category': 'ORG'}, {'entity': 'Cormorant', 'category': 'ORG'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': 'MyoKardia', 'category': 'ORG'}, {'entity': 'Revlimid', 'category': 'ORG'}, {'entity': 'Pomalyst/Imnovid', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'JCAR017', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Roche Group', 'category': 'ORG'}, {'entity': 'PD-L1', 'category': 'ORG'}, {'entity': 'Company', 'category': 'ORG'}, {'entity': '1', 'category': 'PERCENT'}, {'entity': 'Item 8', 'category': 'PERSON'}, {'entity': 'Tecentriq*', 'category': 'PERSON'}, {'entity': 'Tecentriq*', 'category': 'PERSON'}, {'entity': 'Roche Groups PD-L1', 'category': 'PERSON'}, {'entity': 'mavacamten', 'category': 'PRODUCT'}, {'entity': 'January 2021', 'category': 'TIME'}, {'entity': 'Item 8. Financial Statements and Supplementary Data—Note 3. Alliances', 'category': 'WORK_OF_ART'}, {'entity': 'Item 8. Financial Statements and Supplementary Data—Note 4. Acquisitions', 'category': 'WORK_OF_ART'}, {'entity': '—Note 4. Acquisitions', 'category': 'WORK_OF_ART'}, {'entity': 'Item 8. Financial Statements and Supplementary Data—Note 14. Goodwill and Other Intangible Assets', 'category': 'WORK_OF_ART'}, {'entity': 'Item 8. Financial Statements and Supplementary Data—Note 9. Financial Instruments and Fair Value Measurements', 'category': 'WORK_OF_ART'}, {'entity': 'Item 8. Financial Statements and Supplementary Data—Note 6. Restructuring', 'category': 'WORK_OF_ART'}, {'entity': '539', 'category': 'CARDINAL'}, {'entity': '241', 'category': 'CARDINAL'}, {'entity': '280', 'category': 'CARDINAL'}, {'entity': '211', 'category': 'CARDINAL'}, {'entity': '650', 'category': 'CARDINAL'}, {'entity': '200', 'category': 'CARDINAL'}, {'entity': '80', 'category': 'CARDINAL'}, {'entity': '475', 'category': 'CARDINAL'}, {'entity': '200', 'category': 'CARDINAL'}, {'entity': '178', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '50', 'category': 'CARDINAL'}, {'entity': '50', 'category': 'CARDINAL'}, {'entity': '980', 'category': 'CARDINAL'}, {'entity': '1,003', 'category': 'CARDINAL'}, {'entity': '840', 'category': 'CARDINAL'}, {'entity': '470', 'category': 'CARDINAL'}, {'entity': '36', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '115', 'category': 'CARDINAL'}, {'entity': '1,823', 'category': 'CARDINAL'}, {'entity': '1,906', 'category': 'CARDINAL'}, {'entity': '335', 'category': 'CARDINAL'}, {'entity': '1.6', 'category': 'CARDINAL'}, {'entity': '1,334', 'category': 'CARDINAL'}, {'entity': '1,420', 'category': 'CARDINAL'}, {'entity': '1,733', 'category': 'CARDINAL'}, {'entity': '1,527', 'category': 'CARDINAL'}, {'entity': '745', 'category': 'CARDINAL'}, {'entity': '1,228', 'category': 'CARDINAL'}, {'entity': '564', 'category': 'CARDINAL'}, {'entity': '717', 'category': 'CARDINAL'}, {'entity': '542', 'category': 'CARDINAL'}, {'entity': '1,757', 'category': 'CARDINAL'}, {'entity': '281', 'category': 'CARDINAL'}, {'entity': '169', 'category': 'CARDINAL'}, {'entity': '530', 'category': 'CARDINAL'}, {'entity': '82', 'category': 'CARDINAL'}, {'entity': '194', 'category': 'CARDINAL'}, {'entity': '49', 'category': 'CARDINAL'}, {'entity': '149', 'category': 'CARDINAL'}, {'entity': '39', 'category': 'CARDINAL'}, {'entity': '121', 'category': 'CARDINAL'}, {'entity': '9', 'category': 'CARDINAL'}, {'entity': '55', 'category': 'CARDINAL'}, {'entity': '21', 'category': 'CARDINAL'}, {'entity': '76', 'category': 'CARDINAL'}, {'entity': '33', 'category': 'CARDINAL'}, {'entity': '47', 'category': 'CARDINAL'}, {'entity': '720', 'category': 'CARDINAL'}, {'entity': '2,314', 'category': 'CARDINAL'}, {'entity': '3.5', 'category': 'CARDINAL'}, {'entity': '2.6', 'category': 'CARDINAL'}, {'entity': '3.0', 'category': 'CARDINAL'}, {'entity': '8,098', 'category': 'CARDINAL'}, {'entity': '6,871', 'category': 'CARDINAL'}, {'entity': '1,084', 'category': 'CARDINAL'}, {'entity': '2,124', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXtambXYidaKIYTMwfMXjmFkGVtS\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701575842,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#13.4#30.9#2.5#46.5#15.9#15.6#1.0#853#266#0.3#140#2021#2020#4#99.2#264#2,688#315#575#24#33#603#3,300#1#275#2#4#3#279#980#1,003#840#470#36#282#115#1,823#1,906#11,438#10,023#9,688#120#159#542#1,757#72#168#758#1,156#564#717#169#530#76#9#55#281#487#2,211#11,965#24,400#1,122#1,733#983#853#2,105#614#9,860#23,786#6,994#9,015#16,854#14,771#2,245#2,258#35#2,293#3.12#3.99#4.39#10.43#7.51#6.44\\n\\nDATE#Year Ended December 31#Year Ended December 31\\n\\nEVENT#MyoKardia acquisition#Otezla* divestiture\\n\\nGPE#U.S.\\n\\nMONEY#$1.0 billion#$853 million\\n\\nORG#Celgene#IPRD#Ended December 31,Dollars in Millions#BMS#GAAP#Non-GAAP\\n\\nPERCENT#13.4 %#30.9 %#2.5 %#46.5 %#15.9 %#15.6 %#0.3%#264 %\\n\\nPERSON#Otezla*\\n\\nPRODUCT#Note 7. Income Taxes#Exhibit 99.2#Item 8. Financial Statements and Supplementary Data#Celgene awards#Exhibit#Form 8-K#Millions\\n\\nTIME#February 4, 2022\\n\\nWORK_OF_ART#Tax Rate Excluding Specified Items#Financial MeasuresOur non-GAAP financial measures}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2444,\n",
      "    \"completion_tokens\": 443,\n",
      "    \"total_tokens\": 2887\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': 'MyoKardia acquisition', 'category': 'EVENT'}, {'entity': 'Otezla* divestiture', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '$1.0 billion', 'category': 'MONEY'}, {'entity': '$853 million', 'category': 'MONEY'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': 'IPRD', 'category': 'ORG'}, {'entity': 'Ended December 31,Dollars in Millions', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': 'Non-GAAP', 'category': 'ORG'}, {'entity': '13.4 %', 'category': 'PERCENT'}, {'entity': '30.9 %', 'category': 'PERCENT'}, {'entity': '2.5 %', 'category': 'PERCENT'}, {'entity': '46.5 %', 'category': 'PERCENT'}, {'entity': '15.9 %', 'category': 'PERCENT'}, {'entity': '15.6 %', 'category': 'PERCENT'}, {'entity': '0.3%', 'category': 'PERCENT'}, {'entity': '264 %', 'category': 'PERCENT'}, {'entity': 'Otezla*', 'category': 'PERSON'}, {'entity': 'Note 7. Income Taxes', 'category': 'PRODUCT'}, {'entity': 'Exhibit 99.2', 'category': 'PRODUCT'}, {'entity': 'Item 8. Financial Statements and Supplementary Data', 'category': 'PRODUCT'}, {'entity': 'Celgene awards', 'category': 'PRODUCT'}, {'entity': 'Exhibit', 'category': 'PRODUCT'}, {'entity': 'Form 8-K', 'category': 'PRODUCT'}, {'entity': 'Millions', 'category': 'PRODUCT'}, {'entity': 'February 4', 'category': 'TIME'}, {'entity': '2022', 'category': 'TIME'}, {'entity': 'Tax Rate Excluding Specified Items', 'category': 'WORK_OF_ART'}, {'entity': 'Financial MeasuresOur non-GAAP financial measures', 'category': 'WORK_OF_ART'}, {'entity': '13.4', 'category': 'CARDINAL'}, {'entity': '30.9', 'category': 'CARDINAL'}, {'entity': '2.5', 'category': 'CARDINAL'}, {'entity': '46.5', 'category': 'CARDINAL'}, {'entity': '15.9', 'category': 'CARDINAL'}, {'entity': '15.6', 'category': 'CARDINAL'}, {'entity': '1.0', 'category': 'CARDINAL'}, {'entity': '853', 'category': 'CARDINAL'}, {'entity': '266', 'category': 'CARDINAL'}, {'entity': '0.3', 'category': 'CARDINAL'}, {'entity': '140', 'category': 'CARDINAL'}, {'entity': '2021', 'category': 'CARDINAL'}, {'entity': '2020', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '99.2', 'category': 'CARDINAL'}, {'entity': '264', 'category': 'CARDINAL'}, {'entity': '2,688', 'category': 'CARDINAL'}, {'entity': '315', 'category': 'CARDINAL'}, {'entity': '575', 'category': 'CARDINAL'}, {'entity': '24', 'category': 'CARDINAL'}, {'entity': '33', 'category': 'CARDINAL'}, {'entity': '603', 'category': 'CARDINAL'}, {'entity': '3,300', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '275', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '279', 'category': 'CARDINAL'}, {'entity': '980', 'category': 'CARDINAL'}, {'entity': '1,003', 'category': 'CARDINAL'}, {'entity': '840', 'category': 'CARDINAL'}, {'entity': '470', 'category': 'CARDINAL'}, {'entity': '36', 'category': 'CARDINAL'}, {'entity': '282', 'category': 'CARDINAL'}, {'entity': '115', 'category': 'CARDINAL'}, {'entity': '1,823', 'category': 'CARDINAL'}, {'entity': '1,906', 'category': 'CARDINAL'}, {'entity': '11,438', 'category': 'CARDINAL'}, {'entity': '10,023', 'category': 'CARDINAL'}, {'entity': '9,688', 'category': 'CARDINAL'}, {'entity': '120', 'category': 'CARDINAL'}, {'entity': '159', 'category': 'CARDINAL'}, {'entity': '542', 'category': 'CARDINAL'}, {'entity': '1,757', 'category': 'CARDINAL'}, {'entity': '72', 'category': 'CARDINAL'}, {'entity': '168', 'category': 'CARDINAL'}, {'entity': '758', 'category': 'CARDINAL'}, {'entity': '1,156', 'category': 'CARDINAL'}, {'entity': '564', 'category': 'CARDINAL'}, {'entity': '717', 'category': 'CARDINAL'}, {'entity': '169', 'category': 'CARDINAL'}, {'entity': '530', 'category': 'CARDINAL'}, {'entity': '76', 'category': 'CARDINAL'}, {'entity': '9', 'category': 'CARDINAL'}, {'entity': '55', 'category': 'CARDINAL'}, {'entity': '281', 'category': 'CARDINAL'}, {'entity': '487', 'category': 'CARDINAL'}, {'entity': '2,211', 'category': 'CARDINAL'}, {'entity': '11,965', 'category': 'CARDINAL'}, {'entity': '24,400', 'category': 'CARDINAL'}, {'entity': '1,122', 'category': 'CARDINAL'}, {'entity': '1,733', 'category': 'CARDINAL'}, {'entity': '983', 'category': 'CARDINAL'}, {'entity': '853', 'category': 'CARDINAL'}, {'entity': '2,105', 'category': 'CARDINAL'}, {'entity': '614', 'category': 'CARDINAL'}, {'entity': '9,860', 'category': 'CARDINAL'}, {'entity': '23,786', 'category': 'CARDINAL'}, {'entity': '6,994', 'category': 'CARDINAL'}, {'entity': '9,015', 'category': 'CARDINAL'}, {'entity': '16,854', 'category': 'CARDINAL'}, {'entity': '14,771', 'category': 'CARDINAL'}, {'entity': '2,245', 'category': 'CARDINAL'}, {'entity': '2,258', 'category': 'CARDINAL'}, {'entity': '35', 'category': 'CARDINAL'}, {'entity': '2,293', 'category': 'CARDINAL'}, {'entity': '3.12', 'category': 'CARDINAL'}, {'entity': '3.99', 'category': 'CARDINAL'}, {'entity': '4.39', 'category': 'CARDINAL'}, {'entity': '10.43', 'category': 'CARDINAL'}, {'entity': '7.51', 'category': 'CARDINAL'}, {'entity': '6.44', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXuGYnYdYK5aqCCi7PiSC1Bo3a8e\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701575884,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#31#2021#2020#13,979#14,546#2,987#1,285#16,966#16,264#4,948#2,340#39,605#48,336#27,587#34,412#15.1#102#6.2#15.2#5.0#4.4#4.1#5#3.5#4.0#2.0#6.0#2.0#1.0#1.5#2025#2026#5.0#2027#1.5#1.0#2.0#970#750#800#1.2#2022#2023#21.1#7.4#13.7#15.0\\n\\nDATE#2025#2026#January 2022#December 31, 2020#December 31, 2021#February 2022#December 31, 2021\\n\\nEVENT#accelerated share repurchase\\n\\nMONEY#$15.1 billion#$4.4 billion#$2.0 billion#$15.0 billion#$6.2 billion#$15.2 billion#$5.0 billion#$4.4 billion#$4.1 billion#$5 billion#$3.5 billion#$4.0 billion#$2.0 billion#$6.0 billion#$2.0 billion#$1.0 billion#$1.5 billion#$5.0 billion#$1.5 billion#$1.0 billion#$2.0 billion#$970 million#$750 million#$800 million#$1.2 billion\\n\\nORG#Board of Directors#Exchange Act#Equity\\n\\nPERSON#ASR\\n\\nPRODUCT#common stock\\n\\nWORK_OF_ART#Item 8. Financial Statements and Supplementary Data\\u2014Note 16. Equity#Item 8. Financial Statements and Supplementary Data\\u2014Note 9. Financial Instruments and Fair Value Measurements#Item 8. Financial Statements and Supplementary Data\\u2014Note 7. Income Taxes#Item 8. Financial Statements and Supplementary Data\\u2014Note 13. Leases#Item 8. Financial Statements and Supplementary Data\\u2014Note 3. Alliances}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2250,\n",
      "    \"completion_tokens\": 458,\n",
      "    \"total_tokens\": 2708\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': '2025', 'category': 'DATE'}, {'entity': '2026', 'category': 'DATE'}, {'entity': 'January 2022', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': 'February 2022', 'category': 'DATE'}, {'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': 'accelerated share repurchase', 'category': 'EVENT'}, {'entity': '$15.1 billion', 'category': 'MONEY'}, {'entity': '$4.4 billion', 'category': 'MONEY'}, {'entity': '$2.0 billion', 'category': 'MONEY'}, {'entity': '$15.0 billion', 'category': 'MONEY'}, {'entity': '$6.2 billion', 'category': 'MONEY'}, {'entity': '$15.2 billion', 'category': 'MONEY'}, {'entity': '$5.0 billion', 'category': 'MONEY'}, {'entity': '$4.4 billion', 'category': 'MONEY'}, {'entity': '$4.1 billion', 'category': 'MONEY'}, {'entity': '$5 billion', 'category': 'MONEY'}, {'entity': '$3.5 billion', 'category': 'MONEY'}, {'entity': '$4.0 billion', 'category': 'MONEY'}, {'entity': '$2.0 billion', 'category': 'MONEY'}, {'entity': '$6.0 billion', 'category': 'MONEY'}, {'entity': '$2.0 billion', 'category': 'MONEY'}, {'entity': '$1.0 billion', 'category': 'MONEY'}, {'entity': '$1.5 billion', 'category': 'MONEY'}, {'entity': '$5.0 billion', 'category': 'MONEY'}, {'entity': '$1.5 billion', 'category': 'MONEY'}, {'entity': '$1.0 billion', 'category': 'MONEY'}, {'entity': '$2.0 billion', 'category': 'MONEY'}, {'entity': '$970 million', 'category': 'MONEY'}, {'entity': '$750 million', 'category': 'MONEY'}, {'entity': '$800 million', 'category': 'MONEY'}, {'entity': '$1.2 billion', 'category': 'MONEY'}, {'entity': 'Board of Directors', 'category': 'ORG'}, {'entity': 'Exchange Act', 'category': 'ORG'}, {'entity': 'Equity', 'category': 'ORG'}, {'entity': 'ASR', 'category': 'PERSON'}, {'entity': 'common stock', 'category': 'PRODUCT'}, {'entity': 'Item 8. Financial Statements and Supplementary Data—Note 16. Equity', 'category': 'WORK_OF_ART'}, {'entity': 'Item 8. Financial Statements and Supplementary Data—Note 9. Financial Instruments and Fair Value Measurements', 'category': 'WORK_OF_ART'}, {'entity': 'Item 8. Financial Statements and Supplementary Data—Note 7. Income Taxes', 'category': 'WORK_OF_ART'}, {'entity': 'Item 8. Financial Statements and Supplementary Data—Note 13. Leases', 'category': 'WORK_OF_ART'}, {'entity': 'Item 8. Financial Statements and Supplementary Data—Note 3. Alliances', 'category': 'WORK_OF_ART'}, {'entity': '31', 'category': 'CARDINAL'}, {'entity': '2021', 'category': 'CARDINAL'}, {'entity': '2020', 'category': 'CARDINAL'}, {'entity': '13,979', 'category': 'CARDINAL'}, {'entity': '14,546', 'category': 'CARDINAL'}, {'entity': '2,987', 'category': 'CARDINAL'}, {'entity': '1,285', 'category': 'CARDINAL'}, {'entity': '16,966', 'category': 'CARDINAL'}, {'entity': '16,264', 'category': 'CARDINAL'}, {'entity': '4,948', 'category': 'CARDINAL'}, {'entity': '2,340', 'category': 'CARDINAL'}, {'entity': '39,605', 'category': 'CARDINAL'}, {'entity': '48,336', 'category': 'CARDINAL'}, {'entity': '27,587', 'category': 'CARDINAL'}, {'entity': '34,412', 'category': 'CARDINAL'}, {'entity': '15.1', 'category': 'CARDINAL'}, {'entity': '102', 'category': 'CARDINAL'}, {'entity': '6.2', 'category': 'CARDINAL'}, {'entity': '15.2', 'category': 'CARDINAL'}, {'entity': '5.0', 'category': 'CARDINAL'}, {'entity': '4.4', 'category': 'CARDINAL'}, {'entity': '4.1', 'category': 'CARDINAL'}, {'entity': '5', 'category': 'CARDINAL'}, {'entity': '3.5', 'category': 'CARDINAL'}, {'entity': '4.0', 'category': 'CARDINAL'}, {'entity': '2.0', 'category': 'CARDINAL'}, {'entity': '6.0', 'category': 'CARDINAL'}, {'entity': '2.0', 'category': 'CARDINAL'}, {'entity': '1.0', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '2025', 'category': 'CARDINAL'}, {'entity': '2026', 'category': 'CARDINAL'}, {'entity': '5.0', 'category': 'CARDINAL'}, {'entity': '2027', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '1.0', 'category': 'CARDINAL'}, {'entity': '2.0', 'category': 'CARDINAL'}, {'entity': '970', 'category': 'CARDINAL'}, {'entity': '750', 'category': 'CARDINAL'}, {'entity': '800', 'category': 'CARDINAL'}, {'entity': '1.2', 'category': 'CARDINAL'}, {'entity': '2022', 'category': 'CARDINAL'}, {'entity': '2023', 'category': 'CARDINAL'}, {'entity': '21.1', 'category': 'CARDINAL'}, {'entity': '7.4', 'category': 'CARDINAL'}, {'entity': '13.7', 'category': 'CARDINAL'}, {'entity': '15.0', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXuxpOBoTKZDRY1afGcmL2INHS12\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701575927,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#2#2.2 billion#400 million#500 million#300 million#90#15.1 billion#7.0 billion#3.3 billion#4.7 billion#100#76 \\n\\nDATE#Year Ended December 31#2021#2020#August 4, 2004#September 30, 2004 \\n\\nMONEY#$16,207#$14,052#(538)#(10,859)#(16,224)#(1,151)#10.3 billion#11.5 billion#2.4 billion#3.4 billion\\n\\nORDINAL#one \\n\\nORG#Moody\\u2019s Investors Service#Standard & Poor\\u2019s#MyoKardia#SEC#Exhibit 10\\n\\nPERCENT#a stable long-term credit outlook#a negative long-term credit outlook \\n\\nPERSON#MyoKardia \\n\\nTIME#weekly \\n\\nWORK_OF_ART#Form 10-Q\\n}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2113,\n",
      "    \"completion_tokens\": 193,\n",
      "    \"total_tokens\": 2306\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': 'August 4, 2004', 'category': 'DATE'}, {'entity': 'September 30, 2004', 'category': 'DATE'}, {'entity': '$16,207', 'category': 'MONEY'}, {'entity': '$14,052', 'category': 'MONEY'}, {'entity': '538', 'category': 'MONEY'}, {'entity': '10,859', 'category': 'MONEY'}, {'entity': '16,224', 'category': 'MONEY'}, {'entity': '1,151', 'category': 'MONEY'}, {'entity': '10.3 billion', 'category': 'MONEY'}, {'entity': '11.5 billion', 'category': 'MONEY'}, {'entity': '2.4 billion', 'category': 'MONEY'}, {'entity': '3.4 billion', 'category': 'MONEY'}, {'entity': 'Moody’s Investors Service', 'category': 'ORG'}, {'entity': 'Standard & Poor’s', 'category': 'ORG'}, {'entity': 'MyoKardia', 'category': 'ORG'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'Exhibit 10', 'category': 'ORG'}, {'entity': 'a stable long-term credit outlook', 'category': 'PERCENT'}, {'entity': 'a negative long-term credit outlook', 'category': 'PERCENT'}, {'entity': 'MyoKardia', 'category': 'PERSON'}, {'entity': 'weekly', 'category': 'TIME'}, {'entity': 'Form 10-Q', 'category': 'WORK_OF_ART'}, {'entity': 'one', 'category': 'ORDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2.2 billion', 'category': 'CARDINAL'}, {'entity': '400 million', 'category': 'CARDINAL'}, {'entity': '500 million', 'category': 'CARDINAL'}, {'entity': '300 million', 'category': 'CARDINAL'}, {'entity': '90', 'category': 'CARDINAL'}, {'entity': '15.1 billion', 'category': 'CARDINAL'}, {'entity': '7.0 billion', 'category': 'CARDINAL'}, {'entity': '3.3 billion', 'category': 'CARDINAL'}, {'entity': '4.7 billion', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '76', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXvTvn62Lpj7agB05jj0cKIBzxap\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701575959,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#2#42.5#53.2#70 \\n\\nDATE#December 31, 2021#December 31, 2020\\n\\nFAC#Medicaid \\n\\nGPE#U.S.#non-U.S.\\n\\nLAW#340B Drug Pricing Program\\n\\nORG#Department of Defense#U.S. Department of Veterans Affairs#CMS#Celgene\\n\\nPERCENT#2%\\n\\nPRODUCT#Medicare Part D \\n\\nWORK_OF_ART#Item 8. Financial Statements and Supplementary Data\\u2014Note 2. Revenue}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 1998,\n",
      "    \"completion_tokens\": 110,\n",
      "    \"total_tokens\": 2108\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'Medicaid', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'non-U.S.', 'category': 'GPE'}, {'entity': '340B Drug Pricing Program', 'category': 'LAW'}, {'entity': 'Department of Defense', 'category': 'ORG'}, {'entity': 'U.S. Department of Veterans Affairs', 'category': 'ORG'}, {'entity': 'CMS', 'category': 'ORG'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': '2%', 'category': 'PERCENT'}, {'entity': 'Medicare Part D', 'category': 'PRODUCT'}, {'entity': 'Item 8. Financial Statements and Supplementary Data—Note 2. Revenue', 'category': 'WORK_OF_ART'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '42.5', 'category': 'CARDINAL'}, {'entity': '53.2', 'category': 'CARDINAL'}, {'entity': '70', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXvxJen0iWcnqTBUfTk2qmjg85vZ\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701575989,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#$315 million#$840 million#$20.5 billion#$2.7 billion#$1.1 billion#$3.5 billion#$2.8 billion#$585 million#50%\\n\\nDATE#2021#December 31, 2021#2020#December 31, 2020#2022#2021#2009#four year#two years\\n\\nEVENT#Mead Johnson split-off#internal spin-off#conversion of Mead Johnson Class B shares to Class A shares#conversion of Mead Johnson & Company to a limited liability company#exchange offer\\n\\nLAW#Section 382 of the Internal Revenue Code#Internal Revenue Code\\n\\nMONEY#$244 million\\n\\nORG#Inrebic EU#Research and development#Financial Statements and Supplementary Data\\u2014Note 14. Goodwill and Other Intangible Assets#Mead Johnson#Internal Revenue Service#Mead Johnson & Company#Financial Statements and Supplementary Data\\u2014Note 1. Accounting Policies and Recently Issued Accounting Standards\\u2014Income Taxes#Note 7. Income Taxes\\n\\nPERSON#Mead Johnson\\n\\nPRODUCT#IPRD\\n\\nTIME#annually#long-term#interim\\n\\nWORK_OF_ART#Item 8. Financial Statements and Supplementary Data\\u2014Note 14. Goodwill and Other Intangible Assets#\\u201cItem 8. Financial Statements and Supplementary Data\\u2014Note 1. Accounting Policies and Recently Issued Accounting Standards\\u2014Income Taxes\\u201d#\\u201c\\u2014Note 7. Income Taxes\\n}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2105,\n",
      "    \"completion_tokens\": 300,\n",
      "    \"total_tokens\": 2405\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': '2021', 'category': 'DATE'}, {'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2009', 'category': 'DATE'}, {'entity': 'four year', 'category': 'DATE'}, {'entity': 'two years', 'category': 'DATE'}, {'entity': 'Mead Johnson split-off', 'category': 'EVENT'}, {'entity': 'internal spin-off', 'category': 'EVENT'}, {'entity': 'conversion of Mead Johnson Class B shares to Class A shares', 'category': 'EVENT'}, {'entity': 'conversion of Mead Johnson & Company to a limited liability company', 'category': 'EVENT'}, {'entity': 'exchange offer', 'category': 'EVENT'}, {'entity': 'Section 382 of the Internal Revenue Code', 'category': 'LAW'}, {'entity': 'Internal Revenue Code', 'category': 'LAW'}, {'entity': '$244 million', 'category': 'MONEY'}, {'entity': 'Inrebic EU', 'category': 'ORG'}, {'entity': 'Research and development', 'category': 'ORG'}, {'entity': 'Financial Statements and Supplementary Data—Note 14. Goodwill and Other Intangible Assets', 'category': 'ORG'}, {'entity': 'Mead Johnson', 'category': 'ORG'}, {'entity': 'Internal Revenue Service', 'category': 'ORG'}, {'entity': 'Mead Johnson & Company', 'category': 'ORG'}, {'entity': 'Financial Statements and Supplementary Data—Note 1. Accounting Policies and Recently Issued Accounting Standards—Income Taxes', 'category': 'ORG'}, {'entity': 'Note 7. Income Taxes', 'category': 'ORG'}, {'entity': 'Mead Johnson', 'category': 'PERSON'}, {'entity': 'IPRD', 'category': 'PRODUCT'}, {'entity': 'annually', 'category': 'TIME'}, {'entity': 'long-term', 'category': 'TIME'}, {'entity': 'interim', 'category': 'TIME'}, {'entity': 'Item 8. Financial Statements and Supplementary Data—Note 14. Goodwill and Other Intangible Assets', 'category': 'WORK_OF_ART'}, {'entity': '“Item 8. Financial Statements and Supplementary Data—Note 1. Accounting Policies and Recently Issued Accounting Standards—Income Taxes”', 'category': 'WORK_OF_ART'}, {'entity': '“—Note 7. Income Taxes', 'category': 'WORK_OF_ART'}, {'entity': '$315 million', 'category': 'CARDINAL'}, {'entity': '$840 million', 'category': 'CARDINAL'}, {'entity': '$20.5 billion', 'category': 'CARDINAL'}, {'entity': '$2.7 billion', 'category': 'CARDINAL'}, {'entity': '$1.1 billion', 'category': 'CARDINAL'}, {'entity': '$3.5 billion', 'category': 'CARDINAL'}, {'entity': '$2.8 billion', 'category': 'CARDINAL'}, {'entity': '$585 million', 'category': 'CARDINAL'}, {'entity': '50%', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXwXBRbKArLcCic9Aqgbm8q3HO5e\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701576025,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#40#10\\n\\nDATE#August 2021#March 2021#November 2021#October 2021#July 2021#May 2021#April 2021#September 2021#June 2021 \\n\\nEVENT#R&D programs\\n\\nFAC#\\n\\nGPE#Japan\\n\\nLOC#\\n\\nMONEY#\\n\\nNORP#\\n\\nORDINAL#\\n\\nORG#FDA#EMA#EC#Ono\\n\\nPERCENT#\\n\\nPERSON#\\n\\nPRODUCT#Opdivo#Yervoy#CABOMETYX\\n\\nQUANTITY#\\n\\nTIME#\\n\\nWORK_OF_ART#CheckMate-274#CheckMate-649#CheckMate-577#CheckMate-648#CheckMate-040#CheckMate-459#CheckMate-816#CheckMate-9ER#PENGUIN trial#CheckMate-142}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2331,\n",
      "    \"completion_tokens\": 174,\n",
      "    \"total_tokens\": 2505\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'August 2021', 'category': 'DATE'}, {'entity': 'March 2021', 'category': 'DATE'}, {'entity': 'November 2021', 'category': 'DATE'}, {'entity': 'October 2021', 'category': 'DATE'}, {'entity': 'July 2021', 'category': 'DATE'}, {'entity': 'May 2021', 'category': 'DATE'}, {'entity': 'April 2021', 'category': 'DATE'}, {'entity': 'September 2021', 'category': 'DATE'}, {'entity': 'June 2021', 'category': 'DATE'}, {'entity': 'R&D programs', 'category': 'EVENT'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'EMA', 'category': 'ORG'}, {'entity': 'EC', 'category': 'ORG'}, {'entity': 'Ono', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Yervoy', 'category': 'PRODUCT'}, {'entity': 'CABOMETYX', 'category': 'PRODUCT'}, {'entity': 'CheckMate-274', 'category': 'WORK_OF_ART'}, {'entity': 'CheckMate-649', 'category': 'WORK_OF_ART'}, {'entity': 'CheckMate-577', 'category': 'WORK_OF_ART'}, {'entity': 'CheckMate-648', 'category': 'WORK_OF_ART'}, {'entity': 'CheckMate-040', 'category': 'WORK_OF_ART'}, {'entity': 'CheckMate-459', 'category': 'WORK_OF_ART'}, {'entity': 'CheckMate-816', 'category': 'WORK_OF_ART'}, {'entity': 'CheckMate-9ER', 'category': 'WORK_OF_ART'}, {'entity': 'PENGUIN trial', 'category': 'WORK_OF_ART'}, {'entity': 'CheckMate-142', 'category': 'WORK_OF_ART'}, {'entity': '40', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXx3zJ0Xvivc9FVmBaB1cMsfyBsb\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701576057,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#six-and-a-half#48%#67.7#20#two#77.7%#1.0#0%#0.103#36#48#75%#71%#13.9%#11.4%\\n\\nDATE#May 2021#September 2021#May 28, 2022#September 2021#August 2021#September 2021#June 2021#May 2021#May 2021#September 2021#May 2021#July 2021#December 2021#December 2021#March 27, 2022#December 2021#June 2021#November 2021#May 2021#October 2021#February 2021#June 2021#January 2022\\n\\nEVENT#Phase III CheckMate-067 trial#Phase III Checkmate-648 trial#Phase III CheckMate-648 trial#Phase III CheckMate-648 trial#Phase III CheckMate-743 trial#Phase III CheckMate-743 trial#Phase III CheckMate-743 trial#Phase III CheckMate-214 trial#Phase III CheckMate-227 trial#Phase III CheckMate-9LA trial#Phase III CheckMate-651 trial#Phase II ABA2 trial#Phase II BEYOND trial#Phase II BEYOND trial#Phase II BEYOND study#Phase III True North trial#Phase III True North trial#Phase III open-label extension trial DAYBREAK#Phase III QUAZAR AML-001 study\\n\\nORG#FDA#Ono#Japan#EMA#CheckMate#Opdivo#Yervoy#RCC#NSCLC#EXTREME#SCCHN#Orencia#FDA#Reblozyl#EMA#Acceleron#Zeposia#UC#EC#FDA#MS#Inrebic#EC#Onureg#AML#EC#CHMP#Breyanzi\\n\\nPERSON#Opdivo#Opdivo#Yervoy#Opdivo#Yervoy#Opdivo#Yervoy\\n\\nPRODUCT#Opdivo plus Yervoy therapy#Opdivo monotherapy#Yervoy#Opdivo#Yervoy#Opdivo#Yervoy#Opdivo#Yervoy#Opdivo#Yervoy#Opdivo#Yervoy#Opdivo#Yervoy#Opdivo#Yervoy#Opdivo#Yervoy#Opdivo#Yervoy#Opdivo#Yervoy#Opdivo plus Yervoy#Opdivo plus Yervoy#Opdivo#Yervoy#Opdivo#Yervoy#Opdivo plus Yervoy#Opdivo plus Yervoy#Opdivo plus Yervoy#Opdivo plus Yervoy#Opdivo plus Yervoy#Opdivo plus Yervoy#Opdivo plus Yervoy#Opdivo plus Yervoy#Orencia#Reblozyl#Reblozyl#Reblozyl#Reblozyl#Zeposia#Zeposia#Zeposia#Zeposia#Inrebic#Onureg#Onureg#Onureg#Breyanzi\\n\\nWORK_OF_ART#CheckMate-067#CheckMate-745#CheckMate-214#CheckMate-227#CheckMate-9LA#CheckMate-651#ABA2#BEYOND#BEYOND#True North#True North#DAYBREAK#QUAZAR AML-001}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2445,\n",
      "    \"completion_tokens\": 771,\n",
      "    \"total_tokens\": 3216\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'May 2021', 'category': 'DATE'}, {'entity': 'September 2021', 'category': 'DATE'}, {'entity': 'May 28, 2022', 'category': 'DATE'}, {'entity': 'September 2021', 'category': 'DATE'}, {'entity': 'August 2021', 'category': 'DATE'}, {'entity': 'September 2021', 'category': 'DATE'}, {'entity': 'June 2021', 'category': 'DATE'}, {'entity': 'May 2021', 'category': 'DATE'}, {'entity': 'May 2021', 'category': 'DATE'}, {'entity': 'September 2021', 'category': 'DATE'}, {'entity': 'May 2021', 'category': 'DATE'}, {'entity': 'July 2021', 'category': 'DATE'}, {'entity': 'December 2021', 'category': 'DATE'}, {'entity': 'December 2021', 'category': 'DATE'}, {'entity': 'March 27, 2022', 'category': 'DATE'}, {'entity': 'December 2021', 'category': 'DATE'}, {'entity': 'June 2021', 'category': 'DATE'}, {'entity': 'November 2021', 'category': 'DATE'}, {'entity': 'May 2021', 'category': 'DATE'}, {'entity': 'October 2021', 'category': 'DATE'}, {'entity': 'February 2021', 'category': 'DATE'}, {'entity': 'June 2021', 'category': 'DATE'}, {'entity': 'January 2022', 'category': 'DATE'}, {'entity': 'Phase III CheckMate-067 trial', 'category': 'EVENT'}, {'entity': 'Phase III Checkmate-648 trial', 'category': 'EVENT'}, {'entity': 'Phase III CheckMate-648 trial', 'category': 'EVENT'}, {'entity': 'Phase III CheckMate-648 trial', 'category': 'EVENT'}, {'entity': 'Phase III CheckMate-743 trial', 'category': 'EVENT'}, {'entity': 'Phase III CheckMate-743 trial', 'category': 'EVENT'}, {'entity': 'Phase III CheckMate-743 trial', 'category': 'EVENT'}, {'entity': 'Phase III CheckMate-214 trial', 'category': 'EVENT'}, {'entity': 'Phase III CheckMate-227 trial', 'category': 'EVENT'}, {'entity': 'Phase III CheckMate-9LA trial', 'category': 'EVENT'}, {'entity': 'Phase III CheckMate-651 trial', 'category': 'EVENT'}, {'entity': 'Phase II ABA2 trial', 'category': 'EVENT'}, {'entity': 'Phase II BEYOND trial', 'category': 'EVENT'}, {'entity': 'Phase II BEYOND trial', 'category': 'EVENT'}, {'entity': 'Phase II BEYOND study', 'category': 'EVENT'}, {'entity': 'Phase III True North trial', 'category': 'EVENT'}, {'entity': 'Phase III True North trial', 'category': 'EVENT'}, {'entity': 'Phase III open-label extension trial DAYBREAK', 'category': 'EVENT'}, {'entity': 'Phase III QUAZAR AML-001 study', 'category': 'EVENT'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'Ono', 'category': 'ORG'}, {'entity': 'Japan', 'category': 'ORG'}, {'entity': 'EMA', 'category': 'ORG'}, {'entity': 'CheckMate', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Yervoy', 'category': 'ORG'}, {'entity': 'RCC', 'category': 'ORG'}, {'entity': 'NSCLC', 'category': 'ORG'}, {'entity': 'EXTREME', 'category': 'ORG'}, {'entity': 'SCCHN', 'category': 'ORG'}, {'entity': 'Orencia', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'Reblozyl', 'category': 'ORG'}, {'entity': 'EMA', 'category': 'ORG'}, {'entity': 'Acceleron', 'category': 'ORG'}, {'entity': 'Zeposia', 'category': 'ORG'}, {'entity': 'UC', 'category': 'ORG'}, {'entity': 'EC', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'MS', 'category': 'ORG'}, {'entity': 'Inrebic', 'category': 'ORG'}, {'entity': 'EC', 'category': 'ORG'}, {'entity': 'Onureg', 'category': 'ORG'}, {'entity': 'AML', 'category': 'ORG'}, {'entity': 'EC', 'category': 'ORG'}, {'entity': 'CHMP', 'category': 'ORG'}, {'entity': 'Breyanzi', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Yervoy', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Yervoy', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Yervoy', 'category': 'PERSON'}, {'entity': 'Opdivo plus Yervoy therapy', 'category': 'PRODUCT'}, {'entity': 'Opdivo monotherapy', 'category': 'PRODUCT'}, {'entity': 'Yervoy', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Yervoy', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Yervoy', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Yervoy', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Yervoy', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Yervoy', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Yervoy', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Yervoy', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Yervoy', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Yervoy', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Yervoy', 'category': 'PRODUCT'}, {'entity': 'Opdivo plus Yervoy', 'category': 'PRODUCT'}, {'entity': 'Opdivo plus Yervoy', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Yervoy', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Yervoy', 'category': 'PRODUCT'}, {'entity': 'Opdivo plus Yervoy', 'category': 'PRODUCT'}, {'entity': 'Opdivo plus Yervoy', 'category': 'PRODUCT'}, {'entity': 'Opdivo plus Yervoy', 'category': 'PRODUCT'}, {'entity': 'Opdivo plus Yervoy', 'category': 'PRODUCT'}, {'entity': 'Opdivo plus Yervoy', 'category': 'PRODUCT'}, {'entity': 'Opdivo plus Yervoy', 'category': 'PRODUCT'}, {'entity': 'Opdivo plus Yervoy', 'category': 'PRODUCT'}, {'entity': 'Opdivo plus Yervoy', 'category': 'PRODUCT'}, {'entity': 'Orencia', 'category': 'PRODUCT'}, {'entity': 'Reblozyl', 'category': 'PRODUCT'}, {'entity': 'Reblozyl', 'category': 'PRODUCT'}, {'entity': 'Reblozyl', 'category': 'PRODUCT'}, {'entity': 'Reblozyl', 'category': 'PRODUCT'}, {'entity': 'Zeposia', 'category': 'PRODUCT'}, {'entity': 'Zeposia', 'category': 'PRODUCT'}, {'entity': 'Zeposia', 'category': 'PRODUCT'}, {'entity': 'Zeposia', 'category': 'PRODUCT'}, {'entity': 'Inrebic', 'category': 'PRODUCT'}, {'entity': 'Onureg', 'category': 'PRODUCT'}, {'entity': 'Onureg', 'category': 'PRODUCT'}, {'entity': 'Onureg', 'category': 'PRODUCT'}, {'entity': 'Breyanzi', 'category': 'PRODUCT'}, {'entity': 'CheckMate-067', 'category': 'WORK_OF_ART'}, {'entity': 'CheckMate-745', 'category': 'WORK_OF_ART'}, {'entity': 'CheckMate-214', 'category': 'WORK_OF_ART'}, {'entity': 'CheckMate-227', 'category': 'WORK_OF_ART'}, {'entity': 'CheckMate-9LA', 'category': 'WORK_OF_ART'}, {'entity': 'CheckMate-651', 'category': 'WORK_OF_ART'}, {'entity': 'ABA2', 'category': 'WORK_OF_ART'}, {'entity': 'BEYOND', 'category': 'WORK_OF_ART'}, {'entity': 'BEYOND', 'category': 'WORK_OF_ART'}, {'entity': 'True North', 'category': 'WORK_OF_ART'}, {'entity': 'True North', 'category': 'WORK_OF_ART'}, {'entity': 'DAYBREAK', 'category': 'WORK_OF_ART'}, {'entity': 'QUAZAR AML-001', 'category': 'WORK_OF_ART'}, {'entity': 'six-and-a-half', 'category': 'CARDINAL'}, {'entity': '48%', 'category': 'CARDINAL'}, {'entity': '67.7', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': '77.7%', 'category': 'CARDINAL'}, {'entity': '1.0', 'category': 'CARDINAL'}, {'entity': '0%', 'category': 'CARDINAL'}, {'entity': '0.103', 'category': 'CARDINAL'}, {'entity': '36', 'category': 'CARDINAL'}, {'entity': '48', 'category': 'CARDINAL'}, {'entity': '75%', 'category': 'CARDINAL'}, {'entity': '71%', 'category': 'CARDINAL'}, {'entity': '13.9%', 'category': 'CARDINAL'}, {'entity': '11.4%', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXxvaRH7FgFwTVg0leX2sNIeGt7T\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701576111,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL#1#2#3 \\n\\nDATE#June 2021#January 2022#August 2021#March 2021#October 2021#November 2021#February 2021#April 28, 2022#May 2021#September 2021#March 19, 2022\\n\\nEVENT#Phase III TRANSFORM trial#Phase II BB2121-MM-001#Phase I CRB-401 trials#pivotal KarMMa study#Phase II KarMMA study#Phase II LATTICE-UC study#Phase III POETYK PSO-1#Phase III POETYK PSO-2 trials#Phase III EXPLORER-HCM trial#Phase II/III RELATIVITY-047 trial\\n\\nGPE#Japan\\n\\nLAW#Section 27A of the Securities Act, and Section 21E of the Exchange Act\\n\\nORG#TRANSCEND NHL 001 trial#Japan\\u2019s Ministry of Health, Labour and Welfare#FDA#Abecma#bluebird#EMA#Phase III POETYK PSO#NDA#KCCQ OSS#BLA\\n\\nPERSON#deucravacitinib\\n\\nPRODUCT#Breyanzi#Abecma#deucravacitinib#mavacamten#relatlimab#nivolumab#Opdivo\\n\\nTIME#Week 12#16 weeks\\n\\nWORK_OF_ART#Phase II IM011-127#pivotal Phase III EXPLORER-HCM study#Phase III RELATIVITY-047 (CA224-047) trial}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 2460,\n",
      "    \"completion_tokens\": 336,\n",
      "    \"total_tokens\": 2796\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'June 2021', 'category': 'DATE'}, {'entity': 'January 2022', 'category': 'DATE'}, {'entity': 'August 2021', 'category': 'DATE'}, {'entity': 'March 2021', 'category': 'DATE'}, {'entity': 'October 2021', 'category': 'DATE'}, {'entity': 'November 2021', 'category': 'DATE'}, {'entity': 'February 2021', 'category': 'DATE'}, {'entity': 'April 28, 2022', 'category': 'DATE'}, {'entity': 'May 2021', 'category': 'DATE'}, {'entity': 'September 2021', 'category': 'DATE'}, {'entity': 'March 19, 2022', 'category': 'DATE'}, {'entity': 'Phase III TRANSFORM trial', 'category': 'EVENT'}, {'entity': 'Phase II BB2121-MM-001', 'category': 'EVENT'}, {'entity': 'Phase I CRB-401 trials', 'category': 'EVENT'}, {'entity': 'pivotal KarMMa study', 'category': 'EVENT'}, {'entity': 'Phase II KarMMA study', 'category': 'EVENT'}, {'entity': 'Phase II LATTICE-UC study', 'category': 'EVENT'}, {'entity': 'Phase III POETYK PSO-1', 'category': 'EVENT'}, {'entity': 'Phase III POETYK PSO-2 trials', 'category': 'EVENT'}, {'entity': 'Phase III EXPLORER-HCM trial', 'category': 'EVENT'}, {'entity': 'Phase II/III RELATIVITY-047 trial', 'category': 'EVENT'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'Section 27A of the Securities Act', 'category': 'LAW'}, {'entity': 'and Section 21E of the Exchange Act', 'category': 'LAW'}, {'entity': 'TRANSCEND NHL 001 trial', 'category': 'ORG'}, {'entity': 'Japan’s Ministry of Health, Labour and Welfare', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'Abecma', 'category': 'ORG'}, {'entity': 'bluebird', 'category': 'ORG'}, {'entity': 'EMA', 'category': 'ORG'}, {'entity': 'Phase III POETYK PSO', 'category': 'ORG'}, {'entity': 'NDA', 'category': 'ORG'}, {'entity': 'KCCQ OSS', 'category': 'ORG'}, {'entity': 'BLA', 'category': 'ORG'}, {'entity': 'deucravacitinib', 'category': 'PERSON'}, {'entity': 'Breyanzi', 'category': 'PRODUCT'}, {'entity': 'Abecma', 'category': 'PRODUCT'}, {'entity': 'deucravacitinib', 'category': 'PRODUCT'}, {'entity': 'mavacamten', 'category': 'PRODUCT'}, {'entity': 'relatlimab', 'category': 'PRODUCT'}, {'entity': 'nivolumab', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Week 12', 'category': 'TIME'}, {'entity': '16 weeks', 'category': 'TIME'}, {'entity': 'Phase II IM011-127', 'category': 'WORK_OF_ART'}, {'entity': 'pivotal Phase III EXPLORER-HCM study', 'category': 'WORK_OF_ART'}, {'entity': 'Phase III RELATIVITY-047 CA224-047 trial', 'category': 'WORK_OF_ART'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}]\n",
      "Length of chunks:  16\n",
      "{\n",
      "  \"id\": \"chatcmpl-8RXyY5eJvFatH9Lxn6rl78b2WGYpO\",\n",
      "  \"object\": \"chat.completion\",\n",
      "  \"created\": 1701576150,\n",
      "  \"model\": \"gpt-4-0613\",\n",
      "  \"choices\": [\n",
      "    {\n",
      "      \"index\": 0,\n",
      "      \"message\": {\n",
      "        \"role\": \"assistant\",\n",
      "        \"content\": \"{CARDINAL:$678 million#$742 million\\n\\nDATE:December 31, 2021#December 31, 2020#2021\\n\\nGPE:Japan\\n\\nLOC:U.S.\\n\\nMONEY:$3.8 billion#$4.7 billion\\n\\nORG:MyoKardia#Celgene\\n\\nPERCENT:10%#100%\\n\\nPERSON:Item 7A\\n\\nPRODUCT:COVID-19\\n\\nQUANTITY:100 basis points\\n\\nTIME:2021\\n\\nWORK_OF_ART:2021 Form 10-K}\"\n",
      "      },\n",
      "      \"finish_reason\": \"stop\"\n",
      "    }\n",
      "  ],\n",
      "  \"usage\": {\n",
      "    \"prompt_tokens\": 1955,\n",
      "    \"completion_tokens\": 109,\n",
      "    \"total_tokens\": 2064\n",
      "  },\n",
      "  \"system_fingerprint\": null\n",
      "}\n",
      "[{'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': '$3.8 billion', 'category': 'MONEY'}, {'entity': '$4.7 billion', 'category': 'MONEY'}, {'entity': 'MyoKardia', 'category': 'ORG'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': '10%', 'category': 'PERCENT'}, {'entity': '100%', 'category': 'PERCENT'}, {'entity': 'Item 7A', 'category': 'PERSON'}, {'entity': 'COVID-19', 'category': 'PRODUCT'}, {'entity': '100 basis points', 'category': 'QUANTITY'}, {'entity': '2021', 'category': 'TIME'}, {'entity': '2021 Form 10-K', 'category': 'WORK_OF_ART'}, {'entity': '$678 million', 'category': 'CARDINAL'}, {'entity': '$742 million', 'category': 'CARDINAL'}]\n"
     ]
    }
   ],
   "source": [
    "cwd = os.getcwd()\n",
    "pwd = os.path.join(os.path.dirname(cwd), os.path.join('data','10-Ks'))\n",
    "\n",
    "root_directory = pwd\n",
    "target_file = 'Management.txt'\n",
    "gpt_response_file = 'Management_' + str(model) + '_' +str(task) + '_response.json'\n",
    "gpt_result_file = 'Management_' + str(model) + '_' +str(task) + '_results.json'\n",
    "\n",
    "for root, directories, files in os.walk(root_directory):\n",
    "    for directory in directories:\n",
    "        folder_path = os.path.join(root, directory)\n",
    "        files = os.listdir(folder_path)\n",
    "        if gpt_result_file in files:\n",
    "            continue\n",
    "        if target_file in files:\n",
    "            file_pth = os.path.join(folder_path, target_file)\n",
    "            print(file_pth)\n",
    "            try:\n",
    "                with open(file_pth, 'r', encoding = 'utf-8') as rf:\n",
    "                    input_ = rf.read()\n",
    "                    input_ = input_.replace(\"\\n\",\"\")\n",
    "                    res, ent_dict = invoke_LLM(input_,chunk_)\n",
    "                    #print(res)\n",
    "                    output_file_path_responses = os.path.join(folder_path,gpt_response_file)\n",
    "                    #print(output_file_path_responses)\n",
    "                    with open(output_file_path_responses,\"w\") as jsonfile1:\n",
    "                        try:\n",
    "                            json.dump(res,jsonfile1, indent=4)\n",
    "                        except(err):\n",
    "                            print(err)\n",
    "                    \n",
    "                    output_file_path = os.path.join(folder_path,gpt_result_file)\n",
    "                    if len(res)<=5 or res == None:\n",
    "                        continue\n",
    "                    if ent_dict == {}:\n",
    "                        continue\n",
    "                    if res == -1 and ent_dict == -1:\n",
    "                        print(\"Rate Limit Exceeded. Sleep Mode....!!!\")\n",
    "                        exit\n",
    "                    with open(output_file_path,\"w\") as jsonfile:\n",
    "                        try:\n",
    "                            json.dump(ent_dict,jsonfile, indent=4)\n",
    "                        except(err):\n",
    "                            print(err) \n",
    "            except UnicodeDecodeError as err:\n",
    "                print(err)\n",
    "            rf.close()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "/Users/tanmayiballa/Desktop/KG-LLM/l715_23-1/data/10-Ks/Bristol-Myers_Squibb_Company/2014/Management_gpt-3.5-turbo_NER_response.json\n",
      "[{'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'the UK', 'category': 'GPE'}, {'entity': 'Germany', 'category': 'GPE'}, {'entity': 'Europe', 'category': 'GPE'}, {'entity': 'Bristol-Myers Squibb Company', 'category': 'ORG'}, {'entity': 'Bristol-Myers Squibb', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Company', 'category': 'ORG'}]\n",
      "[{'entity': 'May 2012', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': 'February 2014', 'category': 'DATE'}, {'entity': 'the last three years', 'category': 'DATE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'approximately $3 billion', 'category': 'GPE'}, {'entity': 'late', 'category': 'GPE'}, {'entity': 'Devens', 'category': 'LOC'}, {'entity': 'Massachusetts', 'category': 'LOC'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'MCOs', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'Yervoy', 'category': 'PRODUCT'}, {'entity': 'Hepatitis C Portfolio', 'category': 'PRODUCT'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'second', 'category': 'ORDINAL'}, {'entity': 'third', 'category': 'ORDINAL'}, {'entity': 'fourth', 'category': 'ORDINAL'}, {'entity': '10%', 'category': 'ORDINAL'}, {'entity': 'next few', 'category': 'ORDINAL'}, {'entity': 'last', 'category': 'ORDINAL'}, {'entity': 'one', 'category': 'CARDINAL'}, {'entity': '2007', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': 'approximately $1 billion', 'category': 'CARDINAL'}, {'entity': 'approximately $1.4 billion', 'category': 'CARDINAL'}, {'entity': '30-45%', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'April 2013', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': 'December 2013', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': 'February 2013', 'category': 'DATE'}, {'entity': 'March 2015', 'category': 'DATE'}, {'entity': 'October 2013', 'category': 'DATE'}, {'entity': 'June 2013', 'category': 'DATE'}, {'entity': 'December 2013', 'category': 'DATE'}, {'entity': 'September 2013', 'category': 'DATE'}, {'entity': 'June 2013', 'category': 'DATE'}, {'entity': 'January 2013', 'category': 'DATE'}, {'entity': 'June 2013', 'category': 'DATE'}, {'entity': 'September 2013', 'category': 'DATE'}, {'entity': 'Phase II data', 'category': 'EVENT'}, {'entity': 'antiviral treatment regimens', 'category': 'EVENT'}, {'entity': 'Breakthrough Therapy', 'category': 'EVENT'}, {'entity': 'FDA has granted an additional six month period of exclusivity to market Baraclude', 'category': 'EVENT'}, {'entity': 'U.S. District Court for the District of Delaware invalidated the composition of matter patent covering Baraclude', 'category': 'EVENT'}, {'entity': 'results from Study 004, a dose-ranging Phase I trial', 'category': 'EVENT'}, {'entity': 'lung cancer cohort', 'category': 'EVENT'}, {'entity': 'results from the Phase III DASISION study', 'category': 'EVENT'}, {'entity': 'EMA has approved the use of Yervoy in first line chemotherapy naive advanced melanoma patients', 'category': 'EVENT'}, {'entity': 'results were presented from a pooled analysis of survival data for 12 studies', 'category': 'EVENT'}, {'entity': 'results from the Phase III randomized, double-blind clinical trial', 'category': 'EVENT'}, {'entity': 'updated efficacy and safety data from a small, randomized Phase II, open-label study', 'category': 'EVENT'}, {'entity': 'European Commission EC approved Abilify* for the treatment of pediatric bipolar mania', 'category': 'EVENT'}, {'entity': 'FDA has accepted the filing and granted a Priority', 'category': 'EVENT'}, {'entity': 'daclatasvir', 'category': 'FAC'}, {'entity': 'asunaprevir', 'category': 'FAC'}, {'entity': 'BMS-791325', 'category': 'FAC'}, {'entity': 'Cancer', 'category': 'FAC'}, {'entity': 'Hemophilia', 'category': 'FAC'}, {'entity': 'Hemophobia', 'category': 'FAC'}, {'entity': 'University College Cork', 'category': 'FAC'}, {'entity': 'University College Dublin', 'category': 'FAC'}, {'entity': 'University College Galway', 'category': 'FAC'}, {'entity': 'University College Limerick', 'category': 'FAC'}, {'entity': 'National University of Ireland Maynooth', 'category': 'FAC'}, {'entity': 'Scammers', 'category': 'FAC'}, {'entity': 'University College Carlow', 'category': 'FAC'}, {'entity': 'University College Kilkenny', 'category': 'FAC'}, {'entity': 'University College Sligo', 'category': 'FAC'}, {'entity': 'University College Tralee', 'category': 'FAC'}, {'entity': 'University College Waterford', 'category': 'FAC'}, {'entity': 'University College Wexford', 'category': 'FAC'}, {'entity': 'University College Wicklow', 'category': 'FAC'}, {'entity': 'University College Mayo', 'category': 'FAC'}, {'entity': 'University College Offaly', 'category': 'FAC'}, {'entity': 'University College Leitrim', 'category': 'FAC'}, {'entity': 'University College Louth', 'category': 'FAC'}, {'entity': 'University College Meath', 'category': 'FAC'}, {'entity': 'University College Rush', 'category': 'FAC'}, {'entity': 'University College Drogheda', 'category': 'FAC'}, {'entity': 'University College Dundalk', 'category': 'FAC'}, {'entity': 'University College Mullingar', 'category': 'FAC'}, {'entity': 'University College Enniskillen', 'category': 'FAC'}, {'entity': 'University College Newry', 'category': 'FAC'}, {'entity': 'University College Portadown', 'category': 'FAC'}, {'entity': 'University College Londonderry', 'category': 'FAC'}, {'entity': 'University College Lisburn', 'category': 'FAC'}, {'entity': 'University College Bangor', 'category': 'FAC'}, {'entity': 'University College Lisburn', 'category': 'FAC'}, {'entity': 'University College Londonderry', 'category': 'FAC'}, {'entity': 'University College Carrickfergus', 'category': 'FAC'}, {'entity': 'University College Belfast', 'category': 'FAC'}, {'entity': 'Amsterdam', 'category': 'GPE'}, {'entity': '4', 'category': 'GPE'}, {'entity': 'Cupertino', 'category': 'GPE'}, {'entity': 'California', 'category': 'GPE'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'Paris', 'category': 'GPE'}, {'entity': 'Eiffel Tower', 'category': 'GPE'}, {'entity': 'Hilton Hotel', 'category': 'GPE'}, {'entity': 'Delaware', 'category': 'GPE'}, {'entity': 'Sprycel', 'category': 'GPE'}, {'entity': 'Gleevec', 'category': 'GPE'}, {'entity': 'Amsterdam', 'category': 'LOC'}, {'entity': 'Cupertino', 'category': 'LOC'}, {'entity': 'California', 'category': 'LOC'}, {'entity': 'United States', 'category': 'LOC'}, {'entity': 'Delaware', 'category': 'LOC'}, {'entity': 'Philadelphia', 'category': 'LOC'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': 'European Association for the Study of the Liver', 'category': 'ORG'}, {'entity': 'Amsterdam', 'category': 'ORG'}, {'entity': 'Company', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Hepatitis C.Baraclude', 'category': 'ORG'}, {'entity': 'entecavir', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'U.S. District Court', 'category': 'ORG'}, {'entity': 'Delaware', 'category': 'ORG'}, {'entity': 'Teva Pharmaceutical Industries Ltd.', 'category': 'ORG'}, {'entity': 'HIV', 'category': 'ORG'}, {'entity': 'American Society of Hematology', 'category': 'ORG'}, {'entity': 'Otsuka', 'category': 'ORG'}, {'entity': 'Sprycel', 'category': 'ORG'}, {'entity': 'Gleevec', 'category': 'ORG'}, {'entity': 'imatinib meslylate', 'category': 'ORG'}, {'entity': 'Yervoy', 'category': 'ORG'}, {'entity': 'ipilimumab', 'category': 'ORG'}, {'entity': 'prostate cancer', 'category': 'ORG'}, {'entity': 'elotuzumab', 'category': 'ORG'}, {'entity': 'AbbVie Inc.', 'category': 'ORG'}, {'entity': 'AbbVie', 'category': 'ORG'}, {'entity': 'European Cancer Congress', 'category': 'ORG'}, {'entity': 'AstraZeneca', 'category': 'ORG'}, {'entity': 'up to 94%', 'category': 'PERCENT'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': '24%', 'category': 'PERCENT'}, {'entity': '53%', 'category': 'PERCENT'}, {'entity': '80%', 'category': 'PERCENT'}, {'entity': '76%', 'category': 'PERCENT'}, {'entity': '63%', 'category': 'PERCENT'}, {'entity': '84%', 'category': 'PERCENT'}, {'entity': '64%', 'category': 'PERCENT'}, {'entity': '67%', 'category': 'PERCENT'}, {'entity': '65%', 'category': 'PERCENT'}, {'entity': 'genotype 1b', 'category': 'PERSON'}, {'entity': 'daclatasvir', 'category': 'PERSON'}, {'entity': 'asunaprevir', 'category': 'PERSON'}, {'entity': 'Baraclude', 'category': 'PERSON'}, {'entity': 'Hemophilia', 'category': 'PERSON'}, {'entity': 'curriculum', 'category': 'PERSON'}, {'entity': 'Teva Pharmaceutical Industries Ltd.', 'category': 'PERSON'}, {'entity': 'Dasatanib', 'category': 'PERSON'}, {'entity': 'Otsuka', 'category': 'PERSON'}, {'entity': 'Baraclude', 'category': 'PRODUCT'}, {'entity': 'Sustiva', 'category': 'PRODUCT'}, {'entity': 'Nivolumab', 'category': 'PRODUCT'}, {'entity': 'Sprycel', 'category': 'PRODUCT'}, {'entity': 'Yervoy', 'category': 'PRODUCT'}, {'entity': 'Elotuzumab', 'category': 'PRODUCT'}, {'entity': 'Abilify', 'category': 'PRODUCT'}, {'entity': 'Metreleptin', 'category': 'PRODUCT'}, {'entity': '4', 'category': 'TIME'}, {'entity': '36', 'category': 'TIME'}, {'entity': '12', 'category': 'TIME'}, {'entity': '3', 'category': 'TIME'}, {'entity': 'Hamlet', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'four-year', 'category': 'ORDINAL'}, {'entity': 'three', 'category': 'ORDINAL'}, {'entity': 'four', 'category': 'ORDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '24', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '9', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'July 2013', 'category': 'DATE'}, {'entity': 'three-month extension', 'category': 'DATE'}, {'entity': 'February 27', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': 'January 2014', 'category': 'DATE'}, {'entity': 'August 25', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': 'Priority Review designation', 'category': 'EVENT'}, {'entity': 'Endocrinologic and Metabolic Drugs Advisory Committee', 'category': 'EVENT'}, {'entity': 'recommend metreleptin', 'category': 'EVENT'}, {'entity': 'did not recommend metreleptin', 'category': 'EVENT'}, {'entity': 'remain committed', 'category': 'EVENT'}, {'entity': 'pursuing metreleptin', 'category': 'EVENT'}, {'entity': 'marketing authorization', 'category': 'EVENT'}, {'entity': 'FDA approved Farxiga', 'category': 'EVENT'}, {'entity': 'results', 'category': 'EVENT'}, {'entity': 'Phase III study', 'category': 'EVENT'}, {'entity': 'significant improvements', 'category': 'EVENT'}, {'entity': 'reductions', 'category': 'EVENT'}, {'entity': 'improvements', 'category': 'EVENT'}, {'entity': 'FDA announced', 'category': 'EVENT'}, {'entity': 'heart failure', 'category': 'EVENT'}, {'entity': 'SAVOR clinical trial', 'category': 'EVENT'}, {'entity': 'pancreatitis', 'category': 'EVENT'}, {'entity': 'approval', 'category': 'EVENT'}, {'entity': 'year two data', 'category': 'EVENT'}, {'entity': 'stroke prevention', 'category': 'EVENT'}, {'entity': 'EU', 'category': 'EVENT'}, {'entity': 'DVT', 'category': 'EVENT'}, {'entity': 'Pulmonary Embolism', 'category': 'EVENT'}, {'entity': 'risk reduction', 'category': 'EVENT'}, {'entity': 'review', 'category': 'EVENT'}, {'entity': 'PE', 'category': 'EVENT'}, {'entity': 'prevention', 'category': 'EVENT'}, {'entity': 'European Commission', 'category': 'LOC'}, {'entity': 'Japan', 'category': 'LOC'}, {'entity': 'China', 'category': 'LOC'}, {'entity': 'AMEmpireMPLE', 'category': 'LOC'}, {'entity': 'AMPLE', 'category': 'LOC'}, {'entity': 'European Medicines Agency', 'category': 'LOC'}, {'entity': 'PDUFA date', 'category': 'MONEY'}, {'entity': 'BLA', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'Company', 'category': 'ORG'}, {'entity': 'AstraZeneca', 'category': 'ORG'}, {'entity': 'EMDAC', 'category': 'ORG'}, {'entity': 'Companies', 'category': 'ORG'}, {'entity': 'the appropriate patients', 'category': 'ORG'}, {'entity': 'placebo', 'category': 'ORG'}, {'entity': 'metformin monotherapy', 'category': 'ORG'}, {'entity': 'Onglyza', 'category': 'ORG'}, {'entity': 'Ono Pharmaceutical Co.', 'category': 'ORG'}, {'entity': 'Ltd.', 'category': 'ORG'}, {'entity': 'Partial LD', 'category': 'PERCENT'}, {'entity': 'Farxiga/Xigduo', 'category': 'PRODUCT'}, {'entity': 'dapagliflozin', 'category': 'PRODUCT'}, {'entity': 'Onglyza', 'category': 'PRODUCT'}, {'entity': 'saxagliptin', 'category': 'PRODUCT'}, {'entity': 'Orencia', 'category': 'PRODUCT'}, {'entity': 'Eliquis', 'category': 'PRODUCT'}, {'entity': 'Factor Xa inhibitor', 'category': 'PRODUCT'}, {'entity': 'Patients', 'category': 'QUANTITY'}, {'entity': '24 weeks', 'category': 'QUANTITY'}, {'entity': 'eight weeks', 'category': 'QUANTITY'}, {'entity': 'patients', 'category': 'QUANTITY'}, {'entity': 'nonvalvular atrial fibrillation', 'category': 'QUANTITY'}]\n",
      "[{'entity': 'Pfizer', 'category': 'ORG'}, {'entity': 'European Society of Cardiology', 'category': 'ORG'}, {'entity': 'ARISTOTLE', 'category': 'ORG'}, {'entity': 'ESC', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'warfarin', 'category': 'ORG'}, {'entity': 'mitral regurgitation', 'category': 'ORG'}, {'entity': 'mitral stenosis', 'category': 'ORG'}, {'entity': 'aortic regurgitation', 'category': 'ORG'}, {'entity': 'aortic stenosis', 'category': 'ORG'}, {'entity': 'tricuspid regurgitation', 'category': 'ORG'}, {'entity': 'valve surgery', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'Supplemental New Drug Application', 'category': 'ORG'}, {'entity': 'deep vein thrombosis', 'category': 'ORG'}, {'entity': 'pulmonary embolism', 'category': 'ORG'}, {'entity': 'hip or knee replacement surgery', 'category': 'ORG'}, {'entity': 'PDUFA', 'category': 'ORG'}, {'entity': 'AMLPY', 'category': 'ORG'}, {'entity': 'acute venous thromboembolism', 'category': 'ORG'}, {'entity': 'New England Journal of Medicine', 'category': 'ORG'}, {'entity': 'International Society on Thrombosis and Haemostasis', 'category': 'ORG'}, {'entity': 'Circulation', 'category': 'ORG'}, {'entity': 'American Heart Association', 'category': 'ORG'}, {'entity': 'South Korea', 'category': 'ORG'}, {'entity': 'Israel', 'category': 'ORG'}, {'entity': 'Russia', 'category': 'ORG'}, {'entity': 'Mexico', 'category': 'ORG'}, {'entity': 'Colombia', 'category': 'ORG'}, {'entity': 'China', 'category': 'ORG'}, {'entity': 'NVAF', 'category': 'ORG'}, {'entity': 'United States', 'category': 'ORG'}, {'entity': 'Europe', 'category': 'ORG'}, {'entity': 'Rest of the World', 'category': 'ORG'}, {'entity': 'Plavix', 'category': 'ORG'}, {'entity': 'Avapro', 'category': 'ORG'}, {'entity': 'Avalide', 'category': 'ORG'}, {'entity': 'Amylin', 'category': 'ORG'}, {'entity': 'Sanofi', 'category': 'ORG'}, {'entity': 'Japan', 'category': 'ORG'}, {'entity': 'generic competition', 'category': 'ORG'}, {'entity': 'over-the-counter products alliance', 'category': 'ORG'}, {'entity': 'active pharmaceutical ingredient supply.', 'category': 'ORG'}]\n",
      "[{'entity': 'February 2014', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': '$1.7 billion', 'category': 'MONEY'}, {'entity': '$1.1 billion', 'category': 'MONEY'}, {'entity': '1.5 billion', 'category': 'MONEY'}, {'entity': '1.3 billion', 'category': 'MONEY'}, {'entity': '$1', 'category': 'MONEY'}, {'entity': '249', 'category': 'MONEY'}, {'entity': '$1', 'category': 'MONEY'}, {'entity': '108', 'category': 'MONEY'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'AstraZeneca', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Amylin', 'category': 'ORG'}, {'entity': '9%', 'category': 'PERCENT'}, {'entity': '22%', 'category': 'PERCENT'}, {'entity': '14%', 'category': 'PERCENT'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': '20%', 'category': 'PERCENT'}, {'entity': '32%', 'category': 'PERCENT'}, {'entity': '76%', 'category': 'PERCENT'}, {'entity': '62%', 'category': 'PERCENT'}, {'entity': '29%', 'category': 'PERCENT'}, {'entity': '28%', 'category': 'PERCENT'}, {'entity': '75%', 'category': 'PERCENT'}, {'entity': '23%', 'category': 'PERCENT'}, {'entity': '24%', 'category': 'PERCENT'}, {'entity': '10%', 'category': 'PERCENT'}, {'entity': '16%', 'category': 'PERCENT'}, {'entity': '3%', 'category': 'PERCENT'}, {'entity': '2%', 'category': 'PERCENT'}, {'entity': '2%', 'category': 'PERCENT'}, {'entity': '3%', 'category': 'PERCENT'}, {'entity': '6%', 'category': 'PERCENT'}, {'entity': '8%', 'category': 'PERCENT'}, {'entity': 'Amylin', 'category': 'PERSON'}, {'entity': 'diabetes business', 'category': 'PRODUCT'}, {'entity': 'Onglyza', 'category': 'PRODUCT'}, {'entity': 'Forxiga', 'category': 'PRODUCT'}, {'entity': 'Bydureon', 'category': 'PRODUCT'}, {'entity': 'Byetta', 'category': 'PRODUCT'}, {'entity': 'Symlin', 'category': 'PRODUCT'}, {'entity': 'metreleptin', 'category': 'PRODUCT'}, {'entity': 'Abilify', 'category': 'PRODUCT'}, {'entity': 'Atripla', 'category': 'PRODUCT'}, {'entity': '1', 'category': 'QUANTITY'}, {'entity': '2', 'category': 'QUANTITY'}, {'entity': '2013', 'category': 'TIME'}]\n",
      "[{'entity': 'Dec 23', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'Paris', 'category': 'GPE'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': 'Sustiva', 'category': 'ORG'}, {'entity': 'Apple', 'category': 'ORG'}, {'entity': 'Dec', 'category': 'ORG'}, {'entity': 'Cupertino', 'category': 'ORG'}, {'entity': 'California', 'category': 'ORG'}, {'entity': 'United States', 'category': 'ORG'}, {'entity': 'Hamlet', 'category': 'ORG'}, {'entity': 'Paris', 'category': 'ORG'}, {'entity': 'Eiffel Tower', 'category': 'ORG'}, {'entity': 'Hilton Hotel', 'category': 'ORG'}, {'entity': '6%', 'category': 'PERCENT'}, {'entity': '3%', 'category': 'PERCENT'}, {'entity': '2%', 'category': 'PERCENT'}, {'entity': '7%', 'category': 'PERCENT'}, {'entity': '7%', 'category': 'PERCENT'}, {'entity': '2%', 'category': 'PERCENT'}, {'entity': '5%', 'category': 'PERCENT'}, {'entity': 'Mary', 'category': 'PERSON'}, {'entity': 'Peter', 'category': 'PERSON'}, {'entity': 'Lisa', 'category': 'PERSON'}, {'entity': 'Shakespeare', 'category': 'PERSON'}, {'entity': 'Eliquis', 'category': 'PRODUCT'}, {'entity': '5PM', 'category': 'TIME'}, {'entity': '7PM', 'category': 'TIME'}, {'entity': 'Hamlet', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '1,614', 'category': 'CARDINAL'}, {'entity': '1,527', 'category': 'CARDINAL'}, {'entity': '1,485', 'category': 'CARDINAL'}, {'entity': '1,092', 'category': 'CARDINAL'}, {'entity': '1,016', 'category': 'CARDINAL'}, {'entity': '950', 'category': 'CARDINAL'}, {'entity': '522', 'category': 'CARDINAL'}, {'entity': '511', 'category': 'CARDINAL'}, {'entity': '535', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '14', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '40', 'category': 'CARDINAL'}, {'entity': '739', 'category': 'CARDINAL'}, {'entity': '615', 'category': 'CARDINAL'}, {'entity': '504', 'category': 'CARDINAL'}, {'entity': '960', 'category': 'CARDINAL'}, {'entity': '706', 'category': 'CARDINAL'}, {'entity': '360', 'category': 'CARDINAL'}, {'entity': '577', 'category': 'CARDINAL'}, {'entity': '503', 'category': 'CARDINAL'}, {'entity': '323', 'category': 'CARDINAL'}, {'entity': '383', 'category': 'CARDINAL'}, {'entity': '203', 'category': 'CARDINAL'}, {'entity': '37', 'category': 'CARDINAL'}, {'entity': '977', 'category': 'CARDINAL'}, {'entity': '709', 'category': 'CARDINAL'}, {'entity': '360', 'category': 'CARDINAL'}, {'entity': '1,280', 'category': 'CARDINAL'}, {'entity': '1,019', 'category': 'CARDINAL'}, {'entity': '803', 'category': 'CARDINAL'}, {'entity': '541', 'category': 'CARDINAL'}, {'entity': '404', 'category': 'CARDINAL'}, {'entity': '299', 'category': 'CARDINAL'}, {'entity': '739', 'category': 'CARDINAL'}, {'entity': '615', 'category': 'CARDINAL'}, {'entity': '504', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '22', 'category': 'CARDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '696', 'category': 'CARDINAL'}, {'entity': '702', 'category': 'CARDINAL'}, {'entity': '691', 'category': 'CARDINAL'}, {'entity': '682', 'category': 'CARDINAL'}, {'entity': '688', 'category': 'CARDINAL'}, {'entity': '681', 'category': 'CARDINAL'}, {'entity': '14', 'category': 'CARDINAL'}, {'entity': '14', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'Sanofi', 'category': 'ORG'}]\n",
      "[{'entity': 'September 30, 2013', 'category': 'DATE'}, {'entity': 'December 31, 2012', 'category': 'DATE'}, {'entity': 'September 30, 2013', 'category': 'DATE'}, {'entity': 'December 31, 2012', 'category': 'DATE'}, {'entity': 'Europe', 'category': 'GPE'}, {'entity': 'France', 'category': 'GPE'}, {'entity': 'Brazil', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Pharmaceutical', 'category': 'ORG'}, {'entity': '90%', 'category': 'PERCENT'}, {'entity': 'Amylin', 'category': 'PERSON'}, {'entity': 'BMS-986094 intangible asset', 'category': 'WORK_OF_ART'}, {'entity': 'Plavix*', 'category': 'WORK_OF_ART'}, {'entity': 'Avapro*/Avalide*', 'category': 'WORK_OF_ART'}, {'entity': '1.1', 'category': 'CARDINAL'}, {'entity': '1.1', 'category': 'CARDINAL'}, {'entity': '0.7', 'category': 'CARDINAL'}]\n",
      "[{'entity': '2013', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': '2011', 'category': 'DATE'}, {'entity': 'Amylin acquisition', 'category': 'EVENT'}, {'entity': 'Plavix', 'category': 'EVENT'}, {'entity': 'Avapro', 'category': 'EVENT'}, {'entity': 'Avalide', 'category': 'EVENT'}, {'entity': 'Abilify', 'category': 'EVENT'}, {'entity': 'Amylin acquisition', 'category': 'EVENT'}, {'entity': 'FV-100', 'category': 'EVENT'}, {'entity': '$125 million', 'category': 'MONEY'}, {'entity': 'Amylin', 'category': 'ORG'}, {'entity': 'Plavix', 'category': 'ORG'}, {'entity': 'Avapro', 'category': 'ORG'}, {'entity': 'Avalide', 'category': 'ORG'}, {'entity': 'Abilify', 'category': 'ORG'}, {'entity': 'Plavix', 'category': 'PERSON'}, {'entity': 'Avapro', 'category': 'PERSON'}, {'entity': 'Avalide', 'category': 'PERSON'}, {'entity': 'Abilify', 'category': 'PERSON'}, {'entity': 'FV-100', 'category': 'WORK_OF_ART'}, {'entity': '125 million', 'category': 'CARDINAL'}, {'entity': '60 million', 'category': 'CARDINAL'}, {'entity': '$1.8 billion', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'May 2012', 'category': 'DATE'}, {'entity': 'March 2012', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': '2011', 'category': 'DATE'}, {'entity': 'Item 8. Financial Statements—Note 19. Pension, Postretirement and Postemployment Liabilities', 'category': 'EVENT'}, {'entity': 'Item 8. Financial Statements—Note 3. Alliances', 'category': 'EVENT'}, {'entity': '$392 million', 'category': 'MONEY'}, {'entity': '$1,830 million', 'category': 'MONEY'}, {'entity': 'Plavix', 'category': 'ORG'}, {'entity': '16.7%', 'category': 'PERCENT'}, {'entity': 'Inhibitex', 'category': 'PERSON'}, {'entity': 'Amylin', 'category': 'PERSON'}, {'entity': 'BMS-986094', 'category': 'WORK_OF_ART'}, {'entity': 'fourth', 'category': 'ORDINAL'}, {'entity': '3', 'category': 'CARDINAL'}]\n",
      "[{'entity': '2012', 'category': 'DATE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'December 31, 2013', 'category': 'GPE'}, {'entity': 'low-tax jurisdictions', 'category': 'GPE'}, {'entity': '$1.54', 'category': 'MONEY'}, {'entity': '$1.16', 'category': 'MONEY'}, {'entity': '$2.16', 'category': 'MONEY'}, {'entity': '$1.82', 'category': 'MONEY'}, {'entity': '$1.99', 'category': 'MONEY'}, {'entity': '$2.28', 'category': 'MONEY'}, {'entity': '$3,586', 'category': 'MONEY'}, {'entity': '$1,656', 'category': 'MONEY'}, {'entity': '$2.2 billion', 'category': 'MONEY'}, {'entity': '$6.1 billion', 'category': 'MONEY'}, {'entity': '$259 million', 'category': 'MONEY'}, {'entity': '0.12%', 'category': 'MONEY'}, {'entity': '2013', 'category': 'MONEY'}, {'entity': '$820 million', 'category': 'MONEY'}, {'entity': '$2.7 billion', 'category': 'MONEY'}, {'entity': '$600 million', 'category': 'MONEY'}, {'entity': '$582 million', 'category': 'MONEY'}, {'entity': '$1.5 billion', 'category': 'MONEY'}, {'entity': '500 million', 'category': 'MONEY'}, {'entity': '1.750%', 'category': 'MONEY'}, {'entity': '2019', 'category': 'MONEY'}, {'entity': '$500 million', 'category': 'MONEY'}, {'entity': '3.250%', 'category': 'MONEY'}, {'entity': '2023', 'category': 'MONEY'}, {'entity': '$500 million', 'category': 'MONEY'}, {'entity': '4.500%', 'category': 'MONEY'}, {'entity': '2044', 'category': 'MONEY'}, {'entity': '$509 million', 'category': 'MONEY'}, {'entity': '2013', 'category': 'MONEY'}, {'entity': '$322 million', 'category': 'MONEY'}, {'entity': '2012', 'category': 'MONEY'}, {'entity': '$484 million', 'category': 'MONEY'}, {'entity': '2011', 'category': 'MONEY'}, {'entity': '$522 million', 'category': 'MONEY'}, {'entity': '2013', 'category': 'MONEY'}, {'entity': '$634 million', 'category': 'MONEY'}, {'entity': '2012', 'category': 'MONEY'}, {'entity': '$593 million', 'category': 'MONEY'}, {'entity': '2011', 'category': 'MONEY'}, {'entity': '$3,545', 'category': 'MONEY'}, {'entity': '$6,941', 'category': 'MONEY'}, {'entity': '$4,840', 'category': 'MONEY'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Moodys Investors Service', 'category': 'ORG'}, {'entity': 'Standard & Poors', 'category': 'ORG'}, {'entity': 'A2', 'category': 'ORDINAL'}, {'entity': 'Prime-1', 'category': 'ORDINAL'}, {'entity': 'negative', 'category': 'ORDINAL'}, {'entity': 'September 2013', 'category': 'ORDINAL'}, {'entity': 'A+', 'category': 'ORDINAL'}, {'entity': 'A-1+', 'category': 'ORDINAL'}, {'entity': 'stable', 'category': 'ORDINAL'}, {'entity': 'A', 'category': 'ORDINAL'}, {'entity': 'F1', 'category': 'ORDINAL'}, {'entity': 'F2', 'category': 'ORDINAL'}, {'entity': 'July 2013', 'category': 'ORDINAL'}, {'entity': 'negative', 'category': 'ORDINAL'}, {'entity': 'December 2013', 'category': 'ORDINAL'}, {'entity': 'investment grade', 'category': 'ORDINAL'}, {'entity': 'long-term', 'category': 'ORDINAL'}, {'entity': 'short-term', 'category': 'ORDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '1,690', 'category': 'CARDINAL'}, {'entity': '1,708', 'category': 'CARDINAL'}, {'entity': '1,498', 'category': 'CARDINAL'}, {'entity': '1,657', 'category': 'CARDINAL'}, {'entity': '2,559', 'category': 'CARDINAL'}, {'entity': '2,202', 'category': 'CARDINAL'}, {'entity': '629', 'category': 'CARDINAL'}, {'entity': '1,163', 'category': 'CARDINAL'}, {'entity': '572', 'category': 'CARDINAL'}, {'entity': '6,727', 'category': 'CARDINAL'}, {'entity': '1,437', 'category': 'CARDINAL'}, {'entity': '1,068', 'category': 'CARDINAL'}, {'entity': '4,333', 'category': 'CARDINAL'}, {'entity': '2,657', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31, 2013', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': '2011', 'category': 'DATE'}, {'entity': '$967 million', 'category': 'MONEY'}, {'entity': '3.7 billion', 'category': 'MONEY'}, {'entity': '3.6 billion', 'category': 'MONEY'}, {'entity': '205 million', 'category': 'MONEY'}, {'entity': '5.0 billion', 'category': 'MONEY'}, {'entity': '2.5 billion', 'category': 'MONEY'}, {'entity': '360 million', 'category': 'MONEY'}, {'entity': '$44 million', 'category': 'MONEY'}, {'entity': '$859 million', 'category': 'MONEY'}, {'entity': '$1.3 billion', 'category': 'MONEY'}, {'entity': '102 million', 'category': 'MONEY'}, {'entity': '$1.5 billion', 'category': 'MONEY'}, {'entity': '$2.0 billion', 'category': 'MONEY'}, {'entity': '$597 million', 'category': 'MONEY'}, {'entity': '$109 million', 'category': 'MONEY'}, {'entity': '$78 million', 'category': 'MONEY'}, {'entity': '$435 million', 'category': 'MONEY'}, {'entity': '$129 million', 'category': 'MONEY'}, {'entity': '$392 million', 'category': 'MONEY'}, {'entity': '$71 million', 'category': 'MONEY'}, {'entity': '$554 million', 'category': 'MONEY'}, {'entity': '$47 million', 'category': 'MONEY'}, {'entity': 'Plavix', 'category': 'WORK_OF_ART'}, {'entity': 'Avapro', 'category': 'WORK_OF_ART'}, {'entity': '/Avalide*', 'category': 'WORK_OF_ART'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'August 4, 2004', 'category': 'DATE'}, {'entity': 'September 30, 2004', 'category': 'DATE'}, {'entity': 'July 2013', 'category': 'DATE'}, {'entity': 'December 15, 2013', 'category': 'DATE'}, {'entity': 'settlement', 'category': 'EVENT'}, {'entity': 'Consent', 'category': 'EVENT'}, {'entity': 'review and certification process', 'category': 'EVENT'}, {'entity': 'business risk and disclosure group', 'category': 'EVENT'}, {'entity': 'retaining an outside consultant', 'category': 'EVENT'}, {'entity': 'publicly disclosing', 'category': 'EVENT'}, {'entity': 'budget process', 'category': 'EVENT'}, {'entity': 'limit our sales', 'category': 'EVENT'}, {'entity': 'procedures to monitor and limit sales', 'category': 'EVENT'}, {'entity': 'escalate to appropriate management levels', 'category': 'EVENT'}, {'entity': 'timely resolution', 'category': 'EVENT'}, {'entity': 'inventory management agreements', 'category': 'EVENT'}, {'entity': 'gross U.S. revenues', 'category': 'EVENT'}, {'entity': 'months on hand', 'category': 'EVENT'}, {'entity': 'three largest wholesalers', 'category': 'EVENT'}, {'entity': '90%', 'category': 'EVENT'}, {'entity': 'non-U.S. business', 'category': 'EVENT'}, {'entity': 'variety of methods', 'category': 'EVENT'}, {'entity': 'Consent', 'category': 'EVENT'}, {'entity': 'Exhibit', 'category': 'FAC'}, {'entity': 'Hilton Hotel', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Medicare', 'category': 'GPE'}, {'entity': 'Medicaid', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Cupertino', 'category': 'LOC'}, {'entity': 'California', 'category': 'LOC'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': '$250 million', 'category': 'MONEY'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'Exhibit', 'category': 'ORG'}, {'entity': 'Form', 'category': 'ORG'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'U.S. pharmaceutical wholesalers', 'category': 'ORG'}, {'entity': 'wholesaler customers', 'category': 'ORG'}, {'entity': 'U.S. business', 'category': 'ORG'}, {'entity': 'Audit Committee', 'category': 'ORG'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': 'Mary', 'category': 'PERSON'}, {'entity': 'Shakespeare', 'category': 'PERSON'}, {'entity': 'Peter', 'category': 'PERSON'}, {'entity': 'Lisa', 'category': 'PERSON'}, {'entity': 'Hamlet', 'category': 'PRODUCT'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'all', 'category': 'ORDINAL'}, {'entity': '19', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '21', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '15', 'category': 'CARDINAL'}, {'entity': '250', 'category': 'CARDINAL'}]\n",
      "[{'entity': '2011', 'category': 'DATE'}, {'entity': 'Dec 23, 2022', 'category': 'DATE'}, {'entity': '2010', 'category': 'DATE'}, {'entity': 'March 2010', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': 'December 31, 2013', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': 'December 31, 2013', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': 'December 31, 2013', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': 'December 31, 2013', 'category': 'DATE'}, {'entity': 'Medicare Part D program', 'category': 'EVENT'}, {'entity': 'Medicaid rebate accrual', 'category': 'EVENT'}, {'entity': 'Plavix*', 'category': 'EVENT'}, {'entity': 'Avapro*/Avalide*', 'category': 'EVENT'}, {'entity': 'drug recalls', 'category': 'EVENT'}, {'entity': 'product discontinuances', 'category': 'EVENT'}, {'entity': 'hospitals', 'category': 'FAC'}, {'entity': 'group purchasing organizations', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Medicare Part D', 'category': 'GPE'}, {'entity': 'U.S. Department of Defense TRICARE Retail Pharmacy Refund Program', 'category': 'GPE'}, {'entity': 'Cupertino', 'category': 'LOC'}, {'entity': 'California', 'category': 'LOC'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': 'Apple', 'category': 'ORG'}, {'entity': '2%', 'category': 'PERCENT'}, {'entity': '50%', 'category': 'PERCENT'}, {'entity': '15.1%', 'category': 'PERCENT'}, {'entity': '23.1%', 'category': 'PERCENT'}, {'entity': '$67 million', 'category': 'PERCENT'}, {'entity': '$85 million', 'category': 'PERCENT'}, {'entity': '37 million', 'category': 'PERCENT'}, {'entity': '$147 million', 'category': 'PERCENT'}, {'entity': '$173 million', 'category': 'PERCENT'}, {'entity': '6 months', 'category': 'PERCENT'}, {'entity': '12 months', 'category': 'PERCENT'}, {'entity': '4.15%', 'category': 'PERCENT'}, {'entity': '4.62%', 'category': 'PERCENT'}, {'entity': '1%', 'category': 'PERCENT'}, {'entity': '1%', 'category': 'PERCENT'}, {'entity': 'Mary', 'category': 'PERSON'}, {'entity': 'Plavix*', 'category': 'PRODUCT'}, {'entity': 'Avapro*/Avalide*', 'category': 'PRODUCT'}, {'entity': '5PM', 'category': 'TIME'}, {'entity': '7PM', 'category': 'TIME'}, {'entity': 'Plavix*', 'category': 'WORK_OF_ART'}, {'entity': 'Avapro*/Avalide*', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '2%', 'category': 'CARDINAL'}, {'entity': '50%', 'category': 'CARDINAL'}, {'entity': '15.1%', 'category': 'CARDINAL'}, {'entity': '23.1%', 'category': 'CARDINAL'}, {'entity': '$67 million', 'category': 'CARDINAL'}, {'entity': '$85 million', 'category': 'CARDINAL'}, {'entity': '$37 million', 'category': 'CARDINAL'}, {'entity': '$147 million', 'category': 'CARDINAL'}, {'entity': '$173 million', 'category': 'CARDINAL'}, {'entity': '$10 million', 'category': 'CARDINAL'}, {'entity': '$950 million', 'category': 'CARDINAL'}, {'entity': '4.15%', 'category': 'CARDINAL'}, {'entity': '4.62%', 'category': 'CARDINAL'}, {'entity': '1%', 'category': 'CARDINAL'}, {'entity': '1%', 'category': 'CARDINAL'}, {'entity': '6 months', 'category': 'CARDINAL'}, {'entity': 'twelve months', 'category': 'CARDINAL'}]\n",
      "[{'entity': '\"December 31, 2013', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': '2011', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2017\",', 'category': 'DATE'}, {'entity': '\"retirement benefits', 'category': 'EVENT'}, {'entity': 'impairment test\",', 'category': 'EVENT'}, {'entity': '\"Amylin', 'category': 'FAC'}, {'entity': 'Inhibitex', 'category': 'FAC'}, {'entity': 'business combinations\",', 'category': 'FAC'}, {'entity': '\"\"', 'category': 'GPE'}, {'entity': '\"\"', 'category': 'LANGUAGE'}, {'entity': '\"\"', 'category': 'LAW'}, {'entity': '\"U.S.', 'category': 'LOC'}, {'entity': 'December 31, 2013\",', 'category': 'LOC'}, {'entity': '\"$53 million', 'category': 'MONEY'}, {'entity': '$15.6 billion', 'category': 'MONEY'}, {'entity': '$6.2 billion\",', 'category': 'MONEY'}, {'entity': '\"\"', 'category': 'NORP'}, {'entity': '\"U.S.', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'BMS\",', 'category': 'ORG'}, {'entity': '\"41%\"', 'category': 'PERCENT'}, {'entity': '\"Amylin', 'category': 'PERSON'}, {'entity': 'Inhibitex', 'category': 'PERSON'}, {'entity': 'Amira\",', 'category': 'PERSON'}, {'entity': '\"\"', 'category': 'PRODUCT'}, {'entity': '\"Dollars in Millions\"', 'category': 'QUANTITY'}, {'entity': '\"Bydureon*', 'category': 'WORK_OF_ART'}, {'entity': 'Byetta*', 'category': 'WORK_OF_ART'}, {'entity': 'Symlin*', 'category': 'WORK_OF_ART'}, {'entity': 'Recothrom', 'category': 'WORK_OF_ART'}, {'entity': 'BMS-986094 formerly INX-189', 'category': 'WORK_OF_ART'}, {'entity': 'Metreleptin', 'category': 'WORK_OF_ART'}, {'entity': 'AM152\",', 'category': 'WORK_OF_ART'}, {'entity': '\"first\"', 'category': 'ORDINAL'}, {'entity': '\"2013', 'category': 'CARDINAL'}, {'entity': '1%\",', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31, 2013', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': '2011', 'category': 'DATE'}, {'entity': '$2.3 billion', 'category': 'MONEY'}, {'entity': '$525 million', 'category': 'MONEY'}, {'entity': '$1.0 billion', 'category': 'MONEY'}, {'entity': '$241 million', 'category': 'MONEY'}, {'entity': '$548 million', 'category': 'MONEY'}, {'entity': '$1.8 billion', 'category': 'MONEY'}, {'entity': '$30 million', 'category': 'MONEY'}, {'entity': '$120 million', 'category': 'MONEY'}, {'entity': '$310 million', 'category': 'MONEY'}, {'entity': '$160 million', 'category': 'MONEY'}, {'entity': '$2.1 billion', 'category': 'MONEY'}, {'entity': '2012', 'category': 'MONEY'}, {'entity': '$30 million', 'category': 'MONEY'}, {'entity': '2011', 'category': 'MONEY'}, {'entity': '$120 million', 'category': 'MONEY'}, {'entity': '2012', 'category': 'MONEY'}, {'entity': '2012', 'category': 'MONEY'}, {'entity': '2012', 'category': 'MONEY'}, {'entity': 'IPRD', 'category': 'ORG'}, {'entity': 'Medarex, Inc.', 'category': 'ORG'}, {'entity': 'Inhibitex', 'category': 'ORG'}, {'entity': 'BMS-986094', 'category': 'ORG'}, {'entity': 'Medarex, Inc.', 'category': 'ORG'}, {'entity': 'Inhibitex', 'category': 'ORG'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '2.3 billion', 'category': 'CARDINAL'}, {'entity': '525 million', 'category': 'CARDINAL'}, {'entity': '1.0 billion', 'category': 'CARDINAL'}, {'entity': '241 million', 'category': 'CARDINAL'}, {'entity': '548 million', 'category': 'CARDINAL'}, {'entity': '2.1 billion', 'category': 'CARDINAL'}, {'entity': '1.8 billion', 'category': 'CARDINAL'}, {'entity': '30 million', 'category': 'CARDINAL'}, {'entity': '120 million', 'category': 'CARDINAL'}, {'entity': '310 million', 'category': 'CARDINAL'}, {'entity': '160 million', 'category': 'CARDINAL'}, {'entity': '138 million', 'category': 'CARDINAL'}, {'entity': '23 million', 'category': 'CARDINAL'}, {'entity': '784 million', 'category': 'CARDINAL'}, {'entity': '383 million', 'category': 'CARDINAL'}]\n",
      "[{'entity': '2009', 'category': 'DATE'}, {'entity': '$244 million', 'category': 'MONEY'}, {'entity': '$135 million', 'category': 'MONEY'}, {'entity': 'Internal Revenue Service', 'category': 'ORG'}, {'entity': 'Mead Johnson Class B', 'category': 'ORG'}, {'entity': 'Class A', 'category': 'ORG'}, {'entity': 'IRS', 'category': 'ORG'}, {'entity': 'ELA', 'category': 'ORG'}, {'entity': 'Internal Revenue Code', 'category': 'ORG'}, {'entity': 'IPO', 'category': 'ORG'}, {'entity': 'Securities Act', 'category': 'ORG'}, {'entity': 'Securities Exchange Act', 'category': 'ORG'}, {'entity': '10%', 'category': 'PERCENT'}, {'entity': '50%', 'category': 'CARDINAL'}, {'entity': 'four', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': 'one', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': 'Europe', 'category': 'GPE'}, {'entity': '$172 million', 'category': 'MONEY'}, {'entity': '80%', 'category': 'PERCENT'}]\n",
      "/Users/tanmayiballa/Desktop/KG-LLM/l715_23-1/data/10-Ks/Bristol-Myers_Squibb_Company/2022/Management_gpt-3.5-turbo_NER_response.json\n",
      "[{'entity': '2021', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': 'February 10, 2021', 'category': 'DATE'}, {'entity': 'April 28, 2022', 'category': 'DATE'}, {'entity': 'January 5, 2022', 'category': 'DATE'}, {'entity': 'new state-of-the-art cell therapy manufacturing facilities', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'EU', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'Devens', 'category': 'GPE'}, {'entity': 'Massachusetts', 'category': 'GPE'}, {'entity': 'Leiden', 'category': 'GPE'}, {'entity': 'Netherlands', 'category': 'GPE'}, {'entity': 'Dollars in Millions', 'category': 'MONEY'}, {'entity': 'Bristol-Myers Squibb Company', 'category': 'ORG'}, {'entity': 'Abbreviated Terms', 'category': 'ORG'}, {'entity': 'Breyanzi', 'category': 'ORG'}, {'entity': 'Abecma', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Opdivo+Yervoy', 'category': 'ORG'}, {'entity': 'Zeposia', 'category': 'ORG'}, {'entity': 'Deucravacitinib', 'category': 'ORG'}, {'entity': 'mavacamten', 'category': 'ORG'}, {'entity': 'MyoKardia', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'Revlimid', 'category': 'ORG'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': '99%', 'category': 'PERCENT'}, {'entity': 'December 31', 'category': 'PERSON'}, {'entity': 'Year Ended December 31', 'category': 'TIME'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '2021', 'category': 'CARDINAL'}, {'entity': '9', 'category': 'CARDINAL'}, {'entity': '2021', 'category': 'CARDINAL'}, {'entity': '3.12', 'category': 'CARDINAL'}, {'entity': '2021', 'category': 'CARDINAL'}, {'entity': '3.99', 'category': 'CARDINAL'}, {'entity': '1.07', 'category': 'CARDINAL'}, {'entity': '46,385', 'category': 'CARDINAL'}, {'entity': '42,518', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'Dec 2021', 'category': 'DATE'}, {'entity': 'December 2021', 'category': 'DATE'}, {'entity': 'November 2021', 'category': 'DATE'}, {'entity': 'October 2021', 'category': 'DATE'}, {'entity': 'September 2021', 'category': 'DATE'}, {'entity': 'August 2021', 'category': 'DATE'}, {'entity': 'July 2021', 'category': 'DATE'}, {'entity': 'Eiffel Tower', 'category': 'FAC'}, {'entity': 'Hilton Hotel', 'category': 'FAC'}, {'entity': 'Cupertino', 'category': 'GPE'}, {'entity': 'California', 'category': 'GPE'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'Paris', 'category': 'GPE'}, {'entity': 'Puerto Rico', 'category': 'LOC'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': 'Apple', 'category': 'ORG'}, {'entity': 'Bristol Myers Squibb', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Hilton Hotel', 'category': 'ORG'}, {'entity': 'Bristol Myers Squibb', 'category': 'ORG'}, {'entity': 'Bristol Myers Squibb', 'category': 'ORG'}, {'entity': 'COVID-19', 'category': 'ORG'}, {'entity': 'Bristol Myers Squibb', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Abecma', 'category': 'ORG'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': 'Mary', 'category': 'PERSON'}, {'entity': 'Peter', 'category': 'PERSON'}, {'entity': 'Lisa', 'category': 'PERSON'}, {'entity': '5PM', 'category': 'TIME'}, {'entity': '7PM', 'category': 'TIME'}, {'entity': 'Hamlet', 'category': 'WORK_OF_ART'}, {'entity': '1.5 million', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'June 2021', 'category': 'DATE'}, {'entity': 'June 2021', 'category': 'DATE'}, {'entity': 'June 2021', 'category': 'DATE'}, {'entity': 'May 2021', 'category': 'DATE'}, {'entity': 'May 2021', 'category': 'DATE'}, {'entity': 'April 2021', 'category': 'DATE'}, {'entity': 'April 2021', 'category': 'DATE'}, {'entity': 'March 2021', 'category': 'DATE'}, {'entity': 'March 2021', 'category': 'DATE'}, {'entity': 'February 2021', 'category': 'DATE'}, {'entity': 'February 2021', 'category': 'DATE'}, {'entity': 'January 2021', 'category': 'DATE'}, {'entity': 'January 2022', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': 'early 2022', 'category': 'DATE'}, {'entity': 'September 10, 2022', 'category': 'DATE'}, {'entity': 'EC approval of Opdivo plus Yervoy for the treatment of adult patients with mismatch repair deficient or microsatellite instability-high metastatic CRC after prior fluoropyrimidine-based combination chemotherapy', 'category': 'EVENT'}, {'entity': 'EC approval of Onureg as a maintenance therapy in adult patients with AML who achieved complete remission or complete remission with incomplete blood count recovery following induction therapy with or without consolidation treatment and who are not candidates for, including those who choose not to proceed to, hematopoietic stem cell transplantation', 'category': 'EVENT'}, {'entity': 'EC approval of Opdivo plus Yervoy for the first-line treatment of adults with unresectable malignant pleural mesothelioma', 'category': 'EVENT'}, {'entity': 'FDA approval of Zeposia for the treatment of adults with moderately to severely active UC', 'category': 'EVENT'}, {'entity': 'Japan’s Ministry of Health, Labour and Welfare approval of Opdivo and Yervoy in combination therapy for the first-line treatment of unresectable advanced or recurrent malignant pleural mesothelioma', 'category': 'EVENT'}, {'entity': 'FDA approval of Opdivo for the adjuvant treatment of patients with completely resected esophageal or gastroesophageal junction cancer with residual pathologic disease after neoadjuvant chemoradiotherapy', 'category': 'EVENT'}, {'entity': 'FDA approval of Opdivo in combination with chemotherapy for patients with advanced or metastatic gastric cancer, gastroesophageal junction cancer, and esophageal adenocarcinoma, regardless of PD-L1 expression status', 'category': 'EVENT'}, {'entity': 'EC approval of Opdivo in combination with CABOMETYX* for the first-line treatment of patients with advanced RCC', 'category': 'EVENT'}, {'entity': 'FDA approval of Abecma for the treatment of adult patients with relapsed or refractory multiple myeloma after four or more prior lines of therapy, including an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 monoclonal antibody', 'category': 'EVENT'}, {'entity': 'Japan’s Ministry of Health, Labour and Welfare approval of Breyanzi for the treatment of patients with relapsed or refractory large B-cell lymphoma and relapsed or refractory follicular lymphoma', 'category': 'EVENT'}, {'entity': 'EC approval of Inrebic for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis, post-polycythaemia vera myelofibrosis or post-essential thrombocythaemia myelofibrosis, who are Janus Associated Kinase inhibitor naïve or have been treated with ruxolitinib', 'category': 'EVENT'}, {'entity': 'FDA approval of Breyanzi for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy', 'category': 'EVENT'}, {'entity': 'FDA approval of Opdivo in combination with CABOMETYX* for the first-line treatment of patients with advanced RCC', 'category': 'EVENT'}, {'entity': 'EC', 'category': 'GPE'}, {'entity': 'AML', 'category': 'GPE'}, {'entity': 'EC', 'category': 'GPE'}, {'entity': 'UC', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'Opdivo', 'category': 'GPE'}, {'entity': 'FDA', 'category': 'GPE'}, {'entity': 'EC', 'category': 'GPE'}, {'entity': 'FDA', 'category': 'GPE'}, {'entity': 'FDA', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'EC', 'category': 'GPE'}, {'entity': 'FDA', 'category': 'GPE'}, {'entity': 'RCC', 'category': 'GPE'}, {'entity': 'CABOMETYX', 'category': 'GPE'}, {'entity': 'FDA', 'category': 'GPE'}, {'entity': 'EC', 'category': 'GPE'}, {'entity': 'repeated', 'category': 'GPE'}, {'entity': 'FDA', 'category': 'GPE'}, {'entity': 'multituner', 'category': 'GPE'}, {'entity': 'nil', 'category': 'LOC'}, {'entity': 'nil', 'category': 'MONEY'}, {'entity': 'Opdivo+Yervoy', 'category': 'ORG'}, {'entity': 'Onureg', 'category': 'ORG'}, {'entity': 'Opdivo+Yervoy', 'category': 'ORG'}, {'entity': 'Zeposia', 'category': 'ORG'}, {'entity': 'Opdivo and Yervoy', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Abecma', 'category': 'ORG'}, {'entity': 'Breyanzi', 'category': 'ORG'}, {'entity': 'Inrebic', 'category': 'ORG'}, {'entity': 'Breyanzi', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'nil', 'category': 'PERCENT'}, {'entity': 'Opdivo plus Yervoy', 'category': 'PERSON'}, {'entity': 'Opdivo plus Yervoy', 'category': 'PERSON'}, {'entity': 'Opdivo plus Yervoy', 'category': 'PERSON'}, {'entity': 'Yervoy', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'CABOMETYX', 'category': 'PERSON'}, {'entity': 'Abecma', 'category': 'PERSON'}, {'entity': 'Breyanzi', 'category': 'PERSON'}, {'entity': 'Inrebic', 'category': 'PERSON'}, {'entity': 'Breyanzi', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'nil', 'category': 'TIME'}, {'entity': 'FDA', 'category': 'WORK_OF_ART'}, {'entity': 'EC', 'category': 'WORK_OF_ART'}, {'entity': 'FDA', 'category': 'WORK_OF_ART'}, {'entity': 'EC', 'category': 'WORK_OF_ART'}, {'entity': 'FDA', 'category': 'WORK_OF_ART'}, {'entity': 'NDA', 'category': 'WORK_OF_ART'}, {'entity': 'first-line', 'category': 'ORDINAL'}, {'entity': 'first-line', 'category': 'ORDINAL'}, {'entity': 'first-line', 'category': 'ORDINAL'}, {'entity': 'three', 'category': 'CARDINAL'}, {'entity': 'four or more', 'category': 'CARDINAL'}, {'entity': 'two or more', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'April 28, 2022', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Yervoy', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'Revlimid', 'category': 'ORG'}, {'entity': 'Pomalyst', 'category': 'ORG'}, {'entity': 'Revlimid', 'category': 'ORG'}, {'entity': 'Pomalyst', 'category': 'ORG'}, {'entity': 'CELMoD', 'category': 'ORG'}, {'entity': 'iberdomide', 'category': 'ORG'}, {'entity': 'CC-92480', 'category': 'ORG'}, {'entity': 'Orencia', 'category': 'ORG'}, {'entity': 'Sprycel', 'category': 'ORG'}, {'entity': 'Reblozyl', 'category': 'ORG'}, {'entity': 'Inrebic', 'category': 'ORG'}, {'entity': 'Zeposia', 'category': 'ORG'}, {'entity': 'Onureg', 'category': 'ORG'}, {'entity': 'Breyanzi', 'category': 'ORG'}, {'entity': 'Abecma', 'category': 'ORG'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': 'Agenus', 'category': 'ORG'}, {'entity': 'AGEN1777', 'category': 'ORG'}, {'entity': 'Eisai', 'category': 'ORG'}, {'entity': 'MORAb-202', 'category': 'ORG'}, {'entity': 'Prothena', 'category': 'ORG'}, {'entity': 'PRX005', 'category': 'ORG'}, {'entity': 'Alzheimer’s disease', 'category': 'ORG'}, {'entity': 'Rockefeller University', 'category': 'ORG'}, {'entity': 'SARS-CoV-2', 'category': 'ORG'}, {'entity': 'COVID-19', 'category': 'ORG'}, {'entity': 'NIH ACTIV-2', 'category': 'ORG'}]\n",
      "[{'entity': 'March 2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': 'Court of Appeals for the Federal Circuit', 'category': 'EVENT'}, {'entity': 'GTN', 'category': 'ORG'}, {'entity': 'GTN', 'category': 'ORG'}, {'entity': 'GTN', 'category': 'ORG'}, {'entity': 'GTN', 'category': 'ORG'}, {'entity': 'GTN', 'category': 'ORG'}, {'entity': 'GTN', 'category': 'ORG'}, {'entity': 'GTN', 'category': 'ORG'}, {'entity': 'GTN', 'category': 'ORG'}, {'entity': 'GTN', 'category': 'ORG'}, {'entity': 'GTN', 'category': 'ORG'}, {'entity': 'GTN', 'category': 'ORG'}, {'entity': 'GTN', 'category': 'ORG'}, {'entity': 'GTN', 'category': 'ORG'}, {'entity': 'GTN', 'category': 'ORG'}, {'entity': '13', 'category': 'PERCENT'}, {'entity': '24', 'category': 'PERCENT'}, {'entity': '23', 'category': 'PERCENT'}, {'entity': '18', 'category': 'PERCENT'}, {'entity': '22', 'category': 'PERCENT'}, {'entity': '10', 'category': 'PERCENT'}, {'entity': '8', 'category': 'PERCENT'}, {'entity': '9', 'category': 'PERCENT'}, {'entity': '9', 'category': 'PERCENT'}, {'entity': 'Revlimid', 'category': 'PRODUCT'}, {'entity': 'Eliquis', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Pomalyst/Imnovid', 'category': 'PRODUCT'}, {'entity': 'Orencia', 'category': 'PRODUCT'}, {'entity': 'Sprycel', 'category': 'PRODUCT'}, {'entity': 'Yervoy', 'category': 'PRODUCT'}, {'entity': 'Abraxane', 'category': 'PRODUCT'}, {'entity': 'Reblozyl', 'category': 'PRODUCT'}, {'entity': 'Empliciti', 'category': 'PRODUCT'}, {'entity': 'Abecma', 'category': 'PRODUCT'}, {'entity': 'Zeposia', 'category': 'PRODUCT'}, {'entity': 'Breyanzi', 'category': 'PRODUCT'}, {'entity': 'Inrebic', 'category': 'PRODUCT'}, {'entity': 'Onureg', 'category': 'PRODUCT'}, {'entity': 'one', 'category': 'QUANTITY'}, {'entity': 'Revlimid', 'category': 'WORK_OF_ART'}, {'entity': 'third', 'category': 'ORDINAL'}, {'entity': 'fourth', 'category': 'ORDINAL'}, {'entity': 'second', 'category': 'ORDINAL'}, {'entity': '645', 'category': 'CARDINAL'}, {'entity': '2,595', 'category': 'CARDINAL'}, {'entity': '3,093', 'category': 'CARDINAL'}, {'entity': '6,333', 'category': 'CARDINAL'}, {'entity': '7,251', 'category': 'CARDINAL'}, {'entity': '9,581', 'category': 'CARDINAL'}, {'entity': '6,329', 'category': 'CARDINAL'}, {'entity': '23,161', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '207', 'category': 'CARDINAL'}, {'entity': '114', 'category': 'CARDINAL'}, {'entity': '319', 'category': 'CARDINAL'}, {'entity': '7,158', 'category': 'CARDINAL'}, {'entity': '8,763', 'category': 'CARDINAL'}, {'entity': '5,963', 'category': 'CARDINAL'}, {'entity': '21,884', 'category': 'CARDINAL'}, {'entity': '17', 'category': 'CARDINAL'}, {'entity': '152', 'category': 'CARDINAL'}, {'entity': '169', 'category': 'CARDINAL'}, {'entity': '723', 'category': 'CARDINAL'}, {'entity': '3,206', 'category': 'CARDINAL'}, {'entity': '3,193', 'category': 'CARDINAL'}, {'entity': '7,122', 'category': 'CARDINAL'}, {'entity': '22,842', 'category': 'CARDINAL'}, {'entity': '18,695', 'category': 'CARDINAL'}, {'entity': '45,055', 'category': 'CARDINAL'}, {'entity': '41,321', 'category': 'CARDINAL'}, {'entity': '67,897', 'category': 'CARDINAL'}, {'entity': '60,016', 'category': 'CARDINAL'}, {'entity': '7,253', 'category': 'CARDINAL'}, {'entity': '5,827', 'category': 'CARDINAL'}, {'entity': '9,374', 'category': 'CARDINAL'}, {'entity': '7,595', 'category': 'CARDINAL'}, {'entity': '6,215', 'category': 'CARDINAL'}, {'entity': '5,273', 'category': 'CARDINAL'}, {'entity': '319', 'category': 'CARDINAL'}, {'entity': '106', 'category': 'CARDINAL'}, {'entity': '74', 'category': 'CARDINAL'}, {'entity': '55', 'category': 'CARDINAL'}, {'entity': '67', 'category': 'CARDINAL'}, {'entity': '1,900', 'category': 'CARDINAL'}, {'entity': '2,217', 'category': 'CARDINAL'}, {'entity': '46,385', 'category': 'CARDINAL'}, {'entity': '42,518', 'category': 'CARDINAL'}, {'entity': '29,214', 'category': 'CARDINAL'}, {'entity': '26,577', 'category': 'CARDINAL'}, {'entity': '17,171', 'category': 'CARDINAL'}, {'entity': '15,941', 'category': 'CARDINAL'}, {'entity': '9.5 billion', 'category': 'CARDINAL'}, {'entity': '10.0 billion', 'category': 'CARDINAL'}, {'entity': '12,821', 'category': 'CARDINAL'}, {'entity': '12,106', 'category': 'CARDINAL'}, {'entity': '8,695', 'category': 'CARDINAL'}, {'entity': '8,291', 'category': 'CARDINAL'}, {'entity': '4,126', 'category': 'CARDINAL'}, {'entity': '3,815', 'category': 'CARDINAL'}, {'entity': '10,762', 'category': 'CARDINAL'}, {'entity': '9,168', 'category': 'CARDINAL'}, {'entity': '6,456', 'category': 'CARDINAL'}, {'entity': '5,485', 'category': 'CARDINAL'}, {'entity': '4,306', 'category': 'CARDINAL'}, {'entity': '3,683', 'category': 'CARDINAL'}, {'entity': '7,523', 'category': 'CARDINAL'}, {'entity': '6,992', 'category': 'CARDINAL'}, {'entity': '4,202', 'category': 'CARDINAL'}, {'entity': '3,945', 'category': 'CARDINAL'}, {'entity': '3,321', 'category': 'CARDINAL'}, {'entity': '3,047', 'category': 'CARDINAL'}, {'entity': '3,332', 'category': 'CARDINAL'}, {'entity': '3,070', 'category': 'CARDINAL'}, {'entity': '2,249', 'category': 'CARDINAL'}, {'entity': '2,136', 'category': 'CARDINAL'}, {'entity': '1,083', 'category': 'CARDINAL'}, {'entity': '934', 'category': 'CARDINAL'}, {'entity': '3,306', 'category': 'CARDINAL'}, {'entity': '3,157', 'category': 'CARDINAL'}, {'entity': '2,410', 'category': 'CARDINAL'}, {'entity': '2,268', 'category': 'CARDINAL'}, {'entity': '896', 'category': 'CARDINAL'}, {'entity': '889', 'category': 'CARDINAL'}, {'entity': '2,117', 'category': 'CARDINAL'}, {'entity': '2,140', 'category': 'CARDINAL'}, {'entity': '1,297', 'category': 'CARDINAL'}, {'entity': '1,295', 'category': 'CARDINAL'}, {'entity': '820', 'category': 'CARDINAL'}, {'entity': '845', 'category': 'CARDINAL'}, {'entity': '2,026', 'category': 'CARDINAL'}, {'entity': '1,682', 'category': 'CARDINAL'}, {'entity': '1,265', 'category': 'CARDINAL'}, {'entity': '1,124', 'category': 'CARDINAL'}, {'entity': '761', 'category': 'CARDINAL'}, {'entity': '558', 'category': 'CARDINAL'}, {'entity': '1,181', 'category': 'CARDINAL'}, {'entity': '1,247', 'category': 'CARDINAL'}, {'entity': '898', 'category': 'CARDINAL'}, {'entity': '873', 'category': 'CARDINAL'}, {'entity': '283', 'category': 'CARDINAL'}, {'entity': '374', 'category': 'CARDINAL'}, {'entity': '551', 'category': 'CARDINAL'}, {'entity': '274', 'category': 'CARDINAL'}, {'entity': '485', 'category': 'CARDINAL'}, {'entity': '259', 'category': 'CARDINAL'}, {'entity': '66', 'category': 'CARDINAL'}, {'entity': '15', 'category': 'CARDINAL'}, {'entity': '334', 'category': 'CARDINAL'}, {'entity': '381', 'category': 'CARDINAL'}, {'entity': '200', 'category': 'CARDINAL'}, {'entity': '230', 'category': 'CARDINAL'}, {'entity': '134', 'category': 'CARDINAL'}, {'entity': '151', 'category': 'CARDINAL'}, {'entity': '164', 'category': 'CARDINAL'}, {'entity': '158', 'category': 'CARDINAL'}, {'entity': '99', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '87', 'category': 'CARDINAL'}, {'entity': '84', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '1,900', 'category': 'CARDINAL'}, {'entity': '2,217', 'category': 'CARDINAL'}, {'entity': '1,181', 'category': 'CARDINAL'}, {'entity': '1,247', 'category': 'CARDINAL'}, {'entity': '551', 'category': 'CARDINAL'}, {'entity': '274', 'category': 'CARDINAL'}, {'entity': '334', 'category': 'CARDINAL'}, {'entity': '381', 'category': 'CARDINAL'}, {'entity': '87', 'category': 'CARDINAL'}, {'entity': '84', 'category': 'CARDINAL'}, {'entity': '73', 'category': 'CARDINAL'}, {'entity': '17', 'category': 'CARDINAL'}, {'entity': '74', 'category': 'CARDINAL'}, {'entity': '55', 'category': 'CARDINAL'}, {'entity': '67', 'category': 'CARDINAL'}, {'entity': '55', 'category': 'CARDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '580', 'category': 'CARDINAL'}, {'entity': '589', 'category': 'CARDINAL'}]\n",
      "[{'entity': '2021', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': 'monotherapy', 'category': 'EVENT'}, {'entity': 'Opdivo+Yervoy combinations', 'category': 'EVENT'}, {'entity': 'opdivo', 'category': 'EVENT'}, {'entity': 'immune system and other biologically important targets', 'category': 'EVENT'}, {'entity': 'pancreatic cancer', 'category': 'EVENT'}, {'entity': 'chronic phase Philadelphia chromosome-positive CML', 'category': 'EVENT'}, {'entity': 'Opdivo+Yervoy regimen', 'category': 'EVENT'}, {'entity': 'Opdivo+CABOMETYX* combination', 'category': 'EVENT'}, {'entity': 'Opdivo', 'category': 'EVENT'}, {'entity': 'Pros', 'category': 'EVENT'}, {'entity': 'Cons', 'category': 'EVENT'}, {'entity': 'Opdivo+Yervoy combination', 'category': 'EVENT'}, {'entity': 'Opdivo+Yervoy combination', 'category': 'EVENT'}, {'entity': 'Opdivo+Yervoy combination', 'category': 'EVENT'}, {'entity': 'Opdivo+Yervoy combination', 'category': 'EVENT'}, {'entity': 'Opdivo', 'category': 'EVENT'}, {'entity': 'Opdivo', 'category': 'EVENT'}, {'entity': 'Opdivo+Yervoy combination', 'category': 'EVENT'}, {'entity': 'Opdivo', 'category': 'EVENT'}, {'entity': 'Opdivo', 'category': 'EVENT'}, {'entity': 'Opdivo+CABOMETYX* combination', 'category': 'EVENT'}, {'entity': 'Opdivo', 'category': 'EVENT'}, {'entity': 'Opdivo', 'category': 'EVENT'}, {'entity': 'Opdivo', 'category': 'FAC'}, {'entity': 'Yervoy', 'category': 'FAC'}, {'entity': 'Opdivo+CABOMETYX* combination', 'category': 'FAC'}, {'entity': 'Opdivo', 'category': 'FAC'}, {'entity': 'Opdivo+Yervoy', 'category': 'FAC'}, {'entity': 'Opdivo', 'category': 'FAC'}, {'entity': 'Yervoy', 'category': 'FAC'}, {'entity': 'Opdivo+Yervoy', 'category': 'FAC'}, {'entity': 'Opdivo+Eiffel Tower', 'category': 'FAC'}, {'entity': 'Hilton Hotel', 'category': 'FAC'}, {'entity': 'NSCLC', 'category': 'GPE'}, {'entity': 'MM', 'category': 'GPE'}, {'entity': 'MPM', 'category': 'GPE'}, {'entity': 'RCC', 'category': 'GPE'}, {'entity': 'CRC', 'category': 'GPE'}, {'entity': 'RA', 'category': 'GPE'}, {'entity': 'PsA', 'category': 'GPE'}, {'entity': 'JIA', 'category': 'GPE'}, {'entity': 'CML', 'category': 'GPE'}, {'entity': 'JIA', 'category': 'GPE'}, {'entity': 'UC', 'category': 'GPE'}, {'entity': 'CML', 'category': 'GPE'}, {'entity': 'MDS', 'category': 'GPE'}, {'entity': 'UC', 'category': 'GPE'}, {'entity': 'MS', 'category': 'GPE'}, {'entity': 'UC', 'category': 'GPE'}, {'entity': 'AML', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'EU', 'category': 'LOC'}, {'entity': 'Japan', 'category': 'LOC'}, {'entity': 'Opdivo+CABOMETYX* combination', 'category': 'MONEY'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': 'Opdivo', 'category': 'MONEY'}, {'entity': 'Opdivo+Yervoy combinations', 'category': 'MONEY'}, {'entity': 'Opdivo', 'category': 'MONEY'}, {'entity': 'Eiffel Tower', 'category': 'MONEY'}, {'entity': 'Hilton Hotel', 'category': 'MONEY'}, {'entity': '15%', 'category': 'MONEY'}, {'entity': 'Breyanzi', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Yervoy', 'category': 'ORG'}, {'entity': 'Opdivo+Yervoy', 'category': 'ORG'}, {'entity': 'Gleevec', 'category': 'ORG'}, {'entity': 'Abraxane', 'category': 'ORG'}, {'entity': 'Nab®', 'category': 'ORG'}, {'entity': 'Reblozyl', 'category': 'ORG'}, {'entity': 'Empliciti', 'category': 'ORG'}, {'entity': 'Abecma', 'category': 'ORG'}, {'entity': 'Zeposia', 'category': 'ORG'}, {'entity': 'Inrebic', 'category': 'ORG'}, {'entity': 'Onureg', 'category': 'ORG'}, {'entity': '7%', 'category': 'PERCENT'}, {'entity': '5%', 'category': 'PERCENT'}, {'entity': '9%', 'category': 'PERCENT'}, {'entity': '7%', 'category': 'PERCENT'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': '36%', 'category': 'PERCENT'}, {'entity': '2%', 'category': 'PERCENT'}, {'entity': '24%', 'category': 'PERCENT'}, {'entity': '3%', 'category': 'PERCENT'}, {'entity': '2%', 'category': 'PERCENT'}, {'entity': '87%', 'category': 'PERCENT'}, {'entity': 'Breyanzi', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Yervoy', 'category': 'PERSON'}, {'entity': 'Opdivo+CABOMETYX*', 'category': 'PERSON'}, {'entity': 'Sprycel', 'category': 'PERSON'}, {'entity': 'Pancreatic Cancer', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Opdivo+CABOMETYX*', 'category': 'PRODUCT'}, {'entity': 'Pomalyst/Imnovid', 'category': 'PRODUCT'}, {'entity': 'Orencia', 'category': 'PRODUCT'}, {'entity': 'Sprycel', 'category': 'PRODUCT'}, {'entity': 'Yervoy', 'category': 'PRODUCT'}, {'entity': 'Abraxane', 'category': 'PRODUCT'}, {'entity': 'Reblozyl', 'category': 'PRODUCT'}, {'entity': 'Empliciti', 'category': 'PRODUCT'}, {'entity': 'Abecma', 'category': 'PRODUCT'}, {'entity': 'Zeposia', 'category': 'PRODUCT'}, {'entity': 'Breyanzi', 'category': 'PRODUCT'}, {'entity': 'Inrebic', 'category': 'PRODUCT'}, {'entity': 'Onureg', 'category': 'PRODUCT'}, {'entity': '2021', 'category': 'TIME'}, {'entity': '2021', 'category': 'TIME'}, {'entity': '2021', 'category': 'TIME'}, {'entity': '2021', 'category': 'TIME'}, {'entity': '2021', 'category': 'TIME'}, {'entity': '2021', 'category': 'TIME'}, {'entity': '2021', 'category': 'TIME'}, {'entity': '2021', 'category': 'TIME'}, {'entity': '2021', 'category': 'TIME'}, {'entity': '2022', 'category': 'TIME'}, {'entity': '2019', 'category': 'TIME'}, {'entity': 'Nab®', 'category': 'WORK_OF_ART'}, {'entity': 'first-line', 'category': 'ORDINAL'}, {'entity': 'NSCLC', 'category': 'ORDINAL'}, {'entity': 'chronic phase', 'category': 'ORDINAL'}, {'entity': 'CML', 'category': 'ORDINAL'}, {'entity': 'chronic phase', 'category': 'ORDINAL'}, {'entity': 'Philadelphia chromosome-positive CML', 'category': 'ORDINAL'}, {'entity': 'relapsed', 'category': 'ORDINAL'}, {'entity': 'refractory', 'category': 'ORDINAL'}, {'entity': 'UC', 'category': 'ORDINAL'}, {'entity': 'adult patients', 'category': 'ORDINAL'}, {'entity': 'breast cancer', 'category': 'ORDINAL'}, {'entity': 'NSCLC', 'category': 'ORDINAL'}, {'entity': 'pancreatic cancer', 'category': 'ORDINAL'}, {'entity': 'adult patients', 'category': 'ORDINAL'}, {'entity': 'beta thalassemia', 'category': 'ORDINAL'}, {'entity': 'ESA', 'category': 'ORDINAL'}, {'entity': 'MDS', 'category': 'ORDINAL'}, {'entity': 'ring sideroblasts', 'category': 'ORDINAL'}, {'entity': 'UCL', 'category': 'ORDINAL'}, {'entity': 'adult patients', 'category': 'ORDINAL'}, {'entity': 'MM', 'category': 'ORDINAL'}, {'entity': 'lines', 'category': 'ORDINAL'}, {'entity': 'therapy', 'category': 'ORDINAL'}, {'entity': 'large B-cell lymphoma', 'category': 'ORDINAL'}, {'entity': 'systemic therapy', 'category': 'ORDINAL'}, {'entity': 'Myelofibrosis', 'category': 'ORDINAL'}, {'entity': 'AML', 'category': 'ORDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '508', 'category': 'CARDINAL'}, {'entity': '60', 'category': 'CARDINAL'}, {'entity': '2026', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2022', 'category': 'CARDINAL'}, {'entity': '2023', 'category': 'CARDINAL'}, {'entity': '25%', 'category': 'CARDINAL'}, {'entity': '30%', 'category': 'CARDINAL'}, {'entity': '87%', 'category': 'CARDINAL'}, {'entity': '5%', 'category': 'CARDINAL'}, {'entity': '9%', 'category': 'CARDINAL'}, {'entity': '3%', 'category': 'CARDINAL'}, {'entity': '16%', 'category': 'CARDINAL'}, {'entity': '2%', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'September 2020', 'category': 'DATE'}, {'entity': 'September 30, 2021', 'category': 'DATE'}, {'entity': 'June 30, 2021', 'category': 'DATE'}, {'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': '2021 Form 10-K', 'category': 'DATE'}, {'entity': 'Year Ended December 31, 2021', 'category': 'DATE'}, {'entity': '2020 vs 2021', 'category': 'DATE'}, {'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': '$1.8 billion', 'category': 'MONEY'}, {'entity': '$2.4 billion', 'category': 'MONEY'}, {'entity': '$260 million', 'category': 'MONEY'}, {'entity': '$539 million', 'category': 'MONEY'}, {'entity': '$241 million', 'category': 'MONEY'}, {'entity': '$280 million', 'category': 'MONEY'}, {'entity': 'AML', 'category': 'ORG'}, {'entity': 'Onureg', 'category': 'ORG'}, {'entity': 'SEC Consent Order', 'category': 'ORG'}, {'entity': 'ABRAXANE', 'category': 'ORG'}, {'entity': 'Latin America', 'category': 'ORG'}, {'entity': 'U.S.', 'category': 'ORG'}, {'entity': 'Lenalidomide REMS', 'category': 'ORG'}, {'entity': 'Pomalyst REMS', 'category': 'ORG'}, {'entity': 'Revlimid', 'category': 'ORG'}, {'entity': 'Imnovid', 'category': 'ORG'}, {'entity': 'MyoKardia', 'category': 'ORG'}, {'entity': 'Sprycel', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'June', 'category': 'PERSON'}, {'entity': 'December', 'category': 'PERSON'}, {'entity': 'AMortization', 'category': 'PERSON'}, {'entity': 'IPRD', 'category': 'PERSON'}, {'entity': 'MyoKardia acquisition', 'category': 'PERSON'}, {'entity': 'December', 'category': 'PERSON'}, {'entity': 'first', 'category': 'ORDINAL'}]\n",
      "[{'entity': 'December 31', 'category': 'DATE'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': 'MyoKardia', 'category': 'ORG'}, {'entity': 'Roche Group', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}]\n",
      "[{'entity': 'December 31,', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'December 31', 'category': 'LOC'}, {'entity': '$264', 'category': 'MONEY'}, {'entity': '2,688', 'category': 'MONEY'}, {'entity': '315', 'category': 'MONEY'}, {'entity': '575', 'category': 'MONEY'}, {'entity': '4', 'category': 'MONEY'}, {'entity': '33', 'category': 'MONEY'}, {'entity': '603', 'category': 'MONEY'}, {'entity': '3,300', 'category': 'MONEY'}, {'entity': '$1', 'category': 'MONEY'}, {'entity': '275', 'category': 'MONEY'}, {'entity': '2', 'category': 'MONEY'}, {'entity': '4', 'category': 'MONEY'}, {'entity': '3', 'category': 'MONEY'}, {'entity': '279', 'category': 'MONEY'}, {'entity': '$980', 'category': 'MONEY'}, {'entity': '1,003', 'category': 'MONEY'}, {'entity': '840', 'category': 'MONEY'}, {'entity': '470', 'category': 'MONEY'}, {'entity': '1', 'category': 'MONEY'}, {'entity': '36', 'category': 'MONEY'}, {'entity': '1', 'category': 'MONEY'}, {'entity': '115', 'category': 'MONEY'}, {'entity': '1,823', 'category': 'MONEY'}, {'entity': '1,906', 'category': 'MONEY'}, {'entity': '—', 'category': 'MONEY'}, {'entity': '11,438', 'category': 'MONEY'}, {'entity': '10,023', 'category': 'MONEY'}, {'entity': '9,688', 'category': 'MONEY'}, {'entity': '120', 'category': 'MONEY'}, {'entity': '159', 'category': 'MONEY'}, {'entity': '542', 'category': 'MONEY'}, {'entity': '1,757', 'category': 'MONEY'}, {'entity': '72', 'category': 'MONEY'}, {'entity': '168', 'category': 'MONEY'}, {'entity': '758', 'category': 'MONEY'}, {'entity': '1,156', 'category': 'MONEY'}, {'entity': '564', 'category': 'MONEY'}, {'entity': '717', 'category': 'MONEY'}, {'entity': '169', 'category': 'MONEY'}, {'entity': '530', 'category': 'MONEY'}, {'entity': '—', 'category': 'MONEY'}, {'entity': '239', 'category': 'MONEY'}, {'entity': '—', 'category': 'MONEY'}, {'entity': '76', 'category': 'MONEY'}, {'entity': '9', 'category': 'MONEY'}, {'entity': '55', 'category': 'MONEY'}, {'entity': '281', 'category': 'MONEY'}, {'entity': '487', 'category': 'MONEY'}, {'entity': '2,211', 'category': 'MONEY'}, {'entity': '11,965', 'category': 'MONEY'}, {'entity': '24,400', 'category': 'MONEY'}, {'entity': '1,122', 'category': 'MONEY'}, {'entity': '1,733', 'category': 'MONEY'}, {'entity': '—', 'category': 'MONEY'}, {'entity': '266', 'category': 'MONEY'}, {'entity': '983', 'category': 'MONEY'}, {'entity': '853', 'category': 'MONEY'}, {'entity': '2,105', 'category': 'MONEY'}, {'entity': '614', 'category': 'MONEY'}, {'entity': '9,860', 'category': 'MONEY'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': '13.4%', 'category': 'PERCENT'}, {'entity': '30.9%', 'category': 'PERCENT'}, {'entity': '2.5%', 'category': 'PERCENT'}, {'entity': '46.5%', 'category': 'PERCENT'}, {'entity': '15.9%', 'category': 'PERCENT'}, {'entity': '15.6%', 'category': 'PERCENT'}, {'entity': '$1.0 billion', 'category': 'QUANTITY'}, {'entity': '853 million', 'category': 'QUANTITY'}, {'entity': '266 million', 'category': 'QUANTITY'}, {'entity': 'Otezla*', 'category': 'WORK_OF_ART'}, {'entity': '13.4', 'category': 'CARDINAL'}, {'entity': '30.9', 'category': 'CARDINAL'}, {'entity': '2.5', 'category': 'CARDINAL'}, {'entity': '46.5', 'category': 'CARDINAL'}, {'entity': '15.9', 'category': 'CARDINAL'}, {'entity': '15.6', 'category': 'CARDINAL'}, {'entity': '2021', 'category': 'CARDINAL'}, {'entity': '2020', 'category': 'CARDINAL'}, {'entity': '1.0 billion', 'category': 'CARDINAL'}, {'entity': '853 million', 'category': 'CARDINAL'}, {'entity': '266 million', 'category': 'CARDINAL'}, {'entity': '0.3', 'category': 'CARDINAL'}, {'entity': '140 million', 'category': 'CARDINAL'}]\n",
      "[{'entity': '2', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2.245', 'category': 'CARDINAL'}, {'entity': '35', 'category': 'CARDINAL'}, {'entity': '2.293', 'category': 'CARDINAL'}, {'entity': '15.1', 'category': 'CARDINAL'}, {'entity': '102', 'category': 'CARDINAL'}, {'entity': '6.2+', 'category': 'CARDINAL'}, {'entity': '4.4', 'category': 'CARDINAL'}, {'entity': '4.1', 'category': 'CARDINAL'}, {'entity': '5', 'category': 'CARDINAL'}, {'entity': '366', 'category': 'CARDINAL'}, {'entity': '5.0', 'category': 'CARDINAL'}, {'entity': '6.0', 'category': 'CARDINAL'}, {'entity': '364', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '1.0', 'category': 'CARDINAL'}, {'entity': '1.5.', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'August 4, 2004', 'category': 'DATE'}, {'entity': 'September 30, 2004', 'category': 'DATE'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'one month', 'category': 'QUANTITY'}]\n",
      "[{'entity': 'U.S. Department of Defense', 'category': 'ORG'}, {'entity': 'U.S. Department of Veterans Affairs', 'category': 'ORG'}, {'entity': '340B Drug Pricing Program', 'category': 'ORG'}, {'entity': 'CMS', 'category': 'ORG'}, {'entity': 'Medicaid', 'category': 'ORG'}, {'entity': 'Medicare', 'category': 'ORG'}, {'entity': 'CMS', 'category': 'ORG'}, {'entity': '2%', 'category': 'QUANTITY'}]\n",
      "[{'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': '$42.5 billion', 'category': 'MONEY'}, {'entity': '$53.2 billion', 'category': 'MONEY'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': 'Inrebic', 'category': 'PRODUCT'}, {'entity': 'Inrebic EU regulatory approval milestones', 'category': 'WORK_OF_ART'}, {'entity': '$315 million', 'category': 'CARDINAL'}, {'entity': '$840 million', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'Phase III CheckMate-274 trial', 'category': 'EVENT'}, {'entity': 'United States', 'category': 'LOC'}, {'entity': 'Internal Revenue Code', 'category': 'ORG'}, {'entity': 'Section 382', 'category': 'ORG'}, {'entity': 'Internal Revenue Service', 'category': 'ORG'}, {'entity': 'Mead Johnson & Company', 'category': 'ORG'}, {'entity': '40%', 'category': 'PERCENT'}, {'entity': '10%', 'category': 'PERCENT'}, {'entity': 'Mead Johnson', 'category': 'PERSON'}, {'entity': 'Mead Johnson Class B', 'category': 'PERSON'}, {'entity': 'Mead Johnson Class A', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': '$2.7 billion', 'category': 'CARDINAL'}, {'entity': '$1.1 billion', 'category': 'CARDINAL'}, {'entity': '$3.5 billion', 'category': 'CARDINAL'}, {'entity': '$2.8 billion', 'category': 'CARDINAL'}, {'entity': '$585 million', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'Ono', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Japan', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'EMA', 'category': 'ORG'}, {'entity': 'Ministry of Health, Labour and Welfare', 'category': 'ORG'}, {'entity': 'CheckMate-274 ONO-4538-33 trial', 'category': 'ORG'}, {'entity': 'CheckMate-274 trial', 'category': 'ORG'}, {'entity': 'CheckMate-649 ONO-4538-44 trial', 'category': 'ORG'}, {'entity': 'CheckMate-577 ONO-4538-43 trial', 'category': 'ORG'}, {'entity': 'Checkmate-649 trial', 'category': 'ORG'}, {'entity': 'CheckMate-577 trial', 'category': 'ORG'}, {'entity': 'CheckMate-648 trial', 'category': 'ORG'}, {'entity': 'CheckMate-040 trial', 'category': 'ORG'}, {'entity': 'CheckMate-459', 'category': 'ORG'}, {'entity': 'Opdivo plus chemotherapy', 'category': 'ORG'}, {'entity': 'Opdivo plus Yervoy', 'category': 'ORG'}, {'entity': 'CheckMate-816 trial', 'category': 'ORG'}, {'entity': 'Checkmate-9ER trial', 'category': 'ORG'}, {'entity': 'CheckMate-9ER trial', 'category': 'ORG'}, {'entity': 'CheckMate-142 trial', 'category': 'ORG'}, {'entity': 'CheckMate-067 trial', 'category': 'ORG'}, {'entity': 'Checkmate-648 trial', 'category': 'ORG'}]\n",
      "[{'entity': 'CheckMate-648', 'category': 'ORG'}, {'entity': 'EMA', 'category': 'ORG'}, {'entity': 'MAA', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Yervoy', 'category': 'ORG'}, {'entity': 'Opdivo in combination with fluoropyrimidine- and platinum-containing chemotherapy', 'category': 'ORG'}, {'entity': 'CheckMate-648', 'category': 'ORG'}, {'entity': 'CheckMate-648', 'category': 'ORG'}, {'entity': 'Malignant Pleural Mesothelioma', 'category': 'ORG'}, {'entity': 'CheckMate-743', 'category': 'ORG'}, {'entity': 'CheckMate-743', 'category': 'ORG'}, {'entity': 'Ono', 'category': 'ORG'}, {'entity': 'Opdivo and Yervoy', 'category': 'ORG'}, {'entity': 'CheckMate-743', 'category': 'ORG'}, {'entity': 'Opdivo plus Yervoy', 'category': 'ORG'}, {'entity': 'CheckMate-214', 'category': 'ORG'}, {'entity': 'CheckMate-214', 'category': 'ORG'}, {'entity': 'Opdivo plus Yervoy', 'category': 'ORG'}, {'entity': 'Phase III CheckMate-227', 'category': 'ORG'}, {'entity': 'Opdivo plus Yervoy', 'category': 'ORG'}, {'entity': 'CheckMate-9LA', 'category': 'ORG'}, {'entity': 'CheckMate-651', 'category': 'ORG'}, {'entity': 'Opdivo plus Yervoy', 'category': 'ORG'}, {'entity': 'EXTREME regimen', 'category': 'ORG'}, {'entity': 'Orencia', 'category': 'ORG'}, {'entity': 'GvHD', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'Orencia', 'category': 'ORG'}, {'entity': 'ABA2', 'category': 'ORG'}, {'entity': 'Reblozyl', 'category': 'ORG'}, {'entity': 'Beta Thalassemia', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'Reblozyl', 'category': 'ORG'}, {'entity': 'Phase II BEYOND trial', 'category': 'ORG'}, {'entity': 'EMA', 'category': 'ORG'}, {'entity': 'Reblozyl', 'category': 'ORG'}, {'entity': 'Reblozyl', 'category': 'ORG'}, {'entity': 'Phase II BEYOND study', 'category': 'ORG'}, {'entity': 'Zeposia', 'category': 'ORG'}, {'entity': 'UC', 'category': 'ORG'}, {'entity': 'EC', 'category': 'ORG'}, {'entity': 'Zeposia', 'category': 'ORG'}, {'entity': 'Phase III True North trial', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'Zeposia', 'category': 'ORG'}, {'entity': 'MS', 'category': 'ORG'}, {'entity': 'Phase III open-label extension trial DAYBREAK', 'category': 'ORG'}, {'entity': 'Zeposia', 'category': 'ORG'}, {'entity': 'Inrebic', 'category': 'ORG'}, {'entity': 'Myelofibrosis', 'category': 'ORG'}, {'entity': 'EC', 'category': 'ORG'}, {'entity': 'Inrebic', 'category': 'ORG'}, {'entity': 'Onureg', 'category': 'ORG'}, {'entity': 'AML', 'category': 'ORG'}, {'entity': 'EC', 'category': 'ORG'}, {'entity': 'Onureg', 'category': 'ORG'}, {'entity': 'Phase III QUAZAR AML-001 study', 'category': 'ORG'}, {'entity': 'Breyanzi', 'category': 'ORG'}, {'entity': 'Lymphoma', 'category': 'ORG'}, {'entity': 'CHMP', 'category': 'ORG'}, {'entity': 'Breyanzi', 'category': 'ORG'}]\n",
      "[{'entity': 'June 2021', 'category': 'DATE'}, {'entity': 'March 2021', 'category': 'DATE'}, {'entity': 'February 2021', 'category': 'DATE'}, {'entity': 'August 2021', 'category': 'DATE'}, {'entity': 'March 2021', 'category': 'DATE'}, {'entity': 'January 2022', 'category': 'DATE'}, {'entity': 'August 2021', 'category': 'DATE'}, {'entity': 'November 2021', 'category': 'DATE'}, {'entity': 'November 2021', 'category': 'DATE'}, {'entity': 'November 2021', 'category': 'DATE'}, {'entity': 'November 2021', 'category': 'DATE'}, {'entity': 'November 2021', 'category': 'DATE'}, {'entity': 'February 2021', 'category': 'DATE'}, {'entity': 'October 2021', 'category': 'DATE'}, {'entity': 'May 2021', 'category': 'DATE'}, {'entity': 'March 2021', 'category': 'DATE'}, {'entity': 'October 2021', 'category': 'DATE'}, {'entity': 'September 2021', 'category': 'DATE'}, {'entity': 'clinically meaningful and highly statistically significant improvement', 'category': 'EVENT'}, {'entity': 'treatment', 'category': 'EVENT'}, {'entity': 'approval', 'category': 'EVENT'}, {'entity': 'treatment', 'category': 'EVENT'}, {'entity': 'treatment', 'category': 'EVENT'}, {'entity': 'positive', 'category': 'EVENT'}, {'entity': 'approval', 'category': 'EVENT'}, {'entity': 'approval', 'category': 'EVENT'}, {'entity': 'positive', 'category': 'EVENT'}, {'entity': 'Cupertino', 'category': 'FAC'}, {'entity': 'California', 'category': 'FAC'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'Cupertino', 'category': 'LOC'}, {'entity': 'California', 'category': 'LOC'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': 'Apple', 'category': 'ORG'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': 'Mary', 'category': 'PERSON'}, {'entity': 'Breyanzi', 'category': 'PRODUCT'}, {'entity': 'two or more', 'category': 'QUANTITY'}, {'entity': 'at least three', 'category': 'QUANTITY'}, {'entity': 'at least three', 'category': 'QUANTITY'}, {'entity': 'four or more', 'category': 'QUANTITY'}, {'entity': '5PM', 'category': 'TIME'}, {'entity': '7PM', 'category': 'TIME'}, {'entity': 'Hamlet', 'category': 'WORK_OF_ART'}, {'entity': 'second', 'category': 'ORDINAL'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '16', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'March 2021', 'category': 'DATE'}, {'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'Phase II/III RELATIVITY-047 trial', 'category': 'EVENT'}, {'entity': 'Securities Act of the Exchange Act', 'category': 'ORG'}, {'entity': 'RELATIVITY-047', 'category': 'ORG'}, {'entity': 'CA224-047', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Celgene', 'category': 'PERSON'}, {'entity': 'MyoKardia', 'category': 'PERSON'}, {'entity': 'relatlimab', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}]\n",
      "[{'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'Investments', 'category': 'EVENT'}, {'entity': 'credit risk', 'category': 'EVENT'}, {'entity': 'investment policy', 'category': 'EVENT'}, {'entity': 'derivative instruments', 'category': 'EVENT'}, {'entity': 'December 31, 2021', 'category': 'GPE'}, {'entity': 'December 31, 2020', 'category': 'GPE'}, {'entity': 'institutions', 'category': 'LOC'}, {'entity': '$3.8 billion', 'category': 'MONEY'}, {'entity': '$4.7 billion', 'category': 'MONEY'}, {'entity': 'Financial Statements', 'category': 'ORG'}, {'entity': 'high credit quality standards', 'category': 'PERCENT'}, {'entity': 'counterparties', 'category': 'PERSON'}, {'entity': '100 basis points', 'category': 'QUANTITY'}, {'entity': 'in the asset', 'category': 'TIME'}, {'entity': 'derivatives', 'category': 'WORK_OF_ART'}, {'entity': '0', 'category': 'CARDINAL'}]\n",
      "/Users/tanmayiballa/Desktop/KG-LLM/l715_23-1/data/10-Ks/Bristol-Myers_Squibb_Company/2023/Management_gpt-3.5-turbo_NER_response.json\n",
      "[{'entity': '2022 Form 10-K', 'category': 'DATE'}, {'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': 'February 10, 2021EVENT', 'category': 'DATE'}, {'entity': 'Opdualag', 'category': 'DATE'}, {'entity': 'FDA', 'category': 'DATE'}, {'entity': 'EC', 'category': 'DATE'}, {'entity': 'first PD-1 inhibitor and LAG-3 blocking antibody combinationFAC', 'category': 'DATE'}, {'entity': 'ESC', 'category': 'DATE'}, {'entity': 'OpdivoGPE', 'category': 'DATE'}, {'entity': 'Japan', 'category': 'DATE'}, {'entity': 'U.S.', 'category': 'DATE'}, {'entity': 'EU', 'category': 'DATE'}, {'entity': 'Washington', 'category': 'DATE'}, {'entity': 'New Jersey', 'category': 'DATE'}, {'entity': 'Massachusetts', 'category': 'DATE'}, {'entity': 'LeidenLANGUAGE', 'category': 'DATE'}, {'entity': 'N/APERCENT', 'category': 'DATE'}, {'entity': '$0.17PERSON', 'category': 'DATE'}, {'entity': 'President BidenLAW', 'category': 'DATE'}, {'entity': 'N/APRODUCT', 'category': 'DATE'}, {'entity': 'Eliquis', 'category': 'DATE'}, {'entity': 'Opdivo', 'category': 'DATE'}, {'entity': 'Opdualag', 'category': 'DATE'}, {'entity': 'Abecma', 'category': 'DATE'}, {'entity': 'Reblozyl', 'category': 'DATE'}, {'entity': 'Revlimid', 'category': 'DATE'}, {'entity': 'Camzyos', 'category': 'DATE'}, {'entity': 'mavacamten', 'category': 'DATE'}, {'entity': 'Turning Point', 'category': 'DATE'}, {'entity': 'repotrectinibDATE', 'category': 'DATE'}, {'entity': 'August 16, 2022MONEY', 'category': 'DATE'}, {'entity': 'N/AORDINAL', 'category': 'DATE'}, {'entity': 'N/AWORK_OF_ART', 'category': 'DATE'}, {'entity': 'N/AQUANTITY', 'category': 'DATE'}, {'entity': 'N/ACARDINAL', 'category': 'DATE'}, {'entity': '18', 'category': 'DATE'}, {'entity': '2TIME', 'category': 'DATE'}, {'entity': 'N/ALOC', 'category': 'DATE'}, {'entity': 'N/A', 'category': 'DATE'}, {'entity': 'Bristol-Myers Squibb Company', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'EC', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Abecma', 'category': 'ORG'}, {'entity': 'Breyanzi', 'category': 'ORG'}, {'entity': 'Hilton Hotel', 'category': 'ORG'}, {'entity': 'Sotyktu', 'category': 'ORG'}, {'entity': 'Camzyos', 'category': 'ORG'}, {'entity': 'Turning Point', 'category': 'ORG'}, {'entity': 'Revlimid', 'category': 'ORG'}, {'entity': 'IRA', 'category': 'ORG'}]\n",
      "[{'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': 'September 2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': 'April 2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': 'April 2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': 'January 2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': 'pandemic', 'category': 'EVENT'}, {'entity': 'negative impact', 'category': 'EVENT'}, {'entity': 'approval', 'category': 'EVENT'}, {'entity': 'approval', 'category': 'EVENT'}, {'entity': 'approval', 'category': 'EVENT'}, {'entity': 'approval', 'category': 'EVENT'}, {'entity': 'approval', 'category': 'EVENT'}, {'entity': 'approval', 'category': 'EVENT'}, {'entity': 'approval', 'category': 'EVENT'}, {'entity': 'approval', 'category': 'EVENT'}, {'entity': 'approval', 'category': 'EVENT'}, {'entity': 'approval', 'category': 'EVENT'}, {'entity': 'approval', 'category': 'EVENT'}, {'entity': 'approval', 'category': 'EVENT'}, {'entity': 'approval', 'category': 'EVENT'}, {'entity': 'approval', 'category': 'EVENT'}, {'entity': 'approval', 'category': 'EVENT'}, {'entity': 'approval', 'category': 'EVENT'}, {'entity': 'approval', 'category': 'EVENT'}, {'entity': 'approval', 'category': 'EVENT'}, {'entity': 'approval', 'category': 'EVENT'}, {'entity': 'COVID-19', 'category': 'ORG'}, {'entity': 'healthcare systems', 'category': 'ORG'}, {'entity': 'economic', 'category': 'ORG'}, {'entity': 'financial markets', 'category': 'ORG'}, {'entity': 'medicines', 'category': 'ORG'}, {'entity': 'patients', 'category': 'ORG'}, {'entity': 'workforce', 'category': 'ORG'}, {'entity': 'Product', 'category': 'ORG'}, {'entity': 'Breyanzi', 'category': 'ORG'}, {'entity': 'Ministry of Health, Labour and Welfare', 'category': 'ORG'}, {'entity': 'relapsed', 'category': 'ORG'}, {'entity': 'refractory', 'category': 'ORG'}, {'entity': 'large B-cell lymphoma', 'category': 'ORG'}, {'entity': 'journal', 'category': 'ORG'}, {'entity': 'Sotyktu', 'category': 'ORG'}, {'entity': 'plaque psoriasis', 'category': 'ORG'}, {'entity': 'pustular psoriasis', 'category': 'ORG'}, {'entity': 'erythrodermic psoriasis', 'category': 'ORG'}, {'entity': 'inadequate response', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'treatment', 'category': 'ORG'}, {'entity': 'adults', 'category': 'ORG'}, {'entity': 'moderate-to-severe plaque psoriasis', 'category': 'ORG'}, {'entity': 'candidates', 'category': 'ORG'}, {'entity': 'systemic therapy', 'category': 'ORG'}, {'entity': 'phototherapy', 'category': 'ORG'}, {'entity': 'Opdualag', 'category': 'ORG'}, {'entity': 'melanoma', 'category': 'ORG'}, {'entity': 'unresectable', 'category': 'ORG'}, {'entity': 'metastatic', 'category': 'ORG'}, {'entity': 'adolescents', 'category': 'ORG'}, {'entity': 'tumor cell PD-L1 expression', 'category': 'ORG'}, {'entity': 'June 2022', 'category': 'ORG'}, {'entity': 'first-line treatment', 'category': 'ORG'}, {'entity': 'months', 'category': 'ORG'}, {'entity': 'first-line chemoimmunotherapy', 'category': 'ORG'}, {'entity': 'Opdivo+Yervoy', 'category': 'ORG'}, {'entity': 'ESC', 'category': 'ORG'}, {'entity': 'EC', 'category': 'ORG'}, {'entity': 'resectable', 'category': 'ORG'}, {'entity': 'advanced', 'category': 'ORG'}, {'entity': 'EC approval', 'category': 'ORG'}, {'entity': 'recurrent', 'category': 'ORG'}, {'entity': 'Camzyos', 'category': 'ORG'}, {'entity': 'symptomatic obstructive HCM', 'category': 'ORG'}, {'entity': 'diffuse large B-cell lymphoma', 'category': 'ORG'}, {'entity': 'primary mediastinal large B-cell lymphoma', 'category': 'ORG'}, {'entity': 'follicular lymphoma', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'fluoropyrimidine-', 'category': 'ORG'}, {'entity': 'platinum-containing chemotherapy', 'category': 'ORG'}, {'entity': 'adjuvant treatment', 'category': 'ORG'}, {'entity': 'muscle-invasive urothelial carcinoma', 'category': 'ORG'}, {'entity': 'risk', 'category': 'ORG'}, {'entity': 'recurrence', 'category': 'ORG'}, {'entity': 'radical resection', 'category': 'ORG'}, {'entity': 'combination', 'category': 'ORG'}, {'entity': 'nivolumab', 'category': 'ORG'}, {'entity': 'relatlimab', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'chemotherapy', 'category': 'ORG'}, {'entity': 'NSCLC', 'category': 'ORG'}, {'entity': 'Opdivo+Yervoy\\tMay 2022', 'category': 'ORG'}, {'entity': 'unresectable advanced', 'category': 'ORG'}, {'entity': 'metastatic ESCC', 'category': 'ORG'}, {'entity': 'April 2022', 'category': 'ORG'}, {'entity': 'resectable NSCLC', 'category': 'ORG'}, {'entity': 'urothelial carcinoma', 'category': 'ORG'}, {'entity': 'Abecma', 'category': 'ORG'}, {'entity': 'relapsed', 'category': 'ORG'}, {'entity': 'multiple myeloma', 'category': 'ORG'}, {'entity': 'prior therapies', 'category': 'ORG'}, {'entity': 'Product and Pipeline Developments', 'category': 'ORG'}, {'entity': 'portfolio', 'category': 'ORG'}, {'entity': 'medicines', 'category': 'ORG'}, {'entity': 'patients', 'category': 'ORG'}, {'entity': 'diseases', 'category': 'ORG'}, {'entity': 'oncology', 'category': 'ORG'}, {'entity': 'hematology', 'category': 'ORG'}, {'entity': 'franchise', 'category': 'ORG'}, {'entity': 'multiple myeloma', 'category': 'ORG'}, {'entity': 'immunology', 'category': 'ORG'}, {'entity': 'multiple sclerosis', 'category': 'ORG'}, {'entity': 'psoriasis', 'category': 'ORG'}, {'entity': 'psoriatic arthritis', 'category': 'ORG'}, {'entity': 'lupus', 'category': 'ORG'}, {'entity': 'RA', 'category': 'ORG'}, {'entity': 'inflammatory bowel disease', 'category': 'ORG'}, {'entity': 'cardiovascular disease', 'category': 'ORG'}, {'entity': 'fibrotic disease', 'category': 'ORG'}, {'entity': 'lung', 'category': 'ORG'}, {'entity': 'liver', 'category': 'ORG'}, {'entity': 'neuroscience', 'category': 'ORG'}, {'entity': 'neurodegenerative disease', 'category': 'ORG'}, {'entity': 'next wave', 'category': 'ORG'}, {'entity': 'antithrombotic medicine milvexian', 'category': 'ORG'}, {'entity': 'oncology', 'category': 'ORG'}, {'entity': 'precision oncology asset repotrectinib', 'category': 'ORG'}, {'entity': 'ROS-1 mutated NSCLC', 'category': 'ORG'}, {'entity': 'hematology', 'category': 'ORG'}, {'entity': 'multiple myeloma', 'category': 'ORG'}, {'entity': 'lymphoma', 'category': 'ORG'}, {'entity': 'anemia', 'category': 'ORG'}, {'entity': 'MDS', 'category': 'ORG'}, {'entity': 'MF associated anemia', 'category': 'ORG'}, {'entity': 'immunology', 'category': 'ORG'}, {'entity': 'eosinophilic esophagitis', 'category': 'ORG'}]\n",
      "[{'entity': '2022', 'category': 'DATE'}, {'entity': 'blockbuster potential', 'category': 'EVENT'}, {'entity': 'therapeutic areas', 'category': 'EVENT'}, {'entity': 'melanoma', 'category': 'EVENT'}, {'entity': 'oHCM', 'category': 'EVENT'}, {'entity': 'psoriasis', 'category': 'EVENT'}, {'entity': 'cancer development programs', 'category': 'EVENT'}, {'entity': 'oncology mechanisms', 'category': 'EVENT'}, {'entity': 'treatment options', 'category': 'EVENT'}, {'entity': 'refractory oncology patients', 'category': 'EVENT'}, {'entity': 'melanoma', 'category': 'EVENT'}, {'entity': 'lung', 'category': 'EVENT'}, {'entity': 'liver', 'category': 'EVENT'}, {'entity': 'CRC', 'category': 'EVENT'}, {'entity': 'adjuvant melanoma', 'category': 'EVENT'}, {'entity': 'immunology', 'category': 'EVENT'}, {'entity': 'Phase III registrational clinical trials', 'category': 'EVENT'}, {'entity': 'systemic lupus erythematosus', 'category': 'EVENT'}, {'entity': 'psoriatic arthritis', 'category': 'EVENT'}, {'entity': 'Acquisitions', 'category': 'EVENT'}, {'entity': 'Divestitures', 'category': 'EVENT'}, {'entity': 'Licensing and Other Arrangements', 'category': 'EVENT'}, {'entity': 'significant acquisitions', 'category': 'EVENT'}, {'entity': 'divestitures', 'category': 'EVENT'}, {'entity': 'collaborations', 'category': 'EVENT'}, {'entity': 'licensing', 'category': 'EVENT'}, {'entity': 'Other revenues', 'category': 'EVENT'}, {'entity': 'revenues', 'category': 'EVENT'}, {'entity': 'foreign exchange', 'category': 'EVENT'}, {'entity': 'U.S. revenues', 'category': 'EVENT'}, {'entity': 'net selling prices', 'category': 'EVENT'}, {'entity': 'International revenues', 'category': 'EVENT'}, {'entity': 'demand for Revlimid', 'category': 'EVENT'}, {'entity': 'generic erosion', 'category': 'EVENT'}, {'entity': 'In-Line Products', 'category': 'EVENT'}, {'entity': 'New Product Portfolio', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'EVENT'}, {'entity': 'total revenues', 'category': 'EVENT'}, {'entity': 'seasonal', 'category': 'EVENT'}, {'entity': 'GTN Adjustments', 'category': 'EVENT'}, {'entity': 'Critical Accounting Policies', 'category': 'EVENT'}, {'entity': 'significant category of GTN adjustments', 'category': 'EVENT'}, {'entity': 'Charge-Backs', 'category': 'EVENT'}, {'entity': 'Cash Discounts', 'category': 'EVENT'}, {'entity': 'Medicaid', 'category': 'EVENT'}, {'entity': 'Medicare Rebates', 'category': 'EVENT'}, {'entity': 'Other Rebates', 'category': 'EVENT'}, {'entity': 'Returns', 'category': 'EVENT'}, {'entity': 'Discounts', 'category': 'EVENT'}, {'entity': 'Provision related to sales', 'category': 'EVENT'}, {'entity': 'Payments', 'category': 'EVENT'}, {'entity': 'returns', 'category': 'EVENT'}, {'entity': 'foreign currency translation', 'category': 'EVENT'}, {'entity': 'gross product sales', 'category': 'EVENT'}, {'entity': 'Charge-backs', 'category': 'EVENT'}, {'entity': 'cash discounts', 'category': 'EVENT'}, {'entity': 'Medicaid and Medicare rebates', 'category': 'EVENT'}, {'entity': 'rebates', 'category': 'EVENT'}, {'entity': 'returns', 'category': 'EVENT'}, {'entity': 'Net product sales', 'category': 'EVENT'}, {'entity': 'Reductions to provisions for product sales', 'category': 'EVENT'}, {'entity': 'prior periods', 'category': 'EVENT'}, {'entity': 'changes in estimates', 'category': 'EVENT'}, {'entity': 'Camzyos', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Revlimid', 'category': 'ORG'}, {'entity': 'Pomalyst', 'category': 'ORG'}, {'entity': 'Abraxane', 'category': 'ORG'}, {'entity': 'Yervoy', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'Sotyktu', 'category': 'ORG'}, {'entity': 'Opdualag', 'category': 'ORG'}, {'entity': 'three', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'May 2021', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': 'Eiffel Tower', 'category': 'FAC'}, {'entity': 'Hilton Hotel', 'category': 'FAC'}, {'entity': 'Cupertino', 'category': 'GPE'}, {'entity': 'California', 'category': 'GPE'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'Paris', 'category': 'GPE'}, {'entity': 'Hilton Hotel', 'category': 'GPE'}, {'entity': 'Europe', 'category': 'GPE'}, {'entity': 'UK', 'category': 'GPE'}, {'entity': 'Netherlands', 'category': 'GPE'}, {'entity': 'Europe', 'category': 'LOC'}, {'entity': 'UK', 'category': 'LOC'}, {'entity': 'Netherlands', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'EU', 'category': 'LOC'}, {'entity': 'Japan', 'category': 'LOC'}, {'entity': '$229 million', 'category': 'MONEY'}, {'entity': '$319 million', 'category': 'MONEY'}, {'entity': 'GTN', 'category': 'ORG'}, {'entity': 'VAT', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'Product Revenues', 'category': 'ORG'}, {'entity': 'December 31,2022', 'category': 'ORG'}, {'entity': 'December 31,2021', 'category': 'ORG'}, {'entity': 'In-Line Products', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Pomalyst/Imnovid', 'category': 'ORG'}, {'entity': 'Orencia', 'category': 'ORG'}, {'entity': 'Sprycel', 'category': 'ORG'}, {'entity': 'Yervoy', 'category': 'ORG'}, {'entity': 'Empliciti', 'category': 'ORG'}, {'entity': 'Mature and other products', 'category': 'ORG'}, {'entity': 'New Product Portfolio', 'category': 'ORG'}, {'entity': 'Reblozyl', 'category': 'ORG'}, {'entity': 'Abecma', 'category': 'ORG'}, {'entity': 'Opdualag', 'category': 'ORG'}, {'entity': 'Zeposia', 'category': 'ORG'}, {'entity': 'Breyanzi', 'category': 'ORG'}, {'entity': 'Onureg', 'category': 'ORG'}, {'entity': 'Inrebic', 'category': 'ORG'}, {'entity': 'Camzyos', 'category': 'ORG'}, {'entity': 'Sotyktu', 'category': 'ORG'}, {'entity': 'Recent LOE Products', 'category': 'ORG'}, {'entity': 'Revlimid', 'category': 'ORG'}, {'entity': 'Abraxane', 'category': 'ORG'}, {'entity': 'Total Revenues', 'category': 'ORG'}, {'entity': 'Item 1. Financial Statements', 'category': 'ORG'}, {'entity': 'Note 20. Legal Proceedings and Contingencies', 'category': 'ORG'}, {'entity': 'Opdivo+Yervoy', 'category': 'ORG'}, {'entity': 'Opdivo+Cabometyx*', 'category': 'ORG'}, {'entity': 'Pomalyst/Imnovid', 'category': 'ORG'}, {'entity': '21%', 'category': 'PERCENT'}, {'entity': '7%', 'category': 'PERCENT'}, {'entity': '10%', 'category': 'PERCENT'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': '3%', 'category': 'PERCENT'}, {'entity': '8%', 'category': 'PERCENT'}, {'entity': '5%', 'category': 'PERCENT'}, {'entity': '9%', 'category': 'PERCENT'}, {'entity': '2%', 'category': 'PERCENT'}, {'entity': '19%', 'category': 'PERCENT'}, {'entity': '3%', 'category': 'PERCENT'}, {'entity': '9%', 'category': 'PERCENT'}, {'entity': '11%', 'category': 'PERCENT'}, {'entity': '8%', 'category': 'PERCENT'}, {'entity': '17%', 'category': 'PERCENT'}, {'entity': '10%', 'category': 'PERCENT'}, {'entity': '8%', 'category': 'PERCENT'}, {'entity': '5%', 'category': 'PERCENT'}, {'entity': '30%', 'category': 'PERCENT'}, {'entity': '22%', 'category': 'PERCENT'}, {'entity': '91%', 'category': 'PERCENT'}, {'entity': '**', 'category': 'PERCENT'}, {'entity': '87%', 'category': 'PERCENT'}, {'entity': '79%', 'category': 'PERCENT'}, {'entity': '80%', 'category': 'PERCENT'}, {'entity': '70%', 'category': 'PERCENT'}, {'entity': '38%', 'category': 'PERCENT'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': '80%', 'category': 'PERCENT'}, {'entity': '70%', 'category': 'PERCENT'}, {'entity': '1', 'category': 'PERCENT'}, {'entity': '**', 'category': 'PERCENT'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': '3%', 'category': 'PERCENT'}, {'entity': '9%', 'category': 'PERCENT'}, {'entity': '**', 'category': 'PERCENT'}, {'entity': '17%', 'category': 'PERCENT'}, {'entity': '**', 'category': 'PERCENT'}, {'entity': '22%', 'category': 'PERCENT'}, {'entity': '10%', 'category': 'PERCENT'}, {'entity': '5%', 'category': 'PERCENT'}, {'entity': '**', 'category': 'PERCENT'}, {'entity': '31%', 'category': 'PERCENT'}, {'entity': '35%', 'category': 'PERCENT'}, {'entity': '**', 'category': 'PERCENT'}, {'entity': '9%', 'category': 'PERCENT'}, {'entity': '3%', 'category': 'PERCENT'}, {'entity': '17%', 'category': 'PERCENT'}, {'entity': 'Eliquis', 'category': 'PERSON'}, {'entity': 'Cabometyx', 'category': 'PERSON'}, {'entity': '4', 'category': 'QUANTITY'}, {'entity': '2022', 'category': 'TIME'}, {'entity': '2021', 'category': 'TIME'}, {'entity': '60 days', 'category': 'TIME'}, {'entity': 'Opdivo', 'category': 'WORK_OF_ART'}, {'entity': '46,159', 'category': 'ORDINAL'}, {'entity': '46,385', 'category': 'ORDINAL'}, {'entity': '10', 'category': 'ORDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '2022', 'category': 'CARDINAL'}, {'entity': '2021', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Gleevec*', 'category': 'ORG'}, {'entity': 'Opdivo+Yervoy', 'category': 'ORG'}, {'entity': 'Empliciti', 'category': 'ORG'}, {'entity': 'Reblozyl', 'category': 'ORG'}, {'entity': 'Abecma', 'category': 'ORG'}, {'entity': 'Opdualag', 'category': 'ORG'}, {'entity': 'Zeposia', 'category': 'ORG'}, {'entity': 'Breyanzi', 'category': 'ORG'}, {'entity': 'Onureg', 'category': 'ORG'}, {'entity': 'Inrebic', 'category': 'ORG'}, {'entity': 'Camzyos', 'category': 'ORG'}, {'entity': 'Sotyktu', 'category': 'ORG'}, {'entity': 'Revlimid', 'category': 'ORG'}, {'entity': 'Abraxane', 'category': 'ORG'}]\n",
      "[{'entity': 'December 31, 2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': 'September 30, 2022', 'category': 'DATE'}, {'entity': 'generic competition', 'category': 'EVENT'}, {'entity': 'governmental bidding situations', 'category': 'EVENT'}, {'entity': 'EU', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Retail pharmacies', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'direct customer distribution channel', 'category': 'LOC'}, {'entity': '$10,137', 'category': 'MONEY'}, {'entity': '$9,940', 'category': 'MONEY'}, {'entity': '815', 'category': 'MONEY'}, {'entity': '$1,159', 'category': 'MONEY'}, {'entity': '9,595', 'category': 'MONEY'}, {'entity': '$10,023', 'category': 'MONEY'}, {'entity': 'U.S.', 'category': 'ORG'}, {'entity': 'Lenalidomide REMS', 'category': 'ORG'}, {'entity': 'Pomalyst REMS', 'category': 'ORG'}, {'entity': '2%', 'category': 'PERCENT'}, {'entity': '2%', 'category': 'PERCENT'}, {'entity': '7', 'category': 'PERCENT'}, {'entity': '30', 'category': 'PERCENT'}, {'entity': '4', 'category': 'PERCENT'}, {'entity': '**', 'category': 'PERCENT'}, {'entity': '100%', 'category': 'PERCENT'}, {'entity': 'Eliquis', 'category': 'PERSON'}, {'entity': 'CAR-T cell therapy', 'category': 'PRODUCT'}, {'entity': 'Year Ended December 31', 'category': 'TIME'}, {'entity': 'Form 10-K', 'category': 'WORK_OF_ART'}, {'entity': '2022 Form 10-K', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'one', 'category': 'CARDINAL'}, {'entity': 'one', 'category': 'CARDINAL'}]\n",
      "[{'entity': '2022', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': 'the first quarter of 2026', 'category': 'DATE'}, {'entity': 'the fourth quarter of 2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022.', 'category': 'DATE'}, {'entity': 'Dec 23', 'category': 'DATE'}, {'entity': '2022.', 'category': 'DATE'}, {'entity': 'product launch.', 'category': 'EVENT'}, {'entity': 'Eiffel Tower', 'category': 'FAC'}, {'entity': 'Hilton Hotel.', 'category': 'FAC'}, {'entity': '2022', 'category': 'GPE'}, {'entity': '2021', 'category': 'GPE'}, {'entity': '2022', 'category': 'GPE'}, {'entity': '2022.', 'category': 'GPE'}, {'entity': 'Paris', 'category': 'GPE'}, {'entity': 'United States.', 'category': 'GPE'}, {'entity': 'Cupertino', 'category': 'LOC'}, {'entity': 'California.', 'category': 'LOC'}, {'entity': '$686 million', 'category': 'MONEY'}, {'entity': '$80 million', 'category': 'MONEY'}, {'entity': '$1.5 billion', 'category': 'MONEY'}, {'entity': '$428 million', 'category': 'MONEY'}, {'entity': '$1.3 billion', 'category': 'MONEY'}, {'entity': '2022', 'category': 'MONEY'}, {'entity': '$6.0 billion', 'category': 'MONEY'}, {'entity': '$3.5 billion', 'category': 'MONEY'}, {'entity': '$83 million', 'category': 'MONEY'}, {'entity': '$15 million', 'category': 'MONEY'}, {'entity': '$32 million', 'category': 'MONEY'}, {'entity': '$297 million.', 'category': 'MONEY'}, {'entity': '$1.5 million.', 'category': 'MONEY'}, {'entity': 'IPRD', 'category': 'ORG'}, {'entity': 'Turning Point', 'category': 'ORG'}, {'entity': 'Unvested stock', 'category': 'ORG'}, {'entity': 'Financial Statements and Supplementary Data—Note 15.', 'category': 'ORG'}, {'entity': 'IPRD', 'category': 'ORG'}, {'entity': 'Acquired IPRD', 'category': 'ORG'}, {'entity': 'Item 8', 'category': 'ORG'}, {'entity': 'Financial Statements and Supplementary Data—Note 3', 'category': 'ORG'}, {'entity': 'Item 8', 'category': 'ORG'}, {'entity': 'Financial Statements and Supplementary Data—Note 10', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Item 8', 'category': 'ORG'}, {'entity': 'Financial Statements and Supplementary Data—Note 9', 'category': 'ORG'}, {'entity': 'IPRD', 'category': 'ORG'}, {'entity': 'Amortization', 'category': 'ORG'}, {'entity': 'Item 8', 'category': 'ORG'}, {'entity': 'Financial Statements and Supplementary Data—Note 4', 'category': 'ORG'}, {'entity': 'Item 8', 'category': 'ORG'}, {'entity': 'Financial Statements and Supplementary Data—Note 20', 'category': 'ORG'}, {'entity': 'RG2A2809.', 'category': 'ORG'}, {'entity': 'Celgene', 'category': 'PERSON'}, {'entity': 'Nimbus.', 'category': 'PERSON'}, {'entity': 'Pomalyst', 'category': 'WORK_OF_ART'}, {'entity': 'Abraxane', 'category': 'WORK_OF_ART'}, {'entity': 'Keytruda.', 'category': 'WORK_OF_ART'}, {'entity': 'first.', 'category': 'ORDINAL'}, {'entity': '$686 million', 'category': 'CARDINAL'}, {'entity': '2022', 'category': 'CARDINAL'}, {'entity': '2021', 'category': 'CARDINAL'}, {'entity': '295', 'category': 'CARDINAL'}, {'entity': '200', 'category': 'CARDINAL'}, {'entity': '150', 'category': 'CARDINAL'}, {'entity': '90', 'category': 'CARDINAL'}, {'entity': '80', 'category': 'CARDINAL'}, {'entity': '650', 'category': 'CARDINAL'}, {'entity': '—', 'category': 'CARDINAL'}, {'entity': '220', 'category': 'CARDINAL'}, {'entity': '—', 'category': 'CARDINAL'}, {'entity': '58', 'category': 'CARDINAL'}, {'entity': '80', 'category': 'CARDINAL'}, {'entity': '151', 'category': 'CARDINAL'}, {'entity': '815', 'category': 'CARDINAL'}, {'entity': '1,159', 'category': 'CARDINAL'}, {'entity': '428', 'category': 'CARDINAL'}, {'entity': '576', 'category': 'CARDINAL'}, {'entity': '1.3 billion', 'category': 'CARDINAL'}, {'entity': '1,232', 'category': 'CARDINAL'}, {'entity': '1,334', 'category': 'CARDINAL'}, {'entity': '1,283', 'category': 'CARDINAL'}, {'entity': '1,067', 'category': 'CARDINAL'}, {'entity': '832', 'category': 'CARDINAL'}, {'entity': '666', 'category': 'CARDINAL'}, {'entity': '801', 'category': 'CARDINAL'}, {'entity': '745', 'category': 'CARDINAL'}, {'entity': '440', 'category': 'CARDINAL'}, {'entity': '564', 'category': 'CARDINAL'}, {'entity': '266', 'category': 'CARDINAL'}, {'entity': '281', 'category': 'CARDINAL'}, {'entity': '—', 'category': 'CARDINAL'}, {'entity': '9', 'category': 'CARDINAL'}, {'entity': '178', 'category': 'CARDINAL'}, {'entity': '82', 'category': 'CARDINAL'}, {'entity': '—', 'category': 'CARDINAL'}, {'entity': '39', 'category': 'CARDINAL'}, {'entity': '75', 'category': 'CARDINAL'}, {'entity': '169', 'category': 'CARDINAL'}, {'entity': '—', 'category': 'CARDINAL'}, {'entity': '542', 'category': 'CARDINAL'}, {'entity': '90', 'category': 'CARDINAL'}, {'entity': '82', 'category': 'CARDINAL'}, {'entity': '576', 'category': 'CARDINAL'}, {'entity': '720', 'category': 'CARDINAL'}, {'entity': '295', 'category': 'CARDINAL'}, {'entity': '200', 'category': 'CARDINAL'}, {'entity': '150', 'category': 'CARDINAL'}, {'entity': '90', 'category': 'CARDINAL'}, {'entity': '80', 'category': 'CARDINAL'}, {'entity': '650', 'category': 'CARDINAL'}, {'entity': '815', 'category': 'CARDINAL'}, {'entity': '1,159.', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2.', 'category': 'CARDINAL'}]\n",
      "[{'entity': '8', 'category': 'CARDINAL'}, {'entity': '603', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '120', 'category': 'CARDINAL'}, {'entity': '983', 'category': 'CARDINAL'}, {'entity': '1763', 'category': 'CARDINAL'}, {'entity': '68', 'category': 'CARDINAL'}, {'entity': '75', 'category': 'CARDINAL'}, {'entity': '169', 'category': 'CARDINAL'}, {'entity': '564', 'category': 'CARDINAL'}, {'entity': '9', 'category': 'CARDINAL'}, {'entity': '127', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Board of Directors', 'category': 'ORG'}, {'entity': '$1.9 billion', 'category': 'CARDINAL'}, {'entity': '2022', 'category': 'CARDINAL'}, {'entity': '2022', 'category': 'CARDINAL'}, {'entity': '2021', 'category': 'CARDINAL'}, {'entity': '10.6 billion', 'category': 'CARDINAL'}, {'entity': '2026', 'category': 'CARDINAL'}, {'entity': '$2.5 billion', 'category': 'CARDINAL'}, {'entity': '$12.6 billion', 'category': 'CARDINAL'}, {'entity': '$3.3 billion', 'category': 'CARDINAL'}, {'entity': '$13.1 billion', 'category': 'CARDINAL'}, {'entity': '109 million', 'category': 'CARDINAL'}, {'entity': '$8.0 billion', 'category': 'CARDINAL'}, {'entity': '69 million', 'category': 'CARDINAL'}, {'entity': '$5.0 billion', 'category': 'CARDINAL'}, {'entity': '$7.2 billion', 'category': 'CARDINAL'}, {'entity': '$4.6 billion', 'category': 'CARDINAL'}, {'entity': '$4.4 billion', 'category': 'CARDINAL'}, {'entity': '0.54', 'category': 'CARDINAL'}, {'entity': '$5.0 billion', 'category': 'CARDINAL'}, {'entity': '$6.0 billion', 'category': 'CARDINAL'}, {'entity': '$6.0 billion', 'category': 'CARDINAL'}, {'entity': '$4.8 billion', 'category': 'CARDINAL'}, {'entity': '$5.0 billion', 'category': 'CARDINAL'}, {'entity': '5', 'category': 'CARDINAL'}, {'entity': '366 days', 'category': 'CARDINAL'}, {'entity': '$1.1 billion', 'category': 'CARDINAL'}, {'entity': '$970 million', 'category': 'CARDINAL'}, {'entity': '$750 million', 'category': 'CARDINAL'}, {'entity': '$1.2 billion', 'category': 'CARDINAL'}, {'entity': '$22.0 billion', 'category': 'CARDINAL'}, {'entity': '$7.5 billion', 'category': 'CARDINAL'}, {'entity': 'Phase III', 'category': 'CARDINAL'}, {'entity': '$14.5 billion', 'category': 'CARDINAL'}, {'entity': '$17.5 billion', 'category': 'CARDINAL'}, {'entity': 'Stable', 'category': 'CARDINAL'}, {'entity': 'Moody’s Investors Service', 'category': 'CARDINAL'}, {'entity': 'A2', 'category': 'CARDINAL'}, {'entity': 'Prime-1', 'category': 'CARDINAL'}, {'entity': 'Standard & Poor’s', 'category': 'CARDINAL'}, {'entity': 'A+', 'category': 'CARDINAL'}, {'entity': 'A-1', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'September 30, 2004', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': 'Turning Point', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '$3.1 billion', 'category': 'MONEY'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'Form 10-Q', 'category': 'ORG'}, {'entity': 'approximately one month', 'category': 'PERCENT'}, {'entity': 'Exhibit 10', 'category': 'PERSON'}, {'entity': 'Cash Flows', 'category': 'WORK_OF_ART'}, {'entity': 'Operating Activities', 'category': 'WORK_OF_ART'}, {'entity': 'Acquired IPRD', 'category': 'WORK_OF_ART'}, {'entity': 'Stock', 'category': 'WORK_OF_ART'}, {'entity': 'Budget', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '$13,066', 'category': 'CARDINAL'}, {'entity': '16,207', 'category': 'CARDINAL'}, {'entity': '1,062', 'category': 'CARDINAL'}, {'entity': '538', 'category': 'CARDINAL'}, {'entity': '16,962', 'category': 'CARDINAL'}, {'entity': '16,224', 'category': 'CARDINAL'}, {'entity': '3.1 billion', 'category': 'CARDINAL'}, {'entity': '300 million', 'category': 'CARDINAL'}, {'entity': '250 million', 'category': 'CARDINAL'}, {'entity': '524 million', 'category': 'CARDINAL'}, {'entity': '3.2 billion', 'category': 'CARDINAL'}, {'entity': '2.4 billion', 'category': 'CARDINAL'}, {'entity': '4.1 billion', 'category': 'CARDINAL'}, {'entity': '646 million', 'category': 'CARDINAL'}, {'entity': '557 million', 'category': 'CARDINAL'}, {'entity': '738 million', 'category': 'CARDINAL'}, {'entity': '1.7 billion', 'category': 'CARDINAL'}, {'entity': '871 million', 'category': 'CARDINAL'}, {'entity': '100%', 'category': 'CARDINAL'}, {'entity': '78%', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Standards.', 'category': 'ORG'}, {'entity': 'U.S. Department of Defense', 'category': 'ORG'}, {'entity': 'U.S. Department of Veterans Affairs', 'category': 'ORG'}, {'entity': 'Medicaid', 'category': 'ORG'}, {'entity': 'Medicare', 'category': 'ORG'}, {'entity': 'CMS', 'category': 'ORG'}, {'entity': 'U.S.', 'category': 'ORG'}, {'entity': '2%', 'category': 'PERCENT'}, {'entity': '70%', 'category': 'PERCENT'}, {'entity': 'Medicaid rebate', 'category': 'PRODUCT'}, {'entity': 'Medicare Part D drug benefit', 'category': 'PRODUCT'}, {'entity': 'within one month', 'category': 'TIME'}, {'entity': '55', 'category': 'CARDINAL'}]\n",
      "[{'entity': '2022', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '56', 'category': 'DATE'}, {'entity': 'Eiffel Tower', 'category': 'FAC'}, {'entity': 'Hilton Hotel', 'category': 'FAC'}, {'entity': 'Cupertino', 'category': 'GPE'}, {'entity': 'California', 'category': 'GPE'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'Paris', 'category': 'LOC'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': 'MyoKardia', 'category': 'ORG'}, {'entity': 'Apple', 'category': 'ORG'}, {'entity': 'Mead Johnson', 'category': 'PERSON'}, {'entity': '15%', 'category': 'QUANTITY'}, {'entity': '5PM', 'category': 'TIME'}, {'entity': '7PM', 'category': 'TIME'}, {'entity': 'Turning Point', 'category': 'WORK_OF_ART'}, {'entity': 'Shakespeare', 'category': 'WORK_OF_ART'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '101', 'category': 'CARDINAL'}, {'entity': '1.2 billion', 'category': 'CARDINAL'}, {'entity': '1.1 billion', 'category': 'CARDINAL'}, {'entity': '4.1 billion', 'category': 'CARDINAL'}, {'entity': '873 million', 'category': 'CARDINAL'}, {'entity': '2.7 billion', 'category': 'CARDINAL'}, {'entity': '709 million', 'category': 'CARDINAL'}, {'entity': '382', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'April 2022', 'category': 'DATE'}, {'entity': 'April 2022', 'category': 'DATE'}, {'entity': 'February 2, 2023', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2023', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2023', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': 'exchange offer', 'category': 'EVENT'}, {'entity': 'transaction', 'category': 'EVENT'}, {'entity': 'transactions', 'category': 'EVENT'}, {'entity': 'ownership', 'category': 'EVENT'}, {'entity': 'stock ownership', 'category': 'EVENT'}, {'entity': 'exchange offer', 'category': 'EVENT'}, {'entity': 'sale', 'category': 'EVENT'}, {'entity': 'restructuring', 'category': 'EVENT'}, {'entity': 'initial public offering', 'category': 'EVENT'}, {'entity': 'transactions', 'category': 'EVENT'}, {'entity': 'breach', 'category': 'EVENT'}, {'entity': 'transactions', 'category': 'EVENT'}, {'entity': 'stock', 'category': 'EVENT'}, {'entity': 'assets', 'category': 'EVENT'}, {'entity': 'tax sharing agreement', 'category': 'EVENT'}, {'entity': 'creation', 'category': 'EVENT'}, {'entity': 'transaction', 'category': 'EVENT'}, {'entity': 'assessment', 'category': 'EVENT'}, {'entity': 'tax authorities', 'category': 'EVENT'}, {'entity': 'tax exposures', 'category': 'EVENT'}, {'entity': 'tax credits', 'category': 'EVENT'}, {'entity': 'expenses', 'category': 'EVENT'}, {'entity': 'provision', 'category': 'EVENT'}, {'entity': 'taxes', 'category': 'EVENT'}, {'entity': 'income taxes', 'category': 'EVENT'}, {'entity': 'taxes', 'category': 'EVENT'}, {'entity': 'income taxes', 'category': 'EVENT'}, {'entity': 'taxes', 'category': 'EVENT'}, {'entity': 'tax matters', 'category': 'EVENT'}, {'entity': 'taxes', 'category': 'EVENT'}, {'entity': 'accurals', 'category': 'EVENT'}, {'entity': 'contingencies', 'category': 'EVENT'}, {'entity': 'legal proceedings', 'category': 'EVENT'}, {'entity': 'claims', 'category': 'EVENT'}, {'entity': 'government investigations', 'category': 'EVENT'}, {'entity': 'shareholder lawsuits', 'category': 'EVENT'}, {'entity': 'product liability', 'category': 'EVENT'}, {'entity': 'environmental liability', 'category': 'EVENT'}, {'entity': 'contracts', 'category': 'EVENT'}, {'entity': 'tax matters', 'category': 'EVENT'}, {'entity': 'contingencies', 'category': 'EVENT'}, {'entity': 'contingencies', 'category': 'EVENT'}, {'entity': 'contingencies', 'category': 'EVENT'}, {'entity': 'contingencies', 'category': 'EVENT'}, {'entity': 'contingencies', 'category': 'EVENT'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'IOWA', 'category': 'LOC'}, {'entity': '$244 million', 'category': 'MONEY'}, {'entity': 'Internal Revenue Service', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'CheckMate -274', 'category': 'ORG'}, {'entity': 'ONO-4538-33', 'category': 'ORG'}, {'entity': 'CheckMate-274 ONO-4538-33', 'category': 'ORG'}, {'entity': 'ONO-4538-33', 'category': 'ORG'}, {'entity': 'Phase III CheckMate-274', 'category': 'ORG'}, {'entity': 'CheckMate-274', 'category': 'ORG'}, {'entity': 'CheckMate-648', 'category': 'ORG'}, {'entity': 'ONO-4538-50/CA209648', 'category': 'ORG'}, {'entity': 'CheckMate -648', 'category': 'ORG'}, {'entity': 'Phase III CheckMate -648', 'category': 'ORG'}, {'entity': 'Phase III CheckMate -648', 'category': 'ORG'}, {'entity': 'PIVOT IO-001', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Phase III PIVOT IO-001', 'category': 'ORG'}, {'entity': '40%', 'category': 'PERCENT'}, {'entity': '58%', 'category': 'PERCENT'}, {'entity': 'Mead Johnson', 'category': 'PERSON'}, {'entity': 'Mead Johnson', 'category': 'PERSON'}, {'entity': 'Mead Johnson', 'category': 'PERSON'}, {'entity': 'Mead Johnson', 'category': 'PERSON'}, {'entity': 'Mead Johnson', 'category': 'PERSON'}, {'entity': 'Mead Johnson', 'category': 'PERSON'}, {'entity': 'Mead Johnson', 'category': 'PERSON'}, {'entity': 'Mead Johnson', 'category': 'PERSON'}, {'entity': 'Mead Johnson', 'category': 'PERSON'}, {'entity': 'Mead Johnson', 'category': 'PERSON'}, {'entity': 'Mead Johnson', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'fluoropyrimidine', 'category': 'PRODUCT'}, {'entity': 'platinum- containing chemotherapy', 'category': 'PRODUCT'}, {'entity': 'CheckMate -274', 'category': 'PRODUCT'}, {'entity': 'muscile-invasive urothelial carcinoma', 'category': 'PRODUCT'}, {'entity': 'Phase III', 'category': 'PRODUCT'}, {'entity': 'unresectable advanced or metastatic ESCC', 'category': 'PRODUCT'}, {'entity': 'PD-L1 expression', 'category': 'PRODUCT'}, {'entity': 'CheckMate -648', 'category': 'PRODUCT'}, {'entity': 'unresectable advanced or metastatic ESCC', 'category': 'PRODUCT'}, {'entity': 'CheckMate -648', 'category': 'PRODUCT'}, {'entity': 'CheckMate -648', 'category': 'PRODUCT'}, {'entity': 'CheckMate -648', 'category': 'PRODUCT'}, {'entity': 'CheckMate -76K', 'category': 'PRODUCT'}, {'entity': 'stage IIB or IIC melanoma', 'category': 'PRODUCT'}, {'entity': 'recurrence-free survival', 'category': 'PRODUCT'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'Announced', 'category': 'TIME'}, {'entity': 'tri', 'category': 'TIME'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'late-stage', 'category': 'ORDINAL'}, {'entity': 'Phase III', 'category': 'ORDINAL'}]\n",
      "[{'entity': 'April 2022', 'category': 'DATE'}, {'entity': 'Dec 23, 2022', 'category': 'DATE'}, {'entity': 'April 2022', 'category': 'DATE'}, {'entity': 'March 2022', 'category': 'DATE'}, {'entity': 'March 2022', 'category': 'DATE'}, {'entity': 'April 2022', 'category': 'DATE'}, {'entity': 'February 2022', 'category': 'DATE'}, {'entity': 'July 2022', 'category': 'DATE'}, {'entity': 'June 2022', 'category': 'DATE'}, {'entity': 'June 2022', 'category': 'DATE'}, {'entity': 'May 2022', 'category': 'DATE'}, {'entity': 'May 2022', 'category': 'DATE'}, {'entity': 'May 2022', 'category': 'DATE'}, {'entity': 'April 2022', 'category': 'DATE'}, {'entity': 'June 2022', 'category': 'DATE'}, {'entity': 'January 2023', 'category': 'DATE'}, {'entity': 'June 2022', 'category': 'DATE'}, {'entity': 'progression-free survival PFS', 'category': 'EVENT'}, {'entity': 'objective response rate ORR', 'category': 'EVENT'}, {'entity': 'overall survival OS', 'category': 'EVENT'}, {'entity': 'Opdivo in combination with chemotherapy', 'category': 'EVENT'}, {'entity': 'neoadjuvant treatment', 'category': 'EVENT'}, {'entity': 'manufacturing and marketing approval', 'category': 'EVENT'}, {'entity': 'resectable NSCLC', 'category': 'EVENT'}, {'entity': 'disease recurrence', 'category': 'EVENT'}, {'entity': 'disease-free survival', 'category': 'EVENT'}, {'entity': 'metastatic NSCLC', 'category': 'EVENT'}, {'entity': 'urothelial carcinoma', 'category': 'EVENT'}, {'entity': 'ESCC', 'category': 'EVENT'}, {'entity': 'Accelerating COVID-19 Therapeutic Interventions and Vaccines ACTIV-1 immune modulators clinical trial sponsored by the National Institutes of Health', 'category': 'EVENT'}, {'entity': 'time to recovery', 'category': 'EVENT'}, {'entity': 'Reblozyl as a treatment for adult patients with anemia associated with non-transfusion-dependent NTD beta thalassemia', 'category': 'EVENT'}, {'entity': 'sBLA for Reblozyl for the treatment of anemia in adults with non-transfusion dependent beta thalassemia', 'category': 'EVENT'}, {'entity': 'progression-free survival PFS', 'category': 'ORG'}, {'entity': 'objective response rate ORR', 'category': 'ORG'}, {'entity': 'overall survival OS', 'category': 'ORG'}, {'entity': 'bempegaldesleukin in combination with Opdivo', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'DMC', 'category': 'ORG'}, {'entity': 'collaboration with Nektar', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Nektar', 'category': 'ORG'}, {'entity': 'Phase III CheckMate -816 study', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'EMA', 'category': 'ORG'}, {'entity': 'Phase III CheckMate-9ER trial', 'category': 'ORG'}, {'entity': 'Opdivo plus Yervoy', 'category': 'ORG'}, {'entity': 'Phase III CheckMate -914 trial', 'category': 'ORG'}, {'entity': 'Opdivo plus platinum-doublet chemotherapy', 'category': 'ORG'}, {'entity': 'five-year follow up results from Part I of the Phase III CheckMate -227 trial', 'category': 'ORG'}, {'entity': 'three-year follow up results from the Phase III CheckMate -9LA trial', 'category': 'ORG'}, {'entity': 'Phase III CheckMate -901 trial', 'category': 'ORG'}, {'entity': 'Opdivo plus Yervoy', 'category': 'ORG'}, {'entity': 'Phase III CheckMate -648 trial', 'category': 'ORG'}, {'entity': 'EC approval of Opdivo plus Yervoy', 'category': 'ORG'}, {'entity': 'Orencia', 'category': 'ORG'}, {'entity': 'Phase III Accelerating COVID-19 Therapeutic Interventions and Vaccines ACTIV-1 immune modulators clinical trial sponsored by the National Institutes of Health', 'category': 'ORG'}, {'entity': 'Reblozyl', 'category': 'ORG'}, {'entity': 'Committee for Medicinal Product for Human Use CHMP of the European Medicines Agency EMA', 'category': 'ORG'}, {'entity': 'Mary', 'category': 'PERSON'}, {'entity': 'Shakespeare', 'category': 'PERSON'}, {'entity': 'Peter', 'category': 'PERSON'}, {'entity': 'Lisa', 'category': 'PERSON'}]\n",
      "[{'entity': 'October 2022', 'category': 'DATE'}, {'entity': 'Phase II BEYOND trial', 'category': 'DATE'}, {'entity': 'Phase III COMMANDS trial', 'category': 'DATE'}, {'entity': 'August 2022', 'category': 'DATE'}, {'entity': 'Phase III KarMMa-3 trial', 'category': 'DATE'}, {'entity': 'January 2022', 'category': 'DATE'}, {'entity': 'Phase II BB2121-MM-001', 'category': 'DATE'}, {'entity': 'Phase I CRB-401 trials', 'category': 'DATE'}, {'entity': 'Phase III DAYBREAK', 'category': 'DATE'}, {'entity': 'Phase III True North study', 'category': 'DATE'}, {'entity': '52', 'category': 'DATE'}, {'entity': '61', 'category': 'DATE'}, {'entity': 'Developments', 'category': 'DATE'}, {'entity': 'January 2023', 'category': 'DATE'}, {'entity': 'Phase II portion', 'category': 'DATE'}, {'entity': 'TRANSCEND CLL 004', 'category': 'DATE'}, {'entity': 'June 2022', 'category': 'DATE'}, {'entity': 'April 2022', 'category': 'DATE'}, {'entity': 'transplantation', 'category': 'DATE'}, {'entity': 'September 2022', 'category': 'DATE'}, {'entity': 'March 2022', 'category': 'DATE'}, {'entity': 'June 16', 'category': 'DATE'}, {'entity': '2023', 'category': 'DATE'}, {'entity': 'first-line', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'second-line treatment', 'category': 'GPE'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'Reblozyl', 'category': 'ORG'}, {'entity': 'MDS', 'category': 'ORG'}, {'entity': 'adult patients', 'category': 'ORG'}, {'entity': 'Beyonce', 'category': 'ORG'}, {'entity': 'Ministry of Health', 'category': 'ORG'}, {'entity': 'Labour and Welfare', 'category': 'ORG'}, {'entity': 'MS', 'category': 'ORG'}, {'entity': 'UC', 'category': 'ORG'}, {'entity': 'Zeposia', 'category': 'ORG'}, {'entity': 'EMA', 'category': 'ORG'}, {'entity': 'Melanoma', 'category': 'ORG'}, {'entity': 'EC', 'category': 'ORG'}, {'entity': 'Obstructive HCM', 'category': 'ORG'}, {'entity': 'EXPLORER-HCM trial', 'category': 'ORG'}, {'entity': 'MAVA-LTE trial', 'category': 'ORG'}, {'entity': 'Abecma', 'category': 'PRODUCT'}, {'entity': 'Multiple Myeloma', 'category': 'PRODUCT'}, {'entity': 'Zeposia', 'category': 'PRODUCT'}, {'entity': 'daybreak', 'category': 'PRODUCT'}, {'entity': 'Indication', 'category': 'PRODUCT'}, {'entity': 'Breyanzi', 'category': 'PRODUCT'}, {'entity': 'Lymphoma', 'category': 'PRODUCT'}, {'entity': 'Opdualag', 'category': 'PRODUCT'}, {'entity': 'Camzyos', 'category': 'PRODUCT'}, {'entity': 'EXPLORER-LTE cohort', 'category': 'PRODUCT'}, {'entity': 'very low-', 'category': 'ORDINAL'}, {'entity': 'low-', 'category': 'ORDINAL'}, {'entity': 'intermediate-risk', 'category': 'ORDINAL'}, {'entity': 'red blood cell', 'category': 'ORDINAL'}, {'entity': 'transfusion independence', 'category': 'ORDINAL'}, {'entity': 'concurrent hemoglobin increase', 'category': 'ORDINAL'}, {'entity': 'open-label', 'category': 'ORDINAL'}, {'entity': 'extension trial', 'category': 'ORDINAL'}, {'entity': 'relapsing', 'category': 'ORDINAL'}, {'entity': 'MS', 'category': 'ORDINAL'}, {'entity': 'COVID-19', 'category': 'ORDINAL'}, {'entity': 'Phases', 'category': 'ORDINAL'}, {'entity': 'Five', 'category': 'ORDINAL'}, {'entity': 'interferon beta-1a', 'category': 'ORDINAL'}, {'entity': 'annualized rate of brain volume loss', 'category': 'ORDINAL'}, {'entity': 'continuous Zeposia treatment', 'category': 'ORDINAL'}, {'entity': 'up to one year', 'category': 'ORDINAL'}, {'entity': 'treatment interruption', 'category': 'ORDINAL'}, {'entity': 'Phase I/II', 'category': 'ORDINAL'}, {'entity': 'single-arm', 'category': 'ORDINAL'}, {'entity': 'multicenter', 'category': 'ORDINAL'}, {'entity': 'second-line treatment', 'category': 'ORDINAL'}, {'entity': 'adult patients', 'category': 'ORDINAL'}, {'entity': 'large B-cell lymphoma', 'category': 'ORDINAL'}, {'entity': 'diffuse large B-cell lymphoma', 'category': 'ORDINAL'}, {'entity': 'not otherwise specified high-grade B-cell lymphoma', 'category': 'ORDINAL'}, {'entity': 'primary mediastinal large B-cell lymphoma', 'category': 'ORDINAL'}, {'entity': 'follicular lymphoma grade 3B', 'category': 'ORDINAL'}, {'entity': 'refractory disease', 'category': 'ORDINAL'}, {'entity': 'first-line chemoimmunotherapy', 'category': 'ORDINAL'}, {'entity': 'relapse within 12 months', 'category': 'ORDINAL'}, {'entity': 'hematopoietic stem cell transplant', 'category': 'ORDINAL'}, {'entity': 'high grade B-cell lymphoma', 'category': 'ORDINAL'}, {'entity': 'Phase III TRANSFORM study', 'category': 'ORDINAL'}, {'entity': 'first-line treatment', 'category': 'ORDINAL'}, {'entity': 'advanced unresectable', 'category': 'ORDINAL'}, {'entity': 'metastatic melanoma', 'category': 'ORDINAL'}, {'entity': 'adults', 'category': 'ORDINAL'}, {'entity': 'adolescents 12 years of age', 'category': 'ORDINAL'}, {'entity': 'tumor cell PD-L1 expression', 'category': 'ORDINAL'}, {'entity': 'Phase II/III RELATIVITY -047 trial', 'category': 'ORDINAL'}, {'entity': 'resectable or metastatic melanoma', 'category': 'ORDINAL'}, {'entity': 'adult and pediatric patients', 'category': 'ORDINAL'}, {'entity': 'Phase II/III RELATIVITY-047 trial', 'category': 'ORDINAL'}, {'entity': 'expanded indication', 'category': 'ORDINAL'}, {'entity': 'symptomatic', 'category': 'ORDINAL'}, {'entity': 'New York Heart Association class II-III', 'category': 'ORDINAL'}, {'entity': 'interim results', 'category': 'ORDINAL'}, {'entity': 'cardiovascular function', 'category': 'ORDINAL'}, {'entity': 'patient', 'category': 'ORDINAL'}]\n",
      "[{'entity': 'January 2023', 'category': 'DATE'}, {'entity': 'September 2022', 'category': 'DATE'}, {'entity': 'June 2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': 'December 31, 2022', 'category': 'DATE'}, {'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': 'approval', 'category': 'EVENT'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'EC', 'category': 'GPE'}, {'entity': 'FDA', 'category': 'GPE'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'CHMP', 'category': 'ORG'}, {'entity': 'EMA', 'category': 'ORG'}, {'entity': 'Sotyktu', 'category': 'PRODUCT'}, {'entity': '2', 'category': 'QUANTITY'}, {'entity': '10%', 'category': 'QUANTITY'}, {'entity': '10%', 'category': 'QUANTITY'}, {'entity': 'POETYK PSO-1', 'category': 'WORK_OF_ART'}, {'entity': 'POETYK PSO-2', 'category': 'WORK_OF_ART'}, {'entity': 'POETYK PSO', 'category': 'WORK_OF_ART'}]\n",
      "[{'entity': 'ecognition', 'category': 'DATE'}, {'entity': 'ecember 31', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': 'ecember 31', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '15 million', 'category': 'MONEY'}, {'entity': 'tem 8', 'category': 'ORG'}, {'entity': '73 million', 'category': 'PERCENT'}, {'entity': '$58 million.', 'category': 'PERCENT'}, {'entity': 'irst', 'category': 'ORDINAL'}, {'entity': '022', 'category': 'CARDINAL'}, {'entity': '$2.6 billion', 'category': 'CARDINAL'}, {'entity': '$3.8 billion', 'category': 'CARDINAL'}, {'entity': '%', 'category': 'CARDINAL'}, {'entity': 'oss', 'category': 'CARDINAL'}]\n",
      "/Users/tanmayiballa/Desktop/KG-LLM/l715_23-1/data/10-Ks/Bristol-Myers_Squibb_Company/2015/Management_gpt-3.5-turbo_NER_response.json\n",
      "[{'entity': '2014', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': 'diabetes business divestiture', 'category': 'EVENT'}, {'entity': 'certain key events', 'category': 'EVENT'}, {'entity': 'Opdivo', 'category': 'EVENT'}, {'entity': 'other studies', 'category': 'EVENT'}, {'entity': 'clinical collaborations', 'category': 'EVENT'}, {'entity': 'label extension', 'category': 'EVENT'}, {'entity': 'regulatory approvals', 'category': 'EVENT'}, {'entity': 'business development transactions', 'category': 'EVENT'}, {'entity': 'reductions resulting from the expiration of certain rights pertaining to Abilify*', 'category': 'EVENT'}, {'entity': 'royalty and alliance agreements', 'category': 'EVENT'}, {'entity': 'exclusivity losses for Baraclude', 'category': 'EVENT'}, {'entity': 'changes in foreign currency rates', 'category': 'EVENT'}, {'entity': 'Eliquis', 'category': 'FAC'}, {'entity': 'Daklinza', 'category': 'FAC'}, {'entity': 'Sunvepra', 'category': 'FAC'}, {'entity': 'Opdivo', 'category': 'FAC'}, {'entity': 'Hilton Hotel', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'EU', 'category': 'GPE'}, {'entity': 'Devens', 'category': 'GPE'}, {'entity': 'Massachusetts', 'category': 'GPE'}, {'entity': 'Ireland', 'category': 'GPE'}, {'entity': '$1.3 billion', 'category': 'MONEY'}, {'entity': 'Bristol-Myers Squibb', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'the Company', 'category': 'ORG'}, {'entity': 'Bristol-Myers Squibb Company', 'category': 'PERSON'}, {'entity': '$1.7 billion', 'category': 'QUANTITY'}, {'entity': '2014', 'category': 'TIME'}, {'entity': '2015', 'category': 'TIME'}, {'entity': 'Opdivo', 'category': 'WORK_OF_ART'}, {'entity': 'Eliquis', 'category': 'WORK_OF_ART'}, {'entity': 'Sprycel', 'category': 'WORK_OF_ART'}, {'entity': 'Hamlet', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '3%', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '36%', 'category': 'CARDINAL'}, {'entity': '$628 million', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '$348 million', 'category': 'CARDINAL'}, {'entity': '$256 million', 'category': 'CARDINAL'}, {'entity': '15,879', 'category': 'CARDINAL'}, {'entity': '16,385', 'category': 'CARDINAL'}, {'entity': '17,621', 'category': 'CARDINAL'}, {'entity': '13,498', 'category': 'CARDINAL'}, {'entity': '13,494', 'category': 'CARDINAL'}, {'entity': '15,281', 'category': 'CARDINAL'}, {'entity': '2,381', 'category': 'CARDINAL'}, {'entity': '2,891', 'category': 'CARDINAL'}, {'entity': '2,340', 'category': 'CARDINAL'}, {'entity': '352', 'category': 'CARDINAL'}, {'entity': '311', 'category': 'CARDINAL'}, {'entity': '161', 'category': 'CARDINAL'}, {'entity': '14.8%', 'category': 'CARDINAL'}, {'entity': '10.8%', 'category': 'CARDINAL'}, {'entity': '6.9%', 'category': 'CARDINAL'}, {'entity': '2,004', 'category': 'CARDINAL'}, {'entity': '2,563', 'category': 'CARDINAL'}, {'entity': '1,960', 'category': 'CARDINAL'}, {'entity': '3,085', 'category': 'CARDINAL'}, {'entity': '3,019', 'category': 'CARDINAL'}, {'entity': '3,364', 'category': 'CARDINAL'}, {'entity': '1.20', 'category': 'CARDINAL'}, {'entity': '1.54', 'category': 'CARDINAL'}, {'entity': '1.16', 'category': 'CARDINAL'}, {'entity': '1.85', 'category': 'CARDINAL'}, {'entity': '1.82', 'category': 'CARDINAL'}, {'entity': '1.99', 'category': 'CARDINAL'}, {'entity': '11,843', 'category': 'CARDINAL'}, {'entity': '8,272', 'category': 'CARDINAL'}, {'entity': '6,352', 'category': 'CARDINAL'}, {'entity': '$3.5 billion', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 2014', 'category': 'DATE'}, {'entity': 'November 2014', 'category': 'DATE'}, {'entity': 'September 2014', 'category': 'DATE'}, {'entity': 'anti-cancer treatment', 'category': 'EVENT'}, {'entity': 'EMA', 'category': 'ORG'}, {'entity': 'Ono', 'category': 'ORG'}, {'entity': 'CHMP', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'PD-1', 'category': 'PERSON'}, {'entity': 'third', 'category': 'ORDINAL'}, {'entity': 'Frame III', 'category': 'ORDINAL'}, {'entity': 'Phase III', 'category': 'ORDINAL'}, {'entity': 'overall survival', 'category': 'ORDINAL'}, {'entity': 'OS', 'category': 'ORDINAL'}, {'entity': 'DTIC', 'category': 'ORDINAL'}, {'entity': 'ICC', 'category': 'ORDINAL'}, {'entity': 'Phase II', 'category': 'ORDINAL'}, {'entity': 'Phase Ib', 'category': 'ORDINAL'}, {'entity': 'Study-004', 'category': 'ORDINAL'}, {'entity': 'Study-003', 'category': 'ORDINAL'}, {'entity': 'dose cohorts', 'category': 'ORDINAL'}, {'entity': 'Study-063', 'category': 'ORDINAL'}, {'entity': 'IRC', 'category': 'ORDINAL'}, {'entity': 'RECIST 1.1', 'category': 'ORDINAL'}, {'entity': 'Phase1b', 'category': 'ORDINAL'}, {'entity': 'Phase 1b', 'category': 'ORDINAL'}, {'entity': 'Phase 1b', 'category': 'ORDINAL'}]\n",
      "[{'entity': 'April 2014', 'category': 'DATE'}, {'entity': 'December 2014', 'category': 'DATE'}, {'entity': 'May 2014', 'category': 'DATE'}, {'entity': 'February 2015', 'category': 'DATE'}, {'entity': 'November 2014', 'category': 'DATE'}, {'entity': 'August 2014', 'category': 'DATE'}, {'entity': 'July 2014', 'category': 'DATE'}, {'entity': 'January 2015', 'category': 'DATE'}, {'entity': 'Eiffel Tower', 'category': 'FAC'}, {'entity': 'Hilton Hotel', 'category': 'FAC'}, {'entity': 'Cupertino', 'category': 'LOC'}, {'entity': 'California', 'category': 'LOC'}, {'entity': 'Paris', 'category': 'LOC'}, {'entity': 'United States', 'category': 'LOC'}, {'entity': 'Daklinza', 'category': 'LOC'}, {'entity': 'Sunvepra', 'category': 'LOC'}, {'entity': 'Japan', 'category': 'LOC'}, {'entity': '1.5 million', 'category': 'MONEY'}, {'entity': 'CheckMate-012', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'CheckMate-012', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'CheckMate-039', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'UNITY Trial', 'category': 'ORG'}, {'entity': 'DCV-TRIO', 'category': 'ORG'}, {'entity': 'DAKlinza', 'category': 'ORG'}, {'entity': 'SOF', 'category': 'ORG'}, {'entity': 'DCV', 'category': 'ORG'}, {'entity': 'ASV', 'category': 'ORG'}, {'entity': 'DAKlinza', 'category': 'ORG'}, {'entity': 'Sunvepra', 'category': 'ORG'}, {'entity': 'DAKlinza', 'category': 'ORG'}, {'entity': 'Sunvepra', 'category': 'ORG'}, {'entity': 'Daklinza', 'category': 'ORG'}, {'entity': 'Sunvepra', 'category': 'ORG'}, {'entity': 'elotuzumab', 'category': 'ORG'}, {'entity': 'AbbVie', 'category': 'ORG'}, {'entity': 'AbbVie', 'category': 'ORG'}, {'entity': 'elotuzumab', 'category': 'ORG'}, {'entity': 'Reyataz', 'category': 'ORG'}, {'entity': 'Evotaz', 'category': 'ORG'}, {'entity': 'Reyataz', 'category': 'ORG'}, {'entity': 'Evotaz', 'category': 'ORG'}, {'entity': 'Evotaz', 'category': 'ORG'}, {'entity': 'Gilead', 'category': 'ORG'}, {'entity': 'Evotaz', 'category': 'ORG'}, {'entity': 'Gilead', 'category': 'ORG'}, {'entity': 'AbbVie', 'category': 'ORG'}, {'entity': '50%', 'category': 'PERCENT'}, {'entity': '0%', 'category': 'PERCENT'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': '20-22%', 'category': 'PERCENT'}, {'entity': '63-72%', 'category': 'PERCENT'}, {'entity': '43-48%', 'category': 'PERCENT'}, {'entity': '64-65%', 'category': 'PERCENT'}, {'entity': '90%', 'category': 'PERCENT'}, {'entity': '86%', 'category': 'PERCENT'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': '12-week', 'category': 'QUANTITY'}, {'entity': '12 or 24 weeks', 'category': 'QUANTITY'}, {'entity': '5PM', 'category': 'TIME'}, {'entity': '7PM', 'category': 'TIME'}, {'entity': '12', 'category': 'TIME'}, {'entity': '24 weeks', 'category': 'TIME'}, {'entity': '12 or 24 weeks', 'category': 'TIME'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '168', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'FDA', 'category': 'ORG'}, {'entity': 'Reyataz', 'category': 'ORG'}, {'entity': 'Tybost', 'category': 'ORG'}, {'entity': 'Sustiva', 'category': 'ORG'}, {'entity': 'HIV', 'category': 'ORG'}, {'entity': 'Atripla', 'category': 'ORG'}, {'entity': 'Gilead', 'category': 'ORG'}, {'entity': 'Yervoy', 'category': 'ORG'}, {'entity': 'ipilimumab', 'category': 'ORG'}, {'entity': 'melanoma', 'category': 'ORG'}, {'entity': 'Orencia', 'category': 'ORG'}, {'entity': 'abatacept', 'category': 'ORG'}, {'entity': 'RA', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'apixaban', 'category': 'ORG'}, {'entity': 'Pfizer', 'category': 'ORG'}, {'entity': 'Portola Pharmaceuticals', 'category': 'ORG'}, {'entity': 'ANNEXA', 'category': 'ORG'}, {'entity': 'Andexanet Alfa', 'category': 'ORG'}, {'entity': 'fXA Inhibitors', 'category': 'ORG'}, {'entity': 'AMPlIFY-EXT', 'category': 'ORG'}, {'entity': 'EMANATE', 'category': 'ORG'}, {'entity': 'ARISTOTLE', 'category': 'ORG'}]\n",
      "[{'entity': '2014', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': 'Europe', 'category': 'GPE'}, {'entity': 'Rest of the World', 'category': 'LOC'}, {'entity': '$15,879', 'category': 'MONEY'}, {'entity': '$16,385', 'category': 'MONEY'}, {'entity': '$17,621', 'category': 'MONEY'}, {'entity': 'Alliances', 'category': 'ORG'}, {'entity': '7%', 'category': 'PERCENT'}, {'entity': '10%', 'category': 'PERCENT'}, {'entity': '3%', 'category': 'PERCENT'}, {'entity': '20%', 'category': 'PERCENT'}, {'entity': '19%', 'category': 'PERCENT'}, {'entity': '1%', 'category': 'PERCENT'}, {'entity': 'Eliquis', 'category': 'PERSON'}, {'entity': 'Yervoy', 'category': 'PERSON'}, {'entity': 'Sprycel', 'category': 'PERSON'}, {'entity': 'Abilify', 'category': 'PERSON'}, {'entity': 'Plavix', 'category': 'PERSON'}, {'entity': 'Avalide', 'category': 'PERSON'}, {'entity': 'Amylin', 'category': 'PERSON'}, {'entity': 'Sanofi', 'category': 'PERSON'}, {'entity': 'products', 'category': 'PRODUCT'}, {'entity': '2014', 'category': 'TIME'}, {'entity': '2013', 'category': 'TIME'}, {'entity': 'generic competition', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '10,384', 'category': 'CARDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '19', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}]\n",
      "[{'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '147', 'category': 'CARDINAL'}, {'entity': '86', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2015', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '1223', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '201', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'Lilly', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Ono', 'category': 'ORG'}, {'entity': 'Sprycel', 'category': 'ORG'}, {'entity': 'Otsuka Pharmaceutical Co.', 'category': 'ORG'}, {'entity': 'Gleevec*', 'category': 'ORG'}, {'entity': 'Yervoy', 'category': 'ORG'}, {'entity': 'Abilify*', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'Pfizer', 'category': 'ORG'}, {'entity': 'Diabetes Alliance', 'category': 'ORG'}, {'entity': 'AstraZeneca', 'category': 'ORG'}, {'entity': 'Bydureon*', 'category': 'ORG'}, {'entity': 'Byetta*', 'category': 'ORG'}, {'entity': 'Farxiga*', 'category': 'ORG'}, {'entity': 'Onglyza*/Kombiglyze*', 'category': 'ORG'}, {'entity': 'Myalept*', 'category': 'ORG'}, {'entity': 'Symlin*', 'category': 'ORG'}, {'entity': 'Plavix*', 'category': 'ORG'}, {'entity': 'Avapro*/Avalide*', 'category': 'ORG'}, {'entity': 'Sanofi', 'category': 'ORG'}, {'entity': 'Reyataz', 'category': 'ORG'}, {'entity': 'Efferalgan.', 'category': 'ORG'}]\n",
      "[{'entity': 'December 31', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': 'diabetes business divestiture', 'category': 'EVENT'}, {'entity': 'Amylin acquisition', 'category': 'EVENT'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'Form 10-K', 'category': 'ORG'}, {'entity': 'IRS', 'category': 'ORG'}, {'entity': 'Affordable Care Act', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'PRODUCT'}, {'entity': 'Pfizer', 'category': 'PRODUCT'}, {'entity': 'Amylin', 'category': 'PRODUCT'}, {'entity': 'Plavix', 'category': 'PRODUCT'}, {'entity': 'Avapro', 'category': 'PRODUCT'}, {'entity': 'Avalide', 'category': 'PRODUCT'}, {'entity': 'Yervoy', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Hepatitis C Franchise', 'category': 'PRODUCT'}, {'entity': 'third quarter', 'category': 'TIME'}, {'entity': '', 'category': 'WORK_OF_ART'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '24', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '24', 'category': 'CARDINAL'}, {'entity': '28', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '27', 'category': 'CARDINAL'}, {'entity': '500', 'category': 'CARDINAL'}, {'entity': '67', 'category': 'CARDINAL'}, {'entity': '96', 'category': 'CARDINAL'}]\n",
      "[{'entity': '2014', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': 'December 31, 2014', 'category': 'DATE'}, {'entity': 'specialty care transformation initiatives', 'category': 'EVENT'}, {'entity': 'iPierian', 'category': 'EVENT'}, {'entity': 'diabetes business divestiture', 'category': 'EVENT'}, {'entity': 'restructuring', 'category': 'EVENT'}, {'entity': 'Europe', 'category': 'FAC'}, {'entity': 'Ireland', 'category': 'GPE'}, {'entity': 'Puerto Rico', 'category': 'GPE'}, {'entity': '$2.3 billion', 'category': 'MONEY'}, {'entity': '$2.2 billion', 'category': 'MONEY'}, {'entity': '$1.9 billion', 'category': 'MONEY'}, {'entity': '$100 million', 'category': 'MONEY'}, {'entity': '$343 million', 'category': 'MONEY'}, {'entity': '$148 million', 'category': 'MONEY'}, {'entity': 'Inhibitex', 'category': 'ORG'}, {'entity': 'amylin acquisition', 'category': 'ORG'}, {'entity': 'Prudential', 'category': 'ORG'}, {'entity': 'Medarex and ZymoGenetics Inc', 'category': 'ORG'}, {'entity': 'Sanofi', 'category': 'ORG'}, {'entity': 'BMS-986094', 'category': 'ORG'}, {'entity': 'IPRD', 'category': 'ORG'}, {'entity': 'peginterferon lambda', 'category': 'ORG'}, {'entity': 'HCV', 'category': 'ORG'}, {'entity': 'Apotex', 'category': 'ORG'}, {'entity': 'Plavix', 'category': 'ORG'}, {'entity': '14.8%', 'category': 'PERCENT'}, {'entity': '10.8%', 'category': 'PERCENT'}, {'entity': '6.9%', 'category': 'PERCENT'}, {'entity': 'manufacturing operations', 'category': 'PERSON'}, {'entity': 'Amylin', 'category': 'PERSON'}, {'entity': 'Prudential', 'category': 'PERSON'}, {'entity': 'Plavix*', 'category': 'PRODUCT'}, {'entity': '713 million', 'category': 'QUANTITY'}, {'entity': 'December 2014', 'category': 'TIME'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'annually', 'category': 'ORDINAL'}, {'entity': '2.3 billion', 'category': 'CARDINAL'}, {'entity': '2.2 billion', 'category': 'CARDINAL'}, {'entity': '1.9 billion', 'category': 'CARDINAL'}, {'entity': '343 million', 'category': 'CARDINAL'}, {'entity': '310 million', 'category': 'CARDINAL'}, {'entity': '1.8 billion', 'category': 'CARDINAL'}, {'entity': '142 million', 'category': 'CARDINAL'}, {'entity': '27 million', 'category': 'CARDINAL'}, {'entity': '47 million', 'category': 'CARDINAL'}, {'entity': '343 million', 'category': 'CARDINAL'}, {'entity': '148 million', 'category': 'CARDINAL'}, {'entity': '130 million', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '$343 million', 'category': 'CARDINAL'}, {'entity': '$310 million', 'category': 'CARDINAL'}, {'entity': '$148 million', 'category': 'CARDINAL'}, {'entity': '$130 million', 'category': 'CARDINAL'}, {'entity': '$1.8 billion', 'category': 'CARDINAL'}, {'entity': '$142 million', 'category': 'CARDINAL'}, {'entity': '$27 million', 'category': 'CARDINAL'}, {'entity': '$47 million', 'category': 'CARDINAL'}]\n",
      "[{'entity': '2013', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': 'Item 8. Financial Statements—Note 8. Income Taxes', 'category': 'EVENT'}, {'entity': 'Americas', 'category': 'GPE'}, {'entity': 'U.S', 'category': 'GPE'}, {'entity': 'low-tax jurisdictions', 'category': 'GPE'}, {'entity': '$392 million', 'category': 'MONEY'}, {'entity': '16.7 percentage points', 'category': 'MONEY'}, {'entity': '$1,830 million', 'category': 'MONEY'}, {'entity': '$1', 'category': 'MONEY'}, {'entity': '830 million', 'category': 'MONEY'}, {'entity': '$151 million', 'category': 'MONEY'}, {'entity': '$36 million', 'category': 'MONEY'}, {'entity': '$147', 'category': 'MONEY'}, {'entity': '$549 million', 'category': 'MONEY'}, {'entity': '$229', 'category': 'MONEY'}, {'entity': '$273 million', 'category': 'MONEY'}, {'entity': '$114', 'category': 'MONEY'}, {'entity': '$14', 'category': 'MONEY'}, {'entity': '$23', 'category': 'MONEY'}, {'entity': '$325 million', 'category': 'MONEY'}, {'entity': '$285', 'category': 'MONEY'}, {'entity': '$16', 'category': 'MONEY'}, {'entity': '$67', 'category': 'MONEY'}, {'entity': '$16', 'category': 'MONEY'}, {'entity': '$47', 'category': 'MONEY'}, {'entity': '$16', 'category': 'MONEY'}, {'entity': '$216', 'category': 'MONEY'}, {'entity': '$626 million', 'category': 'MONEY'}, {'entity': '$340 million', 'category': 'MONEY'}, {'entity': '$327', 'category': 'MONEY'}, {'entity': '$5,571 million', 'category': 'MONEY'}, {'entity': '$3,586 million', 'category': 'MONEY'}, {'entity': '$1,864 million', 'category': 'MONEY'}, {'entity': '$939 million', 'category': 'MONEY'}, {'entity': '$4,408 million', 'category': 'MONEY'}, {'entity': '$3,747 million', 'category': 'MONEY'}, {'entity': '$11,843 million', 'category': 'MONEY'}, {'entity': '$590 million', 'category': 'MONEY'}, {'entity': '$359 million', 'category': 'MONEY'}, {'entity': '$7,242 million', 'category': 'MONEY'}, {'entity': '$7,981 million', 'category': 'MONEY'}, {'entity': '$4,011 million', 'category': 'MONEY'}, {'entity': '$68 million', 'category': 'MONEY'}, {'entity': '$2.5 billion', 'category': 'MONEY'}, {'entity': 'Inhibitex', 'category': 'ORG'}, {'entity': 'BMS-986094', 'category': 'ORG'}, {'entity': 'Plavix*', 'category': 'ORG'}, {'entity': 'Avapro*/Avalide*', 'category': 'ORG'}, {'entity': 'BMS-986094', 'category': 'ORG'}, {'entity': 'BMS-986094', 'category': 'ORG'}, {'entity': 'Amylin', 'category': 'ORG'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': '$1.20', 'category': 'PERCENT'}, {'entity': '$1.54', 'category': 'PERCENT'}, {'entity': '$1.16', 'category': 'PERCENT'}, {'entity': '0.65', 'category': 'PERCENT'}, {'entity': '0.28', 'category': 'PERCENT'}, {'entity': '0.83', 'category': 'PERCENT'}, {'entity': 'Plavix*', 'category': 'PERSON'}, {'entity': 'Avapro*/Avalide*', 'category': 'PERSON'}, {'entity': 'Sanofi', 'category': 'PERSON'}, {'entity': 'Amylin', 'category': 'PERSON'}, {'entity': 'BMS-986094', 'category': 'PERSON'}, {'entity': '$38', 'category': 'QUANTITY'}, {'entity': '2014', 'category': 'QUANTITY'}, {'entity': '2013', 'category': 'QUANTITY'}, {'entity': '2012', 'category': 'QUANTITY'}, {'entity': '9', 'category': 'QUANTITY'}, {'entity': '1', 'category': 'QUANTITY'}, {'entity': '14', 'category': 'QUANTITY'}, {'entity': '47', 'category': 'QUANTITY'}, {'entity': '37', 'category': 'QUANTITY'}, {'entity': '858', 'category': 'QUANTITY'}, {'entity': '25', 'category': 'QUANTITY'}, {'entity': '17', 'category': 'QUANTITY'}, {'entity': '541', 'category': 'QUANTITY'}, {'entity': '$16 million', 'category': 'QUANTITY'}, {'entity': '$96 million', 'category': 'QUANTITY'}, {'entity': '$16 million', 'category': 'QUANTITY'}, {'entity': '$343 million', 'category': 'QUANTITY'}, {'entity': '$142', 'category': 'QUANTITY'}, {'entity': '$163 million', 'category': 'QUANTITY'}, {'entity': '$226 million', 'category': 'QUANTITY'}, {'entity': '$174', 'category': 'QUANTITY'}, {'entity': '559 million', 'category': 'QUANTITY'}, {'entity': '$51', 'category': 'QUANTITY'}, {'entity': '$877 million', 'category': 'QUANTITY'}, {'entity': '$161 million', 'category': 'QUANTITY'}, {'entity': '$151', 'category': 'QUANTITY'}, {'entity': '$72 million', 'category': 'QUANTITY'}, {'entity': '$10 million', 'category': 'QUANTITY'}, {'entity': '$14 million', 'category': 'QUANTITY'}, {'entity': '$10', 'category': 'QUANTITY'}, {'entity': '$545 million', 'category': 'QUANTITY'}, {'entity': '$242 million', 'category': 'QUANTITY'}, {'entity': '$947', 'category': 'QUANTITY'}, {'entity': '$123 million', 'category': 'QUANTITY'}, {'entity': '$392', 'category': 'QUANTITY'}, {'entity': '$422 million', 'category': 'QUANTITY'}, {'entity': '$242 million', 'category': 'QUANTITY'}, {'entity': '$1,339', 'category': 'QUANTITY'}, {'entity': '1,670', 'category': 'QUANTITY'}, {'entity': '1,662', 'category': 'QUANTITY'}, {'entity': '1,688', 'category': 'QUANTITY'}, {'entity': '$1.85', 'category': 'QUANTITY'}, {'entity': '$1.82', 'category': 'QUANTITY'}, {'entity': '$1.99', 'category': 'QUANTITY'}, {'entity': 'May 2012', 'category': 'TIME'}, {'entity': 'March 2012', 'category': 'TIME'}, {'entity': 'Branded Prescription Drug Fee', 'category': 'WORK_OF_ART'}, {'entity': 'BMS-986094', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '192', 'category': 'CARDINAL'}, {'entity': '3,085', 'category': 'CARDINAL'}, {'entity': '3,019', 'category': 'CARDINAL'}, {'entity': '3,364', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'two', 'category': 'CARDINAL'}, {'entity': 'each of the past three years', 'category': 'CARDINAL'}, {'entity': 'approximately $1.0 billion', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '$3.8 billion', 'category': 'CARDINAL'}, {'entity': '582 million', 'category': 'CARDINAL'}, {'entity': 'December 31, 2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2019', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': '$1.5 billion', 'category': 'CARDINAL'}, {'entity': 'December 31, 2014', 'category': 'CARDINAL'}, {'entity': 'December 31, 2013', 'category': 'CARDINAL'}, {'entity': '$454 million', 'category': 'CARDINAL'}, {'entity': '$509 million', 'category': 'CARDINAL'}, {'entity': '$322 million', 'category': 'CARDINAL'}, {'entity': '$358 million', 'category': 'CARDINAL'}, {'entity': '$522 million', 'category': 'CARDINAL'}, {'entity': '$634 million', 'category': 'CARDINAL'}, {'entity': 'Dollars in Millions', 'category': 'CARDINAL'}, {'entity': '1,560', 'category': 'CARDINAL'}, {'entity': '1,498', 'category': 'CARDINAL'}, {'entity': '2,487', 'category': 'CARDINAL'}, {'entity': '2,559', 'category': 'CARDINAL'}, {'entity': '1,173', 'category': 'CARDINAL'}, {'entity': '629', 'category': 'CARDINAL'}, {'entity': 'Moody’s Investors Service', 'category': 'CARDINAL'}, {'entity': 'A2', 'category': 'CARDINAL'}, {'entity': 'Prime-1', 'category': 'CARDINAL'}, {'entity': 'Standard & Poor’s', 'category': 'CARDINAL'}, {'entity': 'A+', 'category': 'CARDINAL'}, {'entity': 'A-1+', 'category': 'CARDINAL'}, {'entity': 'F2', 'category': 'CARDINAL'}, {'entity': 'December 2014', 'category': 'CARDINAL'}, {'entity': 'A-', 'category': 'CARDINAL'}, {'entity': 'A-1+', 'category': 'CARDINAL'}, {'entity': 'Operating activities', 'category': 'CARDINAL'}, {'entity': '3,148', 'category': 'CARDINAL'}, {'entity': '3,545', 'category': 'CARDINAL'}, {'entity': '6,941', 'category': 'CARDINAL'}, {'entity': 'Investing activities', 'category': 'CARDINAL'}, {'entity': '1,216', 'category': 'CARDINAL'}, {'entity': '572', 'category': 'CARDINAL'}, {'entity': '6,727', 'category': 'CARDINAL'}, {'entity': 'Financing activities', 'category': 'CARDINAL'}, {'entity': '2,437', 'category': 'CARDINAL'}, {'entity': '1,068', 'category': 'CARDINAL'}, {'entity': '4,333', 'category': 'CARDINAL'}, {'entity': 'The $397 million', 'category': 'CARDINAL'}, {'entity': 'approximately $600 million', 'category': 'CARDINAL'}, {'entity': 'Reckitt alliance proceeds of $485 million', 'category': 'CARDINAL'}, {'entity': 'Additional net working capital requirements of $400 million', 'category': 'CARDINAL'}, {'entity': 'The $3.4 billion', 'category': 'CARDINAL'}, {'entity': 'approximately $2.7 billion', 'category': 'CARDINAL'}, {'entity': 'Amylin alliance proceeds of $3.6 billion', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'August 4, 2004', 'category': 'DATE'}, {'entity': 'September 30, 2004', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': 'business acquisitions', 'category': 'EVENT'}, {'entity': 'manufacturing', 'category': 'EVENT'}, {'entity': 'facility-related capital expenditures', 'category': 'EVENT'}, {'entity': 'marketable securities', 'category': 'EVENT'}, {'entity': 'business divestitures', 'category': 'EVENT'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': '$1.4 billion', 'category': 'MONEY'}, {'entity': '$433 million', 'category': 'MONEY'}, {'entity': '$1.3 billion', 'category': 'MONEY'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'iPierian', 'category': 'ORG'}, {'entity': 'iPierian', 'category': 'ORG'}, {'entity': 'Financing Activities', 'category': 'ORG'}, {'entity': 'Financing Activities', 'category': 'ORG'}, {'entity': 'Financing Activities', 'category': 'ORG'}, {'entity': 'Financing Activities', 'category': 'ORG'}, {'entity': 'Financing Activities', 'category': 'ORG'}, {'entity': 'Financing Activities', 'category': 'ORG'}, {'entity': 'Amylin', 'category': 'ORG'}, {'entity': 'Inhibitex', 'category': 'ORG'}, {'entity': 'Financing Activities', 'category': 'ORG'}, {'entity': 'Item 8. Financial Statements', 'category': 'ORG'}, {'entity': 'Note 3. Alliances', 'category': 'ORG'}, {'entity': 'December 31', 'category': 'ORG'}, {'entity': '2014', 'category': 'ORG'}, {'entity': 'Alliances', 'category': 'ORG'}, {'entity': '100%', 'category': 'PERCENT'}, {'entity': 'Diabetes', 'category': 'PERSON'}, {'entity': 'Amylin', 'category': 'PERSON'}, {'entity': 'Inhibitex', 'category': 'PERSON'}, {'entity': 'Amylin', 'category': 'PERSON'}, {'entity': 'Amylin', 'category': 'PERSON'}, {'entity': 'stock', 'category': 'PERSON'}, {'entity': '90 days', 'category': 'QUANTITY'}, {'entity': '2014', 'category': 'QUANTITY'}, {'entity': '2014', 'category': 'QUANTITY'}, {'entity': '2014', 'category': 'QUANTITY'}, {'entity': '2014', 'category': 'QUANTITY'}, {'entity': '2013', 'category': 'QUANTITY'}, {'entity': '2013', 'category': 'QUANTITY'}, {'entity': '2014', 'category': 'QUANTITY'}, {'entity': '2013', 'category': 'QUANTITY'}, {'entity': '2014', 'category': 'QUANTITY'}, {'entity': '2013', 'category': 'QUANTITY'}, {'entity': '2013', 'category': 'QUANTITY'}, {'entity': '2012', 'category': 'QUANTITY'}, {'entity': '$1.1 billion', 'category': 'QUANTITY'}, {'entity': '892 million', 'category': 'QUANTITY'}, {'entity': '$158 million', 'category': 'QUANTITY'}, {'entity': '$564 million', 'category': 'QUANTITY'}, {'entity': '$463 million', 'category': 'QUANTITY'}, {'entity': '8th', 'category': 'ORDINAL'}, {'entity': '$700 million', 'category': 'CARDINAL'}, {'entity': '$1.8 billion', 'category': 'CARDINAL'}, {'entity': '3.5 billion', 'category': 'CARDINAL'}, {'entity': '$1.6 billion', 'category': 'CARDINAL'}, {'entity': '$175 million', 'category': 'CARDINAL'}, {'entity': '$6.2 billion', 'category': 'CARDINAL'}, {'entity': '5.0 billion', 'category': 'CARDINAL'}, {'entity': '$2.5 billion', 'category': 'CARDINAL'}, {'entity': '$1.3 billion', 'category': 'CARDINAL'}, {'entity': '$1.4 billion', 'category': 'CARDINAL'}, {'entity': '$1.6 billion', 'category': 'CARDINAL'}, {'entity': '$676 million', 'category': 'CARDINAL'}, {'entity': '$892 million', 'category': 'CARDINAL'}, {'entity': '$288 million', 'category': 'CARDINAL'}, {'entity': '$564 million', 'category': 'CARDINAL'}, {'entity': '$433 million', 'category': 'CARDINAL'}, {'entity': '$3.3 billion', 'category': 'CARDINAL'}, {'entity': '$2.0 billion', 'category': 'CARDINAL'}, {'entity': '$158 million', 'category': 'CARDINAL'}, {'entity': '$1.1 billion', 'category': 'CARDINAL'}, {'entity': '$158 million', 'category': 'CARDINAL'}, {'entity': '$1.2 billion', 'category': 'CARDINAL'}, {'entity': '$3.3 billion', 'category': 'CARDINAL'}, {'entity': '$2.0 billion', 'category': 'CARDINAL'}, {'entity': '$433 million', 'category': 'CARDINAL'}, {'entity': '$2.4 billion', 'category': 'CARDINAL'}, {'entity': '$1.3 billion', 'category': 'CARDINAL'}, {'entity': '$2013 billion', 'category': 'CARDINAL'}, {'entity': '$158 million', 'category': 'CARDINAL'}, {'entity': '$893 million', 'category': 'CARDINAL'}, {'entity': '$564 million', 'category': 'CARDINAL'}, {'entity': '$463 million', 'category': 'CARDINAL'}, {'entity': '$3.8 billion', 'category': 'CARDINAL'}, {'entity': '$900 million', 'category': 'CARDINAL'}, {'entity': '$2.9 billion', 'category': 'CARDINAL'}, {'entity': '$1.2 billion', 'category': 'CARDINAL'}, {'entity': '$16', 'category': 'CARDINAL'}, {'entity': '122', 'category': 'CARDINAL'}, {'entity': '$1.7 billion', 'category': 'CARDINAL'}, {'entity': '$1.6 billion', 'category': 'CARDINAL'}, {'entity': '$1.5 billion', 'category': 'CARDINAL'}, {'entity': '$661 million', 'category': 'CARDINAL'}, {'entity': '$1.1 billion', 'category': 'CARDINAL'}, {'entity': '$2.0 billion', 'category': 'CARDINAL'}, {'entity': '$2.4 billion', 'category': 'CARDINAL'}, {'entity': '$564 million', 'category': 'CARDINAL'}, {'entity': '$463 million', 'category': 'CARDINAL'}, {'entity': '$2013 billion', 'category': 'CARDINAL'}]\n",
      "[{'entity': '2015', 'category': 'DATE'}, {'entity': 'one month', 'category': 'DATE'}, {'entity': 'six months', 'category': 'DATE'}, {'entity': 'twelve months', 'category': 'DATE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '$300 million', 'category': 'MONEY'}, {'entity': 'IMAs', 'category': 'ORG'}, {'entity': 'U.S.', 'category': 'ORG'}, {'entity': 'EU', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Medicare', 'category': 'ORG'}, {'entity': '90%', 'category': 'CARDINAL'}, {'entity': '340B', 'category': 'CARDINAL'}, {'entity': '2 to four', 'category': 'CARDINAL'}, {'entity': '2%', 'category': 'CARDINAL'}, {'entity': 'D', 'category': 'CARDINAL'}, {'entity': '67 million', 'category': 'CARDINAL'}, {'entity': '2011', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '24 million', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '85 million', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '37 million', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '$1.5 million', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': 'Hilton', 'category': 'GPE'}, {'entity': 'Cupertino', 'category': 'GPE'}, {'entity': 'Paris', 'category': 'GPE'}, {'entity': 'California', 'category': 'GPE'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'Sarah', 'category': 'GPE'}, {'entity': '15%', 'category': 'MONEY'}, {'entity': '$86 million', 'category': 'MONEY'}, {'entity': '$147 million', 'category': 'MONEY'}, {'entity': 'Earnings', 'category': 'ORG'}, {'entity': 'Plavix', 'category': 'ORG'}, {'entity': 'Avapro*/Avalide*', 'category': 'ORG'}, {'entity': 'Plavix*', 'category': 'ORG'}, {'entity': 'Apollo', 'category': 'ORG'}, {'entity': 'Apple', 'category': 'ORG'}, {'entity': 'Eiffel Tower', 'category': 'ORG'}, {'entity': 'Avalide*', 'category': 'ORG'}, {'entity': 'Competitive Products', 'category': 'ORG'}, {'entity': 'Hilton Hotel', 'category': 'ORG'}, {'entity': '$1.5 million', 'category': 'PERCENT'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': 'Plavix', 'category': 'PERSON'}, {'entity': 'Mary', 'category': 'PERSON'}, {'entity': 'Peter', 'category': 'PERSON'}, {'entity': 'Lisa', 'category': 'PERSON'}, {'entity': 'Shakespeare', 'category': 'PERSON'}, {'entity': 'Austin', 'category': 'PERSON'}, {'entity': 'Hamlet', 'category': 'PERSON'}, {'entity': 'Lisa', 'category': 'PERSON'}, {'entity': '3', 'category': 'QUANTITY'}, {'entity': '7PM', 'category': 'TIME'}, {'entity': '5PM', 'category': 'TIME'}, {'entity': 'Hamlet', 'category': 'WORK_OF_ART'}, {'entity': '2012', 'category': 'ORDINAL'}, {'entity': '86', 'category': 'ORDINAL'}, {'entity': '2014', 'category': 'ORDINAL'}, {'entity': '2013', 'category': 'ORDINAL'}, {'entity': '147', 'category': 'ORDINAL'}, {'entity': '15', 'category': 'ORDINAL'}, {'entity': 'Dec', 'category': 'ORDINAL'}, {'entity': '5', 'category': 'ORDINAL'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '2', 'category': 'ORDINAL'}, {'entity': '3', 'category': 'ORDINAL'}, {'entity': 'December 31', 'category': 'ORDINAL'}, {'entity': '2014', 'category': 'ORDINAL'}, {'entity': 'Product', 'category': 'ORDINAL'}, {'entity': 'Price', 'category': 'ORDINAL'}, {'entity': 'Generic Products', 'category': 'ORDINAL'}, {'entity': 'Competitive New Products', 'category': 'ORDINAL'}, {'entity': 'Loss of Exclusivity', 'category': 'ORDINAL'}, {'entity': '$86 million', 'category': 'ORDINAL'}, {'entity': '$147 million', 'category': 'ORDINAL'}, {'entity': '15%', 'category': 'ORDINAL'}, {'entity': '2', 'category': 'ORDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '23', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'Dec 23', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': 'acquisition', 'category': 'EVENT'}, {'entity': 'divestiture', 'category': 'EVENT'}, {'entity': 'sale', 'category': 'EVENT'}, {'entity': 'business combination', 'category': 'EVENT'}, {'entity': 'valuing', 'category': 'EVENT'}, {'entity': 'transaction', 'category': 'EVENT'}, {'entity': 'iPierian', 'category': 'FAC'}, {'entity': 'AstraZeneca', 'category': 'FAC'}, {'entity': 'Cupertino', 'category': 'GPE'}, {'entity': 'California', 'category': 'GPE'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'Paris', 'category': 'GPE'}, {'entity': 'BMS-986094', 'category': 'LOC'}, {'entity': 'Myalept', 'category': 'LOC'}, {'entity': '$148 million', 'category': 'MONEY'}, {'entity': '$550 million', 'category': 'MONEY'}, {'entity': '$600 million', 'category': 'MONEY'}, {'entity': '15%', 'category': 'MONEY'}, {'entity': 'Apple', 'category': 'ORG'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': 'Mary', 'category': 'PERSON'}, {'entity': 'Shakespeare', 'category': 'PERSON'}, {'entity': 'Peter', 'category': 'PERSON'}, {'entity': 'Lisa', 'category': 'PERSON'}, {'entity': 'Hamlet', 'category': 'PRODUCT'}, {'entity': '3', 'category': 'QUANTITY'}, {'entity': '2', 'category': 'QUANTITY'}, {'entity': '5PM', 'category': 'TIME'}, {'entity': '7PM', 'category': 'TIME'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '148', 'category': 'CARDINAL'}, {'entity': '550', 'category': 'CARDINAL'}, {'entity': '600', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '15', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '$310 million', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': 'HCV', 'category': 'GPE'}, {'entity': 'Goodwill', 'category': 'ORG'}, {'entity': 'December', 'category': 'ORG'}, {'entity': 'Phase III', 'category': 'ORG'}, {'entity': '$1.8 billion', 'category': 'QUANTITY'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'th', 'category': 'ORDINAL'}, {'entity': 'at least annually', 'category': 'CARDINAL'}, {'entity': '$2.1 billion', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '$120 million', 'category': 'CARDINAL'}, {'entity': '$36 million', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '$147 million', 'category': 'CARDINAL'}, {'entity': '$151 million', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '$3.8 billion', 'category': 'CARDINAL'}, {'entity': '$4.3 billion', 'category': 'CARDINAL'}, {'entity': '$4.8 billion', 'category': 'CARDINAL'}, {'entity': '$135 million', 'category': 'CARDINAL'}, {'entity': '$26 million', 'category': 'CARDINAL'}, {'entity': '$562 million', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2009', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2008', 'category': 'DATE'}, {'entity': '1933', 'category': 'DATE'}, {'entity': '1934', 'category': 'DATE'}, {'entity': 'Mead Johnson Nutrition Company', 'category': 'ORG'}, {'entity': 'Mead Johnson', 'category': 'ORG'}, {'entity': 'Internal Revenue Service', 'category': 'ORG'}, {'entity': 'financial statements', 'category': 'ORG'}, {'entity': 'Form 10-K', 'category': 'ORG'}, {'entity': 'four', 'category': 'ORDINAL'}, {'entity': 'two', 'category': 'ORDINAL'}, {'entity': '$436 million', 'category': 'CARDINAL'}, {'entity': 'three years', 'category': 'CARDINAL'}, {'entity': 'five years', 'category': 'CARDINAL'}, {'entity': 'i an internal spin-off of Mead Johnson shares while still owned by us', 'category': 'CARDINAL'}, {'entity': 'ii conversion of Mead Johnson Class B shares to Class A shares', 'category': 'CARDINAL'}, {'entity': 'iii conversion of Mead Johnson & Company to a limited liability company', 'category': 'CARDINAL'}, {'entity': '50%', 'category': 'CARDINAL'}, {'entity': '$244 million', 'category': 'CARDINAL'}, {'entity': '2009', 'category': 'CARDINAL'}, {'entity': '$123 million', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': 'hedging', 'category': 'EVENT'}, {'entity': 'Canada', 'category': 'GPE'}, {'entity': 'China', 'category': 'GPE'}, {'entity': 'South Korean', 'category': 'GPE'}, {'entity': '$130 million', 'category': 'MONEY'}, {'entity': '$85 million', 'category': 'MONEY'}, {'entity': 'U.S. dollar', 'category': 'ORG'}, {'entity': '10%', 'category': 'PERCENT'}, {'entity': '100', 'category': 'PERCENT'}, {'entity': 'Roy', 'category': 'PERSON'}, {'entity': '100', 'category': 'QUANTITY'}, {'entity': 'Item 8', 'category': 'WORK_OF_ART'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '123', 'category': 'CARDINAL'}, {'entity': '130', 'category': 'CARDINAL'}, {'entity': '31', 'category': 'CARDINAL'}, {'entity': '634', 'category': 'CARDINAL'}, {'entity': '85', 'category': 'CARDINAL'}]\n",
      "/Users/tanmayiballa/Desktop/KG-LLM/l715_23-1/data/10-Ks/Bristol-Myers_Squibb_Company/2017/Management_gpt-3.5-turbo_NER_response.json\n",
      "[{'entity': '2016', 'category': 'DATE'}, {'entity': 'December 2016', 'category': 'DATE'}, {'entity': 'November 2016', 'category': 'DATE'}, {'entity': 'August 2016', 'category': 'DATE'}, {'entity': 'May 2016', 'category': 'DATE'}, {'entity': 'April 2016', 'category': 'DATE'}, {'entity': 'February 2016', 'category': 'DATE'}, {'entity': 'January 2016', 'category': 'DATE'}, {'entity': 'September 2016', 'category': 'DATE'}, {'entity': 'July 2016', 'category': 'DATE'}, {'entity': 'June 2016', 'category': 'DATE'}, {'entity': '$0.93', 'category': 'MONEY'}, {'entity': '$2.65', 'category': 'MONEY'}, {'entity': '$2.01', 'category': 'MONEY'}, {'entity': '$2.83', 'category': 'MONEY'}, {'entity': '$19', 'category': 'MONEY'}, {'entity': '427', 'category': 'MONEY'}, {'entity': '$16', 'category': 'MONEY'}, {'entity': '560', 'category': 'MONEY'}, {'entity': '$15', 'category': 'MONEY'}, {'entity': '879', 'category': 'MONEY'}, {'entity': '$11', 'category': 'MONEY'}, {'entity': '843', 'category': 'MONEY'}, {'entity': 'Bristol-Myers Squibb Company', 'category': 'ORG'}, {'entity': 'Opdivo+Yervoy', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Ono', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Eliquis', 'category': 'PRODUCT'}, {'entity': 'Orencia', 'category': 'PRODUCT'}, {'entity': 'Erbitux', 'category': 'PRODUCT'}, {'entity': 'Reyataz', 'category': 'PRODUCT'}, {'entity': 'Sustiva', 'category': 'PRODUCT'}, {'entity': 'Baraclude', 'category': 'PRODUCT'}, {'entity': 'Empliciti', 'category': 'PRODUCT'}, {'entity': 'Hepatitis C Franchise', 'category': 'PRODUCT'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '19', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '13', 'category': 'CARDINAL'}, {'entity': '512', 'category': 'CARDINAL'}, {'entity': '14', 'category': 'CARDINAL'}, {'entity': '483', 'category': 'CARDINAL'}, {'entity': '13', 'category': 'CARDINAL'}, {'entity': '498', 'category': 'CARDINAL'}, {'entity': '2016', 'category': 'CARDINAL'}, {'entity': '2015', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': 'advanced liver fibrosis', 'category': 'FAC'}, {'entity': 'liver fibrosis', 'category': 'FAC'}, {'entity': 'rheumatoid arthritis', 'category': 'FAC'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'Europe', 'category': 'LOC'}, {'entity': 'Dollars in Millions', 'category': 'MONEY'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'IO', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Yervoy', 'category': 'ORG'}, {'entity': 'Yervoy', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'Orencia', 'category': 'ORG'}, {'entity': 'Sprycel', 'category': 'ORG'}, {'entity': 'Nitto Denko', 'category': 'ORG'}, {'entity': 'ND-L02-s0201', 'category': 'ORG'}, {'entity': 'Cormorant', 'category': 'ORG'}, {'entity': 'HuMax-IL8', 'category': 'ORG'}, {'entity': 'Padlock', 'category': 'ORG'}, {'entity': 'Factor Xa', 'category': 'ORG'}, {'entity': 'Portola', 'category': 'ORG'}, {'entity': 'andexanet alfa', 'category': 'ORG'}, {'entity': 'California Institute for Biomedical Research', 'category': 'ORG'}, {'entity': 'Dual Therapeutics', 'category': 'ORG'}, {'entity': 'Abilify', 'category': 'ORG'}, {'entity': 'Lung', 'category': 'PERSON'}, {'entity': 'Year Ended December 31', 'category': 'TIME'}, {'entity': 'autoimmune diseases', 'category': 'WORK_OF_ART'}, {'entity': 'anti-fibrotic preclinical compounds', 'category': 'WORK_OF_ART'}, {'entity': 'anti-cancer preclinical compounds', 'category': 'WORK_OF_ART'}, {'entity': '2016', 'category': 'CARDINAL'}, {'entity': '2015', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '31', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'Abilify', 'category': 'ORG'}, {'entity': 'Erbitux', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Daklinza', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'Sprycel', 'category': 'ORG'}, {'entity': 'Yervoy', 'category': 'ORG'}, {'entity': 'Hepatitis C Franchise', 'category': 'ORG'}, {'entity': 'Daklinza and Sunvepra', 'category': 'ORG'}, {'entity': 'Atripla', 'category': 'ORG'}, {'entity': 'Empliciti', 'category': 'ORG'}, {'entity': 'Elotuzumab', 'category': 'ORG'}, {'entity': 'Cetuximab', 'category': 'ORG'}, {'entity': 'Nivolumab', 'category': 'ORG'}, {'entity': 'Dasatinib', 'category': 'ORG'}, {'entity': 'Ipilimumab', 'category': 'ORG'}, {'entity': 'Apixaban', 'category': 'ORG'}, {'entity': 'Orencia', 'category': 'ORG'}]\n",
      "[{'entity': 'December 2015', 'category': 'DATE'}, {'entity': 'May 2016', 'category': 'DATE'}, {'entity': 'September 2016', 'category': 'DATE'}, {'entity': 'October 2015', 'category': 'DATE'}, {'entity': 'Item 8. Financial Statements—Note 3. Alliances', 'category': 'LANGUAGE'}, {'entity': 'EPO Board of Appeals decision', 'category': 'LANGUAGE'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'Orencia', 'category': 'ORG'}, {'entity': 'Baraclude', 'category': 'ORG'}, {'entity': 'Hepatitis C Franchise', 'category': 'ORG'}, {'entity': 'Reyataz Franchise', 'category': 'ORG'}, {'entity': 'Sustiva Franchise', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Sprycel', 'category': 'ORG'}, {'entity': 'Yervoy', 'category': 'ORG'}, {'entity': 'Head and Neck', 'category': 'ORG'}, {'entity': 'Lung', 'category': 'ORG'}, {'entity': 'Blood Cancer', 'category': 'ORG'}, {'entity': 'Eveifies', 'category': 'ORG'}, {'entity': 'Daklinza', 'category': 'ORG'}, {'entity': 'Sunvepra', 'category': 'ORG'}, {'entity': 'Tybost', 'category': 'ORG'}, {'entity': '17%', 'category': 'PERCENT'}, {'entity': '20%', 'category': 'PERCENT'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': '9%', 'category': 'PERCENT'}, {'entity': '4%', 'category': 'PERCENT'}, {'entity': '100%', 'category': 'PERCENT'}, {'entity': '100%', 'category': 'PERCENT'}, {'entity': '62%', 'category': 'PERCENT'}, {'entity': '67%', 'category': 'PERCENT'}, {'entity': '19%', 'category': 'PERCENT'}, {'entity': '35%', 'category': 'PERCENT'}, {'entity': '25%', 'category': 'PERCENT'}, {'entity': '83%', 'category': 'PERCENT'}, {'entity': '100%', 'category': 'PERCENT'}, {'entity': '12%', 'category': 'PERCENT'}, {'entity': '13%', 'category': 'PERCENT'}, {'entity': '7%', 'category': 'PERCENT'}, {'entity': '22%', 'category': 'PERCENT'}, {'entity': '16%', 'category': 'PERCENT'}, {'entity': '18%', 'category': 'PERCENT'}, {'entity': '24%', 'category': 'PERCENT'}, {'entity': '41%', 'category': 'PERCENT'}, {'entity': '4%', 'category': 'PERCENT'}, {'entity': 'Gleevec', 'category': 'PERSON'}, {'entity': 'Opdivo+Yervoy', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Empliciti', 'category': 'WORK_OF_ART'}, {'entity': 'Erbitux', 'category': 'WORK_OF_ART'}, {'entity': 'Opdivo', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'second', 'category': 'ORDINAL'}, {'entity': 'third', 'category': 'ORDINAL'}]\n",
      "[{'entity': 'November 2013', 'category': 'DATE'}, {'entity': 'April 2015', 'category': 'DATE'}, {'entity': 'June 2014', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': 'June 30', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': 'Gilead', 'category': 'ORG'}, {'entity': 'Abilify', 'category': 'ORG'}, {'entity': 'Otsuka', 'category': 'ORG'}, {'entity': 'Sustiva', 'category': 'PRODUCT'}, {'entity': 'Plavix', 'category': 'PRODUCT'}, {'entity': 'Dafalgan', 'category': 'PRODUCT'}, {'entity': 'Efferalgan', 'category': 'PRODUCT'}, {'entity': 'Fervex', 'category': 'PRODUCT'}, {'entity': 'Perfalgan', 'category': 'PRODUCT'}]\n",
      "[{'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'virology products', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Hepatitis C Franchise', 'category': 'ORG'}, {'entity': 'IRS', 'category': 'ORG'}, {'entity': 'Branded Prescription Drug Fee', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Hepatitis C Franchise', 'category': 'ORG'}, {'entity': 'IRS', 'category': 'ORG'}, {'entity': 'Alliances', 'category': 'ORG'}, {'entity': 'Padlock, Nitto Denko, Flexus and Cormorant', 'category': 'ORG'}, {'entity': 'Flexus, Cardioxyl and Five Prime', 'category': 'ORG'}, {'entity': 'iPierian', 'category': 'ORG'}, {'entity': 'Flexus', 'category': 'ORG'}, {'entity': 'LPA1 Antagonist', 'category': 'ORG'}, {'entity': 'peginterferon lambda', 'category': 'ORG'}, {'entity': 'Alliances', 'category': 'ORG'}, {'entity': 'divestiture gains and royalties and licensing income', 'category': 'ORG'}, {'entity': 'litigation and other settlements', 'category': 'ORG'}, {'entity': 'pension and debt redemption charges', 'category': 'ORG'}, {'entity': 'divestiture gains', 'category': 'ORG'}, {'entity': 'divestiture gains', 'category': 'ORG'}, {'entity': 'Mount Vernon, Indiana manufacturing facility', 'category': 'ORG'}, {'entity': 'Erbitux, Ixempra and certain mature and other OTC product businesses', 'category': 'ORG'}, {'entity': 'diabetes business', 'category': 'ORG'}, {'entity': 'Royalties and licensing income', 'category': 'ORG'}, {'entity': 'incurred in 2017', 'category': 'ORG'}, {'entity': 'Item 8. Financial Statements--Note 4. Acquisitions and Divestitures, Note 5. Other Income/Expense, Note 6. Restructuring and Note 16. Pension and Postretirement Benefit Plans', 'category': 'ORG'}]\n",
      "[{'entity': '2014', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '\"Item 8. Financial Statements—Note 7. Income Taxes\"', 'category': 'EVENT'}, {'entity': '\"Item 8. Financial Statements—Note 7. Income Taxes\"', 'category': 'FAC'}, {'entity': 'Switzerland', 'category': 'GPE'}, {'entity': 'Ireland', 'category': 'GPE'}, {'entity': 'Puerto Rico', 'category': 'GPE'}, {'entity': 'Puerto Rico', 'category': 'GPE'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'Puerto Rico', 'category': 'LOC'}, {'entity': 'Puerto Rico', 'category': 'LOC'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': '1.8%', 'category': 'PERCENT'}, {'entity': '0.3%', 'category': 'PERCENT'}, {'entity': '5.1%', 'category': 'PERCENT'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': 'Amylin', 'category': 'PERSON'}, {'entity': 'Shakespeare', 'category': 'PERSON'}, {'entity': 'Peter', 'category': 'PERSON'}, {'entity': 'Lisa', 'category': 'PERSON'}, {'entity': '3', 'category': 'QUANTITY'}, {'entity': '5PM', 'category': 'TIME'}, {'entity': '7PM', 'category': 'TIME'}, {'entity': '\"Item 8. Financial Statements—Note 7. Income Taxes\"', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '35%', 'category': 'CARDINAL'}]\n",
      "[{'entity': '2015', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': '2018', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': 'one', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': 'proceeds', 'category': 'EVENT'}, {'entity': 'redeemed/repurchased', 'category': 'EVENT'}, {'entity': 'construction', 'category': 'EVENT'}, {'entity': '$1.3 billion', 'category': 'MONEY'}, {'entity': '$2.0 billion', 'category': 'MONEY'}, {'entity': '$1.2 billion', 'category': 'MONEY'}, {'entity': '$4.1 billion', 'category': 'MONEY'}, {'entity': '$2.0 billion', 'category': 'MONEY'}, {'entity': '$2.5 billion', 'category': 'MONEY'}, {'entity': '$2.4 billion', 'category': 'MONEY'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': '2%', 'category': 'PERCENT'}, {'entity': 'less than 2%', 'category': 'PERCENT'}, {'entity': 'December', 'category': 'PERSON'}, {'entity': 'target', 'category': 'PERSON'}, {'entity': 'February', 'category': 'PERSON'}, {'entity': '8.', 'category': 'PERSON'}, {'entity': 'December', 'category': 'PERSON'}, {'entity': 'October', 'category': 'PERSON'}, {'entity': 'October', 'category': 'PERSON'}, {'entity': 'December', 'category': 'PERSON'}, {'entity': '120 days to 150 days', 'category': 'TIME'}, {'entity': 'Abilify', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': 'one', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': '2015', 'category': 'CARDINAL'}, {'entity': '1.2 billion', 'category': 'CARDINAL'}, {'entity': '800 million', 'category': 'CARDINAL'}, {'entity': '500 million', 'category': 'CARDINAL'}, {'entity': '1.0 billion', 'category': 'CARDINAL'}, {'entity': '900 million', 'category': 'CARDINAL'}, {'entity': '1.5 billion', 'category': 'CARDINAL'}, {'entity': '1.3 billion', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': 'four', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': '2.5 billion', 'category': 'CARDINAL'}, {'entity': '2.4 billion', 'category': 'CARDINAL'}, {'entity': '4.1 billion', 'category': 'CARDINAL'}, {'entity': '2.0 billion', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': '1.3 billion', 'category': 'CARDINAL'}, {'entity': '2.0 billion', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': '2.0 billion', 'category': 'CARDINAL'}, {'entity': '2.5 billion', 'category': 'CARDINAL'}, {'entity': '1.2 billion', 'category': 'CARDINAL'}, {'entity': '2.4 billion', 'category': 'CARDINAL'}, {'entity': '1.2 billion', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': '1.2 billion', 'category': 'CARDINAL'}, {'entity': '2.5 billion', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': '2.5 billion', 'category': 'CARDINAL'}, {'entity': '$2.5 billion', 'category': 'CARDINAL'}, {'entity': '2.4 billion', 'category': 'CARDINAL'}, {'entity': '1.2 billion', 'category': 'CARDINAL'}, {'entity': '800 million', 'category': 'CARDINAL'}, {'entity': '500 million', 'category': 'CARDINAL'}, {'entity': '1.2 billion', 'category': 'CARDINAL'}, {'entity': '2.0 billion', 'category': 'CARDINAL'}, {'entity': '1.5 billion', 'category': 'CARDINAL'}, {'entity': '2.0 billion', 'category': 'CARDINAL'}, {'entity': '1.3 billion', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': '$2.0 billion', 'category': 'CARDINAL'}, {'entity': '200 billion', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': '2.0 billion', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': 'one', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': 'one', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': '2.0 billion', 'category': 'CARDINAL'}, {'entity': '2.5 billion', 'category': 'CARDINAL'}, {'entity': '2.4 billion', 'category': 'CARDINAL'}, {'entity': 'one', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': 'one', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': 'one', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': 'one', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': '2.0 billion', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': '2.5 billion', 'category': 'CARDINAL'}, {'entity': 'one', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': '2.5 billion', 'category': 'CARDINAL'}, {'entity': '2.4 billion', 'category': 'CARDINAL'}, {'entity': '1.2 billion', 'category': 'CARDINAL'}]\n",
      "[{'entity': '2015', 'category': 'DATE'}, {'entity': 'Abilify alliance', 'category': 'EVENT'}, {'entity': 'divestiture', 'category': 'EVENT'}, {'entity': 'sales levels', 'category': 'EVENT'}, {'entity': 'Mount Vernon', 'category': 'GPE'}, {'entity': 'Indiana', 'category': 'GPE'}, {'entity': '$1.3 billion', 'category': 'MONEY'}, {'entity': '$700 million', 'category': 'MONEY'}, {'entity': '$600 million', 'category': 'MONEY'}, {'entity': '$400 million', 'category': 'MONEY'}, {'entity': '$2.1 billion', 'category': 'MONEY'}, {'entity': '$800 million', 'category': 'MONEY'}, {'entity': '$900 million', 'category': 'MONEY'}, {'entity': '$300 million', 'category': 'MONEY'}, {'entity': '$1.3 billion', 'category': 'MONEY'}, {'entity': '$906 million', 'category': 'MONEY'}, {'entity': '$700 million', 'category': 'MONEY'}, {'entity': '$200 million', 'category': 'MONEY'}, {'entity': '$914 million', 'category': 'MONEY'}, {'entity': '$700 million', 'category': 'MONEY'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'one month', 'category': 'PERCENT'}, {'entity': 'Mary', 'category': 'PERSON'}, {'entity': 'Abilify', 'category': 'PRODUCT'}, {'entity': 'Cormorant', 'category': 'PRODUCT'}, {'entity': 'Padlock', 'category': 'PRODUCT'}, {'entity': 'Flexus', 'category': 'PRODUCT'}, {'entity': 'Cardioxyl', 'category': 'PRODUCT'}, {'entity': 'Mount Vernon', 'category': 'PRODUCT'}, {'entity': 'Ixempra', 'category': 'PRODUCT'}, {'entity': 'HIV', 'category': 'PRODUCT'}, {'entity': 'Abilify', 'category': 'PRODUCT'}, {'entity': 'Cormorant', 'category': 'PRODUCT'}, {'entity': 'Padlock', 'category': 'PRODUCT'}, {'entity': 'Flexus', 'category': 'PRODUCT'}, {'entity': 'Cardioxyl', 'category': 'PRODUCT'}, {'entity': 'Ixempra', 'category': 'PRODUCT'}, {'entity': 'Hamlet', 'category': 'WORK_OF_ART'}, {'entity': '600 million', 'category': 'CARDINAL'}, {'entity': '1.4 billion', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'October 2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': 'self-monitoring period', 'category': 'EVENT'}, {'entity': 'reached a civil settlement', 'category': 'EVENT'}, {'entity': 'early access program', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'France', 'category': 'GPE'}, {'entity': 'SEC', 'category': 'LOC'}, {'entity': 'Cupertino', 'category': 'LOC'}, {'entity': 'California', 'category': 'LOC'}, {'entity': 'Europe', 'category': 'LOC'}, {'entity': '$14.7 million', 'category': 'MONEY'}, {'entity': '$300 million', 'category': 'MONEY'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'SEC of alleged FCPA violations', 'category': 'ORG'}, {'entity': 'SEC of our annual and quarterly reports', 'category': 'ORG'}, {'entity': 'SEC of our gross U.S. revenues', 'category': 'ORG'}, {'entity': 'SEC of alleged FCPA violations in which the Company', 'category': 'ORG'}, {'entity': 'SEC of alleged FCPA violations', 'category': 'ORG'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'BMS.Gross-to-Net', 'category': 'ORG'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': '2%', 'category': 'PERCENT'}, {'entity': 'SEC', 'category': 'PERSON'}, {'entity': 'SEC', 'category': 'PERSON'}, {'entity': 'SEC', 'category': 'PERSON'}, {'entity': 'Mary', 'category': 'PERSON'}, {'entity': 'Daklinza', 'category': 'PRODUCT'}, {'entity': '$300 million', 'category': 'QUANTITY'}, {'entity': 'weekly', 'category': 'TIME'}, {'entity': 'two to four week', 'category': 'TIME'}, {'entity': 'a one month', 'category': 'TIME'}, {'entity': 'Item 8. Financial Statements—Note 1. Accounting Policies—Recently Issued Accounting Standards.”Critical Accounting Policies', 'category': 'WORK_OF_ART'}, {'entity': 'two-year', 'category': 'ORDINAL'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '95', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '14.7', 'category': 'CARDINAL'}, {'entity': '300', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'Medicaid', 'category': 'ORG'}, {'entity': 'Federal', 'category': 'ORG'}, {'entity': 'U.S.', 'category': 'ORG'}, {'entity': 'Centers for Medicare & Medicaid Services', 'category': 'ORG'}, {'entity': 'Medicare', 'category': 'ORG'}, {'entity': 'IRPD', 'category': 'PERSON'}, {'entity': '50%', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'Dec 23', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': 'Cupertino', 'category': 'GPE'}, {'entity': 'California', 'category': 'GPE'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'Paris', 'category': 'GPE'}, {'entity': '98 million', 'category': 'MONEY'}, {'entity': '73 million', 'category': 'MONEY'}, {'entity': '600 million', 'category': 'MONEY'}, {'entity': 'ASC 805 - Business Combinations', 'category': 'ORG'}, {'entity': 'Apple', 'category': 'ORG'}, {'entity': 'Medicines Company', 'category': 'ORG'}, {'entity': 'Valeant Pharmaceuticals International', 'category': 'ORG'}, {'entity': 'Inc.', 'category': 'ORG'}, {'entity': 'AstraZeneca', 'category': 'ORG'}, {'entity': '15', 'category': 'PERCENT'}, {'entity': '2016', 'category': 'PERCENT'}, {'entity': 'Mary', 'category': 'PERSON'}, {'entity': 'Shakespeare', 'category': 'PERSON'}, {'entity': 'Peter', 'category': 'PERSON'}, {'entity': 'Lisa', 'category': 'PERSON'}, {'entity': 'Reckitt', 'category': 'PERSON'}, {'entity': 'BMS-986020', 'category': 'PERSON'}, {'entity': '7PM', 'category': 'TIME'}, {'entity': 'Hamlet', 'category': 'WORK_OF_ART'}, {'entity': 'Eiffel Tower', 'category': 'WORK_OF_ART'}, {'entity': 'Hilton Hotel', 'category': 'WORK_OF_ART'}, {'entity': 'Erbitux*Ixempra*', 'category': 'WORK_OF_ART'}, {'entity': '155', 'category': 'ORDINAL'}, {'entity': 'Phase II', 'category': 'ORDINAL'}, {'entity': '1.5 million', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '5', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '1.4 billion', 'category': 'CARDINAL'}, {'entity': '669 million', 'category': 'CARDINAL'}, {'entity': '107 million', 'category': 'CARDINAL'}, {'entity': '160 million', 'category': 'CARDINAL'}, {'entity': 'IPF', 'category': 'CARDINAL'}, {'entity': 'HCV', 'category': 'CARDINAL'}, {'entity': '104 million', 'category': 'CARDINAL'}, {'entity': '115 million', 'category': 'CARDINAL'}, {'entity': '151 million', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'Dec 2016', 'category': 'DATE'}, {'entity': 'November 2016', 'category': 'DATE'}, {'entity': 'October', 'category': 'DATE'}, {'entity': 'Phase I/II study', 'category': 'EVENT'}, {'entity': 'EC approval', 'category': 'EVENT'}, {'entity': 'Phase III development', 'category': 'EVENT'}, {'entity': 'manufacturing and marketing approval', 'category': 'EVENT'}, {'entity': 'JMHLW', 'category': 'ORG'}, {'entity': 'Ono', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Seattle Genetics, Inc.', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Adcetris', 'category': 'PERSON'}, {'entity': 'brentuximab vedotin', 'category': 'PERSON'}]\n",
      "[{'entity': 'October 2016', 'category': 'DATE'}, {'entity': 'December 2016', 'category': 'DATE'}, {'entity': 'September 2016', 'category': 'DATE'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Opdivo+Yervoy', 'category': 'PRODUCT'}, {'entity': 'Opdivo alone', 'category': 'PRODUCT'}, {'entity': 'Opdivo+Yervoy regimen', 'category': 'PRODUCT'}, {'entity': 'Empliciti', 'category': 'PRODUCT'}, {'entity': 'Yervoy', 'category': 'PRODUCT'}, {'entity': 'Orencia', 'category': 'PRODUCT'}, {'entity': 'Ximency', 'category': 'PRODUCT'}]\n",
      "[{'entity': 'February 2016', 'category': 'DATE'}, {'entity': 'February 2016', 'category': 'DATE'}, {'entity': 'January 2016', 'category': 'DATE'}, {'entity': 'FDA approval of Daklinza for use with sofosbuvir for the treatment of chronic HCV in genotypes 1 and 3 in three additional patient populations', 'category': 'EVENT'}, {'entity': 'Announced results from the first completed all-oral chronic HCV regimen Daklinza in combination with asunaprevir Phase III trial that includes a Chinese patient population', 'category': 'EVENT'}, {'entity': 'EC approval of Daklinza for use with sofosbuvir for the treatment of chronic HCV in three new patient populations', 'category': 'EVENT'}, {'entity': 'Chinese', 'category': 'GPE'}, {'entity': 'China', 'category': 'GPE'}, {'entity': 'Cupertino', 'category': 'LOC'}, {'entity': 'California', 'category': 'LOC'}, {'entity': 'EC', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'Daklinza', 'category': 'ORG'}, {'entity': '3', 'category': 'QUANTITY'}, {'entity': 'Reyataz', 'category': 'WORK_OF_ART'}]\n",
      "[{'entity': 'Europe', 'category': 'ORG'}, {'entity': 'Item 8. Financial Statements', 'category': 'ORG'}, {'entity': 'Note 9. Financial Instruments and Fair Value Measurements', 'category': 'ORG'}]\n",
      "/Users/tanmayiballa/Desktop/KG-LLM/l715_23-1/data/10-Ks/Bristol-Myers_Squibb_Company/2019/Management_gpt-3.5-turbo_NER_response.json\n",
      "[{'entity': '2018 Form 10-K', 'category': 'DATE'}, {'entity': '2018', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': 'December 31,2018', 'category': 'DATE'}, {'entity': 'merger agreement', 'category': 'EVENT'}, {'entity': 'pending acquisition', 'category': 'EVENT'}, {'entity': 'acquisitions', 'category': 'EVENT'}, {'entity': 'divestitures', 'category': 'EVENT'}, {'entity': 'licensing arrangements', 'category': 'EVENT'}, {'entity': 'executive summary', 'category': 'EVENT'}, {'entity': 'financial condition', 'category': 'EVENT'}, {'entity': 'results of operations', 'category': 'EVENT'}, {'entity': 'revenues', 'category': 'EVENT'}, {'entity': 'approvals', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'EU', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'China', 'category': 'GPE'}, {'entity': 'Cupertino', 'category': 'LOC'}, {'entity': 'California', 'category': 'LOC'}, {'entity': '$2.40 million', 'category': 'MONEY'}, {'entity': '$2.04 million', 'category': 'MONEY'}, {'entity': 'Bristol-Myers Squibb Company', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Eliquis', 'category': 'PERSON'}, {'entity': 'Opdivo alone', 'category': 'PERSON'}, {'entity': 'Opdivo+Yervoy', 'category': 'PERSON'}, {'entity': 'Yervoy', 'category': 'PERSON'}, {'entity': 'Peter', 'category': 'PERSON'}, {'entity': 'Lisa', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Opdivo+Yervoy combinations', 'category': 'PRODUCT'}, {'entity': 'TYK2 inhibitor', 'category': 'PRODUCT'}, {'entity': 'Factor XIa inhibitor', 'category': 'PRODUCT'}, {'entity': 'Pegbelfermin PEG-FGF21', 'category': 'PRODUCT'}, {'entity': 'IO portfolio', 'category': 'WORK_OF_ART'}, {'entity': 'Hamlet', 'category': 'WORK_OF_ART'}, {'entity': 'Sprycel', 'category': 'WORK_OF_ART'}, {'entity': 'Philadelphia chromosome-positive ALL', 'category': 'WORK_OF_ART'}, {'entity': 'Sprycel to include the treatment of pediatric patients one year of age and older with newly diagnosed Philadelphia chromosome-positive ALL in combination with chemotherapy', 'category': 'WORK_OF_ART'}, {'entity': 'powder for oral suspension.', 'category': 'WORK_OF_ART'}, {'entity': '14', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}]\n",
      "[{'entity': '2018', 'category': 'DATE'}, {'entity': '2018 and in early 2019', 'category': 'DATE'}, {'entity': 'EC approval', 'category': 'EVENT'}, {'entity': 'development', 'category': 'EVENT'}, {'entity': 'commercialization', 'category': 'EVENT'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': 'several', 'category': 'QUANTITY'}, {'entity': 'Opdivo', 'category': 'WORK_OF_ART'}, {'entity': 'Yervoy', 'category': 'WORK_OF_ART'}, {'entity': 'Eliquis', 'category': 'WORK_OF_ART'}, {'entity': 'Orencia', 'category': 'WORK_OF_ART'}, {'entity': 'Sprycel', 'category': 'WORK_OF_ART'}, {'entity': 'NKTR-214', 'category': 'WORK_OF_ART'}, {'entity': 'Factor XIa', 'category': 'WORK_OF_ART'}, {'entity': 'BMS-986177', 'category': 'WORK_OF_ART'}, {'entity': 'Prostvac', 'category': 'WORK_OF_ART'}, {'entity': 'ONO-4578', 'category': 'WORK_OF_ART'}, {'entity': 'ENHANZE', 'category': 'WORK_OF_ART'}]\n",
      "[{'entity': 'Dec 23, 2022', 'category': 'DATE'}, {'entity': '2018', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': 'product launch', 'category': 'EVENT'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'Paris', 'category': 'GPE'}, {'entity': 'Cupertino, California', 'category': 'LOC'}, {'entity': 'United States', 'category': 'LOC'}, {'entity': 'Paris', 'category': 'LOC'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': 'Millions', 'category': 'MONEY'}, {'entity': '$22,561', 'category': 'MONEY'}, {'entity': '$20,776', 'category': 'MONEY'}, {'entity': '$19,427', 'category': 'MONEY'}, {'entity': '$12,586', 'category': 'MONEY'}, {'entity': '$11,358', 'category': 'MONEY'}, {'entity': '$10,720', 'category': 'MONEY'}, {'entity': '$1977', 'category': 'MONEY'}, {'entity': '$2522', 'category': 'MONEY'}, {'entity': 'IFM', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Biogen', 'category': 'ORG'}, {'entity': 'Mary', 'category': 'PERSON'}, {'entity': 'Peter', 'category': 'PERSON'}, {'entity': 'Lisa', 'category': 'PERSON'}, {'entity': 'Shakespeare', 'category': 'PERSON'}, {'entity': 'BMS-986168', 'category': 'PRODUCT'}, {'entity': 'BMS-986089', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Eliquis', 'category': 'PRODUCT'}, {'entity': 'BMS-986168', 'category': 'PRODUCT'}, {'entity': 'BMS-986089', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Eliquis', 'category': 'PRODUCT'}, {'entity': '3', 'category': 'QUANTITY'}, {'entity': '5PM', 'category': 'TIME'}, {'entity': '7PM', 'category': 'TIME'}, {'entity': 'Hamlet', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'additional', 'category': 'ORDINAL'}, {'entity': 'all', 'category': 'CARDINAL'}, {'entity': 'eight', 'category': 'CARDINAL'}, {'entity': 'additional', 'category': 'CARDINAL'}, {'entity': '2016', 'category': 'CARDINAL'}, {'entity': 'twenty', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': '$6', 'category': 'MONEY'}, {'entity': '735', 'category': 'MONEY'}, {'entity': '$4', 'category': 'MONEY'}, {'entity': '948', 'category': 'MONEY'}, {'entity': '$3', 'category': 'MONEY'}, {'entity': '774', 'category': 'MONEY'}, {'entity': '$6', 'category': 'MONEY'}, {'entity': '438', 'category': 'MONEY'}, {'entity': '$4', 'category': 'MONEY'}, {'entity': '872', 'category': 'MONEY'}, {'entity': '$3', 'category': 'MONEY'}, {'entity': '343', 'category': 'MONEY'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Opdivo+Yervoy', 'category': 'ORG'}, {'entity': 'Orencia', 'category': 'ORG'}, {'entity': 'Sprycel', 'category': 'ORG'}, {'entity': 'Yervoy', 'category': 'ORG'}, {'entity': 'Baraclude', 'category': 'ORG'}, {'entity': 'Reyataz Franchise', 'category': 'ORG'}, {'entity': 'Evotaz', 'category': 'ORG'}, {'entity': 'Hepatitis C Franchise', 'category': 'ORG'}, {'entity': 'Other Brands', 'category': 'ORG'}, {'entity': 'Total Revenues', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Opdivo nivolumab', 'category': 'ORG'}, {'entity': 'PD-1', 'category': 'ORG'}, {'entity': 'T and NKT cells', 'category': 'ORG'}, {'entity': 'bladder', 'category': 'ORG'}, {'entity': 'blood', 'category': 'ORG'}, {'entity': 'colon', 'category': 'ORG'}, {'entity': 'head and neck', 'category': 'ORG'}, {'entity': 'kidney', 'category': 'ORG'}, {'entity': 'liver', 'category': 'ORG'}, {'entity': 'lung', 'category': 'ORG'}, {'entity': 'melanoma', 'category': 'ORG'}, {'entity': 'stomach', 'category': 'ORG'}, {'entity': 'market share', 'category': 'ORG'}, {'entity': 'NVAF', 'category': 'ORG'}, {'entity': 'VTE disorders', 'category': 'ORG'}, {'entity': 'Factor Xa inhibitor', 'category': 'ORG'}, {'entity': 'RA', 'category': 'ORG'}, {'entity': 'PsA', 'category': 'ORG'}, {'entity': 'CML', 'category': 'ORG'}, {'entity': 'imatinib mesylate', 'category': 'ORG'}, {'entity': 'ipilimumab', 'category': 'ORG'}, {'entity': 'unresectable or metastatic melanoma', 'category': 'ORG'}, {'entity': 'entecavir', 'category': 'ORG'}, {'entity': 'chronic hepatitis B', 'category': 'ORG'}, {'entity': 'atazanavir sulfate', 'category': 'ORG'}, {'entity': 'HIV', 'category': 'ORG'}, {'entity': 'Efavirenz', 'category': 'ORG'}, {'entity': 'non-nucleoside reverse transcriptase inhibitor', 'category': 'ORG'}, {'entity': 'Atripla', 'category': 'ORG'}, {'entity': '36%', 'category': 'PERCENT'}, {'entity': '31%', 'category': 'PERCENT'}, {'entity': '32%', 'category': 'PERCENT'}, {'entity': '46%', 'category': 'PERCENT'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'Item 8', 'category': 'ORDINAL'}, {'entity': 'Note 3', 'category': 'ORDINAL'}, {'entity': '36', 'category': 'CARDINAL'}, {'entity': '31', 'category': 'CARDINAL'}, {'entity': '37', 'category': 'CARDINAL'}, {'entity': '16', 'category': 'CARDINAL'}, {'entity': '35', 'category': 'CARDINAL'}, {'entity': '30', 'category': 'CARDINAL'}, {'entity': '9', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '40', 'category': 'CARDINAL'}, {'entity': '52', 'category': 'CARDINAL'}, {'entity': '27', 'category': 'CARDINAL'}, {'entity': '35', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '61', 'category': 'CARDINAL'}, {'entity': '96', 'category': 'CARDINAL'}, {'entity': '29', 'category': 'CARDINAL'}, {'entity': '23', 'category': 'CARDINAL'}, {'entity': '26', 'category': 'CARDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '29', 'category': 'CARDINAL'}, {'entity': '39', 'category': 'CARDINAL'}, {'entity': '61', 'category': 'CARDINAL'}, {'entity': '96', 'category': 'CARDINAL'}, {'entity': '29', 'category': 'CARDINAL'}, {'entity': '23', 'category': 'CARDINAL'}, {'entity': '26', 'category': 'CARDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '4,239', 'category': 'CARDINAL'}, {'entity': '3,102', 'category': 'CARDINAL'}, {'entity': '2,664', 'category': 'CARDINAL'}, {'entity': '37', 'category': 'CARDINAL'}, {'entity': '16', 'category': 'CARDINAL'}, {'entity': '6,438', 'category': 'CARDINAL'}, {'entity': '4,872', 'category': 'CARDINAL'}, {'entity': '3,343', 'category': 'CARDINAL'}, {'entity': '32', 'category': 'CARDINAL'}, {'entity': '46', 'category': 'CARDINAL'}, {'entity': '3,760', 'category': 'CARDINAL'}, {'entity': '2,887', 'category': 'CARDINAL'}, {'entity': '1,963', 'category': 'CARDINAL'}, {'entity': '30', 'category': 'CARDINAL'}, {'entity': '47', 'category': 'CARDINAL'}, {'entity': '2,678', 'category': 'CARDINAL'}, {'entity': '1,985', 'category': 'CARDINAL'}, {'entity': '1,380', 'category': 'CARDINAL'}, {'entity': '35', 'category': 'CARDINAL'}, {'entity': '44', 'category': 'CARDINAL'}, {'entity': '2,710', 'category': 'CARDINAL'}, {'entity': '2,479', 'category': 'CARDINAL'}, {'entity': '2,265', 'category': 'CARDINAL'}, {'entity': '9', 'category': 'CARDINAL'}, {'entity': '9', 'category': 'CARDINAL'}, {'entity': '1,875', 'category': 'CARDINAL'}, {'entity': '1,704', 'category': 'CARDINAL'}, {'entity': '1,532', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '11', 'category': 'CARDINAL'}, {'entity': '835', 'category': 'CARDINAL'}, {'entity': '775', 'category': 'CARDINAL'}, {'entity': '733', 'category': 'CARDINAL'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '2,000', 'category': 'CARDINAL'}, {'entity': '2,005', 'category': 'CARDINAL'}, {'entity': '1,824', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '1,091', 'category': 'CARDINAL'}, {'entity': '1,105', 'category': 'CARDINAL'}, {'entity': '969', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '14', 'category': 'CARDINAL'}, {'entity': '909', 'category': 'CARDINAL'}, {'entity': '900', 'category': 'CARDINAL'}, {'entity': '855', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '5', 'category': 'CARDINAL'}, {'entity': '1,330', 'category': 'CARDINAL'}, {'entity': '1,244', 'category': 'CARDINAL'}, {'entity': '1,053', 'category': 'CARDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '18', 'category': 'CARDINAL'}, {'entity': '941', 'category': 'CARDINAL'}, {'entity': '908', 'category': 'CARDINAL'}, {'entity': '802', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '13', 'category': 'CARDINAL'}, {'entity': '389', 'category': 'CARDINAL'}, {'entity': '336', 'category': 'CARDINAL'}, {'entity': '251', 'category': 'CARDINAL'}, {'entity': '16', 'category': 'CARDINAL'}, {'entity': '34', 'category': 'CARDINAL'}, {'entity': '247', 'category': 'CARDINAL'}, {'entity': '231', 'category': 'CARDINAL'}, {'entity': '150', 'category': 'CARDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '54', 'category': 'CARDINAL'}, {'entity': '164', 'category': 'CARDINAL'}, {'entity': '151', 'category': 'CARDINAL'}, {'entity': '133', 'category': 'CARDINAL'}, {'entity': '9', 'category': 'CARDINAL'}, {'entity': '14', 'category': 'CARDINAL'}, {'entity': '83', 'category': 'CARDINAL'}, {'entity': '80', 'category': 'CARDINAL'}, {'entity': '17', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '744', 'category': 'CARDINAL'}, {'entity': '1,052', 'category': 'CARDINAL'}, {'entity': '1,192', 'category': 'CARDINAL'}, {'entity': '29', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '32', 'category': 'CARDINAL'}, {'entity': '53', 'category': 'CARDINAL'}, {'entity': '66', 'category': 'CARDINAL'}, {'entity': '40', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '712', 'category': 'CARDINAL'}, {'entity': '999', 'category': 'CARDINAL'}, {'entity': '1,126', 'category': 'CARDINAL'}, {'entity': '29', 'category': 'CARDINAL'}, {'entity': '11', 'category': 'CARDINAL'}, {'entity': '427', 'category': 'CARDINAL'}, {'entity': '698', 'category': 'CARDINAL'}, {'entity': '912', 'category': 'CARDINAL'}, {'entity': '39', 'category': 'CARDINAL'}, {'entity': '23', 'category': 'CARDINAL'}, {'entity': '157', 'category': 'CARDINAL'}, {'entity': '327', 'category': 'CARDINAL'}, {'entity': '484', 'category': 'CARDINAL'}, {'entity': '52', 'category': 'CARDINAL'}, {'entity': '32', 'category': 'CARDINAL'}, {'entity': '270', 'category': 'CARDINAL'}, {'entity': '371', 'category': 'CARDINAL'}, {'entity': '428', 'category': 'CARDINAL'}, {'entity': '27', 'category': 'CARDINAL'}, {'entity': '13', 'category': 'CARDINAL'}, {'entity': '283', 'category': 'CARDINAL'}, {'entity': '729', 'category': 'CARDINAL'}, {'entity': '1,065', 'category': 'CARDINAL'}, {'entity': '61', 'category': 'CARDINAL'}, {'entity': '32', 'category': 'CARDINAL'}, {'entity': '27', 'category': 'CARDINAL'}, {'entity': '622', 'category': 'CARDINAL'}, {'entity': '901', 'category': 'CARDINAL'}, {'entity': '96', 'category': 'CARDINAL'}, {'entity': '31', 'category': 'CARDINAL'}, {'entity': '256', 'category': 'CARDINAL'}, {'entity': '107', 'category': 'CARDINAL'}, {'entity': '164', 'category': 'CARDINAL'}, {'entity': '35', 'category': 'CARDINAL'}, {'entity': '17', 'category': 'CARDINAL'}, {'entity': '406', 'category': 'CARDINAL'}, {'entity': '1,578', 'category': 'CARDINAL'}, {'entity': '96', 'category': 'CARDINAL'}, {'entity': '74', 'category': 'CARDINAL'}, {'entity': '16', 'category': 'CARDINAL'}, {'entity': '109', 'category': 'CARDINAL'}, {'entity': '827', 'category': 'CARDINAL'}, {'entity': '33', 'category': 'CARDINAL'}, {'entity': '297', 'category': 'CARDINAL'}, {'entity': '751', 'category': 'CARDINAL'}, {'entity': '89', 'category': 'CARDINAL'}, {'entity': '60', 'category': 'CARDINAL'}, {'entity': '1,630', 'category': 'CARDINAL'}, {'entity': '2,112', 'category': 'CARDINAL'}, {'entity': '2,271', 'category': 'CARDINAL'}, {'entity': '23', 'category': 'CARDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '316', 'category': 'CARDINAL'}, {'entity': '390', 'category': 'CARDINAL'}, {'entity': '379', 'category': 'CARDINAL'}, {'entity': '19', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '1,314', 'category': 'CARDINAL'}, {'entity': '1,722', 'category': 'CARDINAL'}, {'entity': '1,892', 'category': 'CARDINAL'}, {'entity': '24', 'category': 'CARDINAL'}, {'entity': '9', 'category': 'CARDINAL'}, {'entity': '22,561', 'category': 'CARDINAL'}, {'entity': '20,776', 'category': 'CARDINAL'}, {'entity': '19,427', 'category': 'CARDINAL'}, {'entity': '9', 'category': 'CARDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '12,586', 'category': 'CARDINAL'}, {'entity': '11,358', 'category': 'CARDINAL'}, {'entity': '10,720', 'category': 'CARDINAL'}, {'entity': '11', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '9,975', 'category': 'CARDINAL'}, {'entity': '9,418', 'category': 'CARDINAL'}, {'entity': '8,707', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '8', 'category': 'CARDINAL'}]\n",
      "[{'entity': '2018', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': '2018', 'category': 'DATE'}, {'entity': 'June 30', 'category': 'DATE'}, {'entity': '2018', 'category': 'DATE'}, {'entity': 'September 30', 'category': 'DATE'}, {'entity': '2018', 'category': 'DATE'}, {'entity': '10', 'category': 'DATE'}, {'entity': 'next quarterly report', 'category': 'DATE'}, {'entity': 'Form 10-Q', 'category': 'DATE'}, {'entity': '$204 million', 'category': 'MONEY'}, {'entity': 'U.S. Atripla', 'category': 'ORG'}, {'entity': 'Daklinza', 'category': 'ORG'}, {'entity': 'Sunvepra', 'category': 'ORG'}, {'entity': 'beclabuvir', 'category': 'ORG'}, {'entity': 'Plavix', 'category': 'ORG'}, {'entity': 'Abilify', 'category': 'ORG'}, {'entity': 'Canada', 'category': 'ORG'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'Dafalgan', 'category': 'ORG'}, {'entity': 'Efferalgan', 'category': 'ORG'}, {'entity': 'Fervex', 'category': 'ORG'}, {'entity': 'Perfalgan', 'category': 'ORG'}, {'entity': 'Sustiva', 'category': 'ORG'}, {'entity': 'U.S.', 'category': 'ORG'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2018', 'category': 'CARDINAL'}, {'entity': '2017', 'category': 'CARDINAL'}, {'entity': '97%', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '2016', 'category': 'CARDINAL'}]\n",
      "[{'entity': '2018', 'category': 'DATE'}, {'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': 'Equity investments', 'category': 'DATE'}, {'entity': 'Swords', 'category': 'GPE'}, {'entity': 'Ireland', 'category': 'GPE'}, {'entity': 'BMS', 'category': 'GPE'}, {'entity': '$905 million', 'category': 'MONEY'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Daklinza', 'category': 'ORG'}, {'entity': 'R&D', 'category': 'ORG'}, {'entity': 'NKTR-214', 'category': 'ORG'}, {'entity': 'Nektar', 'category': 'ORG'}, {'entity': 'IFM', 'category': 'ORG'}, {'entity': 'CytomX', 'category': 'ORG'}, {'entity': 'Cardioxyl', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'NKTR-214', 'category': 'PRODUCT'}, {'entity': 'primarily', 'category': 'ORDINAL'}, {'entity': 'remaining', 'category': 'ORDINAL'}, {'entity': 'Research and development', 'category': 'ORDINAL'}, {'entity': '2018', 'category': 'ORDINAL'}, {'entity': 'Opdivo', 'category': 'ORDINAL'}, {'entity': 'a', 'category': 'ORDINAL'}, {'entity': 'Cormorant', 'category': 'ORDINAL'}, {'entity': 'b', 'category': 'ORDINAL'}, {'entity': 'Halozyme', 'category': 'ORDINAL'}, {'entity': 'Flexus', 'category': 'ORDINAL'}, {'entity': 'PsiOxus', 'category': 'ORDINAL'}, {'entity': 'Ono', 'category': 'ORDINAL'}, {'entity': 'Padlock', 'category': 'ORDINAL'}, {'entity': 'Nitto Denko', 'category': 'ORDINAL'}, {'entity': 'Other', 'category': 'ORDINAL'}, {'entity': 'F-Star', 'category': 'ORDINAL'}, {'entity': 'IPRD impairments', 'category': 'ORDINAL'}, {'entity': 'Site exit costs', 'category': 'ORDINAL'}, {'entity': '2017', 'category': 'ORDINAL'}, {'entity': 'Nektar', 'category': 'ORDINAL'}, {'entity': 'restructuring', 'category': 'ORDINAL'}, {'entity': 'Litigation and other settlements', 'category': 'ORDINAL'}, {'entity': '93', 'category': 'ORDINAL'}, {'entity': 'Divestiture gains', 'category': 'ORDINAL'}, {'entity': 'Transition and other service fees', 'category': 'ORDINAL'}, {'entity': 'Pension and postretirement', 'category': 'ORDINAL'}, {'entity': '27', 'category': 'ORDINAL'}, {'entity': 'Intangible asset impairment', 'category': 'ORDINAL'}, {'entity': 'Loss on debt redemption', 'category': 'ORDINAL'}, {'entity': '850', 'category': 'ORDINAL'}, {'entity': 'Loss/gain on equity investments', 'category': 'ORDINAL'}, {'entity': '$534 million', 'category': 'ORDINAL'}, {'entity': 'Restructuring charges', 'category': 'ORDINAL'}, {'entity': '753 million', 'category': 'CARDINAL'}, {'entity': '2017', 'category': 'CARDINAL'}, {'entity': '2018', 'category': 'CARDINAL'}, {'entity': 'Significant charges', 'category': 'CARDINAL'}, {'entity': '79', 'category': 'CARDINAL'}, {'entity': '383', 'category': 'CARDINAL'}, {'entity': '512', 'category': 'CARDINAL'}, {'entity': '131', 'category': 'CARDINAL'}, {'entity': '76', 'category': 'CARDINAL'}, {'entity': 'Equity in net income of affiliates', 'category': 'CARDINAL'}, {'entity': '178', 'category': 'CARDINAL'}, {'entity': 'Royalties and licensing income', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '353', 'category': 'CARDINAL'}, {'entity': '64', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '$268 million', 'category': 'CARDINAL'}, {'entity': '$826 million', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 22, 2017', 'category': 'DATE'}, {'entity': '2018', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': '$2.9 billion', 'category': 'DATE'}, {'entity': 'fourth quarter of 2017', 'category': 'DATE'}, {'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': 'Earnings Before Income Taxes', 'category': 'EVENT'}, {'entity': 'Provision for Income Taxes', 'category': 'EVENT'}, {'entity': 'Effective Tax Rate', 'category': 'EVENT'}, {'entity': 'Impact of Specified Items', 'category': 'EVENT'}, {'entity': 'Tax Cuts and Jobs Act of 2017', 'category': 'EVENT'}, {'entity': 'Specified Items', 'category': 'EVENT'}, {'entity': 'tax reform legislation', 'category': 'EVENT'}, {'entity': 'U.S. tax reform legislation known as the Tax Cuts and Jobs Act of 2017', 'category': 'EVENT'}, {'entity': 'Dollars', 'category': 'EVENT'}, {'entity': 'Millions', 'category': 'EVENT'}, {'entity': 'Revenue', 'category': 'EVENT'}, {'entity': 'income', 'category': 'EVENT'}, {'entity': 'tax rate', 'category': 'EVENT'}, {'entity': 'effective tax rate', 'category': 'EVENT'}, {'entity': 'tax system', 'category': 'EVENT'}, {'entity': 'deemed repatriation transition tax', 'category': 'EVENT'}, {'entity': 'foreign earnings and profits', 'category': 'EVENT'}, {'entity': 'new U.S. tax rate', 'category': 'EVENT'}, {'entity': 'tax expense', 'category': 'EVENT'}, {'entity': 'post-1986 foreign earnings and profits', 'category': 'EVENT'}, {'entity': 'foreign corporations', 'category': 'EVENT'}, {'entity': 'cash', 'category': 'EVENT'}, {'entity': 'assets', 'category': 'EVENT'}, {'entity': 'tax reserves', 'category': 'EVENT'}, {'entity': 'deferred tax assets', 'category': 'EVENT'}, {'entity': 'reduction of deferred tax assets', 'category': 'EVENT'}, {'entity': 'taxable income', 'category': 'EVENT'}, {'entity': 'raccomanded information', 'category': 'EVENT'}, {'entity': 'net periodic benefit cost credit', 'category': 'EVENT'}, {'entity': 'deferred tax assets', 'category': 'EVENT'}, {'entity': 'the interest cost, expected return on plan assets and amortization components of the net periodic benefit cost credit as well as net charges for settlements, curtailments and special termination benefits of', 'category': 'EVENT'}, {'entity': 'Intangible asset impairment includes $64 million in 2018 for an out-licensed asset obtained in the 2010 acquisition of ZymoGenetics, Inc., which did not meet its primary endpoint in a Phase II clinical study.', 'category': 'EVENT'}, {'entity': 'those earnings were effectively taxed', 'category': 'EVENT'}, {'entity': 'taxes attributed to internal cash repatriations and earnings mix between high and low tax jurisdictions', 'category': 'EVENT'}, {'entity': 'impact of specified items, the effective tax rate decreased by 1.0% in 2017 primarily due to the adoption of amended income tax accounting guidance related to share-based payments and the early adoption of intra-entity transfers of assets other than inventory partially offset', 'category': 'EVENT'}, {'entity': 'Refer to “Item 8. Financial Statements and Supplementary Data—Note 7. Income Taxes” for further information', 'category': 'EVENT'}, {'entity': 'R&D charges in connection with the acquisition or licensing of third-party intellectual property rights, divestiture gains or losses, pension, legal and other contractual settlement charges and debt redemption gains or losses, among other items', 'category': 'EVENT'}, {'entity': 'out-licensed asset obtained in the 2010 acquisition of ZymoGenetics', 'category': 'FAC'}, {'entity': 'diabetes product sales', 'category': 'FAC'}, {'entity': 'investigational HIV medicines', 'category': 'FAC'}, {'entity': 'OTC brands', 'category': 'FAC'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'Cupertino', 'category': 'LOC'}, {'entity': 'California', 'category': 'LOC'}, {'entity': '$481 million', 'category': 'MONEY'}, {'entity': '$70 million', 'category': 'MONEY'}, {'entity': '$42 million', 'category': 'MONEY'}, {'entity': '$109 million', 'category': 'MONEY'}, {'entity': '$50 million', 'category': 'MONEY'}, {'entity': '$25 million', 'category': 'MONEY'}, {'entity': '$2.9 billion', 'category': 'MONEY'}, {'entity': '$2.6 billion', 'category': 'MONEY'}, {'entity': '$285 million', 'category': 'MONEY'}, {'entity': '$56 million', 'category': 'MONEY'}, {'entity': 'Apple', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Merck', 'category': 'ORG'}, {'entity': 'Keytruda', 'category': 'ORG'}, {'entity': 'Roche', 'category': 'ORG'}, {'entity': 'Biogen', 'category': 'ORG'}, {'entity': 'Erbitux', 'category': 'ORG'}, {'entity': 'ZymoGenetics Inc.', 'category': 'ORG'}, {'entity': 'Hilton Hotel', 'category': 'ORG'}, {'entity': 'ZymoGenetics Inc.', 'category': 'ORG'}, {'entity': '17.1%', 'category': 'PERCENT'}, {'entity': '81.0%', 'category': 'PERCENT'}, {'entity': '23.8%', 'category': 'PERCENT'}, {'entity': '56.7%', 'category': 'PERCENT'}, {'entity': '0.9%', 'category': 'PERCENT'}, {'entity': '0.9%', 'category': 'PERCENT'}, {'entity': '3.3%', 'category': 'PERCENT'}, {'entity': '1.8%', 'category': 'PERCENT'}, {'entity': '3.9%', 'category': 'PERCENT'}, {'entity': '1.0%', 'category': 'PERCENT'}, {'entity': '$25 million', 'category': 'PERSON'}, {'entity': 'PD-1 antibody Keytruda*A debt', 'category': 'PRODUCT'}, {'entity': 'diabetes business', 'category': 'PRODUCT'}, {'entity': 'Erbitux*', 'category': 'PRODUCT'}, {'entity': 'multiple mature global product lines', 'category': 'PRODUCT'}, {'entity': 'OTC brands', 'category': 'PRODUCT'}, {'entity': 'investigational HIV medicines businesses', 'category': 'PRODUCT'}, {'entity': 'Mercks PD-1 antibody Keytruda*', 'category': 'PRODUCT'}, {'entity': 'certain investigational genetically defined disease compounds', 'category': 'PRODUCT'}, {'entity': 'diabetes business divestitures', 'category': 'PRODUCT'}, {'entity': 'the Companys earnings release for the fourth quarter of 2018', 'category': 'TIME'}, {'entity': '5PM', 'category': 'TIME'}, {'entity': '7PM', 'category': 'TIME'}, {'entity': 'Phase II clinical study', 'category': 'WORK_OF_ART'}, {'entity': 'fourth', 'category': 'ORDINAL'}, {'entity': '$481 million', 'category': 'CARDINAL'}, {'entity': '2017', 'category': 'CARDINAL'}, {'entity': '$70 million', 'category': 'CARDINAL'}, {'entity': '2018', 'category': 'CARDINAL'}, {'entity': '$42 million', 'category': 'CARDINAL'}, {'entity': '2018', 'category': 'CARDINAL'}, {'entity': '$15.5%', 'category': 'CARDINAL'}, {'entity': '8.0%', 'category': 'CARDINAL'}, {'entity': '$285 million', 'category': 'CARDINAL'}, {'entity': '2018', 'category': 'CARDINAL'}, {'entity': '$56 million', 'category': 'CARDINAL'}, {'entity': '2018', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Ireland', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'Ireland', 'category': 'LOC'}, {'entity': 'Ireland', 'category': 'LOC'}, {'entity': '$4,920', 'category': 'MONEY'}, {'entity': '1,007', 'category': 'MONEY'}, {'entity': '4,457', 'category': 'MONEY'}, {'entity': '1,596', 'category': 'MONEY'}, {'entity': '3,963', 'category': 'MONEY'}, {'entity': '293', 'category': 'MONEY'}, {'entity': '6,516', 'category': 'MONEY'}, {'entity': '4,970', 'category': 'MONEY'}, {'entity': '4,750', 'category': 'MONEY'}, {'entity': '$6,911', 'category': 'MONEY'}, {'entity': '5,421', 'category': 'MONEY'}, {'entity': '1,973', 'category': 'MONEY'}, {'entity': '1,391', 'category': 'MONEY'}, {'entity': '1,775', 'category': 'MONEY'}, {'entity': '2,480', 'category': 'MONEY'}, {'entity': '10,659', 'category': 'MONEY'}, {'entity': '9,292', 'category': 'MONEY'}, {'entity': '1,703', 'category': 'MONEY'}, {'entity': '987', 'category': 'MONEY'}, {'entity': '5,646', 'category': 'MONEY'}, {'entity': '6,975', 'category': 'MONEY'}, {'entity': '3,310', 'category': 'MONEY'}, {'entity': '1,330', 'category': 'MONEY'}, {'entity': '9.3 billion', 'category': 'MONEY'}, {'entity': '2.1 billion', 'category': 'MONEY'}, {'entity': 'U.S.', 'category': 'MONEY'}, {'entity': '$1.3 billion', 'category': 'MONEY'}, {'entity': '2019', 'category': 'MONEY'}, {'entity': '$2.6 billion', 'category': 'MONEY'}, {'entity': '2018', 'category': 'MONEY'}, {'entity': '2017', 'category': 'MONEY'}, {'entity': '2016', 'category': 'MONEY'}, {'entity': '$1.0 billion', 'category': 'MONEY'}, {'entity': '2018', 'category': 'MONEY'}, {'entity': '$1.1 billion', 'category': 'MONEY'}, {'entity': '2017', 'category': 'MONEY'}, {'entity': '$1.2 billion', 'category': 'MONEY'}, {'entity': '2016', 'category': 'MONEY'}, {'entity': '$800 million', 'category': 'MONEY'}, {'entity': '2019', 'category': 'MONEY'}, {'entity': '$600 million', 'category': 'MONEY'}, {'entity': '2020', 'category': 'MONEY'}, {'entity': '1.85 billion', 'category': 'MONEY'}, {'entity': '2018', 'category': 'MONEY'}, {'entity': 'December 31, 2018', 'category': 'MONEY'}, {'entity': '$5.0 billion', 'category': 'MONEY'}, {'entity': '$2.0 billion', 'category': 'MONEY'}, {'entity': 'March 2019', 'category': 'MONEY'}, {'entity': '$1.5 billion', 'category': 'MONEY'}, {'entity': 'September 2022', 'category': 'MONEY'}, {'entity': 'July 2023', 'category': 'MONEY'}, {'entity': '$33.5 billion', 'category': 'MONEY'}, {'entity': 'January 2019', 'category': 'MONEY'}, {'entity': '$8 billion', 'category': 'MONEY'}, {'entity': '$1 billion', 'category': 'MONEY'}, {'entity': '$4 billion', 'category': 'MONEY'}, {'entity': 'three-year', 'category': 'MONEY'}, {'entity': 'five-year', 'category': 'MONEY'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'U.S.', 'category': 'ORG'}, {'entity': 'Ireland', 'category': 'ORG'}, {'entity': 'U.S.', 'category': 'ORG'}, {'entity': '$19 million', 'category': 'ORG'}, {'entity': '1.27%', 'category': 'ORG'}, {'entity': '2018', 'category': 'ORG'}, {'entity': '300 million', 'category': 'ORG'}, {'entity': 'December 31, 2018', 'category': 'ORG'}, {'entity': 'Nektar', 'category': 'ORG'}, {'entity': 'December 31', 'category': 'PERSON'}, {'entity': '2018', 'category': 'PERSON'}, {'entity': '2017', 'category': 'PERSON'}, {'entity': '2016', 'category': 'PERSON'}, {'entity': 'December 31', 'category': 'TIME'}, {'entity': '2018', 'category': 'TIME'}, {'entity': '2017', 'category': 'TIME'}, {'entity': '2016', 'category': 'TIME'}, {'entity': '17', 'category': 'CARDINAL'}, {'entity': '146', 'category': 'CARDINAL'}, {'entity': '41', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '21', 'category': 'CARDINAL'}, {'entity': '58', 'category': 'CARDINAL'}, {'entity': '149', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1,135', 'category': 'CARDINAL'}, {'entity': '1,130', 'category': 'CARDINAL'}, {'entity': '439', 'category': 'CARDINAL'}, {'entity': '75', 'category': 'CARDINAL'}, {'entity': '13', 'category': 'CARDINAL'}, {'entity': '79', 'category': 'CARDINAL'}, {'entity': '383', 'category': 'CARDINAL'}, {'entity': '83', 'category': 'CARDINAL'}, {'entity': '1,214', 'category': 'CARDINAL'}, {'entity': '1,588', 'category': 'CARDINAL'}, {'entity': '535', 'category': 'CARDINAL'}, {'entity': '512', 'category': 'CARDINAL'}, {'entity': '70', 'category': 'CARDINAL'}, {'entity': '177', 'category': 'CARDINAL'}, {'entity': '126', 'category': 'CARDINAL'}, {'entity': '559', 'category': 'CARDINAL'}, {'entity': '75', 'category': 'CARDINAL'}, {'entity': '497', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '121', 'category': 'CARDINAL'}, {'entity': '162', 'category': 'CARDINAL'}, {'entity': '91', 'category': 'CARDINAL'}, {'entity': '64', 'category': 'CARDINAL'}, {'entity': '15', 'category': 'CARDINAL'}, {'entity': '109', 'category': 'CARDINAL'}, {'entity': '646', 'category': 'CARDINAL'}, {'entity': '540', 'category': 'CARDINAL'}, {'entity': '314', 'category': 'CARDINAL'}, {'entity': '1,920', 'category': 'CARDINAL'}, {'entity': '1,198', 'category': 'CARDINAL'}, {'entity': '242', 'category': 'CARDINAL'}, {'entity': '268', 'category': 'CARDINAL'}, {'entity': '87', 'category': 'CARDINAL'}, {'entity': '51', 'category': 'CARDINAL'}, {'entity': '56', 'category': 'CARDINAL'}, {'entity': '2,911', 'category': 'CARDINAL'}, {'entity': '324', 'category': 'CARDINAL'}, {'entity': '2,824', 'category': 'CARDINAL'}, {'entity': '1,596', 'category': 'CARDINAL'}, {'entity': '4,022', 'category': 'CARDINAL'}, {'entity': '59', 'category': 'CARDINAL'}, {'entity': '1,596', 'category': 'CARDINAL'}, {'entity': '3,963', 'category': 'CARDINAL'}, {'entity': '293', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'June 2016', 'category': 'DATE'}, {'entity': 'January 2019', 'category': 'DATE'}, {'entity': 'February 25, 2019', 'category': 'DATE'}, {'entity': '$25.5 billion', 'category': 'MONEY'}, {'entity': '$3.0 billion', 'category': 'MONEY'}, {'entity': '$2.0 billion', 'category': 'MONEY'}, {'entity': '$1.0 billion', 'category': 'MONEY'}, {'entity': '$7.6 billion', 'category': 'MONEY'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Moodys Investors Service', 'category': 'ORG'}, {'entity': 'Standard & Poors', 'category': 'ORG'}, {'entity': 'less than 3%', 'category': 'PERCENT'}, {'entity': 'Opdivo', 'category': 'WORK_OF_ART'}, {'entity': 'Yervoy', 'category': 'WORK_OF_ART'}, {'entity': 'Empliciti', 'category': 'WORK_OF_ART'}, {'entity': '$25.5 billion', 'category': 'CARDINAL'}, {'entity': '$3.0 billion', 'category': 'CARDINAL'}, {'entity': '$2.0 billion', 'category': 'CARDINAL'}, {'entity': '$1.0 billion', 'category': 'CARDINAL'}, {'entity': '364-day', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2019', 'category': 'CARDINAL'}, {'entity': '2020', 'category': 'CARDINAL'}, {'entity': '2022', 'category': 'CARDINAL'}, {'entity': '$7.6 billion', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '30', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}]\n",
      "[{'entity': '90 days', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': 'Dec 31, 2018.EVENTmanufacturing operations', 'category': 'DATE'}, {'entity': 'purchase of 8.3 million shares of Nektar common stock', 'category': 'DATE'}, {'entity': 'divestiture of manufacturing operations', 'category': 'DATE'}, {'entity': 'repurchase of common stock.LOCSwords', 'category': 'DATE'}, {'entity': 'Ireland', 'category': 'DATE'}, {'entity': 'Cupertino', 'category': 'DATE'}, {'entity': 'California.CARDINALfirst', 'category': 'DATE'}, {'entity': '3rd', 'category': 'DATE'}, {'entity': '900', 'category': 'DATE'}, {'entity': '500', 'category': 'DATE'}, {'entity': '8.3ORGSEC', 'category': 'DATE'}, {'entity': 'Form 10-QPERSONSEC', 'category': 'DATE'}, {'entity': 'Nektar', 'category': 'ORG'}, {'entity': 'IFM', 'category': 'ORG'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': '25%', 'category': 'PERCENT'}, {'entity': '5%', 'category': 'PERCENT'}, {'entity': '40%', 'category': 'PERCENT'}, {'entity': '90%', 'category': 'PERCENT'}, {'entity': '100%', 'category': 'PERCENT'}, {'entity': '100%', 'category': 'PERCENT'}, {'entity': '100%', 'category': 'PERCENT'}, {'entity': '100%', 'category': 'PERCENT'}, {'entity': '100%', 'category': 'PERCENT'}, {'entity': '100%', 'category': 'PERCENT'}, {'entity': '100%', 'category': 'PERCENT'}, {'entity': '100%.PERSONApple', 'category': 'PERCENT'}, {'entity': 'Nektar', 'category': 'PERCENT'}, {'entity': 'Swords', 'category': 'PERCENT'}, {'entity': 'Mary Shakespeare', 'category': 'PERCENT'}, {'entity': 'Peter and Lisa.', 'category': 'PERCENT'}, {'entity': '$800 million', 'category': 'CARDINAL'}, {'entity': '$900 million', 'category': 'CARDINAL'}, {'entity': '$500 million', 'category': 'CARDINAL'}, {'entity': '$1.5 billion', 'category': 'CARDINAL'}, {'entity': '$700 million', 'category': 'CARDINAL'}, {'entity': '$600 million', 'category': 'CARDINAL'}, {'entity': '$300 million', 'category': 'CARDINAL'}, {'entity': '$500 million', 'category': 'CARDINAL'}, {'entity': '$2.1 billion', 'category': 'CARDINAL'}, {'entity': '$2.2 billion', 'category': 'CARDINAL'}, {'entity': '$500 million', 'category': 'CARDINAL'}, {'entity': '$1.5 billion', 'category': 'CARDINAL'}, {'entity': '$2.1 billion', 'category': 'CARDINAL'}, {'entity': '$2.2 billion', 'category': 'CARDINAL'}, {'entity': '$900 million', 'category': 'CARDINAL'}, {'entity': '$14.0 billion', 'category': 'CARDINAL'}, {'entity': '$5.5 billion', 'category': 'CARDINAL'}, {'entity': '$8.5 billion', 'category': 'CARDINAL'}, {'entity': '$4.4 billion', 'category': 'CARDINAL'}, {'entity': '90', 'category': 'CARDINAL'}, {'entity': '8.3 million', 'category': 'CARDINAL'}, {'entity': '$454', 'category': 'CARDINAL'}, {'entity': '$6,776.', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'Item 8. Financial Statements and Supplementary Data—Note 1. Accounting Policies and Recently Issued Accounting Standards', 'category': 'DATE'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'United States', 'category': 'LOC'}, {'entity': 'U.S. Department of Defense', 'category': 'ORG'}, {'entity': 'U.S. Department of Veterans Affairs', 'category': 'ORG'}, {'entity': '340B Drug Pricing Program', 'category': 'ORG'}, {'entity': 'Medicaid', 'category': 'ORG'}, {'entity': 'Medicare', 'category': 'ORG'}, {'entity': 'CMS', 'category': 'ORG'}, {'entity': '2%', 'category': 'PERCENT'}, {'entity': 'Medicare Part D beneficiaries', 'category': 'PERSON'}, {'entity': 'five-step', 'category': 'QUANTITY'}]\n",
      "[{'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': '2018', 'category': 'DATE'}, {'entity': 'UPSA', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'BMS', 'category': 'LOC'}, {'entity': 'Bristol-Myers Squibb', 'category': 'ORG'}, {'entity': 'pain treatment', 'category': 'PRODUCT'}, {'entity': 'OTC products', 'category': 'PRODUCT'}, {'entity': '$500 million', 'category': 'QUANTITY'}, {'entity': '42 million', 'category': 'QUANTITY'}, {'entity': '1.1 billion', 'category': 'QUANTITY'}, {'entity': '“Item 8. Financial Statements and Supplementary Data—Note 16. Retirement Benefits.”', 'category': 'WORK_OF_ART'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2018', 'category': 'DATE'}, {'entity': 'exchange offer', 'category': 'EVENT'}, {'entity': 'IPO', 'category': 'EVENT'}, {'entity': 'Mead Johnson', 'category': 'ORG'}, {'entity': 'Internal Revenue Service', 'category': 'ORG'}, {'entity': 'ELA', 'category': 'ORG'}, {'entity': '21%', 'category': 'PERCENT'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'three', 'category': 'QUANTITY'}, {'entity': 'two', 'category': 'QUANTITY'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'fourth', 'category': 'ORDINAL'}, {'entity': '21%', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'August 2018', 'category': 'DATE'}, {'entity': 'July 2018', 'category': 'DATE'}, {'entity': 'June 2018', 'category': 'DATE'}, {'entity': 'April 2018', 'category': 'DATE'}, {'entity': 'January 2019', 'category': 'DATE'}, {'entity': 'October 2018', 'category': 'DATE'}, {'entity': 'Various', 'category': 'DATE'}, {'entity': 'February 2019', 'category': 'DATE'}, {'entity': 'May 2018', 'category': 'DATE'}, {'entity': 'Approval in Japan for treatment of adjuvant melanoma', 'category': 'EVENT'}, {'entity': 'EC approval for the adjuvant treatment of adult patients with involvement of lymph nodes or metastatic disease who have undergone complete resection', 'category': 'EVENT'}, {'entity': 'Announced results from the Phase III CheckMate-238 trial evaluating Opdivo versus Yervoy in patients with stage IIIB/C or stage IV melanoma who are at high risk of recurrence following complete surgical resection demonstrated statistically longer recurrence-free survival for Opdivo', 'category': 'EVENT'}, {'entity': 'the primary endpoint of the study', 'category': 'EVENT'}, {'entity': 'versus Yervoy at a minimum follow-up of 24 months across key subgroups', 'category': 'EVENT'}, {'entity': 'including disease stages and BRAF mutation status', 'category': 'EVENT'}, {'entity': 'Announced in June 2018 that the FDA lifted a partial clinical hold placed on CheckMate-602', 'category': 'EVENT'}, {'entity': 'a randomized', 'category': 'EVENT'}, {'entity': 'open-label Phase III study evaluating the addition of Opdivo to pomalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma. The decision follows consultation with the FDA and agreement on amendments to the study protocol. In August 2018', 'category': 'EVENT'}, {'entity': 'the Company discontinued further enrollment of this study following a futility analysis', 'category': 'EVENT'}, {'entity': 'Approval in China for the treatment of locally advanced or metastatic NSCLC after prior platinum-based chemotherapy in adult patients without EGFR or ALK genomic tumor aberrations', 'category': 'EVENT'}, {'entity': 'Announced that the pivotal', 'category': 'EVENT'}, {'entity': 'randomized Phase III CheckMate-078 trial evaluating Opdivo versus docetaxel in a predominantly Chinese population with previously treated advanced NSCLC demonstrated superior overall survival benefit in the primary endpoint regardless of PD-L1 expression or tumor histology', 'category': 'EVENT'}, {'entity': 'Acceptance in China of sBLA filing for patients who had previously been treated for metastatic or recurrent SCCHN', 'category': 'EVENT'}, {'entity': 'Announced two-year overall survival data from CheckMate-141', 'category': 'EVENT'}, {'entity': 'a Phase III study', 'category': 'EVENT'}, {'entity': 'evaluating Opdivo compared with investigator’s choice chemotherapy cetuximab', 'category': 'EVENT'}, {'entity': 'docetaxel or methotrexate in patients with recurrent or metastatic SCCHN after failure on platinum-based therapy', 'category': 'EVENT'}, {'entity': 'Announced topline results from the Phase III CheckMate-331 study did not meet its primary endpoint of overall survival with Opdivo versus chemotherapy in patients with previously treated relapsed SCLC', 'category': 'EVENT'}, {'entity': 'FDA approval as the first and only IO treatment option for patients with metastatic SCLC whose cancer has progressed after platinum-based chemotherapy and at least one other line of therapy', 'category': 'EVENT'}, {'entity': 'Approval in Japan for patients with MPM which has progressed after chemotherapy', 'category': 'EVENT'}, {'entity': 'Approval in Japan of an every 2 week/30 minute infusion dose and administration schedule for Opdivo in six indications', 'category': 'EVENT'}, {'entity': 'Announced preliminary data from the ongoing PIVOT Phase I/II Study', 'category': 'EVENT'}, {'entity': 'which is evaluating the combination of Opdivo with Nektars investigational medicine', 'category': 'EVENT'}, {'entity': 'NKTR-214. The preliminary results presented at the 2018 American Society of Clinical Oncology reported safety', 'category': 'EVENT'}, {'entity': 'efficacy and biomarker data for patients enrolled in the Phase I dose-escalation stage of the study and for the first patients consecutively enrolled in select dose expansion cohorts in Phase II', 'category': 'EVENT'}, {'entity': 'EC approval of an every four-week Q4W Opdivo dosing schedule of 480 mg infused over 60 minutes as an option for patients with advanced melanoma and previously treated RCC as well as the approval of a two-week Opdivo dosing option of 240 mg infused over 30 minutes to replace weight-based dosing for all six approved monotherapy indications in the EU', 'category': 'EVENT'}, {'entity': 'FDA approval of the Companys sBLA to update Opdivo dosing to include 480 mg infused every four weeks for a majority of approved indications as well as a shorter 30 minute infusion across all approved indications', 'category': 'EVENT'}, {'entity': 'Announced new data from a cohort of the CheckMate-142 study in which Opdivo plus low-dose Yervoy demonstrated durable clinical benefit as a first-line treatment in patients with MSI-H or dMMR mCRC', 'category': 'EVENT'}, {'entity': 'FDA approval of Opdivo plus low-dose Yervoy for the treatment of adult and pediatric patients 12 years and older with MSI-H or dMMR mCRC that has progressed following treatment with a fluoropyrimidine', 'category': 'EVENT'}, {'entity': 'oxaliplatin and irinotecan', 'category': 'EVENT'}, {'entity': 'Announced results from an interim analysis of the Phase II CheckMate-650 trial evaluating Opdivo+Yervoy in patients with mCRPC showed that among 32 asymptomatic or minimally symptomatic patients whose disease had progressed after second-generation hormone therapy and who had not received chemotherapy cohort 1', 'category': 'EVENT'}, {'entity': 'with a median follow-up of 11.9 months', 'category': 'EVENT'}, {'entity': 'the objective response rate was 25%. Additionally', 'category': 'EVENT'}, {'entity': 'among 30 patients whose disease progressed after taxane-based chemotherapy cohort 2', 'category': 'EVENT'}, {'entity': 'with a median follow-up of 13.5 months', 'category': 'EVENT'}, {'entity': 'the objective response rate was 10%', 'category': 'EVENT'}, {'entity': 'Announced four-year data from the Phase III CheckMate-067 clinical trial which continues to demonstrate durable', 'category': 'EVENT'}, {'entity': 'long-term survival benefits with the first-line combination of Opdivo+Yervoy', 'category': 'EVENT'}, {'entity': 'versus Yervoy alone', 'category': 'EVENT'}, {'entity': 'in patients with advanced melanoma', 'category': 'EVENT'}, {'entity': 'Approval in Japan of Opdivo+Yervoy combination for chemotherapy-naive patients with unresectable melanoma', 'category': 'EVENT'}, {'entity': 'Announced follow-up data evaluating Opdivo monotherapy and Opdivo in combination with Yervoy in patients with platinum-pretreated mUC. Results from the Phase I/II CheckMate-032 trial showed that patients who received the combination of Opdivo1 mg/kg plus Yervoy 3 mg/kg experienced a higher objective response rate compared to those who received Opdivo 3 mg/kg plus Yervoy 1 mg/kg or Opdivo alone', 'category': 'EVENT'}, {'entity': 'Announced voluntary withdrawal of the Companys sBLA for the Opdivo plus low-dose Yervoy for treatment of first-line advanced NSCLC in patients with TMB greater than or equal to 10 mutations per megabase as data from CheckMate-227', 'category': 'EVENT'}, {'entity': 'Part 1a', 'category': 'EVENT'}, {'entity': 'will not be available within the PDUFA goal date of May 20', 'category': 'EVENT'}, {'entity': '2019', 'category': 'EVENT'}, {'entity': 'Announced updates regarding regulatory actions by the CHMP in the EU for the ongoing review of its applications for an indication in metastatic first-line NSCLC with Opdivo plus low-dose Yervoy in patients with TMB greater than or equal to 10 mutations per megabase. The CHMP requested additional information from CheckMate-227', 'category': 'EVENT'}, {'entity': 'including an overall survival analysis of Opdivo+Yervoy in patients who have TMB less than 10 mutations per megabase', 'category': 'EVENT'}, {'entity': 'Announced results from a part of the Phase III CheckMate-227 trial that evaluated Opdivo plus low-dose Yervoy and Opdivo plus chemotherapy versus chemotherapy in patients with first-line NSCLC with PD-L1 expression <1%', 'category': 'EVENT'}, {'entity': 'across squamous and non-squamous tumor histologies extended progression-free survival', 'category': 'EVENT'}]\n",
      "[{'entity': 'February 2019', 'category': 'DATE'}, {'entity': 'January 2019', 'category': 'DATE'}, {'entity': 'August 2018', 'category': 'DATE'}, {'entity': 'June 2018', 'category': 'DATE'}, {'entity': 'April 2018', 'category': 'DATE'}, {'entity': 'November 2018', 'category': 'DATE'}, {'entity': 'January 2018', 'category': 'DATE'}, {'entity': 'September 2018', 'category': 'DATE'}, {'entity': 'CheckMate-214 study', 'category': 'EVENT'}, {'entity': 'CheckMate-214 trial', 'category': 'EVENT'}, {'entity': 'CheckMate-451 study', 'category': 'EVENT'}, {'entity': 'Phase II study', 'category': 'EVENT'}, {'entity': 'Japan', 'category': 'LOC'}, {'entity': 'EMA', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Yervoy', 'category': 'ORG'}, {'entity': 'EC', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'NVAF', 'category': 'ORG'}, {'entity': 'BMS-986165', 'category': 'ORG'}, {'entity': 'Opdivo+Yervoy combination', 'category': 'PRODUCT'}, {'entity': 'BMS-986165', 'category': 'PRODUCT'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '10', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': 'Financial Instruments and Fair Value Measurements', 'category': 'EVENT'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'Accumulated other', 'category': 'LOC'}, {'entity': 'Accumulated other', 'category': 'LOC'}, {'entity': '$231 million', 'category': 'MONEY'}, {'entity': '$175 million', 'category': 'MONEY'}, {'entity': '$482 million', 'category': 'MONEY'}, {'entity': '$569 million', 'category': 'MONEY'}, {'entity': 'Foreign Exchange RiskSignificant', 'category': 'ORG'}, {'entity': 'Foreign Exchange RiskSignificant', 'category': 'ORG'}, {'entity': '10%', 'category': 'PERCENT'}, {'entity': '100', 'category': 'PERCENT'}, {'entity': '100', 'category': 'PERCENT'}, {'entity': 'Accumulated other comprehensive loss', 'category': 'PERSON'}, {'entity': '100', 'category': 'QUANTITY'}, {'entity': '\"Item 8. Financial Statements and Supplementary Data—Note 9. Financial Instruments and Fair Value Measurements', 'category': 'TIME'}, {'entity': 'Foreign Exchange RiskSignificant', 'category': 'WORK_OF_ART'}, {'entity': 'Foreign Exchange RiskSignificant', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '231 million', 'category': 'CARDINAL'}, {'entity': '175 million', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '31, 2018', 'category': 'CARDINAL'}, {'entity': '31, 2017', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '31, 2018', 'category': 'CARDINAL'}, {'entity': '31, 2017', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '31, 2018', 'category': 'CARDINAL'}, {'entity': '31, 2017', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '31, 2018', 'category': 'CARDINAL'}, {'entity': '31, 2017', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '31, 2018', 'category': 'CARDINAL'}, {'entity': '31, 2017', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '31, 2018', 'category': 'CARDINAL'}, {'entity': '31, 2017', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}]\n",
      "/Users/tanmayiballa/Desktop/KG-LLM/l715_23-1/data/10-Ks/Bristol-Myers_Squibb_Company/2021/Management_gpt-3.5-turbo_NER_response.json\n",
      "[{'entity': '2020', 'category': 'DATE'}, {'entity': 'full year', 'category': 'DATE'}, {'entity': 'November 20, 2019', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': 'November 17, 2020', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': 'large B-cell lymphoma', 'category': 'DATE'}, {'entity': 'significant risks and disruptions', 'category': 'EVENT'}, {'entity': 'COVID-19 pandemic', 'category': 'EVENT'}, {'entity': 'full year', 'category': 'EVENT'}, {'entity': 'acquisition', 'category': 'EVENT'}, {'entity': 'acquisitions', 'category': 'EVENT'}, {'entity': 'COVID-19 pandemic', 'category': 'EVENT'}, {'entity': 'deucravacitinib', 'category': 'EVENT'}, {'entity': 'mavacamten', 'category': 'EVENT'}, {'entity': 'The U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'EU', 'category': 'LOC'}, {'entity': 'Japan', 'category': 'LOC'}, {'entity': '$13.1 billion', 'category': 'MONEY'}, {'entity': '$15.7 billion', 'category': 'MONEY'}, {'entity': '2020', 'category': 'MONEY'}, {'entity': '2.01', 'category': 'MONEY'}, {'entity': 'Bristol-Myers Squibb Company', 'category': 'ORG'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': 'November 20, 2019', 'category': 'ORG'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': '2020 Form 10-K', 'category': 'ORG'}, {'entity': 'MyoKardia', 'category': 'ORG'}, {'entity': 'November 17, 2020', 'category': 'ORG'}, {'entity': 'MyoKardia', 'category': 'ORG'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': 'MyoKardia', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Opdivo+Yervoy', 'category': 'ORG'}, {'entity': 'Revlimid', 'category': 'ORG'}, {'entity': 'Pomalyst', 'category': 'ORG'}, {'entity': 'Zeposia', 'category': 'ORG'}, {'entity': 'Onureg', 'category': 'ORG'}, {'entity': 'liso-cel', 'category': 'ORG'}, {'entity': 'CELMoD', 'category': 'ORG'}, {'entity': 'BCMA', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'TYK2', 'category': 'ORG'}, {'entity': 'Factor XIa', 'category': 'ORG'}, {'entity': 'MyoKardia', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': 'IPRD', 'category': 'ORG'}, {'entity': 'inventory fair value adjustments', 'category': 'ORG'}, {'entity': 'tax charges', 'category': 'ORG'}, {'entity': 'Otezla', 'category': 'ORG'}, {'entity': 'fair value adjustments', 'category': 'ORG'}, {'entity': 'Dollars', 'category': 'ORG'}, {'entity': 'non-GAAP', 'category': 'ORG'}, {'entity': '60%', 'category': 'PERCENT'}, {'entity': 'December 31', 'category': 'PERSON'}, {'entity': 'Otezla', 'category': 'PERSON'}, {'entity': '2020', 'category': 'TIME'}, {'entity': '2020', 'category': 'TIME'}, {'entity': 'Opdivo+Yervoy', 'category': 'WORK_OF_ART'}, {'entity': '13', 'category': 'CARDINAL'}, {'entity': '2020', 'category': 'CARDINAL'}, {'entity': '60', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2019', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2020', 'category': 'CARDINAL'}, {'entity': '60', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '15.7 billion', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '175', 'category': 'CARDINAL'}, {'entity': '2019', 'category': 'CARDINAL'}, {'entity': '63', 'category': 'CARDINAL'}, {'entity': '2.01', 'category': 'CARDINAL'}, {'entity': '15.7 billion', 'category': 'CARDINAL'}, {'entity': '60', 'category': 'CARDINAL'}]\n",
      "[{'entity': '2022', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': 'recovery', 'category': 'EVENT'}, {'entity': 'pandemic', 'category': 'EVENT'}, {'entity': 'manufacturing facilities', 'category': 'EVENT'}, {'entity': 'commercialization', 'category': 'EVENT'}, {'entity': 'availability', 'category': 'EVENT'}, {'entity': 'patient assistance programs', 'category': 'EVENT'}, {'entity': 'clinical development activities', 'category': 'EVENT'}, {'entity': 'financial markets', 'category': 'EVENT'}, {'entity': 'changes to tax laws', 'category': 'EVENT'}, {'entity': 'pricing laws', 'category': 'EVENT'}, {'entity': 'importation restrictions', 'category': 'EVENT'}, {'entity': 'participation in clinical programs', 'category': 'EVENT'}, {'entity': 'financial flexibility', 'category': 'EVENT'}, {'entity': 'economic conditions', 'category': 'EVENT'}, {'entity': 'transition period', 'category': 'EVENT'}, {'entity': 'Hilton Hotel', 'category': 'FAC'}, {'entity': 'harvests', 'category': 'FAC'}, {'entity': 'warehouse', 'category': 'FAC'}, {'entity': 'Feit', 'category': 'FAC'}, {'entity': 'warehouse', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Paris', 'category': 'GPE'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Canada', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Canada', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'EU', 'category': 'GPE'}, {'entity': 'UK', 'category': 'GPE'}, {'entity': 'EU', 'category': 'GPE'}, {'entity': 'UK', 'category': 'GPE'}, {'entity': 'EU', 'category': 'GPE'}, {'entity': 'Cupertino', 'category': 'LOC'}, {'entity': 'California', 'category': 'LOC'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': 'Mary', 'category': 'PERSON'}, {'entity': 'Peter', 'category': 'PERSON'}, {'entity': 'Lisa', 'category': 'PERSON'}, {'entity': '5PM', 'category': 'TIME'}, {'entity': '7PM', 'category': 'TIME'}, {'entity': '2020', 'category': 'TIME'}, {'entity': '2021', 'category': 'TIME'}, {'entity': 'December 31, 2020', 'category': 'TIME'}, {'entity': 'Zeposia', 'category': 'WORK_OF_ART'}, {'entity': 'Reblozyl', 'category': 'WORK_OF_ART'}, {'entity': 'Onureg', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '2021', 'category': 'CARDINAL'}, {'entity': '53', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}]\n",
      "[{'entity': '2020', 'category': 'DATE'}, {'entity': 'Dec 23, 2022', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': 'September 2020', 'category': 'DATE'}, {'entity': 'June 2020', 'category': 'DATE'}, {'entity': 'May 2020', 'category': 'DATE'}, {'entity': 'April 2020', 'category': 'DATE'}, {'entity': 'March 2020', 'category': 'DATE'}, {'entity': 'January 2021', 'category': 'DATE'}, {'entity': 'February 2021', 'category': 'DATE'}, {'entity': 'early 2021', 'category': 'DATE'}, {'entity': 'the treatment of adults with unresectable advanced, recurrent or metastatic ESCC after prior fluoropyrimidine- and platinum-based combination chemotherapy', 'category': 'EVENT'}, {'entity': 'the treatment of adult patients with metastatic NSCLC whose tumors have no sensitizing epidermal growth factor receptor mutation or anaplastic lymphoma kinase translocation', 'category': 'EVENT'}, {'entity': 'the first-line treatment of adult patients with unresectable MPM', 'category': 'EVENT'}, {'entity': 'the continued treatment of adult patients with AML who achieved first complete remission or complete remission with incomplete blood count recovery following intensive induction chemotherapy and who are not able to complete intensive curative therapy', 'category': 'EVENT'}, {'entity': 'the treatment of adult patients with transfusion-dependent anemia due to very low-, low- and intermediate-risk MDS with ring sideroblasts, who had an unsatisfactory response or are ineligible for erythropoietin-based therapy, or beta thalassemia', 'category': 'EVENT'}, {'entity': 'the treatment of patients with unresectable advanced, recurrent or metastic ESCC after prior fluoropyrimidine- and platinum-based chemotherapy', 'category': 'EVENT'}, {'entity': 'the treatment of adult patients with RRMS with active disease as defined by clinical or imaging features', 'category': 'EVENT'}, {'entity': 'given with two cycles of platinum-doublet chemotherapy for the first-line treatment of adult patients with metastatic or recurrent NSCLC with no EGFR or ALK genomic tumor aberrations', 'category': 'EVENT'}, {'entity': 'first-line treatment of adult patients with metastatic NSCLC whose tumors express PD-L1 ≥1% with no EGFR or ALK genomic tumor aberrations', 'category': 'EVENT'}, {'entity': 'patients with AIDS-related Kaposi sarcoma whose disease has become resistant to highly active antiretroviral therapy, or in patients with Kaposi sarcoma who are HIV-negative', 'category': 'EVENT'}, {'entity': 'the treatment of anemia failing an erythropoiesis stimulating agent in adult patients with very low- to intermediate-risk MDS who have ring sideroblasts and require RBC transfusions', 'category': 'EVENT'}, {'entity': 'for the treatment of adults with RMS, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease', 'category': 'EVENT'}, {'entity': 'combination for the treatment of HCC in patients who have been previously treated with sorafenib', 'category': 'EVENT'}, {'entity': 'approval of the use of Opdivo in combination with Cabometyx* for the first-line treatment of patients with advanced RCC', 'category': 'EVENT'}, {'entity': 'the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy', 'category': 'EVENT'}, {'entity': 'approved for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis, post-polycythaemia vera myelofibrosis or post-essential thrombocythaemia myelofibrosis, who are Janus Associated Kinase inhibitor naïve or have been treated with ruxolitinib', 'category': 'EVENT'}]\n",
      "[{'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Apple', 'category': 'ORG'}, {'entity': 'Yervoy', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'Revlimid', 'category': 'ORG'}, {'entity': 'Pomalyst', 'category': 'ORG'}, {'entity': 'Orencia', 'category': 'ORG'}, {'entity': 'Sprycel', 'category': 'ORG'}, {'entity': 'Reblozyl', 'category': 'ORG'}, {'entity': 'Inrebic', 'category': 'ORG'}, {'entity': 'Zeposia', 'category': 'ORG'}, {'entity': 'Onureg', 'category': 'ORG'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': 'MyoKardia', 'category': 'ORG'}, {'entity': 'Dragonfly', 'category': 'ORG'}, {'entity': 'Forbius', 'category': 'ORG'}]\n",
      "[{'entity': 'each significant category of GTN adjustments were as follows', 'category': 'DATE'}, {'entity': '$\\t391', 'category': 'DATE'}, {'entity': '$\\t1', 'category': 'DATE'}, {'entity': '859', 'category': 'DATE'}, {'entity': '$\\t2', 'category': 'DATE'}, {'entity': '416', 'category': 'DATE'}, {'entity': '$\\t4', 'category': 'DATE'}, {'entity': '666', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2020Dollars', 'category': 'DATE'}, {'entity': 'Millions\\tCharge-Backs', 'category': 'DATE'}, {'entity': 'Cash Discounts\\t\\tMedicaid', 'category': 'DATE'}, {'entity': 'Medicare Rebates\\t\\tOther Rebates', 'category': 'DATE'}, {'entity': 'Returns', 'category': 'DATE'}, {'entity': 'Discounts and Adjustments\\t\\tTotalBalance', 'category': 'DATE'}, {'entity': 'Provision related to sales made in', 'category': 'DATE'}, {'entity': '2020\\t5', 'category': 'DATE'}, {'entity': '824', 'category': 'DATE'}, {'entity': '7', 'category': 'DATE'}, {'entity': '687', 'category': 'DATE'}, {'entity': '5', 'category': 'DATE'}, {'entity': '290', 'category': 'DATE'}, {'entity': '18', 'category': 'DATE'}, {'entity': '801', 'category': 'DATE'}, {'entity': 'Period\\t3', 'category': 'DATE'}, {'entity': '92', 'category': 'DATE'}, {'entity': '17', 'category': 'DATE'}, {'entity': '106', 'category': 'DATE'}, {'entity': 'Payments and returns', 'category': 'DATE'}, {'entity': '5', 'category': 'DATE'}, {'entity': '586', 'category': 'DATE'}, {'entity': '6', 'category': 'DATE'}, {'entity': '859', 'category': 'DATE'}, {'entity': '4', 'category': 'DATE'}, {'entity': '820', 'category': 'DATE'}, {'entity': 'Balance at December 31', 'category': 'DATE'}, {'entity': '2020\\t$\\t645', 'category': 'DATE'}, {'entity': '2', 'category': 'DATE'}, {'entity': '595', 'category': 'DATE'}, {'entity': '3', 'category': 'DATE'}, {'entity': '093', 'category': 'DATE'}, {'entity': '6', 'category': 'DATE'}, {'entity': '333', 'category': 'DATE'}, {'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': '2020\\t\\t% ChangeDollars', 'category': 'DATE'}, {'entity': '2020\\t\\t2019\\t\\t2020 vs. 2019Gross product sales', 'category': 'DATE'}, {'entity': '$\\t60', 'category': 'DATE'}, {'entity': '016', 'category': 'DATE'}, {'entity': '$\\t37', 'category': 'DATE'}, {'entity': '206', 'category': 'DATE'}, {'entity': '61 \\t%GTN Adjustments\\t\\t\\t\\t\\tCharge-backs', 'category': 'DATE'}, {'entity': '5', 'category': 'DATE'}, {'entity': '827', 'category': 'DATE'}, {'entity': '3', 'category': 'DATE'}, {'entity': '675', 'category': 'DATE'}, {'entity': '59 \\t%Medicaid and Medicare rebates', 'category': 'DATE'}, {'entity': '7', 'category': 'DATE'}, {'entity': '595', 'category': 'DATE'}, {'entity': '4', 'category': 'DATE'}, {'entity': '941', 'category': 'DATE'}, {'entity': '54 \\t%Other rebates', 'category': 'DATE'}, {'entity': 'returns', 'category': 'DATE'}, {'entity': '5', 'category': 'DATE'}, {'entity': '273', 'category': 'DATE'}, {'entity': '3', 'category': 'DATE'}, {'entity': '416', 'category': 'DATE'}, {'entity': '54 \\t%Total GTN Adjustments', 'category': 'DATE'}, {'entity': '18', 'category': 'DATE'}, {'entity': '695', 'category': 'DATE'}, {'entity': '12', 'category': 'DATE'}, {'entity': '032', 'category': 'DATE'}, {'entity': '55 \\t%Net product sales', 'category': 'DATE'}, {'entity': '$\\t41', 'category': 'DATE'}, {'entity': '321', 'category': 'DATE'}, {'entity': '$\\t25', 'category': 'DATE'}, {'entity': '174', 'category': 'DATE'}, {'entity': '64 \\t%\\t\\t\\t\\t\\tGTN adjustments percentage', 'category': 'DATE'}, {'entity': '31 \\t%\\t\\t32 \\t%\\t\\t1', 'category': 'DATE'}, {'entity': '%U.S.\\t37 \\t%\\t\\t40 \\t%\\t\\t3', 'category': 'DATE'}, {'entity': '%Non-U.S.\\t16 \\t%\\t\\t15 \\t%\\t\\t1', 'category': 'DATE'}, {'entity': '%Reductions to provisions for product sales made in prior periods resulting from changes in estimates were', 'category': 'DATE'}, {'entity': '$\\t106', 'category': 'DATE'}, {'entity': '2020 and 2019', 'category': 'DATE'}, {'entity': 'respectively', 'category': 'DATE'}, {'entity': 'primarily a function of product sales volume', 'category': 'DATE'}, {'entity': 'regional and payer channel mix', 'category': 'DATE'}, {'entity': 'contractual or legislative discounts and rebates. U', 'category': 'DATE'}, {'entity': 'S. GTN adjustments percentage decreased primarily due to the addition of Celgene hematology brands', 'category': 'DATE'}, {'entity': 'which have lower GTN adjustment percentages', 'category': 'DATE'}, {'entity': 'partially offset by higher U.S. Eliquis gross product sales', 'category': 'DATE'}, {'entity': 'which have higher U.S. GTN adjustment percentages.Product Revenues', 'category': 'DATE'}, {'entity': '2020\\t\\t2019\\t\\t2020 vs. 2019Prioritized Brands', 'category': 'DATE'}, {'entity': 'Revlimid\\t$\\t12', 'category': 'DATE'}, {'entity': '106', 'category': 'DATE'}, {'entity': '$\\t1', 'category': 'DATE'}, {'entity': '299', 'category': 'DATE'}, {'entity': '**U.S.\\t8', 'category': 'DATE'}, {'entity': '291', 'category': 'DATE'}, {'entity': '899', 'category': 'DATE'}, {'entity': '**Non-U.S.\\t3', 'category': 'DATE'}, {'entity': '815', 'category': 'DATE'}, {'entity': '400', 'category': 'DATE'}, {'entity': '**\\t\\t\\t\\t\\tEliquis\\t9', 'category': 'DATE'}, {'entity': '168', 'category': 'DATE'}, {'entity': '7', 'category': 'DATE'}, {'entity': '929', 'category': 'DATE'}, {'entity': '16 \\t%U.S.\\t5', 'category': 'DATE'}, {'entity': '485', 'category': 'DATE'}, {'entity': '4', 'category': 'DATE'}, {'entity': '755', 'category': 'DATE'}, {'entity': '15 \\t%Non-U.S.\\t3', 'category': 'DATE'}, {'entity': '683', 'category': 'DATE'}, {'entity': '3', 'category': 'DATE'}, {'entity': '174', 'category': 'DATE'}, {'entity': '16 \\t%\\t\\t\\t\\t\\tOpdivo\\t6', 'category': 'DATE'}, {'entity': '992', 'category': 'DATE'}, {'entity': '7', 'category': 'DATE'}, {'entity': '204', 'category': 'DATE'}, {'entity': '3\\t%U.S.\\t3', 'category': 'DATE'}, {'entity': '945', 'category': 'DATE'}, {'entity': '4', 'category': 'DATE'}, {'entity': '344', 'category': 'DATE'}, {'entity': '9\\t%Non-U.S.\\t3', 'category': 'DATE'}, {'entity': '047', 'category': 'DATE'}, {'entity': '2', 'category': 'DATE'}, {'entity': '860', 'category': 'DATE'}, {'entity': '7 \\t%\\t\\t\\t\\t\\tOrencia\\t3', 'category': 'DATE'}, {'entity': '157', 'category': 'DATE'}, {'entity': '2', 'category': 'DATE'}, {'entity': '977', 'category': 'DATE'}, {'entity': '6 \\t%U.S.\\t2', 'category': 'DATE'}, {'entity': '268', 'category': 'DATE'}, {'entity': '2', 'category': 'DATE'}, {'entity': '146', 'category': 'DATE'}, {'entity': '6 \\t%Non-U.S.\\t889', 'category': 'DATE'}, {'entity': '831', 'category': 'DATE'}, {'entity': '7 \\t%\\t\\t\\t\\t\\tPomalyst/Imnovid\\t3', 'category': 'DATE'}, {'entity': '070', 'category': 'DATE'}, {'entity': '322', 'category': 'DATE'}, {'entity': '**U.S.\\t2', 'category': 'DATE'}, {'entity': '136', 'category': 'DATE'}, {'entity': '226', 'category': 'DATE'}, {'entity': '**Non-U.S.\\t934', 'category': 'DATE'}, {'entity': '96', 'category': 'DATE'}, {'entity': '**\\t\\t\\t\\t\\tSprycel\\t2', 'category': 'DATE'}, {'entity': '140', 'category': 'DATE'}, {'entity': '2', 'category': 'DATE'}, {'entity': '110', 'category': 'DATE'}, {'entity': '1 \\t%U.S.\\t1', 'category': 'DATE'}, {'entity': '295', 'category': 'DATE'}, {'entity': '1', 'category': 'DATE'}, {'entity': '191', 'category': 'DATE'}, {'entity': '9 \\t%Non-U.S.\\t845', 'category': 'DATE'}, {'entity': '919', 'category': 'DATE'}, {'entity': '8\\t%\\t\\t\\t\\t\\tYervoy\\t1', 'category': 'DATE'}, {'entity': '682', 'category': 'DATE'}, {'entity': '1', 'category': 'DATE'}, {'entity': '489', 'category': 'DATE'}, {'entity': '13 \\t%U.S.\\t1', 'category': 'DATE'}, {'entity': '124', 'category': 'DATE'}, {'entity': '1', 'category': 'DATE'}, {'entity': '004', 'category': 'DATE'}, {'entity': '12 \\t%Non-U.S.\\t558', 'category': 'DATE'}, {'entity': '485', 'category': 'DATE'}, {'entity': '15 \\t%\\t\\t\\t\\t\\tAbraxane\\t1', 'category': 'DATE'}, {'entity': '247', 'category': 'DATE'}, {'entity': '166', 'category': 'DATE'}, {'entity': '**U.S.\\t873', 'category': 'DATE'}, {'entity': '122', 'category': 'DATE'}, {'entity': '**Non-U.S.\\t374', 'category': 'DATE'}, {'entity': '44', 'category': 'DATE'}, {'entity': '**\\t\\t\\t\\t\\tEmpliciti\\t381', 'category': 'DATE'}, {'entity': '357', 'category': 'DATE'}, {'entity': '7 \\t%U.S.\\t230', 'category': 'DATE'}, {'entity': '246', 'category': 'DATE'}, {'entity': '7\\t%Non-U.S.\\t151', 'category': 'DATE'}, {'entity': '111', 'category': 'DATE'}, {'entity': '36 \\t%\\t\\t\\t\\t\\tReblozyl\\t274', 'category': 'DATE'}, {'entity': '—', 'category': 'DATE'}, {'entity': 'N/AU.S.\\t259', 'category': 'DATE'}, {'entity': 'N/ANon-U.S.\\t15', 'category': 'DATE'}, {'entity': 'N/A\\t\\t\\t\\t\\tInrebic\\t55', 'category': 'DATE'}, {'entity': '5', 'category': 'DATE'}, {'entity': '**U.S.\\t55', 'category': 'DATE'}, {'entity': '**Non-U.S.\\t—', 'category': 'DATE'}, {'entity': 'N/A\\t\\t\\t\\t\\tOnureg\\t17', 'category': 'DATE'}, {'entity': 'N/AU.S.\\t17', 'category': 'DATE'}, {'entity': 'N/ANon-U.S', 'category': 'DATE'}]\n",
      "[{'entity': 'Philadelphia chromosome-positive CML', 'category': 'PERSON'}, {'entity': 'Gleevec', 'category': 'PERSON'}, {'entity': 'Yervoy', 'category': 'PERSON'}, {'entity': 'Opdivo+Yervoy', 'category': 'PERSON'}, {'entity': 'Abraxane', 'category': 'PERSON'}, {'entity': 'paclitaxel albumin-bound particles for injectable suspension', 'category': 'PERSON'}, {'entity': 'Nab', 'category': 'PERSON'}, {'entity': 'Reblozyl', 'category': 'PERSON'}, {'entity': 'fedratinib', 'category': 'PERSON'}, {'entity': 'Onureg', 'category': 'PERSON'}, {'entity': 'Zeposia', 'category': 'PERSON'}, {'entity': 'Vidaza', 'category': 'PERSON'}, {'entity': 'Baraclude', 'category': 'PERSON'}, {'entity': 'UPSACardinal9%', 'category': 'PERSON'}, {'entity': '2020', 'category': 'PERSON'}, {'entity': '8%', 'category': 'PERSON'}, {'entity': '2020', 'category': 'PERSON'}, {'entity': '12%', 'category': 'PERSON'}, {'entity': '2020', 'category': 'PERSON'}, {'entity': '15%', 'category': 'PERSON'}, {'entity': '2020', 'category': 'PERSON'}, {'entity': '1.5', 'category': 'PERSON'}, {'entity': 'months', 'category': 'PERSON'}, {'entity': '2.2', 'category': 'PERSON'}, {'entity': 'months', 'category': 'PERSON'}, {'entity': '75%', 'category': 'PERSON'}, {'entity': '31, 2020', 'category': 'PERSON'}, {'entity': 'Revlimid', 'category': 'PERSON'}, {'entity': 'Pomalyst', 'category': 'PERSON'}, {'entity': 'Revlimid REMS', 'category': 'PERSON'}, {'entity': 'Pomalyst REMS', 'category': 'PERSON'}, {'entity': 'second', 'category': 'PERSON'}, {'entity': 'third-party', 'category': 'PERSON'}, {'entity': '2020', 'category': 'PERSON'}, {'entity': 'varies', 'category': 'PERSON'}, {'entity': 'hospitals', 'category': 'PERSON'}]\n",
      "[{'entity': 'December 31', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': 'Celgene acquisition', 'category': 'EVENT'}, {'entity': '$3.7 billion', 'category': 'MONEY'}, {'entity': '$11', 'category': 'MONEY'}, {'entity': '773', 'category': 'MONEY'}, {'entity': '$11', 'category': 'MONEY'}, {'entity': '143', 'category': 'MONEY'}, {'entity': 'Dragonfly', 'category': 'NORP'}, {'entity': 'Forbius', 'category': 'NORP'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'MyoKardia', 'category': 'ORG'}, {'entity': 'Research and development', 'category': 'ORG'}, {'entity': 'IPRD charge - MyoKardia acquisition', 'category': 'ORG'}, {'entity': 'Impression Biologic', 'category': 'ORG'}, {'entity': 'Revlimid', 'category': 'ORG'}, {'entity': '46%', 'category': 'PERCENT'}, {'entity': '**Other income/expense', 'category': 'PERCENT'}, {'entity': '**Total Expenses', 'category': 'PERCENT'}, {'entity': '57%', 'category': 'PERCENT'}, {'entity': '81%', 'category': 'PERCENT'}, {'entity': 'Cormorant', 'category': 'PERSON'}, {'entity': 'orva-cel program', 'category': 'WORK_OF_ART'}, {'entity': 'Pomalyst/Imnovid', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '+/- 100%', 'category': 'CARDINAL'}, {'entity': '$2.0 billion', 'category': 'CARDINAL'}, {'entity': '$650 million', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '078', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '148', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'January 2021', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': 'Celgene acquisition', 'category': 'EVENT'}, {'entity': 'Royalties and licensing income', 'category': 'EVENT'}, {'entity': 'up-front and milestone licensing fees', 'category': 'EVENT'}, {'entity': 'Equity investment gains', 'category': 'EVENT'}, {'entity': 'integration expenses', 'category': 'EVENT'}, {'entity': 'Provision for restructuring', 'category': 'EVENT'}, {'entity': 'Transition and other service fees', 'category': 'EVENT'}, {'entity': 'Investment income', 'category': 'EVENT'}, {'entity': 'Reversion excise tax', 'category': 'EVENT'}, {'entity': 'Divestiture gains', 'category': 'EVENT'}, {'entity': 'Pension and postretirement', 'category': 'EVENT'}, {'entity': 'Acquisition expenses', 'category': 'EVENT'}, {'entity': 'Europe', 'category': 'GPE'}, {'entity': 'Asia', 'category': 'GPE'}, {'entity': 'LAW', 'category': 'LANGUAGE'}, {'entity': 'NORP', 'category': 'LANGUAGE'}, {'entity': 'and QUANTITY. Therefore', 'category': 'LANGUAGE'}, {'entity': 'they are not included in the output.', 'category': 'LANGUAGE'}, {'entity': '$1.4 billion', 'category': 'MONEY'}, {'entity': '$3.0 billion', 'category': 'MONEY'}, {'entity': '$1.5 billion', 'category': 'MONEY'}, {'entity': '$1.2 billion', 'category': 'MONEY'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': 'Keytruda', 'category': 'ORG'}, {'entity': 'Tecentriq', 'category': 'ORG'}, {'entity': 'Sanofi', 'category': 'ORG'}, {'entity': 'Otezla', 'category': 'ORG'}, {'entity': 'Bristol-Myers Squibb', 'category': 'ORG'}, {'entity': '30.9%', 'category': 'PERCENT'}, {'entity': '30.5%', 'category': 'PERCENT'}, {'entity': '46.5%', 'category': 'PERCENT'}, {'entity': '15.7%', 'category': 'PERCENT'}, {'entity': '15.6%', 'category': 'PERCENT'}, {'entity': '14.8%', 'category': 'PERCENT'}, {'entity': '2020', 'category': 'TIME'}, {'entity': '2019', 'category': 'TIME'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '4.5', 'category': 'CARDINAL'}, {'entity': '1.4', 'category': 'CARDINAL'}, {'entity': '3.0', 'category': 'CARDINAL'}, {'entity': '15', 'category': 'CARDINAL'}, {'entity': '72', 'category': 'CARDINAL'}, {'entity': '80', 'category': 'CARDINAL'}, {'entity': '197', 'category': 'CARDINAL'}, {'entity': '1.2', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '853', 'category': 'CARDINAL'}, {'entity': '266', 'category': 'CARDINAL'}, {'entity': '81', 'category': 'CARDINAL'}, {'entity': '140', 'category': 'CARDINAL'}, {'entity': '170', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'February 4, 2021', 'category': 'DATE'}, {'entity': 'Dec 23, 2022', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'December 31, 2019', 'category': 'DATE'}, {'entity': 'product launch', 'category': 'EVENT'}, {'entity': 'Hilton Hotel', 'category': 'FAC'}, {'entity': 'Cupertino', 'category': 'GPE'}, {'entity': 'California', 'category': 'GPE'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'no entities in this category', 'category': 'LANGUAGE'}, {'entity': 'no entities in this category', 'category': 'LAW'}, {'entity': 'Cupertino', 'category': 'LOC'}, {'entity': 'California', 'category': 'LOC'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': '2,688', 'category': 'MONEY'}, {'entity': '660', 'category': 'MONEY'}, {'entity': '575', 'category': 'MONEY'}, {'entity': '4', 'category': 'MONEY'}, {'entity': '33', 'category': 'MONEY'}, {'entity': '3,300', 'category': 'MONEY'}, {'entity': '858', 'category': 'MONEY'}, {'entity': '275', 'category': 'MONEY'}, {'entity': '27', 'category': 'MONEY'}, {'entity': '279', 'category': 'MONEY'}, {'entity': '36', 'category': 'MONEY'}, {'entity': '1,003', 'category': 'MONEY'}, {'entity': '25', 'category': 'MONEY'}, {'entity': '470', 'category': 'MONEY'}, {'entity': '32', 'category': 'MONEY'}, {'entity': '36', 'category': 'MONEY'}, {'entity': '282', 'category': 'MONEY'}, {'entity': '33', 'category': 'MONEY'}, {'entity': '115', 'category': 'MONEY'}, {'entity': '167', 'category': 'MONEY'}, {'entity': '1,906', 'category': 'MONEY'}, {'entity': '257', 'category': 'MONEY'}, {'entity': '11,438', 'category': 'MONEY'}, {'entity': '9,688', 'category': 'MONEY'}, {'entity': '1,062', 'category': 'MONEY'}, {'entity': '159', 'category': 'MONEY'}, {'entity': '322', 'category': 'MONEY'}, {'entity': '1,757', 'category': 'MONEY'}, {'entity': '523', 'category': 'MONEY'}, {'entity': '168', 'category': 'MONEY'}, {'entity': '24', 'category': 'MONEY'}, {'entity': '1,156', 'category': 'MONEY'}, {'entity': '279', 'category': 'MONEY'}, {'entity': '717', 'category': 'MONEY'}, {'entity': '415', 'category': 'MONEY'}, {'entity': '530', 'category': 'MONEY'}, {'entity': '301', 'category': 'MONEY'}, {'entity': '239', 'category': 'MONEY'}, {'entity': '75', 'category': 'MONEY'}, {'entity': '55', 'category': 'MONEY'}, {'entity': '1,168', 'category': 'MONEY'}, {'entity': 'no entities in this category', 'category': 'NORP'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': 'BMS', 'category': 'PERSON'}, {'entity': '2', 'category': 'QUANTITY'}, {'entity': 'February 4, 2021', 'category': 'TIME'}, {'entity': '5PM', 'category': 'TIME'}, {'entity': '7PM', 'category': 'TIME'}, {'entity': 'Exhibit 99.2', 'category': 'WORK_OF_ART'}, {'entity': 'Form 8-K', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '99.2', 'category': 'CARDINAL'}, {'entity': '8-K', 'category': 'CARDINAL'}, {'entity': '2021', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '2020', 'category': 'CARDINAL'}, {'entity': '2019', 'category': 'CARDINAL'}, {'entity': '2,688', 'category': 'CARDINAL'}, {'entity': '660', 'category': 'CARDINAL'}, {'entity': '575', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '33', 'category': 'CARDINAL'}, {'entity': '3,300', 'category': 'CARDINAL'}, {'entity': '858', 'category': 'CARDINAL'}, {'entity': '275', 'category': 'CARDINAL'}, {'entity': '27', 'category': 'CARDINAL'}, {'entity': '279', 'category': 'CARDINAL'}, {'entity': '36', 'category': 'CARDINAL'}, {'entity': '1,003', 'category': 'CARDINAL'}, {'entity': '25', 'category': 'CARDINAL'}, {'entity': '470', 'category': 'CARDINAL'}, {'entity': '32', 'category': 'CARDINAL'}, {'entity': '36', 'category': 'CARDINAL'}, {'entity': '282', 'category': 'CARDINAL'}, {'entity': '33', 'category': 'CARDINAL'}, {'entity': '115', 'category': 'CARDINAL'}, {'entity': '167', 'category': 'CARDINAL'}, {'entity': '1,906', 'category': 'CARDINAL'}, {'entity': '257', 'category': 'CARDINAL'}, {'entity': '11,438', 'category': 'CARDINAL'}, {'entity': '9,688', 'category': 'CARDINAL'}, {'entity': '1,062', 'category': 'CARDINAL'}, {'entity': '159', 'category': 'CARDINAL'}, {'entity': '322', 'category': 'CARDINAL'}, {'entity': '1,757', 'category': 'CARDINAL'}, {'entity': '523', 'category': 'CARDINAL'}, {'entity': '168', 'category': 'CARDINAL'}, {'entity': '24', 'category': 'CARDINAL'}, {'entity': '1,156', 'category': 'CARDINAL'}, {'entity': '279', 'category': 'CARDINAL'}, {'entity': '717', 'category': 'CARDINAL'}, {'entity': '415', 'category': 'CARDINAL'}, {'entity': '530', 'category': 'CARDINAL'}, {'entity': '301', 'category': 'CARDINAL'}, {'entity': '239', 'category': 'CARDINAL'}, {'entity': '75', 'category': 'CARDINAL'}, {'entity': '55', 'category': 'CARDINAL'}, {'entity': '1,168', 'category': 'CARDINAL'}, {'entity': '—', 'category': 'CARDINAL'}, {'entity': '1,635', 'category': 'CARDINAL'}, {'entity': '—', 'category': 'CARDINAL'}, {'entity': '657', 'category': 'CARDINAL'}, {'entity': '—', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2,262', 'category': 'CARDINAL'}, {'entity': '24,400', 'category': 'CARDINAL'}, {'entity': '4,475', 'category': 'CARDINAL'}, {'entity': '1,733', 'category': 'CARDINAL'}, {'entity': '687', 'category': 'CARDINAL'}, {'entity': '266', 'category': 'CARDINAL'}, {'entity': '808', 'category': 'CARDINAL'}, {'entity': '853', 'category': 'CARDINAL'}, {'entity': '121', 'category': 'CARDINAL'}, {'entity': '23,786', 'category': 'CARDINAL'}, {'entity': '4,596', 'category': 'CARDINAL'}, {'entity': '9,015', 'category': 'CARDINAL'}, {'entity': '3,439', 'category': 'CARDINAL'}, {'entity': '14,771', 'category': 'CARDINAL'}, {'entity': '8,035', 'category': 'CARDINAL'}, {'entity': '2,258', 'category': 'CARDINAL'}, {'entity': '1,712', 'category': 'CARDINAL'}, {'entity': '35', 'category': 'CARDINAL'}, {'entity': '2,293', 'category': 'CARDINAL'}, {'entity': '1,712', 'category': 'CARDINAL'}, {'entity': '3.99', 'category': 'CARDINAL'}, {'entity': '2.01', 'category': 'CARDINAL'}, {'entity': '10.43', 'category': 'CARDINAL'}, {'entity': '2.68', 'category': 'CARDINAL'}, {'entity': '6.44', 'category': 'CARDINAL'}, {'entity': '4.69', 'category': 'CARDINAL'}, {'entity': '2020', 'category': 'CARDINAL'}, {'entity': '2019', 'category': 'CARDINAL'}, {'entity': '14,546', 'category': 'CARDINAL'}, {'entity': '12,346', 'category': 'CARDINAL'}, {'entity': '1,285', 'category': 'CARDINAL'}, {'entity': '3,047', 'category': 'CARDINAL'}, {'entity': '433', 'category': 'CARDINAL'}, {'entity': '767', 'category': 'CARDINAL'}, {'entity': '16,264', 'category': 'CARDINAL'}, {'entity': '16,160', 'category': 'CARDINAL'}, {'entity': '2,340', 'category': 'CARDINAL'}, {'entity': '3,346', 'category': 'CARDINAL'}, {'entity': '48,336', 'category': 'CARDINAL'}, {'entity': '43,387', 'category': 'CARDINAL'}, {'entity': '34,412', 'category': 'CARDINAL'}, {'entity': '30,573', 'category': 'CARDINAL'}, {'entity': '15.8', 'category': 'CARDINAL'}, {'entity': '6.0', 'category': 'CARDINAL'}, {'entity': '1.0', 'category': 'CARDINAL'}, {'entity': 'no entities in this category', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'January 2021', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': '2018', 'category': 'DATE'}, {'entity': 'January 2022', 'category': 'DATE'}, {'entity': 'April 9, 2021', 'category': 'DATE'}, {'entity': 'February 2021', 'category': 'DATE'}, {'entity': 'November 2020', 'category': 'DATE'}, {'entity': 'February 2021', 'category': 'DATE'}, {'entity': '3 years', 'category': 'DATE'}, {'entity': '30 years', 'category': 'DATE'}, {'entity': '75 days', 'category': 'DATE'}, {'entity': '90 days', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': 'Dollars in Millions', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': 'the share repurchase authorization', 'category': 'EVENT'}, {'entity': 'the commercial paper program', 'category': 'EVENT'}, {'entity': 'the revolving credit facilities', 'category': 'EVENT'}, {'entity': 'the commercial paper borrowings', 'category': 'EVENT'}, {'entity': 'the term loan', 'category': 'EVENT'}, {'entity': 'the fixed rate unsecured senior notes', 'category': 'EVENT'}, {'entity': 'the aggregate cash consideration payable', 'category': 'EVENT'}, {'entity': 'the investment portfolio', 'category': 'EVENT'}, {'entity': 'the interest rate fluctuations', 'category': 'EVENT'}, {'entity': 'changes in fair value', 'category': 'EVENT'}, {'entity': 'the credit ratings', 'category': 'EVENT'}, {'entity': 'the long-term credit outlook', 'category': 'EVENT'}, {'entity': 'the short-term credit outlook', 'category': 'EVENT'}, {'entity': 'the interest rate', 'category': 'EVENT'}, {'entity': 'the fair market value', 'category': 'EVENT'}, {'entity': 'the existing debt', 'category': 'EVENT'}, {'entity': 'cash flow activities', 'category': 'EVENT'}, {'entity': 'Operating activities', 'category': 'EVENT'}, {'entity': 'Investing activities', 'category': 'EVENT'}, {'entity': 'Financing activities', 'category': 'EVENT'}, {'entity': 'Operating Activities', 'category': 'EVENT'}, {'entity': 'cash flow from operating activities', 'category': 'EVENT'}, {'entity': 'cash receipts', 'category': 'EVENT'}, {'entity': 'disbursements', 'category': 'EVENT'}, {'entity': 'Investing Activities', 'category': 'EVENT'}, {'entity': 'cash used for acquisitions', 'category': 'EVENT'}, {'entity': 'manufacturing and facility-related capital expenditures', 'category': 'EVENT'}, {'entity': 'purchases of marketable securities', 'category': 'EVENT'}, {'entity': 'proceeds from business divestitures', 'category': 'EVENT'}, {'entity': 'the sale and maturity of marketable', 'category': 'EVENT'}, {'entity': 'January 2021', 'category': 'GPE'}, {'entity': '2021', 'category': 'GPE'}, {'entity': '2022', 'category': 'GPE'}, {'entity': '2020', 'category': 'GPE'}, {'entity': '2019', 'category': 'GPE'}, {'entity': '2018', 'category': 'GPE'}, {'entity': 'January 2022', 'category': 'GPE'}, {'entity': 'April 9, 2021', 'category': 'GPE'}, {'entity': 'December 31, 2020', 'category': 'GPE'}, {'entity': 'September 2024', 'category': 'GPE'}, {'entity': 'July 2025', 'category': 'GPE'}, {'entity': 'December 31, 2019', 'category': 'GPE'}, {'entity': 'December 31, 2020', 'category': 'LOC'}, {'entity': 'December 31, 2020', 'category': 'LOC'}, {'entity': '$2.0 billion', 'category': 'MONEY'}, {'entity': '$4.1 billion', 'category': 'MONEY'}, {'entity': '$2.7 billion', 'category': 'MONEY'}, {'entity': '$2.6 billion', 'category': 'MONEY'}, {'entity': '$750 million', 'category': 'MONEY'}, {'entity': '$800 million', 'category': 'MONEY'}, {'entity': '$1.0 billion', 'category': 'MONEY'}, {'entity': '$1.3 billion', 'category': 'MONEY'}, {'entity': '$1.2 billion', 'category': 'MONEY'}, {'entity': '$5 billion', 'category': 'MONEY'}, {'entity': '$6.0 billion', 'category': 'MONEY'}, {'entity': '$2.0 billion', 'category': 'MONEY'}, {'entity': '$2.6 billion', 'category': 'MONEY'}, {'entity': '$1.0 billion', 'category': 'MONEY'}, {'entity': '$1.5 billion', 'category': 'MONEY'}, {'entity': '$4.0 billion', 'category': 'MONEY'}, {'entity': '$7.0 billion', 'category': 'MONEY'}, {'entity': '$1.1 billion', 'category': 'MONEY'}, {'entity': '$500 million', 'category': 'MONEY'}, {'entity': '$5.8 billion', 'category': 'MONEY'}, {'entity': '$1.2 billion', 'category': 'MONEY'}, {'entity': '$1.9 billion', 'category': 'MONEY'}, {'entity': '$1.1 billion', 'category': 'MONEY'}, {'entity': 'Item 8', 'category': 'ORG'}, {'entity': 'Board of Directors', 'category': 'ORG'}, {'entity': 'Equity', 'category': 'ORG'}, {'entity': 'Apple', 'category': 'ORG'}, {'entity': 'MyoKardia', 'category': 'ORG'}, {'entity': 'Moodys Investors Service', 'category': 'ORG'}, {'entity': 'Standard & Poors', 'category': 'ORG'}, {'entity': 'results of operations', 'category': 'ORG'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': 'Otezla*', 'category': 'ORG'}, {'entity': 'A2', 'category': 'PERCENT'}, {'entity': 'Prime-1', 'category': 'PERCENT'}, {'entity': 'A+', 'category': 'PERCENT'}, {'entity': 'A-1', 'category': 'PERCENT'}, {'entity': 'MyoKardia', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Yervoy', 'category': 'PRODUCT'}, {'entity': 'Empliciti', 'category': 'PRODUCT'}, {'entity': 'Otezla', 'category': 'PRODUCT'}, {'entity': 'April 9', 'category': 'TIME'}, {'entity': '2021', 'category': 'TIME'}, {'entity': 'Note 16', 'category': 'WORK_OF_ART'}, {'entity': 'MyoKardia', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '$2.0 billion', 'category': 'CARDINAL'}, {'entity': '$4.1 billion', 'category': 'CARDINAL'}, {'entity': '$2.7 billion', 'category': 'CARDINAL'}, {'entity': '$2.6 billion', 'category': 'CARDINAL'}, {'entity': '$750 million', 'category': 'CARDINAL'}, {'entity': '$800 million', 'category': 'CARDINAL'}, {'entity': '$1.0 billion', 'category': 'CARDINAL'}, {'entity': '$1.3 billion', 'category': 'CARDINAL'}, {'entity': '$1.2 billion', 'category': 'CARDINAL'}, {'entity': '$5 billion', 'category': 'CARDINAL'}, {'entity': '364', 'category': 'CARDINAL'}, {'entity': '366', 'category': 'CARDINAL'}, {'entity': '2020', 'category': 'CARDINAL'}, {'entity': '2019', 'category': 'CARDINAL'}, {'entity': '2018', 'category': 'CARDINAL'}, {'entity': '2021', 'category': 'CARDINAL'}, {'entity': '2022', 'category': 'CARDINAL'}, {'entity': '$1.0 billion', 'category': 'CARDINAL'}, {'entity': '$1.5 billion', 'category': 'CARDINAL'}, {'entity': '$6.0 billion', 'category': 'CARDINAL'}, {'entity': '$2.0 billion', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '30', 'category': 'CARDINAL'}, {'entity': '364', 'category': 'CARDINAL'}, {'entity': '$7.0 billion', 'category': 'CARDINAL'}, {'entity': '14,052', 'category': 'CARDINAL'}, {'entity': '8,210', 'category': 'CARDINAL'}, {'entity': '10,859', 'category': 'CARDINAL'}, {'entity': '9,913', 'category': 'CARDINAL'}, {'entity': '1,151', 'category': 'CARDINAL'}, {'entity': '7,621', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'August 4, 2004', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'March 31, 2021', 'category': 'DATE'}, {'entity': 'September 30, 2004', 'category': 'DATE'}, {'entity': 'January 2021', 'category': 'DATE'}, {'entity': '$946 million', 'category': 'MONEY'}, {'entity': '$15.0 billion', 'category': 'MONEY'}, {'entity': '$11.7 billion', 'category': 'MONEY'}, {'entity': '$2.3 billion', 'category': 'MONEY'}, {'entity': 'approximately $1.4 billion', 'category': 'MONEY'}, {'entity': '$5.8 billion', 'category': 'MONEY'}, {'entity': '$7.0 billion', 'category': 'MONEY'}, {'entity': 'approximately $22.0 billion', 'category': 'MONEY'}, {'entity': '$8.1 billion', 'category': 'MONEY'}, {'entity': '$13.9 billion', 'category': 'MONEY'}, {'entity': '$14.7 billion', 'category': 'MONEY'}, {'entity': '$9.00', 'category': 'MONEY'}, {'entity': 'Apple', 'category': 'ORG'}, {'entity': 'Otezla*', 'category': 'ORG'}, {'entity': 'UPSA', 'category': 'ORG'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': 'MyoKardia', 'category': 'ORG'}, {'entity': 'Alliances', 'category': 'ORG'}, {'entity': 'CVR', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'Exhibit 10', 'category': 'ORG'}, {'entity': 'Form 10-Q', 'category': 'ORG'}, {'entity': '15%', 'category': 'PERCENT'}]\n",
      "[{'entity': 'Item 8. Financial Statements and Supplementary Data—Note 1. Accounting Policies and Recently Issued Accounting Standards.', 'category': 'DATE'}, {'entity': 'Item 8. Financial Statements and Supplementary Data—Note 2. Revenue', 'category': 'DATE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S', 'category': 'GPE'}, {'entity': 'Department of Defense', 'category': 'ORG'}, {'entity': 'Department of Veterans Affairs', 'category': 'ORG'}, {'entity': '340B Drug Pricing Program', 'category': 'ORG'}, {'entity': 'Medicaid', 'category': 'ORG'}, {'entity': 'Medicaid', 'category': 'ORG'}, {'entity': 'Medicaid', 'category': 'ORG'}, {'entity': 'Medicaid', 'category': 'ORG'}, {'entity': 'Medicaid', 'category': 'ORG'}, {'entity': 'Medicaid', 'category': 'ORG'}, {'entity': 'Medicaid', 'category': 'ORG'}, {'entity': 'Medicaid', 'category': 'ORG'}, {'entity': 'Medicaid', 'category': 'ORG'}, {'entity': 'Medicaid', 'category': 'ORG'}, {'entity': 'Medicaid', 'category': 'ORG'}, {'entity': 'Medicare', 'category': 'ORG'}, {'entity': 'Medicare', 'category': 'ORG'}, {'entity': 'GTN', 'category': 'ORG'}, {'entity': 'U.S.', 'category': 'ORG'}, {'entity': 'CMS', 'category': 'ORG'}, {'entity': 'Medicare Part D', 'category': 'ORG'}, {'entity': '70%', 'category': 'PERCENT'}, {'entity': '75%', 'category': 'QUANTITY'}, {'entity': '70%', 'category': 'QUANTITY'}, {'entity': '2%', 'category': 'QUANTITY'}, {'entity': 'two', 'category': 'TIME'}, {'entity': 'four week', 'category': 'TIME'}, {'entity': 'one month', 'category': 'TIME'}, {'entity': 'three', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': 'five', 'category': 'CARDINAL'}]\n",
      "[{'entity': '\"December 31, 2020', 'category': 'DATE'}, {'entity': 'December 31, 2019', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2022\",', 'category': 'DATE'}, {'entity': '\"U.S.\"', 'category': 'GPE'}, {'entity': '\"$575 million', 'category': 'MONEY'}, {'entity': '$470 million\",', 'category': 'MONEY'}, {'entity': '\"Celgene\"', 'category': 'ORG'}, {'entity': '\"Celgene\"', 'category': 'PERSON'}, {'entity': '\"Inrebic', 'category': 'PRODUCT'}, {'entity': 'orva-cel\",', 'category': 'PRODUCT'}, {'entity': '\"full\"', 'category': 'ORDINAL'}, {'entity': '\"53.2 billion', 'category': 'CARDINAL'}, {'entity': '64.0 billion', 'category': 'CARDINAL'}, {'entity': '575 million', 'category': 'CARDINAL'}, {'entity': '470 million', 'category': 'CARDINAL'}, {'entity': '20.5 billion', 'category': 'CARDINAL'}, {'entity': '22.5 billion', 'category': 'CARDINAL'}, {'entity': '3.5 billion', 'category': 'CARDINAL'}, {'entity': '2.8 billion', 'category': 'CARDINAL'}, {'entity': '2.1 billion', 'category': 'CARDINAL'}, {'entity': '1.5 billion', 'category': 'CARDINAL'}, {'entity': '382\",', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'February 2020', 'category': 'DATE'}, {'entity': 'October 2020', 'category': 'DATE'}, {'entity': 'August 2020', 'category': 'DATE'}, {'entity': 'January 2021', 'category': 'DATE'}, {'entity': 'October 2020', 'category': 'DATE'}, {'entity': 'Phase III CheckMate-816 trial', 'category': 'EVENT'}, {'entity': 'Phase III clinical study TASUKI-52', 'category': 'EVENT'}, {'entity': 'FDA approval', 'category': 'EVENT'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'Mead Johnson', 'category': 'ORG'}, {'entity': 'Internal Revenue Code', 'category': 'ORG'}, {'entity': 'Internal Revenue Service', 'category': 'ORG'}, {'entity': 'Revlimid', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'CheckMate-816 trial', 'category': 'PRODUCT'}, {'entity': 'CheckMate-9ER trial', 'category': 'PRODUCT'}, {'entity': 'Opdivo combination group', 'category': 'WORK_OF_ART'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2020', 'category': 'CARDINAL'}, {'entity': '52', 'category': 'CARDINAL'}, {'entity': '40', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '15', 'category': 'CARDINAL'}, {'entity': '244', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'April 2020', 'category': 'DATE'}, {'entity': 'February 2020', 'category': 'DATE'}, {'entity': 'January 2021', 'category': 'DATE'}, {'entity': 'December 2020', 'category': 'DATE'}, {'entity': 'November 2020', 'category': 'DATE'}, {'entity': 'September 2020', 'category': 'DATE'}, {'entity': 'August 2020', 'category': 'DATE'}, {'entity': 'June 2020', 'category': 'DATE'}, {'entity': 'May 2020', 'category': 'DATE'}, {'entity': 'March 2020', 'category': 'DATE'}, {'entity': 'December 2020', 'category': 'DATE'}, {'entity': 'February 2020', 'category': 'DATE'}, {'entity': 'development and commercialization', 'category': 'EVENT'}, {'entity': 'treatment', 'category': 'EVENT'}, {'entity': 'results', 'category': 'EVENT'}, {'entity': 'submission', 'category': 'EVENT'}, {'entity': 'approval', 'category': 'EVENT'}, {'entity': 'EC approval', 'category': 'EVENT'}, {'entity': 'clinical study', 'category': 'EVENT'}, {'entity': 'update', 'category': 'EVENT'}, {'entity': 'Phase III trial', 'category': 'EVENT'}, {'entity': 'therapy', 'category': 'EVENT'}, {'entity': 'consultation', 'category': 'EVENT'}, {'entity': 'withdrawal', 'category': 'EVENT'}, {'entity': 'Taiwan', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'LOC'}, {'entity': 'Japans', 'category': 'LOC'}, {'entity': 'Japan, South Korea', 'category': 'LOC'}, {'entity': 'China', 'category': 'LOC'}, {'entity': '5 million', 'category': 'MONEY'}, {'entity': 'Exelixis', 'category': 'ORG'}, {'entity': 'Gastric and Esophageal Cancers', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'EMA', 'category': 'ORG'}, {'entity': 'Ono', 'category': 'ORG'}, {'entity': 'CheckMate -9ER', 'category': 'ORG'}, {'entity': 'CheckMate-025', 'category': 'ORG'}, {'entity': 'CheckMate-577', 'category': 'ORG'}, {'entity': 'CheckMate -649', 'category': 'ORG'}, {'entity': 'Phase II/III', 'category': 'ORG'}, {'entity': 'NMPA', 'category': 'ORG'}, {'entity': 'MHLW', 'category': 'ORG'}, {'entity': 'ATTRACTION-3', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Phase III ATTRACTION-3 trial', 'category': 'ORG'}, {'entity': 'SCLC', 'category': 'ORG'}, {'entity': 'Phase I/II CheckMate-032 trial', 'category': 'ORG'}, {'entity': 'CheckMate-451', 'category': 'ORG'}, {'entity': 'CheckMate-331', 'category': 'ORG'}, {'entity': 'MHLW', 'category': 'ORG'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': 'Exelixis', 'category': 'PERSON'}, {'entity': 'Shakespeare', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': '2', 'category': 'QUANTITY'}, {'entity': 'May 20, 2021', 'category': 'TIME'}, {'entity': 'May 25, 2021', 'category': 'TIME'}, {'entity': 'chemotherapy', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '3L', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'Opdivo+Yervoy NSCLC+Phase III CheckMate-274 trial', 'category': 'DATE'}, {'entity': 'CheckMate-142 study+Dec 23, 2022', 'category': 'DATE'}, {'entity': 'November 2020', 'category': 'DATE'}, {'entity': 'February 2021', 'category': 'DATE'}, {'entity': 'December 2020', 'category': 'DATE'}, {'entity': 'January 2020', 'category': 'DATE'}, {'entity': 'May 2020', 'category': 'DATE'}, {'entity': 'October 2020', 'category': 'DATE'}, {'entity': 'September 2020', 'category': 'DATE'}, {'entity': 'April 2020', 'category': 'DATE'}, {'entity': 'result from Opdivo monotherapy cohort', 'category': 'EVENT'}, {'entity': 'routine review', 'category': 'EVENT'}, {'entity': 'independent data monitoring commitee', 'category': 'EVENT'}, {'entity': 'Phase III CheckMate-548 trial', 'category': 'EVENT'}, {'entity': 'Phase III CheckMate-274 trial', 'category': 'EVENT'}, {'entity': 'three-year follow-up results', 'category': 'EVENT'}, {'entity': 'application in the EU', 'category': 'EVENT'}, {'entity': 'results for the co-primary endpoint', 'category': 'EVENT'}, {'entity': 'EMA validated the type II variation application', 'category': 'EVENT'}, {'entity': 'BMS', 'category': 'FAC'}, {'entity': 'Opdivo plus standard of care', 'category': 'FAC'}, {'entity': 'temozolomide and radiation therapy', 'category': 'FAC'}, {'entity': 'Opdivo plus Yervoy', 'category': 'FAC'}, {'entity': 'platinum-doublet chemotherapy', 'category': 'FAC'}, {'entity': 'Opdivo and Yervoy', 'category': 'FAC'}, {'entity': 'PD-L1 expression', 'category': 'FAC'}, {'entity': 'Platinum-based standard of care chemotherapy', 'category': 'FAC'}, {'entity': 'pemetrexed and cisplatin', 'category': 'FAC'}, {'entity': 'CheckMate-214 clinical trial', 'category': 'FAC'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'CRC', 'category': 'LOC'}, {'entity': 'HSI-H', 'category': 'LOC'}, {'entity': 'Opdivo plus Yervoy', 'category': 'LOC'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Ono', 'category': 'ORG'}, {'entity': 'Ono', 'category': 'ORG'}, {'entity': 'Ono', 'category': 'ORG'}, {'entity': 'CheckMate-227', 'category': 'ORG'}, {'entity': 'CHMP', 'category': 'ORG'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': 'Mary', 'category': 'PERSON'}, {'entity': 'Shakespeare', 'category': 'PERSON'}, {'entity': 'Peter', 'category': 'PERSON'}, {'entity': 'Lisa', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Opdivo plus Yervoy', 'category': 'PRODUCT'}, {'entity': 'Opdivo plus Yervoy', 'category': 'PRODUCT'}, {'entity': '5PM', 'category': 'TIME'}, {'entity': '7PM', 'category': 'TIME'}, {'entity': 'Hamlet', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}]\n",
      "[{'entity': 'February 2020', 'category': 'DATE'}, {'entity': 'September 2020', 'category': 'DATE'}, {'entity': 'March 2020', 'category': 'DATE'}, {'entity': 'June 2020', 'category': 'DATE'}, {'entity': 'May 2020', 'category': 'DATE'}, {'entity': 'April 2020', 'category': 'DATE'}, {'entity': 'Phase III CheckMate-214 study', 'category': 'EVENT'}, {'entity': 'American Society of Clinical Oncology 2020 Genitourinary Cancers Symposium', 'category': 'EVENT'}, {'entity': 'Opdivo 1mg/kg plus Yervoy 3 mg/kg', 'category': 'EVENT'}, {'entity': 'Early AMPLE', 'category': 'EVENT'}, {'entity': 'Phase IV exploratory biomarker study', 'category': 'EVENT'}, {'entity': 'Phase I/II CheckMate-040 trial', 'category': 'EVENT'}, {'entity': 'Phase III ELOQUENT-1 trial', 'category': 'EVENT'}, {'entity': 'EC approval', 'category': 'EVENT'}, {'entity': 'FDA approval', 'category': 'EVENT'}, {'entity': 'pivotal Phase III trial True North', 'category': 'EVENT'}, {'entity': 'Phase III open-label extension trial DAYBREAK', 'category': 'EVENT'}, {'entity': 'FDA approved Zeposia ozanimod 0.92 mg', 'category': 'EVENT'}, {'entity': 'San Francisco', 'category': 'FAC'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'manufacturing and marketing approval', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'San Francisco', 'category': 'LOC'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Yervoy', 'category': 'ORG'}, {'entity': 'Ono', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'HCC', 'category': 'ORG'}, {'entity': 'Orencia', 'category': 'ORG'}, {'entity': 'RA', 'category': 'ORG'}, {'entity': 'Pomalyst', 'category': 'ORG'}, {'entity': 'Empliciti', 'category': 'ORG'}, {'entity': 'Revlimid', 'category': 'ORG'}, {'entity': 'Multiple Myeloma', 'category': 'ORG'}, {'entity': 'Reblozyl', 'category': 'ORG'}, {'entity': 'MDS', 'category': 'ORG'}, {'entity': 'Beta Thalassemia', 'category': 'ORG'}, {'entity': 'Zeposia', 'category': 'ORG'}, {'entity': 'UC', 'category': 'ORG'}, {'entity': 'EMA', 'category': 'ORG'}, {'entity': 'RMS', 'category': 'ORG'}, {'entity': 'Zeposia', 'category': 'ORG'}, {'entity': 'RMS', 'category': 'ORG'}, {'entity': 'Inrebic', 'category': 'ORG'}, {'entity': 'Myelofibrosis', 'category': 'ORG'}, {'entity': 'Mary', 'category': 'PERSON'}, {'entity': 'Shakespeare', 'category': 'PERSON'}, {'entity': 'Peter', 'category': 'PERSON'}, {'entity': 'Lisa', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Yervoy', 'category': 'PRODUCT'}, {'entity': 'Opdivo+Yervoy', 'category': 'PRODUCT'}, {'entity': 'Opdivo+Yervoy', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Opdivo+Yervoy', 'category': 'PRODUCT'}, {'entity': 'Empliciti plus Revlimid and dexamethasone', 'category': 'PRODUCT'}, {'entity': 'Revlimid and dexamethasone alone', 'category': 'PRODUCT'}, {'entity': 'Reblozyl', 'category': 'PRODUCT'}, {'entity': 'Reblozyl', 'category': 'PRODUCT'}, {'entity': 'Reblozyl', 'category': 'PRODUCT'}, {'entity': 'Zeposia', 'category': 'PRODUCT'}, {'entity': 'Zeposia', 'category': 'PRODUCT'}, {'entity': 'Zeposia', 'category': 'PRODUCT'}, {'entity': 'Zeposia', 'category': 'PRODUCT'}, {'entity': 'Zeposia', 'category': 'PRODUCT'}, {'entity': 'Zeposia', 'category': 'PRODUCT'}, {'entity': 'Zeposia', 'category': 'PRODUCT'}, {'entity': 'Zeposia', 'category': 'PRODUCT'}, {'entity': 'Zeposia', 'category': 'PRODUCT'}, {'entity': 'Zeposia', 'category': 'PRODUCT'}, {'entity': 'Zeposia', 'category': 'PRODUCT'}, {'entity': 'Zeposia', 'category': 'PRODUCT'}, {'entity': 'Zeposia', 'category': 'PRODUCT'}, {'entity': 'Zeposia', 'category': 'PRODUCT'}, {'entity': 'Zeposia', 'category': 'PRODUCT'}, {'entity': 'Inrebic', 'category': 'PRODUCT'}]\n",
      "[{'entity': 'September 2020', 'category': 'DATE'}, {'entity': 'May 2020', 'category': 'DATE'}, {'entity': 'February 2021', 'category': 'DATE'}, {'entity': 'July 2020', 'category': 'DATE'}, {'entity': 'March 27, 2021', 'category': 'DATE'}, {'entity': 'November 2020', 'category': 'DATE'}, {'entity': 'August 2020', 'category': 'DATE'}, {'entity': 'Announced FDA approval of Onureg azacitidine for the continued treatment of adult patients with AML who achieved first complete remission or complete remission with incomplete blood count recovery following intensive induction chemotherapy and who are not able to complete intensive curative therapy', 'category': 'EVENT'}, {'entity': 'Announced that the EMA validated the MAA for CC-486 Onureg for the maintenance treatment of adult patients with AML, who achieved complete remission or complete remission with incomplete blood count recovery, following induction therapy with or without consolidation treatment, and who are not candidates for, or who choose not to proceed to, hematopoietic stem cell transplantation', 'category': 'EVENT'}, {'entity': 'Announced that the FDA approved Breyanzi lisocabtagene maraleucel; liso-cel, for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy, including diffuse large B-cell lymphoma not otherwise specified including DLBCL arising from indolent lymphoma, high-grade B-cell lymphoma, primary mediastinal large B-cell lymphoma, and follicular lymphoma grade 3B', 'category': 'EVENT'}, {'entity': 'Announced that the EMA validated the MAA for liso-cel, an investigational CD19-directed CAR T cell therapy, for the treatment of adults with relapsed or refractory diffuse large B-cell lymphoma, primary mediastinal B-cell lymphoma and follicular lymphoma grade 3B after at least two prior therapies', 'category': 'EVENT'}, {'entity': 'Announced with bluebird bio that the FDA has accepted for Priority Review the BLA for ide-cel for the treatment of adult patients with multiple myeloma who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 antibody', 'category': 'EVENT'}, {'entity': 'Announced that the EMA validated the MAA for ide-cel bb2121 for the treatment of adult patients with multiple myeloma who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 antibody', 'category': 'EVENT'}, {'entity': 'Announced updated results from the pivotal, Phase II KarMMa study evaluating the efficacy and safety of ide-cel bb2121 in RRMM', 'category': 'EVENT'}, {'entity': 'Announced positive results from POETYK PSO-2, the second pivotal Phase III trial evaluating deucravacitinib, a novel, oral, selective tyrosine kinase 2 inhibitor, for the treatment of patients with moderate to severe plaque psoriasis', 'category': 'EVENT'}, {'entity': 'Announced results from the Phase III POETYK PSO-1 trial evaluating deucravacitinib BMS-986165, a novel, oral, selective tyrosine kinase 2 inhibitor, for the treatment of patients with moderate to severe plaque psoriasis', 'category': 'EVENT'}, {'entity': 'Announced that the Phase III IDHENTIFY study evaluating Idhifa plus best supportive care BSC versus conventional care regimens, which include BSC only, azacitidine plus BSC, low-dose cytarabine plus BSC or intermediate-dose cytarabine plus BSC, did not meet the primary endpoint of overall survival in patients with relapsed or refractory AML with an isocitrate dehydrogenase-2 mutation', 'category': 'EVENT'}, {'entity': 'Hilton Hotel', 'category': 'FAC'}, {'entity': 'Paris', 'category': 'GPE'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'Cupertino', 'category': 'LOC'}, {'entity': 'California', 'category': 'LOC'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'Item 7A', 'category': 'ORG'}, {'entity': 'Item 8. Financial Statements and Supplementary Data—Note 9. Financial Instruments and Fair Value Measurements', 'category': 'ORG'}, {'entity': 'Financial Statements and Supplementary Data—Note 9. Financial Instruments and Fair Value Measurements', 'category': 'ORG'}, {'entity': 'Financial Instruments and Fair Value Measurements', 'category': 'ORG'}]\n",
      "/Users/tanmayiballa/Desktop/KG-LLM/l715_23-1/data/10-Ks/Bristol-Myers_Squibb_Company/2020/Management_gpt-3.5-turbo_NER_response.json\n",
      "[{'entity': 'OR XIa INHIBITOR Factor XIa inhibitor program', 'category': 'FAC'}]\n",
      "[{'entity': 'oncology', 'category': 'LOC'}, {'entity': 'hematology', 'category': 'LOC'}, {'entity': 'immunology', 'category': 'LOC'}, {'entity': 'cardiovascular', 'category': 'LOC'}, {'entity': 'fibrosis', 'category': 'LOC'}, {'entity': 'multiple myeloma', 'category': 'LOC'}, {'entity': 'Biopharmaceutical Organisation', 'category': 'ORG'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Yervoy', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'Revlimid', 'category': 'ORG'}, {'entity': 'Pomalyst', 'category': 'ORG'}, {'entity': 'Orencia', 'category': 'ORG'}, {'entity': 'Sprycel', 'category': 'ORG'}, {'entity': 'Amgen', 'category': 'ORG'}, {'entity': 'UPSA', 'category': 'ORG'}, {'entity': 'Taisho Pharmaceutical Co.', 'category': 'ORG'}, {'entity': 'Ltd.', 'category': 'ORG'}, {'entity': 'Reblozyl', 'category': 'PRODUCT'}, {'entity': 'Inrebic', 'category': 'PRODUCT'}, {'entity': 'one', 'category': 'ORDINAL'}, {'entity': 'first-in-class', 'category': 'ORDINAL'}]\n",
      "[{'entity': 'December 31, 2019', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': '2019 vs. 2018', 'category': 'DATE'}, {'entity': '23', 'category': 'DATE'}, {'entity': '2019 vs. 2018', 'category': 'DATE'}, {'entity': '16', 'category': 'DATE'}, {'entity': '2019 vs. 2018', 'category': 'DATE'}, {'entity': 'December 31,230', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': '2018', 'category': 'DATE'}, {'entity': '365', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': 'Opdivo+Yervoy combination', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Europe', 'category': 'GPE'}, {'entity': 'Opdivo gross product sales', 'category': 'GPE'}, {'entity': 'Non-U.S.', 'category': 'GPE'}, {'entity': 'Asia', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'Asia', 'category': 'LOC'}, {'entity': '$1.3 billion', 'category': 'MONEY'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': '$397 million', 'category': 'MONEY'}, {'entity': '$210 million', 'category': 'MONEY'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Celgene acquisition', 'category': 'ORG'}, {'entity': 'GTN Adjustments', 'category': 'ORG'}, {'entity': 'Critical Accounting Policies', 'category': 'ORG'}, {'entity': 'Revlimid', 'category': 'ORG'}, {'entity': 'Eliquis gross product sales', 'category': 'ORG'}, {'entity': 'Medicare Part D', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Opdivo+Yervoy combination', 'category': 'ORG'}, {'entity': 'Orencia', 'category': 'ORG'}, {'entity': 'RA', 'category': 'ORG'}, {'entity': 'PsA', 'category': 'ORG'}, {'entity': 'polyarticular JIA', 'category': 'ORG'}, {'entity': 'Pomalyst/Imnovid', 'category': 'ORG'}, {'entity': '10%', 'category': 'PERCENT'}, {'entity': '7%', 'category': 'PERCENT'}, {'entity': '6%', 'category': 'PERCENT'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': '30%', 'category': 'PERCENT'}, {'entity': '17%', 'category': 'PERCENT'}, {'entity': '32%', 'category': 'PERCENT'}, {'entity': '28%', 'category': 'PERCENT'}, {'entity': '6%', 'category': 'PERCENT'}, {'entity': '40%', 'category': 'PERCENT'}, {'entity': '40%', 'category': 'PERCENT'}, {'entity': '4%', 'category': 'PERCENT'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': '13%', 'category': 'PERCENT'}, {'entity': '2%', 'category': 'PERCENT'}, {'entity': '25%', 'category': 'PERCENT'}, {'entity': '14%', 'category': 'PERCENT'}, {'entity': '1%', 'category': 'PERCENT'}, {'entity': '12%', 'category': 'PERCENT'}, {'entity': '7%', 'category': 'PERCENT'}, {'entity': 'Mary', 'category': 'PERSON'}, {'entity': 'Revlimid', 'category': 'PRODUCT'}, {'entity': 'Eliquis', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Orencia', 'category': 'PRODUCT'}, {'entity': 'Pomalyst/Imnovid', 'category': 'PRODUCT'}, {'entity': 'December 31', 'category': 'TIME'}, {'entity': '2019', 'category': 'TIME'}, {'entity': 'Revlimid', 'category': 'WORK_OF_ART'}, {'entity': 'Eliquis', 'category': 'WORK_OF_ART'}, {'entity': 'Opdivo', 'category': 'WORK_OF_ART'}, {'entity': 'Orencia', 'category': 'WORK_OF_ART'}, {'entity': 'Pomalyst/Imnovid', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '50', 'category': 'CARDINAL'}, {'entity': '2018', 'category': 'CARDINAL'}, {'entity': '27', 'category': 'CARDINAL'}, {'entity': '25', 'category': 'CARDINAL'}, {'entity': '26', 'category': 'CARDINAL'}, {'entity': '2019', 'category': 'CARDINAL'}, {'entity': '25', 'category': 'CARDINAL'}, {'entity': '112', 'category': 'CARDINAL'}, {'entity': '38', 'category': 'CARDINAL'}, {'entity': '32', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '16', 'category': 'CARDINAL'}, {'entity': '50', 'category': 'CARDINAL'}, {'entity': '55', 'category': 'CARDINAL'}, {'entity': '29', 'category': 'CARDINAL'}, {'entity': '31', 'category': 'CARDINAL'}, {'entity': '1.3 billion', 'category': 'CARDINAL'}, {'entity': '1.5 million', 'category': 'CARDINAL'}, {'entity': '397 million', 'category': 'CARDINAL'}, {'entity': '210 million', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '116', 'category': 'CARDINAL'}, {'entity': '426', 'category': 'CARDINAL'}, {'entity': '846', 'category': 'CARDINAL'}, {'entity': '1,388', 'category': 'CARDINAL'}, {'entity': '3,679', 'category': 'CARDINAL'}, {'entity': '5,003', 'category': 'CARDINAL'}, {'entity': '3,482', 'category': 'CARDINAL'}, {'entity': '12,164', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '62', 'category': 'CARDINAL'}, {'entity': '66', 'category': 'CARDINAL'}, {'entity': '132', 'category': 'CARDINAL'}, {'entity': '3,643', 'category': 'CARDINAL'}, {'entity': '4,569', 'category': 'CARDINAL'}, {'entity': '3,196', 'category': 'CARDINAL'}, {'entity': '11,408', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': '391', 'category': 'CARDINAL'}, {'entity': '1,859', 'category': 'CARDINAL'}, {'entity': '2,416', 'category': 'CARDINAL'}, {'entity': '4,666', 'category': 'CARDINAL'}, {'entity': '37,206', 'category': 'CARDINAL'}, {'entity': '30,174', 'category': 'CARDINAL'}, {'entity': '23', 'category': 'CARDINAL'}, {'entity': '3,675', 'category': 'CARDINAL'}, {'entity': '2,735', 'category': 'CARDINAL'}, {'entity': '34', 'category': 'CARDINAL'}, {'entity': '4,941', 'category': 'CARDINAL'}, {'entity': '3,225', 'category': 'CARDINAL'}, {'entity': '53', 'category': 'CARDINAL'}, {'entity': '3,416', 'category': 'CARDINAL'}, {'entity': '2,633', 'category': 'CARDINAL'}, {'entity': '30', 'category': 'CARDINAL'}, {'entity': '25,174', 'category': 'CARDINAL'}, {'entity': '21,581', 'category': 'CARDINAL'}, {'entity': '17', 'category': 'CARDINAL'}, {'entity': '32', 'category': 'CARDINAL'}, {'entity': '28', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '15', 'category': 'CARDINAL'}, {'entity': '13', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '12,032', 'category': 'CARDINAL'}, {'entity': '8,593', 'category': 'CARDINAL'}, {'entity': '40', 'category': 'CARDINAL'}, {'entity': '25,174', 'category': 'CARDINAL'}, {'entity': '21,581', 'category': 'CARDINAL'}, {'entity': '17', 'category': 'CARDINAL'}, {'entity': '555', 'category': 'CARDINAL'}, {'entity': '744', 'category': 'CARDINAL'}, {'entity': '25', 'category': 'CARDINAL'}, {'entity': '535', 'category': 'CARDINAL'}, {'entity': '712', 'category': 'CARDINAL'}, {'entity': '25', 'category': 'CARDINAL'}, {'entity': '37', 'category': 'CARDINAL'}, {'entity': '206', 'category': 'CARDINAL'}, {'entity': '2,710', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '2,000', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '1,330', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '1,330', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'Pomalyst/Imnovid', 'category': 'PRODUCT'}, {'entity': 'lenalidomide', 'category': 'PRODUCT'}, {'entity': 'proteasome inhibitor', 'category': 'PRODUCT'}, {'entity': 'Sprycel', 'category': 'PRODUCT'}, {'entity': 'dasatinib', 'category': 'PRODUCT'}, {'entity': 'Philadelphia chromosome-positive CML', 'category': 'PRODUCT'}]\n",
      "[{'entity': 'December 31', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': '2018', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': '2018', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '$1.6 billion', 'category': 'MONEY'}, {'entity': '702 million', 'category': 'MONEY'}, {'entity': '660 million', 'category': 'MONEY'}, {'entity': '126 million', 'category': 'MONEY'}, {'entity': '320 million', 'category': 'MONEY'}, {'entity': '400 million', 'category': 'MONEY'}, {'entity': '184 million', 'category': 'MONEY'}, {'entity': '1.1 billion', 'category': 'MONEY'}, {'entity': '500 million', 'category': 'MONEY'}, {'entity': '25 million', 'category': 'MONEY'}, {'entity': '1.214 billion', 'category': 'MONEY'}, {'entity': '60 million', 'category': 'MONEY'}, {'entity': '33 million', 'category': 'MONEY'}, {'entity': '167 million', 'category': 'MONEY'}, {'entity': '257 million', 'category': 'MONEY'}, {'entity': '1.0 billion', 'category': 'MONEY'}, {'entity': '2.0 billion', 'category': 'MONEY'}, {'entity': '1.6 billion', 'category': 'MONEY'}, {'entity': '1.2 billion', 'category': 'MONEY'}, {'entity': '$1.0 billion', 'category': 'MONEY'}, {'entity': '$1.8 billion', 'category': 'MONEY'}, {'entity': '$1.6 billion', 'category': 'MONEY'}, {'entity': '$1.2 billion', 'category': 'MONEY'}, {'entity': '$656 million', 'category': 'MONEY'}, {'entity': '$183 million', 'category': 'MONEY'}, {'entity': '$1.599 billion', 'category': 'MONEY'}, {'entity': '$27 million', 'category': 'MONEY'}, {'entity': '$1.36 billion', 'category': 'MONEY'}, {'entity': '$1.353 billion', 'category': 'MONEY'}, {'entity': '$1.168 billion', 'category': 'MONEY'}, {'entity': '$178 million', 'category': 'MONEY'}, {'entity': '$657 million', 'category': 'MONEY'}, {'entity': '$2 billion', 'category': 'MONEY'}, {'entity': '$1.2 billion', 'category': 'MONEY'}, {'entity': '$1.6 billion', 'category': 'MONEY'}, {'entity': '$415 million', 'category': 'MONEY'}, {'entity': '$301 million', 'category': 'MONEY'}, {'entity': '$464 million', 'category': 'MONEY'}, {'entity': '$173 million', 'category': 'MONEY'}, {'entity': '$279 million', 'category': 'MONEY'}, {'entity': '$512 million', 'category': 'MONEY'}, {'entity': '$77 million', 'category': 'MONEY'}, {'entity': '$76 million', 'category': 'MONEY'}, {'entity': '$37 million', 'category': 'MONEY'}, {'entity': '$12 million', 'category': 'MONEY'}, {'entity': '$15 million', 'category': 'MONEY'}, {'entity': '$64 million', 'category': 'MONEY'}, {'entity': '$4 million', 'category': 'MONEY'}, {'entity': '$93 million', 'category': 'MONEY'}, {'entity': '$1 million', 'category': 'MONEY'}, {'entity': '$16 million', 'category': 'MONEY'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': 'royalties and profit sharing', 'category': 'ORG'}, {'entity': 'in excess of one month on hand', 'category': 'ORG'}, {'entity': 'Form 10-Q', 'category': 'ORG'}, {'entity': 'Cost of products sold', 'category': 'ORG'}, {'entity': 'Celgene expenses', 'category': 'ORG'}, {'entity': 'Nektar', 'category': 'ORG'}, {'entity': 'IO', 'category': 'ORG'}, {'entity': 'IFM Therapeutics', 'category': 'ORG'}, {'entity': 'Medarex', 'category': 'ORG'}, {'entity': 'rresearch and development', 'category': 'ORG'}, {'entity': 'Cormorant Pharmaceuticals', 'category': 'ORG'}, {'entity': 'same quarter last year', 'category': 'ORG'}, {'entity': 'Celgene transaction', 'category': 'ORG'}, {'entity': 'USPA business', 'category': 'ORG'}, {'entity': 'equity investments fair value adjustments', 'category': 'ORG'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': 'Amortization of Acquired Intangible Assets', 'category': 'ORG'}, {'entity': 'Provision for restructuring', 'category': 'ORG'}, {'entity': 'Contingent value rights', 'category': 'ORG'}, {'entity': 'Integration expenses', 'category': 'ORG'}, {'entity': 'Pension and postretirement', 'category': 'ORG'}, {'entity': 'Divestiture gains', 'category': 'ORG'}, {'entity': 'Other income/expense', 'category': 'ORG'}, {'entity': '25%', 'category': 'PERCENT'}, {'entity': '2%', 'category': 'PERCENT'}, {'entity': 'Eliquis', 'category': 'PERSON'}, {'entity': 'facility', 'category': 'PERSON'}, {'entity': 'priority review voucher', 'category': 'PERSON'}, {'entity': 'Celgene transaction', 'category': 'PERSON'}, {'entity': 'R&D sites', 'category': 'PERSON'}, {'entity': 'Pharmaceuticals', 'category': 'PERSON'}, {'entity': 'Therapeutics', 'category': 'PERSON'}, {'entity': 'Nektar', 'category': 'PERSON'}, {'entity': 'Nektar', 'category': 'PERSON'}, {'entity': 'Cormorant Pharmaceuticals', 'category': 'PERSON'}, {'entity': 'IFM Therapeutics', 'category': 'PERSON'}, {'entity': 'Celgene', 'category': 'PERSON'}, {'entity': 'Celgene', 'category': 'PERSON'}, {'entity': '8,078', 'category': 'CARDINAL'}, {'entity': '6,467', 'category': 'CARDINAL'}, {'entity': '4,871', 'category': 'CARDINAL'}, {'entity': '4,551', 'category': 'CARDINAL'}, {'entity': '6,148', 'category': 'CARDINAL'}, {'entity': '6,332', 'category': 'CARDINAL'}, {'entity': '1,135', 'category': 'CARDINAL'}, {'entity': '97', 'category': 'CARDINAL'}, {'entity': '938', 'category': 'CARDINAL'}, {'entity': '$25 million', 'category': 'CARDINAL'}, {'entity': '$1.1 billion', 'category': 'CARDINAL'}, {'entity': '$60 million', 'category': 'CARDINAL'}, {'entity': '$25 million', 'category': 'CARDINAL'}, {'entity': '$1.1 billion', 'category': 'CARDINAL'}, {'entity': '2018', 'category': 'CARDINAL'}, {'entity': '2018', 'category': 'CARDINAL'}, {'entity': '$2.0 billion', 'category': 'CARDINAL'}, {'entity': '$1.6 billion', 'category': 'CARDINAL'}, {'entity': '$415 million', 'category': 'CARDINAL'}, {'entity': '$657 million', 'category': 'CARDINAL'}, {'entity': '$523 million', 'category': 'CARDINAL'}, {'entity': '$301 million', 'category': 'CARDINAL'}, {'entity': '$279 million', 'category': 'CARDINAL'}, {'entity': '$77 million', 'category': 'CARDINAL'}, {'entity': '$37 million', 'category': 'CARDINAL'}, {'entity': '$15 million', 'category': 'CARDINAL'}, {'entity': '$4 million', 'category': 'CARDINAL'}, {'entity': '$1 million', 'category': 'CARDINAL'}, {'entity': '$938 million', 'category': 'CARDINAL'}, {'entity': '$854 million', 'category': 'CARDINAL'}]\n",
      "[{'entity': '2019', 'category': 'DATE'}, {'entity': '2018', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': 'Dollars', 'category': 'DATE'}, {'entity': '1', 'category': 'DATE'}, {'entity': '021', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': '$1.6 billion', 'category': 'MONEY'}, {'entity': '$650 million', 'category': 'MONEY'}, {'entity': '$661 million', 'category': 'MONEY'}, {'entity': '$545 million', 'category': 'MONEY'}, {'entity': '$343 million', 'category': 'MONEY'}, {'entity': '$145 million', 'category': 'MONEY'}, {'entity': '$50 million', 'category': 'MONEY'}, {'entity': '$25 million', 'category': 'MONEY'}, {'entity': '$135 million', 'category': 'MONEY'}, {'entity': '$278 million', 'category': 'MONEY'}, {'entity': '$244 million', 'category': 'MONEY'}, {'entity': '$256 million', 'category': 'MONEY'}, {'entity': '$80 million', 'category': 'MONEY'}, {'entity': '$75 million', 'category': 'MONEY'}, {'entity': '$70 million', 'category': 'MONEY'}, {'entity': '$64 million', 'category': 'MONEY'}, {'entity': '$81 million', 'category': 'MONEY'}, {'entity': '$119 million', 'category': 'MONEY'}, {'entity': '$4', 'category': 'MONEY'}, {'entity': '975', 'category': 'MONEY'}, {'entity': '$5', 'category': 'MONEY'}, {'entity': '968', 'category': 'MONEY'}, {'entity': '$1', 'category': 'MONEY'}, {'entity': '515', 'category': 'MONEY'}, {'entity': 'Bristol-Myers Squibb', 'category': 'ORG'}, {'entity': 'UPSA', 'category': 'ORG'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': 'ZymoGenetics', 'category': 'ORG'}, {'entity': 'Inc.', 'category': 'ORG'}, {'entity': 'Sanofi', 'category': 'ORG'}, {'entity': '30.5%', 'category': 'PERCENT'}, {'entity': '17.1%', 'category': 'PERCENT'}, {'entity': '15.7%', 'category': 'PERCENT'}, {'entity': '14.8%', 'category': 'PERCENT'}, {'entity': 'Keytruda', 'category': 'PERSON'}, {'entity': 'Erbitux', 'category': 'PERSON'}, {'entity': 'uniQure N.V.', 'category': 'PERSON'}, {'entity': 'Nektar', 'category': 'PERSON'}]\n",
      "[{'entity': 'December 31, 2019', 'category': 'DATE'}, {'entity': 'November 20, 2019', 'category': 'DATE'}, {'entity': 'Ireland', 'category': 'LOC'}, {'entity': '$97 million', 'category': 'MONEY'}, {'entity': '$660', 'category': 'MONEY'}, {'entity': '$1,135', 'category': 'MONEY'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': 'EPS', 'category': 'ORG'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': 'December 31', 'category': 'PERSON'}, {'entity': '2019', 'category': 'PERSON'}, {'entity': '105 million', 'category': 'QUANTITY'}, {'entity': '99 million', 'category': 'QUANTITY'}, {'entity': 'December 2019', 'category': 'TIME'}, {'entity': 'January 2020', 'category': 'TIME'}, {'entity': 'FDA', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'January 2022', 'category': 'DATE'}, {'entity': 'September 2023 and July 2024', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': '2018', 'category': 'DATE'}, {'entity': 'May 2019', 'category': 'DATE'}, {'entity': 'maturities ranging from 18 months to 30 years', 'category': 'DATE'}, {'entity': 'our 2019 exchange offer', 'category': 'DATE'}, {'entity': 'January 31, 2020', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'less than 3%', 'category': 'DATE'}, {'entity': 'the spread of the 2019 Novel Coronavirus', 'category': 'DATE'}, {'entity': 'November 2019', 'category': 'DATE'}, {'entity': 'A2', 'category': 'DATE'}, {'entity': 'A+', 'category': 'DATE'}, {'entity': '9,770', 'category': 'DATE'}, {'entity': '874', 'category': 'DATE'}, {'entity': '7,621', 'category': 'DATE'}, {'entity': '8,067', 'category': 'DATE'}, {'entity': '5,940', 'category': 'DATE'}, {'entity': '1st quarter of the subsequent year', 'category': 'DATE'}, {'entity': '90 days in 2019 and 90 to 120 days in 2018', 'category': 'DATE'}, {'entity': '2.1 billion', 'category': 'DATE'}, {'entity': '2018', 'category': 'DATE'}, {'entity': 'approximately $3.0 billion', 'category': 'DATE'}, {'entity': 'approximately $1.0 billion', 'category': 'DATE'}, {'entity': 'Celgene', 'category': 'DATE'}, {'entity': '$1.0 billion', 'category': 'DATE'}, {'entity': 'approximately $1.0 billion', 'category': 'DATE'}, {'entity': 'approximately $1.1 billion', 'category': 'DATE'}, {'entity': 'approximately $23.4 billion', 'category': 'DATE'}, {'entity': 'Celgene', 'category': 'DATE'}, {'entity': 'approximately $14.6 billion', 'category': 'DATE'}, {'entity': 'Otezla* and UPSA consumer health business', 'category': 'DATE'}, {'entity': '11.2 billion', 'category': 'DATE'}, {'entity': '', 'category': 'DATE'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31, 2019', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': 'March 31, 2021', 'category': 'DATE'}, {'entity': '$18.2 billion', 'category': 'MONEY'}, {'entity': '$7.0 billion', 'category': 'MONEY'}, {'entity': '$20.7 billion', 'category': 'MONEY'}, {'entity': '$6.9 billion', 'category': 'MONEY'}, {'entity': '$13.8 billion', 'category': 'MONEY'}, {'entity': '$14.7 billion', 'category': 'MONEY'}, {'entity': '$6.8 billion', 'category': 'MONEY'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': 'Item 8. Financial Statements and Supplementary Data—Note 3. Alliances', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}]\n",
      "[{'entity': 'Celgene', 'category': 'ORG'}, {'entity': '$64.0 billion', 'category': 'CARDINAL'}, {'entity': '$1.1 billion', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31', 'category': 'DATE'}, {'entity': '2018', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': 'the balance sheet date', 'category': 'DATE'}, {'entity': '$1.1 billion', 'category': 'MONEY'}, {'entity': 'IPRD', 'category': 'ORG'}, {'entity': 'Goodwill', 'category': 'ORG'}, {'entity': 'Held-for-Sale', 'category': 'ORG'}, {'entity': 'Income Taxes', 'category': 'ORG'}, {'entity': 'Item 8', 'category': 'ORDINAL'}, {'entity': 'Note 7', 'category': 'ORDINAL'}, {'entity': '$216 million', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 2019', 'category': 'DATE'}, {'entity': 'September 2019', 'category': 'DATE'}, {'entity': 'March 2019', 'category': 'DATE'}, {'entity': 'IPO', 'category': 'GPE'}, {'entity': 'Mead Johnson’s', 'category': 'GPE'}, {'entity': 'FL', 'category': 'GPE'}, {'entity': 'France', 'category': 'GPE'}, {'entity': 'Europe', 'category': 'GPE'}, {'entity': 'Paris', 'category': 'GPE'}, {'entity': 'France', 'category': 'GPE'}, {'entity': 'Orlando', 'category': 'GPE'}, {'entity': 'Florida', 'category': 'GPE'}, {'entity': '$244 million', 'category': 'MONEY'}, {'entity': 'Mead Johnson', 'category': 'ORG'}, {'entity': 'Internal Revenue Service', 'category': 'ORG'}, {'entity': 'Internal Revenue Code', 'category': 'ORG'}, {'entity': 'Mead Johnson Class B', 'category': 'ORG'}, {'entity': 'Class A', 'category': 'ORG'}, {'entity': 'Mead Johnson', 'category': 'PERSON'}, {'entity': 'Revlimid', 'category': 'PRODUCT'}, {'entity': 'Eliquis', 'category': 'PRODUCT'}, {'entity': 'APIXABAN', 'category': 'PRODUCT'}, {'entity': 'approximately 40-50% of', 'category': 'QUANTITY'}, {'entity': 'greater than 10% of', 'category': 'QUANTITY'}, {'entity': 'Revlimid', 'category': 'WORK_OF_ART'}, {'entity': 'rituximab anti-CD20 antibody', 'category': 'WORK_OF_ART'}, {'entity': 'chemotherapy-free', 'category': 'WORK_OF_ART'}, {'entity': 'Revlimid and rituximab R2', 'category': 'WORK_OF_ART'}, {'entity': 'ELA', 'category': 'WORK_OF_ART'}, {'entity': 'APIXABAN', 'category': 'WORK_OF_ART'}, {'entity': 'NAXOS', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'Phase III', 'category': 'CARDINAL'}, {'entity': 'Phase IV', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'June 2019', 'category': 'DATE'}, {'entity': 'March 2019', 'category': 'DATE'}, {'entity': 'September 2019', 'category': 'DATE'}, {'entity': 'November 2019', 'category': 'DATE'}, {'entity': 'May 2019', 'category': 'DATE'}, {'entity': 'August 2019', 'category': 'DATE'}, {'entity': 'October 2019', 'category': 'DATE'}, {'entity': 'January 2019', 'category': 'DATE'}, {'entity': 'Phase I/II CheckMate-040 study', 'category': 'EVENT'}, {'entity': 'Phase III ATTRACTION-3 trial', 'category': 'EVENT'}, {'entity': 'Phase III CheckMate-548 trial', 'category': 'EVENT'}, {'entity': 'Phase III CheckMate-498 trial', 'category': 'EVENT'}, {'entity': 'CheckMate-459', 'category': 'EVENT'}, {'entity': 'Phase III CheckMate-238 study', 'category': 'EVENT'}, {'entity': 'EC approval of Opdivo', 'category': 'EVENT'}, {'entity': 'PIVOT-02 Phase I/II clinical study', 'category': 'EVENT'}, {'entity': 'Phase III CheckMate-017', 'category': 'EVENT'}, {'entity': 'Phase III CheckMate-057', 'category': 'EVENT'}, {'entity': 'Phase III CheckMate-063', 'category': 'EVENT'}, {'entity': 'Phase III CheckMate-003', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'FAC'}, {'entity': 'Japan', 'category': 'FAC'}, {'entity': 'American Society of Clinical Oncology', 'category': 'FAC'}, {'entity': 'China', 'category': 'FAC'}, {'entity': 'HCC', 'category': 'GPE'}, {'entity': 'LMWH', 'category': 'GPE'}, {'entity': 'CRNM', 'category': 'GPE'}, {'entity': 'VTE', 'category': 'GPE'}, {'entity': 'warfarin', 'category': 'GPE'}, {'entity': 'Opdivo', 'category': 'GPE'}, {'entity': 'CRC', 'category': 'GPE'}, {'entity': 'MSI-H', 'category': 'GPE'}, {'entity': 'ESCC', 'category': 'GPE'}, {'entity': 'GBM', 'category': 'GPE'}, {'entity': 'HCC', 'category': 'GPE'}, {'entity': 'Melanoma', 'category': 'GPE'}, {'entity': 'NSCLC', 'category': 'GPE'}, {'entity': 'docetaxel', 'category': 'GPE'}, {'entity': 'SCCHN', 'category': 'GPE'}, {'entity': 'sorafenib', 'category': 'GPE'}, {'entity': 'Yervoy', 'category': 'GPE'}, {'entity': '$', 'category': 'MONEY'}, {'entity': 'BMS-Pfizer alliance', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Ono', 'category': 'ORG'}, {'entity': 'PIVOT-02 Phase I/II clinical study', 'category': 'ORG'}, {'entity': 'AVDM', 'category': 'ORG'}, {'entity': 'NKTR-214', 'category': 'ORG'}, {'entity': 'American Society of Clinical Oncology', 'category': 'ORG'}, {'entity': 'CheckMate-017', 'category': 'ORG'}, {'entity': 'PD-L1', 'category': 'ORG'}, {'entity': 'check-point inhibitors', 'category': 'ORG'}, {'entity': 'PD-L1 expression', 'category': 'ORG'}, {'entity': 'sBLA', 'category': 'ORG'}, {'entity': 'PDUFA', 'category': 'ORG'}, {'entity': '23%', 'category': 'PERCENT'}, {'entity': '2.5%', 'category': 'PERCENT'}, {'entity': '58%', 'category': 'PERCENT'}, {'entity': '45%', 'category': 'PERCENT'}, {'entity': '13.4%', 'category': 'PERCENT'}, {'entity': '2.6%', 'category': 'PERCENT'}, {'entity': '14%', 'category': 'PERCENT'}, {'entity': '19%', 'category': 'PERCENT'}, {'entity': '11%', 'category': 'PERCENT'}, {'entity': '31%', 'category': 'PERCENT'}, {'entity': 'Response', 'category': 'PERCENT'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Yervoy', 'category': 'PERSON'}, {'entity': 'Eliquis', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Opdivo+Yervoy', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Opdivo+Yervoy', 'category': 'PRODUCT'}, {'entity': 'Opdivo+Yervoy', 'category': 'PRODUCT'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'three-year', 'category': 'ORDINAL'}, {'entity': 'four-year', 'category': 'ORDINAL'}, {'entity': 'five-year', 'category': 'ORDINAL'}, {'entity': '31', 'category': 'CARDINAL'}, {'entity': '70', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'February 2019', 'category': 'DATE'}, {'entity': 'November 2019', 'category': 'DATE'}, {'entity': 'September 2019', 'category': 'DATE'}, {'entity': 'June 2019', 'category': 'DATE'}, {'entity': 'March 2019', 'category': 'DATE'}, {'entity': 'January 2020', 'category': 'DATE'}, {'entity': 'October 2019', 'category': 'DATE'}, {'entity': 'July 2019', 'category': 'DATE'}, {'entity': 'January 2019', 'category': 'DATE'}, {'entity': 'Phase II CheckMate-650 trial', 'category': 'EVENT'}, {'entity': 'CheckMate-915', 'category': 'EVENT'}, {'entity': 'CheckMate-067 clinical trial', 'category': 'EVENT'}, {'entity': 'Phase I CA209-004 study', 'category': 'EVENT'}, {'entity': 'CheckMate-067', 'category': 'EVENT'}, {'entity': 'CheckMate-227', 'category': 'EVENT'}, {'entity': 'Phase III CheckMate-9LA trial', 'category': 'EVENT'}, {'entity': 'Phase III CheckMate-227 trial', 'category': 'EVENT'}, {'entity': 'sBLA for the Opdivo plus low-dose Yervoy', 'category': 'EVENT'}, {'entity': 'Cupertino', 'category': 'GPE'}, {'entity': 'California', 'category': 'GPE'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'Paris', 'category': 'GPE'}, {'entity': 'EU', 'category': 'GPE'}, {'entity': 'Cupertino', 'category': 'LOC'}, {'entity': 'California', 'category': 'LOC'}, {'entity': 'Paris', 'category': 'LOC'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': 'Response Evaluation Criteria in Solid Tumors', 'category': 'ORG'}, {'entity': 'Opdivo+Yervoy', 'category': 'ORG'}, {'entity': 'Yervoy', 'category': 'ORG'}, {'entity': 'CheckMate-650', 'category': 'ORG'}, {'entity': 'CheckMate-915', 'category': 'ORG'}, {'entity': 'CheckMate-067', 'category': 'ORG'}, {'entity': 'CA209-004', 'category': 'ORG'}, {'entity': 'BRAF Mutant', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': '25%', 'category': 'PERCENT'}, {'entity': '10%', 'category': 'PERCENT'}, {'entity': '52%', 'category': 'PERCENT'}, {'entity': '44%', 'category': 'PERCENT'}, {'entity': '26%', 'category': 'PERCENT'}, {'entity': '57%', 'category': 'PERCENT'}, {'entity': '40%', 'category': 'PERCENT'}, {'entity': '33%', 'category': 'PERCENT'}, {'entity': '23%', 'category': 'PERCENT'}, {'entity': 'Mary', 'category': 'PERSON'}, {'entity': 'Shakespeare', 'category': 'PERSON'}, {'entity': 'Peter', 'category': 'PERSON'}, {'entity': 'Lisa', 'category': 'PERSON'}, {'entity': '5PM', 'category': 'TIME'}, {'entity': '7PM', 'category': 'TIME'}, {'entity': 'Hamlet', 'category': 'WORK_OF_ART'}]\n",
      "[{'entity': 'February 2019', 'category': 'DATE'}, {'entity': 'April 2019', 'category': 'DATE'}, {'entity': 'December 2019', 'category': 'DATE'}, {'entity': 'June 2019', 'category': 'DATE'}, {'entity': 'March 2019', 'category': 'DATE'}, {'entity': 'August 2019', 'category': 'DATE'}, {'entity': 'November 2019', 'category': 'DATE'}, {'entity': 'February 2020', 'category': 'DATE'}, {'entity': 'CheckMate-227, Part 1a', 'category': 'EVENT'}, {'entity': 'CheckMate-214', 'category': 'EVENT'}, {'entity': 'EC approval', 'category': 'EVENT'}, {'entity': 'CheckMate-714', 'category': 'EVENT'}, {'entity': 'Breakthrough Therapy Designation', 'category': 'EVENT'}, {'entity': 'EC notification', 'category': 'EVENT'}, {'entity': 'Phase IV mechanistic study', 'category': 'EVENT'}, {'entity': 'Phase III CheckMate-214 study', 'category': 'EVENT'}, {'entity': 'EC approval of Sprycel', 'category': 'EVENT'}, {'entity': 'sJNDA approval of Empliciti', 'category': 'EVENT'}, {'entity': 'updated data from ELOQUENT-3', 'category': 'EVENT'}, {'entity': 'completion of sJNDA filing', 'category': 'EVENT'}, {'entity': 'late-cycle review meeting', 'category': 'EVENT'}, {'entity': 'BLA acceptance for liso-cel', 'category': 'EVENT'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'Cupertino', 'category': 'GPE'}, {'entity': 'California', 'category': 'GPE'}, {'entity': 'Paris', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'proposed changes', 'category': 'LAW'}, {'entity': 'RCC', 'category': 'LOC'}, {'entity': 'SCCHN', 'category': 'LOC'}, {'entity': 'Orencia', 'category': 'LOC'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': 'Genetic', 'category': 'NORP'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'Company', 'category': 'ORG'}, {'entity': 'CheckMate-227', 'category': 'ORG'}, {'entity': 'EC', 'category': 'ORG'}, {'entity': 'Phase IV', 'category': 'ORG'}, {'entity': 'BM', 'category': 'ORG'}, {'entity': 'Acceleron Pharma Inc.', 'category': 'ORG'}, {'entity': 'ODAC', 'category': 'ORG'}, {'entity': 'FDA for lisocabtagene maraleucel', 'category': 'ORG'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': 'Mary', 'category': 'PERSON'}, {'entity': 'Shakespeare', 'category': 'PERSON'}, {'entity': 'Peter', 'category': 'PERSON'}, {'entity': 'Lisa', 'category': 'PERSON'}, {'entity': 'Yervoy', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Orencia', 'category': 'PRODUCT'}, {'entity': 'Sprycel', 'category': 'PRODUCT'}, {'entity': 'Empliciti', 'category': 'PRODUCT'}, {'entity': 'Reblozyl', 'category': 'PRODUCT'}, {'entity': 'liso-cel', 'category': 'PRODUCT'}, {'entity': '3 tickets', 'category': 'QUANTITY'}, {'entity': '5PM', 'category': 'TIME'}, {'entity': '7PM', 'category': 'TIME'}, {'entity': 'Hamlet', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '1a', 'category': 'CARDINAL'}, {'entity': '1mL', 'category': 'CARDINAL'}, {'entity': '18.3', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '80', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '250mg', 'category': 'CARDINAL'}, {'entity': '125mg', 'category': 'CARDINAL'}, {'entity': '50 mg', 'category': 'CARDINAL'}, {'entity': '87.5 mg', 'category': 'CARDINAL'}, {'entity': '15', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}]\n",
      "[{'entity': '2019', 'category': 'DATE'}, {'entity': 'Section 27A', 'category': 'DATE'}, {'entity': 'the Securities Act of 1933', 'category': 'DATE'}, {'entity': 'Section 21E', 'category': 'DATE'}, {'entity': 'the next several years', 'category': 'DATE'}, {'entity': 'English', 'category': 'LANGUAGE'}, {'entity': 'Japanese', 'category': 'LANGUAGE'}, {'entity': 'TIONU.S.', 'category': 'LOC'}, {'entity': 'EMA', 'category': 'ORG'}, {'entity': 'DLBC', 'category': 'ORG'}, {'entity': 'Celgene', 'category': 'ORG'}, {'entity': 'Item 1A', 'category': 'ORG'}, {'entity': '10-K', 'category': 'QUANTITY'}, {'entity': '10', 'category': 'QUANTITY'}, {'entity': '12/31/2019', 'category': 'QUANTITY'}, {'entity': '12/31/2018', 'category': 'QUANTITY'}, {'entity': 'One', 'category': 'CARDINAL'}, {'entity': '2019', 'category': 'CARDINAL'}, {'entity': '358 million', 'category': 'CARDINAL'}, {'entity': '231 million', 'category': 'CARDINAL'}, {'entity': '100 basis point', 'category': 'CARDINAL'}, {'entity': '3.8 billion', 'category': 'CARDINAL'}, {'entity': '482 million', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'Financial Statements and Supplementary Data—Note 9. Financial Instruments and Fair Value Measurements', 'category': 'LOC'}, {'entity': 'counterparties', 'category': 'ORG'}]\n",
      "/Users/tanmayiballa/Desktop/KG-LLM/l715_23-1/data/10-Ks/Bristol-Myers_Squibb_Company/2018/Management_gpt-3.5-turbo_NER_response.json\n",
      "[{'entity': '2017', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': 'December 2017', 'category': 'DATE'}, {'entity': 'February 2017', 'category': 'DATE'}, {'entity': 'April 2017', 'category': 'DATE'}, {'entity': 'Summary of Abbreviated Terms', 'category': 'EVENT'}, {'entity': 'U.S', 'category': 'LOC'}, {'entity': 'EU', 'category': 'LOC'}, {'entity': 'Japan', 'category': 'LOC'}, {'entity': 'China', 'category': 'LOC'}, {'entity': 'lung', 'category': 'LOC'}, {'entity': 'head & neck', 'category': 'LOC'}, {'entity': 'liver', 'category': 'LOC'}, {'entity': 'kidney', 'category': 'LOC'}, {'entity': 'bladder', 'category': 'LOC'}, {'entity': 'gastric', 'category': 'LOC'}, {'entity': '35', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'North America', 'category': 'LOC'}, {'entity': 'Reyataz', 'category': 'LOC'}, {'entity': 'Sustiva', 'category': 'LOC'}, {'entity': 'Baraclude', 'category': 'LOC'}, {'entity': 'lymph nodes', 'category': 'LOC'}, {'entity': 'metastatic disease', 'category': 'LOC'}, {'entity': 'advanced', 'category': 'LOC'}, {'entity': 'recurrent gastric cancer', 'category': 'LOC'}, {'entity': 'chemotherapy', 'category': 'LOC'}, {'entity': 'adult', 'category': 'LOC'}, {'entity': 'pediatric', 'category': 'LOC'}, {'entity': 'MSI-H', 'category': 'LOC'}, {'entity': 'TIONfluoropyrimidine', 'category': 'LOC'}, {'entity': 'TIONoxaliplatin', 'category': 'LOC'}, {'entity': 'TIONirinotecan', 'category': 'LOC'}, {'entity': 'urothelial carcinoma', 'category': 'LOC'}, {'entity': 'platinum-containing therapy', 'category': 'LOC'}, {'entity': 'TIONOrencia', 'category': 'LOC'}, {'entity': 'TIONdisease-modifying antirheumatic drug', 'category': 'LOC'}, {'entity': 'TIONmethotrexate', 'category': 'LOC'}, {'entity': 'TIONpsoriatic skin', 'category': 'LOC'}, {'entity': 'TIONsubcutaneous', 'category': 'LOC'}, {'entity': 'Philadelphia', 'category': 'LOC'}, {'entity': 'metastatic melanoma', 'category': 'LOC'}, {'entity': 'TIONgenotype 1b', 'category': 'LOC'}, {'entity': 'TIONchronic HCV', 'category': 'LOC'}, {'entity': 'TIONRefer', 'category': 'LOC'}, {'entity': 'Bristol-Myers Squibb Company', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'FGF21', 'category': 'ORG'}, {'entity': 'TYK-2', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'Daklinza', 'category': 'ORG'}, {'entity': 'Erbitux', 'category': 'ORG'}, {'entity': 'Dollars', 'category': 'ORG'}, {'entity': 'Ono', 'category': 'ORG'}, {'entity': 'dMMR mCRC', 'category': 'ORG'}, {'entity': 'EC', 'category': 'ORG'}, {'entity': 'bladder cancer', 'category': 'ORG'}, {'entity': 'SCCHN', 'category': 'ORG'}, {'entity': 'Japan', 'category': 'ORG'}, {'entity': 'recurrent', 'category': 'ORG'}, {'entity': 'metastatic HNC', 'category': 'ORG'}, {'entity': 'July 2017', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'China', 'category': 'ORG'}, {'entity': 'Product and Pipeline Developments', 'category': 'ORG'}, {'entity': 'Yervoy', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'FDA', 'category': 'PERSON'}, {'entity': 'melanoma', 'category': 'PERSON'}, {'entity': 'adults', 'category': 'PERSON'}, {'entity': 'Sprycel', 'category': 'PERSON'}, {'entity': 'Hepatitis C Franchise', 'category': 'PERSON'}, {'entity': 'Daklinza', 'category': 'PERSON'}, {'entity': 'Sunvepra', 'category': 'PERSON'}, {'entity': 'HCV', 'category': 'PERSON'}, {'entity': 'sofosbuvir', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '17', 'category': 'ORDINAL'}, {'entity': 'Diluted', 'category': 'ORDINAL'}, {'entity': 'Earnings Per Share', 'category': 'ORDINAL'}, {'entity': '15', 'category': 'CARDINAL'}, {'entity': '7%', 'category': 'CARDINAL'}, {'entity': '17', 'category': 'CARDINAL'}, {'entity': '2.04', 'category': 'CARDINAL'}, {'entity': '0.61', 'category': 'CARDINAL'}, {'entity': '2.65', 'category': 'CARDINAL'}, {'entity': '0.93', 'category': 'CARDINAL'}, {'entity': '3.01', 'category': 'CARDINAL'}, {'entity': '2.83', 'category': 'CARDINAL'}, {'entity': '2.01', 'category': 'CARDINAL'}, {'entity': '2017', 'category': 'CARDINAL'}, {'entity': 'intravenous', 'category': 'CARDINAL'}, {'entity': 'sorafenib', 'category': 'CARDINAL'}, {'entity': 'June 2017', 'category': 'CARDINAL'}, {'entity': 'April 2017', 'category': 'CARDINAL'}, {'entity': 'active PsA', 'category': 'CARDINAL'}, {'entity': 'March 2017', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': 'moderately', 'category': 'CARDINAL'}, {'entity': 'severely active polyarticular JIA', 'category': 'CARDINAL'}, {'entity': 'CML', 'category': 'CARDINAL'}, {'entity': 'unresectable', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Ono', 'category': 'ORG'}, {'entity': 'Halozyme', 'category': 'ORG'}, {'entity': 'IFM', 'category': 'ORG'}, {'entity': 'Biogen', 'category': 'ORG'}, {'entity': 'Roche', 'category': 'ORG'}, {'entity': 'CytomX', 'category': 'ORG'}, {'entity': 'PsiOxus', 'category': 'ORG'}, {'entity': 'Padlock', 'category': 'ORG'}, {'entity': 'Cormorant', 'category': 'ORG'}, {'entity': 'Nitto Denko', 'category': 'ORG'}, {'entity': 'Flexus', 'category': 'ORG'}, {'entity': 'Cardioxyl', 'category': 'ORG'}]\n",
      "[{'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'Cupertino', 'category': 'GPE'}, {'entity': 'California', 'category': 'GPE'}, {'entity': 'Paris', 'category': 'GPE'}, {'entity': 'Apple', 'category': 'LOC'}, {'entity': 'Hilton Hotel', 'category': 'LOC'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Five Prime', 'category': 'ORG'}, {'entity': 'CSF1R', 'category': 'ORG'}, {'entity': 'cabiralizumab', 'category': 'ORG'}, {'entity': 'PVNS', 'category': 'ORG'}, {'entity': 'Promedior', 'category': 'ORG'}, {'entity': 'PRM-151', 'category': 'ORG'}, {'entity': 'Bavarian Nordic', 'category': 'ORG'}, {'entity': 'Prostvac', 'category': 'ORG'}, {'entity': 'uniQure', 'category': 'ORG'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': 'Mary', 'category': 'PERSON'}, {'entity': 'Shakespeare', 'category': 'PERSON'}, {'entity': 'Peter', 'category': 'PERSON'}, {'entity': 'Lisa', 'category': 'PERSON'}, {'entity': 'Eliquis', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Daklinza', 'category': 'PRODUCT'}, {'entity': 'Abilify*', 'category': 'PRODUCT'}, {'entity': 'Erbitux*', 'category': 'PRODUCT'}, {'entity': 'Yervoy', 'category': 'PRODUCT'}, {'entity': 'PRM-151', 'category': 'PRODUCT'}, {'entity': '5PM', 'category': 'TIME'}, {'entity': '7PM', 'category': 'TIME'}, {'entity': 'Hamlet', 'category': 'WORK_OF_ART'}, {'entity': '1', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'Atripla*\" \"Atripla*\"', 'category': 'FAC'}, {'entity': 'U.S.\" \"U.S.\"', 'category': 'GPE'}, {'entity': 'Europe\" \"Europe\"', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'Canada\" \"U.S.', 'category': 'LOC'}, {'entity': 'Canada\",', 'category': 'LOC'}, {'entity': 'Tybost\" \"Tybost\"', 'category': 'LOC'}, {'entity': 'GTN\" \"GTN\"', 'category': 'ORG'}, {'entity': 'Orencia\" \"Orencia\"', 'category': 'ORG'}, {'entity': 'Sprycel\" \"Sprycel\"', 'category': 'ORG'}, {'entity': 'Yervoy\" \"Yervoy\"', 'category': 'ORG'}, {'entity': 'Empliciti\" \"Empliciti\"', 'category': 'ORG'}, {'entity': 'Baraclude\" \"Baraclude\"', 'category': 'ORG'}, {'entity': 'Sustiva Franchise\" \"Sustiva Franchise\"', 'category': 'ORG'}, {'entity': 'Reyataz Franchise\" \"Reyataz Franchise\"', 'category': 'ORG'}, {'entity': 'Opdivo\" \"Opdivo\"', 'category': 'ORG'}, {'entity': 'Gilead\" \"Gilead\"', 'category': 'ORG'}, {'entity': 'Evotaz\" \"Evotaz\"', 'category': 'ORG'}, {'entity': '31%', 'category': 'PERCENT'}, {'entity': '16%', 'category': 'PERCENT'}, {'entity': '66%', 'category': 'PERCENT'}, {'entity': '46%', 'category': 'PERCENT'}, {'entity': '80%', 'category': 'PERCENT'}, {'entity': '47%', 'category': 'PERCENT'}, {'entity': '92%', 'category': 'PERCENT'}, {'entity': '44%', 'category': 'PERCENT'}, {'entity': '65%\" \"31%', 'category': 'PERCENT'}, {'entity': '16%', 'category': 'PERCENT'}, {'entity': '66%', 'category': 'PERCENT'}, {'entity': '46%', 'category': 'PERCENT'}, {'entity': '80%', 'category': 'PERCENT'}, {'entity': '47%', 'category': 'PERCENT'}, {'entity': '92%', 'category': 'PERCENT'}, {'entity': '44%', 'category': 'PERCENT'}, {'entity': '65%\",', 'category': 'PERCENT'}, {'entity': '9%', 'category': 'PERCENT'}, {'entity': '20%', 'category': 'PERCENT'}, {'entity': '11%', 'category': 'PERCENT'}, {'entity': '21%', 'category': 'PERCENT'}, {'entity': '6%', 'category': 'PERCENT'}, {'entity': '19%\" \"9%', 'category': 'PERCENT'}, {'entity': '20%', 'category': 'PERCENT'}, {'entity': '11%', 'category': 'PERCENT'}, {'entity': '21%', 'category': 'PERCENT'}, {'entity': '6%', 'category': 'PERCENT'}, {'entity': '19%\",', 'category': 'PERCENT'}, {'entity': '10%', 'category': 'PERCENT'}, {'entity': '13%', 'category': 'PERCENT'}, {'entity': '14%', 'category': 'PERCENT'}, {'entity': '17%', 'category': 'PERCENT'}, {'entity': '5%', 'category': 'PERCENT'}, {'entity': '8%\" \"10%', 'category': 'PERCENT'}, {'entity': '13%', 'category': 'PERCENT'}, {'entity': '14%', 'category': 'PERCENT'}, {'entity': '17%', 'category': 'PERCENT'}, {'entity': '5%', 'category': 'PERCENT'}, {'entity': '8%\",', 'category': 'PERCENT'}, {'entity': '18%', 'category': 'PERCENT'}, {'entity': '13%', 'category': 'PERCENT'}, {'entity': '34%', 'category': 'PERCENT'}, {'entity': '30%', 'category': 'PERCENT'}, {'entity': '33%', 'category': 'PERCENT'}, {'entity': '34%', 'category': 'PERCENT'}, {'entity': '251%', 'category': 'PERCENT'}, {'entity': '524%', 'category': 'PERCENT'}, {'entity': '336%\" \"18%', 'category': 'PERCENT'}, {'entity': '13%', 'category': 'PERCENT'}, {'entity': '34%', 'category': 'PERCENT'}, {'entity': '30%', 'category': 'PERCENT'}, {'entity': '33%', 'category': 'PERCENT'}, {'entity': '34%', 'category': 'PERCENT'}, {'entity': '251%', 'category': 'PERCENT'}, {'entity': '524%', 'category': 'PERCENT'}, {'entity': '336%\",', 'category': 'PERCENT'}, {'entity': '54%', 'category': 'PERCENT'}, {'entity': '14%\" \"54%', 'category': 'PERCENT'}, {'entity': '14%\",', 'category': 'PERCENT'}, {'entity': '20%', 'category': 'PERCENT'}, {'entity': '31%', 'category': 'PERCENT'}, {'entity': '35%', 'category': 'PERCENT'}, {'entity': '32%', 'category': 'PERCENT'}, {'entity': '11%', 'category': 'PERCENT'}, {'entity': '4%\" \"20%', 'category': 'PERCENT'}, {'entity': '31%', 'category': 'PERCENT'}, {'entity': '35%', 'category': 'PERCENT'}, {'entity': '32%', 'category': 'PERCENT'}, {'entity': '11%', 'category': 'PERCENT'}, {'entity': '4%\",', 'category': 'PERCENT'}, {'entity': '32%', 'category': 'PERCENT'}, {'entity': '31%', 'category': 'PERCENT'}, {'entity': '35%', 'category': 'PERCENT'}, {'entity': '13%', 'category': 'PERCENT'}, {'entity': '22%\" \"32%', 'category': 'PERCENT'}, {'entity': '31%', 'category': 'PERCENT'}, {'entity': '35%', 'category': 'PERCENT'}, {'entity': '13%', 'category': 'PERCENT'}, {'entity': '22%\",', 'category': 'PERCENT'}, {'entity': '23%', 'category': 'PERCENT'}, {'entity': '20%', 'category': 'PERCENT'}, {'entity': '32%', 'category': 'PERCENT'}, {'entity': '18%', 'category': 'PERCENT'}, {'entity': '13%', 'category': 'PERCENT'}, {'entity': '22%\" \"23%', 'category': 'PERCENT'}, {'entity': '20%', 'category': 'PERCENT'}, {'entity': '32%', 'category': 'PERCENT'}, {'entity': '18%', 'category': 'PERCENT'}, {'entity': '13%', 'category': 'PERCENT'}, {'entity': '22%\",', 'category': 'PERCENT'}, {'entity': '74%', 'category': 'PERCENT'}, {'entity': '87%', 'category': 'PERCENT'}, {'entity': '60%', 'category': 'PERCENT'}, {'entity': '41%\" \"74%', 'category': 'PERCENT'}, {'entity': '87%', 'category': 'PERCENT'}, {'entity': '60%', 'category': 'PERCENT'}, {'entity': '41%\",', 'category': 'PERCENT'}, {'entity': '7%', 'category': 'PERCENT'}, {'entity': '9%', 'category': 'PERCENT'}, {'entity': '41%', 'category': 'PERCENT'}, {'entity': '9%', 'category': 'PERCENT'}, {'entity': '17%\" \"7%', 'category': 'PERCENT'}, {'entity': '9%', 'category': 'PERCENT'}, {'entity': '41%', 'category': 'PERCENT'}, {'entity': '9%', 'category': 'PERCENT'}, {'entity': '17%\",', 'category': 'PERCENT'}, {'entity': '3%', 'category': 'PERCENT'}, {'entity': '76%', 'category': 'PERCENT'}, {'entity': '17%\" \"3%', 'category': 'PERCENT'}, {'entity': '76%', 'category': 'PERCENT'}, {'entity': '17%\",', 'category': 'PERCENT'}, {'entity': 'PD-1\" \"PD-1\"', 'category': 'PERSON'}, {'entity': 'Eliquis\" \"Eliquis\"', 'category': 'PRODUCT'}, {'entity': 'Opdivo nivolumab\" \"Opdivo nivolumab\"', 'category': 'PRODUCT'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '13', 'category': 'CARDINAL'}, {'entity': '11\" \"2', 'category': 'CARDINAL'}, {'entity': '13', 'category': 'CARDINAL'}, {'entity': '11\",', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 2017', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': 'July 2015', 'category': 'DATE'}, {'entity': 'April 2015', 'category': 'DATE'}, {'entity': 'October 2015', 'category': 'DATE'}, {'entity': 'September 30, 2017', 'category': 'DATE'}, {'entity': 'June 30, 2017', 'category': 'DATE'}, {'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': 'June 30, 2017', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': 'Hepatitis C Franchise — Daklinza daclatasvir - an NS5A replication complex inhibitor; Sunvepra asunaprevir - an NS3 protease inhibitor; and beclabuvir - an NS5B inhibitor.', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'International', 'category': 'GPE'}, {'entity': 'France', 'category': 'GPE'}, {'entity': 'France', 'category': 'GPE'}, {'entity': 'France', 'category': 'GPE'}, {'entity': 'France', 'category': 'GPE'}, {'entity': 'Europe', 'category': 'LOC'}, {'entity': 'Gulf Countries', 'category': 'LOC'}, {'entity': '$6,066', 'category': 'MONEY'}, {'entity': '$4,946', 'category': 'MONEY'}, {'entity': '$3,909', 'category': 'MONEY'}, {'entity': '$15,645', 'category': 'MONEY'}, {'entity': '$13,512', 'category': 'MONEY'}, {'entity': '$14,483', 'category': 'MONEY'}, {'entity': '$187', 'category': 'MONEY'}, {'entity': '$1,519', 'category': 'MONEY'}, {'entity': '$1,285', 'category': 'MONEY'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Lilly', 'category': 'ORG'}, {'entity': '23%', 'category': 'PERCENT'}, {'entity': '27%', 'category': 'PERCENT'}, {'entity': '5%', 'category': 'PERCENT'}, {'entity': '1%', 'category': 'PERCENT'}, {'entity': '30%', 'category': 'PERCENT'}, {'entity': '17%', 'category': 'PERCENT'}, {'entity': '18%', 'category': 'PERCENT'}, {'entity': '16%', 'category': 'PERCENT'}, {'entity': '7%', 'category': 'PERCENT'}, {'entity': 'France', 'category': 'PERSON'}, {'entity': 'Daklinza', 'category': 'PRODUCT'}, {'entity': 'Abilify*', 'category': 'PRODUCT'}, {'entity': 'Erbitux*', 'category': 'PRODUCT'}, {'entity': 'Dafalgan', 'category': 'PRODUCT'}, {'entity': 'Efferalgan', 'category': 'PRODUCT'}, {'entity': 'Fervex', 'category': 'PRODUCT'}, {'entity': 'Perfalgan', 'category': 'PRODUCT'}, {'entity': 'December 31', 'category': 'TIME'}, {'entity': '2017', 'category': 'TIME'}, {'entity': 'Item 8. Financial Statements—Note 3. Alliances', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '1.7', 'category': 'CARDINAL'}, {'entity': '1.2', 'category': 'CARDINAL'}, {'entity': '1.2', 'category': 'CARDINAL'}, {'entity': '3.0', 'category': 'CARDINAL'}, {'entity': '4.0', 'category': 'CARDINAL'}, {'entity': '2.6', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': 'Item 8. Financial Statements---Note 4. Acquisitions', 'category': 'EVENT'}, {'entity': 'Divestitures and Licensing Arrangements', 'category': 'EVENT'}, {'entity': 'Acquisition and Licensing Arrangements', 'category': 'EVENT'}, {'entity': 'Swords', 'category': 'FAC'}, {'entity': 'Ireland', 'category': 'GPE'}, {'entity': 'R&D', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'Wallingford', 'category': 'LOC'}, {'entity': 'Puerto Rico', 'category': 'LOC'}, {'entity': 'Wallinforg', 'category': 'LOC'}, {'entity': 'Connecticut', 'category': 'LOC'}, {'entity': '$719 million', 'category': 'MONEY'}, {'entity': '$146 million', 'category': 'MONEY'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'R&D', 'category': 'ORG'}, {'entity': 'F-Star Alpha', 'category': 'ORG'}, {'entity': 'Other', 'category': 'ORG'}, {'entity': 'Cormorant', 'category': 'ORG'}, {'entity': 'Nitto Denko', 'category': 'ORG'}, {'entity': 'Promedior', 'category': 'ORG'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': '83', 'category': 'PERCENT'}, {'entity': '23%', 'category': 'PERCENT'}, {'entity': '26%', 'category': 'PERCENT'}, {'entity': 'OPDIVO', 'category': 'PERSON'}, {'entity': 'Daklinza', 'category': 'PERSON'}, {'entity': 'BMS', 'category': 'PERSON'}, {'entity': 'f-star-alpha', 'category': 'PERSON'}, {'entity': 'LPA1 Antagonist', 'category': 'PERSON'}, {'entity': 'in oncology', 'category': 'PERSON'}, {'entity': 'cardiovascular', 'category': 'PERSON'}, {'entity': 'immunoscience', 'category': 'PERSON'}, {'entity': 'fibrotic disease', 'category': 'PERSON'}, {'entity': 'Eliquis', 'category': 'PERSON'}, {'entity': 'Flexus', 'category': 'PERSON'}, {'entity': 'Cardioxyl', 'category': 'PERSON'}, {'entity': 'Dollars', 'category': 'PERSON'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'third', 'category': 'ORDINAL'}, {'entity': '26', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '700', 'category': 'CARDINAL'}, {'entity': '50', 'category': 'CARDINAL'}, {'entity': '40', 'category': 'CARDINAL'}, {'entity': '13', 'category': 'CARDINAL'}, {'entity': '180', 'category': 'CARDINAL'}, {'entity': '105', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '2020', 'category': 'CARDINAL'}, {'entity': '350', 'category': 'CARDINAL'}, {'entity': '18', 'category': 'CARDINAL'}, {'entity': '800', 'category': 'CARDINAL'}]\n",
      "[{'entity': '2017', 'category': 'DATE'}, {'entity': 'January 1, 2017', 'category': 'DATE'}, {'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': 'January 1, 2024', 'category': 'DATE'}, {'entity': 'December 31, 2026', 'category': 'DATE'}, {'entity': 'December 22, 2017', 'category': 'DATE'}, {'entity': '$826 million', 'category': 'MONEY'}, {'entity': '625 million', 'category': 'MONEY'}, {'entity': '625 million', 'category': 'MONEY'}, {'entity': '481 million', 'category': 'MONEY'}, {'entity': '15%', 'category': 'MONEY'}, {'entity': '2.9 billion', 'category': 'MONEY'}, {'entity': '2.6 billion', 'category': 'MONEY'}, {'entity': '285 million', 'category': 'MONEY'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Ono', 'category': 'ORG'}, {'entity': 'Merck', 'category': 'ORG'}, {'entity': 'Hilton', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Amylin', 'category': 'ORG'}, {'entity': 'Biogen', 'category': 'ORG'}, {'entity': 'Roche', 'category': 'ORG'}, {'entity': 'Erbitux', 'category': 'ORG'}, {'entity': 'Ixempra', 'category': 'ORG'}, {'entity': 'Erbitux', 'category': 'ORG'}, {'entity': '81.0%', 'category': 'PERCENT'}, {'entity': '23.8%', 'category': 'PERCENT'}, {'entity': '21.5%', 'category': 'PERCENT'}, {'entity': '56.7%', 'category': 'PERCENT'}, {'entity': 'Mary', 'category': 'PERSON'}, {'entity': 'Shakespeare', 'category': 'PERSON'}, {'entity': 'Peter', 'category': 'PERSON'}, {'entity': 'Lisa', 'category': 'PERSON'}, {'entity': 'Hamlet', 'category': 'WORK_OF_ART'}, {'entity': '$826 million', 'category': 'CARDINAL'}, {'entity': '2017', 'category': 'CARDINAL'}, {'entity': '6.5%', 'category': 'CARDINAL'}, {'entity': '2.5%', 'category': 'CARDINAL'}, {'entity': '6.5%', 'category': 'CARDINAL'}, {'entity': '2.5%', 'category': 'CARDINAL'}, {'entity': '75/25', 'category': 'CARDINAL'}, {'entity': '81.0', 'category': 'CARDINAL'}, {'entity': '23.8', 'category': 'CARDINAL'}, {'entity': '21.5', 'category': 'CARDINAL'}, {'entity': '35%', 'category': 'CARDINAL'}, {'entity': '21%', 'category': 'CARDINAL'}, {'entity': '2.9 billion', 'category': 'CARDINAL'}, {'entity': '56.7%', 'category': 'CARDINAL'}, {'entity': '2.6 billion', 'category': 'CARDINAL'}, {'entity': '15.5%', 'category': 'CARDINAL'}, {'entity': '8.0%', 'category': 'CARDINAL'}, {'entity': '285 million', 'category': 'CARDINAL'}, {'entity': '21%', 'category': 'CARDINAL'}, {'entity': '3.3%', 'category': 'CARDINAL'}, {'entity': '1.8%', 'category': 'CARDINAL'}, {'entity': '0.3%', 'category': 'CARDINAL'}, {'entity': '35%', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'prior periods', 'category': 'DATE'}, {'entity': 'the future periods', 'category': 'DATE'}, {'entity': 'Dec 23, 2022', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': 'restructuring costs', 'category': 'EVENT'}, {'entity': 'product launch', 'category': 'EVENT'}, {'entity': 'Cupertino', 'category': 'GPE'}, {'entity': 'California', 'category': 'GPE'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'Paris', 'category': 'GPE'}, {'entity': 'Facilities', 'category': 'LOC'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': 'BMS', 'category': 'PERSON'}, {'entity': 'Shakespeare', 'category': 'PERSON'}, {'entity': 'Peter', 'category': 'PERSON'}, {'entity': 'Lisa', 'category': 'PERSON'}, {'entity': 'Hamlet', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'Eight', 'category': 'CARDINAL'}, {'entity': 'one-time', 'category': 'CARDINAL'}]\n",
      "[{'entity': '$5.0 billion', 'category': 'MONEY'}, {'entity': '$2.0 billion', 'category': 'MONEY'}, {'entity': '$1.5 billion', 'category': 'MONEY'}, {'entity': '$1.5 billion', 'category': 'MONEY'}, {'entity': '15%', 'category': 'MONEY'}, {'entity': '$2.2 billion', 'category': 'MONEY'}, {'entity': '$1.5 billion', 'category': 'MONEY'}, {'entity': '$470 million', 'category': 'MONEY'}, {'entity': '$481 million', 'category': 'MONEY'}, {'entity': '$400 million', 'category': 'MONEY'}, {'entity': '$300 million', 'category': 'MONEY'}, {'entity': '$1.0 billion', 'category': 'MONEY'}, {'entity': '$700 million', 'category': 'MONEY'}, {'entity': '$600 million', 'category': 'MONEY'}, {'entity': '$1.4 billion', 'category': 'MONEY'}, {'entity': '$1.5 billion', 'category': 'MONEY'}, {'entity': '$745 million', 'category': 'MONEY'}, {'entity': '$600 million', 'category': 'MONEY'}, {'entity': '$350 million', 'category': 'MONEY'}, {'entity': '$3.1 billion', 'category': 'MONEY'}, {'entity': '$2.1 billion', 'category': 'MONEY'}, {'entity': '$800 million', 'category': 'MONEY'}, {'entity': '$600 million', 'category': 'MONEY'}, {'entity': '$400', 'category': 'MONEY'}]\n",
      "[{'entity': 'August 4, 2004', 'category': 'DATE'}, {'entity': 'September 30, 2004', 'category': 'DATE'}, {'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': 'FCPA Settlement', 'category': 'EVENT'}, {'entity': '$1.4 billion', 'category': 'MONEY'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'Item 8. Financial Statements—Note 3. Alliances', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '$400 million', 'category': 'CARDINAL'}, {'entity': '$1.4 billion', 'category': 'CARDINAL'}, {'entity': '$2.2 billion', 'category': 'CARDINAL'}, {'entity': '$880 million', 'category': 'CARDINAL'}, {'entity': '$1.0 billion', 'category': 'CARDINAL'}, {'entity': '$1.3 billion', 'category': 'CARDINAL'}, {'entity': '$200 million', 'category': 'CARDINAL'}, {'entity': '$987', 'category': 'CARDINAL'}, {'entity': '$6,835', 'category': 'CARDINAL'}, {'entity': '$3,083', 'category': 'CARDINAL'}, {'entity': '$793', 'category': 'CARDINAL'}, {'entity': '$3,386', 'category': 'CARDINAL'}, {'entity': '$69', 'category': 'CARDINAL'}, {'entity': '$2,497', 'category': 'CARDINAL'}, {'entity': '$17,650', 'category': 'CARDINAL'}, {'entity': '$2,992', 'category': 'CARDINAL'}, {'entity': '$2,490', 'category': 'CARDINAL'}, {'entity': '$981', 'category': 'CARDINAL'}, {'entity': '$724', 'category': 'CARDINAL'}, {'entity': '$1,452', 'category': 'CARDINAL'}, {'entity': '$9,011', 'category': 'CARDINAL'}, {'entity': '$17.0 billion', 'category': 'CARDINAL'}, {'entity': '$3.1 billion', 'category': 'CARDINAL'}, {'entity': '$10.4 billion', 'category': 'CARDINAL'}, {'entity': '$3.5 billion', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'October 2017', 'category': 'DATE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Federal', 'category': 'GPE'}, {'entity': 'state', 'category': 'GPE'}, {'entity': '$14.7 million', 'category': 'MONEY'}, {'entity': 'Company', 'category': 'ORG'}, {'entity': 'U.S. Department of Defense', 'category': 'ORG'}, {'entity': 'U.S. Department of Veterans Affairs', 'category': 'ORG'}, {'entity': '340B Drug Pricing Program', 'category': 'ORG'}, {'entity': 'Medicaid', 'category': 'ORG'}, {'entity': 'Medicare', 'category': 'ORG'}, {'entity': 'Centers for Medicare & Medicaid Services', 'category': 'ORG'}, {'entity': '47', 'category': 'QUANTITY'}, {'entity': '50%', 'category': 'ORDINAL'}, {'entity': 'established', 'category': 'ORDINAL'}, {'entity': 'new', 'category': 'ORDINAL'}]\n",
      "[{'entity': 'December 31', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': 'Biogen', 'category': 'ORG'}, {'entity': 'Roche', 'category': 'ORG'}]\n",
      "[{'entity': '2017', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': 'Phase I development', 'category': 'EVENT'}, {'entity': 'Phase II development', 'category': 'EVENT'}, {'entity': 'treatment', 'category': 'EVENT'}, {'entity': 'breast', 'category': 'EVENT'}, {'entity': 'cancer', 'category': 'EVENT'}, {'entity': 'gastric cancer', 'category': 'EVENT'}, {'entity': 'treatment of IPF', 'category': 'EVENT'}, {'entity': 'IPRD impairments', 'category': 'EVENT'}, {'entity': 'Swords,Ireland', 'category': 'GPE'}, {'entity': 'Walliford, Connecticut', 'category': 'GPE'}, {'entity': 'Swords,Ireland', 'category': 'LOC'}, {'entity': 'Wallingford, Connecticut', 'category': 'LOC'}, {'entity': '$2.3 billion', 'category': 'MONEY'}, {'entity': '$4.3 billion', 'category': 'MONEY'}, {'entity': '2017', 'category': 'MONEY'}, {'entity': '2016', 'category': 'MONEY'}, {'entity': '2018', 'category': 'MONEY'}, {'entity': '2.6 billion', 'category': 'MONEY'}, {'entity': 'F-Star Alpha', 'category': 'ORG'}, {'entity': 'FS102', 'category': 'ORG'}, {'entity': 'BMS-986020', 'category': 'ORG'}, {'entity': '$75 million', 'category': 'PERCENT'}, {'entity': '160 million', 'category': 'PERCENT'}, {'entity': 'Shakespeare', 'category': 'PERSON'}, {'entity': '1', 'category': 'QUANTITY'}, {'entity': '2017', 'category': 'TIME'}, {'entity': '2016', 'category': 'TIME'}, {'entity': '2015', 'category': 'TIME'}, {'entity': 'Item 8', 'category': 'WORK_OF_ART'}, {'entity': 'Financial Statements—Note 13', 'category': 'WORK_OF_ART'}, {'entity': 'Goodwill and Other Intangible Assets', 'category': 'WORK_OF_ART'}, {'entity': 'small molecule active pharmaceutical ingredient manufacturing operations', 'category': 'WORK_OF_ART'}, {'entity': 'R&D facility', 'category': 'WORK_OF_ART'}, {'entity': '146', 'category': 'CARDINAL'}, {'entity': '79', 'category': 'CARDINAL'}, {'entity': '533', 'category': 'CARDINAL'}, {'entity': '104', 'category': 'CARDINAL'}, {'entity': '115', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'four year period beginning two years before', 'category': 'DATE'}, {'entity': '2009', 'category': 'DATE'}, {'entity': 'April 2017', 'category': 'DATE'}, {'entity': 'June 2017', 'category': 'DATE'}, {'entity': 'December 2017', 'category': 'DATE'}, {'entity': 'September 2017', 'category': 'DATE'}, {'entity': 'January 2017', 'category': 'DATE'}, {'entity': 'August 2017', 'category': 'DATE'}, {'entity': 'March 2017', 'category': 'DATE'}, {'entity': 'June 2017', 'category': 'DATE'}, {'entity': 'April 2017', 'category': 'DATE'}, {'entity': 'September 2017', 'category': 'DATE'}, {'entity': 'December 2017', 'category': 'DATE'}, {'entity': 'Mead Johnson', 'category': 'ORG'}, {'entity': 'IRS', 'category': 'ORG'}, {'entity': 'Internal Revenue Code', 'category': 'ORG'}, {'entity': 'IPO', 'category': 'ORG'}, {'entity': 'Mead Johnson’s', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Ono', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': '50%', 'category': 'PERCENT'}, {'entity': 'Ono', 'category': 'PERSON'}, {'entity': 'Seattle Genetics, Inc.', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Adcetris', 'category': 'PRODUCT'}]\n",
      "[{'entity': 'October 2017', 'category': 'DATE'}, {'entity': 'September 2017', 'category': 'DATE'}, {'entity': 'July 2017', 'category': 'DATE'}, {'entity': 'June 2017', 'category': 'DATE'}, {'entity': 'February 2017', 'category': 'DATE'}, {'entity': 'December 2017', 'category': 'DATE'}, {'entity': 'April 2017', 'category': 'DATE'}, {'entity': 'January 2018', 'category': 'DATE'}, {'entity': 'April 2017', 'category': 'DATE'}, {'entity': 'February 2018', 'category': 'DATE'}, {'entity': 'November 2017', 'category': 'DATE'}, {'entity': 'August 2017', 'category': 'DATE'}, {'entity': 'August 2017', 'category': 'DATE'}, {'entity': 'July 2017', 'category': 'DATE'}, {'entity': 'December 2017', 'category': 'DATE'}, {'entity': 'November 2017', 'category': 'DATE'}, {'entity': 'September 2017', 'category': 'DATE'}, {'entity': 'June 2017', 'category': 'DATE'}, {'entity': '480 million', 'category': 'MONEY'}, {'entity': 'dMMR', 'category': 'NORP'}, {'entity': 'MSI-H', 'category': 'NORP'}, {'entity': 'CRC', 'category': 'NORP'}, {'entity': 'Melanoma', 'category': 'NORP'}, {'entity': 'MPM', 'category': 'NORP'}, {'entity': 'NSCLC', 'category': 'NORP'}, {'entity': 'RCC', 'category': 'NORP'}, {'entity': 'HNC', 'category': 'NORP'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'EMA', 'category': 'ORG'}, {'entity': 'CheckMate-039', 'category': 'ORG'}, {'entity': 'CA204142', 'category': 'ORG'}, {'entity': 'Clovis Oncology Inc.', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Incyte', 'category': 'ORG'}, {'entity': 'Rubraca*', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'epacadostat', 'category': 'PRODUCT'}, {'entity': 'Yervoy', 'category': 'PRODUCT'}, {'entity': 'Three-year', 'category': 'CARDINAL'}, {'entity': 'five-year', 'category': 'CARDINAL'}, {'entity': '142', 'category': 'CARDINAL'}, {'entity': '204', 'category': 'CARDINAL'}, {'entity': '067', 'category': 'CARDINAL'}, {'entity': '1501', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'October 2017', 'category': 'DATE'}, {'entity': 'EMANATE', 'category': 'DATE'}, {'entity': 'polyarticular JIA', 'category': 'DATE'}, {'entity': 'FDA', 'category': 'DATE'}, {'entity': 'CheckMate-032 study', 'category': 'EVENT'}, {'entity': 'clinical development collaboration', 'category': 'EVENT'}, {'entity': 'Phase III study', 'category': 'EVENT'}, {'entity': 'Phase IV study', 'category': 'EVENT'}, {'entity': 'U.S. Humana database', 'category': 'FAC'}, {'entity': 'real-world data analysis', 'category': 'FAC'}, {'entity': 'stroke/systemic embolism', 'category': 'FAC'}, {'entity': 'major bleeding', 'category': 'FAC'}, {'entity': 'Yervoy', 'category': 'FAC'}, {'entity': 'NVAF', 'category': 'GPE'}, {'entity': 'August 2017', 'category': 'GPE'}, {'entity': 'May 2017', 'category': 'GPE'}, {'entity': 'Yervoy', 'category': 'GPE'}, {'entity': 'China', 'category': 'GPE'}, {'entity': 'HCV', 'category': 'GPE'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Opdivo+Yervoy', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Exelixis', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'warfarin', 'category': 'ORG'}, {'entity': 'patients aged 65 years and older', 'category': 'ORG'}, {'entity': 'NVAF', 'category': 'ORG'}, {'entity': 'Sprycel', 'category': 'ORG'}, {'entity': 'Phase II CA180-372 study', 'category': 'ORG'}, {'entity': 'CML', 'category': 'ORG'}, {'entity': 'EC', 'category': 'ORG'}, {'entity': 'Hepatitis C Franchise', 'category': 'ORG'}, {'entity': 'Bavarian Nordic A/S', 'category': 'ORG'}, {'entity': '1 mm', 'category': 'PERCENT'}, {'entity': 'stroke/systemic embolism', 'category': 'PERCENT'}, {'entity': 'major bleeding', 'category': 'PERCENT'}, {'entity': 'NVAF.Announced data', 'category': 'PERCENT'}, {'entity': 'EMANATE', 'category': 'PERCENT'}, {'entity': 'patients', 'category': 'PERCENT'}, {'entity': 'CML', 'category': 'PERCENT'}, {'entity': 'Eliquis', 'category': 'PERSON'}, {'entity': 'Humana', 'category': 'PERSON'}, {'entity': 'Orencia', 'category': 'PERSON'}, {'entity': 'Sprycel', 'category': 'WORK_OF_ART'}, {'entity': 'August 2017', 'category': 'ORDINAL'}, {'entity': 'June 2017', 'category': 'ORDINAL'}, {'entity': 'subcutaneous', 'category': 'ORDINAL'}, {'entity': 'JIA', 'category': 'ORDINAL'}, {'entity': 'December 2017', 'category': 'ORDINAL'}, {'entity': 'phase', 'category': 'ORDINAL'}, {'entity': 'Philadelphia', 'category': 'ORDINAL'}, {'entity': 'EMA', 'category': 'ORDINAL'}, {'entity': 'CML', 'category': 'ORDINAL'}, {'entity': 'children and adolescents aged 1 year to 18 years', 'category': 'ORDINAL'}, {'entity': 'January 2018', 'category': 'ORDINAL'}, {'entity': 'melanoma', 'category': 'ORDINAL'}, {'entity': 'October 2017', 'category': 'ORDINAL'}, {'entity': 'five-year overall survival data', 'category': 'ORDINAL'}, {'entity': 'CA184-029 study', 'category': 'ORDINAL'}, {'entity': 'FDA', 'category': 'ORDINAL'}, {'entity': 'July 2017', 'category': 'ORDINAL'}, {'entity': 'pediatric patients', 'category': 'ORDINAL'}, {'entity': 'Phase III study', 'category': 'ORDINAL'}, {'entity': 'high risk', 'category': 'ORDINAL'}, {'entity': 'recurrence', 'category': 'ORDINAL'}, {'entity': 'surgical resection', 'category': 'ORDINAL'}, {'entity': 'Empliciti', 'category': 'ORDINAL'}, {'entity': 'four-year', 'category': 'ORDINAL'}, {'entity': 'April 2017', 'category': 'ORDINAL'}, {'entity': 'Daklinza', 'category': 'ORDINAL'}, {'entity': 'Sunvepra', 'category': 'ORDINAL'}, {'entity': 'Prostvac*', 'category': 'ORDINAL'}, {'entity': 'September 2017', 'category': 'ORDINAL'}, {'entity': 'independent Data Monitoring Committee', 'category': 'ORDINAL'}, {'entity': 'Phase III PROSPECT study', 'category': 'ORDINAL'}, {'entity': 'patients', 'category': 'ORDINAL'}, {'entity': 'metastatic castration-resistant prostate cancer', 'category': 'ORDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '5', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': 'hedging', 'category': 'EVENT'}, {'entity': 'purchase transactions', 'category': 'EVENT'}, {'entity': 'expo= exposures', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': '$175 million', 'category': 'MONEY'}, {'entity': 'Item 7A', 'category': 'ORG'}, {'entity': 'Item 8', 'category': 'ORG'}, {'entity': 'Financial Statements—Note 9. Financial Instruments and Fair Value Measurements', 'category': 'ORG'}, {'entity': '10%', 'category': 'PERCENT'}, {'entity': '100', 'category': 'PERCENT'}, {'entity': '100', 'category': 'PERCENT'}, {'entity': '100', 'category': 'PERCENT'}, {'entity': 'euro', 'category': 'PERSON'}, {'entity': 'Japanese yen', 'category': 'PERSON'}, {'entity': 'forward contracts', 'category': 'PRODUCT'}, {'entity': '10%', 'category': 'QUANTITY'}, {'entity': '175 million', 'category': 'QUANTITY'}, {'entity': '100 basis points', 'category': 'QUANTITY'}, {'entity': '25 million', 'category': 'QUANTITY'}, {'entity': '569 million', 'category': 'QUANTITY'}, {'entity': '100 basis points', 'category': 'QUANTITY'}, {'entity': '70 million', 'category': 'QUANTITY'}, {'entity': '100 basis points', 'category': 'QUANTITY'}, {'entity': 'December 31', 'category': 'TIME'}, {'entity': '2017', 'category': 'TIME'}, {'entity': 'accumulated other comprehensive income/loss', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '10', 'category': 'CARDINAL'}]\n",
      "/Users/tanmayiballa/Desktop/KG-LLM/l715_23-1/data/10-Ks/Bristol-Myers_Squibb_Company/2016/Management_gpt-3.5-turbo_NER_response.json\n",
      "[{'entity': '2015', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': 'Bristol-Myers Squibb Company', 'category': 'ORG'}, {'entity': 'Bristol-Myers Squibb', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Company', 'category': 'ORG'}, {'entity': '4%', 'category': 'PERCENT'}, {'entity': '21.5%', 'category': 'PERCENT'}, {'entity': '14.8%', 'category': 'PERCENT'}, {'entity': '10.8%', 'category': 'PERCENT'}, {'entity': 'Hepatitis C Franchise', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Eliquis', 'category': 'PRODUCT'}, {'entity': 'Abilify', 'category': 'PRODUCT'}, {'entity': 'Baraclude', 'category': 'PRODUCT'}, {'entity': 'Reyataz', 'category': 'PRODUCT'}, {'entity': 'Sustiva', 'category': 'PRODUCT'}, {'entity': 'Flexus Biosciences, Inc.', 'category': 'PRODUCT'}, {'entity': 'Cardioxyl Pharmaceuticals, Inc.', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Japanese Ministry of Health, Labour and Welfare', 'category': 'PRODUCT'}, {'entity': 'Ono Pharmaceutical Co.', 'category': 'PRODUCT'}, {'entity': 'Ltd.', 'category': 'PRODUCT'}, {'entity': 'U.S. Food and Drug Administration', 'category': 'PRODUCT'}, {'entity': 'BRAF V600', 'category': 'PRODUCT'}, {'entity': 'NSCLC', 'category': 'PRODUCT'}, {'entity': 'FDA', 'category': 'PRODUCT'}, {'entity': 'renal cell carcinoma', 'category': 'PRODUCT'}, {'entity': 'EU', 'category': 'PRODUCT'}, {'entity': 'squamous NSCLC', 'category': 'PRODUCT'}, {'entity': 'FDA', 'category': 'PRODUCT'}, {'entity': 'BRAF status', 'category': 'PRODUCT'}, {'entity': 'FDA', 'category': 'PRODUCT'}, {'entity': 'cutaneous melanoma', 'category': 'PRODUCT'}, {'entity': 'Japanese Ministry of Health, Labour and Welfare', 'category': 'PRODUCT'}, {'entity': 'multiple myeloma', 'category': 'PRODUCT'}, {'entity': 'Revlimid', 'category': 'PRODUCT'}, {'entity': 'dexamethasone', 'category': 'PRODUCT'}, {'entity': 'Hepatitis C Portfolio - Daklinza', 'category': 'PRODUCT'}, {'entity': 'FDA', 'category': 'PRODUCT'}, {'entity': 'HCV', 'category': 'PRODUCT'}, {'entity': 'immuno-oncology', 'category': 'PRODUCT'}, {'entity': 'PD-1', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Opdivos', 'category': 'PRODUCT'}, {'entity': 'U.S.', 'category': 'PRODUCT'}, {'entity': 'NSCLC', 'category': 'PRODUCT'}, {'entity': 'FDA', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'US', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': '43', 'category': 'PRODUCT'}, {'entity': '2015', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2015', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '16,560', 'category': 'CARDINAL'}, {'entity': '15,879', 'category': 'CARDINAL'}, {'entity': '16,385', 'category': 'CARDINAL'}, {'entity': '14,483', 'category': 'CARDINAL'}, {'entity': '13,498', 'category': 'CARDINAL'}, {'entity': '13,494', 'category': 'CARDINAL'}, {'entity': '2,077', 'category': 'CARDINAL'}, {'entity': '2,381', 'category': 'CARDINAL'}, {'entity': '2,891', 'category': 'CARDINAL'}, {'entity': '446', 'category': 'CARDINAL'}, {'entity': '352', 'category': 'CARDINAL'}, {'entity': '311', 'category': 'CARDINAL'}, {'entity': '1,565', 'category': 'CARDINAL'}, {'entity': '2,004', 'category': 'CARDINAL'}, {'entity': '2,563', 'category': 'CARDINAL'}, {'entity': '3,378', 'category': 'CARDINAL'}, {'entity': '3,085', 'category': 'CARDINAL'}, {'entity': '3,019', 'category': 'CARDINAL'}, {'entity': '0.93', 'category': 'CARDINAL'}, {'entity': '1.20', 'category': 'CARDINAL'}, {'entity': '1.54', 'category': 'CARDINAL'}, {'entity': '2.01', 'category': 'CARDINAL'}, {'entity': '1.85', 'category': 'CARDINAL'}, {'entity': '1.82', 'category': 'CARDINAL'}, {'entity': '8,930', 'category': 'CARDINAL'}, {'entity': '11,843', 'category': 'CARDINAL'}, {'entity': '8,272', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}]\n",
      "[{'entity': '2015', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': 'divestiture', 'category': 'EVENT'}, {'entity': 'HIV.U.S.', 'category': 'GPE'}, {'entity': 'vilonodular', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Europe', 'category': 'GPE'}, {'entity': 'Fast Track designation', 'category': 'LAW'}, {'entity': 'Orphan designation', 'category': 'LAW'}, {'entity': 'Japan', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'Europe', 'category': 'LOC'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': 'Kyorin', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Cardioxyl', 'category': 'ORG'}, {'entity': 'Five Prime', 'category': 'ORG'}, {'entity': 'Promedior', 'category': 'ORG'}, {'entity': 'uniQure', 'category': 'ORG'}, {'entity': 'Flexus', 'category': 'ORG'}, {'entity': 'Novo Nordisk', 'category': 'ORG'}, {'entity': 'Bavarian Nordic', 'category': 'ORG'}, {'entity': 'Rigel', 'category': 'ORG'}, {'entity': '$900 million', 'category': 'PERCENT'}, {'entity': '$1.9 billion', 'category': 'PERCENT'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': '9.9%', 'category': 'PERCENT'}, {'entity': '19.9%', 'category': 'PERCENT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Yervoy', 'category': 'PRODUCT'}, {'entity': 'Sprycel', 'category': 'PRODUCT'}, {'entity': 'Orencia', 'category': 'PRODUCT'}, {'entity': 'Eliquis', 'category': 'PRODUCT'}, {'entity': 'Daklinza', 'category': 'PRODUCT'}, {'entity': 'Reyataz', 'category': 'PRODUCT'}, {'entity': 'Baraclude', 'category': 'PRODUCT'}, {'entity': 'PRM-151', 'category': 'PRODUCT'}, {'entity': 'F001287', 'category': 'PRODUCT'}, {'entity': 'Prostvac*', 'category': 'PRODUCT'}, {'entity': '10', 'category': 'QUANTITY'}, {'entity': 'in 2015', 'category': 'TIME'}, {'entity': 'Phase II', 'category': 'TIME'}, {'entity': 'Phase I', 'category': 'TIME'}, {'entity': 'CXL-1427', 'category': 'WORK_OF_ART'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '2.4 million', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'Inc.', 'category': 'ORG'}, {'entity': 'Rigel', 'category': 'ORG'}, {'entity': 'Company', 'category': 'ORG'}, {'entity': 'Calibr', 'category': 'ORG'}, {'entity': 'California Institute for Biomedical Research', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Yervoy', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'Hilton Hotel', 'category': 'ORG'}, {'entity': 'Apple', 'category': 'ORG'}, {'entity': 'Paris', 'category': 'ORG'}, {'entity': 'Eiffel Tower', 'category': 'ORG'}, {'entity': 'Peter', 'category': 'ORG'}, {'entity': 'Lisa', 'category': 'ORG'}, {'entity': 'Hamlet', 'category': 'ORG'}, {'entity': 'Shakespeare', 'category': 'ORG'}, {'entity': 'Hilton Hotel', 'category': 'ORG'}, {'entity': 'Hilton Hotel', 'category': 'ORG'}, {'entity': 'Hilton Hotel', 'category': 'ORG'}, {'entity': 'United States', 'category': 'ORG'}, {'entity': 'Abilify', 'category': 'ORG'}, {'entity': 'Erbitux', 'category': 'ORG'}, {'entity': 'Sustiva', 'category': 'ORG'}, {'entity': 'Daklinza', 'category': 'ORG'}, {'entity': 'Sunvepra', 'category': 'ORG'}, {'entity': 'France', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Daklinza', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'Yervoy', 'category': 'ORG'}, {'entity': 'Sprycel', 'category': 'ORG'}, {'entity': 'Abilify', 'category': 'ORG'}, {'entity': 'Daklinza', 'category': 'ORG'}, {'entity': 'Japan', 'category': 'ORG'}, {'entity': '10', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'March 31, 2015', 'category': 'DATE'}, {'entity': 'product sales', 'category': 'EVENT'}, {'entity': 'France', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'Cupertino', 'category': 'LOC'}, {'entity': 'California', 'category': 'LOC'}, {'entity': 'United States', 'category': 'LOC'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': '$180 million', 'category': 'MONEY'}, {'entity': 'Company', 'category': 'ORG'}, {'entity': 'Apple', 'category': 'ORG'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': 'Mary', 'category': 'PERSON'}, {'entity': 'Peter', 'category': 'PERSON'}, {'entity': 'Lisa', 'category': 'PERSON'}, {'entity': 'Eliquis', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Daklinza', 'category': 'PRODUCT'}, {'entity': 'Plavix', 'category': 'PRODUCT'}, {'entity': 'Baraclude', 'category': 'PRODUCT'}, {'entity': 'Hepatitis C Franchise', 'category': 'PRODUCT'}, {'entity': 'Reyataz', 'category': 'PRODUCT'}, {'entity': 'Sustiva', 'category': 'PRODUCT'}, {'entity': 'Empliciti', 'category': 'PRODUCT'}, {'entity': 'Erbitux', 'category': 'PRODUCT'}, {'entity': 'Sprycel', 'category': 'PRODUCT'}, {'entity': 'Yervoy', 'category': 'PRODUCT'}, {'entity': 'Abilify', 'category': 'PRODUCT'}, {'entity': 'Orencia', 'category': 'PRODUCT'}, {'entity': 'Eliquis', 'category': 'PRODUCT'}, {'entity': 'evotaz', 'category': 'PRODUCT'}, {'entity': 'Sustiva', 'category': 'PRODUCT'}, {'entity': 'Atripla', 'category': 'PRODUCT'}, {'entity': 'six months', 'category': 'ORDINAL'}, {'entity': 'twelve months', 'category': 'ORDINAL'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'second', 'category': 'ORDINAL'}, {'entity': 'third', 'category': 'ORDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'November 2013', 'category': 'DATE'}, {'entity': 'Europe', 'category': 'GPE'}, {'entity': 'France', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'North America', 'category': 'LOC'}, {'entity': 'Japan', 'category': 'LOC'}, {'entity': 'EU', 'category': 'LOC'}, {'entity': 'de minimis', 'category': 'MONEY'}, {'entity': 'NSQ', 'category': 'NORP'}, {'entity': 'SQ NSCLC', 'category': 'NORP'}, {'entity': 'RCC', 'category': 'NORP'}, {'entity': 'RA', 'category': 'NORP'}, {'entity': 'NVAF', 'category': 'NORP'}, {'entity': 'VTE', 'category': 'NORP'}, {'entity': 'EU', 'category': 'NORP'}, {'entity': 'Eli Lilly', 'category': 'ORG'}, {'entity': '50%', 'category': 'PERCENT'}, {'entity': '33%', 'category': 'PERCENT'}, {'entity': '34%', 'category': 'PERCENT'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Opdivo', 'category': 'PERSON'}, {'entity': 'Orencia', 'category': 'PERSON'}, {'entity': 'Eliquis', 'category': 'PERSON'}, {'entity': '1.1', 'category': 'QUANTITY'}, {'entity': '1.2', 'category': 'QUANTITY'}, {'entity': '1.4', 'category': 'QUANTITY'}, {'entity': 'Atripla', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}]\n",
      "[{'entity': 'June 30', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': 'Russia', 'category': 'FAC'}, {'entity': 'France', 'category': 'FAC'}, {'entity': 'Russia', 'category': 'GPE'}, {'entity': '$3,909', 'category': 'MONEY'}, {'entity': '$3,932', 'category': 'MONEY'}, {'entity': '$4,619', 'category': 'MONEY'}, {'entity': '$14,483', 'category': 'MONEY'}, {'entity': '$13,498', 'category': 'MONEY'}, {'entity': '$13,494', 'category': 'MONEY'}, {'entity': '$1.1 billion', 'category': 'MONEY'}, {'entity': '$290 million', 'category': 'MONEY'}, {'entity': '$96 million', 'category': 'MONEY'}, {'entity': '$500 million', 'category': 'MONEY'}, {'entity': '$96 million', 'category': 'MONEY'}, {'entity': '$16 million', 'category': 'MONEY'}, {'entity': 'Fervex', 'category': 'ORG'}, {'entity': 'Donormyl', 'category': 'ORG'}, {'entity': 'U.S.', 'category': 'ORG'}, {'entity': 'IRS', 'category': 'ORG'}, {'entity': 'Affordable Care Act', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': '31 %', 'category': 'PERCENT'}, {'entity': '22 %', 'category': 'PERCENT'}, {'entity': '7 %', 'category': 'PERCENT'}, {'entity': '—', 'category': 'PERCENT'}, {'entity': '2 %', 'category': 'PERCENT'}, {'entity': '100%', 'category': 'PERCENT'}, {'entity': 'Eliquis', 'category': 'PRODUCT'}, {'entity': 'Opdivo', 'category': 'PRODUCT'}, {'entity': 'Hepatitis C Franchise', 'category': 'PRODUCT'}, {'entity': 'Yervoy', 'category': 'PRODUCT'}, {'entity': 'June 30', 'category': 'TIME'}, {'entity': '2015', 'category': 'TIME'}, {'entity': 'diabetes business divestiture', 'category': 'WORK_OF_ART'}, {'entity': '2.9', 'category': 'CARDINAL'}, {'entity': '3.1', 'category': 'CARDINAL'}, {'entity': '6.4', 'category': 'CARDINAL'}, {'entity': '4.8', 'category': 'CARDINAL'}, {'entity': '95%', 'category': 'CARDINAL'}]\n",
      "[{'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': 'Switzerland', 'category': 'GPE'}, {'entity': 'Ireland', 'category': 'GPE'}, {'entity': 'Puerto Rico', 'category': 'GPE'}, {'entity': '$184', 'category': 'MONEY'}, {'entity': 'Investment income', 'category': 'MONEY'}, {'entity': '$101', 'category': 'MONEY'}, {'entity': 'Restructuring', 'category': 'MONEY'}, {'entity': '$118', 'category': 'MONEY'}, {'entity': 'Litigation', 'category': 'MONEY'}, {'entity': '$159', 'category': 'MONEY'}, {'entity': 'Loss on sale', 'category': 'MONEY'}, {'entity': '$196', 'category': 'MONEY'}, {'entity': 'Pension charges', 'category': 'MONEY'}, {'entity': '$160', 'category': 'MONEY'}, {'entity': 'Loss on debt redemption', 'category': 'MONEY'}, {'entity': '$180', 'category': 'MONEY'}, {'entity': 'Litigation charge', 'category': 'MONEY'}, {'entity': '$90', 'category': 'MONEY'}, {'entity': '$343', 'category': 'MONEY'}, {'entity': 'Mature and other over-the-counter product businesses', 'category': 'MONEY'}, {'entity': '$123', 'category': 'MONEY'}, {'entity': 'Group annuity contract', 'category': 'MONEY'}, {'entity': '$713', 'category': 'MONEY'}, {'entity': 'Tax grant', 'category': 'MONEY'}, {'entity': '$446', 'category': 'MONEY'}, {'entity': 'Income taxes', 'category': 'MONEY'}, {'entity': '$352', 'category': 'MONEY'}, {'entity': 'Income taxes', 'category': 'MONEY'}, {'entity': '$311', 'category': 'MONEY'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Five Prime', 'category': 'ORG'}, {'entity': 'iPierian', 'category': 'ORG'}, {'entity': 'iPierian', 'category': 'ORG'}, {'entity': 'Reckitt', 'category': 'ORG'}, {'entity': '21.5%', 'category': 'PERCENT'}, {'entity': '14.8%', 'category': 'PERCENT'}, {'entity': '10.8%', 'category': 'PERCENT'}, {'entity': 'Flexus', 'category': 'PERSON'}, {'entity': 'Cardioxyl', 'category': 'PERSON'}, {'entity': 'iPierian', 'category': 'PERSON'}, {'entity': 'Reckitt', 'category': 'PERSON'}, {'entity': 'Flexus', 'category': 'PERSON'}, {'entity': 'Cardioxyl', 'category': 'PERSON'}, {'entity': 'Five Prime', 'category': 'PERSON'}, {'entity': 'Erbitux', 'category': 'PERSON'}, {'entity': 'Amylin', 'category': 'PERSON'}, {'entity': 'Peter', 'category': 'PERSON'}, {'entity': 'Lisa', 'category': 'PERSON'}, {'entity': 'Ixempra', 'category': 'WORK_OF_ART'}, {'entity': 'Erbitux', 'category': 'WORK_OF_ART'}, {'entity': 'Amylin', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'other', 'category': 'ORDINAL'}, {'entity': 'second', 'category': 'ORDINAL'}, {'entity': 'third', 'category': 'ORDINAL'}, {'entity': '35%', 'category': 'CARDINAL'}, {'entity': '2023', 'category': 'CARDINAL'}, {'entity': '0.3%', 'category': 'CARDINAL'}, {'entity': '5.1%', 'category': 'CARDINAL'}, {'entity': '4.6%', 'category': 'CARDINAL'}, {'entity': '800 million', 'category': 'CARDINAL'}, {'entity': '167 million', 'category': 'CARDINAL'}, {'entity': '350 million', 'category': 'CARDINAL'}, {'entity': '130 million', 'category': 'CARDINAL'}, {'entity': '$800 million', 'category': 'CARDINAL'}, {'entity': '$167 million', 'category': 'CARDINAL'}, {'entity': '$350 million', 'category': 'CARDINAL'}, {'entity': '$130 million', 'category': 'CARDINAL'}, {'entity': '$800 million', 'category': 'CARDINAL'}, {'entity': '$167 million', 'category': 'CARDINAL'}, {'entity': 'LPA1 antagonist in 2015', 'category': 'CARDINAL'}, {'entity': '$160 million', 'category': 'CARDINAL'}, {'entity': '2015', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '$84', 'category': 'CARDINAL'}, {'entity': '151', 'category': 'CARDINAL'}, {'entity': '36', 'category': 'CARDINAL'}, {'entity': '549', 'category': 'CARDINAL'}, {'entity': '273', 'category': 'CARDINAL'}, {'entity': '14', 'category': 'CARDINAL'}, {'entity': '326', 'category': 'CARDINAL'}, {'entity': '96', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '105', 'category': 'CARDINAL'}, {'entity': '1,679', 'category': 'CARDINAL'}, {'entity': '278', 'category': 'CARDINAL'}, {'entity': '123', 'category': 'CARDINAL'}, {'entity': '72', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '16', 'category': 'CARDINAL'}, {'entity': '160', 'category': 'CARDINAL'}, {'entity': '343', 'category': 'CARDINAL'}, {'entity': '158', 'category': 'CARDINAL'}, {'entity': '27', 'category': 'CARDINAL'}, {'entity': '23', 'category': 'CARDINAL'}, {'entity': '13', 'category': 'CARDINAL'}, {'entity': '11', 'category': 'CARDINAL'}, {'entity': '180', 'category': 'CARDINAL'}, {'entity': '316', 'category': 'CARDINAL'}, {'entity': '626', 'category': 'CARDINAL'}, {'entity': '340', 'category': 'CARDINAL'}, {'entity': '2,293', 'category': 'CARDINAL'}, {'entity': '1,503', 'category': 'CARDINAL'}, {'entity': '698', 'category': 'CARDINAL'}, {'entity': '115', 'category': 'CARDINAL'}, {'entity': '163', 'category': 'CARDINAL'}, {'entity': '226', 'category': 'CARDINAL'}, {'entity': '187', 'category': 'CARDINAL'}, {'entity': '559', 'category': 'CARDINAL'}, {'entity': '160', 'category': 'CARDINAL'}, {'entity': '877', 'category': 'CARDINAL'}, {'entity': '161', 'category': 'CARDINAL'}, {'entity': '-123', 'category': 'CARDINAL'}, {'entity': '-10', 'category': 'CARDINAL'}, {'entity': '-480', 'category': 'CARDINAL'}, {'entity': '-545', 'category': 'CARDINAL'}, {'entity': '-242', 'category': 'CARDINAL'}, {'entity': '1,813', 'category': 'CARDINAL'}, {'entity': '1,081', 'category': 'CARDINAL'}, {'entity': '456', 'category': 'CARDINAL'}, {'entity': '2,385', 'category': 'CARDINAL'}, {'entity': '5,571', 'category': 'CARDINAL'}, {'entity': '1,885', 'category': 'CARDINAL'}, {'entity': '1,864', 'category': 'CARDINAL'}, {'entity': '4,660', 'category': 'CARDINAL'}, {'entity': '4,408', 'category': 'CARDINAL'}, {'entity': '8,930', 'category': 'CARDINAL'}, {'entity': '11,843', 'category': 'CARDINAL'}, {'entity': '139', 'category': 'CARDINAL'}, {'entity': '590', 'category': 'CARDINAL'}, {'entity': '6,550', 'category': 'CARDINAL'}, {'entity': '7,242', 'category': 'CARDINAL'}, {'entity': '2,241', 'category': 'CARDINAL'}, {'entity': '4,011', 'category': 'CARDINAL'}, {'entity': '1.7 billion', 'category': 'CARDINAL'}, {'entity': '7.2 billion', 'category': 'CARDINAL'}, {'entity': '1.3 billion', 'category': 'CARDINAL'}, {'entity': '2.0 billion', 'category': 'CARDINAL'}, {'entity': '$1.3 billion', 'category': 'CARDINAL'}, {'entity': '$2.5 billion', 'category': 'CARDINAL'}, {'entity': '$2.4 billion', 'category': 'CARDINAL'}, {'entity': '$2.3 billion', 'category': 'CARDINAL'}, {'entity': '$800 million', 'category': 'CARDINAL'}, {'entity': '$500 million', 'category': 'CARDINAL'}, {'entity': '$1.3 billion', 'category': 'CARDINAL'}, {'entity': '$1.0 billion', 'category': 'CARDINAL'}, {'entity': '2019', 'category': 'CARDINAL'}, {'entity': '$1.5 billion', 'category': 'CARDINAL'}, {'entity': '2015', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': 'December 31, 2015', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}]\n",
      "[{'entity': '\"April 2015\"', 'category': 'DATE'}, {'entity': '\"2013\"', 'category': 'DATE'}, {'entity': '\"2014\"', 'category': 'DATE'}, {'entity': '\"December 31', 'category': 'DATE'}, {'entity': '2015\"', 'category': 'DATE'}, {'entity': '\"$1.3 billion\"', 'category': 'MONEY'}, {'entity': '\"Moodys Investors Service\"', 'category': 'ORG'}, {'entity': '\"Standard & Poors\"', 'category': 'ORG'}, {'entity': '\"Fitch\"', 'category': 'ORG'}, {'entity': '\"Reckitt\"', 'category': 'ORG'}, {'entity': '\"Flexus\"', 'category': 'ORG'}, {'entity': '\"Cardioxyl\"', 'category': 'ORG'}, {'entity': '\"iPierian\"', 'category': 'ORG'}, {'entity': '\"Abilify\"', 'category': 'PRODUCT'}]\n",
      "[{'entity': 'August 4, 2004', 'category': 'DATE'}, {'entity': 'September 30, 2004', 'category': 'DATE'}, {'entity': 'October 2015', 'category': 'DATE'}, {'entity': '$14.7 million', 'category': 'MONEY'}, {'entity': 'September 30, 2004', 'category': 'ORG'}, {'entity': 'IMAs', 'category': 'ORG'}, {'entity': 'FCPA', 'category': 'ORG'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'Consent', 'category': 'ORG'}, {'entity': '100%', 'category': 'PERCENT'}, {'entity': 'Form 10-Q', 'category': 'PRODUCT'}, {'entity': 'Exhibit 10-Q', 'category': 'WORK_OF_ART'}, {'entity': '31', 'category': 'CARDINAL'}, {'entity': '139', 'category': 'CARDINAL'}, {'entity': '6,339', 'category': 'CARDINAL'}, {'entity': '750', 'category': 'CARDINAL'}, {'entity': '500', 'category': 'CARDINAL'}, {'entity': '4,308', 'category': 'CARDINAL'}, {'entity': '187', 'category': 'CARDINAL'}, {'entity': '194', 'category': 'CARDINAL'}, {'entity': '192', 'category': 'CARDINAL'}, {'entity': '186', 'category': 'CARDINAL'}, {'entity': '185', 'category': 'CARDINAL'}, {'entity': '3,364', 'category': 'CARDINAL'}, {'entity': '822', 'category': 'CARDINAL'}, {'entity': '134', 'category': 'CARDINAL'}, {'entity': '111', 'category': 'CARDINAL'}, {'entity': '99', 'category': 'CARDINAL'}, {'entity': '78', 'category': 'CARDINAL'}, {'entity': '62', 'category': 'CARDINAL'}, {'entity': '338', 'category': 'CARDINAL'}, {'entity': '2,809', 'category': 'CARDINAL'}, {'entity': '1,226', 'category': 'CARDINAL'}, {'entity': '491', 'category': 'CARDINAL'}, {'entity': '381', 'category': 'CARDINAL'}, {'entity': '284', 'category': 'CARDINAL'}, {'entity': '228', 'category': 'CARDINAL'}, {'entity': '199', 'category': 'CARDINAL'}, {'entity': '75', 'category': 'CARDINAL'}, {'entity': '480', 'category': 'CARDINAL'}, {'entity': '9,253', 'category': 'CARDINAL'}, {'entity': '14,972', 'category': 'CARDINAL'}, {'entity': '1,761', 'category': 'CARDINAL'}, {'entity': '1,647', 'category': 'CARDINAL'}, {'entity': '724', 'category': 'CARDINAL'}, {'entity': '1,081', 'category': 'CARDINAL'}, {'entity': '506', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'France', 'category': 'GPE'}, {'entity': 'EU', 'category': 'GPE'}, {'entity': 'France', 'category': 'GPE'}, {'entity': 'Cupertino', 'category': 'GPE'}, {'entity': 'California', 'category': 'GPE'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'Paris', 'category': 'GPE'}, {'entity': 'Paris', 'category': 'GPE'}, {'entity': 'Cupertino', 'category': 'GPE'}, {'entity': 'California', 'category': 'GPE'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'Paris', 'category': 'GPE'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '$300 million', 'category': 'MONEY'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': 'Board of Directors', 'category': 'ORG'}, {'entity': 'Apple', 'category': 'ORG'}, {'entity': 'France', 'category': 'ORG'}, {'entity': 'France', 'category': 'ORG'}, {'entity': 'France', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'U.S. Department of Defense', 'category': 'ORG'}, {'entity': 'U.S. Department of Veterans Affairs', 'category': 'ORG'}, {'entity': 'U.S.', 'category': 'ORG'}, {'entity': 'U.S.', 'category': 'ORG'}, {'entity': 'U.S.', 'category': 'ORG'}, {'entity': 'Medicaid', 'category': 'ORG'}, {'entity': 'Medicaid', 'category': 'ORG'}, {'entity': 'Medicaid', 'category': 'ORG'}, {'entity': 'Medicare', 'category': 'ORG'}, {'entity': 'Medicare', 'category': 'ORG'}, {'entity': 'Centers for Medicare & Medicaid Services', 'category': 'ORG'}, {'entity': 'Mary', 'category': 'PERSON'}, {'entity': 'Shakespeare', 'category': 'PERSON'}, {'entity': 'Peter', 'category': 'PERSON'}, {'entity': 'Lisa', 'category': 'PERSON'}, {'entity': 'Daklinza', 'category': 'WORK_OF_ART'}]\n",
      "[{'entity': '2015', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Promedior', 'category': 'ORG'}, {'entity': 'AstraZeneca', 'category': 'ORG'}, {'entity': 'The Medicines Company', 'category': 'ORG'}, {'entity': 'Valeant Pharmaceuticals International Inc.', 'category': 'ORG'}, {'entity': 'Erbitux', 'category': 'PERSON'}, {'entity': 'Ixempra', 'category': 'PERSON'}, {'entity': '4.0%', 'category': 'QUANTITY'}, {'entity': '4.2%', 'category': 'QUANTITY'}, {'entity': '1.0 billion', 'category': 'QUANTITY'}, {'entity': '1', 'category': 'QUANTITY'}, {'entity': '9 million', 'category': 'QUANTITY'}, {'entity': '7.8%', 'category': 'QUANTITY'}, {'entity': '39 million', 'category': 'QUANTITY'}, {'entity': 'December 31, 2015', 'category': 'TIME'}, {'entity': 'September 30, 2014', 'category': 'TIME'}, {'entity': 'IPRD', 'category': 'WORK_OF_ART'}, {'entity': '$8.3 billion', 'category': 'CARDINAL'}, {'entity': '26%', 'category': 'CARDINAL'}, {'entity': '2015', 'category': 'CARDINAL'}, {'entity': '600 million', 'category': 'CARDINAL'}, {'entity': '73 million', 'category': 'CARDINAL'}, {'entity': '600 million', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'GPE'}, {'entity': 'December 31, 2014', 'category': 'GPE'}, {'entity': '2022', 'category': 'GPE'}, {'entity': '2017', 'category': 'GPE'}, {'entity': 'IPS-Idaho', 'category': 'LOC'}, {'entity': 'Mexico', 'category': 'LOC'}, {'entity': 'Indiana', 'category': 'LOC'}, {'entity': 'Item 8. Financial Statements—Note 3. Alliances', 'category': 'ORG'}, {'entity': 'Item 8. Financial Statements—Note 14. Goodwill and Other Intangible Assets', 'category': 'ORG'}, {'entity': 'Mead Johnson Nutrition Company', 'category': 'ORG'}, {'entity': 'Internal Revenue Code', 'category': 'ORG'}, {'entity': 'Internal Revenue Service', 'category': 'ORG'}, {'entity': 'Mead Johnson Class B', 'category': 'ORG'}, {'entity': 'Mead Johnson Class A', 'category': 'ORG'}, {'entity': 'Mead Johnson & Company', 'category': 'ORG'}, {'entity': '$115 million', 'category': 'PERCENT'}, {'entity': '$151 million', 'category': 'PERCENT'}, {'entity': '$36 million', 'category': 'PERCENT'}, {'entity': 'BMS-986020', 'category': 'PERSON'}, {'entity': 'idiopathic pulmonary fibrosis', 'category': 'PERSON'}, {'entity': 'peginterferon lambda', 'category': 'PERSON'}, {'entity': 'HCV', 'category': 'PERSON'}, {'entity': 'Item 8. Financial Statements—Note 1. Accounting Policies—Contingencies', 'category': 'WORK_OF_ART'}, {'entity': 'Item 8. Financial Statements—Note 8. Income Taxes', 'category': 'WORK_OF_ART'}, {'entity': 'Item 8. Financial Statements—Note 22. Legal Proceedings and Contingencies', 'category': 'WORK_OF_ART'}, {'entity': 'Mead Johnson split-off', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'II', 'category': 'ORDINAL'}, {'entity': 'III', 'category': 'ORDINAL'}, {'entity': '1.4 billion', 'category': 'CARDINAL'}, {'entity': '266 million', 'category': 'CARDINAL'}, {'entity': '758 million', 'category': 'CARDINAL'}, {'entity': '275 million', 'category': 'CARDINAL'}, {'entity': '120 million', 'category': 'CARDINAL'}, {'entity': '160 million', 'category': 'CARDINAL'}, {'entity': '343 million', 'category': 'CARDINAL'}, {'entity': '310 million', 'category': 'CARDINAL'}, {'entity': '115 million', 'category': 'CARDINAL'}, {'entity': '151 million', 'category': 'CARDINAL'}, {'entity': '36 million', 'category': 'CARDINAL'}, {'entity': '4.1 billion', 'category': 'CARDINAL'}, {'entity': '3.5 billion', 'category': 'CARDINAL'}, {'entity': '3.8 billion', 'category': 'CARDINAL'}, {'entity': '146 million', 'category': 'CARDINAL'}, {'entity': '27 million', 'category': 'CARDINAL'}, {'entity': '6 million', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'January 2016', 'category': 'DATE'}, {'entity': 'November 2015', 'category': 'DATE'}, {'entity': 'September 2015', 'category': 'DATE'}, {'entity': 'July 2015', 'category': 'DATE'}, {'entity': 'January 2016', 'category': 'DATE'}, {'entity': 'January 2016', 'category': 'DATE'}, {'entity': 'January 2016', 'category': 'DATE'}, {'entity': 'November 2015', 'category': 'DATE'}, {'entity': 'November 2015', 'category': 'DATE'}, {'entity': 'September 2015', 'category': 'DATE'}, {'entity': 'July 2015', 'category': 'DATE'}, {'entity': 'a taxable sale', 'category': 'EVENT'}, {'entity': 'T', 'category': 'GPE'}, {'entity': 'NKT', 'category': 'GPE'}, {'entity': 'Mead Johnson', 'category': 'ORG'}, {'entity': 'In addition', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'Ono', 'category': 'ORG'}, {'entity': 'Ono', 'category': 'ORG'}, {'entity': '57.7%', 'category': 'PERCENT'}, {'entity': 'PD-1', 'category': 'PERSON'}, {'entity': 'the first', 'category': 'ORDINAL'}, {'entity': '$244 million', 'category': 'CARDINAL'}, {'entity': '10%', 'category': 'CARDINAL'}, {'entity': '30-45%', 'category': 'CARDINAL'}, {'entity': 'III', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': 'three-year', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'Phase III CheckMate-067 study', 'category': 'DATE'}, {'entity': 'Phase II CheckMate-069 study', 'category': 'DATE'}, {'entity': 'Phase Ib CA209-004 study', 'category': 'DATE'}, {'entity': 'June 2015', 'category': 'DATE'}, {'entity': 'April 2015', 'category': 'DATE'}, {'entity': 'May 2015', 'category': 'DATE'}, {'entity': 'November 2015', 'category': 'DATE'}, {'entity': 'October 2015', 'category': 'DATE'}, {'entity': 'September 2015', 'category': 'DATE'}, {'entity': 'December 2015', 'category': 'DATE'}, {'entity': 'July 2015', 'category': 'DATE'}, {'entity': 'European Commission EC approved Opdivo', 'category': 'EVENT'}, {'entity': 'approval given by the EC for a PD-1 inhibitor in any cancer', 'category': 'EVENT'}, {'entity': 'positive results of a Phase III trial CheckMate-067', 'category': 'EVENT'}, {'entity': 'positive results from a Phase II trial CheckMate-069', 'category': 'EVENT'}, {'entity': 'received manufacturing and marketing approval for Opdivo in Japan', 'category': 'EVENT'}, {'entity': 'EC approved the reconciliation of indications for nivolumab under the Opdivo European Marketing Authorization Application MAA', 'category': 'EVENT'}, {'entity': 'FDA approved Opdivo for the treatment of previously treated patients with NSQ NSCLC regardless of PD-L1 expression', 'category': 'EVENT'}, {'entity': 'updated results from the Opdivo+Yervoy arms in CheckMate-012', 'category': 'EVENT'}, {'entity': 'longer term survival and safety data from CheckMate-017 and -063', 'category': 'EVENT'}, {'entity': 'EMA validated the Company’s type II variation application', 'category': 'EVENT'}, {'entity': 'EMAs centralized review process', 'category': 'FAC'}, {'entity': 'EU', 'category': 'FAC'}, {'entity': 'Opdivo', 'category': 'FAC'}, {'entity': 'Yervoy', 'category': 'FAC'}, {'entity': 'Europe', 'category': 'GPE'}, {'entity': 'Japan', 'category': 'GPE'}, {'entity': 'no entities', 'category': 'LOC'}, {'entity': 'no entities', 'category': 'MONEY'}, {'entity': 'Company', 'category': 'ORG'}, {'entity': 'European Commission EC', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'BMS', 'category': 'ORG'}, {'entity': 'Opdivo European Marketing Authorization Application MAA', 'category': 'ORG'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'EC', 'category': 'ORG'}, {'entity': 'no entities', 'category': 'PERCENT'}, {'entity': 'no entities', 'category': 'PERSON'}, {'entity': 'no entities', 'category': 'PRODUCT'}, {'entity': 'no entities', 'category': 'QUANTITY'}, {'entity': 'no entities', 'category': 'TIME'}, {'entity': 'Opdivo', 'category': 'WORK_OF_ART'}, {'entity': 'Yervoy', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'no entities', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'July 2015', 'category': 'DATE'}, {'entity': 'more than a decade', 'category': 'DATE'}, {'entity': 'May 2015', 'category': 'DATE'}, {'entity': 'CheckMate-017', 'category': 'DATE'}, {'entity': 'one year', 'category': 'DATE'}, {'entity': '9.2 months', 'category': 'DATE'}, {'entity': '6 months', 'category': 'DATE'}, {'entity': 'April 2015', 'category': 'DATE'}, {'entity': 'March 2015', 'category': 'DATE'}, {'entity': 'September 2015', 'category': 'DATE'}, {'entity': '25 months', 'category': 'DATE'}, {'entity': '19.6 months', 'category': 'DATE'}, {'entity': 'May 2015', 'category': 'DATE'}, {'entity': 'January 2016', 'category': 'DATE'}, {'entity': 'December 2015', 'category': 'DATE'}, {'entity': 'November 2015', 'category': 'DATE'}, {'entity': 'June 2015', 'category': 'DATE'}, {'entity': 'approval', 'category': 'EVENT'}, {'entity': 'adoption', 'category': 'EVENT'}, {'entity': 'positive opinion', 'category': 'EVENT'}, {'entity': 'extended follow-up data', 'category': 'EVENT'}, {'entity': 'pre-specified interim overall survival analysis', 'category': 'EVENT'}, {'entity': 'improvement', 'category': 'EVENT'}, {'entity': 'FDA approval', 'category': 'EVENT'}, {'entity': 'results', 'category': 'EVENT'}, {'entity': 'interim analysis', 'category': 'EVENT'}, {'entity': 'randomized', 'category': 'EVENT'}, {'entity': 'open-label ELOQUENT-2 trial', 'category': 'EVENT'}, {'entity': 'treatment', 'category': 'EVENT'}, {'entity': 'evaluation', 'category': 'EVENT'}, {'entity': 'Opdivo monotherapy', 'category': 'ORG'}, {'entity': 'NSQ NSCLC', 'category': 'ORG'}, {'entity': 'Phase III CheckMate-057 study', 'category': 'ORG'}, {'entity': 'EC', 'category': 'ORG'}, {'entity': 'Nivolumab BMS', 'category': 'ORG'}, {'entity': 'SQ NSCLC', 'category': 'ORG'}, {'entity': 'Phase III', 'category': 'ORG'}, {'entity': 'docetaxel', 'category': 'ORG'}, {'entity': 'Opdivo', 'category': 'ORG'}, {'entity': 'CheckMate-017', 'category': 'ORG'}, {'entity': 'Opdivo arm', 'category': 'ORG'}, {'entity': 'docetaxel arm', 'category': 'ORG'}, {'entity': 'CheckMate-025', 'category': 'ORG'}, {'entity': 'everolimus', 'category': 'ORG'}, {'entity': 'prespecified interim analysis', 'category': 'ORG'}, {'entity': 'CA209-040', 'category': 'ORG'}, {'entity': 'Phase I/II dose-ranging trial', 'category': 'ORG'}, {'entity': 'Hepatocellular carcinoma', 'category': 'ORG'}, {'entity': 'HCC', 'category': 'ORG'}, {'entity': 'liver cancer', 'category': 'ORG'}, {'entity': 'Empliciti', 'category': 'ORG'}, {'entity': 'multiple myeloma', 'category': 'ORG'}, {'entity': 'AbbVie Inc.', 'category': 'ORG'}, {'entity': 'Committee for Medicinal Products for Human Use', 'category': 'ORG'}, {'entity': 'CHMP', 'category': 'ORG'}, {'entity': 'positive opinion', 'category': 'ORG'}, {'entity': 'approval', 'category': 'ORG'}, {'entity': 'ELOQUENT-2', 'category': 'ORG'}, {'entity': 'Revlimid', 'category': 'ORG'}, {'entity': 'dexamethasone', 'category': 'ORG'}, {'entity': 'combination therapy', 'category': 'ORG'}, {'entity': 'follow-up data', 'category': 'ORG'}, {'entity': 'progression-free survival', 'category': 'ORG'}, {'entity': 'primary analysis', 'category': 'ORG'}, {'entity': 'FDA approval', 'category': 'ORG'}, {'entity': 'patients', 'category': 'ORG'}, {'entity': 'Phase III', 'category': 'ORG'}, {'entity': 'lenalidomide', 'category': 'ORG'}, {'entity': 'PFS', 'category': 'ORG'}, {'entity': 'ORR', 'category': 'ORG'}, {'entity': 'disease progression', 'category': 'ORG'}, {'entity': 'odds ratio', 'category': 'ORG'}, {'entity': 'safety profile', 'category': 'ORG'}]\n",
      "[{'entity': 'Empliciti', 'category': 'PERSON'}, {'entity': 'lenalidomide', 'category': 'PERSON'}, {'entity': 'dexamethasone', 'category': 'PERSON'}, {'entity': 'Sprycel', 'category': 'PERSON'}, {'entity': 'Otsuka Pharmaceutical Co.', 'category': 'PERSON'}, {'entity': 'imatinib mesylate', 'category': 'PERSON'}, {'entity': 'Gleevec*', 'category': 'PERSON'}, {'entity': 'Yervoy', 'category': 'PERSON'}, {'entity': 'HCV', 'category': 'PERSON'}, {'entity': 'Daklinza', 'category': 'PERSON'}, {'entity': 'DCV', 'category': 'PERSON'}, {'entity': 'Sunvepra', 'category': 'PERSON'}, {'entity': 'ASV', 'category': 'PERSON'}, {'entity': 'Beclabuvir', 'category': 'PERSON'}, {'entity': 'BCV', 'category': 'PERSON'}, {'entity': 'Sofosbuvir', 'category': 'PERSON'}, {'entity': 'Gilead Sciences, Inc.', 'category': 'PERSON'}, {'entity': 'ALLY-3', 'category': 'PERSON'}, {'entity': 'NICE', 'category': 'PERSON'}, {'entity': 'EU', 'category': 'PERSON'}, {'entity': 'ALLY-1', 'category': 'PERSON'}, {'entity': 'ALLY-2', 'category': 'PERSON'}]\n",
      "[{'entity': 'February 2015', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': 'July 2015', 'category': 'DATE'}, {'entity': 'June 2015', 'category': 'DATE'}, {'entity': 'January 2015', 'category': 'DATE'}, {'entity': 'April 2015', 'category': 'DATE'}, {'entity': 'December 2015', 'category': 'DATE'}, {'entity': 'September 2015', 'category': 'DATE'}, {'entity': 'SVR12', 'category': 'EVENT'}, {'entity': 'HIV-1 infection', 'category': 'EVENT'}, {'entity': 'RA', 'category': 'EVENT'}, {'entity': 'AMPLIFY trial', 'category': 'EVENT'}, {'entity': 'Acute Coronary Syndrome', 'category': 'EVENT'}, {'entity': 'percutaneous coronary intervention', 'category': 'EVENT'}, {'entity': 'first patient', 'category': 'EVENT'}, {'entity': 'Evotaz atazanavir 300 mg and cobicistat 150 mg', 'category': 'FAC'}, {'entity': 'license agreement', 'category': 'FAC'}, {'entity': 'Gilead', 'category': 'FAC'}, {'entity': 'Tybost', 'category': 'FAC'}, {'entity': 'Gilead', 'category': 'FAC'}, {'entity': 'EU', 'category': 'FAC'}, {'entity': 'The EU', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': 'FDA', 'category': 'ORG'}, {'entity': 'Company', 'category': 'ORG'}, {'entity': 'Reyataz Franchise', 'category': 'ORG'}, {'entity': 'HIV', 'category': 'ORG'}, {'entity': 'Orencia', 'category': 'ORG'}, {'entity': 'EMA', 'category': 'ORG'}, {'entity': 'Eliquis', 'category': 'ORG'}, {'entity': 'Pfizer, Inc.', 'category': 'ORG'}, {'entity': 'AM', 'category': 'ORG'}, {'entity': '97%', 'category': 'PERCENT'}, {'entity': '96%', 'category': 'PERCENT'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': 'HCV', 'category': 'PERSON'}, {'entity': 'HIV', 'category': 'PERSON'}, {'entity': 'SVR12 weeks', 'category': 'PERSON'}, {'entity': 'SVR12', 'category': 'PERSON'}, {'entity': 'daclatasvir', 'category': 'PERSON'}, {'entity': 'sofosbuvir', 'category': 'PERSON'}, {'entity': 'daclatasvir', 'category': 'PERSON'}, {'entity': 'BMS', 'category': 'PERSON'}, {'entity': 'HCV.Reyataz Franchise', 'category': 'PERSON'}, {'entity': 'Evotaz', 'category': 'PERSON'}, {'entity': 'atazanavir', 'category': 'PERSON'}, {'entity': 'cobicistat', 'category': 'PERSON'}, {'entity': 'Gilead', 'category': 'PERSON'}, {'entity': 'Reyataz', 'category': 'PERSON'}, {'entity': 'Tybost', 'category': 'PERSON'}, {'entity': 'Orencia', 'category': 'PERSON'}, {'entity': 'RA', 'category': 'PERSON'}, {'entity': 'AMP', 'category': 'PERSON'}, {'entity': 'daclatasvir', 'category': 'PRODUCT'}, {'entity': 'BMS', 'category': 'PRODUCT'}, {'entity': 'HIV', 'category': 'PRODUCT'}, {'entity': 'Evotaz', 'category': 'PRODUCT'}, {'entity': 'Tybost', 'category': 'PRODUCT'}, {'entity': 'Gilead', 'category': 'PRODUCT'}, {'entity': 'ab', 'category': 'PRODUCT'}, {'entity': 'ClickJect', 'category': 'PRODUCT'}, {'entity': 'Pre-Filled Pen', 'category': 'PRODUCT'}, {'entity': 'Orencia', 'category': 'PRODUCT'}, {'entity': 'EMA', 'category': 'PRODUCT'}, {'entity': 'Eliquis', 'category': 'PRODUCT'}, {'entity': 'two', 'category': 'QUANTITY'}, {'entity': '400 mg', 'category': 'QUANTITY'}, {'entity': 'AST to Plate', 'category': 'QUANTITY'}, {'entity': 'Gilead', 'category': 'QUANTITY'}, {'entity': 'U,EL', 'category': 'QUANTITY'}, {'entity': '12 weeks', 'category': 'TIME'}, {'entity': '12 weeks', 'category': 'TIME'}, {'entity': '7, 21 and 90 days', 'category': 'TIME'}, {'entity': 'NVAF', 'category': 'TIME'}, {'entity': 'Phase III AMPLIFY trial', 'category': 'WORK_OF_ART'}, {'entity': 'Phase IV clinical trial', 'category': 'WORK_OF_ART'}, {'entity': 'AUGUSTUS', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '97', 'category': 'CARDINAL'}, {'entity': '149', 'category': 'CARDINAL'}, {'entity': '153', 'category': 'CARDINAL'}, {'entity': '96', 'category': 'CARDINAL'}, {'entity': '80', 'category': 'CARDINAL'}, {'entity': '83', 'category': 'CARDINAL'}, {'entity': '15', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'European', 'category': 'ORG'}, {'entity': 'U.S. dollar', 'category': 'ORG'}, {'entity': 'Greece', 'category': 'ORG'}, {'entity': 'Portugal', 'category': 'ORG'}, {'entity': 'Italy', 'category': 'ORG'}, {'entity': 'Spain', 'category': 'ORG'}, {'entity': 'counterparty', 'category': 'ORG'}, {'entity': '10%', 'category': 'PERCENT'}, {'entity': '100', 'category': 'PERCENT'}]\n",
      "/Users/tanmayiballa/Desktop/KG-LLM/l715_23-1/data/10-Ks/Aerojet_Rocketdyne_Holdings_Inc./2013/Management_gpt-3.5-turbo_NER_response.json\n",
      "[{'entity': 'fiscal 2012', 'category': 'DATE'}, {'entity': 'fiscal 2011', 'category': 'DATE'}, {'entity': 'November 30, 2012', 'category': 'DATE'}, {'entity': 'November 30, 2011', 'category': 'DATE'}, {'entity': 'first half of 2013', 'category': 'DATE'}, {'entity': 'January 28, 2013', 'category': 'DATE'}, {'entity': 'July 21, 2013', 'category': 'DATE'}, {'entity': 'one-month', 'category': 'DATE'}, {'entity': '360 days', 'category': 'DATE'}, {'entity': 'August 16, 2012', 'category': 'DATE'}, {'entity': 'Management’s Discussion and Analysis of Financial Condition and Results of Operations', 'category': 'EVENT'}, {'entity': 'overview', 'category': 'EVENT'}, {'entity': 'results of operations', 'category': 'EVENT'}, {'entity': 'liquidity and capital resources', 'category': 'EVENT'}, {'entity': 'critical accounting policies', 'category': 'EVENT'}, {'entity': 'significant financial highlights', 'category': 'EVENT'}, {'entity': 'net sales', 'category': 'EVENT'}, {'entity': 'net loss', 'category': 'EVENT'}, {'entity': 'Adjusted EBITDAP', 'category': 'EVENT'}, {'entity': 'Segment performance', 'category': 'EVENT'}, {'entity': 'Cash provided by operating activities', 'category': 'EVENT'}, {'entity': 'Free cash flow', 'category': 'EVENT'}, {'entity': 'Funded backlog', 'category': 'EVENT'}, {'entity': 'Acquisition', 'category': 'EVENT'}, {'entity': 'liquid rocket propulsion designer', 'category': 'EVENT'}, {'entity': 'net proceeds', 'category': 'EVENT'}, {'entity': '7 1/8% Notes offering', 'category': 'EVENT'}, {'entity': 'proposed acquisition', 'category': 'EVENT'}, {'entity': 'issuance of debt', 'category': 'EVENT'}, {'entity': 'Notes to the Consolidated Financial Statements', 'category': 'EVENT'}, {'entity': 'financing of the Acquisition', 'category': 'EVENT'}, {'entity': 'integration of our operations', 'category': 'EVENT'}, {'entity': 'GenCorp Inc.', 'category': 'ORG'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': 'UTC', 'category': 'ORG'}, {'entity': 'Rocketdyne Business', 'category': 'ORG'}, {'entity': 'NASA', 'category': 'ORG'}, {'entity': 'Rules 144A', 'category': 'ORG'}, {'entity': 'Regulation S', 'category': 'ORG'}, {'entity': 'Securities Act', 'category': 'ORG'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '2011', 'category': 'CARDINAL'}, {'entity': '2.6', 'category': 'CARDINAL'}, {'entity': '0.04', 'category': 'CARDINAL'}, {'entity': '2.9', 'category': 'CARDINAL'}, {'entity': '0.05', 'category': 'CARDINAL'}, {'entity': '110.9', 'category': 'CARDINAL'}, {'entity': '11.1', 'category': 'CARDINAL'}, {'entity': '115.4', 'category': 'CARDINAL'}, {'entity': '12.6', 'category': 'CARDINAL'}, {'entity': '119.2', 'category': 'CARDINAL'}, {'entity': '114.2', 'category': 'CARDINAL'}, {'entity': '86.2', 'category': 'CARDINAL'}, {'entity': '76.8', 'category': 'CARDINAL'}, {'entity': '49.0', 'category': 'CARDINAL'}, {'entity': '55.7', 'category': 'CARDINAL'}, {'entity': '86.6', 'category': 'CARDINAL'}, {'entity': '138.4', 'category': 'CARDINAL'}, {'entity': '1,018', 'category': 'CARDINAL'}, {'entity': '902', 'category': 'CARDINAL'}, {'entity': '550', 'category': 'CARDINAL'}, {'entity': '20.0', 'category': 'CARDINAL'}, {'entity': '1,600', 'category': 'CARDINAL'}, {'entity': '460.0', 'category': 'CARDINAL'}, {'entity': '7 1/8', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'fiscal 2012', 'category': 'DATE'}, {'entity': 'November 30, 2012', 'category': 'DATE'}, {'entity': 'fiscal 2011', 'category': 'DATE'}, {'entity': 'fiscal 2010', 'category': 'DATE'}, {'entity': 'fiscal 2012', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': 'September 30, 2012', 'category': 'DATE'}, {'entity': 'February 13, 2012', 'category': 'DATE'}, {'entity': 'on-going', 'category': 'DATE'}, {'entity': 'GFY 2013', 'category': 'DATE'}, {'entity': 'a year ago', 'category': 'DATE'}, {'entity': 'final GFY 2012', 'category': 'DATE'}, {'entity': 'fiscal 2013', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': 'next five years', 'category': 'DATE'}, {'entity': 'ten years', 'category': 'DATE'}, {'entity': 'beginning on January 2, 2013', 'category': 'DATE'}, {'entity': 'American Taxpayer Relief Act of 2012', 'category': 'DATE'}, {'entity': 'January 2, 2013', 'category': 'DATE'}, {'entity': 'over the next year', 'category': 'DATE'}, {'entity': 'November 30, 2012', 'category': 'DATE'}, {'entity': 'The Rocketdyne Business', 'category': 'EVENT'}, {'entity': 'LDACS program', 'category': 'EVENT'}, {'entity': 'Standard Missile program', 'category': 'EVENT'}, {'entity': 'GFY 2013 budget', 'category': 'EVENT'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'Cupertino', 'category': 'GPE'}, {'entity': 'California', 'category': 'GPE'}, {'entity': 'Paris', 'category': 'GPE'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'U.S. government', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'NASA', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S. government', 'category': 'GPE'}, {'entity': 'U.S. aerospace', 'category': 'GPE'}, {'entity': 'U.S. aerospace', 'category': 'GPE'}, {'entity': 'U.S. government', 'category': 'GPE'}, {'entity': 'DoD', 'category': 'GPE'}, {'entity': 'United States', 'category': 'LOC'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': '$34.3 million', 'category': 'MONEY'}, {'entity': '$259 billion', 'category': 'MONEY'}, {'entity': '$487 billion', 'category': 'MONEY'}, {'entity': '$525.4 billion', 'category': 'MONEY'}, {'entity': '$45 billion', 'category': 'MONEY'}, {'entity': '$5.2 billion', 'category': 'MONEY'}, {'entity': '$936.9', 'category': 'MONEY'}, {'entity': '94%', 'category': 'MONEY'}, {'entity': '$855.8', 'category': 'MONEY'}, {'entity': '93', 'category': 'MONEY'}, {'entity': '786.1', 'category': 'MONEY'}, {'entity': '92', 'category': 'MONEY'}, {'entity': 'Rocketdyne Business', 'category': 'ORG'}, {'entity': 'DoD', 'category': 'ORG'}, {'entity': 'NASA', 'category': 'ORG'}, {'entity': 'Lockheed Martin', 'category': 'ORG'}, {'entity': 'Lockheed Martin', 'category': 'ORG'}, {'entity': 'Raytheon', 'category': 'ORG'}, {'entity': 'Budget Control Act', 'category': 'ORG'}, {'entity': 'DoD', 'category': 'ORG'}, {'entity': 'NASA', 'category': 'ORG'}, {'entity': 'DoD', 'category': 'ORG'}, {'entity': 'Congress', 'category': 'ORG'}, {'entity': '10', 'category': 'PERCENT'}, {'entity': '11.6 million', 'category': 'PERCENT'}, {'entity': '10', 'category': 'PERCENT'}, {'entity': '37', 'category': 'PERCENT'}, {'entity': '36', 'category': 'PERCENT'}, {'entity': '37', 'category': 'PERCENT'}, {'entity': '32', 'category': 'PERCENT'}, {'entity': '28', 'category': 'PERCENT'}, {'entity': '27', 'category': 'PERCENT'}, {'entity': '24', 'category': 'PERCENT'}, {'entity': '26', 'category': 'PERCENT'}, {'entity': '25', 'category': 'PERCENT'}, {'entity': '24', 'category': 'PERCENT'}, {'entity': '26', 'category': 'PERCENT'}, {'entity': '$259 billion', 'category': 'PERCENT'}, {'entity': 'over the next five years', 'category': 'PERCENT'}, {'entity': 'over ten years', 'category': 'PERCENT'}, {'entity': '$487 billion', 'category': 'PERCENT'}, {'entity': '$525.4 billion', 'category': 'PERCENT'}, {'entity': 'GFY 2013', 'category': 'PERCENT'}, {'entity': '2013', 'category': 'PERCENT'}, {'entity': 'a year ago', 'category': 'PERCENT'}, {'entity': 'GFY 2012', 'category': 'PERCENT'}, {'entity': '$1.2 trillion', 'category': 'PERCENT'}, {'entity': '2021', 'category': 'PERCENT'}, {'entity': 'until late 2014/early 2015', 'category': 'PERCENT'}, {'entity': '73', 'category': 'PERCENT'}, {'entity': '228', 'category': 'PERCENT'}, {'entity': '562', 'category': 'PERCENT'}, {'entity': 'Rocketdyne', 'category': 'PERSON'}, {'entity': 'November 30, 2012', 'category': 'PERSON'}, {'entity': 'LDACS program', 'category': 'PRODUCT'}, {'entity': 'Standard Missile program', 'category': 'PRODUCT'}, {'entity': 'November 30, 2012', 'category': 'TIME'}, {'entity': 'several years', 'category': 'TIME'}, {'entity': 'two to three years', 'category': 'TIME'}, {'entity': 'Notes', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '$11.6 million', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '37', 'category': 'CARDINAL'}, {'entity': '36', 'category': 'CARDINAL'}, {'entity': '37', 'category': 'CARDINAL'}, {'entity': '32', 'category': 'CARDINAL'}, {'entity': '28', 'category': 'CARDINAL'}, {'entity': '27', 'category': 'CARDINAL'}, {'entity': '25', 'category': 'CARDINAL'}, {'entity': '24', 'category': 'CARDINAL'}, {'entity': '26', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '2011', 'category': 'CARDINAL'}, {'entity': '2010', 'category': 'CARDINAL'}, {'entity': '936.9', 'category': 'CARDINAL'}, {'entity': '855.8', 'category': 'CARDINAL'}, {'entity': '786.1', 'category': 'CARDINAL'}, {'entity': '259 billion', 'category': 'CARDINAL'}, {'entity': '487 billion', 'category': 'CARDINAL'}, {'entity': '525.4 billion', 'category': 'CARDINAL'}, {'entity': '$45 billion', 'category': 'CARDINAL'}, {'entity': '5.2 billion', 'category': 'CARDINAL'}, {'entity': '17.7 billion', 'category': 'CARDINAL'}, {'entity': '$34.3 million', 'category': 'CARDINAL'}, {'entity': '$1.2 trillion', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'November 30', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '140.5', 'category': 'CARDINAL'}, {'entity': '102.5', 'category': 'CARDINAL'}, {'entity': '140.5', 'category': 'CARDINAL'}, {'entity': '220.5', 'category': 'CARDINAL'}, {'entity': '31.2', 'category': 'CARDINAL'}, {'entity': '22.8', 'category': 'CARDINAL'}, {'entity': '31.2', 'category': 'CARDINAL'}, {'entity': '63.5', 'category': 'CARDINAL'}, {'entity': '10.8', 'category': 'CARDINAL'}, {'entity': '10.1', 'category': 'CARDINAL'}, {'entity': '10.8', 'category': 'CARDINAL'}, {'entity': '25.8', 'category': 'CARDINAL'}, {'entity': '7.0', 'category': 'CARDINAL'}, {'entity': '0.8', 'category': 'CARDINAL'}, {'entity': '7.0', 'category': 'CARDINAL'}, {'entity': '11.1', 'category': 'CARDINAL'}, {'entity': '189.5', 'category': 'CARDINAL'}, {'entity': '136.2', 'category': 'CARDINAL'}, {'entity': '189.5', 'category': 'CARDINAL'}, {'entity': '320.9', 'category': 'CARDINAL'}, {'entity': '69.3', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '37', 'category': 'CARDINAL'}, {'entity': '15', 'category': 'CARDINAL'}, {'entity': '510', 'category': 'CARDINAL'}, {'entity': '50', 'category': 'CARDINAL'}, {'entity': '759', 'category': 'CARDINAL'}, {'entity': '454.5', 'category': 'CARDINAL'}, {'entity': '1,243.1', 'category': 'CARDINAL'}, {'entity': '64', 'category': 'CARDINAL'}, {'entity': '2010', 'category': 'CARDINAL'}, {'entity': '2011', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '32', 'category': 'CARDINAL'}, {'entity': '37', 'category': 'CARDINAL'}, {'entity': '29.0', 'category': 'CARDINAL'}, {'entity': '23.4', 'category': 'CARDINAL'}]\n",
      "[{'entity': '2012', 'category': 'DATE'}, {'entity': '2011', 'category': 'DATE'}, {'entity': '2010', 'category': 'DATE'}, {'entity': 'Hawk', 'category': 'GPE'}, {'entity': '$24.9 million', 'category': 'MONEY'}, {'entity': 'Apple', 'category': 'ORG'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': '2.6', 'category': 'QUANTITY'}, {'entity': '2.9', 'category': 'QUANTITY'}, {'entity': '6.8', 'category': 'QUANTITY'}, {'entity': '5PM', 'category': 'TIME'}, {'entity': '7PM', 'category': 'TIME'}, {'entity': 'first', 'category': 'ORDINAL'}]\n",
      "[{'entity': 'November 2010', 'category': 'DATE'}, {'entity': 'March 2011', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': '2011', 'category': 'DATE'}, {'entity': '2010', 'category': 'DATE'}, {'entity': 'fire suppression programs', 'category': 'EVENT'}, {'entity': 'capital expenditures', 'category': 'EVENT'}, {'entity': 'Rocketdyne Business acquisition related costs', 'category': 'EVENT'}, {'entity': 'Executive severance agreements', 'category': 'EVENT'}, {'entity': 'Loss on debt repurchased', 'category': 'EVENT'}, {'entity': 'Loss on bank amendment', 'category': 'EVENT'}, {'entity': 'Gain on legal settlement', 'category': 'EVENT'}, {'entity': 'realized losses and interest associated with the failure to register with the SEC the issuance of certain of our common shares under the defined contribution 401k employee benefit plan', 'category': 'EVENT'}, {'entity': 'proposed Rocketdyne Business acquisition announced in July 2012', 'category': 'EVENT'}, {'entity': 'redemption of $75.0 million of our 9 1/2% Senior Subordinated Notes “9 1/2% Notes” at a redemption price of 100% of the principal amount', 'category': 'EVENT'}, {'entity': 'realized losses and interest associated with the failure to register with the SEC the issuance of certain of our common shares under the defined contribution 401k employee benefit plan', 'category': 'EVENT'}, {'entity': 'repurchase of $22.0 million principal amount of our 2 1/4% Convertible Subordinated Debentures “2 1/4% Debentures” at various prices ranging from 99.0% of par to 99.6% of par', 'category': 'EVENT'}, {'entity': 'losses related to an amendment to the Senior Credit Facility', 'category': 'EVENT'}, {'entity': 'charge of $3.3 million related to a legal settlement', 'category': 'EVENT'}, {'entity': 'repurchase of $77.8 million principal amount of our 2 1/4% Debentures at various prices ranging from 93.0% of par to 98.975% of par', 'category': 'EVENT'}, {'entity': 'repurchase of $22.5 million principal amount of our 9 1/2% Notes at 102% of par', 'category': 'EVENT'}, {'entity': 'Rocketdyne Business', 'category': 'FAC'}, {'entity': 'Senior Subordinated Notes “9 1/2% Notes”', 'category': 'FAC'}, {'entity': 'Senior Credit Facility', 'category': 'FAC'}, {'entity': 'unusual items', 'category': 'FAC'}, {'entity': 'space science education', 'category': 'FAC'}, {'entity': 'common shares under the defined contribution 401k employee benefit plan', 'category': 'FAC'}, {'entity': '4 1/16% Debentures', 'category': 'FAC'}, {'entity': '9 1/2% Notes', 'category': 'FAC'}, {'entity': 'internal labor costs', 'category': 'FAC'}, {'entity': 'net proceeds', 'category': 'FAC'}, {'entity': 'fire suppression programs', 'category': 'FAC'}, {'entity': 'July 2012', 'category': 'GPE'}, {'entity': 'December 2009', 'category': 'GPE'}, {'entity': 'fiscal 2011', 'category': 'LOC'}, {'entity': 'fourth quarter of fiscal 2010', 'category': 'LOC'}, {'entity': 'fourth quarter of fiscal 2010', 'category': 'LOC'}, {'entity': '$0.7 million', 'category': 'MONEY'}, {'entity': '$11.6 million', 'category': 'MONEY'}, {'entity': '$75.0 million', 'category': 'MONEY'}, {'entity': '$0.4 million', 'category': 'MONEY'}, {'entity': '$3.3 million', 'category': 'MONEY'}, {'entity': '$0.8 million', 'category': 'MONEY'}, {'entity': '$22.0 million', 'category': 'MONEY'}, {'entity': '$0.2 million', 'category': 'MONEY'}, {'entity': '$1.3 million', 'category': 'MONEY'}, {'entity': '$1.4 million', 'category': 'MONEY'}, {'entity': '$1.9 million', 'category': 'MONEY'}, {'entity': '$0.9 million', 'category': 'MONEY'}, {'entity': '$2.7 million', 'category': 'MONEY'}, {'entity': '$2.2 million', 'category': 'MONEY'}, {'entity': '$12.7 million', 'category': 'MONEY'}, {'entity': '$5.6 million', 'category': 'MONEY'}, {'entity': '$3.4 million', 'category': 'MONEY'}, {'entity': '$0.7 million', 'category': 'MONEY'}, {'entity': '$74.3 million', 'category': 'MONEY'}, {'entity': '$6.3 million', 'category': 'MONEY'}, {'entity': '$2.9 million', 'category': 'MONEY'}, {'entity': '$22.5 million', 'category': 'MONEY'}, {'entity': '$23.0 million', 'category': 'MONEY'}, {'entity': '$0.3 million', 'category': 'MONEY'}, {'entity': '$0.9 million', 'category': 'MONEY'}, {'entity': '$22.3 million', 'category': 'MONEY'}, {'entity': '$30.8 million', 'category': 'MONEY'}, {'entity': '$19.4 million', 'category': 'MONEY'}, {'entity': '$3.5 million', 'category': 'MONEY'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'Aerospace and Defense', 'category': 'ORG'}, {'entity': 'Aerospace and defense unusual items', 'category': 'ORG'}, {'entity': 'Corporate', 'category': 'ORG'}, {'entity': 'Corporate unusual items', 'category': 'ORG'}, {'entity': '4.7%', 'category': 'PERCENT'}, {'entity': '3.5%', 'category': 'PERCENT'}, {'entity': '8.5%', 'category': 'PERCENT'}, {'entity': '2.4%', 'category': 'PERCENT'}, {'entity': 'fiscal 2012', 'category': 'PERSON'}, {'entity': 'fiscal 2011', 'category': 'PERSON'}, {'entity': 'fiscal 2010', 'category': 'PERSON'}, {'entity': 'various prices ranging from 99.0% of par to 99.6% of par', 'category': 'TIME'}, {'entity': '4 1/16% Debentures', 'category': 'TIME'}, {'entity': 'at a redemption price of 100% of the principal amount', 'category': 'TIME'}, {'entity': 'at 102% of par', 'category': 'TIME'}, {'entity': 'unusual items below', 'category': 'WORK_OF_ART'}, {'entity': 'common shares under the defined contribution 401k employee benefit plan', 'category': 'WORK_OF_ART'}, {'entity': 'unusual items', 'category': 'WORK_OF_ART'}, {'entity': 'common shares under the defined contribution 401k employee benefit plan', 'category': 'WORK_OF_ART'}, {'entity': 'unusual items below', 'category': 'WORK_OF_ART'}, {'entity': 'unusual items below', 'category': 'WORK_OF_ART'}, {'entity': 'unusual items below', 'category': 'WORK_OF_ART'}, {'entity': 'unusual items below', 'category': 'WORK_OF_ART'}, {'entity': 'unusual items below', 'category': 'WORK_OF_ART'}, {'entity': 'unusual items', 'category': 'WORK_OF_ART'}, {'entity': 'unusual items', 'category': 'WORK_OF_ART'}, {'entity': 'unusual items', 'category': 'WORK_OF_ART'}, {'entity': 'unusual items', 'category': 'WORK_OF_ART'}, {'entity': 'unusual items', 'category': 'WORK_OF_ART'}, {'entity': 'unusual items', 'category': 'WORK_OF_ART'}, {'entity': 'unusual items below', 'category': 'WORK_OF_ART'}, {'entity': 'unusual items below', 'category': 'WORK_OF_ART'}, {'entity': 'unusual items', 'category': 'WORK_OF_ART'}, {'entity': 'unusual items below', 'category': 'WORK_OF_ART'}, {'entity': 'is as follows', 'category': 'WORK_OF_ART'}, {'entity': 'third', 'category': 'ORDINAL'}, {'entity': 'fourth', 'category': 'ORDINAL'}]\n",
      "[{'entity': 'sale of our GDX Automotive business', 'category': 'ORG'}, {'entity': 'sale of our Fine Chemicals business', 'category': 'ORG'}, {'entity': 'Snappon SA', 'category': 'ORG'}]\n",
      "[{'entity': 'November 2003', 'category': 'DATE'}, {'entity': 'June 2004', 'category': 'DATE'}, {'entity': 'fiscal 2009', 'category': 'DATE'}, {'entity': 'fiscal 2012', 'category': 'DATE'}, {'entity': 'January 15, 2009', 'category': 'DATE'}, {'entity': 'April 15, 2009', 'category': 'DATE'}, {'entity': 'the first full payroll in July 2010', 'category': 'DATE'}, {'entity': 'fiscal 2012', 'category': 'DATE'}, {'entity': 'fiscal 2011', 'category': 'DATE'}, {'entity': 'fiscal 2010', 'category': 'DATE'}, {'entity': 'closing', 'category': 'EVENT'}, {'entity': 'Chartres', 'category': 'GPE'}, {'entity': 'France', 'category': 'GPE'}, {'entity': 'Paris', 'category': 'GPE'}, {'entity': 'Commercial Court', 'category': 'GPE'}, {'entity': 'Paris Commercial Court', 'category': 'GPE'}, {'entity': '€2.9 million', 'category': 'MONEY'}, {'entity': '$3.8 million', 'category': 'MONEY'}, {'entity': '$1.0 million', 'category': 'MONEY'}, {'entity': '$10.8 million', 'category': 'MONEY'}, {'entity': '$9.9 million', 'category': 'MONEY'}, {'entity': '$3.7 million', 'category': 'MONEY'}, {'entity': 'Snappon SA', 'category': 'ORG'}, {'entity': 'Fine Chemicals business', 'category': 'ORG'}, {'entity': 'GDX', 'category': 'ORG'}, {'entity': 'Manufacturing facility', 'category': 'ORG'}, {'entity': 'Chartres', 'category': 'ORG'}, {'entity': 'France', 'category': 'ORG'}, {'entity': 'Company', 'category': 'ORG'}, {'entity': 'French automobile manufacturers', 'category': 'ORG'}, {'entity': 'Paris Commercial Court', 'category': 'ORG'}, {'entity': '65%', 'category': 'PERCENT'}, {'entity': '11.7%', 'category': 'PERCENT'}, {'entity': '11.9%', 'category': 'PERCENT'}, {'entity': '8.6%', 'category': 'PERCENT'}, {'entity': '8.2%', 'category': 'PERCENT'}, {'entity': '7.9%', 'category': 'PERCENT'}]\n",
      "[{'entity': 'fiscal 2012', 'category': 'DATE'}, {'entity': 'fiscal 2011', 'category': 'DATE'}, {'entity': 'fiscal 2010', 'category': 'DATE'}, {'entity': 'THAAD program', 'category': 'EVENT'}, {'entity': 'product launch', 'category': 'EVENT'}, {'entity': 'Standard Missile programs', 'category': 'EVENT'}, {'entity': 'engineering technology activities', 'category': 'EVENT'}, {'entity': 'Hawk program', 'category': 'EVENT'}, {'entity': 'Hamlet', 'category': 'EVENT'}, {'entity': 'air-breathing propulsion programs', 'category': 'EVENT'}, {'entity': 'SSST', 'category': 'EVENT'}, {'entity': 'T3 contracts', 'category': 'EVENT'}, {'entity': 'Bomb Live Unit — 129B composite case', 'category': 'EVENT'}, {'entity': 'Orion program', 'category': 'EVENT'}, {'entity': 'aerospace and defense total', 'category': 'FAC'}, {'entity': 'environmental remediation provision adjustments', 'category': 'FAC'}, {'entity': 'retirement benefit plan expense', 'category': 'FAC'}, {'entity': 'Unusual items', 'category': 'FAC'}, {'entity': 'Primary reason for change', 'category': 'FAC'}, {'entity': 'Primary reason for change', 'category': 'FAC'}, {'entity': 'real estate segment', 'category': 'FAC'}, {'entity': 'land sales', 'category': 'FAC'}, {'entity': 'Cupertino', 'category': 'GPE'}, {'entity': 'California', 'category': 'GPE'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': '$1.2 million', 'category': 'MONEY'}, {'entity': '8.8', 'category': 'MONEY'}, {'entity': '8.4', 'category': 'MONEY'}, {'entity': '7.2$3.7', 'category': 'MONEY'}, {'entity': '0.2 million', 'category': 'MONEY'}, {'entity': 'Primary reason for change', 'category': 'ORG'}, {'entity': '11.7', 'category': 'PERCENT'}, {'entity': '11.9', 'category': 'PERCENT'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': 'Mary', 'category': 'PERSON'}, {'entity': 'Shakespeare', 'category': 'PERSON'}, {'entity': 'Peter', 'category': 'PERSON'}, {'entity': 'Lisa', 'category': 'PERSON'}, {'entity': '5PM', 'category': 'TIME'}, {'entity': '7PM', 'category': 'TIME'}, {'entity': 'Hamlet', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '18.9', 'category': 'CARDINAL'}, {'entity': '21.0', 'category': 'CARDINAL'}, {'entity': '2.1', 'category': 'CARDINAL'}, {'entity': '29.3', 'category': 'CARDINAL'}, {'entity': '8.3', 'category': 'CARDINAL'}, {'entity': '0.7', 'category': 'CARDINAL'}, {'entity': '4.1', 'category': 'CARDINAL'}, {'entity': '3.4', 'category': 'CARDINAL'}, {'entity': '2.8', 'category': 'CARDINAL'}, {'entity': '1.3', 'category': 'CARDINAL'}, {'entity': '84.5', 'category': 'CARDINAL'}, {'entity': '74.6', 'category': 'CARDINAL'}, {'entity': '9.9', 'category': 'CARDINAL'}, {'entity': '67.3', 'category': 'CARDINAL'}, {'entity': '7.3', 'category': 'CARDINAL'}, {'entity': '39.6', 'category': 'CARDINAL'}, {'entity': '34.5', 'category': 'CARDINAL'}, {'entity': '17.7', 'category': 'CARDINAL'}, {'entity': '24.9', 'category': 'CARDINAL'}, {'entity': '27.7', 'category': 'CARDINAL'}, {'entity': '24.8', 'category': 'CARDINAL'}, {'entity': '22.2', 'category': 'CARDINAL'}, {'entity': '22.0', 'category': 'CARDINAL'}, {'entity': '8.3', 'category': 'CARDINAL'}, {'entity': '6.4', 'category': 'CARDINAL'}, {'entity': '6.8', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'November 30, 2012', 'category': 'DATE'}, {'entity': 'November 30, 2011', 'category': 'DATE'}, {'entity': 'November 30, 2010', 'category': 'DATE'}, {'entity': 'November 30, 2009', 'category': 'DATE'}, {'entity': 'Cupertino', 'category': 'LOC'}, {'entity': 'California', 'category': 'LOC'}, {'entity': 'United States', 'category': 'LOC'}, {'entity': 'Aerojet -Sacramento', 'category': 'LOC'}, {'entity': 'Aerojet -BPOU', 'category': 'LOC'}, {'entity': 'OtherAerojetSites', 'category': 'LOC'}, {'entity': '$ 248.7 million', 'category': 'MONEY'}, {'entity': '$ 326.4 million', 'category': 'MONEY'}, {'entity': '$ 396.7 million', 'category': 'MONEY'}, {'entity': '$ 162.1', 'category': 'MONEY'}, {'entity': '$ 188.0', 'category': 'MONEY'}, {'entity': '$ 181.5', 'category': 'MONEY'}, {'entity': '-$ 16.2 million', 'category': 'MONEY'}, {'entity': '-$ 188.0 million', 'category': 'MONEY'}, {'entity': '$ 86.6 million', 'category': 'MONEY'}, {'entity': '$ 138.4 million', 'category': 'MONEY'}, {'entity': '$ 188.5 million', 'category': 'MONEY'}, {'entity': '$ 6.3 million', 'category': 'MONEY'}, {'entity': '$ 7.1 million', 'category': 'MONEY'}, {'entity': '$ 8.8 million', 'category': 'MONEY'}, {'entity': '-$ 6.3 million', 'category': 'MONEY'}, {'entity': '-$ 7.1 million', 'category': 'MONEY'}, {'entity': '-$ 8.8 million', 'category': 'MONEY'}, {'entity': 'Debt principal', 'category': 'ORG'}, {'entity': 'Cash and cash equivalents', 'category': 'ORG'}, {'entity': 'Marketable securities', 'category': 'ORG'}, {'entity': 'Net debt', 'category': 'ORG'}, {'entity': 'Environment Matters', 'category': 'ORG'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': 'BPOU site', 'category': 'ORG'}, {'entity': 'Aerojet-Sacramento', 'category': 'ORG'}, {'entity': 'Aerojet-BPOU', 'category': 'ORG'}, {'entity': 'OtherAerojetSites', 'category': 'ORG'}, {'entity': 'TotalAerojet', 'category': 'ORG'}, {'entity': 'Other', 'category': 'ORG'}, {'entity': 'Total Environmental Reserve', 'category': 'ORG'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': '248.7', 'category': 'CARDINAL'}, {'entity': '326.4', 'category': 'CARDINAL'}, {'entity': '396.7', 'category': 'CARDINAL'}, {'entity': '162.1', 'category': 'CARDINAL'}, {'entity': '188.0', 'category': 'CARDINAL'}, {'entity': '181.5', 'category': 'CARDINAL'}, {'entity': '86.6', 'category': 'CARDINAL'}, {'entity': '138.4', 'category': 'CARDINAL'}, {'entity': '188.5', 'category': 'CARDINAL'}, {'entity': '152.5', 'category': 'CARDINAL'}, {'entity': '47.8', 'category': 'CARDINAL'}, {'entity': '10.8', 'category': 'CARDINAL'}, {'entity': '211.1', 'category': 'CARDINAL'}, {'entity': '11.6', 'category': 'CARDINAL'}, {'entity': '222.7', 'category': 'CARDINAL'}, {'entity': '6.7', 'category': 'CARDINAL'}, {'entity': '9.5', 'category': 'CARDINAL'}, {'entity': '11.7', 'category': 'CARDINAL'}, {'entity': '27.9', 'category': 'CARDINAL'}, {'entity': '8.6', 'category': 'CARDINAL'}, {'entity': '36.5', 'category': 'CARDINAL'}, {'entity': '139.8', 'category': 'CARDINAL'}, {'entity': '46.1', 'category': 'CARDINAL'}, {'entity': '20.1', 'category': 'CARDINAL'}, {'entity': '206.0', 'category': 'CARDINAL'}, {'entity': '11.7', 'category': 'CARDINAL'}, {'entity': '217.7', 'category': 'CARDINAL'}, {'entity': '21.2', 'category': 'CARDINAL'}, {'entity': '5.9', 'category': 'CARDINAL'}, {'entity': '5.9', 'category': 'CARDINAL'}, {'entity': '33.0', 'category': 'CARDINAL'}, {'entity': '-0.1', 'category': 'CARDINAL'}, {'entity': '32.9', 'category': 'CARDINAL'}, {'entity': '130.7', 'category': 'CARDINAL'}, {'entity': '38.6', 'category': 'CARDINAL'}, {'entity': '12.1', 'category': 'CARDINAL'}, {'entity': '181.4', 'category': 'CARDINAL'}, {'entity': '9.2', 'category': 'CARDINAL'}, {'entity': '190.6', 'category': 'CARDINAL'}, {'entity': '24.5', 'category': 'CARDINAL'}, {'entity': '5.9', 'category': 'CARDINAL'}, {'entity': '3.8', 'category': 'CARDINAL'}, {'entity': '34.2', 'category': 'CARDINAL'}, {'entity': '0.5', 'category': 'CARDINAL'}, {'entity': '34.7', 'category': 'CARDINAL'}, {'entity': '140.5', 'category': 'CARDINAL'}, {'entity': '31.2', 'category': 'CARDINAL'}, {'entity': '10.8', 'category': 'CARDINAL'}, {'entity': '182.5', 'category': 'CARDINAL'}, {'entity': '7.0', 'category': 'CARDINAL'}, {'entity': '189.5', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'Fullerton, California', 'category': 'FAC'}, {'entity': 'Camden, Arkansas', 'category': 'FAC'}, {'entity': 'Toledo, Ohio', 'category': 'FAC'}, {'entity': 'Sacramento', 'category': 'FAC'}, {'entity': 'Azusa', 'category': 'FAC'}, {'entity': 'BPOU site', 'category': 'FAC'}]\n",
      "[{'entity': 'November 30', 'category': 'DATE'}, {'entity': '2009', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': '2010', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': '2011', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': '$ 125.3', 'category': 'MONEY'}, {'entity': '$ 103.4', 'category': 'MONEY'}, {'entity': '$ 228.7', 'category': 'MONEY'}, {'entity': '128.4', 'category': 'MONEY'}, {'entity': '103.0', 'category': 'MONEY'}, {'entity': '231.4', 'category': 'MONEY'}, {'entity': '111.2', 'category': 'MONEY'}, {'entity': '98.8', 'category': 'MONEY'}, {'entity': '210.0', 'category': 'MONEY'}, {'entity': '$ 111.5', 'category': 'MONEY'}, {'entity': '$ 94.0', 'category': 'MONEY'}, {'entity': '$ 205.5', 'category': 'MONEY'}, {'entity': '$ 23.1', 'category': 'MONEY'}, {'entity': '$ 11.6', 'category': 'MONEY'}, {'entity': '$ 34.7', 'category': 'MONEY'}, {'entity': '$ 24.3', 'category': 'MONEY'}, {'entity': '$ 8.6', 'category': 'MONEY'}, {'entity': '$ 32.9', 'category': 'MONEY'}, {'entity': '$ 2.8', 'category': 'MONEY'}, {'entity': '$ 27.7', 'category': 'MONEY'}, {'entity': '$ 36.5', 'category': 'MONEY'}, {'entity': '$ 18.2', 'category': 'MONEY'}, {'entity': 'Northrop', 'category': 'ORG'}, {'entity': 'U.S. Government', 'category': 'ORG'}, {'entity': 'Camden', 'category': 'ORG'}, {'entity': 'Fullerton', 'category': 'ORG'}, {'entity': 'Consolidated Statements of Operations', 'category': 'ORG'}]\n",
      "[{'entity': 'June 2011', 'category': 'DATE'}, {'entity': 'December 1, 2011', 'category': 'DATE'}, {'entity': 'September 1, 2011', 'category': 'DATE'}, {'entity': 'March 1, 2010', 'category': 'DATE'}, {'entity': 'December 1, 2011', 'category': 'DATE'}, {'entity': 'fiscal 2012', 'category': 'DATE'}, {'entity': 'fiscal 2011', 'category': 'DATE'}, {'entity': 'fiscal 2010', 'category': 'DATE'}, {'entity': 'In millions', 'category': 'DATE'}, {'entity': 'December 2010', 'category': 'DATE'}, {'entity': 'fiscal 2012', 'category': 'DATE'}, {'entity': 'second quarter', 'category': 'DATE'}, {'entity': 'fiscal 2013', 'category': 'DATE'}, {'entity': 'fiscal 2012', 'category': 'GPE'}, {'entity': 'fiscal 2010', 'category': 'GPE'}, {'entity': 'December 2009', 'category': 'GPE'}, {'entity': 'fiscal 2012', 'category': 'GPE'}, {'entity': '$86.2 million', 'category': 'MONEY'}, {'entity': '$76.8 million', 'category': 'MONEY'}, {'entity': '$148.1 million', 'category': 'MONEY'}, {'entity': '$64.1 million', 'category': 'MONEY'}, {'entity': '$22.3 million', 'category': 'MONEY'}, {'entity': '$25.9 million', 'category': 'MONEY'}, {'entity': '$6.5 million', 'category': 'MONEY'}, {'entity': '$55.2 million', 'category': 'MONEY'}, {'entity': '$37.2 million', 'category': 'MONEY'}, {'entity': '$14.9 million', 'category': 'MONEY'}, {'entity': '$21.1 million', 'category': 'MONEY'}, {'entity': '$16.9 million', 'category': 'MONEY'}, {'entity': '$0.6 million', 'category': 'MONEY'}, {'entity': '$26.7 million', 'category': 'MONEY'}, {'entity': '$26.6 million', 'category': 'MONEY'}, {'entity': '$77.7 million', 'category': 'MONEY'}, {'entity': '$2.2 million', 'category': 'MONEY'}, {'entity': '$70.1 million', 'category': 'MONEY'}, {'entity': '$1.8 million', 'category': 'MONEY'}, {'entity': '$4.2 million', 'category': 'MONEY'}, {'entity': '$200.0 million', 'category': 'MONEY'}, {'entity': '$240.2 million', 'category': 'MONEY'}, {'entity': '$7.7 million', 'category': 'MONEY'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': '4 1/16%', 'category': 'MONEY'}, {'entity': '86.2', 'category': 'MONEY'}, {'entity': '30.1 million', 'category': 'MONEY'}, {'entity': '$37.2 million', 'category': 'MONEY'}, {'entity': '14.9 million', 'category': 'MONEY'}, {'entity': '$21.1 million', 'category': 'MONEY'}, {'entity': '$16.9 million', 'category': 'MONEY'}, {'entity': '$37.2 million', 'category': 'MONEY'}, {'entity': '1/16%', 'category': 'MONEY'}, {'entity': 'four', 'category': 'MONEY'}, {'entity': 'FASB', 'category': 'ORG'}, {'entity': 'U.S. GAAP', 'category': 'ORG'}, {'entity': 'level 3', 'category': 'ORG'}, {'entity': '+ $0.6', 'category': 'PERCENT'}, {'entity': '100%', 'category': 'PERCENT'}, {'entity': 'March 1', 'category': 'PERSON'}, {'entity': '22.3', 'category': 'PERSON'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'second', 'category': 'ORDINAL'}, {'entity': 'third', 'category': 'ORDINAL'}, {'entity': 'two', 'category': 'ORDINAL'}, {'entity': 'one', 'category': 'CARDINAL'}, {'entity': 'an entity', 'category': 'CARDINAL'}, {'entity': 'more than 50%', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': '6%', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'November 30,2011', 'category': 'DATE'}, {'entity': 'November 30,2012', 'category': 'DATE'}, {'entity': 'Wells Fargo Bank', 'category': 'ORG'}, {'entity': 'National Association', 'category': 'ORG'}, {'entity': 'Acquisition', 'category': 'ORG'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': 'Aerojet', 'category': 'ORG'}, {'entity': 'First Amendment', 'category': 'ORG'}, {'entity': 'Second Amendment', 'category': 'ORG'}, {'entity': 'Third Amendment', 'category': 'ORG'}, {'entity': 'Notes to the Consolidated Financial Statements', 'category': 'ORG'}, {'entity': 'LIBOR', 'category': 'ORG'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': 'Loan Facility', 'category': 'ORG'}, {'entity': 'Easton', 'category': 'ORG'}, {'entity': 'Orange', 'category': 'ORG'}, {'entity': 'Virginia', 'category': 'ORG'}, {'entity': 'Redmond', 'category': 'ORG'}, {'entity': 'Washington', 'category': 'ORG'}, {'entity': 'California', 'category': 'ORG'}, {'entity': 'Rocketdyne Business', 'category': 'ORG'}, {'entity': '$ 50.0', 'category': 'CARDINAL'}, {'entity': '$ 2.5', 'category': 'CARDINAL'}, {'entity': '$ 47.5', 'category': 'CARDINAL'}, {'entity': '75.0', 'category': 'CARDINAL'}, {'entity': '75.0', 'category': 'CARDINAL'}, {'entity': '&', 'category': 'CARDINAL'}, {'entity': '200.0', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '1.2', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '1.0', 'category': 'CARDINAL'}, {'entity': '326.4', 'category': 'CARDINAL'}, {'entity': '77.7', 'category': 'CARDINAL'}, {'entity': '248.7', 'category': 'CARDINAL'}, {'entity': '$ 20.0', 'category': 'CARDINAL'}, {'entity': '&$30.0', 'category': 'CARDINAL'}, {'entity': '$510 million', 'category': 'CARDINAL'}, {'entity': '$50 million', 'category': 'CARDINAL'}, {'entity': '300.0', 'category': 'CARDINAL'}, {'entity': '5-year', 'category': 'CARDINAL'}, {'entity': '150.0', 'category': 'CARDINAL'}, {'entity': '5-year', 'category': 'CARDINAL'}, {'entity': '$50.0 million', 'category': 'CARDINAL'}, {'entity': '$50.0 million', 'category': 'CARDINAL'}, {'entity': '$150.0 million', 'category': 'CARDINAL'}, {'entity': '$100.0 million', 'category': 'CARDINAL'}, {'entity': '$5.0 million', 'category': 'CARDINAL'}, {'entity': '5.0%', 'category': 'CARDINAL'}, {'entity': '350 basis points', 'category': 'CARDINAL'}, {'entity': '250 basis points', 'category': 'CARDINAL'}, {'entity': '50 basis points', 'category': 'CARDINAL'}, {'entity': '25 basis points', 'category': 'CARDINAL'}, {'entity': '3.50 to 1.00', 'category': 'CARDINAL'}, {'entity': '6.05 to 1.00', 'category': 'CARDINAL'}, {'entity': '2.40 to 1.00', 'category': 'CARDINAL'}, {'entity': '3.50 to 1.00', 'category': 'CARDINAL'}, {'entity': 'November 30, 2012', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'July 2012', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': 'January 28, 2013', 'category': 'DATE'}, {'entity': 'November 30, 2012', 'category': 'DATE'}, {'entity': '$550 million', 'category': 'MONEY'}, {'entity': 'Rocketdyne Business', 'category': 'ORG'}, {'entity': 'UTC', 'category': 'ORG'}, {'entity': '7 1/8%', 'category': 'PERCENT'}, {'entity': 'Notes', 'category': 'PERSON'}, {'entity': 'Rule 144A', 'category': 'PERSON'}, {'entity': '$47.5 million', 'category': 'QUANTITY'}, {'entity': '$2.5 million', 'category': 'QUANTITY'}, {'entity': '$5.0 million', 'category': 'QUANTITY'}, {'entity': '$40.0 million', 'category': 'QUANTITY'}, {'entity': '$200.0 million', 'category': 'QUANTITY'}, {'entity': '$1.2 million', 'category': 'QUANTITY'}, {'entity': '$0.2 million', 'category': 'QUANTITY'}, {'entity': '$0.6 million', 'category': 'QUANTITY'}, {'entity': '$0.4 million', 'category': 'QUANTITY'}, {'entity': '$32.9 million', 'category': 'QUANTITY'}, {'entity': '$12.7 million', 'category': 'QUANTITY'}, {'entity': '$16.6 million', 'category': 'QUANTITY'}, {'entity': '$3.6 million', 'category': 'QUANTITY'}, {'entity': '$64.6 million', 'category': 'QUANTITY'}, {'entity': '$7.5 million', 'category': 'QUANTITY'}, {'entity': '$14.8 million', 'category': 'QUANTITY'}, {'entity': '$13.9 million', 'category': 'QUANTITY'}, {'entity': '$28.4 million', 'category': 'QUANTITY'}, {'entity': '$22.4 million', 'category': 'QUANTITY'}, {'entity': '$8.2 million', 'category': 'QUANTITY'}, {'entity': '$9.6 million', 'category': 'QUANTITY'}, {'entity': '$3.9 million', 'category': 'QUANTITY'}, {'entity': '$0.7 million', 'category': 'QUANTITY'}, {'entity': '$20.8 million', 'category': 'QUANTITY'}, {'entity': '$3.8 million', 'category': 'QUANTITY'}, {'entity': '$17.0 million', 'category': 'QUANTITY'}, {'entity': '$9.3 million', 'category': 'QUANTITY'}, {'entity': '$7.0 million', 'category': 'QUANTITY'}, {'entity': '$2.3 million', 'category': 'QUANTITY'}, {'entity': 'first half', 'category': 'TIME'}, {'entity': 'July 21, 2013', 'category': 'TIME'}, {'entity': '$550 million', 'category': 'CARDINAL'}, {'entity': '$460.0 million', 'category': 'CARDINAL'}, {'entity': '7 1/8%', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '4 1/16%', 'category': 'CARDINAL'}]\n",
      "[{'entity': '\"occasionally\"', 'category': 'DATE'}, {'entity': '\"standard\"', 'category': 'DATE'}, {'entity': '\"significantly\"', 'category': 'DATE'}, {'entity': '\"reimbursement\"', 'category': 'MONEY'}, {'entity': '\"purchase orders\"', 'category': 'ORG'}, {'entity': '\"our board of directors\"', 'category': 'ORG'}, {'entity': '\"the SEC\"', 'category': 'ORG'}, {'entity': '\"Notes to Consolidated Financial Statements\"', 'category': 'ORG'}, {'entity': '\"Aerospace and Defense\"', 'category': 'ORG'}, {'entity': '\"Management\"', 'category': 'PERSON'}, {'entity': '\"volumes\"', 'category': 'QUANTITY'}, {'entity': '\"long-term contracts\"', 'category': 'QUANTITY'}, {'entity': '\"monthly\"', 'category': 'QUANTITY'}, {'entity': '\"product warranties\"', 'category': 'WORK_OF_ART'}, {'entity': '\"positive\"', 'category': 'ORDINAL'}, {'entity': '\"negative\"', 'category': 'ORDINAL'}, {'entity': '\"one-year\"', 'category': 'CARDINAL'}, {'entity': '\"Note 1\"', 'category': 'CARDINAL'}, {'entity': '\"financial statements\"', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'September 1', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': 'learning', 'category': 'EVENT'}, {'entity': 'pension plan', 'category': 'FAC'}, {'entity': 'Aerospace and Defense', 'category': 'GPE'}, {'entity': 'September 1', 'category': 'LOC'}, {'entity': '2012', 'category': 'LOC'}, {'entity': 'fair values', 'category': 'MONEY'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'DCAA', 'category': 'ORG'}, {'entity': 'FAR', 'category': 'ORG'}, {'entity': 'CAS', 'category': 'ORG'}, {'entity': 'PPA', 'category': 'ORG'}, {'entity': 'Aerospace and Defense', 'category': 'ORG'}, {'entity': 'more than 50%', 'category': 'PERCENT'}, {'entity': 'employees', 'category': 'PERSON'}, {'entity': '401k plan', 'category': 'QUANTITY'}, {'entity': 'far in the future', 'category': 'TIME'}, {'entity': 'Goodwill impairment charges in future periods', 'category': 'WORK_OF_ART'}, {'entity': 'annual basis', 'category': 'ORDINAL'}, {'entity': 'Step Zero analysis', 'category': 'ORDINAL'}, {'entity': 'Step One', 'category': 'ORDINAL'}, {'entity': 'two-step goodwill test', 'category': 'ORDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '2011', 'category': 'CARDINAL'}]\n",
      "[{'entity': '2012', 'category': 'DATE'}, {'entity': '2011', 'category': 'DATE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'November 30', 'category': 'LOC'}, {'entity': 'AccumulatedBenefitObligation', 'category': 'LOC'}, {'entity': 'Consolidated Financial Statements', 'category': 'LOC'}, {'entity': 'Consolidated Financial Statements', 'category': 'LOC'}, {'entity': 'Consolidated Financial Statements', 'category': 'LOC'}, {'entity': 'Consolidated Financial Statements', 'category': 'LOC'}, {'entity': 'Consolidated Financial Statements', 'category': 'LOC'}, {'entity': 'U.S. Government', 'category': 'ORG'}, {'entity': '3.68%', 'category': 'PERCENT'}, {'entity': '4.95%', 'category': 'PERCENT'}, {'entity': '4.58%', 'category': 'PERCENT'}, {'entity': '4.65%', 'category': 'PERCENT'}, {'entity': '8.00%', 'category': 'PERCENT'}, {'entity': 'one-fifth', 'category': 'QUANTITY'}, {'entity': 'five years', 'category': 'TIME'}, {'entity': 'Environmental Matters', 'category': 'WORK_OF_ART'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '4.95', 'category': 'CARDINAL'}, {'entity': '4.95', 'category': 'CARDINAL'}, {'entity': '5.21', 'category': 'CARDINAL'}, {'entity': '3.24', 'category': 'CARDINAL'}, {'entity': '4.58', 'category': 'CARDINAL'}, {'entity': '8.00', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'November 30,2012', 'category': 'DATE'}, {'entity': 'November 30,2011', 'category': 'DATE'}, {'entity': 'November 30,2012', 'category': 'DATE'}, {'entity': 'November 30,2011', 'category': 'DATE'}, {'entity': '$248.7 million', 'category': 'MONEY'}, {'entity': '81%', 'category': 'MONEY'}, {'entity': '4.09%', 'category': 'MONEY'}, {'entity': '19%', 'category': 'MONEY'}, {'entity': '3.71%', 'category': 'MONEY'}, {'entity': '9 1/2%', 'category': 'MONEY'}, {'entity': '4 1/16%', 'category': 'MONEY'}, {'entity': 'Item 7A', 'category': 'ORG'}, {'entity': 'second', 'category': 'ORDINAL'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'one', 'category': 'CARDINAL'}]\n",
      "/Users/tanmayiballa/Desktop/KG-LLM/l715_23-1/data/10-Ks/Aerojet_Rocketdyne_Holdings_Inc./2022/Management_gpt-3.5-turbo_NER_response.json\n",
      "[{'entity': 'December 20, 2020', 'category': 'DATE'}, {'entity': 'December 31, 2019', 'category': 'DATE'}, {'entity': 'January 25, 2022', 'category': 'DATE'}, {'entity': 'February 13, 2022', 'category': 'DATE'}, {'entity': 'February 14, 2022', 'category': 'DATE'}, {'entity': 'February 18, 2021', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': 'Company', 'category': 'EVENT'}, {'entity': 'Lockheed Martin', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'SEC', 'category': 'LOC'}, {'entity': '$51.00', 'category': 'MONEY'}, {'entity': '56.00', 'category': 'MONEY'}, {'entity': '$5.00', 'category': 'MONEY'}, {'entity': '2,188.0', 'category': 'MONEY'}, {'entity': '2,072.7', 'category': 'MONEY'}, {'entity': '$1.75', 'category': 'MONEY'}, {'entity': '1.66', 'category': 'MONEY'}, {'entity': '1.97', 'category': 'MONEY'}, {'entity': '1.67', 'category': 'MONEY'}, {'entity': '298.5', 'category': 'MONEY'}, {'entity': '270.2', 'category': 'MONEY'}, {'entity': '199.6', 'category': 'MONEY'}, {'entity': '363.8', 'category': 'MONEY'}, {'entity': '162.3', 'category': 'MONEY'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'Company', 'category': 'ORG'}, {'entity': 'Lockheed Martin', 'category': 'ORG'}, {'entity': 'Mizar Sub, Inc.', 'category': 'ORG'}, {'entity': '6.6%', 'category': 'PERCENT'}, {'entity': '6.6%', 'category': 'PERCENT'}, {'entity': '7.4%', 'category': 'PERCENT'}, {'entity': '6.7%', 'category': 'PERCENT'}, {'entity': '13.6%', 'category': 'PERCENT'}, {'entity': '13.0%', 'category': 'PERCENT'}, {'entity': '7.4', 'category': 'PERCENT'}, {'entity': 'Lockheed Martin', 'category': 'PERSON'}, {'entity': '13', 'category': 'TIME'}, {'entity': 'Merger Agreement', 'category': 'WORK_OF_ART'}, {'entity': '1', 'category': 'ORDINAL'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '2020', 'category': 'CARDINAL'}, {'entity': '10-K', 'category': 'CARDINAL'}, {'entity': '2020', 'category': 'CARDINAL'}, {'entity': '2021', 'category': 'CARDINAL'}, {'entity': '2021', 'category': 'CARDINAL'}, {'entity': '2020', 'category': 'CARDINAL'}, {'entity': '138.4', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'March 27, 2020', 'category': 'DATE'}, {'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': 'COVID-19 pandemic', 'category': 'EVENT'}, {'entity': 'negative impacts', 'category': 'EVENT'}, {'entity': 'product launch', 'category': 'EVENT'}, {'entity': 'Cupertino', 'category': 'FAC'}, {'entity': 'California', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': '$21.2 million', 'category': 'MONEY'}, {'entity': 'CARES Act', 'category': 'ORG'}, {'entity': 'NASA', 'category': 'ORG'}, {'entity': 'Missile Defense Agency', 'category': 'ORG'}, {'entity': 'U.S. Army', 'category': 'ORG'}, {'entity': 'U.S. Air Force', 'category': 'ORG'}, {'entity': 'U.S. Navy', 'category': 'ORG'}, {'entity': 'American Rescue Plan Act', 'category': 'ORG'}, {'entity': 'Lockheed Martin', 'category': 'ORG'}, {'entity': 'Raytheon', 'category': 'ORG'}, {'entity': '96%', 'category': 'PERCENT'}, {'entity': '96%', 'category': 'PERCENT'}, {'entity': '5%', 'category': 'PERCENT'}, {'entity': '100%', 'category': 'PERCENT'}, {'entity': '17%', 'category': 'PERCENT'}, {'entity': '12%', 'category': 'PERCENT'}, {'entity': '10%', 'category': 'PERCENT'}, {'entity': '8%', 'category': 'PERCENT'}, {'entity': '34%', 'category': 'PERCENT'}, {'entity': '21%', 'category': 'PERCENT'}, {'entity': '32%', 'category': 'PERCENT'}, {'entity': '17%', 'category': 'PERCENT'}, {'entity': 'U.S.', 'category': 'PERSON'}, {'entity': 'Baldwin Park Operable Unit', 'category': 'PERSON'}, {'entity': '$10.4 million', 'category': 'QUANTITY'}, {'entity': '$461.3 million', 'category': 'QUANTITY'}, {'entity': '$1,005.0 million', 'category': 'QUANTITY'}, {'entity': '$1,279.3 million', 'category': 'QUANTITY'}, {'entity': '$274.3 million', 'category': 'QUANTITY'}, {'entity': '$15 million', 'category': 'QUANTITY'}, {'entity': 'PAC-3 program', 'category': 'WORK_OF_ART'}, {'entity': 'THAAD program', 'category': 'WORK_OF_ART'}, {'entity': 'Standard Missile program', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}]\n",
      "[{'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': 'December 31,\\t\\t  \\t2021\\t\\t2020\\t\\tChange \\tIn millions', 'category': 'DATE'}, {'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': 'Merger', 'category': 'EVENT'}, {'entity': 'United Technologies Corporation', 'category': 'FAC'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'Rocketdyne Business', 'category': 'LOC'}, {'entity': 'Customers', 'category': 'LOC'}, {'entity': '$2,188.0', 'category': 'MONEY'}, {'entity': '2,072.7', 'category': 'MONEY'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': '$154.1 million', 'category': 'MONEY'}, {'entity': '10.8 million', 'category': 'MONEY'}, {'entity': '$20.1 million', 'category': 'MONEY'}, {'entity': '$2.5 million', 'category': 'MONEY'}, {'entity': '$14.2', 'category': 'MONEY'}, {'entity': '$5.9', 'category': 'MONEY'}, {'entity': 'GBSD', 'category': 'ORG'}, {'entity': 'ATACMS', 'category': 'ORG'}, {'entity': 'THAAD', 'category': 'ORG'}, {'entity': 'RS-68', 'category': 'ORG'}, {'entity': 'SG&A', 'category': 'ORG'}, {'entity': 'Rocketdyne Business', 'category': 'ORG'}, {'entity': 'United Technologies Corporation', 'category': 'ORG'}, {'entity': '82.3%', 'category': 'PERCENT'}, {'entity': '82.1%', 'category': 'PERCENT'}, {'entity': '2.1%', 'category': 'PERCENT'}, {'entity': '2.7%', 'category': 'PERCENT'}, {'entity': '2.1%', 'category': 'PERCENT'}, {'entity': '2.7%', 'category': 'PERCENT'}, {'entity': '1.2%', 'category': 'PERCENT'}, {'entity': '1.2%', 'category': 'PERCENT'}, {'entity': '82.3', 'category': 'PERCENT'}, {'entity': '82.1', 'category': 'PERCENT'}, {'entity': '2.1', 'category': 'PERCENT'}, {'entity': '2.7', 'category': 'PERCENT'}, {'entity': '1.2', 'category': 'PERCENT'}, {'entity': '1.2', 'category': 'PERCENT'}, {'entity': 'cost', 'category': 'PERCENT'}, {'entity': 'cost of sales', 'category': 'PERCENT'}, {'entity': 'Percentage of net sales', 'category': 'PERCENT'}, {'entity': 'Percentage of net sales excluding stock-based compensation', 'category': 'PERCENT'}, {'entity': 'Amortization of debt discount and deferred financing costs', 'category': 'PERCENT'}, {'entity': 'stock appreciation rights', 'category': 'PERCENT'}, {'entity': 'income tax', 'category': 'PERCENT'}, {'entity': 'effective tax rate', 'category': 'PERCENT'}, {'entity': 'state income taxes', 'category': 'PERCENT'}, {'entity': 'uncertain tax positions', 'category': 'PERCENT'}, {'entity': 'federal income tax', 'category': 'PERCENT'}, {'entity': 'state income taxes', 'category': 'PERCENT'}, {'entity': 'uncertain tax positions', 'category': 'PERCENT'}, {'entity': 'Mary', 'category': 'PERSON'}, {'entity': 'Peter', 'category': 'PERSON'}, {'entity': 'Lisa', 'category': 'PERSON'}, {'entity': 'Notes', 'category': 'WORK_OF_ART'}, {'entity': 'year', 'category': 'ORDINAL'}, {'entity': 'profit', 'category': 'ORDINAL'}, {'entity': 'initial', 'category': 'ORDINAL'}, {'entity': 'tax', 'category': 'ORDINAL'}, {'entity': 'effective tax', 'category': 'ORDINAL'}, {'entity': 'statutory federal income tax', 'category': 'ORDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '115.3', 'category': 'CARDINAL'}, {'entity': '98.8', 'category': 'CARDINAL'}, {'entity': '0.6', 'category': 'CARDINAL'}, {'entity': '10.7', 'category': 'CARDINAL'}, {'entity': '10.1', 'category': 'CARDINAL'}, {'entity': '0.4', 'category': 'CARDINAL'}, {'entity': '3.5', 'category': 'CARDINAL'}, {'entity': '23.5', 'category': 'CARDINAL'}, {'entity': '14.1', 'category': 'CARDINAL'}, {'entity': '10.5', 'category': 'CARDINAL'}, {'entity': '3.8', 'category': 'CARDINAL'}, {'entity': '6.0', 'category': 'CARDINAL'}, {'entity': '4.0', 'category': 'CARDINAL'}, {'entity': '10.0', 'category': 'CARDINAL'}, {'entity': '51.3', 'category': 'CARDINAL'}, {'entity': '42.5', 'category': 'CARDINAL'}, {'entity': '20.0', 'category': 'CARDINAL'}, {'entity': '34.0', 'category': 'CARDINAL'}, {'entity': '9.3', 'category': 'CARDINAL'}, {'entity': '0.9', 'category': 'CARDINAL'}, {'entity': '3.2', 'category': 'CARDINAL'}, {'entity': '60.5', 'category': 'CARDINAL'}, {'entity': '26.3', 'category': 'CARDINAL'}, {'entity': '21', 'category': 'CARDINAL'}, {'entity': '23.6', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31', 'category': 'DATE'}, {'entity': '20213 EVENT', 'category': 'DATE'}, {'entity': 'Merger1 ORG', 'category': 'DATE'}, {'entity': 'Aerospace and Defense1 GPE', 'category': 'DATE'}, {'entity': 'GBSD', 'category': 'DATE'}, {'entity': 'ATACMS', 'category': 'DATE'}, {'entity': 'THAAD', 'category': 'DATE'}, {'entity': 'RS-685 ORG', 'category': 'DATE'}, {'entity': 'Real Estate1', 'category': 'DATE'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'Free Cash Flow', 'category': 'EVENT'}, {'entity': 'Senior Credit Facility', 'category': 'EVENT'}, {'entity': 'Senior Credit Facility matures', 'category': 'EVENT'}, {'entity': 'Revolver', 'category': 'EVENT'}, {'entity': 'Term Loan', 'category': 'EVENT'}, {'entity': 'Term Loan and any borrowings', 'category': 'EVENT'}, {'entity': 'Consolidated Net Leverage Ratio', 'category': 'EVENT'}, {'entity': 'commitment fees', 'category': 'EVENT'}, {'entity': 'financial and non-financial covenants', 'category': 'EVENT'}, {'entity': '\"LANGUAGE\"', 'category': 'FAC'}, {'entity': '\"LAW\"', 'category': 'FAC'}, {'entity': '\"NORP\"', 'category': 'FAC'}, {'entity': 'and \"QUANTITY\" are not present in the given input. Hence', 'category': 'FAC'}, {'entity': 'they are not displayed in the output.', 'category': 'FAC'}, {'entity': 'December 31, 2021', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '$199.6', 'category': 'MONEY'}, {'entity': '37.3', 'category': 'MONEY'}, {'entity': '$162.3', 'category': 'MONEY'}, {'entity': '$309.2', 'category': 'MONEY'}, {'entity': 'Lockheed Martin', 'category': 'ORG'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': 'Audit Committee', 'category': 'ORG'}, {'entity': 'Form 10-K', 'category': 'ORG'}, {'entity': 'Mary', 'category': 'PERSON'}, {'entity': 'Board of Directors', 'category': 'PERSON'}, {'entity': 'In millions', 'category': 'QUANTITY'}, {'entity': '$650.0 million', 'category': 'QUANTITY'}, {'entity': '175', 'category': 'QUANTITY'}, {'entity': '250 basis points', 'category': 'QUANTITY'}, {'entity': '175 to 250 basis points', 'category': 'QUANTITY'}, {'entity': '175 to 250 basis points', 'category': 'QUANTITY'}, {'entity': '30 to 45 basis points', 'category': 'QUANTITY'}, {'entity': '7.5% per annum', 'category': 'QUANTITY'}, {'entity': '10.0% per annum', 'category': 'QUANTITY'}, {'entity': 'December 31, 2021', 'category': 'QUANTITY'}, {'entity': 'December 31, 2021', 'category': 'TIME'}, {'entity': 'September 20, 2023', 'category': 'TIME'}, {'entity': 'LIBOR', 'category': 'TIME'}, {'entity': 'quarterly installments', 'category': 'TIME'}, {'entity': 'maturity date', 'category': 'TIME'}, {'entity': 'Non-GAAP', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'next twelve', 'category': 'ORDINAL'}, {'entity': '1A', 'category': 'ORDINAL'}, {'entity': '$700.4 million', 'category': 'CARDINAL'}, {'entity': '$622.2 million', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '$449.1 million', 'category': 'CARDINAL'}, {'entity': '$1,152.5 million', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'Dec 23', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': 'product launch', 'category': 'EVENT'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'Cupertino', 'category': 'LOC'}, {'entity': 'California', 'category': 'LOC'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': 'Apple', 'category': 'ORG'}, {'entity': '5PM', 'category': 'TIME'}, {'entity': '7PM', 'category': 'TIME'}, {'entity': 'Hamlet', 'category': 'WORK_OF_ART'}, {'entity': '15.2', 'category': 'CARDINAL'}, {'entity': '15.0', 'category': 'CARDINAL'}, {'entity': '9.8', 'category': 'CARDINAL'}, {'entity': '22.9', 'category': 'CARDINAL'}, {'entity': '16.8', 'category': 'CARDINAL'}, {'entity': '2.7', 'category': 'CARDINAL'}, {'entity': '4.5', 'category': 'CARDINAL'}, {'entity': '3.6', 'category': 'CARDINAL'}, {'entity': '6.0', 'category': 'CARDINAL'}, {'entity': '1,409.6', 'category': 'CARDINAL'}, {'entity': '921.4', 'category': 'CARDINAL'}, {'entity': '483.7', 'category': 'CARDINAL'}, {'entity': '3.9', 'category': 'CARDINAL'}, {'entity': '0.6', 'category': 'CARDINAL'}, {'entity': '51.8', 'category': 'CARDINAL'}, {'entity': '19.8', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '2,053.6', 'category': 'CARDINAL'}, {'entity': '1,126.3', 'category': 'CARDINAL'}, {'entity': '791.0', 'category': 'CARDINAL'}, {'entity': '26.5', 'category': 'CARDINAL'}, {'entity': '109.8', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '15', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': 'year', 'category': 'DATE'}, {'entity': 'Aerospace', 'category': 'ORG'}, {'entity': 'Defense', 'category': 'ORG'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': '2.90', 'category': 'PERCENT'}, {'entity': '2.52', 'category': 'PERCENT'}, {'entity': '2.77', 'category': 'PERCENT'}, {'entity': '2.28', 'category': 'PERCENT'}, {'entity': '2.52', 'category': 'PERCENT'}, {'entity': '3.28', 'category': 'PERCENT'}, {'entity': '2.28', 'category': 'PERCENT'}, {'entity': '3.19', 'category': 'PERCENT'}, {'entity': '7.00', 'category': 'QUANTITY'}, {'entity': 'one-fifth', 'category': 'ORDINAL'}, {'entity': 'expected', 'category': 'ORDINAL'}, {'entity': 'high-quality', 'category': 'ORDINAL'}, {'entity': 'matched', 'category': 'ORDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2009', 'category': 'CARDINAL'}, {'entity': '31', 'category': 'CARDINAL'}, {'entity': '2009', 'category': 'CARDINAL'}, {'entity': '2021', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '34.8', 'category': 'CARDINAL'}, {'entity': '38.5', 'category': 'CARDINAL'}, {'entity': '31.2', 'category': 'CARDINAL'}, {'entity': '45.1', 'category': 'CARDINAL'}, {'entity': '23.0', 'category': 'CARDINAL'}, {'entity': '34.5', 'category': 'CARDINAL'}, {'entity': '0.29', 'category': 'CARDINAL'}, {'entity': '0.44', 'category': 'CARDINAL'}, {'entity': '0.28', 'category': 'CARDINAL'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': '5', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': 'balance', 'category': 'EVENT'}, {'entity': 'treatment facilities', 'category': 'FAC'}, {'entity': 'Northrop', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': '$18.9', 'category': 'MONEY'}, {'entity': '$132.3', 'category': 'MONEY'}, {'entity': '$8.8', 'category': 'MONEY'}, {'entity': '$0.1', 'category': 'MONEY'}, {'entity': '$0.2', 'category': 'MONEY'}, {'entity': '$16.1', 'category': 'MONEY'}, {'entity': '$111.5', 'category': 'MONEY'}, {'entity': '39.5', 'category': 'MONEY'}, {'entity': 'Northrop', 'category': 'ORG'}, {'entity': '1%', 'category': 'PERCENT'}, {'entity': '1%', 'category': 'PERCENT'}, {'entity': 'Legislation', 'category': 'PERSON'}, {'entity': 'limited liability company', 'category': 'PERSON'}, {'entity': 'millions', 'category': 'QUANTITY'}, {'entity': '2021', 'category': 'TIME'}, {'entity': 'Global Settlement', 'category': 'WORK_OF_ART'}, {'entity': 'other expense', 'category': 'ORDINAL'}, {'entity': '2021', 'category': 'CARDINAL'}, {'entity': '2021', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'U.S.', 'category': 'NORP'}, {'entity': 'Item 8', 'category': 'ORG'}, {'entity': 'Item 7A', 'category': 'ORG'}, {'entity': 'Retirement Benefit Plans', 'category': 'ORG'}, {'entity': '34%', 'category': 'PERCENT'}, {'entity': '66%', 'category': 'PERCENT'}, {'entity': 'December 31', 'category': 'PERSON'}, {'entity': '2021', 'category': 'PERSON'}, {'entity': '2020', 'category': 'PERSON'}, {'entity': 'three years', 'category': 'QUANTITY'}, {'entity': 'second', 'category': 'ORDINAL'}, {'entity': 'third-party', 'category': 'ORDINAL'}, {'entity': 'absolute', 'category': 'ORDINAL'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '$428.1 million', 'category': 'CARDINAL'}]\n",
      "/Users/tanmayiballa/Desktop/KG-LLM/l715_23-1/data/10-Ks/Aerojet_Rocketdyne_Holdings_Inc./2023/Management_gpt-3.5-turbo_NER_response.json\n",
      "[{'entity': 'L3Harris', 'category': 'ORG'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'Lockheed Martin', 'category': 'ORG'}, {'entity': 'Mizar Sub, Inc.', 'category': 'ORG'}, {'entity': 'FTC', 'category': 'ORG'}, {'entity': 'Form 10-K', 'category': 'ORG'}, {'entity': 'Lockheed Terminated Merger Agreement', 'category': 'ORG'}, {'entity': 'Mizar Sub', 'category': 'ORG'}, {'entity': 'RS-25 program', 'category': 'ORG'}, {'entity': 'Standard Missile program', 'category': 'ORG'}, {'entity': 'PAC-3 program', 'category': 'ORG'}, {'entity': 'Lockheed Martin', 'category': 'ORG'}, {'entity': 'Raytheon', 'category': 'ORG'}, {'entity': 'NASA', 'category': 'ORG'}, {'entity': 'Part I, Item 1. Business', 'category': 'ORG'}]\n",
      "[{'entity': 'December 31', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2023', 'category': 'DATE'}, {'entity': 'March 11', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': 'January 2023', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': 'Ended December 31', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': '$34.5 million', 'category': 'MONEY'}, {'entity': '$303.1 million', 'category': 'MONEY'}, {'entity': '$706.9 million', 'category': 'MONEY'}, {'entity': '$949.7 million', 'category': 'MONEY'}, {'entity': '$242.8 million', 'category': 'MONEY'}, {'entity': '$7 million', 'category': 'MONEY'}, {'entity': '$10.6 million', 'category': 'MONEY'}, {'entity': '$2', 'category': 'MONEY'}, {'entity': '237.6 million', 'category': 'MONEY'}, {'entity': '$2', 'category': 'MONEY'}, {'entity': '188.0 million', 'category': 'MONEY'}, {'entity': 'American Business Enterprise', 'category': 'ORG'}, {'entity': 'Northrop', 'category': 'ORG'}, {'entity': 'December 31', 'category': 'ORG'}, {'entity': '2022', 'category': 'ORG'}, {'entity': 'ARPA', 'category': 'ORG'}, {'entity': '$9.8 million', 'category': 'QUANTITY'}]\n",
      "[{'entity': 'Dec 23', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': 'product launch', 'category': 'EVENT'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'LAW', 'category': 'LANGUAGE'}, {'entity': 'NORP', 'category': 'LANGUAGE'}, {'entity': 'and QUANTITY categories are not mentioned as there are no entities in those categories.', 'category': 'LANGUAGE'}, {'entity': 'Cupertino', 'category': 'LOC'}, {'entity': 'California', 'category': 'LOC'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': 'Standard Missile', 'category': 'ORG'}, {'entity': 'RS-68', 'category': 'ORG'}, {'entity': 'Rocketdyne Business', 'category': 'ORG'}, {'entity': 'United Technologies Corporation', 'category': 'ORG'}, {'entity': '85.2', 'category': 'PERCENT'}, {'entity': '82.3', 'category': 'PERCENT'}, {'entity': '2.5', 'category': 'PERCENT'}, {'entity': '2.1', 'category': 'PERCENT'}, {'entity': '1.3', 'category': 'PERCENT'}, {'entity': '1.2', 'category': 'PERCENT'}, {'entity': 'Mary', 'category': 'PERSON'}, {'entity': '154.1 million', 'category': 'QUANTITY'}, {'entity': '2.9 million', 'category': 'QUANTITY'}, {'entity': '5PM', 'category': 'TIME'}, {'entity': '7PM', 'category': 'TIME'}, {'entity': 'Hamlet', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2¼%', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31, 2022', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': 'CAS recoverable retirement benefits expense', 'category': 'EVENT'}, {'entity': 'RS-68 program', 'category': 'FAC'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'Unfunded backlog', 'category': 'LOC'}, {'entity': '$33.8 million', 'category': 'MONEY'}, {'entity': '31.2 million', 'category': 'MONEY'}, {'entity': '6.8 billion', 'category': 'MONEY'}, {'entity': 'Aerospace and Defense Segment', 'category': 'ORG'}, {'entity': 'NGI', 'category': 'ORG'}, {'entity': 'RS-25', 'category': 'ORG'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': 'Real Estate Segment', 'category': 'ORG'}, {'entity': '3.3%', 'category': 'PERCENT'}, {'entity': '10.7%', 'category': 'PERCENT'}, {'entity': '13.6%', 'category': 'PERCENT'}, {'entity': '1.51', 'category': 'PERCENT'}, {'entity': '13.6', 'category': 'PERCENT'}, {'entity': 'December 31', 'category': 'PERSON'}, {'entity': '6.3', 'category': 'PERSON'}, {'entity': '$2.4', 'category': 'PERSON'}, {'entity': '8.7', 'category': 'PERSON'}, {'entity': '1.0', 'category': 'PERSON'}, {'entity': '2.9', 'category': 'PERSON'}, {'entity': '2.3', 'category': 'PERSON'}, {'entity': '6.8', 'category': 'PERSON'}, {'entity': '12 months', 'category': 'PERSON'}, {'entity': 'Standard Missile program', 'category': 'PRODUCT'}, {'entity': '2022', 'category': 'TIME'}, {'entity': '2021', 'category': 'TIME'}, {'entity': 'Critical Accounting Policies and Estimates - Retirement Benefit Plans', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '$32 million', 'category': 'CARDINAL'}, {'entity': '2023', 'category': 'CARDINAL'}, {'entity': '55.9', 'category': 'CARDINAL'}, {'entity': '33.0', 'category': 'CARDINAL'}, {'entity': '2,235.2', 'category': 'CARDINAL'}, {'entity': '2,179.3', 'category': 'CARDINAL'}, {'entity': '2509', 'category': 'CARDINAL'}, {'entity': '285.9', 'category': 'CARDINAL'}, {'entity': '11.3', 'category': 'CARDINAL'}, {'entity': '13.1', 'category': 'CARDINAL'}, {'entity': '42.3', 'category': 'CARDINAL'}, {'entity': '15', 'category': 'CARDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '45, 55, 43', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31, 2022', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': 'September 20', 'category': 'DATE'}, {'entity': '2025', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '$48.7', 'category': 'MONEY'}, {'entity': '40.7', 'category': 'MONEY'}, {'entity': '89.4', 'category': 'MONEY'}, {'entity': '162.3', 'category': 'MONEY'}, {'entity': '$48.7 million', 'category': 'MONEY'}, {'entity': '$40.7 million', 'category': 'MONEY'}, {'entity': '1.7 million', 'category': 'MONEY'}, {'entity': '$287.1 million', 'category': 'MONEY'}, {'entity': '263.8 million', 'category': 'MONEY'}, {'entity': '18.9 million', 'category': 'MONEY'}, {'entity': '1.7 million', 'category': 'MONEY'}, {'entity': '2.7 million', 'category': 'MONEY'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': 'Audit Committee', 'category': 'ORG'}, {'entity': 'December 31', 'category': 'ORG'}, {'entity': '2022', 'category': 'ORG'}, {'entity': '10 basis points', 'category': 'PERCENT'}, {'entity': '175 to 250 basis points', 'category': 'PERCENT'}, {'entity': '5.0%', 'category': 'PERCENT'}, {'entity': 'Management', 'category': 'PERSON'}, {'entity': '$650.0 million', 'category': 'QUANTITY'}, {'entity': '269.1 million', 'category': 'QUANTITY'}, {'entity': '$1', 'category': 'QUANTITY'}, {'entity': '353.8', 'category': 'QUANTITY'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'December 31', 'category': 'ORDINAL'}, {'entity': '2022', 'category': 'ORDINAL'}, {'entity': '2022', 'category': 'ORDINAL'}, {'entity': '5.0% per annum', 'category': 'ORDINAL'}, {'entity': '15 years', 'category': 'ORDINAL'}, {'entity': '3.2', 'category': 'ORDINAL'}, {'entity': '10', 'category': 'ORDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '$378.2 million', 'category': 'CARDINAL'}, {'entity': '325.2 million', 'category': 'CARDINAL'}, {'entity': '703.4 million', 'category': 'CARDINAL'}, {'entity': '2021', 'category': 'CARDINAL'}, {'entity': '$42.4 million', 'category': 'CARDINAL'}, {'entity': '$262.3', 'category': 'CARDINAL'}, {'entity': '$65.0', 'category': 'CARDINAL'}, {'entity': '$65.1', 'category': 'CARDINAL'}, {'entity': '$14.9', 'category': 'CARDINAL'}, {'entity': '$57.4', 'category': 'CARDINAL'}, {'entity': '$1', 'category': 'CARDINAL'}, {'entity': '860.2', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'next 10 years', 'category': 'DATE'}, {'entity': '2023', 'category': 'DATE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '$7 million', 'category': 'MONEY'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'CAS', 'category': 'ORG'}, {'entity': 'Item 8', 'category': 'PERSON'}, {'entity': 'SEC', 'category': 'PERSON'}, {'entity': '8', 'category': 'ORDINAL'}]\n",
      "[{'entity': '2021', 'category': 'DATE'}, {'entity': 'December 31, 2022', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': 'Eiffel Tower', 'category': 'FAC'}, {'entity': 'Hilton Hotel', 'category': 'FAC'}, {'entity': 'Paris', 'category': 'GPE'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'Cupertino', 'category': 'LOC'}, {'entity': 'California', 'category': 'LOC'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': 'Aerospace and Defense', 'category': 'ORG'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': 'Mary', 'category': 'PERSON'}, {'entity': 'Shakespeare', 'category': 'PERSON'}, {'entity': 'Peter', 'category': 'PERSON'}, {'entity': 'Lisa', 'category': 'PERSON'}, {'entity': '5PM', 'category': 'TIME'}, {'entity': '7PM', 'category': 'TIME'}, {'entity': 'Hamlet', 'category': 'WORK_OF_ART'}, {'entity': '21.4', 'category': 'CARDINAL'}, {'entity': '34.8', 'category': 'CARDINAL'}, {'entity': '33.8', 'category': 'CARDINAL'}, {'entity': '31.2', 'category': 'CARDINAL'}, {'entity': '23.1', 'category': 'CARDINAL'}, {'entity': '0.29', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'January 1, 2022', 'category': 'DATE'}, {'entity': 'December 31, 2022', 'category': 'DATE'}, {'entity': 'environmental reserve', 'category': 'EVENT'}, {'entity': 'remediation related to operable treatment units', 'category': 'EVENT'}, {'entity': 'additional operations and maintenance for treatment facilities', 'category': 'EVENT'}, {'entity': 'additional costs at inactive Rancho Cordova Test Sites', 'category': 'EVENT'}, {'entity': 'other environmental clean-up matters', 'category': 'EVENT'}, {'entity': 'Company', 'category': 'ORG'}, {'entity': '50%', 'category': 'PERCENT'}, {'entity': 'Report', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '2022', 'category': 'CARDINAL'}, {'entity': '33.8', 'category': 'CARDINAL'}, {'entity': '39.7', 'category': 'CARDINAL'}, {'entity': '290.5', 'category': 'CARDINAL'}, {'entity': '13.9', 'category': 'CARDINAL'}, {'entity': '13.0', 'category': 'CARDINAL'}, {'entity': '3.9', 'category': 'CARDINAL'}, {'entity': '3.0', 'category': 'CARDINAL'}, {'entity': '4.1', 'category': 'CARDINAL'}, {'entity': '29.6', 'category': 'CARDINAL'}, {'entity': '34.9', 'category': 'CARDINAL'}, {'entity': '6.0', 'category': 'CARDINAL'}, {'entity': '287.6', 'category': 'CARDINAL'}, {'entity': '4.1', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31', 'category': 'DATE'}, {'entity': '2022', 'category': 'DATE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '$261.5 million', 'category': 'MONEY'}, {'entity': '6.17%', 'category': 'MONEY'}, {'entity': 'Note 1d', 'category': 'ORG'}, {'entity': '259.4 million', 'category': 'QUANTITY'}, {'entity': '\"Retirement Benefit Plans\"', 'category': 'WORK_OF_ART'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '2022', 'category': 'CARDINAL'}, {'entity': '31', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}]\n",
      "/Users/tanmayiballa/Desktop/KG-LLM/l715_23-1/data/10-Ks/Aerojet_Rocketdyne_Holdings_Inc./2015/Management_gpt-3.5-turbo_NER_response.json\n",
      "[{'entity': 'GenCorp Inc.', 'category': 'ORG'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': 'Consolidated Financial Statements', 'category': 'ORG'}, {'entity': 'Notes', 'category': 'ORG'}, {'entity': 'Consolidated Financial Statements and Supplementary Data', 'category': 'ORG'}, {'entity': 'Real Estate', 'category': 'ORG'}, {'entity': 'Easton Development Company, LLC', 'category': 'ORG'}, {'entity': 'U.S. Highway 50', 'category': 'ORG'}, {'entity': 'Rancho Cordova', 'category': 'ORG'}, {'entity': 'Folsom', 'category': 'ORG'}, {'entity': 'Sacramento', 'category': 'ORG'}, {'entity': 'Aerospace and Defense', 'category': 'ORG'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': 'DoD', 'category': 'ORG'}, {'entity': 'NASA', 'category': 'ORG'}, {'entity': 'Aerospace', 'category': 'ORG'}, {'entity': 'Defense', 'category': 'ORG'}, {'entity': 'Rocketdyne Business', 'category': 'ORG'}, {'entity': 'Net sales', 'category': 'ORG'}, {'entity': 'Rocketdyne Business', 'category': 'ORG'}, {'entity': 'Antares AJ-26 program', 'category': 'ORG'}, {'entity': 'Debentures', 'category': 'ORG'}, {'entity': 'Adjusted EBITDAP', 'category': 'ORG'}, {'entity': 'Segment performance', 'category': 'ORG'}, {'entity': 'cash advances', 'category': 'ORG'}, {'entity': 'November 30, 2014', 'category': 'ORG'}, {'entity': 'funded backlog', 'category': 'ORG'}, {'entity': 'November 30, 2013', 'category': 'ORG'}, {'entity': 'net debt', 'category': 'ORG'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': 'UTC', 'category': 'ORG'}, {'entity': 'Original Purchase Agreement', 'category': 'ORG'}, {'entity': 'FTC', 'category': 'ORG'}, {'entity': 'Hart-Scott-Rodino Antitrust Improvements Act of 1976', 'category': 'ORG'}, {'entity': 'Amended and Restated Purchase Agreement', 'category': 'ORG'}, {'entity': 'RDA Acquisition', 'category': 'ORG'}, {'entity': 'RD Amross', 'category': 'ORG'}, {'entity': 'Russian governmental regulatory approvals', 'category': 'ORG'}]\n",
      "[{'entity': 'up to four additional three-month periods', 'category': 'DATE'}, {'entity': 'June 12, 2015', 'category': 'DATE'}, {'entity': 'December 2014', 'category': 'DATE'}, {'entity': 'for three months', 'category': 'DATE'}, {'entity': 'March 2015', 'category': 'DATE'}, {'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'December 2014', 'category': 'DATE'}, {'entity': 'fiscal 2015', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': 'Amended and Restated Purchase Agreement', 'category': 'EVENT'}, {'entity': 'RDA Acquisition', 'category': 'EVENT'}, {'entity': 'Rocketdyne Business', 'category': 'EVENT'}, {'entity': 'Advance Agreement with the DCMA', 'category': 'EVENT'}, {'entity': '$38.5 million', 'category': 'MONEY'}, {'entity': '$1,382.1', 'category': 'MONEY'}, {'entity': '$994.9', 'category': 'MONEY'}, {'entity': '$1,762.7', 'category': 'MONEY'}, {'entity': '$1,694.0', 'category': 'MONEY'}, {'entity': '$30.7', 'category': 'MONEY'}, {'entity': '$38.2', 'category': 'MONEY'}, {'entity': 'Amended and Restated Purchase Agreement', 'category': 'ORG'}, {'entity': 'Amended and Restated Purchase Agreement', 'category': 'ORG'}, {'entity': 'Amended and Restated Purchase Agreement', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'Rocketdyne Business', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'DCAA', 'category': 'ORG'}, {'entity': 'Under Secretary of Defense', 'category': 'ORG'}, {'entity': 'RDA Acquisition', 'category': 'ORG'}, {'entity': 'Rocketdyne Business', 'category': 'ORG'}, {'entity': 'DCMA', 'category': 'ORG'}, {'entity': 'a factor of at least two to one', 'category': 'PERCENT'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': 'a factor of two to one', 'category': 'PERCENT'}, {'entity': 'two to one', 'category': 'PERCENT'}, {'entity': 'two to one', 'category': 'PERCENT'}, {'entity': 'the Russian government approvals', 'category': 'PERSON'}, {'entity': 'we', 'category': 'PERSON'}, {'entity': 'December 2014', 'category': 'PERSON'}, {'entity': 'the DCAA', 'category': 'PERSON'}, {'entity': 'we', 'category': 'PERSON'}, {'entity': 'We', 'category': 'PERSON'}, {'entity': 'Rocketdyne Business', 'category': 'PERSON'}, {'entity': 'the periods set forth below', 'category': 'PERSON'}, {'entity': 'Rocketdyne Business', 'category': 'PERSON'}, {'entity': 'Rocketdyne Business', 'category': 'PERSON'}, {'entity': 'fiscal year', 'category': 'PERSON'}, {'entity': 'Rocketdyne Business integration costs', 'category': 'PERSON'}, {'entity': 'Diluted income loss per share', 'category': 'PERSON'}, {'entity': 'Increasing complexity', 'category': 'PERSON'}, {'entity': 'customers', 'category': 'PERSON'}, {'entity': 'Multiple customers', 'category': 'PERSON'}, {'entity': 'the U.S. government agencies', 'category': 'PERSON'}, {'entity': 'Lockheed Martin', 'category': 'PERSON'}, {'entity': 'ULA', 'category': 'PERSON'}, {'entity': 'Raytheon', 'category': 'PERSON'}, {'entity': 'NASA', 'category': 'PERSON'}, {'entity': 'THAAD', 'category': 'PERSON'}, {'entity': 'DoD', 'category': 'PERSON'}, {'entity': 'NASA', 'category': 'PERSON'}, {'entity': 'U.S. President', 'category': 'PERSON'}, {'entity': 'a factor of at least two to one', 'category': 'QUANTITY'}, {'entity': 'at least five business days prior to the termination date', 'category': 'TIME'}, {'entity': '5PM', 'category': 'TIME'}, {'entity': '7PM', 'category': 'TIME'}]\n",
      "[{'entity': '2013', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': 'January 2016', 'category': 'DATE'}, {'entity': 'Omnibus Appropriations bill', 'category': 'EVENT'}, {'entity': 'Bipartisan Budget Act of 2013', 'category': 'EVENT'}, {'entity': '2014 QDR', 'category': 'EVENT'}, {'entity': 'Missile Defense', 'category': 'EVENT'}, {'entity': 'Space', 'category': 'EVENT'}, {'entity': 'Nuclear Deterrence', 'category': 'EVENT'}, {'entity': 'Precision Strike', 'category': 'EVENT'}, {'entity': 'NASA Authorization Act', 'category': 'EVENT'}, {'entity': 'strong relationship', 'category': 'EVENT'}, {'entity': 'retirement', 'category': 'EVENT'}, {'entity': 'SLS program', 'category': 'FAC'}, {'entity': 'NASA launch vehicles', 'category': 'FAC'}, {'entity': 'commercial cargo and crew ISS resupply capability', 'category': 'FAC'}, {'entity': 'rocket motors', 'category': 'FAC'}, {'entity': 'liquid engines', 'category': 'FAC'}, {'entity': 'space propulsion systems', 'category': 'FAC'}, {'entity': 'heavy lift launch vehicles', 'category': 'FAC'}, {'entity': 'tactical propulsion business segments', 'category': 'FAC'}, {'entity': 'missile defense', 'category': 'FAC'}, {'entity': 'U.S', 'category': 'GPE'}, {'entity': 'NASA', 'category': 'GPE'}, {'entity': 'DoD', 'category': 'GPE'}, {'entity': 'SLS', 'category': 'GPE'}, {'entity': 'ISS', 'category': 'GPE'}, {'entity': 'SpaceX', 'category': 'GPE'}, {'entity': 'Blue Origin', 'category': 'GPE'}, {'entity': 'SLS', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': '$18.0 billion', 'category': 'MONEY'}, {'entity': '74.8 million', 'category': 'MONEY'}, {'entity': 'Bipartisan Budget Act', 'category': 'ORG'}, {'entity': 'GFY', 'category': 'ORG'}, {'entity': 'CR', 'category': 'ORG'}, {'entity': 'Department of Homeland Security', 'category': 'ORG'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': 'Northrop', 'category': 'PERSON'}, {'entity': 'January 2016', 'category': 'TIME'}, {'entity': 'QDR', 'category': 'WORK_OF_ART'}, {'entity': 'SLS', 'category': 'WORK_OF_ART'}, {'entity': 'U.S. space program', 'category': 'WORK_OF_ART'}, {'entity': 'top', 'category': 'ORDINAL'}, {'entity': 'small', 'category': 'ORDINAL'}, {'entity': '$1.0 trillion', 'category': 'CARDINAL'}, {'entity': '11', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2015', 'category': 'CARDINAL'}, {'entity': '490.2 billion', 'category': 'CARDINAL'}, {'entity': '3.3 billion', 'category': 'CARDINAL'}, {'entity': '18.0 billion', 'category': 'CARDINAL'}, {'entity': '0.5 billion', 'category': 'CARDINAL'}, {'entity': '0.4 billion', 'category': 'CARDINAL'}, {'entity': '15%', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'January 1, 2015', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': 'fiscal 2016', 'category': 'DATE'}, {'entity': 'fiscal 2014', 'category': 'DATE'}, {'entity': 'fiscal 2013', 'category': 'DATE'}, {'entity': 'fiscal 2012', 'category': 'DATE'}, {'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2012', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '388.2', 'category': 'DATE'}, {'entity': '214.3', 'category': 'DATE'}, {'entity': '360.0', 'category': 'DATE'}, {'entity': '71.9', 'category': 'DATE'}, {'entity': '113.9', 'category': 'DATE'}, {'entity': '27.8', 'category': 'DATE'}, {'entity': '21.7', 'category': 'DATE'}, {'entity': '26.4', 'category': 'DATE'}, {'entity': '24.6', 'category': 'DATE'}, {'entity': '27.8', 'category': 'DATE'}, {'entity': 'Retirement Benefits', 'category': 'EVENT'}, {'entity': 'Rocketdyne Business ERP Integration', 'category': 'EVENT'}, {'entity': 'Results of Operations', 'category': 'EVENT'}, {'entity': 'Primary reason for change', 'category': 'EVENT'}, {'entity': 'The increase in net sales was primarily due to an increase of $360.0 million of net sales from the acquired Rocketdyne Business', 'category': 'EVENT'}, {'entity': 'Fiscal 2014 and 2013 results include 12 months and 51/2 months', 'category': 'EVENT'}, {'entity': 'increase of $360.0 million', 'category': 'EVENT'}, {'entity': 'increased deliveries on the Atlas V, THAAD, and Orion programs totaling $71.9 million', 'category': 'EVENT'}, {'entity': 'sales from the Rocketdyne Business contributed $319.4 million', 'category': 'EVENT'}, {'entity': 'an increase of $53.7 million in the various Standard Missile programs primarily from increased development activities', 'category': 'EVENT'}, {'entity': 'increased deliveries on the Atlas V program generating additional sales of $21.0 million', 'category': 'EVENT'}, {'entity': 'The increase in net sales was partially offset by i a decrease of $113.9 million in the various Standard Missile contracts', 'category': 'EVENT'}, {'entity': 'an additional week of operations in the first quarter', 'category': 'EVENT'}, {'entity': '16.1 million', 'category': 'EVENT'}, {'entity': '27.8 million', 'category': 'EVENT'}, {'entity': '982.7 million', 'category': 'EVENT'}, {'entity': '92.6 million', 'category': 'EVENT'}, {'entity': 'Hilton Hotel', 'category': 'FAC'}, {'entity': 'Rocketdyne Business', 'category': 'FAC'}, {'entity': 'Rocketdyne Business', 'category': 'FAC'}, {'entity': 'acquired Rocketdyne Business', 'category': 'FAC'}, {'entity': 'Aerojet Rocketdyne', 'category': 'FAC'}, {'entity': 'Rocketdyne', 'category': 'FAC'}, {'entity': 'real estate', 'category': 'FAC'}, {'entity': 'Rocketdyne Business', 'category': 'FAC'}, {'entity': 'Rocketdyne', 'category': 'FAC'}, {'entity': 'a Bomblive', 'category': 'FAC'}, {'entity': 'BLU', 'category': 'FAC'}, {'entity': 'the follow-on BLU-129B', 'category': 'FAC'}, {'entity': 'the BLU-129B', 'category': 'FAC'}, {'entity': 'composites', 'category': 'FAC'}, {'entity': 'real estate activities', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'national', 'category': 'LOC'}, {'entity': 'the U.S.', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': '$782.2 million', 'category': 'MONEY'}, {'entity': '$920.4 million', 'category': 'MONEY'}, {'entity': '15%', 'category': 'MONEY'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': '$113.9 million', 'category': 'MONEY'}, {'entity': '$360.0 million', 'category': 'MONEY'}, {'entity': '$71.9 million', 'category': 'MONEY'}, {'entity': '$21.0 million', 'category': 'MONEY'}, {'entity': '$16.1 million', 'category': 'MONEY'}, {'entity': '$16.0 million', 'category': 'MONEY'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': 'the Standard Missile', 'category': 'ORG'}, {'entity': 'rocketdyne', 'category': 'ORG'}, {'entity': 'Atlas V', 'category': 'ORG'}, {'entity': 'THAAD', 'category': 'ORG'}, {'entity': 'Orion', 'category': 'ORG'}, {'entity': 'T3 IIA', 'category': 'ORG'}, {'entity': 'IIB', 'category': 'ORG'}, {'entity': 'Antares', 'category': 'ORG'}, {'entity': 'GEM-T', 'category': 'ORG'}, {'entity': 'all other Aerosjet', 'category': 'ORG'}, {'entity': 'programs', 'category': 'ORG'}, {'entity': 'Standard Missile-3 Block IB', 'category': 'ORG'}, {'entity': 'TDACS', 'category': 'ORG'}, {'entity': 'Standard Missile-1 Regrain', 'category': 'ORG'}, {'entity': 'Standard Missile-3 Block IIA', 'category': 'ORG'}, {'entity': 'Bomb Live', 'category': 'ORG'}, {'entity': 'composite case', 'category': 'ORG'}, {'entity': 'Bomb - 129B', 'category': 'ORG'}, {'entity': 'BLU-129B', 'category': 'ORG'}, {'entity': 'the ROcketdyne Business', 'category': 'ORG'}, {'entity': 'Rocketdyne Business', 'category': 'ORG'}, {'entity': 'commerical', 'category': 'ORG'}, {'entity': 'the Internal Revenue Service', 'category': 'ORG'}, {'entity': 'Aerijet Rocketdyne', 'category': 'ORG'}, {'entity': 'Aerojet', 'category': 'ORG'}, {'entity': 'November 30', 'category': 'ORG'}, {'entity': 'November 30th', 'category': 'ORG'}, {'entity': 'the last Saturday of November', 'category': 'ORG'}, {'entity': '86%', 'category': 'PERCENT'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': '50%', 'category': 'PERCENT'}, {'entity': '46%', 'category': 'PERCENT'}, {'entity': '52%', 'category': 'PERCENT'}, {'entity': '88.1%', 'category': 'PERCENT'}, {'entity': '88.9%', 'category': 'PERCENT'}, {'entity': 'MILLIONS', 'category': 'PERSON'}, {'entity': 'MILLIONS', 'category': 'PERSON'}, {'entity': 'REARS', 'category': 'PERSON'}, {'entity': 'MILLIONS', 'category': 'PERSON'}, {'entity': 'MILLIONS', 'category': 'PERSON'}, {'entity': 'MILLIONS', 'category': 'PERSON'}, {'entity': 'mILLIONS', 'category': 'PERSON'}, {'entity': 'mILLIONS', 'category': 'PERSON'}, {'entity': 'MILLIONS', 'category': 'PERSON'}, {'entity': 'Millions', 'category': 'PERSON'}, {'entity': 'business', 'category': 'PRODUCT'}, {'entity': 'ERP system', 'category': 'PRODUCT'}, {'entity': 'data validation process', 'category': 'PRODUCT'}, {'entity': '31', 'category': 'PRODUCT'}, {'entity': '5PM', 'category': 'TIME'}, {'entity': '7PM', 'category': 'TIME'}, {'entity': 'first quarter of fiscal 2013', 'category': 'TIME'}, {'entity': 'November 30', 'category': 'TIME'}, {'entity': 'last Saturday of November', 'category': 'TIME'}, {'entity': 'additional week', 'category': 'TIME'}, {'entity': '312.8', 'category': 'TIME'}, {'entity': '52 weeks', 'category': 'TIME'}, {'entity': 'Hamlet', 'category': 'WORK_OF_ART'}, {'entity': '86%', 'category': 'ORDINAL'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '53rd', 'category': 'ORDINAL'}, {'entity': '52nd', 'category': 'ORDINAL'}, {'entity': 'last', 'category': 'ORDINAL'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'primary', 'category': 'ORDINAL'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'fiscal 2014', 'category': 'DATE'}, {'entity': 'June 2013', 'category': 'DATE'}, {'entity': 'Dec 23, 2022', 'category': 'DATE'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': '$23.6 million', 'category': 'MONEY'}, {'entity': '3.2', 'category': 'MONEY'}, {'entity': '2.2', 'category': 'MONEY'}, {'entity': '1.0', 'category': 'MONEY'}, {'entity': '18.9', 'category': 'MONEY'}, {'entity': '25.3', 'category': 'MONEY'}, {'entity': '$1,408.1', 'category': 'MONEY'}, {'entity': '1,229.6', 'category': 'MONEY'}, {'entity': '178.5', 'category': 'MONEY'}, {'entity': '1,229.6', 'category': 'MONEY'}, {'entity': '869.6', 'category': 'MONEY'}, {'entity': '360.0', 'category': 'MONEY'}, {'entity': '37.9', 'category': 'MONEY'}, {'entity': '53.6', 'category': 'MONEY'}, {'entity': '15.7', 'category': 'MONEY'}, {'entity': '53.6', 'category': 'MONEY'}, {'entity': '41.9', 'category': 'MONEY'}, {'entity': '11.7', 'category': 'MONEY'}, {'entity': '21.1', 'category': 'MONEY'}, {'entity': '18.7', 'category': 'MONEY'}, {'entity': '2.4', 'category': 'MONEY'}, {'entity': '18.7', 'category': 'MONEY'}, {'entity': '13.3', 'category': 'MONEY'}, {'entity': '5.4', 'category': 'MONEY'}, {'entity': '5.7', 'category': 'MONEY'}, {'entity': '14.1', 'category': 'MONEY'}, {'entity': '8.4', 'category': 'MONEY'}, {'entity': '14.1', 'category': 'MONEY'}, {'entity': '6.5', 'category': 'MONEY'}, {'entity': '7.6', 'category': 'MONEY'}, {'entity': '11.1', 'category': 'MONEY'}, {'entity': '20.8', 'category': 'MONEY'}, {'entity': '9.7', 'category': 'MONEY'}, {'entity': '20.8', 'category': 'MONEY'}, {'entity': '22.1', 'category': 'MONEY'}, {'entity': '1.3', 'category': 'MONEY'}, {'entity': '63.7', 'category': 'MONEY'}, {'entity': '43.8', 'category': 'MONEY'}, {'entity': '19.9', 'category': 'MONEY'}, {'entity': '43.8', 'category': 'MONEY'}, {'entity': '22.3', 'category': 'MONEY'}, {'entity': '21.5', 'category': 'MONEY'}, {'entity': '48.5', 'category': 'MONEY'}, {'entity': '35.8', 'category': 'MONEY'}, {'entity': '12.7', 'category': 'MONEY'}, {'entity': '35.8', 'category': 'MONEY'}, {'entity': '19.3', 'category': 'MONEY'}, {'entity': '16.5', 'category': 'MONEY'}, {'entity': '13.5', 'category': 'MONEY'}, {'entity': '6.5', 'category': 'MONEY'}, {'entity': '7.0', 'category': 'MONEY'}, {'entity': '1.5', 'category': 'MONEY'}, {'entity': '5.0', 'category': 'MONEY'}, {'entity': '1.7', 'category': 'MONEY'}, {'entity': '1.5', 'category': 'MONEY'}, {'entity': '88.9%', 'category': 'PERCENT'}, {'entity': '87.4%', 'category': 'PERCENT'}, {'entity': '86.4%', 'category': 'PERCENT'}, {'entity': '85.5%', 'category': 'PERCENT'}, {'entity': '85.5%', 'category': 'PERCENT'}, {'entity': 'first', 'category': 'ORDINAL'}]\n",
      "[{'entity': '$0.5 million', 'category': 'MONEY'}, {'entity': '$1.0 million', 'category': 'MONEY'}, {'entity': '$20.0 million', 'category': 'MONEY'}, {'entity': '$1.4 million', 'category': 'MONEY'}, {'entity': '$5.2', 'category': 'MONEY'}, {'entity': '$10.1', 'category': 'MONEY'}, {'entity': '$0.1', 'category': 'MONEY'}, {'entity': '$5.0', 'category': 'MONEY'}, {'entity': '$0.7 million', 'category': 'MONEY'}, {'entity': '$11.6 million', 'category': 'MONEY'}, {'entity': '$75.0 million', 'category': 'MONEY'}, {'entity': '$0.4 million', 'category': 'MONEY'}, {'entity': '$0.1', 'category': 'MONEY'}, {'entity': '$0.2', 'category': 'MONEY'}, {'entity': '$0.2', 'category': 'MONEY'}, {'entity': '$0.6', 'category': 'MONEY'}, {'entity': '$52.7', 'category': 'MONEY'}, {'entity': '$48.7', 'category': 'MONEY'}, {'entity': '$48.7', 'category': 'MONEY'}, {'entity': '$22.3', 'category': 'MONEY'}, {'entity': '$26.4', 'category': 'MONEY'}, {'entity': '$49.1', 'category': 'MONEY'}, {'entity': '$44.2', 'category': 'MONEY'}, {'entity': '$44.2', 'category': 'MONEY'}, {'entity': '$19.4', 'category': 'MONEY'}, {'entity': '$24.8', 'category': 'MONEY'}, {'entity': '$3.6', 'category': 'MONEY'}, {'entity': '$4.5', 'category': 'MONEY'}, {'entity': '$4.5', 'category': 'MONEY'}, {'entity': '$2.9', 'category': 'MONEY'}, {'entity': '$1.6', 'category': 'MONEY'}, {'entity': '$12.9', 'category': 'MONEY'}, {'entity': '$-193.9', 'category': 'MONEY'}, {'entity': '$18.9', 'category': 'MONEY'}, {'entity': '$13.8', 'category': 'MONEY'}, {'entity': '$9.2', 'category': 'MONEY'}, {'entity': '$4.6', 'category': 'MONEY'}, {'entity': '$1.9', 'category': 'MONEY'}, {'entity': '$2.7', 'category': 'MONEY'}, {'entity': '$-0.2', 'category': 'MONEY'}, {'entity': '$-7.7', 'category': 'MONEY'}, {'entity': '$-0.3', 'category': 'MONEY'}, {'entity': '$1.5', 'category': 'MONEY'}, {'entity': '$2.8', 'category': 'MONEY'}, {'entity': '$0.1', 'category': 'MONEY'}, {'entity': '$-178.4', 'category': 'MONEY'}, {'entity': '$13.0', 'category': 'MONEY'}, {'entity': '$0.3', 'category': 'MONEY'}, {'entity': '$-0.4', 'category': 'MONEY'}, {'entity': '$0.2', 'category': 'MONEY'}, {'entity': '$2.3', 'category': 'MONEY'}, {'entity': '$2.8', 'category': 'MONEY'}, {'entity': '$2.8', 'category': 'MONEY'}, {'entity': '$21.1', 'category': 'MONEY'}, {'entity': '$1.7', 'category': 'MONEY'}, {'entity': '$3.1', 'category': 'MONEY'}, {'entity': '$1.3', 'category': 'MONEY'}, {'entity': '$-1.2', 'category': 'MONEY'}, {'entity': '$-10.0', 'category': 'MONEY'}, {'entity': '$-1.9', 'category': 'MONEY'}, {'entity': '$-1.3', 'category': 'MONEY'}, {'entity': '$0.3', 'category': 'MONEY'}, {'entity': '$0.3', 'category': 'MONEY'}, {'entity': '$1.0', 'category': 'MONEY'}, {'entity': '$39.4 million', 'category': 'MONEY'}, {'entity': '$35%', 'category': 'MONEY'}, {'entity': '$32.7%', 'category': 'MONEY'}, {'entity': '$26.2 million', 'category': 'MONEY'}, {'entity': '$740.1%', 'category': 'MONEY'}, {'entity': '$282.4 million', 'category': 'MONEY'}, {'entity': '$178.7 million', 'category': 'MONEY'}, {'entity': '$1.1 million', 'category': 'MONEY'}, {'entity': '$102.6 million', 'category': 'MONEY'}, {'entity': '$35%', 'category': 'MONEY'}, {'entity': '$$439.5 million', 'category': 'MONEY'}, {'entity': '$401.1 million', 'category': 'MONEY'}, {'entity': '$30th November 2014', 'category': 'MONEY'}, {'entity': '$18.9 Nov', 'category': 'MONEY'}, {'entity': '$2013', 'category': 'MONEY'}, {'entity': '$30th November 2014', 'category': 'MONEY'}, {'entity': 'fiscal 2015', 'category': 'MONEY'}]\n",
      "[{'entity': 'December 2014', 'category': 'DATE'}, {'entity': 'the first quarter of fiscal 2015', 'category': 'DATE'}, {'entity': 'fiscal 2014', 'category': 'DATE'}, {'entity': 'fiscal 2013', 'category': 'DATE'}, {'entity': 'fiscal 2012', 'category': 'DATE'}, {'entity': 'November 30, 2013', 'category': 'DATE'}, {'entity': 'November 30, 2005', 'category': 'DATE'}, {'entity': 'August 31, 2004', 'category': 'DATE'}, {'entity': 'September 2013', 'category': 'DATE'}, {'entity': 'November 30, 2013', 'category': 'DATE'}, {'entity': 'fiscal 2014', 'category': 'DATE'}, {'entity': 'fiscal 2013', 'category': 'DATE'}, {'entity': 'fiscal 2012', 'category': 'DATE'}, {'entity': 'November 30, 2013', 'category': 'DATE'}, {'entity': 'November 30, 2012', 'category': 'DATE'}, {'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'November 30, 2013', 'category': 'DATE'}, {'entity': 'acquisition', 'category': 'EVENT'}, {'entity': 'Rocketdyne Business', 'category': 'FAC'}, {'entity': 'Bipartisan Budget Act of 2013', 'category': 'FAC'}, {'entity': 'GDX Automotive', 'category': 'FAC'}, {'entity': 'Fine Chemicals', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': '$1.6 million', 'category': 'MONEY'}, {'entity': 'approximately $6.6 million', 'category': 'MONEY'}, {'entity': '$3.8 million', 'category': 'MONEY'}, {'entity': '$1.0 million', 'category': 'MONEY'}, {'entity': 'Rocketdyne Business', 'category': 'ORG'}, {'entity': 'Bipartisan Budget Act of 2013', 'category': 'ORG'}, {'entity': 'Tax Increase Prevention Act of 2014', 'category': 'ORG'}, {'entity': 'GDX Automotive “GDX” business', 'category': 'ORG'}, {'entity': 'Fine Chemicals business', 'category': 'ORG'}, {'entity': 'Bipartisan Budget Act of 2013', 'category': 'ORG'}, {'entity': 'Pension Protection Act of 2006', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'Rocketdyne Business', 'category': 'ORG'}, {'entity': 'Bipartisan Budget Act of 2013', 'category': 'ORG'}, {'entity': 'GDX Automotive “GDX” business', 'category': 'ORG'}, {'entity': 'Fine Chemicals business', 'category': 'ORG'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': '4.54%', 'category': 'PERCENT'}, {'entity': '3.68%', 'category': 'PERCENT'}, {'entity': '3.96%', 'category': 'PERCENT'}, {'entity': 'Congressional', 'category': 'PERSON'}, {'entity': 'R&D credit', 'category': 'PRODUCT'}, {'entity': '5PM', 'category': 'TIME'}, {'entity': '7PM', 'category': 'TIME'}, {'entity': '12.5%', 'category': 'TIME'}, {'entity': '8%', 'category': 'TIME'}, {'entity': '4.54%', 'category': 'TIME'}, {'entity': '3.68%', 'category': 'TIME'}, {'entity': '3.96%', 'category': 'TIME'}, {'entity': '12.5%', 'category': 'TIME'}, {'entity': 'valuation', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'three', 'category': 'CARDINAL'}, {'entity': 'one', 'category': 'CARDINAL'}, {'entity': 'two', 'category': 'CARDINAL'}, {'entity': 'four', 'category': 'CARDINAL'}, {'entity': 'three', 'category': 'CARDINAL'}, {'entity': 'one', 'category': 'CARDINAL'}, {'entity': '$67 million', 'category': 'CARDINAL'}, {'entity': '$35.6 million', 'category': 'CARDINAL'}]\n",
      "[{'entity': '$24.4 million', 'category': 'CARDINAL'}, {'entity': '$14.7 million', 'category': 'CARDINAL'}, {'entity': '$10.8 million', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '$213.8', 'category': 'CARDINAL'}, {'entity': '6.7%', 'category': 'CARDINAL'}, {'entity': '7.1%', 'category': 'CARDINAL'}, {'entity': '10.7%', 'category': 'CARDINAL'}, {'entity': '12.0', 'category': 'CARDINAL'}, {'entity': '12.7', 'category': 'CARDINAL'}, {'entity': '4.9', 'category': 'CARDINAL'}, {'entity': '$360.0 million', 'category': 'CARDINAL'}, {'entity': '12 months', 'category': 'CARDINAL'}, {'entity': '51/2 months', 'category': 'CARDINAL'}, {'entity': '$71.9 million', 'category': 'CARDINAL'}, {'entity': '$113.9 million', 'category': 'CARDINAL'}, {'entity': '$27.8 million', 'category': 'CARDINAL'}, {'entity': '$21.7 million', 'category': 'CARDINAL'}, {'entity': '$26.4 million', 'category': 'CARDINAL'}, {'entity': '$24.6 million', 'category': 'CARDINAL'}, {'entity': '$192.7', 'category': 'CARDINAL'}, {'entity': '$306.6', 'category': 'CARDINAL'}, {'entity': '114.3', 'category': 'CARDINAL'}, {'entity': '95.4', 'category': 'CARDINAL'}, {'entity': '7.9', 'category': 'CARDINAL'}, {'entity': '$34.3', 'category': 'CARDINAL'}, {'entity': '43.1', 'category': 'CARDINAL'}, {'entity': '17.8', 'category': 'CARDINAL'}, {'entity': '0.6', 'category': 'CARDINAL'}, {'entity': '$25.2', 'category': 'CARDINAL'}, {'entity': '69.4', 'category': 'CARDINAL'}, {'entity': '41.7', 'category': 'CARDINAL'}, {'entity': '18.2', 'category': 'CARDINAL'}, {'entity': '$39.9', 'category': 'CARDINAL'}, {'entity': '465.6', 'category': 'CARDINAL'}, {'entity': '$469.3', 'category': 'CARDINAL'}, {'entity': '$679.4', 'category': 'CARDINAL'}, {'entity': '$319.4', 'category': 'CARDINAL'}, {'entity': 'June 14, 2013', 'category': 'CARDINAL'}, {'entity': '$23.6 million', 'category': 'CARDINAL'}, {'entity': '1.5%', 'category': 'CARDINAL'}, {'entity': '$319.4 million', 'category': 'CARDINAL'}, {'entity': '$53.7 million', 'category': 'CARDINAL'}, {'entity': '$21.0 million', 'category': 'CARDINAL'}, {'entity': '$16.1 million', 'category': 'CARDINAL'}, {'entity': '$16.0 million', 'category': 'CARDINAL'}, {'entity': '52 weeks', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'fiscal 2013', 'category': 'DATE'}, {'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'November 30,2013', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': 'Year Ended 2014', 'category': 'DATE'}, {'entity': 'Year Ended 2013', 'category': 'DATE'}, {'entity': 'Year ended 2014', 'category': 'DATE'}, {'entity': 'Year ended 2013', 'category': 'DATE'}, {'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'November 30, 2013', 'category': 'DATE'}, {'entity': '$27.8 million', 'category': 'MONEY'}, {'entity': '$2.2', 'category': 'MONEY'}, {'entity': '$1.7', 'category': 'MONEY'}, {'entity': '0.9', 'category': 'MONEY'}, {'entity': '0.8', 'category': 'MONEY'}, {'entity': '$3.1', 'category': 'MONEY'}, {'entity': '$2.5', 'category': 'MONEY'}, {'entity': '$1.5 billion', 'category': 'MONEY'}, {'entity': '$6.2', 'category': 'MONEY'}, {'entity': '$5.7', 'category': 'MONEY'}, {'entity': '$0.5', 'category': 'MONEY'}, {'entity': '$5.7', 'category': 'MONEY'}, {'entity': '$8.8', 'category': 'MONEY'}, {'entity': '$3.1', 'category': 'MONEY'}, {'entity': '4.2', 'category': 'MONEY'}, {'entity': '3.8', 'category': 'MONEY'}, {'entity': '0.4', 'category': 'MONEY'}, {'entity': '3.8', 'category': 'MONEY'}, {'entity': '3.7', 'category': 'MONEY'}, {'entity': '0.1', 'category': 'MONEY'}, {'entity': '39.4', 'category': 'MONEY'}, {'entity': '26.2', 'category': 'MONEY'}, {'entity': '13.2', 'category': 'MONEY'}, {'entity': '52.7', 'category': 'MONEY'}, {'entity': '48.7', 'category': 'MONEY'}, {'entity': '22.3', 'category': 'MONEY'}, {'entity': '0.1', 'category': 'MONEY'}, {'entity': '0.2', 'category': 'MONEY'}, {'entity': '0.6', 'category': 'MONEY'}, {'entity': '63.7', 'category': 'MONEY'}, {'entity': '43.8', 'category': 'MONEY'}, {'entity': '22.3', 'category': 'MONEY'}, {'entity': '35.6', 'category': 'MONEY'}, {'entity': '65.0', 'category': 'MONEY'}, {'entity': '41.0', 'category': 'MONEY'}, {'entity': '61.7', 'category': 'MONEY'}, {'entity': '24.5', 'category': 'MONEY'}, {'entity': '12.7', 'category': 'MONEY'}, {'entity': '$174.2', 'category': 'MONEY'}, {'entity': '$155.6', 'category': 'MONEY'}, {'entity': '$110.9', 'category': 'MONEY'}, {'entity': '$150.4', 'category': 'MONEY'}, {'entity': '$77.6', 'category': 'MONEY'}, {'entity': '$86.2', 'category': 'MONEY'}, {'entity': '43.4', 'category': 'MONEY'}, {'entity': '63.2', 'category': 'MONEY'}, {'entity': '37.2', 'category': 'MONEY'}, {'entity': '$107.0', 'category': 'MONEY'}, {'entity': '$14.4', 'category': 'MONEY'}, {'entity': '$49.0', 'category': 'MONEY'}, {'entity': '$782.2', 'category': 'MONEY'}, {'entity': '$699.2', 'category': 'MONEY'}, {'entity': '265.9', 'category': 'MONEY'}, {'entity': '197.6', 'category': 'MONEY'}, {'entity': '$516.3', 'category': 'MONEY'}, {'entity': '$501.6', 'category': 'MONEY'}, {'entity': '10.9%', 'category': 'PERCENT'}, {'entity': '11.3%', 'category': 'PERCENT'}, {'entity': '11.1%', 'category': 'PERCENT'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'one year', 'category': 'ORDINAL'}, {'entity': 'primary', 'category': 'ORDINAL'}]\n",
      "[{'entity': 'fiscal 2013', 'category': 'DATE'}, {'entity': 'fiscal 2012', 'category': 'DATE'}, {'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'November 30, 2011', 'category': 'DATE'}, {'entity': 'November 30, 2012', 'category': 'DATE'}, {'entity': 'November 30, 2013', 'category': 'DATE'}, {'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': '$4.9 million', 'category': 'MONEY'}, {'entity': '$6.3 million', 'category': 'MONEY'}, {'entity': '$106.6 million', 'category': 'MONEY'}, {'entity': '$166.0 million', 'category': 'MONEY'}, {'entity': '$74.8 million', 'category': 'MONEY'}, {'entity': '$33.7 million', 'category': 'MONEY'}, {'entity': '$18.8 million', 'category': 'MONEY'}, {'entity': '$34.7 million', 'category': 'MONEY'}, {'entity': '$20.0 million', 'category': 'MONEY'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': 'Northrop', 'category': 'ORG'}, {'entity': '$74.8 million', 'category': 'QUANTITY'}, {'entity': '15 years', 'category': 'QUANTITY'}, {'entity': '$33.7 million', 'category': 'QUANTITY'}, {'entity': '$18.8 million', 'category': 'QUANTITY'}, {'entity': '$20.0 million', 'category': 'QUANTITY'}, {'entity': '2017', 'category': 'TIME'}, {'entity': '$4.9 million', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '$6.3 million', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '$106.6 million', 'category': 'CARDINAL'}, {'entity': '$166.0 million', 'category': 'CARDINAL'}, {'entity': '15 years', 'category': 'CARDINAL'}, {'entity': '2017', 'category': 'CARDINAL'}, {'entity': '$74.8 million', 'category': 'CARDINAL'}, {'entity': '$33.7 million', 'category': 'CARDINAL'}, {'entity': '$18.8 million', 'category': 'CARDINAL'}, {'entity': '$34.7 million', 'category': 'CARDINAL'}, {'entity': '$20.0 million', 'category': 'CARDINAL'}]\n",
      "[{'entity': '30', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '20.0', 'category': 'CARDINAL'}, {'entity': '17.4', 'category': 'CARDINAL'}, {'entity': '2.6', 'category': 'CARDINAL'}, {'entity': '15', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '37', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '82.5', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '107.', 'category': 'CARDINAL'}]\n",
      "[{'entity': '$8.7 million', 'category': 'MONEY'}, {'entity': '$3.9 million', 'category': 'MONEY'}, {'entity': '$2.6 million', 'category': 'MONEY'}, {'entity': '$0.9 million', 'category': 'MONEY'}, {'entity': '$1.3 million', 'category': 'MONEY'}, {'entity': '$30.5 million', 'category': 'MONEY'}, {'entity': '$11.5 million', 'category': 'MONEY'}, {'entity': '$9.3 million', 'category': 'MONEY'}, {'entity': '$2.1 million', 'category': 'MONEY'}, {'entity': '$1.6 million', 'category': 'MONEY'}, {'entity': '$6.0 million', 'category': 'MONEY'}, {'entity': '$29.7 million', 'category': 'MONEY'}, {'entity': '$14.7 million', 'category': 'MONEY'}, {'entity': '$7.1 million', 'category': 'MONEY'}, {'entity': '$1.8 million', 'category': 'MONEY'}, {'entity': '$1.3 million', 'category': 'MONEY'}, {'entity': '$4.8 million', 'category': 'MONEY'}, {'entity': 'US government', 'category': 'ORG'}, {'entity': '10.8', 'category': 'PERCENT'}, {'entity': '8.4', 'category': 'PERCENT'}, {'entity': '11.6', 'category': 'PERCENT'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': 'first quarter of fiscal 2014', 'category': 'TIME'}, {'entity': 'fourth quarter of fiscal 2014', 'category': 'TIME'}, {'entity': 'November 30, 2017', 'category': 'TIME'}, {'entity': '21.7', 'category': 'CARDINAL'}, {'entity': '21.7', 'category': 'CARDINAL'}, {'entity': '8.7', 'category': 'CARDINAL'}, {'entity': '3.9', 'category': 'CARDINAL'}, {'entity': '2.6', 'category': 'CARDINAL'}, {'entity': '0.9', 'category': 'CARDINAL'}, {'entity': '1.3', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '11.5', 'category': 'CARDINAL'}, {'entity': '9.3', 'category': 'CARDINAL'}, {'entity': '2.1', 'category': 'CARDINAL'}, {'entity': '1.6', 'category': 'CARDINAL'}, {'entity': '6.0', 'category': 'CARDINAL'}, {'entity': '29.7', 'category': 'CARDINAL'}, {'entity': '14.7', 'category': 'CARDINAL'}, {'entity': '7.1', 'category': 'CARDINAL'}, {'entity': '1.8', 'category': 'CARDINAL'}, {'entity': '1.3', 'category': 'CARDINAL'}, {'entity': '4.8', 'category': 'CARDINAL'}, {'entity': '22.9', 'category': 'CARDINAL'}, {'entity': '10.4', 'category': 'CARDINAL'}, {'entity': '23.1', 'category': 'CARDINAL'}, {'entity': '10.8', 'category': 'CARDINAL'}, {'entity': '8.4', 'category': 'CARDINAL'}, {'entity': '11.6', 'category': 'CARDINAL'}, {'entity': '33.7', 'category': 'CARDINAL'}, {'entity': '18.8', 'category': 'CARDINAL'}, {'entity': '34.7', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '150.4', 'category': 'CARDINAL'}, {'entity': '77.6', 'category': 'CARDINAL'}, {'entity': '86.2', 'category': 'CARDINAL'}, {'entity': '35.7', 'category': 'CARDINAL'}, {'entity': '474.9', 'category': 'CARDINAL'}, {'entity': '36.6', 'category': 'CARDINAL'}, {'entity': '46.4', 'category': 'CARDINAL'}, {'entity': '432.8', 'category': 'CARDINAL'}, {'entity': '75.5', 'category': 'CARDINAL'}, {'entity': '68.3', 'category': 'CARDINAL'}, {'entity': '35.5', 'category': 'CARDINAL'}, {'entity': '25.9', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'fiscal 2014', 'category': 'DATE'}, {'entity': 'fiscal 2013', 'category': 'DATE'}, {'entity': 'fiscal 2012', 'category': 'DATE'}, {'entity': 'fiscal 2014', 'category': 'DATE'}, {'entity': 'fiscal 2013', 'category': 'DATE'}, {'entity': 'fiscal 2014 and 2013', 'category': 'DATE'}, {'entity': 'fiscal 2014', 'category': 'DATE'}, {'entity': 'fiscal 2013 and 2012', 'category': 'DATE'}, {'entity': 'fiscal 2014', 'category': 'DATE'}, {'entity': 'fiscal 2013', 'category': 'DATE'}, {'entity': 'Real Estate Activities', 'category': 'FAC'}, {'entity': 'Rocketdyne Business Facilities', 'category': 'FAC'}, {'entity': 'Note 4', 'category': 'GPE'}, {'entity': 'Non-cashActivity', 'category': 'GPE'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': '29.9 million', 'category': 'MONEY'}, {'entity': '4.9 million', 'category': 'MONEY'}, {'entity': '$18.3 million', 'category': 'MONEY'}, {'entity': '$43.4 million', 'category': 'MONEY'}, {'entity': '63.2 million', 'category': 'MONEY'}, {'entity': '37.2 million', 'category': 'MONEY'}, {'entity': '16.4 million', 'category': 'MONEY'}, {'entity': '14.9 million', 'category': 'MONEY'}, {'entity': '$7.5 million', 'category': 'MONEY'}, {'entity': '$0.2 million', 'category': 'MONEY'}, {'entity': '$189.0 million', 'category': 'MONEY'}, {'entity': '166.3 million', 'category': 'MONEY'}, {'entity': '$4.2 million', 'category': 'MONEY'}, {'entity': '412.2 million', 'category': 'MONEY'}, {'entity': '77.7 million', 'category': 'MONEY'}, {'entity': '64.5 million', 'category': 'MONEY'}, {'entity': '460.0 million', 'category': 'MONEY'}, {'entity': '12.8 million', 'category': 'MONEY'}, {'entity': '$0.6 million', 'category': 'MONEY'}, {'entity': '$0.8 million', 'category': 'MONEY'}, {'entity': '$150.0 million', 'category': 'MONEY'}, {'entity': '0.2', 'category': 'MONEY'}, {'entity': '89.0', 'category': 'MONEY'}, {'entity': '60.3', 'category': 'MONEY'}, {'entity': '0.6', 'category': 'MONEY'}, {'entity': '$782.2', 'category': 'MONEY'}, {'entity': '164.2 million', 'category': 'MONEY'}, {'entity': '7 1/8%', 'category': 'MONEY'}, {'entity': '460.0', 'category': 'MONEY'}, {'entity': '4 1/16%', 'category': 'MONEY'}, {'entity': '193.2', 'category': 'MONEY'}, {'entity': '133.6', 'category': 'MONEY'}, {'entity': '2 1/4%', 'category': 'MONEY'}, {'entity': '2.40 to 1.00', 'category': 'MONEY'}, {'entity': '4.50 to 1.00', 'category': 'MONEY'}, {'entity': '3.57 to 1.00', 'category': 'MONEY'}, {'entity': '3.53 to 1.00', 'category': 'MONEY'}, {'entity': '\"Rocketdyne Business\"', 'category': 'ORG'}, {'entity': 'Subordinated Credit Facility', 'category': 'ORG'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': 'November', 'category': 'PERSON'}, {'entity': 'ERP Implementation', 'category': 'PRODUCT'}, {'entity': 'fiscal periods ending November 30, 2015', 'category': 'TIME'}, {'entity': 'fiscal periods ending November 30, 2017', 'category': 'TIME'}, {'entity': 'fiscal periods ending November 30, 2014', 'category': 'TIME'}, {'entity': 'Notes to Consolidated Financial Statements', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'Nov 30, 2014', 'category': 'ORDINAL'}, {'entity': '3.5 million', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'GenCorp', 'category': 'ORG'}, {'entity': 'UTC', 'category': 'ORG'}, {'entity': 'RD Amross', 'category': 'ORG'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': '7 1/8% Notes', 'category': 'ORG'}]\n",
      "[{'entity': 'fiscal years', 'category': 'DATE'}, {'entity': 'fiscal 2014', 'category': 'DATE'}, {'entity': 'fiscal 2013', 'category': 'DATE'}, {'entity': 'fiscal 2012', 'category': 'DATE'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': 'Aerospace and Defense', 'category': 'ORG'}, {'entity': 'management', 'category': 'PERSON'}]\n",
      "[{'entity': 'September 1, 2014', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': 'pension contributions', 'category': 'MONEY'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'DCAA', 'category': 'ORG'}, {'entity': 'Aerospace and Defense', 'category': 'ORG'}, {'entity': '50%', 'category': 'PERCENT'}, {'entity': 'five-year', 'category': 'QUANTITY'}, {'entity': 'Goodwill', 'category': 'WORK_OF_ART'}, {'entity': 'FAR', 'category': 'CARDINAL'}, {'entity': 'Cost Accounting Standards', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'fiscal 2009', 'category': 'DATE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': 'Consolidated Financial Statements', 'category': 'WORK_OF_ART'}]\n",
      "[{'entity': 'November 30', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': 'Subordinated Credit Facility', 'category': 'ORG'}, {'entity': 'three', 'category': 'ORDINAL'}, {'entity': '76%', 'category': 'CARDINAL'}, {'entity': '24%', 'category': 'CARDINAL'}, {'entity': '$782.2 million', 'category': 'CARDINAL'}, {'entity': '$594.4 million', 'category': 'CARDINAL'}, {'entity': '$187.8 million', 'category': 'CARDINAL'}, {'entity': '6.44%', 'category': 'CARDINAL'}, {'entity': '5.94%', 'category': 'CARDINAL'}, {'entity': '$98.8 million', 'category': 'CARDINAL'}, {'entity': '$45.0 million', 'category': 'CARDINAL'}, {'entity': '7 1/8%', 'category': 'CARDINAL'}, {'entity': '$483.6 million', 'category': 'CARDINAL'}, {'entity': '$494.5 million', 'category': 'CARDINAL'}, {'entity': '$460.0 million', 'category': 'CARDINAL'}, {'entity': '4 1/16%', 'category': 'CARDINAL'}, {'entity': '$248.2 million', 'category': 'CARDINAL'}, {'entity': '$398.1 million', 'category': 'CARDINAL'}, {'entity': '$133.6 million', 'category': 'CARDINAL'}, {'entity': '$193.2 million', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '$920.4', 'category': 'MONEY'}, {'entity': '$938.6', 'category': 'MONEY'}, {'entity': '$782.2', 'category': 'MONEY'}, {'entity': '$699.2', 'category': 'MONEY'}, {'entity': 'Debentures', 'category': 'ORG'}, {'entity': '1/16%', 'category': 'PERCENT'}, {'entity': 'term loans', 'category': 'PRODUCT'}, {'entity': '4', 'category': 'QUANTITY'}, {'entity': '1/16%', 'category': 'QUANTITY'}, {'entity': 'November 30, 2014', 'category': 'WORK_OF_ART'}, {'entity': '2013', 'category': 'WORK_OF_ART'}, {'entity': '7 1/8%', 'category': 'ORDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '30', 'category': 'CARDINAL'}]\n",
      "/Users/tanmayiballa/Desktop/KG-LLM/l715_23-1/data/10-Ks/Aerojet_Rocketdyne_Holdings_Inc./2017/Management_gpt-3.5-turbo_NER_response.json\n",
      "[{'entity': 'January 2016', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': 'December 2015', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': 'product launch', 'category': 'EVENT'}, {'entity': 'United States of America', 'category': 'LOC'}, {'entity': 'Cupertino', 'category': 'LOC'}, {'entity': 'California', 'category': 'LOC'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': 'Aerojet Rocketdyne Holdings, Inc.', 'category': 'ORG'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': 'DoD', 'category': 'ORG'}, {'entity': 'NASA', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': 'Mary', 'category': 'PERSON'}, {'entity': 'Shakespeare', 'category': 'PERSON'}, {'entity': 'Peter', 'category': 'PERSON'}, {'entity': 'Lisa', 'category': 'PERSON'}, {'entity': '5PM', 'category': 'TIME'}, {'entity': '7PM', 'category': 'TIME'}, {'entity': 'Form 10-K', 'category': 'WORK_OF_ART'}, {'entity': '$1.5 million', 'category': 'CARDINAL'}, {'entity': '$32.2 million', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '52', 'category': 'CARDINAL'}, {'entity': '53', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'fiscal 2016', 'category': 'DATE'}, {'entity': 'fiscal 2015', 'category': 'DATE'}, {'entity': 'fiscal 2014', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '$82 million', 'category': 'MONEY'}, {'entity': '31 million', 'category': 'MONEY'}, {'entity': 'The Standard Missile program', 'category': 'ORG'}, {'entity': 'THAAD program', 'category': 'ORG'}, {'entity': 'Lockheed Martin', 'category': 'ORG'}, {'entity': 'ULA', 'category': 'ORG'}, {'entity': 'Raytheon', 'category': 'ORG'}, {'entity': 'NASA', 'category': 'ORG'}, {'entity': '12%', 'category': 'PERCENT'}, {'entity': '14%', 'category': 'PERCENT'}, {'entity': '12%', 'category': 'PERCENT'}, {'entity': '12%', 'category': 'PERCENT'}, {'entity': '13%', 'category': 'PERCENT'}, {'entity': '13%', 'category': 'PERCENT'}, {'entity': '12%', 'category': 'PERCENT'}, {'entity': '13%', 'category': 'PERCENT'}, {'entity': '85', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '14', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '13', 'category': 'CARDINAL'}, {'entity': '13', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '13', 'category': 'CARDINAL'}, {'entity': '13', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}, {'entity': '13', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '27', 'category': 'CARDINAL'}, {'entity': '29', 'category': 'CARDINAL'}, {'entity': '28', 'category': 'CARDINAL'}, {'entity': '24', 'category': 'CARDINAL'}, {'entity': '21', 'category': 'CARDINAL'}, {'entity': '19', 'category': 'CARDINAL'}, {'entity': '25', 'category': 'CARDINAL'}, {'entity': '28', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '17', 'category': 'CARDINAL'}, {'entity': '19', 'category': 'CARDINAL'}, {'entity': '13', 'category': 'CARDINAL'}, {'entity': '11', 'category': 'CARDINAL'}, {'entity': '11', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'fiscal 2016', 'category': 'DATE'}, {'entity': 'Dec 23, 2022', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'fiscal 2017', 'category': 'DATE'}, {'entity': '$145 million', 'category': 'MONEY'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': '$25 million', 'category': 'MONEY'}, {'entity': '$19 million', 'category': 'MONEY'}, {'entity': '$38 million', 'category': 'MONEY'}, {'entity': '$18.4 million', 'category': 'MONEY'}, {'entity': '$28.9 million', 'category': 'MONEY'}, {'entity': '$725.6 million', 'category': 'MONEY'}, {'entity': '$72.0 million', 'category': 'MONEY'}, {'entity': '$37.0 million', 'category': 'MONEY'}, {'entity': '$35.0 million', 'category': 'MONEY'}, {'entity': '$32.8 million', 'category': 'MONEY'}, {'entity': '$27.5 million', 'category': 'MONEY'}, {'entity': '$5.3 million', 'category': 'MONEY'}, {'entity': '$68.0 million', 'category': 'MONEY'}, {'entity': '$6.3 million', 'category': 'MONEY'}, {'entity': 'millions', 'category': 'QUANTITY'}, {'entity': '2016', 'category': 'QUANTITY'}, {'entity': '2019', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2016', 'category': 'CARDINAL'}, {'entity': '5', 'category': 'CARDINAL'}, {'entity': '2017', 'category': 'CARDINAL'}, {'entity': '96.3', 'category': 'CARDINAL'}, {'entity': '126.8', 'category': 'CARDINAL'}, {'entity': '178.3', 'category': 'CARDINAL'}, {'entity': '8.5', 'category': 'CARDINAL'}, {'entity': '14.4', 'category': 'CARDINAL'}, {'entity': '264.4', 'category': 'CARDINAL'}, {'entity': '345.4', 'category': 'CARDINAL'}, {'entity': '518.7', 'category': 'CARDINAL'}, {'entity': '0.6', 'category': 'CARDINAL'}, {'entity': '349.7', 'category': 'CARDINAL'}, {'entity': '525.0', 'category': 'CARDINAL'}, {'entity': '2016', 'category': 'CARDINAL'}, {'entity': '1,761.3', 'category': 'CARDINAL'}, {'entity': '1,708.3', 'category': 'CARDINAL'}, {'entity': '1,602.2', 'category': 'CARDINAL'}, {'entity': '96.3', 'category': 'CARDINAL'}, {'entity': '75.4', 'category': 'CARDINAL'}, {'entity': '32.1', 'category': 'CARDINAL'}, {'entity': '53.6', 'category': 'CARDINAL'}, {'entity': '49.0', 'category': 'CARDINAL'}, {'entity': '38.2', 'category': 'CARDINAL'}, {'entity': '2.8', 'category': 'CARDINAL'}, {'entity': '64.9', 'category': 'CARDINAL'}, {'entity': '65.1', 'category': 'CARDINAL'}, {'entity': '63.7', 'category': 'CARDINAL'}, {'entity': '5.1', 'category': 'CARDINAL'}, {'entity': '34.5', 'category': 'CARDINAL'}, {'entity': '1.9', 'category': 'CARDINAL'}, {'entity': '60.8', 'category': 'CARDINAL'}, {'entity': '19.7', 'category': 'CARDINAL'}, {'entity': '17.4', 'category': 'CARDINAL'}, {'entity': '13.7', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '83.5', 'category': 'CARDINAL'}, {'entity': '61.2', 'category': 'CARDINAL'}, {'entity': '33.3', 'category': 'CARDINAL'}, {'entity': '19.6', 'category': 'CARDINAL'}, {'entity': '12.8', 'category': 'CARDINAL'}, {'entity': '0.6', 'category': 'CARDINAL'}, {'entity': '0.3', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '32.5', 'category': 'CARDINAL'}, {'entity': '50.4', 'category': 'CARDINAL'}, {'entity': '52.7', 'category': 'CARDINAL'}, {'entity': '3.8', 'category': 'CARDINAL'}, {'entity': '31.9', 'category': 'CARDINAL'}, {'entity': '50.1', 'category': 'CARDINAL'}, {'entity': '52.6', 'category': 'CARDINAL'}, {'entity': '3.8', 'category': 'CARDINAL'}, {'entity': '29.3', 'category': 'CARDINAL'}, {'entity': '16.8', 'category': 'CARDINAL'}, {'entity': '33.0', 'category': 'CARDINAL'}, {'entity': '9.0', 'category': 'CARDINAL'}, {'entity': '11.2', 'category': 'CARDINAL'}, {'entity': '0.3', 'category': 'CARDINAL'}, {'entity': '16.3', 'category': 'CARDINAL'}, {'entity': '2.0', 'category': 'CARDINAL'}, {'entity': '18.1', 'category': 'CARDINAL'}, {'entity': '17.1', 'category': 'CARDINAL'}, {'entity': '49.3', 'category': 'CARDINAL'}, {'entity': '7.0', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '0.7', 'category': 'CARDINAL'}, {'entity': '18.0', 'category': 'CARDINAL'}, {'entity': '16.2', 'category': 'CARDINAL'}, {'entity': '50.0', 'category': 'CARDINAL'}, {'entity': '7.0', 'category': 'CARDINAL'}, {'entity': '0.27', 'category': 'CARDINAL'}, {'entity': '0.28', 'category': 'CARDINAL'}, {'entity': '0.85', 'category': 'CARDINAL'}, {'entity': '0.11', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'Cupertino', 'category': 'LOC'}, {'entity': 'California', 'category': 'LOC'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': 'Apple', 'category': 'ORG'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': 'Mary', 'category': 'PERSON'}, {'entity': 'Shakespeare', 'category': 'PERSON'}, {'entity': 'Peter', 'category': 'PERSON'}, {'entity': 'Lisa', 'category': 'PERSON'}, {'entity': '5PM', 'category': 'TIME'}, {'entity': '7PM', 'category': 'TIME'}, {'entity': 'Hamlet', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '550', 'category': 'CARDINAL'}, {'entity': '65.6', 'category': 'CARDINAL'}, {'entity': '61.1', 'category': 'CARDINAL'}, {'entity': '57.9', 'category': 'CARDINAL'}, {'entity': '62.9', 'category': 'CARDINAL'}, {'entity': '65.7', 'category': 'CARDINAL'}, {'entity': '106.1', 'category': 'CARDINAL'}, {'entity': '1,761.3', 'category': 'CARDINAL'}, {'entity': '1,708.3', 'category': 'CARDINAL'}, {'entity': '53.0', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'Dec 23, 2022', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': 'Year Ended', 'category': 'DATE'}, {'entity': 'AR1', 'category': 'DATE'}, {'entity': 'November 30, November 30', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': 'November 30, November 30', 'category': 'DATE'}, {'entity': 'December 31, November 30, December 31, 2015', 'category': 'DATE'}, {'entity': 'fiscal 2015', 'category': 'DATE'}, {'entity': 'month ended December 31, 2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': 'cost of sales', 'category': 'EVENT'}, {'entity': 'inventory', 'category': 'EVENT'}, {'entity': 'contract losses', 'category': 'EVENT'}, {'entity': 'electric propulsion contract', 'category': 'EVENT'}, {'entity': 'Research and Development', 'category': 'EVENT'}, {'entity': 'component of cost of sales', 'category': 'EVENT'}, {'entity': 'financial 2015', 'category': 'EVENT'}, {'entity': 'AR1 R&D costs net', 'category': 'EVENT'}, {'entity': 'total AR1 R&D costs net', 'category': 'EVENT'}, {'entity': 'Selling', 'category': 'EVENT'}, {'entity': 'General', 'category': 'EVENT'}, {'entity': 'Administrative', 'category': 'EVENT'}, {'entity': 'retirement benefit expense', 'category': 'EVENT'}, {'entity': 'stock-based compensation', 'category': 'EVENT'}, {'entity': 'fair value of the stock appreciation rights', 'category': 'EVENT'}, {'entity': 'Cupertino', 'category': 'GPE'}, {'entity': 'California', 'category': 'GPE'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'Paris', 'category': 'GPE'}, {'entity': 'Eiffel Tower', 'category': 'GPE'}, {'entity': 'Hilton Hotel', 'category': 'GPE'}, {'entity': 'Cupertino', 'category': 'LOC'}, {'entity': 'California', 'category': 'LOC'}, {'entity': '$71.2', 'category': 'MONEY'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': 'Rocketdyne', 'category': 'ORG'}, {'entity': 'Apple', 'category': 'ORG'}, {'entity': '3.0%', 'category': 'PERCENT'}, {'entity': '1.9%', 'category': 'PERCENT'}, {'entity': '2.9%', 'category': 'PERCENT'}, {'entity': '1.9%', 'category': 'PERCENT'}, {'entity': '2.4%', 'category': 'PERCENT'}, {'entity': '2.9%', 'category': 'PERCENT'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': 'Mary', 'category': 'PERSON'}, {'entity': '1.2', 'category': 'QUANTITY'}, {'entity': '4.3', 'category': 'QUANTITY'}, {'entity': '2.9', 'category': 'QUANTITY'}, {'entity': '1.4', 'category': 'QUANTITY'}, {'entity': '32.1', 'category': 'QUANTITY'}, {'entity': '2.7', 'category': 'QUANTITY'}, {'entity': '16.1', 'category': 'QUANTITY'}, {'entity': '48.2', 'category': 'QUANTITY'}, {'entity': '5PM', 'category': 'TIME'}, {'entity': '7PM', 'category': 'TIME'}, {'entity': 'Standard Missile and THAAD programs', 'category': 'WORK_OF_ART'}, {'entity': 'Hamlet', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '1.2', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '4.1', 'category': 'CARDINAL'}, {'entity': '75.4', 'category': 'CARDINAL'}, {'entity': '32.1', 'category': 'CARDINAL'}, {'entity': '20.5', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '1.7', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '64.9', 'category': 'CARDINAL'}, {'entity': '49.6', 'category': 'CARDINAL'}, {'entity': '49.8', 'category': 'CARDINAL'}, {'entity': '13.3', 'category': 'CARDINAL'}, {'entity': '13.4', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '65.1', 'category': 'CARDINAL'}, {'entity': '5.1', 'category': 'CARDINAL'}, {'entity': '3.8', 'category': 'CARDINAL'}, {'entity': '1.1', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '54.2', 'category': 'CARDINAL'}, {'entity': '69.3', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '50.0', 'category': 'CARDINAL'}, {'entity': '0.9', 'category': 'CARDINAL'}, {'entity': '0.4', 'category': 'CARDINAL'}, {'entity': '34.4', 'category': 'CARDINAL'}, {'entity': '1.9', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'July 18, 2016', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'product launch', 'category': 'EVENT'}, {'entity': 'Eiffel Tower', 'category': 'FAC'}, {'entity': 'Hilton Hotel', 'category': 'FAC'}, {'entity': 'Paris', 'category': 'GPE'}, {'entity': 'SEC', 'category': 'LANGUAGE'}, {'entity': 'Loss on bank amendment', 'category': 'LAW'}, {'entity': 'Cupertino', 'category': 'LOC'}, {'entity': 'California', 'category': 'LOC'}, {'entity': '$460.0 million', 'category': 'MONEY'}, {'entity': '$34.1 million', 'category': 'MONEY'}, {'entity': '$13.0 million', 'category': 'MONEY'}, {'entity': '$0.3 million', 'category': 'MONEY'}, {'entity': '$50.0 million', 'category': 'MONEY'}, {'entity': 'Apple', 'category': 'ORG'}, {'entity': 'NIZATION7 1/8% Notes', 'category': 'ORG'}, {'entity': 'Second-Priority Senior Secured Notes \"7 1/8% Notes\"', 'category': 'ORG'}, {'entity': '7 1/8% Notes', 'category': 'ORG'}, {'entity': '7 1/8% Notes', 'category': 'ORG'}, {'entity': '7 1/8% Notes', 'category': 'ORG'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': '2¼% Notes', 'category': 'ORG'}, {'entity': '5.5 million shares', 'category': 'ORG'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': 'Mary', 'category': 'PERSON'}, {'entity': '$34.5', 'category': 'QUANTITY'}, {'entity': '$51.9', 'category': 'QUANTITY'}, {'entity': '$61.7', 'category': 'QUANTITY'}, {'entity': '$0.4', 'category': 'QUANTITY'}, {'entity': '5PM', 'category': 'TIME'}, {'entity': '7PM', 'category': 'TIME'}, {'entity': 'Hamlet', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'third', 'category': 'ORDINAL'}, {'entity': '7.125%', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': 'event', 'category': 'EVENT'}, {'entity': 'product launch', 'category': 'EVENT'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Cupertino', 'category': 'LOC'}, {'entity': 'California', 'category': 'LOC'}, {'entity': 'Paris', 'category': 'LOC'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': 'IRS', 'category': 'ORG'}, {'entity': 'Rocketdyne Business', 'category': 'ORG'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': 'Mary', 'category': 'PERSON'}, {'entity': 'Peter', 'category': 'PERSON'}, {'entity': 'Lisa', 'category': 'PERSON'}, {'entity': 'fiscal 2015', 'category': 'TIME'}, {'entity': 'December 31, 2016', 'category': 'TIME'}, {'entity': 'Hamlet', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '$439.7 million', 'category': 'CARDINAL'}, {'entity': '$343.7 million', 'category': 'CARDINAL'}, {'entity': '2015', 'category': 'CARDINAL'}]\n",
      "[{'entity': '2016', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '1,753.9', 'category': 'CARDINAL'}, {'entity': '1,660.0', 'category': 'CARDINAL'}, {'entity': '93.9', 'category': 'CARDINAL'}, {'entity': '1,660.0', 'category': 'CARDINAL'}, {'entity': '1,596.0', 'category': 'CARDINAL'}, {'entity': '64.0', 'category': 'CARDINAL'}, {'entity': '143.3', 'category': 'CARDINAL'}, {'entity': '48.9', 'category': 'CARDINAL'}, {'entity': '94.4', 'category': 'CARDINAL'}, {'entity': '48.9', 'category': 'CARDINAL'}, {'entity': '113.7', 'category': 'CARDINAL'}, {'entity': '64.8', 'category': 'CARDINAL'}, {'entity': '8.2', 'category': 'CARDINAL'}, {'entity': '2.9', 'category': 'CARDINAL'}, {'entity': '2.9', 'category': 'CARDINAL'}, {'entity': '7.1', 'category': 'CARDINAL'}, {'entity': '11.6', 'category': 'CARDINAL'}, {'entity': '11.4', 'category': 'CARDINAL'}, {'entity': '11.4', 'category': 'CARDINAL'}, {'entity': '11.1', 'category': 'CARDINAL'}, {'entity': '203.1', 'category': 'CARDINAL'}, {'entity': '189.2', 'category': 'CARDINAL'}, {'entity': '13.9', 'category': 'CARDINAL'}, {'entity': '189.2', 'category': 'CARDINAL'}, {'entity': '177.3', 'category': 'CARDINAL'}, {'entity': '11.9', 'category': 'CARDINAL'}, {'entity': '18.3', 'category': 'CARDINAL'}, {'entity': '16.6', 'category': 'CARDINAL'}, {'entity': '1.7', 'category': 'CARDINAL'}, {'entity': '16.6', 'category': 'CARDINAL'}, {'entity': '8.8', 'category': 'CARDINAL'}, {'entity': '7.8', 'category': 'CARDINAL'}, {'entity': '22.5', 'category': 'CARDINAL'}, {'entity': '50.2', 'category': 'CARDINAL'}, {'entity': '27.7', 'category': 'CARDINAL'}, {'entity': '50.2', 'category': 'CARDINAL'}, {'entity': '25.2', 'category': 'CARDINAL'}, {'entity': '25.0', 'category': 'CARDINAL'}, {'entity': '50.0', 'category': 'CARDINAL'}, {'entity': '12.0', 'category': 'CARDINAL'}, {'entity': '12.0', 'category': 'CARDINAL'}, {'entity': '12.0', 'category': 'CARDINAL'}, {'entity': '12.0', 'category': 'CARDINAL'}, {'entity': '12.0', 'category': 'CARDINAL'}, {'entity': '6.8', 'category': 'CARDINAL'}, {'entity': '11.2', 'category': 'CARDINAL'}, {'entity': '4.4', 'category': 'CARDINAL'}, {'entity': '11.2', 'category': 'CARDINAL'}, {'entity': '13.5', 'category': 'CARDINAL'}, {'entity': '2.3', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '0.3', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '0.3', 'category': 'CARDINAL'}, {'entity': '3.2', 'category': 'CARDINAL'}, {'entity': '2.9', 'category': 'CARDINAL'}, {'entity': '143.3', 'category': 'CARDINAL'}, {'entity': '48.9', 'category': 'CARDINAL'}, {'entity': '94.4', 'category': 'CARDINAL'}, {'entity': '48.9', 'category': 'CARDINAL'}, {'entity': '113.7', 'category': 'CARDINAL'}, {'entity': '64.8', 'category': 'CARDINAL'}, {'entity': '27.5', 'category': 'CARDINAL'}, {'entity': '15', 'category': 'CARDINAL'}, {'entity': '2.9', 'category': 'CARDINAL'}, {'entity': '1,753.9', 'category': 'CARDINAL'}, {'entity': '1,660.0', 'category': 'CARDINAL'}, {'entity': '93.9', 'category': 'CARDINAL'}, {'entity': '1,660.0', 'category': 'CARDINAL'}, {'entity': '1,596.0', 'category': 'CARDINAL'}, {'entity': '64.0', 'category': 'CARDINAL'}, {'entity': '143.3', 'category': 'CARDINAL'}, {'entity': '48.9', 'category': 'CARDINAL'}, {'entity': '94.4', 'category': 'CARDINAL'}, {'entity': '48.9', 'category': 'CARDINAL'}, {'entity': '113.7', 'category': 'CARDINAL'}, {'entity': '64.8', 'category': 'CARDINAL'}, {'entity': '32.2', 'category': 'CARDINAL'}, {'entity': '8.2', 'category': 'CARDINAL'}, {'entity': '2.9', 'category': 'CARDINAL'}, {'entity': '2.9', 'category': 'CARDINAL'}, {'entity': '7.1', 'category': 'CARDINAL'}, {'entity': '11.6', 'category': 'CARDINAL'}, {'entity': '11.4', 'category': 'CARDINAL'}, {'entity': '11.4', 'category': 'CARDINAL'}, {'entity': '11.1', 'category': 'CARDINAL'}, {'entity': '203.1', 'category': 'CARDINAL'}, {'entity': '189.2', 'category': 'CARDINAL'}, {'entity': '13.9', 'category': 'CARDINAL'}, {'entity': '189.2', 'category': 'CARDINAL'}, {'entity': '177.3', 'category': 'CARDINAL'}, {'entity': '11.9', 'category': 'CARDINAL'}, {'entity': '18.3', 'category': 'CARDINAL'}, {'entity': '16.6', 'category': 'CARDINAL'}, {'entity': '1.7', 'category': 'CARDINAL'}, {'entity': '16.6', 'category': 'CARDINAL'}, {'entity': '8.8', 'category': 'CARDINAL'}, {'entity': '7.8', 'category': 'CARDINAL'}, {'entity': '22.5', 'category': 'CARDINAL'}, {'entity': '50.2', 'category': 'CARDINAL'}, {'entity': '27.7', 'category': 'CARDINAL'}, {'entity': '50.2', 'category': 'CARDINAL'}, {'entity': '25.2', 'category': 'CARDINAL'}, {'entity': '25.0', 'category': 'CARDINAL'}, {'entity': '50.0', 'category': 'CARDINAL'}, {'entity': '12.0', 'category': 'CARDINAL'}, {'entity': '12.0', 'category': 'CARDINAL'}, {'entity': '12.0', 'category': 'CARDINAL'}, {'entity': '12.0', 'category': 'CARDINAL'}, {'entity': '12.0', 'category': 'CARDINAL'}, {'entity': '6.8', 'category': 'CARDINAL'}, {'entity': '11.2', 'category': 'CARDINAL'}, {'entity': '4.4', 'category': 'CARDINAL'}, {'entity': '11.2', 'category': 'CARDINAL'}, {'entity': '13.5', 'category': 'CARDINAL'}, {'entity': '2.3', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '0.3', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '0.3', 'category': 'CARDINAL'}, {'entity': '3.2', 'category': 'CARDINAL'}, {'entity': '2.9', 'category': 'CARDINAL'}, {'entity': '143.3', 'category': 'CARDINAL'}, {'entity': '48.9', 'category': 'CARDINAL'}, {'entity': '94.4', 'category': 'CARDINAL'}, {'entity': '48.9', 'category': 'CARDINAL'}, {'entity': '113.7', 'category': 'CARDINAL'}, {'entity': '64.8', 'category': 'CARDINAL'}, {'entity': '189.2', 'category': 'CARDINAL'}, {'entity': '177.3', 'category': 'CARDINAL'}, {'entity': '11.9', 'category': 'CARDINAL'}, {'entity': '32.1', 'category': 'CARDINAL'}, {'entity': '84.3', 'category': 'CARDINAL'}, {'entity': 'RS-25 program', 'category': 'CARDINAL'}, {'entity': 'SLS development program', 'category': 'CARDINAL'}, {'entity': 'Orion program', 'category': 'CARDINAL'}, {'entity': 'J-2X program', 'category': 'CARDINAL'}, {'entity': 'THAAD program', 'category': 'CARDINAL'}, {'entity': 'PAC-3 contracts', 'category': 'CARDINAL'}, {'entity': 'Rocketdyne', 'category': 'CARDINAL'}, {'entity': 'Antares AJ-26 program', 'category': 'CARDINAL'}, {'entity': 'Rocketdyne', 'category': 'CARDINAL'}, {'entity': 'Antares AJ-26 program', 'category': 'CARDINAL'}, {'entity': 'AR1 program', 'category': 'CARDINAL'}, {'entity': 'AR1 program', 'category': 'CARDINAL'}, {'entity': '空间发射计划', 'category': 'CARDINAL'}, {'entity': 'RL10 program', 'category': 'CARDINAL'}, {'entity': '航空航天', 'category': 'CARDINAL'}, {'entity': '防御', 'category': 'CARDINAL'}, {'entity': '年度', 'category': 'CARDINAL'}, {'entity': '净销售额', 'category': 'CARDINAL'}, {'entity': '段绩效', 'category': 'CARDINAL'}, {'entity': 'Segment margin', 'category': 'CARDINAL'}, {'entity': '环境修复准备金调整前业绩', 'category': 'CARDINAL'}, {'entity': '退休福利支出', 'category': 'CARDINAL'}, {'entity': '定向动碰供应后的火箭引擎采购会计调整', 'category': 'CARDINAL'}, {'entity': '除外项目', 'category': 'CARDINAL'}, {'entity': '火箭引擎', 'category': 'CARDINAL'}, {'entity': '定向动碰', 'category': 'CARDINAL'}, {'entity': '共同防卫计划', 'category': 'CARDINAL'}, {'entity': '美国政府合同', 'category': 'CARDINAL'}, {'entity': 'TAL-2导弹配送项目', 'category': 'CARDINAL'}, {'entity': '火箭动力工程', 'category': 'CARDINAL'}, {'entity': '美国政府', 'category': 'CARDINAL'}, {'entity': '移动火箭动力业务', 'category': 'CARDINAL'}, {'entity': '道钉3', 'category': 'CARDINAL'}, {'entity': '中国', 'category': 'CARDINAL'}, {'entity': '朝鲜', 'category': 'CARDINAL'}, {'entity': '女强人', 'category': 'CARDINAL'}, {'entity': '反火药', 'category': 'CARDINAL'}, {'entity': '特殊任务导弹', 'category': 'CARDINAL'}, {'entity': '叛乱分子', 'category': 'CARDINAL'}, {'entity': '9900', 'category': 'CARDINAL'}, {'entity': '导弹的建造成本', 'category': 'CARDINAL'}, {'entity': '火箭动力工程', 'category': 'CARDINAL'}, {'entity': '多年合同', 'category': 'CARDINAL'}, {'entity': '公用', 'category': 'CARDINAL'}, {'entity': '通用', 'category': 'CARDINAL'}, {'entity': '标准导弹', 'category': 'CARDINAL'}, {'entity': '议会', 'category': 'CARDINAL'}, {'entity': '特殊导弹', 'category': 'CARDINAL'}, {'entity': '刚性推进器', 'category': 'CARDINAL'}, {'entity': '发动机', 'category': 'CARDINAL'}, {'entity': '航空工业', 'category': 'CARDINAL'}, {'entity': '罐体外壳', 'category': 'CARDINAL'}, {'entity': '州立罪', 'category': 'CARDINAL'}, {'entity': '地理政治实体', 'category': 'CARDINAL'}, {'entity': '违法行为', 'category': 'CARDINAL'}, {'entity': '防护设施', 'category': 'CARDINAL'}, {'entity': '语言', 'category': 'CARDINAL'}, {'entity': '法律文件', 'category': 'CARDINAL'}, {'entity': '地理位置', 'category': 'CARDINAL'}, {'entity': '金钱', 'category': 'CARDINAL'}, {'entity': '国籍或宗教或政治团体', 'category': 'CARDINAL'}, {'entity': '次序的', 'category': 'CARDINAL'}, {'entity': '组织', 'category': 'CARDINAL'}, {'entity': '百分之', 'category': 'CARDINAL'}, {'entity': '人', 'category': 'CARDINAL'}, {'entity': '产品', 'category': 'CARDINAL'}, {'entity': '数量', 'category': 'CARDINAL'}, {'entity': '时间', 'category': 'CARDINAL'}, {'entity': '艺术品', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'November 30, 2016', 'category': 'DATE'}, {'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': '$26.4 million', 'category': 'MONEY'}, {'entity': '$42.0 million', 'category': 'MONEY'}, {'entity': '30.6 million', 'category': 'MONEY'}, {'entity': '$410.3', 'category': 'MONEY'}, {'entity': '$208.5', 'category': 'MONEY'}, {'entity': 'THAAD', 'category': 'ORG'}, {'entity': 'Standard Missile', 'category': 'ORG'}, {'entity': 'RL10', 'category': 'ORG'}, {'entity': 'Atlas V', 'category': 'ORG'}, {'entity': 'Commercial Crew Development', 'category': 'ORG'}, {'entity': 'RS-25', 'category': 'ORG'}, {'entity': 'SLS', 'category': 'ORG'}, {'entity': 'Rocketdyne', 'category': 'ORG'}, {'entity': '11.5%', 'category': 'PERCENT'}, {'entity': '12.8%', 'category': 'PERCENT'}, {'entity': '11.3%', 'category': 'PERCENT'}, {'entity': '24.8%', 'category': 'PERCENT'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '$32.4 million', 'category': 'CARDINAL'}, {'entity': '$26.1 million', 'category': 'CARDINAL'}, {'entity': '$2.3', 'category': 'CARDINAL'}, {'entity': '2.4', 'category': 'CARDINAL'}, {'entity': '2.2', 'category': 'CARDINAL'}, {'entity': '1.6', 'category': 'CARDINAL'}, {'entity': '$4.5', 'category': 'CARDINAL'}, {'entity': '4.0', 'category': 'CARDINAL'}, {'entity': '$1.7', 'category': 'CARDINAL'}, {'entity': '1.6', 'category': 'CARDINAL'}, {'entity': '$7.4', 'category': 'CARDINAL'}, {'entity': '48.3', 'category': 'CARDINAL'}, {'entity': '42.1', 'category': 'CARDINAL'}, {'entity': '4.3', 'category': 'CARDINAL'}, {'entity': '34.4', 'category': 'CARDINAL'}, {'entity': '30.2', 'category': 'CARDINAL'}, {'entity': '$0.5', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '202.0', 'category': 'CARDINAL'}, {'entity': '217.9', 'category': 'CARDINAL'}, {'entity': '181.5', 'category': 'CARDINAL'}, {'entity': '23.9', 'category': 'CARDINAL'}, {'entity': '158.4', 'category': 'CARDINAL'}, {'entity': '65.1', 'category': 'CARDINAL'}, {'entity': '150.6', 'category': 'CARDINAL'}, {'entity': '1.2', 'category': 'CARDINAL'}, {'entity': '$110.8', 'category': 'CARDINAL'}, {'entity': '28.3', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '3.5', 'category': 'CARDINAL'}, {'entity': '$725.6', 'category': 'CARDINAL'}, {'entity': '650.6', 'category': 'CARDINAL'}, {'entity': '$315.3', 'category': 'CARDINAL'}, {'entity': '442.1', 'category': 'CARDINAL'}]\n",
      "[{'entity': '1950s and 1960s', 'category': 'DATE'}, {'entity': 'fiscal 2016', 'category': 'DATE'}, {'entity': 'fiscal 2015', 'category': 'DATE'}, {'entity': 'fiscal 2014', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'November 30, 2013', 'category': 'DATE'}, {'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'Potentially Responsible Parties \"PRP\"', 'category': 'EVENT'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': '$6.5 million', 'category': 'MONEY'}, {'entity': '2016', 'category': 'MONEY'}, {'entity': '2015', 'category': 'MONEY'}, {'entity': '2014', 'category': 'MONEY'}, {'entity': '$68.0 million', 'category': 'MONEY'}, {'entity': 'December 31, 2016', 'category': 'MONEY'}, {'entity': '$85.4 million', 'category': 'MONEY'}, {'entity': '176.0', 'category': 'MONEY'}, {'entity': '87.4', 'category': 'MONEY'}, {'entity': 'fiscal 2016', 'category': 'TIME'}, {'entity': 'fiscal 2015', 'category': 'TIME'}, {'entity': 'fiscal 2014', 'category': 'TIME'}, {'entity': 'December 31, 2016', 'category': 'TIME'}, {'entity': 'November 30, 2013', 'category': 'TIME'}, {'entity': 'November 30, 2014', 'category': 'TIME'}, {'entity': 'November 30, 2015', 'category': 'TIME'}, {'entity': 'December 31, 2015', 'category': 'TIME'}, {'entity': 'U.S. government', 'category': 'WORK_OF_ART'}, {'entity': 'fifteen', 'category': 'ORDINAL'}, {'entity': 'fifteen year', 'category': 'ORDINAL'}, {'entity': 'new', 'category': 'ORDINAL'}, {'entity': 'longer', 'category': 'ORDINAL'}, {'entity': '$6.5 million', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '15', 'category': 'CARDINAL'}, {'entity': '68.0', 'category': 'CARDINAL'}, {'entity': '6.3', 'category': 'CARDINAL'}, {'entity': '518.7', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '15', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '31.8', 'category': 'CARDINAL'}, {'entity': '34.7', 'category': 'CARDINAL'}, {'entity': '35.3', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '87.4', 'category': 'CARDINAL'}, {'entity': '59.4', 'category': 'CARDINAL'}, {'entity': '15', 'category': 'CARDINAL'}, {'entity': '5.9', 'category': 'CARDINAL'}, {'entity': '2.7', 'category': 'CARDINAL'}, {'entity': '10.4', 'category': 'CARDINAL'}, {'entity': '9.0', 'category': 'CARDINAL'}, {'entity': '87.4', 'category': 'CARDINAL'}, {'entity': '0.5', 'category': 'CARDINAL'}, {'entity': '13.8', 'category': 'CARDINAL'}, {'entity': '13.5', 'category': 'CARDINAL'}, {'entity': '17.8', 'category': 'CARDINAL'}, {'entity': '33.7', 'category': 'CARDINAL'}, {'entity': '8.1', 'category': 'CARDINAL'}, {'entity': '5.8', 'category': 'CARDINAL'}, {'entity': '4.0', 'category': 'CARDINAL'}, {'entity': '3.0', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '11.3', 'category': 'CARDINAL'}]\n",
      "[{'entity': '2003', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'fiscal 2017', 'category': 'DATE'}, {'entity': 'May 6, 2016', 'category': 'DATE'}, {'entity': 'January 12, 1999', 'category': 'DATE'}, {'entity': 'December 1, 1998', 'category': 'DATE'}, {'entity': '2001', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'Fiscal 2016', 'category': 'DATE'}, {'entity': 'acquisition', 'category': 'EVENT'}, {'entity': 'resolution', 'category': 'EVENT'}, {'entity': 'settlement', 'category': 'EVENT'}, {'entity': 'Sacramento', 'category': 'LOC'}, {'entity': '$20.0 million', 'category': 'MONEY'}, {'entity': '68.0 million', 'category': 'MONEY'}, {'entity': '189.7 million', 'category': 'MONEY'}, {'entity': '2.5 million', 'category': 'MONEY'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': 'Atlantic Research Corporation', 'category': 'ORG'}, {'entity': 'ARC', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'EIS', 'category': 'ORG'}, {'entity': 'Northrop', 'category': 'ORG'}, {'entity': '24%', 'category': 'PERCENT'}, {'entity': 'December 31', 'category': 'TIME'}, {'entity': '2016', 'category': 'TIME'}, {'entity': '20.0', 'category': 'CARDINAL'}, {'entity': '19.9', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '24', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'FPOU site', 'category': 'FAC'}, {'entity': 'Camden', 'category': 'LOC'}, {'entity': 'Arkansas', 'category': 'LOC'}, {'entity': '$15.7 million', 'category': 'MONEY'}, {'entity': '$3.8 million', 'category': 'MONEY'}, {'entity': '$3.6 million', 'category': 'MONEY'}, {'entity': '$2.7 million', 'category': 'MONEY'}, {'entity': '$2.1 million', 'category': 'MONEY'}, {'entity': '$7.2 million', 'category': 'MONEY'}, {'entity': '$0.4 million', 'category': 'MONEY'}, {'entity': '$3.8 million', 'category': 'MONEY'}, {'entity': '$3.6 million', 'category': 'MONEY'}, {'entity': '$133.6 million', 'category': 'MONEY'}, {'entity': '$95.6 million', 'category': 'MONEY'}, {'entity': '$10.5 million', 'category': 'MONEY'}, {'entity': '$10.2 million', 'category': 'MONEY'}, {'entity': '$3.9 million', 'category': 'MONEY'}, {'entity': '$13.4 million', 'category': 'MONEY'}, {'entity': '$31.2 million', 'category': 'MONEY'}, {'entity': '$13.8 million', 'category': 'MONEY'}, {'entity': '$6.8 million', 'category': 'MONEY'}, {'entity': '$3.4 million', 'category': 'MONEY'}, {'entity': '$2.8 million', 'category': 'MONEY'}, {'entity': '$1.1 million', 'category': 'MONEY'}, {'entity': '$3.3 million', 'category': 'MONEY'}, {'entity': '$25.4 million', 'category': 'MONEY'}, {'entity': '$21.4 million', 'category': 'MONEY'}, {'entity': '$5.1 million', 'category': 'MONEY'}, {'entity': '$3.7 million', 'category': 'MONEY'}, {'entity': '$2.5 million', 'category': 'MONEY'}, {'entity': '$1.9 million', 'category': 'MONEY'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': '$6.7 million', 'category': 'MONEY'}, {'entity': '$31.0 million', 'category': 'MONEY'}, {'entity': '$12.6 million', 'category': 'MONEY'}, {'entity': '$8.1 million', 'category': 'MONEY'}, {'entity': '$1.7 million', 'category': 'MONEY'}, {'entity': '$1.3 million', 'category': 'MONEY'}, {'entity': '$4.6 million', 'category': 'MONEY'}, {'entity': '$69.1', 'category': 'MONEY'}, {'entity': '$159.3', 'category': 'MONEY'}, {'entity': '$22.9', 'category': 'MONEY'}, {'entity': '$0.6', 'category': 'MONEY'}, {'entity': '$18.3', 'category': 'MONEY'}, {'entity': '$17.3', 'category': 'MONEY'}, {'entity': '$10.8', 'category': 'MONEY'}, {'entity': '$0.1', 'category': 'MONEY'}, {'entity': '$87.4', 'category': 'MONEY'}, {'entity': '$176.6', 'category': 'MONEY'}, {'entity': '$33.7', 'category': 'MONEY'}, {'entity': '$0.5', 'category': 'MONEY'}, {'entity': '$158.4', 'category': 'MONEY'}, {'entity': '$65.1', 'category': 'MONEY'}, {'entity': '$150.6', 'category': 'MONEY'}, {'entity': '$2.3', 'category': 'MONEY'}, {'entity': '$47.1', 'category': 'MONEY'}, {'entity': '$35.8', 'category': 'MONEY'}, {'entity': '$35.7', 'category': 'MONEY'}, {'entity': '$1.2', 'category': 'MONEY'}, {'entity': '$90.5', 'category': 'MONEY'}, {'entity': '$84.1', 'category': 'MONEY'}, {'entity': '$46.6', 'category': 'MONEY'}, {'entity': '$0.9', 'category': 'MONEY'}, {'entity': '$201.8', 'category': 'MONEY'}, {'entity': '$54.8', 'category': 'MONEY'}, {'entity': '$68.3', 'category': 'MONEY'}, {'entity': '$2.6.', 'category': 'MONEY'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '5', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '5', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0.', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'December 31,2015', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': '$150.6 million', 'category': 'MONEY'}, {'entity': '$127.4 million', 'category': 'MONEY'}, {'entity': '$69.6 million', 'category': 'MONEY'}, {'entity': '$96.9 million', 'category': 'MONEY'}, {'entity': '$4.9 million', 'category': 'MONEY'}, {'entity': '$2.3 million', 'category': 'MONEY'}, {'entity': '$47.6 million', 'category': 'MONEY'}, {'entity': '$36.8 million', 'category': 'MONEY'}, {'entity': '$43.4 million', 'category': 'MONEY'}, {'entity': '$1.2 million', 'category': 'MONEY'}, {'entity': '$700.6 million', 'category': 'MONEY'}, {'entity': '$800.0 million', 'category': 'MONEY'}, {'entity': '$81.2 million', 'category': 'MONEY'}, {'entity': '$64.5 million', 'category': 'MONEY'}, {'entity': '$189.0 million', 'category': 'MONEY'}, {'entity': '$166.3 million', 'category': 'MONEY'}, {'entity': '$4.2 million', 'category': 'MONEY'}, {'entity': '$92.5 million', 'category': 'MONEY'}, {'entity': '$400.0 million', 'category': 'MONEY'}, {'entity': '$102.5 million', 'category': 'MONEY'}, {'entity': '$390.0 million', 'category': 'MONEY'}, {'entity': '$100.0 million', 'category': 'MONEY'}, {'entity': '$100.0 million', 'category': 'MONEY'}, {'entity': '$460.0 million', 'category': 'MONEY'}, {'entity': '$24.6 million', 'category': 'MONEY'}, {'entity': '$84.6 million', 'category': 'MONEY'}, {'entity': '$49.0 million', 'category': 'MONEY'}, {'entity': '$35.6 million', 'category': 'MONEY'}, {'entity': '$0.2 million', 'category': 'MONEY'}, {'entity': '$300.0 million', 'category': 'MONEY'}, {'entity': '$300.0 million', 'category': 'MONEY'}, {'entity': '$13.0 million', 'category': 'MONEY'}, {'entity': '$0.3 million', 'category': 'MONEY'}, {'entity': '$650.6 million', 'category': 'MONEY'}, {'entity': '$725.6 million', 'category': 'MONEY'}, {'entity': '$390.0 million', 'category': 'MONEY'}, {'entity': '$304.7 million', 'category': 'MONEY'}, {'entity': '$35.6 million', 'category': 'MONEY'}, {'entity': '$72.0 million', 'category': 'MONEY'}, {'entity': '3.9 million', 'category': 'MONEY'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'Dec 23', 'category': 'DATE'}, {'entity': 'Apple', 'category': 'FAC'}, {'entity': 'Hilton Hotel', 'category': 'FAC'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'Cupertino', 'category': 'LOC'}, {'entity': 'California', 'category': 'LOC'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': 'Mary', 'category': 'PERSON'}, {'entity': 'Shakespeare', 'category': 'PERSON'}, {'entity': 'Peter', 'category': 'PERSON'}, {'entity': 'Lisa', 'category': 'PERSON'}, {'entity': 'Hamlet', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '1.5 million', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2022', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'GAAP', 'category': 'DATE'}, {'entity': 'SEC', 'category': 'DATE'}, {'entity': 'the current period', 'category': 'DATE'}, {'entity': 'the last three fiscal years', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': 'SEC', 'category': 'GPE'}, {'entity': 'SEC', 'category': 'LOC'}, {'entity': 'estimable and probable', 'category': 'MONEY'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': '94%', 'category': 'PERCENT'}, {'entity': 'GAAP', 'category': 'PERCENT'}, {'entity': 'one-year', 'category': 'PERCENT'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'second', 'category': 'ORDINAL'}, {'entity': 'third', 'category': 'ORDINAL'}, {'entity': 'significant', 'category': 'ORDINAL'}, {'entity': 'last', 'category': 'ORDINAL'}, {'entity': 'ninety-fourth', 'category': 'ORDINAL'}, {'entity': 'one month', 'category': 'ORDINAL'}]\n",
      "[{'entity': 'December 31', 'category': 'DATE'}, {'entity': '2015 CARDINAL2016 org_percent PERCENT50% ORMfair_value PERCENT50% ENTITYrevenue GPEU.S. GPEU.S. GPEU.S. ORGbusiness_segment CARDINALtwo-step ORMgoodwill_lastname GPEAerospace and Defense ORGReporting Unit ORMImpairment CARDINALannual ORMgoodwill_lastname DATEOctober 1', 'category': 'DATE'}, {'entity': '2016 DATESeptember 1', 'category': 'DATE'}, {'entity': '2016 DATESeptember 1', 'category': 'DATE'}, {'entity': '2015 ORMgoodwill CARDINALone ORMgoodwill lastname ENTITYgoodwill CARDINAL50% PERCENT50% CARDINAL50% CARDINAL50% DATESeptember 1', 'category': 'DATE'}, {'entity': '2015 CARDINALone ENTITYgoodwill GPEAerospace and Defense CARDINAL50% CARDINAL50% CARDINALone', 'category': 'DATE'}, {'entity': 'Aerospace and Defense ORGFAR ORGCAS ORMDCAA GPEU.S. GPEGovernment ORGAerospace and Defense ORGFAR ORGCAS ORGDCAA ORGU.S. GPEU.S. monet ENTITYcontracts GPEU.S. GPEU.S. GPEU.S. GPEU.S. ORMrevenue ENTITYrevenue ORMcontract_value GPEU.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'ORG'}]\n",
      "[{'entity': 'September 1', 'category': 'DATE'}, {'entity': 'each year', 'category': 'DATE'}, {'entity': 'October 1', 'category': 'DATE'}, {'entity': 'each year', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'September 1, 2016', 'category': 'DATE'}, {'entity': 'October 1, 2016', 'category': 'DATE'}, {'entity': 'fiscal 2009', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': 'September 1', 'category': 'DATE'}, {'entity': 'each year', 'category': 'DATE'}, {'entity': 'October 1', 'category': 'DATE'}, {'entity': 'each year', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'September 1, 2016', 'category': 'DATE'}, {'entity': 'October 1, 2016', 'category': 'DATE'}, {'entity': 'fiscal 2009', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': 'change', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S. government', 'category': 'GPE'}, {'entity': 'U.S. government', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': '$0.3', 'category': 'MONEY'}, {'entity': '$22.8', 'category': 'MONEY'}, {'entity': '158.3', 'category': 'MONEY'}, {'entity': '$1.0', 'category': 'MONEY'}, {'entity': '19.5', 'category': 'MONEY'}, {'entity': '133.0', 'category': 'MONEY'}, {'entity': '0.3', 'category': 'MONEY'}, {'entity': '1.0', 'category': 'MONEY'}, {'entity': '1.1', 'category': 'MONEY'}, {'entity': 'November 30', 'category': 'ORG'}, {'entity': 'December 31', 'category': 'ORG'}, {'entity': '7.00', 'category': 'PERCENT'}, {'entity': '8.00', 'category': 'PERCENT'}, {'entity': '8.0%', 'category': 'PERCENT'}, {'entity': '7.0%', 'category': 'PERCENT'}, {'entity': 'one-fifth', 'category': 'PERCENT'}, {'entity': '4.02', 'category': 'PERCENT'}, {'entity': '2016', 'category': 'CARDINAL'}, {'entity': '2009', 'category': 'CARDINAL'}, {'entity': '401k', 'category': 'CARDINAL'}, {'entity': '4.02', 'category': 'CARDINAL'}, {'entity': '4.36', 'category': 'CARDINAL'}, {'entity': '22.8', 'category': 'CARDINAL'}, {'entity': '158.3', 'category': 'CARDINAL'}, {'entity': '0.4', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}]\n",
      "[{'entity': '\"December 31', 'category': 'DATE'}, {'entity': '2016\"', 'category': 'DATE'}, {'entity': 'Retirement Benefit Plans', 'category': 'EVENT'}, {'entity': 'Notes', 'category': 'ORG'}, {'entity': 'Apple', 'category': 'ORG'}, {'entity': '$725.6 million', 'category': 'CARDINAL'}, {'entity': '$335.6 million', 'category': 'CARDINAL'}, {'entity': '46%', 'category': 'CARDINAL'}, {'entity': '2.44%', 'category': 'CARDINAL'}, {'entity': '$390.0 million', 'category': 'CARDINAL'}, {'entity': '54%', 'category': 'CARDINAL'}, {'entity': '3.02%', 'category': 'CARDINAL'}]\n",
      "[{'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': 'In December 2016', 'category': 'ORG'}, {'entity': 'February 3, 2017', 'category': 'ORG'}, {'entity': '7 1/8%', 'category': 'PERCENT'}, {'entity': '2 1/4%', 'category': 'PERCENT'}, {'entity': '4 1/16%', 'category': 'PERCENT'}, {'entity': '4 1/16% Debentures', 'category': 'WORK_OF_ART'}, {'entity': '3.9 million shares of common stock', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '35.6', 'category': 'CARDINAL'}, {'entity': '3.9', 'category': 'CARDINAL'}, {'entity': '92.5', 'category': 'CARDINAL'}, {'entity': '479.6', 'category': 'CARDINAL'}, {'entity': '460.0', 'category': 'CARDINAL'}, {'entity': '294.9', 'category': 'CARDINAL'}, {'entity': '300.0', 'category': 'CARDINAL'}, {'entity': '70.8', 'category': 'CARDINAL'}, {'entity': '13.0', 'category': 'CARDINAL'}, {'entity': '0.6', 'category': 'CARDINAL'}, {'entity': '0.5', 'category': 'CARDINAL'}, {'entity': '755.7', 'category': 'CARDINAL'}, {'entity': '735.2', 'category': 'CARDINAL'}, {'entity': '725.6', 'category': 'CARDINAL'}, {'entity': '650.6', 'category': 'CARDINAL'}]\n",
      "/Users/tanmayiballa/Desktop/KG-LLM/l715_23-1/data/10-Ks/Aerojet_Rocketdyne_Holdings_Inc./2019/Management_gpt-3.5-turbo_NER_response.json\n",
      "[{'entity': '\"2018\"', 'category': 'DATE'}, {'entity': '\"U.S.', 'category': 'GPE'}, {'entity': 'NASA', 'category': 'GPE'}, {'entity': 'Missile Defense Agency', 'category': 'GPE'}, {'entity': 'U.S. Air Force', 'category': 'GPE'}, {'entity': 'U.S. Army', 'category': 'GPE'}, {'entity': 'U.S. Navy', 'category': 'GPE'}, {'entity': 'Lockheed Martin', 'category': 'GPE'}, {'entity': 'Raytheon', 'category': 'GPE'}, {'entity': 'ULA\",', 'category': 'GPE'}, {'entity': '\"$1,895.9 million', 'category': 'MONEY'}, {'entity': '$9.2 million', 'category': 'MONEY'}, {'entity': '$151.5 million', 'category': 'MONEY'}, {'entity': '$76.0 million\",', 'category': 'MONEY'}, {'entity': '\"FASB\"', 'category': 'ORG'}, {'entity': '\"94%', 'category': 'PERCENT'}, {'entity': '92%', 'category': 'PERCENT'}, {'entity': '91%', 'category': 'PERCENT'}, {'entity': '25%', 'category': 'PERCENT'}, {'entity': '7%', 'category': 'PERCENT'}, {'entity': '5%', 'category': 'PERCENT'}, {'entity': '6%', 'category': 'PERCENT'}, {'entity': '100%', 'category': 'PERCENT'}, {'entity': '30%', 'category': 'PERCENT'}, {'entity': '17%', 'category': 'PERCENT'}, {'entity': '18%\",', 'category': 'PERCENT'}, {'entity': '\"Management\"', 'category': 'PERSON'}, {'entity': '\"RS-25 program', 'category': 'WORK_OF_ART'}, {'entity': 'Standard Missile program', 'category': 'WORK_OF_ART'}, {'entity': 'THAAD program\",', 'category': 'WORK_OF_ART'}]\n",
      "[{'entity': '\"December 31', 'category': 'DATE'}, {'entity': '2018\"', 'category': 'DATE'}, {'entity': '\"\"', 'category': 'FAC'}, {'entity': '\"\"', 'category': 'GPE'}, {'entity': '\"\"', 'category': 'LANGUAGE'}, {'entity': '\"\"', 'category': 'LAW'}, {'entity': '\"\"', 'category': 'LOC'}, {'entity': '\"$235.0 million', 'category': 'MONEY'}, {'entity': '$131.4 million', 'category': 'MONEY'}, {'entity': '$48.1 million', 'category': 'MONEY'}, {'entity': '$625.4 million', 'category': 'MONEY'}, {'entity': '$95.0 million', 'category': 'MONEY'}, {'entity': '$37.0 million\",', 'category': 'MONEY'}, {'entity': '\"\"', 'category': 'NORP'}, {'entity': '\"\"', 'category': 'ORG'}, {'entity': '\"\"', 'category': 'PERCENT'}, {'entity': '\"\"', 'category': 'PERSON'}, {'entity': '\"\"', 'category': 'PRODUCT'}, {'entity': '\"\"', 'category': 'QUANTITY'}, {'entity': '\"\"', 'category': 'TIME'}, {'entity': '\"\"', 'category': 'WORK_OF_ART'}, {'entity': '\"\"', 'category': 'ORDINAL'}, {'entity': '\"three', 'category': 'CARDINAL'}, {'entity': 'two\",', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': 'Global Settlement', 'category': 'WORK_OF_ART'}, {'entity': 'Environmental Matters', 'category': 'WORK_OF_ART'}, {'entity': 'third', 'category': 'ORDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}]\n",
      "[{'entity': '8.9', 'category': 'CARDINAL'}, {'entity': '8.5', 'category': 'CARDINAL'}, {'entity': '0.4', 'category': 'CARDINAL'}, {'entity': '2.3', 'category': 'CARDINAL'}, {'entity': '6.2', 'category': 'CARDINAL'}, {'entity': '34.4', 'category': 'CARDINAL'}, {'entity': '30.9', 'category': 'CARDINAL'}, {'entity': '3.5', 'category': 'CARDINAL'}, {'entity': '30.9', 'category': 'CARDINAL'}, {'entity': '32.5', 'category': 'CARDINAL'}, {'entity': '1.6', 'category': 'CARDINAL'}, {'entity': '4.52', 'category': 'CARDINAL'}, {'entity': '3.82', 'category': 'CARDINAL'}, {'entity': '7.125', 'category': 'CARDINAL'}, {'entity': '110.6', 'category': 'CARDINAL'}, {'entity': '35.0', 'category': 'CARDINAL'}, {'entity': '64.6', 'category': 'CARDINAL'}, {'entity': '74.4', 'category': 'CARDINAL'}, {'entity': '36.2', 'category': 'CARDINAL'}, {'entity': '5.8', 'category': 'CARDINAL'}, {'entity': '51.3', 'category': 'CARDINAL'}, {'entity': '96.1', 'category': 'CARDINAL'}, {'entity': '11.2', 'category': 'CARDINAL'}, {'entity': '27.2', 'category': 'CARDINAL'}, {'entity': '21', 'category': 'CARDINAL'}, {'entity': '$127.7', 'category': 'CARDINAL'}, {'entity': '19.8', 'category': 'CARDINAL'}, {'entity': '5.9', 'category': 'CARDINAL'}, {'entity': '$5.9', 'category': 'CARDINAL'}, {'entity': '$50.9', 'category': 'CARDINAL'}, {'entity': '59.1', 'category': 'CARDINAL'}, {'entity': '8.2', 'category': 'CARDINAL'}, {'entity': '59.1', 'category': 'CARDINAL'}, {'entity': '66.0', 'category': 'CARDINAL'}, {'entity': '6.9', 'category': 'CARDINAL'}, {'entity': '60.1', 'category': 'CARDINAL'}, {'entity': '49.5', 'category': 'CARDINAL'}, {'entity': '10.6', 'category': 'CARDINAL'}, {'entity': '49.5', 'category': 'CARDINAL'}, {'entity': '56.1', 'category': 'CARDINAL'}, {'entity': '6.6', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '1.1', 'category': 'CARDINAL'}, {'entity': '1.0', 'category': 'CARDINAL'}, {'entity': '66.9', 'category': 'CARDINAL'}, {'entity': '63.7', 'category': 'CARDINAL'}, {'entity': '3.2', 'category': 'CARDINAL'}, {'entity': '63.7', 'category': 'CARDINAL'}, {'entity': '60.1', 'category': 'CARDINAL'}, {'entity': '3.6', 'category': 'CARDINAL'}, {'entity': '57.6', 'category': 'CARDINAL'}, {'entity': '73.2', 'category': 'CARDINAL'}, {'entity': '15.6', 'category': 'CARDINAL'}, {'entity': '73.2', 'category': 'CARDINAL'}, {'entity': '68.9', 'category': 'CARDINAL'}, {'entity': '4.3', 'category': 'CARDINAL'}, {'entity': '$26', 'category': 'CARDINAL'}, {'entity': '1,888.1', 'category': 'CARDINAL'}, {'entity': '1,870.8', 'category': 'CARDINAL'}, {'entity': '17.3', 'category': 'CARDINAL'}, {'entity': '1,870.8', 'category': 'CARDINAL'}, {'entity': '1,753.9', 'category': 'CARDINAL'}, {'entity': '116.9', 'category': 'CARDINAL'}, {'entity': '264.6', 'category': 'CARDINAL'}, {'entity': '177.9', 'category': 'CARDINAL'}, {'entity': '86.7', 'category': 'CARDINAL'}, {'entity': '177.9', 'category': 'CARDINAL'}, {'entity': '143.3', 'category': 'CARDINAL'}, {'entity': '34.6', 'category': 'CARDINAL'}, {'entity': '14.0', 'category': 'CARDINAL'}, {'entity': '9.5', 'category': 'CARDINAL'}, {'entity': '8.2', 'category': 'CARDINAL'}, {'entity': '12.4', 'category': 'CARDINAL'}, {'entity': '10.7', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'January 1, 2018', 'category': 'DATE'}, {'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': 'revenue recognition guidance', 'category': 'EVENT'}, {'entity': '$43.0 million', 'category': 'MONEY'}, {'entity': '1,902.2 million', 'category': 'MONEY'}, {'entity': '31.4 million', 'category': 'MONEY'}, {'entity': '126.0 million', 'category': 'MONEY'}, {'entity': '94.6 million', 'category': 'MONEY'}, {'entity': '15%', 'category': 'MONEY'}, {'entity': '158.0 million', 'category': 'MONEY'}, {'entity': '36.5 million', 'category': 'MONEY'}, {'entity': '42.6 million', 'category': 'MONEY'}, {'entity': '89.1 million', 'category': 'MONEY'}, {'entity': '59.1 million', 'category': 'MONEY'}, {'entity': '37.2 million', 'category': 'MONEY'}, {'entity': '32.2 million', 'category': 'MONEY'}, {'entity': '7.8', 'category': 'MONEY'}, {'entity': '6.4', 'category': 'MONEY'}, {'entity': '1.4', 'category': 'MONEY'}, {'entity': '4.1 billion', 'category': 'MONEY'}, {'entity': '1.9 billion', 'category': 'MONEY'}, {'entity': '2.1', 'category': 'MONEY'}, {'entity': '2.2', 'category': 'MONEY'}, {'entity': '2.5', 'category': 'MONEY'}, {'entity': '4.6 billion', 'category': 'MONEY'}, {'entity': '0.6 billion', 'category': 'MONEY'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'Note 8d', 'category': 'ORG'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': 'Aerojet Rocketdyne', 'category': 'PERSON'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '$43.0 million', 'category': 'CARDINAL'}, {'entity': '1,902.2 million', 'category': 'CARDINAL'}, {'entity': '31.4 million', 'category': 'CARDINAL'}, {'entity': '126.0 million', 'category': 'CARDINAL'}, {'entity': '94.6 million', 'category': 'CARDINAL'}, {'entity': '15', 'category': 'CARDINAL'}, {'entity': '158.0 million', 'category': 'CARDINAL'}, {'entity': '36.5 million', 'category': 'CARDINAL'}, {'entity': '42.6 million', 'category': 'CARDINAL'}, {'entity': '89.1 million', 'category': 'CARDINAL'}, {'entity': '59.1 million', 'category': 'CARDINAL'}, {'entity': '37.2 million', 'category': 'CARDINAL'}, {'entity': '52 weeks', 'category': 'CARDINAL'}, {'entity': '53 weeks', 'category': 'CARDINAL'}, {'entity': '32.2 million', 'category': 'CARDINAL'}, {'entity': '7.8', 'category': 'CARDINAL'}, {'entity': '6.4', 'category': 'CARDINAL'}, {'entity': '1.4', 'category': 'CARDINAL'}, {'entity': '4.1 billion', 'category': 'CARDINAL'}, {'entity': '1.8 billion', 'category': 'CARDINAL'}, {'entity': '29%', 'category': 'CARDINAL'}, {'entity': '26%', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': 'Northrop', 'category': 'FAC'}, {'entity': 'Aerojet Rocketdyne', 'category': 'GPE'}, {'entity': 'Sacramento', 'category': 'GPE'}, {'entity': 'Baldwin Park Operable Unit', 'category': 'GPE'}, {'entity': 'Non-GAAP', 'category': 'LANGUAGE'}, {'entity': 'BPOU', 'category': 'LOC'}, {'entity': '1.75', 'category': 'MONEY'}, {'entity': '$0.13', 'category': 'MONEY'}, {'entity': '$0.27', 'category': 'MONEY'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': '16.1%', 'category': 'PERCENT'}, {'entity': '11.9%', 'category': 'PERCENT'}, {'entity': '11.3%', 'category': 'PERCENT'}, {'entity': 'Stakeholders', 'category': 'PERSON'}, {'entity': '76.8', 'category': 'QUANTITY'}, {'entity': '73.0', 'category': 'QUANTITY'}, {'entity': '65.7', 'category': 'QUANTITY'}, {'entity': '73.1', 'category': 'QUANTITY'}, {'entity': '72.8', 'category': 'QUANTITY'}, {'entity': '76.8', 'category': 'QUANTITY'}, {'entity': 'May 2027', 'category': 'TIME'}, {'entity': 'Free Cash Flow', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': 'Cupertino', 'category': 'LOC'}, {'entity': 'California', 'category': 'LOC'}, {'entity': 'Sacramento', 'category': 'LOC'}, {'entity': '$341.4', 'category': 'MONEY'}, {'entity': '$349.7', 'category': 'MONEY'}, {'entity': '$302.3', 'category': 'MONEY'}, {'entity': '$23.3', 'category': 'MONEY'}, {'entity': '$31.3', 'category': 'MONEY'}, {'entity': '$87.4', 'category': 'MONEY'}, {'entity': '36.8', 'category': 'MONEY'}, {'entity': '$39.6', 'category': 'MONEY'}, {'entity': '$40.0', 'category': 'MONEY'}, {'entity': '$327.9', 'category': 'MONEY'}, {'entity': '$341.4', 'category': 'MONEY'}, {'entity': '$349.7', 'category': 'MONEY'}, {'entity': '23.3', 'category': 'MONEY'}, {'entity': '$8.8', 'category': 'MONEY'}, {'entity': '$4.6', 'category': 'MONEY'}, {'entity': '$3.8', 'category': 'MONEY'}, {'entity': '$2.2', 'category': 'MONEY'}, {'entity': '$3.9', 'category': 'MONEY'}, {'entity': '$31.3', 'category': 'MONEY'}, {'entity': '$13.4', 'category': 'MONEY'}, {'entity': '$6.7', 'category': 'MONEY'}, {'entity': '$2.3', 'category': 'MONEY'}, {'entity': '$8.9', 'category': 'MONEY'}, {'entity': '$87.4', 'category': 'MONEY'}, {'entity': '$59.4', 'category': 'MONEY'}, {'entity': '$10.4', 'category': 'MONEY'}, {'entity': '$5.9', 'category': 'MONEY'}, {'entity': '$2.7', 'category': 'MONEY'}, {'entity': '$9.0', 'category': 'MONEY'}, {'entity': '12%', 'category': 'MONEY'}, {'entity': '$18.2', 'category': 'MONEY'}, {'entity': '$21.4', 'category': 'MONEY'}, {'entity': '$67.3', 'category': 'MONEY'}, {'entity': '$28.1', 'category': 'MONEY'}, {'entity': '$31.5', 'category': 'MONEY'}, {'entity': '$35.1', 'category': 'MONEY'}, {'entity': '$32.8', 'category': 'MONEY'}, {'entity': '$1.7', 'category': 'MONEY'}, {'entity': '$344.1', 'category': 'MONEY'}, {'entity': '$333.0', 'category': 'MONEY'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'Northrop', 'category': 'ORG'}, {'entity': '12%', 'category': 'PERCENT'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}]\n",
      "[{'entity': '$43.2 million', 'category': 'MONEY'}, {'entity': '$29.4 million', 'category': 'MONEY'}, {'entity': '$47.6 million', 'category': 'MONEY'}, {'entity': '$1.9 million', 'category': 'MONEY'}, {'entity': '$20.4 million', 'category': 'MONEY'}, {'entity': '$17.0 million', 'category': 'MONEY'}, {'entity': '$25.3 million', 'category': 'MONEY'}, {'entity': '$20.0 million', 'category': 'MONEY'}, {'entity': '$700.6 million', 'category': 'MONEY'}, {'entity': '$800.0 million', 'category': 'MONEY'}, {'entity': '$670.9 million', 'category': 'MONEY'}, {'entity': '$27.2', 'category': 'MONEY'}, {'entity': 'in millions', 'category': 'MONEY'}, {'entity': '$1.0 billion', 'category': 'MONEY'}, {'entity': '$735.3 million', 'category': 'MONEY'}, {'entity': '$620.6 million.', 'category': 'MONEY'}, {'entity': 'Coleman Aerospace', 'category': 'ORG'}, {'entity': '2¼%', 'category': 'PERCENT'}]\n",
      "[{'entity': 'December 31', 'category': 'DATE'}, {'entity': '2018', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': 'Note 1', 'category': 'DATE'}, {'entity': 'each obligated good', 'category': 'DATE'}, {'entity': 'each performance obligation', 'category': 'DATE'}, {'entity': '$37.0 million', 'category': 'MONEY'}, {'entity': 'Consolidated Financial Statements', 'category': 'ORG'}, {'entity': 'Aerospace and Defense', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'Off-Balance Sheet Risk', 'category': 'ORG'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': 'Financial Statements', 'category': 'ORG'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': 'GAAP', 'category': 'PERSON'}, {'entity': 'U.S. government', 'category': 'PERSON'}, {'entity': '10 years', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': 'one', 'category': 'CARDINAL'}, {'entity': 'multiple', 'category': 'CARDINAL'}, {'entity': '15', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31', 'category': 'DATE'}, {'entity': '2018', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': 'Aerospace and Defense', 'category': 'FAC'}, {'entity': 'U.S. government', 'category': 'GPE'}, {'entity': 'Aerospace and Defense reporting unit', 'category': 'LOC'}, {'entity': 'unbilled receivables', 'category': 'MONEY'}, {'entity': '12 million', 'category': 'MONEY'}, {'entity': 'CAS', 'category': 'ORG'}, {'entity': 'a likelihood of more than 50%', 'category': 'PERCENT'}, {'entity': 'annually', 'category': 'TIME'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'annual', 'category': 'ORDINAL'}, {'entity': 'future', 'category': 'ORDINAL'}, {'entity': 'In millions', 'category': 'CARDINAL'}, {'entity': 'except per share amountsNet', 'category': 'CARDINAL'}, {'entity': '68.2', 'category': 'CARDINAL'}, {'entity': '33.7', 'category': 'CARDINAL'}, {'entity': '2.7', 'category': 'CARDINAL'}, {'entity': '59.1', 'category': 'CARDINAL'}, {'entity': '37.2', 'category': 'CARDINAL'}, {'entity': '14.1', 'category': 'CARDINAL'}, {'entity': '43.1', 'category': 'CARDINAL'}, {'entity': '22.3', 'category': 'CARDINAL'}, {'entity': '8.5', 'category': 'CARDINAL'}, {'entity': '0.56', 'category': 'CARDINAL'}, {'entity': '0.31', 'category': 'CARDINAL'}, {'entity': '0.13', 'category': 'CARDINAL'}, {'entity': '0.55', 'category': 'CARDINAL'}, {'entity': '0.11', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': 'December 31, 2018', 'category': 'TIME'}, {'entity': '2018', 'category': 'TIME'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': '2018', 'category': 'DATE'}, {'entity': '\"Retirement Benefit Plans\"', 'category': 'EVENT'}, {'entity': 'December', 'category': 'LOC'}, {'entity': '2.25%', 'category': 'MONEY'}, {'entity': '4.52%', 'category': 'MONEY'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': 'Term loan', 'category': 'WORK_OF_ART'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '46', 'category': 'CARDINAL'}, {'entity': '54', 'category': 'CARDINAL'}]\n",
      "/Users/tanmayiballa/Desktop/KG-LLM/l715_23-1/data/10-Ks/Aerojet_Rocketdyne_Holdings_Inc./2021/Management_gpt-3.5-turbo_NER_response.json\n",
      "[{'entity': 'December 20, 2020', 'category': 'DATE'}, {'entity': 'December 31, 2019', 'category': 'DATE'}, {'entity': 'December 19, 2020', 'category': 'DATE'}, {'entity': 'March 24, 2021', 'category': 'DATE'}, {'entity': 'March 10, 2021', 'category': 'DATE'}, {'entity': 'second half of 2021', 'category': 'DATE'}, {'entity': 'Management’s Discussion and Analysis of Financial Condition and Results of Operations', 'category': 'EVENT'}, {'entity': 'Merger Agreement', 'category': 'EVENT'}, {'entity': 'Merger Sub', 'category': 'EVENT'}, {'entity': 'Company', 'category': 'EVENT'}, {'entity': 'Pre-Closing Dividend', 'category': 'EVENT'}, {'entity': 'Merger', 'category': 'EVENT'}, {'entity': 'fiscal year', 'category': 'EVENT'}, {'entity': 'Hart-Scott-Rodino Antitrust Improvements Act of 1976', 'category': 'EVENT'}, {'entity': 'business outlook', 'category': 'EVENT'}, {'entity': 'COVID-19 pandemic', 'category': 'EVENT'}, {'entity': 'vaccine', 'category': 'EVENT'}, {'entity': 'environmental matters', 'category': 'EVENT'}, {'entity': 'underfunded pension plan', 'category': 'EVENT'}, {'entity': 'c', 'category': 'EVENT'}, {'entity': 'Apple', 'category': 'GPE'}, {'entity': 'Cupertino', 'category': 'GPE'}, {'entity': 'California', 'category': 'GPE'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'Paris', 'category': 'GPE'}, {'entity': 'Hilton Hotel', 'category': 'LOC'}, {'entity': 'Eiffel Tower', 'category': 'LOC'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': '$56.00', 'category': 'MONEY'}, {'entity': '$51.00', 'category': 'MONEY'}, {'entity': 'Item 7', 'category': 'ORG'}, {'entity': 'Report', 'category': 'ORG'}, {'entity': 'Lockheed Martin', 'category': 'ORG'}, {'entity': 'Merger Sub', 'category': 'ORG'}, {'entity': 'Merger Agreement', 'category': 'ORG'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'Form 10-K', 'category': 'ORG'}, {'entity': 'Mary', 'category': 'PERSON'}, {'entity': 'December 31, 2022', 'category': 'PERSON'}, {'entity': 'Peter', 'category': 'PERSON'}, {'entity': 'Lisa', 'category': 'PERSON'}, {'entity': '$56.00 per share', 'category': 'QUANTITY'}, {'entity': '$5.00', 'category': 'QUANTITY'}, {'entity': 'years', 'category': 'QUANTITY'}, {'entity': '2¼% Notes', 'category': 'QUANTITY'}, {'entity': 'cash', 'category': 'QUANTITY'}, {'entity': 'Percentage', 'category': 'QUANTITY'}, {'entity': 'per share amounts', 'category': 'QUANTITY'}, {'entity': 'net sales', 'category': 'QUANTITY'}, {'entity': 'Net sales', 'category': 'QUANTITY'}, {'entity': '$\\t2,072.7', 'category': 'QUANTITY'}, {'entity': '$\\t1,981.5', 'category': 'QUANTITY'}, {'entity': 'Net income\\t137.7 \\t141.0', 'category': 'QUANTITY'}, {'entity': '5PM', 'category': 'TIME'}, {'entity': '7PM', 'category': 'TIME'}, {'entity': 'Hamlet', 'category': 'WORK_OF_ART'}, {'entity': 'earliest', 'category': 'ORDINAL'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'second', 'category': 'ORDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '6.6', 'category': 'CARDINAL'}, {'entity': '7.1', 'category': 'CARDINAL'}, {'entity': '138.4', 'category': 'CARDINAL'}, {'entity': '130.1', 'category': 'CARDINAL'}, {'entity': '1.66', 'category': 'CARDINAL'}, {'entity': '1.69', 'category': 'CARDINAL'}, {'entity': '1.67', 'category': 'CARDINAL'}, {'entity': '1.56', 'category': 'CARDINAL'}, {'entity': '270.2', 'category': 'CARDINAL'}, {'entity': '271.7', 'category': 'CARDINAL'}, {'entity': '13.0', 'category': 'CARDINAL'}, {'entity': '13.7', 'category': 'CARDINAL'}, {'entity': '363.8', 'category': 'CARDINAL'}, {'entity': '261.2', 'category': 'CARDINAL'}, {'entity': '309.2', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'December 31, 2019', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': 'COVID-19 pandemic', 'category': 'EVENT'}, {'entity': 'cyber threats', 'category': 'EVENT'}, {'entity': '$624.3 million', 'category': 'MONEY'}, {'entity': '$957.0 million', 'category': 'MONEY'}, {'entity': '$1,381.5 million', 'category': 'MONEY'}, {'entity': '$424.5 million', 'category': 'MONEY'}, {'entity': '$94 million', 'category': 'MONEY'}, {'entity': '$43 million', 'category': 'MONEY'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'NASA', 'category': 'ORG'}, {'entity': 'MDA', 'category': 'ORG'}, {'entity': 'U.S. Army', 'category': 'ORG'}, {'entity': 'U.S. Air Force', 'category': 'ORG'}, {'entity': 'U.S. Navy', 'category': 'ORG'}, {'entity': 'Other U.S. government', 'category': 'ORG'}, {'entity': 'Lockheed Martin', 'category': 'ORG'}, {'entity': 'Raytheon', 'category': 'ORG'}, {'entity': 'ULA', 'category': 'ORG'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': 'Internal Revenue Service', 'category': 'ORG'}, {'entity': '96%', 'category': 'PERCENT'}, {'entity': '25%', 'category': 'PERCENT'}, {'entity': '23%', 'category': 'PERCENT'}, {'entity': '19%', 'category': 'PERCENT'}, {'entity': '12%', 'category': 'PERCENT'}, {'entity': '10%', 'category': 'PERCENT'}, {'entity': '7%', 'category': 'PERCENT'}, {'entity': '34%', 'category': 'PERCENT'}, {'entity': '21%', 'category': 'PERCENT'}, {'entity': '17%', 'category': 'PERCENT'}, {'entity': '82%', 'category': 'PERCENT'}, {'entity': '10%', 'category': 'QUANTITY'}, {'entity': '2', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'no entities found', 'category': 'DATE'}, {'entity': 'no entities found', 'category': 'EVENT'}, {'entity': 'no entities found', 'category': 'FAC'}, {'entity': 'no entities found', 'category': 'GPE'}, {'entity': 'no entities found', 'category': 'LANGUAGE'}, {'entity': 'no entities found', 'category': 'LAW'}, {'entity': 'no entities found', 'category': 'LOC'}, {'entity': 'no entities found', 'category': 'MONEY'}, {'entity': 'no entities found', 'category': 'NORP'}, {'entity': 'Standard Missile program', 'category': 'ORG'}, {'entity': 'Commercial Crew Development program', 'category': 'ORG'}, {'entity': 'AJ-60 solid rocket motor delivery', 'category': 'ORG'}, {'entity': 'RS-68', 'category': 'ORG'}, {'entity': 'MRBM', 'category': 'ORG'}, {'entity': 'THAAD programs', 'category': 'ORG'}, {'entity': 'no entities found', 'category': 'PERCENT'}, {'entity': 'no entities found', 'category': 'PERSON'}, {'entity': 'no entities found', 'category': 'PRODUCT'}, {'entity': 'no entities found', 'category': 'QUANTITY'}, {'entity': 'no entities found', 'category': 'TIME'}, {'entity': 'no entities found', 'category': 'WORK_OF_ART'}, {'entity': 'no entities found', 'category': 'ORDINAL'}]\n",
      "[{'entity': 'December 31', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': 'reserve release', 'category': 'EVENT'}, {'entity': 'final AJ-60 solid rocket motor delivery', 'category': 'EVENT'}, {'entity': 'improved performance', 'category': 'EVENT'}, {'entity': 'risk retirements', 'category': 'EVENT'}, {'entity': 'lower depreciation expense', 'category': 'EVENT'}, {'entity': 'net favorable changes in contract estimates', 'category': 'EVENT'}, {'entity': 'net favorable changes of $38.4 million during 2019', 'category': 'EVENT'}, {'entity': 'net sales', 'category': 'EVENT'}, {'entity': 'rental property operations', 'category': 'EVENT'}, {'entity': 'driven primarily by delays in new tenant starts as a result of the COVID-19 pandemic', 'category': 'EVENT'}, {'entity': 'contract modification for the production of an additional 18 RS-25 engines', 'category': 'EVENT'}, {'entity': 'support future deep space exploration missions', 'category': 'EVENT'}, {'entity': 'funded backlog', 'category': 'EVENT'}, {'entity': 'unfilled orders for which funding is authorized', 'category': 'EVENT'}, {'entity': 'appropriated and contractually obligated by the customer', 'category': 'EVENT'}, {'entity': 'unfunded backlog', 'category': 'EVENT'}, {'entity': 'firm orders for which funding has not been appropriated', 'category': 'EVENT'}, {'entity': 'Indefinite delivery', 'category': 'EVENT'}, {'entity': 'Real Estate Segment', 'category': 'LOC'}, {'entity': '$6.7 billion', 'category': 'MONEY'}, {'entity': '$5.4 billion', 'category': 'MONEY'}, {'entity': '$1.8 billion', 'category': 'MONEY'}, {'entity': '$2.2 billion', 'category': 'MONEY'}, {'entity': 'Commercial Crew Development program', 'category': 'ORG'}, {'entity': '6.6%', 'category': 'PERCENT'}, {'entity': '7.1%', 'category': 'PERCENT'}, {'entity': '13.0%', 'category': 'PERCENT'}, {'entity': '13.7%', 'category': 'PERCENT'}, {'entity': '81.9', 'category': 'PERCENT'}, {'entity': '2020', 'category': 'PERCENT'}, {'entity': '2019', 'category': 'PERCENT'}, {'entity': 'Change', 'category': 'PERCENT'}, {'entity': '81.7', 'category': 'PERCENT'}, {'entity': 'December', 'category': 'PERSON'}, {'entity': 'Net Income', 'category': 'PERSON'}, {'entity': 'EPSWe', 'category': 'PERSON'}, {'entity': 'Free Cash Flow', 'category': 'PERSON'}, {'entity': 'year', 'category': 'PERSON'}, {'entity': '32%', 'category': 'QUANTITY'}, {'entity': '12 months', 'category': 'QUANTITY'}, {'entity': '24%', 'category': 'QUANTITY'}, {'entity': 'year', 'category': 'QUANTITY'}, {'entity': '44%', 'category': 'QUANTITY'}, {'entity': 'the following twelve months', 'category': 'QUANTITY'}, {'entity': 'COVID-19', 'category': 'TIME'}, {'entity': '31', 'category': 'TIME'}, {'entity': '31', 'category': 'TIME'}, {'entity': '2020', 'category': 'TIME'}, {'entity': '2019', 'category': 'TIME'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '$45.1 million', 'category': 'CARDINAL'}, {'entity': '$38.4 million', 'category': 'CARDINAL'}, {'entity': '$3.3', 'category': 'CARDINAL'}, {'entity': '$7.5', 'category': 'CARDINAL'}, {'entity': '$4.2', 'category': 'CARDINAL'}, {'entity': 'page', 'category': 'CARDINAL'}, {'entity': ',8,$,1,$,$,7,.,5,.,Segment performance\\t1.8\\t\\t\\t2', 'category': 'CARDINAL'}, {'entity': '1 \\t\\t\\t3.9\\tPrimary reason for change', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': 'Baldwin Park Operable Unit \"BPOU\"', 'category': 'LOC'}, {'entity': '$6.0 million', 'category': 'MONEY'}, {'entity': '$5.3 million', 'category': 'MONEY'}, {'entity': '$322.0', 'category': 'MONEY'}, {'entity': '$344.1', 'category': 'MONEY'}, {'entity': '$308.3', 'category': 'MONEY'}, {'entity': '$322.0', 'category': 'MONEY'}, {'entity': '$4.3 million', 'category': 'MONEY'}, {'entity': '$2.1 million', 'category': 'MONEY'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': '12%', 'category': 'PERCENT'}, {'entity': '$32.4 million', 'category': 'CARDINAL'}, {'entity': '$6.0 million', 'category': 'CARDINAL'}, {'entity': '$5.3 million', 'category': 'CARDINAL'}, {'entity': '$28.3 million', 'category': 'CARDINAL'}, {'entity': '$14.5 million', 'category': 'CARDINAL'}, {'entity': '$36.0', 'category': 'CARDINAL'}, {'entity': '$30.6', 'category': 'CARDINAL'}, {'entity': '$6.0', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': 'December 19, 2020.', 'category': 'DATE'}, {'entity': 'COVID-19 pandemic.', 'category': 'EVENT'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'December 31', 'category': 'LOC'}, {'entity': '2020.', 'category': 'LOC'}, {'entity': '$363.8', 'category': 'MONEY'}, {'entity': '$261.2', 'category': 'MONEY'}, {'entity': '$216.9', 'category': 'MONEY'}, {'entity': 'millions', 'category': 'MONEY'}, {'entity': '54.6', 'category': 'MONEY'}, {'entity': '42.9', 'category': 'MONEY'}, {'entity': '$6.7', 'category': 'MONEY'}, {'entity': '21.7', 'category': 'MONEY'}, {'entity': '$51.7', 'category': 'MONEY'}, {'entity': '12.5', 'category': 'MONEY'}, {'entity': '$1,149.5', 'category': 'MONEY'}, {'entity': '$622.4', 'category': 'MONEY'}, {'entity': '$21.4', 'category': 'MONEY'}, {'entity': '$100 million', 'category': 'MONEY'}, {'entity': '$100 million', 'category': 'MONEY'}, {'entity': '$48.3 million.', 'category': 'MONEY'}, {'entity': 'Cash', 'category': 'ORG'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': 'RS-25', 'category': 'ORG'}, {'entity': 'Term loan', 'category': 'ORG'}, {'entity': '2 1/4% Notes', 'category': 'ORG'}, {'entity': 'finance leases', 'category': 'ORG'}, {'entity': 'Total Debt Activity.', 'category': 'ORG'}, {'entity': '%15%.', 'category': 'PERCENT'}, {'entity': 'December 31', 'category': 'PERSON'}, {'entity': 'December 31', 'category': 'PERSON'}, {'entity': '48.3 million.', 'category': 'PERSON'}, {'entity': 'Merger Agreement', 'category': 'PRODUCT'}, {'entity': 'COVID-19 pandemic', 'category': 'PRODUCT'}, {'entity': 'CARES Act.', 'category': 'PRODUCT'}, {'entity': 'millions', 'category': 'QUANTITY'}, {'entity': '1.3 million.', 'category': 'QUANTITY'}, {'entity': 'December 31, 2020', 'category': 'TIME'}, {'entity': '18 months', 'category': 'TIME'}, {'entity': '2020', 'category': 'TIME'}, {'entity': 'Notes 8a', 'category': 'TIME'}, {'entity': '8b.', 'category': 'TIME'}, {'entity': 'Notes.', 'category': 'WORK_OF_ART'}, {'entity': 'next twelve months', 'category': 'ORDINAL'}, {'entity': 'first.', 'category': 'ORDINAL'}, {'entity': 'millions', 'category': 'CARDINAL'}, {'entity': '2020', 'category': 'CARDINAL'}, {'entity': '2019', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '1.3.', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'Item 8', 'category': 'DATE'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': 'an accounting estimate', 'category': 'ORG'}, {'entity': 'our management', 'category': 'ORG'}, {'entity': 'our positions', 'category': 'ORG'}, {'entity': 'the reported amounts', 'category': 'ORG'}, {'entity': 'the development of accounting estimates', 'category': 'ORG'}, {'entity': 'the positions we have taken', 'category': 'ORG'}, {'entity': 'others', 'category': 'ORG'}, {'entity': 'time', 'category': 'ORG'}, {'entity': 'the financial results', 'category': 'ORG'}, {'entity': 'our business segments', 'category': 'ORG'}, {'entity': 'income taxes', 'category': 'ORG'}, {'entity': 'our operating segments', 'category': 'ORG'}, {'entity': 'the financial statements', 'category': 'ORG'}, {'entity': 'each obligated good', 'category': 'PERSON'}]\n",
      "[{'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': '$38.5', 'category': 'MONEY'}, {'entity': '$38.6', 'category': 'MONEY'}, {'entity': '45.1', 'category': 'MONEY'}, {'entity': '38.4', 'category': 'MONEY'}, {'entity': '34.5', 'category': 'MONEY'}, {'entity': '28.2', 'category': 'MONEY'}, {'entity': 'Aerospace and Defense', 'category': 'ORG'}, {'entity': 'FAR', 'category': 'ORG'}, {'entity': 'CAS', 'category': 'ORG'}, {'entity': 'U.S.', 'category': 'ORG'}, {'entity': 'DCAA', 'category': 'ORG'}, {'entity': '0.44', 'category': 'CARDINAL'}, {'entity': '0.36', 'category': 'CARDINAL'}, {'entity': '0.42', 'category': 'CARDINAL'}, {'entity': '0.34', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'December 31, 2019', 'category': 'DATE'}, {'entity': '$0.1', 'category': 'MONEY'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': '2.52%', 'category': 'PERCENT'}, {'entity': '3.28%', 'category': 'PERCENT'}, {'entity': '2.28%', 'category': 'PERCENT'}, {'entity': '3.19%', 'category': 'PERCENT'}, {'entity': '3.28%', 'category': 'PERCENT'}, {'entity': '4.27%', 'category': 'PERCENT'}, {'entity': '3.19%', 'category': 'PERCENT'}, {'entity': '4.09%', 'category': 'PERCENT'}, {'entity': '7.00%', 'category': 'PERCENT'}, {'entity': '7.00%', 'category': 'PERCENT'}, {'entity': 'U.S.', 'category': 'PERSON'}, {'entity': 'fifth', 'category': 'ORDINAL'}, {'entity': '2', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'December 31, 2019', 'category': 'DATE'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': '49%', 'category': 'PERCENT'}, {'entity': '51%', 'category': 'PERCENT'}, {'entity': '2¼% Notes', 'category': 'PRODUCT'}, {'entity': '2', 'category': 'QUANTITY'}, {'entity': 'December 31, 2020', 'category': 'TIME'}, {'entity': 'December 31, 2019', 'category': 'TIME'}, {'entity': '3', 'category': 'CARDINAL'}]\n",
      "/Users/tanmayiballa/Desktop/KG-LLM/l715_23-1/data/10-Ks/Aerojet_Rocketdyne_Holdings_Inc./2020/Management_gpt-3.5-turbo_NER_response.json\n",
      "[{'entity': 'February 19, 2019', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': 'December 31, 2019', 'category': 'DATE'}, {'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': 'Major Customers', 'category': 'EVENT'}, {'entity': 'Competitive Improvement Program', 'category': 'EVENT'}, {'entity': 'Sacramento', 'category': 'FAC'}, {'entity': 'California', 'category': 'FAC'}, {'entity': 'Gainesville', 'category': 'FAC'}, {'entity': 'Virginia', 'category': 'FAC'}, {'entity': 'Huntsville', 'category': 'FAC'}, {'entity': 'Alabama', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Item 8', 'category': 'LOC'}, {'entity': 'December 31', 'category': 'LOC'}, {'entity': 'U.S. aerospace', 'category': 'LOC'}, {'entity': 'U.S. government', 'category': 'LOC'}, {'entity': 'NASA', 'category': 'LOC'}, {'entity': 'U.S. Air Force', 'category': 'LOC'}, {'entity': 'U.S. Army', 'category': 'LOC'}, {'entity': 'MDA', 'category': 'LOC'}, {'entity': 'U.S. Navy', 'category': 'LOC'}, {'entity': 'California', 'category': 'LOC'}, {'entity': 'Virginia', 'category': 'LOC'}, {'entity': 'Huntsville', 'category': 'LOC'}, {'entity': 'Alabama', 'category': 'LOC'}, {'entity': '$1,981.5 million', 'category': 'MONEY'}, {'entity': '$1,895.9 million', 'category': 'MONEY'}, {'entity': '$141.0 million', 'category': 'MONEY'}, {'entity': '$137.3 million', 'category': 'MONEY'}, {'entity': '$130.1 million', 'category': 'MONEY'}, {'entity': '$151.5 million', 'category': 'MONEY'}, {'entity': '$271.7 million', 'category': 'MONEY'}, {'entity': '$304.9 million', 'category': 'MONEY'}, {'entity': '$261.2 million', 'category': 'MONEY'}, {'entity': '$252.7 million', 'category': 'MONEY'}, {'entity': '$218.3 million', 'category': 'MONEY'}, {'entity': '$209.5 million', 'category': 'MONEY'}, {'entity': '$5.4 billion', 'category': 'MONEY'}, {'entity': '$4.1 billion', 'category': 'MONEY'}, {'entity': '$637.0 million', 'category': 'MONEY'}, {'entity': 'Form 10-K', 'category': 'ORG'}, {'entity': '96', 'category': 'PERCENT'}, {'entity': '94', 'category': 'PERCENT'}, {'entity': '18', 'category': 'PERCENT'}, {'entity': '33', 'category': 'PERCENT'}, {'entity': '30', 'category': 'PERCENT'}, {'entity': '17', 'category': 'PERCENT'}, {'entity': '19', 'category': 'PERCENT'}, {'entity': '10', 'category': 'PERCENT'}, {'entity': '17', 'category': 'PERCENT'}, {'entity': 'Overview', 'category': 'PERSON'}, {'entity': 'Year Ended December 31', 'category': 'PERSON'}, {'entity': 'RS-25 program', 'category': 'PERSON'}, {'entity': 'Standard Missile program', 'category': 'PERSON'}, {'entity': 'THAAD program', 'category': 'PERSON'}, {'entity': 'PAC-3 program', 'category': 'PERSON'}, {'entity': 'Lockheed Martin', 'category': 'PERSON'}, {'entity': 'Raytheon', 'category': 'PERSON'}, {'entity': 'ULA', 'category': 'PERSON'}, {'entity': 'net sales', 'category': 'PRODUCT'}, {'entity': 'product lines and programs', 'category': 'PRODUCT'}, {'entity': '3', 'category': 'QUANTITY'}, {'entity': '2019', 'category': 'TIME'}, {'entity': '2018', 'category': 'TIME'}, {'entity': 'year ended December 31', 'category': 'TIME'}, {'entity': 'April 6, 2017', 'category': 'TIME'}, {'entity': 'prior to the CIP', 'category': 'TIME'}, {'entity': 'December 31, 2019', 'category': 'TIME'}, {'entity': 'Item 8', 'category': 'WORK_OF_ART'}, {'entity': 'CIP', 'category': 'WORK_OF_ART'}, {'entity': 'Environmental Matters', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '96', 'category': 'CARDINAL'}, {'entity': '94', 'category': 'CARDINAL'}, {'entity': '18', 'category': 'CARDINAL'}, {'entity': '27', 'category': 'CARDINAL'}, {'entity': '14', 'category': 'CARDINAL'}, {'entity': '19', 'category': 'CARDINAL'}, {'entity': '23', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '7', 'category': 'CARDINAL'}, {'entity': '96', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '17', 'category': 'CARDINAL'}, {'entity': '17', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '30', 'category': 'CARDINAL'}, {'entity': '13', 'category': 'CARDINAL'}, {'entity': '11', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '33', 'category': 'CARDINAL'}, {'entity': '19', 'category': 'CARDINAL'}, {'entity': '10', 'category': 'CARDINAL'}, {'entity': '17', 'category': 'CARDINAL'}, {'entity': '2015', 'category': 'CARDINAL'}, {'entity': 'I', 'category': 'CARDINAL'}, {'entity': 'II', 'category': 'CARDINAL'}, {'entity': '$230.0 million', 'category': 'CARDINAL'}, {'entity': '$197.0 million', 'category': 'CARDINAL'}, {'entity': '$60.5 million', 'category': 'CARDINAL'}, {'entity': '$38.0 million', 'category': 'CARDINAL'}, {'entity': '$235.0 million', 'category': 'CARDINAL'}, {'entity': '$197.0 million', 'category': 'CARDINAL'}, {'entity': '$170.4 million', 'category': 'CARDINAL'}, {'entity': '$53.5 million', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31, 2019', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'Huntsville', 'category': 'LOC'}, {'entity': 'Alabama', 'category': 'LOC'}, {'entity': '$932.5 million', 'category': 'MONEY'}, {'entity': '$1,349.8 million', 'category': 'MONEY'}, {'entity': '$417.3 million', 'category': 'MONEY'}, {'entity': '$46.0 million', 'category': 'MONEY'}, {'entity': '$13.9 million', 'category': 'MONEY'}, {'entity': '$32.1 million', 'category': 'MONEY'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': '83%', 'category': 'PERCENT'}, {'entity': '81.4%', 'category': 'PERCENT'}, {'entity': '81.7%', 'category': 'PERCENT'}, {'entity': '2.7%', 'category': 'PERCENT'}, {'entity': '2.3%', 'category': 'PERCENT'}, {'entity': '26.5%', 'category': 'PERCENT'}, {'entity': '27.2%', 'category': 'PERCENT'}, {'entity': 'PAC-3', 'category': 'PERSON'}, {'entity': 'GMLRS', 'category': 'PERSON'}, {'entity': 'RS-68', 'category': 'PERSON'}, {'entity': 'AJ-60', 'category': 'PERSON'}, {'entity': 'RS-25', 'category': 'PERSON'}, {'entity': 'Commercial Crew Development', 'category': 'PRODUCT'}, {'entity': 'PAC-3', 'category': 'PRODUCT'}, {'entity': 'GMLRS', 'category': 'PRODUCT'}, {'entity': 'hypersonic booster', 'category': 'PRODUCT'}, {'entity': 'RS-68', 'category': 'PRODUCT'}, {'entity': 'AJ-60', 'category': 'PRODUCT'}, {'entity': 'RS-25', 'category': 'PRODUCT'}, {'entity': 'Environmental Matters', 'category': 'WORK_OF_ART'}, {'entity': 'Global Settlement', 'category': 'WORK_OF_ART'}, {'entity': '4', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31, 2019', 'category': 'DATE'}, {'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': 'Global Settlement', 'category': 'EVENT'}, {'entity': 'contract estimates', 'category': 'EVENT'}, {'entity': 'Sacramento Land', 'category': 'LOC'}, {'entity': '$49.1 million', 'category': 'MONEY'}, {'entity': '$43.0 million', 'category': 'MONEY'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '2019', 'category': 'CARDINAL'}, {'entity': '49.1', 'category': 'CARDINAL'}, {'entity': '43.0', 'category': 'CARDINAL'}, {'entity': '37', 'category': 'CARDINAL'}, {'entity': '38.4', 'category': 'CARDINAL'}, {'entity': '59.1', 'category': 'CARDINAL'}, {'entity': '57.6', 'category': 'CARDINAL'}, {'entity': '26.1', 'category': 'CARDINAL'}, {'entity': '48', 'category': 'CARDINAL'}, {'entity': '37', 'category': 'CARDINAL'}, {'entity': '2.1', 'category': 'CARDINAL'}, {'entity': '1.9', 'category': 'CARDINAL'}, {'entity': '5.4', 'category': 'CARDINAL'}, {'entity': '2.0', 'category': 'CARDINAL'}, {'entity': '1.4', 'category': 'CARDINAL'}, {'entity': '7.5', 'category': 'CARDINAL'}, {'entity': '7.8', 'category': 'CARDINAL'}, {'entity': '5.4', 'category': 'CARDINAL'}, {'entity': '4.1', 'category': 'CARDINAL'}, {'entity': '2.1', 'category': 'CARDINAL'}, {'entity': '1.9', 'category': 'CARDINAL'}, {'entity': '3.3', 'category': 'CARDINAL'}, {'entity': '2.2', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'Year Ended December 31', 'category': 'DATE'}, {'entity': 'December 31, 2019', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': '2018', 'category': 'DATE'}, {'entity': 'May 2027', 'category': 'DATE'}, {'entity': 'product launch', 'category': 'EVENT'}, {'entity': 'Hilton Hotel', 'category': 'FAC'}, {'entity': 'Apple', 'category': 'GPE'}, {'entity': 'Paris', 'category': 'GPE'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'Cupertino', 'category': 'LOC'}, {'entity': 'California', 'category': 'LOC'}, {'entity': '$141.0', 'category': 'MONEY'}, {'entity': '$137.3', 'category': 'MONEY'}, {'entity': '$35.7', 'category': 'MONEY'}, {'entity': '$34.4', 'category': 'MONEY'}, {'entity': '$15.5', 'category': 'MONEY'}, {'entity': '$10.0', 'category': 'MONEY'}, {'entity': '$50.9', 'category': 'MONEY'}, {'entity': '$51.3', 'category': 'MONEY'}, {'entity': '$74.5', 'category': 'MONEY'}, {'entity': '$72.3', 'category': 'MONEY'}, {'entity': '$26.1', 'category': 'MONEY'}, {'entity': '$57.6', 'category': 'MONEY'}, {'entity': '-$41.3', 'category': 'MONEY'}, {'entity': '-$38.2', 'category': 'MONEY'}, {'entity': '$0.3', 'category': 'MONEY'}, {'entity': '$0.2', 'category': 'MONEY'}, {'entity': '-$42.9', 'category': 'MONEY'}, {'entity': '-$43.2', 'category': 'MONEY'}, {'entity': '$261.2', 'category': 'MONEY'}, {'entity': '$252.7', 'category': 'MONEY'}, {'entity': '$218.3', 'category': 'MONEY'}, {'entity': '$209.5', 'category': 'MONEY'}, {'entity': '$5.3', 'category': 'MONEY'}, {'entity': '$5.9', 'category': 'MONEY'}, {'entity': '$52.5', 'category': 'MONEY'}, {'entity': '$203.6', 'category': 'MONEY'}, {'entity': '$325.8', 'category': 'MONEY'}, {'entity': '$78.8', 'category': 'MONEY'}, {'entity': '$89.6', 'category': 'MONEY'}, {'entity': '$106.1', 'category': 'MONEY'}, {'entity': '$10.8', 'category': 'MONEY'}, {'entity': '$11.8', 'category': 'MONEY'}, {'entity': '$22.3', 'category': 'MONEY'}, {'entity': '$0.7', 'category': 'MONEY'}, {'entity': '$4.2', 'category': 'MONEY'}, {'entity': '$5.6', 'category': 'MONEY'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': 'Non-GAAP', 'category': 'ORG'}, {'entity': '7.1%', 'category': 'PERCENT'}, {'entity': '7.2%', 'category': 'PERCENT'}, {'entity': '13.7%', 'category': 'PERCENT'}, {'entity': '16.1%', 'category': 'PERCENT'}, {'entity': 'Mary', 'category': 'PERSON'}, {'entity': 'Hamlet', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '81.7', 'category': 'CARDINAL'}, {'entity': '76.8', 'category': 'CARDINAL'}, {'entity': '-$1.13', 'category': 'CARDINAL'}, {'entity': '$1.93', 'category': 'CARDINAL'}]\n",
      "[{'entity': '2018', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': 'environmental reserve additions', 'category': 'EVENT'}, {'entity': 'adjustments to the environmental reserves', 'category': 'EVENT'}, {'entity': 'treatment facilities', 'category': 'FAC'}, {'entity': 'Eiffel Tower', 'category': 'FAC'}, {'entity': 'Hilton Hotel', 'category': 'FAC'}, {'entity': 'U.S. government', 'category': 'GPE'}, {'entity': 'Global Settlement', 'category': 'LOC'}, {'entity': 'consolidated financial statements', 'category': 'LOC'}, {'entity': '$10.0 million', 'category': 'MONEY'}, {'entity': '$1.9 million', 'category': 'MONEY'}, {'entity': '$0.7 million', 'category': 'MONEY'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': '15%', 'category': 'MONEY'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': '12%', 'category': 'PERCENT'}, {'entity': 'December 31', 'category': 'TIME'}, {'entity': 'Global Settlement', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '$10.0 million', 'category': 'CARDINAL'}, {'entity': '12%', 'category': 'CARDINAL'}, {'entity': '$23.3 million', 'category': 'CARDINAL'}, {'entity': '8.8 million', 'category': 'CARDINAL'}, {'entity': '4.6 million', 'category': 'CARDINAL'}, {'entity': '3.8 million', 'category': 'CARDINAL'}, {'entity': '2.2 million', 'category': 'CARDINAL'}, {'entity': '3.9 million', 'category': 'CARDINAL'}, {'entity': '15', 'category': 'CARDINAL'}, {'entity': '14.5', 'category': 'CARDINAL'}, {'entity': '18.2', 'category': 'CARDINAL'}, {'entity': '30.6', 'category': 'CARDINAL'}, {'entity': '28.1', 'category': 'CARDINAL'}, {'entity': '6.0', 'category': 'CARDINAL'}, {'entity': '32.8', 'category': 'CARDINAL'}, {'entity': '344.1', 'category': 'CARDINAL'}, {'entity': '321.2', 'category': 'CARDINAL'}, {'entity': '30.4', 'category': 'CARDINAL'}, {'entity': '322.0', 'category': 'CARDINAL'}, {'entity': '344.1', 'category': 'CARDINAL'}, {'entity': '2.1', 'category': 'CARDINAL'}, {'entity': '36.9', 'category': 'CARDINAL'}, {'entity': '261.2', 'category': 'CARDINAL'}, {'entity': '252.7', 'category': 'CARDINAL'}, {'entity': '41.8', 'category': 'CARDINAL'}, {'entity': '20.9', 'category': 'CARDINAL'}, {'entity': '24.1', 'category': 'CARDINAL'}, {'entity': '26.5', 'category': 'CARDINAL'}, {'entity': '195.3', 'category': 'CARDINAL'}, {'entity': '205.3', 'category': 'CARDINAL'}, {'entity': '8.5 million', 'category': 'CARDINAL'}, {'entity': '43.0 million', 'category': 'CARDINAL'}, {'entity': '42.9 million', 'category': 'CARDINAL'}, {'entity': '43.2 million', 'category': 'CARDINAL'}, {'entity': '20.4 million', 'category': 'CARDINAL'}, {'entity': '20.8 million', 'category': 'CARDINAL'}, {'entity': '25.3 million', 'category': 'CARDINAL'}, {'entity': '3.3 million', 'category': 'CARDINAL'}, {'entity': '2.1 million', 'category': 'CARDINAL'}, {'entity': '345.6', 'category': 'CARDINAL'}, {'entity': '17.5', 'category': 'CARDINAL'}, {'entity': '328.1', 'category': 'CARDINAL'}, {'entity': '300.0', 'category': 'CARDINAL'}, {'entity': '27.2', 'category': 'CARDINAL'}, {'entity': '3.3', 'category': 'CARDINAL'}, {'entity': '23.8', 'category': 'CARDINAL'}, {'entity': '47.7', 'category': 'CARDINAL'}, {'entity': '672.8', 'category': 'CARDINAL'}, {'entity': '675.8', 'category': 'CARDINAL'}, {'entity': '932.6 million', 'category': 'CARDINAL'}, {'entity': '620.3 million', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31, 2019', 'category': 'DATE'}, {'entity': 'January 1, 2020', 'category': 'DATE'}, {'entity': 'March 31, 2020', 'category': 'DATE'}, {'entity': '20 days', 'category': 'DATE'}, {'entity': '30 day', 'category': 'DATE'}, {'entity': 'December 31, 2019', 'category': 'DATE'}, {'entity': '10 years', 'category': 'DATE'}, {'entity': '2020', 'category': 'DATE'}, {'entity': 'LANGUAGE', 'category': 'DATE'}, {'entity': 'LAW', 'category': 'DATE'}, {'entity': 'NORP', 'category': 'DATE'}, {'entity': 'WORK_OF_ART', 'category': 'DATE'}, {'entity': 'FAC', 'category': 'DATE'}, {'entity': 'PRODUCT', 'category': 'DATE'}, {'entity': 'and TIME. Therefore', 'category': 'DATE'}, {'entity': 'these categories are not mentioned in the final output.', 'category': 'DATE'}, {'entity': 'acquisitions', 'category': 'EVENT'}, {'entity': 'acquisitions', 'category': 'EVENT'}, {'entity': 'acquisitions', 'category': 'EVENT'}, {'entity': 'acquisitions', 'category': 'EVENT'}, {'entity': 'acquisitions', 'category': 'EVENT'}, {'entity': 'conversion', 'category': 'EVENT'}, {'entity': 'conversion', 'category': 'EVENT'}, {'entity': 'cash', 'category': 'EVENT'}, {'entity': 'cash', 'category': 'EVENT'}, {'entity': 'cash', 'category': 'EVENT'}, {'entity': 'cash', 'category': 'EVENT'}, {'entity': 'cash', 'category': 'EVENT'}, {'entity': 'Debt', 'category': 'EVENT'}, {'entity': 'debt', 'category': 'EVENT'}, {'entity': 'cash', 'category': 'EVENT'}, {'entity': 'cash', 'category': 'EVENT'}, {'entity': 'cash', 'category': 'EVENT'}, {'entity': 'debt', 'category': 'EVENT'}, {'entity': 'debt', 'category': 'EVENT'}, {'entity': 'debt', 'category': 'EVENT'}, {'entity': 'debt', 'category': 'EVENT'}, {'entity': 'debt', 'category': 'EVENT'}, {'entity': 'debt', 'category': 'EVENT'}, {'entity': 'debt', 'category': 'EVENT'}, {'entity': 'debt', 'category': 'EVENT'}, {'entity': 'debt', 'category': 'EVENT'}, {'entity': 'debt', 'category': 'EVENT'}, {'entity': 'debt', 'category': 'EVENT'}, {'entity': 'debt', 'category': 'EVENT'}, {'entity': 'debt', 'category': 'EVENT'}, {'entity': 'debt', 'category': 'EVENT'}, {'entity': 'debt', 'category': 'EVENT'}, {'entity': 'debt', 'category': 'EVENT'}, {'entity': 'debt', 'category': 'EVENT'}, {'entity': 'debt', 'category': 'EVENT'}, {'entity': 'debt', 'category': 'EVENT'}, {'entity': 'debt', 'category': 'EVENT'}, {'entity': 'debt', 'category': 'EVENT'}, {'entity': 'debt', 'category': 'EVENT'}, {'entity': 'debt', 'category': 'EVENT'}, {'entity': 'debt', 'category': 'EVENT'}, {'entity': 'debt', 'category': 'EVENT'}, {'entity': 'debt', 'category': 'EVENT'}, {'entity': 'debt', 'category': 'EVENT'}, {'entity': 'debt', 'category': 'EVENT'}, {'entity': 'debt', 'category': 'EVENT'}, {'entity': 'debt', 'category': 'EVENT'}, {'entity': 'debt', 'category': 'EVENT'}, {'entity': 'debt', 'category': 'EVENT'}, {'entity': 'debt', 'category': 'EVENT'}, {'entity': 'debt', 'category': 'EVENT'}, {'entity': 'debt', 'category': 'EVENT'}, {'entity': 'debt', 'category': 'EVENT'}, {'entity': 'debt', 'category': 'EVENT'}, {'entity': 'debt', 'category': 'EVENT'}, {'entity': 'debt', 'category': 'EVENT'}, {'entity': 'debt', 'category': 'EVENT'}, {'entity': 'debt', 'category': 'EVENT'}, {'entity': 'debt', 'category': 'EVENT'}, {'entity': 'debt', 'category': 'EVENT'}, {'entity': 'debt', 'category': 'EVENT'}, {'entity': 'debt', 'category': 'EVENT'}, {'entity': '—', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '—', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': '—', 'category': 'MONEY'}, {'entity': '—', 'category': 'MONEY'}, {'entity': '—', 'category': 'MONEY'}, {'entity': '—', 'category': 'MONEY'}, {'entity': '13.9 million', 'category': 'MONEY'}, {'entity': 'Items', 'category': 'ORG'}, {'entity': 'Item', 'category': 'ORG'}, {'entity': 'December 31, 2019', 'category': 'ORG'}, {'entity': '2020', 'category': 'ORG'}, {'entity': 'Item 8', 'category': 'ORG'}, {'entity': 'Item 1A', 'category': 'ORG'}, {'entity': 'CAS.Arrangements', 'category': 'ORG'}, {'entity': 'Note 9d', 'category': 'ORG'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': '20', 'category': 'PERCENT'}, {'entity': '10', 'category': 'PERCENT'}, {'entity': 'available', 'category': 'PERSON'}, {'entity': '1', 'category': 'QUANTITY'}, {'entity': '2020', 'category': 'TIME'}, {'entity': 'financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'in the consolidated financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'in the consolidated financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'in the consolidated financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'in the consolidated financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'financial statements', 'category': 'WORK_OF_ART'}, {'entity': 'financial statements after', 'category': 'WORK_OF_ART'}, {'entity': 'funding', 'category': 'WORK_OF_ART'}, {'entity': 'funding', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'next', 'category': 'ORDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '2¼', 'category': 'CARDINAL'}, {'entity': '2¼', 'category': 'CARDINAL'}, {'entity': '2¼', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'consolidated financial statements', 'category': 'ORG'}, {'entity': 'Aerospace and Defense', 'category': 'ORG'}, {'entity': 'Item 8 of this Report', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'major aerospace and defense prime contractors', 'category': 'ORG'}, {'entity': 'commercial sector', 'category': 'ORG'}, {'entity': 'FAR and CAS', 'category': 'ORG'}]\n",
      "[{'entity': '2009', 'category': 'DATE'}, {'entity': 'December 31, 2019', 'category': 'DATE'}, {'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': 'December 31, 2019', 'category': 'DATE'}, {'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': 'remediation', 'category': 'EVENT'}, {'entity': 'best estimates', 'category': 'FAC'}, {'entity': 'U.S. government contracts', 'category': 'GPE'}, {'entity': 'pension costs', 'category': 'LANGUAGE'}, {'entity': 'pension funding rules', 'category': 'LAW'}, {'entity': 'Item 8', 'category': 'LOC'}, {'entity': 'in millions', 'category': 'MONEY'}, {'entity': '$17.2', 'category': 'MONEY'}, {'entity': '141.4', 'category': 'MONEY'}, {'entity': '9.3', 'category': 'MONEY'}, {'entity': '0.1', 'category': 'MONEY'}, {'entity': '0.3', 'category': 'MONEY'}, {'entity': '$14.8', 'category': 'MONEY'}, {'entity': '119.0', 'category': 'MONEY'}, {'entity': '9.3', 'category': 'MONEY'}, {'entity': '0.1', 'category': 'MONEY'}, {'entity': '0.3', 'category': 'MONEY'}, {'entity': 'high-quality fixed income instruments', 'category': 'NORP'}, {'entity': 'DCAA', 'category': 'ORG'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': 'Hilton Hotel', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'one-percentage-point', 'category': 'PERCENT'}, {'entity': 'one-percentage-point', 'category': 'PERCENT'}, {'entity': 'one-percentage-point', 'category': 'PERCENT'}, {'entity': 'market gains and losses', 'category': 'PERCENT'}, {'entity': 'pension accounting', 'category': 'PERSON'}, {'entity': 'benefit payments', 'category': 'PRODUCT'}, {'entity': 'one-fifth', 'category': 'QUANTITY'}, {'entity': 'in years', 'category': 'TIME'}, {'entity': 'pension funding', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': 'fifth', 'category': 'ORDINAL'}, {'entity': '2009', 'category': 'CARDINAL'}, {'entity': '401k', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2009', 'category': 'CARDINAL'}, {'entity': 'one-fifth', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31', 'category': 'DATE'}, {'entity': '2019', 'category': 'DATE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': '2.25%', 'category': 'MONEY'}, {'entity': '3.55%', 'category': 'MONEY'}, {'entity': '$628.1 million', 'category': 'MONEY'}, {'entity': '$300.0 million', 'category': 'MONEY'}, {'entity': '$328.1 million', 'category': 'MONEY'}, {'entity': '$345.6', 'category': 'MONEY'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': 'Company', 'category': 'ORG'}, {'entity': 'U.S.', 'category': 'ORG'}, {'entity': '48%', 'category': 'PERCENT'}, {'entity': '52%', 'category': 'PERCENT'}, {'entity': 'December 31', 'category': 'PERSON'}, {'entity': '2', 'category': 'QUANTITY'}, {'entity': 'December 31', 'category': 'TIME'}, {'entity': '\"Retirement Benefit Plans\"', 'category': 'WORK_OF_ART'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '48', 'category': 'CARDINAL'}, {'entity': '52', 'category': 'CARDINAL'}]\n",
      "[]\n",
      "/Users/tanmayiballa/Desktop/KG-LLM/l715_23-1/data/10-Ks/Aerojet_Rocketdyne_Holdings_Inc./2018/Management_gpt-3.5-turbo_NER_response.json\n",
      "[{'entity': '1,877.2 million', 'category': 'MONEY'}, {'entity': '1,761.3 million', 'category': 'MONEY'}, {'entity': '$9.2 million', 'category': 'MONEY'}, {'entity': '$18.0 million', 'category': 'MONEY'}, {'entity': '$64.6 million', 'category': 'MONEY'}, {'entity': 'between 27% and 29%', 'category': 'MONEY'}, {'entity': '$225.4 million', 'category': 'MONEY'}, {'entity': '$201.9 million', 'category': 'MONEY'}, {'entity': '$205.4 million', 'category': 'MONEY'}, {'entity': 'cash provided', 'category': 'MONEY'}, {'entity': '212.8 million', 'category': 'MONEY'}, {'entity': '$158.7 million', 'category': 'MONEY'}, {'entity': '$183.4 million', 'category': 'MONEY'}, {'entity': '$111.1 million', 'category': 'MONEY'}, {'entity': '$4.6 billion', 'category': 'MONEY'}, {'entity': '$4.5 billion', 'category': 'MONEY'}, {'entity': '$2.1 billion', 'category': 'MONEY'}, {'entity': '$2.3 billion', 'category': 'MONEY'}, {'entity': 'Item 7', 'category': 'ORG'}, {'entity': 'Report', 'category': 'ORG'}, {'entity': 'Consolidated Financial Statements and Supplementary Data', 'category': 'ORG'}, {'entity': 'Report', 'category': 'ORG'}, {'entity': 'Risk Factors', 'category': 'ORG'}, {'entity': 'Report', 'category': 'ORG'}, {'entity': 'Item 1A', 'category': 'ORG'}, {'entity': 'Report', 'category': 'ORG'}, {'entity': 'Item 1', 'category': 'ORG'}, {'entity': 'Discussion and Analysis', 'category': 'ORG'}, {'entity': 'Report', 'category': 'ORG'}, {'entity': 'Item 8', 'category': 'ORG'}, {'entity': 'Consolidated Financial Statements and Supplementary Data', 'category': 'ORG'}, {'entity': 'Report', 'category': 'ORG'}, {'entity': 'Historical results', 'category': 'ORG'}, {'entity': 'Report', 'category': 'ORG'}, {'entity': 'Item 6', 'category': 'ORG'}, {'entity': 'Selected Financial Data', 'category': 'ORG'}, {'entity': 'Item 8', 'category': 'ORG'}, {'entity': 'Consolidated Financial Statements and Supplementary Data', 'category': 'ORG'}, {'entity': 'Report', 'category': 'ORG'}, {'entity': 'Overview', 'category': 'ORG'}, {'entity': 'fiscal 2017', 'category': 'ORG'}, {'entity': 'management', 'category': 'ORG'}, {'entity': 'operating performance', 'category': 'ORG'}, {'entity': 'financial condition', 'category': 'ORG'}, {'entity': 'Net sales', 'category': 'ORG'}, {'entity': 'fiscal 2017', 'category': 'ORG'}, {'entity': 'fiscal 2016', 'category': 'ORG'}, {'entity': 'Net loss', 'category': 'ORG'}, {'entity': 'fiscal 2017', 'category': 'ORG'}, {'entity': 'net income', 'category': 'ORG'}, {'entity': 'fiscal 2016', 'category': 'ORG'}, {'entity': 'December 22, 2017', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'comprehensive tax legislation', 'category': 'ORG'}, {'entity': 'Tax Cuts and Jobs Act', 'category': 'ORG'}, {'entity': 'Tax Act', 'category': 'ORG'}, {'entity': 'federal corporate statutory income tax rate', 'category': 'ORG'}, {'entity': 'cash activities', 'category': 'ORG'}, {'entity': 'Selected Financial Data', 'category': 'ORG'}, {'entity': 'Report', 'category': 'ORG'}, {'entity': 'December 31, 2017', 'category': 'ORG'}, {'entity': 'December 31, 2016', 'category': 'ORG'}, {'entity': 'December 31, 2017', 'category': 'ORG'}, {'entity': 'December 31, 2016', 'category': 'ORG'}, {'entity': 'December 31, 2017', 'category': 'ORG'}, {'entity': 'December 31, 2016', 'category': 'ORG'}, {'entity': 'Non-GAAP measures', 'category': 'ORG'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': 'Non-GAAP measures', 'category': 'ORG'}, {'entity': 'Management’s Discussion and Analysis', 'category': 'ORG'}, {'entity': 'Operating Segment Information', 'category': 'ORG'}, {'entity': 'Use of Non-GAAP Financial Measures', 'category': 'ORG'}, {'entity': 'long-term view', 'category': 'ORG'}, {'entity': 'value creation', 'category': 'ORG'}, {'entity': 'initiatives', 'category': 'ORG'}, {'entity': 'future prospects', 'category': 'ORG'}, {'entity': 'near term', 'category': 'ORG'}, {'entity': 'portfolio', 'category': 'ORG'}, {'entity': 'contracts', 'category': 'ORG'}, {'entity': 'operational excellence', 'category': 'ORG'}, {'entity': 'CIP programs', 'category': 'ORG'}, {'entity': 'invest', 'category': 'ORG'}, {'entity': 'R&D initiatives', 'category': 'ORG'}, {'entity': 'grow', 'category': 'ORG'}, {'entity': 'customers', 'category': 'ORG'}, {'entity': 'expand markets', 'category': 'ORG'}, {'entity': 'product life', 'category': 'ORG'}, {'entity': 'requirements', 'category': 'ORG'}, {'entity': 'future systems', 'category': 'ORG'}, {'entity': 'diversified', 'category': 'ORG'}, {'entity': 'balance', 'category': 'ORG'}, {'entity': 'cost-reimbursable', 'category': 'ORG'}, {'entity': 'fixed-price', 'category': 'ORG'}, {'entity': 'follow-on business', 'category': 'ORG'}, {'entity': 'attractive customer profile', 'category': 'ORG'}, {'entity': 'growth strategy', 'category': 'ORG'}, {'entity': 'select acquisitions', 'category': 'ORG'}, {'entity': 'product', 'category': 'ORG'}, {'entity': 'service offerings', 'category': 'ORG'}, {'entity': 'capabilities', 'category': 'ORG'}, {'entity': 'new markets', 'category': 'ORG'}, {'entity': 'challenges', 'category': 'ORG'}, {'entity': 'dependence', 'category': 'ORG'}, {'entity': 'U.S. government programs', 'category': 'ORG'}, {'entity': 'contracts', 'category': 'ORG'}, {'entity': 'future reductions', 'category': 'ORG'}, {'entity': 'U.S. government spending', 'category': 'ORG'}, {'entity': 'CIP', 'category': 'ORG'}, {'entity': 'environmental matters', 'category': 'ORG'}, {'entity': 'capital structure', 'category': 'ORG'}, {'entity': 'underfunded retirement benefit plans', 'category': 'ORG'}, {'entity': 'Major Customers', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'products', 'category': 'ORG'}, {'entity': 'technology', 'category': 'ORG'}, {'entity': 'agencies', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'sales', 'category': 'ORG'}, {'entity': 'U.S. aerospace', 'category': 'ORG'}, {'entity': 'defense spending', 'category': 'ORG'}, {'entity': 'U.S. government agencies', 'category': 'ORG'}, {'entity': 'military services', 'category': 'ORG'}, {'entity': 'NASA', 'category': 'ORG'}, {'entity': 'Missile Defense Agency', 'category': 'ORG'}, {'entity': 'prime contractors', 'category': 'ORG'}, {'entity': 'customers', 'category': 'ORG'}, {'entity': 'Percentage of Net Sales', 'category': 'ORG'}, {'entity': 'Fiscal 2017', 'category': 'ORG'}, {'entity': 'Fiscal 2016', 'category': 'ORG'}, {'entity': 'Fiscal 2015', 'category': 'ORG'}, {'entity': 'One month ended December 31, 2015', 'category': 'ORG'}, {'entity': 'principal end user', 'category': 'ORG'}, {'entity': 'fiscal 2017', 'category': 'ORG'}, {'entity': 'NASA', 'category': 'ORG'}, {'entity': 'U.S. Air Force', 'category': 'ORG'}, {'entity': 'U.S. Army', 'category': 'ORG'}, {'entity': 'Missile Defense Agency', 'category': 'ORG'}, {'entity': 'U.S. Navy', 'category': 'ORG'}, {'entity': 'U.S. government customers', 'category': 'ORG'}, {'entity': 'other customers', 'category': 'ORG'}, {'entity': 'significant programs', 'category': 'ORG'}, {'entity': 'U.S. government sales', 'category': 'ORG'}, {'entity': 'RS-25 program', 'category': 'ORG'}, {'entity': 'Standard Missile program', 'category': 'ORG'}, {'entity': 'THAAD program', 'category': 'ORG'}, {'entity': 'demand', 'category': 'ORG'}, {'entity': 'services', 'category': 'ORG'}, {'entity': 'funding', 'category': 'ORG'}, {'entity': 'U.S. government programs', 'category': 'ORG'}, {'entity': 'Customers', 'category': 'ORG'}, {'entity': 'net sales', 'category': 'ORG'}, {'entity': 'Lockheed Martin', 'category': 'ORG'}, {'entity': 'ULA', 'category': 'ORG'}, {'entity': 'Raytheon', 'category': 'ORG'}]\n",
      "[{'entity': '2', 'category': 'CARDINAL'}, {'entity': '2017', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '2018', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '5', 'category': 'CARDINAL'}, {'entity': '2018', 'category': 'CARDINAL'}, {'entity': '230', 'category': 'CARDINAL'}, {'entity': '235.1', 'category': 'CARDINAL'}, {'entity': '60.5', 'category': 'CARDINAL'}, {'entity': '79.5', 'category': 'CARDINAL'}, {'entity': '31', 'category': 'CARDINAL'}, {'entity': '2017', 'category': 'CARDINAL'}, {'entity': '42.0', 'category': 'CARDINAL'}, {'entity': '37.5', 'category': 'CARDINAL'}, {'entity': '4.5', 'category': 'CARDINAL'}, {'entity': '2017', 'category': 'CARDINAL'}, {'entity': '75.8', 'category': 'CARDINAL'}, {'entity': '33.7', 'category': 'CARDINAL'}, {'entity': '42.1', 'category': 'CARDINAL'}, {'entity': '2017', 'category': 'CARDINAL'}, {'entity': '670.9', 'category': 'CARDINAL'}, {'entity': '4', 'category': 'CARDINAL'}, {'entity': '1,877.2', 'category': 'CARDINAL'}, {'entity': '1,761.3', 'category': 'CARDINAL'}, {'entity': '115.9', 'category': 'CARDINAL'}, {'entity': '1,761.3', 'category': 'CARDINAL'}, {'entity': '1,708.3', 'category': 'CARDINAL'}, {'entity': '53.0', 'category': 'CARDINAL'}, {'entity': '158.0', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '2016', 'category': 'CARDINAL'}, {'entity': '2020', 'category': 'CARDINAL'}, {'entity': '2016', 'category': 'CARDINAL'}, {'entity': '2020', 'category': 'CARDINAL'}, {'entity': '2016', 'category': 'CARDINAL'}, {'entity': '2017', 'category': 'CARDINAL'}, {'entity': '2016', 'category': 'CARDINAL'}, {'entity': '32.5', 'category': 'CARDINAL'}, {'entity': '36.5', 'category': 'CARDINAL'}, {'entity': '2016', 'category': 'CARDINAL'}, {'entity': '2016', 'category': 'CARDINAL'}, {'entity': '2017', 'category': 'CARDINAL'}, {'entity': '52', 'category': 'CARDINAL'}, {'entity': '2015', 'category': 'CARDINAL'}, {'entity': '2020', 'category': 'CARDINAL'}, {'entity': '2016', 'category': 'CARDINAL'}, {'entity': '2015', 'category': 'CARDINAL'}, {'entity': '2016', 'category': 'CARDINAL'}, {'entity': '2015', 'category': 'CARDINAL'}, {'entity': '2016', 'category': 'CARDINAL'}, {'entity': '2015', 'category': 'CARDINAL'}, {'entity': '2015', 'category': 'CARDINAL'}]\n",
      "[{'entity': '31, 2017', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': 'FACILITIES', 'category': 'EVENT'}, {'entity': 'GPE', 'category': 'EVENT'}, {'entity': 'LANGUAGE', 'category': 'EVENT'}, {'entity': 'LAW', 'category': 'EVENT'}, {'entity': 'NORP', 'category': 'EVENT'}, {'entity': 'PRODUCT', 'category': 'EVENT'}, {'entity': 'and TIME in the given input.', 'category': 'EVENT'}, {'entity': 'AR1', 'category': 'LOC'}, {'entity': 'land', 'category': 'LOC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'Sacramento', 'category': 'LOC'}, {'entity': 'Europe', 'category': 'LOC'}, {'entity': 'Asia', 'category': 'LOC'}, {'entity': 'Pacific Asia', 'category': 'LOC'}, {'entity': 'Middle East', 'category': 'LOC'}, {'entity': 'Non-U.S.', 'category': 'LOC'}, {'entity': 'North America', 'category': 'LOC'}, {'entity': 'South America', 'category': 'LOC'}, {'entity': 'U.S. government contracts', 'category': 'LOC'}, {'entity': 'Common stock', 'category': 'LOC'}, {'entity': 'CIP', 'category': 'LOC'}, {'entity': 'AR1 Research', 'category': 'ORG'}, {'entity': 'Sacramento Land', 'category': 'ORG'}, {'entity': '86.1%', 'category': 'PERCENT'}, {'entity': '86.7%', 'category': 'PERCENT'}, {'entity': '83.2%', 'category': 'PERCENT'}, {'entity': '83.9%', 'category': 'PERCENT'}, {'entity': '78.3%', 'category': 'PERCENT'}, {'entity': '73.9%', 'category': 'PERCENT'}, {'entity': '86.7%', 'category': 'PERCENT'}, {'entity': '82.5%', 'category': 'PERCENT'}, {'entity': '3.6%', 'category': 'PERCENT'}, {'entity': '3.0%', 'category': 'PERCENT'}, {'entity': '1.3%', 'category': 'PERCENT'}, {'entity': '1.2%', 'category': 'PERCENT'}, {'entity': '2.9%', 'category': 'PERCENT'}, {'entity': '2.9%', 'category': 'PERCENT'}, {'entity': 'November', 'category': 'PERSON'}, {'entity': 'December', 'category': 'PERSON'}, {'entity': 'AR1', 'category': 'PERSON'}, {'entity': 'Standard Missile', 'category': 'PERSON'}, {'entity': 'THAAD', 'category': 'PERSON'}, {'entity': 'Electric propulsion', 'category': 'PERSON'}, {'entity': 'August', 'category': 'PERSON'}, {'entity': '$22', 'category': 'PERSON'}, {'entity': 'Executive Chairman', 'category': 'PERSON'}, {'entity': 'Shakespeare', 'category': 'PERSON'}, {'entity': '2', 'category': 'QUANTITY'}, {'entity': 'AR1', 'category': 'WORK_OF_ART'}, {'entity': '550', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '32.1', 'category': 'CARDINAL'}, {'entity': '16.8', 'category': 'CARDINAL'}, {'entity': '20.5', 'category': 'CARDINAL'}, {'entity': '48.2', 'category': 'CARDINAL'}, {'entity': '2.7', 'category': 'CARDINAL'}, {'entity': '75.4', 'category': 'CARDINAL'}, {'entity': '71.3', 'category': 'CARDINAL'}, {'entity': '4.1', 'category': 'CARDINAL'}, {'entity': '16.1', 'category': 'CARDINAL'}, {'entity': '2.8', 'category': 'CARDINAL'}, {'entity': '1.7', 'category': 'CARDINAL'}, {'entity': '56.7', 'category': 'CARDINAL'}, {'entity': '49.6', 'category': 'CARDINAL'}, {'entity': '7.1', 'category': 'CARDINAL'}, {'entity': '49.8', 'category': 'CARDINAL'}, {'entity': '49.7', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '13.7', 'category': 'CARDINAL'}, {'entity': '13.3', 'category': 'CARDINAL'}, {'entity': '0.4', 'category': 'CARDINAL'}, {'entity': '13.4', 'category': 'CARDINAL'}, {'entity': '13.4', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '2.2', 'category': 'CARDINAL'}, {'entity': '2.0', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '72.6', 'category': 'CARDINAL'}, {'entity': '64.9', 'category': 'CARDINAL'}, {'entity': '7.7', 'category': 'CARDINAL'}, {'entity': '65.1', 'category': 'CARDINAL'}, {'entity': '65.1', 'category': 'CARDINAL'}, {'entity': '-0.2', 'category': 'CARDINAL'}, {'entity': '5.1', 'category': 'CARDINAL'}, {'entity': '3.8', 'category': 'CARDINAL'}, {'entity': '1.1', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': 'Loss On Debt 54.3', 'category': 'CARDINAL'}, {'entity': '32.1', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': 'June 30, 2017', 'category': 'DATE'}, {'entity': 'July 18, 2016', 'category': 'DATE'}, {'entity': 'October 28, 2014', 'category': 'DATE'}, {'entity': 'June 30, 2017', 'category': 'DATE'}, {'entity': 'June 30, 2017', 'category': 'DATE'}, {'entity': 'December 2015', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': 'Environmental Matters', 'category': 'EVENT'}, {'entity': 'unusual items', 'category': 'EVENT'}, {'entity': 'product launch', 'category': 'EVENT'}, {'entity': 'Settlement and Mutual Release Agreement', 'category': 'EVENT'}, {'entity': 'Antares', 'category': 'FAC'}, {'entity': 'Cygnus ORB-3', 'category': 'FAC'}, {'entity': 'Coleman Aerospace', 'category': 'FAC'}, {'entity': 'Hilton Hotel', 'category': 'FAC'}, {'entity': 'SEC', 'category': 'GPE'}, {'entity': 'Plan', 'category': 'GPE'}, {'entity': 'Coleman Aerospace', 'category': 'GPE'}, {'entity': 'L3 Technologies, Inc', 'category': 'GPE'}, {'entity': 'Aerojet Rocketdyne', 'category': 'GPE'}, {'entity': 'Orbital Sciences Corporation', 'category': 'GPE'}, {'entity': 'June 30, 2017', 'category': 'LOC'}, {'entity': 'June 30, 2017', 'category': 'LOC'}, {'entity': 'December 2015', 'category': 'LOC'}, {'entity': '$10.1 million', 'category': 'MONEY'}, {'entity': '$17.4 million', 'category': 'MONEY'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': '$3.5 million', 'category': 'MONEY'}, {'entity': '$460.0 million', 'category': 'MONEY'}, {'entity': '$34.1 million', 'category': 'MONEY'}, {'entity': '$13.0 million', 'category': 'MONEY'}, {'entity': '$0.3 million', 'category': 'MONEY'}, {'entity': '$50.0 million', 'category': 'MONEY'}, {'entity': '$1.9 million', 'category': 'MONEY'}, {'entity': '$0.4 million', 'category': 'MONEY'}, {'entity': '$2.0 million', 'category': 'MONEY'}, {'entity': '$1.0 million', 'category': 'MONEY'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'Plan', 'category': 'ORG'}, {'entity': 'Coleman Aerospace', 'category': 'ORG'}, {'entity': 'L3 Technologies, Inc', 'category': 'ORG'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': 'Orbital Sciences Corporation', 'category': 'ORG'}, {'entity': '110.6%', 'category': 'PERCENT'}, {'entity': '35.0%', 'category': 'PERCENT'}, {'entity': 'participants', 'category': 'PERSON'}, {'entity': '7 1/8% Notes', 'category': 'QUANTITY'}, {'entity': '34.4', 'category': 'QUANTITY'}, {'entity': '1.9', 'category': 'QUANTITY'}, {'entity': '7 1/8% Notes', 'category': 'QUANTITY'}, {'entity': '7 1/8% Notes', 'category': 'QUANTITY'}, {'entity': '7.125% Second-Priority Senior Secured Notes', 'category': 'QUANTITY'}, {'entity': '7 1/8% Notes', 'category': 'QUANTITY'}, {'entity': '7 1/8% Notes', 'category': 'QUANTITY'}, {'entity': '7 1/8% Notes', 'category': 'QUANTITY'}, {'entity': '7.125% Second-Priority Senior Secured Notes', 'category': 'QUANTITY'}, {'entity': '7 1/8% Notes', 'category': 'QUANTITY'}, {'entity': '7 1/8% Notes', 'category': 'QUANTITY'}, {'entity': '7.125% Second-Priority Senior Secured Notes', 'category': 'QUANTITY'}, {'entity': '4 1/16% Debentures', 'category': 'QUANTITY'}, {'entity': '5PM', 'category': 'TIME'}, {'entity': '7PM', 'category': 'TIME'}, {'entity': 'Contract', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '$10.1 million', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '30', 'category': 'CARDINAL'}, {'entity': '105.344%', 'category': 'CARDINAL'}, {'entity': '460.0 million', 'category': 'CARDINAL'}, {'entity': '7.125%', 'category': 'CARDINAL'}, {'entity': '34.1 million', 'category': 'CARDINAL'}, {'entity': '$24.6 million', 'category': 'CARDINAL'}, {'entity': '9.5 million', 'category': 'CARDINAL'}, {'entity': '$13.0 million', 'category': 'CARDINAL'}, {'entity': '$0.3 million', 'category': 'CARDINAL'}, {'entity': '$0.1 million', 'category': 'CARDINAL'}, {'entity': '$76.0 million', 'category': 'CARDINAL'}, {'entity': '1.9 million', 'category': 'CARDINAL'}, {'entity': '$50.0 million', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '0.4 million', 'category': 'CARDINAL'}, {'entity': '$0.2 million', 'category': 'CARDINAL'}, {'entity': '2.0', 'category': 'CARDINAL'}, {'entity': '1.0', 'category': 'CARDINAL'}, {'entity': '1.0', 'category': 'CARDINAL'}, {'entity': '34.4', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '0.0', 'category': 'CARDINAL'}, {'entity': '0.4', 'category': 'CARDINAL'}, {'entity': '0.4', 'category': 'CARDINAL'}, {'entity': '3.5', 'category': 'CARDINAL'}, {'entity': '0.6', 'category': 'CARDINAL'}, {'entity': '2.9', 'category': 'CARDINAL'}, {'entity': '0.6', 'category': 'CARDINAL'}, {'entity': '0.3', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': 'fiscal 2018', 'category': 'DATE'}, {'entity': 'Tax Act', 'category': 'EVENT'}, {'entity': '$64.6 million', 'category': 'MONEY'}, {'entity': 'Tax Act', 'category': 'ORG'}, {'entity': '35%', 'category': 'PERCENT'}, {'entity': '21%', 'category': 'PERCENT'}, {'entity': '74.4%', 'category': 'PERCENT'}, {'entity': '36.2%', 'category': 'PERCENT'}, {'entity': '27%', 'category': 'PERCENT'}, {'entity': '29%', 'category': 'PERCENT'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': 'December 31', 'category': 'TIME'}, {'entity': '2015', 'category': 'TIME'}, {'entity': '5.6', 'category': 'TIME'}, {'entity': '35%', 'category': 'CARDINAL'}, {'entity': '21%', 'category': 'CARDINAL'}, {'entity': '2017', 'category': 'CARDINAL'}, {'entity': '64.6 million', 'category': 'CARDINAL'}, {'entity': '74.4%', 'category': 'CARDINAL'}, {'entity': '36.2%', 'category': 'CARDINAL'}, {'entity': '27%', 'category': 'CARDINAL'}, {'entity': '29%', 'category': 'CARDINAL'}, {'entity': '2016', 'category': 'CARDINAL'}, {'entity': '2015', 'category': 'CARDINAL'}, {'entity': '$1.7 million', 'category': 'CARDINAL'}, {'entity': 'December 31', 'category': 'CARDINAL'}, {'entity': '2017', 'category': 'CARDINAL'}, {'entity': '2.8 million', 'category': 'CARDINAL'}, {'entity': '60 million', 'category': 'CARDINAL'}, {'entity': '2017', 'category': 'CARDINAL'}, {'entity': '$33.7 million', 'category': 'CARDINAL'}, {'entity': '2016', 'category': 'CARDINAL'}, {'entity': '2016', 'category': 'CARDINAL'}, {'entity': '52 weeks', 'category': 'CARDINAL'}, {'entity': '2016', 'category': 'CARDINAL'}, {'entity': '52 weeks', 'category': 'CARDINAL'}, {'entity': '2017', 'category': 'CARDINAL'}, {'entity': '30', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': 'November 30, 2017', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'December 31, 2015', 'category': 'DATE'}, {'entity': 'THAAD program', 'category': 'EVENT'}, {'entity': 'Commercial Crew Development program', 'category': 'EVENT'}, {'entity': 'PAC-3 contracts', 'category': 'EVENT'}, {'entity': 'Antares AJ-26 Settlement Agreement', 'category': 'EVENT'}, {'entity': 'Standard Missile contracts', 'category': 'EVENT'}, {'entity': 'Atlas V program', 'category': 'EVENT'}, {'entity': 'RS-25 program', 'category': 'EVENT'}, {'entity': 'Hilton Hotel', 'category': 'FAC'}, {'entity': 'Paris', 'category': 'GPE'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'Cupertino', 'category': 'LOC'}, {'entity': 'California', 'category': 'LOC'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': '15.9%', 'category': 'PERCENT'}, {'entity': '20.5%', 'category': 'PERCENT'}, {'entity': 'Mary', 'category': 'PERSON'}, {'entity': 'Hamlet', 'category': 'PRODUCT'}, {'entity': '5PM', 'category': 'TIME'}, {'entity': '7PM', 'category': 'TIME'}, {'entity': 'Standard Missile', 'category': 'WORK_OF_ART'}, {'entity': 'THAAD and Standard Missile programs', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '$95.0 million', 'category': 'CARDINAL'}, {'entity': '$37.2 million', 'category': 'CARDINAL'}, {'entity': '$36.8 million', 'category': 'CARDINAL'}, {'entity': '$32.2 million', 'category': 'CARDINAL'}]\n",
      "[{'entity': '0.5', 'category': 'PERCENT'}, {'entity': '%', 'category': 'PERCENT'}, {'entity': '1.0', 'category': 'PERCENT'}, {'entity': '%', 'category': 'PERCENT'}, {'entity': '0.9', 'category': 'PERCENT'}, {'entity': '%', 'category': 'PERCENT'}, {'entity': '7.3', 'category': 'PERCENT'}, {'entity': '%', 'category': 'PERCENT'}]\n",
      "[{'entity': '$59.4 million', 'category': 'CARDINAL'}, {'entity': '15 year', 'category': 'CARDINAL'}, {'entity': '10.4 million', 'category': 'CARDINAL'}, {'entity': '5.9 million', 'category': 'CARDINAL'}, {'entity': '2.7 million', 'category': 'CARDINAL'}, {'entity': '9.0 million', 'category': 'CARDINAL'}, {'entity': '0.5 million', 'category': 'CARDINAL'}, {'entity': '176.6 million', 'category': 'CARDINAL'}, {'entity': '126.3 million', 'category': 'CARDINAL'}, {'entity': '13.8 million', 'category': 'CARDINAL'}, {'entity': '13.5 million', 'category': 'CARDINAL'}, {'entity': '5.2 million', 'category': 'CARDINAL'}, {'entity': '17.8 million', 'category': 'CARDINAL'}, {'entity': '333.0', 'category': 'CARDINAL'}, {'entity': '300.4', 'category': 'CARDINAL'}, {'entity': '181.4', 'category': 'CARDINAL'}, {'entity': '303.1', 'category': 'CARDINAL'}, {'entity': '21.4', 'category': 'CARDINAL'}, {'entity': '67.3', 'category': 'CARDINAL'}, {'entity': '133.6', 'category': 'CARDINAL'}, {'entity': '0.4', 'category': 'CARDINAL'}, {'entity': '31.5', 'category': 'CARDINAL'}, {'entity': '35.1', 'category': 'CARDINAL'}, {'entity': '31.2', 'category': 'CARDINAL'}, {'entity': '3.8', 'category': 'CARDINAL'}, {'entity': '1.8', 'category': 'CARDINAL'}, {'entity': '1.6', 'category': 'CARDINAL'}, {'entity': '25.4', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '3.5', 'category': 'CARDINAL'}, {'entity': '1.2', 'category': 'CARDINAL'}, {'entity': '6.1', 'category': 'CARDINAL'}, {'entity': '0.5', 'category': 'CARDINAL'}, {'entity': '321.2', 'category': 'CARDINAL'}, {'entity': '303.1', 'category': 'CARDINAL'}, {'entity': '300.4', 'category': 'CARDINAL'}, {'entity': '23.1', 'category': 'CARDINAL'}, {'entity': '69.1', 'category': 'CARDINAL'}, {'entity': '159.3', 'category': 'CARDINAL'}, {'entity': '0.6', 'category': 'CARDINAL'}, {'entity': '8.2', 'category': 'CARDINAL'}, {'entity': '18.3', 'category': 'CARDINAL'}, {'entity': '17.3', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '31.3', 'category': 'CARDINAL'}, {'entity': '87.4', 'category': 'CARDINAL'}, {'entity': '0.6', 'category': 'CARDINAL'}, {'entity': '212.8', 'category': 'CARDINAL'}, {'entity': '158.7', 'category': 'CARDINAL'}, {'entity': '67.6', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '66.4', 'category': 'CARDINAL'}, {'entity': '47.1', 'category': 'CARDINAL'}, {'entity': '35.8', 'category': 'CARDINAL'}, {'entity': '1.2', 'category': 'CARDINAL'}, {'entity': '21.7', 'category': 'CARDINAL'}, {'entity': '90.2', 'category': 'CARDINAL'}, {'entity': '86.6', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '124.7', 'category': 'CARDINAL'}, {'entity': '201.8', 'category': 'CARDINAL'}, {'entity': '54.8', 'category': 'CARDINAL'}, {'entity': '2.6', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'Dec 23, 2022', 'category': 'DATE'}, {'entity': 'fiscal 2015', 'category': 'DATE'}, {'entity': 'December 2015', 'category': 'DATE'}, {'entity': 'fiscal 2017', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': 'the one month ended December 31, 2015', 'category': 'DATE'}, {'entity': 'fiscal 2016', 'category': 'DATE'}, {'entity': 'the one month ended December 31, 2017', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'September 30, 2018', 'category': 'DATE'}, {'entity': 'December 31, 2018', 'category': 'DATE'}, {'entity': 'two quarters', 'category': 'DATE'}, {'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': 'next twelve months', 'category': 'DATE'}, {'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': 'the next twelve months', 'category': 'DATE'}, {'entity': 'cash provided by net loss before income taxes', 'category': 'EVENT'}, {'entity': 'offset by cash used to fund the following', 'category': 'EVENT'}, {'entity': 'real estate activities', 'category': 'EVENT'}, {'entity': 'cash used to fund working capital', 'category': 'EVENT'}, {'entity': 'immortal financing activities', 'category': 'EVENT'}, {'entity': 'Debt Activity and Covenants', 'category': 'EVENT'}, {'entity': 'maintain an interest coverage ratio', 'category': 'EVENT'}, {'entity': 'maintain a leverage ratio', 'category': 'EVENT'}, {'entity': 'may generally make certain investments', 'category': 'EVENT'}, {'entity': 'make certain restricted payments', 'category': 'EVENT'}, {'entity': 'compliance with our financial and non-financial covenants', 'category': 'EVENT'}, {'entity': 'Outlook', 'category': 'EVENT'}, {'entity': 'short-term liquidity requirements consist primarily of recurring operating expenses', 'category': 'EVENT'}, {'entity': 'sufficient funds to meet our operating plan', 'category': 'EVENT'}, {'entity': 'our growth strategy', 'category': 'EVENT'}, {'entity': 'our cash management strategy', 'category': 'EVENT'}, {'entity': 'repurchase shares depending on economic and other conditions', 'category': 'EVENT'}, {'entity': 'retire or purchase our outstanding debt', 'category': 'EVENT'}, {'entity': 'potential future acquisitions', 'category': 'EVENT'}, {'entity': 'availability of financial resources', 'category': 'EVENT'}, {'entity': 'renegotiation of credit limits', 'category': 'EVENT'}, {'entity': 'environmental matters', 'category': 'EVENT'}, {'entity': '17', 'category': 'CARDINAL'}, {'entity': '12', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': '10 years', 'category': 'DATE'}, {'entity': 'fiscal 2018', 'category': 'DATE'}, {'entity': 'future', 'category': 'DATE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'Huntsville', 'category': 'LOC'}, {'entity': 'Alabama', 'category': 'LOC'}, {'entity': '$1,133.1 million', 'category': 'MONEY'}, {'entity': '$370.0 million', 'category': 'MONEY'}, {'entity': '$25.0 million', 'category': 'MONEY'}, {'entity': '$65.0 million', 'category': 'MONEY'}, {'entity': '$280.0 million', 'category': 'MONEY'}, {'entity': '$300.0 million', 'category': 'MONEY'}, {'entity': '$0.9 million', 'category': 'MONEY'}, {'entity': '$0.2 million', 'category': 'MONEY'}, {'entity': '$0.4 million', 'category': 'MONEY'}, {'entity': '$0.3 million', 'category': 'MONEY'}, {'entity': '$84.5 million', 'category': 'MONEY'}, {'entity': '$20.7 million', 'category': 'MONEY'}, {'entity': '$38.2 million', 'category': 'MONEY'}, {'entity': '$19.1 million', 'category': 'MONEY'}, {'entity': '$6.5 million', 'category': 'MONEY'}, {'entity': '$83.1 million', 'category': 'MONEY'}, {'entity': '$2.2 million', 'category': 'MONEY'}, {'entity': '$7.4 million', 'category': 'MONEY'}, {'entity': '$7.5 million', 'category': 'MONEY'}, {'entity': '$66.0 million', 'category': 'MONEY'}, {'entity': '$121.9 million', 'category': 'MONEY'}, {'entity': '$29.4 million', 'category': 'MONEY'}, {'entity': '$52.7 million', 'category': 'MONEY'}, {'entity': '$39.8 million', 'category': 'MONEY'}, {'entity': '$33.6 million', 'category': 'MONEY'}, {'entity': '$4.8 million', 'category': 'MONEY'}, {'entity': '$8.7 million', 'category': 'MONEY'}, {'entity': '$7.4 million', 'category': 'MONEY'}, {'entity': '$12.7 million', 'category': 'MONEY'}, {'entity': '$95.1 million', 'category': 'MONEY'}, {'entity': '$15.1 million', 'category': 'MONEY'}, {'entity': '$28.7 million', 'category': 'MONEY'}, {'entity': '$27.4 million', 'category': 'MONEY'}, {'entity': '$23.9 million', 'category': 'MONEY'}, {'entity': '$44.0 million', 'category': 'MONEY'}, {'entity': '$1.3 million', 'category': 'MONEY'}, {'entity': '$2.6 million', 'category': 'MONEY'}, {'entity': '$17.6 million', 'category': 'MONEY'}, {'entity': '$22.5 million', 'category': 'MONEY'}, {'entity': '$42.0 million', 'category': 'MONEY'}, {'entity': '$37.5 million', 'category': 'MONEY'}, {'entity': '$4.5 million', 'category': 'MONEY'}, {'entity': '$38.6 million', 'category': 'MONEY'}, {'entity': '$52.8 million', 'category': 'MONEY'}, {'entity': '$120.0 million', 'category': 'MONEY'}, {'entity': '$121.9 million', 'category': 'MONEY'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '10', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': 'filings', 'category': 'EVENT'}, {'entity': 'significant judgment', 'category': 'EVENT'}, {'entity': 'disclosures', 'category': 'EVENT'}, {'entity': 'audit committee', 'category': 'EVENT'}, {'entity': 'accounting estimates', 'category': 'EVENT'}, {'entity': 'financial disclosures', 'category': 'EVENT'}, {'entity': 'audit committee', 'category': 'EVENT'}, {'entity': 'positions', 'category': 'EVENT'}, {'entity': 'information', 'category': 'EVENT'}, {'entity': 'accounting estimate changes', 'category': 'EVENT'}, {'entity': 'effects', 'category': 'EVENT'}, {'entity': 'notes', 'category': 'EVENT'}, {'entity': 'consolidated financial statements', 'category': 'EVENT'}, {'entity': 'segment', 'category': 'EVENT'}, {'entity': 'discussed below', 'category': 'EVENT'}, {'entity': 'products and services', 'category': 'EVENT'}, {'entity': 'percentage of completion method', 'category': 'EVENT'}, {'entity': 'sales', 'category': 'EVENT'}, {'entity': 'contracted performance objectives', 'category': 'EVENT'}, {'entity': 'contracts', 'category': 'EVENT'}, {'entity': 'costs', 'category': 'EVENT'}, {'entity': 'cost-to-cost', 'category': 'EVENT'}, {'entity': 'deliverable units', 'category': 'EVENT'}, {'entity': 'units-of-delivery', 'category': 'EVENT'}, {'entity': 'agreed upon unit price', 'category': 'EVENT'}, {'entity': 'fixed-price contracts', 'category': 'EVENT'}, {'entity': 'variance', 'category': 'EVENT'}, {'entity': 'contract performance period', 'category': 'EVENT'}, {'entity': 'cost-reimbursable contracts', 'category': 'EVENT'}, {'entity': 'variable consideration', 'category': 'EVENT'}, {'entity': 'awards', 'category': 'EVENT'}, {'entity': 'incentives', 'category': 'EVENT'}, {'entity': 'penalties', 'category': 'EVENT'}, {'entity': 'customers assessment', 'category': 'EVENT'}, {'entity': 'targets', 'category': 'EVENT'}, {'entity': 'performance', 'category': 'EVENT'}, {'entity': 'quality', 'category': 'EVENT'}, {'entity': 'schedule', 'category': 'EVENT'}, {'entity': 'Aerospace and Defense segment', 'category': 'EVENT'}, {'entity': 'profit', 'category': 'EVENT'}, {'entity': 'long-term contracts', 'category': 'EVENT'}, {'entity': 'total contract revenue', 'category': 'EVENT'}, {'entity': 'cost at completion', 'category': 'EVENT'}, {'entity': 'progress towards completion', 'category': 'EVENT'}, {'entity': 'programs', 'category': 'EVENT'}, {'entity': 'estimated total contract revenue', 'category': 'EVENT'}, {'entity': 'costs at completion', 'category': 'EVENT'}, {'entity': 'significant judgment', 'category': 'EVENT'}, {'entity': 'contract performance', 'category': 'EVENT'}, {'entity': 'cost estimates', 'category': 'EVENT'}, {'entity': 'contract profit', 'category': 'EVENT'}, {'entity': 'statement of operations', 'category': 'EVENT'}, {'entity': 'changes in estimates', 'category': 'EVENT'}, {'entity': 'assumptions', 'category': 'EVENT'}, {'entity': 'long-term contracts', 'category': 'EVENT'}, {'entity': 'material effect', 'category': 'EVENT'}, {'entity': 'operating results', 'category': 'EVENT'}, {'entity': 'table', 'category': 'EVENT'}, {'entity': 'change in significant contract accounting estimates', 'category': 'EVENT'}, {'entity': 'Aerospace and Defense segment', 'category': 'EVENT'}, {'entity': 'percentage-of-completion method of accounting', 'category': 'EVENT'}, {'entity': 'Year Ended', 'category': 'EVENT'}, {'entity': 'One month ended', 'category': 'EVENT'}, {'entity': 'the fiscal 2017 favorable changes', 'category': 'EVENT'}, {'entity': 'improved performance', 'category': 'EVENT'}, {'entity': 'overhead cost reductions', 'category': 'EVENT'}, {'entity': 'reduced program risks', 'category': 'EVENT'}, {'entity': 'THAAD program', 'category': 'EVENT'}, {'entity': 'cost growth', 'category': 'EVENT'}, {'entity': 'manufacturing inefficiencies', 'category': 'EVENT'}, {'entity': 'electric propulsion contracts', 'category': 'EVENT'}, {'entity': 'the fiscal 2016 favorable changes', 'category': 'EVENT'}, {'entity': 'space launch systems', 'category': 'EVENT'}, {'entity': 'affordability initiatives', 'category': 'EVENT'}, {'entity': 'lower overhead costs', 'category': 'EVENT'}, {'entity': 'the one month ended December 31, 2015 favorable changes', 'category': 'EVENT'}, {'entity': 'tactical and missile defense programs', 'category': 'EVENT'}, {'entity': 'electric propulsion contract', 'category': 'EVENT'}, {'entity': 'the fiscal 2015 favorable changes', 'category': 'EVENT'}, {'entity': 'expected favorable contract performance', 'category': 'EVENT'}, {'entity': 'close-out activities', 'category': 'EVENT'}, {'entity': 'J-2X program', 'category': 'EVENT'}, {'entity': 'Revenue on service or time and material contracts', 'category': 'EVENT'}, {'entity': 'performed', 'category': 'EVENT'}, {'entity': 'expected costs', 'category': 'EVENT'}, {'entity': 'value', 'category': 'EVENT'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'October 1, 2017', 'category': 'DATE'}, {'entity': 'October 1, 2016', 'category': 'DATE'}, {'entity': 'September 1, 2016', 'category': 'DATE'}, {'entity': 'fiscal 2009', 'category': 'DATE'}, {'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'less than 50%', 'category': 'PERCENT'}, {'entity': '3.59%', 'category': 'PERCENT'}, {'entity': '4.02%', 'category': 'PERCENT'}, {'entity': '3.37%', 'category': 'PERCENT'}, {'entity': '3.68%', 'category': 'PERCENT'}, {'entity': 'Step Zero analysis', 'category': 'WORK_OF_ART'}, {'entity': 'Step One analysis', 'category': 'WORK_OF_ART'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '2009', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': 'November 30, 2017', 'category': 'DATE'}, {'entity': 'November 30, 2017', 'category': 'DATE'}, {'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': '2016', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': '2017', 'category': 'DATE'}, {'entity': 'Not applicable as our medical and life insurance benefits are unfunded', 'category': 'ORG'}, {'entity': 'Medical and Life Insurance Benefits', 'category': 'ORG'}, {'entity': 'December 31', 'category': 'ORG'}, {'entity': '2017', 'category': 'ORG'}, {'entity': '7.00%', 'category': 'PERCENT'}, {'entity': '7.00%', 'category': 'PERCENT'}, {'entity': '8.00%', 'category': 'PERCENT'}, {'entity': '7.00%', 'category': 'PERCENT'}, {'entity': '7.00%', 'category': 'PERCENT'}, {'entity': '1%', 'category': 'PERCENT'}, {'entity': '9.2', 'category': 'PERCENT'}, {'entity': '0.2', 'category': 'PERCENT'}, {'entity': '0.7', 'category': 'PERCENT'}, {'entity': '0.3', 'category': 'PERCENT'}, {'entity': '0.8', 'category': 'PERCENT'}, {'entity': 'fifth', 'category': 'ORDINAL'}, {'entity': '4.02', 'category': 'CARDINAL'}, {'entity': '4.36', 'category': 'CARDINAL'}, {'entity': '3.96', 'category': 'CARDINAL'}, {'entity': '4.26', 'category': 'CARDINAL'}, {'entity': '3.68', 'category': 'CARDINAL'}, {'entity': '3.99', 'category': 'CARDINAL'}, {'entity': '3.54', 'category': 'CARDINAL'}, {'entity': '3.87', 'category': 'CARDINAL'}, {'entity': 'one', 'category': 'CARDINAL'}, {'entity': 'three', 'category': 'CARDINAL'}, {'entity': '21.7', 'category': 'CARDINAL'}, {'entity': '153.5', 'category': 'CARDINAL'}, {'entity': '18.5', 'category': 'CARDINAL'}, {'entity': '128.9', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31, 2017', 'category': 'DATE'}, {'entity': 'December 31, 2016', 'category': 'DATE'}, {'entity': '$670.9 million', 'category': 'MONEY'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': '45%', 'category': 'PERCENT'}, {'entity': '55%', 'category': 'PERCENT'}, {'entity': 'Retirement Benefit Plans', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '74.4%', 'category': 'CARDINAL'}]\n",
      "/Users/tanmayiballa/Desktop/KG-LLM/l715_23-1/data/10-Ks/Aerojet_Rocketdyne_Holdings_Inc./2016/Management_gpt-3.5-turbo_NER_response.json\n",
      "[{'entity': 'Item 7', 'category': 'DATE'}, {'entity': 'Item 10-K', 'category': 'DATE'}, {'entity': 'GAAP', 'category': 'DATE'}, {'entity': 'United States of America', 'category': 'DATE'}, {'entity': 'Item 8. Consolidated Financial Statements and Supplementary Data', 'category': 'DATE'}, {'entity': 'Item 1A. Risk Factors', 'category': 'DATE'}, {'entity': 'Item 1. Business', 'category': 'DATE'}, {'entity': 'Item 6. Selected Financial Data', 'category': 'DATE'}, {'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': 'Restatement', 'category': 'EVENT'}, {'entity': 'Aerojet Rocketdyne Holdings, Inc.', 'category': 'ORG'}, {'entity': 'Rocketdyne Business', 'category': 'ORG'}, {'entity': 'Company', 'category': 'ORG'}, {'entity': 'DoD', 'category': 'ORG'}, {'entity': 'NASA', 'category': 'ORG'}, {'entity': 'Easton', 'category': 'ORG'}, {'entity': '11.3%', 'category': 'PERCENT'}, {'entity': '12.8%', 'category': 'PERCENT'}, {'entity': '86', 'category': 'PERCENT'}]\n",
      "[{'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'January 20, 2016', 'category': 'DATE'}, {'entity': 'July 2012', 'category': 'DATE'}, {'entity': 'June 12, 2013', 'category': 'DATE'}, {'entity': 'June 14, 2013', 'category': 'DATE'}, {'entity': 'June 14, 2015', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': 'Year Ended 2013', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': 'fiscal year', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': 'each year', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': 'the last Saturday of November', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': 'first quarter of fiscal 2013', 'category': 'DATE'}, {'entity': 'first quarter of fiscal 2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '13 weeks', 'category': 'DATE'}, {'entity': 'first quarter of fiscal 2013', 'category': 'DATE'}, {'entity': 'June 14, 2013', 'category': 'DATE'}, {'entity': 'Russian', 'category': 'DATE'}, {'entity': 'Amended and Restated Purchase Agreement', 'category': 'DATE'}, {'entity': 'June 14, 2015', 'category': 'DATE'}, {'entity': 'fiscal 2013', 'category': 'DATE'}, {'entity': 'fair value adjustments', 'category': 'DATE'}, {'entity': 'property, plant and equipment and intangible assets', 'category': 'DATE'}, {'entity': 'pro forma information', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': 'Pro forma', 'category': 'DATE'}, {'entity': 'income', 'category': 'DATE'}, {'entity': 'As reported', 'category': 'DATE'}, {'entity': 'certain conditions', 'category': 'DATE'}, {'entity': 'Russian governmental regulatory approvals', 'category': 'DATE'}, {'entity': 'Pro forma', 'category': 'DATE'}, {'entity': '$27.8 million', 'category': 'DATE'}, {'entity': 'the Acquisition', 'category': 'DATE'}, {'entity': 'that time', 'category': 'DATE'}, {'entity': 'Pro forma\\tYear Ended\\t2013', 'category': 'DATE'}, {'entity': 'Net sales', 'category': 'DATE'}, {'entity': 'Pro forma\\t$\\t1,378.1', 'category': 'DATE'}, {'entity': 'Pro forma\\t$\\t1,757.7', 'category': 'DATE'}, {'entity': 'Net income', 'category': 'DATE'}, {'entity': 'Pro forma\\t$\\t162.9', 'category': 'DATE'}, {'entity': 'Pro forma\\t$\\t25.7', 'category': 'DATE'}, {'entity': 'Basic income per share', 'category': 'DATE'}, {'entity': 'Pro forma\\t$\\t2.68', 'category': 'DATE'}, {'entity': 'Pro forma\\t$\\t0.42', 'category': 'DATE'}, {'entity': 'Diluted income per share', 'category': 'DATE'}, {'entity': 'Pro forma\\t$\\t2.05', 'category': 'DATE'}, {'entity': 'Pro forma\\t$\\t0.41', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': 'fiscal year-end', 'category': 'DATE'}, {'entity': 'each year', 'category': 'DATE'}, {'entity': 'July 2012', 'category': 'DATE'}, {'entity': 'the Original Purchase Agreement', 'category': 'DATE'}, {'entity': 'UTC', 'category': 'DATE'}, {'entity': 'the Rocketdyne Business', 'category': 'DATE'}, {'entity': 'UTC', 'category': 'DATE'}, {'entity': 'June 14, 2013', 'category': 'DATE'}, {'entity': 'the Amended and Restated Purchase Agreement', 'category': 'DATE'}, {'entity': 'the UTC business', 'category': 'DATE'}, {'entity': 'Additional week', 'category': 'DATE'}, {'entity': 'June 14, 2015', 'category': 'DATE'}, {'entity': 'RDA Acquisition', 'category': 'DATE'}, {'entity': 'fiscal 2013', 'category': 'DATE'}, {'entity': 'results of operations', 'category': 'DATE'}, {'entity': 'Year Ended\\t2013', 'category': 'DATE'}, {'entity': 'Pro forma', 'category': 'DATE'}, {'entity': 'Net sales', 'category': 'DATE'}, {'entity': 'As reported\\t$\\t1,378.1', 'category': 'DATE'}, {'entity': 'Pro forma\\t$\\t1,757.7', 'category': 'DATE'}, {'entity': 'Net income', 'category': 'DATE'}, {'entity': 'As reported\\t$\\t162.9', 'category': 'DATE'}, {'entity': 'Pro forma\\t$\\t25.7', 'category': 'DATE'}, {'entity': 'Basic income per share', 'category': 'DATE'}, {'entity': 'As reported\\t$\\t2.68', 'category': 'DATE'}, {'entity': 'Pro forma\\t$\\t0.42', 'category': 'DATE'}, {'entity': 'Diluted income per share', 'category': 'DATE'}, {'entity': 'As reported\\t$\\t2.05', 'category': 'DATE'}, {'entity': 'Pro forma\\t$\\t0.41', 'category': 'DATE'}, {'entity': 'multiple categories', 'category': 'DATE'}, {'entity': 'GAAP', 'category': 'DATE'}, {'entity': 'Non-GAAP measures', 'category': 'DATE'}, {'entity': 'Non-GAAP measures to the most directly comparable GAAP measures', 'category': 'DATE'}, {'entity': 'Management’s Discussion and Analysis', 'category': 'DATE'}, {'entity': 'Operating Segment Information', 'category': 'DATE'}, {'entity': 'Use of Non-GAAP Financial Measures', 'category': 'DATE'}, {'entity': 'The Acquisition', 'category': 'DATE'}, {'entity': 'Paris', 'category': 'DATE'}, {'entity': 'Apple.', 'category': 'DATE'}]\n",
      "[{'entity': '2011', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': 'November 2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': 'March 2015', 'category': 'DATE'}, {'entity': 'fiscal 2019', 'category': 'DATE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'NASA', 'category': 'GPE'}, {'entity': 'DoD', 'category': 'GPE'}, {'entity': 'Russian', 'category': 'GPE'}, {'entity': 'Soyuz', 'category': 'GPE'}, {'entity': 'SLS', 'category': 'GPE'}, {'entity': 'entrepreneurs', 'category': 'GPE'}, {'entity': 'DoD', 'category': 'ORG'}, {'entity': 'NASA', 'category': 'ORG'}, {'entity': 'NASA', 'category': 'ORG'}, {'entity': 'Boeing', 'category': 'ORG'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': 'SpaceX', 'category': 'ORG'}, {'entity': 'Blue Origin', 'category': 'ORG'}, {'entity': 'missile defense', 'category': 'ORG'}, {'entity': 'tactical propulsion', 'category': 'ORG'}, {'entity': 'CIP', 'category': 'ORG'}, {'entity': 'second', 'category': 'ORDINAL'}, {'entity': '10 years', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2015', 'category': 'CARDINAL'}, {'entity': '$1.1 trillion', 'category': 'CARDINAL'}, {'entity': '$514.1 billion', 'category': 'CARDINAL'}, {'entity': '$58.6 billion', 'category': 'CARDINAL'}, {'entity': '12.8 billion', 'category': 'CARDINAL'}, {'entity': '7.7 billion', 'category': 'CARDINAL'}, {'entity': '$19.3 billion', 'category': 'CARDINAL'}, {'entity': '2012', 'category': 'CARDINAL'}, {'entity': '2016', 'category': 'CARDINAL'}, {'entity': '2017', 'category': 'CARDINAL'}, {'entity': 'this decade', 'category': 'CARDINAL'}, {'entity': 'a few', 'category': 'CARDINAL'}, {'entity': 'several', 'category': 'CARDINAL'}, {'entity': 'three', 'category': 'CARDINAL'}, {'entity': '500', 'category': 'CARDINAL'}, {'entity': 'four years', 'category': 'CARDINAL'}, {'entity': '$110 million', 'category': 'CARDINAL'}, {'entity': '$145 million', 'category': 'CARDINAL'}, {'entity': 'Approximately $43 million', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'February 28, 2015', 'category': 'DATE'}, {'entity': 'Accrual established', 'category': 'DATE'}, {'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': 'third quarter of fiscal 2015', 'category': 'DATE'}, {'entity': 'fiscal 2015', 'category': 'DATE'}, {'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': 'CIP', 'category': 'EVENT'}, {'entity': 'VRIF', 'category': 'EVENT'}, {'entity': 'implementation of the CIP initiative', 'category': 'EVENT'}, {'entity': 'Hamlet', 'category': 'EVENT'}, {'entity': 'Cupertino', 'category': 'FAC'}, {'entity': 'California', 'category': 'FAC'}, {'entity': 'Eiffel Tower', 'category': 'FAC'}, {'entity': 'Hilton Hotel', 'category': 'FAC'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'Paris', 'category': 'GPE'}, {'entity': 'Aerojet Rocketdyne - Sacramento', 'category': 'LOC'}, {'entity': 'Aerojet Rocketdyne - BPOU', 'category': 'LOC'}, {'entity': 'Other Aerojet Rocketdyne sites', 'category': 'LOC'}, {'entity': 'other sites', 'category': 'LOC'}, {'entity': '$27 million', 'category': 'MONEY'}, {'entity': '$40 million', 'category': 'MONEY'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': '$0.8 million', 'category': 'MONEY'}, {'entity': '$2.6 million', 'category': 'MONEY'}, {'entity': '$68.7 million$751.5 million', 'category': 'MONEY'}, {'entity': 'Aerojet Rocketdyne', 'category': 'ORG'}, {'entity': 'Northrop', 'category': 'ORG'}, {'entity': '83%', 'category': 'PERCENT'}, {'entity': 'AR1', 'category': 'PERSON'}, {'entity': 'Severance', 'category': 'PERSON'}, {'entity': 'Retention', 'category': 'PERSON'}, {'entity': 'Total', 'category': 'PERSON'}, {'entity': 'in prior years and reimbursable under the Northrop Agreement', 'category': 'PERSON'}, {'entity': 'No entities found', 'category': 'QUANTITY'}, {'entity': '5PM', 'category': 'TIME'}, {'entity': '7PM', 'category': 'TIME'}, {'entity': 'AR1', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '$27 million', 'category': 'CARDINAL'}, {'entity': '40 million', 'category': 'CARDINAL'}, {'entity': '1.5 million', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '15.6', 'category': 'CARDINAL'}, {'entity': '12.9', 'category': 'CARDINAL'}, {'entity': '1.8', 'category': 'CARDINAL'}, {'entity': '11.1', 'category': 'CARDINAL'}, {'entity': '2.7', 'category': 'CARDINAL'}, {'entity': '13.8', 'category': 'CARDINAL'}, {'entity': '0.8', 'category': 'CARDINAL'}, {'entity': '2.6', 'category': 'CARDINAL'}, {'entity': '0.7', 'category': 'CARDINAL'}, {'entity': '5.2', 'category': 'CARDINAL'}, {'entity': '118.0', 'category': 'CARDINAL'}, {'entity': '153.0', 'category': 'CARDINAL'}, {'entity': '108.1', 'category': 'CARDINAL'}, {'entity': '140.1', 'category': 'CARDINAL'}, {'entity': '7.6', 'category': 'CARDINAL'}, {'entity': '7.8', 'category': 'CARDINAL'}, {'entity': '0.3', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '50.4', 'category': 'CARDINAL'}, {'entity': '52.7', 'category': 'CARDINAL'}, {'entity': '33.3', 'category': 'CARDINAL'}, {'entity': '19.6', 'category': 'CARDINAL'}, {'entity': '12.8', 'category': 'CARDINAL'}, {'entity': '0.3', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '16.8', 'category': 'CARDINAL'}, {'entity': '33.0', 'category': 'CARDINAL'}, {'entity': '35.7', 'category': 'CARDINAL'}, {'entity': '0.3', 'category': 'CARDINAL'}, {'entity': '16.3', 'category': 'CARDINAL'}, {'entity': '17.1', 'category': 'CARDINAL'}, {'entity': '49.3', 'category': 'CARDINAL'}, {'entity': '0.7', 'category': 'CARDINAL'}, {'entity': '0.9', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '16.2', 'category': 'CARDINAL'}, {'entity': '50.0', 'category': 'CARDINAL'}, {'entity': '162.9', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'October 28, 2014', 'category': 'DATE'}, {'entity': 'fiscal 2014', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': 'fiscal 2013', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': 'contract', 'category': 'EVENT'}, {'entity': 'launch failure', 'category': 'EVENT'}, {'entity': 'October 28, 2014', 'category': 'EVENT'}, {'entity': 'Antares launch vehicle', 'category': 'EVENT'}, {'entity': 'ORB-3 service and cargo module', 'category': 'EVENT'}, {'entity': 'provision', 'category': 'EVENT'}, {'entity': 'liquid propulsion rocket engines', 'category': 'EVENT'}, {'entity': 'Antares program', 'category': 'EVENT'}, {'entity': 'launch vehicle', 'category': 'EVENT'}, {'entity': 'service and cargo module', 'category': 'EVENT'}, {'entity': 'Agreement', 'category': 'EVENT'}, {'entity': 'Settlement and Mutual Release Agreement', 'category': 'EVENT'}, {'entity': 'termination', 'category': 'EVENT'}, {'entity': 'termination for convenience', 'category': 'EVENT'}, {'entity': 'Cygnus ORB-3 service and cargo module', 'category': 'EVENT'}, {'entity': 'Orbital Sciences Corporation', 'category': 'EVENT'}, {'entity': 'rocket engines', 'category': 'EVENT'}, {'entity': 'October 28', 'category': 'EVENT'}, {'entity': 'Antares AJ-26 program', 'category': 'EVENT'}, {'entity': 'Orbital', 'category': 'EVENT'}, {'entity': 'Sacramento', 'category': 'GPE'}, {'entity': 'Sacramento Land', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '$1,708.3', 'category': 'MONEY'}, {'entity': '1,602.2', 'category': 'MONEY'}, {'entity': '106.1', 'category': 'MONEY'}, {'entity': '1,602.2', 'category': 'MONEY'}, {'entity': '1,378.1', 'category': 'MONEY'}, {'entity': '224.1', 'category': 'MONEY'}, {'entity': '$84.3 million', 'category': 'MONEY'}, {'entity': '$84.3', 'category': 'MONEY'}, {'entity': 'RS-25 program', 'category': 'MONEY'}, {'entity': '$84.3 million', 'category': 'MONEY'}, {'entity': 'significant development and integration effort', 'category': 'MONEY'}, {'entity': 'SLS development program', 'category': 'MONEY'}, {'entity': 'development work', 'category': 'MONEY'}, {'entity': 'Orion program', 'category': 'MONEY'}, {'entity': 'successful completion', 'category': 'MONEY'}, {'entity': 'current J-2X program', 'category': 'MONEY'}, {'entity': '$80.3 million', 'category': 'MONEY'}, {'entity': 'missile defense and strategic systems programs', 'category': 'MONEY'}, {'entity': 'THAAD and Standard Missile programs', 'category': 'MONEY'}, {'entity': 'sale', 'category': 'MONEY'}, {'entity': '550 acres', 'category': 'MONEY'}, {'entity': 'Sacramento Land', 'category': 'MONEY'}, {'entity': '$42.0 million', 'category': 'MONEY'}, {'entity': '5519.99995', 'category': 'MONEY'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': '681.9 million', 'category': 'MONEY'}, {'entity': '2014', 'category': 'MONEY'}, {'entity': '311.8 million', 'category': 'MONEY'}, {'entity': '2013', 'category': 'MONEY'}, {'entity': 'THAAD', 'category': 'MONEY'}, {'entity': 'Standard Missile programs', 'category': 'MONEY'}, {'entity': '2014', 'category': 'MONEY'}, {'entity': 'national sales', 'category': 'MONEY'}, {'entity': 'increased deliveries', 'category': 'MONEY'}, {'entity': 'Step-Up', 'category': 'MONEY'}, {'entity': 'Fair value', 'category': 'MONEY'}, {'entity': 'inventory', 'category': 'MONEY'}, {'entity': '2015', 'category': 'MONEY'}, {'entity': '2014', 'category': 'MONEY'}, {'entity': 'Change', 'category': 'MONEY'}, {'entity': 'AJ60', 'category': 'MONEY'}, {'entity': 'Antares', 'category': 'MONEY'}, {'entity': 'increased deliveries', 'category': 'MONEY'}, {'entity': 'Standard Missile contracts', 'category': 'MONEY'}, {'entity': 'development activities', 'category': 'MONEY'}, {'entity': 'TDACS', 'category': 'MONEY'}, {'entity': 'Standard Missile-3 Block IIA contract', 'category': 'MONEY'}, {'entity': 'cessation', 'category': 'MONEY'}, {'entity': 'deliveries', 'category': 'MONEY'}, {'entity': 'Standard Missile-1 Regrain contract', 'category': 'MONEY'}, {'entity': '2013', 'category': 'MONEY'}, {'entity': 'additional week', 'category': 'MONEY'}, {'entity': 'operations', 'category': 'MONEY'}, {'entity': 'first quarter of fiscal 2013', 'category': 'MONEY'}, {'entity': '27.8 million', 'category': 'MONEY'}, {'entity': 'net sales excluding retirement benefit expense', 'category': 'MONEY'}, {'entity': 'percentage amountsCost of sales\\t$\\t1,459.5', 'category': 'MONEY'}, {'entity': '1,406.2', 'category': 'MONEY'}, {'entity': '53.3', 'category': 'MONEY'}, {'entity': '1,406.2', 'category': 'MONEY'}, {'entity': '1,234.3', 'category': 'MONEY'}, {'entity': '171.9\\tPercentage of net sales', 'category': 'MONEY'}, {'entity': '85.4', 'category': 'MONEY'}, {'entity': '%', 'category': 'MONEY'}, {'entity': '87.8', 'category': 'MONEY'}, {'entity': '%', 'category': 'MONEY'}, {'entity': '87.8', 'category': 'MONEY'}, {'entity': '%', 'category': 'MONEY'}, {'entity': '89.6', 'category': 'MONEY'}, {'entity': '%\\tComponents of cost of sales', 'category': 'MONEY'}, {'entity': 'Cost of sales excluding retirement benefit expense and step-up in fair value of inventory\\t$\\t1,409.0', 'category': 'MONEY'}, {'entity': '1,377.8', 'category': 'MONEY'}, {'entity': '31.2', 'category': 'MONEY'}, {'entity': '1,377.8', 'category': 'MONEY'}, {'entity': '1,187.9', 'category': 'MONEY'}, {'entity': '189.9', 'category': 'MONEY'}, {'entity': 'Cost of sales associated with the Acquisition step-up in fair value of inventory not allocable to our U.S. government contracts\\t0.3', 'category': 'MONEY'}, {'entity': '3.2', 'category': 'MONEY'}, {'entity': '2.9', 'category': 'MONEY'}, {'entity': '3.2', 'category': 'MONEY'}, {'entity': '2.2', 'category': 'MONEY'}, {'entity': '1.0\\tRetirement benefit expense\\t50.2', 'category': 'MONEY'}, {'entity': '25.2', 'category': 'MONEY'}, {'entity': '25.0', 'category': 'MONEY'}, {'entity': '25.2', 'category': 'MONEY'}, {'entity': '44.2', 'category': 'MONEY'}, {'entity': '19.0', 'category': 'MONEY'}, {'entity': 'Cost of sales\\t$\\t1,459.5', 'category': 'MONEY'}, {'entity': '1,406.2', 'category': 'MONEY'}, {'entity': '53.3', 'category': 'MONEY'}, {'entity': '1,406.2', 'category': 'MONEY'}, {'entity': '1,234.3', 'category': 'MONEY'}, {'entity': '171.9* Primary reason for change. The decrease in cost of sales as a percentage of net sales excluding retirement benefit expense and the step-up in fair value of inventory is primarily due to i land sale of approximately 550 acres of Sacramento Land resulting in gross profit of $30.6 million', 'category': 'MONEY'}, {'entity': '1.8', 'category': 'MONEY'}, {'entity': '%', 'category': 'MONEY'}, {'entity': 'ii the close-out of the Antares AJ-26 program. Aerojet Rocketdyne entered into a Settlement and Mutual Release Agreement the “Agreement” with Orbital Sciences Corporation “Orbital” pursuant to which the parties mutually agreed to a termination for convenience of the contract relating to the provision by Aerojet Rocketdyne of 20 AJ-26 liquid propulsion rocket engines to Orbital for the Antares program the “Contract”. The Agreement also settles all claims the parties may have had against one another arising out of the Contract and the launch failure that occurred on October 28', 'category': 'MONEY'}, {'entity': '2022 of an Antares launch vehicle carrying the Cygnus ORB-3 service and cargo module. We incurred a $50.0 million legal settlement charge reported as an unusual item and not included in cost of sales related to the legal settlement', 'category': 'MONEY'}, {'entity': 'table below and Note 9b of the notes to consolidated financial statements.\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t \\tYear Ended\\t \\t  \\t2015', 'category': 'MONEY'}, {'entity': '2014', 'category': 'MONEY'}, {'entity': 'Change \\tIn millions', 'category': 'MONEY'}, {'entity': 'except percentage amountsAntares AJ-26 program\\t \\t \\t \\t \\t Net sales\\t$\\t2.2', 'category': 'MONEY'}, {'entity': '7.9', 'category': 'MONEY'}, {'entity': '10.1\\tCost of sales - benefit expense\\t10.3', 'category': 'MONEY'}, {'entity': '40.2', 'category': 'MONEY'}, {'entity': '50.5\\tGross contract profit loss\\t$\\t8.1', 'category': 'MONEY'}, {'entity': '32.3\\t\\t \\t$\\t40.4\\tGross contract profit loss as a percentage of net sales\\t0.5\\t%', 'category': 'MONEY'}, {'entity': '2.0\\t%\\t ** Primary reason for change. The increase in cost of sales excluding retirement benefit expense and step-up in fair value of inventory as a percentage of net sales was primarily due to $23.6 million of cost growth in fiscal 2014 on the Antares AJ-26 program, including the cost to repair or replace engines as necessary in light of the previously reported engine test failures', 'category': 'MONEY'}, {'entity': 'an associated increase in hardware inspections and corrective actions on remaining engines', 'category': 'MONEY'}, {'entity': 'costs to repair the damaged test stand', 'category': 'MONEY'}, {'entity': 'costs resulting from delayed deliveries', 'category': 'MONEY'}, {'entity': 'AR1 Research and Development \"R&D\"\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t \\tYear Ended\\t \\t \\t \\tYear Ended\\t \\t  \\t2015', 'category': 'MONEY'}, {'entity': '2014', 'category': 'MONEY'}, {'entity': 'Change*\\t \\t2014', 'category': 'MONEY'}, {'entity': '2013', 'category': 'MONEY'}, {'entity': 'Change** \\tIn millions', 'category': 'MONEY'}, {'entity': 'except percentage amountsAR1 R&D\\t$\\t32.1', 'category': 'MONEY'}, {'entity': '—', 'category': 'MONEY'}, {'entity': '32.1', 'category': 'MONEY'}, {'entity': '—', 'category': 'MONEY'}, {'entity': '—', 'category': 'MONEY'}, {'entity': '—\\tPercentage of net sales\\t1.9\\t%', 'category': 'MONEY'}, {'entity': '—\\t%\\t \\t \\t \\t—\\t%', 'category': 'MONEY'}, {'entity': '—\\t%\\t \\t  * Primary reason for change. During the third quarter of fiscal 2015', 'category': 'MONEY'}, {'entity': 'we began separately reporting the portion of the engine development expenses associated with our newest liquid booster engine', 'category': 'MONEY'}, {'entity': 'the AR1', 'category': 'MONEY'}, {'entity': 'which are currently not allocated across all contracts and programs in progress under U.S. governmental contractual arrangements', 'category': 'MONEY'}, {'entity': 'additional discussion in Note 1 of the notes to consolidated financial statements.Selling', 'category': 'MONEY'}, {'entity': 'General and Administrative “SG&A”\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t \\tYear Ended\\t \\t \\t \\tYear Ended\\t \\t  \\t2015', 'category': 'MONEY'}, {'entity': '2014', 'category': 'MONEY'}, {'entity': 'Change*\\t \\t2014', 'category': 'MONEY'}, {'entity': '2013', 'category': 'MONEY'}, {'entity': 'Change** \\t \\t \\tAs Restated\\t \\t \\t \\tAs Restated\\t \\t \\t \\t \\tIn millions', 'category': 'MONEY'}, {'entity': 'except percentage amountsSG&A\\t$\\t49.0', 'category': 'MONEY'}, {'entity': '38.2', 'category': 'MONEY'}, {'entity': '10.8', 'category': 'MONEY'}, {'entity': '38.2', 'category': 'MONEY'}, {'entity': '53.6', 'category': 'MONEY'}, {'entity': '15.4\\tPercentage of net sales\\t2.9\\t%', 'category': 'MONEY'}, {'entity': '2.4\\t%\\t \\t \\t \\t2.4\\t%', 'category': 'MONEY'}, {'entity': '3.9\\t%\\t \\t Percentage of net sales excluding retirement benefit expense and stock-based compensation\\t1.3\\t%', 'category': 'MONEY'}, {'entity': '1.3\\t%\\t \\t \\t \\t1.3\\t%', 'category': 'MONEY'}, {'entity': '1.4\\t%\\t \\t Components of SG&A\\t \\t \\t \\t \\t \\t \\t \\t \\t \\t \\t SG&A excluding retirement benefit expense and stock-based compensation\\t$\\t23.0', 'category': 'MONEY'}, {'entity': '21.2', 'category': 'MONEY'}]\n",
      "[{'entity': 'fiscal 2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': 'stock appreciation rights', 'category': 'EVENT'}, {'entity': '$1.9 million$6.5 million$2.4 million$50.0 million$0.9 million$0.2 million$1.9 million$60.6 million$0.5 million$0.1 million$5.0 million$0.1 million$50.4 million$52.7 million$4.0 million', 'category': 'MONEY'}, {'entity': 'Rocketdyne Business', 'category': 'ORG'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'Debentures', 'category': 'ORG'}, {'entity': '15.4', 'category': 'PERCENT'}, {'entity': 'Rocketdyne', 'category': 'PERSON'}, {'entity': 'Rocketdyne Business acquisition', 'category': 'WORK_OF_ART'}, {'entity': '21.2', 'category': 'CARDINAL'}, {'entity': '1.8', 'category': 'CARDINAL'}, {'entity': '21.2', 'category': 'CARDINAL'}, {'entity': '18.7', 'category': 'CARDINAL'}, {'entity': '2.5', 'category': 'CARDINAL'}, {'entity': '8.6', 'category': 'CARDINAL'}, {'entity': '5.7', 'category': 'CARDINAL'}, {'entity': '2.9', 'category': 'CARDINAL'}, {'entity': '5.7', 'category': 'CARDINAL'}, {'entity': '14.1', 'category': 'CARDINAL'}, {'entity': '8.4', 'category': 'CARDINAL'}, {'entity': '17.4', 'category': 'CARDINAL'}, {'entity': '11.3', 'category': 'CARDINAL'}, {'entity': '6.1', 'category': 'CARDINAL'}, {'entity': '11.3', 'category': 'CARDINAL'}, {'entity': '20.8', 'category': 'CARDINAL'}, {'entity': '9.5', 'category': 'CARDINAL'}, {'entity': '49.0', 'category': 'CARDINAL'}, {'entity': '38.2', 'category': 'CARDINAL'}, {'entity': '10.8', 'category': 'CARDINAL'}, {'entity': '38.2', 'category': 'CARDINAL'}, {'entity': '53.6', 'category': 'CARDINAL'}, {'entity': '15.4', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '50', 'category': 'CARDINAL'}, {'entity': '1.4', 'category': 'CARDINAL'}, {'entity': '65.1', 'category': 'CARDINAL'}, {'entity': '63.7', 'category': 'CARDINAL'}, {'entity': '49.8', 'category': 'CARDINAL'}, {'entity': '48.5', 'category': 'CARDINAL'}, {'entity': '35.5', 'category': 'CARDINAL'}, {'entity': '13.0', 'category': 'CARDINAL'}, {'entity': '13.4', 'category': 'CARDINAL'}, {'entity': '13.5', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '6.5', 'category': 'CARDINAL'}, {'entity': '7.0', 'category': 'CARDINAL'}, {'entity': '3.1', 'category': 'CARDINAL'}, {'entity': '65.1', 'category': 'CARDINAL'}, {'entity': '43.5', 'category': 'CARDINAL'}, {'entity': '20.2', 'category': 'CARDINAL'}, {'entity': '69.3', 'category': 'CARDINAL'}, {'entity': '74.5', 'category': 'CARDINAL'}, {'entity': '5.2', 'category': 'CARDINAL'}, {'entity': '33.9', 'category': 'CARDINAL'}, {'entity': '40.6', 'category': 'CARDINAL'}, {'entity': '51.9', 'category': 'CARDINAL'}, {'entity': '61.7', 'category': 'CARDINAL'}, {'entity': '24.5', 'category': 'CARDINAL'}, {'entity': '76.0', 'category': 'CARDINAL'}, {'entity': '1.9', 'category': 'CARDINAL'}, {'entity': '60.6', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '0.5', 'category': 'CARDINAL'}, {'entity': '59.6', 'category': 'CARDINAL'}, {'entity': '119.9', 'category': 'CARDINAL'}, {'entity': '0.3', 'category': 'CARDINAL'}, {'entity': '0.9', 'category': 'CARDINAL'}, {'entity': '20.0', 'category': 'CARDINAL'}, {'entity': '1.4', 'category': 'CARDINAL'}, {'entity': '5.2', 'category': 'CARDINAL'}, {'entity': '10.1', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '0.3', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '50.4', 'category': 'CARDINAL'}, {'entity': '52.7', 'category': 'CARDINAL'}, {'entity': '2.3', 'category': 'CARDINAL'}, {'entity': '47.7', 'category': 'CARDINAL'}, {'entity': '49.1', 'category': 'CARDINAL'}, {'entity': '1.4', 'category': 'CARDINAL'}, {'entity': '4.9', 'category': 'CARDINAL'}, {'entity': '2.7', 'category': 'CARDINAL'}, {'entity': '3.6', 'category': 'CARDINAL'}, {'entity': '0.9', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': 'fiscal 2015', 'category': 'DATE'}, {'entity': 'fiscal 2014', 'category': 'DATE'}, {'entity': '2015', 'category': 'GPE'}, {'entity': '2014', 'category': 'GPE'}, {'entity': '2013', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'state', 'category': 'GPE'}, {'entity': 'Tax Hikes Act of 2015', 'category': 'LANGUAGE'}, {'entity': 'TIONU.S.', 'category': 'LOC'}, {'entity': '$16.8 million', 'category': 'MONEY'}, {'entity': '$33.0 million', 'category': 'MONEY'}, {'entity': '$35.7 million', 'category': 'MONEY'}, {'entity': 'approximately $178.7 million', 'category': 'MONEY'}, {'entity': '$1.1 million', 'category': 'MONEY'}, {'entity': '$102.6 million', 'category': 'MONEY'}, {'entity': '$282.4 million', 'category': 'MONEY'}, {'entity': '$89.0 million', 'category': 'MONEY'}, {'entity': '$16.8 million', 'category': 'MONEY'}, {'entity': '$33.0 million', 'category': 'MONEY'}, {'entity': '$35.7 million', 'category': 'MONEY'}, {'entity': 'Rocketdyne Business', 'category': 'ORG'}, {'entity': 'U.S. government', 'category': 'ORG'}, {'entity': 'Rocketdyne Business', 'category': 'ORG'}, {'entity': 'Rocketdyne acquisition', 'category': 'ORG'}, {'entity': 'U.S.', 'category': 'ORG'}, {'entity': '1.8%', 'category': 'PERCENT'}, {'entity': '49.4%', 'category': 'PERCENT'}, {'entity': '555.7%', 'category': 'PERCENT'}, {'entity': '49.4%', 'category': 'PERCENT'}, {'entity': '555.7%', 'category': 'PERCENT'}, {'entity': '1.8%', 'category': 'PERCENT'}, {'entity': '49.4%', 'category': 'PERCENT'}, {'entity': '35%', 'category': 'PERCENT'}, {'entity': '555.7%', 'category': 'PERCENT'}, {'entity': '35%', 'category': 'PERCENT'}, {'entity': '555.7%', 'category': 'PERCENT'}, {'entity': 'November', 'category': 'PERSON'}, {'entity': '2015', 'category': 'PERSON'}, {'entity': '2014', 'category': 'PERSON'}, {'entity': '2013', 'category': 'PERSON'}, {'entity': 'November', 'category': 'PERSON'}, {'entity': '2015', 'category': 'PERSON'}, {'entity': '2014', 'category': 'PERSON'}, {'entity': '2013', 'category': 'PERSON'}, {'entity': 'Rocketdyne Business', 'category': 'PERSON'}, {'entity': 'Rocketdyne acquisition', 'category': 'PERSON'}, {'entity': 'Effective Tax Rate', 'category': 'PERSON'}, {'entity': 'valuation allowance', 'category': 'PERSON'}, {'entity': 'Rocketdyne Business', 'category': 'PERSON'}, {'entity': 'fiscal 2014', 'category': 'TIME'}, {'entity': 'fiscal 2015', 'category': 'TIME'}, {'entity': 'month', 'category': 'TIME'}, {'entity': 'November 30, 2015', 'category': 'TIME'}, {'entity': '2014', 'category': 'TIME'}, {'entity': 'fiscal 2015', 'category': 'TIME'}, {'entity': 'fiscal 2014', 'category': 'TIME'}, {'entity': 'fiscal 2013', 'category': 'TIME'}, {'entity': 'fiscal 2013', 'category': 'TIME'}, {'entity': 'R&D credit', 'category': 'WORK_OF_ART'}, {'entity': 'bonus\" depreciation', 'category': 'WORK_OF_ART'}, {'entity': '$89.0 million', 'category': 'CARDINAL'}, {'entity': '4 1/16', 'category': 'CARDINAL'}, {'entity': '7 1/8', 'category': 'CARDINAL'}, {'entity': '282.4 million', 'category': 'CARDINAL'}, {'entity': '409.9 million', 'category': 'CARDINAL'}, {'entity': '473.6 million', 'category': 'CARDINAL'}, {'entity': '4 1/16', 'category': 'CARDINAL'}, {'entity': '7 1/8', 'category': 'CARDINAL'}, {'entity': '282.4 million', 'category': 'CARDINAL'}, {'entity': '409.9 million', 'category': 'CARDINAL'}, {'entity': '473.6 million', 'category': 'CARDINAL'}, {'entity': 'fiscal 2015', 'category': 'CARDINAL'}, {'entity': '35.0%', 'category': 'CARDINAL'}, {'entity': 'fiscal 2014', 'category': 'CARDINAL'}, {'entity': 'fiscal 2013', 'category': 'CARDINAL'}, {'entity': '$178.7 million', 'category': 'CARDINAL'}, {'entity': '$1.1 million', 'category': 'CARDINAL'}, {'entity': '$102.6 million', 'category': 'CARDINAL'}, {'entity': '$282.4 million', 'category': 'CARDINAL'}, {'entity': '$282.4 million', 'category': 'CARDINAL'}, {'entity': 'estimated $89.0 million', 'category': 'CARDINAL'}, {'entity': 'estimated $89.0 million', 'category': 'CARDINAL'}, {'entity': '$89.0 million', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'fiscal 2016', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': 'fiscal 2016', 'category': 'DATE'}, {'entity': 'fiscal 2014', 'category': 'DATE'}, {'entity': 'fiscal 2013', 'category': 'DATE'}, {'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'November 30, 2013', 'category': 'DATE'}, {'entity': 'fiscal 2015', 'category': 'DATE'}, {'entity': 'fiscal 2014', 'category': 'DATE'}, {'entity': 'fiscal 2016', 'category': 'DATE'}, {'entity': '$2.7 million', 'category': 'MONEY'}, {'entity': '$3 million', 'category': 'MONEY'}, {'entity': '$2.7 million', 'category': 'MONEY'}, {'entity': '3 million', 'category': 'MONEY'}, {'entity': 'Aerospace and Defense Segment', 'category': 'ORG'}, {'entity': 'Rocketdyne', 'category': 'ORG'}, {'entity': 'Rocketdyne Business', 'category': 'ORG'}, {'entity': 'Rocketdyne Business', 'category': 'ORG'}, {'entity': 'Rocketdyne Business', 'category': 'ORG'}, {'entity': '3.96%', 'category': 'PERCENT'}, {'entity': '4.54%', 'category': 'PERCENT'}, {'entity': '2.9%', 'category': 'PERCENT'}, {'entity': '7.1%', 'category': 'PERCENT'}, {'entity': '11.4%', 'category': 'PERCENT'}, {'entity': '11.1%', 'category': 'PERCENT'}, {'entity': '7.1%', 'category': 'PERCENT'}, {'entity': '6.4%', 'category': 'PERCENT'}, {'entity': '11.1%', 'category': 'PERCENT'}, {'entity': '11.3%', 'category': 'PERCENT'}, {'entity': '$2.7 million', 'category': 'PERSON'}, {'entity': '3 million', 'category': 'PERSON'}, {'entity': '$67 million', 'category': 'PERSON'}, {'entity': '$24.9 million', 'category': 'PERSON'}, {'entity': 'THAAD', 'category': 'PERSON'}, {'entity': 'Antares AJ-26', 'category': 'PERSON'}, {'entity': 'November 30, 2014', 'category': 'TIME'}, {'entity': 'November 30, 2013', 'category': 'TIME'}, {'entity': 'fifth', 'category': 'TIME'}, {'entity': 'November 30, 2014', 'category': 'TIME'}, {'entity': 'November 30, 2013', 'category': 'TIME'}, {'entity': 'November 30, 2014', 'category': 'TIME'}, {'entity': 'November 30, 2013', 'category': 'TIME'}, {'entity': 'November 30, 2014', 'category': 'TIME'}, {'entity': 'November 30, 2013', 'category': 'TIME'}, {'entity': 'November 30, 2014', 'category': 'TIME'}, {'entity': 'November 30, 2013', 'category': 'TIME'}, {'entity': '11.4%', 'category': 'TIME'}, {'entity': '11.1%', 'category': 'TIME'}, {'entity': 'Antares AJ-26', 'category': 'WORK_OF_ART'}, {'entity': '$2.7 million', 'category': 'CARDINAL'}, {'entity': '$3 million', 'category': 'CARDINAL'}, {'entity': '$67 million', 'category': 'CARDINAL'}, {'entity': '$24.9 million', 'category': 'CARDINAL'}, {'entity': '$24.4 million', 'category': 'CARDINAL'}, {'entity': '$14.7 million', 'category': 'CARDINAL'}, {'entity': '$67 million', 'category': 'CARDINAL'}, {'entity': '1,660.0', 'category': 'CARDINAL'}, {'entity': '1,596.0', 'category': 'CARDINAL'}, {'entity': '64.0', 'category': 'CARDINAL'}, {'entity': '1,372.4', 'category': 'CARDINAL'}, {'entity': '223.6', 'category': 'CARDINAL'}, {'entity': '48.9', 'category': 'CARDINAL'}, {'entity': '113.7', 'category': 'CARDINAL'}, {'entity': '64.8', 'category': 'CARDINAL'}, {'entity': '113.7', 'category': 'CARDINAL'}, {'entity': '87.7', 'category': 'CARDINAL'}, {'entity': '26.0', 'category': 'CARDINAL'}, {'entity': '189.2', 'category': 'CARDINAL'}, {'entity': '177.3', 'category': 'CARDINAL'}, {'entity': '11.9', 'category': 'CARDINAL'}, {'entity': '155.6', 'category': 'CARDINAL'}, {'entity': '21.7', 'category': 'CARDINAL'}, {'entity': '16.6', 'category': 'CARDINAL'}, {'entity': '8.8', 'category': 'CARDINAL'}, {'entity': '7.8', 'category': 'CARDINAL'}, {'entity': '8.8', 'category': 'CARDINAL'}, {'entity': '4.6', 'category': 'CARDINAL'}, {'entity': '4.2', 'category': 'CARDINAL'}, {'entity': '50.2', 'category': 'CARDINAL'}, {'entity': '25.2', 'category': 'CARDINAL'}, {'entity': '25.0', 'category': 'CARDINAL'}, {'entity': '25.2', 'category': 'CARDINAL'}, {'entity': '44.2', 'category': 'CARDINAL'}, {'entity': '19.0', 'category': 'CARDINAL'}, {'entity': '50.0', 'category': 'CARDINAL'}, {'entity': '0.9', 'category': 'CARDINAL'}, {'entity': '49.1', 'category': 'CARDINAL'}, {'entity': '0.9', 'category': 'CARDINAL'}, {'entity': '1.6', 'category': 'CARDINAL'}, {'entity': '0.7', 'category': 'CARDINAL'}, {'entity': '12.0', 'category': 'CARDINAL'}, {'entity': '12.0', 'category': 'CARDINAL'}, {'entity': '12.0', 'category': 'CARDINAL'}, {'entity': '5.0', 'category': 'CARDINAL'}, {'entity': '7.0', 'category': 'CARDINAL'}, {'entity': '11.2', 'category': 'CARDINAL'}, {'entity': '13.5', 'category': 'CARDINAL'}, {'entity': '2.3', 'category': 'CARDINAL'}, {'entity': '10.3', 'category': 'CARDINAL'}, {'entity': '3.2', 'category': 'CARDINAL'}, {'entity': '1.0', 'category': 'CARDINAL'}, {'entity': '48.9', 'category': 'CARDINAL'}, {'entity': '113.7', 'category': 'CARDINAL'}, {'entity': '64.8', 'category': 'CARDINAL'}, {'entity': '113.7', 'category': 'CARDINAL'}, {'entity': '87.7', 'category': 'CARDINAL'}, {'entity': '26.0', 'category': 'CARDINAL'}, {'entity': '84.3', 'category': 'CARDINAL'}, {'entity': '80.3', 'category': 'CARDINAL'}, {'entity': '109.7', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '5', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '5', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '2015', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '2015', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '$2.7 million', 'category': 'CARDINAL'}, {'entity': '$3 million', 'category': 'CARDINAL'}, {'entity': '$67 million', 'category': 'CARDINAL'}, {'entity': '24.9 million', 'category': 'CARDINAL'}, {'entity': '$24.4 million', 'category': 'CARDINAL'}, {'entity': '$14.7 million', 'category': 'CARDINAL'}, {'entity': '1,660.0', 'category': 'CARDINAL'}, {'entity': '1,596.0', 'category': 'CARDINAL'}, {'entity': '64.0', 'category': 'CARDINAL'}, {'entity': '1,596.0', 'category': 'CARDINAL'}, {'entity': '1,372.4', 'category': 'CARDINAL'}, {'entity': '223.6', 'category': 'CARDINAL'}, {'entity': '48.9', 'category': 'CARDINAL'}, {'entity': '113.7', 'category': 'CARDINAL'}, {'entity': '64.8', 'category': 'CARDINAL'}, {'entity': '113.7', 'category': 'CARDINAL'}, {'entity': '87.7', 'category': 'CARDINAL'}, {'entity': '26.0', 'category': 'CARDINAL'}, {'entity': '189.2', 'category': 'CARDINAL'}, {'entity': '177.3', 'category': 'CARDINAL'}, {'entity': '11.9', 'category': 'CARDINAL'}, {'entity': '155.6', 'category': 'CARDINAL'}, {'entity': '21.7', 'category': 'CARDINAL'}, {'entity': '16.6', 'category': 'CARDINAL'}, {'entity': '8.8', 'category': 'CARDINAL'}, {'entity': '7.8', 'category': 'CARDINAL'}, {'entity': '8.8', 'category': 'CARDINAL'}, {'entity': '4.6', 'category': 'CARDINAL'}, {'entity': '4.2', 'category': 'CARDINAL'}, {'entity': '50.2', 'category': 'CARDINAL'}, {'entity': '25.2', 'category': 'CARDINAL'}, {'entity': '25.0', 'category': 'CARDINAL'}, {'entity': '25.2', 'category': 'CARDINAL'}, {'entity': '44.2', 'category': 'CARDINAL'}, {'entity': '19.0', 'category': 'CARDINAL'}, {'entity': '50.0', 'category': 'CARDINAL'}, {'entity': '0.9', 'category': 'CARDINAL'}, {'entity': '49.1', 'category': 'CARDINAL'}, {'entity': '0.9', 'category': 'CARDINAL'}, {'entity': '1.6', 'category': 'CARDINAL'}, {'entity': '0.7', 'category': 'CARDINAL'}, {'entity': '12.0', 'category': 'CARDINAL'}, {'entity': '12.0', 'category': 'CARDINAL'}, {'entity': '12.0', 'category': 'CARDINAL'}, {'entity': '5.0', 'category': 'CARDINAL'}, {'entity': '7.0', 'category': 'CARDINAL'}, {'entity': '11.2', 'category': 'CARDINAL'}, {'entity': '13.5', 'category': 'CARDINAL'}, {'entity': '2.3', 'category': 'CARDINAL'}, {'entity': '10.3', 'category': 'CARDINAL'}, {'entity': '3.2', 'category': 'CARDINAL'}, {'entity': '1.0', 'category': 'CARDINAL'}, {'entity': '48.9', 'category': 'CARDINAL'}, {'entity': '113.7', 'category': 'CARDINAL'}, {'entity': '64.8', 'category': 'CARDINAL'}, {'entity': '113.7', 'category': 'CARDINAL'}, {'entity': '87.7', 'category': 'CARDINAL'}, {'entity': '26.0', 'category': 'CARDINAL'}, {'entity': '84.3', 'category': 'CARDINAL'}, {'entity': '80.3', 'category': 'CARDINAL'}, {'entity': '109.7', 'category': 'CARDINAL'}]\n",
      "[{'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '$681.9 million', 'category': 'MONEY'}, {'entity': '$71.9 million', 'category': 'MONEY'}, {'entity': '$1.6 billion', 'category': 'MONEY'}, {'entity': '$57.0 million', 'category': 'MONEY'}, {'entity': '$46.7 million', 'category': 'MONEY'}, {'entity': '$10.3 million', 'category': 'MONEY'}, {'entity': '$40.0 million', 'category': 'MONEY'}, {'entity': '$9.0 million', 'category': 'MONEY'}, {'entity': '$30.6 million', 'category': 'MONEY'}, {'entity': '$1.3 million', 'category': 'MONEY'}, {'entity': 'AR1', 'category': 'ORG'}, {'entity': 'U.S.', 'category': 'ORG'}, {'entity': 'Rocketdyne', 'category': 'ORG'}, {'entity': 'Antares AJ-26', 'category': 'ORG'}, {'entity': 'AJ60', 'category': 'ORG'}, {'entity': 'THAAD', 'category': 'ORG'}, {'entity': 'Orion', 'category': 'ORG'}, {'entity': 'Standard Missile', 'category': 'ORG'}, {'entity': 'TDACS', 'category': 'ORG'}, {'entity': 'T3 IIA', 'category': 'ORG'}, {'entity': 'T3 IIB', 'category': 'ORG'}, {'entity': 'Antares', 'category': 'ORG'}, {'entity': 'November 30', 'category': 'ORG'}, {'entity': '2015', 'category': 'ORG'}, {'entity': 'November 30', 'category': 'ORG'}, {'entity': '2014', 'category': 'ORG'}, {'entity': 'Hillsborough', 'category': 'ORG'}, {'entity': 'Adjusted EBITDAP', 'category': 'ORG'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '8.1', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '2.4', 'category': 'CARDINAL'}, {'entity': '2.2', 'category': 'CARDINAL'}, {'entity': '0.9', 'category': 'CARDINAL'}, {'entity': '4.1', 'category': 'CARDINAL'}, {'entity': '$333.0 million', 'category': 'CARDINAL'}, {'entity': '$110.9 million', 'category': 'CARDINAL'}, {'entity': '700', 'category': 'CARDINAL'}, {'entity': '550', 'category': 'CARDINAL'}, {'entity': '$6.7 million', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'fiscal 2015', 'category': 'DATE'}, {'entity': 'fiscal 2014', 'category': 'DATE'}, {'entity': 'fiscal 2013', 'category': 'DATE'}, {'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'Adjusted EBITDAP', 'category': 'EVENT'}, {'entity': 'product launch', 'category': 'EVENT'}, {'entity': 'Aerojet Rocketdyne', 'category': 'FAC'}, {'entity': 'Aerojet Rocketdyne', 'category': 'FAC'}, {'entity': 'Northrop Agreement', 'category': 'FAC'}, {'entity': 'Northrop', 'category': 'GPE'}, {'entity': 'Northrop', 'category': 'GPE'}, {'entity': 'millions', 'category': 'LANGUAGE'}, {'entity': 'millions', 'category': 'LANGUAGE'}, {'entity': '1', 'category': 'LANGUAGE'}, {'entity': 'millions', 'category': 'LANGUAGE'}, {'entity': 'millions', 'category': 'LANGUAGE'}, {'entity': 'millions', 'category': 'LANGUAGE'}, {'entity': 'millions', 'category': 'LANGUAGE'}, {'entity': 'millions', 'category': 'LANGUAGE'}, {'entity': 'millions', 'category': 'LANGUAGE'}, {'entity': 'GAAP', 'category': 'LAW'}, {'entity': 'Sacramento', 'category': 'LOC'}, {'entity': 'BPOU', 'category': 'LOC'}, {'entity': '$16.8', 'category': 'MONEY'}, {'entity': '33.0', 'category': 'MONEY'}, {'entity': '35.7', 'category': 'MONEY'}, {'entity': '50.4', 'category': 'MONEY'}, {'entity': '52.7', 'category': 'MONEY'}, {'entity': '48.7', 'category': 'MONEY'}, {'entity': '0.3', 'category': 'MONEY'}, {'entity': '0.1', 'category': 'MONEY'}, {'entity': '0.2', 'category': 'MONEY'}, {'entity': '65.1', 'category': 'MONEY'}, {'entity': '63.7', 'category': 'MONEY'}, {'entity': '43.5', 'category': 'MONEY'}, {'entity': '67.6', 'category': 'MONEY'}, {'entity': '36.5', 'category': 'MONEY'}, {'entity': '65.0', 'category': 'MONEY'}, {'entity': '51.9', 'category': 'MONEY'}, {'entity': '61.7', 'category': 'MONEY'}, {'entity': '24.5', 'category': 'MONEY'}, {'entity': '217.9', 'category': 'MONEY'}, {'entity': '181.5', 'category': 'MONEY'}, {'entity': '145.8', 'category': 'MONEY'}, {'entity': '28.3', 'category': 'MONEY'}, {'entity': '107.2', 'category': 'MONEY'}, {'entity': '14.2', 'category': 'MONEY'}, {'entity': '652.0', 'category': 'MONEY'}, {'entity': '782.2', 'category': 'MONEY'}, {'entity': '211.1', 'category': 'MONEY'}, {'entity': '265.9', 'category': 'MONEY'}, {'entity': '440.9', 'category': 'MONEY'}, {'entity': '516.3', 'category': 'MONEY'}, {'entity': '5.5', 'category': 'MONEY'}, {'entity': '7.1', 'category': 'MONEY'}, {'entity': '4.9', 'category': 'MONEY'}, {'entity': '153.0', 'category': 'MONEY'}, {'entity': '118.0', 'category': 'MONEY'}, {'entity': '140.1', 'category': 'MONEY'}, {'entity': '183.9', 'category': 'MONEY'}, {'entity': '7.6', 'category': 'MONEY'}, {'entity': '7.8', 'category': 'MONEY'}, {'entity': '13.6', 'category': 'MONEY'}, {'entity': '0.7', 'category': 'MONEY'}, {'entity': '5.2', 'category': 'MONEY'}, {'entity': '6.9', 'category': 'MONEY'}, {'entity': '234.4', 'category': 'MONEY'}, {'entity': '306.1', 'category': 'MONEY'}, {'entity': '457.4', 'category': 'MONEY'}, {'entity': '68.7', 'category': 'MONEY'}, {'entity': 'GAAP', 'category': 'NORP'}, {'entity': 'Non-GAAP', 'category': 'NORP'}, {'entity': 'Adjusted EBITDAP', 'category': 'ORG'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': 'Adjusted EBITDAP', 'category': 'ORG'}, {'entity': 'net loss income', 'category': 'ORG'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': 'free cash flow', 'category': 'ORG'}, {'entity': 'net debt', 'category': 'ORG'}, {'entity': 'Non-GAAP', 'category': 'ORG'}, {'entity': 'company', 'category': 'ORG'}, {'entity': '12.8%', 'category': 'PERCENT'}, {'entity': '11.3%', 'category': 'PERCENT'}, {'entity': '10.6%', 'category': 'PERCENT'}, {'entity': 'As Restated', 'category': 'PERSON'}, {'entity': 'As Restated', 'category': 'PERSON'}, {'entity': 'As Restated', 'category': 'PERSON'}, {'entity': '15 year period', 'category': 'QUANTITY'}, {'entity': 'fiscal 2015', 'category': 'TIME'}, {'entity': 'fiscal 2014', 'category': 'TIME'}, {'entity': 'fiscal 2013', 'category': 'TIME'}, {'entity': 'PRP', 'category': 'WORK_OF_ART'}, {'entity': '1', 'category': 'ORDINAL'}, {'entity': '12.8', 'category': 'CARDINAL'}, {'entity': '11.3', 'category': 'CARDINAL'}, {'entity': '10.6', 'category': 'CARDINAL'}, {'entity': '2015', 'category': 'CARDINAL'}, {'entity': '2014', 'category': 'CARDINAL'}, {'entity': '2013', 'category': 'CARDINAL'}, {'entity': '16.8', 'category': 'CARDINAL'}, {'entity': '33.0', 'category': 'CARDINAL'}, {'entity': '35.7', 'category': 'CARDINAL'}, {'entity': '50.4', 'category': 'CARDINAL'}, {'entity': '52.7', 'category': 'CARDINAL'}, {'entity': '48.7', 'category': 'CARDINAL'}, {'entity': '0.3', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '0.2', 'category': 'CARDINAL'}, {'entity': '65.1', 'category': 'CARDINAL'}, {'entity': '63.7', 'category': 'CARDINAL'}, {'entity': '43.5', 'category': 'CARDINAL'}, {'entity': '67.6', 'category': 'CARDINAL'}, {'entity': '36.5', 'category': 'CARDINAL'}, {'entity': '65.0', 'category': 'CARDINAL'}, {'entity': '51.9', 'category': 'CARDINAL'}, {'entity': '61.7', 'category': 'CARDINAL'}, {'entity': '24.5', 'category': 'CARDINAL'}, {'entity': '217.9', 'category': 'CARDINAL'}, {'entity': '181.5', 'category': 'CARDINAL'}, {'entity': '145.8', 'category': 'CARDINAL'}, {'entity': '28.3', 'category': 'CARDINAL'}, {'entity': '107.2', 'category': 'CARDINAL'}, {'entity': '14.2', 'category': 'CARDINAL'}, {'entity': '652.0', 'category': 'CARDINAL'}, {'entity': '782.2', 'category': 'CARDINAL'}, {'entity': '211.1', 'category': 'CARDINAL'}, {'entity': '265.9', 'category': 'CARDINAL'}, {'entity': '440.9', 'category': 'CARDINAL'}, {'entity': '516.3', 'category': 'CARDINAL'}, {'entity': '5.5', 'category': 'CARDINAL'}, {'entity': '7.1', 'category': 'CARDINAL'}, {'entity': '4.9', 'category': 'CARDINAL'}, {'entity': '153.0', 'category': 'CARDINAL'}, {'entity': '118.0', 'category': 'CARDINAL'}, {'entity': '140.1', 'category': 'CARDINAL'}, {'entity': '183.9', 'category': 'CARDINAL'}, {'entity': '7.6', 'category': 'CARDINAL'}, {'entity': '7.8', 'category': 'CARDINAL'}, {'entity': '13.6', 'category': 'CARDINAL'}, {'entity': '0.7', 'category': 'CARDINAL'}, {'entity': '5.2', 'category': 'CARDINAL'}, {'entity': '6.9', 'category': 'CARDINAL'}, {'entity': '234.4', 'category': 'CARDINAL'}, {'entity': '306.1', 'category': 'CARDINAL'}, {'entity': '457.4', 'category': 'CARDINAL'}, {'entity': '68.7', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'November 30, 2012', 'category': 'DATE'}, {'entity': 'November 30, 2013', 'category': 'DATE'}, {'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': 'ORG', 'category': 'DATE'}, {'entity': 'and PERCENT. Therefore', 'category': 'DATE'}, {'entity': 'these categories are not displayed in the final output.', 'category': 'DATE'}, {'entity': '$140.5', 'category': 'MONEY'}, {'entity': '$31.2', 'category': 'MONEY'}, {'entity': '$10.8', 'category': 'MONEY'}, {'entity': '15.0', 'category': 'MONEY'}, {'entity': '176.6', 'category': 'MONEY'}, {'entity': '$33.7', 'category': 'MONEY'}, {'entity': 'AerojetRocketdyne-Sacramento', 'category': 'ORG'}, {'entity': 'AerojetRocketdyne-BPOU', 'category': 'ORG'}, {'entity': 'OtherAerojetRocketdyneSites', 'category': 'ORG'}, {'entity': 'TotalAerojetRocketdyne', 'category': 'ORG'}, {'entity': 'The Atlantic Research Corporation “ARC” propulsion business', 'category': 'ORG'}, {'entity': 'ARC', 'category': 'ORG'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '9.8', 'category': 'CARDINAL'}, {'entity': '5.1', 'category': 'CARDINAL'}, {'entity': '0.1', 'category': 'CARDINAL'}, {'entity': '15.0', 'category': 'CARDINAL'}, {'entity': '22.3', 'category': 'CARDINAL'}, {'entity': '9.4', 'category': 'CARDINAL'}, {'entity': '2.7', 'category': 'CARDINAL'}, {'entity': '34.4', 'category': 'CARDINAL'}, {'entity': '21.6', 'category': 'CARDINAL'}, {'entity': '11.3', 'category': 'CARDINAL'}, {'entity': '2.3', 'category': 'CARDINAL'}, {'entity': '35.3', 'category': 'CARDINAL'}, {'entity': '$176.6', 'category': 'CARDINAL'}, {'entity': '18.8', 'category': 'CARDINAL'}, {'entity': '6.6', 'category': 'CARDINAL'}, {'entity': '4.4', 'category': 'CARDINAL'}, {'entity': '2.3', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '4.0', 'category': 'CARDINAL'}, {'entity': '176.0', 'category': 'CARDINAL'}, {'entity': '0.6', 'category': 'CARDINAL'}, {'entity': '20.0', 'category': 'CARDINAL'}, {'entity': '18.5', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '189.7', 'category': 'CARDINAL'}, {'entity': '113.2', 'category': 'CARDINAL'}, {'entity': '76.5', 'category': 'CARDINAL'}, {'entity': '68.7', 'category': 'CARDINAL'}, {'entity': '7.8', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'November 30, 2012', 'category': 'DATE'}, {'entity': 'November 30, 2013', 'category': 'DATE'}, {'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': 'Fiscal 2015', 'category': 'DATE'}, {'entity': 'Fiscal 2014', 'category': 'DATE'}, {'entity': 'Fiscal 2013', 'category': 'DATE'}, {'entity': 'Year Ended 2015', 'category': 'DATE'}, {'entity': 'Year Ended 2014', 'category': 'DATE'}, {'entity': 'Year Ended 2013', 'category': 'DATE'}, {'entity': 'BPOU site', 'category': 'FAC'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': 'Camden, Arkansas', 'category': 'LOC'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': 'U.S. Government', 'category': 'ORG'}, {'entity': 'Northrop', 'category': 'ORG'}, {'entity': '15%', 'category': 'PERCENT'}, {'entity': 'Northrop', 'category': 'PERSON'}, {'entity': 'Aerospace', 'category': 'PRODUCT'}, {'entity': 'Defense', 'category': 'PRODUCT'}, {'entity': '24%', 'category': 'QUANTITY'}, {'entity': '5PM', 'category': 'TIME'}, {'entity': '7PM', 'category': 'TIME'}, {'entity': '111.5', 'category': 'CARDINAL'}, {'entity': '94.0', 'category': 'CARDINAL'}, {'entity': '205.5', 'category': 'CARDINAL'}, {'entity': '8.7', 'category': 'CARDINAL'}, {'entity': '22.6', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '1.6', 'category': 'CARDINAL'}, {'entity': '2.7', 'category': 'CARDINAL'}, {'entity': '99.2', 'category': 'CARDINAL'}, {'entity': '87.9', 'category': 'CARDINAL'}, {'entity': '187.1', 'category': 'CARDINAL'}, {'entity': '21.4', 'category': 'CARDINAL'}, {'entity': '23.2', 'category': 'CARDINAL'}, {'entity': '31.0', 'category': 'CARDINAL'}, {'entity': '1.7', 'category': 'CARDINAL'}, {'entity': '5.4', 'category': 'CARDINAL'}, {'entity': '7.1', 'category': 'CARDINAL'}, {'entity': '99.1', 'category': 'CARDINAL'}, {'entity': '82.3', 'category': 'CARDINAL'}, {'entity': '181.4', 'category': 'CARDINAL'}, {'entity': '133.6', 'category': 'CARDINAL'}, {'entity': '27.2', 'category': 'CARDINAL'}, {'entity': '4.0', 'category': 'CARDINAL'}, {'entity': '21.1', 'category': 'CARDINAL'}, {'entity': '4.3', 'category': 'CARDINAL'}, {'entity': '25.4', 'category': 'CARDINAL'}, {'entity': '226.6', 'category': 'CARDINAL'}, {'entity': '76.5', 'category': 'CARDINAL'}, {'entity': '303.1', 'category': 'CARDINAL'}, {'entity': '133.6', 'category': 'CARDINAL'}, {'entity': '10.5', 'category': 'CARDINAL'}, {'entity': '10.2', 'category': 'CARDINAL'}, {'entity': '3.9', 'category': 'CARDINAL'}, {'entity': '13.4', 'category': 'CARDINAL'}, {'entity': '31.2', 'category': 'CARDINAL'}, {'entity': '13.8', 'category': 'CARDINAL'}, {'entity': '6.8', 'category': 'CARDINAL'}, {'entity': '3.4', 'category': 'CARDINAL'}, {'entity': '2.8', 'category': 'CARDINAL'}, {'entity': '1.1', 'category': 'CARDINAL'}, {'entity': '3.3', 'category': 'CARDINAL'}, {'entity': '31.2', 'category': 'CARDINAL'}, {'entity': '25.4', 'category': 'CARDINAL'}, {'entity': '21.4', 'category': 'CARDINAL'}, {'entity': '5.1', 'category': 'CARDINAL'}, {'entity': '3.7', 'category': 'CARDINAL'}, {'entity': '2.5', 'category': 'CARDINAL'}, {'entity': '1.9', 'category': 'CARDINAL'}, {'entity': '1.5', 'category': 'CARDINAL'}, {'entity': '6.7', 'category': 'CARDINAL'}, {'entity': '31.0', 'category': 'CARDINAL'}, {'entity': '12.6', 'category': 'CARDINAL'}, {'entity': '8.1', 'category': 'CARDINAL'}, {'entity': '2.7', 'category': 'CARDINAL'}, {'entity': '1.7', 'category': 'CARDINAL'}, {'entity': '1.3', 'category': 'CARDINAL'}, {'entity': '4.6', 'category': 'CARDINAL'}, {'entity': '31.0', 'category': 'CARDINAL'}, {'entity': '8.7', 'category': 'CARDINAL'}, {'entity': '3.9', 'category': 'CARDINAL'}, {'entity': '2.6', 'category': 'CARDINAL'}, {'entity': '0.9', 'category': 'CARDINAL'}, {'entity': '1.3', 'category': 'CARDINAL'}, {'entity': '30.5', 'category': 'CARDINAL'}, {'entity': '176.6', 'category': 'CARDINAL'}, {'entity': '33.7', 'category': 'CARDINAL'}, {'entity': '18.8', 'category': 'CARDINAL'}, {'entity': '65.1', 'category': 'CARDINAL'}, {'entity': '150.6', 'category': 'CARDINAL'}, {'entity': '77.4', 'category': 'CARDINAL'}, {'entity': '35.8', 'category': 'CARDINAL'}, {'entity': '35.7', 'category': 'CARDINAL'}, {'entity': '474.9', 'category': 'CARDINAL'}, {'entity': '84.1', 'category': 'CARDINAL'}, {'entity': '46.6', 'category': 'CARDINAL'}, {'entity': '433.0', 'category': 'CARDINAL'}, {'entity': '54.8', 'category': 'CARDINAL'}, {'entity': '68.3', 'category': 'CARDINAL'}, {'entity': '35.5', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'fiscal 2014', 'category': 'DATE'}, {'entity': 'fiscal 2013', 'category': 'DATE'}, {'entity': 'fiscal 2015', 'category': 'DATE'}, {'entity': 'November 30,2014', 'category': 'DATE'}, {'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': 'November 30', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': 'Rocketdyne Business integration activities', 'category': 'EVENT'}, {'entity': 'consolidating the Rocketdyne Business facilities', 'category': 'EVENT'}, {'entity': 'ERP implementation', 'category': 'EVENT'}, {'entity': 'purchase price adjustment for the Rocketdyne Business', 'category': 'EVENT'}, {'entity': 'sale of non-core technology', 'category': 'EVENT'}, {'entity': 'repurchased 3.5 million of our common shares', 'category': 'EVENT'}, {'entity': 'fund our tax-qualified defined benefit pension plan', 'category': 'FAC'}, {'entity': 'Eiffel Tower', 'category': 'GPE'}, {'entity': 'Hilton Hotel', 'category': 'GPE'}, {'entity': 'Senior Credit Facility', 'category': 'LAW'}, {'entity': 'Subordinated Credit Facility', 'category': 'LAW'}, {'entity': 'Cupertino', 'category': 'LOC'}, {'entity': 'California', 'category': 'LOC'}, {'entity': 'Paris', 'category': 'LOC'}, {'entity': 'United States', 'category': 'LOC'}, {'entity': '$132.7 million', 'category': 'MONEY'}, {'entity': '$69.6 million', 'category': 'MONEY'}, {'entity': '$96.9 million', 'category': 'MONEY'}, {'entity': '$4.9 million', 'category': 'MONEY'}, {'entity': '$77.4 million', 'category': 'MONEY'}, {'entity': '$96.0 million', 'category': 'MONEY'}, {'entity': '$36.8 million', 'category': 'MONEY'}, {'entity': '$43.4 million', 'category': 'MONEY'}, {'entity': '$63.2 million', 'category': 'MONEY'}, {'entity': '$11.3 million', 'category': 'MONEY'}, {'entity': '$25.4 million', 'category': 'MONEY'}, {'entity': '$16.4 million', 'category': 'MONEY'}, {'entity': '$0.2 million', 'category': 'MONEY'}, {'entity': '$7.5 million', 'category': 'MONEY'}, {'entity': '$64.5 million', 'category': 'MONEY'}, {'entity': '$189.0 million', 'category': 'MONEY'}, {'entity': '$166.3 million', 'category': 'MONEY'}, {'entity': '$4.2 million', 'category': 'MONEY'}, {'entity': '$460.0 million', 'category': 'MONEY'}, {'entity': '$12.8 million', 'category': 'MONEY'}, {'entity': '$81.2 million', 'category': 'MONEY'}, {'entity': '$0.2 million', 'category': 'MONEY'}, {'entity': '$98.8', 'category': 'MONEY'}, {'entity': '$93.8', 'category': 'MONEY'}, {'entity': '460.0', 'category': 'MONEY'}, {'entity': '133.6', 'category': 'MONEY'}, {'entity': '84.6', 'category': 'MONEY'}, {'entity': '0.2', 'category': 'MONEY'}, {'entity': '89.0', 'category': 'MONEY'}, {'entity': '$76.0', 'category': 'MONEY'}, {'entity': '0.6', 'category': 'MONEY'}, {'entity': '$0.2', 'category': 'MONEY'}, {'entity': '$411.2', 'category': 'MONEY'}, {'entity': '$652.0', 'category': 'MONEY'}, {'entity': '$150.0 million', 'category': 'MONEY'}, {'entity': '$155.9 million', 'category': 'MONEY'}, {'entity': '$23 million', 'category': 'MONEY'}, {'entity': '$4 1/16% Debentures', 'category': 'MONEY'}, {'entity': '7 1/8% Notes', 'category': 'MONEY'}, {'entity': '4 1/16% Debentures', 'category': 'MONEY'}, {'entity': 'Rocketdyne Business', 'category': 'ORG'}, {'entity': '4.77 to 1.00', 'category': 'PERCENT'}, {'entity': '2.21 to 1.00', 'category': 'PERCENT'}, {'entity': '4.50 to 1.00', 'category': 'PERCENT'}, {'entity': 'Rocketdyne Business', 'category': 'PERSON'}, {'entity': 'Note 5', 'category': 'PERSON'}, {'entity': 'November 30', 'category': 'PERSON'}, {'entity': 'Rocketdyne', 'category': 'PERSON'}, {'entity': '3 tickets', 'category': 'QUANTITY'}, {'entity': 'fiscal 2014', 'category': 'TIME'}, {'entity': 'fiscal 2013', 'category': 'TIME'}, {'entity': 'fiscal 2015', 'category': 'TIME'}, {'entity': 'CIP', 'category': 'WORK_OF_ART'}, {'entity': 'AR1 engine development', 'category': 'WORK_OF_ART'}, {'entity': 'cash used for the Rocketdyne Business integration activities', 'category': 'ORDINAL'}, {'entity': 'increase of $96.9 million in cash advances on long-term contracts', 'category': 'ORDINAL'}, {'entity': 'timing of customer payments', 'category': 'ORDINAL'}, {'entity': 'increase in accounts receivables', 'category': 'ORDINAL'}, {'entity': 'timing of sales and billing during the quarter', 'category': 'ORDINAL'}, {'entity': 'increase in accounts payable related to the increase in cost-reimbursable contract sales and timing of payments', 'category': 'ORDINAL'}, {'entity': 'increase in other current liabilities primarily related to the timing of payments', 'category': 'ORDINAL'}, {'entity': '$64.5 million of common shares', 'category': 'ORDINAL'}, {'entity': '3.5 million', 'category': 'CARDINAL'}, {'entity': '4.8 million', 'category': 'CARDINAL'}, {'entity': '25.4 million', 'category': 'CARDINAL'}, {'entity': '16.4 million', 'category': 'CARDINAL'}, {'entity': '460.0 million', 'category': 'CARDINAL'}, {'entity': '411.2 million', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': 'fiscal 2016', 'category': 'DATE'}, {'entity': 'U.S.', 'category': 'LOC'}, {'entity': '$23 million', 'category': 'MONEY'}, {'entity': '44.1 million', 'category': 'MONEY'}, {'entity': '45.5 million', 'category': 'MONEY'}, {'entity': '120.0 million', 'category': 'MONEY'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': '7 1/8% Notes', 'category': 'ORG'}, {'entity': '7.8 million', 'category': 'PERCENT'}, {'entity': 'November 30', 'category': 'TIME'}, {'entity': '2015', 'category': 'TIME'}, {'entity': 'Aerojet Rocketdyne', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '035.8', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'the last three fiscal years', 'category': 'DATE'}, {'entity': 'fiscal 2015', 'category': 'DATE'}, {'entity': '2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}, {'entity': '2013', 'category': 'DATE'}, {'entity': 'research and/or development efforts', 'category': 'EVENT'}, {'entity': 'development effort', 'category': 'EVENT'}, {'entity': 'service or time and material contracts', 'category': 'EVENT'}, {'entity': 'SEC', 'category': 'FAC'}, {'entity': 'GAAP', 'category': 'GPE'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'Close-out activities', 'category': 'LOC'}, {'entity': 'J-2X program', 'category': 'LOC'}, {'entity': 'Antares AJ-26 program', 'category': 'LOC'}, {'entity': '$41.2', 'category': 'MONEY'}, {'entity': '41.2', 'category': 'MONEY'}, {'entity': '9.2', 'category': 'MONEY'}, {'entity': '23.2', 'category': 'MONEY'}, {'entity': '24.7', 'category': 'MONEY'}, {'entity': '5.5', 'category': 'MONEY'}, {'entity': '13.6', 'category': 'MONEY'}, {'entity': '0.40', 'category': 'MONEY'}, {'entity': '0.10', 'category': 'MONEY'}, {'entity': '0.22', 'category': 'MONEY'}, {'entity': '0.16', 'category': 'MONEY'}, {'entity': 'Aerospace and Defense', 'category': 'ORG'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': 'SEC', 'category': 'ORG'}, {'entity': 'Antares', 'category': 'PERSON'}, {'entity': 'AJ-26', 'category': 'PERSON'}, {'entity': '83%', 'category': 'QUANTITY'}, {'entity': '83%', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'U.S.', 'category': 'GPE'}, {'entity': 'September 1, 2015', 'category': 'GPE'}, {'entity': 'September 1, 2014', 'category': 'GPE'}, {'entity': 'DCAA', 'category': 'ORG'}, {'entity': 'contracts', 'category': 'PERSON'}, {'entity': 'management personnel', 'category': 'PERSON'}, {'entity': 'five-year', 'category': 'PERSON'}, {'entity': 'debt', 'category': 'PERSON'}, {'entity': 'equity', 'category': 'PERSON'}, {'entity': 'investors', 'category': 'PERSON'}, {'entity': 'annual basis', 'category': 'TIME'}, {'entity': 'September 1, 2015', 'category': 'TIME'}, {'entity': 'September 1, 2014', 'category': 'TIME'}, {'entity': 'five-year', 'category': 'TIME'}, {'entity': 'valuation date', 'category': 'TIME'}, {'entity': 'Aerospace and Defense', 'category': 'WORK_OF_ART'}, {'entity': 'one', 'category': 'CARDINAL'}, {'entity': 'multiple', 'category': 'CARDINAL'}, {'entity': 'lengthy', 'category': 'CARDINAL'}, {'entity': 'pension', 'category': 'CARDINAL'}, {'entity': 'excess', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'fiscal 2009', 'category': 'DATE'}, {'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': 'December 1, 2015', 'category': 'DATE'}, {'entity': 'U.S.', 'category': 'GPE'}, {'entity': '26.5', 'category': 'MONEY'}, {'entity': '166.1', 'category': 'MONEY'}, {'entity': '11.1', 'category': 'MONEY'}, {'entity': '22.5', 'category': 'MONEY'}, {'entity': '139.6', 'category': 'MONEY'}, {'entity': '1.3', 'category': 'MONEY'}, {'entity': '1.5', 'category': 'MONEY'}, {'entity': 'GAAP', 'category': 'ORG'}, {'entity': 'Notes 9b', 'category': 'PERSON'}, {'entity': '9c', 'category': 'PERSON'}, {'entity': '9c', 'category': 'PERSON'}, {'entity': '9d', 'category': 'PERSON'}, {'entity': '1.5%', 'category': 'TIME'}, {'entity': '8.0%', 'category': 'TIME'}, {'entity': '8.0%', 'category': 'TIME'}, {'entity': 'three years', 'category': 'TIME'}, {'entity': 'Smoothing', 'category': 'WORK_OF_ART'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': '4.26', 'category': 'CARDINAL'}, {'entity': '3.96', 'category': 'CARDINAL'}, {'entity': '3.87', 'category': 'CARDINAL'}, {'entity': '3.54', 'category': 'CARDINAL'}, {'entity': '4.54', 'category': 'CARDINAL'}, {'entity': '3.68', 'category': 'CARDINAL'}, {'entity': '3.98', 'category': 'CARDINAL'}, {'entity': '3.24', 'category': 'CARDINAL'}, {'entity': '8.00', 'category': 'CARDINAL'}, {'entity': '8.00', 'category': 'CARDINAL'}, {'entity': '*', 'category': 'CARDINAL'}, {'entity': '7.0', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': 'November 30, 2014', 'category': 'DATE'}, {'entity': '$652.0 million', 'category': 'MONEY'}, {'entity': '$545.2 million', 'category': 'MONEY'}, {'entity': '6.65%', 'category': 'MONEY'}, {'entity': '3.20%', 'category': 'MONEY'}, {'entity': 'Company', 'category': 'ORG'}, {'entity': 'Senior Credit Facility', 'category': 'ORG'}, {'entity': 'Subordinated Credit Facility', 'category': 'ORG'}, {'entity': 'November 30, 2015', 'category': 'ORG'}, {'entity': 'November 30, 2014', 'category': 'ORG'}, {'entity': '84%', 'category': 'PERCENT'}, {'entity': '16%', 'category': 'PERCENT'}, {'entity': '$93.8', 'category': 'QUANTITY'}, {'entity': '98.8', 'category': 'QUANTITY'}, {'entity': '7 1/8% Notes', 'category': 'QUANTITY'}, {'entity': '480.1', 'category': 'QUANTITY'}, {'entity': '483.6', 'category': 'QUANTITY'}, {'entity': '460.0', 'category': 'QUANTITY'}, {'entity': '460.0', 'category': 'QUANTITY'}, {'entity': '4 1/16% Debentures', 'category': 'QUANTITY'}, {'entity': '164.0', 'category': 'QUANTITY'}, {'entity': '248.2', 'category': 'QUANTITY'}, {'entity': '84.6', 'category': 'QUANTITY'}, {'entity': '133.6', 'category': 'QUANTITY'}, {'entity': 'Delayed draw term loan', 'category': 'QUANTITY'}, {'entity': '13.0', 'category': 'QUANTITY'}, {'entity': '89.0', 'category': 'QUANTITY'}, {'entity': 'Other debt', 'category': 'QUANTITY'}, {'entity': '0.6', 'category': 'QUANTITY'}, {'entity': '0.8', 'category': 'QUANTITY'}, {'entity': 'past three fiscal years', 'category': 'TIME'}, {'entity': 'open markets', 'category': 'WORK_OF_ART'}, {'entity': 'third', 'category': 'ORDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'November 30, 2015', 'category': 'DATE'}, {'entity': '2014', 'category': 'DATE'}]\n",
      "/Users/tanmayiballa/Desktop/KG-LLM/l715_23-1/data/10-Ks/Rocket_Lab_USA_Inc/2022/Management_gpt-3.5-turbo_NER_response.json\n",
      "[{'entity': 'approximately 8,000 kg', 'category': 'PERCENT'}, {'entity': '2021', 'category': 'PERCENT'}, {'entity': '20 successful missions', 'category': 'PERCENT'}, {'entity': '109 spacecraft', 'category': 'PERCENT'}, {'entity': '8,000 kg', 'category': 'PERCENT'}, {'entity': '2029', 'category': 'PERCENT'}, {'entity': '3D printed', 'category': 'PERCENT'}, {'entity': '4th', 'category': 'PERCENT'}, {'entity': '5PM', 'category': 'PERCENT'}, {'entity': '7PM', 'category': 'PERCENT'}, {'entity': 'Neutron', 'category': 'PERCENT'}, {'entity': 'December 31, 2021', 'category': 'PERCENT'}, {'entity': 'second', 'category': 'PERCENT'}, {'entity': 'Rocket Lab', 'category': 'PERCENT'}, {'entity': '8,000 kg', 'category': 'PERCENT'}, {'entity': '8,000 kg', 'category': 'PERCENT'}, {'entity': '2029', 'category': 'PERCENT'}, {'entity': '4', 'category': 'PERCENT'}, {'entity': '8,000 kg', 'category': 'PERCENT'}, {'entity': '109 spacecraft', 'category': 'PERCENT'}, {'entity': '8,000 kg', 'category': 'PERCENT'}, {'entity': '4', 'category': 'PERCENT'}, {'entity': '8,000 kg', 'category': 'PERCENT'}, {'entity': '8,000 kg', 'category': 'PERCENT'}, {'entity': '8,000 kg', 'category': 'PERCENT'}, {'entity': '8,000 kg', 'category': 'PERCENT'}, {'entity': 'Newton 1', 'category': 'PERCENT'}, {'entity': '6', 'category': 'PERCENT'}, {'entity': '2', 'category': 'PERCENT'}, {'entity': '57,505', 'category': 'PERCENT'}, {'entity': '8,000 kg', 'category': 'PERCENT'}, {'entity': '8,000 kg', 'category': 'PERCENT'}, {'entity': '8,000 kg', 'category': 'PERCENT'}]\n",
      "[{'entity': 'August 25, 2021', 'category': 'DATE'}, {'entity': 'October 12, 2021', 'category': 'DATE'}, {'entity': 'November 15, 2021', 'category': 'DATE'}, {'entity': 'December 10, 2021', 'category': 'DATE'}, {'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': 'November 30, 2021', 'category': 'DATE'}, {'entity': 'January 18, 2022', 'category': 'DATE'}, {'entity': 'Cayman Islands', 'category': 'GPE'}, {'entity': 'Delaware', 'category': 'GPE'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'New Zealand', 'category': 'GPE'}, {'entity': 'Vector Delaware', 'category': 'LOC'}, {'entity': 'Legacy Rocket Lab', 'category': 'LOC'}, {'entity': 'ASI Aerospace', 'category': 'LOC'}, {'entity': 'Willis Vern Holdings', 'category': 'LOC'}, {'entity': 'PSC Merger Sub', 'category': 'LOC'}, {'entity': 'Platinum Merger Sub', 'category': 'LOC'}, {'entity': 'Planetary Systems Corporation', 'category': 'LOC'}, {'entity': 'Michael Whalen', 'category': 'LOC'}, {'entity': 'SolAero Merger Sub', 'category': 'LOC'}, {'entity': 'SolAero Holdings', 'category': 'LOC'}, {'entity': 'Fortis Advisors', 'category': 'LOC'}, {'entity': '$40 million', 'category': 'MONEY'}, {'entity': '$5.5 million', 'category': 'MONEY'}, {'entity': '$42 million', 'category': 'MONEY'}, {'entity': '$80 million', 'category': 'MONEY'}, {'entity': '3.6 million', 'category': 'MONEY'}, {'entity': 'Vector Acquisition Corporation', 'category': 'ORG'}, {'entity': 'Vector Delaware', 'category': 'ORG'}, {'entity': 'Rocket Lab USA, Inc', 'category': 'ORG'}, {'entity': 'ASI Aerospace LLC', 'category': 'ORG'}, {'entity': 'Willis Vern Holdings, Inc', 'category': 'ORG'}, {'entity': 'ASI', 'category': 'ORG'}, {'entity': 'John A. Cuseo', 'category': 'ORG'}, {'entity': 'ASI Purchase Agreement', 'category': 'ORG'}, {'entity': 'Platinum Merger Sub, Inc', 'category': 'ORG'}, {'entity': 'Planetary Systems Corporation', 'category': 'ORG'}, {'entity': 'Michael Whalen', 'category': 'ORG'}, {'entity': 'SolAero Merger Sub', 'category': 'ORG'}, {'entity': 'SolAero Holdings, Inc', 'category': 'ORG'}, {'entity': 'Fortis Advisors LLC', 'category': 'ORG'}, {'entity': '6-month anniversary', 'category': 'PERCENT'}, {'entity': '100%', 'category': 'PERCENT'}, {'entity': 'Legacy Rocket Lab', 'category': 'PERSON'}, {'entity': 'Vector Delaware', 'category': 'PERSON'}, {'entity': 'John A. Cuseo', 'category': 'PERSON'}, {'entity': 'Michael Whalen', 'category': 'PERSON'}, {'entity': 'Merger Agreement', 'category': 'WORK_OF_ART'}, {'entity': 'certificate of incorporation', 'category': 'WORK_OF_ART'}, {'entity': 'certificate of corporate domestication', 'category': 'WORK_OF_ART'}, {'entity': 'membership interest purchase agreement', 'category': 'WORK_OF_ART'}, {'entity': 'Agreement and Plan of Merger', 'category': 'WORK_OF_ART'}, {'entity': '100%', 'category': 'CARDINAL'}, {'entity': '1,720,841', 'category': 'CARDINAL'}, {'entity': '956,023', 'category': 'CARDINAL'}, {'entity': '$40 million', 'category': 'CARDINAL'}, {'entity': '$5.5 million', 'category': 'CARDINAL'}, {'entity': '$42 million', 'category': 'CARDINAL'}, {'entity': '$80 million', 'category': 'CARDINAL'}, {'entity': '3.6 million', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 2, 2021', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': 'Auckland', 'category': 'GPE'}, {'entity': 'New Zealand', 'category': 'GPE'}, {'entity': '$62.2 million', 'category': 'MONEY'}, {'entity': '$35.2 million', 'category': 'MONEY'}, {'entity': 'Rocket Lab', 'category': 'ORG'}, {'entity': '77%', 'category': 'PERCENT'}, {'entity': 'Electron', 'category': 'WORK_OF_ART'}, {'entity': 'Photon', 'category': 'WORK_OF_ART'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': '2020', 'category': 'CARDINAL'}, {'entity': '8', 'category': 'CARDINAL'}, {'entity': '2021', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': '$8.1 million', 'category': 'MONEY'}, {'entity': '$5.5 million', 'category': 'MONEY'}, {'entity': '$9.2 million', 'category': 'MONEY'}, {'entity': '$6.5 million', 'category': 'MONEY'}, {'entity': '$241.5 million', 'category': 'MONEY'}]\n",
      "[{'entity': 'Dec 23, 2022', 'category': 'DATE'}, {'entity': 'December 31,20212020', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'December 31, 2020', 'category': 'DATE'}, {'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': 'years', 'category': 'DATE'}, {'entity': '20212020', 'category': 'DATE'}, {'entity': '20212020', 'category': 'DATE'}, {'entity': '20212020', 'category': 'DATE'}, {'entity': '20212020 WORK_OF_ART', 'category': 'DATE'}, {'entity': 'New Landmarks', 'category': 'DATE'}, {'entity': 'Space vehicles', 'category': 'DATE'}, {'entity': 'public buildings', 'category': 'DATE'}, {'entity': 'Corporate Towers', 'category': 'DATE'}, {'entity': 'Financial Centers', 'category': 'DATE'}, {'entity': 'High-rise Buildings', 'category': 'DATE'}, {'entity': 'public art facility', 'category': 'DATE'}, {'entity': 'mid-rise Buildings', 'category': 'DATE'}, {'entity': 'transit art facility. MONEY', 'category': 'DATE'}, {'entity': '$6', 'category': 'DATE'}, {'entity': '117320', 'category': 'DATE'}, {'entity': '101218', 'category': 'DATE'}, {'entity': '15151.5 million', 'category': 'DATE'}, {'entity': '22.6 million', 'category': 'DATE'}, {'entity': '34.4 million', 'category': 'DATE'}, {'entity': '6.4 million', 'category': 'DATE'}, {'entity': 'Launch Services Revenues FAC', 'category': 'EVENT'}, {'entity': 'Space Systems LOC', 'category': 'EVENT'}, {'entity': 'Cupertino', 'category': 'EVENT'}, {'entity': 'California', 'category': 'EVENT'}, {'entity': 'Paris', 'category': 'EVENT'}, {'entity': 'Times Square', 'category': 'EVENT'}, {'entity': 'Eiffel Tower', 'category': 'EVENT'}, {'entity': 'United States PRODUCT', 'category': 'GPE'}, {'entity': 'Launch Services Work_Of_Art', 'category': 'GPE'}, {'entity': 'Business Combination NORP', 'category': 'GPE'}, {'entity': 'COVID-19 TIME', 'category': 'GPE'}, {'entity': 'during', 'category': 'GPE'}, {'entity': 'December 31 ORG', 'category': 'GPE'}, {'entity': 'Hilton Hotel', 'category': 'GPE'}, {'entity': 'Apple', 'category': 'GPE'}, {'entity': 'New Zealand Dollar', 'category': 'GPE'}, {'entity': 'Canadian Dollar', 'category': 'GPE'}, {'entity': 'Public Company', 'category': 'GPE'}, {'entity': 'Neutron', 'category': 'GPE'}, {'entity': 'ASI', 'category': 'GPE'}, {'entity': 'PSC ORDINAL', 'category': 'GPE'}, {'entity': 'fourth', 'category': 'GPE'}, {'entity': 'fourth COST', 'category': 'GPE'}, {'entity': '103%', 'category': 'GPE'}, {'entity': '100.0%', 'category': 'GPE'}, {'entity': '56%', 'category': 'GPE'}, {'entity': '143%', 'category': 'GPE'}, {'entity': '36%', 'category': 'GPE'}, {'entity': '36%', 'category': 'GPE'}, {'entity': '24.6%', 'category': 'GPE'}, {'entity': 'U.S. Dollar LAW', 'category': 'LANGUAGE'}, {'entity': 'fair PERCENT', 'category': 'LANGUAGE'}, {'entity': '33.6%', 'category': 'LANGUAGE'}, {'entity': '15', 'category': 'CARDINAL'}, {'entity': '117320', 'category': 'CARDINAL'}, {'entity': '55', 'category': 'CARDINAL'}, {'entity': '11', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '20', 'category': 'CARDINAL'}, {'entity': '5', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '124840', 'category': 'CARDINAL'}, {'entity': '888', 'category': 'CARDINAL'}, {'entity': '798', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '352', 'category': 'CARDINAL'}, {'entity': '30', 'category': 'CARDINAL'}, {'entity': '13', 'category': 'CARDINAL'}, {'entity': '877', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}, {'entity': '9', 'category': 'CARDINAL'}, {'entity': '0', 'category': 'CARDINAL'}, {'entity': '6', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'June 1, 2024', 'category': 'DATE'}, {'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': 'December 31', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': 'December 31, 2021', 'category': 'DATE'}, {'entity': 'Silicon Valley Bank', 'category': 'FAC'}, {'entity': 'Long Beach', 'category': 'FAC'}, {'entity': 'California', 'category': 'FAC'}, {'entity': 'Mahia', 'category': 'FAC'}, {'entity': 'New Zealand', 'category': 'FAC'}, {'entity': 'the United States', 'category': 'GPE'}, {'entity': 'December 31, 2021', 'category': 'GPE'}, {'entity': 'Long Beach', 'category': 'LOC'}, {'entity': 'California', 'category': 'LOC'}, {'entity': 'Mahia', 'category': 'LOC'}, {'entity': 'New Zealand', 'category': 'LOC'}, {'entity': '$691.0 million', 'category': 'MONEY'}, {'entity': '$1 million', 'category': 'MONEY'}, {'entity': '$3.25 million', 'category': 'MONEY'}, {'entity': '$100 million', 'category': 'MONEY'}, {'entity': '$100.1 million', 'category': 'MONEY'}, {'entity': '$35 million', 'category': 'MONEY'}, {'entity': '$15 million', 'category': 'MONEY'}, {'entity': '$15 million', 'category': 'MONEY'}, {'entity': '$28.1 million', 'category': 'MONEY'}, {'entity': '$92.1 million', 'category': 'MONEY'}, {'entity': '$66.4 million', 'category': 'MONEY'}, {'entity': '$25.7 million', 'category': 'MONEY'}, {'entity': 'Hercules Capital', 'category': 'ORG'}, {'entity': 'Hercules Capital, Inc.', 'category': 'ORG'}, {'entity': 'Silicon Valley Bank', 'category': 'ORG'}, {'entity': 'AS', 'category': 'ORG'}, {'entity': 'PSC', 'category': 'ORG'}, {'entity': 'December 31', 'category': 'PERSON'}, {'entity': 'December 31', 'category': 'PERSON'}, {'entity': 'December 31', 'category': 'PERSON'}, {'entity': 'December 31', 'category': 'PERSON'}, {'entity': 'December 31', 'category': 'PERSON'}, {'entity': 'December 31', 'category': 'PERSON'}, {'entity': 'December 31', 'category': 'PERSON'}, {'entity': 'December 31', 'category': 'PERSON'}, {'entity': 'December 31', 'category': 'PERSON'}, {'entity': 'December 31', 'category': 'PERSON'}, {'entity': 'June 10, 2021', 'category': 'TIME'}, {'entity': 'December 23, 2020', 'category': 'TIME'}, {'entity': 'May 13, 2021', 'category': 'TIME'}, {'entity': 'June 10, 2021', 'category': 'TIME'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2024', 'category': 'CARDINAL'}, {'entity': '15', 'category': 'CARDINAL'}, {'entity': '100', 'category': 'CARDINAL'}, {'entity': '35', 'category': 'CARDINAL'}, {'entity': '121689', 'category': 'CARDINAL'}, {'entity': '128', 'category': 'CARDINAL'}, {'entity': '20212020', 'category': 'CARDINAL'}, {'entity': '71.8', 'category': 'CARDINAL'}, {'entity': '117.3', 'category': 'CARDINAL'}, {'entity': '53.5', 'category': 'CARDINAL'}, {'entity': '8.0', 'category': 'CARDINAL'}, {'entity': '32.6', 'category': 'CARDINAL'}, {'entity': '15.3', 'category': 'CARDINAL'}, {'entity': '10.9', 'category': 'CARDINAL'}, {'entity': '12.7', 'category': 'CARDINAL'}, {'entity': '10.5', 'category': 'CARDINAL'}, {'entity': '7.8', 'category': 'CARDINAL'}, {'entity': '28.1', 'category': 'CARDINAL'}, {'entity': '92.1', 'category': 'CARDINAL'}, {'entity': '66.4', 'category': 'CARDINAL'}, {'entity': '25.7', 'category': 'CARDINAL'}, {'entity': '2.8', 'category': 'CARDINAL'}, {'entity': '15', 'category': 'CARDINAL'}, {'entity': '100.1', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}, {'entity': '3.25', 'category': 'CARDINAL'}, {'entity': '638142', 'category': 'CARDINAL'}, {'entity': '43.761', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'December 31', 'category': 'DATE'}, {'entity': '2021', 'category': 'DATE'}, {'entity': 'EVENT', 'category': 'DATE'}, {'entity': 'FAC', 'category': 'DATE'}, {'entity': 'LANGUAGE', 'category': 'DATE'}, {'entity': 'LAW', 'category': 'DATE'}, {'entity': 'LOC', 'category': 'DATE'}, {'entity': 'NORP', 'category': 'DATE'}, {'entity': 'ORDINAL', 'category': 'DATE'}, {'entity': 'PRODUCT', 'category': 'DATE'}, {'entity': 'QUANTITY', 'category': 'DATE'}, {'entity': 'TIME', 'category': 'DATE'}, {'entity': 'and WORK_OF_ART in the given input. Therefore', 'category': 'DATE'}, {'entity': 'these categories are not mentioned in the final output.', 'category': 'DATE'}, {'entity': 'New Zealand', 'category': 'GPE'}, {'entity': '$799.9 million', 'category': 'MONEY'}, {'entity': '728.3 million', 'category': 'MONEY'}, {'entity': '98.9 million', 'category': 'MONEY'}, {'entity': '$3.1 million', 'category': 'MONEY'}, {'entity': '30.4 million', 'category': 'MONEY'}, {'entity': 'Curie', 'category': 'ORG'}, {'entity': 'a reasonable profit', 'category': 'PERCENT'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '1', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'August 2021', 'category': 'DATE'}, {'entity': 'Dec 23, 2022', 'category': 'DATE'}, {'entity': 'the succeeding 12-month period', 'category': 'DATE'}, {'entity': 'August 2021', 'category': 'DATE'}, {'entity': 'Eiffel Tower', 'category': 'FAC'}, {'entity': 'Hilton Hotel', 'category': 'FAC'}, {'entity': 'Paris', 'category': 'GPE'}, {'entity': 'United States', 'category': 'GPE'}, {'entity': 'Cupertino', 'category': 'LOC'}, {'entity': 'California', 'category': 'LOC'}, {'entity': '$1.5 million', 'category': 'MONEY'}, {'entity': 'Apple', 'category': 'ORG'}, {'entity': 'the Business Combination', 'category': 'ORG'}, {'entity': 'zero', 'category': 'PERCENT'}, {'entity': 'Mary', 'category': 'PERSON'}, {'entity': 'Peter', 'category': 'PERSON'}, {'entity': 'Lisa', 'category': 'PERSON'}, {'entity': '5PM', 'category': 'TIME'}, {'entity': '7PM', 'category': 'TIME'}, {'entity': 'Hamlet', 'category': 'WORK_OF_ART'}, {'entity': 'first', 'category': 'ORDINAL'}, {'entity': '3', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}, {'entity': '2', 'category': 'CARDINAL'}]\n",
      "[{'entity': 'ASC 815-40', 'category': 'LAW'}]\n"
     ]
    }
   ],
   "source": [
    "# cwd = os.getcwd()\n",
    "# pwd = os.path.join(os.path.dirname(cwd), os.path.join('data','10-Ks'))\n",
    "\n",
    "# root_directory = pwd\n",
    "# target_file = 'Management.txt'\n",
    "# gpt_response_file = 'Management_' + str(model) + '_' +str(task) + '_response.json'\n",
    "# gpt_result_file = 'Management_' + str(model) + '_' +str(task) + '_results.json'\n",
    "\n",
    "# for root, directories, files in os.walk(root_directory):\n",
    "#     for directory in directories:\n",
    "#         folder_path = os.path.join(root, directory)\n",
    "#         files = os.listdir(folder_path)\n",
    "#         if gpt_response_file in files:\n",
    "#             entities_dictionary = []\n",
    "#             file_pth = os.path.join(folder_path, gpt_response_file)\n",
    "#             print(file_pth)\n",
    "#             with open(file_pth) as rf:\n",
    "#                 input_ = json.load(rf)\n",
    "#                 for inp in input_:\n",
    "#                     entities_dictionary.extend(to_json_ner(inp))\n",
    "#             output_file_path = os.path.join(folder_path, gpt_result_file)\n",
    "#             with open(output_file_path,\"w\") as jsonfile:\n",
    "#                 try:\n",
    "#                     json.dump(entities_dictionary,jsonfile, indent=4)\n",
    "#                 except(err):\n",
    "#                     print(err)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.6"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
